{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 202,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Requirement already satisfied: pypdf in c:\\linkdin projects\\medical - system\\.venv-old\\lib\\site-packages (6.4.1)\n"
     ]
    }
   ],
   "source": [
    "!pip install pypdf"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 203,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "\n",
    "os.chdir(\"../\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 204,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'c:\\\\'"
      ]
     },
     "execution_count": 204,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 210,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.document_loaders import PyPDFLoader, DirectoryLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "\n",
    "from langchain.document_loaders import TextLoader"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 206,
   "metadata": {},
   "outputs": [],
   "source": [
    "def Extract_Data(pdf_paths):\n",
    "    loader = DirectoryLoader(\n",
    "        pdf_paths,\n",
    "        glob=\"*.pdf\",\n",
    "        loader_cls=PyPDFLoader\n",
    "    )\n",
    "\n",
    "    documents = loader.load()\n",
    "    return documents\n",
    "\n",
    "# def Extract_Data_txt(txt_paths):\n",
    "#     loader = DirectoryLoader(\n",
    "#         txt_paths,\n",
    "#         glob=\"*.txt\",\n",
    "#         loader_cls=TextLoader  # ✔ correct loader for text files\n",
    "#     )\n",
    "#     documents = loader.load()\n",
    "#     return documents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 211,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "PdfReadError(\"Invalid Elementary Object starting with b'P' @21741325: b'6 0 obj<</Universal PDF(The process that creates this PDF constitutes a trade se'\")\n"
     ]
    }
   ],
   "source": [
    "extracted_data=Extract_Data(\"C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\")\n",
    "\n",
    "# extracted_data = Extract_Data(\"C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\")\n",
    "# txt_extracted = Extract_Data_txt('C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Author')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 212,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 0, 'page_label': 'Cover'}, page_content=''),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 1, 'page_label': 'i'}, page_content='Tintinalli’s  \\nEmergency Medicine Manual\\n00_Cydulka_FM.indd   1 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 2, 'page_label': 'ii'}, page_content='Notice\\nMedicine is an ever-changing science. As new research and clinical experience broaden our \\nknowledge, changes in treatment and drug therapy are required. The authors and the pub-\\nlisher of this work have checked with sources believed to be reliable in their efforts to provide \\ninformation that is complete and generally in accord with the standards accepted at the time \\nof publication. However, in view of the possibility of human error or changes in medical \\nsciences, neither the authors nor the publisher nor any other party who has been involved in \\nthe preparation or publication of this work warrants that the information contained herein \\nis in every respect accurate or complete, and they disclaim all responsibility for any errors \\nor omissions or for the results obtained from use of the information contained in this work. \\nReaders are encouraged to confirm the information contained herein with other sources. For \\nexample and in particular, readers are advised to check the product information sheet in-\\ncluded in the package of each drug they plan to administer to be certain that the information \\ncontained in this work is accurate and that changes have not been made in the recommended \\ndose or in the contraindications for administration. This recommendation is of particular \\nimportance in connection with new or infrequently used drugs.\\n00_Cydulka_FM.indd   2 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 3, 'page_label': 'iii'}, page_content='Tintinalli’s  \\nEmergency Medicine Manual \\n8th Edition\\nRita K. Cydulka, MD, MS\\nProfessor, Department of Emergency Medicine\\nAssociate Professor, Department of Biostatistics and Epidemiology\\nCase Western Reserve University\\nMetroHealth Medical Center\\nCleveland, Ohio\\nMichael T. Fitch, MD, PhD\\nProfessor and Vice Chair for Academic Affairs\\nDepartment of Emergency Medicine\\nWake Forest School of Medicine\\nWinston-Salem, North Carolina\\nScott A. Joing, MD\\nAssociate Professor\\nDepartment of Emergency Medicine\\nUniversity of Minnesota Medical School\\nFaculty Physician\\nHennepin County Medical Center\\nMinneapolis, Minnesota\\nVincent J. Wang, MD, MHA\\nProfessor of Clinical Pediatrics\\nKeck School of Medicine of the University of Southern California\\nAssociate Division Head\\nDivision of Emergency Medicine\\nChildren’s Hospital Los Angeles\\nLos Angeles, California\\nDavid M. Cline, MD\\nProfessor and Director of Departmental Research\\nDepartment of Emergency Medicine\\nWake Forest School of Medicine\\nWinston-Salem, North Carolina\\nO. John Ma, MD\\nProfessor and Chair\\nDepartment of Emergency Medicine\\nOregon Health & Science University\\nPortland, Oregon\\nNew Y ork Chicago San Francisco  Athens  London  Madrid  Mexico City\\nMilan  New Delhi  Singapore  Sydney  Toronto\\n00_Cydulka_FM.indd   3 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 4, 'page_label': 'iv'}, page_content='Copyright © 2018 by McGraw-Hill Education. All rights reserved. Except as permit-\\nted under the United States Copyright Act of 1976, no part of this publication may \\nbe reproduced or distributed in any form or by any means, or stored in a database or \\nretrieval system, without the prior written permission of the publisher.\\nISBN: 978-0-07-183704-0\\nMHID: 0-07-183704-3.\\nThe material in this eBook also appears in the print version of this title: ISBN: 978-0-\\n07-183702-6, MHID: 0-07-183702-7.\\neBook conversion by codeMantra\\nVersion 1.0\\nAll trademarks are trademarks of their respective owners. Rather than put a trademark \\nsymbol after every occurrence of a trademarked name, we use names in an editorial \\nfashion only, and to the benefit of the trademark owner, with no intention of infringe-\\nment of the trademark. Where such designations appear in this book, they have been \\nprinted with initial caps.\\nMcGraw-Hill Education eBooks are available at special quantity discounts to use as \\npremiums and sales promotions or for use in corporate training programs. To contact \\na representative, please visit the Contact Us page at www.mhprofessional.com.\\nTERMS OF USE\\nThis is a copyrighted work and McGraw-Hill Education and its licensors reserve all \\nrights in and to the work. Use of this work is subject to these terms. Except as permit-\\nted under the Copyright Act of 1976 and the right to store and retrieve one copy of \\nthe work, you may not decompile, disassemble, reverse engineer, reproduce, modify, \\ncreate derivative works based upon, transmit, distribute, disseminate, sell, publish or \\nsublicense the work or any part of it without McGraw-Hill Education’s prior consent. \\nYou may use the work for your own noncommercial and personal use; any other use \\nof the work is strictly prohibited. Your right to use the work may be terminated if you \\nfail to comply with these terms.\\nTHE WORK IS PROVIDED “AS IS.” McGRAW-HILL EDUCATION AND ITS \\nLICENSORS MAKE NO GUARANTEES OR WARRANTIES AS TO THE ACCU-\\nRACY , ADEQUACY OR COMPLETENESS OF OR RESULTS TO BE OBTAINED \\nFROM USING THE WORK, INCLUDING ANY INFORMATION THAT CAN BE \\nACCESSED THROUGH THE WORK VIA HYPERLINK OR OTHERWISE, AND  \\nEXPRESSLY DISCLAIM ANY WARRANTY , EXPRESS OR IMPLIED, INCLUD-\\nING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABIL -\\nITY OR FITNESS FOR A PARTICULAR PURPOSE. McGraw-Hill Education and \\nits licensors do not warrant or guarantee that the functions contained in the work will \\nmeet your requirements or that its operation will be uninterrupted or error free. Nei-\\nther McGraw-Hill Education nor its licensors shall be liable to you or anyone else for \\nany inaccuracy, error or omission, regardless of cause, in the work or for any damages \\nresulting therefrom. McGraw-Hill Education has no responsibility for the content of \\nany information accessed through the work. Under no circumstances shall McGraw-\\nHill Education and/or its licensors be liable for any indirect, incidental, special, puni-\\ntive, consequential or similar damages that result from the use of or inability to use \\nthe work, even if any of them has been advised of the possibility of such damages. \\nThis limitation of liability shall apply to any claim or cause whatsoever whether such \\nclaim or cause arises in contract, tort or otherwise.'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 5, 'page_label': 'v'}, page_content='v\\nContents\\nContributors xi\\nPreface xix\\nSection 1 Resuscitation Techniques  1\\n 1 Advanced Airway Support   Darren Braude 1\\n 2 Management of Cardiac Rhythm Disturbances   James K. Takayesu 10\\n 3 Resuscitation of Children and Neonates   Marc F. Collin 29\\n 4 Fluids, Electrolytes, and Acid-Base Disorders   Benjamin W. Wachira 37\\n 5 Therapeutic Approach to The Hypotensive Patient   Saurin P . Bhatt 60\\n 6 Anaphylaxis, Acute Allergic Reactions, and Angioedema   Alix L. Mitchell 64\\nSection 2 Analgesia, Anesthesia, and Sedation  67\\n 7 Acute Pain Management and Procedural Sedation   Michael S. Mitchell 67\\n 8 Chronic Pain   David M. Cline 77\\nSection 3 Emergency Wound Management  81\\n 9 Evaluating and Preparing Wounds   Timothy J. Reeder 81\\n 10 Methods for Wound Closure   Corey R. Heitz 85\\n 11 Lacerations to The Face and Scalp   J. Hayes Calvert 96\\n 12 Injuries to the Arm, Hand, Fingertip, and Nail   John Pettey Sandifer 101\\n 13 Lacerations to the Leg and Foot   Moira Davenport 108\\n 14 Soft Tissue Foreign Bodies   Michael T. Fitch 112\\n 15 Puncture Wounds and Bites   Michael T. Fitch 115\\n 16 Postrepair Wound Care   Eugenia B. Quackenbush 121\\nSection 4 Cardiovascular Diseases  125\\n 17 Chest Pain: Cardiac or Not   Andrew Nyce 125\\n 18  Acute Coronary Syndromes: Myocardial Infarction and Unstable \\nAngina   Maame Yaa A. B. Yiadom 131\\n 19 Cardiogenic Shock   Brian Hiestand 138\\n 20 Low-Probability Acute Coronary Syndrome   David A. Wald 141\\n 21 Syncope   Jo Anna Leuck 146\\n 22 Acute Heart Failure   Lori J. Whelan 149\\n 23 Valvular Emergencies   Boyd Burns 152\\n 24  The Cardiomyopathies, Myocarditis, and Pericardial Disease    \\nLorraine Thibodeau 160\\n 25 Venous Thromboembolism   Christopher Kabrhel 167\\n 26 Systemic and Pulmonary Hypertension   Michael Cassara 175\\n 27 Aortic Aneurysms and Aortic Dissection   David E. Manthey 181\\n 28 Arterial Occlusion   Carolyn K. Synovitz 187\\nSection 5 Pulmonary Emergencies  191\\n 29 Respiratory Distress   Baruch S. Fertel 191\\n 30  Bronchitis, Pneumonia, and Novel Respiratory Infections    \\nJeffrey M. Goodloe 199\\n 31 Tuberculosis   Amy J. Behrman 204\\n 32 Spontaneous and Iatrogenic Pneumothorax   Mike Cadogan 208\\n 33 Hemoptysis   Nilesh Patel 211\\n 34 Asthma and Chronic Obstructive Pulmonary Disease   Stacey L. Poznanski 213\\n00_Cydulka_FM.indd   5 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 6, 'page_label': 'vi'}, page_content='Section 6 Gastrointestinal Emergencies  217\\n 35 Acute Abdominal Pain   Bryan E. Baskin 217\\n 36 Nausea and Vomiting   Jonathan A. Maisel 222\\n 37 Disorders Presenting Primarily with Diarrhea   Jonathan A. Maisel 225\\n 38 Acute and Chronic Constipation   Thomas E. Carter 233\\n 39 Gastrointestinal Bleeding   Mitchell C. Sokolosky 237\\n 40 Esophageal Emergencies   Mitchell C. Sokolosky 239\\n 41 Peptic Ulcer Disease and Gastritis   Teresa Bowen-Spinelli 244\\n 42 Pancreatitis and Cholecystitis   Rita K. Cydulka 247\\n 43 Acute Appendicitis   Charles E. Stewart 252\\n 44 Diverticulitis   James O’Neill 256\\n 45 Intestinal Obstruction and Volvulus   Olumayowa U. Kolade 259\\n 46 Hernia in Adults and Children   Louise Finnel 262\\n 47 Anorectal Disorders   Chad E. Branecki 265\\n 48 Jaundice, Hepatic Disorders, and Hepatic Failure   Cem Oktay 273\\n 49 Complications of General Surgical Procedures   Daniel J. Egan 282\\nSection 7 Renal and Genitourinary Disorders  287\\n 50 Acute Kidney Injury   Sum Ambur 287\\n 51 Rhabdomyolysis   Annet Alenyo Ngabirano 292\\n 52 Emergencies in Renal Failure and Dialysis Patients   Jonathan A. Maisel 296\\n 53 Urinary Tract Infections and Hematuria   David R. Lane 299\\n 54 Acute Urinary Retention   Casey Glass 303\\n 55 Male Genital Problems   Gavin R. Budhram 306\\n 56 Urologic Stone Disease   Geetika Gupta 312\\n 57 Complications of Urologic Procedures and Devices   Steven Go 316\\nSection 8 Gynecology and Obstetrics  319\\n 58  Vaginal Bleeding and Pelvic Pain in the Nonpregnant Patient    \\nJoelle Borhart 319\\n 59  Ectopic Pregnancy and Emergencies in The First 20 Weeks of  \\nPregnancy   Robert Jones 323\\n 60 Comorbid Diseases in Pregnancy   Abigail D. Hankin 328\\n 61  Emergencies After 20 Weeks of Pregnancy and The Postpartum \\nPeriod   Kathleen Kerrigan 335\\n 62 Emergency Delivery   Stacie Zelman 340\\n 63 Vulvovaginitis   Robert R. Cooney 344\\n 64 Pelvic Inflammatory Disease   Abigail D. Hankin 347\\n 65 Complications of Gynecologic Procedures   Robert R. Cooney 350\\nSection 9 Pediatrics  353\\n 66 Fever and Serious Bacterial Illness in Children   Todd P . Chang 353\\n 67 Common Neonatal Problems   Lance Brown 361\\n 68 Common Infections of the Ears, Nose, Neck, and Throat   Yu-Tsun Cheng 366\\n 69  Upper Respiratory Emergencies—Stridor and Drooling    \\nChristopher S. Cavagnaro 372\\n 70 Wheezing in Infants and Children   Richard J. Scarfone 379\\n 71 Pneumonia in Infants and Children   Ameer P . Mody 385\\n 72 Pediatric Heart Disease   Garth D. Meckler 388\\n 73 Vomiting and Diarrhea in Infants and Children   Stephen B. Freedman 395\\n 74 Pediatric Abdominal Emergencies   Janet Semple-Hess 400\\n 75 Pediatric Urinary Tract Infections   Marie Waterhouse 407\\n 76 Seizures and Status Epilepticus in Children   Ara Festekjian 409\\n 77 Altered Mental Status and Headache in Children   Carlo Reyes 412\\n 78 Syncope and Sudden Death in Children and Adolescents   Derya Caglar 417\\nvi Contents\\n00_Cydulka_FM.indd   6 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 7, 'page_label': 'vii'}, page_content='79  Hypoglycemia and Metabolic Emergencies in Infants and Children    \\nTeresa J. Riech 420\\n 80 Diabetes in Children   Adam Vella 425\\n 81 Fluid and Electrolyte Therapy in Infants and Children   Ron L. Kaplan 428\\n 82 Musculoskeletal Disorders in Children   Mark X. Cicero 432\\n 83 Rashes in Children   Lance Brown 443\\n 84 Sickle Cell Anemia in Children   Ilene Claudius 455\\n 85 Hematologic-Oncologic Emergencies in Children   Ilene Claudius 461\\n 86 Renal Emergencies in Infants and Children   Saranya Srinivasan 468\\nSection 10 Infectious and Immunologic Diseases  473\\n 87 Sexually Transmitted Infections   Jennifer L. Hannum 473\\n 88 Toxic Shock Syndromes   Sorabh Khandelwal 480\\n 89 Sepsis   John E. Gough 484\\n 90 Soft Tissue Infections   Jon Femling 491\\n 91 Serious Viral Infections   Matthew J. Scholer 497\\n 92 HIV Infection and AIDS   Sarah Battistich 505\\n 93 Infective Endocarditis   Kristin M. Berona 513\\n 94 Tetanus and Rabies   Michael T. Fitch 517\\n 95 Malaria   Jennifer L. Hannum 523\\n 96 Foodborne and Waterborne Diseases   Benjamin Weston 527\\n 97 Zoonotic Infections   David Gordon 531\\n 98 World Travelers   Bret A. Nicks 540\\n 99 The Transplant Patient   Sarah E. Unterman 546\\nSection 11 Toxicology and Pharmacology  555\\n 100 General Management of the Poisoned Patient   L. Keith French 555\\n 101 Anticholinergic Toxicity   O. John Ma 564\\n 102 Psychopharmacologic Agents Shan Yin  566\\n 103 Sedatives and Hypnotics   Shan Yin 574\\n 104 Alcohols   Michael Levine 580\\n 105 Drugs of Abuse   D. Adam Algren 584\\n 106 Analgesics   Joshua N. Nogar 591\\n 107 Xanthines and Nicotine   Robert J. Hoffman 598\\n 108 Cardiac Medications   Michael Levine 602\\n 109 Anticonvulsants   Robert J. Hoffman 613\\n 110 Iron   O. John Ma 617\\n 111 Hydrocarbons and Volatile Substances   Allyson A. Kreshak 621\\n 112 Caustics   Jennifer Cullen 624\\n 113 Pesticides   Charles W. O’Connell 626\\n 114 Metals and Metalloids   D. Adam Algren 631\\n 115 Industrial Toxins   Landen Rentmeester 637\\n 116 Vitamins and Herbals   Janna H. Villano 643\\n 117 Dyshemoglobinemias   Chulathida Chomchai 646\\nSection 12 Environmental Injuries  649\\n 118 Cold Injuries   Gerald (Wook) Beltran 649\\n 119 Heat Emergencies   Eric Kraska 655\\n 120 Bites and Stings   Michael Levine 658\\n 121 Trauma and Envenomation from Marine Fauna   Christian A. Tomaszewski 666\\n 122 High-Altitude Disorders   Shaun D. Carstairs 670\\n 123 Dysbarism and Complications of Diving   Christian A. Tomaszewski 673\\n 124 Near Drowning   Richard A. Walker 675\\n 125 Thermal and Chemical Burns   Sandra L. Werner 678\\n 126 Electrical and Lightning Injuries   Norberto Navarrete 686\\nContents vii \\n00_Cydulka_FM.indd   7 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 8, 'page_label': 'viii'}, page_content='127 Carbon Monoxide   Jon B. Cole 692\\n 128 Mushroom and Plant Poisoning   Chulathida Chomchai 695\\nSection 13 Endocrine Emergencies  701\\n 129 Diabetic Emergencies   Michael P . Kefer 701\\n 130 Alcoholic Ketoacidosis   Michael P . Kefer 709\\n 131 Thyroid Disease Emergencies   Aziz Darawsha 711\\n 132 Adrenal Insufficiency   Michael P . Kefer 715\\nSection 14 Hematologic and Oncologic Emergencies  719\\n 133 Evaluation of Anemia and the Bleeding Patient   Rita K. Cydulka 719\\n 134 Acquired Bleeding Disorders   Alisheba Hurwitz 726\\n 135 Hemophilias and von Willebrand Disease   Colin G. Kaide 729\\n 136 Sickle Cell Disease and Other Hereditary Hemolytic Anemias   Colleen Fant 734\\n 137 Transfusion Therapy   Özlem Köksal 739\\n 138 Anticoagulants, Antiplatelet Agents, and Fibrinolytics   Jessica L. Smith 745\\n 139 Emergency Complications of Malignancy   Ross J. Fleischman 751\\nSection 15 Neurology  759\\n 140 Headache   Steven Go 759\\n 141  Stroke Syndromes and Spontaneous Subarachnoid Hemorrhage    \\nSteven Go 765\\n 142 Altered Mental Status and Coma   C. Crawford Mechem 775\\n 143 Ataxia and Gait Disturbances   Ross J. Fleischman 781\\n 144 Acute Vertigo   Steven Go 784\\n 145 Seizures and Status Epilepticus in Adults   C. Crawford Mechem 792\\n 146 Acute Peripheral Neurologic Lesions   Nicholas E. Kman 796\\n 147 Chronic Neurologic Disorders   Michael T. Fitch 800\\n 148 Central Nervous System and Spinal Infections   Michael T. Fitch 806\\nSection 16 Eye, Ear, Nose, Throat, and Oral Emergencies  813\\n 149 Eye Emergencies   Steven Go 813\\n 150 Face and Jaw Emergencies   Jeffrey G. Norvell 826\\n 151 Ear, Nose, and Sinus Emergencies   Michael E. Vrablik 831\\n 152 Oral and Dental Emergencies   Steven Go 838\\n 153 Neck and Upper Airway Disorders   Rebecca Kornas 845\\nSection 17 Disorders of the Skin  851\\n 154 Dermatologic Emergencies   Jason P . Stopyra 851\\n 155 Other Dermatologic Disorders   Jason P . Stopyra 856\\nSection 18 Trauma  865\\n 156 Trauma in Adults   Rita K. Cydulka 865\\n 157 Trauma in Children   Matthew Hansen 869\\n 158 Trauma in the Elderly   O. John Ma 873\\n 159 Trauma in Pregnancy   John Ashurst 877\\n 160 Head Trauma   O. John Ma 880\\n 161 Spine Trauma   Jeffrey Dan 886\\n 162 Facial Injuries   Gerald (Wook) Beltran 892\\n 163 Neck Injuries   Steven Go 897\\n 164 Cardiothoracic Injuries   Paul Nystrom 903\\n 165 Abdominal Injuries   O. John Ma 909\\n 166 Penetrating Trauma to The Flank and Buttocks   Sum Ambur 914\\n 167 Genitourinary Injuries   Thomas Dalton 916\\nviii Contents\\n00_Cydulka_FM.indd   8 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 9, 'page_label': 'ix'}, page_content='168 Trauma to The Extremities   Amy M. Stubbs 920\\nSection 19 Injuries to the Bones, Joints, and Soft Tissue  923\\n 169  Initial Evaluation and Management of Orthopedic Injuries    \\nGregory M. Johnston 923\\n 170 Hand and Wrist Injuries   Robert R. Cooney 929\\n 171 Forearm and Elbow Injuries   Sandra L. Najarian 934\\n 172 Shoulder and Humerus Injuries   Sandra L. Najarian 942\\n 173 Pelvis, Hip, and Femur Injuries   Jeffrey G. Norvell 949\\n 174 Knee and Leg Injuries   Sandra L. Najarian 956\\n 175 Ankle and Foot Injuries   Sarah Elisabeth Frasure 961\\n 176 Compartment Syndrome   Sandra L. Najarian 966\\nSection 20 Nontraumatic Musculoskeletal Disorders  969\\n 177 Neck and Back Pain   Amy M. Stubbs 969\\n 178 Shoulder Pain   Andrew D. Perron 975\\n 179 Hip and Knee Pain   Augusta Czysz 979\\n 180 Acute Disorders of The Joints and Bursae   Andrew D. Perron 983\\n 181 Emergencies in Systemic Rheumatic Diseases   Nicholas Genes 988\\n 182 Nontraumatic Disorders of The Hand   Michael P . Kefer 995\\n 183 Soft Tissue Problems of The Foot   Gavin R. Budhram 998\\nSection 21 Psychosocial Disorders  1003\\n 184 Clinical Features of Behavioral Disorders   Leslie S. Zun 1003\\n 185  Emergency Assessment and Stabilization of Behavioral Disorders    \\nLeslie S. Zun 1007\\n 186 Panic and Conversion Disorders   Kimberly Nordstrom 1010\\nSection 22 Abuse and Assault  1013\\n 187 Child and Elderly Abuse   Jonathan Glauser 1013\\n 188  Sexual Assault and Intimate Partner Violence and Abuse   Mary Hancock 1016\\nSection 23 Special Situations  1021\\n 189 Palliative Care   Kate Aberger 1021\\nIndex 1025\\nContents ix \\n00_Cydulka_FM.indd   9 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 10, 'page_label': 'x'}, page_content='x\\nContributors\\nKate Aberger, MD FACEP , Medical Director, Palliative Care Division, St. Joseph’s \\nRegional Medical Center, Paterson, New Jersey; Associate Professor of Emergency \\nMedicine, New York Medical College\\nD. Adam Algren, MD, Associate Professor of Emergency Medicine and Pediatrics, \\nTruman Medical Center/Children’s Mercy Kansas City, University of Missouri; Kan-\\nsas City School of Medicine, University of Kansas Hospital Poison Control Center, \\nKansas City, Kansas\\nSum Ambur, MD, FACEP , FAAEM, Emergency Medicine Faculty, Hennepin County \\nMedical Center, Abbott Northwestern Hospital Intensivist, Minneapolis, Minnesota\\nJohn Ashurst, DO, MSc, Kingman Regional Medical Center, Kingman, Arizona\\nBryan E. Baskin, DO, FAAEM, Assistant Professor, Department of Emergency Medi-\\ncine, Case Western Reserve University School of Medicine; Associate Clinical Oper-\\nations Director, Department of Emergency Medicine, MetroHealth Medical System, \\nCleveland, Ohio; Attending Physician, Department of Emergency Medicine, Metro-\\nHealth Medical Center, Cleveland, Ohio\\nSarah Battistich, MD, MSc, DTM&H, Assistant Professor, Liaison, Program for the \\nSurvivors of Torture, Bellevue Hospital, University Department of Emergency Medi-\\ncine, New York\\nAmy J. Behrman, MD, FACOEM, FACP , Associate Professor, Department of Emergen-\\ncy Medicine, Perelman University of Pennsylvania School of Medicine, Philadelphia, \\nPennsylvania\\nGerald (Wook) Beltran, DO, MPH, FACEP , FAEMS, Chief, Department of Emergency \\nMedicine, Division of Prehospital and Disaster Medicine, Baystate Health Systems, \\nSpringfield, Massachusetts\\nKristin M. Berona, MD, Department of Emergency Medicine, Keck School of Medi-\\ncine of USC, LAC + USC Medical Center, Los Angeles, California\\nSaurin P . Bhatt, MD, Center for Emergency Medicine, Cleveland Clinic, Cleveland, \\nOhio\\nJoelle Borhart, MD, FACEP , FAAEM, Assistant Program Director, Assistant Professor \\nof Emergency Medicine, Department of Emergency Medicine, Georgetown Univer -\\nsity Hospital & Washington Hospital Center, Washington, DC\\nChad E. Branecki, MD, FACEP , University of Nebraska Medical Center, Omaha, \\nNebraska\\nDarren Braude, MD, MPH, FACEP , FAEMS, Chief, Division of Prehospital, Austere \\nand Disaster Medicine, Professor of Emergency Medicine, EMS and Anesthesiology, \\nUniversity of New Mexico Health Sciences Center, Albuquerque, New Mexico\\nLance Brown, MD, MPH, Professor of Emergency Medicine and Pediatrics, Loma \\nLinda University School of Medicine, Chief, Division of Pediatric Emergency Med-\\nicine, Loma Linda University Medical Center, Loma Linda University Children’s \\nHospital, Loma Linda, California\\nGavin R. Budhram, MD, Director, Emergency Ultrasound Fellowship, Associate \\nProfessor of Emergency Medicine, Department of Emergency Medicine, Baystate \\nMedical Center, University of Massachusetts Medical School\\n00_Cydulka_FM.indd   10 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 11, 'page_label': 'xi'}, page_content='Contributors  xi \\nBoyd Burns, DO, FACEP , FAAEM, George Kaiser Family Foundation, Chair in Emer-\\ngency Medicine, Associate Professor & Program Director, Department of Emergency \\nMedicine, University of Oklahoma School of Community Medicine, Tulsa, Oklahoma\\nMike Cadogan, FACEM, FFSEM, Emergency Physician, Sir Charles Gairdner Hospital, \\nPerth, Australia\\nDerya Caglar, MD, Associate Professor, Department of Pediatrics, University of \\nWashington School of Medicine; Attending Physician, Seattle Children’s Hospital, \\nSeattle, Washington\\nJ. Hayes Calvert, DO, Department of Emergency Medicine, Wake Forest School of \\nMedicine, Winston-Salem, North Carolina\\nShaun D. Carstairs, MD, FACEP , FACMT, Division of Medical Toxicology, Department \\nof Emergency Medicine, University of California, San Diego, California\\nThomas E. Carter, MD, FACEP , Emergency Consultant, Palmerston North Hospital, \\nPalmerston North, New Zealand; Clinical Associate Professor, Ohio University Heri-\\ntage College of Osteopathic Medicine\\nMichael Cassara, DO, MSEd, FACEP , CHSE, Associate Professor of Emergency Medi-\\ncine, Hofstra Northwell Health School of Medicine; Director of Simulation/Core \\nFaculty, Department of Emergency Medicine, North Shore University Hospital; As-\\nsociate Professor of Nursing, Hofstra Northwell School of Graduate Nursing and \\nPhysician Assistant Studies; Adjunct Associate Professor, Department of Specialized \\nPrograms in Education, Hofstra University School of Education; Medical Director, \\nNorthwell Health Patient Safety Institute/Emergency Medical Institute, Marcus Av-\\nenue Suite, Lake Success, New York\\nChristopher S. Cavagnaro, MD, Attending Physician, Division of Pediatric Emergen-\\ncy Medicine, Children’s Hospital at Montefiore; Assistant Professor, Albert Einstein \\nCollege of Medicine, Bronx, New York\\nTodd P . Chang, MD, MAcM, Director of Research & Scholarship, Pediatric Emergen-\\ncy Medicine; Associate Fellowship Director, Children’s Hospital Los Angeles; As-\\nsociate Professor of Clinical Pediatrics (Educational Scholar), University of Southern \\nCalifornia, Los Angeles, California\\nYu-Tsun Cheng, MD, Rady Children’s Hospital San Diego, University of California, \\nSan Diego, California\\nChulathida Chomchai, MD, Associate Professor of Pediatrics, Mahidol University In-\\nternational College, Bangkok, Thailand\\nMark X. Cicero, MD, Departments of Pediatrics and Emergency Medicine, Yale Uni-\\nversity School of Medicine\\nIlene Claudius, MD, Associate Professor, Department of Emergency Medicine, \\nLAC+USC, Los Angeles, California\\nDavid M. Cline, MD, Professor of Emergency Medicine, Wake Forest School of Medi-\\ncine, Winston-Salem, North Carolina\\nJon B. Cole, MD, FACEP , FACMT, Department of Emergency Medicine, Hennepin \\nCounty Medical Center; Medical Director, Minnesota Poison Control System; As-\\nsociate Professor of Emergency Medicine, University of Minnesota Medical School\\nMarc F. Collin, MD, Associate Professor of Pediatrics, Department of Pediatrics, Case \\nWestern Reserve University School of Medicine; NICU Medical Director, Metro-\\nHealth Medical Center, Cleveland, Ohio\\nRobert R. Cooney, MD, MSMedEd, RDMS, FAAEM, FACEP , Associate Program Direc-\\ntor, Emergency Medicine Residency Program, Geisinger Medical Center, Danville, \\nPennsylvania\\n00_Cydulka_FM.indd   11 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 12, 'page_label': 'xii'}, page_content='Jennifer Cullen, MD, Emergency Medicine Physician, Tri-City Medical Center, San \\nDiego, California\\nRita K. Cydulka, MD, MS, Professor, Department of Emergency Medicine, Case West-\\nern Reserve University, Cleveland, Ohio\\nAugusta Czysz, MD, Conemaugh Memorial Medical Center, Franklin St, Johnstown, \\nPennsylvania\\nThomas Dalton, MD, Clinical Assistant Professor, Department of Emergency Medi-\\ncine, Stanford Medical Center, Standford, California\\nJeffrey Dan, MD, Adjunct Professor, Baystate Medical Center, Tufts University \\nSchool of Medicine, Baystate Medical Center, Springfield, Massachusetts\\nAziz Darawsha, MD, Head of Emergency Medicine Department Hadassah University \\nHospital, Ein Kerem Jerusalem, Israel\\nMoira Davenport, MD, Departments of Emergency Medicine and Orthopaedic Sur -\\ngery, Allegheny General Hospital, Pittsburgh, Pennsylvania; Associate Professor, \\nTemple University School of Medicine\\nDaniel J. Egan, MD, Associate Professor of Emergency Medicine, Icahn School of \\nMedicine at Mount Sinai; Residency Program Director, Mount Sinai St. Lukes and \\nRoosevelt, New York\\nColleen Fant, MD, MPH, Emergency Medicine Fellow, Ann and Robert H. Lurie Chil-\\ndren’s Hospital of Chicago, Chicago, Illinois\\nJon Femling, MD, PhD, Department of Emergency Medicine, University of New \\nMexico, Albuquerque, New Mexico\\nBaruch S. Fertel, MD, MPA, FACEP , Assistant Professor of Medicine, Center for \\nEmergency Medicine; Medical Director Clinical Systems Office, Cleveland Clinic, \\nCleveland, Ohio\\nAra Festekjian, MD, MS, Assistant Professor of Clinical Pediatrics, Keck School of \\nMedicine, University of Southern California, Division of Emergency & Transport \\nMedicine, Children’s Hospital Los Angeles, Los Angeles, California\\nLouise Finnel, MD, Fellow of the Australasian College for Emergency Medicine (FA-\\nCEM), West Melbourne, Victoria, Australia\\nMichael T. Fitch, MD, PhD, Professor and Vice Chair for Academic Affairs Depart-\\nment of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, \\nNorth Carolina\\nRoss J. Fleischman, MD, MCR, Department of Emergency Medicine, Harbor-UCLA \\nMedical Center, Torrance, California\\nSarah Elisabeth Frasure, MD, Clinical Instructor, Department of Emergency Medicine, \\nHarvard Medical School, Brigham and Women’s Hospital, Boston, Massachusetts\\nStephen B. Freedman, MDCM, MSc, Associate Professor of Pediatrics, Alberta \\nChildren’s Hospital, Foundation Professor in Child Health and Wellness, Alberta \\nChildren’s Hospital, Theme Lead, Alberta Children’s Hospital Research Institute, \\nCumming School of Medicine, University of Calgary, Calgary, Albarta, Canada\\nL. Keith French, MD, Adjunct Professor, Oregon Health & Science University, Oregon \\nPoison Center, Portland, Oregon\\nNicholas Genes, MD, PhD, FACEP , Associate Professor, Department of Emergency \\nMedicine, Icahn School of Medicine at Mount Sinai, New York, New York\\nCasey Glass, MD, Assistant Professor, Department of Emergency Medicine, Wake \\nForest School of Medicine, Winston-Salem, North California\\nxii Contributors \\n00_Cydulka_FM.indd   12 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 13, 'page_label': 'xiii'}, page_content='Contributors  xiii \\nJonathan Glauser, MD, FACEP , MBA, Professor, Emergency Medicine, Case Western \\nReserve University, Faculty Residency Program in Emergency Medicine, Metro-\\nHealth Medical Center, Cleveland, Ohio\\nSteven Go, MD, Associate Professor of Emergency Medicine, Department of Emer -\\ngency Medicine, University of Missouri, Kansas City School of Medicine, Kansas \\nCity, Missouri\\nJeffrey M. Goodloe, MD, NRP , FACEP , FAEMS, Professor & EMS Section Chief Direc-\\ntor, Department of Emergency Medicine, Oklahoma Center for Prehospital & Disas-\\nter Medicine, The University of Oklahoma, Norman, Oklahoma\\nDavid Gordon, MD, Associate Professor, Division of Emergency Medicine, Depart-\\nment of Surgery, Duke University, Durham, North Carolina\\nJohn E. Gough, MD, Professor, Department of Emergency Medicine, East Carolina \\nUniversity, Greenville, North Carolina\\nGeetika Gupta, MD, Core Clinical Faculty, St Joseph Mercy Health System, \\nEmergency Medicine Department, University of Michigan Emergency Medicine \\nResidency, Ann Arbor, Michigan\\nMary Hancock, MD, Attending Physician, Emergency Services Institute, Cleveland \\nClinic, Euclid Ave, Cleveland, Ohio\\nAbigail D. Hankin, MD, MPH, Assistant Professor, Emergency Medicine, Emory \\nUniversity, Atlanta, Georgia\\nJennifer L. Hannum, MD, FACEP , Assistant Professor, Department of Emergency Med-\\nicine, Wake Forest School of Medicine, Winston-Salem, North Carolina\\nMatthew Hansen, MD, MCR, Assistant Professor of Emergency Medicine and Pediat-\\nrics, Oregon Health & Science University, Portland, Oregon\\nCorey R. Heitz, MD, Associate Professor of Emergency Medicine, Carilion Clinic, \\nVirginia Tech Carilion School of Medicine, Roanoke, Virginia\\nJanet Semple-Hess, MD, Clinical Assistant Professor of Pediatrics, Keck School \\nof Medicine, University of Southern California, Division of Emergency Medicine, \\nChildren’s Hospital Los Angeles, Los Angeles, California\\nBrian Hiestand, MD, MPH, FACEP , Professor and Vice Chair of Clinical Operations, \\nDepartment of Emergency Medicine, Wake Forest School of Medicine, Winston-\\nSalem, North Carolina\\nRobert J. Hoffman, MD, MS, Attending Physician, Division of Emergency Medicine \\nSidra Medical and Research Center, Doha, Qatar\\nAlisheba Hurwitz, MD, Clinical Assistant Professor of Emergency Medicine, Thomas \\nJefferson University, Philadelphia, Pennsylvania\\nGregory M. Johnston, MD, MS, FACEP , FAAEM, Staff Physician, Department of Emer-\\ngency Medicine, Hunter Holmes McGuire V A Medical Center, Richmond, Virginia\\nRobert Jones, DO, FACEP , Director, Emergency Ultrasound, Director, Emergency Ul-\\ntrasound Fellowship, MetroHealth Medical Center, Cleveland, Ohio; Associate Pro-\\nfessor, Case Western Reserve University, Cleveland, Ohio\\nChristopher Kabrhel, MD, MPH, Director, Department of Emergency Medicine, Cen-\\nter for Vascular Emergencies, Massachusetts General Hospital; Associate Professor \\nof Emergency Medicine, Harvard Medical School, Boston, Massachusetts\\nColin G. Kaide, MD, FACEP , FAAEM, UHM, Associate Professor of Emergency Medi-\\ncine, Department of Emergency Medicine, Board-Certified Specialist in Hyperbaric \\nMedicine, Wexner Medical Center, The Ohio State University, Columbus, Ohio\\n00_Cydulka_FM.indd   13 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 14, 'page_label': 'xiv'}, page_content='Ron L. Kaplan, MD, Associate Professor, Department of Pediatrics, University of \\nWashington School of Medicine; Attending Physician, Emergency Department, Se-\\nattle Children’s Hospital, Seattle, Washington\\nMichael P . Kefer, MD, Attending Physician, Summit Medical Center, Oconomowoc, \\nWisconsin\\nKathleen Kerrigan, MD, FACEP , FACOG, Assistant Professor, Department of Emer -\\ngency Medicine, Baystate Medical Center, Tufts University School of Medicine, \\nSpringfield, Massachusetts\\nSorabh Khandelwal, MD, Samuel J Kiehl Professor in Emergency Medicine, \\nResidency Program Director, Department of Emergency Medicine, Director of \\nthe Patient Care Competency, College of Medicine, The Ohio State University, \\nColumbus, Ohio\\nNicholas E. Kman, MD, FACEP , Director, Part 3, Med 4 Academic Program, Clinical-\\nAssociate Professor of Emergency Medicine, Department of Emergency Medicine, \\nWexner Medical Center, The Ohio State University, Columbus, Ohio\\nOlumayowa U. Kolade, MBBS, FISQua, Fellow, International Society for Quality in \\nHealthcare (ISQua), Dublin, Ireland; Liaison to Nigeria, American College of Emer-\\ngency Physician (ACEP); Medical Officer, University College Hospital, Ibadan, Oyo \\nState, Nigeria\\nRebecca Kornas, MD, Emergency Medicine Specialist, S.C. Milwaukee, Wisconsin; \\nDivision of Medical Toxicology, Department of Emergency Medicine, San Diego \\nSchool of Medicine, University of California, La Jolla, California\\nEric Kraska, MD, CEP America, St Alphonsus Regional Medical Center, Boise, \\nIdaho\\nAllyson A. Kreshak, MD, FACEP , FACMT, Assistant Clinical Professor, Emergency \\nMedicine, University of California, San Diego, California\\nDavid R. Lane, MD, FACEP , Associate Professor of Emergency Medicine, Georgetown \\nUniversity School of Medicine; Vice Chairman, Department of Emergency Medicine, \\nMedStar Southern Maryland Hospital Center, Clinton, Maryland\\nJo Anna Leuck, MD, FACEP , Vice Chair of Academics and the Program Director for \\nthe Department of Emergency Medicine, John Peter Smith Health System in Fort \\nWorth, Texas\\nMichael Levine, MD, Division of Medical Toxicology, Department of Emergency \\nMedicine, University of Southern California, Los Angeles, California\\nO. John Ma, MD, Professor and Chair, Department of Emergency Medicine, Oregon \\nHealth & Science University, Portland, Oregon\\nJonathan A. Maisel, Associate Residency Director, Department of Emergency Medi-\\ncine, Yale EM Residency, Yale University, New Haven, Connecticut\\nDavid E. Manthey, MD, FACEP , FAAEM, Professor of Emergency Medicine, Wake For-\\nest School of Medicine, Winston-Salem, North Carolina\\nC. Crawford Mechem, MD, Professor, Department of Emergency Medicine, Perelman \\nSchool of Medicine at the University of Pennsylvania Hospital, University of Penn-\\nsylvania, Philadelphia, Pennsylvania\\nGarth D. Meckler, MD, MSHS, Associate Professor and Division Head, Pediatric \\nEmergency Medicine, University of British Columbia/BC Children’s Hospital, \\nVancouver, British Columbia\\nAlix L. Mitchell, MD, Attending Physician, MetroHealth Medical Center, Cleveland, \\nOhio; Assistant Professor, Case Western Reserve University, Cleveland, Ohio\\nxiv Contributors \\n00_Cydulka_FM.indd   14 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 15, 'page_label': 'xv'}, page_content='Contributors  xv \\nMichael S. Mitchell, MD, Assistant Professor of Emergency Medicine, Section \\nof Pediatric Emergency Medicine, Wake Forest University School of Medicine, \\nWinston-Salem, North Carolina\\nAmeer P . Mody, MD, MPH, FAAP , Clinical Assistant Professor of Pediatrics, Keck \\nSchool of Medicine, University of Southern California, Division of Emergency \\nMedicine, Children’s Hospital Los Angeles, Los Angeles, California\\nSandra L. Najarian, MD, Assistant Professor, Department of Emergency Medicine, \\nMetroHealth Medical Center, Cleveland, Ohio\\nNorberto Navarrete, MD, MSc, Emergency Physician, Clinical Epidemiology, Burn \\nIntensive Care Unit, Hospital Simón Bolívar, Bogotá, Colombia\\nAnnet Alenyo Ngabirano, MD, Emergency Medicine Registrar, Stellenbosch Univer-\\nsity, Cape Town, South Africa\\nBret A. Nicks, MD, MHA, Professor, Department of Emergency Medicine, Wake \\nForest School of Medicine, Winston-Salem, North Carolina\\nJoshua N. Nogar, MD, Assistant Professor, Emergency Medicine, Assistant Fellow-\\nship Director, Medical Toxicology, Northwell Health, NSUH/LIJ, Hofstra NSUH/LIJ \\nSchool of Medicine, Hempstead, New York\\nKimberly Nordstrom, MD, JD, Medical Director, Office of Behavioral Health, School \\nof Medicine, University of Colorado Denver, Denver, Colorado; Immediate Past-\\nPresident, American Association for Emergency Psychiatry, Parker, Colorado\\nJeffrey G. Norvell, MD, Assistant Professor, Division of Emergency Medicine, Uni-\\nversity of Kansas School of Medicine, Kansas City, Kansas\\nAndrew Nyce, MD, Associate Professor of Emergency Medicine, Cooper Medical \\nSchool of Rowan University, Camden, New Jersey\\nPaul Nystrom, MD, Assistant Professor of Emergency Medicine, University of \\nMinnesota Medical School, Department of Emergency Medicine, Hennepin County \\nMedical Center, Minneapolis, Minnesota\\nCharles W. O’Connell, MD, Clinical Professor, Division of Medical Toxicology, \\nDepartment of Emergency Medicine, University of California, San Diego, Scripps \\nClinical Medical Group, San Diego, California\\nCem Oktay, MD, Akdeniz University School of Medicine, Antalya, Turkey\\nJames O’Neill, MD, Associate Professor, Department of Emergency Medicine, Wake \\nForest School of Medicine, Winston-Salem, North Carolina\\nÖzlem Köksal, MD, PhD, Associate Professor, Department of Emergency Medicine, \\nSchool of Medicine, Uludag University, Bursa, Turkey\\nNilesh Patel, DO, FAAEM, FACOEP , Assistant Professor, Clinical Emergency \\nMedicine, New York Medical College; Program Director, Emergency Medicine, \\nSt. Joseph’s Regional Medical Center, Paterson, New Jersey\\nAndrew D. Perron, MD, FACEP , Professor and Residency Program Director, Depart-\\nment of Emergency Medicine, Maine Medical Center, Portland, Maine\\nStacey L. Poznanski, DO, Med, Associate Professor, Boonshoft School of Medicine, \\nWright State University, Dayton, Ohio\\nEugenia B. Quackenbush, MD, FACEP , Assistant Professor, Department of Emergency \\nMedicine, UNC-Chapel Hill School of Medicine, Chapel Hill, North Carolina\\nTimothy J. Reeder, MD, MPH, Vice Chair for Clinical Operations, Department of \\nEmergency Medicine, Brody School of Medicine East Carolina University; Clinical \\nDirector, Emergency Department, Vidant Medical Center, Greenville, North Carolina\\n00_Cydulka_FM.indd   15 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 16, 'page_label': 'xvi'}, page_content='Landen Rentmeester, MD, Emergency Medicine Specialist, S.C. Milwaukee, Wiscon-\\nsin; Division of Medical Toxicology, Department of Emergency Medicine, San Diego \\nSchool of Medicine, University of California, La Jolla, California\\nCarlo Reyes, MD, Esq, FACEP , FAAP , Vice Chief of Staff, Assistant Medical Direc-\\ntor, Department of Emergency Medicine, Los Robles Hospital and Medical Center, \\nThousand Oaks, California\\nTeresa J. Riech, MD, MPH, Emergency Medicine/Pediatrics, Medical Director, Pedi-\\natric Emergency Department, OSF St. Francis Medical Center, Peoria, Illinois\\nJohn Pettey Sandifer, MD, Associate Professor, Associate Program Director, Department \\nof Emergency Medicine, University of Mississippi Medical Center, Jackson, Mississippi\\nRichard J. Scarfone, MD, Associate Professor of Pediatrics, Perelman School of \\nMedicine, University of Pennsylvania; Medical Director, Disaster Preparedness, The \\nChildren’s Hospital of Philadelphia, Philadelphia, Pennsylvania\\nMatthew J. Scholer, MD, PhD, FACEP , Assistant Professor, Department of Emergency \\nMedicine, University of North Carolina, Chapel Hill, North Carolina\\nJessica L. Smith, MD, FACEP , Residency Program Director, Department of Emergen-\\ncy Medicine, Alpert Medical School of Brown University, Rhode Island Hospital/The \\nMiriam Hospital, Providence, Rhode Island\\nMitchell C. Sokolosky, MD, FACEP , Associate Dean, Graduate Medical Education, AC-\\nGME Designated Institutional Official, Associate Chief Medical Officer, Associate \\nProfessor of Emergency Medicine, Wake Forest Baptist Medical Center, Winston-\\nSalem, North Carolina\\nTeresa Bowen-Spinelli, MD, Clinical Assistant Professor, Department of Emergency \\nMedicine, NYU Lutheran Medical Center, Brooklyn, New York\\nSaranya Srinivasan, MD, Assistant Professor of Pediatrics, Baylor College of Medi-\\ncine, Pediatric Emergency Medicine Attending, Texas Children’s Hospital; Pediatric \\nEmergency Medicine Attending, Memorial Hermann Hospital; Assistant Medical \\nDirector, Houston Fire Department, Houstan, Texas\\nCharles E. Stewart, MD, EMDM, MPH, Emergency Physician, Tulsa, Oklahoma\\nJason P . Stopyra, MD, FACEP , FAEMS, Assistant Professor of Emergency Medicine, \\nDepartment of Emergency Medicine, Wake Forest School of Medicine, Winston-\\nSalem, North Carolina\\nAmy M. Stubbs, MD, Assistant Professor, Residency Program Director, Department \\nof Emergency Medicine, Truman Medical Center - Hospital Hill, University of Mis-\\nsouri-Kansas City School of Medicine, Kansas City, Missouri\\nCarolyn K. Synovitz, MD, MPH, FACEP , Clinical Associate Professor, Department of \\nEmergency Medicine, University of Oklahoma School of Community Medicine, \\nTulsa, Oklahoma\\nJames K. Takayesu, MD, MS, Assistant Residency Director, Harvard-Affiliated Emer-\\ngency Medicine Residency at BWH/MGH; Clerkship Co-Director, MGH, Depart-\\nmental Simulation Officer; Assistant Professor of Emergency Medicine, Harvard \\nMedical School, Boston, Massachusetts\\nLorraine Thibodeau, MD, Director of Undergraduate Medical Education, Department \\nof Emergency Medicine, Albany Medical Center, Albany, New York\\nChristian A. Tomaszewski, MD, MS, MBA, FACEP , FACMT, FIFEM, Professor of Clinical \\nEmergency Medicine, Chief Medical Officer, El Centro Regional Medical Center; \\nAttending in Emergency Medicine, Medical Toxicology, and Hyperbarics, Univer -\\nsity of California San Diego Health Department of Emergency Medicine, San Diego, \\nCalifornia\\nxvi Contributors \\n00_Cydulka_FM.indd   16 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 17, 'page_label': 'xvii'}, page_content='Contributors  xvii \\nSarah E. Unterman, MD, Chief of Emergency Medicine, Jesse Brown V A Medical \\nCenter, Chicago, Illinois; Clinical Assistant Professor, University of Illinois Hospital \\nand Health Sciences System, University of Illinois at Chicago, Chicago, Illinois\\nAdam Vella, MD, Associate Professor, Department of Emergency Medicine, Mount \\nSinai Medical Center, New York, New York\\nJanna H. Villano, MD, Department of Emergency Medicine, Sharp Chula Vista Medi-\\ncal Center, University of California, San Diego, California\\nMichael E. Vrablik, DO, Division of Emergency Medicine, University of Washington \\nSchool of Medicine, Seattle, Washington\\nBenjamin W. Wachira, MD Dip PEC(SA), FCEM(SA), Assistant Professor, The Aga \\nKhan University, Nairobi; Director, Emergency Medicine Kenya Foundation, \\nExecutive Committee Member, African Federation for Emergency Medicine, \\nNairobi, Kenya, Africa\\nDavid A. Wald, DO, Professor of Emergency Medicine, Lewis Katz School of Medi-\\ncine, Philadelphia, Pennsylvania\\nRichard A. Walker , MD, FACEP , FAAEM, Associate Professor of Emergency Medicine \\nUniversity of Nebraska Medical Center Omaha, Nebraska\\nMarie Waterhouse, MD, Clinical Assistant Professor of Pediatrics, Keck School of \\nMedicine, University of Southern California, Division of Emergency Medicine, Chil-\\ndren’s Hospital Los Angeles, Los Angeles, California\\nSandra L. Werner, MD, FACEP , Clinical Operations Director, Associate Director, \\nEmergency Medicine Residency Program, Associate Professor, Case Western Re-\\nserve School of Medicine, MetroHealth Medical Center, Cleveland, Ohio\\nBenjamin Weston, MD, MPH, Assistant Professor, Section of EMS and Disaster Med-\\nicine, Department of Emergency Medicine, Medical College of Wisconsin, Milwau-\\nkee, Wisconsin\\nLori J. Whelan, MD, Vice Chair, OU Department of Emergency Medicine, Associate \\nProfessor & Director of Ultrasound, Associate Program Director, University of Okla-\\nhoma School of Community Medicine, Tulsa, Oklahoma\\nMaame Yaa A. B. Yiadom, MD, MPH, VEMRT-NHLBI K12 Emergency Care Scholar, \\nDirector, The ED Operations Study Group, Assistant Professor, Emergency Medi-\\ncine, Vanderbilt University, Nashville, Tennessee\\nShan Yin, MD, MPH, Assistant Professor of Pediatrics, Division of Emergency Medi-\\ncine, Cincinnati Children’s Hospital, University of Cincinnati School of Medicine; \\nMedical Director, Drug and Poison Information Center, Cincinnati, Ohio\\nStacie Zelman, MD, FACEP , Assistant Professor, Department of Emergency Medicine, \\nWake Forest Baptist Medical Center, Winston-Salem, North Carolina\\nLeslie S. Zun, MD, MBA, President, American Association for Emergency Psychiatry; \\nProfessor and Chair, Department of Emergency Medicine, Professor, Department of \\nPsychiatry, Chicago Medical School, Rosalind Franklin University of Medicine and \\nScience, North Chicago, Illinois; System Chair, Department of Emergency Medicine, \\nSinai Health System, Chicago, Illinois\\n00_Cydulka_FM.indd   17 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 18, 'page_label': 'xviii'}, page_content='xviii\\nPreface\\nPrior to the spring of my third year of medical school, I hadn’t heard of the specialty \\nemergency medicine. I didn’t know where in the medical center our “emergency \\nroom” (ER)1 was and I didn’t know that we had a combined emergency medicine \\n(EM)/internal medicine (IM) residency program. Apparently, they didn’t promote \\nthe program much among the medical students. One day, shortly before I was to \\nbegin my final year of medical school, an EM/IM resident enlightened me and con-\\nvinced me to squeeze an EM elective into my upcoming schedule. Fast forward a \\nfew months, I began my EM rotation and was hooked. On September 21,1979, three \\nweeks into my EM elective, emergency medicine (EM) was recognized as the 23rd \\nAmerican specialty. Yes, I’m that old and so is our specialty.\\nI prepared for my initial EM certification board exams using the first edition of \\nThe Study Guide. It was well written, easy to read, and much shorter than the current \\neighth edition of Tintinalli’s Emergency Medicine Manual, which is derived from the \\neighth edition of Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. \\nWhat a great honor it has been to work with Dr. Tintinalli and to contribute to both \\nher namesake textbook and manual.\\nWhile a single editor compiled Tintinalli’s first Study Guide, the eighth edition \\nof Tintinalli’s Emergency Medicine Manual includes contributors from across the \\nglobe, including several African nations where emergency medicine is an emerg-\\ning specialty. The eighth edition includes “Palliative Care,” which was certainly \\nnot on emergency medicine’s radar in 1979, but is now recognized as a subspe-\\ncialty of our discipline. We continue to publish the Manual in multiple languages \\nfor our readers around the world and hope that the Manual and its online version \\nat accessemergencymedicine.mhmedical.com continues to serve the daily needs of \\nmedical students, residents, advanced practice providers, and practicing emergency \\nphysicians.\\nThe co-editors Michael T. Fitch, Scott Joing, Vincent Wang, David M. Cline, O. \\nJohn Ma, and I would like to thank all the authors for their excellent efforts in writing \\nand updating chapters while also maintaining busy clinical schedules. Thanks, too, \\nto the hardworking crew at McGraw Hill Education for their guidance in taking this \\nproject from draft to publication: Brian Belval, Christie Naglieri, Jessica Gonzalez, \\nJuanita Thompson, and Poonam Bisht. Finally, I am grateful to have had such won-\\nderful team of editors with whom to work. They made publishing this handbook a \\ndelight. Thanks Michael, Scott, Vincent, David, and John.\\nRKC dedicates this book to Marc, Matthew, Lissy, and Noah, as well as to emer -\\ngency care providers around the world; MF dedicates this book to Missy, Mira, and \\nMaya, and in memory of Dr. John Marx; SJ dedicates this book to wonderful Eliza-\\nbeth, Micah, Owen, Britta, and Emmy along with the outstanding Hennepin County \\nMedical Center EM faculty and residents; VW dedicates this book to Esther, Elijah, \\nand Evaline; DMC dedicates this book to family: home, church, and professional; \\nOJM dedicates this book to everyone dedicated to advancing quality of care and pa-\\ntient safety in emergency medicine.\\n1 Prior to becoming known as the Emergency Department (ED), the area was known as the \\nemergency room.\\n00_Cydulka_FM.indd   18 03/05/17   2:16 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 19, 'page_label': '1'}, page_content='1\\nAdvanced Airway Support\\nDarren Braude\\nAirway assessment and management is one of the most critical interven-\\ntions that emergency physicians perform. Intubation is not always neces-\\nsary, however, and rushing into invasive airway management before initial \\nresuscitation can be problematic.\\n■ ■RAPID AIRWAY ASSESSMENT\\nPerform a rapid clinical airway assessment which includes noting the \\npatient’s level of responsiveness, skin color, respiratory rate, and depth of \\nrespirations. Obtain oxygen saturation and capnography unless the patient \\nis in impending or actual cardiac arrest. The goal is to determine if the \\npatient is maintaining and protecting their airway and meeting critical oxy-\\ngenation and ventilation goals. Nothing should be placed in the pharynx to \\nassess gag reflex. Emergent and immediate decisions on airway manage-\\nment may proceed before obtaining blood gases and x-rays.\\n■ ■IMPENDING/ACTUAL CARDIAC ARREST\\nOpen the airway and initiate low-volume ventilation unless following car -\\ndiocerebral resuscitation protocols. The primary focus of initial cardiopul-\\nmonary resuscitation is on establishing quality chest compressions and \\nevaluating for a shockable rhythm. Once these priorities are addressed, the \\nairway can be further managed with an extraglottic device or endotracheal \\nintubation.\\n■ ■BASIC AIRWAY MANAGEMENT\\nPosition the patient to open the airway, drain secretions and maximize oxygen-\\nation and ventilation, while maintaining cervical stabilization precautions if \\nindicated. Place conscious patients in a sitting position, if possible, and \\nunconscious patients on their side unless they require urgent invasive proce-\\ndures. Patients who are unable to maintain an open airway should have one \\nor two properly sized nasal trumpets placed if they are not anticoagulated or \\nat risk for mid-face fractures; an oral airway may be used instead of, or in \\n1\\nCh APTER\\n1\\nSECTION\\nResuscitation Techniques\\n01_Cydulka_Ch01.indd   1 3/6/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 20, 'page_label': '2'}, page_content='2 SECTION 1: Resuscitation Techniques\\naddition to, the nasal airways if no gag reflex present. Provide supplemental \\noxygen if the room air saturation is below 94% with the goal of increasing \\nsaturation to above 94%; high flow oxygen should be avoided when possible.\\n■ ■NONINVASIVE POSITIVE PRESSURE VENTILATION\\nIf ventilation is adequate but oxygenation is poor, consider immediate ini-\\ntiation of noninvasive ventilation. Noninvasive positive pressure ventilation \\n(NIPPV) may be used as a temporizing measure while other treatments are \\ninitiated (e.g., nitrates in acute cardiogenic pulmonary edema), for pre-\\noxygenation prior to intubation in any medical condition, or as an alterna-\\ntive to invasive airway management in some cases, such as in patients with \\nDNR or DNI status. NIPPV for emergency situations is commonly deliv-\\nered via a full-face mask using either continuous positive airway pressure \\n(CPAP) or bilevel positive airway pressure (BPAP) using a ventilator, \\nstand-alone reusable device, or a disposable device (CPAP only). CPAP \\nprovides the same amount of pressure support during inspiration and \\npositive end-expiratory pressure (PEEP) during exhalation—usually 5 to \\n10 mmHg—while BPAP allows for increasing pressure support up to \\n15 mm Hg without overwhelming the patient with expiratory resistance, \\nwhich may remain at 5 to 10 mm Hg. There are no studies showing a \\nsignificant advantage to one system over another.\\n■ ■MASK VENTILATION\\nBegin mask ventilation for patients with poor respiratory effort. Patients \\nshould be placed in a sniffing or ramped position with airway adjuncts as \\npreviously discussed. Apply a properly fitted mask with one provider dedi-\\ncated to maintaining a tight seal while a second provider or mechanical \\nventilator provides just enough volume to raise the chest. Two different hand \\ngrips are described to achieve a mask seal during two-person mask ventila-\\ntion with the “T-E” preferred over the “E-C” in most cases (Fig. 1-1). If you \\nare unable to achieve a tight mask seal consider placing an extraglottic device \\nif there is no gag reflex or other contraindication. If good chest rise is noted \\nbut saturations remain poor despite supplemental oxygen, add PEEP.\\n■ ■EXTRAGLOTTIC DEVICES\\nExtraglottic devices (EGDs) are placed blindly and fit into the following \\ncategory: (1) supraglottic devices that include a mask that sits internally \\nover the glottic opening or (2) retroglottic, dual-balloon devices that sit \\nwithin the proximal esophagus and include distal and proximal balloons to \\ndirect the ventilation that occurs through holes between the two balloons \\ninto the airway. Supraglottic devices include, but are not limited to, the \\nAmbu Auragain®, LMA Supreme®, LMA Protector®, LMA Fastrach, Inter-\\nsurgical iGel®, and CookGas AirQ. Retroglottic devices include the Esoph-\\nageal-Tracheal Combitube, the Rusch EasyTube, and the King Laryngeal \\nTube®. Many of these devices now include a channel for gastric decompres-\\nsion (theoretically lessens the risk of aspiration) and some facilitate blind \\nor endoscopic intubation.\\nExtraglottic devices are most commonly used in the ED after a failed airway \\nbut may also be used primarily during cardiac arrest, for difficult mask \\n01_Cydulka_Ch01.indd   2 3/6/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 21, 'page_label': '3'}, page_content='CHAPTER 1: Advanced Airway Support 3 \\nFigure 1-1. Mask ventilation: traditional “E-C” hand grip (A) and modified “T-E” \\nhand grip (B).\\nA\\nB\\nventilation or as part of rapid sequence airway procedures. It is critical to always \\nhave an appropriately sized EGD available during airway management to place \\nthe device in case difficulties are encountered but do not rely on an EGD to \\nthe exclusion of surgical airway when critical hypoxemia is encountered.\\n01_Cydulka_Ch01.indd   3 3/6/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 22, 'page_label': '4'}, page_content='4 SECTION 1: Resuscitation Techniques\\n■ ■INTUBATION\\nIntubate patients in cardiac arrest after other critical resuscitation steps have \\nbeen assured. Intubation is indicated for unconscious, nonarrested patients \\nunless a rapidly correctable situation is suspected, such as an opioid over -\\ndose or simple postictal state. Consider intubation for conscious patients \\nwith refractory hypoxemia or a deteriorating clinical course. Rapid \\nsequence intubation (RSI) technique should be used unless the patient’s \\ncondition makes it unnecessary (i.e., cardiac arrest) or when it is contrain-\\ndicated because of an anticipated difficult airway. RSI includes the simul-\\ntaneous administration of an induction agent and a neuromuscular blocking \\nagent to facilitate orotracheal intubation in the nonarrested/peri-arrested \\npatient. Anticipated difficulty in mask ventilation, intubation, rescue with \\nan extraglottic device and surgical airway placement are relative contrain-\\ndications to RSI; awake techniques should be considered in these circum-\\nstances. Current evidence suggests that multiple intubation attempts are \\nassociated with adverse events. Thus, all efforts should be made to set up \\nsuccess on the first intubation attempt.\\n■ ■OROTRAChEAL INTUBATION\\n1. Prepare equipment, personnel, and drugs before attempting intubation. \\nAssess airway diff iculty and anticipate required airway rescue. As-\\nsemble and place suction, bag-valve-mask, and rescue devices within \\neasy reach. Sufficient personnel should be present at the bedside to \\nassist. Assign all the tasks in advance, including medication adminis-\\ntration, cervical spine stabilization, external laryngeal manipulation, \\netc. Use of a checklist is strongly encouraged.\\n2. Ensure adequate ventilation and oxygenation and monitoring while pre-\\nparing equipment. Preoxygenate with a non-rebreather oxygen mask at \\nmaximal oxygen flow rates, NIPPV , or mask ventilation if the patient is not \\nventilating adequately. Place a nasal cannula with up to 15 L/min of oxy-\\ngen flow under the mask to provide for apneic oxygenation. An inability to \\nachieve an oxygen saturation of greater than 93% with these maneuvers \\nplaces the patient at risk for critical desaturation after apnea is induced; \\nbe prepared to perform controlled positive pressure mask ventilation.\\n3. Optimize physiology prior to intubation if at all possible to lessen the \\nrisk of peri-intubation complications. This may include administration \\nof IV fluid boluses, inotropes, and/or vasopressors in addition to oxy-\\ngenation as above.\\n4. Select, connect, and test the laryngoscope and blade. Video laryngos-\\ncopy (VL) is a good first choice if the operator is familiar with this \\ntechnique. Direct laryngoscopy (DL) is a reasonable option if the \\noperator has more experience with this technique. Select and test the \\nendotracheal tube, commonly 7.5 mm in women and 8 mm in men. Use \\na stylet with a “straight-to-cuff” configuration for DL/nonhyperangu-\\nlated VL blades; hyperangulated VL blades often come with proprie-\\ntary stylets that include an optimal bend (Fig. 1-2).\\n5. Position the patient in the sniffing or ramped position to align the exter-\\nnal ear canal and sternal notch (Fig. 1-3). If C-spine injury is suspected, \\nmaintain the head and neck in a neutral position with an assistant per -\\nforming inline stabilization and a jaw thrust maneuver.\\n01_Cydulka_Ch01.indd   4 3/6/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 23, 'page_label': '5'}, page_content='CHAPTER 1: Advanced Airway Support 5 \\n6. Evidence is mixed on whether pretreatment improves outcomes and is \\nno longer routinely recommended. Fentanyl, 3 μg/kg, may be consid-\\nered in normotensive patients with possible raised intracranial pressure, \\ncardiac ischemia, or aortic dissection.\\nFigure 1-2. Top shows a stylet from Intubrite® intended for the hyperangulated video \\nblade. Bottom demonstrates straight-to-cuff stylet shape for direct laryngoscopy.\\nFigure 1-3. Sniffing position for optimal mask ventilation and intubation when \\ncervical precautions not indicated. With permission from The Difficult Airway \\nCourse™ (www.theairwaysite.com).\\n01_Cydulka_Ch01.indd   5 3/6/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 24, 'page_label': '6'}, page_content='6 SECTION 1: Resuscitation Techniques\\n7. Administer an intravenous induction agent via rapid push. Etomidate, \\n0.3 mg/kg, is an excellent choice in most circumstances. Ketamine, \\n1 to 2 mg/kg, has become a popular alternative and is generally safe, \\nalthough cases of hypotension and hypertension have been reported. \\nPropofol, 0.5 to 1.5 mg/kg, is another option in patients who are not at \\nrisk for hypotension.\\n8. The induction agent is immediately flushed with a paralytic agent. \\nSuccinylcholine, 1 to 2 mg/kg of total body weight, is commonly used \\nunless there is risk of serious hyperkalemia (e.g., renal f ailure, neuro-\\nmuscular disorders, subacute spinal cord injury, crush injury or burns). \\nRocuronium, 1 to 1.5 mg/kg of ideal body weight, is an increasingly \\ncommon alternative.\\n9. Cricoid pressure is no longer recommended due to limited evidence of \\nbenefit and clear evidence of worsening laryngoscopic view.\\n10. Wait for paralysis to occur to diminish the risk of vomiting and aspira-\\ntion. Succinylcholine usually takes effect in 30 to 45 seconds and \\nrocuruonium in 60 seconds. Oxygenation should continue via non-\\nrebreather or gentle mask ventilation during this interval.\\n11. Insert hyperangulated VL blades in the midline. Insert traditional \\ncurved blades (whether direct or video) on the right side of the mouth \\nand sweep tongue to the left. Both blades are advanced into the \\nvaleculla to trigger to the hyoepiglottic ligament. Do not over-insert \\nhyperangulated blades; keep the blade as shallow as possible with the \\nairway visualized in the top half of the screen. Insert straight blades on \\nthe right side of the tongue and maintain this “paraglossal” position \\nwithout sweeping the tongue and gently advance blade as far as it will \\ngo. Withdraw the blade slowly until the epiglottis drops into view and \\nthen lift it with the tip of the blade. Lift all the blades along the axis of \\nthe laryngoscope handle to avoid levering the blade on the teeth and \\ncausing dental trauma.\\n12. If only the epiglottis is visible, use an intubating stylet (aka Bougie) \\nand/or perform external laryngeal manipulation of the thyroid cartilage \\nwith the operator’s right hand on top of an assistant’ s hand (Fig. 1-4) \\nto help bring the cords into view.\\n13. Once the vocal cords or posterior cartilages are visualized, gently pass \\nthe tube between the cords (or anterior to the posterior cartilages) until \\nthe balloon completely disappears and remov e the stylet. When using \\na hyperangulated blade stylet, it helps to withdraw the stylet 2 to 3 cm \\nonce the tip of the tube just enters the airway, before advancing further. \\nAdvance tubes in adult females to approximately 21 cm at the corner \\nof the mouth and in adult males to approximately 23 cm and then \\nremove the stylet.\\n14. Confirm tracheal tube placement immediately with ETCO2. Confirm \\nappropriate depth by listening for bilateral lung sounds and then secure \\ntube. Obtain a portable chest x-ray to further ev aluate tube depth and \\nlung pathology. A chest x-ray should never be used to assess tracheal \\nversus esophageal positioning.\\n15. Abort the intubation attempt early if oxygen saturation is dropping and \\nbegin immediate mask ventilation. Consider an additional attempt \\nwhen saturations are maintained in the normal range with appropriate \\n01_Cydulka_Ch01.indd   6 3/6/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 25, 'page_label': '7'}, page_content='CHAPTER 1: Advanced Airway Support 7 \\nmodification to the operator, laryngoscope and blade selection, patient \\npositioning, use of bougie, etc. If unable to maintain saturations with \\nmask ventilation, insert an EGD while preparing for a possible surgical \\nairway. If saturations are maintained but intubation is unsuccessful \\nwithin three attempts, or deemed unlikely to be successful at any point, \\nplace an EGD.\\nSurgical Airway\\nA surgical airway is performed either when intubation via the mouth or \\nnose is not considered a reasonable clinical option or when intubation has \\nfailed and critical oxygen saturation cannot be maintained via other means. \\nFigure 1-4.  External laryngeal manipulation with the intubator’s right hand \\nplaced on top of assistant’s hand which is holding the laryngeal cartilage. Another \\nassistant is maintaining in-line cervical stabilization and providing a jaw thrust.\\n01_Cydulka_Ch01.indd   7 3/6/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 26, 'page_label': '8'}, page_content='8 SECTION 1: Resuscitation Techniques\\nA surgical airway is contraindicated in children younger than 10 years of \\nage in whom transtracheal jet v entilation is the preferred subglottic \\ntechnique. Although several surgical techniques have been described, the \\nbougie-aided technique is described here. There are kits available for \\nSeldinger-based and other “less invasive” techniques but these are not \\nreviewed here.\\n1. Use sterile technique if possible.\\n2. Palpate the cricothyroid membrane and stabilize the larynx.\\n3. With a scalpel, make a vertical, 3- to 4-cm incision starting at the supe -\\nrior border of the thyroid cartilage. Incise caudally toward the supraster-\\nnal notch (Fig. 1-5).\\n4. Identify the cricothyroid membrane using blunt dissection if necessary \\nand make a 2-cm horizontal incision. Immediately withdraw and secure \\nthe blade while inserting a gloved finger into the incision.\\n5. Place an adult bougie into the incision with the coude tip directed \\ndistally. The bougie should pass easily without resistance until hold-up \\nis appreciated in the smaller airways, generally confirming tracheal \\nplacement.\\n6. Pass a 6.0-cuffed endotracheal tube or #4 cuffed tracheostomy tube over \\nthe bougie and into the airway (Fig. 1-6). If using an endotracheal \\ntube stop advancing as soon the cuff is completely within the airway. \\nInflate cuff.\\n7. Confirm with capnography and easy chest rise with bilateral breath \\nsounds.\\n8. Secure the tube.\\nFigure 1-5. A 3- to 4-cm vertical midline incision overlying the cricothyroid mem-\\nbrane while the laryngeal cartilage is stabilized.\\n01_Cydulka_Ch01.indd   8 3/6/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 27, 'page_label': '9'}, page_content='CHAPTER 1: Advanced Airway Support 9 \\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 28, “Noninvasive Airway Management,” by Jestin N. \\nCarlson and Henry E. Wang; Chapter 29, “Intubation and Mechanical Ventilation,” \\nby Robert J. Vissers and Daniel F. Danzl; and Chapter 30, “Surgical Airways,” by \\nMichael D. Smith and Donald M. Yealy.\\nFigure 1-6. Passing a 6-0 endotracheal tube over a bougie that has been placed \\ninto the trachea through the cricothyroid membrane incision.\\n01_Cydulka_Ch01.indd   9 3/6/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 28, 'page_label': '10'}, page_content='10\\nManagement of Cardiac Rhythm \\nDisturbances\\nJames K. Takayesu\\n■ ■NONTACHYCARDIC IRREGULAR DYSRHYTHMIAS\\nSinus Arrhythmia\\nSome variation in the sinoatrial (SA) node discharge rate is common; how-\\never, if the variation exceeds 120 milliseconds between the longest and \\nshortest intervals, sinus arrhythmia is present. The electrocardiogram \\n(ECG) characteristics of sinus arrhythmia are (a) normal sinus P waves and \\nPR intervals, (b) 1:1 atrioventricular (A V) conduction, and (c) variation of \\nat least 120 milliseconds between the shortest and longest P–P interval \\n(Fig. 2-1). If two or more different P wave morphologies are present, atrial \\nectopy, wandering atrial pacemaker, or another competing nonsinus focus \\nmay be present. Sinus arrhythmias are affected primarily by respiration and \\nare most commonly found in children and young adults, disappearing with \\nadvancing age. Occasional junctional escape beats may be present during \\nvery long P–P intervals. No treatment is required.\\nPremature Atrial Contractions\\nPremature atrial contractions (PACs) have the following ECG characteris-\\ntics: (a) the ectopic P wave appears sooner (premature) than the next \\nexpected sinus beat; (b) the ectopic P wave has a different shape and direc-\\ntion; and (c) the ectopic P wave may or may not be conducted through the \\nA V node (Fig. 2-2). Most PACs are conducted with typical QRS complexes, \\nbut some may be conducted aberrantly through the infranodal system, \\ntypically with a right bundle branch block pattern. When the PAC occurs \\nduring the absolute refractory period, it is not conducted. Since the sinus \\nnode is often depolarized and reset, the interval between normal P waves \\nbefore and after the PAC will not be twice the existing P to P interval, cre-\\nating a shorter pause than a fully compensatory pause (unlike that seen after \\nmost premature ventricular contractions). PACs are associated with stress, \\nfatigue, alcohol use, tobacco, coffee, chronic obstructive pulmonary disease \\n(COPD), digoxin toxicity, and coronary artery disease, and may occur after \\nadenosine-converted paroxysmal supraventricular tachycardia (PSVT). \\nPatients may complain of palpitations or an intermittent “sinking” or \\n“fluttering” feeling in the chest. PACs are common in all ages, often in the \\n2\\nC HA p TER\\nFiguRe 2-1. Sinus arrhythmia.\\n02_Cydulka_Ch02.indd   10 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 29, 'page_label': '11'}, page_content='CHAPTER 2: Management of Cardiac Rhythm Disturbances 11 \\nabsence of significant heart disease, but can precipitate sustained atrial \\ntachycardia, flutter, or fibrillation under certain circumstances.\\nEmergency Department Care and Disposition\\n1. Discontinue precipitating drugs (alcohol, tobacco, or coffee) or toxins.\\n2. Treat underlying disorders (stress or fatigue).\\nPremature Ventricular Contractions\\nClinical Features\\nPremature ventricular contractions (PVCs) are due to impulses originating \\nfrom single or multiple areas in the ventricles. The ECG characteristics of \\nPVCs are as follows: (a) a premature and wide QRS complex; (b) no pre-\\nceding P wave; (c) the ST segment and T wave of the PVC are directed \\nopposite the preceding major QRS deflection; (d) most PVCs do not affect \\nthe sinus node, so there is usually a fully compensatory postectopic pause, \\nor the PVC may be interpolated between two sinus beats; (e) many PVCs \\nhave a fixed coupling interval (within 40 milliseconds) from the preceding \\nsinus beat; and (f) many PVCs are conducted into the atria, thus producing \\na retrograde P wave (Fig. 2-3). If three or more PVCs occur in a row, \\npatients are considered to have nonsustained ventricular tachycardia.\\nPVCs are very common, occurring in most patients with ischemic heart \\ndisease and acute myocardial infarction (MI). Other common causes of \\nPVCs include digoxin toxicity, congestive heart failure (CHF), hypokale-\\nmia, alkalosis, hypoxia, and sympathomimetic drugs. Pooled data and \\nmeta-analyses have found no reduction in mortality from suppressive or \\nprophylactic treatment of PVCs. Ventricular parasystole occurs when the \\nectopic ventricular focus fires frequently enough to compete with the SA \\nnode and is associated with cardiac ischemia, electrolyte imbalance, and \\nhypertensive or ischemic heart disease.\\nFiguRe 2-2. Premature atrial contractions (PACs). A. Ectopic P ′ waves (arrows). \\nB. Atrial bigeminy.\\n02_Cydulka_Ch02.indd   11 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 30, 'page_label': '12'}, page_content='12 SECTION 1: Resuscitation Techniques\\nEmergency Department Care and Disposition\\n1. Stable patients require no treatment.\\n2. Patients with three or more sequential PVCs should be managed as non-\\nsustained VT.\\n3. Potential causes such as hypoxia, drug effect, or electrolyte disturbances \\nshould be treated.\\n■ ■BRADYDYSRHYTHMIAS\\nSinus Bradycardia\\nClinical Features\\nSinus bradycardia occurs when the SA node rate becomes slower than  \\n60 beats/min. The ECG characteristics of sinus bradycardia are (a) normal \\nsinus P waves and PR intervals, (b) 1:1 A V conduction, and (c) atrial rate \\nslower than 60 beats/min. Sinus bradycardia represents a suppression of the \\nsinus node discharge rate, usually in response to three categories of stimuli: \\n(a) physiologic (vagal tone), (b) pharmacologic (calcium channel blockers, \\nβ-blockers, or digoxin), and (c) pathologic (acute inferior myocardial \\ninfarction (MI), increased intracranial pressure, carotid sinus hypersensitiv-\\nity, hypothyroidism, or sick sinus syndrome).\\nFiguRe 2-3.  Premature ventricular contractions (PVCs). A. Unifocal PVC. B.  \\nInterpolated PVC. C. Multifocal PVCs.\\n02_Cydulka_Ch02.indd   12 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 31, 'page_label': '13'}, page_content='CHAPTER 2: Management of Cardiac Rhythm Disturbances 13 \\nEmergency Department Care and Disposition\\nSinus bradycardia usually does not require specific treatment unless the \\nheart rate is slower than 50 beats/min and there is evidence of hypoperfusion.\\n1. Transcutaneous cardiac pacing is the only Class I treatment for \\nunstable patients.\\na. Attach the patient to the monitor leads of the external pacing device.\\nb. When placing transcutaneous pacing pads, place the anterior pad \\nover the left lateral precordium and the posterior pad at the lev el of \\nthe heart in the right infrascapular area. Do not use multifunction \\npacing defibrillation pads unless the patient is unconscious as the \\npads cause a lot of discomfort.\\nc. Slowly increase the pacing output from 0  mA to the lo west point \\nwhere capture is observed, usually at 50 to 100 mA, but may be up \\nto 200 mA. A widened QRS after each pacing spike denotes electri-\\ncal capture.\\nd. If needed, administer a sedative, such as lorazepam, 1 to 2 mg IV , or \\nan opiate, such as morphine, 2 to 4 mg IV, for pain control.\\n2. Atropine is a Class IIa treatment for symptomatic bradycardia. The \\ndose is 0.5 mg IV push, repeated every 3 to 5 minutes as needed up to \\na total of 3 mg IV . If given via endotracheal tube, increase the dose by \\n2 to 2.5 times over the IV dose. Slow administration or lower doses \\nmay cause paradoxical bradycardia. Atropine may not be effective in \\ncardiac transplant patients since the heart is denervated and has no \\nvagal stimulation.\\n3. Epinephrine, 2 to 10 μg/min IV , or dopamine, 3 to 10 μg/kg/min IV , \\nmay be used if external pacing is not available.\\n4. Permanent pacemaker placement is indicated in the patient with \\nsymptomatic recurrent or persistent sinus bradycardia due to sick \\nsinus syndrome.\\n5. Glucagon 3 to 10 mg IV over 1 to 2 minutes, followed by an infusion of \\n1 to 5 mg/h may be used in β-blocker or calcium channel blocker toxicity.\\nJunctional Rhythms\\nClinical Features\\nIn patients with sinus bradycardia, SA node exit block, or A V block, junc-\\ntional escape beats may occur, usually at a rate between 40 and 60 beats/\\nmin, depending on the level of the rescue pacemaker within the conduction \\nsystem. Junctional escape beats may conduct retrogradely into the atria, but \\nthe QRS complex usually will mask any retrograde P wave (Fig. 2-4). \\nWhen alternating rhythmically with the SA node, junctional escape beats \\nFiguRe 2-4. Junctional escape rhythm, rate 42.\\n02_Cydulka_Ch02.indd   13 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 32, 'page_label': '14'}, page_content='14 SECTION 1: Resuscitation Techniques\\nmay cause bigeminal or trigeminal rhythms. Sustained junctional escape \\nrhythms may be seen with CHF, myocarditis, acute MI (especially inferior \\nMI), hyperkalemia, or digoxin toxicity (“regularized Afib”). If the ventricu-\\nlar rate is too slow, myocardial or cerebral ischemia may develop. In cases \\nof enhanced junctional automaticity, junctional rhythms may be accelerated \\n(60 to 100 beats/min) or tachycardic (≥100 beats/min), thus overriding the \\nSA node rate.\\nEmergency Department Care and Disposition\\n1. Isolated, infrequent junctional escape beats usually do not require spe-\\ncific treatment.\\n2. If sustained junctional escape rhythms are producing symptoms, treat \\nthe underlying cause.\\n3. In unstable patients, give atropine 0.5 mg IV every 5 minutes to a total \\nof 3 mg. This will accelerate the SA node discharge rate and enhance A V \\nnodal conduction.\\n4. Use transcutaneous or transvenous pacing in unstable patients not \\nresponsive to atropine.\\n5. Manage patients with digoxin toxicity as discussed for SVT.\\nidioventricular Rhythm\\nClinical Features\\nThe ECG characteristics of idioventricular rh ythm (IVR) are (a ) wide \\nand regular QRS complexes; (b ) a rate between 40 and 100 beats/min, \\noften close to the preceding sinus rate; (c ) mostly runs of short duration \\n(3 to 30 beats/min); and (d ) an AIVR often beginning with a fusion beat \\n(Fig. 2-5). This condition is found most commonly with an acute MI or \\nin the setting of reperfusion after successful thrombolysis.\\nEmergency Department Care and Disposition\\nTreatment is not necessary unless the patient is unstable or pulseless. On \\noccasion, especially after reperfusion therapy, the IVR may be the only \\nfunctioning pacemaker, and suppression with lidocaine can lead to cardiac \\nasystole.\\nIf the patient is hypotensive or in arrest, treatment includes identifying \\ncontributing mechanical factors (e.g., aggressive volume resuscitation) and \\nα-adrenergic agents.\\nFiguRe 2-5. Accelerated idioventricular rhythms (AIVRs).\\n02_Cydulka_Ch02.indd   14 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 33, 'page_label': '15'}, page_content='CHAPTER 2: Management of Cardiac Rhythm Disturbances 15 \\nSick Sinus Syndrome\\nClinical Features\\nOtherwise known as tachy-brady syndrome, sick sinus syndrome consists \\nof a variety of abnormalities in impulse generation and conduction, leading \\nto various supraventricular tachycardic rhythms as well as bradycardia due \\nto sinus arrest and SA block. It can be seen in myocardial ischemia, myo-\\ncarditis, rheumatologic disease, cardiomyopathies, or metastatic disease. \\nConditions that increase vagal tone such acute abdominal pain, thyrotoxi-\\ncosis, and hypo- or hyperkalemia exacerbate this condition.\\nEmergency Department Care and Disposition\\nTreatment should be based on the presenting rhythm depending on the heart \\nrate and patient instability. Temporary pacing may be needed and admission \\nfor permanent pacemaker placement is frequently indicated.\\n■ ■ATRIOVENTRICULAR BLOCKS\\nFirst-Degree Atrioventricular (AV) Block\\nFirst-degree A V block is characterized by a delay in A V conduction, mani-\\nfested by a prolonged PR interval (>200 milliseconds). It can be found in \\nnormal hearts and in association with increased vagal tone, digoxin toxicity, \\ninferior MI, amyloid, and myocarditis. First-degree A V block needs no \\ntreatment. Second-degree A V block is characterized by intermittent A V \\nnodal conduction: some atrial impulses reach the ventricles, whereas others \\nare blocked, thereby causing “grouped beating.” These blocks can be sub-\\ndivided into nodal blocks which are typically reversible and infranodal \\nblocks which are due to irreversible conduction system disease. Third-\\ndegree A V block is characterized by complete interruption in A V conduc-\\ntion with resulting A V dissociation.\\nSecond-Degree Mobitz i (Wenckebach) AV Block\\nClinical Features\\nMobitz I A V block is a nodal block causing a progressive prolongation of \\nconduction through the A V node until the atrial impulse is completely \\nblocked. Usually, only one atrial impulse is blocked at a time. After the \\ndropped beat, the A V conduction returns to normal and the cycle usually \\nrepeats itself with the same conduction ratio (fixed ratio) or a different \\nconduction ratio (variable ratio). Although the PR intervals progressively \\nlengthen before the dropped beat, the increments by which they lengthen \\ndecrease with successive beats causing a progressive shortening of each \\nsuccessive R–R interval before the dropped beat (Fig. 2-6). This block is \\nFiguRe 2-6. Second-degree Mobitz I (Wenckebach) AV block 4:3 AV conduction.\\n02_Cydulka_Ch02.indd   15 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 34, 'page_label': '16'}, page_content='16 SECTION 1: Resuscitation Techniques\\noften transient and usually associated with an acute inferior MI, digoxin \\ntoxicity, or myocarditis or can be seen after cardiac surgery. Because the \\nblockade occurs at the level of the A V node itself rather than at the infrano-\\ndal conducting system, this is usually a stable rhythm.\\nEmergency Department Care and Disposition\\n1. Specific treatment is not necessary unless slow ventricular rates produce \\nsigns of hypoperfusion.\\n2. In cases associated with acute inferior MI, provide adequate volume \\nresuscitation before initiating further interventions.\\n3. Administer atropine 0.5 mg IV repeated every 5 minutes. T itrate to the \\ndesired heart rate or until the total dose reaches 3 mg.\\n4. Although rarely needed, transcutaneous pacing may be used.\\nSecond-Degree Mobitz ii AV Block\\nClinical Features\\nMobitz II AV block is typically due to infranodal disease, causing a constant \\nPR interval with intermittent nonconducted atrial beats (Fig. 2-7). One or more \\nbeats may be nonconducted at a single time. This block indicates significant \\ndamage or dysfunction of the infranodal conduction system; therefore, the \\nQRS complexes are usually wide coming from the low His–Purkinje bundle \\nor the ventricles. Type II blocks are more dangerous than type I blocks because \\nthey are usually permanent and may progress suddenly to complete heart \\nblock, especially in the setting of an acute anterior MI, and almost always \\nrequire permanent cardiac pacemaker placement. When second-degree A V \\nblock occurs with a fixed conduction ratio of 2:1, it is not possible to differen-\\ntiate between a Mobitz type I (Wenckebach) and Mobitz type II block.\\nEmergency Department Care and Disposition\\n1. Atropine 0.5 to 1 mg IV bolus repeated ev ery 5 minutes as needed up \\nto 3 mg total dose is first-line treatment for symptomatic patients but \\nFiguRe 2-7. A. Second-degree Mobitz II AV block. B.  Second-degree A V block \\nwith 2:1 AV conduction.\\n02_Cydulka_Ch02.indd   16 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 35, 'page_label': '17'}, page_content='CHAPTER 2: Management of Cardiac Rhythm Disturbances 17 \\nmay be ineffective. All patients should have transcutaneous pacing pads \\npositioned and ready for use in the case of further deterioration into \\ncomplete heart block.\\n2. Initiate transcutaneous cardiac pacing (see section on sinus bradycardia) \\nin patients unresponsive to atropine.\\n3. If transcutaneous pacing is unsuccessful, initiate transvenous pacing \\n(0.2 to 20 mA at 40 to 140 beats/min via a semi-floating or balloon-\\ntipped pacing catheter).\\nThird-Degree (Complete) AV Block\\nClinical Features\\nIn third-degree A V block, there is no A V conduction. The ventricles are \\npaced by an escape pacemaker from the A V node or the infranodal conduc-\\ntion system at a rate slower than the atrial rate (Fig. 2-8). When third-degree \\nA V block occurs at the A V node, a junctional escape pacemaker takes over \\nwith a ventricular rate of 40 to 60 beats/min, and because the rhythm \\noriginates from above the bifurcation of the His bundle, the QRS com-\\nplexes are narrow. Nodal third-degree A V block may develop in up to 8% \\nof acute inferior MIs and it is usually transient, although it may last for \\nseveral days.\\nWhen third-degree A V block occurs at the infranodal level, the ventri-\\ncles are driven by a ventricular escape rhythm at a rate slower than 40 beats/\\nmin. Third-degree A V block located in the bundle branch or the Purkinje \\nsystem invariably has an escape rhythm with a wide QRS complex. Like \\nMobitz type II block, this indicates structural damage to the infranodal \\nconduction system and can be seen in acute anterior MIs. The ventricular \\nescape pacemaker is usually inadequate to maintain cardiac output and is \\nunstable with periods of ventricular asystole.\\nEmergency Department Care and Disposition\\n1. Perform transcutaneous cardiac pacing in unstable patients until a trans-\\nvenous pacemaker can be placed.\\n2. In stable patients, apply transcutaneous pacing pads. Treat the same as \\nsecond-degree Mobitz II A V block.\\n■ ■FASCICULAR BLOCKS\\nConduction blocks may arise in one or more of the three infranodal conduc-\\ntion pathways. Blockage of either of the left fascicles does not prolong the \\nQRS duration, but will change the QRS axis. Left anterior fascicular block \\n(LAFB) causes left axis deviation with qR complex seen in aVR, while the \\nFiguRe 2-8. Third-degree AV block.\\n02_Cydulka_Ch02.indd   17 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 36, 'page_label': '18'}, page_content='18 SECTION 1: Resuscitation Techniques\\nmuch less common left posterior fascicular block (LPFB) causes right axis \\ndeviation. Right bundle branch block (RBBB) will prolong the QRS dura-\\ntion (>120 milliseconds) and cause an RSR’, or \"rabbit ears,\" in the early \\nprecordial leads (V1–2). Bifascicular block denotes a combination of any \\ntwo of these fascicles, the most notable of which is left bundle branch block \\n(LAFB + LPFB). Trifascicular block denotes the presence of first degree \\nA V block in the presence of a bifascicular block and is indicative of sig-\\nnificant conduction system disease that includes the A V node, thus increas-\\ning the risk of Mobitz II or third-degree A V block and the potential need for \\npermanent pacemaker placement.\\n■ ■NARROW COMpLEX TACHYCARDIAS\\nSinus Tachycardia\\nClinical Features\\nThe ECG characteristics of sinus tachycardia are (a) normal sinus P waves \\nand PR intervals and (b) an atrial rate usually between 100 and 160 beats/\\nmin. Sinus tachycardia is in response to one of three categories of stimuli: \\n(a) physiologic (pain or exertion), (b) pharmacologic (sympathomimetics, \\ncaffeine, or bronchodilators), or (c) pathologic (fever, hypoxia, anemia, \\nhypovolemia, pulmonary embolism, or hyperthyroidism). In many of these \\nconditions, the increased heart rate is an effort to increase cardiac output to \\nmatch increased circulatory needs.\\nEmergency Department Care and Disposition\\nSince sinus tachycardia is a compensatory rhythm, the focus should be on \\ndiagnosing and treating the underlying condition.\\nAtrial Flutter\\nClinical Features\\nAtrial flutter is a rhythm that originates from a small area within the atria. \\nECG characteristics of atrial flutter are (a) a regular atrial rate between 250 \\nand 350 beats/min; (b) “saw tooth” flutter waves directed superiorly and \\nmost visible in leads II, III, and aV F; and (c) A V block, usually 2:1, but \\noccasionally greater or irregular (Fig. 2-9). One-to-one conduction may \\noccur if a bypass tract is present. Carotid sinus massage or Valsalva maneu-\\nvers are useful techniques to slow the ventricular response by increasing the \\ndegree of A V block, which can unmask flutter waves in uncertain cases. \\nFiguRe 2-9. Atrial flutter.\\n02_Cydulka_Ch02.indd   18 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 37, 'page_label': '19'}, page_content='CHAPTER 2: Management of Cardiac Rhythm Disturbances 19 \\nAtrial flutter is seen most commonly in patients with ischemic heart disease \\nas well as CHF, acute MI, pulmonary embolus, myocarditis, blunt chest \\ntrauma, and digoxin toxicity. Atrial flutter may be a transitional arrhythmia \\nbetween sinus rhythm and atrial fibrillation. Consider anticoagulation in \\npatients with an unclear time of onset or duration longer than 48 hours \\nbefore conversion to sinus rhythm due to increased risk of atrial thrombus \\nand embolization.\\nEmergency Department Care\\nThe treatment is the same as atrial fibrillation and is discussed below.\\nAtrial Fibrillation\\nClinical Features\\nAtrial fibrillation (Afib) occurs when there are multiple, small areas of \\natrial myocardium continuously discharging in a disorganized fashion. This \\nresults in loss of effective atrial contraction and decreases left ventricular \\nend-diastolic volume, which may precipitate CHF in patients with impaired \\ncardiac function. The ECG characteristics of Afib are (a) fibrillatory waves \\nof atrial activity, best seen in leads V1, V2, V3, and aVF; and (b) an irregular \\nventricular response, usually between 170 and 180 beats/min in patients \\nwith a healthy A V node (Fig. 2-10).\\nAfib may be paroxysmal (lasting for less than 7 days), persistent (lasting \\nfor more than 7 days), or chronic (continuous). Afib can be idiopathic (lone \\nAfib) or may be found in association with longstanding hypertension, isch-\\nemic heart disease, rheumatic heart disease, alcohol use (“holiday heart”), \\nCOPD, and thyrotoxicosis. Patients with LV dysfunction who depend on \\natrial contraction may suffer acute CHF with Afib onset. Rates of greater \\nthan 300 beats/min with a wide QRS complex are concerning for a preex-\\ncitation syndrome such as Wolff–Parkinson–White (WPW) (Fig. 2-11).\\nPatients with Afib who are not anticoagulated have a yearly embolic \\nevent rate as high as 5% and a lifetime risk greater than 25%. Conversion \\nfrom atrial fibrillation of 12 hours duration or less to sinus rhythm carries \\na 0.3% risk of arterial embolism compared to a risk of 1% for durations of \\n12 to 48 hours. Patients with heart failure and diabetes mellitus are particu-\\nlarly at risk with embolic rates as high as 9.8%. Anticoagulation for  \\n3 weeks is required before cardioversion in patients with atrial fibrillation \\nfor longer than 48 hours duration and in those patients with an uncertain \\ntime of onset who are not on anticoagulation therapy.\\nFiguRe 2-10. Atrial fibrillation.\\n02_Cydulka_Ch02.indd   19 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 38, 'page_label': '20'}, page_content='20 SECTION 1: Resuscitation Techniques\\nEmergency Department Care and Disposition\\n1. Treat unstable patients with synchronized cardioversion (150 to 200 J).\\n2. Stable patients with Afib for longer than 48 hours should be anticoagu-\\nlated before cardioversion. Consider a transesophageal echocardiogram \\nto rule out atrial thrombus before cardioversion.\\n3. Control rate with diltiazem. Administer 15 to 20 mg (or 0.25 mg/kg) IV \\nover 2 minutes followed by a continuous IV infusion, 5 to 10 mg/h,  \\nto maintain rate control. Give a second dose of 25 mg (0.35 mg/kg) in 15 \\nminutes if the first dose fails to control the rate. Alternative rate control \\nagents for patients with normal cardiac function include verapamil 2.5 \\nto 5 mg IV or metoprolol 5 to 10 mg IV . Treat patients with preexcita-\\ntion syndromes (e.g., WPW) with procainamide 15 to 17 mg/kg IV \\nover 30 minutes followed by an infusion of at 1 to 4 mg/min up to  \\n50 mg/kg or until 50% QRS widening is noted. Avoid β-adrenergic or \\ncalcium channel blockers (i.e., verapamil) due to the risk of causing \\ndegeneration to VF.\\n4. In patients with impaired cardiac function (EF <40%), use amiodarone \\n5 mg/kg IV over 30 minutes, followed by 1200 mg over 24 hours (con-\\ntraindicated in patients with iodine or shellfish allergy; increased risk of \\nrhabdomyolysis if coadministered with simvastatin).\\n5. Patients with Afib with a clear duration less than 48 hours may be con -\\nsidered for chemical or electrical cardioversion in the emergency depart-\\nment. Ibutilide has the highest success rate and is dosed at 0.01 mg/kg \\nIV up to 1 mg, infused over 10 minutes. Median time to conversion is \\n20 to 30 minutes. Ibutilide should not be administered to patients with \\nknown structural heart disease, hypokalemia, prolonged QTc intervals, \\nhypomagnesemia, or CHF because of the possibility of provoking tors-\\nades de pointes. Monitor for 4 to 6 hours after giving ibutilide. Patients \\nwith impaired cardiac function may be cardioverted with amiodarone or \\nelectrically.\\nFiguRe 2-11. Atrial fibrillation in Wolff–Parkinson–White syndrome.\\n02_Cydulka_Ch02.indd   20 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 39, 'page_label': '21'}, page_content='CHAPTER 2: Management of Cardiac Rhythm Disturbances 21 \\nMultifocal Atrial Tachycardia\\nClinical Features\\nMultifocal atrial tachycardia (MAT) is def ined as at least three different \\nsites of atrial ectopy. The ECG characteristics of MAT are (a) three or more \\ndifferently shaped P waves; (b) changing PP, PR, and RR intervals; and (c) \\natrial rhythm usually between 100 and 180 beats/min (Fig. 2-12). Because \\nthe rhythm is irregularly irregular, MAT can be confused with atrial flutter \\nor atrial fibrillation (AFib). MAT is found most often in elderly patients \\nwith decompensated COPD, but it also may be found in patients with CHF, \\nsepsis, methylxanthine toxicity, or digoxin toxicity.\\nEmergency Department Care and Disposition\\n1. Treat the underlying disorder.\\n2. Specific antiarrhythmic treatment is not indicated.\\n3. Magnesium sulfate 2 g IV over 60 seconds followed by a constant infu-\\nsion of 1 to 2 g/h may decrease ectopy and convert MAT to sinus rhythm \\nin some patients.\\n4. Replete potassium levels to greater than 4 mEq/L to increase myocardial \\nmembrane stability.\\nParoxysmal Supraventricular Tachycardia\\nClinical Features\\nSupraventricular tachycardia (SVT) is a regular, rapid rhythm that arises from \\nimpulse reentry or an ectopic pacemaker above the bifurcation of the His \\nbundle. The reentrant variety is the most common (Fig. 2-13). Patients often \\npresent with acute, symptomatic episodes termed paroxysmal supraventricu-\\nlar tachycardia (PSVT). Atrioventricular nodal reentrant tachycardia (A VnRT) \\ncan occur in a normal heart or in association with rheumatic heart disease, \\nacute pericarditis, MI, mitral valve prolapse, or preexcitation syndromes. In \\npatients with atrioventricular bypass tracts (A VRT), reentry can occur in \\neither direction, usually (80% to 90% of patients) in a direction that goes \\ndown the A V node and up the bypass tract producing a narrow QRS complex \\n(orthodromic conduction). In the remaining 10% to 20% of patients, reentry \\noccurs in the reverse direction (antidromic conduction). Ectopic SVT usually \\noriginates in the atria, with an atrial rate of 100 to 250 beats/min and may be \\nseen in patients with acute MI, chronic lung disease, pneumonia, alcohol \\nintoxication, or digoxin toxicity. There is a high incidence of tachyarrhyth-\\nmias in patients with preexcitation syndromes including PSVT (40% to \\n80%), atrial fibrillation (10% to 20%), and atrial flutter (about 5%).\\nFiguRe 2-12. Multifocal atrial tachycardia (MFAT).\\n02_Cydulka_Ch02.indd   21 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 40, 'page_label': '22'}, page_content='22 SECTION 1: Resuscitation Techniques\\nEmergency Department Care and Disposition\\n1. Perform synchronized cardioversion in any unstable patient (e.g., hypo-\\ntension, pulmonary edema, or severe chest pain).\\n2. In stable patients, the first intervention should be vagal maneuvers, \\nincluding:\\na. Valsalva maneuver: While in the supine position, ask the patient to \\nstrain for at least 10 seconds. The legs may be lifted to increase \\nvenous return and augment the reflex.\\nb. Diving reflex: Hav e the patient immerse the face in cold water or \\napply a bag of ice water to the face for 6 to 7 seconds. This maneuver \\nis particularly effective in infants.\\nc. Carotid sinus massage: Auscultate to ensure that there is no carotid \\nbruit and massage the carotid sinus against the transverse process of C6 \\nfor 10 seconds at a time, first on the side of the nondominant cerebral \\nhemisphere. This should never be done simultaneously on both sides.\\n3. Administer adenosine, 6 mg rapid IV bolus, into a large vein followed \\nby a 20-mL normal saline rapid flush. If there is no effect within  \\n2 minutes, give a second dose of 12 mg IV . Most patients experience \\ndistressing chest pain, flushing, or anxiety lasting less than 1 minute. \\nTen percent of patients may experience transient atrial fibrillation or \\nflutter after conversion. This is first-line treatment for WPW-associated \\nSVT with a narrow QRS complex (orthodromic conduction) but is inef-\\nfective in cases of anterograde conduction over an accessory pathway. \\nAdenosine may induce bronchospasm in asthmatics requiring treatment \\nwith bronchodilators.\\n4. Patients with wide complex SVT (antidromic conduction across acces-\\nsory pathway) should be approached as presumed ventricular tachycardia \\nFiguRe 2-13. Reentrant supraventricular tachycardia (SVT). A. Second asterisk (*) \\ninitiates run of PAT. B. SVT, rate 286.\\n02_Cydulka_Ch02.indd   22 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 41, 'page_label': '23'}, page_content='CHAPTER 2: Management of Cardiac Rhythm Disturbances 23 \\n(VT; see Ventricular Tachycardia) unless there is a known history of \\nWPW syndrome. Patients with this type of tachycardia are at risk for \\nrapid ventricular rates and degeneration into VF; therefore, agents that \\npreferentially block the A V node such as β-blockers, calcium channel \\nblockers, and digoxin should not be used. Treat stable patients with \\nprocainamide, 15 to 17 mg/kg IV over 30 minutes up to 50 mg/kg, or \\nuntil 50% QRS widening is noted (contraindicated in patients with \\nmyasthenia gravis since it may increase weakness).\\n■ ■WIDE COMpLEX TACHYCARDIAS\\nVentricular Tachycardia\\nClinical Features\\nVT is the occurrence of three or more successive beats from a ventricular \\nectopic pacemaker at a rate faster than 100 beats/min. The ECG character -\\nistics of VT are (a ) a wide QRS complex, (b ) a rate faster than 100 beats/\\nmin (most commonly 150 to 200 beats/min), (c ) a regular rhythm, \\nalthough there may be some initial beat-to-beat variation, and (d ) a con-\\nstant QRS axis (Fig. 2-14). The most common causes of VT are ischemic \\nheart disease and acute MI, accounting for approximately 50% of all cases \\nof symptomatic VT.\\nOther etiologies include hypertrophic cardiomyopathy, mitral valve pro-\\nlapse, drug toxicity (digoxin, antiarrhythmics, or sympathomimetics), \\nhypoxia, hypokalemia, and hyperkalemia. In general, all wide complex \\ntachycardia should be treated as VT regardless of clinical symptoms or initial \\nvital signs. Adenosine appears to cause little harm in patients with VT; there-\\nfore, stable patients with wide complex tachycardia due to suspected SVT \\nwith aberrancy (see previous section) may be treated safely with adenosine \\nwhen the diagnosis is in doubt. Atypical VT (torsade de pointes, or twisting \\nof the points) occurs when the QRS axis swings from a positive to a negative \\ndirection in a single lead at a rate of 200 to 240 beats/min (Fig. 2-15). Drugs \\nthat further prolong repolarization—quinidine, disopyramide, procainamide, \\nphenothiazines, and tricyclic antidepressants—exacerbate this arrhythmia.\\nEmergency Department Care and Disposition\\n1. Defibrillate pulseless VT with unsynchronized cardioversion starting at \\n150 to 200 J. Treat unstable patients who are not pulseless with synchro-\\nnized cardioversion.\\n2. Treat hemodynamically stable patients with amiodarone  150 mg IV \\nover 10 minutes with repeated boluses every 10 minutes up to a total of \\n2 g. Alternatively, an infusion of 0.5 mg/min over 18 hours may be given \\nFiguRe 2-14. Ventricular tachycardia.\\n02_Cydulka_Ch02.indd   23 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 42, 'page_label': '24'}, page_content='24 SECTION 1: Resuscitation Techniques\\nafter the initial bolus. Second-line agents include procainamide (in \\npatients without suspected MI or LV dysfunction) and lidocaine.\\n3. For patients with torsades de pointes: Try o verdrive pacing set at 90 to \\n120 beats/min to terminate torsades de pointes.\\n4. Magnesium sulfate 1 to 2 g IV over 60 to 90 seconds follo wed by an \\ninfusion of 1 to 2 g/h can be effective.\\n5. Isoproterenol, 2 to 10 μg/min IV infusion, is also used in refractory \\ntorsades but carries a risk of increased myocardial oxygen demand.\\nundifferentiated Wide Complex Tachycardia\\nPatients with wide comple x tachycardia should be approached as having \\nVT until proven otherwise. Age over 35 years, a history of MI, CHF, or \\ncoronary artery bypass grafting strongly favor VT. ECG signs favoring VT \\ninclude A V dissociation, fusion beats, precordial lead QRS concordance, \\nand a QRS duration longer than 0.14 second. It is a misconception that \\npatients with VT are typically unstable. At the bedside, one should assume \\nany new and symptomatic wide complex tachycardia is ventricular in origin \\nand focus on treating the rhythm as VT, as well as any contributing cause, \\nespecially in the unstable patient.\\nVentricular Fibrillation\\nClinical Features\\nVF is the totally disorganized depolarization and contraction of small areas \\nof ventricular myocardium during which there is no effective ventricular \\npumping activity. The ECG shows a fine-to-coarse zigzag pattern without \\ndiscernible P waves or QRS complexes (Fig. 2-16). VF is seen most com-\\nmonly in patients with severe ischemic heart disease, with or without an \\nacute MI. It also can be caused by digoxin or quinidine toxicity, hypother -\\nmia, chest trauma, hypokalemia, hyperkalemia, or mechanical stimulation \\n(e.g., catheter wire). Primary VF occurs suddenly, without preceding hemo-\\ndynamic deterioration, and usually is due to acute ischemia or peri-infarct \\nFiguRe 2-15.  Two examples of short runs of atypical ventricular tachycardia \\nshowing sinusoidal variation in amplitude and direction of the QRS complexes: “Le \\ntorsade de pointes” (twisting of the points). Note that the top example is initiated \\nby a late-occurring PVC (lead II).\\n02_Cydulka_Ch02.indd   24 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 43, 'page_label': '25'}, page_content='CHAPTER 2: Management of Cardiac Rhythm Disturbances 25 \\nscar reentry. Secondary VF occurs after a prolonged period of hemody-\\nnamic deterioration due to left ventricular failure or circulatory shock.\\nEmergency Department Care and Disposition\\n1. Perform immediate electrical defibrillation (unsynchronized) at 200 J \\n(biphasic) and 360 J (monophasic) along with immediate vigorous chest \\ncompressions to augment coronary perfusion. Keep defibrillation pads \\non the patient and in the same location because, with successi ve coun-\\ntershocks, transthoracic impedance decreases.\\n2. If the initial two cycles of cardiopulmonary resuscitation (CPR) and \\ndefibrillation are unsuccessful, administer antiarrhythmic treatment \\nusing amiodarone 300 mg IV push. Lidocaine is second-line and is \\ndosed at 1.5 mg/kg IV followed by 0.75 mg/kg IV for two more doses. \\nRepeat the CPR-defibrillation cycle.\\n3. If no pulse is present after the third CPR-defibrillation cycle, giv e \\nepinephrine 1 mg IV push, or vasopressin 40 units IV push (one time \\nonly), followed by a 20-mL normal saline flush and immediate resump-\\ntion of the CPR-defibrillation cycle.\\n4. In refractory VF, administer magnesium sulfate 1 to 2 g IV over 60 to \\n90 seconds followed by an infusion of 1 to 2 g/h.\\n■ ■DYSRHYTHMIA-ASSOCIATED CONDUCTION \\nABNORMALITIES\\nWolff–Parkinson–White (WPW) Syndrome\\nWPW syndrome is the most common form of ventricular preexcitation \\ninvolving an accessory conduction pathway that bypasses the A V node \\n(Fig. 2-17). The ventricles are activated by an impulse from the atria \\nsooner than would be expected if the impulse were transmitted down the \\nnormal conducting pathway. This premature activation causes initial \\nfusion beat morphology with slurring of initial QRS complex, causing the \\npathognomonic delta wave. Among patients with WPW–PSVT, 80% to \\n90% will conduct in the orthodromic direction and the remaining 10% to \\n20% will conduct in the antidromic direction. ECG findings of atrial fibril-\\nlation or flutter with antidromic conduction down the bypass tract show a \\nwide QRS complex that is irregular with a rate faster than 180 to 200 \\nbeats/min (see Atrial Fibrillation).\\nEmergency Department Care and Disposition\\n1. Treatment of the tachydysrhythmia should be based on the QRS dura -\\ntion and regularity of the rhythm. All unstable patient should be cardio-\\nverted (synchronized) at 150 to 200 J.\\nFiguRe 2-16. Ventricular fibrillation.\\n02_Cydulka_Ch02.indd   25 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 44, 'page_label': '26'}, page_content='26 SECTION 1: Resuscitation Techniques\\n2. Patients with a narrow regular tachycardia should be treated as SVT (ortho-\\ndromic conduction) using vagal maneuvers followed by adenosine, if inef-\\nfective. Refractory cases may require procainamide, 15 to 17 mg/kg IV \\nover 30 minutes up to 50 mg/kg, or until 50% QRS widening is noted.\\n3. All patients with wide QRS tachycardias, whether regular (SVT with \\nantidromic conduction) or irregular (atrial fibrillation with antidromic \\nconduction), should be treated with procainamide.\\n4. Nodal blocking agents such as β-blockers and calcium channel blockers \\nshould be avoided due to the risk of enhancing conduction across the \\nbypass tract.\\n5. Patients with stable recurrent episodes may be monitored after cardiover-\\nsion and discharged to outpatient follow-up. Instability, loss of conscious-\\nness, or other concerning features warrant observation on monitoring for \\nrecurrence. Asymptomatic patients with WPW, found incidentally, warrant \\noutpatient referral to a cardiologist for further evaluation.\\nBrugada Syndrome and Long-QT Syndrome\\nBrugada syndrome and long-QT syndrome increase the risk of spontane-\\nous VT/VF and require evaluation for implantable cardiac defibrillator \\nplacement when diagnosed. Brugada syndrome is a genetic disorder of fast \\nsodium channels causing an RBBB pattern in the early precordial leads \\n(V1–2) with a pathognomonic J-point elevation and saddle-shaped or \\nsloped ST segment (Fig. 2-18). Long-QT syndrome is characterized by a \\nQT interval greater than 470 milliseconds in men and greater than  \\n480 milliseconds in women and may be congenital or acquired, leading to \\nan increased risk of torsades de pointes. The risk of arrhythmia increases \\nsignificantly with QTc durations greater than 500 milliseconds.\\nEmergency Department Care and Disposition\\n1. Recognition of the ECG pattern should prompt close outpatient follow-\\nup with a cardiologist, especially in stable symptomatic patients.\\nFiguRe 2-17. Type A Wolff–Parkinson–White syndrome.\\n02_Cydulka_Ch02.indd   26 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 45, 'page_label': '27'}, page_content='CHAPTER 2: Management of Cardiac Rhythm Disturbances 27 \\n2. Patients presently with unstable rhythms or concerning clinical presen -\\ntations (e.g., drop attacks) should be admitted for monitoring and cardi-\\nology consultation.\\n3. Patients should be advised to avoid an y medications that may poten-\\ntially worsen QT prolongation (http://www.brugadadrugs.org). Patients \\nwith long-QT syndrome should be advised to avoid strenuous exercise, \\nparticularly swimming, which can increase the chance of sudden \\ndeath.\\n■ ■pRETERMINAL RHYTHMS\\nPulseless electrical Activity\\nPulseless electrical activity is the presence of electrical complexes without \\naccompanying mechanical contraction of the heart. Potential mechanical \\ncauses should be diagnosed and treated, including severe hypovolemia, \\ncardiac tamponade, tension pneumothorax, massive pulmonary embolus, \\nMI, and toxic ingestions (e.g., tricyclic antidepressants, calcium channel \\nblockers, β-blockers). In addition, profound metabolic abnormalities such \\nas acidosis, hypoxia, hypokalemia, hyperkalemia, and hypothermia also \\nshould be considered and treated.\\nAfter intubation and initiating CPR, administer epinephrine 1  mg IV/\\nIO (1:10,000 solution) every 3 to 5 minutes. If giving via endotracheal tube, \\nincrease the dose 2 to 2.5 times and follow with several rapid ventilations \\nto disperse the drug. Treatment is guided by rapid identification and treat-\\nment of the underlying cause. Use agents with α-adrenergic activity, such \\nas norepinephrine and phenylephrine, to improve vascular tone when indi-\\ncated. Electrical pacing is not effective.\\nAsystole (Cardiac Standstill)\\nAsystole is the complete absence of cardiac electrical activity and carries \\na grim prognosis. Treatment is the same as that for pulseless electrical \\nactivity.\\nFiguRe 2-18. Brugada syndrome.\\n02_Cydulka_Ch02.indd   27 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 46, 'page_label': '28'}, page_content='28 SECTION 1: Resuscitation Techniques\\n■ ■CARDIAC pACEMAKERS AND AUTOMATED INTERNAL \\nCARDIAC DEFIBRILLATORS (AICDS)\\nPacemakers, AICDs, or combination units may be used in patients with a \\nhistory of sudden death, heart failure, or cardiomyopathy. Malfunction \\ncan occur at any level of the device, including infection or hematoma in \\nthe pocket housing the device, lead infection/displacement, failure to \\npace, failure to sense, overpacing, or inappropriate defibrillation. Most \\npacemakers will have a magnetic switch which, when triggered by \\nmagnet application to the unit, will cause the pacemaker to function in a \\nfixed asynchronous mode.\\nemergency Department Care and Disposition\\n1. Evaluation should include an ECG, electrolytes, and chest x-ray to \\nassess lead position and integrity. Arrangements should be made for \\nelectrical interrogation of the unit.\\n2. Patients with pacing failure may require treatment based on their under-\\nlying rhythm and associated symptoms.\\n3. Patients with overpacing may require magnet application to con vert the \\npacemaker to asynchronous mode pacing at a lower rate.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 18, “Cardiac Rhythm Disturbances,” by William J. \\nBrady, Thomas S. Laughrey, and Chris A. Ghaemmaghami; Chapter 19, “Pharma-\\ncology of Antiarrhythmics and Antihypertensives” by Sara Shields, Rachel M. \\nHolland, R. Dustin Pippin, and Benjamin Small; Chapter 20, “Pharmacology of \\nVasopressors and Inotropes” by Sara Shields and Rachel M. Holland.\\n02_Cydulka_Ch02.indd   28 20/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 47, 'page_label': '29'}, page_content='29\\nResuscitation of Children \\nand Neonates\\nMarc F. Collin\\nChildren primarily develop cardiac arrest secondary to hypoxia from respi-\\nratory arrest or shock syndromes. Because of age and size differences \\namong children, equipment sizes also differ (Table 3-1).\\n■ ■PEDIATRIC CARDIOPULMONARY RESUSCITATION\\nSecuring the Airway\\nThe airway in infants and children is smaller, variable in size, and higher \\nand more anterior than that in the adult. The prominent occiput and rela-\\ntively large tongue and epiglottis may lead to obstruction when the child is \\nin the supine position.\\nMild extension of the neck in the sniffing position opens the airway. \\nThis may be maintained by placing a towel beneath the shoulders. Chin lift \\nor jaw thrust maneuvers may relieve obstruction of the airway related to the \\ntongue. Oral airways are not commonly used in pediatrics but may be use-\\nful in the unconscious child who requires continuous jaw thrust or chin lift \\nto maintain airway patency. Oral airways are inserted by direct visualiza-\\ntion with a tongue blade.\\nA bag-valve-mask system is commonly used for ventilation. Minimum \\nvolume for ventilation bags for infants and children is 450 mL. The tidal \\nvolume necessary to ventilate children is 8 to 10 mL/kg. Observation of \\nchest rise and auscultation of breath sounds will ensure adequate ventilation.\\nEndotracheal intubation usually is performed with a Miller straight \\nblade with a properly sized tube. Resuscitation measuring tapes have been \\nfound to be the most accurate for determining tube size. The formula 16 \\nplus age in years divided by 4 calculates approximate tube size. Uncuffed \\ntubes are commonly used in children up to 8 years, but cuffed tubes can be \\nused in younger children as well.\\nRespiratory rates should be started at 20 breaths/min for infants beyond \\nthe neonatal period, 15 breaths/min for young children, and 10 breaths/min \\nfor adolescents unless hyperventilation is required.\\nRapid Sequence Intubation\\nRapid sequence intubation is the administration of an intravenous (IV) \\nanesthetic with a neuromuscular blocking agent to facilitate endotracheal \\nintubation, and is associated with the highest success and lowest complica-\\ntion rates, compared to other methods. See Table 3-2 for common medica-\\ntions for rapid sequence intubation.\\n1. All equipment and supplies must be prepared. A well-functioning IV \\nline must be in place. A cardiac monitor and oximetry should be used, \\nand if available, noninvasive capnometry as well. The laryngoscope light \\nsource must be checked. Suction equipment should be turned on and \\nimmediately available.\\n3\\nCh APTER\\n03_Cydulka_Ch03.indd   29 20/04/17   2:35 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 48, 'page_label': '30'}, page_content='30 SECTION 1: Resuscitation Techniques\\nTAble 3-1 Length-Based Equipment Chart (Length = Centimeters *)\\nItem 54–70 70–85 85–95 95–107 107–124 124–138 138–155\\nEndotracheal tube size (mm) 3.5 4.0 4.5 5.0 5.5 6.0 6.5\\nLip–tip length (mm) 10.5 12.0 13.5 15.0 16.5 18.0 19.5\\nLaryngoscope 1 straight 1 straight 2 straight 2 straight or curved 2 straight or curved 2–3 straight or curved 3 straight or curved\\nSuction catheter 8F 8F–10F 10F 10F 10F 10F 12F\\nStylet 6F 6F 6F 6F 14F 14F 14F\\nOral airway Infant/small child Small child Child Child Child/small adult Child/adult Medium adult\\nBag-valve mask nfant Child Child Child Child Child/adult Adult\\nOxygen mask Newborn Pediatric Pediatric Pediatric Pediatric Adult Adult\\nVascular access (gauge)\\n  Catheter 22–24 20–22 18–22 18–22 18–20 18–20 16–20\\n Butterfly 23–25 23–25 21–23 21–23 21–23 21–22 18–21\\nNasogastric tube 5F–8F 8F–10F 10F 10F–12F 12F–14F 14F–18F 18F\\nUrinary catheter 5F–8F 8F–10F 10F 10F–12F 10F–12F 12F 12F\\nChest tube 10F–12F 16F–20F 20F–24F 20F–24F 24F–32F 28F–32F 32F–40F\\nBlood pressure cuff Newborn/infant Infant/child Child Child Child Child/adult Adult\\nDirections for use: (1) measure patient length with centimeter tape; (2) using measured length in centimeters, access appropriate equipment column.\\n03_Cydulka_Ch03.indd   30 20/04/17   2:35 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 49, 'page_label': '31'}, page_content='CHAPTER 3: Resuscitation of Children and Neonates 31 \\n2. Preoxygenate with 100% oxygen.\\n3. Cricoid pressure may not be needed because it has been associated with \\ndifficulty with intubation and bag-mask ventilation, and in children, \\ncricoid pressure can occlude the pliable trachea. If cricoid pressure is \\napplied, release pressure if laryngoscop y and intubation are difficult. \\nVisualization may or may not be enhanced by the Backward-Upward-\\nRightward-Pressure on the thyroid cartilage (the “BURP” maneuver), \\nmoving the cords into better view.\\n4. Atropine 0.02 mg/kg (minimum dose 0.1 mg; maximum dose 1 mg) \\nmay be used if symptomatic reflex bradycardia occurs.\\n5. The trachea should be intubated, proper placement confirmed, and the \\ntube secured.\\nTAble 3-2 Common Rapid-Sequence Intubation Medications in Children*\\nMedication Dose† Comments\\nInduction agents\\n Etomidate 0.3 mg/kg Preserves hemodynamic stability; may \\nsuppress adrenal axis even in a single \\ndose; short acting, requires anxiolysis or \\nanalgesia after intubation\\n Ketamine 1–2 mg/kg Bronchodilator, preserves respiratory drive, \\ncardiovascular stimulant; drug of choice \\nfor intubation for asthma and sepsis\\n Propofol 1–2 mg/kg Rapid push, higher dose in infants, may \\ncause hypotension; short acting, requires \\nongoing anxiolysis or analgesia after \\nintubation\\nParalytics\\n Rocuronium 1 mg/kg Nondepolarizing agent; longer duration \\nthan succinylcholine\\n Succinylcholine <10 kg: 1.5–2.0 mg/kg\\n>10 kg: 1.0–1.5 mg/kg\\nShorter duration than rocuronium; better \\nintubating conditions at 60 s; may cause \\nbradycardia in children and hyperkalemic \\ncardiac arrest in children with undiag-\\nnosed neuromuscular disease\\nSedatives\\n Midazolam 0.1 mg/kg Short-acting sedative\\n Lorazepam 0.1 mg/kg Longer-acting sedative\\nAnalgesics\\n Fentanyl 1–2 μg/kg Short-acting analgesic; preserves hemo-\\ndynamic stability\\n Morphine 0.1–0.2 mg/kg Longer-acting analgesic; may cause \\nhistamine release\\n*Premedication is no longer routinely recommended in children due to a lack of supporting evidence.\\n†Rapid-sequence intubation medications can be given IO when IV access cannot be obtained.\\n03_Cydulka_Ch03.indd   31 20/04/17   2:35 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 50, 'page_label': '32'}, page_content='32 SECTION 1: Resuscitation Techniques\\nVascular Access\\nVascular access is obtained in the quickest, least invasive manner possible; \\nperipheral veins (antecubital, hand, foot, or scalp) are tried first. Intraosse-\\nous access is also a quick, safe, and reliable route for resuscitation medica-\\ntions, especially in the critically ill infant or child suffering from \\nhypovolemia or shock. Percutaneous access of the femoral vein or saphe-\\nnous vein cutdown may be attempted, but is more time consuming. Airway \\nmanagement is paramount in pediatric arrest, and should not be delayed \\nwhile obtaining vascular access.\\nThe technique for insertion of the intraosseous line is as follows: the \\nbone most commonly used is the proximal tibia. The anterior tibial \\ntuberosity is palpated with the index finger. The cannulation site is 1 to \\n3 cm below this tuberosity and in the middle of the anteromedial surface \\nof the tibia. Manual and powered devices are commonly used. If a bone \\nmarrow needle is not available, an 18-G spinal needle can be used but is \\nprone to bending. With sterile technique, the needle is inserted in a \\nslightly caudal direction until the needle punctures the cortex. The stylet \\nis removed, and marrow is aspirated to confirm placement. If no marrow \\nis aspirated but the needle is thought to be in place, flushing the needle \\nmay be attempted. Fluids or drugs (including glucose, epinephrine, \\ndopamine, anticonvulsants, and antibiotics) may then be administered as \\nwith a standard IV .\\nFluids\\nIn hypotension or frank shock, IV isotonic fluid (i.e., normal saline solu-\\ntion) boluses of 20 mL/kg should be given as rapidly as possible and \\npotentially repeated, depending on the clinical response. If hypovolemia \\nhas been corrected and shock or hypotension persist, a pressor agent \\nshould be considered.\\nDrugs\\nThe indications for resuscitation drugs are the same for children as for \\nadults; the exception is epinephrine, which is considered first-line therapy \\nin children with bradycardia (Table 3-3).\\nProper drug dosages in children require knowledge of the patient’s weight. \\nThe use of a length-based system for estimating the weight of a child in an \\nemergency situation reduces dosage errors when an exact weight is unavail-\\nable and cannot be safely obtained due to the patient’s medical condition.\\nThe rule of 6s may be used to quickly calculate continuous drug infu-\\nsions of drugs such as dopamine and dobutamine. The calculation is 6 mg \\ntimes weight in kilograms: fill to 100 mL with 5% dextrose in water. The \\ninfusion rate in milliliters per hour equals the microgram per kilogram per \\nminute rate (i.e., an infusion running at 1 mL/h = 1 μg/kg/min, or 5 mL/h \\n= 5 μg/kg/min).\\nEpinephrine is indicated in pulseless arrest and in hypoxia-induced \\nbradycardia unresponsive to oxygenation and ventilation. The initial dose \\nis 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution) IV/IO or 0.1 mg/kg (0.1 \\nmL/kg) of 1:1,000 solution by endotracheal route. Subsequent doses of \\nepinephrine are at the same dose and concentration and may be adminis-\\ntered every 3–5 minutes.\\n03_Cydulka_Ch03.indd   32 20/04/17   2:35 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 51, 'page_label': '33'}, page_content='CHAPTER 3: Resuscitation of Children and Neonates 33 \\nTAble 3-3 Drugs for Pediatric Resuscitation\\nDrug Pediatric Dosage Remarks\\nAdenosine IV/IO: 0.1 mg/kg, followed by \\n2–5 mL NS bolus\\nDouble dose and repeat once, if \\nneeded\\nMaximum single dose: 6 mg first \\ndose, 12 mg second dose.\\nAmiodarone IV/IO: 5 mg/kg over 20–60 min; \\nthen 5–15 μg/kg/min infusion\\nMaximum bolus repetition to \\n15 mg/kg/d. Use lowest effective \\ndose.\\nBolus may be given more rapidly in \\nshock states.\\nAtropine IV/IO: 0.02 mg/kg, repeat in 5 min \\n(minimum single dose is 0.1 mg)\\nEndotracheal: 0.04–0.06 mg/kg \\ndiluted with NS to 3–5 mL\\nMaximum single dose: 0.5 mg \\n(child) and 1 mg (adolescent).\\nMaximum cumulative dose: 1 mg \\n(child) and 2 mg (adolescent).\\nCalcium \\nchloride (10%)\\nIV/IO: 20 mg/kg\\n(maximum dose 2 g)\\nNot routinely recommended. Use in \\ndocumented hypocalcemia, calcium \\nchannel blocker overdose, hyper-\\nmagnesemia, or hyperkalemia. \\nAdminister slowly.\\nEpinephrine Bradycardia:\\nIV/IO: 0.01 mg/kg (0.1 mL/kg of \\n1:10,000)\\nEndotracheal: 0.1 mg/kg (0.1 mL/\\nkg of 1:1000)\\nPulseless arrest:\\nIV/IO: 0.01 mg/kg (0.1 mL/kg of \\n1:10,000)\\nEndotracheal: 0.1 mg/kg (0.1 mL/\\nkg of 1:1000)\\nMaximum dose: 1 mg IV/IO;  \\n2.5 mg ETT.\\nUnlike other agents, epinephrine \\nper endotracheal tube is 10 × the \\nIV dose. Follow endotracheal dose \\nwith several positive pressure \\nventilations.\\nMaximum dose: 1 mg IV/IO;  \\n2.5 mg ETT.\\nNo evidence for high-dose par-\\nenteral epinephrine (may worsen \\noutcomes).\\nGlucose IV/IO:\\nNewborn: 2 mL/kg D10W\\nInfants and children: 2 mL/kg D25W\\nAdolescents: 1 mL/kg D50W\\nLidocaine IV/IO: 1 mg/kg bolus\\nEndotracheal: double IV dose and \\ndilute with NS to 3–5 mL\\nNaloxone IV/IO: If <5 years or ≤20 kg: 0.1 \\nmg/kg\\nIf >5 years and >20 kg: 2.0 mg\\nTitrate to desired effect.\\nSodium \\nbicarbonate\\nIV/IO: 1 mEq/kg (1 mEq/mL) Not routinely recommended.  \\nInfuse slowly and use only \\nif ventilation is adequate for \\ntricyclic antidepressant overdose \\nand hyperkalemia.\\nAbbreviation: D10W, 10% dextrose in water; D25W, 25% dextrose in water; D50W, 50% dextrose in \\nwater; ETT, endotracheal tube; NS, normal saline.\\n03_Cydulka_Ch03.indd   33 20/04/17   2:35 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 52, 'page_label': '34'}, page_content='34 SECTION 1: Resuscitation Techniques\\nSodium bicarbonate is no longer recommended as a first-line resuscita-\\ntion drug. It is recommended only with persistent acidosis after the estab -\\nlishment of effective ventilation, administration of epinephrine, and perfor-\\nmance of chest compressions to ensure adequate circulation.\\nCalcium also is not recommended in routine resuscitation but may be \\nuseful in hyperkalemia, hypocalcemia, and calcium-channel blocker over -\\ndose. Calcium may be given as calcium chloride, 20 mg/kg (0.2 mL/kg of \\n10% solution) or calcium gluconate, 60–100 mg/kg (0.6–1 mL/kg of 10% \\nsolution) via IV or IO route.\\nDysrhythmias\\nDysrhythmias in infants and children are most often the result of respiratory \\ninsufficiency or hypoxia, not of primary cardiac causes, as in adults. Care-\\nful attention to oxygenation and ventilation therefore are cornerstones of \\ndysrhythmia management in children.\\nThe most common rhythm seen in pediatric arrest situations is bradycar-\\ndia leading to asystole. Oxygenation and ventilation are often sufficient \\ntherapy in this situation. Epinephrine may be useful if the child is unrespon-\\nsive to this respiratory intervention.\\nThe next most common dysrhythmia in children is supraventricular \\ntachycardia (SVT), which presents with a narrow-complex tachycardia \\nwith rates between 250 and 350 beats/min. On EKG, p waves are either \\nabsent or abnormal. Adenosine 0.1 mg/kg given via rapid IV push followed \\nby a normal saline flush through a well-functioning IV line as close to the \\ncentral circulation as possible is the recommended treatment for stable SVT \\nin children. This dose may be doubled if the first dose is unsuccessful. \\nTreatment of unstable SVT is synchronized cardioversion at 0.5–1 J/kg. \\nIf not effective, increase to 2 J/kg. Sedation prior to cardioversion is \\nrecommended.\\nIt may be difficult to distinguish between a fast sinus tachycardia and \\nSVT. Young infants may have sinus tachycardia with rates as fast as 200–\\n220 beats/min. The presence of normal p waves is strongly suggestive of \\nsinus tachycardia rather than SVT. Patients with sinus tachycardia may \\nhave a history of fever, dehydration, or shock, while SVT is usually associ-\\nated with a vague, nonspecific history.\\nDefibrillation and Cardioversion\\nVentricular fibrillation and ventricular tachycardia are rare in children. \\nWhen present, immediate defibrillation at 2 J/kg is recommended. Imme-\\ndiately after defibrillation, give 2 minutes of high-quality uninterrupted \\nCPR (five cycles of 15:2 compressions and ventilations) to restore coronary \\nperfusion and improve oxygen delivery to the myocardium before addi-\\ntional attempts at defibrillation. If the first defibrillation attempt is unsuc-\\ncessful, the energy is doubled to 4 J/kg for each subsequent attempt. \\nEpinephrine may also be given and oxygenation and acid–base status \\nshould be reassessed. Synchronized cardioversion is used to treat unstable \\ntachydysrhythmias at a dose of 0.5 J/kg. Double the energy level to 1 J/kg \\nif the first attempt is unsuccessful.\\nThe largest paddles that still allow contact of the entire paddle with the \\nchest wall are used. Electrode cream or paste is used to prevent burns. One \\n03_Cydulka_Ch03.indd   34 20/04/17   2:35 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 53, 'page_label': '35'}, page_content='CHAPTER 3: Resuscitation of Children and Neonates 35 \\npaddle is placed on the right of the sternum at the second intercostal space, \\nand the other is placed at the left midclavicular line at the level of the \\nxiphoid.\\n■ ■NEONATAL RESUSCITATION\\nMost newborns do not require specific resuscitation after delivery, but \\nabout 6% of newborns require some form of life support in the delivery \\nroom. Emergency departments, therefore, must be prepared to provide \\nneonatal resuscitation in the event of delivery in the emergency department.\\n1. The first step in neonatal resuscitation is to maintain body temperature. \\nThe infant should be dried and placed on a radiant warmer . Very-low-\\nbirth-weight newborns (<1500 g) may also be better maintained in a \\nnormothermic state by placement of their torso and limbs in polyethyl-\\nene bags that have been developed for that purpose. Pulse oximetry or \\nECG monitoring is now recommended as an adjunct to newborn \\nresuscitation.\\n2. The airway may be cleared by suctioning the mouth followed by the \\nnose with a b ulb syringe or mechanical suction device. It is now rec-\\nommended that suctioning immediately following birth should be \\nreserved for babies who have obvious obstruction to spontaneous \\nbreathing or who require positive-pressure ventilation. Routine deep \\nsuctioning is no longer recommended due to the potential for vagally \\ninduced bradycardia.\\n3. While aspiration of meconium-stained amniotic fluid may result in \\nboth morbidity and mortality, current evidence indicates that tracheal \\nintubation and suctioning does not help, even in the nonvigorous \\nnewborn.\\n4. The examiner should then assess heart rate, respiratory effort, color, \\nand activity quickly over the next 5–10 seconds. If the infant is apneic \\nor the heart rate is slow (<100 beats/min), positive-pressure ventilation \\nshould be administered with bag-mask ventilation. New research sug-\\ngests that initiating resuscitation with room air may actually result in \\nless morbidity and mortality than 100% oxygen. If the baby is brady-\\ncardic (HR <60 beats/minute) after 90 seconds of resuscitation in \\nroom air (or with blended oxygen), the oxygen concentration should be \\nincreased to 100% until normalization of the heart rate is accom-\\nplished. Assisted ventilation rates of 40–60 breaths/min are recom-\\nmended. Inflation pressure should begin at 20–25 cm H 2O with PEEP \\nof 5 cm H2O. If chest rise is inadequate and the baby is not responding, \\npressures as high as 30–40 cm H 2O may be required initially in some \\nterm infants. Utilization of high pressures should be undertaken with \\nextreme caution, however, especially in preterm infants due to the pos-\\nsibility of pneumothoraces. In mildly depressed infants, a prompt \\nimprovement in heart rate and respiratory effort usually occurs.\\n5. Resuscitation of newborns less than 35 weeks gestation should be initi-\\nated with 21–30% oxygen during positive-pressure ventilation due to \\nconcerns for oxygen toxicity. Free-flow oxygen should begin with 30% \\noxygen. If labored breathing or oxygen desaturations persist even after \\nincreasing to 100% oxygen, a trial of CPAP should be instituted.\\n03_Cydulka_Ch03.indd   35 20/04/17   2:35 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 54, 'page_label': '36'}, page_content='36 SECTION 1: Resuscitation Techniques\\n6. If no heart rate improvement is noted after 15 seconds of bag-mask \\nventilation, then continue PPV for another 15 seconds. If the heart rate \\nis not impro ving and/or chest rise is inadequate, initiate corrective \\nactions as follows: Mask adjustment, Reposition head, Suction mouth \\nand nose, Open mouth, increase Pressure, and consider Alternate air -\\nway (acronym =MR SOPA). If still no improvement, endotracheal \\nintubation and ventilation should be performed. End tidal CO 2 detec-\\ntors may aid in determining whether the baby is properly intubated, but \\nit should be noted that CO 2 detector color change indicating intratra-\\ncheal placement is also dependent on adequate circulation. Proper tube \\nplacement can also be determined by noting good chest rise, visualiza-\\ntion of vapor steam in the endotracheal tube, and auscultation.\\n7. If the heart rate is still slower than 60 beats/min after intubation and \\nassisted ventilation for at least 30 seconds, cardiac massage should be \\nstarted with 90 chest compressions and 30 breaths each minute (3:1 \\nratio). The “2 thumbs-encircling hands” technique is superior to the \\n“2-finger” technique when performing chest compressions.\\n8. If there is no improvement in heart rate after these efforts, drug therapy \\nshould be initiated. Most neonates respond to appropriate airway man-\\nagement; therefore, drug therapy is rarely needed. Vascular access may \\nbe obtained peripherally or via the umbilical vein. The most expedient \\nprocedure in the neonate is to place an umbilical catheter in the umbil-\\nical vein and advance to 10–12 cm or until free flow of blood is seen \\nin the catheter.\\n9. Epinephrine 0.01–0.03 mg/kg of 1:10,000 solution IV push, which \\nequals 0.1–0.3 mL/kg, may be used if the heart rate is still slower than \\n60 beats/min despite adequate ventilation and oxygenation for at least \\n30 seconds and an additional 60 seconds of chest compressions. Repeat \\nevery 3–5 minutes if necessary. New data suggests that intratracheal \\nepinephrine is inferior to the IV route.\\n10. V olume expansion should be considered if hypovolemia is suspected. \\nThis may be the result of blood loss and associated with pallor, slow \\ncapillary refill time, weak pulses, and inadequate response to the other \\nresuscitative measures. An initial dose of 10–20 mL/kg of normal \\nsaline (or Type O/Rh negative blood, if available) is recommended. \\nLactated Ringer’s solution is not recommended.\\n11. Sodium bicarbonate during neonatal resuscitation is now generally \\ncontraindicated during initial resuscitation. A dose of 1 mEq/kg of a \\n4.2% solution (0.5 mEq/mL) IV may be given if there is a significant \\nmetabolic acidosis; this therapy should be guided by blood gas values.\\n12. Naloxone is no longer recommended in the resuscitation for newborns \\nwith respiratory depression.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, \\n8th Edition, see Chapter 109, “Resuscitation of Children” by William E. Hauda, II; \\nChapter 108, “Resuscitation of Neonates” by Marc F. Collin; Chapter 111, “Intuba-\\ntion and Ventilation in Infants and Children” by Robert J. Vissers and Nathan W. \\nMick; and Chapter 112, “Intravenous and Intraosseous Access in Infants and Chil-\\ndren” by Matthew Hansen.\\n03_Cydulka_Ch03.indd   36 20/04/17   2:35 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 55, 'page_label': '37'}, page_content='37\\nFluids, Electrolytes, \\nand Acid-Base Disorders\\nBenjamin W. Wachira\\nManagement of fluids, electrolytes, and acid-base disorders in the emer -\\ngency department (ED) involves immediate correction of life-threatening \\nabnormalities, identification and treatment of the underlying disorder, and \\neventual restoration of normal tissue homeostasis.\\n■ ■FLUIDS\\nCrystalloid fluids for human administration have three general components: \\nwater, electrolytes, and glucose (Table 4-1).\\nBecause the osmolarity of normal saline (NS) and Lactated Ringer’s \\nsolution matches that of serum, they are excellent fluids for volume \\nreplacement. Dextrose solutions are hypotonic and should never be used to \\nreplace volume but may be given as maintenance fluids with or without \\npotassium.\\nHypovolemia and Hypervolemia\\nHypovolemia or hypervolemia can be determined entirely from the history \\nand physical examination. History of bleeding, vomiting, diarrhea, fever, \\nand/or findings of dry mucous membranes with features of poor perfusion, \\nfor example, decreased capillary refill, reduced urine output, and altered \\n4\\nChapter\\nTABlE 4-1 electrolyte Concentrations of Fluids (meq/L)\\nSolution plasma Normal Saline Lactated ringer’s Solution\\nCations\\n   Sodium 142 154 130\\n   Potassium 4 – 4\\n   Magnesium* 2 – –\\n   Calcium† 5 – 3\\n   Total cations 153 154 137\\nanions\\n   Chloride 104 154 109\\n   Lactate‡ – – 28\\n   Phosphates 2 – –\\n   Sulfates 1 – –\\n   Bicarbonate 27 – –\\n   Proteins 13 – –\\n   Organic adds 6 – –\\n   Total anions 153 154 137\\n*Multiply by 0.411 to convert to International System of Units (SI) units in mmol/L.\\n†Multiply by 0.25 to convert to SI units in mmol/L.\\n‡Multiply by 0.323 to convert to SI units in mmol/L.\\n04_Cydulka_Ch04.indd   37 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 56, 'page_label': '38'}, page_content='38 SECTION 1: Resuscitation Techniques\\nlevel of consciousness are suggesti ve of hypovolemia. Lethargy and coma \\nare more ominous signs and may indicate a significant comorbid condition. \\nRisk factors for hypervolemia include renal, cardiovascular, and liver dis-\\neases. Edema (central or peripheral), respiratory distress (pulmonary \\nedema), and jugular venous distention (in congestive heart failure) are \\nclinical features of hypervolemia.\\nBlood pressure and heart rate do not necessarily correlate with vol-\\nume status alone and laboratory values are not reliable indicators of \\nfluid status. Bedside ultrasound can be used to assess the volume status \\nas an adjunct to, not a replacement for, the physical exam. Measure-\\nments of the IVC and following changes in size and respiratory dynam-\\nics over time with fluid challenges effectively determine the vascular \\nvolume status.\\n■ ■eLeCtrOLYte DISOrDerS\\nManagement of electrolyte disorders is guided by two variables: severity of \\nsymptoms and rate of onset. If the clinical picture and the laboratory data \\nconflict, repeat the lab test prior to initiating therapy. Abnormalities should \\nbe corrected at the same rate they develop; however, slower correction is \\nusually safer unless in life-threatening situations which warrant rapid or \\nearly intervention.\\nHyponatremia ([Na+] <138 mEq/l)\\nHyponatremia is a condition of excess water relative to [Na+].\\nClinical Features\\nSymptomatic hyponatremia rarely occurs until [Na +] falls below 135 \\nmEq/L or lower. Symptoms can be divided into moderately severe ([Na +] \\n<130 mEq/L)—headache, nausea, disorientation, confusion, agitation, \\nataxia, and areflexia, and severe ([Na+] <120 mEq/L)—intractable vomit-\\ning, seizures, coma, and ultimately respiratory arrest due to brainstem  \\nherniation.\\nDiagnosis and Differential\\nEvaluate volume status plus measure and calculate plasma osmolality. The \\nformula to calculate effective osmolality is\\n2 × [Na+] + Glucose/18 (Normal range,  275 − 290 mOsm/L)\\nIf values are in SI units (e.g., mmol/L), do not divide by their molecular \\nweight.\\nIn true hyponatremia, plasma osmolality is reduced; in factitious hypo-\\nnatremic states, for example, in the presence of hyperproteinemia and \\nhyperlipidemia, it is normal or increased due to the displacement of serum \\nwater by elevated concentration of lipids or protein creating laboratory \\nmisinterpretation of normal [Na+].\\nThe diagnosis of hyponatremia and its subtypes is based on the clinical \\nfindings of volume status in association with specific laboratory values \\nincluding serum [Na +], serum osmolality, volume status, urinary sodium \\n(UNa\\n+), and urine osmolality (Uosm) (Table 4-2).\\n04_Cydulka_Ch04.indd   38 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 57, 'page_label': '39'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 39 \\nTwo important hyponatremic disorders are the syndrome of inappropri-\\nate ADH secretion (Table 4-3) and the less common cerebral salt-wasting \\nsyndrome. Both conditions are diagnoses of exclusion after dismissing \\nother causes of hyponatremia.\\nMethylenedioxymethamphetamine (MDMA or Ecstasy) induces inap-\\npropriate secretion of ADH and causes increased gut water absorption, and \\nintoxication may lead to profound hyponatremia (see also Chapter 105, \\n“Drugs of Abuse”).\\nEmergency Department Care and Disposition\\n1. Infuse 3% hypertonic saline (Table 4-4)  when [Na +] is less than 120 \\nmEq/L, the patient presents with severe neurologic symptoms, and hy-\\nponatremia is acute.\\n2. After clinical improvement in severe symptoms, stop the 3% hypertonic \\nsaline and either reduce its rate or use a different saline solution, for \\nexample, isotonic (0.9%) saline.\\nTABlE 4-2 Classification, Differential Diagnosis, and Features of hyponatremia \\naccording to Volume Status\\nClinical Conditions\\nOrthostatic \\nhypotension edema\\nHypervolemic \\nhypernatremia\\nCHF\\nCirrhosis\\nNephrotic syndrome\\nAcute and chronic \\nkidney disease\\nAbsent Yes\\nNormovolemic \\nhyponatremia\\nPsychogenic polydipsia\\nGlucocorticoid deficit\\nHypokalemia\\nDrugs\\nSIADH\\nAbsent No\\nRenal hypovolemic \\nhyponatremia\\nDiuretics\\nMineralocorticoid deficit\\nSalt-losing nephropathy\\nNormally present No\\nExtrarenal hypovolemic \\nhyponatremia\\nVomiting\\nDiarrhea\\nNormally present No\\nAbbreviations: CHF, congestive heart failure; SIADH, syndrome of inappropriate ADH secretion.\\nTABlE 4-3 Syndrome of Inappropriate Secretion of antidiuretic hormone \\nDiagnostic Criteria\\nHypotonic hyponatremia with (Posm <275 mOsm/kg H2O)\\nInappropriately elevated urinary osmolality (usually >200 mOsm/kg)\\nElevated urinary [Na+] (typically >20 mEq/L)\\nClinical euvolemia\\nNormal adrenal, renal, cardiac, hepatic, and thyroid functions\\n04_Cydulka_Ch04.indd   39 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 58, 'page_label': '40'}, page_content='40 SECTION 1: Resuscitation Techniques\\n3. Calculate the volume of a saline solution required to raise the serum \\nsodium to the desired amount using the following formula:\\nExpected change in serum Na+(mEq/L) =\\nInfusate Na+(mEq/L) − Serum Na+(mEq/L)/(TBW + 1)\\nTBW estimates are based on age, sex, and weight of the patient. In \\nchildren and adult males <65 years old, TBW is 60% of the weight; in \\nadult females <65 years old and elderly males, TBW is 50% of the weight, \\nin elderly females, TBW is 45% of weight. Three percent hypertonic saline \\ncontains 513 mEq/L of sodium while isotonic (0.9%) saline contains \\n154 mEq/L of sodium.\\n4. For chronic hyponatremia [Na+], do not exceed 6 mEq/24 h in high-risk \\npatients ([Na+] <120 mEq/L, chronic heart failure, alcoholism, cirrhosis, \\nhypokalemia, malnutrition, and treatment with vasopressin antagonists, \\n[e.g., tolvaptan]) or 12 mEq/24 h in low-risk patients. Rapid correction of \\nhyponatremia (> 12 mEq/L/24 h) may cause a neurologic disorder \\nreferred to as osmotic demyelination syndrome.\\nHypernatremia ([Na+] >145 mEq/l)\\nHypernatremia is defined as serum or plasma [Na +] >145 mEq/L and \\nhyperosmolality (serum osmolality >295 mOsm/L).\\nTABlE 4-4 treatment for hyponatremia Symptomatic with Seizures or Coma\\nStep 1 Assess for indication for 3% hypertonic saline: severe symptoms of \\nhyponatremia such as seizures or coma with suspected impending \\nbrainstem herniation in setting of acute * or chronic† hyponatremia\\nStep 2 Infuse 100 mL of 3% hypertonic saline IV over 10–15 min ‡\\nStep 3 Measure serum sodium level after each 3% hypertonic saline \\ninfusion\\nStep 4 Stop infusion when symptoms improve, or a target of 5 mEq/L \\n(range 4–6 mEq/L) increase in serum sodium concentration is \\nachieved.\\nStep 5 May repeat 100 ml of 3% hypertonic saline up to three total doses, \\nor a total of 300 ml IV of 3% hypertonic saline.\\nStep 6 Keep the IV line open with minimal volume of 0.9% normal saline \\nuntil cause-specific treatment is started. Limit increase in sodium \\nlevel to no more than 8 mEq/L during the first 24 hours.\\n*Both European guidelines and U.S. expert panel recommend 3% hypertonic saline infusion for acute \\nlife-threatening hyponatremia, which is most commonly due to self-induced water intoxication during \\nendurance exercise, psychiatric illness, in association with ethylenedioxymethamphetamine intoxication, \\nor intracranial pathology or increased intracranial pressure.\\n†European guidelines state that regardless of onset of acute or chronic hyponatremia, presence of \\nseizures or coma is an indication for brief infusion of hypertonic saline to improve symptoms.\\n‡European guidelines recommend a prompt 150-mL 3% hypertonic saline infusion over 20 minutes, \\nthen checking the serum sodium concentration after 20 minutes while repeating an infusion of 150 mL \\n3% hypertonic saline for the next 20 minutes, repeating this sequence up to twice more, and stopping \\nwith clinical improvement or when target sodium level is reached.\\n04_Cydulka_Ch04.indd   40 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 59, 'page_label': '41'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 41 \\nClinical Features\\nHistory may reveal nausea and vomiting, lethar gy, weakness, increased \\nthirst, low water intake, salt intake, and polyuria (>3000 mL of urine per \\n24 hours). Hypotension, tachycardia, orthostatic blood pressures, sunken \\neyes, dry mucous membranes (symptoms of hypovolemia), altered mental \\nstatus, poor skin turgor, or edema in hypervolemic hypernatremia may be \\npresent on physical examination. Without intervention, coma, seizures, and \\nshock may occur.\\nDiagnosis and Differential\\nBased on volume status, hypernatremia may be classified as hypervolemic \\nhypernatremia (increased total body Na + with normal or increased TBW), \\nnormovolemic hypernatremia (near normal total body Na + and decreased \\nTBW), or hypovolemic hypernatremia (decreased TBW and total body Na+ \\nwith a relatively greater decrease in TBW) (Table 4-5).\\nEmergency Department Care and Disposition\\n1. Treat shock, hypoperfusion, or volume def icits with isotonic (0.9%) \\nsaline or Lactated Ringer’s solution.\\n2. Treat any existing underlying cause, such as diabetes insipidus, vomiting, \\ndiarrhea, or fever.\\n3. Correct the patient’s free water deficit (FWD) using the following formula:\\nFree water deficit = TBW × Posm − 285/Posm\\nTABlE 4-5 hypernatremia Classification and Features according to \\nVolume Status\\nClinical Conditions\\nOrthostatic \\nhypotension edema\\nHypervolemic \\nhypernatremia\\nCushing’s syndrome\\nPrimary hyperaldosteronism\\nSalt water intake\\nIatrogenic\\nAbsent unless treated \\nwith diuretics\\nYes\\nNormovolemic \\nhypernatremia\\nDI\\nCentral DI\\nPartial DI\\nGestational DI\\nNephrogenic DI\\nHypodipsia\\nAbsent No\\nRenal hypovolemic \\nhypernatremia\\nOsmotic diuretics\\nLoop diuretics\\nPostobstructive diuresis\\nNormally present No\\nExtrarenal \\nhypovolemic \\nhypernatremia\\nVomiting\\nDiarrhea\\nGI fistulas\\nSweating\\nBurns\\nNormally present No\\nAbbreviation: DI, diabetes insipidus.\\n04_Cydulka_Ch04.indd   41 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 60, 'page_label': '42'}, page_content='42 SECTION 1: Resuscitation Techniques\\nwhere TBW is calculated based on age and sex (see hyponatremia treat-\\nment section for scale), Posm = 2 × [Na+] + glucose/18, and 285 is used as \\nnormal plasma osmolality. In an alert patient capable of safely drinking water, \\ngive two-thirds free water orally and one-third IV in the form of D5W.\\nIn acute hypernatremia (onset over less than 48 hours), correct at a rate \\nof 1 mEq/L/h. In cases of a lethal sodium chloride ingestion/load (0.75 to \\n3.0 g/kg) <6 hours prior to presentation, FWD may be replaced rapidly \\nwith no reported adverse events. In cases of chronic hypernatremia, correct \\n(lower) the sodium level at a rate of no more than 0.5 mEq/L/h or 10 to \\n12 mEq/24 h to avoid the risk of cerebral edema.\\n4. Hemodialysis may be used as an alternative or as a supplement to D5W \\nto replace FWD in life-threatening acute cases of salt ingestion.\\nHypokalemia ([K+] <3.5 mEq/l)\\nClinical Features\\nSymptoms of hypokalemia (Table 4-6) usually start when serum concentra-\\ntions reach 2.5 mEq/L, although they may appear sooner with rapid \\ndecreases in concentration or appear later (i.e., at even lower [K+]) for \\nchronic depletion.\\nDiagnosis and Differential\\nThe most frequent causes of hypokalemia are listed in Table 4-7.\\nEmergency Department Care and Disposition\\n1. In stable patients with mild hypokalemia (>3.0 mEq/L) who are able to \\ntolerate oral intak e, replacement of K + should be done orally using \\nTABlE 4-6 Symptoms and Signs of hypokalemia\\nCardiovascular Hypertension\\nOrthostatic hypotension\\nPotentiation of digitalis toxicity\\nDysrhythmias (usually tachyarrhythmias)\\nT-wave flattening, QT prolongation, U waves, ST depression\\nNeuromuscular Malaise, weakness, fatigue\\nHyporeflexia\\nCramps\\nParesthesias\\nParalysis\\nRhabdomyolysis\\nGI Nausea, vomiting\\nAbdominal distension\\nIleus\\nRenal Increased ammonia production\\nUrinary concentrating defects\\nMetabolic alkalemia, paradoxical aciduria\\nNephrogenic diabetes insipidus\\nEndocrine Glucose intolerance\\n04_Cydulka_Ch04.indd   42 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 61, 'page_label': '43'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 43 \\nTABlE 4-7 Causes of hypokalemia\\nTranscellular shifts Alkalosis*\\nIncreased plasma insulin (treatment of diabetic \\nketoacidosis)\\nβ-Adrenergic agonists\\nDecreased intake Fasting\\nAlcoholism (worsened by hypomagnesemia)\\nEating disorders\\nGI loss Vomiting*, nasogastric suction\\nDiarrhea* (including laxative, enema abuse)\\nMalabsorption\\nEnteric fistula\\nRenal loss Diuretics (carbonic anhydrase inhibitors, loop \\ndiuretics, and thiazide-like diuretics)*\\nPrimary hyperaldosteronism\\nSecondary hyperaldosteronism\\nRenal tubular acidosis\\nOsmotic diuresis\\nSweat loss Heavy exercise\\nHeat stroke\\nFever\\nOther Hypomagnesemia\\nAcute leukemia and lymphomas\\nHypothermia (accidental or induced)\\n*Frequently encountered etiologies in the ED.\\nfoods rich in K + (fruits, dried fruits, vegetables) as well as salt substi-\\ntutes or K+ supplements.\\n2. When giving IV , use KCl (maximum recommended [K+] in 500 mL of \\na saline solution is 40 mEq, to be infused in 4 to 6 hours) in a peripheral \\nline. If a more aggressive correction is needed, an identical solution can \\nbe administered in a second peripheral line. Higher concentrations can \\nbe administered through a central line, but infusion rates should never \\nexceed 20 mEq/h).\\n3. ECG monitoring is recommended.\\n4. In most cases, hypokalemic patients are also hypomagnesemic. Mg 2+ \\n20 to 60 mEq/24 h may be added to the infusion both to optimize tu-\\nbular reuptake of potassium and to contrast proarrhythmic effect of \\nhypokalemia\\nHyperkalemia ([K+] >5.5 mEq/l)\\nClinical Features\\nCardiac dysrhythmias, such as ventricular f ibrillation, sinoatrial and atrio-\\nventricular blocks until complete heart block, and asystole, may occur. \\nDeath from hyperkalemia is usually the result of diastolic arrest or ven-\\ntricular fibrillation. Other common symptoms include neuromuscular dys-\\nfunctional weakness, paresthesias, areflexia, ascending paralysis, and GI \\neffects (nausea, vomiting, and diarrhea).\\n04_Cydulka_Ch04.indd   43 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 62, 'page_label': '44'}, page_content='44 SECTION 1: Resuscitation Techniques\\nDiagnosis and Differential\\nAppropriate tests for management include an ECG, electrolytes, and blood \\ngases. The most common cause is factitious hyperkalemia due to release of \\nintracellular potassium caused by hemolysis during phlebotomy. Other \\ncauses are listed in Table 4-8.\\nEmergency Department Care and Disposition\\n1. A stat ECG and continuous ECG monitoring is essential in all hyperka-\\nlemic patients. If ECG changes are present (Table 4-9), with or without \\nelectrolyte levels, emergency treatment of hyperkalemia should start \\nimmediately.\\n2. Emergency treatment is divided into three modalities administered \\nsequentially in rapid succession: membrane stabilization (calcium chlo -\\nride (10%) or gluconate (10%)) (crucial for cardiac tissue, must be done \\nimmediately), intracellular shift of K+ (NaHCO3, albuterol, insulin, and \\nglucose), and removal/excretion of K + from the body (furosemide, \\nsodium polystyrene sulfonate, patiromer, hemodialysis) (Table 4-10).\\n3. If acidotic, correct the underlying cause of the acid-base imbalance.\\nTABlE 4-9 eCG Changes associated with hyperkalemia\\n[K+] (meq/L) eCG Changes*\\n6.5–7.5 Prolonged PR interval, tall peaked T waves, short QT interval\\n7.5–8.0 Flattening of the P wave, QRS widening\\n10–12 QRS complex degradation into a sinusoidal pattern\\n*In chronic or slowly developing hyperkalemia, ECG changes may not occur until higher [K +] levels are \\nreached.\\nTABlE 4-8 Causes of hyperkalemia\\nPseudohyperkalemia Tourniquet use\\nHemolysis (in vitro)*\\nLeukocytosis\\nThrombocytosis\\nIntra- to extracellular potassium shift Acidosis*\\nHeavy exercise\\nβ-Blockade\\nInsulin deficiency\\nDigitalis intoxication\\nPotassium load Transfusion of aged blood\\nHemolysis (in vivo)\\nGI bleeding\\nCell destruction after chemotherapy\\nRhabdomyolysis/crush injury*\\nExtensive tissue necrosis\\nDecreased potassium excretion Renal failure*\\nDrugs—potassium-sparing diuretics*\\nAldosterone deficiency*\\n*Frequent or important ED diagnostic considerations.\\n04_Cydulka_Ch04.indd   44 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 63, 'page_label': '45'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 45 \\n4. Consider calcium administration in association with antidigoxin anti-\\nbodies in severe h yperkalemia secondary to digitalis intoxication with \\nadvanced intraventricular conduction impairment (wide, low-voltage \\nQRS complexes).\\nHypomagnesemia\\nClinical Findings\\nHypomagnesemia may present with a wide variety of neuromuscular, GI, \\nand cardiovascular effects (Table 4-11).\\nDiagnosis and Differential\\nTable 4-12 lists the different causes of hypomagnesemia.\\nHypokalemia, hypocalcemia, and hypophosphatemia are often present \\nwith severe hypomagnesemia and must be monitored carefully. Hypocalce-\\nmia does not develop until [Mg2+] falls below 1.2 mg/dL.\\nEmergency Department Care and Disposition\\n1. Treat or stop the cause of the hypomagnesemia.\\n2. For asymptomatic patients (including ECG changes), administer magne-\\nsium supplements orally.\\nTABlE 4-10 emergency therapy of hyperkalemia\\ntherapy Dose and route Onset of action Duration of effect\\nCalcium chloride (10%)* 5–10 mL IV 1–3 min 30–50 min\\nCalcium gluconate (10%)* 10–20 mL IV 1–3 min 30–50 min\\nNaHCO3 50–150 mEq IV 5–10 min 1–2 h\\nAlbuterol (nebulized) 10–20 mg in 4 mL \\nof normal saline, \\nnebulized over 10 min\\n15–30 min 2–4 h\\nInsulin† and glucose‡ 5–10 units regular \\ninsulin IV\\n30 min 4–6 h\\nGlucose 25 g (50% \\nsolution) IV\\nFurosemide 40–80 mg IV Varies Varies\\nSodium polystyrene \\nsulfonate\\n25–50 g PO or PR 1–2 h 4–6 h\\nPatiromer 8.4 g PO 4–7 h 24 h\\nHemodialysis — Minutes Varies\\n*Calcium chloride has three times the elemental calcium when compared to calcium gluconate. 10% \\ncalcium chloride = 27.2 mg [Ca]/mL; 10% calcium gluconate = 9 mg [Ca]/mL. Due to its short duration, \\ncalcium administration (both chloride and gluconate) can be repeated up to four times per hour.\\n†Reduce dose of insulin in patients with renal failure.\\n‡Glucose infusion should be administered after initial bolus to prevent hypoglycemia. Glucose should not \\nbe administered in hyperglycemic patients.\\n04_Cydulka_Ch04.indd   45 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 64, 'page_label': '46'}, page_content='46 SECTION 1: Resuscitation Techniques\\n3. In life-threatening conditions (torsade de pointes, eclampsia), give \\nmagnesium sulfate (MgSO4) 1 to 4 gm or 8 to 32 mEQ diluted in at least \\n100 mL of 5% dextrose or normal saline (0.9%) solution in 10 to 60 min-\\nutes under continuous monitoring: ECG (risk of hypokinetic arrhythmias), \\nTABlE 4-11 Symptoms and Signs of hypomagnesemia\\nNeuromuscular Tetany\\nMuscle weakness\\nChvostek and Trousseau signs\\nCerebellar (ataxia, nystagmus, vertigo)\\nConfusion, obtundation, coma\\nSeizures\\nApathy, depression\\nIrritability\\nParesthesias\\nGI Dysphagia\\nAnorexia, nausea\\nCardiovascular Heart failure\\nDysrhythmias\\nHypotension\\nMiscellaneous Hypokalemia\\nHypocalcemia\\nAnemia\\nTABlE 4-12 Causes of hypomagnesemia\\nRedistribution IV glucose\\nCorrection of diabetic ketoacidosis\\nAcute pancreatitis\\nExtrarenal loss Profuse sweating, burns, sepsis\\nIntestinal or biliary fistula\\nDiarrhea\\nDecreased intake Alcoholism (cirrhosis)\\nMalnutrition, poor intake\\nMalabsorption (steatorrhea)\\nRenal loss Ketoacidosis\\nSaline or osmotic diuresis\\nPotassium depletion\\nPhosphorus depletion\\nDrugs Loop diuretics\\nAminoglycosides\\nAlcohol\\nTheophylline\\nProton pump inhibitors\\nEndocrine disorders Syndrome of inappropriate antidiuretic hormone \\nsecretion\\nHyperthyroidism\\nHyperparathyroidism\\nHypercalcemic states\\n04_Cydulka_Ch04.indd   46 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 65, 'page_label': '47'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 47 \\nnoninvasive blood pressure (risk of hypotension), and ventilatory pattern \\n(risk of respiratory depression, usually preceded by areflexia, that can be \\nmonitored as an alarm sign). As a minor side effect, flushing due to vaso-\\ndilatation is common.\\nHypermagnesemia\\nClinical Findings\\nMagnesium decreases the transmission of neuromuscular messages and \\nthus acts as a CNS depressant and decreases neuromuscular activity \\n(Table 4-13).\\nDiagnosis and Differential\\nSerum [Mg2+] is usually diagnostic. Consider hypermagnesemia in patients \\nwith hyperkalemia or hypercalcemia. Hypermagnesemia also should be \\nsuspected in patients with renal failure, particularly in those who are taking \\nmagnesium-containing antacids or laxatives (Table 4-14).\\nEmergency Department Care and Disposition\\n1. Immediately cease Mg2+ administration.\\n2. If renal failure is not evident, dilution by IV fluids followed by furose -\\nmide (40 to 80 mg IV) may be indicated.\\nTABlE 4-13 Symptoms and Signs of hypermagnesemia\\nLevel (meq/L) Clinical Manifestations\\n2.0–3.0 Nausea\\n3.0–4.0 Somnolence\\n4.0–8.0 Loss of deep tendon reflexes\\n8.0–12.0 Respiratory depression\\n12.0–15.0 Hypotension, heart block, cardiac arrest\\nTABlE 4-14 Causes of hypermagnesemia\\nrenal Failure acute or Chronic\\nIncreased magnesium load Magnesium-containing laxatives, antacids, or \\nenemas*\\nTreatment of pre-eclampsia/eclampsia (mothers and \\nneonates)\\nDiabetic ketoacidosis (untreated)*\\nTumor lysis\\nRhabdomyolysis*\\nIncreased renal magnesium \\nabsorption\\nHyperparathyroidism\\nFamilial hypocalduric hypercalcemia\\nHypothyroidism\\nMineralocorticoid deficiency, adrenal insufficiency \\n(Addison’s disease)\\n*Most likely presentation relevant to the ED.\\n04_Cydulka_Ch04.indd   47 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 66, 'page_label': '48'}, page_content='48 SECTION 1: Resuscitation Techniques\\n3. In severe symptomatic hypermagnesemia, gi ve 10% CaCl 2 10 ML IV \\nover 2 to 3 minutes. Further infusion of 40 to 60 mL during the next 24 \\nhours can be administered.\\n4. Patients with renal failure may benefit from dialysis.\\nHypocalcemia (ionized [Ca2+] level <2.0 mEq/l (<4 mg/dl or <1.1 mmol/l))\\nClinical Features\\nThe severity of signs and symptoms depends greatly on the rapidity of the \\ndecrease in [Ca2+] (Table 4-15).\\nDiagnosis and Differential\\nTable 4-16 lists the most common causes of hypocalcemia and the primary \\nmechanism of each.\\nEmergency Department Care and Disposition\\n1. If a patient is asymptomatic or if the hypocalcemia is not severe or  \\nprolonged for more than 10 to 14 days, give oral Ca2+therapy 500 to \\n3000 mg of elemental calcium daily, in one dose or up to three divided \\ndoses, with or without vitamin D.\\n2. In severe acute hypocalcemia (ionized [Ca 2+] <1.9 mEq/L or <0.95 \\nmmol/L), give 10% CaCl2 10 ml or 10 to 30 mL of 10% Ca2+ gluconate \\nIV over 10 to 20 minutes and repeat every 60 minutes until symptoms \\nresolve or follow with a continuous IV infusion of 10% CaCl2 at 0.02 \\nto 0.08 mL/kg/h (1.4 to 5.6 mL/h in a 70-kg patient).\\n3. Replace magnesium before, or in conjunction with, Ca 2+.\\nTABlE 4-15 Symptoms and Signs of hypocalcemia\\nMuscular Weakness, fatigue\\nSpasms, cramps\\nNeurologic Tetany\\nChvostek sign, Trousseau sign\\nCircumoral and digital paresthesias\\nImpaired memory, confusion\\nHallucinations, dementia, seizures\\nExtrapyramidal disorders\\nDermatologic Hyperpigmentation\\nCoarse, brittle hair\\nDry, scaly skin\\nCardiovascular Heart failure\\nVentricular arrhythmias, torsade de pointes\\nVasoconstriction\\nSkeletal Osteodystrophy\\nRickets\\nOsteomalacia\\nMiscellaneous Dental hypoplasia\\nCataracts\\nDecreased insulin secretion\\n04_Cydulka_Ch04.indd   48 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 67, 'page_label': '49'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 49 \\nHypercalcemia (total [Ca2+] >10.5 mg/dl or an ionized [Ca2+] >2.7 mEq/l)\\nClinical Features\\nHypercalcemic patients with plasma total [Ca 2+] <12.0 mg/dL are usually \\nasymptomatic, but higher levels can cause a wide variety of symptoms \\n(Table 4-17).\\nA mnemonic sometimes used for the signs and symptoms of hypercal-\\ncemia is stones (renal calculi), bones (osteolysis), moans (psychiatric dis-\\norders), and groans (peptic ulcer disease, pancreatitis, and constipation).\\nOn ECG, hypercalcemia may be associated with depressed ST seg-\\nments, widened T waves, and shortened ST segments and QT intervals. \\nBradyarrhythmias may occur, with bundle-branch patterns that may prog-\\nress to second-degree block or complete heart block. Levels of [Ca 2+] \\nabove 20 mg/dL may cause cardiac arrest.\\nDiagnosis and Differential\\nA corrected calcium level should be calculated if albumin is not in the \\nnormal range:\\nCorrected Ca2+(mg/dL) =\\nMeasured total Ca2+(mg/dL) + 0.8(4.0 − Serum  albumin[g/dL])\\nwhere 4.0 represents the average albumin level in g/dL.\\nIf the reference lab reports values in mmol/L, use the following formula:\\nCorrected Ca2+(mmol/L) =\\nMeasured total Ca2+(mmol/L) + 0.02(40 − Serum  albumin[grams/L])\\nwhere 40 represents the average albumin level in g/L.\\nMore than 90% of occurrences are associated with hyperparathyroid-\\nism or malignancy, the latter being the most likely presentation in the ED \\n(Table 4-18).\\nTABlE 4-16 Some Causes of hypocalcemia\\nDecreased calcium absorption\\n   Vitamin D deficiency\\n   Malabsorption syndromes\\nIncreased calcium excretion/reduced bone resorption\\n   Alcoholism\\n   Hypoparathyroidism\\n   Pseudohypoparathyroidism\\n   Hypomagnesemia\\n   Drugs, e.g., phenytoin, phenobarbital, loop diuretics, antibiotics, magnesium sulfate, etc.\\n   Sepsis\\n   Acute pancreatitis\\n   Massive transfusions\\n   Rhabdomyolysis\\n04_Cydulka_Ch04.indd   49 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 68, 'page_label': '50'}, page_content='50 SECTION 1: Resuscitation Techniques\\nTABlE 4-17 Signs and Symptoms of hypercalcemia\\n●■ General\\nMalaise, weakness\\nPolydipsia, dehydration\\n●■ Neurologic\\nConfusion\\nApathy, depression, stupor\\nDecreased memory\\nIrritability\\nHallucinations\\nHeadache\\nAtaxia\\nHyporeflexia, hypotonia\\nMental retardation (infants)\\n●■ Metastatic calcification\\nBand keratopathy\\nConjunctivitis\\nPruritus\\n●■ Skeletal\\nFractures\\nBone pain\\nDeformities\\n●■ Cardiovascular\\nHypertension\\nDysrhythmias\\nVascular calcifications\\nECG abnormalities\\nQT shortening\\nCoving of ST-T wave\\nWidening of T wave\\nDigitalis sensitivity\\n●■ Gastrointestinal\\nAnorexia, weight loss\\nNausea, vomiting\\nConstipation\\nAbdominal pain\\nPeptic ulcer disease\\nPancreatitis\\n●■ Urologic\\nPolyuria, nocturia\\nRenal insufficiency\\nNephrolithiasis\\nEmergency Department Care and Disposition\\n1. For symptomatic patients or asymptomatic patients with [Ca 2+] levels \\n>14 mg/dL, give 0.9% normal saline at 500 to 1000 mL/h for 2 to  \\n4 hours as tolerated by the patient. In general, 3 to 4 L should be given \\nover the first 24 hours, then 2 to 3 L per 24 hours until a urine output of \\n2 L/d is achieved.\\n04_Cydulka_Ch04.indd   50 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 69, 'page_label': '51'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 51 \\n2. Furosemide 20 to 40 mg is recommended to promote a diuresis of 150 \\nto 200 mL/h, which increases the calciuric effect.\\n3. Decreased mobilization of [Ca2+] from bone through reduction of osteo-\\nclastic activity can be obtained with corticosteroids, such as prednisone \\n1 to 2 mg/kg PO, or hydrocortisone, 200 to 300 mg IV initial dose, in \\nAddison’s disease or in steroid-responsive malignancies. For hypercal-\\ncemia associated with malignancy, give intravenous bisphosphonates \\n(pamidronate or zoledronate (zoledronic acid)). Zoledronic acid 4 mg \\nIV as a single dose over 15 minutes is recommended for a corrected \\n[Ca2+] level of 12 mg/dL or higher. Calcitonin 4 U/kg SC or IM works \\nmore rapidly than bisphosphonates.\\n4. In very severe cases, initiate hemodialysis.\\nHypophosphatemia ([PO3\\n4\\n-] <2.5 mg/dl)\\nClinical Features\\nSevere symptoms may not occur until the [PO 3\\n4\\n−] level drops to <1 mg/dL \\n(Table 4-19).\\nTABlE 4-18 Causes of hypercalcemia\\nHypercalcemia due to increased bone Ca2+resorption\\nPrimary hyperparathyroidism\\nMalignancy\\nPseudohyperparathyroidism\\nRenal failure\\nAddison’s disease\\nHyperthyroidism\\nImmobilization\\nHypercalcemia due to decreased urinary Ca2+excretion\\nFamilial hypercalcemic hypocalciuria\\nThiazides\\nHypercalcemia due to increased GI Ca2+ absorption\\nGranulomatous diseases (sarcoidosis, tuberculosis, coccidioidomycosis, histoplasmosis)\\nMilk (calcium)-alkali syndrome\\nVitamin D intoxication\\nTABlE 4-19 Symptoms and Signs of hypophosphatemia\\n●■ Hematologic\\nReduced survival and function of platelets and red and white blood cells\\nImpaired macrophage function\\n●■ Neuromuscular\\nWeakness, tremors, circumoral and fingertip paresthesias, decreased deep tendon \\nreflexes, decreased mental status, anorexia\\n●■ Cardiac\\nImpaired myocardial function\\n●■ Metabolic\\nInsulin resistance\\n04_Cydulka_Ch04.indd   51 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 70, 'page_label': '52'}, page_content='52 SECTION 1: Resuscitation Techniques\\nDiagnosis and Differential\\nCauses of hypophosphatemia are listed in Table 4-20.\\nEmergency Department Care and Disposition\\n1. When symptomatic, correct both orally and IV (Table 4-21).\\n2. In asymptomatic or mildly symptomatic patients, give 50 mmol/d orally \\nfor 7 to 10 days\\n3. In severe hypophosphatemia, higher doses may be necessary.\\nTABlE 4-20 Causes of hypophosphatemia\\nShift from ECF to ICF without depletion of \\n[PO3\\n4\\n−]\\nGlucose\\nInsulin\\nCatecholamines\\nRespiratory alkalosis\\nShift from ECF to ICF with depletion of \\n[PO3\\n4\\n−]\\nHyperalimentation\\nRefeeding syndrome\\nDecreased intestinal absorption Low intake\\nMalabsorption\\nChronic use of calcium acetate or \\nbicarbonate, aluminum hydroxide\\nVitamin D deficiency\\nIncreased renal loss Hyperparathyroidism\\nTubular acidosis\\nFanconi’s syndrome\\nHypokalemia\\nHypomagnesemia\\nPolyuria\\nAcidosis\\nMiscellaneous causes Alcoholism (poor intake, vitamin D  \\ndeficiency)\\nDiabetic ketoacidosis (osmotic diuresis)\\nToxic shock syndrome\\nDrugs Osmotic diuretics, loop diuretics, carbonic \\nanhydrase inhibitor, acyclovir, acetamino-\\nphen, tyrosine kinase inhibitors, bisphos-\\nphonates, aminoglycosides, tetracyclines, \\nvalproic acid, cyclophosphamide, cisplatin, \\nand corticosteroids\\nAbbreviations: ECF, extracellular fluid; ICF, intracellular fluid.\\nTABlE 4-21 IV [pO3\\n4\\n−] replacement Dose (6 to 72 hours)\\nSerum [pO3\\n4\\n−] (mg/dL) Dose (mmol/kg) Duration (hours)\\n<1 0.6 6–72\\n1–1.7 0.3–0.4 6–72\\n1.8–2.2 0.15–0.2 6–72\\n04_Cydulka_Ch04.indd   52 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 71, 'page_label': '53'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 53 \\nHyperphosphatemia ([PO3\\n4\\n-] >4.5 mg/dl)\\nClinical Features\\nThe acute symptoms are due to renal failure, hypocalcemia, and hypomag-\\nnesemia.\\nDiagnosis and Differential\\nThe causes of hyperphosphatemia can be divided into three groups accord-\\ning to mechanism (Table 4-22).\\nEmergency Department Care and Disposition\\nPhosphate binders such as calcium carbonate or calcium acetate may be \\nused. In very high [PO3\\n4\\n−] levels, institute hemodialysis.\\n■ ■aCID-BaSe DISOrDerS\\nAcid-base disturbances are classified as respiratory or metabolic. Respira-\\ntory acid-base disorders are due to primary changes in PCO2, and metabolic \\nacid-base disorders reflect primary changes in [HCO 3\\n−].\\nClinical Features\\nHistory should emphasize events that may result in the gain or loss of acid \\nor base, such as vomiting, diarrhea, medications, or ingestions of toxins, \\nand seek evidence of dysfunction of the organs of acid-base homeostasis—\\nthe liver, kidneys, and lungs.\\nDiagnosis and Differential\\nDiagnosis and differential must begin with defining the nature of the acid-\\nbase disorder and then determining the most likely etiology. Determine \\nblood gases (pH, PCO 2, and [HCO 3\\n−]) from an arterial puncture, though \\nvenous or capillary blood may also be used. Evaluate electrolytes ([Na +], \\n[K+], [Cl–], and [HCO 3\\n−]), and other factors that affect the patient’s acid-\\nbase status (albumin, lactic acid, creatinine, BUN, drug levels of suspected \\nTABlE 4-22 Causes of hyperphosphatemia\\nDecrease in renal excretion of [PO3\\n4\\n−] Acute and chronic renal failure*\\nHypoparathyroidism, pseudohypoparathyroidism\\nShift of [PO3\\n4\\n−] from ICF to ECF Hemolysis*\\nRhabdomyolysis*\\nTumor lysis syndrome\\nRespiratory acidosis\\nDiabetic ketoacidosis\\nAddition of [PO3\\n4\\n−] exogenous to the ECF Oral or IV treatment of hypophosphatemia\\nPhosphate-containing laxatives, antacids*\\nDrugs Excess of vitamin D\\nGrowth hormone\\nBisphosphonates\\n*Most likely presentation relevant to the ED.\\n04_Cydulka_Ch04.indd   53 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 72, 'page_label': '54'}, page_content='54 SECTION 1: Resuscitation Techniques\\ningestions, such as salicylate). Based on current history and physical and \\npast medical history, consider the need for calcium, magnesium, phosphate, \\nserum ketones and glucose, serum osmolality, and urine electrolytes, osmo-\\nlality, and glucose.\\nDefining the Nature of the Acid-Base Disorder (Figure 4-1)\\nUse the patient’s pre-illness values as a baseline if available; the normal pH \\nrange is 7.35 to 7.45 (95% CI), the normal PCO 2 range is 35 to 45 mm Hg \\n(95% CI), and the normal [HCO3\\n−] is usually 21 to 28 mEq/L (95% CI). \\nHowever, a patient’s values may all fall within the “normal range” and still \\nhave significant acid-base disturbances.\\n1. Examine the pH for acidosis (pH <7.35) or alkalosis (pH > 7.45).\\n2. Establish the primary mechanism by evaluating the [ HCO3\\n−] and PCO2.\\n∆ ↓ P\\nCO\\n2 > ∆ ↓[HCO\\n3\\n– ] ∆ ↓ P\\nCO\\n2 < ∆ ↓[HCO\\n3 –]\\n∆ ↓ PCO2 =\\n∆ ↓[HCO3–]\\npH <7 .35\\n[HCO\\n–3 low]\\nPCO\\n2  elevated (>40)\\nCheck Respiratory\\nacidosis\\nRespiratory\\nacidosis\\nalso\\nNormal\\nrespiratory\\ncompensation\\nMetabolic\\nacidosis\\nalso*\\nMetabolic\\nacidosis\\nalso\\nNormal\\nA.G. type\\nmetabolic\\nacidosis\\nalso\\nPure\\nAcute\\nAcute\\nor\\nchronic\\nMetabolic\\nalkalosis\\nalso\\nRespiratory\\nalkalosis\\nalso\\nCheck\\nMetabolic\\nacidosis\\n∆ ↓ PCO2\\n∆ ↓ [HCO3–]\\n∆ ↑ AG\\n∆ ↓ [HCO3\\n–]\\n∆ ↑ [H+]\\n∆ ↑ PCO2\\n∆ ↑ AG\\n > ∆ ↓[HCO\\n3\\n– ] ∆ ↑ AG\\n < ∆ ↓[HCO\\n3 –]\\n∆ ↑ AG = \\n∆ ↓[HCO3–]\\nWide\\nAG type\\nNormal\\nAG type\\nCheck\\nChronic\\n>0.8 0.8\\n0.8 to 0.33\\n0.33 <0.33\\nKey: * It is likely that [HCO3\\n–] is <25 in this scenario and the tree could have been started on the left.\\nAG, anion gap.\\nA\\nFigurE 4-1. A. Algorithm for determination of type of acidosis. AG, anion gap = \\n[Na+] – ([HCO3\\n−] + [Cl–]) (normal value 12 ± 4 mEq/L). B. Algorithm for determina-\\ntion of type of alkalosis. C. Algorithm to check for acid-base disturbances when pH is \\nwithin the “normal” range. ∆AG, delta gap, is a relative change in the AG which may \\nbe more important than the actual AG value. Virtually all AG values >15 mEq/L can be \\nconsidered abnormal, even when there are no previous comparison values available.\\n04_Cydulka_Ch04.indd   54 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 73, 'page_label': '55'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 55 \\npH >7.45\\n[HCO\\n– 3] high\\nP\\nCO\\n2  low\\nCheck\\nCheck Respiratory\\nacidosis\\nRespiratory\\nacidosis\\nalso\\nNormal\\nventilatory\\nresponse\\nRespiratory\\nalkalosis\\nalso\\nMetabolic\\nalkalosis\\n∆ ↑ PCO2\\n∆ ↑ [HCO3\\n–]\\n<0.7\\n<0.4 0.4 0.75\\n>0.7\\nMetabolic\\nacidosis\\nalso*\\nAcute\\nMetabolic\\nalkalosis\\nalso\\n∆ ↓ [H+]\\n∆ ↓ PCO2\\nChronic\\nKey: *Implies that the ∆ in [H+] is not low,\\nbut elevated, and thus the pH would be\\n<7.40. Therefore, this algorithm would\\nnot be selected but rather Fig. 15-2A.\\nIt is likely that the HCO3\\n– will be >25\\nin this scenario and then the tree could\\nhave started on the left. AG, anion gap.\\n0.7\\n>0.75\\nB\\n∆ AG\\nOr\\nMetabolic acidosis\\nand respiratory alkalosis\\n↓ PCO2 and\\n↓[HCO\\n3\\n– ]\\n↑ P\\nCO\\n2 and↑[HCO\\n3 –]\\nPCO2 and\\n[HCO3–] normal\\nNormal Wide AG type\\nMetabolic acidosis\\nand\\nMetabolic alkalosis\\nNon-AG type\\nMetabolic acidosis and\\nMetabolic alkalosis\\n(unlikely scenario)\\nNo change\\nIncreased\\nC\\nMetabolic alkalosis\\nand respiratory acidosis\\n7.35< pH <7.45\\nFigurE 4-1. Continued\\n04_Cydulka_Ch04.indd   55 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 74, 'page_label': '56'}, page_content='56 SECTION 1: Resuscitation Techniques\\nMetabolic Acidosis\\nMetabolic acidosis may be divided into elev ated AG acidosis (Table 4-23) \\nand normal AG acidosis (Table 4-24).\\nClinical Features\\nPatients may complain of abdominal pain, headache, nausea with or with-\\nout vomiting, and generalized weakness, and because acidosis stimulates \\nthe respiratory center, the patient may complain of dyspnea.\\nTABlE 4-23 Causes of elevated anion Gap Metabolic acidosis\\nRenal failure (uremia)\\nKetoacidosis\\n    Diabetic\\n    Alcoholic\\n    Starvation\\nLactic acidosis*\\n    Sepsis\\n    Cardiac arrest\\n    Liver failure\\n    Iron\\n    Metformin\\n    Cyanide\\n    Carbon monoxide\\n    Thiamine deficiency\\nExogenous poisoning*\\n    Methanol\\n    Ethylene glycol (EG)\\n    Salicylate\\n    Isoniazid\\n*This is not an exhaustive list; several other causes exist.\\nTABlE 4-24 Causes of Normal anion Gap Metabolic acidosis\\nWith a tendency to hyperkalemia With a tendency to hypokalemia\\nSubsiding diabetic ketoacidosis Renal tubular acidosis, type I (classical distal \\nacidosis)\\nEarly uremic acidosis Renal tubular acidosis, type II (proximal acidosis)\\nEarly obstructive uropathy Acetazolamide\\nRenal tubular acidosis, type IV Acute diarrhea with losses of HCO3\\n− and K+\\nHypoaldosteronism (Addison’s \\ndisease)\\nUreterosigmoidostomy with increased resorption \\nof [H+] and [Cl–] and losses of HCO3\\n− and K+\\nInfusion or ingestion of HCl, NH4 Cl, \\nlysine-HCl, or arginine-HCl\\nObstruction of artificial ileal bladder\\nPotassium-sparing diuretics Dilution acidosis (may occur with 0.9%  \\nNaCl infusion)\\n04_Cydulka_Ch04.indd   56 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 75, 'page_label': '57'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 57 \\nDiagnosis and Differential\\nThe differential diagnoses to be considered in emergency practice f all into \\nfour broad categories: renal failure (uremia), ketoacidosis (diabetic keto-\\nacidosis, alcoholic ketoacidosis, starvation ketoacidosis), lactic acidosis, \\nand ingestions (methanol, ethylene glycol, salicylates, and many others). \\nLactic acidosis is not a diagnosis, but a syndrome with its own differential \\ndiagnosis (Table 4-23).\\nEmergency Department Care and Disposition\\n1. Treat the underlying disorder with particularly emphasis on restoration \\nof normal tissue perfusion and oxygenation.\\n2. Determine whether there is a respiratory component to the acidosis (i.e., a \\nprimary respiratory acidosis). With normal respiratory compensation,  \\nPCO2 decreases by 1 mm Hg for every 1 mEq/L net decrease in [HCO3\\n−]. \\nIf there is inadequate respiratory compensation, correct the respiratory \\nproblem.\\n3. Address electrolyte disturbances.\\n4. Administer antidotes for toxins as appropriate, and initiate treatment for \\nunderlying causes such as sepsis (see Chapter 88, “Toxic Shock”) or \\ndiabetic ketoacidosis (see Chapter 129, “Diabetic Emergencies”).\\n5. Use of bicarbonate therapy for cardiac arrest, diabetic ketoacidosis, and \\nlactic acidosis, has not shown an y benefit. Pediatric patients with dia-\\nbetic ketoacidosis treated with bicarbonate have an increased rate of \\ndevelopment of cerebral edema. The goal of bicarbonate and dialysis \\ntherapy in lactic acidosis may be to “bridge” the patient physiologially \\nto definitive treatment of the etiology of the acidosis. Bicarbonate ther -\\napy may be appropriate for limited indications (Table 4-25).\\nTABlE 4-25 potential Indications for Bicarbonate therapy in Metabolic acidosis\\nIndication rationale\\nSevere hypobicarbonatemia (<4 mEq/L) Insufficient buffer concentrations may lead \\nto extreme increases in academia with \\nsmall increases in acidosis.\\nSevere acidemia (pH <7.00–7.15)* in cases \\nof wide anion gap acidosis, with signs of \\nshock or myocardial irritability that has not \\nresponded to supportive measures includ-\\ning adequate ventilation and fluid resusci-\\ntation as indicated by the patient’s clinical \\ncharacteristics\\nTherapy for the underlying cause of \\nacidosis depends on adequate organ \\nperfusion.\\nSevere hyperchloremic acidemia† Lost bicarbonate must be regenerated by \\nkidneys and liver, which may require days.\\n*Presented as a range because recommendations differ among authors; data do not support a specific \\nthreshold for treatment.\\n†No specific threshold indication by pH exists. The presence of serious hemodynamic insufficiency \\ndespite supportive care should guide the use of bicarbonate therapy for this indication.\\n04_Cydulka_Ch04.indd   57 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 76, 'page_label': '58'}, page_content='58 SECTION 1: Resuscitation Techniques\\nWhen given, HCO3\\n− be dosed 0.5 mEq/kg for each milliequivalent per liter \\nrise [HCO3\\n−] desired. The goal is to restore adequate buffer capacity \\n([HCO3\\n−] >8 mEq/L) or to achieve clinical improvement in shock or dys-\\nrhythmias. Bicarbonate should be given as slowly as the clinical situation \\npermits. Seventy-five milliliters of 8.4% sodium bicarbonate in 500 mL of \\ndextrose 5% in water produces a nearly isotonic solution for infusion.\\nMetabolic Alkalosis\\nMetabolic alkalosis results from gain of bicarbonate or loss of acid. It is \\ntypically classified as [Cl−] sensitive and [Cl−] insensitive.\\nClinical Features\\nPatients may complain of generalized weakness, dizziness, myalgia, palpi-\\ntations, nausea with or without vomiting, paresthesia, and possibly muscle \\nspasm or twitching. Neurologic abnormalities, especially tetany, neuromus-\\ncular instability, and seizures, are common.\\nDiagnosis and Differential\\nConditions producing “chloride-responsive alkalosis” result in chloride \\nloss, for example, vomiting (which also causes acid loss), diarrhea, diuretic \\ntherapy, and chloride-wasting diseases (e.g., cystic fibrosis and chloride-\\nwasting enteropathy), which tend to reduce serum chloride concentration \\nand extracellular volume. Conditions producing “chloride-unresponsive \\nalkalosis” and hypertension include renal artery stenosis, renin-secreting \\ntumors, adrenal hyperplasia, hyperaldosteronism, Cushing’s syndrome, \\nLiddle’s syndrome, and exogenous mineralocorticoids (e.g., licorice, \\nfludrocortisone). Chloride-unresponsive alkalosis caused by Bartter’s and \\nGitelman’s syndromes is usually associated with normotension. Alkalosis \\nresults in reductions in ionized calcium, potassium, magnesium, and phos-\\nphate levels.\\nEmergency Department Care and Disposition\\n1. Treat the underlying cause with careful supportive care.\\n2. If alkalosis is severe ([HCO3\\n−] >45 mmol/L) and associated with serious \\nsigns or symptoms not responsive to supportive care, consider IV hydro-\\nchloric acid.\\nrespiratory Acidosis\\nRespiratory acidosis is defined by alveolar h ypoventilation and is diag-\\nnosed when the PCO2 is greater than the expected value.\\nClinical Features\\nThe clinical picture usually is dominated by the underlying disorder. Typi-\\ncally, respiratory acidosis depresses the mental function, which may pro-\\ngressively slow the respiratory rate. Patients may be confused, somnolent, \\nand, eventually, unconscious.\\n04_Cydulka_Ch04.indd   58 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 77, 'page_label': '59'}, page_content='CHAPTER 4: Fluids, Electrolytes, and Acid-Base Disorders 59 \\nDiagnosis and Differential\\nInadequate ventilation most frequently results from head trauma, chest \\ntrauma, lung disease, or excess sedation. The chronic h ypoventilation seen \\nin extremely obese patients is often referred to as the Pickwickian Syn-\\ndrome. Patients with severe chronic obstructive pulmonary disease have \\nincreased dead space and frequently also have decreased minute ventila-\\ntion. Pulse oximetry may be misleading, making arterial blood gases essen-\\ntial for the diagnosis.\\nEmergency Department Care and Disposition\\n1. Improve alveolar ventilation.\\n2. Ventilatory assistance (intubation or noninvasi ve ventilatory support) \\nmay be required in some patients who do not respond adequately to \\nlesser measures, particularly if the pH falls below 7.25.\\n3. Treat the underlying disorder.\\nrespiratory Alkalosis\\nRespiratory alkalosis is defined by alveolar hyperventilation and exists \\nwhen PCO2 is less than expected.\\nClinical Features\\nSymptoms of hyperventilation include dizziness, carpal-pedal spasm, and, \\nfrequently, a chest pain described as tightness.\\nDiagnosis and Differential\\nIt is caused by conditions that stimulate respiratory centers, including CNS \\ntumors or stroke, infections, pregnancy, hypoxia, and toxins (e.g., salicy-\\nlates). Anxiety, pain, and iatrogenic overventilation of patients on mechan-\\nical ventilators also cause respiratory alkalosis.\\nEmergency Department Care and Disposition\\n1. Identify and treat the underlying cause.\\n2. Rule out life-threatening causes of hyperventilation before diagnosing \\nanxiety. The use of “paper-bag” rebreathing in the treatment of respira-\\ntory alkalosis should be avoided because it may lead to hypoxia, and \\npatients respond to calm reassurance, which is more effective treatment.\\n■ ■FUrther reaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 15, “Acid-Base Disorders,” by Gabor D. Kelen, David \\nD. Nicolaou and David M. Cline; Chapter 17, “Fluids and Electrolytes,” by \\nRoberta Petrino and Roberta Marino.\\n04_Cydulka_Ch04.indd   59 01/05/17   10:20 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 78, 'page_label': '60'}, page_content='60\\nTherapeutic Approach to  \\nThe Hypotensive Patient\\nSaurin P . Bhatt\\nShock is circulatory insufficiency that creates an imbalance between tissue \\noxygen supply (delivery) and oxygen demand (consumption). Such tissue \\nhypoperfusion is associated with decreased venous oxygen content and \\nmetabolic acidosis (lactic acidosis). Shock is classified into four categories \\nbased on etiology: (a) hypovolemic, (b) cardiogenic, (c) distributive (e.g., \\nneurogenic and anaphylactic), and (d) obstructive.\\n■ ■CLINICAL FEATURES\\nFactors that influence the clinical presentation of a patient in shock include \\nthe etiology, duration, and severity of the shock state and the underlying \\nmedical status of the patient. Often the precipitating cause of shock may be \\nreadily apparent (e.g., acute myocardial infarction, trauma, gastrointestinal \\n[GI] bleeding, or anaphylaxis). It is not uncommon for the patient to present \\nwith nonspecific symptoms (e.g., generalized weakness, lethargy, or altered \\nmental status). A targeted history of the presenting symptoms and previ-\\nously existing conditions (e.g., cardiovascular disease, GI bleeding, adrenal \\ninsufficiency, or diabetes) will aid in identifying the cause and guide the \\ninitial treatment of shock. Drug use (prescribed and nonprescribed) is an \\nessential element of the initial history. Medication use may be the cause or \\na contributing factor to the evolution of shock. For example, diuretics can \\nlead to volume depletion and cardiovascular medications (e.g., β-blockers) \\ncan depress the pumping action of the heart. The possibility of drug toxicity \\nand anaphylactic reactions to medications also should be considered.\\nAssessment of vital signs is a routine part of the physical examination; \\nhowever, no single vital sign or value is diagnostic in the evaluation of the \\npresence or absence of shock. The presence of hyperthermia or hypother -\\nmia may be a result of endogenous factors (e.g., infections or hypometa-\\nbolic states) or exogenous causes (e.g., environmental exposures). The \\nheart rate is typically elevated; however, bradycardia may be present with \\nmany conditions, such as excellent baseline physiologic status (young \\nathletes), intraabdominal hemorrhage (secondary to vagal stimulation), \\ncardiovascular medication use (e.g., β -blockers and digoxin), hypoglyce-\\nmia, and preexisting cardiovascular disease.\\nThe respiratory rate is frequently elevated early in shock. Increased \\nminute ventilation, increased dead space, bronchospasm, and hypocapnia \\nmay be seen. As shock progresses, hypoventilation, respiratory failure, and \\nrespiratory distress syndrome may occur.\\nShock is usually, but not always, associated with systemic arterial hypo-\\ntension, defined as a systolic blood pressure (BP) below 90 mm  Hg. The \\ninsensitivity of blood pressure to detect global tissue hypoperfusion has \\nbeen repeatedly conf irmed. Thus, shock may occur with a normal blood \\npressure, and hypotension may occur without shock. Early in shock, the \\nsystolic and diastolic BPs may initially be normal or elevated in response \\nto a compensatory mechanism such as tachycardia and vasoconstriction.  \\n5\\nCh APTER\\n05_Cydulka_Ch05.indd   60 20/04/17   2:39 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 79, 'page_label': '61'}, page_content='CHAPTER 5: Therapeutic Approach to The Hypotensive Patient  61 \\nAs the body’s compensatory mechanisms fail, BP typically falls. Postural \\nchanges in BP, commonly seen with hypovolemic states, will precede overt \\nhypotension. The pulse pressure, the difference between systolic and dia-\\nstolic BP measurements, may be a more sensitive indicator. The pulse pres-\\nsure usually rises early in shock and then decreases before a change in the \\nsystolic BP is seen.\\nIn addition to these vital sign abnormalities, physical examination find-\\nings in shock may include neck vein distention or flattening and cardiac \\ndysrhythmias. A third heart sound (S3) may be auscultated in high-output \\nstates. Decreased coronary perfusion pressures can lead to myocardial isch-\\nemia, decreased ventricular compliance, increased left ventricular diastolic \\npressures, and pulmonary edema.\\nDecreased cerebral perfusion leads to mental status changes such as \\nweakness, restlessness, confusion, disorientation, delirium, syncope, and \\ncoma. Patients with long-standing hypertension may exhibit these changes \\nwithout severe hypotension. Cutaneous manifestations may include pallor, \\npale or dusky skin, sweating, bruising, petechiae, cyanosis (may not be \\nevident if the hemoglobin level is less than 5 g/dL), altered temperature, and \\ndelayed capillary refill.\\nGI manifestations resulting from low flow states may include ileus, GI \\nbleeding, pancreatitis, acalculous cholecystitis, and mesenteric ischemia. \\nTo conserve water and sodium, levels of aldosterone and antidiuretic hor -\\nmone are increased. This results in a reduced glomerular filtration rate, \\nredistribution of blood flow from the renal cortex to the renal medulla, and \\noliguria. In sepsis, a paradoxical polyuria may occur and be mistaken for \\nadequate hydration.\\nEarly in shock a common metabolic abnormality is a respiratory alkalo-\\nsis. As the shock state continues and compensatory mechanisms begin to \\nfail, anaerobic metabolism occurs, leading to the formation of lactic acid \\nand resulting in a metabolic acidosis. Other metabolic abnormalities that \\nmay be seen are hyperglycemia, hypoglycemia, and hyperkalemia.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe clinical presentation and presumed etiology of shock will dictate the \\ndiagnostic studies, monitoring modalities, and interventions used. The \\napproach to each patient must be individualized; however, frequently per -\\nformed laboratory studies include complete blood count; platelet count; \\nelectrolytes, blood urea nitrogen, and creatinine determinations; prothrom-\\nbin and partial thromboplastin times; and urinalysis. Other tests commonly \\nused are arterial blood gas, lactic acid, fibrinogen, fibrin split products, \\nd-dimer, and cortisol determinations; hepatic function panel; cerebrospinal \\nfluid studies; and cultures of potential sources of infection. A pregnancy test \\nshould be performed on all females of childbearing potential. No single \\nlaboratory value is sensitive or specific for shock. Other common diagnostic \\ntests include radiographs (chest and abdominal), electrocardiographs, com-\\nputed tomography scans (chest, head, abdomen, and pelvis), and echocar -\\ndiograms. Bedside ultrasound (US) may also help determine the etiology of \\nshock. The following US views are helpful in this assessment: subcostal \\ncardiac, parasternal long-axis cardiac, apical four-chamber cardiac inferior \\nvena cava, right upper quadrant abdominal, pelvic, and abdominal aorta.\\n05_Cydulka_Ch05.indd   61 20/04/17   2:39 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 80, 'page_label': '62'}, page_content='62 SECTION 1: Resuscitation Techniques\\nContinuous monitoring of vital signs should be instituted in all patients. \\nModalities such as pulse oximetry, end-tidal CO2, central venous pressure, \\ncentral venous O 2 saturation, cardiac output, and calculation of systemic \\nvascular resistance and systemic oxygen delivery may be indicated.\\nA search to determine the etiology of the shock must be undertaken. \\nLack of response to appropriate stabilization measures should cause the \\nclinician to evaluate the patient for a more occult cause. First, the physician \\nmust be certain that the basic steps of resuscitation have been carried out \\nappropriately. Consider whether or not the patient has been adequately \\nvolume resuscitated. Early use of vasopressors may elevate the central \\nvenous pressure and mask the presence of continued hypovolemia. Ensure \\nthat all equipment is connected and functioning appropriately. Carefully \\nexpose and examine the patient for occult wounds. Consider less commonly \\nseen diagnoses, such as cardiac tamponade, tension pneumothorax, adrenal \\ninsufficiency, toxic or allergic reactions, and occult bleeding (e.g., rupture \\nectopic pregnancy, or occult intraabdominal or pelvic bleeding) in the \\npatient who is not responding as expected.\\nPlease refer to other chapters in this book regarding the evaluation of the \\nspecific forms of shock.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\nThe goal of intervention is to restore adequate tissue perfusion in concert \\nwith the identification and treatment of the underlying etiology.\\n1. Airway: Aggressive airway control, best obtained through endotracheal \\nintubation, is indicated. Remember that associated interventions such as \\nmedications (i.e., sedatives can exacerbate hypotension) and positive \\npressure ventilation may reduce preload and cardiac output and may \\ncontribute to hemodynamic collapse.\\n2. Breathing: All patients should receive supplemental high-flow oxygen. \\nIf mechanical ventilation is used, neuromuscular blocking agents should \\nbe used to decrease lactic acidosis from muscle fatigue and increased \\noxygen consumption. Arterial oxygen saturation should be restored to \\n>93% and ventilation controlled to maintain a PaCO2 of 35 to 40 mm Hg.\\n3. Circulation: Circulatory hemodynamic stabilization be gins with IV \\naccess through large-bore peripheral venous lines. Central venous \\naccess aids in assessing volume status (preload) and monitoring ScvO 2. \\nUS guidance has proven helpful with these procedures. Central venous \\naccess is the preferred route for the long-term administration of vaso-\\npressor therapy. The Trendelenburg position does not improve cardio-\\npulmonary performance compared with the supine position, and it may \\nworsen pulmonary gas exchange and predispose to aspiration. Passive \\nleg raising above the level of the heart with the patient supine can be \\neffective. Early surgical consultation is indicated for internal bleeding. \\nMost external hemorrhage can be controlled by direct compression. \\nRarely will clamping or tying off of vessels be needed.\\n4. The type, amount, and rate of fluid replacement remain areas of contro-\\nversy. There is no difference in survival comparing crystalloid with \\ncolloid resuscitation. Crystalloid solutions continue to be recommended \\nbecause of the increased cost of colloid agents. Most practitioners use \\nisotonic crystalloid intravenous fluids (0.9% NaCl, Ringer lactate) in the \\n05_Cydulka_Ch05.indd   62 20/04/17   2:39 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 81, 'page_label': '63'}, page_content='CHAPTER 5: Therapeutic Approach to The Hypotensive Patient  63 \\ninitial resuscitation phase. Due to the increased cost, lack of proven \\nbenefit, and potential for disease transmission (with FFP), the routine \\nuse of colloids (5% alb umin, purified protein fraction, fresh-frozen \\nplasma [FFP], and synthetic colloid solutions [hydroxyethyl starch or \\ndextran 70]) is questionable. Standard therapy in the hemodynamically \\nunstable patient is 20 to 40 mL/kg given rapidly (over 10 to 20 minutes). \\nBecause only about 30% of infused isotonic crystalloids remain in the \\nintravascular space, it is recommended to infuse approximately three \\ntimes the estimated blood loss in acute hemorrhagic shock. However, the \\nbenefits of early and aggressive fluid replacement in these trauma \\npatients remain unproven as do the benefits of permissive hypotension.\\n5. Blood remains the ideal resuscitative fluid. When possible, use fully \\ncross-matched PRBCs. If the clinical situation dictates more rapid inter-\\nvention, type-specific, type O (rhesus negative to be given to females of \\nchildbearing years) may be used. The decision to use platelets or FFP \\nshould be based on clinical evidence of impaired hemostasis and fre-\\nquent monitoring of coagulation parameters. Platelets are generally \\ngiven if there is ongoing hemorrhage and the platelet count is 50000/\\nmm3 or lower; administer 6 units initially. FFP is indicated if the pro-\\nthrombin time is prolonged beyond 1.5 seconds; administer 2 units \\ninitially. Trauma patients requiring transfusion of multiple units of \\npacked RBCs should receive FFP and platelets early in ratios that \\napproach 1:1:1 in order to address the accompanying coagulopathy that \\nwill likely be present. The use of fresh whole blood has also been advo-\\ncated and may be the most effective approach for such patients. The \\npotential need for FFP and platelet transfusions should be considered \\nearly and reassessed frequently in an effort to detect and limit the \\nadverse effects of trauma-induced coagulopathy.\\n6. Vasopressors are used after appropriate volume resuscitation has \\noccurred and there is persistent h ypotension. Possible choices include \\ndobutamine 2.0 to 20.0  μg/kg/min, dopamine 5.0 to 20.0  μg/kg/min, \\nnorepinephrine 0.5 to 30.0 μg/min, and epinephrine 2.0 to 10.0 μg/min.\\n7. The goal of resuscitation is to maximize survival and minimize mor -\\nbidity using objectiv e hemodynamic and physiologic values to guide \\ntherapy. A goal-directed approach of urine output > 0.5 mL/kg/h, CVP  \\n8 to12  mm Hg, MAP 65 to 90  mm Hg, and ScvO 2 >70% during ED \\nresuscitation of septic shock significantly decreases mortality.\\n8. Acidosis should be treated with adequate ventilation and fluid resuscita-\\ntion. The use of sodium bicarbonate 1 mEq/kg use is controversial. Use \\nonly in the setting of sev ere acidosis refractory to above-mentioned \\nmethods. Correct only to arterial pH 7.25.\\n9. Early surgical or medical consultation for admission or transfer is \\nindicated.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 12, “Approach to Shock,” by Bret A. Nicks and \\nJohn Gaillard; Chapter 13, “Fluid and Blood Resuscitation in Traumatic \\nShock,” by David M. Somand and Kevin R. Ward.\\n05_Cydulka_Ch05.indd   63 20/04/17   2:39 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 82, 'page_label': '64'}, page_content='64\\nAnaphylaxis, Acute Allergic \\nReactions, and Angioedema\\nAlix L. Mitchell\\nAllergic reactions range from localized urticaria to life-threatening ana-\\nphylaxis. Anaphylaxis refers to the most severe form of immediate hyper -\\nsensitivity reaction and encompasses both IgE-mediated reactions and \\nanaphylactoid reactions, which do not require a previous sensitizing \\nexposure.\\n■ ■CLINICAL FEATURES\\nAnaphylaxis may occur within seconds or be delayed over an hour after an \\nexposure; rapid reactions are associated with higher mortality. Common \\nexposures are foods, medications, insect stings, and allergen immunother -\\napy. Many cases are idiopathic. Criteria for anaphylaxis describe an acute \\nprogression of organ system involvement that may lead to cardiovascular \\ncollapse. Organ system involvement can include dermatologic (pruritus, \\nflushing, urticaria, erythema multiforme, angioedema), respiratory tract \\n(dyspnea, hypoxia, wheezing, cough, stridor), cardiovascular (dysrhyth-\\nmias, collapse, arrest), gastrointestinal (cramping, vomiting, diarrhea), \\ngenitourinary (urgency, cramping), and eye (pruritus, tearing, redness).  \\nA biphasic response may occur causing recurrence of symptoms up to  \\n11 hours after the initial exposure, but clinically important events are \\nuncommon. Patients on β-blockers are susceptible to an exaggerated aller -\\ngic response and may be refractory to first-line treatment.\\nAngioedema is caused by edema in the dermis, often of the face, neck, \\nor extremities. Angioedema may accompany allergic reactions, or it may be \\ntriggered by angiotensin-converting enzyme inhibitors (ACEIs) or due to \\nhereditary angioedema. Urticaria is a pruritic cutaneous reaction that may \\nbe associated with allergic reactions but may also be nonallergic. Many \\nurticarial reactions are caused by viruses.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nAnaphylaxis is a clinical diagnosis. A history of exposure to an allergen, \\nsuch as a new drug, food, or sting may make the diagnosis obvious. There \\nis no specific test to verify the diagnosis in real time. Anaphylaxis should \\nbe considered in any rapidly progressing multi-system illness. Workup is \\ndirected at ruling out other diagnoses while stabilizing the patient. The dif-\\nferential depends on the organ systems involved and may include myocar -\\ndial ischemia, gastroenteritis, asthma, carcinoid, epiglottitis, hereditary \\nangioedema, and vasovagal reactions.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\nResuscitation must begin with airway, breathing, and circulation. Patients \\nshould be placed on a cardiac monitor with pulse oximetry and intravenous \\naccess obtained.\\n6\\nCh APTER\\n06_Cydulka_Ch06.indd   64 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 83, 'page_label': '65'}, page_content='CHAPTER 6: Anaphylaxis, Acute Allergic Reactions, and Angioedema 65 \\n1.  Administer oxygen as indicated by oximetry. Angioedema or respira-\\ntory distress should prompt early consideration for intubation.\\n2.  Limit further exposure. This may be as simple as stopping an intrav e-\\nnous drug or removing a stinger. First-aid measures, ice, and elevation \\nmay be helpful for local symptoms. Gastric decontamination is not \\nrecommended for ingested allergens.\\n3.  First-line therapy for anaphylaxis is epinephrine . In patients without \\ncardiovascular collapse, administer 0.3 to 0.5 mg (0.3 to 0.5 mL of \\n1:1000; pediatric dose, 0.01 mg/kg) intramuscularly in the thigh. The \\ndose may be repeated every 5 minutes as needed. Patients who are \\nrefractory to IM dosing or with cardiovascular compromise should \\nreceive intravenous epinephrine. A bolus of 100 μg (place 0.1 mL of \\n1:1000 in 10 mL normal saline) can be infused over 5 to 10 minutes. If \\nneeded, proceed to an infusion (start at 1 μg/min of mix of 1 mL \\n1:1000 dilution added to 500 mL NS infused at 0.5 mL/min, titrate as \\nneeded; pediatric dose, 0.1 to 0.3 μg/kg/min). Stop the infusion for \\nchest pain or arrhythmias. For patients with refractory shock who do \\nnot tolerate IV epinephrine, another vasopressor should be chosen. \\nThere is no evidence for superiority of any specific agent.\\n4.  Hypotensive patients require aggressive fluid resuscitation with normal \\nsaline 1 to 2 L (pediatric dose, 10 to 20 mL/kg).\\n5.  Steroids are generally recommended in order to control persistent or \\ndelayed reactions, although supportive evidence is sparse. Severe cases can \\nbe treated with methylprednisolone 125 mg IV (pediatric dose, 2 mg/kg) \\nor hydrocortisone 500 mg IV (pediatric dose, 10 mg/kg).\\n6.  Antihistamines have theoretical benefit. Diphenhydramine 50 mg is \\ntypically given IV or IM (pediatric dose, 1 mg/kg). In addition, an H 2 \\nblocker such as ranitidine 50 mg IV (pediatric dose, 0.5 mg/kg) is \\nrecommended in severe cases.\\n7.  Bronchospasm should be treated with nebulized β-agonists such as \\nalbuterol 2.5 mg. If refractory, add nebulized ipratropium bromide \\n250 μg and intravenous magnesium 2 g (25 to 50 mg/kg in children) \\ninfused over 20 minutes.\\n8.  For patients on β-blockers with hypotension refractory to epinephrine \\nand fluids, use glucagon 1 mg IV every 5 minutes (pediatric dose, \\n50 μg/kg). An infusion of 5 to 15 μg/min should be started once blood \\npressure improves.\\n9.  Angioedema is treated with supportive care and consideration for \\nearly intubation if the airway is compromised. Episodes may last hours \\nto days. Patients with mild swelling without airway involvement can be \\nobserved for 12 to 24 hours and discharged if symptoms are improving. \\nACEI-induced angioedema can be treated with icatibant (30 mg SC). \\nC1 esterase inhibitor (human) (1000 U IV) has been shown to be \\neffective in case series. The ACEI must be discontinued.\\n10.  Patients with hereditary angioedema can be treated with intravenous \\nC1 esterase inhibitor r eplacement (C1 esterase inhibitor (human) \\n20 U/kg; C1 esterase inhibitor (recombinant) 50 U/kg to maximum \\n4200 units). Treatment with fresh frozen plasma has been used as an \\nalternative when C1 esterase inhibitor replacement is not available  \\n(2 to 3 U IV). Icatibant (30 mg SC) and ecallantide (30 mg SC) are \\nalso effective in shortening attacks of hereditary angioedema.\\n06_Cydulka_Ch06.indd   65 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 84, 'page_label': '66'}, page_content='66 SECTION 1: Resuscitation Techniques\\n11.  Unstable or refractory patients merit admission to the intensive care \\nunit. Patients with moderate to severe symptoms should be admitted for \\nobservation. Patient with mild allergic reactions should be observed in \\nthe ED and may be sent home if symptoms are stable or improving. \\nStable patients who received epinephrine are generally felt to be safe for \\ndischarge after 4 hours without symptoms. Consider longer observation \\nfor patients with a history of severe reactions, patients on β -blockers, \\nand patients who live alone or might have difficulty returning.\\n12.  Discharge patients on a 3-day course of antihistamines and prednisone; \\nlonger courses may be necessary for idiopathic anaphylaxis. Counsel \\nall patients about the need to return to the ED for recurrence of symp-\\ntoms. Instruct patients in a voiding future exposures to the allergen, if \\nknown. All patients who have experienced a severe allergic reaction or \\nanaphylaxis should have and know how to use an epinephrine autoin-\\njector. Consider Medic-Alert bracelets and referral to an allergist in \\nthese patients.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 14, “Anaphylaxis, Allergies, and Angioedema,” by \\nBrian H. Rowe and Theodore J. Gaeta\\n06_Cydulka_Ch06.indd   66 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 85, 'page_label': '67'}, page_content='67\\nAcute Pain Management and \\nProcedural Sedation\\nMichael S. Mitchell\\nAcute pain is the chief complaint for 75% to 80% of all ED visits. Proce-\\ndural sedation and analgesia often are needed for painful interventions or \\ndiagnostic studies.\\n■ ■CLINICAL FEATURES\\nResponses to pain vary and may include increased heart rate, blood pres-\\nsure, respiratory rate, and behavioral changes, however these responses \\nmay only have a mild correlation, so they cannot be relied upon exclu-\\nsively. Pain is most objectively assessed with the use of several validated \\npain scales, though these scales may not be as accurate in elderly patients \\nor trauma patients. Pain scales are a mainstay of assessing pain in young \\nchildren.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\nDuring the primary assessment, determine the patient’s perception of the \\ndegree of pain and continue to reassess their pain after any intervention. Be \\naware that children are vulnerable to oligoanalgesia for several reasons \\nincluding difficulty assessing their pain and provider discomfort as well as \\nunfamiliarity with medication dosing regimens.\\nPharmacologic and nonpharmacologic interventions may be helpful for \\ntreating anxiety and pain in the ED. Nonpharmacologic interventions \\ninclude the application of heat or cold, immobilization and elevation of \\ninjured extremities, and distraction methods, such as feeding sucrose solu-\\ntion to infants. When pharmacologic intervention is needed, the selection of \\nagent should be guided by the severity of pain necessitating analgesia, the \\nroute of delivery, and the desired duration of effects.\\nAcute Pain Control\\nNonopioid Analgesics, such as acetaminophen,  650 to 1000 mg PO  \\n(15 mg/kg PO or PR in children) or nonsteroidal anti-inflammatory \\ndrugs (NSAIDS) such as ibuprofen, 400 to 800 mg PO (10 mg/kg PO \\nin children) can be used to treat mild to moderate pain. Parenteral \\n7\\nCh APTER\\nAnalgesia, Anesthesia,  \\nand Sedation\\n 2\\nSECTION\\n07_Cydulka_Ch07.indd   67 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 86, 'page_label': '68'}, page_content='68 SECTION 2: Analgesia, Anesthesia, and Sedation\\nNSAIDs are no more effective than oral medications. Adverse effects of \\nNSAIDS include gastrointestinal irritation, renal dysfunction, platelet dys-\\nfunction, and impaired coagulation. Furthermore, NSAIDs increase the risk \\nof cardiac death in patients with ischemic heart disease. Aspirin should be \\navoided in children because of an association with Reye syndrome.\\nOpiates, such as morphine, 0.1 mg/kg IV (0.1 to 0.2 mg/kg IV in \\nchildren), fentanyl, 1 μg/kg IV (1 to 2 µg/kg in children), and \\nhydromorphone, 0.2 to 1 mg IV (0.01 mg IV in children) are the agents of \\nchoice for moderate to severe pain. Children require more opiates \\nproportionate to their weight than adults. The goal of therapy is to titrate the \\ndoses to effect. Side effects of opiates include respiratory depression, \\nnausea and vomiting, confusion, pruritus, and urinary retention. Oral \\nopioids may be tried as an alternative to parenteral administration, however \\nthey can have variable absorption and a slower effect.\\nSpecial caution should be given to the use of codeine and tramadol. \\nCodeine is not a reliable analgesic as up to 10% of the US population lack \\nthe necessary enzyme to convert it to its active state. Tramadol can produce \\nsignificant CNS toxicity.\\nProcedural Sedation and Analgesia (PSA)\\nProcedural sedation is the use of medication to induce a depressed level of \\nconsciousness while maintaining cardiorespiratory function so that a pain-\\nful procedure can be performed. There are various levels of sedation \\nachieved with different medications. See Table 7-1. Be aware that with \\nincreased depth of sedation, the risk of depressed breathing and potential \\nloss of airway patency is increased.\\nPreparation\\nRecent oral intake is not a contraindication to procedural sedation in the \\nemergency department. If concerned, however, waiting 3 hours after last \\noral intake is associated with a low risk of aspiration regardless of the level \\nof sedation. The complication rate of PSA depends strongly on depth of \\nsedation and patient’s physiological reserve as determined by chronic or \\nacute illness. Consider anesthesia consultation for patients with signifi-\\ncantly limited physiologic reserve, especially cardiorespiratory conditions, \\nTAble 7-1 Levels of Sedation and Analgesia\\nResponsiveness Airway Breathing Circulation\\nMinimal sedation \\n(aka “anxiolysis”)\\nNormal but slowed \\nresponse to verbal \\nstimulation\\nUnaffected Unaffected Unaffected\\nModerate seda-\\ntion (aka “con-\\nscious sedation”)\\nPurposeful response \\nto verbal or physical \\nstimulation\\nUsually \\nmaintained\\nUsually \\nadequate\\nUsually \\nmaintained\\nDeep sedation Purposeful response \\nafter repeated or \\npainful physical \\nstimulation\\nMay be \\nimpaired\\nMay be  \\nsuppressed\\nUsually \\nmaintained\\n07_Cydulka_Ch07.indd   68 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 87, 'page_label': '69'}, page_content='CHAPTER 7: Acute Pain Management and Procedural Sedation 69 \\nthose with severe systemic disease, at the extremes of age, and those with \\npredicted difficult airway.\\nWhen PSA is performed, necessary equipment includes a continuous \\ncardiac monitor with pulse oximetry, oxygen, suction, and immediate \\navailability of appropriately sized resuscitation equipment. Informed con-\\nsent should be obtained. The patient should be under constant observation \\nby a provider trained in airway management. Blood pressure, heart rate, \\nrespiratory rate, and level of consciousness should be monitored. Some \\nadvocate routine use of capnography to monitor ventilation in sedated \\npatients, as it has been shown to detect changes in ventilation before \\nclinical observation allowing for earlier recognition of adverse events. The \\napplication of supplemental oxygen reduces hypoxemia and has no \\nadverse clinical effects.\\nThe analgesic or sedative agents chosen should be individualized to the \\npatient and the planned procedure. The agents used for PSA often have a \\nnarrow therapeutic index. Therefore, these medications should be adminis-\\ntered in small, incremental intravenous doses, with adequate time between \\ndoses to determine peak effect. All patients undergoing PSA should be \\nreassessed continuously. Patients experiencing transient respiratory depres-\\nsion can usually be managed by bag-mask ventilation.\\nSedation Management\\nTable 7-2 describes selected sedation agents for procedural sedation.\\nNitrous Oxide is used for minimal sedation and is supplied in a 50:50 \\nmixture with oxygen. It requires a special setup of a demand delivery sys-\\ntem and a scavenging system to prevent exam room accumulation of nitrous \\noxide. It is contraindicated in pregnant women and those with pneumotho-\\nrax, pneumocephalus, and vascular air embolus.\\nFentanyl has a rapid onset of action and is easily titratable. Chest wall \\nrigidity unresponsive to naloxone may occur at higher doses (5 to 15 mcg/\\nkg) or when rapidly administered potentially necessitating neuromuscular \\nblockade and mechanical ventilation. Slow administration (e.g., over 3 to 5 \\nminutes) and careful flushing of the IV can prevent rigid chest syndrome.\\nMidazolam is commonly used as a sole agent for minimal sedation. \\nRespiratory depression and hypotension may develop. Flumazenil quickly \\nreverses sedation and respiratory depression due to benzodiazepines. Rou-\\ntine use to reverse sedation is not recommended.\\nKetamine is a dissociative analgesic with sedative, analgesic, and \\namnestic properties that causes minimal respiratory depression and has a \\nminimal effect on blood pressure. Ketamine may be administered IV or IM. \\nIn lower doses, it can produce analgesia. In higher doses (approximately \\n1mg/kg and above IV) a critical dosing threshold is exceeded and produces \\na dissociative state. Ketamine may cause increased intraocular pressure, \\nhypersalivation, laryngospasm, and a hallucinatory emergence reaction in \\nolder children and adults. Ketamine can cause vomiting, especially in ado-\\nlescents. Pretreatment with ondansetron can reduce the incidence of vomit-\\ning. There is conflicting data on whether ketamine causes increased intra-\\ncranial pressure, thus there is no concluding evidence to restrict its use in \\nhead injury patients. Emergence reaction is best treated with midazolam \\n(0.1 mg/kg IM or IV). Ketamine is contraindicated in children less than  \\n3 months as well as those with increased intraocular pressure or obstructive \\n07_Cydulka_Ch07.indd   69 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 88, 'page_label': '70'}, page_content='TAble 7-2  Sedation Agents for Adult Procedural Sedation and Analgesia\\nMedication Recommended Dosage\\nRoute of  \\nAdministration Peak Effect\\nApproximate  \\nDuration Use\\nNitrous oxide 50:50 mixture with oxygen Inhalational 1–2 min 3–5 min Minimal sedation\\nMidazolam 0.05–0.1 mg/kg. May repeat 0.05 mg/kg \\nevery 2 min until adequately sedated\\n0.1 mg/kg\\nIV\\nIM\\n2–3 min\\n15–30 min\\n20–30 min\\n1–2 h\\nMinimal or moderate sedation\\nMinimal sedation\\nFentanyl 1–3 µg/kg, can be titrated  \\nup to 5 µg/kg\\nIV 2–3 min 30–60 min Minimal sedation\\nFentanyl and midazolam 1–2 µg/kg fentanyl plus  \\n0.1 mg/kg midazolam\\nIV 2–3 min 1 h Moderate and deep sedation\\nMethohexital 1 mg/kg IV 1 min 3–5 min Moderate or deep sedation\\nPentobarbital 2.5 mg/kg followed by 1.25 mg/kg, as \\nneeded, up to two times\\nIV rate should be  \\n<50 mg/min\\n3–5 min 15 min Minimal and moderate sedation. \\nFrequently used for radiologic procedures.\\nKetamine 1 mg/kg\\n2–5 mg/kg\\nIV\\nIM\\n1–3 min\\n5–20 min\\n15–30 min\\n30–60 min\\nDissociative sedation\\nDissociative sedation\\nKetamine and midazolam Ketamine as above plus  \\nmidazolam, 0.03–0.05 mg/kg\\nIV 1–3 min 30–60 min Dissociative sedation\\nEtomidate 0.15 mg/kg, followed by  \\n0.1 mg/kg every 2 min, if needed\\nIV 15–30 s 3–8 min Moderate and deep sedation\\nPropofol 0.5–1.0 mg/kg, followed by 0.5 mg/kg \\nevery 3 min, if needed\\nIV 30–60 s 5–6 min Moderate and deep sedation\\nKetamine and propofol \\n“ketofol”\\nKetamine 0.125–0.5 mg/kg and Propofol \\n0.5 mg/kg\\nIV 30–60 s 15 min Moderate and deep sedation\\n70\\n07_Cydulka_Ch07.indd   70 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 89, 'page_label': '71'}, page_content='CHAPTER 7: Acute Pain Management and Procedural Sedation 71 \\nhydrocephalus and should be used in caution in patients with significant \\nupper respiratory tract infectious symptoms or those undergoing a proce -\\ndure involving major stimulation of the oropharynx (e.g., endoscopy).\\nEtomidate is a rapid onset sedative with short duration of effect. It \\ncauses temporary adrenal insufficiency which is associated with increased \\nmortality in critically-ill patients; however, this effect has not been shown \\nto cause adverse events when used in stable patients. Up to 20% of patients \\ncan have myoclonic jerking.\\nPropofol is an anesthetic agent administered by intravenous infusion that \\nhas a short duration of effect, which results in shorter recovery time and ED \\nlength of stay. The most common side effect is respiratory depression and \\napnea. Side effects include hypotension, therefore hypovolemia should be \\ncorrected before propofol administration. Adjunct analgesic is mandatory for \\npainful procedures. Pain at the IV site is common during administration and \\ncan be blunted with adjunct use of lidocaine (e.g., 0.05 mg/kg IV). Propofol \\nuse is contraindicated in patients who are allergic to eggs or soy products.\\nKetamine and Propofol can be used in combination and may have syn-\\nergy with each other. Ketamine may blunt the hypotension and respiratory \\ndepression seen with propofol. Propofol may prevent the emergence reaction \\nand vomiting seen with ketamine. Ketamine use precludes the use of an anal-\\ngesic with propofol alone. The greatest advantage of using this combination is \\nlikely that sedation can be achieved with lower doses of either drug used alone.\\nelderly\\nProcedural sedation in the elderly is associated with increased adverse \\nevents. The risk of respiratory depression is increased with all agents. \\nEtomidate is a good choice owing to its minimal cardiovascular effects. \\nWhen using propofol in this age group, the initial and subsequent doses \\nshould be 50% of those recommended for younger adults.\\nChildren\\nChildren of all ages feel pain, even neonates. Anxiety issues, pain control, \\nand need for sedation must be addressed. Anxiety may be a significant bar-\\nrier to a successful procedure performance, especially when patient’s coop-\\neration is needed. Parents can provide significant anxiety relief and should \\nbe allowed to stay with children. Age appropriate distraction techniques \\nshould also be employed. Benzodiazepines, such as midazolam, provide \\neffective pharmacologic anxiety relief when needed. Oral sucrose is an \\neffective analgesic in infants undergoing painful procedures such as IV \\ncatheter placement. Procedural sedation and analgesia should be used when \\nperforming painful procedures or when procedures require the patient to be \\nstill. Common medications used for pediatric procedural sedation are listed \\nin Table 7-3.\\nDisposition\\nPatients are eligible for discharge only when fully recovered. When dis-\\ncharged, the patient must be accompanied by an adult and should not drive \\nor operate machinery for 24 hours. Because many of the agents used for \\nPSA produce anterograde amnesia, discharge instructions must be given to \\nresponsible accompanying adults.\\n07_Cydulka_Ch07.indd   71 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 90, 'page_label': '72'}, page_content='TAble 7-3 Medications for Procedural Sedation \\nClass Drug Route Dose Onset Duration Advantages Disadvantages Examples Comments\\nAnxiolytic Midazolam PO, PR, IV, \\nIM, IN\\nPO/PR 0.5 \\nmg/kg\\nIV/IM 0.05–0.1 \\nmg/kg\\nIN 0.2–0.4 \\nmg/kg\\nPO/PR 20–30 \\nmin IV\\n3–5 min\\nIM 10–20 min\\nIN 5–10 min\\n1–4 h Flexible route of \\nadministration\\nNo analgesia, \\nparadoxical \\nreaction\\nPremedication \\nfor IV start, \\nlaceration repair \\nusing local \\nanesthetic\\nAcidic, nasal admin-\\nistration stings, may \\ncause increased secre-\\ntions; oral/rectal slow \\nonset, less predictable\\nHypnotic/\\nsedative\\nPropofol IV 1–2 mg/kg, \\nfollowed by \\n0.5 mg/kg \\nrepeat doses \\nas needed\\nSeconds Minutes Rapid onset and \\nshort duration, \\nmotionlessness, \\nmuscle relaxant\\nNo analgesia, \\nrespiratory and \\ncardiovascular \\ndepressant\\nCT scan, LP with \\ntopical analgesic, \\nlaceration repair, \\nreduction of  \\ndislocation\\nNon-analgesic, \\nincreased requirement \\nfor younger patients, \\npainful injection\\nEtomidate IV 0.2–0.3 mg/kg Seconds Minutes Rapid onset, \\nshort duration\\nNo analgesia, \\nmyoclonus, \\nrespiratory \\ndepressant\\nCT scan, short \\nprocedures \\nrequiring \\nmotionlessness\\nAvoid in patients with \\nincreased tone (e.g., \\nCP) due to myoclonic \\njerks, painful injection\\nPentobarbital IV 1–2 mg/kg, \\nrepeated every \\n3–5 min as \\nneeded\\n<1 min 15–45 min Well studied, \\nmotionlessness, \\nneuroprotective\\nNo analgesia, \\nrespiratory and \\ncardiovascular \\ndepressant\\nCT scan, no \\nreversal agent\\nVariable dosing, long \\nrecovery times\\nMethohexital IV 0.5–1 mg/kg Seconds 10–60 min Rapid onset No analgesia, \\nrespiratory and \\ncardiovascular \\ndepressant\\nCT scan, no \\nreversal agent\\n—\\n72\\n07_Cydulka_Ch07.indd   72 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 91, 'page_label': '73'}, page_content='73\\nDissociative Ketamine IV, IM IV 1–1.5 mg/kg\\nIM 4–5 mg/kg\\nIV 1–2 min\\nIM 3–5 min\\nIV 15 min\\nIM 30–45 \\nmin\\nAnalgesic, \\nanesthetic, \\nmotionlessness, \\nrespiratory and \\ncardiovascular \\nstimulant, bron-\\nchodilator\\nIncreased intra-\\nocular pressure, \\nsalivation; \\nemetogenic; \\nlaryngospasm\\nPainful proce-\\ndures requiring \\nmotionlessness \\n(complex lac-\\nerations, fracture \\nreductions, I & D),  \\nno reversal agent\\nConsider pretreatment \\nwith ondansetron; \\natropine and \\nmidazolam \\nco-administration \\nunnecessary\\nCombinations Fentanyl + \\nmidazolam\\nIV Fentanyl 1–2 \\nµg/kg,  \\nmidazolam \\n0.05–0.1 mg/kg\\n1–2 min 1–3 h Analgesic and \\nanxiolytic\\nRespiratory \\ndepressant\\nFracture reduc-\\ntion, reduction \\nof dislocation, \\nlaceration repair\\nReversal with flumaze-\\nnil and naloxone\\nPropofol + \\nketamine\\nIV Propofol 1  \\nmg/kg,  \\nketamine 0.5 \\nmg/kg\\n1 min Propofol \\n(minutes); \\nketamine \\n15–45 min\\nDecreased \\ndosing for both \\nagents, comple-\\nmentary side \\neffects (lessens \\nrespiratory and \\ncardiovascular \\ndepression, \\nemesis)\\n— Fracture reduc-\\ntion, I & D, com-\\nplex laceration\\nConsider ondansetron \\npretreatment\\nOther Nitrous oxide Inhaled Titrate to \\neffect\\nMinutes Minutes Self-dosing Not readily \\navailable\\nAdjunct to  \\nanesthetics\\n—\\nAbbreviations: CP = cerebral palsy; I & D = incision and drainage; IN = intranasally.\\n07_Cydulka_Ch07.indd   73 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 92, 'page_label': '74'}, page_content='74 SECTION 2: Analgesia, Anesthesia, and Sedation\\nlocal and Regional Anesthesia\\nLocal and regional anesthetics are essential tools for ED pain management. \\nAgents can be administered topically, intravenously, by infiltration directly \\ninto the area to be anesthetized, or into the area of the peripheral nerves \\nsupplying the area. This discussion focuses on topical and infiltrative anes-\\nthetics.\\nThe toxicity of local anesthetics (LAs) is related to the total dose and the \\nrate of plasma concentration increase. The risk of toxicity is heightened in \\nthe setting of hypoxia, hypercarbia, and acidosis. Toxic effects include CNS \\neffects progressing to coma and cardiovascular effects progressing to car -\\ndiovascular collapse. Allergic reactions to LAs are uncommon and are \\nusually due to a preservative. If an allergy is suspected, the best approach \\nis to use a preservative-free agent from the other class of LAs. Alternatively, \\ndiphenhydramine or benzyl alcohol may be used as an LA in the setting of \\na true allergy to conventional LAs.\\nLAs often cause pain during administration. Slow injection through a \\n27- or 30-gauge needle, injecting through the wound margin, using warm \\nsolution, and using buffered (with sodium bicarbonate) solution decrease \\ninjection pain.\\nEpinephrine (1:100 000) is often added to LAs before administration. \\nAddition of epinephrine increases the duration of anesthesia, provides \\nwound hemostasis, and slows systemic absorption. Epinephrine is safe for \\nuse in end-arterial fields, but should be avoided in those with suspected \\ndigital vascular injury or those with known peripheral vascular disease.\\nLidocaine, which is the most commonly used LA in the ED, has a 2- to \\n5-minute onset of effect and a 1- to 2-hour duration of effect. The maximum \\ndose of infiltrative lidocaine is 4.5 mg/kg without or 7 mg/kg with epineph-\\nrine. Lidocaine is buffered to decrease the pain of injection by adding 1 mL \\nNaHCO3 to 9 mL lidocaine, but for maximum effectiveness, it should only \\nbe added immediately before use.\\nBupivacaine, which has an onset of effect of 3 to 7 minutes and dura-\\ntion of effect of 90 minutes to 6 hours, is preferred for prolonged proce-\\ndures. The maximum dose of infiltrative bupivacaine is 2 mg/kg without \\nor 3 mg/kg with epinephrine. Buffer bupivacaine with 1 mL NaHCO3 to 29 \\nmL bupivacaine.\\nLocal Anesthetic Infiltration\\nLAs can provide anesthesia at a site by infiltrating directly into the site or \\nby infiltrating around the peripheral nerves supplying the site. For some \\nwounds, LA infiltration around the peripheral nerves is advantageous due \\nto decreased total LA required and decreased pain at the site of injection. \\nDuring administration, the syringe plunger must be drawn back to avoid \\nintravascular injection of LA.\\nTopical Anesthetics\\nTopical anesthetics can eliminate the need for LA infiltration, are applied \\npainlessly, do not distort wound edges, and may provide hemostasis. Com-\\nmon preparations include lidocaine, epinephrine, and tetracaine (LET), \\nlidocaine and prilocaine (EMLA), and various preparations of lidocaine. \\nLET is applied by placing a LET-saturated cotton ball or gauze pad onto an \\n07_Cydulka_Ch07.indd   74 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 93, 'page_label': '75'}, page_content='CHAPTER 7: Acute Pain Management and Procedural Sedation 75 \\nopen wound for a minimum of 20 to 30 minutes. LET should not be used \\non mucus membranes or in end-arterial fields.\\nEMLA is a cream composed of lidocaine and prilocaine used only on \\nintact skin to relieve the pain associated with venipuncture, arterial punc-\\nture, port access, and other superficial skin procedures. It has a 45- to \\n60-minute onset of effect and a 60-minute duration upon withdrawal. \\nBecause prilocaine may cause methemoglobinemia, EMLA should be used \\nwith caution in infants younger than 3 months and avoided in patients pre-\\ndisposed to methemoglobinemia.\\nRegional Blocks\\nRegional anesthesia is a technique that infiltrates local anesthetic agents \\nadjacent to peripheral nerves (\"nerve blocks\") and is typically used for \\ncomplicated lacerations, fractures, and dislocations. Distortion of the site is \\navoided. US guidance can be used. Care must be taken not to inject the \\nanesthetic solution directly into the nerve. Prior to anesthetic use, distal \\nneurovascular and neurologic status should be assessed. This chapter will \\ndiscuss commonly used regional blocks in basic descriptions.\\nDigital Blocks\\nPurpose: Finger and toe blocks are advantageous because less anesthetic is \\nneeded, better anesthesia is obtained, and tissues are not distorted. The \\nonset of anesthesia is delayed when compared with that of LA. Assess and \\ndocument neurovascular status before the procedure.\\nPositioning: Place the hand in the prone (palm down) position. The \\nnerves travel on the lateral aspect of the finger on both the dorsal and pal-\\nmar sides.\\nTechnique: Insert the needle on the dorsal surface of the proximal pha-\\nlanx and advance toward the volar surface staying immediately adjacent to \\nthe phalanx. Aspirate to ensure no vascular puncture has occurred and inject \\n1 mL of anesthetic. Slowly retract the needle while injecting another 1 mL \\nof anesthetic. Prior to withdrawing the needle, direct it across the dorsum \\nto the other side of the digit and inject 1 mL while withdrawing slowly. \\nRepeat the first injection on the other side of the digit. Toes can be blocked \\nin the same manner.\\nFlexor Tendon Sheath Digital Nerve Block\\nPurpose: This is a one-injection alternative to the traditional digit block. \\nBe aware that this technique may not provide adequate anesthesia to the \\ndistal fingertip.\\nPositioning: Place the hand in the supine (palm up) position. Have the \\npatient flex the finger to identify the flexor tendon and its corresponding \\ntendon sheath.\\nTechnique: Inject the needle at the distal palmar crease into the flexor \\ntendon sheath. Once the “pop” is felt, inject 2 to 3 mL of anesthetic.\\nIntercostal Nerve Block\\nPurpose: This block will provide anesthesia in a band-like fashion above \\nand below the affected rib. These blocks are useful to ameliorate pain from \\na rib fracture or are useful in tube thoracostomy placement.\\n07_Cydulka_Ch07.indd   75 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 94, 'page_label': '76'}, page_content='76 SECTION 2: Analgesia, Anesthesia, and Sedation\\nPositioning: The patient sits upright with the ipsilateral arm raised and \\nresting on the head. The site of injection is either the mid-axillary line of \\nthe affected rib or the “rib angle,” which is approximately 6 cm posterior of \\nthe mid-axillary line and immediately lateral to the paraspinous muscles. \\nThe “rib angle” site is preferred to ensure adequate analgesia to all branches \\nof the intercostal nerve.\\nTechnique: Palpate the inferior border of the rib to be blocked and \\nretract the skin cephalad. Raise a wheal in the subcutaneous space and \\ninsert the needle bevel up and direct it toward the lower aspect of the bone \\nwith needle up and syringe down allowing a needle angle of approximately \\n10 degrees off perpendicular. Once bone is contacted, release the skin \\nretraction and march the needle caudally until it drops off the bone. Aspi-\\nrate before injection, and inject 2 to 5 mL of anesthetic. Note that pneumo-\\nthorax can occur in up to 9% of patients, so close monitoring for respiratory \\nsymptoms is recommended for 30 minutes after procedure.\\nFemoral Nerve Block\\nPurpose: The femoral nerve block and a larger block involving the femo-\\nral, obturator, and lateral femoral cutaneous nerves (“three-in-one” block) \\nare good for proximal femur fractures and hip fracture patients.\\nPositioning: The patient lies supine and the inguinal crease is exposed. \\nThe femoral nerve is 1 cm lateral to the femoral artery at the inguinal crease \\nand is fairly superficial.\\nTechnique: Ultrasound guidance is recommended. Locate the nerve \\nlocation as described above and raise a wheal of anesthetic. With US guid-\\nance, direct the needle toward the femoral nerve. Correct positioning is \\nconfirmed when the patient reports anterior thigh parathesias. If this is not \\nfelt, the needle may need to be directed more laterally to find the nerve. \\nOnce found, retract the needle slightly and inject approximately 20 mL of \\nanesthetic into the perineural space. To perform the “three-in-one” block, \\nhold firm pressure distal to the injection site for 5 minutes to help promote \\ncephalad distribution of the anesthetic.\\nHematoma Block\\nPurpose: This block delivers anesthesia to a fracture site to aid in reduction.\\nPositioning: The patient is supine with the limb placed to access the \\nfracture site.\\nTechnique: A sterile approach is recommended. Direct the needle \\ntoward the fracture site. Aspiration of blood will confirm that the needle is \\nlikely within the confines of the hematoma. Inject 5 to 15 mL of anesthetic. \\nBe careful not to exceed the maximum dose of anesthetic.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 35, “Acute Pain Management,” by James Ducharme; \\nChapter 113, “Pain Management and Procedural Sedation in Infants and Chil-\\ndren,” by Peter S. Auerbach; Chapter 36, “Local and Regional Anesthesia,” by \\nDouglas C. Dillon and Michael A. Gibbs; and Chapter 37, “Procedural Sedation,” \\nby Chris Weaver.\\n07_Cydulka_Ch07.indd   76 20/04/17   2:40 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 95, 'page_label': '77'}, page_content='77\\nChronic Pain\\nDavid M. Cline\\n■ ■MANAGEMENT OF PATIENTS WITH CHRONIC PAIN\\nChronic pain is a painful condition that lasts longer than 3 months, pain that \\npersists beyond the reasonable time for an injury to heal, or pain that per -\\nsists 1 month beyond the usual course of an acute disease. Complete eradi-\\ncation of pain is not a reasonable endpoint in most cases. Rather, the goal \\nof therapy is pain reduction and a return to functional status.\\nClinical Features\\nSigns and symptoms of chronic pain syndromes are summarized in \\nTable 8-1. Many of these syndromes will be familiar to emergency \\nphysicians.\\nComplex regional pain type I, previously known as reflex sympathetic \\ndystrophy, and complex regional pain type II, previously known as \\ncausalgia, may be seen in the emergency department (ED) 2 weeks or more \\n8\\nC HAPTER\\nTable 8-1 Signs and Symptoms of Selected Chronic Pain Syndromes\\nDisorder Pain Symptoms Signs\\nTransformed migraine Initially migraine-like, becomes \\nconstant, dull, nausea, vomiting\\nMuscle tenderness and \\ntension, normal neurologic \\nexamination\\nFibromyalgia Diffuse muscular pain, stiffness, \\nfatigue, sleep disturbance\\nDiffuse muscle tenderness, \\n>11 trigger points\\nPoststroke pain Same side as weakness, \\nthrobbing, shooting pain, allodynia\\nLoss of hot and cold \\ndifferentiation\\nChronic back pain Constant dull pain, occasionally \\nshooting pain, pain does not \\nfollow nerve distribution\\nNo trigger points, poor \\nROM in involved muscle\\nHIV-associated sensory \\nneuropathy\\nSymmetric pain and paresthesia, \\nmost prominent in toes and feet\\nSensory loss in areas of \\ngreatest pain symptoms\\nComplex regional pain \\ntypes I and II\\nBurning persistent pain, \\nallodynia, associated with \\nimmobilization/disuse (type I) or \\nperipheral nerve injury (type II)\\nEarly: edema, warmth, local \\nsweating; late: the early \\nsigns alternate with cold, \\npale, cyanosis, eventually \\natrophic changes\\nPostherpetic neuralgia Allodynia, shooting, lancinating \\npain\\nSensory changes in the \\ninvolved dermatome\\nPainful diabetic \\nneuropathy\\nSymmetric numbness and \\nburning or stabbing pain in lower \\nextremities; allodynia may occur\\nSensory loss in lower \\nextremities\\nPhantom limb pain Variable: aching, cramping, \\nburning, squeezing, or tearing \\nsensation\\nMay have peri-incisional \\nsensory loss\\nAbbreviations: HIV, human immunodeficiency virus; ROM, range of motion.\\n008_Cydulka_Ch008.indd   77 10/03/17   4:28 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 96, 'page_label': '78'}, page_content='78 SECTION 2: Analgesia, Anesthesia, and Sedation\\nafter an acute injury. These disorders should be suspected when a patient \\npresents with classic symptoms: allodynia (pain provoked with gentle touch \\nof the skin) and a persistent burning or shooting pain. Early associated signs \\nduring the disease include edema, warmth, and localized sweating.\\nDiagnosis and Differential\\nThe most important task of the emergency physician is to distinguish \\nchronic pain from acute pain that heralds a life- or limb-threatening condi-\\ntion. A complete history and physical examination should confirm the \\nchronic condition or point to the need for further evaluation when unex-\\npected signs or symptoms are elicited.\\nRarely, a provisional diagnosis of a chronic pain condition is made for \\nthe first time in the ED. The exception is a form of post-nerve injury pain—\\ncomplex regional pain. The sharp pain from acute injuries, including frac-\\ntures, rarely continues beyond 2 weeks duration. Pain in an injured body \\npart beyond this period should alert the clinician to the possibility of nerve \\ninjury.\\nDefinitive diagnostic testing of chronic pain conditions is difficult, \\nrequires expert opinion and, often, expensive procedures such as magnetic \\nresonance imaging, computed tomography, or thermography. Therefore, \\nreferral to the primary source of care and eventual specialist referral are \\nwarranted to confirm the diagnosis.\\nemergency Department Care and Disposition\\n1. Opioids are not recommended for the primary treatment chronic pain \\nin the ED. Patients who state their prescription opioids hav e been lost \\nor stolen should be referred to their pain specialist or primary care \\ndoctor and the prescription should not be refilled by the emergency \\nphysician.\\n2. The evidence-based management of chronic pain conditions is listed in \\nTable 8-2. The need for longstanding treatment of chronic pain condi -\\ntions limits the safety of the nonsteroidal anti-inflammatory drugs. \\nDoses of drugs are as follows. Amitriptyline—start 25 mg/d PO. \\nTable 8-2 Management of Selected Chronic Pain Syndromes\\nDisorder Primary Treatment Secondary Treatment\\nTransformed migraine Stop prior medications Celecoxib or prednisone taper\\nFibromyalgia Duloxetine Pregabalin\\nChronic back or neck pain Duloxetine Amitriptyline\\nPoststroke pain Pregabalin Gabapentin\\nHIV-associated sensory \\nneuropathy\\nOptimize antiretroviral \\ntherapy\\nLamotrigine\\nComplex regional pain \\ntypes I and II\\nAcute: Prednisone taper Ketamine by specialist\\nPostherpetic neuralgia Pregabalin or gabapentin Amitriptyline\\nPainful diabetic neuropathy Duloxetine Pregabalin or gabapentin\\nPhantom limb pain Gabapentin Amitriptyline\\n008_Cydulka_Ch008.indd   78 10/03/17   4:28 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 97, 'page_label': '79'}, page_content='CHAPTER 8: Chronic Pain 79 \\nGabapentin is started with an initial dose of 300 mg daily and is \\nincreased up to a maximum of 1200 mg three times daily according to \\nresponse. Pregabalin—start 50 mg three times daily. Duloxetine—start \\n30 mg PO daily. Lamotrigine—begin with 25 mg daily.\\n3. Referral to the appropriate specialist is one of the most productive \\nmeans to aid in the care of chronic pain patients who present to the ED. \\nPossible outcomes of referral to pain specialists include optimization \\nof medical therapy, trigger point injections, dedicated exercise pro-\\ngrams, physical therapy, epidural steroid injections, or nerve blocks as \\nindicated.\\n■ ■MANAGEMENT OF PATIENTS WITH ABERRANT \\nDRUG-RELATED BEHAVIOR\\nThe spectrum of patients with aberrant drug-related behavior includes those \\nwho have chronic pain and are now dependent on narcotics to “hustlers” \\nwho are obtaining prescription drugs to sell on the street.\\nClinical Features\\nBecause of the wide spectrum of patients with aberrant drug-related behav-\\nior, the history given may be factual or fraudulent. Patients with aberrant \\ndrug-related behavior may be demanding, intimidating, or flattering. In one \\nED study, the most common complaints of patients seeking drugs were (in \\ndecreasing order) back pain, headache, extremity pain, and dental pain. \\nMany fraudulent techniques are used, including “lost” prescriptions, or \\ndoctor’s note explaining need for opioids, “impending” surgery, fictitious \\nhematuria with a complaint of kidney stones, self-mutilation, and fictitious \\ninjury.\\nDiagnosis and Differential\\nThe diagnosis of aberrant drug-related behaviors may not be possible in the \\nED. The medical record can provide a wealth of information regarding the \\npatient, including documentation proving that the patient is supplying false \\ninformation. Most states now have controlled drug databases that can be \\nqueried. Aberrant drug-related behaviors are listed in Table 8-3. The predic-\\ntive behaviors are illegal in many states and form a solid basis to refuse \\nnarcotics to the patient.\\nTable 8-3 Aberrant Drug-Related Behaviors\\nForges/alters prescriptions*\\nSells controlled/illicit drugs*\\nUses aliases to receive opioids*\\nCurrent illicit drug use*\\nFictitious illness, requests opioids\\nConceals multiple ED visits for opioids\\nConceals multiple physicians prescribing opioids\\nAbusive when refused\\n*Unlawful in many states.\\n008_Cydulka_Ch008.indd   79 10/03/17   4:28 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 98, 'page_label': '80'}, page_content='80 SECTION 2: Analgesia, Anesthesia, and Sedation\\nemergency Department Care and Disposition\\nThe treatment of aberrant drug-related behavior is to refuse the controlled \\nsubstance, consider the need for alternativ e medication or treatment, and \\nconsider referral for drug counseling.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 38 “Chronic Pain,” by David M. Cline.\\n008_Cydulka_Ch008.indd   80 10/03/17   4:28 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 99, 'page_label': '81'}, page_content='81\\nEvaluating and Preparing Wounds\\nTimothy J. Reeder\\n■ ■CLINICAL FEATURES\\nTraumatic wounds are regularly encountered problems in the emergency \\ndepartment. It is important to document important historical information \\nsuch as the mechanism, timing, location of injury, and the degree of con-\\ntamination. Associated symptoms of pain, swelling, paresthesias, and loss \\nof function should be identified. Determine factors that affect wound heal-\\ning, such as patient age, location of injury, medications, chronic medical \\nconditions, and previous keloid or scar formation. Adults with the sensation \\nof a foreign body are much more likely to have retained a foreign body that \\nshould be removed. Review allergies, particularly to latex, and determine \\nwhether tetanus immunization is required (see Chapter 94). When caring \\nfor wounds, the ultimate goal is to restore the physical integrity and func-\\ntion of the injured tissue without infection.\\nWhen treating a wound, consider factors that impact risks for infection, \\nsuch as time since injury, mechanism, and location. Shear forces are pro-\\nduced by sharp objects with relatively low energy, resulting in a wound \\nwith a straight edge and little contamination that can be expected to heal \\nwith a good result. Wounds caused by compression forces crush the skin \\nagainst the underlying bone and often produce stellate lacerations. Tension \\nforces may produce flap-type lacerations with surrounding devitalized tis-\\nsue and may be more susceptible to infection. Other predictive factors for \\ninfection include location, depth, characteristics, contamination, and \\npatient age. The risk of infection also relates to the interaction of bacterial \\ncontamination and blood supply. The density of bacteria is quite low over \\nthe trunk and proximal arms and legs, and thus these areas have lower risks \\nfor infection. Moist areas such as the axilla, perineum, and exposed hands \\nand feet have a higher degree of colonization and may be at higher risk of \\ninfection. Wounds located on the face or scalp, both highly vascularized \\nareas, are at lower risk for infection.\\nWounds of the oral cavity are heavily contaminated with bacteria, \\nalthough evidence supporting routine antibiotic use in simple intra-oral \\nlaceration is inconclusive. Wounds sustained from contaminated objects or \\nenvironments and animal and human bites have an increased infection risk. \\n9\\nCh A p TER\\nEmergency Wound \\nManagement\\n 3\\nSECTION\\n09_Cydulka_Ch09.indd   81 15/03/17   10:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 100, 'page_label': '82'}, page_content='82 SECTION 3: Emergency Wound Management \\nWounds contaminated with feces hav e a high risk of infection even when \\ntreated with antibiotic therapy. Although there is no clearly defined rela-\\ntionship between time to closure and infection rate, consider time since \\ninjury when making decisions about wound repair. Delayed primary clo-\\nsure after 4 days of open wound management is recommended for wounds \\nwith a high risk for infection during the first care encounter.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nWound examination is greatly facilitated by a cooperative patient, good \\npositioning, optimal lighting, and little or no bleeding. A thorough exami-\\nnation will minimize the risk of missed foreign bodies, tendon injuries, and \\nnerve injuries. While performing wound assessment, repositioning the joint \\nor extremity in the position assumed during injury may help identify under-\\nlying damaged structures.\\nAssess wound location, size, shape, margins, and depth. Pay particular \\nattention to sensory and motor functions, tendon injury, vascular compro-\\nmise, and injuries to specialized structures. Carefully palpate and inspect the \\nwound and surrounding area to identify a retained foreign body or bone \\ninjury, and consider radiographic imaging when these complicating features \\nare suspected. For wounds overlying joints, consider additional assessment to \\ndetermine whether a violation of the joint space may have occurred.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nProper wound preparation is an important first step to restoring the integrity \\nand function of the injured tissue, preventing infection, and maximizing \\ncosmetic results.\\nAnesthesia\\n1. Control pain with local or regional anesthesia to enable better prepara-\\ntion and evaluation of the wound.\\n2. Perform a neurovascular examination of the in volved and distal areas \\nbefore anesthesia. Two-point discrimination (normal < 6 mm) will \\nhelp identify digital nerve injury.\\nIrrigation\\n1. Wound irrigation reduces the risk of infection.\\n2. Use low-pressure irrigation with a slow , gentle wash for simple \\nuncontaminated wounds in highly vascular areas such as the face and \\nscalp.\\n3. Use high-pressure irrigation with an appropriate 18-gauge catheter, \\nsyringe, and splash guard for contaminated w ounds.\\n4. Consider anesthesia before irrigation.\\n5. Wound soaking is not effectiv e in cleaning contaminated wounds and \\nmay increase wound bacterial counts.\\n6. Although sterile normal saline solution is commonly used, tap water is \\nsafe and effective. There is no added benefit of adding povidone iodine \\nor hydrogen peroxide to irrigation fluid. Polyhexanide irrigation may \\nhave benefit in high-risk wounds.\\n7. Warmed fluids may be more comfortable for wound irrigation.\\n09_Cydulka_Ch09.indd   82 15/03/17   10:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 101, 'page_label': '83'}, page_content='CHAPTER 9: Evaluating and Preparing Wounds 83 \\nSkin Disinfection and Sterile Technique\\n1. Sterilizing the surrounding skin with a povidone iodine- or chlorhexi-\\ndine-containing agent is common practice. Avoid contact with nonintact \\nskin when these agents are used.\\n2. Full sterile technique has not been shown to reduce infection after repair \\nof wounds in the acute setting. Clean, nonsterile glov es and attention to \\ncleanliness may be used to improve efficiency and cost savings.\\nHemostasis\\n1. Control of bleeding is necessary for proper wound evaluation and treatment.\\n2. Direct pressure is the preferred method and is usually effective.\\n3. Epinephrine-containing local anesthetics can be helpful in controlling \\nbleeding associated with wounds and can be used for digital nerve blocks, \\nnose, and ears except in patients with underlying small vessel disease.\\n4. Other means of hemostasis can be used, such as applying pressure with \\ngelatin, cellulose, or collagen sponges placed directly into the wound.\\n5. Ligation of minor vessels may be necessary and can be achiev ed by \\nligating with an absorbable suture material after isolating and clamping \\nthe involved vessel.\\n6. Cautery, with a bipolar device for v essels <2 mm and battery-powered \\ndevice for capillaries, can be used to control extensive bleeding.\\n7. Finger tourniquets or a blood pressure cuff placed proximal to the \\ninjury and inflated above the systolic blood pressure will control \\nbleeding. The duration of tourniquet use should be minimized and \\nnot left in place for more than 20 to 30 min at a time.\\nForeign Body and Hair Removal\\n1. Visually inspect the full depth and course of all wounds for foreign \\nbodies. Carefully remove foreign debris with forceps.\\n2. Many opaque foreign bodies can be detected by routine radiographs. \\nForeign bodies with densities similar to those of soft tissue may require \\nthe use of computed tomography, magnetic resonance imaging, or ultra-\\nsound to visualize.\\n3. Routine hair removal does not appear to hav e an effect on infections, \\nand shaving may increase the rate of postoperative skin and soft tissue \\ninfections.\\n4. When hair removal is required to adequately assess or repair a wound, \\nclip with scissors 1 to 2 mm abo ve the skin surface.\\nDebridement\\n1. Devitalized tissue may increase the risk of infection and delay healing. \\nDebridement removes foreign matter, bacteria, and devitalized tissue and \\ncreates a clean wound edge.\\n2. Elliptical excision around the wound edges with a standard surgical \\nblade is the easiest technique for e xcisional debridement.\\n3. Wounds with an extensiv e amount of nonviable tissue may require a \\nlarge amount of tissue removal and will need more delayed wound clo-\\nsure or grafting. In general, a surgical specialist should be consulted to \\nmanage these wounds.\\n09_Cydulka_Ch09.indd   83 15/03/17   10:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 102, 'page_label': '84'}, page_content='84 SECTION 3: Emergency Wound Management \\nProphylactic Antibiotics\\nAlthough there is no clear evidence that antibiotic prophylaxis pre vents \\nwound infection in most emergency department patients, it may have a role \\nin selected higher-risk wounds and populations.\\n1. When used, antibiotic prophylaxis should be initiated before significant \\ntissue manipulation, performed with agents that are effecti ve against \\npredicted pathogens, and administered through routes that rapidly \\nachieve desired blood levels. Oral antibiotics may be as effective as in-\\ntravenous if the agent has sufficient spectrum of coverage and rapid ab-\\nsorption.\\n2. Most non-bite infections are caused by staphylococci or streptococci, \\nand coverage with a β-lactam antibiotics is typically adequate.\\n3. Prophylactic antibiotics are recommended for human bites, mamma-\\nlian bites to the hand, and other high-risk bite wounds (see  \\nChapter 15, Puncture Wounds and Bites).\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 37, “Wound Evaluation,” by Adam J. Singer and \\nJudd E. Hollander; and Chapter 40, “Wound Preparation,” by Aleksandr M. \\nTichter, Wallace A. Carter, and Susan C. Stone.\\n09_Cydulka_Ch09.indd   84 15/03/17   10:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 103, 'page_label': '85'}, page_content='85\\nMethods for Wound Closure\\nCorey R. Heitz\\nWound closure in the emergency department can reduce the risk of infec-\\ntion, provide for improved cosmetic outcome, and maintain the skin’s pro-\\ntective functions. Methods for wound repair include primary closure \\n(immediately after injury), secondary closure (allowing a wound to heal on \\nits own, which may be useful for contaminated or infected wounds), and \\ndelayed closure (packing the wound and performing closure at a later date \\nonce infection is ruled out).\\nClinicians should consider several factors when choosing a wound clo-\\nsure method: time since injury, wound tension, whether tension is static or \\ndynamic, and risk of scar formation. The cosmetic outcome after wound \\nclosure is primarily a function of technique and not necessarily reflective of \\nthe specific closure method or device that is selected. Options for closure \\ninclude sutures, staples, adhesive tape, tissue adhesives, and hair apposition.\\n■ ■SUTURES\\nSutures are strong, reliable, and adaptable and allow good approximation of \\nwounds that are under tension. Absorbable suture material loses its tensile \\nstrength in <60 days and thus does not require removal after healing. Non-\\nabsorbable sutures maintain their tensile strength and will require removal \\nafter a suitable time period for tissue healing. For most emergency depart-\\nment applications, either choice is acceptable as both have similar rates of \\ninfection, cosmetic outcomes, and wound dehiscence risks. Absorbable \\nsutures are suitable for deep tissue structures such as dermis and fascia or \\nwhen avoiding the need for suture removal is desired. Often, monofilament \\nnonabsorbable sutures are used due to ease of use, good tensile strength, \\nand low rates of infection. Suture material is available in a wide variety of \\nsizes, with higher gauge sizes (such as 5-0 and 6-0) being very thin with \\nless tensile strength. Smaller gauge sizes (such as 3-0 and 4-0) are larger in \\ndiameter with greater strength. Large gauge (e.g., 6-0) is most often chosen \\nfor areas of low tension where minimizing scars is desired, such as on the \\nface. Smaller gauge suture (e.g., 3-0) is often used for the scalp, extremi-\\nties, or other areas where increased tension requires suture material with \\ngreater tensile strength. When placing sutures of any size, be sure to evert \\nthe skin edges and avoid applying excessive crushing force on the tissue \\nthat can further damage the area and impair healing. Direct pressure, topical \\nvasoconstrictors, or local anesthetic with vasoconstrictor are all useful for \\nachieving hemostasis when repairing a wound.\\n■ ■SUTURING TECHNIQUES\\nSimple Interrupted Percutaneous Sutures\\nPlacing simple interrupted sutures is the easiest and most commonly used \\ntechnique for wound repair. The needle is introduced on one side of the \\nwound, through the deep tissues, and exits the other side of the wound \\n10\\nCHAPTER\\n10_Cydulka_Ch10.indd   85 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 104, 'page_label': '86'}, page_content='86 SECTION 3: Emergency Wound Management\\n(Fig.\\xa010-1). Be sure to keep the needle tip at 90 de grees to the skin and \\nevert the wound edges for best results, and take care not to pucker the skin \\nwhen tying the knot. Square knots are generally tied with the number of \\nknots corresponding to the suture gauge (e.g.,four knots when using 4-0 \\nsuture material). Position the knots so that they all remain on the same side \\nof the wound.\\nContinuous (Running) Percutaneous Sutures\\nA rapid method for closure of high-tension wounds, this method can be chal-\\nlenging to get cosmetically optimal results in irregularly shaped wounds and \\nA\\nD\\nE F\\nG\\nB\\nC\\nFIguRe 10-1. Placement of simple interrupted sutures. (A) Enter at 90 degrees. \\n(B–D) Exit the same distance as the entrance. (E–G) Be consistent and tie knots on \\none side of wound.\\nReproduced with permission from E. F. Reichman: Emergency Medicine Procedures. \\n2nd ed. New York: McGraw-Hill Education; 2013.\\n10_Cydulka_Ch10.indd   86 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 105, 'page_label': '87'}, page_content='CHAPTER 10: Methods for Wound Closure 87 \\nthus is most appropriate for long linear lacerations. Place a suture at one end \\nof the wound, tie, but do not cut the suture material. Then sew back and forth \\ndown the wound at a 65 degree angle until the opposite end is reached, at \\nwhich point the suture material is tied off and cut (Fig. 10-2).\\nAB\\nC D\\nEF\\nG\\nH\\nI\\nFIguRe 10-2. Continuous running. (A–C) Begin like a simple interrupted. (D–F) Be \\nconsistent, use a 65 degree angle. (G–I) Tie off at the end.\\nReproduced with permission from E. F. Reichman: Emergency Medicine Procedures. \\n2nd ed. New York: McGraw-Hill Education; 2013.\\n10_Cydulka_Ch10.indd   87 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 106, 'page_label': '88'}, page_content='88 SECTION 3: Emergency Wound Management\\nBuried Dermal Sutures\\nThese sutures are placed to reduce tension on the wound and close dead \\nspaces by approximating underlying structures. Place these sutures by \\nentering the deep tissues first and e xiting in the subcutaneous layer, then \\nentering the other side of the wound in the subcutaneous layer and exiting \\nin the deep tissue (Fig. 10-3). This allows the knot to be buried deep within \\nthe tissue and thus should be completed with absorbable suture material. \\nClosing adipose tissue with deep sutures is unnecessary as it does not \\nAB\\nC D\\nE\\nFIguRe 10-3. Buried (deep) dermal suture. Reverse of a simple interrupted, to bury \\nthe knot. (A) Insert the needle into one side of the base of the wound, and drive the \\nneedle from deep to superficial and exiting at the dermal–epidermal junction. (B) Insert \\nthe needle through the dermal–epidermal junction on the opposite side of the wound \\nand drive it through the base of the wound. The suture should exit the base of the \\nwound across from and level with the entrance site of the first throw. (C) Pull both free \\nends of the suture up and out through the laceration. (D) Tie a knot in the suture. (E) Pull \\nboth free ends of the suture to lower the knot to the base of the wound and oppose \\nthe tissue. Tie two additional knots to secure the suture. Cut off any excess suture.\\nReproduced with permission from E. F. Reichman: Emergency Medicine Procedures. \\n2nd ed. New York: McGraw-Hill Education; 2013.\\n10_Cydulka_Ch10.indd   88 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 107, 'page_label': '89'}, page_content='CHAPTER 10: Methods for Wound Closure 89 \\nenhance cosmetic outcome or wound healing. Infection risks can be \\ndecreased when clinicians minimize the number of buried sutures used for \\nwound repair.\\nContinuous Subcuticular Sutures\\nA more complex method, subcuticular sutures are performed with absorb-\\nable sutures and do not require removal. Begin by anchoring the suture at \\none end, and then weave horizontally in and out of the dermal–epidermal \\njunction, subcutaneously (Fig. 10-4). This technique allows for excellent \\napproximation of wound edges.\\nVertical Mattress Sutures\\nVertical mattress sutures allow for closure of deep and epidermal layers \\nwith a single suture placement, and allow for excellent wound edge ever -\\nsion. Enter the wound on one side a few millimeters from the edge, take a \\nAB C\\nDE F\\nFIguRe 10-4. Continuous subcuticular suture. (A–C) Tie the anchor knot. (D, E) Use \\nhorizontal subcutaneous stitching. (F) Bury the knot at the end.\\nReproduced with permission from E. F. Reichman: Emergency Medicine Procedures. \\n2nd ed. New York: McGraw-Hill Education; 2013.\\n10_Cydulka_Ch10.indd   89 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 108, 'page_label': '90'}, page_content='90 SECTION 3: Emergency Wound Management\\ndeep bite of tissue, and exit on the other side, similar to a simple interrupted \\nsuture technique. Then before tying the knot, reenter the same side of the \\nwound that was just exited at a point closer to the wound edge and then exit \\nin a similar position on the other side in a “far-far/near-near” fashion for \\neach suture placement (Fig. 10-5).\\nHorizontal Mattress Sutures\\nFor horizontal mattress sutures, begin similarly to a simple interrupted suture. \\nInstead of tying the knot after the first suture throw, go several millimeters \\nparallel to the wound and perform another throw, tying the knot on the origi-\\nnal side of the wound (Fig 10-6). This technique is useful for wounds with \\npoor circulation and other delicate areas as it distributes wound tension and \\nprevents further skin disruption close to the wound edge.\\nHorizontal Half-Buried Mattress Sutures\\nThis technique is useful for skin flaps and stellate lacerations because the \\nsuture passes through the dermis of the skin tip and not the epidermal layer. \\nA\\nCD\\nE\\nB\\nFIguRe 10-5. Vertical mattress suture. (A, B) Far-far. (C, D) Near-near. (E) Finished \\nproduct, knots on one side.\\nReproduced with permission from E. F. Reichman: Emergency Medicine Procedures. \\n2nd ed. New York: McGraw-Hill Education; 2013.\\n10_Cydulka_Ch10.indd   90 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 109, 'page_label': '91'}, page_content='CHAPTER 10: Methods for Wound Closure 91 \\nEnter one side of the wound and run the suture in the dermal layer subcu-\\ntaneously through the other edge(s), exiting near the original entrance point \\n(Fig. 10-7).\\n■ ■NON-SUTURE TECHNIQUES\\nStaples\\nStaples are fast and easy to use but not as precise as other wound closure \\nmethods. Staples should not be used on the face as the cosmetic outcome is \\nnot as favorable as suture repairs. This wound closure method is excellent \\nfor scalp wound repair and other locations where cosmetic outcome is not \\nas important. In some wounds, deep sutures may be needed to close dermal \\nlayers prior to staple application. Align the wound edges and keep the staple \\ndevice perpendicular to and centered on the wound. Avoid firm downward \\npressure on the wound as this can cause depression of the wound edges. \\nInstead, use gentle pressure to evert the wound edges at the time of each \\nstaple deployment (Fig. 10-8).\\nDC\\nEF\\nAB\\nFIguRe 10-6.  Horizontal mattress suture. (A, B) Start like a simple interrupted.  \\n(C) Enter on the same side as exit. (D–F) Exit and tie.\\nReproduced with permission from E. F. Reichman: Emergency Medicine Procedures. \\n2nd ed. New York: McGraw-Hill Education; 2013.\\n10_Cydulka_Ch10.indd   91 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 110, 'page_label': '92'}, page_content='92 SECTION 3: Emergency Wound Management\\nAdhesive Tapes\\nAdhesive tapes are inexpensive, simple, painless, and rapid. They slough \\noff when exposed to moisture and thus should only be used for low tension, \\nfragile wounds such as skin tears. Use an adhesive adjunct such as tincture \\nof benzoin and place the tape segments perpendicular to the wound about 3 \\nmm apart. Reinforce with parallel strips, if needed.\\nTissue Adhesives\\nCyanoacrylate tissue adhesives are rapid, painless, and have similar tensile \\nstrength to 4-0 poliglecaprone subcuticular sutures. They provide a mois-\\nture and infection barrier, but can come off more easily when exposed to \\nmoisture. This wound repair does not require removal after healing, as the \\ncompound sloughs off spontaneously in 5 to 10 days. Do not use this \\nwound repair material over joints or areas of high tension. Approximate the \\nwound well, and place a thin coat of adhesive over the wound extending 5 \\nto 10 mm on either side, repeating once dry (Fig. 10-9). Adhesive tape can \\nbe used as an adjunct for long or complex wounds.\\nHair Apposition\\nScalp wounds can be closed by hair apposition. After cleaning the wound \\nthoroughly, twist several strands of hair together on either side. Then twist \\nA\\nB\\nFIguRe 10-7. Horizontal half-buried suture. Enter and exit on the same side, keep-\\ning stitch buried under edges of flaps.\\nReproduced with permission from E. F. Reichman: Emergency Medicine Procedures. \\n2nd ed. New York: McGraw-Hill Education; 2013.\\n10_Cydulka_Ch10.indd   92 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 111, 'page_label': '93'}, page_content='CHAPTER 10: Methods for Wound Closure 93 \\nA\\nCD\\nEF\\nB\\nFIguRe 10-8.  Laceration repair with staple closure. (A) The wound edges are \\nopposed and everted. (B) The stapler is applied over the laceration. (C) The stapler \\nis applied over the everted wound edges. (D) The plunger advances the staple into \\nthe wound margins. (E) The anvil bends the staple into shape. (F) The final result.\\nReproduced with permission from E. F. Reichman: Emergency Medicine Procedures. \\n2nd ed. New York: McGraw-Hill Education; 2013.\\nthese two bundles together and apply a drop of tissue adhesive to hold them \\ntogether. This technique minimizes patient discomfort, but cannot be done \\nfor large lacerations (>10 cm), grossly contaminated wounds, uncontrolled \\nbleeding, or gaping wounds with significant tension.\\n10_Cydulka_Ch10.indd   93 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 112, 'page_label': '94'}, page_content='94 SECTION 3: Emergency Wound Management\\nAB\\nC D\\nEF\\nGH\\nI\\nFIguRe 10-9. Laceration repair with adhesive tapes. (A) After the initial cleansing \\nof the skin, clean the skin surface with acetone or alcohol to remove any surface \\noils. Allow the skin to dry. Apply benzoin solution to the skin on both sides of the \\nwound with a cotton applicator. (B) Cut the skin closure tapes to the proper length. \\n(C) Gently tear the end-tab off the back of the card to prevent the strips from \\ndeforming. (D) Remove a strip from the card. (E) Firmly secure the tape to one side \\nof the wound. (F) Use the nondominant hand to oppose the wound edges as the tape \\nis brought over and secured to the skin on the opposite wound edge. \\nReproduced with permission from E. F. Reichman: Emergency Medicine Procedures. \\n2nd ed. New York: McGraw-Hill Education; 2013.\\n(Continued)\\n10_Cydulka_Ch10.indd   94 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 113, 'page_label': '95'}, page_content='CHAPTER 10: Methods for Wound Closure 95 \\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 41, “Wound Closure,” by Adam J. Singer and Judd E. \\nHollander.\\nAB\\nC D\\nEF\\nGH\\nI\\nFIguRe 10-9. (G, H) Place additional tapes at 2 to 3 mm intervals until the wound \\nedges are opposed. (I) Place pieces of tape across the tape edges to prevent pre-\\nmature removal and skin blistering from the tape ends.\\n10_Cydulka_Ch10.indd   95 15/03/17   11:20 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 114, 'page_label': '96'}, page_content='96\\nLacerations to The Face  \\nand Scalp\\nJ. Hayes Calvert\\n■ ■SCALP AND FOREHEAD\\nThe scalp and forehead have thick skin and little cushioning fat (Fig. 11-1). \\nWounds of the scalp and forehead can usually be repaired with primary \\nclosure when they are not visibly infected, regardless of the time since the \\ninjury and even if the injury was secondary to a bite. After performing \\nwound cleansing and achieving hemostasis, palpate the base of the wound \\nto assess for possible skull fracture. CT scan can be used to further evaluate \\nan injury when an underlying fracture is suspected.\\nExamine the wound edges for signs of devitalized tissue that may \\nrequire debridement. When hemostasis is not easily achieved, use direct \\npressure or vessel clamping to control bleeding at the wound edges. Irrigate \\nthe wound well to remove contamination and reduce the risk of wound \\ninfection. Close scalp lacerations with surgical staples or simple interrupted \\nsutures using nonabsorbable monofilament or rapidly absorbable material. \\n11\\nC HAP t ER\\nFigure 11-1. The layers of the scalp.\\n11_Cydulka_Ch11.indd   96 15/03/17   11:26 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 115, 'page_label': '97'}, page_content='CHAPTER 11: Lacerations to The Face and Scalp  97 \\nConsider a pressure dressing over deep scalp lacerations for the first  \\n24 hours to reduce the chance of hematoma formation.\\nSuperficial forehead lacerations are not associated with injury to the \\nfrontalis muscle, while deep lacerations do have damage to the frontalis \\nmuscle. Close superficial forehead lacerations with 6-0 nonabsorbable \\ninterrupted suture, rapidly absorbable suture, or tissue adhesive. Close \\nthe muscular layer of deep forehead lacerations with buried 5-0 absorb-\\nable suture, and then close the epidermal layer with 6-0 nonabsorbable \\nsuture, skin closure strips, or tissue adhesive. Eyebrows are important \\nlandmarks to assist with reapproximation of wound edges. When wounds \\ninvolve the eyebrows, minimize skin debridement and leave suture tails \\nlong to facilitate removal. Remove scalp staples or sutures in 10 to 14 \\ndays, while forehead nonabsorbable sutures can be removed in 5 to  \\n7 days.\\n■ ■EYELIDS\\nThe eyelids are thin and offer limited protection from injuries to the \\nglobe and surrounding structures. Examine lid injuries for involvement \\nof the canthi, the lacrimal system, or penetration through the tarsal plate \\nor lid margin (Fig. 11-2). Eyelid injuries within 6 to 8  mm of the medial \\ncanthus are at risk for canalicular laceration, particularly when associ-\\nated with medial wall blo w-out fractures. Consider consultation with an \\nophthalmologist when ptosis is present or for complex eyelid wounds \\nsuch as those involving the inner surface of the lid, lid margins, lacrimal \\nduct, and tarsal plate. Close uncomplicated eyelid lacerations with non-\\nabsorbable 6-0 or 7-0 simple interrupted percutaneous sutures. Avoid the \\nuse of tissue adhesive near the eye. Remove nonabsorbable sutures in  \\n3 to 5 days.\\nFigure 11-2. Periorbital anatomy.\\n11_Cydulka_Ch11.indd   97 15/03/17   11:26 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 116, 'page_label': '98'}, page_content='98 SECTION 3:  Emergency Wound Management\\n■ ■NOSE\\nExamine nasal lacerations to determine depth and involvement of deep tis-\\nsue layers. Exposed cartilage or deep involvement of the tissue layers \\nincreases the risk of infection. Topical lidocaine into the nasal cavity may \\nprovide sufficient anesthesia for some local wound repair, and injected \\nintradermal lidocaine with or without epinephrine is appropriate when \\nneeded to facilitate wound evaluation, cleansing, and repair.\\nClose superficial nasal lacerations with 6-0 nonabsorbable monofila-\\nment simple interrupted sutures. When the laceration extends through all \\ntissue layers, begin closure with a 5-0 nonabsorbable, monofilament suture \\nthat aligns the skin surrounding the entrances of the nasal canals to prevent \\nmalposition and notching of the alar rim. Gentle traction on the long, untied \\nends of this suture facilitates alignment of the mucosa and cartilage layers \\nduring subsequent suture placement. Close the mucosal layer with 5-0 \\nrapidly absorbable interrupted sutures, and then irrigate the area gently \\nfrom the outside before completing the repair. Avoid suture placement \\ndirectly into the cartilage. Complete the repair with 6-0 nonabsorbable \\nmonofilament material close to the wound edges. Percutaneous nonabsorb-\\nable sutures should be removed in 3 to 5 days.\\nDrain small unilateral septal hematomas with an 18G needle, or incise \\nthe hematoma if it is larger. After the hematoma has been evacuated, place \\nan anterior nasal packing to prevent reaccumulation. Consider a course of \\noral antibiotics to prevent infection while nasal packing is in place.\\n■ ■EAR\\nClose superficial lacerations of the ear with 6-0 nonabsorbable monofila-\\nment interrupted sutures, taking care to cover any exposed cartilage and \\nminimize skin debridement. In most through-and-through lacerations of \\nthe ear, the skin can be approximated and the underlying cartilage will be \\nsupported adequately (Fig. 11-3). After laceration repair is complete, \\nFigure 11-3.  Repair of auricular laceration. A. Laceration through auricle. B.  \\nInterrupted 6-0 nonabsorbable sutures approximate the skin edges.\\n11_Cydulka_Ch11.indd   98 15/03/17   11:26 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 117, 'page_label': '99'}, page_content='CHAPTER 11: Lacerations to The Face and Scalp  99 \\nplace a small piece of nonadherent gauze over the laceration and apply a  \\npressure dressing to prevent development of a perichondral hematoma. To \\ncreate a pressure dressing, place gauze squares behind the ear to apply \\npressure, and wrap the head circumferentially with gauze. Discontinue \\nthe pressure dressing after 24 hours when reevaluation demonstrates that \\nno hematoma has accumulated. Consider consultation with an otolaryn-\\ngologist or plastic surgeon for complex lacerations, ear avulsions, or \\nauricular hematomas. Remove nonabsorbable percutaneous sutures in  \\n5 to 7 days.\\n■ ■LIPS\\nThe external surface of the lips has three distinct regions: the skin, the \\nvermilion border (junction of the skin and red portion of the lips), and the \\noral mucosa. Isolated intraoral lesions of the lip often do not need to be \\nsutured, especially if they are <1 cm in length. Repair large or gaping intra-\\noral lip wounds with a rapidly absorbable 5-0 suture. Through-and-through \\nlacerations of the lip that do not include the vermilion border can be closed \\nin layers. Begin repair with 5-0 rapidly absorbable suture for the mucosal \\nsurface, then gently irrigate the wound from the outside before closing the \\norbicularis oris muscle with 4-0 or 5-0 absorbable suture. Finally, close the \\nskin layer with 6-0 nonabsorbable monofilament sutures in a simple inter -\\nrupted fashion.\\nBegin closure of a complicated lip laceration at the junction between the \\nvermilion and the skin with a 6-0 nonabsorbable, monofilament suture to \\nprecisely align the edges of the vermilion border (Fig. 11-4). After placing \\nthat first stitch, continue to repair the vermilion and skin with the same 6-0 \\nnonabsorbable monofilament suture and then use 5-0 rapidly absorbable \\nsuture for any needed mucosal surface repair. Consider oral antibiotics for \\ncontaminated wounds or through-and-through lacerations. Remove nonab-\\nsorbable percutaneous sutures in 5 to 7 days.\\nOrbicularis oris muscle\\nAB C\\nFigure 11-4.  Lip laceration repair. A. The first suture is placed to align the \\nvermilion skin junction. B. The orbicularis oris muscle is then repaired with 5-0 \\nabsorbable sutures. C. The irregular edges of the skin are then approximated with \\n6-0 nonabsorbable sutures.\\n11_Cydulka_Ch11.indd   99 15/03/17   11:27 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 118, 'page_label': '100'}, page_content='100 SECTION 3:  Emergency Wound Management\\n■ ■CHEEKS AND FACE\\nEvaluate cheek and other facial lacerations to determine wound depth and \\nto assess for damage to the parotid gland, parotid duct, and facial nerve \\n(Fig. 11-5), which would necessitate specialty consultation and operative \\nrepair. Repair superficial facial lacerations without underlying complica-\\ntions with 6-0 nonabsorbable monofilament, simple interrupted sutures. \\nTissue adhesive may also be used for wounds of appropriate size and loca-\\ntion. Full-thickness cheek lacerations can be repaired in layers beginning \\nwith the intraoral mucosa using absorbable sutures. After irrigation of the \\nexternal wound, close the subcutaneous and skin layers using 5-0 or 6-0 \\nsuture material. Remove nonabsorbable percutaneous sutures in 5 to 7 days.\\n■ ■FURtHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 42, “Face and Scalp Lacerations,” by Wendy C. \\nCoates.\\nFacial nerve\\nParotid duct Parotid \\nsalivary gland\\nTemporal nerve\\nZygomatic nerve\\nBuccal nerve\\nMarginal mandibular \\nnerve\\nCervical nerve\\nFigure 11-5. Cheek anatomy. The course of the parotid duct is within 1.5 cm of \\nthe midportion of a line drawn from the lower border of the tragus to the cheilion. \\nThe five branches of the facial nerve are the temporal, zygomatic, buccal, marginal \\nmandibular, and cervical.\\n11_Cydulka_Ch11.indd   100 15/03/17   11:27 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 119, 'page_label': '101'}, page_content='101\\nInjuries to the Arm, Hand, \\nFingertip, and Nail\\nJohn Pettey Sandifer\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nWhen taking a history, consider occupation, time and mechanism of injury, \\nand hand dominance. Examination of all arm and hand injuries includes \\ninspection at rest, evaluation of motor, nerve, and tendon functions, evaluation \\nof sensory nerve function, and assessment of perfusion. Examine active \\nmotion and resistance to passive motion. (See Tables 12-1 and 12-2.) Examine \\nall wounds for evidence of potential artery, nerve, tendon, or bone injuries, and \\nthe possible presence of foreign bodies, debris, or bacterial contamination.\\nControl bleeding to achieve adequate visualization and assessment of an \\ninjury. When necessary, a manual blood pressure cuff can be used as a \\ntemporary tourniquet for proximal injuries or a penrose drain can be used \\nfor distal finger injuries, taking care to apply for only limited time periods. \\nOnce adequate visualization is obtained, examine the wound for foreign \\nbodies and tendon or joint capsule injuries. Examine the hand and arm \\nthroughout normal range of motion, including in the position of injury to \\navoid missing deep structure injuries that may have moved out of the field \\nof view when examined in a neutral position. Obtain anteroposterior and \\nlateral x-rays if bony injuries, retained radiopaque foreign bodies, or joint \\ninvolvement are suspected.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\n1. Clean and irrigate all wounds after appropriate local anesthesia is provided.\\n2. Provide tetanus prophylaxis as indicated (see Chapter 16).\\n12\\nCh APTER\\nTAble 12-1 Motor Testing of the Peripheral Nerves in the Upper Extremity\\nNerve Motor Exam\\nRadial Dorsiflexion of wrist\\nMedian Thumb abduction away from the palm\\nThumb interphalangeal joint flexion\\nUlnar Adduction/abduction of digits\\nTAble 12-2 Sensory Testing of Peripheral Nerves in the Upper Extremity\\nNerve Sensory Exam\\nRadial First dorsal web space\\nMedian Volar tip of index finger\\nUlnar Volar tip of little finger\\n12_Cydulka_Ch12.indd   101 20/04/17   4:30 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 120, 'page_label': '102'}, page_content='102 SECTION 3: Emergency Wound Management\\n3. Consider consultation with a hand specialist for complex or extensiv e \\ninjuries, injuries that may require skin grafting, repairs requiring techni-\\ncally demanding skills, or injuries that may impact recovery of function.\\n4. Prophylactic antibiotics are not routinely needed for uncomplicated \\nhand lacerations.\\n5. Consider antibiotics for complex wounds such as bites, injuries more \\nthan 12 hours old, contaminated wounds, e xposed bone, or significant \\ncomorbidities.\\n6. See below for additional care instructions for specific injuries.\\nDorsal Forearm, Wrist, and Hand lacerations\\n1. Examine tendons and nerves distal to the wound to assess for potential \\ninjury.\\n2. Dorsal forearm and hand skin is often thin without underlying tissue. \\nThis can make wound edge approximation challenging.\\n3. For most lacerations, use 5-0 nonabsorbable sutures for closure. Con-\\nsider subcuticular sutures with 5-0 absorbable material on the dorsum of \\nthe hand.\\nClenched Fist Injuries\\n1. Clenched fist injuries, also known as “fight bites,” occur when a patient \\nthrows a punch that impacts the front teeth of another individual and \\nleads to lacerations over the dorsal metacarpophalangeal joint.\\n2. These lacerations often are accompanied with polymicrobial infections \\nwith pathogens such as Staphylococcus aureus, Streptococcus spp., \\nCorynebacterium spp., and Eikenella corrodens.\\n3. Lacerations from clenched fist injuries are often not sutured, but instead \\nallowed to heal by secondary intention. If signs of infection are already \\npresent, consider admission for IV antibiotics such as ampicillin–\\nsulbactam or cefoxitin.\\n4. If outpatient treatment is recommended, splint the hand in a position of \\nfunction with a 3- to 5-day course of prophylactic antibiotics such as \\namoxicillin–clavulanic acid. Arrange close follow-up in 24 to 48 hours \\nwith strict return instructions in the event of erythema, drainage, or in-\\ncreased pain.\\nextensor Tendon lacerations\\n1. Discuss tendon injuries with a hand specialist for preferred repair tech-\\nnique and to arrange follow-up. Experienced emergency physicians may \\nrepair simple extensor tendon injuries over the dorsum of the hand. \\nRefer cases to a hand specialist when severe contamination or injuries to \\nthe tendons of the thumb are involved.\\n2. Small partial extensor tendon injuries (< 50% transected) can be \\nrepaired with absorbable suture material, while larger injuries should be \\nrepaired with 4-0 or 5-0 colorless nonabsorbable suture. A figure-of-\\neight stitch with the knot at the edge of the tendon is recommended for \\nrepair of lacerated extensors. Splint the hand or digit in the position of \\nfunction and recommend follow-up with a hand specialist within 7 days \\n(Fig. 12-1).\\n12_Cydulka_Ch12.indd   102 20/04/17   4:30 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 121, 'page_label': '103'}, page_content='CHAPTER 12: Injuries to the Arm, Hand, Fingertip, and Nail 103 \\n3. Lacerations to the extensor tendons over the distal interphalangeal (DIP) \\njoint may produce a mallet deformity , and if not repaired may result in \\na swan neck deformity. Lacerations over the proximal interphalangeal \\njoint may produce a boutonniere deformity. Open DIP tendon lacera-\\ntions require operative repair by a hand surgeon; closed tendon injuries \\nshould be splinted in extension for up to 6 weeks or until operative re-\\npair. Refer these cases to a hand specialist.\\nFIgure 12-1. Extensor tendon laceration repair with a figure-of-eight stitch.\\n12_Cydulka_Ch12.indd   103 20/04/17   4:30 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 122, 'page_label': '104'}, page_content='104 SECTION 3: Emergency Wound Management\\nVolar Forearm, Wrist, and Hand lacerations\\n1. Linear lacerations over the volar aspect of the wrist or forearm may raise \\nthe possibility of self-inflicted injuries. In appropriate circumstances, \\nquestion the patient about how the injury occurred and assess risks for \\npossible self-injurious behavior.\\n2. Most simple lacerations to the volar surface of the forearm and wrist can \\nbe repaired with 4-0 or 5-0 nonabsorbable monofilament sutures.\\n3. Injuries that inv olve more than one parallel laceration, which may be \\nseen with self-inflicted injuries, can sometimes be repaired with hori-\\nzontal mattress sutures that cross adjacent lacerations. This can help to \\nprevent compromising the vascular supply of any skin islands located \\nbetween incisions (Fig. 12-2).\\n4. Examine the function of tendons and distal nerves individually to assess \\nfor possible damage. (See Tables 12-3 and 12-4.)\\nPalm lacerations\\n1. Injuries to the palm can damage deep structures, even those with a be-\\nnign superficial appearance. Regional anesthesia with a median or ulnar \\nnerve block may be useful for exploring such wounds.\\nFIgure 12-2. Horizontal mattress sutures for multiple parallel lacerations.\\n12_Cydulka_Ch12.indd   104 20/04/17   4:30 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 123, 'page_label': '105'}, page_content='CHAPTER 12: Injuries to the Arm, Hand, Fingertip, and Nail 105 \\n2. If no deep injury is identified, close the wound with sutures to re-oppose the \\nskin creases accurately. Interrupted horizontal mattress sutures with 5-0 \\nmonofilament suture can be helpful to promote appropriate skin eversion.\\nFlexor Tendon lacerations\\n1. Refer all flexor tendon injuries to a hand specialist. Many surgeons \\nprefer to repair these injuries within 24 hours after injury .\\n2. Timely repair by a hand surgeon is important, as post-injury scarring and \\nretraction make flexor tendon repairs more difficult after 10 to 14 days.\\nTAble 12-3 Extensor Compartments in the Forearm Compartment\\nCompartment Muscle Function\\nFirst compartment Abductor pollicis longus\\nExtensor pollicis brevis\\nAbducts and extends thumb\\nExtends thumb at MCP joint\\nSecond compartment Extensor carpi radialis \\nlongus\\nExtensor carpi radialis \\nbrevis\\nExtends and radially \\ndeviates wrist\\nExtends and radially \\ndeviates wrist\\nThird compartment Extensor pollicis longus Extends thumb at  \\ninterphalangeal joint\\nFourth compartment Extensor digitorum  \\ncommunis\\nExtensor indicis proprius\\nSplits into four tendons at \\nlevel of the wrist; extends \\nindex, long, ring, and little \\ndigits\\nExtends index finger\\nFifth compartment Extensor digiti minimi Extends little finger at \\nMCP joint\\nSixth compartment Extensor carpi ulnaris Extends and radially \\ndeviates wrist\\nAbbreviation: MCP , metacarpophalangeal.\\nTAble 12-4 Flexor Tendons in the Forearm\\nFlexor Tendon Function\\nFlexor carpi radialis Flexes and radially deviates wrist\\nFlexor carpi ulnaris Flexes and ulnarly deviates wrist\\nPalmaris longus Flexes wrist\\nFlexor pollicis longus Flexes thumb at MCP and interphalangeal \\njoints\\nFlexor digitorum superficialis Flexes index, long, ring, and little digits at \\nMCP and PIP joints\\nFlexor digitorum profundus Flexes index, long, ring, and little digits at \\nMCP, PIP , and DIP joints\\nAbbreviations: DIP , distal interphalangeal; MCP , metacarpophalangeal; PIP , proximal interphalangeal.\\n12_Cydulka_Ch12.indd   105 20/04/17   4:30 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 124, 'page_label': '106'}, page_content='106 SECTION 3: Emergency Wound Management\\n3. If operative repair is delayed, clean the wound and suture the o verlying \\nskin. Splint with the wrist and metacarpophalangeal joint flexed and the \\nproximal interphalangeal and DIP joints in extension.\\nFinger Injuries\\n1. Many finger lacerations are straightforward and can be repaired by using \\n5-0 nonabsorbable suture materials.\\n2. Assess for underlying injuries, such as sensory nerve damage or exten-\\nsor and flexor tendon injuries.\\n3. Partial or complete digit amputations should involve consultation with a \\nhand surgeon to discuss whether implantation is a feasible option.\\n4. Digital nerve injuries are suspected when static two-point discrimination \\nis >10 mm or distinctly greater on one side of the volar pad than the other.\\nFinger Tip Injuries\\n1. Successful repair of fingertip injuries requires knowledge of anatomy \\n(Fig. 12-3) and an understanding of techniques of reconstruction.\\n2. Distal fingertip amputations with skin or pulp loss only are usually man-\\naged conservatively, with serial dressing changes.\\n3. For some distal fingertip amputations without exposed bone, a full-\\nthickness skin graft using the se vered tip itself may be considered. For \\nlarger injuries, skin can also be harvested from a distant site by a hand \\nspecialist with skin graft expertise.\\n4. Injuries with exposed bone are not amenable to skin grafting, and most \\nof these injuries require specialist advice and management.\\nInjuries Involving the Nail and Nail bed\\n1. Subungual hematomas of >50% of the nail bed are often decompressed \\nby simple trephination of the nail plate. This produces good to excellent \\nInsertion of\\nextensor tendon\\nPeriosteum\\nNail well\\nEponychium\\nLunula\\nNail bed\\nHyponychium\\nInsertion of deep\\nflexor tendon\\nDistal\\ninterphalangeal\\njoint\\nVentral floor\\nNail foldDorsal roof\\nFIgure 12-3. Anatomy of the perionychium.\\n12_Cydulka_Ch12.indd   106 20/04/17   4:30 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 125, 'page_label': '107'}, page_content='CHAPTER 12: Injuries to the Arm, Hand, Fingertip, and Nail 107 \\noutcomes in most patients regardless of subungual hematoma size, in -\\njury mechanism, or presence of fracture. Use of nail drill, electrocautery, \\nscalpel, or 18 gauge needle is recommended for trephination.\\n2. Remove the nail only if there is an associated nail avulsion or sur -\\nrounding nail fold disruption. Repair a nail bed laceration with 6-0  \\nabsorbable sutures to provide a smooth surface for nail regrowth. \\nClean and trephinate the removed nail and secure with sutures in its \\nanatomic position.\\n3. Avulsion injuries to the nail bed have the poorest prognosis of an y \\nfingertip injury. Fragments of germinal matrix tissue left on the under -\\nside of the nail should be preserved and the nail anatomically reat-\\ntached, if possible (Fig. 12-4). If there is extensive injury to the nail \\nbed with avulsed tissue, consultation with a hand specialist is recom-\\nmended.\\nring Tourniquet Syndrome\\n1. A tight ring encircling the proximal phalanx may become entrapped due \\nto distal swelling. For this reason, rings should be removed from all in -\\njured fingers.\\n2. Ring removal techniques include lubrication, ring cutting, and the string \\nor rubber band technique.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, \\n8th ed., see Chapter 43, “Arm and Hand Lacerations,” by Moira Davenport.\\nA\\nB\\nFIgure 12-4. (A, B). Technique for repair of an avulsion of the germinal matrix \\nusing three horizontal mattress sutures.\\n12_Cydulka_Ch12.indd   107 20/04/17   4:30 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 126, 'page_label': '108'}, page_content='108\\nLacerations to the Leg and Foot\\nMoira Davenport\\n■ ■CLINICAL FEATURES\\nLacerations to the leg and foot are commonly seen in the Emergency \\nDepartment. The mechanism of injury determines the likelihood of disrup-\\ntion to underlying tissue, the risk of a retained foreign body, and the degree \\nof potential contamination. See Chapter 9 for additional information about \\nevaluating and preparing wounds for repair. As with other extremity inju-\\nries, evaluating limb positioning at the time of injury and replicating this \\nduring wound evaluation may help to uncover occult tendon injuries.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nAssess lower extremity wounds for any associated nerve, vessel, or ten-\\ndon injuries. Evaluate distal motor and sensory function and compare \\nfindings from the injured extremity to the contralateral side. Sensory \\nfunction is best evaluated prior to providing anesthetic agents, but a full \\nassessment of motor function and wound exploration may be easier to \\nperform after the wound is anesthetized. Evaluate the superficial peroneal \\nnerve (foot eversion), the deep peroneal nerve (foot inversion and ankle \\ndorsiflexion), and the tibial nerve (ankle plantar flexion). Move the limb \\nthrough its full range of motion to exclude tendon injury. Test each tendon \\nfunction individually and visually inspect the wound at rest and in motion \\nto rule out a partial laceration. Evaluate the extensor hallucis longus \\n(great toe extension with ankle inversion), tibialis anterior (ankle dosi-\\nflexion and inversion), and achilles tendon (ankle plantar flexion and \\ninversion).\\nLaboratory studies are not typically indicated for simple lacerations. \\nConsider x-rays if there is suspicion for a fracture or radiopaque foreign \\nbody. Ultrasonography may also be useful to identify a foreign body, ten-\\ndon injury, or bony abnormality.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\nGeneral Recommendations\\n1. See Chapter 9 for discussion of wound preparation. Thorough wound \\nexploration and irrigation of lower extremity wounds are important.\\n2. Wounds on the lower extremities may be under greater tension than \\nthose on an upper limb. Consider performing a layered closure with 4-0 \\nabsorbable material to close the fascia and interrupted 4-0 nonabsorb-\\nable sutures to close the skin, when appropriate. This type of layered \\nclosure is not typically required for wounds on the foot.\\n3. When possible, avoid placement of absorbable deep sutures in patients \\nwith diabetes, immunocompromise, or venous stasis changes due to an \\nincreased risk of infection.\\n13\\nCh APTER\\n13_Cydulka_Ch13.indd   108 15/03/17   11:55 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 127, 'page_label': '109'}, page_content='CHAPTER 13: Lacerations to the Leg and Foot 109 \\n4. Determine each patient’s tetanus immunization status and update as \\nnecessary (see Chapter 94).\\n5. Cyanoacrylate glue is not used as often for wound repair on the lower \\nextremities because of the greater wound tension associated with these \\ninjuries.\\n6. Once repaired, lacerations involving the joint or tendons should be \\nsplinted in a position of function.\\n7. Evidence does not support routine antibiotic prophylaxis in uncompli-\\ncated lacerations of the lower e xtremity. Antibiotics are recommended \\nfor open fractures, tendon or joint involvement, heavily contaminated \\nwounds, bite wounds, patients with higher risks for infection, and \\nwounds that exhibit early signs of infection.\\nKnee Injuries\\n1. Examine knee wounds throughout the range of movement of the joint. \\nAssess patellar and quadriceps tendon function.\\n2. Evaluate these wounds to determine whether penetration of the joint \\ncapsule may have occurred. An x-ray may show air in the joint. Another \\napproach to diagnose joint penetration is to inject 65 to 95  mL of sterile \\nsaline into the joint at a site separate from the laceration. Leakage of the \\nsolution from the wound indicates joint capsule injury.\\n3. Assess for potential injury to the popliteal artery, the popliteal nerve, and \\nthe tibial nerve.\\nAnkle Injuries\\n1. Move the ankle through its full range of motion and directly inspect the \\nwound to ensure there are no tendon injuries. The Achilles tendon, the \\ntibialis anterior, and the extensor hallucis longus in particular are at risk \\nfor injury and should be repaired if an injury is identified.\\n2. The Achilles tendon can rupture without a penetrating injury when a \\ntensed gastrocnemius is suddenly contracted. The Thompson test can be \\nused to assess the Achilles tendon. Have the patient kneel on a chair or lie \\nsupine with feet extending beyond the stretcher (see Fig. 13-1). Squeeze \\nthe patient’s calf gently at the midpoint. Absent plantar flexion of the foot \\nindicates complete Achilles tendon laceration.\\nFoot Injures\\n1. Explore lacerations on the sole of the foot to assess for tendon injury or \\nretained foreign bodies. Place the patient in a prone position with the \\nfoot supported on a pillow or overhanging the bed.\\n2. Regional anesthesia can be helpful to facilitate exploration and repair of \\nlacerations in this area.\\n3. Repair wounds as soon as possible after injury, ideally within 6 hours to \\nminimize infection risks. Wounds presenting between 6 and 12 hours \\nfrom the time of injury can often be repaired primarily. Evaluate each \\nwound individually for infection risks.\\n4. When repairing foot wounds, a large needle is often required to pene-\\ntrate the thick dermis of the sole. Use nonabsorbable 3-0 or 4-0 suture \\nmaterial to repair wounds located on the sole and 4-0 or 5-0 nonabsorb-\\nable sutures to repair the dorsal foot.\\n13_Cydulka_Ch13.indd   109 15/03/17   11:55 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 128, 'page_label': '110'}, page_content='110 SECTION 3: Emergency Wound Management\\n5. Lacerations between the toes can be difficult to repair and may be facili-\\ntated by an assistant to hold the toes apart during repair. An interrupted \\nmattress suture may be helpful to optimize adequate skin apposition.\\n6. Consider prescribing crutches and/or a walking boot after repair of a \\nfoot laceration.\\n7. Lawn mowers and bicycle spokes may cause extensive soft tissue injury \\nalong with underlying fractures and tendon lacerations. Severe injuries \\nmay require consultation with an orthopedic specialist.\\nHair-Thread Tourniquet Syndrome\\n1. Hair-thread tourniquet syndrome is an unusual type of injury seen in \\ninfants. A long strand of hair or thread wraps around one of the toes and \\ncan lead to vascular compromise.\\n2. Remove the hair or thread completely to relieve neurovascular compromise \\nby unwinding it, if possible. Otherwise, consider making a midline longitu-\\ndinal incision along the extensor surface of the toe to cut the hair or thread.\\n■ ■DISPOSITION\\n1. Instruct patients to keep wounds clean and dry.\\n2. Recommend suture removal in 10 to 14 days for wounds of the lo wer \\nlimb and in 14 days for lacerations over joints.\\nFIGuRe 13-1.  Thompson test. “With the patient’s feet extending beyond the \\nstretcher, squeeze both calfs at the midpoint. Normal response is shown on the \\npatient’s left, absent plantar flexion (abnormal) shown on patient’s right.”\\n13_Cydulka_Ch13.indd   110 15/03/17   11:55 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 129, 'page_label': '111'}, page_content='CHAPTER 13: Lacerations to the Leg and Foot 111 \\n3. Provide wound care instructions. Elevation of the affected limb can help \\nto reduce edema and may aid healing.\\n4. Consider recommending a w ound recheck after 48 hours for a heavily \\ncontaminated wound, when a complex repair is required, or if the patient \\nis at higher risk for wound infections.\\n5. Crutches may be recommended for 7 to 10 days after a wound repair, as \\nneeded, to prev ent additional tension on the wound during the initial \\nhealing process.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 44, “Leg and Foot Lacerations,” by Annabella \\nSalvador-Kelly and Nancy Kwon.\\n13_Cydulka_Ch13.indd   111 15/03/17   11:55 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 130, 'page_label': '112'}, page_content='112\\nSoft Tissue Foreign Bodies\\nMichael T. Fitch\\nEmergency providers are often called upon to evaluate acute wounds that \\nare at risk for embedded foreign bodies. Assessment of older wounds may \\nalso be complicated by retained foreign material that was initially unrecog-\\nnized and can impact the healing process and risk of subsequent infection. \\nCareful evaluation of wounds, radiographic imaging when indicated, and \\nlocal exploration allow identification of most foreign bodies. Once identi-\\nfied, many foreign bodies can be removed in the emergency department, \\nalthough some may be left in place or referred to appropriate specialists for \\ndelayed removal.\\n■ ■CLINICAL FEATURES\\nWhile only a small percentage of lacerations and puncture wounds contain \\nforeign bodies, carefully assess all injuries to evaluate for potentially unrec-\\nognized retained material. The mechanism of injury, composition and shape \\nof the wounding object, and the shape and location of the wound are all \\nfactors to consider. Objects that have broken, shattered, or splintered at the \\ntime of injury may increase the risk of an embedded foreign body. Brittle \\nmaterials such as thorns, spikes, or branches may penetrate deeply into tis-\\nsue before breaking. Wood splinters often fragment when pulled from a \\npuncture wound.\\nAdult patients who complain of a foreign body sensation in an acute \\nwound more than doubles the likelihood of one being present. Wounds that \\nhave healed but continue to be the source of sharp pain with movement or \\npressure over the site may represent a retained foreign object. Other poten-\\ntial signs of an unrecognized foreign body may include poor wound heal-\\ning, recurrent infections, or the development of soft tissue masses.\\nMost foreign bodies can be identified through deliberate and careful \\nexploration of wounds determined to be at risk. Use adequate lighting, \\nappropriate anesthesia, and hemostasis techniques to optimize wound \\nevaluation. Visually inspect all recesses of a wound, when possible, recog-\\nnizing that wounds deeper than 5 mm or where the full depth cannot be \\nvisualized have a higher association with foreign bodies. Consider extend-\\ning the wound margins with a scalpel to permit a more complete explora-\\ntion when appropriate. Blind and gentle probing with a closed hemostat can \\nbe an effective method to identify some foreign bodies, such as glass frag-\\nments, when direct visualization is not possible.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nWhen a foreign body is suspected but not identified and removed during \\nvisual inspection, consider radiographic imaging for further evaluation. \\nMost foreign bodies can be seen on plain radiographs, although CT scan, \\nultrasound, or MRI may be indicated in some circumstances (Table 14-1). \\nUse an underpenetrated soft tissue plain radiography technique or adjust \\n14\\nCh A p TER\\n14_Cydulka_Ch14.indd   112 15/03/17   12:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 131, 'page_label': '113'}, page_content='CHAPTER 14: Soft Tissue Foreign Bodies 113 \\nthe contrast and brightness when using a digital system to increase the \\nlikelihood of identifying a foreign body. CT scan is capable of detecting \\nmore types of materials than plain film radiography, and may be useful for \\nthorns, spines, wood splinters, or plastic foreign bodies. Ultrasound can be \\nuseful at the bedside for directing exploration and removal of foreign bod-\\nies. It is >90% sensitive for detecting foreign bodies larger than 4 to 5 mm \\ntaking into account the composition of the foreign body, proximity to echo-\\ngenic structures, and operator experience. MRI is more accurate than the \\nother modalities for identifying wood, plastic, spines, and thorns, but is \\noften less available for emergency use.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Once a foreign body has been identified, consider the risks and benefits \\nof immediate remov al, delayed removal, or leaving in place. Consider \\nthe potential for infection, toxicity, functional problems, or persistent \\npain, recognizing that not all foreign bodies require removal. Objects \\nthat are small, inert, deeply embedded, and causing no symptoms can \\noften be left in place. Thorns, wood splinters, spines, vegetative mate-\\nrial, or contaminated objects are often best removed promptly to prevent \\nsubsequent inflammation, pain, or infection.\\n2. Techniques for soft tissue foreign body removal are based on clinical \\nexperience, as there are no systematic studies comparing different tech-\\nniques. Many objects can be removed by the emergency provider when \\nfacilitated by adequate lighting, hemostasis, and anesthesia. Consider \\nreferral to a specialist for complicated or delayed foreign body removal. \\nThere is no proven benefit for prophylactic antibiotics for wounds that \\nare not infected.\\n3. Provide tetanus immunization and appropriate wound care after foreign \\nobjects are removed. Primary closure of wounds can be considered \\nafter foreign contaminants are removed and the risks of infection are \\nlow. Consider delayed primary closure for wounds with higher risks of \\ninfection.\\n4. Superficially embedded metallic needles can be removed with a hemo-\\nstat after a small incision over one end. Remove more deeply embedded \\nTaBle 14-1 Imaging Modalities for Detection of Soft Tissue Foreign Bodies\\nMaterial plain Radiographs high-Resolution US CT MRI\\nWood Poor Good Moderate \\nto good\\nModerate\\nMetal Excellent Good Excellent Poor\\nGlass Excellent Good Excellent Good\\nOrganic (e.g., \\nplant thorns and \\ncactus spines)\\nPoor Good Good Good\\nPlastic Moderate Moderate to good Good Good\\nPalm thorn Poor Moderate Good Good\\n14_Cydulka_Ch14.indd   113 15/03/17   12:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 132, 'page_label': '114'}, page_content='114 SECTION 3: Emergency Wound Management\\nneedles by making an incision at the midpoint of the needle, grasp it \\nwith a hemostat, and push it back out through the entrance wound. For \\nneedles perpendicular to the skin, extend an incision and use pressure on \\nthe wound edges to expose the needle and facilitate removal.\\n5. Wood splinters and organic spines can be remo ved using forceps when \\nthey are small and superficially located. Removal for deeper objects can \\nbe facilitated by an incision along the long axis of the foreign body when \\nit is parallel to the skin surface. If the object is small and localization is \\ndifficult, a small elliptical block of tissue may be removed and the \\nremaining wound closed primarily. Remove subungual splinters using \\ntraction or by excising a portion of nail over the splinter. Cactus spines \\nembedded in the dermis may be removed individually or using an adhe-\\nsive such as facial gel, rubber cement, or household glue applied to the \\nskin and removed when dry.\\n6. Fishing hooks can be removed using one of several described techniques \\nafter providing adequate anesthesia to the skin around the site of entry. \\nSuperficial fishing hooks can be removed using a retrograde technique \\nof gentle downward pressure on the shank while the hook is pulled back \\nout the path of entry. The string pull method uses one hand to depress \\nthe shank of the hook to disengage the barb while the other hand gives \\na quick tug on a string that has been wrapped around the bend in the \\nhook. When the advance-and-cut technique is used, the point and the \\nbarb of the fishhook are pushed through the skin and clipped with wire \\ncutters, and the remaining part of the hook is threaded back through the \\noriginal wound. The incision technique is nearly always successful, and \\ninvolves enlarging the entrance wound to expose the bend in the hook \\nand the barb until disengaged from the subcutaneous tissue. This tech-\\nnique allows for easier wound exploration and cleaning.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 45, “Soft Tissue Foreign Bodies,” by Richard L. \\nLammers.\\n14_Cydulka_Ch14.indd   114 15/03/17   12:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 133, 'page_label': '115'}, page_content='115\\nPuncture Wounds and Bites\\nMichael T. Fitch\\n■ ■PUNCTURE WOUNDS\\nPuncture wounds can be challenging to manage due to difficulty visualizing \\nand cleaning the full depth of an injury. These injuries commonly occur to \\nthe extremities, such as on the plantar surface of the foot. Puncture wounds \\nalso include injuries caused by high-pressure injection equipment, health \\ncare associated needle-stick injuries, and some bite wounds from animals. \\nInfections are reported in 6% to 11% of puncture wounds, with Staphylo-\\ncoccus aureus predominating (including methicillin-resistant S. aureus—\\nMRSA). Pseudomonas aeruginosa is the most common pathogen in \\npost-puncture wound osteomyelitis, particularly when penetration occurs \\nthrough the sole of an athletic shoe. Post-puncture wound infections despite \\ntreatment with antibiotics suggest the possibility of a retained foreign body.\\nClinical Features\\nPuncture wounds treated more than 6 hours after they occur have a greater \\nrisk of infection. Wood, glass, or plastic materials may break or splinter \\nwhen an injury occurs, increasing the chance for retained fragments within \\nthe puncture track. Patient perception of a foreign body may be useful for \\npredicting the presence of such a contaminant or fragment.\\nOn physical examination, assess the wound and the likelihood of injury \\nto structures beneath the skin by evaluating distal function of tendons, \\nnerves, and blood vessels. Inspect the wound location, condition of sur -\\nrounding skin, and the potential presence of foreign matter, debris, or devi-\\ntalized tissue. Signs of infection include significant pain, swelling, erythema, \\nwarmth, fluctuance, decreased range of motion, or drainage from the site.\\nDiagnosis and Differential\\nPlain film radiographs should be obtained for any wound suspected of \\nhaving a potential radiopaque retained foreign body (Table 15-1).\\n15\\nCha PTER\\nTaBle 15-1 Indications for Imaging in Puncture Wounds\\nPlain radiographs\\nSuspicion of fracture\\nInfected wound\\nWound caused by materials prone to fragment (wood, glass, etc.)\\nForeign body sensation reported by patient\\nCT or MRI\\nSuspected deep-space infection\\nPersistent pain after injury\\nFailure to respond to treatment\\n15_Cydulka_Ch15.indd   115 15/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 134, 'page_label': '116'}, page_content='116 SECTION 3: Emergency Wound Management\\nOrganic substances, such as w ood or plant matter, are not reliably \\ndetected by plan radiographs, but >90% of radiopaque foreign bodies that \\nare >1 mm in diameter can be found this way. CT scan is the imaging \\nmodality to use when a retained foreign body continues to be suspected \\nafter negative plain film radiography.\\nemergency Department Care and Disposition\\nTreatment recommendations for puncture wounds are based almost entirely \\non anecdotal evidence and uncontrolled case series.\\n1. Uncomplicated, clean puncture wounds less than 6 hours after injury \\nand without foreign body should have superf icial wound cleansing and \\ntetanus prophylaxis as indicated. Soaking has no proven benefit. \\nDebridement or coring of the wound tract does not reduce rates of \\ninfection. There is no proven benefit of prophylactic antibiotics for any \\ntype of puncture wound, and therefore routine use of antibiotics for \\nhealthy patients with clean puncture wounds is not recommended.\\n2. High-risk patients with plantar puncture wounds are recommended to \\nreceive prophylactic antibiotics along with superficial wound cleansing and \\ntetanus prophylaxis. Consider antibiotics for diabetic patients or patients \\nwith other sources of impaired host defenses, forefoot puncture wound \\ninjuries, or punctures through athletic shoes. A first-generation cephalospo-\\nrin, anti-staphylococcal penicillin, or macrolide are suitable antibiotics for \\nmost puncture wounds where antibiotics are prescribed. Consider an oral \\nfluoroquinolone with anti-pseudomonal activity, such as ciprofloxacin 500 \\nmg twice daily, for plantar puncture wounds through athletic shoes.\\n3. Cellulitis is a complication of puncture wounds that is most often local-\\nized without significant drainage and de velops within the first 4 days \\nafter injury. This can usually be treated with a 7- to10-day course of a \\nfirst-generation cephalosporin, anti-staphylococcal penicillin, trime-\\nthoprim-sulfamethoxazole, or clindamycin.\\n4. A local abscess may develop at the puncture site, especially if a foreign \\nbody remains. Treatment includes incision, drainage, and careful explo-\\nration for a retained foreign body. Antibiotics are typically only required \\nif there is surrounding cellulitis.\\n5. Osteomyelitis is an uncommon but serious complication of puncture \\nwounds\\xa0and may have a greater prevalence in forefoot punctures through \\nathletic shoes. Symptoms typically present more than 7 days after injury \\nand diagnosis can be challenging as radiographs are normal in early \\nstages. Elevations of erythrocyte sedimentation rate or C-reactive protein \\nmay support the diagnosis. MRI is the most commonly used imaging \\nmodality from the emergency department to help identify this complica-\\ntion. Surgical consultation with discussion of timing of IV antibiotics \\nand admission for surgical treatment is important when osteomyelitis is \\ndiagnosed.\\n■ ■NEEDLE-STICK INJURIES\\nNeedle-stick injuries in health care professionals create the most concerns \\nabout infection risk from potential exposure to\\xa0hepatitis viruses or human \\nimmunodeficiency virus (HIV). The risk of infection after an inadvertent \\n15_Cydulka_Ch15.indd   116 15/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 135, 'page_label': '117'}, page_content='CHAPTER 15: Puncture Wounds and Bites 117 \\nneedle stick contaminated from an infectious source has been estimated to \\nbe negligible for hepatitis A, 6% for hepatitis B, 2% for hepatitis C, and \\n0.3% for HIV . Because recommendations in this area are comple x and \\nevolving, each hospital should have a predesigned protocol developed by \\ninfectious disease specialists for the evaluation, testing, and treatment of \\nneedle-stick injuries, including hepatitis B and HIV prophylaxis.\\n■ ■hIGh-PRESSURE-INJECTION INJURIES\\nHigh-pressure-injection injuries may present as puncture wounds, usually to \\nthe hand or foot. These are caused by industrial equipment that forces grease, \\npaint, or other liquids through a small nozzle under high pressure. Patients \\ninitially may have pain with minimal swelling, but these injuries can still be \\nsevere as the injected liquid spreads along fascial planes and causes a delayed \\ninflammatory response. Pain can be controlled with parenteral analgesics \\nwhile avoiding digital blocks with local anesthesia as these can further \\nincrease tissue pressure. An appropriate hand specialist should be consulted \\nfor consideration of early surgical debridement of these injuries.\\n■ ■EPINEPhRINE aUTOINJECTOR INJURIES\\nThese injuries typically occur when a patient inadvertently injects \\nepinephrine into the hand or finger while\\xa0 attempting to treat an allergic \\nreaction. Patients present with pain due to the needle stick, paresthesias, \\nand epinephrine-induced vasospasm to the injected area. In the case of \\nfinger injections, the entire digit may be blanched and cold. There is no \\nclear evidence that active treatment is better than observation alone, so \\nmany patients can be effectively treated with supportive care. Subcutaneous \\nphentolamine injected into the original puncture site is the one treatment \\nconsistently described that rapidly reverses digital ischemia from accidental \\nepinephrine injection. A mixture of 0.5 mL of standard phentolamine \\nsolution (5 mg/mL concentration) and 0.5 mL of 1% lidocaine solution will \\nproduce a 1 mL total volume containing 2.5 mg of phentolamine that can \\nbe subcutaneously injected directly through the site of an autoinjector \\npuncture. Patients can be discharged home once ischemia is resolved, as \\nrelapse appears unlikely.\\n■ ■MaMMaLIaN BITES\\nClinical Features\\nComplications from bite wounds include tissue\\xa0injury from the bite itself, \\nlocal infections, or systemic illness. All wounds should be examined and \\ncleaned well with irrigation and debridement as necessary. Evaluate for \\nunderlying injury to joints or tendons. Patient evaluation should also \\ninclude assessment for the potential need for tetanus and/or rabies prophy-\\nlaxis (see Chapter 94).\\nDiagnosis and Differential\\nBite wounds with low risks for infection can often be repaired primarily. \\nFace or scalp wounds without devitalized tissue that have no underlying \\nfractures can be candidates for primary closure in patients with normal \\n15_Cydulka_Ch15.indd   117 15/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 136, 'page_label': '118'}, page_content='118 SECTION 3: Emergency Wound Management\\nimmune systems and w ound healing properties. Delayed primary closure \\ncan be considered for wounds at higher risk of infection.\\nemergency Department Care and Disposition\\n1. Consider primary closure for low-risk wounds after careful assessment, \\ncleaning, and irrigation.\\n2. Avoid primary closure in patients with immunodeficienc y or comor -\\nbidities that may impact successful wound healing.\\n3. High-risk wounds should be cleaned, debrided, and dressed to maintain \\na moist environment for healing. Recommend wound ree valuation for \\nsigns of infection in 24 to\\xa048 hours.\\n4. Prophylactic antibiotics are recommended for human bites and for \\nhigher risk wounds, particularly if primary wound closure is re -\\nquired\\xa0(Table 15-1).\\n■ ■INFECTIONS FROM CaT aND DOG BITES\\nClinical Features\\nMost dog bite wounds are superficial and have a relatively low risk (5%)\\xa0of \\ninfection. Cat bites tend to be deeper puncture wounds\\xa0and are reported to \\nbecome infected in up to 80% of patients who present for emergency care. \\nHowever, the true rate of infection is likely much lower than this because \\nmost patients with cat bites do not present for care unless the bite appears \\nsevere or already has signs of infection.\\nDiagnosis and Differential\\nDespite a lack of evidence that antibiotics are effective for reducing the \\nrates of infection after dog or cat bites, prophylactic antibiotics are often \\nsuggested for treatment of higher\\xa0risk uninfected wounds. Many clinicians \\nrecommend antibiotics for cat bites, bites in immunocompromised \\npatients, deep dog bite puncture wounds, hand wounds, or wounds needing \\ndebridement.\\nemergency Department Care and Disposition\\n1. Common first-line antibiotics can be used when prophylactic antibiotics \\nare desired (Table 15-2). Amoxicillin-clavulanate, 500 to 800 mg by \\nmouth twice daily, is the antibiotic most commonly recommended for \\ntreatment of local infections after dog or cat bites.\\n2. Penicillin V 500 mg four\\xa0times daily, or ampicillin\\xa0500 mg four times \\ndaily, may be adequate to cover Pasteurella multocida infections from \\ncat bites\\xa0 and may be a lower\\xa0 cost alternative for prophylaxis of cat \\nbites.\\n3. Cephalexin, dicloxacillin, erythromycin, or clindamycin alone are likely \\nnot sufficient for dog or cat bites, as they do not reliably provide cover -\\nage for Pasteurella species.\\n4. Serious systemic infections after dog or cat bites are rare, but can develop \\ndays after the injury. Capnocytophaga canimorsus produces a rare but \\nfulminant bacteremic illness after a dog bite\\xa0 and is more common in \\nalcoholics, post-splenectomy, or other immunosuppressed patients. \\n15_Cydulka_Ch15.indd   118 15/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 137, 'page_label': '119'}, page_content='CHAPTER 15: Puncture Wounds and Bites 119 \\nBroad-spectrum antibiotic coverage and appropriate resuscitative efforts \\nare indicated with any such systemic infection.\\n5. Cat-scratch disease is characterized by regional lymphadenopathy 7 to \\n12 days after a cat bite or scratch, and is caused by Bartonella henselae. \\nAntibiotics are not usually indicated as patients can be managed with \\npain relief and symptomatic care. Patients with severe painful lymph-\\nadenopathy may benefit from a 5-day course of azithromycin. Immu-\\nnosuppressed patients can be treated with a 7- to\\xa0 10-day course of \\ntrimethoprim-sulfamethoxazole, ciprofloxacin, or rifampin.\\n■ ■hUMaN BITES\\nHuman bite wounds are at higher risk for polymicrobial infection with \\nstaphylococcal and streptococcal species or Eikenella corrodens. Treatment \\nwith prophylactic amoxicillin-clavulanate is recommended\\xa0 and typically \\nsuture repair is not advised with the possible exception of facial wounds. \\nInfections requiring parenteral antibiotics can be treated with ampicillin-\\nsulbactam, cefoxitin, or piperacillin-tazobactam. Patients with closed fist \\ninjuries, or “fight bite” wounds, to the knuckle caused by impact with \\nTaBle 15-2 Common Bites and First-Line Treatment\\nanimal Organism First-Line antibiotic\\nCat Pasteurella multocida\\nBartonella henselae (cat-\\nscratch fever)\\nAmoxicillin-clavulanate\\nAzithromycin\\nDog Pasteurella, strepto-\\ncocci, staphylococci, \\nCapnocytophaga canimorsus\\nAmoxicillin-clavulanate\\nHuman Eikenella, staphylococci, \\nstreptococci\\nHerpes simplex (herpetic \\nwhitlow)\\nAmoxicillin-clavulanate\\nAcyclovir or valacyclovir\\nRats, mice, squirrels, gerbils Streptobacillus moniliformis \\n(North America) or Spirillum \\nminus/minor (Asia)\\nAmoxicillin-clavulanate\\nLivestock, large game \\nanimals\\nMultiple organisms\\nBrucella, Leptospira, \\nFrancisella tularensis\\nAmoxicillin-clavulanate or \\nspecific agent for disease\\nBats, monkeys, dogs, \\nskunks, raccoons, foxes (all \\ncarnivores and omnivores)\\nRabies Rabies immune globulin, \\nrabies vaccine\\nMonkeys Herpes B virus \\n(Cercopithecine herpesvirus)\\nAcyclovir or valacyclovir\\nFreshwater fish Aeromonas, staphylococci, \\nstreptococci\\nFluoroquinolone or trime-\\nthoprim-sulfamethoxazole\\nSaltwater fish Vibrio, staphylococci, \\nstreptococci\\nFluoroquinolone\\n15_Cydulka_Ch15.indd   119 15/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 138, 'page_label': '120'}, page_content='120 SECTION 3: Emergency Wound Management\\nanother individual’s teeth may require sur gical treatment (see Chapter 12, \\nInjuries to the Arm, Hand, Fingertip, and Nail).\\n■ ■RODENTS, LIVESTOCK, aND EXOTIC aND WILD \\naNIMaLS\\nRodent bites are typically trivial, rodents are not known to carry rabies, and \\nthese bites have a low risk for infection. Most patients can be treated con-\\nservatively with standard wound care. Livestock and large game animals \\ncan cause serious injury with a significant risk of infection and systemic \\nillness caused by brucellosis, leptospirosis, or tularemia (see Chapters 97 \\nand 98). Aggressive wound care and broad-spectrum prophylactic antibiot-\\nics are recommended.\\n■ ■FURThER REaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 46, “Puncture Wounds and Bites,” by James Quinn\\n15_Cydulka_Ch15.indd   120 15/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 139, 'page_label': '121'}, page_content='121\\nPostrepair Wound Care\\nEugenia B. Quackenbush\\nAfter an acute wound is repaired, focus subsequent wound care to optimize \\nhealing and prevent complications. Issues to consider include the appropriate \\nuse of dressings, efforts to minimize edema, prophylactic antibiotics, tetanus \\nprophylaxis, cleansing, and use of packing or drains. Provide patients with \\nappropriate pain control, follow-up instructions, and patient education.\\n■ ■USE OF DRESSINGS\\nWound dressings provide a moist environment to promote epithelialization \\nand speed healing. Cover appropriate sutured or stapled wounds with a \\nprotective, nonadherent dressing for 24 to 48 hours. Semipermeable films \\nsuch as OpSite® are available as an alternative to conventional gauze dress-\\nings, although one of the disadvantages of these newer materials is their \\ninability to absorb large amounts of fluid. As an alternative to traditional \\ndressings, topical antibiotics may be used to facilitate a warm, moist envi-\\nronment to promote initial wound healing and may help to prevent scab \\nformation. Wounds closed with tissue adhesives should not be treated with \\ntopical antibiotic ointment because it will loosen the adhesive and may \\nresult in wound dehiscence.\\n■ ■PATIENT POSITIONING AFTER WOUND REPAIR\\nRecommend elevation of the injured body part, if possible, to reduce \\nedema around the wound and facilitate healing. Splints can be useful for \\nextremity injuries as they decrease motion across the wound and may help \\nlimit movement-associated discomfort or the development of additional \\nedema. Pressure dressings can be used in some circumstances to help \\nminimize the accumulation of fluid and are useful for ear and scalp \\nlacerations (see Chapter 11).\\n■ ■PROPHYLACTIC ANTIBIOTICS\\nProphylactic antibiotics are not routinely recommended for all wounds, but \\ninstead should be reserved for selected special circumstances. When decid-\\ning whether or not to prescribe antibiotics, consider the mechanism of \\ninjury, location of the wound, degree of any bacterial or soil contamination, \\nand host factors that may predispose to infection.\\nProphylactic antibiotics are often recommended for human bites, dog or \\ncat bites on the extremities (see Chapter 15), open fractures, and wounds \\nwith exposed joints or tendons (see Chapters 12 and 13). Patients with \\nwounds in areas with lymphedema may also benefit from prophylactic \\nantibiotics. When indicated, a 3- to 5-day course of antibiotics is adequate \\nfor nonbite injuries and a 5- to 7-day course is adequate for bite wounds. \\nSee Table 16-1 for recommended antibiotic regimens for those special \\ncircumstances when antibiotics may be indicated. Patients at high risk for \\ninfection should be advised to return for a wound check in 24 to 48 hours.\\n16\\nC HAPTER\\n16_Cydulka_Ch16.indd   121 15/03/17   12:19 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 140, 'page_label': '122'}, page_content='122 SECTION 3: Emergency Wound Management\\n■ ■TETANUS PROPHYLAXIS\\nEvaluate patients to determine whether tetanus prophylaxis will be recom-\\nmended. Inquire about the mechanism of injury, age of the wound, and the \\npatient’s tetanus immunization status. The only absolute contraindication \\nto tetanus toxoid is a history of neurologic or severe systemic reaction after \\na previous dose (see Table 16-2 for a summary of recommendations for \\ntetanus prophylaxis).\\nTable 16-1 Postrepair Oral Antibiotic Prophylaxis\\nSituation Primary Recommendation Alternative Recommendation\\nUncomplicated patient First-generation cephalo-\\nsporin or antistaphylococcal \\npenicillin\\nMacrolide\\nClindamycin\\nGrossly contaminated \\nwounds and/or retained \\nforeign body\\nAmoxicillin/clavulanate  \\nor second-generation \\ncephalosporin\\nClindamycin plus a \\nfluoroquinolone\\nBite wounds Amoxicillin/clavulanate Clindamycin plus either a fluo-\\nroquinolone or trimethoprim-\\nsulfamethoxazole\\nPlantar puncture wounds Ciprofloxacin First-generation cephalosporin \\nor antistaphylococcal penicillin\\nUnderlying systemic \\nimmunodeficiency \\n(AIDS, chronic steroid \\nuse, poorly controlled \\ndiabetes mellitus)\\nAmoxicillin/clavulanate \\nor second-generation \\ncephalosporin\\nClindamycin plus a \\nfluoroquinolone\\nImpaired local defenses \\n(peripheral arterial \\ndisease, lymphedema)\\nAmoxicillin/clavulanate Clindamycin or erythromycin\\nTable 16-2 Recommendations for Tetanus Prophylaxis\\nHistory of Tetanus \\nImmunization\\nClean Minor Wounds All Other Wounds*\\nAdminister \\nTetanus Toxoid†\\nAdminister \\nTIG‡\\nAdminister \\nTetanus Toxoid\\nAdminister \\nTIG\\n<3 or uncertain doses Yes No Yes Yes\\n≥3 doses\\n Last dose within 5 years No No No No\\n  Last dose within  \\n 5–10 years\\nNo No Yes No\\n Last dose >10 years Yes No Yes No\\n* Especially if wound care delayed (>6 h), deep (>1 cm), grossly contaminated, exposed to saliva or \\nfeces, stellate, ischemic or infected, avulsions, punctures, or crush injuries.\\n† Tetanus toxoid: Tdap if adult and no prior record of administration; otherwise, tetanus-diphtheria toxoid \\nif >7 years and diphtheria-tetanus toxoid if <7 years, preferably administered into the deltoid.\\n‡ Tetanus immune globulin: adult dose, 250–500 IU administered into deltoid opposite the tetanus-\\ndiphtheria toxoid immunization site.\\n16_Cydulka_Ch16.indd   122 15/03/17   12:19 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 141, 'page_label': '123'}, page_content='CHAPTER 16: Postrepair Wound Care 123 \\n■ ■WOUND CLEANSING\\nWounds that have been repaired with sutures or staples may be cleansed as \\nearly as 8 hours after closure without increasing the risk of wound infec-\\ntion. Clean the wound area with soap and water and examine for signs of \\ninfection daily. Application of topical antibiotics for the first 3 to 5 days \\nmay decrease scab formation and help to prevent wound edge separation. \\nPatients with wounds closed with tissue adhesives may shower, but should \\nnot completely immerse the wound or apply topical antibiotics, as this will \\nloosen the adhesive bond and cause earlier sloughing of the adhesive.\\n■ ■WOUND DRAINS\\nDrains or wound packing may be placed in healing wounds to remove \\ninterstitial fluid or blood, keep an open tract for drainage of infectious \\nmaterial, or to prevent an abscess from forming by allowing drainage from \\na contaminated area. Ribbon gauze packing is often used to pack an \\nabscess cavity after incision and drainage, and can be changed regularly as \\nlong as the wound continues to drain. Closed drainage systems have \\nlargely replaced open wound drains placed after surgical procedures, as \\nclosed systems prevent secondary bacterial contamination into the wound. \\nProvide appropriate follow-up instructions for patients with drains or \\npacking in place.\\n■ ■PAIN CONTROL\\nEducate patients about the expected degree of pain associated with a wound \\nand the measures they can take to reduce that pain. Splints may help to \\nreduce pain and swelling in significant extremity lacerations. Analgesics \\nmay be needed for a short time period, although narcotic analgesia is rarely \\nnecessary after the first 48 hours of healing for most wounds.\\n■ ■FOLLOW-UP\\nProvide instructions for regular wound examination during the healing \\nprocess and when to return for suture or staple removal. Recommend \\nreevaluation in 24 to 48 hours for patients with high-risk wounds or comor-\\nbidities that may impair successful wound healing. Facial sutures are typi-\\ncally removed in 3 to 5 days, while sutures in most other areas of the body \\ncan be removed after 7 to 10 days of healing. Sutures in some locations \\nsuch as the hands, feet, buttocks, or over joints should remain in place for \\n10 to 14 days to reduce the chance of wound dehiscence after suture \\nremoval.\\nWhen removing sutures or adhesive tapes, take care to avoid tension \\nperpendicular to the wound that could cause dehiscence. When needed, \\ngently debride scab or crusting over each suture with hydrogen peroxide–\\nsoaked gauze. Grasp the suture knot with forceps and use scissors or an \\nappropriate scalpel blade to cut the suture. Remove skin staples with an \\nappropriate device that deforms the center and extracts the legs from the \\nskin. For wounds closed with tissue adhesive, advise patients to avoid rub-\\nbing, picking, scrubbing, or exposing the area to water for more than brief \\nperiods of time during the healing process. Tissue adhesive will slough off \\n16_Cydulka_Ch16.indd   123 15/03/17   12:19 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 142, 'page_label': '124'}, page_content='124 SECTION 3: Emergency Wound Management\\nitself over time, typically within 5 to 10 days of application, as w ound \\nhealing progresses.\\n■ ■PATIENT EDUCATION ABOUT LONG-TERM  \\nCOSMETIC OUTCOME\\nInform patients that all traumatic lacerations result in some degree of tissue \\nscarring and that the short-term cosmetic appearance may not be predictive \\nof the ultimate cosmetic outcome. Instruct patients to avoid sun exposure \\nwhile wounds are healing, as wounds exposed to the sun can develop per -\\nmanent hyperpigmentation. Patients should wear sunblock for at least 6 to \\n12 months after injury to optimize the cosmetic outcome.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 47, “Postrepair Wound Care,” by Adam J. Singer and \\nJudd E. Hollander.\\n16_Cydulka_Ch16.indd   124 15/03/17   12:19 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 143, 'page_label': '125'}, page_content='125\\nChest Pain: Cardiac or Not\\nAndrew Nyce\\nMillions of patients present to emergency departments (EDs) each year \\nwith acute nontraumatic chest pain. Varied clinical presentations coupled \\nwith a wide differential diagnosis make patients with chest pain some of the \\nmost challenging cared for by emergency care providers. An organized \\napproach will assist clinicians when differentiating acute coronary syn-\\ndrome (ACS) from other causes of chest pain.\\n■ ■CLINICAL FEATURES\\nClassically described cardiac chest pain is retrosternal in the left anterior \\nchest with crushing, tightness, squeezing, or pressure that is often \\nbrought on by exertion and relieved with rest. Patients may also com-\\nplain of dyspnea, diaphoresis, and nausea with pain radiating to the left \\nshoulder, jaw, arm, or hand. Some patients, such as premenopausal and \\nearly menopausal women, racial minorities, diabetics, the elderly, and \\npatients with psychiatric disease or altered mental status, may have non-\\nclassic presentations of ACS that may or may not be associated with \\nchest pain. Patients with acute myocardial infarction (AMI) who present \\nwithout chest pain have diagnostic and treatment delays and a higher \\nmortality rate compared to AMI patients who do have chest pain. The \\nonset of symptoms attributed to cardiac disease may be sudden or grad-\\nual, and traditionally angina pain lasts 2 to 10 minutes, unstable angina \\nlasts 10 to 30 minutes, and AMI pain often lasts longer than 30 minutes. \\nDyspnea at rest or with exertion, nausea, light-headedness, generalized \\nweakness, acute changes in mental status, diaphoresis, or shoulder, arm, \\nor jaw discomfort may be the only presenting symptoms for ACS for \\nsome patients.\\nCardiac risk factors are useful in predicting coronary artery disease in \\npatient populations but may be less useful when applied to an individual \\npatient. Cocaine abuse and HIV infection can accelerate atherosclerosis. \\nClassic symptoms such as radiation of pain to the arms, an exertional com-\\nponent, associated diaphoresis, nausea, and vomiting increase the likeli-\\nhood that a patient is suffering from an AMI while other symptoms such as \\npain that is pleuritic in nature, positional, sharp and reproducible with \\n17\\nCh A p TER\\nCardiovascular Diseases\\n 4\\nSECTION\\n17_Cydulka_Ch17.indd   125 01/05/17   10:23 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 144, 'page_label': '126'}, page_content='126 SECTION 4: Cardiovascular Diseases\\npalpation/positioning decrease the likelihood of disease. Unfortunately, \\nthere is no identifiable symptom comple x that definitively rules in or out \\nthe disease without objective testing.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nPatients with ACS often have a normal physical exam but may present with \\nabnormal vital signs. Tachycardia may result from increased sympathetic \\ntone and decreased left ventricular stroke volume. Bradycardia may result \\nfrom ischemia to the conduction system. The degree of hemodynamic \\ninstability is dependent on the amount of myocardium at risk, associated \\ndysrhythmias, or preexisting valvular or myocardial dysfunction. Patients \\nwith acute ischemia may have a third or fourth heart sound from changes \\nin ventricular compliance, a new murmur from ruptured cordae tendineae \\nor an aortic root dissection, or crackles on lung auscultation from conges-\\ntive heart failure. Chest wall tenderness has been demonstrated in up to \\n15% of patients with AMI, making this physical examination finding \\nunlikely to be useful by itself to completely exclude the possibility of ACS. \\nResponse to a particular treatment such as nitroglycerin or a “gastrointesti-\\nnal (GI) cocktail” poorly discriminates between cardiac and noncardiac \\nchest pain in isolation.\\nA detailed history and physical exam allows an emergency provider to \\nrisk stratify serious pathology in the differential diagnosis of a chest pain \\npatient. Focused diagnostic testing should be performed based on the likeli-\\nhood of serious pathology. When history and exam make ACS a likely \\npotential cause, initial testing commonly includes an electrocardiogram \\n(ECG), chest x-ray, and cardiac biomarkers.\\nElectrocardiography\\nGuidelines recommend ECG screening within 10 minutes of ED arrival \\nfor patients with chest pain of potential cardiac etiology. A normal ECG \\nlacks the sensitivity to exclude ACS in isolation; notably patients with \\nunstable angina or non-ST-segment elevation MI may have nonspecific or \\nnormal ECG tracings. ECGs demonstrating new ST-segment elevations \\n≥1 mm in two contiguous leads represent acute MI that will benefit from \\nrapid reperfusion interventions. New ST-segment elevations, Q waves, \\nleft bundle branch block, and T-wave inversions or normalizations in \\nsymptomatic patients are suggestive of ischemia and should be further \\ninvestigated. Misinterpretation of ECGs occurs in up to 40% of missed \\nAMI cases, and the diagnostic value of an ECG can be improved by com-\\nparing it to a prior ECG and/or repeating it during the patient evaluation \\nprocess.\\nImaging\\nChest radiography is commonly performed for patients with chest pain. \\nPatients with ACS will most often have a normal chest x-ray, but images are \\nuseful to evaluate for other diagnostic possibilities such as thoracic aortic \\naneurysm, aortic dissection, pneumonia or pneumothorax. Chest CT may \\nbe useful to diagnose other possible conditions such as pulmonary embo-\\nlism or aortic dissection.\\n17_Cydulka_Ch17.indd   126 01/05/17   10:23 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 145, 'page_label': '127'}, page_content='CHAPTER 17: Chest Pain: Cardiac or Not 127 \\nSerum Markers\\nDue to its high sensitivity and nearly complete cardiac specificity, cardiac \\ntroponin (cTn) is the biomark er of choice for the detection of myocardial \\ninjury. Serum cTn should be obtained in patients with suspected ACS. \\nWhile other clinical conditions such as aortic dissection, pulmonary embo-\\nlism, acute CHF, aortic valve disease, and cardiac procedures can also be \\nassociated with an elevated troponin level, acute myocardial ischemia can \\nbe differentiated from nonischemic troponin elevations based on the pattern \\nof elevation and the clinical context. With contemporary assays, cTn is \\ndetected as early as 2 hours after symptom onset in AMI patients but may \\nnot be reliably elevated until 6 hours after symptoms. Elevations peak at 48 \\nhours from symptom onset and may remain elevated for 10 days. Patients \\nwith early presentation (within 6 hours of symptom onset) or those with \\nintermittent symptoms should have serial measurements over time. A single \\ncTn may be sufficient to exclude AMI for constant symptoms >8 to 12 \\nhours. The measurement of cTn at short time intervals (delta cTn) is more \\nsensitive for AMI than a single cTn. Patients with renal failure often have \\nelevation of cTn and comparing baseline measures can assist the provider \\nin risk stratifying the patient. Although almost obsolete, creatine kinase-\\nMB testing may be useful in a subset of patients in whom the timing of \\ninfarction remains unclear.\\nDifferential Diagnosis\\nCommon causes of chest pain are listed in Table 17-1.\\nThe classic symptoms of life-threatening causes of acute chest pain are \\nlisted in Table 17-2.\\nPulmonary Embolism\\nPatients with pulmonary embolism often complain of sudden onset pleuritic \\nchest pain associated with dyspnea, tachypnea, tachycardia, or hypoxemia. \\nRisk factors include prolonged immobilization, active cancer, recent surgery \\nor trauma, procoagulant syndromes, exogenous estrogen, or previous throm-\\nboembolic disease. Clinical decision aids such as the Wells and Revised \\nGeneva Scores and the Pulmonary Embolism Rule-Out Criteria (PERC) can \\nhelp risk stratify patients for diagnostic evaluation. Serum D-dimer may be a \\nuseful test in low-risk patients to help determine which patients need further \\nTablE 17-1 Common Causes of Acute Chest pain\\nVisceral pain pleuritic pain Chest Wall pain\\nTypical angina Pulmonary embolism Costosternal syndrome\\nUnstable angina Pneumonia Costochondritis (Tietze’s \\nsyndrome)\\nacute myocardial \\ninfarction\\nSpontaneous pneumothorax Precordial catch syndrome\\naortic dissection Pericarditis Xiphodynia\\nEsophageal rupture Pleurisy Radicular syndromes\\nEsophageal reflux or spasm Intercostal nerve syndromes\\nMitral valve prolapse Fibromyalgia\\n17_Cydulka_Ch17.indd   127 01/05/17   10:23 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 146, 'page_label': '128'}, page_content='128 SECTION 4: Cardiovascular Diseases\\ntesting with CT pulmonary angiography to identify pulmonary embolism. \\nFor more details, see Chapter 25, “Thromboembolism.”\\nAortic Dissection\\nPatients with aortic dissection classically describe a sudden onset of severe, \\ntearing pain radiating to the intrascapular area of the back. Secondary symp-\\ntoms result from arterial branch occlusions and may include ischemic stroke, \\nAMI, or limb ischemia. Risk factors include male sex, age >50, uncontrolled \\nhypertension, connective tissue disorders, cocaine use, bicuspid valve or aortic \\nvalve replacement, and pregnancy. Physical exam findings may include unilat-\\neral pulse deficits or focal neurologic deficits. If aortic dissection is suspected, \\nobtain a CT aortogram or transesophageal echocardiogram. A normal chest \\nx-ray and negative D-dimer lowers the probability but does not completely \\nexclude the diagnosis of an aortic dissection. Additionally, this diagnosis can \\nbe associated with nonspecific ST segment or T-wave changes on ECG test-\\ning. For more details see Chapter 27, “Aortic Dissection and Aneurysms.”\\nEsophageal Rupture (Boerhaave’s Syndrome)\\nPatients with esophageal rupture often present with sudden-onset, sharp \\nsubsternal chest pain that follows an episode of forceful vomiting. Patients \\nare usually ill appearing with tachycardia, fever, dyspnea, and diaphoresis. \\nTablE 17-2 Classic Symptoms of potentially Life-Threatening Causes of Chest pain*\\nDisorder pain Location pain Character Radiation\\nAssociated Signs \\nand Symptoms\\nAcute  \\ncoronary  \\nsyndrome\\nRetrosternal,  \\nL chest, or  \\nepigastric\\nCrushing, tight-\\nness, squeezing, \\npressure\\nR or L shoulder, \\nR or L arm/\\nhand, jaw\\nDyspnea,  \\ndiaphoresis, \\nnausea\\nPulmonary \\nembolism\\nFocal chest Pleuritic None Tachycardia, \\ntachypnea, \\nhypoxia, may have \\nhemoptysis\\nAortic \\ndissection\\nMidline, \\nsubsternal\\nRipping, tearing Intrascapular \\narea of back\\nSecondary arterial \\nbranch occlusion\\nPneumonia Focal chest Sharp, pleuritic None Fever, hypoxia, \\nmay see signs of \\nsepsis\\nEsophageal \\nrupture\\nSubsternal Sudden, sharp, \\nafter forceful \\nvomiting\\nBack Dyspnea, diapho-\\nresis, may see \\nsigns of sepsis\\nPneumothorax One side of \\nchest\\nSudden, sharp, \\nlancinating, \\npleuritic\\nShoulder, back Dyspnea\\nPericarditis Substernal Sharp, constant \\nor pleuritic\\nBack, neck, \\nshoulder\\nFever, pericardial \\nfriction rub\\nPerforated \\npeptic ulcer\\nEpigastric Severe, sharp Back, up into \\nchest\\nAcute distress, \\ndiaphoresis\\n*A typical presentations are common.\\nAbbreviations: L, left; R, right.\\n17_Cydulka_Ch17.indd   128 01/05/17   10:23 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 147, 'page_label': '129'}, page_content='CHAPTER 17: Chest Pain: Cardiac or Not 129 \\nPhysical examination may reveal crepitus in the neck or chest from subcu-\\ntaneous emphysema, while audible crepitus on cardiac auscultation (Ham-\\nman’s crunch) is a rare finding. A chest x-ray may be normal or demonstrate \\na pleural effusion (left more common), pneumothorax, pneumomediasti-\\nnum, pneumoperitoneum, or subcutaneous air. Diagnosis is made via CT of \\nchest with oral water-soluble contrast. For more details see Chapter 40, \\n“Esophageal Emergencies.”\\nSpontaneous Pneumothorax\\nA spontaneous pneumothorax causes sudden-onset, sharp, pleuritic chest \\npain with dyspnea. These classically occur in tall, slender male patients and \\nrisk factors include smoking, COPD, and asthma. Physical exam findings \\nare inconsistent but auscultation may reveal decreased breath sounds on the \\naffected side. The diagnosis is made by chest x-ray with only a small per -\\ncentage of patients progressing to develop a tension pneumothorax. See \\nmore details in Chapter 32, “Spontaneous and Iatrogenic Pneumothorax.”\\nAcute Pericarditis\\nPain from acute pericarditis is typically sharp, severe, constant, and \\nretrosternal that radiates to the back, neck, or jaw. Pain is classically wors-\\nened by lying supine and is relieved by sitting forward. The presence of a \\npericardial friction rub supports the diagnosis. ECG may show PR-segment \\ndepressions, diffuse ST-segment elevations, or T-wave inversions that are \\ntypically diffuse. See more details in Chapter 24, “The Cardiomyopathies, \\nMyocarditis, and Pericardial Disease.”\\nMusculoskeletal Causes\\nChest pain due to irritation or inflammation of structures in the chest wall is \\ncommonly seen in the ED. Possible causes include costochondritis, xipho-\\ndynia (inflammation of the xiphoid process), precordial catch syndrome, \\nintercostal strain due to coughing, and pectoralis muscle strain in the setting \\nof recent physical exertion. Patients often complain of sharp pain that is wors-\\nened with movement of the chest wall and palpation. While chest wall tender-\\nness is also present in some patients with ACS or other significant disease \\nprocesses, a clear musculoskeletal etiology with completely reproducible pain \\nin a patient without other symptoms or risk factors support this diagnosis.\\nGastrointestinal Causes\\nGastrointestinal disorders such as esophageal reflux, dyspepsia syndromes, \\nand esophageal motility disorders often cannot be reliably differentiated \\nfrom ACS by history and physical exam alone. Symptoms can range from \\na gnawing or burning pain in the lower chest with gastritis to postprandial \\ndull, boring pain in the epigastric region with peptic ulcer disease. Esopha-\\ngeal spasm is often associated with reflux disease and is characterized by \\na sudden onset of dull or tight substernal chest pain. The pain is typically \\nprecipitated by drinking cold liquids and can be relieved by nitroglycerin. \\nClinicians should determine whether the symptoms are due to a GI disorder \\nbased on the clinical presentation and the absence of findings and/or risk \\nfactors suggesting an ischemic cause. Diagnostic decisions should not be \\nmade solely on the basis of a response to a therapeutic trial of antacids, \\n17_Cydulka_Ch17.indd   129 01/05/17   10:23 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 148, 'page_label': '130'}, page_content='130 SECTION 4: Cardiovascular Diseases\\nGI cocktails, or nitroglycerin. See more details in Chapter 40, \"Esophageal \\nEmergencies” and Chapter 41, “Peptic Ulcer Disease and Gastritis.”\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Patients with abnormal vital signs, concerning ECG findings, or clini-\\ncal history concerning for an acute cardiac event should be promptly \\nevaluated and treated according to immediate airway, breathing, or \\ncirculation needs.\\n2. Place patients with suspicious histories for serious pathology on car -\\ndiac monitors, establish IV access, and provide supplemental oxygen \\nas necessary. Vital signs and pulse oximetry should be monitored at \\nregular intervals.\\n3. Perform an ECG within 10 minutes in patients for whom there is a \\nreasonable suspicion of myocardial ischemia.\\n4. Obtain a focused history to elicit potential features of life-threatening \\ncauses of chest pain such as ACS, aortic dissection, pulmonary embo-\\nlism, se vere pneumonia, and esophageal rupture. Ask about onset, \\ntiming, severity, radiation and character of the chest pain; alleviating \\nand exacerbating factors; and presence of associated symptoms such as \\nvomiting, diaphoresis, and dyspnea.\\n5. Perform physical examination of the thorax for prior surgical incisions, \\nchest wall deformities, and symmetric rise and fall of the chest. Palpate \\nfor tenderness, masses, or crepitus. Auscultate to identify chest con-\\nsolidation or pneumothorax, murmurs, gallops, or friction rubs.\\n6. Administer aspirin for patients at risk for AMI (see Chapter 18, “Acute \\nCoronary Syndromes: Management of Myocardial Inf arction and \\nUnstable Angina,” for details and additional medications).\\n7. Consider serum laboratory studies including cardiac troponin levels \\nwhen concern for ACS remains after history and physical examination.\\n8. Consider chest radiography for patients with acute chest pain where \\nthe etiology remains uncertain after history and ph ysical examination. \\nEvaluate the radiograph for findings of pneumonia, pneumothorax, \\naortic dissection, pneumomediastinum, or other diagnoses.\\n9. ED treatment and disposition is contingent on the suspected etiology \\nof the patient’s chest pain. Patients in whom ACS cannot be reliably \\nexcluded after ED evaluation and diagnostic workup may require fur -\\nther diagnostic evaluation in the hospital.\\n10. The Thrombosis in Myocardial Infarction (TIMI) risk score or Global \\nRegistry of Acute Coronary Events score can aid clinicians when risk \\nstratifying patients for ACS. However, a low-risk score is not sensitive \\nenough to reliably exclude ACS or identify patients for early discharge \\nwithout further evaluation.\\n11. If the etiology of chest pain remains unclear after the initial ED \\nworkup, clinicians should consider further testing and observation or \\nadmission as guided by clinical suspicion and findings.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 48, “Chest Pain” by Simon A. Mahler.\\n17_Cydulka_Ch17.indd   130 01/05/17   10:23 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 149, 'page_label': '131'}, page_content='131\\nAcute Coronary Syndromes: \\nMyocardial Infarction and \\nUnstable Angina\\nMaame Yaa A. B. Yiadom\\nAcute coronary syndromes (ACS) encompass a spectrum of cardiac disor -\\nders with myocardial ischemia and/or injury. These include ST-elevation \\nmyocardial infarction (STEMI), non-STEMI (NSTEMI), and unstable \\nangina.\\n■ ■CLINICAL FEATURES\\nChest pain is the most common symptom for patients with ACS. Impor -\\ntant elements of the history include the timing of symptom onset, loca-\\ntion, quality, severity, and duration. Also important is whether the pain is \\nintermittent, constant, or waxing and waning. Twenty percent to 30% of \\nall patients diagnosed with ACS report atypical symptoms, and their chief \\ncomplaint may not include chest pain. These atypical symptoms can \\ninclude shortness of breath, nausea, diaphoresis, back pain, abdominal \\npain, dizziness, or palpitations. Clinical features associated with chest \\npain that is diagnosed as ACS include substernal or left-sided chest pain, \\nradiation of pain to one or both arms, and chest pain accompanied with \\nnausea, vomiting, or diaphoresis.\\nDiscuss risk factors for coronary artery disease (CAD) with patients to \\nstratify the risk of ACS. These risk factors include older age, male gender, \\nfamily history, smoking, hypertension, hypercholesterolemia, and diabetes. \\nPatients with a long history of cocaine use may be at risk for accelerated \\nCAD development, and recent use can cause acute ischemia from coronary \\nvasospasm. The presence or absence of risk factors alone are poorly predic-\\ntive of the likelihood of myocardial infarction in a patient presenting with \\nacute symptoms. Physical examination can help identify signs of hemody-\\nnamic dysfunction from cardiac strain or acute heart failure such as pallor, \\ndiaphoresis, altered mental status, elevated jugular venous distension, \\nperipheral edema, or rales on pulmonary exam.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nConsider alternative diagnoses for patient symptoms based on clinical \\nassessment, which may include diseases such as pulmonary embolism, \\ncongestive heart failure, gastroesophageal reflux disease, symptomatic \\nhiatal hernia, chronic obstructive pulmonary disease, asthma, pneumonia, \\npneumothorax, pericarditis, myocarditis, aortic dissection, chest trauma, \\nchest wall disorders, or mediastinal disorders.\\nPromptly obtain an ECG to assess for signs of cardiac ischemia. Find-\\nings diagnostic for STEMI include at least one of the four criteria listed in \\nTable 18-1.\\nIn the setting of symptoms suggestive of ischemia, ECG findings con-\\nsistent with STEMI should be acted upon promptly to initiate appropriate \\n18\\nCh A p TER\\n18_Cydulka_Ch18.indd   131 15/03/17   12:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 150, 'page_label': '132'}, page_content='132 SECTION 4: Cardiovascular Diseases\\ntherapy. ECG findings that do not meet criteria for STEMI b ut raise con-\\ncerns for NSTEMI or unstable angina may include ST or T wave changes \\nin a coronary artery distribution (see Table 18-2).\\nFor patients with suspected ACS, obtain serum troponin, chest radio-\\ngraph, CBC, electrolytes, and PT/PTT. NSTEMI is diagnosed when an \\nelevated serum troponin is identified in a patient with symptoms consistent \\nwith myocardial ischemia. Consider repeating troponin levels within  \\n3 hours when diagnostic uncertainty remains. Over time, a patient may \\nprogress in disease severity, prompting consideration for serial ECGs to \\nidentify any dynamic ischemic changes, bedside echocardiography to \\nassess for cardiac wall motion abnormalities, and/or additional serum \\ntroponin testing. Consult with cardiology to determine whether early car -\\ndiac catheterization may be appropriate for patients with NSTEMI who \\ncontinue to have concerning symptoms or dynamic changes.\\nTAble 18-1 Electrocardiographic ST-Segment-Based Criteria for Acute \\nMyocardial Infarction\\nLocation Electrocardiographic Findings\\nAnteroseptal ST-segment elevations in V1, V2, and possibly, V3\\nAnterior ST-segment elevations in V1, V2, V3, and V4\\nAnterolateral ST-segment elevations in V1–V6, I, and aVL\\nLateral ST-segment elevations in I and aVL\\nInferior ST-segment elevations in II, III, and aVF\\nInferolateral ST-segment elevations in II, III, aVF, and V5 and V6\\nTrue posterior* Initial R waves in V1 and V2 > 0.04 s and R/S ratio ≥1\\nRight ventricular ST-segment elevations in II, III, and aVF and ST elevation in right-side V4\\n*Posterior wall infarction does not produce Q-wave abnormalities in conventional leads and is \\ndiagnosed in the presence of tall R waves in V 1 and V2.\\nTAble 18-2 Anatomic Distribution of Ischemic ECG Changes\\nLocation\\nLocation of ST or T Wave \\nChanges\\nCoronary Artery \\nInvolvement\\nInferior II, III, AVF* RCA in 80%; RCX in 20%\\nLateral I, AVL, V5-6 LCX\\nSeptal V1-3* LAD septal branches\\nAnterior V1-4, loss of Q wave in V 5-6* LAD\\nRight ventricular V1, right-sided V4 RCA\\nPosterior V 7-9 (left-sided leads), R waves in V 1, LCX\\nAtrial V1-6 RCA\\n*Can be accompanied with signs of dysrhythmia.\\nAbbreviations: RCA, right coronary artery; RCX, right circumflex artery; LCX, left circumflex artery;  \\nLAD, left anterior descending artery.\\n18_Cydulka_Ch18.indd   132 15/03/17   12:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 151, 'page_label': '133'}, page_content='CHAPTER 18: Acute Coronary Syndromes 133 \\nUnstable angina is a clinical diagnosis based on history, physical \\nexamination findings, and diagnostic testing that does not reveal a STEMI \\nor NSTEMI. This may precede STEMI or NSTEMI or may be the present-\\ning diagnosis that leads to a new diagnosis of CAD. Unstable angina \\ncharacteristically presents with chest pain (or atypical ACS symptoms) \\nassociated with evidence of obstructive coronary artery disease and has \\none of the following three characteristics: (1) began within the past 2 \\nmonths; (2) has increasing frequency, intensity, or duration of existing \\nangina symptoms; or (3) existing angina begins to occur at rest. Additional \\ndiagnostic testing that may be helpful when unstable angina is considered \\nincludes coronary CT angiogram, exercise treadmill testing, cardiac \\nnuclear perfusion imaging, or cardiac MRI.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. STEMI treatment begins immediately upon recognition of diagnostic \\nECG findings. Goals include reperfusion by reducing thrombus, limit -\\ning thrombus extension, and relieving obstructive CAD. The effective-\\nness of interventions is time sensitive. Options include administering \\nsystemic thrombolytic therapy within 30 minutes of arrival or initiating \\npercutaneous coronary intervention (PCI) within 90 minutes. PCI is the \\npreferred therapy, when possible, based on greater benefits and fewer \\nrisks in patients without contraindications to thrombolysis (Table 18-3) \\nwho can achieve PCI within 120 minutes. See Table 18-3 for medica-\\ntions used in the treatment of STEMI.\\n2. For patients with a suspected ACS, begin cardiac monitoring, place an \\nintravenous line, and provide supplemental oxygen if oxygen satura-\\ntion is less than 95%. Administer aspirin 160 to 325 mg orally chewed. \\nConsider oral, transdermal, or intravenous nitroglycerin to treat any \\nongoing angina. Morphine sulfate may be used as an adjunct if pain \\ncontinues despite treatment with nitroglycerin.\\n3. Clopidogrel is recommended for use along with aspirin for patients \\nwith moderate to high-risk NSTEMI and STEMI, and in patients in \\nwhom PCI is planned. Use as an alternative to aspirin in patients aller-\\ngic to aspirin. Clopidogrel increases risk of bleeding, and should be \\nheld at least 5 days before coronary artery bypass grafting (CABG).\\n4. Begin anticoagulation for patients with unstable angina or NSTEMI \\nusing unfractionated heparin or lo w-molecular-weight heparins \\n(LMWH). These are also options for patients undergoing PCI revascu-\\nlarization, in consultation with your cardiology consultant. Unfraction-\\nated heparin is preferred for patients in whom CABG is planned.\\n5. Factor Xa inhibitors such as fondaparinux  have similar efficacy to \\nunfractionated heparin in patients with unstable angina or NSTEMI, \\nand current guidelines consider it an option as an antithrombin. In \\nSTEMI patients lacking renal impairment, fondaparinux may be con-\\nsidered for those patients treated with thrombolytics that are not fibrin \\nspecific such as streptokinase.\\n6. Direct thrombin inhibitors, such as bivalirudin, bind directly to throm-\\nbin in clot and are resistant to agents that degrade heparin. Comparison \\nof bivalirudin with unfractionated heparin found no outcomes benefit \\n18_Cydulka_Ch18.indd   133 15/03/17   12:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 152, 'page_label': '134'}, page_content='134 SECTION 4: Cardiovascular Diseases\\nTAble 18-3 Drugs Used in the Emergency Treatment of STEMI\\nAntiplatelet Agents\\nAspirin 162–325 mg\\nClopidogrel Loading dose of 600 mg PO followed by 75 mg/d. \\nNo loading dose is administered in patients > 75 \\nyears old receiving fibrinolytics\\nPrasugrel Loading dose of 60 mg promptly and no more than \\n1 h after PCI once coronary anatomy is defined and \\na decision is made to proceed with PCI\\nTicagrelor Loading dose is 180 mg PO followed by 90 mg \\ntwice a day\\nAntithrombins\\nUnfractionated heparin Bolus of 60 U/kg (maximum, 4000 U) followed by \\ninfusion of 12 U/kg/h (maximum, 1000 U/h) titrated \\nto a partial thromboplastin time 1.5-2.5 × control\\nEnoxaparin 30 mg IV bolus followed by 1 mg/kg SC every 12 h\\nFondaparinux 2.5 mg SC*\\nFibrinolytic Agents\\nStreptokinase 1.5 MU over 60 min\\nAnistreplase 30 U IV over 2–5 min\\nAlteplase Body weight > 67 kg: 15 mg initial IV bolus; 50 \\nmg infused over next 30 min; 35 mg infused over \\nnext 60 min\\nBody weight < 67 kg: 15 mg initial IV bolus; 0.75 \\nmg/kg infused over next 30 min; 0.5 mg/kg infused \\nover next 60 min\\nReteplase 10 U IV over 2 min followed by 10 U IV bolus 30 \\nmin later\\nTenecteplase Weight Dose (total dose not to \\nexceed 50 mg)\\n<60 kg 30 mg\\n≥60 but <70 kg 35 mg\\n≥70 but <80 kg 40 mg\\n≥80 but <90 45 mg\\n≥90 50 mg\\nGlycoprotein IIb/IIIa Inhibitors†\\nAbciximab 0.25 mg/kg bolus followed by infusion of 0.125 µg/\\nkg/min (maximum, 10 µg/min) for 12–24 h\\nEptifibatide 180 µg/kg bolus followed by infusion of 2.0 µg/kg/\\nmin for 72–96 h\\nTirofiban 0.4 µg/kg/min for 30 min followed by infusion of \\n0.1 µg/kg/min for 48–96 h\\nOther Anti-Ischemic Therapies\\nNitroglycerin Sublingual: 0.4 mg every 5 min × 3 PRN pain\\nIV: Start at 10 µg/min, titrate to 10% reduction \\nin MAP if normotensive, 30% reduction in MAP if \\nhypertensive\\nMorphine 2–5 mg IV every 5–15 min PRN pain\\n(Continued)\\n18_Cydulka_Ch18.indd   134 15/03/17   12:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 153, 'page_label': '135'}, page_content='CHAPTER 18: Acute Coronary Syndromes 135 \\nin NSTEMI patients, but less bleeding occurred and no dosage adjust-\\nment is required in renal impairment. For patients with STEMI, bivali-\\nrudin may be considered as an alternative to unfractionated heparin and \\nGP IIb/IIIa inhibitors.\\n7. In treatment settings without timely access to PCI, fibrinolytics are \\nindicated for patients with STEMI if time to treatment is <6 to 12 \\nhours from symptom onset, and the ECG has at least 1-mm ST-segment \\nelevation in two or more contiguous leads. The dosages of individual \\nfibrinolytic agents are listed in Table 18-3.\\n8. STEMI patients who have receiv ed fibrinolytics should receive full-\\ndose anticoagulation started in the ED and maintained for a minimum \\nof 48 hours. Similar efficacy and safety profiles have been demon-\\nstrated for tPA, rtPA, and TNK. Contraindications for fibrinolytics \\nare listed in Table 18-4. Before administering thrombolytics, obtain \\ninformed consent. Arterial puncture should be avoided, as should \\nvenipuncture or central line placement in areas which are not readily \\ncompressible.\\n9. Tissue plasminogen activator  (tPA) is a naturally occurring human \\nprotein and is not antigenic. tPA is fibrin-specific and has a half-life of \\n5 minutes. When compared with traditional dosing, front-loaded tPA \\nhas been shown to have superior 90-minute patency rates and reocclu-\\nsion rates, with no increase in bleeding risk.\\n10. Reteplase (rPA) is a non-fibrin-specific deletion mutant of tPA with a \\nprolonged half-life of 18 minutes and its use may have a faster time to \\nperfusion. The main advantage of reteplase is that it is given as a dou-\\nble bolus rather than continuous infusion.\\nTAble 18-3 Drugs Used in the Emergency Treatment of STEMI\\nMetoprolol 50 mg PO every 12 h on first day, unless significant \\nhypertension, may consider 5 mg IV over 2 min \\nevery 5 min up to 15 mg; withhold β-blockers \\ninitially if the patient is at risk for cardiogenic \\nshock/adverse effects‡\\nAtenolol 25–50 mg PO, unless significant hypertension, may \\nconsider 5 mg IV over 5 min, repeat once 10 min \\nlater; withhold β-blockers initially if the patient is \\nat risk for cardiogenic shock/adverse effects‡\\n*Fondaparinux should not be used as monotherapy for PCI; if used, addition of unfractionated heparin or \\nbivalirudin is recommended before PCI.\\n†American College of Cardiology/American Heart Association 2009 focused update for STEMI patients \\nrecommended glycoprotein IIB/IIa inhibitors be given at the time of PCI; benefit prior to arrival in the \\ncardiac catheterization laboratory is uncertain.\\n‡Risk factors for cardiogenic shock/adverse effects: (1) signs of heart failure; (2) evidence of a low cardiac \\noutput state; (3) increased risk for cardiogenic shock (cumulatively: age >70 years old, systolic blood \\npressure <120 mm Hg, sinus tachycardia >110 beats/min or bradycardia <60 beats/min, and longer \\nduration of STEMI symptoms before diagnosis and treatment); or (4) standard relative contraindications \\nto β-blockade (PR interval >0.24 s, second- or third-degree heart block, active asthma, or reactive airway \\ndisease).\\nAbbreviations: MAP , mean arterial pressure; PCI, percutaneous coronary intervention; PRN, as needed; \\nSTEMI, ST-segment elevation myocardial infarction.\\n(Continued)\\n18_Cydulka_Ch18.indd   135 15/03/17   12:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 154, 'page_label': '136'}, page_content='136 SECTION 4: Cardiovascular Diseases\\n11. Tenecteplase (TNK) is a fibrin-specific substitution mutant of tPA that \\nis given as a single weight-based bolus.\\n12. Streptokinase (SK) activ ates circulating plasminogen, is not fibrin-\\nspecific, and is capable of generating an allergic reaction (minor: 5% \\nto 5.7%, anaphylaxis: <0.2% to 0.7%). Hypotension occurs in up to \\n15% of patients and is usually responsive to fluids and slowing of SK \\ninfusion. Contraindications include hypotension, prior SK administra-\\ntion within 6 months, and streptococcal infection within a year. SK’s \\nhalf-life is 23 minutes, but systemic fibrinolysis persists for 24 hours. \\nAdminister heparin within 4 hours of starting SK.\\n13. The most significant complication of systemic thrombolytics is bleed-\\ning, particularly intracranial hemorrhage. If significant bleeding  \\noccurs, discontinue thrombolytics, heparin, and aspirin. Crystalloid \\nand red blood cell infusion may be necessary. Cryoprecipitate and \\nfresh frozen plasma (FFP) may be used to reverse fibrinolysis by \\nreplenishing thrombotic factors. Begin with 10 units of cryoprecipitate \\nand obtain fibrinogen levels. If the fibrinogen level is <1 g/L, admin-\\nister a second 10 U of cryoprecipitate. If bleeding continues despite a \\nfibrinogen >1 g/L, or if the fibrinogen level is <1 g/L after 20 U of \\ncryoprecipitate, administer 2 U of FFP. If hemorrhage continues, \\nadminister platelets or antifibrinolytic agents such as aminocaproic \\nacid or tranexamic acid.\\nTAble 18-4 Contraindications to Fibrinolytic Therapy in ST-Segment Elevation \\nMyocardial Infarction\\nAbsolute contraindications\\nAny prior intracranial hemorrhage\\nKnown structural cerebral vascular lesion (e.g., arteriovenous malformation)\\nKnown intracranial neoplasm\\nIschemic stroke within 3 months\\nActive internal bleeding (excluding menses)\\nSuspected aortic dissection or pericarditis\\nRelative contraindications\\nSevere uncontrolled blood pressure (>180/100 mm Hg)\\nHistory of chronic, severe, poorly controlled hypertension\\nHistory of prior ischemic stroke >3 months or known intracranial pathology not \\ncovered in contraindications\\nCurrent use of anticoagulants with known INR >2–3\\nKnown bleeding diathesis\\nRecent trauma (past 2 weeks)\\nProlonged CPR (>10 min)\\nMajor surgery (<3 weeks)\\nNoncompressible vascular punctures (including subclavian and internal jugular  \\ncentral lines)\\nRecent internal bleeding (within 2–4 weeks)\\nPatients treated previously with streptokinase should not receive streptokinase  \\na second time\\nPregnancy\\nActive peptic ulcer disease\\nOther medical conditions likely to increase risk of bleeding (e.g., diabetic retinopathy)\\n18_Cydulka_Ch18.indd   136 15/03/17   12:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 155, 'page_label': '137'}, page_content='CHAPTER 18: Acute Coronary Syndromes 137 \\n14. Recent evidence sho ws no benefit to early IV administration of \\nβ-blockers on cardiac rhythm, infarct size, reinfarction, or mortality. \\nOral β-blocker therapy does not need to be initiated emergently unless \\nthere is a specific indication such as significant tachycardia or hyper -\\ntension. β-blockers should be initiated within the first 24 hours of \\nhospitalization for patients lacking contraindications.\\n15. Glycoprotein IIb/IIIa (GP IIb/IIIa) antagonists bind to platelets and \\ninhibit their aggregation. Abciximab, eptifibatide, and tirofiban are cur-\\nrently available. There is no current evidence supporting the routine \\nuse of GP IIb/IIIa inhibitor therapy prior to angiography in patients \\nwith STEMI, and the use of these agents upstream is uncertain. Use of \\nGP IIb/IIIa inhibitors should be guided by local interdisciplinary \\nreview of ongoing clinical trials, guidelines, and recommendations.\\n16. The disposition of A CS patients depends on their specific ischemic \\ndiagnosis and hemodynamic status. STEMI patients often are taken \\nimmediately to the catheterization laboratory for definitive treatment. \\nPatients treated with thrombolytics who have continued hemodynamic \\ninstability and pain or have not reperfused may be candidates for res-\\ncue angioplasty. Emergent CABG may also be indicated for some \\npatients. Patients in refractory cardiogenic shock should undergo emer-\\ngent angioplasty. Intraaortic balloon pump or other LV-assisting \\ndevices may also be indicated for these patients. Admission to a critical \\ncare unit is appropriate.\\n17. NSTEMI or unstable angina patients who have ongoing chest pain, \\nECG changes, dysrhythmias, or hemodynamic compromise are also \\nadmitted for further care in a cardiac intensi ve care unit. Patients with \\nsymptoms of unstable angina but resolved chest pain, normal or non-\\nspecific ECG changes, and no complications may often be admitted to \\na monitored inpatient bed.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 49, “Acute Coronary Syndromes” by Judd E. \\nHollander and Deborah B. Diercks.\\n18_Cydulka_Ch18.indd   137 15/03/17   12:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 156, 'page_label': '138'}, page_content='138\\nCardiogenic Shock\\nBrian Hiestand\\nCardiogenic shock occurs when there is insufficient cardiac output to meet \\nthe metabolic demands of the tissues. It is most commonly caused by an \\nacute myocardial infarction (AMI) with extensive cardiac tissue damage, \\nimpaired right ventricular cardiac contractility, or subsequent rupture of a \\npapillary muscle. Other potential causes of cardiogenic shock include car -\\ndiotoxic drug effects, infection such as myopericarditis or endocarditis, and \\nmechanical cardiac dysfunction caused by valvular disease, pulmonary \\nembolism, cardiac tamponade, or myocardial contusion. Early treatment \\nand stabilization of patients suffering from cardiogenic shock are impor -\\ntant, as mortality approaches 50% for an AMI that is complicated by car -\\ndiogenic shock.\\n■ ■CLINICAL FEATURES\\nA hallmark of all types of shock is tissue hypoperfusion and the resulting \\nend-organ manifestations of this lack of adequate blood supply. Cardio-\\ngenic shock generally presents with hypotension (systolic blood pressure \\n[SBP] <90 mm Hg), although SBP may be greater than 90 mm Hg in some \\npatients such as those with preexisting and uncontrolled hypertension. \\nSinus tachycardia is frequently seen, but may be absent particularly when \\npatients are taking medications that can inhibit an appropriate tachycardic \\nresponse, such as β-blockers. Evidence of end-organ tissue hypoperfusion \\nin cardiogenic shock may include cool or mottled skin, oliguria, or altered \\nmental status. Left ventricular failure can present with findings concerning \\nfor acute pulmonary edema, such as tachypnea, rales, wheezing, and frothy \\nsputum. Patients with hypotension who have jugular venous distention \\nwithout pulmonary edema may be suffering from right ventricular failure \\ndue to infarction, cardiac tamponade, or pulmonary embolism. The pres-\\nence of a new heart murmur on cardiac auscultation may represent a ven-\\ntricular septal defect or an acute valvular dysfunction from papillary muscle \\ndysfunction or chordae tendineae rupture that can manifest clinically as \\ncardiogenic shock.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nOnce the diagnosis of shock has been made, a key task for the clinician is \\nto differentiate cardiogenic shock from shock that is caused by other dis-\\nease processes, such as hypovolemia, overwhelming sepsis, or neurogenic \\nshock. Evaluation of a hypotensive patient for signs of gastrointestinal \\nbleeding, severe dehydration, potential sources of significant infection, or \\nthe presence of new neurologic deficits may help to establish an alternate \\ndiagnosis.\\nWhen cardiogenic shock is suspected, an electrocardiogram (ECG) is \\nappropriate to assist in the detection of acute cardiac ischemia or infarction, \\n19\\nCHAPTER\\n19_Cydulka_Ch19.indd   138 15/03/17   1:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 157, 'page_label': '139'}, page_content='CHAPTER 19: Cardiogenic Shock 139 \\narrhythmias, electrolyte abnormalities, or signs of drug toxicity with car -\\ndiac manifestations. ST-segment depression in the lateral leads of the ECG \\nmay be suggestive of a right ventricular infarction, which is associated with \\nincreased mortality and may not manifest itself with ST-segment elevation \\nin a standard twelve lead ECG. Look for pulmonary edema, widened medi-\\nastinum, enlarged cardiac silhouette, or other alternative diagnoses such as \\npneumonia or pneumothorax on chest radiograph.\\nBedside echocardiography, while not a substitute for emergent formal \\ntransthoracic echocardiography when clinically indicated, can rapidly \\nexclude other causes of hypotension, identify some mechanical precipitants \\nof shock, and help guide therapy. Visualization of the inferior cava can help \\nto determine volume status when considering hypovolemic shock. A peri-\\ncardial effusion can be diagnosed using limited bedside echocardiography \\nand along with findings such as diastolic collapse of the right atrium and \\nventricle can be diagnostic for cardiac tamponade. Left ventricular function \\nand cardiac contractility can also be evaluated with bedside testing and may \\nsupport the clinician’s impression of cardiogenic shock when decreased \\nfrom normal cardiac function.\\nThere is no single laboratory test that is diagnostic for cardiogenic \\nshock. Obtain a complete blood count and chemistries (including liver \\nfunction tests) to evaluate for anemia, potential signs of infection, and \\nsome components of end organ dysfunction. In the absence of ST-seg-\\nment elevation that is diagnostic for an acute MI, elevations of cardiac \\nmarkers such as troponin can establish the diagnosis of non-ST-segment \\nelevation MI (NSTEMI). In addition, these markers may add prognostic \\nvalue in patients with other causes of shock such as acute heart failure and \\nsepsis. Given their high negative predictive value, natriuretic peptides, \\nsuch as cardiac BNP or n-terminal pro-BNP, suggest a noncardiac etiol-\\nogy of patient condition if normal. In the setting of shock, serum lactate \\nlevels indicate the degree of hypoperfusion present and may be useful to \\nfollow during resuscitative efforts. Blood gas measurements will provide \\ninsight into acid-base status and CO 2 retention. Specialized laboratory \\ntesting, such as toxicology studies, should be guided by the specific \\nclinical situation.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\nAirway management when necessary, circulatory stabilization, and arrange-\\nments for definitive cardiac care often occur simultaneously for patients in \\ncardiogenic shock. Cardiology and/or cardiothoracic surgery should be \\nconsulted early when cardiogenic shock is diagnosed, as emergent coronary \\nrevascularization is an important intervention when ischemia is the under -\\nlying cause. Transfer to a facility with such specialized care should be \\narranged when indicated.\\n 1.  Supplemental oxygen should be provided. Noninvasi ve positive pres-\\nsure ventilation may provide temporary support, but many patients in \\ncardiogenic shock will require definitive airway management and thus \\nendotracheal intubation should be considered as needed for respiratory \\nsupport.\\n19_Cydulka_Ch19.indd   139 15/03/17   1:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 158, 'page_label': '140'}, page_content='140 SECTION 4: Cardiovascular Diseases\\n 2.  Intravenous access should be obtained. Cardiac rhythm and pulse oxim-\\netry monitoring should be initiated. Rhythm disturbances, hypoxia, \\nhypovolemia, and electrolyte abnormalities should be identified and \\ntreated.\\n 3.  Early revascularization is required for cardiogenic shock due to acute \\ncardiac ischemia. Percutaneous coronary intervention (PCI) is superior \\nto fibrinolysis in the setting of cardiogenic shock. However, when PCI \\nis not available (or prolonged transfer times are anticipated) fibrinoly-\\nsis is superior to supportive measures alone.\\n 4.  In AMI, aspirin and heparin should be given unless there is an abso -\\nlute contraindication present. Typical anti-anginal therapies may \\nprecipitate cardiovascular collapse, especially in patients with right \\nventricular ischemia. To treat acute chest pain in the setting of car -\\ndiogenic shock, consider cautious use of titrated intravenous nitro-\\nglycerin 5 to 100 µg/min or morphine sulfate given in 2 mg \\nincrements with close monitoring of blood pressure. Avoid the use \\nof β-blockers in patients with cardiogenic shock as this may worsen \\ncardiac function.\\n 5.  A small intravenous fluid challenge (250 to 500 mL bolus) with \\nclose monitoring for ef fectiveness may be considered for patients \\nwith mild hypotension and no pulmonary edema. Hypotension in the \\nsetting of right ventricular ischemia will warrant a more robust fluid \\nresuscitation.\\n 6.  Norepinephrine may be considered for severe hypotension as a vaso-\\npressor and positive inotrope. An infusion should begin at 2 µg/min and \\ntitrated to the desired effect.\\n 7.  Dobutamine 2 to 20.0 µg/kg/min can be used to support blood pressure \\nfor hypotension due to cardiogenic shock in the absence of hypovole-\\nmia. Dobutamine may cause peripheral vasodilatation, and concomitant \\nuse of dopamine 2 to 20.0 µg/kg/min can be added and titrated to the \\ndesired effect with the lowest dose possible.\\n 8.  Milrinone may be considered as a positive inotrope and can be started \\nwith a loading dose of 50 µg/kg IV o ver 10 minutes followed by an \\ninfusion of 0.5 µg/kg/min.\\n 9.  In the setting of acute mitral regurgitation, afterload reduction via \\nintravenous sodium nitroprusside 0.5 to 10.0 µg/kg/min should be \\ncombined with inotropic support via dobutamine 2 to 20.0 µg/kg/min.\\n10.  Consider using intraaortic balloon pump counterpulsation (if avail-\\nable) as a temporizing measure to decrease afterload and to aug -\\nment coronary perfusion. This is contraindicated in severe aortic \\nregurgitation.\\n11.  Consider more advanced mechanical circulatory support, such as per -\\ncutaneous left ventricular assist devices or e xtracorporeal membrane \\noxygenation, in selected refractory cases.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 50, “Cardiogenic Shock,” by Casey Glass and  \\nDavid Manthey.\\n19_Cydulka_Ch19.indd   140 15/03/17   1:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 159, 'page_label': '141'}, page_content='141\\nLow-Probability Acute Coronary \\nSyndrome\\nDavid A. Wald\\nPatients presenting to the emergency department (ED) with chest pain or \\nother symptoms suggesting possible coronary ischemia should be risk-\\nstratified based on the probability of having an acute coronary syndrome \\n(ACS). Patients with a low-probability ACS have no objective evidence of \\nacute coronary ischemia or infarction. These patients do not have charac-\\nteristic ST-segment elevation or depression on an electrocardiogram \\n(ECG), and initial cardiac biomarkers are not elevated.\\n■ ■CLINICAL FEATURES\\nAfter performing an initial history and physical examination, an emergency \\nprovider needs to determine how much of a diagnostic evaluation to under-\\ntake for a patient presenting with chest pain. Approximately 3% to 6% of \\npatients with an initial diagnosis of noncardiac chest pain or another alter -\\nnative diagnosis may later develop a short-term adverse cardiac event, \\nmaking risk stratification an important aspect of clinical decision making.\\nAmong patients who are assessed as low-probability for ACS, aspects that \\nhave been shown to be associated with a low-risk profile include chest pain that \\nis described as pleuritic, positional, sharp, stabbing, or that is found to be repro-\\nducible. High-risk historical features include chest pain that radiates to the arm \\nor shoulders, is exertional, described as pressure, is accompanied by nausea or \\ndiaphoresis, or is similar to prior cardiac pain. However, even patients who \\npresent with atypical features may have some risk, and the absence of high-risk \\nfeatures alone cannot completely exclude the possibility of ACS. Significant \\ncoronary artery disease is rare in patients <30 years old, although age alone \\ndoes not completely eliminate ACS as a cause of acute chest pain. In addition, \\ntreatment responsiveness to nitrates, antacids, or nonsteroidal anti-inflammatory \\nmedications cannot reliably confirm or exclude ACS. Focus the initial evalua-\\ntion to identify potential alternative diagnoses and detect findings that may be \\nconsistent with heart failure or other underlying conditions.\\nThe results and timing of previous cardiac testing, such as ECG, stress \\ntest, and cardiac catheterization, can be helpful to consider when determin-\\ning the appropriate evaluation for possible ACS. For example, new ECG \\nchanges consistent with cardiac ischemia offer strong evidence of underly-\\ning cardiac disease. Conversely, a recent negative cardiac catheterization \\nwith no coronary luminal irregularities is associated with a very low inci-\\ndence of myocardial infarction or ACS within a 2-year period. Previous \\nstress test results can add evidence to the clinician’s diagnostic decision \\nmaking, but cannot confirm the presence or absence of disease.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe evaluation of patients presenting to the ED with possible ACS can be \\nconceptualized into primary and secondary assessments (see Fig. 20-1). \\nThe goal of the primary evaluation is to identify patients with definite ACS \\n20\\nCh A p TER\\n20_Cydulka_Ch20.indd   141 22/04/17   4:36 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 160, 'page_label': '142'}, page_content='142 SECTION 4: Cardiovascular Diseases\\nand differentiate them from those with probable or possible ACS. Identify-\\ning patients with alternative causes of chest pain that are unlikely to be ACS \\nshould also be considered (see Chapter 17).\\nThe primary evaluation for patients with suspected ACS includes a \\ndetailed history, physical examination, ECG, chest radiography as indi-\\ncated, and cardiac biomarkers. Serial ECGs can be helpful in further evalu-\\nating patients with ongoing symptoms or changes in condition. Data \\nobtained from this primary survey should be used to further risk-stratify \\npatients presenting to the ED with possible ACS. Some experts have deter-\\nmined that when the pretest probability of ACS is ≤2% further testing is \\nnot indicated, whereas others have suggested a threshold of <1% to deter -\\nmine when additional testing is unnecessary.\\nUpon completion of the primary evaluation, classify patients into one of \\nthe following categories of the prognosis-based classification system: acute \\nmyocardial infarction (AMI), probable acute ischemia, possible acute isch-\\nemia, or definitely not ischemia (see Table 20-1). Patients with probable or \\npossible acute ischemia can be further stratified based on their risk for \\nadverse events using scoring systems such as the TIMI risk score or the \\nHEART pathway based on clinical features, ECG findings, and initial diag-\\nnostic testing results. These scoring systems can assist clinicians in deter -\\nmining the extent of additional testing that is recommended.\\nThe secondary assessment can be conducted in an ED, a hospital-based \\nobservation unit, or in the inpatient setting. The specific components of this \\nsecondary evaluation is informed by appropriate risk stratification. The \\ngoal of this assessment should be to exclude both components of ACS: \\nmyocardial infarction and unstable angina. In the absence of ST-segment \\nelevation on the ECG, a myocardial infarction is excluded through the use \\nof serial troponin measurements to detect myocardial necrosis. Serum tro-\\nponin levels can take as long as 8 hours from the time of infarction to \\nFigure 20-1. Evaluation process for patients with possible acute coronary syn-\\ndrome (ACS). AMI, acute myocardial infarction.\\nChest pain not\\nfrom ACS\\nTreat alternative\\ndiagnosis\\nPrimary evaluation\\nPossible ACS\\nDefinite ACS or\\nHigh-risk features\\nSecondary evaluation\\nChest pain not\\nfrom ACS\\nTreat alternative\\ndiagnosis\\nEmergency department\\nHistory\\nPhysical exam\\nECG\\nFirst set of cardiac\\n   biomarkers (biomarkers \\nmay not be needed for \\nnoncardiac chest pain)\\nObservation unit or\\n    inpatient\\nSerial ECGs\\nSerial cardiac markers\\n(Excludes AMI)\\nObjective cardiac testing\\n(Excludes unstable\\n    angina)\\nAdmission to\\ncoronary care unit or\\nrevascularization\\n(see chapter 49,\\nAcute Coronary\\nSyndromes)\\n20_Cydulka_Ch20.indd   142 22/04/17   4:36 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 161, 'page_label': '143'}, page_content='CHAPTER 20: Low-Probability Acute Coronary Syndrome 143 \\nbecome elevated. Therefore, using cardiac biomark ers to diagnose a myo-\\ncardial infarction in the absence of dynamic ECG changes should take into \\naccount the time from symptom onset and generally include multiple mea-\\nsurements. A modified approach in appropriate low-risk patients is to \\nobtain two troponin measurements, at least 2 hours apart with one measure-\\nment at least 6 hours after the onset of pain.\\nNormal serial cardiac biomarker measurements reduce the likelihood of \\nAMI but do not exclude unstable angina. Patients with a continued suspi-\\ncion for ACS despite negative biomarkers often undergo some form of \\nadvanced cardiac testing. Common modalities of advanced cardiac testing \\ninclude exercise or pharmacologically induced ECG stress test, stress echo-\\ncardiography, nuclear imaging, cardiac magnetic resonance imaging \\nTAbLe 20-1 prognosis-Based Classification System for ED Chest pain patients*\\n     i. Acute myocardial infarction: immediate revascularization candidate\\n  ii. Probable acute ischemia: high risk for adverse events (any of the following):\\nEvidence of clinical instability (i.e., pulmonary edema, hypotension, arrhythmia, \\ntransient mitral regurgitation murmur, diaphoresis)\\nOngoing pain thought to be ischemic (consider chest pain or discomfort as chief \\nsymptom, reproducing documented angina, or pain in setting of known coronary \\nartery disease, including myocardial infarction)\\nPain at rest associated with ischemic ECG changes (consider new, or presumably \\nnew, transient, ST-segment deviation, 1 mm or greater, or T-wave inversion in multiple \\nprecordial leads)\\nOne or more positive myocardial marker measurements\\nPositive perfusion imaging study\\niii.  Possible acute ischemia: intermediate risk for adverse events. History \\nsuggestive of ischemia with absence of high-risk features, and any of the \\nfollowing:\\nRest pain, now resolved\\nNew onset of pain\\nCrescendo pattern of pain\\nIschemic pattern on ECG not associated with pain (may include ST-segment depres-\\nsion <1 mm or T-wave inversion >1 mm)\\n iV.  Possible acute ischemia: low risk for adverse events. History not strongly \\nsuggestive of ischemia and all of the following:\\nECG normal, unchanged from previous, or nonspecific changes\\nNegative myocardial marker measurement\\nor (all of the following)\\n>2 weeks of unchanged symptom pattern or long-standing symptoms with only mild \\nchange in exertional pain threshold\\nECG normal, unchanged from previous, or nonspecific changes\\nNegative initial myocardial marker measurement\\n    V.  Definitely not ischemia: very low risk for adverse events. All of the following:\\nClear evidence of nonischemic symptom etiology\\nECG normal, unchanged from previous, or nonspecific changes\\nNegative initial myocardial marker measurement†\\nor\\nUnstructured clinician estimate of acute coronary syndrome ≤2%\\n*Authors’ analyses from multiple sources.\\n†Literature not conclusive.\\n20_Cydulka_Ch20.indd   143 22/04/17   4:36 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 162, 'page_label': '144'}, page_content='144 SECTION 4: Cardiovascular Diseases\\n(MRI), computed tomography coronary angiography (CTCA), or cardiac \\ncatheterization. Based on risk stratification and institutional resources, \\nsome patients will undergo this type of testing during the initial hospitaliza-\\ntion. However, additional testing as an outpatient is an option for low-risk \\npatients in whom AMI has been excluded.\\nThe use of advanced cardiac testing should be guided by general prin-\\nciples discussed below along with available resources and institutional \\npractice patterns:\\n1. Cardiac imaging with CTCA may play a role in the evaluation of low-\\nrisk patients presenting with chest pain, as this approach can result in a \\nmore rapid and cost-effective diagnosis than stress myocardial perfusion \\nimaging.\\n2. Noninvasive stress testing is often recommended for patients risk-\\nstratified as low to intermediate risk. Treadmill exercise testing may be \\nuseful in patients who are able to exercise. In patients with physical \\nlimitations, pharmacologic stress testing may be necessary.\\n3. When stress testing is ordered, select a method of cardiac assessment \\nsuch as electrocardiography, nuclear imaging, echocardiography, or \\nmagnetic resonance imaging. Selection from these options is often based \\non local practice, institutional expertise, and resource availability.\\na. ECG-based exercise treadmill testing is the least costly and most \\nwidely available but has the lowest sensitivity (68%) of the imaging \\noptions which may limit its use for high-risk patients. In addition, \\nECG-based exercise treadmill testing should not be used in patients \\nwith abnormal baseline ECGs due to difficulties in interpretation.\\nb.  Stress echocardiography has the advantages of no radiation expo -\\nsure, improved sensitivity (80%), and wide availability.\\nc.  Nuclear imaging is also widely available, allows assessment of myo-\\ncardial perfusion, and has high accuracy. However, there is associated \\nradiation exposure and radioisotope-related delays.\\nd.  Cardiac MRI is also highly accurate and does not expose patients to \\nradiation, but is less widely available.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nThe evaluation and treatment of patients with suspected ACS is typically \\ninitiated prior to either confirmation or exclusion of this condition. If an \\nalternative diagnosis is confirmed and ACS is excluded, treatment should \\nbegin for the alternative diagnosis. Treat patients with suspected ACS as \\nfollows:\\n1. Provide supplemental oxygen via nasal cannula or as needed to maintain \\nappropriate pulse oxygenation.\\n2. Administer aspirin 160 to 325 mg orally.\\n3. Provide nitroglycerin 0.4  mg spray or sublingual to treat suspected \\nischemic chest pain. Intravenous nitroglycerin may be used for patients \\nwith persistent ischemic chest pain unrelieved by other methods. Nitro-\\nglycerin paste applied to the skin is an alternative to intravenous nitro-\\nglycerin in patients without ongoing or recurrent ischemia.\\n4. Consider morphine 1 to 5  mg IV in patients with persistent ischemic \\nchest pain.\\n20_Cydulka_Ch20.indd   144 22/04/17   4:36 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 163, 'page_label': '145'}, page_content='CHAPTER 20: Low-Probability Acute Coronary Syndrome 145 \\n5. Prescribe metoprolol 25 to 50 mg PO in the first 24 hours when ACS is \\nsuspected.\\n6. Antiplatelet and/or anticoagulant therapy may be appropriate for \\npatients with definitive or likely ACS. The decision to administer these \\nmedications and specific doses may be institution-specific based on \\nprotocols or guidelines and are balanced with the patient’s bleeding risk. \\nThese decisions may be determined through multidisciplinary discus-\\nsions. These options include (a) dual antiplatelet therapy: a common \\nregimen is clopidogrel 300 to 600  mg PO in addition to aspirin, (b) \\nantithrombin therapy: common regimens are heparin  60 U/kg IV bolus \\n(maximum bolus 4000  units) with 12  U/kg/h IV infusion (maximum \\ninfusion 1000 U/h) or enoxaparin 1 mg/kg SC every 12 hours.\\n7. Selected patients can be managed primarily in the ED or within a dedi-\\ncated ED Observation Unit. Appropriately risk-stratif ied patients with \\nnegative serial cardiac markers, without diagnostic ECG changes, and \\nwho have normal advanced cardiac testing (when indicated) are unlikely \\nto have ACS as a cause of their symptoms. Evaluate for alternative diag-\\nnoses and recommend appropriate close follow-up resources.\\n8. Patients with positive cardiac mark ers, diagnostic ECG changes, or \\npositive diagnostic testing suggesting ACS should receive appropriate \\nconsultation and admission to the hospital for inpatient management.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 51, “Low-Probability Acute Coronary Syndromes,” by \\nKathleen A. Hosmer and Chadwick D. Miller.\\n20_Cydulka_Ch20.indd   145 22/04/17   4:36 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 164, 'page_label': '146'}, page_content='146\\nSyncope\\nJo Anna Leuck\\nSyncope accounts for up to 2% of all emergency department (ED) visits \\nand 6% of hospital admissions. Syncope is defined as a transient loss of \\nconsciousness accompanied by loss of postural tone, followed by complete \\nresolution without intervention. Although syncope often is a benign vaso-\\nvagal event, it may represent a life-threatening dysrhythmia or other con-\\ndition, particularly in the elderly. Near-syncope, or feeling an impending \\nloss of consciousness without syncope, may carry the same risk as syn-\\ncope. In up to half of syncope cases presenting to the ED, there is no \\ndefinite etiology established for the syncopal episode.\\n■ ■CLINICAL FEATURES\\nCardiac-related syncope can be due to a structural cardiac lesion that limits \\nthe heart’s ability to appropriately increase cardiac output. Examples of \\nstructural cardiac disease that can cause syncope include hypertrophic car -\\ndiomyopathy, aortic stenosis, pulmonary embolism, and myocardial infarc-\\ntion. Tachydysrhythmias such as ventricular tachycardia, torsades des \\npointes, and supraventricular tachycardia are common causes of syncope, \\nbut bradycardic syndromes may cause it as well. Syncope from a dysrhyth-\\nmia\\xa0is typically sudden and without prodrome. In young people, familial \\ndysrhythmias such as Brugada or QT syndromes are uncommon but poten-\\ntially serious causes of syncope.\\nSyncope is most commonly caused by vasovagal reflexes. Inappropriate \\nvagal or sympathetic tone may lead to bradycardia, hypotension, or both. \\nThe hallmark of vasovagal syncope is a slow progressive prodrome of diz-\\nziness, nausea, pallor, diaphoresis, and diminished vision. The history \\nshould include a search for possible stimuli that are known to be associated \\nwith vasovagal syncope, such as phlebotomy, prolonged standing in a warm \\nplace, or fear. In situational syncope, the autonomic reflexive response \\nresults from a specific physical stimulus such as micturition, defecation, or \\nextreme coughing. Carotid sinus hypersensitivity is another type of reflex-\\nmediated syncope that is suggested by a history of presyncope when \\nshaving, head-turning, or wearing of a constricting collar. This should be \\nconsidered as a potential cause in elderly patients with recurrent syncope \\ndespite a negative cardiac workup.\\nOrthostatic syncope occurs when a sudden change in posture after \\nrecumbence is associated with inadequate compensatory increases in \\nheart rate and peripheral vascular resistance. Orthostatic syncope can be \\ndue to decreased intravascular volume or poor vascular tone, which has \\na myriad of potential causes such as peripheral neuropathy, spinal cord \\ninjury, or medication side-effects. Since orthostatic changes can also be \\nassociated with other serious illnesses, alternative causes of syncope \\nshould still be considered even in the presence of orthostatic changes in \\nblood pressure.\\n21\\nCh A p TER\\n21_Cydulka_Ch21.indd   146 15/03/17   2:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 165, 'page_label': '147'}, page_content='CHAPTER 21: Syncope 147 \\nNeurologic syncope is rarely the primary cause of syncopal episodes, \\nas patients with loss of consciousness with persistent neurological deficits \\nor altered mental status do not meet the usual diagnostic criteria for syn-\\ncope. When brainstem ischemia or vertebrobasilar insufficiency is the \\ncause of syncope, patients will often report other posterior circulation \\ndeficits such as diplopia, vertigo, focal neurological deficits, or nausea \\nassociated with the syncopal episode. If patients report that upper extrem-\\nity exercise preceded the event, there may be intermittent obstruction of \\nthe brachiocephalic or subclavian artery such as subclavian steal syn-\\ndrome. Subarachnoid hemorrhage may also present with syncope, but it is \\nusually accompanied by persistent symptoms such as headache. A trau-\\nmatic subarachnoid hemorrhage can also occur as a result of injuries \\nassociated with syncope from another cause. Seizure is the most common \\ndisorder mistaken for syncope. Brief tonic-clonic movements are often \\nseen with syncope, but the presence of a postictal state, tongue biting, \\nincontinence, or an epileptic aura can point toward\\xa0seizure as a more likely \\nalternative diagnosis.\\nMedication-induced syncope can be a common complication of pharma-\\ncotherapy. Because of poor autonomic responses and multiple medications, \\nthe elderly are particularly prone to syncope as a side effect of medication \\nuse. Cardiovascular responses to orthostatic or vasodilatory challenges may \\nbe blunted by antihypertensive agents such as β-blockers and calcium chan-\\nnel antagonists. Cardiovascular medications may also cause conduction \\nabnormalities or life-threatening dysrhythmias. Diuretics also contribute to \\nthe risk of orthostatic hypotension\\xa0due to their volume-depleting effect.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nAlthough an etiology for a syncopal episode may be difficult to establish, the \\nmost important components of the syncope workup are a comprehensive his-\\ntory, physical examination, and ECG. From there, risk stratification is a \\npractical approach. The history should be directed to high-risk factors, \\nincluding age, medications, and prodromal associations. Sudden events that \\noccur without warning suggest dysrhythmias, while preceding exertion may \\nimply a structural cardiopulmonary lesion. Associated symptoms such as \\npalpitations or chest pains may suggest an underlying cardiac etiology, while \\nvertigo or focal weakness can point toward\\xa0 a neurologic cause. Back or \\nabdominal pain may suggest a leaking abdominal aortic aneurysm or rup-\\ntured ectopic pregnancy in the appropriate patient populations. Single-vehicle \\ncrashes or trauma in the absence of defensive injuries may prompt a consid-\\neration of syncope as a precipitating event. The medical history is useful in \\nrevealing likely cardiac or psychiatric causes for syncope. When present, a \\nfamily history of cardiac disease or sudden death may also be informative.\\nPhysical examination may occasionally reveal the cause of syncope. \\nThe cardiac examination may uncover a ventricular flow obstruction or a \\ncardiac murmur suggestive of aortic stenosis or hypertrophic cardiomyopa-\\nthy. Consider obtaining orthostatic vital sign measurements, as orthostatic \\nhypotension with a systolic blood pressure drop of at least 20 mm Hg upon \\nstanding may support a diagnosis of vasovagal syncope. A significant blood \\npressure differential between upper extremities (>20 mm Hg) suggests \\n21_Cydulka_Ch21.indd   147 15/03/17   2:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 166, 'page_label': '148'}, page_content='148 SECTION 4: Cardiovascular Diseases\\nsubclavian steal syndrome as a possible etiology. In appropriate circum-\\nstances, a complete neurologic assessment or stool guaiac testing may yield \\ninformation about secondary causes for syncope.\\nAn ECG should be obtained for patients with syncope to assess for signs \\nof ischemia or dysrhythmia. Suggestive ECG findings include prolonged \\nQT interval, which may indicate a propensity for torsades des pointes, or \\nPR interval shortening with a delta wave diagnostic for Wolf–Parkinson–\\nWhite syndrome. Prolonged cardiac monitoring may show a transient \\nrecurrent dysrhythmia. Laboratory testing should be selective based on \\nhistory and physical examination. An abnormal hemoglobin level in a \\npatient with symptoms suggestive of anemia may explain orthostatic syn-\\ncope and direct further workup. Women of childbearing age warrant a \\npregnancy test. Although not recommended routinely, serum electrolytes \\nmay be helpful in limited cases. If a patient is asymptomatic or does not \\nhave trauma, neuroimaging is not typically indicated in the routine workup \\nof syncope.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nBy definition, syncope results in spontaneous recovery of consciousness. \\nTherefore, the main goal of ED care is to identify those patients at risk for \\nfurther medical problems.\\n1. Patients with an established medical condition leading to syncope, such \\nas cardiac dysrh ythmia, pulmonary embolism, or GI bleeding, can be \\nappropriately managed by appropriately treating the underlying diagno-\\nsis. Patients for whom a life-threatening etiology is identified, including \\nthose with cardiac or neurologic causes, warrant admission.\\n2. Patients with unclear diagnoses who are at high-risk for morbidity and \\nmortality are those for whom there is concern about sudden cardiac \\ndeath or ventricular dysrhythmia. Per the San Francisco Syncope Rule \\nand other studies, features that suggest a risk for adv erse events \\ninclude\\xa0abnormal ECG, complaint of shortness of breath, systolic blood \\npressure of <90 mm Hg on arrival, hematocrit <30%, age older than 45 \\nyears, or a history of ventricular dysrhythmia or congestive heart failure. \\nConsider admission for patients determined to be at higher risk to \\nmonitor for cardiac arrhythmias and to facilitate an expedited workup.\\n3. Patients with unclear diagnoses who are at low-risk are unlikely to have \\na cardiac etiology for their syncope. These patients lack the high-risk \\ncriteria noted above, tend to be young with few comorbidities, and have \\na normal physical examination and ECG. Low-risk patients can be \\nsafely discharged home with instructions for outpatient follow-up and to \\nreturn for any recurrence of syncope or nearsyncopal symptoms.\\n4. Additional factors to consider when making inpatient versus outpatient \\ndecisions may include syncope while supine or during exercise, absence \\nof prodromal symptoms, palpitations, or elderly patients.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 52, “Syncope,” by James Quinn.\\n21_Cydulka_Ch21.indd   148 15/03/17   2:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 167, 'page_label': '149'}, page_content='149\\nAcute Heart Failure\\nLori J. Whelan\\nAcute heart failure covers a wide spectrum of illness, with symptoms \\nranging from a gradual increase in leg swelling, shortness of breath, or \\ndecreased exercise tolerance to the abrupt onset of pulmonary edema and \\nrespiratory distress. While the term congestive heart failure was historically \\nused to describe volume overload, current terminology describes patients as \\nhaving acute heart failure when they present with an acute exacerbation of \\nchronic heart failure or when new-onset heart failure is diagnosed. Heart \\nfailure has a poor prognosis with an approximately 50% mortality rate \\nwithin 5 years of initial diagnosis. The most common precipitating factors \\nof acute heart failure are atrial fibrillation, acute myocardial infarction or \\nischemia, discontinuation of medications (diuretics), increased sodium \\nload, drugs that impair myocardial function, and physical overexertion.\\n■ ■CLINICAL FEATURES\\nNo single historical or physical finding is sensitive and specific enough to \\naccurately diagnose acute heart failure in all patients. On physical examination, \\npatients with acute heart failure may present with dyspnea, frothy pink spu-\\ntum, or respiratory distress. Patients are frequently tachycardic and hyperten-\\nsive, and a third heart sound (S3) may be identified on auscultation. \\nAbdominojugular reflux and jugular venous distension may also be seen.\\nAcute heart failure can be further classified as follows:\\n1.  Hypertensive acute heart failure is characterized by signs and symp -\\ntoms of acute heart failure with relatively preserved left ventricular \\nfunction, systolic blood pressure >140 mmHg, a chest radiograph com-\\npatible with pulmonary edema, and symptom onset less than 48 hours.\\n2.  Pulmonary edema presents with respiratory distress, rales on chest \\nauscultation, reduced oxygen saturation from baseline, and characteris-\\ntic chest radiograph findings.\\n3.  Cardiogenic shock is characterized by evidence of tissue hypoperfusion \\nand systolic blood pressure <90 mmHg.\\n4.  Acute-on-chronic heart failure has signs and symptoms of acute heart \\nfailure that are mild to moderate and do not meet criteria for hypertensive \\nheart failure, pulmonary edema, or cardiogenic shock. Systolic blood \\npressure is typically < 140 mmHg and > 90 mmHg, associated with \\nincreased peripheral edema, and has symptom onset over several days.\\n5.  High-output failure presents with high cardiac output, tachycardia, \\nwarm extremities, and pulmonary congestion.\\n6.  Right heart failure is a low-output syndrome with jugular venous  \\ndistention, hepatomegaly, and variable hypotension.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nCommonly, patients with acute heart failure present with dyspnea and the \\ndifferential diagnosis may include other conditions such as COPD, asthma, \\npneumonia, pneumothorax, pleural effusion, pulmonary embolus, and \\n22\\nCh A p TER\\n22_Cydulka_Ch22.indd   149 21/04/17   3:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 168, 'page_label': '150'}, page_content='150 SECTION 4: Cardiovascular Diseases\\nacute coronary syndrome. There is no single diagnostic test for heart fail-\\nure; it is a clinical diagnosis based on the history, physical examination, and \\ndiagnostic testing. The most useful historical parameter is a history of acute \\nheart failure. The symptom with the highest sensitivity for diagnosis is \\ndyspnea on exertion (84%) and the most specific symptoms are paroxysmal \\nnocturnal dyspnea, orthopnea, and edema (77% to 84%).\\nChest radiographs showing pulmonary venous congestion, cardiomeg-\\naly, and interstitial edema are the most specific for a diagnosis of acute \\nheart failure, although up to 20% of patients may have an initially negative \\nCXR. ECG is not useful for diagnosis, although it may reveal an underlying \\ncause or precipitant. BNP (B-type natriuretic peptide/N-terminal B-type \\nnatriuretic peptide) testing is useful to supplement provider assessment \\nwhen diagnostic uncertainty exists. Bedside cardiac ultrasound may be use-\\nful to determine other causes for acute dyspnea, such as cardiac tamponade, \\nand may also be useful to determine left ventricle function and volume \\nstatus or identify signs of pulmonary congestion. These ancillary tests com-\\nbined with an appropriate history and physical can help determine the \\nlikelihood of acute heart failure.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1.  Provide supplemental oxygen to keep saturations above 95%.\\n2.  Consider noninvasive ventilation with continuous positive airway pres-\\nsure (CPAP) or bilevel positive airway pressure (BiPAP). Ensure ade-\\nquate facemask seal, hemodynamic stability, and close monitoring for \\nadequate tidal volumes, patient cooperation, and effectiveness.\\n3.  While many patients with hypertensive acute heart failure present with \\nsevere hypertension, pulmonary edema can occur with systolic blood \\npressures as low as 150 mmHg. Prompt recognition of this condition \\nand afterload reduction with vasodilators can improve symptoms and \\navoid the need for emergent intubation.\\n4.  Administer nitroglycerin 0.4 mg sublingual up to one dose per minute \\nor nitroglycerin 0.5 to 0.7 μg/kg/min IV up to 200 μg/min. Titrate dos-\\nages based on patient symptoms blood pressure levels.\\n5.  Nitroprusside 0.3 μg/kg/min titrated upward every 5 to 10 minutes as \\nneeded to maximum 10 μg/kg/min may be initiated if elevated blood \\npressure is unresponsive to nitroglycerin.\\n6.  When volume overload is suspected, consider loop diuretics such as \\nfurosemide 40 mg IV , bumetanide 1 to 3 mg IV , or torsemide 10 to \\n20 mg IV .\\n7.  Shortness of breath, orthopnea, jugular venous distention, rales and \\npossibly an S3 may be evident in patients with normotensive heart \\nfailure, even in the presence of normal vital signs, oxygen and ventila-\\ntion. For these patients, treat with loop diuretics initially and then base \\nadditional treatment on responses to therapy.\\n8.  Transient hypotension may develop after nitroglycerin is started. This \\nmay be due to marked clinical improvement, and should improve with \\ndecreasing the dose or discontinuing nitroglycerin. If hypotension per-\\nsists, initiate an IV fluid bolus 250 to 1000 cc and consider causes such as \\nright ventricular infarction, valvular pathology such as severe aortic ste-\\nnosis, hypovolemia, or recent use of medications for erectile dysfunction\\n22_Cydulka_Ch22.indd   150 15/03/17   2:49 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 169, 'page_label': '151'}, page_content='CHAPTER 22: Acute Heart Failure 151 \\n9.  Morphine 2 to 5 mg IV can relieve congestion and anxiety but is asso-\\nciated with adverse events such as need for mechanical ventilation, \\nprolonged hospitalization, ICU admission, and mortality.\\n10. For hypotensive patients or patients in need of additional inotropic sup-\\nport, see Chapter 19, “Cardiogenic Shock,” for management recom-\\nmendations.\\n11. Identify high-risk patient characteristics for severe illness that may \\nrequire intensive care unit admission such as altered mental status, per-\\nsistent hypoxia, hypotension, troponin elevation, ischemic ECG changes, \\nBUN >43, creatinine >2.75, tachypnea, or inadequate urine output.\\n12. See Fig. 22-1 for some of the many f actors to consider when making \\ndisposition decisions for outpatient management, observation care, in-\\npatient admission, or need for intensive care for patients with acute \\nheart failure.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, \\n8th ed., see Chapter 53, “Acute Heart Failure,” by Sean P. Collins and Alan B.Storrow.\\nFigure 22-1. Factors impacting disposition decisions in ED patients with acute \\nheart failure.\\nComprehensive AHF Evaluation for Disposition\\nACUTE HEART FAILURE\\nProvider Risk Determination  Patient-Centric Self-Care Evaluation\\nClinical\\nGestalt\\nPhysiologic Risk\\nProfile\\nFacilitators or Barriers\\nto\\nIdeal Self-Care \\nMay include\\nconsideration of some\\nphysiologic or self-\\ncare measures \\nVital signs\\nExamination\\nLaboratory testing\\nRadiography\\nPast cardiac measures \\nCaregiver support\\nHospitalization history\\nSymptom monitoring\\nLevel education\\nMedication/healthcare\\n   provider access\\nGeospatial environment\\nDisease knowledge\\nMedication adherence \\nHighly variable Risk models\\nSeverity scores\\nInterviews\\nPast medical history\\nEstablished measures of activation,\\n   education, disease knowledge,\\n   literacy, numeracy & adherence\\nGIS measures\\nLevel of care needs\\nMorbidity\\nMortality\\nReadmission risk\\nComponents\\nQuantification \\nIdeal\\nDisposition\\nPlan Shared Decision\\nMaking\\n22_Cydulka_Ch22.indd   151 15/03/17   2:49 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 170, 'page_label': '152'}, page_content='152\\nValvular Emergencies\\nBoyd Burns\\nMany patients with chronic cardiac valve abnormalities who present for \\nemergency care have previously established disease. Acute valvular dys-\\nfunction can present with significant symptoms, and emergency physicians \\nmust be alert to the presenting signs and symptoms to identify the undiag-\\nnosed patient. With bedside echocardiography becoming more commonly \\navailable, the initial diagnosis of valvular disease may become more com-\\nmon in the ED.\\n■ ■THE NEWLY DISCOVERED MURMUR\\nWhen an emergency provider identifies a new murmur on exam, the first \\nstep in the ED is to determine the potential clinical significance of this find-\\ning. Benign murmurs are not likely to cause symptoms and may be found \\nincidentally. These are typically soft systolic ejection murmurs and occur \\nafter S1 and end before S 2 and are not associated with specific symptoms. \\nIn contrast, a new diastolic murmur or a new systolic murmur with symp-\\ntoms at rest warrants emergent echocardiographic imaging and further \\nevaluation. In addition, risks for possible infections such as endocarditis \\nshould be considered in patients with a newly discovered murmur and the \\npresence of fever (Fig. 23-1).\\n■ ■MITRAL STENOSIS\\nClinical Features\\nMitral stenosis prevents normal diastolic filling of the left ventricle, and \\ndyspnea with exertion is the most common presenting symptom. In the \\npast, hemoptysis was the second most common presenting symptom, but \\nthis is less common now that patients are typically diagnosed and treated \\nearlier in the disease course. As the obstructive process progresses, left \\natrial pressures rise and lead to left atrial enlargement and symptoms of \\nheart failure. Systemic emboli may develop, especially when accompanied \\nby atrial fibrillation, and can result in myocardial, kidney, central nervous \\nsystem, or peripheral infarction. Most patients with mitral stenosis eventu-\\nally develop atrial fibrillation due to progressive dilatation of the atria.  \\nThe classic murmur of mitral stenosis and associated signs are listed in \\nTable 23-1.\\nDiagnosis and Differential\\nIn the presence of mitral stenosis, the electrocardiogram (ECG) may dem-\\nonstrate notched or diphasic P waves and right axis deviation. On the chest \\nradiograph, straightening of the left heart border is a typical early radio-\\ngraphic finding suggestive of left atrial enlargement. Later in the illness, \\nfindings of pulmonary congestion develop, such as redistribution of flow to \\nthe upper lung fields, Kerley B lines, and an increase in vascular markings. \\n23\\nC HA p TER\\n23_Cydulka_Ch23.indd   152 22/04/17   4:37 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 171, 'page_label': '153'}, page_content='CHAPTER 23: Valvular Emergencies 153 \\nTablE 23-1 Comparison of Heart Murmurs, Sounds, and Signs\\nMitral  \\nstenosis\\nMid-diastolic rumble, crescendos \\ninto S2\\nLoud snapping S1, small apical \\nimpulse, tapping due to under-\\nfilled ventricle\\nMitral  \\nregurgitation\\nAcute: harsh apical systolic murmur \\nstarts with S1 and may end before S2\\nChronic: high-pitched apical holosys-\\ntolic murmur radiating into S2\\nS3 and S4 may be heard\\nMitral valve \\nprolapse\\nClick may be followed by a late sys-\\ntolic murmur that crescendos into S2\\nMid-systolic click; S2 may be dimin-\\nished by the late systolic murmur\\nAortic  \\nstenosis\\nHarsh systolic ejection murmur Paradoxical splitting of S 2, S3, \\nand S4 may be present; pulse of \\nsmall amplitude with a slow rise \\nand sustained peak\\nAortic  \\nregurgitation\\nHigh-pitched blowing diastolic  \\nmurmur immediately after S2\\nS3 may be present; wide pulse \\npressure\\nFigurE 23-1. Algorithm for evaluation of newly discovered systolic murmur. CXR, \\nchest x-ray.\\nNew cardiac murmur\\nSystolic murmur Diastolic murmur\\nEchocardiography\\nMid-systolic grade 2\\nNo further workup\\n/uni25CF Mid-systolic grade 3\\n/uni25CF Early or late systolic\\n/uni25CF Holosystolic\\n/uni25CF Symptomatic\\n/uni25CF Signs of cardiovascular \\ndisease\\n/uni25CF Abnormal ECG or CXR\\n/uni25CF Murmur increases in \\nintensity with Valsalva or \\nstanding\\n/uni25CF Asymptomatic\\n/uni25CF No signs of cardiovascular \\ndisease\\n/uni25CF Normal ECG and CXR\\n/uni25CF Murmur does not increase\\nin intensity with Valsalva\\nor standing\\nThe diagnosis of mitral stenosis is confirmed with echocardiography. The \\nurgency for an accurate diagnosis and appropriate referral depends on the \\nseverity of symptoms and initial management will typically focus on \\nsymptom control.\\n23_Cydulka_Ch23.indd   153 22/04/17   4:37 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 172, 'page_label': '154'}, page_content='154 SECTION 4: Cardiovascular Diseases\\nEmergency Department Care and Disposition\\n1.  Heart rate control is typically necessary for patients with persistent tachy-\\ncardia and dyspnea who hav e atrial fibrillation with rapid ventricular  \\nresponse.\\n2.  Anticoagulation is recommended for patients who have an atrial diam-\\neter greater than 55 mm, atrial f ibrillation, left atrial thrombus, or a \\nhistory of embolic disease.\\n3.  Patients with asymptomatic mitral stenosis should be referred for outpa-\\ntient ev aluation, as mechanical intervention, balloon valvotomy, and \\nvalve repair or replacements are recommended before the disease  \\nprogresses to pulmonary hypertension.\\n■ ■MITRAL REGURGITATION\\nClinical Features\\nAcute mitral regurgitation secondary to rupture of the chordae tendineae or \\npapillary muscles (or rarely due to blunt thoracic trauma) presents with \\ndyspnea, tachycardia, and pulmonary edema as the acute valvular dysfunc-\\ntion allows retrograde flow of blood to occur from the left ventricle to the \\nleft atrium. These patients may quickly develop cardiogenic shock or \\ncardiac arrest. Intermittent mitral regurgitation usually presents with acute \\nepisodes of respiratory distress due to pulmonary edema and may be \\nasymptomatic between attacks. In contrast, chronic mitral regurgitation \\nmay be tolerated by patients for many years without specific treatment. In \\nthese cases, the first symptom is usually dyspnea with exertion that is some-\\ntimes precipitated by new-onset atrial fibrillation. If patients are not appro-\\npriately anticoagulated, systemic emboli may occur in up to 20% of \\npatients and may initially be asymptomatic. The classic murmur and signs \\nof mitral regurgitation are listed in Table 23-1.\\nDiagnosis and Differential\\nConsider mitral regurgitation in a patient without significant cardiomegaly \\nwho presents with new onset and marked pulmonary edema. In an acute \\nvalvular rupture, the ECG may show evidence of acute inferior wall infarc-\\ntion or ischemia. On chest radiography, acute mitral regurgitation from \\npapillary muscle rupture may result in a minimally enlarged left atrium and \\npulmonary edema. In chronic disease, the ECG may demonstrate findings \\nof left atrial and left ventricular hypertrophy associated with corresponding \\nenlargement visible on chest radiography.\\nEchocardiography can confirm the diagnosis, and bedside testing may \\nbe needed in an acutely ill patient. While transthoracic echocardiography \\ncan help to make the diagnosis, this technique may underestimate lesion \\nseverity. Therefore, transesophageal echo should be used for definitive \\ndiagnostic purposes when a patient is stable and able to have this testing \\ncompleted.\\nEmergency Department Care and Disposition\\n1.  For acute mitral regurgitation due to papillary muscle rupture, emergent \\nconsultation for surgical repair is indicated.\\n23_Cydulka_Ch23.indd   154 22/04/17   4:37 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 173, 'page_label': '155'}, page_content='CHAPTER 23: Valvular Emergencies 155 \\n2.  Nitrates and noninvasive ventilation can be used to provide preload and \\nafterload reduction and to decrease the work of breathing. Dobutamine \\nmay be used to provide inotropic support when necessary.\\n3.  In severe cases, aortic balloon counterpulsation can be utilized to  \\nincrease forward flow and mean arterial pressure while decreasing the \\nseverity of the regurgitation. This approach may be necessary to stabilize \\npatients prior to emergent surgical repair.\\n■ ■MITRAL VALVE pROLApSE\\nClinical Features\\nMost patients with mitral valve prolapse are asymptomatic. When symp-\\ntoms do occur, patients may report atypical chest pain, palpitations, fatigue, \\nand dyspnea. The abnormal heart sounds are listed in Table 23-1. In patients \\nwith mitral valve prolapse who do not have mitral regurgitation at rest, \\nexercise can provoke mitral regurgitation in about one-third of patients and \\nis associated with a higher risk for morbid events.\\nDiagnosis and Differential\\nThis diagnosis is unlikely to be made in the ED as the ECG and chest x-ray \\nare usually normal. Echocardiography is recommended nonemergently to \\nconfirm the clinical diagnosis of mitral valve prolapse and to identify any \\nassociated mitral regurgitation. Echocardiography or consultation with a \\ncardiologist can be performed on an outpatient basis and specific ED treat-\\nment for this conditionis rarely required.\\nEmergency Department Care and Disposition\\n1. Acute treatment for mitral valve prolapse is rarely required.\\n2.  Patients with mitral valve prolapse who also ha ve concomitant  \\nmitral regurgitation should receive recommendations for endocarditis \\nprophylaxis.\\n3.  Patients with palpitations attributed to mitral valv e prolapse may be \\nprescribed β-blocker therapy to provide symptomatic relief.\\n■ ■AORTIC STENOSIS\\nClinical Features\\nAortic stenosis presents an obstruction to left ventricular outflow. In the \\nUnited Sates, the most common cause in adults is degenerative calcification \\nassociated with increasing age, hypertension, smoking, elevated choles-\\nterol, and diabetes. The classic triad of symptoms is dyspnea, chest pain, \\nand syncope. Dyspnea is usually the first symptom to appear, followed by \\nparoxysmal nocturnal dyspnea, syncope on exertion, angina, and myocar -\\ndial infarction. The classic murmur and associated signs of aortic stenosis \\nare listed in Table 23-1. Blood pressure is typically normal or low, with a \\nnarrow pulse pressure.\\nBrachioradial delay is often present in aortic stenosis. To evaluate for \\nthis finding, the examiner palpates simultaneously the right brachial artery \\n23_Cydulka_Ch23.indd   155 22/04/17   4:37 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 174, 'page_label': '156'}, page_content='156 SECTION 4: Cardiovascular Diseases\\nand the right radial artery of the patient, and any palpable delay is consid-\\nered abnormal. Because patients with aortic stenosis are very preload \\ndependent, the presence of atrial f ibrillation may have significant conse-\\nquences, as the absence of effective atrial contraction leads to a drop in \\ncardiac output. This can lead to hypotension, especially when patients are \\ntreated with nitroglycerin for chest pain or dyspnea.\\nDiagnosis and Differential\\nElectrocardiogram and chest radiographic findings lack sensitivity and \\nspecificity for aortic stenosis. The ECG often demonstrates criteria for LVH \\nand may have a left or right bundle branch block in up to 10% of patients. \\nThe chest radiograph is normal early, but eventually LVH and findings of \\ncongestive heart failure will develop if the patient does not have valve \\nreplacement. Transthoracic echocardiography can confirm the suspected \\ndiagnosis of aortic stenosis and determine disease severity.\\nEmergency Department Care and Disposition\\n1.  Positive pressure ventilation and supplemental oxygen can be helpful in \\nthe treatment of pulmonary edema.\\n2.  Negative inotropic drugs and vasodilators are often poorly tolerated and \\nshould be used with caution.\\n3.  New-onset atrial fibrillation may require cardiov ersion to maintain car-\\ndiac output.\\n4.  Patients discharged from the ED should av oid vigorous activity and be \\npromptly seen in follow-up by a cardiologist.\\n■ ■AORTIC REGURGITATION\\nClinical Features\\nAortic regurgitation occurs when valve leaflets do not fully close and result \\nin retrograde flow of blood from the aorta into the left ventricle during \\ndiastole. In acute disease, dyspnea from pulmonary edema is the most com-\\nmon presenting symptom. Patients may also complain of fever and chills \\nwhen endocarditis is the underlying cause. Dissection of the ascending \\naorta that impacts the function of the aortic valve typically produces a \\n“tearing” chest pain that may radiate between the shoulder blades. The clas-\\nsic murmur and signs of aortic regurgitation are listed in Table 23-1. Tachy-\\ncardia develops in an attempt to maintain cardiac output in the setting of \\nacute aortic regurgitation, although this may be inadequate and cardiogenic \\nshock or arrest may occur.\\nChronic aortic regurgitation typically presents with gradually worsening \\nfatigue or dyspnea with exertion. Signs include a wide pulse pressure with \\na prominent ventricular impulse, and may be associated with head bobbing. \\nA “water hammer pulse” characterized by a quick rise in peripheral pulse \\nupstroke followed by a rapid collapse may also be present. Other classic  \\nfindings may include an accentuated precordial apical thrust, pulsus bis-\\nferiens, a “to-and-fro” femoral murmur (Duroziez sign), and capillary pul-\\nsations visible at the proximal nailbed while pressure is applied at the tip \\n(Quincke sign).\\n23_Cydulka_Ch23.indd   156 22/04/17   4:37 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 175, 'page_label': '157'}, page_content='CHAPTER 23: Valvular Emergencies 157 \\nDiagnosis and Differential\\nIn patients with acute aortic regurgitation, the chest radiograph demon-\\nstrates acute pulmonary edema with less cardiac enlar gement than may be \\nexpected. When an aortic dissection is the underlying cause, a chest x-ray \\nmay demonstrate a widened mediastinum and prompt ordering of a CT of \\nthe chest with IV contrast. ECG changes that may be seen with aortic dis-\\nsection include ischemia or findings of acute inferior myocardial infarction \\nsuggesting right coronary artery involvement.\\nIn chronic aortic regurgitation, the ECG demonstrates LVH, and the \\nchest radiograph may demonstrate LVH, aortic dilation, and/or evidence of \\ncongestive heart failure. Echocardiography is used to confirm the diagnosis \\nand severity of valvular regurgitation. Bedside transthoracic echocardiogra-\\nphy can be undertaken to further evaluate an unstable patient who may need \\nemergency surgery. Otherwise, transesophageal echocardiography is rec-\\nommended when aortic dissection is suspected to more completely evaluate \\nthe aorta and valvular function.\\nEmergency Department Care and Disposition\\n1.  Patients with acute aortic regurgitation should ha ve immediate surgical \\nconsultation for repair.\\n2.  Treat pulmonary edema with oxygen and noninvasi ve ventilation, and \\nprepare for intubation in the setting of respiratory failure. Diuretics and \\nnitrates are typically ineffective.\\n3.  Nitroprusside when used in combination with inotropic agents such as \\ndobutamine or dopamine can reduce left ventricular end-diastolic pres-\\nsure and augment forward flow.\\n4.  Avoid β-blockers in the setting of acute aortic regurgitation as these can \\ninhibit the reflex tachycardia that is necessary to maintain cardiac output.\\n5.  Intraaortic balloon counterpulsation is contraindicated as it can worsen \\nregurgitant flow.\\n6.  Chronic aortic regurgitation is typically treated with vasodilators such as \\nangiotensin-converting enzyme inhibitors or dihydropyridine calcium \\nchannel blockers.\\n■ ■RIGHT-SIDED VALVULAR HEART DISEASE\\nPathologic tricuspid regurgitation is typically due to elevated right heart \\npressures or volume overload, which can be seen in conditions such as \\npulmonary hypertension, chronic lung disease, pulmonary embolism, and/\\nor atrial septal defects. Acute tricuspid disease is most often found in the \\nsetting of acute endocarditis from organisms such as Staphylococcus \\naureus, which can lead to rapid valve destruction.\\nThe pulmonic valve is least affected by acquired disease and most disease \\npresent here is congenital. Pulmonary hypertension, rheumatic heart disease, \\nand carcinoid syndrome can all cause some degree of pulmonic valve disease.\\nClinical Features\\nClinically significant right-sided valvular disease leads to right heart failure \\nsymptoms such as jugular venous distension, peripheral edema, hepato-\\nmegaly, splenomegaly, and ascites. Dyspnea with exertion is often the first \\n23_Cydulka_Ch23.indd   157 22/04/17   4:37 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 176, 'page_label': '158'}, page_content='158 SECTION 4: Cardiovascular Diseases\\nsymptom in patients with right-sided valvular disease associated with pul-\\nmonary hypertension. Pulmonic stenosis often presents with dyspnea with \\nexertion, syncope, chest pain, and findings consistent with right heart  \\nfailure.\\nDiagnosis and Differential\\nEchocardiography is needed to confirm the diagnosis of right-sided valvu-\\nlar disease, and the transesophageal approach is more sensitive than trans-\\nthoracic. Chest x-ray and ECG lack sensitivity and specificity, although \\nchest radiography may demonstrate evidence of right atrial enlargement or \\nright ventricular hypertrophy.\\nEmergency Department Care and Disposition\\n1.  Target treatment of right-sided valvular disease based on the underlying \\ncausative disease process.\\n2.  Patients with symptomatic pulmonic or tricuspid stenosis may be candi-\\ndates for balloon valv otomy, while severe tricuspid regurgitation may \\nrequire valve replacement.\\n■ ■pROSTHETIC VALVE DISEASE\\nProsthetic valves are divided into two major groups: mechanical and bio-\\nprosthetic. Mechanical valves are more durable but require lifelong antico-\\nagulation secondary to the thrombotic risk. Bioprosthetic valves, whether \\nfrom bovine, porcine, or human sources, are less thrombogenic but more \\nlikely to fail and require repeat surgical repair.\\nSystemic thromboembolism is a common complication of mechanical \\nheart valves, and therefore lifelong anticoagulation is recommended. Anti-\\ncoagulation decreases the thrombotic risk from 8% to 1–2% per year. The \\nrisk for embolic complications is highest during the first three postoperative \\nmonths, and prosthetic mitral valves are more likely than prosthetic aortic \\nvalves to produce emboli.\\nMalfunction of prosthetic valves can occur in many ways including \\nthrombosis, dehiscence of sutures, gradual degeneration, or sudden frac-\\nture. Symptom progression is typically gradual except in acute failure, \\nwhich can present with an acute onset of respiratory distress, pulmonary \\nedema, and cardiogenic shock. Infectious complications of endocarditis \\ncarry a high mortality rate and occur in 6% of patients within 5 years of \\nsurgery.\\nClinical Features\\nThe replacement of a diseased or damaged valve relieves the obstruction or \\nregurgitation that had developed, but any cardiac remodeling that occurred \\nover time due to the abnormal valve will remain and can lead to chronic \\nsymptoms. Many patients will have continued dyspnea or other symptoms \\nof heart failure because of the long-standing volume or pressure overload. \\nThese patients are also likely to have comorbid conditions such as coronary \\nartery disease, systemic hypertension or atrial fibrillation.\\n23_Cydulka_Ch23.indd   158 22/04/17   4:37 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 177, 'page_label': '159'}, page_content='CHAPTER 23: Valvular Emergencies 159 \\nThromboembolism from a prosthetic valve source may cause transient \\nneurologic symptoms, ischemic stroke, or ischemic episodes in an affected \\nextremity or organ. Although anticoagulation can minimize the risks of \\nthromboembolism, this is associated with its own potential complications \\nfrom increased bleeding risks such as hemorrhagic stroke.\\nAcute failure of a prosthetic valve presents with acute respiratory dis-\\ntress, pulmonary edema, and cardiogenic shock and can be caused by \\nmechanical valve failure, tearing of a bioprothesis, or presence of a large \\nobstructive clot preventing proper closure of the valve. An acute valve fail-\\nure often results in sudden death before emergent corrective surgery can be \\nperformed. A paravalvular leak may present with new congestive failure \\nsymptoms with severity based on the degree of the leak.\\nDiagnosis and Differential\\nPatients with prosthetic valves who present with new or increasing dyspnea \\non exertion, congestive heart failure, or chest pain are at risk for valvular \\nmalfunction. Patients with new neurologic symptoms may have thrombo-\\nembolic disease or hemorrhagic stroke from excessive anticoagulation. The \\npresence of a persistent fever or fever without a source should prompt \\nconcern for endocarditis, as patients with prosthetic valves are at increased \\nrisk for this infection.\\nEmergency Department Care and Disposition\\n1.  The treatment and disposition of prosthetic valve dysfunction varies \\ndepending on the acuity, nature, and severity of the symptoms.\\n2.  Emergent consulation with cardiology and cardiotho racic surgery \\nexperts is needed when acute prosthetic valve dysfunction is suspected. \\nEmergency surgery or thrombolytic therapy may be required in severe \\ncases.\\n3.  Aspirin therapy is recommended for all patients with prosthetic valves. \\nAnticoagulation for mechanical mitral valves requires an INR of 2.5–3.5 \\nwhile mechanical aortic valves should be anticoagulated to an INR of \\n2.0–3.0.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 54, “Valvular Emergencies,” by William D. Alley and \\nSimon A. Mahler.\\n23_Cydulka_Ch23.indd   159 22/04/17   4:37 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 178, 'page_label': '160'}, page_content='160\\nThe Cardiomyopathies, \\nMyocarditis, and Pericardial \\nDisease\\nLorraine Thibodeau\\nCardiomyopathies are the third most prevalent form of heart disease in the \\nUnited States. Cardiomyopathies alter cardiac structure, myocardial func\\xad\\ntion, and/or electrical conduction. Primary cardiomyopathies principally \\naffect the myocardium and secondary cardiomyopathies are associated with \\nother specific systemic disorders. Cardiomyopathies can be further catego\\xad\\nrized by systolic and/or diastolic dysfunction.\\n■ ■PRIMARY CARDIOMYOPATHIES WITH SYSTOLIC  \\nAND DIASTOLIC DYSFUNCTION\\nDilated Cardiomyopathy\\nDilated cardiomyopathy is the most common type of cardiomyopathy over\\xad\\nall and is usually idiopathic, but may be familial or associated with specific \\nassociated causes. Peripartum cardiomyopathy is a form of dilated cardio\\xad\\nmyopathy that affects pregnant women from 20 weeks gestation into the \\npostpartum period. Idiopathic dilated cardiomyopathy is characterized by \\nsystolic and diastolic dysfunction and is the primary indication for cardiac \\ntransplant in the United States.\\nClinical Features\\nMost patients with dilated cardiomyopathy present with signs and symp\\xad\\ntoms of acute heart failure from systolic pump dysfunction. Symptoms \\ninclude dyspnea on exertion, orthopnea, and paroxysmal nocturnal dys\\xad\\npnea. Physical findings include rales, dependent edema, an enlarged liver, \\nand a holosystolic murmur. Patients may also present with chest pain which \\nmay be a function of limited coronary vascular reserve.\\nDiagnosis and Differential\\nTypical chest radiograph and electrocardiogram (ECG) findings can be \\nhelpful, but the definitive diagnosis is typically made by echocardiogram. \\nChest radiographs usually show an enlarged cardiac silhouette, biventri\\xad\\ncular enlargement, and pulmonary vascular congestion. The ECG often \\nshows left ventricular hypertrophy, left atrial enlargement, Q or QS waves, \\nand poor R wave progression across the precordium. The diagnostic echo\\xad\\ncardiogram shows a decreased ejection fraction, ventricular enlargement, \\nand increased systolic and diastolic volumes. The differential diagnosis \\nincludes acute myocardial infarction, restrictive pericarditis, acute valvu\\xad\\nlar disruption, sepsis, or any other condition that results in a low cardiac \\noutput state.\\n24\\nC HAPTER\\n24_Cydulka_Ch24.indd   160 15/03/17   3:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 179, 'page_label': '161'}, page_content='CHAPTER 24: The Cardiomyopathies, Myocarditis, and Pericardial Disease 161 \\nEmergency Department Care and Disposition\\nPatients with symptomatic or newly diagnosed dilated cardiomyopathy \\ntypically require admission to a monitored bed or intensi ve care unit \\ndepending on severity of presentation. Patients with known dilated cardio\\xad\\nmyopathy benefit from identification of an underlying cause for an exacer\\xad\\nbation, including myocardial ischemia, anemia, infection, new \\xadonset atrial \\nfibrillation, bradydysrhythmia, v alvular insufficiency, renal dysfunction, \\npulmonary embolism, or thyroid dysfunction.\\n1. Establish intravenous access, provide supplemental oxygen, and initiate \\ncardiac monitoring.\\n2. Standard therapies for the treatment of acute heart failure should be \\nemployed. Guidelines from the American College of Cardiology that \\ninclude issues important for the management of heart failure are \\navailable online at http://www.cardiosource.org/Science \\xadAnd\\xadQuality/\\nPractice \\xadGuidelines \\xadand\\xadQuality \\xadStandards.aspx.\\n3. Complex ventricular ectopy can be treated with amiodarone 150 mg IV \\nover 10 min and then 1 mg/min for 6 hours.\\n4. Chronic therapy includes diuretics and digoxin, which improve symp \\xad\\ntoms but have not been shown to impact survival. Angiotensin\\xadconverting \\nenzyme (ACE) inhibitors and ß \\xadblockers, such as carvedilol, are often  \\nused as they have been shown to improve patient survival.\\n5. A growing subset of advanced dilated cardiomyopathy patients are  \\ntreated with Left Ventricular Assist Devices (LV ADs) while awaiting \\nheart transplant.\\nMyocarditis\\nMyocarditis is a common cause of dilated cardiomyopathy. Myocarditis is \\nan inflammation of the myocardium and may be the result of a systemic \\ndisorder or an infectious agent including viral or bacterial etiologies. Peri\\xad\\ncarditis frequently accompanies myocarditis.\\nClinical Features\\nSystemic signs and symptoms of myocarditis are nonspecific and can \\ninclude myalgias, headache, rigors, and fever and tachycardia. Chest pain \\nwith a coexisting pericarditis is frequently present and may be accompanied \\nby a pericardial friction rub. In severe cases, there may be symptoms of \\nprogressive heart failure with dyspnea on exertion, pulmonary rales, pedal \\nedema, and/or cardiogenic shock.\\nDiagnosis and Differential\\nECG may be normal or may demonstrate nonspecific changes such as \\natrioventricular block, prolonged QRS duration, or ST \\xadsegment elevation \\nand PR depression if there is accompanying pericarditis. Chest radiogra\\xad\\nphy is typically normal, but may demonstrate pulmonary congestion if \\nsymptoms are severe. Cardiac enzymes may be elevated. Differential \\ndiagnosis includes cardiac ischemia or infarction, valvular disease, and \\nsepsis.\\n24_Cydulka_Ch24.indd   161 15/03/17   3:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 180, 'page_label': '162'}, page_content='162 SECTION 4: Cardiovascular Diseases\\nEmergency Department Care and Disposition\\n1. Admission with supportive care is the mainstay of treatment for myo\\xad\\ncarditis.\\n2. Initiate appropriate antibiotics for patients with suspected bacterial \\nmyocarditis.\\n3. Patients with progressive heart f ailure symptoms associated with myo\\xad\\ncarditis may require admission to an ICU setting.\\nLeft Ventricular Assist Devices\\nIn patients with severe cardiomyopathy, LV ADs may be used to augment \\nleft ventricular output. These devices consist of an implanted pump that \\ntransfers blood from the apex of the left ventricle to the proximal aorta. The \\npump receives its power from an external source (a battery or bedside \\npower unit outside of the body) that is connected to a controller outside of \\nthe body. The controller drives the pump via a drive line that connects the \\npump to the outside battery and controller through a small abdominal wall \\nincision.\\nPatients and their families usually have extensive training on the devices \\nand should be involved in the evaluation of the LV AD patient. In addition, \\nmost patients will carry a card with their LV AD coordinator’s contact infor\\xad\\nmation in the bag with their spare battery and controller. It is imperative to \\ncontact these coordinators as soon as possible to discuss diagnostic and \\nmanagement options.\\nClinical Features\\nMost LV ADs now employ pumps that create continuous blood flow to \\nmaintain a normal mean arterial pressure. However, because flow is con\\xad\\ntinuous, many LV AD patients may not have a normal palpable pulse. Blood \\npressure readings can be obtained via Doppler or mechanical cuff. Auscul\\xad\\ntation reveals heart sounds associated with a whirr from the LV AD pump. \\nThe ECG should have discernible QRS complexes. The chest radiograph \\nshould show the LV AD components in place.\\nEmergency Department Care and Disposition\\n1. Many experts recommend to nev er perform CPR on an LV AD patient \\nwith hemodynamic instability, as chest compressions may dislodge the \\nLV AD causing LV rupture with intractable hemorrhage.\\n2. Listen to the heart. If the whirr of the pump is heard, go on to step 3. If \\nthe whirr is not heard, enlist the patient and family to help search for a \\ncause of mechanical failure and to change the battery and controller, but \\ndo not disconnect any of the equipment.\\n3. If the whirr of the pump is heard, obtain a blood pressure via Doppler or \\nmechanical cuff, place the patient on the monitor, obtain IV access, and \\nadminister a bolus of normal saline.\\n4. Evaluate for the common complications (infection, anemia, bleed\\xad\\ning, and thromboembolism). If identified, treat according to the  \\nfollowing:\\na.  Infection at the abdominal wall outlet for the drive site is treated with \\nantibiotics.\\n24_Cydulka_Ch24.indd   162 15/03/17   3:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 181, 'page_label': '163'}, page_content='CHAPTER 24: The Cardiomyopathies, Myocarditis, and Pericardial Disease 163 \\nb. Anemia secondary to red cell destruction from the pump or hemorrhage \\nfrom anticoagulation is treated with blood transfusions as needed.\\nc. Thromboembolic events (such as pulmonary embolism, mesenteric \\nischemia, or stroke) are treated with heparin once bleeding has been \\nruled out.\\n5. If hypotension persists and/or if right ventricular failure is present, \\nadminister pressors to support appropriate hemodynamics.\\n6. Communication with the LV AD coordinator can be of considerable \\nassistance to augment diagnostic and management strate gies for any \\nLV AD patient.\\n■ ■CARDIOMYOPATHIES WITH DIASTOLIC DYSFUNCTION\\nHypertrophic Cardiomyopathy\\nHypertrophic cardiomyopathy is characterized by asymmetric left ven\\xad\\ntricular and/or right ventricular hypertrophy primarily involving the intra\\xad\\nventricular septum. The result is decreased compliance of the left ventricle \\nleading to impaired diastolic relaxation and diastolic filling. Cardiac out\\xad\\nput and ejection fraction are usually normal. This condition is often \\nhereditary.\\nClinical Features\\nThe type and severity of symptoms depend on age and tend to be more \\nsevere as patients get older. Dyspnea on exertion is the most common \\nsymptom, followed by chest pain, palpitations, and syncope. Patients may \\nbe aware of forceful ventricular contractions as well. Physical exam usually \\nreveals a fourth heart sound and a systolic ejection murmur heard best at \\nthe lower left sternal boarder or apex that does not typically radiate to the \\nneck. The examiner may enhance this murmur by having the patient Val\\xad\\nsalva or stand, and a decrease in the murmur may be heard with maneuvers \\nthat increase LV filling such as squatting and passive leg elevation.\\nDiagnosis and Differential\\nThe ECG in hypertrophic cardiomyopathy is nonspecific, but often demon\\xad\\nstrates left ventricular hypertrophy and left atrial enlargement. Deep S \\nwaves may be seen with large septal Q waves (>0.3 mV) and upright T \\nwaves. In contrast, inverted T waves can suggest ischemia. Chest radio\\xad\\ngraph is usually normal. Echocardiography is the diagnostic study of choice \\nand will demonstrate disproportionate septal hypertrophy.\\nEmergency Department Care and Disposition\\nTreatment is primarily supportive. Patients with suspected hypertrophic \\ncardiomyopathy should be referred for echocardiographic evaluation.\\n1. Patients with suspected hypertrophic cardiomyopathy who have syncope \\nshould be hospitalized for cardiac monitoring and a thorough evaluation. \\nThis presentation can be a precursor to sudden cardiac death.\\n2. Following definitive diagnosis, ß\\xadblockers, such as atenolol 25 to 50 mg \\norally every day, are the mainstay of treatment for patients with hyper \\xad\\ntrophic cardiomyopathy and chest pain.\\n24_Cydulka_Ch24.indd   163 15/03/17   3:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 182, 'page_label': '164'}, page_content='164 SECTION 4: Cardiovascular Diseases\\nRestrictive Cardiomyopathy\\nThis type of cardiomyopathy is relatively uncommon and can be idiopathic \\nor caused by a number of dif ferent etiologies such as sarcoidosis, sclero\\xad\\nderma, and amyloidosis. In this disorder, ventricular filling is restricted \\nleading to normal or diminished diastolic volume while systolic function is \\nusually normal.\\nClinical Features\\nThe predominant symptoms are dyspnea, orthopnea, and pedal edema that \\noccur without associated cardiomegaly or systolic dysfunction. Chest pain \\nis uncommon. Physical examination is consistent with the degree of dis\\xad\\nease, and may show a third or fourth heart sound, cardiac gallop, pulmonary \\nrales, jugular venous distension, inspiratory jugular venous distention \\n(Kussmaul’s sign), hepatomegaly, pedal edema, or ascites.\\nDiagnosis and Differential\\nThe ECG is usually nonspecific, but may show conduction disturbances or \\nlow voltage in the setting of sarcoidosis or amyloidosis. The chest radio\\xad\\ngraph may show signs of acute heart failure without cardiomegaly. The \\ndifferential diagnosis includes constrictive pericarditis and diastolic left \\nventricular dysfunction. Differentiating between restrictive cardiomyopa\\xad\\nthy and constrictive pericarditis is important as constrictive pericarditis can \\nbe treated surgically.\\nEmergency Department Care and Disposition\\n1. Most patients should be admitted for further diagnostic and therapeutic \\ninterventions.\\n2. Direct treatment towards symptom control by using diuretics and A CE \\ninhibitors.\\n3. Some causes of restrictive cardiomyopathy may have specific treatment \\ntherapies, such as corticosteroids for sarcoidosis or chelation for the \\ntreatment of hemochromatosis.\\nAcute Pericarditis\\nPericarditis involves inflammation of the layers covering the heart and may \\nbe idiopathic or due to infections such as a virus, bacteria, or fungus. Other \\netiologies include malignancy, drugs, radiation, connective tissue disease, \\nuremia, myxedema, or postmyocardial infarction (Dressler’s syndrome).\\nClinical Features\\nThe most common symptom of pericarditis is sharp or stabbing precordial \\nor retrosternal chest pain that may radiate to the back, neck, shoulder, or \\narm. The classic description is pain that is made worse by lying supine, and \\nlessened by sitting up and leaning slightly forward. Movement, swallowing, \\nor inspiration may also aggravate the pain. Radiation to the left trapezial \\nridge is distinctive. Associated symptoms include recent or current infec\\xad\\ntion, low\\xadgrade intermittent fever , dyspnea, and dysphagia. The physical \\nexam is usually normal, but an intermittent friction rub heard best at the \\nlower left sternal border or apex may be present.\\n24_Cydulka_Ch24.indd   164 15/03/17   3:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 183, 'page_label': '165'}, page_content='CHAPTER 24: The Cardiomyopathies, Myocarditis, and Pericardial Disease 165 \\nDiagnosis and Differential\\nECG changes of acute pericarditis and its convalescence have been divided \\ninto four stages. Stage 1 demonstrates diffuse ST \\xadsegment elevation, espe\\xad\\ncially in leads I, V5, and V6, with PR\\xadsegment depression in leads II, aVF, \\nand V4\\xad6. As the disease begins to resolve (stage 2), the ST segments nor \\xad\\nmalize and T \\xadwave amplitudes decrease. In stage 3, T \\xadwave inversion \\nappears in leads previously showing ST elevations. Finally, stage 4 shows \\nresolution of repolarization abnormalities and a return to a normal ECG.\\nWhen sequential ECGs are not available, it can be difficult to distin\\xad\\nguish pericarditis from a normal variant with “early repolarization.” In \\nthese cases, the finding of a ST \\xadsegment/T\\xadwave amplitude ratio greater \\nthan 0.25 in leads I, V5, or V6 is suggestive of acute pericarditis.\\nChest x\\xadray is usually normal but may show an enlarged cardiac silhou\\xad\\nette if a large pericardial effusion is present. Echocardiography can be used \\nto assess for the presence of an associated pericardial effusion. Routine \\nlaboratory testing may reveal additional abnormalities including an ele\\xad\\nvated creatine kinase or troponin in the setting of associated myocarditis.\\nEmergency Department Care and Disposition\\n1. Stable patients with idiopathic or presumed viral pericarditis can be \\ntreated as outpatients with nonsteroidal anti \\xadinflammatory agents, such \\nas ibuprofen 600 mg every 6 hours or 800 mg every 8 hours.\\n2. Colchicine, 0.5 mg orally twice a day, may be a beneficial adjuvant and \\nmay prevent recurrent episodes.\\n3. Patients with pericarditis who also have myocarditis, an enlar ged car\\xad\\ndiac silhouette on chest radiograph, an identified pericardial effusion \\nby echo, uremic pericarditis, or hemodynamic compromise should be \\nadmitted into a monitored environment for further care.\\nNontraumatic Cardiac Tamponade\\nWhen fluid accumulates in the pericardial space and eventually exceeds the \\nfilling pressure of the right ventricle, cardiac tamponade occurs resulting in \\nrestricted filling and decreased cardiac output. Potential etiologies include \\nuremia, malignant effusion, hemorrhage associated with anticoagulation, \\nbacterial or tubercular infection, chronic pericarditis, lupus, radiation, myx\\xad\\nedema, or idiopathic.\\nClinical Features\\nPatients with cardiac tamponade may present with mild to severe shock, \\nand the most common chief complaint is dyspnea. Physical findings can \\ninclude tachycardia, low systolic blood pressure, and a narrow pulse pres\\xad\\nsure. Pulsus paradoxus (a drop in systolic pressure greater than 10 mm Hg \\nduring normal inspiration), neck vein distention, distant heart sounds, and \\nright upper quadrant pain (due to hepatic congestion) may be present. \\nPulmonary rales are usually absent.\\nDiagnosis and Differential\\nECG may demonstrate low \\xadvoltage QRS complex es and ST elevations \\nwith PR depression as in pericarditis. Electrical alternans (beat \\xadto\\xadbeat \\n24_Cydulka_Ch24.indd   165 15/03/17   3:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 184, 'page_label': '166'}, page_content='166 SECTION 4: Cardiovascular Diseases\\nvariability in the amplitude of the P and R wav es unrelated to inspiratory \\ncycle) is a classic but uncommon finding. Chest radiograph may or may \\nnot show an enlarged cardiac silhouette. Bedside ultrasound or echocar \\xad\\ndiogram is the diagnostic test of choice and demonstrates a large pericar \\xad\\ndial effusion with right atrium or ventricle diastolic collapse.\\nEmergency Department Care and Disposition\\nCardiac tamponade is a rare and challenging diagnosis and when unrecog\\xad\\nnized can lead to hypotension and cardiac arrest with pulseless electrical \\nactivity (PEA).\\n1. Initiate resuscitative measures with large bore peripheral IVs, oxygen, \\nand continuous cardiac monitoring.\\n2. An intravenous fluid bolus of 500 to 1000 mL normal saline can facili \\xad\\ntate right heart filling and may temporarily improve patient hemody\\xad\\nnamics.\\n3. When hemodynamics permit, perform pericardiocentesis in the cardiac \\ncatheterization lab or coronary care unit under echocardiographic guid\\xad\\nance. Emergency pericardiocentesis in the ED may be required if patient \\nis unstable.\\nConstrictive Pericarditis\\nPericardial injury and inflammation can lead to abnormal diastolic filling \\nof the cardiac chambers, which may lead to constrictive pericarditis. Poten\\xad\\ntial causes include fungal or tuberculous pericarditis, uremic pericarditis, \\npostcardiac trauma, and postsurgical changes after pericardiotomy.\\nClinical Features\\nTypical presentations involve the gradual development of symptoms similar \\nto heart failure and restrictive cardiomyopathy. Common signs and symp\\xad\\ntoms include exertional dyspnea, pedal edema, hepatomegaly, and ascites. \\nKussmaul’s sign (inspiratory neck vein distention) is frequently seen in \\npatients with constrictive pericarditis.\\nECG findings are nonspecific, but may include low \\xadvoltage QRS com\\xad\\nplexes and inverted T waves. Chest radiography may demonstrate normal \\nor slightly enlarged cardiac silhouette. Two\\xaddimensional echocardiography \\nis typically not useful, while CT scan, MRI, or Doppler echocardiograph y \\ncan be helpful for making this diagnosis.\\nEmergency Department Care and Disposition\\n1. Evaluate ventricular function when making the diagnosis of constrictive \\npericarditis.\\n2. Surgical pericardiectomy may be required when significant constriction \\nand impaired ventricular filling are present.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 55, “Cardiomyopathies and Pericardial Disease,” by \\nJames T. Niemann.\\n24_Cydulka_Ch24.indd   166 15/03/17   3:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 185, 'page_label': '167'}, page_content='167\\nVenous Thromboembolism\\nChristopher Kabrhel\\nVenous thromboembolism (VTE) includes deep vein thrombosis (DVT) \\nand pulmonary embolism (PE). DVT occurs when blood coagulates inside \\na deep vein such as those in the leg, arm, or pelvis. Most PEs occur when \\na portion of a venous clot breaks off, travels through the venous system \\nthrough the right side of the heart, and subsequently enters a pulmonary \\nartery. The clinical presentation of VTE is highly variable, thus clinicians \\nmust maintain a high index of suspicion for the diagnosis. Mortality from \\nVTE is variable, with case fatality rates ranging from 1% to 45%, depend-\\ning on the clinical presentation and comorbid conditions.\\n■ ■CLINICAL FEATURES\\nThere are numerous factors that affect the risk of VTE and the clinical \\npresentation. Factors that increase the risk of VTE include advanced age, \\nobesity, pregnancy, prior VTE, malignancy, inherited thrombophilia, recent \\nsurgery or major trauma, immobility, an indwelling central venous catheter, \\nsmoking, long-distance travel, congestive heart failure, stroke, estrogen \\nuse, and inflammatory conditions.\\nDeep Vein Thrombosis\\nPatients with lower extremity DVT often present with calf or leg pain, red-\\nness, swelling, tenderness, and warmth. Patients with upper extremity DVT, \\nwhich often occurs in the setting of an indwelling catheter, present with \\nsimilar symptoms in an upper extremity. This classic constellation of find-\\nings is present in fewer than 50% of DVT patients, and while a 2-cm dif-\\nference in lower leg circumference is predictive, pain in the calf with forced \\ndorsiflexion of the foot (Homans’ sign) is neither sensitive nor specific for \\nDVT.\\nUncommon but severe presentations of DVT include phlegmasia ceru-\\nlea dolens and phlegmasia alba dolens. Phlegmasia cerulea dolens presents \\nas an extremely swollen and cyanotic limb due to a high-grade obstruction \\nthat elevates compartment pressures and can compromise limb perfusion. \\nPhlegmasia alba dolens has a similar pathophysiology but presents as a \\npale limb secondary to arterial spasm.\\nPulmonary Embolism\\nThe clinical presentation of PE is highly variable, ranging from sudden \\ndeath to incidental diagnosis in patients who are completely asymptomatic. \\nConsider the possibility of PE in a patient who experiences acute dyspnea, \\npleuritic chest pain, unexplained tachycardia, hypoxemia, syncope, or \\nshock—especially in the absence of physical examination or radiographic \\nfindings for alternative diagnoses. The most common symptoms of an acute \\nPE are dyspnea and pleuritic chest pain. Syncope occurs in 3% to 4% of \\npatients with PE, which can be accompanied by convulsions or seizures. \\nPhysical findings that may accompany a PE include hypoxemia, tachypnea, \\n25\\nCh A p TER\\n25_Cydulka_Ch25.indd   167 15/03/17   3:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 186, 'page_label': '168'}, page_content='168 SECTION 4: Cardiovascular Diseases\\ntachycardia, hemoptysis, diaphoresis, and low-grade fever. Clinical signs of \\nDVT occur in about 50% of patients with PE. Massive PE can cause hypo-\\ntension, severe hypoxemia, or cardiopulmonary arrest. However, the clini-\\ncal presentation of VTE can be insidious and there may be poor correlation \\nbetween the size of a PE and the severity of symptoms.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe extremity pain and swelling associated with DVT are similar to other \\ndiagnoses such as cellulitis, congestive heart failure, musculoskeletal inju-\\nries, and venous stasis without thrombosis. The differential diagnosis for \\npatients with symptoms concerning for PE may include many other pulmo-\\nnary disorders, such as asthma, bronchitis, chronic obstructive pulmonary \\ndisease, pleural effusion, pneumonia, and pneumothorax. Cardiac disorders \\nwith symptoms similar to PE can include angina, myocardial infarction, \\ncongestive heart failure, pericarditis, and tachydysrhythmia. Muscle strain \\nand costochondritis can mimic the pleuritic chest pain of PE. The presence \\nof hypoxemia or dyspnea with clear lungs on physical exam and negative \\nradiographic imaging prompt consideration for PE as a possible diagnosis.\\nPretest Probability Assessment\\nEstimating the pretest probability for VTE is the first step for selecting a \\ndiagnostic pathway. Aggressive diagnostic testing can cause harm dispro-\\nportionate to benefit, and therefore specific testing for PE is typically recom-\\nmended for patients whose probability of disease is higher than 2.5%. Below \\nthis threshold, diagnostic testing is more likely to harm than help an indi-\\nvidual patient. When a clinician’s clinical gestalt after history and physical \\nexamination is that an individual patient is low risk for PE, the Pulmonary \\nEmbolism Rule-Out Criteria (PERC) rule can help to identify patients for \\nwhom specific diagnostic testing is not recommended (Table 25-1).\\nFor patients that may need additional diagnostic testing, there are sev-\\neral clinical scoring systems that can be used to calculate a patient’s pretest \\nprobability of VTE. The most robust systems are the Wells’ Scores for PE \\nand DVT (Tables 25-2 and 25-3).\\nTAblE 25-1 pulmonary Embolism Rule-Out Criteria Rule (all nine factors must \\nbe present to exclude pulmonary embolism)\\nClinical low probability (<15% probability of pulmonary embolism based on gestalt \\nassessment)\\nAge <50 years\\nPulse <100 beats/min during entire stay in ED\\nPulse oximetry >94% at near sea level (>92% at altitudes near 5000 feet above sea level)\\nNo hemoptysis\\nNo prior venous thromboembolism history\\nNo surgery or trauma requiring endotracheal or epidural anesthesia within the last 4 weeks\\nNo estrogen use\\nNo unilateral leg swelling, defined as asymmetrical calves on visual inspection with \\npatient’s heels raised off the bed\\n25_Cydulka_Ch25.indd   168 15/03/17   3:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 187, 'page_label': '169'}, page_content='CHAPTER 25: Venous Thromboembolism 169 \\nTAblE 25-2 Wells’ Score for pulmonary Embolism\\nFactors points*\\nSuspected deep venous thrombosis   3\\nAlternative diagnosis less likely than PE   3\\nHeart rate >100 beats/min 1.5\\nPrior venous thromboembolism 1.5\\nImmobilization within prior 4 weeks 1.5\\nActive malignancy   1\\nHemoptysis   1\\n*Risk score interpretation (probability of PE): >6 points = high risk (78.4%); 2–6 points = moderate risk \\n(27.8%); and <2 points = low risk (3.4%).\\nSource: Adapted with permission from Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple \\nclinical model to categorize patients probability of pulmonary embolism: increasing the models utility \\nwith the SimpliRED d-dimer. Thromb Haemost. 2000;83(3):416–420.\\nTAblE 25-3 Wells’ Score for Deep Vein Thrombosis\\nClinical Features points*\\nActive cancer (treatment within 6 months, or palliation)   1\\nParalysis, paresis, or immobilization of lower extremity   1\\nBedridden for >3 days because of surgery (within 12 weeks)   1\\nLocalized tenderness along distribution of deep veins   1\\nEntire leg swollen   1\\nUnilateral calf swelling of >3 cm (below tibial tuberosity)   1\\nUnilateral pitting edema   1\\nCollateral superficial veins   1\\nAlternative diagnosis as likely as or more likely than deep \\nvenous thrombosis\\n–2\\nPrior history of DVT or PE†   1\\n*Risk score interpretation (probability of deep venous thrombosis) in original Wells’ DVT model: \\n≥3 points: high risk (75%); 1 or 2 points: moderate risk (17%); <1 point: low risk (3%).\\n†Only awarded in the modified (dichotomized) Wells DVT model: ≤1 point DVT unlikely >1 point DVT likely.\\nSource: Adapted with permission from Geersing GJ, Zuithoff NP , Kearon C, et al: Exclusion of deep vein \\nthrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis. \\nBMJ. March 10, 2014;348:g1340.\\nDiagnostic Testing\\nFor patients who need additional testing and have low or intermediate pretest \\nprobability, serum d-dimer testing is the recommended initial test. The diag-\\nnostic sensitivity of automated quantitative d-dimer assays ranges from 94% \\nto 98% and the specificity from 50% to 60% for PE and DVT. The d-dimer \\nhas a half-life of approximately 8 hours and can be elevated for at least \\n3 days after symptomatic VTE. Advanced age, pregnancy, active malig-\\nnancy, recent surgery, liver disease, rheumatologic disease, infection, \\ntrauma, and sickle cell disease can all elevate d-dimer levels in the absence \\nof VTE. d-dimer cutoffs for use in screening for VTE can be adjusted for age \\nto maintain adequate exclusionary ability. The most commonly used formula \\n25_Cydulka_Ch25.indd   169 15/03/17   3:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 188, 'page_label': '170'}, page_content='170 SECTION 4: Cardiovascular Diseases\\nis age × 10 ng/mL to determine the upper limit of normal. For patients with \\nhigh pretest probability of VTE, those with a positive d -dimer, or those in \\nwhom d-dimer testing is very likely to be positive, imaging is indicated.\\nFigure 25-1 illustrates a recommended diagnostic pathway for sus-\\npected DVT. Patients with a low pretest probability of DVT can be ade-\\nquately evaluated with a serum d-dimer. Patients with a moderate or high \\npretest probability for DVT or those who have a positive d-dimer should \\nundergo venous ultrasound (US). Venous US is nonionizing and has high \\nsensitivity (90% to 95%) and specificity (95%) for lower extremity DVT. \\nSensitivity of venous US is lower for pelvic and isolated calf DVT and in \\nobese patients. To rule out DVT in patients with high clinical probability, \\nsome diagnostic algorithms recommend both a negative initial ultrasound \\nand a concurrent negative d-dimer or a follow-up ultrasound performed  \\n1 week after the initial negative testing.\\nFigure 25-2 shows one recommended diagnostic algorithm for PE, \\nthough no singular diagnostic test or approach perfectly diagnoses or \\nexcludes PE. For patients who need radiographic imaging to evaluate for \\nPE, a computed tomography (CT) pulmonary angiography of the chest is \\nthe test of choice (see Fig. 25-3) where a blood clot appears as a filling \\ndefect in a contrast-enhanced pulmonary artery. The sensitivity of a \\ntechnically adequate CT for PE is about 90%, and specificity is 95%. \\nUnfortunately, about 10% of scans are technically inadequate and should be \\ninterpreted with this limitation in mind. The negative likelihood ratio of a \\nCT scan is 0.12, which is similar to that of a negative d-dimer. Therefore, \\nFigurE 25-1. Diagnostic algorithm for deep vein thrombosis, applied in patients \\nwith leg symptoms compatible with DVT. +, positive test result; –, negative test \\nresult.\\n−+−\\n+\\nDetermine pretest probability\\nof DVT using Wells’ criteria\\nLow probability \\nscore (<1 point)\\nHigh or moderate \\nprobability score\\n(>0 points)\\nD-dimer testing\\nD-dimer\\ntesting\\nDVT ruled\\nout\\nTreat\\nDVT\\nDVT ruled\\nout\\n−+ −+\\nUS\\nUS\\nDVT ruled\\nout\\nRepeat \\nUS in 1 week\\n25_Cydulka_Ch25.indd   170 15/03/17   3:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 189, 'page_label': '171'}, page_content='CHAPTER 25: Venous Thromboembolism 171 \\nas with d-dimer testing, CT scan results should be interpreted in the appro-\\npriate context of pretest probability. Compared to other imaging modalities, \\nCT scanning has the advantage of demonstrating important alternative \\ndiagnoses in 18% to 22% of patients.\\nVentilation-perfusion (V˙/Q˙) scanning is another testing option to assess \\nfor possible PE. This is performed by comparing emission of radioisotope \\nthat has been injected into the pulmonary arteries to emission of radioisotope \\nFigurE 25-2. Pulmonary Embolism Rule-Out Criteria (PERC) rule—diagnostic algo-\\nrithm for pulmonary embolism (PE). +, positive for PE; –, negative for PE; Cr, creatinine; \\nHigh, high probability scan findings; LMWH, low-molecular-weight heparin; Nl, normal; \\nNondx, nondiagnostic (any reading other than normal or high probability); quant, \\nquantitative.* Some physicians prefer to start with a clinical decision rule such as the \\nWells’ score (where <2, 2 to 6, and >6 are used instead of <15%, 15% to 40%, and \\n>40%, respectively). Note: Determine renal function by clinical picture (healthy, no risk \\nfactors for reduced glomerular filtration rate (GFR)) or calculated GFR. Nondiagnostic \\nventilation-perfusion (V˙/Q˙  ) scan findings require confirmation from results of another \\ntest, such as CT pulmonary angiography (CTPA), if benefits outweigh risks.\\nOrder\\nimaging\\nPE (+)\\nNo PE\\nNl High Nondx\\nCTPA\\n− +\\nAssess gestalt\\npretest probability*\\n<15%\\nPERC rule\\nNo PE Quant\\nD-dimer\\n−+\\nLMWH if no\\ncontraindication\\nSerum Cr–\\nGFR <60 mL/min\\nSerum Cr–\\nGFR >59 mL/min\\n−+\\n− +\\n15–40% >40%\\nV/Q\\n25_Cydulka_Ch25.indd   171 15/03/17   3:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 190, 'page_label': '172'}, page_content='172 SECTION 4: Cardiovascular Diseases\\nthat has been inhaled into the alveoli. A V˙/Q˙ scan that demonstrates homo-\\ngeneous scintillation throughout the lung in the perfusion portion rules out \\nPE with 100% sensitivity. A V˙/Q˙ scan with two or more unmatched filling \\ndefects indicates 80% probability of PE. However, only about one-third of \\nV˙/Q˙ scans demonstrate findings sufficient to diagnose or rule out PE with \\ncertainty.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nThe treatment of VTE consists of initial stabilization, anticoagulation, and \\nthrombolytic or surgical therapy in severe cases. All patients suspected of \\nhaving PE should have their cardiac rhythm, blood pressure, and pulse \\noxygenation measured.\\n1. Utilize supplemental oxygen when necessary to maintain adequate pulse \\noximetry readings.\\n2. Administer intravenous crystalloid fluids as needed to augment preload \\nand correct hypotension.\\nFigurE 25-3.  Axial image from a chest CT angiogram demonstrating a filling \\ndefect consistent with acute pulmonary embolism. Two white arrowheads outline \\na circular filling defect in the right middle lobar pulmonary artery . The long white \\narrow projecting in the left lung points to a filling defect in a segmental artery in \\nthe posterior medial segmental artery.\\n25_Cydulka_Ch25.indd   172 15/03/17   3:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 191, 'page_label': '173'}, page_content='CHAPTER 25: Venous Thromboembolism 173 \\n3. Initial anticoagulation should be initiated as soon as possible to prevent \\nfurther clot formation and allow endogenous f ibrinolysis to proceed. \\nAnticoagulation can be achieved by administering intravenous unfrac-\\ntionated heparin (UFH), subcutaneous low-molecular-weight heparin \\n(LMWH), or a factor Xa inhibitor such as rivaroxaban, apixaban, or \\nfondaparinux. Dabigatran (a direct thrombin inhibitor) and edoxaban \\n(a factor Xa inhibitor) can also be used, but require initial anticoagula-\\ntion with heparin for several days. (See Table 25-4.)\\n4. Current data favor the use of LMWH over UFH for treatment of PE or \\nDVT, although the magnitude of benefit is small. LWMH can result in \\nunpredictable anticoagulation in patients with severe renal insufficiency, \\nso UFH is preferred in this setting. Potentially decreased absorption of \\nLMWH in obese patients or high risk of bleeding in selected patients \\nmay also favor the use of UFH.\\n5. Systemic fibrinolytic therapy should be considered for selected patients \\nwith severe PE and no contraindications. Currently, the only patients \\nwith PE who have been shown to clearly benefit from thrombolytic \\nTAblE 25-4 Antithrombotic Therapy for Deep Venous Thrombosis and \\npulmonary Embolism\\nDosage Comments\\nUnfractionated heparin 80 U/kg bolus, then Recommended if outpatient \\ntherapy not appropriate or in \\ncases of severe renal failure18 U/kg/h infusion\\nLMWHs Outpatient treatment with \\nLMWH preferred\\nDalteparin 100 IU/kg SC every 12 h or\\n200 IU/kg SC every day\\nEnoxaparin 1 mg/kg SC every 12 h or\\n1.5 mg/kg SC every day\\nTinzaparin 175 IU/kg SC every day\\nFactor Xa inhibitors\\nFondaparinux <50 kg, 5 mg SC every day; \\n50–100 kg, 7.5 mg SC every \\nday; >100 kg, 10 mg SC \\nevery day\\nDo not use in renal failure\\nTarget-specific  \\nanticoagulants\\nRivaroxaban (Xarelto®) 15 mg BID for 21 days, then \\n20 mg every day with food\\nNo heparin requirement; good \\nchoice for outpatient treatment\\nApixaban (Eliquis®) 10 mg BID for 7 days then \\n5 mg BID\\nNo heparin requirement; good \\nchoice for outpatient treatment\\nDabigatran (Pradaxa®) 150 mg BID Requires run in of heparin for \\n5–10 days; renal excretion\\nThrombolytic therapy Tissue plasminogen activa-\\ntor or alteplase (Activase®), \\n10-mg IV bolus followed by \\n90 mg infused over 2 h\\nFor PE with hemodynamic \\ncompromise; after infusion, \\nbegin unfractionated heparin \\nor LMWH\\nAbbreviations: BID, twice a day; LMWH, low-molecular-weight heparin; VTE, venous thromboembolism.\\n25_Cydulka_Ch25.indd   173 15/03/17   3:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 192, 'page_label': '174'}, page_content='174 SECTION 4: Cardiovascular Diseases\\ntherapy are those with a massive PE causing systolic blood pressure \\nbelow 90 mm Hg or an observed decrease in blood pressure of \\n40 mm Hg. Fibrinolysis may also benefit patients with submassive PE \\nthat is associated with right heart strain on echocardiogram, elevated \\ntroponin or B-type natriuetric peptide, or severe hypoxemia and respira-\\ntory distress. In these patients fibrinolysis is associated with improved \\nsurvival and quality of life, but with an increased risk of bleeding—\\nespecially among patients >65 years old. Alteplase (tPA) is the only \\nfibrinolytic available in the United States that is Food and Drug Admin-\\nistration (FDA) approved for the treatment of PE and is administered as \\n100 mg infused over 2 hours. Heparin or LMWH is typically started \\nafter the thrombolytic infusion.\\n6. Severe DVT that causes phlegmasia cerulea dolens can lead to loss of \\nlimb and requires immediate treatment. The affected limb should be \\nmaintained at neutral level, constrictive clothing, casts, or dressings \\nshould be removed, and anticoagulation should be initiated. Catheter-\\nbased thrombectomy or thrombolysis should be discussed with an \\ninterventional radiologist, peripheral interventional cardiologist, or \\nvascular surgeon. If this service is not available, consider intravenous \\nthrombolysis.\\n7. Surgical and suction thromboembolectomy are options for patients with \\nlife-threatening PE and contraindications to fibrinolysis. The mortality \\nassociated with open surgical thromboembolectomy is high, but may be \\nimproved with early and appropriate patient selection.\\n8. An inferior vena cava filter should be considered when anticoagulation \\nhas failed, is contraindicated, or when submassive PE is associated with \\npersistent large DVT.\\n9. Admit patients to an intensive care setting when signs of circulatory com-\\npromise are present or when thrombolytic therap y is given and close \\nmonitoring is needed. Patients with PE are typically admitted to a telem-\\netry bed, but selected low-risk patients may be appropriate for outpatient \\nmanagement. Low-risk patients with DVT are often treated as outpatients. \\nAppropriate follow-up must be assured when the eligibility for outpatient \\ntreatment is being evaluated, and practical limitations such as the ability \\nto reliably comply with treatments at home should be considered.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 56, “Venous Thromboembolism,” by Jeffrey A. Kline.\\n25_Cydulka_Ch25.indd   174 15/03/17   3:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 193, 'page_label': '175'}, page_content='175\\nSystemic and Pulmonary \\nHypertension\\nMichael Cassara\\nClinical presentations of acute systemic hypertension may be classified into \\nfollowing three categories:\\n1. Hypertensive emergency  is characterized by elevated blood pressures \\nwith target organ dysfunction. Organ dysfunction is caused by persis-\\ntent mechanical wall stress and endothelial injury leading to increased \\nvascular permeability and fibrinoid necrosis within large arteries and \\narterioles of target organs such as brain, kidneys, heart, and lungs. \\nClinical manifestations of hypertensive emergency may include the \\nfollowing:\\n●   Chest pain associated with aortic dissection, acute pulmonary edema, \\nor acute coronary syndrome.\\n●   Shortness of breath from acute pulmonary edema.\\n●   Acute neurologic symptoms such as altered mental status, focal motor \\nor sensory deficits, headache, or visual disturbances. These can be \\nassociated with hypertensive encephalopathy, subarachnoid hemor -\\nrhage, intracranial hemorrhage, or acute ischemic stroke.\\n●   Peripheral edema secondary to acute renal failure or severe  \\npreeclampsia.\\n●   Sympathetic crisis due to sympathomimetic toxicity, adverse drug \\nreactions and food–drug interactions, or pheochromocytoma.\\n2. Hypertensive urgency  is accompanied by profound blood pressure \\nelevations without acute target organ dysfunction. Some clinicians rec-\\nommend acute pharmacologic treatment for blood pressures of 180/120 \\nmm Hg or greater, although the clinical benefits of such acute interven-\\ntions are unclear.\\n3. Chronic systemic hypertension is identified in patients with longstand-\\ning blood pressure elevations without obvious progression to acute tar -\\nget organ dysfunction. This diagnosis is defined by serial blood pressure \\nmeasurements over several weeks. See Table 26-1.\\n26\\nChapter\\nTable 26-1 JNC7 Classification of hypertension\\nClass Systolic Bp (mm hg) Diastolic Bp (mm hg)\\nNormal <120 and <80\\nPrehypertension 120–139 or 80–89\\nStage 1 140–159 or 90–99\\nStage 2 160 or greater or 100 or greater\\nAbbreviations: BP , blood pressure; JNC7, Seventh Report of the Joint National Committee on the \\nPrevention, Detection, Evaluation, and Treatment of High Blood Pressure.\\n26_Cydulka_Ch26.indd   175 15/03/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 194, 'page_label': '176'}, page_content='176 SECTION 4: Cardiovascular Diseases\\n■ ■CLINICaL FeatUreS\\nPatients presenting with elevated blood pressure and accompanying acute \\nsymptoms often provide a history of hypertension. Many patients have \\ncoexisting medical conditions such as cardiovascular disease, renal dys-\\nfunction, cerebrovascular disease, diabetes, hyperlipidemia, chronic \\nobstructive pulmonary disease, asthma, or renal artery stenosis. Secondary \\nprecipitants of acute hypertension may include pregnancy, sympathomi-\\nmetic toxicity, adverse drug reactions, drug–drug interactions, or with-\\ndrawal from medications or recreational substances.\\nWhen a significantly elevated blood pressure is present, consider the \\npossibility of hypertensive emergency in patients with any of the following \\nsigns and symptoms of target organ involvement:\\n●   Nervous system signs and symptoms such as headaches, visual changes, \\npapilledema, retinal exudates, seizures, encephalopathy , focal motor or \\nsensory deficits, vomiting, seizures, or confusion\\n●   Cardiovascular signs and symptoms such as chest pain, palpitations, \\ndyspnea, rales, syncope, carotid bruits, new cardiac murmurs or gallops, \\nasymmetric pulses, unequal blood pressures, pulsatile abdominal masses, \\nor tearing pain radiating to the back or abdomen\\n●   Renal system signs and symptoms such as anuria, peripheral edema, or \\nhematuria\\nConsider preeclampsia in pregnant or recently postpartum patients with \\nhypertension, hyperreflexia, and peripheral edema. Consider coarctation or \\naortic dissection in patients with hypertension, asymmetric peripheral \\npulses, and unequal blood pressures.\\n■ ■DIaGNOSIS aND DIFFereNtIaL\\nThe primary goal of diagnostic testing is to reveal evidence of target organ \\ninjury when such injury is not otherwise clinically obvious. Urinalysis, \\npregnancy testing, and electrocardiograms are commonly ordered. When \\nindicated in specific cases, additional testing such as metabolic profiles, \\ntoxicology screens, and radiographic imaging may provide additional sup-\\nporting data. See Table 26-2.\\nHematuria, proteinuria, and red cell casts on urinalysis, coupled with \\nserum blood urea nitrogen, creatinine, and potassium elevations, suggest \\nrenal injury. Electrocardiographic abnormalities may reflect cardiac or \\nrenal dysfunction with findings such as tachycardia, altered QRS wave-\\nforms, and ST segment or T-wave changes. Chest radiographs may reveal \\nfindings of acute pulmonary edema or mediastinal widening suggestive of \\nacute aortic dissection. Computed tomography or ultrasound may be neces-\\nsary to confirm clinical suspicions when plain radiographs are nondiagnos-\\ntic. Computed tomography of the head may reveal ischemic changes, \\nedema, or hemorrhage.\\n■ ■eMerGeNCY DepartMeNt Care aND DISpOSItION\\nStabilize patients with hypertensive emergencies with an appropriate \\nairway assessment, ventilatory support, supplemental oxygen administra-\\ntion, continuous cardiac monitoring, and intravenous catheter placement. \\n26_Cydulka_Ch26.indd   176 15/03/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 195, 'page_label': '177'}, page_content='CHAPTER 26: Systemic and Pulmonary Hypertension 177 \\nFormulate a problem-specific plan of care with a primary therapeutic goal \\nof safely reducing arterial pressure while avoiding hypoperfusion.\\n1. Aortic dissection. Initiate treatments to reduce heart rate to 60 beats \\nper minute or less and systolic blood pressure between 100 and \\n140 mm Hg, with an ideal target of less than 120 mm Hg. Initiate beta-\\nadrenergic antagonists before starting vasodilator agents. Initial options \\ninclude esmolol 250 to 500 µg/kg IV over 1 to 3 minutes followed by \\ncontinuous infusion of 50 µg/kg/min, or labetalol 10 to 20 mg IV over \\n2 minutes followed by subsequent doses of 40 to 80 mg every \\n10 minutes as needed to a maximum dose of 300 mg. If beta-adrenergic \\nantagonists are contraindicated, diltiazem 0.25 mg/kg over 2 minutes, \\nalpha-adrenergic antagonists, benzodiazepines, or vasodilators may be \\nnecessary. When additional blood pressure control is needed, consider \\nnicardipine 5 mg/h IV with incremental increases by 2.5 mg/h every \\n5 to 15 minutes to a maximum infusion rate of 15 mg/h. An alternative \\nblood pressure control agent is sodium nitroprusside 0.3 to 0.5 µg/kg \\nIV with incremental increases by 0.5 µg/kg/min.\\n2. Acute hypertensive pulmonary edema. The primary therapeutic goal \\nis to reduce systemic afterload by 20% to 30%. There are no clear \\nTable 26-2 hypertensive emergencies\\nDiagnostic Category evidence of acute end-Organ Damage\\nAcute aortic dissection Abnormal CT angiogram of chest and abdomen/pel-\\nvis or transesophageal echocardiogram of the aorta\\nAcute pulmonary edema Interstitial edema on chest radiograph\\nAcute myocardial infarction Changes on ECG or elevated levels of cardiac \\nbiomarkers\\nAcute coronary syndrome Clinical diagnosis, changes on ECG, or elevated \\nlevels of cardiac biomarkers\\nAcute renal failure Elevated serum creatinine level, proteinuria\\nSevere preeclampsia, HELLP \\nsyndrome, eclampsia\\nProteinuria, hemolysis, elevated liver enzyme levels, \\nlow platelet counts\\nHypertensive retinopathy Retinal hemorrhages and cotton-wool spots, hard \\nexudates, and sausage-shaped veins\\nHypertensive encephalopathy May see papilledema or arteriolar hemorrhage or \\nexudates on funduscopic examination, may note \\ncerebral edema with a predilection for the posterior \\nwhite matter of the brain on MRI\\nSubarachnoid hemorrhage Abnormal CT of the brain\\nIntracranial hemorrhage Abnormal CT of the brain; RBC on lumbar puncture\\nAcute ischemic stroke Abnormal MRI or CT of the brain\\nAcute perioperative hypertension Clinical diagnosis; manifestations of other hyperten-\\nsive emergencies\\nSympathetic crisis Clinical diagnosis in the setting of sympathomimetic \\ndrug use (i.e., cocaine or amphetamines) or pheochro-\\nmocytoma (24-h urine assay for catecholamines and \\nmetanephrine or plasma fractionated metanephrines)\\nAbbreviation: HELLP , hemolysis, elevated liver enzymes, low platelets.\\n26_Cydulka_Ch26.indd   177 15/03/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 196, 'page_label': '178'}, page_content='178 SECTION 4: Cardiovascular Diseases\\nevidence-based guidelines for the single best treatment for hyperten -\\nsive pulmonary edema, although diuresis and vasodilation are com-\\nmonly used. Nitroglycerin 0.4 mg sublingual up to three doses, topical \\n1 to 2 inches transdermal, or IV infusion starting at 5 µg/min with \\nincreases by 5 µg/min every 3 to 5 minutes up to 20 µg/min. Refractory \\ncases can continue nitroglycerin IV infusion with incremental \\nincreases by 10 µg/min every 3 to 5 minutes to a maximum of 200 µg/\\nmin or add nicardipine (see dose above, #1). Consider sodium nitro-\\nprusside (see dose above, #1) when other agents are unsuccessful, \\nkeeping in mind its association with cyanide and thiocyanate toxicity \\nin patients with prolonged therapy or renal failure. Intravenous enala-\\nprilat 0.625 to 1.25 mg IV over 5 minutes every 4 to 6 hours, incre-\\nmentally increased by 1.25 mg to a maximum of 5 mg every 6 hours is \\nan additional adjunct, but may induce significant “first-dose” hypoten-\\nsion, and is pregnancy category D.\\n3. Acute coronary syndromes. The primary therapeutic goals are to limit \\nischemia and reduce the mean arterial pressure by no more than 25%. \\nSublingual or intravenous nitroglycerin (see dose above, #2) is pre-\\nferred. Routine use of intravenous beta-adrenergic antagonists has \\nfallen out of favor, and these agents are currently recommended only \\nwhen patients have severe hypertension and should be avoided for \\nthose with risk for progression to cardiogenic shock. Oral beta-adrenergic \\nantagonists may not provide sufficiently rapid blood pressure control in \\na hypertensive emergency.\\n4. Acute sympathetic crisis. The primary therapeutic goals are to \\ndecrease adrenergic stimulation and to relieve symptoms. Benzodiaz-\\nepines are the recommended first intervention. Nitroglycerin (see \\ndose above, #2), phentolamine 5 to 15 mg IV followed by continuous \\ninfusion of 0.2 to 0.5 mg/min, or nicardipine (see dose above, #1) are \\nsecondary adjuncts to consider.\\n5. Acute renal failure. The primary therapeutic goals are to reduce sys-\\ntemic vascular resistance with acute blood pressure reductions of less \\nthan 20% to help preserve renal blood flow. Recommended agents \\ninclude fenoldopam 0.1 µg/kg/min IV titrated to desired effect every \\n15 minutes to a maximum of 1.6 µg/kg/min, clevidipine 1 to 2 mg/h \\nIV , or nicardipine (see dose above, #1).\\n6. Preeclampsia. The primary therapeutic goals are to reduce signif icant \\nelevations of blood pressure and prevent progression to eclampsia. \\nLabetalol (see dose above, #1) and hydralazine 5 to 10 mg IV are \\ncommonly prescribed agents for blood pressure levels greater than \\n160/100 mm Hg.\\n7. Hypertensive encephalopathy . The primary therapeutic goal is to \\nrapidly reduce significantly elevated mean arterial pressures by 20% to \\n25% once other neurologic emergencies are excluded. Recommended \\nagents include nicardipine (see dose above, #1), labetalol (see dose \\nabove, #1), fenoldopam (see dose above, #5), or clevidipine (see dose \\nabove, #5).\\n8. Subarachnoid hemorrhage. The primary therapeutic goals for blood \\npressure control in subarachnoid hemorrhage are unclear, although \\nreduction of systolic blood pressure to 160 mm Hg or lower is generally \\nrecommended. Recommended agents include nicardipine (see dose \\n26_Cydulka_Ch26.indd   178 15/03/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 197, 'page_label': '179'}, page_content='CHAPTER 26: Systemic and Pulmonary Hypertension 179 \\nabove, #1), labetalol (see dose above, #1), esmolol (see dose above, #1), \\nor clevidipine (see dose above, #5). Oral nimodipine may reduce vaso-\\nspasm and subsequent cerebral infarction rate in patients with moder -\\nately increased blood pressure not requiring an intravenous agent.\\n9. Intracranial hemorrhage. The primary therapeutic goals for blood \\npressure control in intracranial hemorrhage are to reduce hemorrhage \\nexpansion and to lower systolic blood pressures to 120 to 160 mm Hg. \\nRecommended agents include nicardipine (see dose above, #1), labet-\\nalol (see dose above, #1), or esmolol (see dose above, #1).\\n10. Acute ischemic stroke: The primary therapeutic goals for blood pres-\\nsure control in acute ischemic stroke depend on the likelihood of fibri-\\nnolytic therapy, and should be balanced to avoid worsening ischemia \\nfrom excessive blood pressure reduction. If fibrinolytic therapy is \\nplanned, blood pressure should be below 185/110 mm Hg, with a sys-\\ntolic blood pressure goal of 141 to 150 mm Hg. Recommended agents \\ninclude labetalol (see dose above, #1), nicardipine (see dose above, \\n#1), or sodium nitroprusside (see dose above, #1). If no fibrinolytic \\ntherapy is planned and significantly elevated blood pressures remain \\n(e.g., 220/120 mm Hg), blood pressure should be lowered by no more \\nthan 10% to 15% in the first 24 hours.\\n11. For hypertensive urgency, useful agents include labetalol 200 to 400 \\nmg orally, captopril 12.5 to 25 mg orally every 4 to 6 hours, losartan \\n50 mg orally per day, or clonidine 0.1 to 0.2 mg orally.\\n12. Consider starting an oral agent on an outpatient basis for asymptomatic \\npatients with severe hypertension, such as those with systolic blood \\npressures above 180 to 200 mm Hg or diastolic blood pressures above \\n110 to 120 mm Hg. A diuretic agent such as hydrochlorothiazide \\n25 mg orally each day is an appropriate medication to consider starting \\nin patients with uncomplicated asymptomatic severe hypertension. For \\npatients with angina, postmyocardial infarction, migraines, or supra-\\nventricular arrhythmias, consider a beta-adrenergic antagonists such as \\nmetoprolol 50 mg orally once or twice daily. An angiotensin-converting \\nenzyme inhibitor such as lisinopril 10 mg orally each day can be used \\nin patients with a history of heart failure, renal disease, recurrent \\nstrokes, or diabetes mellitus.\\n■ ■ChILDhOOD hYperteNSIVe eMerGeNCIeS\\nHypertensive emergencies in children, as for adults, refer to profoundly \\nelevated blood pressures associated with target organ damage. Neonates \\noften present with nonspecific signs such as apnea, cyanosis, or poor feed-\\ning. Older children may present with symptoms and physical examination \\nfindings more typical of adults such as throbbing frontal headaches or \\nblurred vision.\\nRenovascular lesions and pheochromocytoma are the most commonly \\nidentified etiologies for pediatric hypertensive emergencies. The decision \\nto treat a hypertensive emergency in a child is based on the blood pressure \\nand associated symptoms indicating target organ damage. Consider urgent \\ntreatment if the hypertensive blood pressure exceeds prior measurements \\nby 30%, or if diastolic or systolic blood pressures exceed the 90th to 95th \\npercentiles on a standardized table of blood pressure by age. The primary \\n26_Cydulka_Ch26.indd   179 15/03/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 198, 'page_label': '180'}, page_content='180 SECTION 4: Cardiovascular Diseases\\ntherapeutic goal for blood pressure control in an acutely symptomatic child \\nwith a hypertensiv e emergency is to lower the mean arterial pressure by \\n25% within 1 hour. Preferred medications include labetalol 0.2 to 1 mg/kg \\nIV to a maximum of 40 mg per dose or a continuous infusion of 0.25 to 3 \\nmg/kg/h or nicardipine 0.5 to 3 µg/kg/min IV .\\nThe second-line agents include hydralazine 0.2 to 0.6 mg/kg IV to a \\nmaximum of 20 mg per dose, esmolol 100 to 500 µg/kg followed by an \\ninfusion of 50 to 150 µg/kg/min, or clevidipine 0.5 to 3.5 µg/kg/min IV . \\nRefractory cases may be treated with nitroprusside 0.5 to 10 µg/kg/min IV . \\nPhentolamine 0.1 mg/kg IV to a maximum of 5 mg is the drug of choice \\nfor significantly elevated blood pressure in the setting of a pheochromocy-\\ntoma, while awaiting definitive surgical treatment.\\n■ ■pULMONarY hYperteNSION\\nPulmonary hypertension is characterized by an elevated pressure within the \\npulmonary vascular system compromising right ventricular function. Pul-\\nmonary hypertension is defined as a mean pulmonary artery pressure \\nexceeding 25 mm Hg at rest or 30 mm Hg with exertion. Pulmonary hyper-\\ntension can manifest with isolated pulmonary arterial pressure elevations or \\ncombined pulmonary arterial and venous pressure elevations. Definitive \\ndiagnosis requires right heart catheterization.\\nThe most common symptom of pulmonary hypertension is dyspnea, \\neither at rest or with exertion. Other symptoms include fatigue, syncope or \\nnear-syncope, and chest pain. Typically, this disorder will be seen in asso-\\nciation with other cardiovascular or pulmonary disorders such as chronic \\nobstructive pulmonary disease, left ventricular dysfunction, or disorders \\nassociated with hypoxemia.\\nWhen treating patients with suspected or known pulmonary hypertension:\\n●   Provide supplemental oxygen to maintain saturation levels greater than \\n90% in patients presenting with hypoxia. Intubation in patients with severe \\npulmonary hypertension can cause rapid cardiovascular collapse due to \\nincreased intrathoracic pressure from positive pressure ventilation.\\n●   Optimize intravascular volume to treat or prevent hypotension.\\n●   Augment right ventricular function when necessary by using dobutamine \\n2 to 10 µg/kg/min IV or milrinone 0.375 µg/kg/min IV .\\n●   Maintain coronary artery perfusion when necessary by using norepi-\\nnephrine 0.05 to 0.75 µg/kg/min IV.\\n●   Reduce right ventricular afterload with prostanoids  (e.g., epoprostenol) \\nand phosphodiesterase-5 inhibitors (e.g., sildenafil). Although these \\nagents are rarely initiated in the emergency department, patients with pre-\\nviously diagnosed pulmonary hypertension may present already receiving \\ncontinuous infusions of one of these agents. When assessing these patients \\nin the acute setting, confirm catheter and pump function as one possible \\ncause of clinical decompensation.\\n■ ■FUrther reaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 57, “Systemic Hypertension,” by Brigitte M. Baumann; \\nChapter 58, “Pulmonary Hypertension,” by Michael E. Winters.\\n26_Cydulka_Ch26.indd   180 15/03/17   3:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 199, 'page_label': '181'}, page_content='181\\nAortic Aneurysms and  \\nAortic Dissection\\nDavid E. Manthey\\n■ ■ABDOMINAL AORTIC ANEURYSMS\\nAn abdominal aortic aneurysm (AAA) is commonly ≥3.0 cm in diameter and \\ncan be a significant cause of morbidity and mortality. Symptomatic aneurysms \\nand those ≥5.0 cm in diameter frequently require prompt operative repair.\\nClinical Features\\nAn acute rupturing AAA is an emergent condition that will lead to death if \\nnot rapidly identified and repaired. The classically described presentation \\nof a ruptured AAA is an older male smoker with atherosclerosis who pres-\\nents with sudden severe back or abdominal pain, hypotension, and a pulsa-\\ntile abdominal mass. Patients may also present with syncope or pain that \\nlocalizes to the flank, groin, hip, or abdomen.\\nHalf of patients with a rupturing aneurysm describe a ripping or tearing \\npain that is severe and abrupt in onset. On examination, patients may have \\na tender pulsatile abdominal mass, although this finding may be challeng-\\ning to identify in obese patients. Patients with a ruptured AAA may present \\nwith persistent hypotension due to blood loss, although this may transiently \\nimprove due to compensatory mechanisms. Femoral pulsations are typi-\\ncally normal. Retroperitoneal hemorrhage may rarely present with external \\nfindings such as periumbilical ecchymosis (Cullen’s sign), flank ecchymo-\\nsis (Grey–Turner’s sign), or a scrotal hematoma.\\nAortoenteric fistulas, although rare, may present as gastrointestinal \\nbleeding with either a small sentinel bleed or a massive life-threatening \\nhemorrhage. Patients with prior aortic grafting are at an increased risk of \\nthis complication. The duodenum is a common site for fistula formation, \\nand patients with this complication may present with hematemesis, melena, \\nor hematochezia. Aortovenous fistulas can lead to high-output cardiac fail-\\nure with decreased arterial blood flow distal to the fistula.\\nAn uncommon presentation of AAA is rupture into the retroperitoneum, \\nwhere significant fibrosis may lead to a chronic contained rupture. These \\npatients can appear well and may complain of pain for an extended period \\nof time before the diagnosis is made.\\nClinicians may discover an asymptomatic AAA on physical examination \\nor as an incidental finding on a radiologic study. Refer patients with a newly \\ndiagnosed AAA to a vascular surgeon for evaluation, keeping in mind that \\naneurysms larger than 5 cm in diameter are at a greater risk for rupture.\\nDiagnosis and Differential\\nIdentifying a new AAA can be a challenging diagnosis. When the diagnosis \\nis not initially identified, renal colic is the most common incorrect initial \\ndiagnosis. Consider this diagnosis in patients with symptoms of back pain, \\nan intraabdominal process, testicular torsion, or gastrointestinal bleeding.\\n27\\nCh A p TER\\n27_Cydulka_Ch27.indd   181 01/05/17   10:25 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 200, 'page_label': '182'}, page_content='182 SECTION 4: Cardiovascular Diseases\\nWhen the diagnosis is unclear , consider additional studies to further \\nevaluate patients with symptoms concerning for an expanding or rupturing \\nAAA. Bedside abdominal ultrasound has >90% sensitivity for identifying \\nAAA and can be used to accurately measure the diameter of the aneurysm \\n(see Fig. 27-1), although aortic rupture or retroperitoneal bleed cannot be \\nreliably identified with this modality. Computed tomography (CT) can \\nidentify AAA and delineate the anatomic details of the aneurysm and any \\nassociated rupture. The role of plain radiography in the diagnosis of ruptur-\\ning AAA is unclear, as a calcified, bulging aortic contour is present in only \\n65% of patients with a symptomatic AAA.\\nEmergency Department Care and Disposition\\n1. Consult emergently with a vascular surgeon when a rupturing AAA or \\naortoenteric fistula is suspected.\\n2. Stabilize hemodynamics by obtaining large-bore IV access and admin-\\nistering fluids judiciously to treat hypotension. Target a goal systolic \\nblood pressure of 90 mm Hg, and transfuse packed red blood cells if \\nneeded. Provide pain control while avoiding hypotension.\\n3. When a small asymptomatic AAA (3.0 to 5.0 cm) is identified as an \\nincidental finding, refer the patient to see a vascular surgeon. Large \\nAAAs (>5.0 cm) are at higher risk for spontaneous rupture and may \\nwarrant close follow-up.\\n4. Nonaortic large-artery aneurysms can also cause symptoms from expan-\\nsion and rupture (see Table 27-1). These can also be diagnosed and \\nevaluated using ultrasound or CT scan.\\nFigurE 27-1. Ultrasound image of an abdominal aortic aneurysm in the transverse \\nplane.\\n27_Cydulka_Ch27.indd   182 01/05/17   10:25 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 201, 'page_label': '183'}, page_content='CHAPTER 27: Aortic Aneurysms and Aortic Dissection  183 \\nTAblE 27-1 Nonaortic Large-Artery Aneurysms\\nArtery Risk Factors Clinical presentation Management\\nPopliteal (>2 cm  \\nor >150% of \\nnormal caliber)\\nAdvanced age, male \\ngender, trauma, \\ncongenital disorders\\nMost common \\nperipheral aneurysm; \\ndiscomfort behind knee \\nwith swelling with or \\nwithout deep venous \\nthrombosis\\nThrombolysis, liga-\\ntion, arterial bypass, \\nendovascular repair\\nSubclavian Arteriosclerosis, \\nthoracic outlet \\nobstruction\\nPulsatile mass above \\nor below clavicle, dys-\\nphagia, stridor, chest \\npain, hoarseness, \\nupper extremity fatigue \\nor numbness and \\ntingling, limb ischemic \\nsymptoms\\nSurgical repair\\nFemoral Advanced age, male \\ngender, trauma, \\ncongenital disorders\\nPulsatile mass with \\nor without pain, limb \\nischemic symptoms, \\nperipheral embolic \\nsymptoms\\nThrombolysis, liga-\\ntion, arterial bypass, \\nendovascular repair\\nFemoral \\npseudoaneurysm\\nPrior femoral artery \\ncatheterization, \\ntrauma, infection\\nPulsatile mass with or \\nwithout pain\\nSurgical repair\\nIliac Pain in groin, scro-\\ntum, or lower abdo-\\nmen; sciatica; vulvar \\nor groin hematoma \\nwith rupture\\nSurgical repair\\nRenal Age 40–60 years, \\nno gender pref-\\nerence, HTN, \\nfibrodysplasia, \\narteriosclerosis\\nFlank pain, hematuria, \\ncollecting system \\nobstruction, shock if \\nruptured\\nSurgical repair, \\nnephrectomy\\nSplenic Advanced age, \\nfemale gender, HTN, \\ncongenital, arterio-\\nsclerosis, liver dis-\\nease, multiparous, \\nrupture increased in \\npregnancy\\nRapid symptom onset; \\nepigastric or left upper \\nquadrant pain first, \\nthen diffuse abdominal \\npain with rupture, \\nshock\\nSurgical repair, \\nsplenectomy, \\nembolization if \\nunruptured\\nHepatic Infection, \\narteriosclerosis, \\ntrauma, vasculitis\\nObstructive jaundice, \\nhemobilia from rupture \\ninto common bile duct, \\nright upper quadrant \\npain, peritonitis, upper \\nGI bleed\\nSurgical ligation, \\nembolization\\nAbbreviation: HTN, hypertension.\\n27_Cydulka_Ch27.indd   183 01/05/17   10:25 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 202, 'page_label': '184'}, page_content='184 SECTION 4: Cardiovascular Diseases\\n■ ■AORTIC DISSECTION\\nClinical Features\\nAortic dissection occurs when blood dissects between the intimal and \\nadventitial layers of the aorta, and classically presents with acute chest pain \\nthat is most severe at onset and radiates to the back. The location of the pain \\nmay indicate the area of the aorta that is involved. Sixty percent of patients \\nwith dissection of the ascending aorta have anterior chest pain, and involve-\\nment of the descending aorta may cause abdominal or back pain. The pain \\npattern may change as the dissection progresses from one anatomic area to \\nanother. The pain is most commonly described as sharp, ripping, or tearing \\npain. Syncope can occur in 10% of patients.\\nMost patients with aortic dissection are male (66%), older than 50 years, \\nand have a history of hypertension. Chronic cocaine use and prior cardiac \\nsurgery are additional risk factors. Younger patients with identifiable risk \\nfactors such as connective tissue disorders, congenital heart disease, and \\npregnancy are also at risk. Up to 30% of patients with Marfan’s syndrome \\nwill develop a dissection. Iatrogenic aortic dissection may occur after aortic \\ncatheterization or cardiac surgery.\\nThe Stanford classification divides dissections into those that involve \\nthe ascending aorta (type A) and those that are restricted to the descending \\naorta (type B). The DeBakey classification divides dissections into three \\ngroups: involvement of the ascending and descending aortas (type I), \\ninvolvement of only the ascending aorta (type II), or involvement of only \\nthe descending aorta (type III).\\nAs an aortic dissection progresses, seemingly unrelated symptom com-\\nplexes may present themselves. Presentations include aortic valve insuffi-\\nciency, coronary artery occlusion with myocardial infarction, carotid \\ninvolvement with stroke symptoms, occlusion of vertebral blood supply \\nwith paraplegia, cardiac tamponade with shock and jugular venous disten-\\ntion, compression of the recurrent laryngeal nerve with hoarseness of the \\nvoice, and compression of the superior cervical sympathetic ganglion with \\nHorner’s syndrome.\\nFindings on physical examination will depend on the location and pro-\\ngression of the dissection. A diastolic murmur of aortic insufficiency may \\nbe heard. Hypertension and tachycardia are common, but hypotension also \\nmay be present. Fifty percent of patients have decreased pulsation in the \\nradial, femoral, or carotid arteries, although no specific threshold values \\nhave been defined for blood pressure differences in extremities. Forty per -\\ncent of patients have neurologic sequelae.\\nDiagnosis and Differential\\nThe differential diagnosis to be considered depends on the location and \\nprogression of the dissection, but may include myocardial infarction, peri-\\ncardial disease, stroke, spinal cord disorders, and primary conditions caus-\\ning abdominal, back, or chest pain.\\nd-dimer testing is one of several biomarkers that have been investigated \\nfor potential utility in identifying or excluding dissection. No current guide-\\nline endorses the use of d-dimer as the sole means for excluding aortic \\ndissection, partially due to a false-negative rate as high as 18%.\\n27_Cydulka_Ch27.indd   184 01/05/17   10:25 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 203, 'page_label': '185'}, page_content='CHAPTER 27: Aortic Aneurysms and Aortic Dissection  185 \\nThe diagnosis of aortic dissection depends on radiographic confir -\\nmation. The most commonly found abnormalities on chest x-ray are an \\nabnormal aortic contour and widening of the mediastinum, while other  \\nfindings may include deviation of the trachea, mainstem bronchi, or \\nesophagus, apical capping, pleural effusion, or displacement of aortic \\nintimal calcifications. The chest x-ray is normal in 12% to 37% of \\npatients with aortic dissection. CT scan with IV contrast is the imaging \\nmodality of choice and can reliably detect a false lumen as well as help \\nto identify the extent of the dissection including extension into other \\nvessels (see Fig. 27-2). Transesophageal echocardiograms are 97% to \\n100% sensitive and 97% to 99% specific. The preferential use of these \\nstudies may be institutionally dependent, and clinicians should \\ncoordinate diagnostic testing with the consulting vascular or thoracic \\nsurgeon.\\nEmergency Department Care and Disposition\\n1. Consult with a vascular or thoracic surgeon for patients with confirmed \\nor strongly suspected aortic dissection to determine if operati ve inter-\\nvention is indicated.\\n2. Stabilize hemodynamics with large-bore IV access, IV fluids for hypo-\\ntension, and blood transfusion when required.\\n3. Manage hypertension with β-blockers such as esmolol 0.1 to 0.5 mg/kg \\nIV bolus followed by a 0.025 to 0.2 mg/kg/min infusion, or labetolol 20 \\nmg IV followed by subsequent doses of 20 to 40 mg IV every 10 min-\\nutes. Reduce the heart rate to a goal of between 60 and 70 beats per \\nminute and the systolic blood pressure to a goal of 100 to 120 mm Hg.\\nFigurE 27-2. CT image of a type A aortic dissection. True and false lumens are \\npresent in the ascending aorta and descending aorta (descending false lumen at \\narrow) on noncontrast (left) and contrast ( right) images. AF, ascending false lumen; \\nAT, ascending true lumen; DT, descending true lumen.\\n27_Cydulka_Ch27.indd   185 01/05/17   10:25 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 204, 'page_label': '186'}, page_content='186 SECTION 4: Cardiovascular Diseases\\n4. Additional blood pressure reduction with agents such as nitroprusside \\nor nicardipine should be used when needed after adequate inotropic \\nblockade has been achieved and systolic blood pressures remain above \\n120 mm Hg.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 59, “Aortic Dissection and Related Aortic Syn-\\ndromes,” by Gary A. Johnson and Louise A. Prince; and Chapter 60, “Aneurysmal \\nDisease” by Louise A. Prince and Gary A. Johnson.\\n27_Cydulka_Ch27.indd   186 01/05/17   10:25 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 205, 'page_label': '187'}, page_content='187\\nArterial Occlusion\\nCarolyn K. Synovitz\\nPeripheral arterial disease is defined as an ankle-brachial index (ABI) of \\n<0.9 (see ABI definition below). The disease prevalence is 4.3% in Amer-\\nicans under age 40 years, and prevalence climbs to 15.5% in those over  \\n70 years of age. High-risk individuals (such as those over 70 years, or those \\nover 50 years with risk factors such as diabetes) should be evaluated care-\\nfully when complaints are indicative of possible occlusive arterial disease. \\nTobacco use significantly increases the risks that an individual will develop \\nperipheral arterial disease. Limb ischemia from an acute arterial occlusion \\ncan lead to irreversible changes in peripheral nerves and skeletal muscle \\ntissue in 4 to 6 hours. The most frequently diseased arteries leading to limb \\nischemia are the femoropopliteal, tibial, aortoiliac, and brachiocephalic. \\nThe common femoral and popliteal arteries are the most common sites of \\narterial embolism.\\n■ ■CLINICAL FEATURES\\nPatients with acute arterial limb ischemia typically present with one or \\nmore of the “six Ps”: pain, pallor, poikilothermia (coldness), pulseless-\\nness, paresthesias, and paralysis. Pain is the earliest symptom and may \\nincrease with elevation of the limb. Changes in skin color with mottling, \\nsplotchiness, and cool temperature are common. Patients may present \\nwith muscle weakness as one early sign of limb ischemia, and the pres-\\nence of acute anesthesia progressing to paralysis is concerning for acute \\nischemia that may negatively impact limb viability. A decreased pulse \\npalpated distal to a vascular obstruction is an unreliable finding for early \\nischemia, especially in patients with chronic peripheral vascular disease \\nand well-developed collateral circulation. Claudication is a cramping \\npain, ache, or tiredness in an ischemic limb that is brought on by exer -\\ncise and relieved by rest. It is reproducible, resolves within 2 to 5 min-\\nutes of rest, and reoccurs at consistent walking distances. Claudication \\nis a classically described symptom of peripheral vascular disease, but \\nmay only be present in 20% to 30% of patients with significant disease. \\nThese symptoms are contrasted with the pain of an acute episode of limb \\nischemia which is not well localized, is unrelieved by rest or gravity, and \\ncan present as a worsening of chronic pain when caused by an acute \\nthrombotic event.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nAlthough thromboembolic disease is the most common cause of acute \\narterial occlusion, the differential diagnosis for some of the presenting \\nsymptoms may include catheterization complications, vasculitis, Raynaud \\ndisease, thromboangiitis obliterans, blunt or penetrating trauma, or low-\\nflow shock states such as sepsis. Vasospasm caused by intentional or \\naccidental intraarterial drug injections may present as acute ischemic \\n28\\nCh A p TER\\n28_Cydulka_Ch28.indd   187 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 206, 'page_label': '188'}, page_content='188 SECTION 4: Cardiovascular Diseases\\ndigits. Most commonly, a history of an abruptly ischemic limb in a patient \\nwith atrial fibrillation or recent myocardial infarction is strongly sugges-\\ntive of an embolus. A history of chronic claudication suggests the pres-\\nence of peripheral vascular disease, and an acute episode is likely caused \\nby thrombosis and worsening limb ischemia. Examine the patient for \\ndifferences in peripheral pulses, capillary refill, and skin findings on the \\nextremities.\\nObjective bedside testing with a handheld Doppler can document the \\npresence or absence of blood flow in an affected limb. Duplex ultrasonog-\\nraphy can further be used to detect an obstruction to flow with sensitivity \\ngreater than 85%. In addition, the ABI can be easily measured in the emer-\\ngency department using a blood pressure cuff and Doppler ultrasound to \\nmeasure the systolic pressure of occlusion at the brachial artery and poste-\\nrior tibial or dorsalis pedis arteries. The ABI is the leg occlusion pressure \\ndivided by the arm occlusion pressure and a normal ABI is >0.9. An \\nabnormal ABI suggests peripheral vascular disease, and a ratio lower than \\n0.41:1 is concerning for critical limb ischemia. A CT angiogram is a diag-\\nnostic option that can be helpful in identifying the lesion location if the \\nlimb does not show signs of critical ischemia. The diagnostic gold standard \\nis an arteriogram, which can define the anatomy of the obstruction and \\ndirect treatment of the limb.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Patients with acute arterial occlusion should be stabilized. Fluid resus-\\ncitation and pain medications should be administered as needed. De-\\npendent positioning can increase perfusion pressure. Obtain an ECG \\nand consider echocardiograph y to assess for conditions associated with \\nembolism.\\n2. Staging of disease can be accomplished using the Rutherford Catego-\\nries for acute limb ischemia (see Table 28-1). Patients that meet criteria \\nI (Viable) to IIa (Marginally Threatened) may have diagnostic testing \\nbefore definitive treatment. Patients with criteria IIb (Immediately \\nThreatened) need immediate consultation and intervention. Patients that \\nmeet criteria III (Irreversible) may require limb amputation.\\n3. Initiate anticoagulation in patients with acute arterial occlusion using \\nunfractionated heparin 80 U/kg intravenous bolus followed by IV \\ninfusion of 18 U/kg/h in collaboration with a consulting vascular  \\nsurgeon.\\n4. Definitive treatment should be provided in consultation with a vascular \\nsurgeon and may include catheter-directed thrombolysis, percutaneous \\nmechanical thrombectomy, revision of an occluded bypass graft, or \\nrevascularization.\\n5. All patients with an acute arterial occlusion should be admitted to a \\ntelemetry bed or to the intensive care unit, depending on the stability of \\nthe patient and the planned course of therapy.\\n6. Patients with chronic peripheral arterial disease who lack comorbidities \\nand have no immediate limb threat can be discharged on aspirin 81 mg \\norally each day with an initial loading dose of 325 mg orally before \\ndischarge, with close vascular surgery or primary care follow-up for \\nreassessment and further care.\\n28_Cydulka_Ch28.indd   188 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 207, 'page_label': '189'}, page_content='CHAPTER 28: Arterial Occlusion 189 \\nTAble 28-1 Rutherford Criteria for Acute Limb Ischemia\\nCategory\\nDescription/\\nprognosis\\nFindings Doppler Signals\\nSensory Loss\\nMuscle \\nWeakness Arterial Venous\\nI. Viable Not immediately \\nthreatened\\nNone None Audible Audible\\nII. Threatened\\n\\xa0a. Marginally Salvageable if \\npromptly treated\\nMinimal (toes) \\nor none\\nNone Inaudible Audible\\n\\xa0b. Immediately Salvageable  \\nwith immediate \\nrevascularization\\nMore than toes, \\nassociated with \\nrest pain\\nMild,  \\nmoderate\\nInaudible Audible\\nIII. Irreversible Major tissue loss \\nor permanent \\nnerve damage \\ninevitable\\nProfound,  \\nanesthetic\\nProfound, \\nparalysis \\n(rigor)\\nInaudible Inaudible\\nReproduced with permission from Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for \\nreports dealing with lower extremity ischemia: revised version. J Vasc Surg. September 1997;26(3): 517–538.\\n■ ■FURThER READING\\nFor further reading in  Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 61, “Arterial Occlusion,” by Anil Chopra and  \\nDavid Carr.\\n28_Cydulka_Ch28.indd   189 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 208, 'page_label': '190'}, page_content='28_Cydulka_Ch28.indd   190 15/03/17   4:27 PM\\nThis page intentionally left blank'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 209, 'page_label': '191'}, page_content='191\\nRespiratory Distress\\nBaruch S. Fertel\\nThe term respiratory distress includes both symptoms of dyspnea and signs \\nindicating difficulty breathing. The cause of respiratory distress is often \\nmultifactorial and may include the findings of hypoxia, hypercapnia, and \\ncyanosis.\\n■ ■DYSPNEA\\nDyspnea is the subjective feeling of difficult, labored, or uncomfortable \\nbreathing. There is no single pathophysiologic mechanism that causes dys-\\npnea and its etiology may be secondary to pulmonary, cardiac, or neuro-\\nlogical dysfunction.\\nClinical Features\\nThe initial assessment of any patient with dyspnea should be directed \\ntoward identifying respiratory failure, which requires more immediate \\naction. Dyspnea alone is a subjective complaint often difficult to quantify; \\ntherefore, objective findings are often needed to aid in diagnosis. Assess for \\nsigns of impending respiratory failure which include tachycardia, tachy-\\npnea, stridor, the use of accessory respiratory muscles (intercostals, sterno-\\ncleidomastoid), stridor, lethargy, agitation, altered mental status, and \\ninability to speak due to breathlessness. If present, oxygen should be \\nadministered immediately. Early use of noninvasive ventilation is often \\nhelpful in reversing the downward trajectory, although the need for aggres-\\nsive airway management and mechanical ventilation should be anticipated. \\nLesser degrees of distress allow for a more detailed approach.\\nDiagnosis and Differential\\nThe history and physical examination, together with ancillary testing, will \\nhelp identify the etiology of dyspnea (Table 29-1).\\nIt can be challenging to differentiate cardiac (CHF) and pulmonary \\ncauses. Signs such as an S3 gallop, edema, jugular venous distention, a his-\\ntory of orthopnea, an elevated brain natriuretic peptide (BNP), or  \\ntroponin and chest radiograph findings of edema and cardiomegaly may \\npoint to cardiac causes. Pulse oximetry is a rapid but insensitive screen for \\n29\\nCHAPTER\\nPulmonary Emergencies \\n 5\\nSECTION\\n29_Cydulka_Ch29.indd   191 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 210, 'page_label': '192'}, page_content='192 SECTION 5: Pulmonary Emergencies \\ndisorders of gas exchange as it may be f alsely elevated as in methemoglo-\\nbinemia. Arterial blood gas (ABG) analysis is more sensitive, detects both \\nhypoxia and hypercarbia, and is useful for identifying metabolic causes, \\nsuch as acidosis with compensatory tachypnea, but does not take into \\naccount work of breathing and fatigue. A peak expiratory flow rate may \\nindicate reactive airway disease and a negative inspiratory force (NIF) may \\nidentify neurological causes of dyspnea. Additional ancillary tests that may \\nprove helpful include a complete blood count to look for anemia, d-dimer \\nassay when used with clinical decision rules to look for pulmonary embolus \\n(PE), chest radiograph, electrocardiogram, and computed tomography of \\nthe chest. Bedside cardiopulmonary ultrasound is increasingly being used \\nto look for pneumothorax, tamponade, pulmonary consolidation or effu-\\nsion, right heart strain suggesting PE, and congestive heart failure.\\nEmergency Department Care and Disposition\\n1.  The goal of oxygen therapy is to maintain the PaO2 above 60 mm Hg or \\nthe oxygen saturation above 90%. Lower PaO 2 or saturation may be  \\nappropriate in those with longstanding lung disease such as chronic \\nobstructive pulmonary disease (COPD).\\n2.  After oxygenation has been ensured with an appropriate delivery device \\n(nasal cannula, facemask, non-rebreather, BVM, NIV , or intubation) and \\nthe patient is stabilized, disorder-specific treatment and evaluation can \\nbe pursued.\\n3.  The disposition of patients with dyspnea often depends on its etiology \\nand acuity. Patients with hypoxia and an unclear cause of dyspnea will \\nrequire hospital admission.\\n■ ■HYPOXIA AND HYPOXEMIA\\nHypoxia is the insufficient delivery of oxygen to the tissues. Oxygen deliv-\\nery is a function of cardiac output, hemoglobin concentration, and oxygen \\nsaturation. Hypoxemia is defined as a PaO 2 below 60 mm Hg. While \\nhypoxia is often the result of hypoxemia, these two terms are not inter -\\nchangeable and one can occur without the other. Hypoxemia results from a \\nTablE 29-1 Common Causes of Dyspnea in the ED\\nMost Common Causes\\nMost Immediately Life-Threatening \\nCauses\\nObstructive airway disease: asthma, chronic \\nobstructive pulmonary disease\\nUpper airway obstruction: foreign body, \\nangioedema, hemorrhage\\nDecompensated heart failure/cardiogenic \\npulmonary edema\\nTension pneumothorax\\nIschemic heart disease: unstable angina and \\nmyocardial infarction\\nPulmonary embolism\\nPneumonia Neuromuscular weakness: myasthenia gra-\\nvis, Guillain-Barré syndrome, botulism\\nPsychogenic Fat embolism\\n29_Cydulka_Ch29.indd   192 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 211, 'page_label': '193'}, page_content='CHAPTER 29: Respiratory Distress 193 \\ncombination of five distinct mechanisms: (a) hypoventilation in which lack \\nof ventilation increases PaCO2, thereby displacing oxygen from the alveo-\\nlus and lowering the amount delivered to the alveolar capillaries; (b) right-\\nto-left shunt in which blood bypasses the lungs, thereby increasing the \\namount of unoxygenated blood entering the systemic circulation; (c) venti-\\nlation/perfusion mismatch in which areas of the lung are perfused but not \\nventilated; (d) diffusion impairment in which alveolar-blood barrier abnor-\\nmality causes impairment of oxygenation; and (e) low inspired oxygen, \\nsuch as that occurs at high altitude.\\nClinical Features\\nSigns and symptoms of hypoxemia are nonspecific. Acute physiologic \\nresponses to hypoxemia include pulmonary arterial vasoconstriction and \\nincreases in minute ventilation and sympathetic tone manifesting as tachy-\\npnea, tachycardia, and an initial hyperdynamic cardiac state. The predomi-\\nnant features are often neurologic, and may include headache, somnolence, \\nlethargy, anxiety, agitation, coma, or seizures. Chronic hypoxemia may result \\nin polycythemia, digital clubbing, cor pulmonale, and changes in body habi-\\ntus (e.g., pulmonary cachexia or barreled chest of COPD). Cyanosis may be \\npresent but is not a sensitive or specific indicator of hypoxemia.\\nDiagnosis and Differential\\nA formal diagnosis of hypoxemia requires ABG analysis; however, pulse \\noximetry may be useful for gross abnormalities or trends. Hypoxemia may \\nbe quantified, and clues to its etiology may be obtained, by calculation of \\nthe alveolar-arterial oxygen gradient (“A-a gradient,” where the capital “A” \\nrepresents alveolar oxygen tension and “a” indicates arterial oxygen level). \\nThe formula for calculating A-a gradient while breathing room air at sea \\nlevel is\\nP(A - a)O2 = 147 − (PaCO2 × 1.25) − PaCO2\\nThe A-a gradient is increased in cases of right-to-left shunts, ventila-\\ntion-perfusion mismatch, and diffusion impairment. The normal value \\nfor a 20-year-old seated upright and healthy nonsmoker is 5 to 10; the \\nupper limit of normal increases by 1 for each decade of life. Patients with \\nshunt will often not respond to supplemental oxygen while those with \\nVQ mismatch, diffusion impairment, low inspired oxygen will improve \\ntheir Pa0 2.\\nEmergency Department Care and Disposition\\nRegardless of the specific cause of hypoxemia, the initial approach remains \\nthe same. The following are general treatment guidelines for hypoxia:\\n1.  Supplemental oxygen is administered to achieve an O2 saturation greater \\nthan 90%.\\n2.  The airway is managed aggressively if there are signs of respiratory \\nfailure (see Chapter 1).\\n3. Cause-specific treatment and evaluation should be pursued.\\n4.  All patients with new hypoxemia should be admitted and monitored \\nuntil their condition is stabilized.\\n29_Cydulka_Ch29.indd   193 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 212, 'page_label': '194'}, page_content='194 SECTION 5: Pulmonary Emergencies \\n■ ■HYPERCAPNIA\\nHypercapnia occurs exclusively due to alveolar hypoventilation (releasing \\nof CO 2) and is defined as a PaCO 2 above 45  mm Hg. Factors that affect \\nalveolar ventilation include respiratory rate, tidal volume, and dead space \\nvolume, all of which are controlled by the body to maintain PaCO 2 in a \\nnarrow range.\\nClinical Features\\nThe signs and symptoms of hypercapnia depend on the absolute value of \\nthe PaCO2 and the rate of change. Acute elevations result in increased intra-\\ncranial pressure, prompting patient complaints of headache, confusion, and \\nlethargy. Coma, encephalopathy, and seizures may occur when the PaCO 2 \\nacutely rises above 80 mm Hg; similar PaCO2 levels may be well tolerated \\nif elevations are chronic.\\nDiagnosis and Differential\\nThe diagnosis of hypercapnia requires clinical suspicion and ABG analysis \\nas pulse oximetry may be completely normal. In acute cases, the ABG will \\ndemonstrate an elevation in PaCO2 with a respiratory acidosis and minimal \\nmetabolic compensation. Common causes of hypercapnia include COPD, \\nrespiratory center depression from drugs (e.g., opiates, sedatives, and anes-\\nthetics), neuromuscular impairment from disease (e.g., Guillain–Barré \\nsyndrome) or toxin (e.g., botulism), and finally thoracic cage disorders \\n(e.g., morbid obesity, kyphoscoliosis).\\nEmergency Department Care and Disposition\\nTreatment of acute hypercapnia requires aggressive measures to increase \\nminute ventilation.\\n1. Airway maintenance is crucial.\\n2.  A trial of biphasic positive airway pressure or continuous positive air -\\nway pressure may prove helpful and improve minute ventilation; how-\\never, vigilance should be maintained in patients with depressed mental \\nstatus as mechanical ventilation may be needed. Ensure that the respira-\\ntory rate is set to facilitate the removal of CO 2.\\n3.  Where indicated, treatment should include condition-specific therapies, \\nsuch as bronchodilators for COPD, or reversal agents for opiate o ver-\\ndose.\\n4.  Disposition depends on acuity, but many patients with hypercapnia re-\\nquire hospital admission and monitoring.\\n■ ■WHEEZING\\nWheezes are “musical” adventitious lung sounds produced by airflow \\nthrough the central and distal airways. It is usually more prominent on \\nexhalation, in contrast to upper airway stridor which is more prominent \\nduring inspiration, but it may be difficult to tell the two apart.\\nWheezing is usually associated with lower airway disease such as \\nasthma or other obstructive pulmonary diseases; however, the differential \\n29_Cydulka_Ch29.indd   194 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 213, 'page_label': '195'}, page_content='CHAPTER 29: Respiratory Distress 195 \\nis broad and may also include pulmonary edema (commonly referred to \\nas “cardiac asthma”), foreign body, bronchiolitis, and other pathologies.\\n■ ■COUGH\\nCough is a protective reflex for clearing secretions and foreign debris from \\nthe tracheobronchial tree. Coughing is initiated by stimulation of irritant \\nreceptors located throughout the respiratory tract. Such irritants may \\ninclude inflammation as in asthma, irritants such as mold or dust or pulmo-\\nnary secretions.\\nClinical Features\\nAcute cough (<3 weeks) is most often caused by infection of the respira-\\ntory tract, or allergic reactions. Common upper respiratory infections are \\nassociated with a combination of rhinorrhea, sinusitis, pharyngitis, and \\nlaryngitis, with the cough a result of drainage from the nasopharynx onto \\ncough receptors in the pharynx and larynx. A productive cough is the hall-\\nmark of acute bronchitis. Pertussis may last 1 to 6 weeks. A subacute cough \\nmay last for 3 to 8 weeks and is often post-infectious and related to airway \\ninflammation and secretions.\\nThe most common cause of a chronic cough lasting more than  \\n6 weeks is smoking. Features of smoking-related cough include peak \\nseverity in the morning and sputum production. Other causes of chronic \\ncough include upper airway cough syndrome (formerly postnasal dis-\\ncharge) which is associated with mucus drainage from the nose, a history \\nof “allergies or sinus problems,” and frequent clearing of the throat or \\nswallowing of mucus. Asthma-related chronic cough is often worse at \\nnight, exacerbated by irritants, and associated with episodic wheezing \\nand dyspnea. Gastroesophageal reflux-related cough often has a history \\nof heartburn, is worse when lying down, and improves with anti-acid \\ntherapy (e.g., antacids, H 2 blockers, or proton pump blockers). Angioten-\\nsin-converting enzyme (ACE) inhibitor or angiotensin II receptor \\nblocker (ARB) therapy cough is highly variable in onset, severity, and \\nvariation during the day and can begin as early as 1 week to as late as 1 \\nyear after starting treatment. The cough is dry and typically resolves in \\n1 to 4 weeks after ACE or ARB therapy is stopped but may linger for up \\nto 3 months.\\nDiagnosis and Differential\\nObtain a chest radiograph in patients with purulent sputum and/or fever. \\nUse spirometry to document the presence of airflow obstruction in patients \\nwith asthma. In both children and adults, acute coughing illnesses can last \\nup to 3 weeks and appropriate guidance should be given.\\nIn addition to disease-specific therapy, patients with acute cough may \\nbenefit from symptomatic treatment with antitussives, which block the \\ncough reflex at various locations, or demulcents, which soothe the pharynx \\nand somewhat suppress the cough reflex. For intractable coughing parox-\\nysms in the ED, nebulized lidocaine may provide relief.\\nFigure 29-1 outlines a sequential approach for evaluation of subacute \\nand chronic cough.\\n29_Cydulka_Ch29.indd   195 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 214, 'page_label': '196'}, page_content='196 SECTION 5: Pulmonary Emergencies \\n■ ■HICCUPS\\nHiccups are the involuntary spastic contraction of the inspiratory muscles.\\nClinical Features\\nBenign hiccups are generally initiated by gastric distention from food or \\ndrink, especially carbonated beverages or alcohol. Persistent hiccups are usu-\\nally the result of injury or irritation to a branch of the vagus or phrenic nerves.\\nDiagnosis and Differential\\nDetermine whether a specific triggering event exists. Ask about the rela-\\ntionship with sleep; if there is resolution during sleep it suggests a psycho-\\ngenic cause. Consider obtaining a chest radiograph to evaluate for \\nintrathoracic pathology.\\nEmergency Department Care and Disposition\\nThere are various physical maneuvers and drugs that can be used to termi-\\nnate an acute episode.\\nPneumonia\\nPertussis\\nBronchitis\\n A cute\\n Chronic\\nSee relevant \\nchapters for \\ntreatment\\nStop smoking\\nStop ACEI\\nTreat\\npresumed\\netiology\\nNew onset or\\nexacerbation of:\\nUACS: 1st generation A/D\\nAsthma: bronchodilators,\\nICS, LTRA\\nNAEB: ICS\\nGERD: PPI, diet/lifestyle\\nchanges\\nUACS: 1st generation A/D\\nAsthma: bronchodilators,\\nICS, LTRA\\nNAEB: ICS\\nGERD: PPI, diet/lifestyle\\nchanges\\nEtiology suggested?\\nPostinfectious Not\\npostinfectious\\nGreater than\\n8 weeks’ duration\\n3–8 weeks’ duration\\nHistory and physical exam,\\nchest x-ray\\nSubacute or chronic cough\\nNoYes\\nFiguRE 29-1. Evaluation of subacute and chronic cough for patients 15 years of \\nage and older. ACEI, angiotensin-converting enzyme inhibitor; A/D, antihistamine/\\ndecongestant; GERD, gastroesophageal reflux disease; ICS, inhaled corticosteroids; \\nLTRA, leukotriene receptor antagonist; NAEB, nonasthmatic eosinophilic bronchitis; \\nPPI, proton pump inhibitor; UACS, upper airway cough syndrome.\\n29_Cydulka_Ch29.indd   196 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 215, 'page_label': '197'}, page_content='CHAPTER 29: Respiratory Distress 197 \\nChlorpromazine is the only drug with FDA approval for hiccups though \\nmetoclopramide and haloperidol have also been used.\\n■ ■CYANOSIS\\nCyanosis is a bluish color of the skin or mucous membranes, resulting from \\nan increased amount of deoxyhemoglobin (reduced Hb). The detection of \\ncyanosis is highly subjective and not a sensitive indicator of arterial oxy-\\ngenation. It is usually visible when the deoxyhemoglobin level exceeds  \\n5 mg/dL.\\nClinical Features\\nThe presence of cyanosis suggests tissue hypoxia. Cyanosis is divided into \\ncentral and peripheral categories. Central cyanosis, which is most reliably \\nobserved under the tongue or on the buccal mucosa, is due to inadequate \\npulmonary oxygenation or abnormal hemoglobin such as methemoglobin \\nand peripheral cyanosis of the fingers or extremities is due to diminished \\nperipheral blood flow.\\nDiagnosis and Differential\\nThe causes of cyanosis may be multifactorial (Table 29-2). In some cases, \\ndiagnosis is confounded by the coexistence of central and peripheral \\ncyanosis. Pulse oximetry is easily available for continuous monitoring \\nbut may be inaccurate in the presence of a hemaglobinopathy. Obtain an \\nABG analysis with co-oximetry as ABG alone may also be misleading in \\nthe presence of a hemaglobinopathy. For example, methemoglobinemia \\nand carboxyhemoglobinemia may cause cyanosis with a normal PaO 2. \\nMethemoglobinemia is associated with blood that has been described as \\nchocolate brown, and which does not change color with exposure to room \\nair. An extremely elevated carboxyhemoglobin level may produce cherry-\\nred mucous membrane discoloration. A hematocrit may demonstrate \\npolycythemia vera or severe anemia, both of which may contribute to \\ncyanosis.\\nTablE 29-2 Differential Diagnosis of Cyanosis\\nCentral Cyanosis Peripheral Cyanosis\\nHypoxemia\\nDecreased fraction of inspired oxygen:\\nhigh altitude\\nHypoventilation\\nVentilation–perfusion mismatch\\n Right-to-left shunt: congenital heart disease, \\npulmonary arteriovenous fistulas, multiple \\nintrapulmonary shunts\\nAbnormal hemoglobin\\nMethemoglobinemia: hereditary, acquired\\nSulfhemoglobinemia: acquired\\nCarboxyhemoglobinemia\\nReduced cardiac output\\nCold extremities\\nMaldistribution of blood flow:  \\ndistributive forms of shock\\nArterial or venous obstruction\\n29_Cydulka_Ch29.indd   197 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 216, 'page_label': '198'}, page_content='198 SECTION 5: Pulmonary Emergencies \\n■ ■PLEURAL EFFUSION\\nPleural effusions result from fluid accumulating in the potential space \\nbetween the visceral and parietal pleurae.\\nClinical Features\\nA pleural effusion may be clinically silent or symptomatic, due to symp-\\ntoms of an underlying disease, an increase in volume of the effusion with \\nthe production of dyspnea, or the development of inflammation and associ-\\nated pain with respiration. Physical findings of a pleural effusion include \\npercussion dullness and decreased breath sounds.\\nDiagnosis and Differential\\nThe underlying etiologies of pleural effusion are numerous. In developed \\ncountries, the most common causes are heart failure, pneumonia, and can-\\ncer. The presence of pleural effusion on chest radiograph or ultrasound \\nshould prompt a search for the underlying cause.\\nEmergency Department Care and Disposition\\nThoracentesis may be performed for diagnostic purposes to differentiate \\nbetween an exudate and transudate or to identify infection. It may also be \\nperformed for therapeutic purposes if a patient has dyspnea at rest. Typi-\\ncally 1-1.5 L are remov ed; more may precipitate re-expansion pulmonary \\nedema.\\nThe management of parapneumonic effusions and empyemas may \\ninclude antibiotics to target the underlying infectious agent and the place-\\nment of a thoracostomy tube. The decision to admit should take into \\naccount the acuity and severity of symptoms.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 62, “Respiratory Distress,” by John Sarko, and  \\nJ. Stephen Stapczynski.\\n29_Cydulka_Ch29.indd   198 15/03/17   4:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 217, 'page_label': '199'}, page_content='199\\nBronchitis, Pneumonia, and \\nNovel Respiratory Infections\\nJeffrey M. Goodloe\\n■ ■BRONCHITIS\\nAcute bronchitis is a commonly encountered, self-limited, infection pro-\\nducing inflammatory changes within the larger airways. Sharing the viral \\npathogens of upper respiratory infections, including those of the common \\ncold, acute bronchitis is often caused by one of the following: influenza \\nA or B virus, adenovirus, rhinovirus, parainfluenza virus, respiratory \\nsyncytial virus, or coronavirus. Far less frequent in etiology, the bacterial \\npathogens Streptococcus pneumoniae, Haemophilus influenzae, Chla-\\nmydia pneumoniae, Mycoplasma pneumoniae, and Bordatella pertussis  \\nmay lead to more severe presentations in older populations, especially in \\nthose with increased comorbidities.\\nClinical Features\\nThe predominant cough of acute bronchitis may be productive and can eas-\\nily last up to 3 weeks. Sputum purulence is usually indicative of sloughed \\ninflammatory airway cells and, taken alone, does not indicate a bacterial \\netiology. Bronchitis most commonly lacks the suggestive symptoms and \\nsigns of pneumonia, specifically fever >38°C (100.4°F), adult heart rate \\n>100 beats/min, and/or adult respiratory rate >24 breaths/min. Wheezing \\nmay be present.\\nDiagnosis and Differential\\nThe diagnosis of acute bronchitis can be made clinically with the following \\ncriteria: (a) acute-onset cough (shorter than 3 weeks duration), (b) absence \\nof chronic lung disease history, (c) normal vital signs, and (d) absence of \\nauscultatory abnormalities that suggest pneumonia. Pulse oximetry is indi-\\ncated if the patient describes dyspnea or appears short of breath. Bedside \\npeak flow testing may reveal reductions in forced expiratory volume in 1 \\nsecond. A chest radiograph is not required in non-elderly patients who \\nappear nontoxic. Consider pertussis in adolescents and young adults whose \\ncoughs persist beyond 2 to 3 weeks, particularly if they exhibit coughing \\nparoxysms with prominent post-tussive emesis or had exposure to pertussis.\\nEmergency Department Care and Disposition\\n1. The use of antibiotics for acute bronchitis, while commonly requested \\nby patients and prescribed by practitioners, does NOT confer clinically \\nrelevant benefits in a viral illness, but produces side effects such as gas-\\ntrointestinal distress, vaginitis, and future pathogen resistance.\\n2. If pertussis is strongly suspected, prescribe azithromycin 500 mg orally \\non day 1, followed by 250 mg orally on days 2 to 5. This treatment does \\nnot shorten the illness, but decreases coughing paroxysms and limits \\ndisease transmission.\\n30\\nC H ap T e R\\n30_Cydulka_Ch30.indd   199 15/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 218, 'page_label': '200'}, page_content='200 SECTION 5: Pulmonary Emergencies\\n3. Patients with evidence of airflow obstruction who are treated with bron-\\nchodilators experience faster cough resolution. Albuterol two puffs \\nevery 4 to 6 hours using a metered dose inhaler and spacer provides \\nsymptomatic relief in dyspnea and cough.\\n4. Consider additional agents for cough suppression, mucolysis, and other \\nsymptomatic relief on an individual basis factoring comorbidities, drug \\ninteractions, and potential side effects.\\n5. Discharge patients with instructions for timely follow-up with a primary \\ncare physician, smoking cessation when applicable, and when to return \\nto the emergency department based upon clinical symptoms.\\n■ ■pNeUMONIa\\nPneumonia is most commonly a bacterial infection of the alveolar lung. \\nPneumococcus (Streptococcus pneumoniae) is the classic bacterial etiol-\\nogy, although incidence from atypical and opportunistic agents, particu-\\nlarly if pneumonia is acquired in health care settings, is increasing. \\nStaphylococcus aureus, Klebsiella pneumoniae, Pseudomonas aerugi-\\nnosa, and Haemophilus influenzae are additional causative bacterial \\nagents. Legionella pneumophila, Mycoplasma pneumoniae, Chlamydia \\npneumoniae, and a spectrum of respiratory viruses account for the bulk \\nof atypical pneumonias. Anaerobes are less frequently encountered, but \\nmust be highly suspected if aspiration is suspected. Risk factors for \\npneumonia are multiple, and include diseases of the respiratory tract \\n(e.g., chronic obstructive pulmonary disease or COPD) and immune \\nsystem (e.g., cancer, AIDS), as well as chronic conditions associated \\nwith aspiration, bacteremia, and debilitation.\\nClinical Features\\nPatients with undifferentiated bacterial pneumonia typically present with \\nsome combination of cough, fatigue, fever, dyspnea, sputum production, \\nand pleuritic chest pain. Physical examination often reveals tachypnea, \\ntachycardia, low pulse oximetry, and the auscultatory findings of bron-\\nchial breath sounds and rhonchi suggestive of consolidation. Impaired air \\npassage may be indicated by wheezing. While historical features and \\nassociated symptoms and signs can prove helpful in predicting a likely \\ncausative organism, the treatment of pneumonia has shifted to empiric \\ntreatment based on the patient’s environment. The clinician should diffe -\\nrentiate between community acquired pneumonia (CAP) versus health \\ncare-associated pneumonia (HCAP) with HCAP’s risk for or ganisms that \\nrequire specific and/or broadened antibiotic coverage, such as Pseudomo-\\nnas aeruginosa and/or methicillin-resistant Staphylococcus aureus  \\n(MRSA). Patients meeting criteria for HCAP include patients hospital-\\nized over 48 hours within the prior 90 days, those receiving routine out-\\npatient treatments of dialysis, chemotherapy, wound care, or home IV \\nantibiotic therapy, and residents of a nursing facility.\\nClinical features of aspiration pneumonitis depend on the volume and \\npH of the aspirate, the presence of particulate matter in the aspirate, and \\nbacterial contamination. Although aspiration of acidic, larger volumes \\nresult in a relatively rapid onset of tachypnea, tachycardia, and respiratory \\n30_Cydulka_Ch30.indd   200 15/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 219, 'page_label': '201'}, page_content='CHAPTER 30: Bronchitis, Pneumonia, and Novel Respiratory Infections 201 \\ndistress that may progress to pulmonary failure, most cases of aspiration \\npneumonia progress insidiously. While aspiration pneumonias may occur \\nanywhere in the lung, aspirated material has a predilection for the right \\nlower lobe due to gravity and tracheobronchial tree anatomy. Untreated or \\npartially treated aspiration pneumonia may progress to empyema, defined \\nas pus in the pleural space, or a lung abscess.\\nDiagnosis and Differential\\nUncomplicated presentations in otherwise healthy patients may not \\nrequire use of radiology, laboratory, or pathology resources; however, \\nchest radiography is most commonly used for diagnosis (see Fig. 30-1). \\nDepending upon the anticipated etiology and disposition course, assess-\\ning white blood count with differential analysis, serum electrolytes, \\nblood urea nitrogen, creatinine, glucose, blood gases, sputum Gram \\nstaining, and cultures of sputum and blood provide benefit, particularly \\nin patients requiring intensive care unit (ICU) admission. Most patients \\ndo not require identification of a specific organism to make a diagnosis \\nand begin treatment.\\nThe differential diagnosis of nontrauma patients with respiratory com-\\nplaints and radiographic abnormality is lengthy and partially includes non-\\ninfectious atelectasis; chronic pulmonary fibrosis; pleural effusion; chemical \\npneumonitis; inflammatory disorders, such as sarcoidosis; neoplasm; post-\\nsurgical changes; tuberculosis; bronchiolitis obliterans; pulmonary embolus; \\nFIguRE 30-1. Lobar pneumonia.\\n30_Cydulka_Ch30.indd   201 15/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 220, 'page_label': '202'}, page_content='202 SECTION 5: Pulmonary Emergencies\\ncongestive heart failure; and pulmonary vasculitides, such as Goodpasture \\ndisease or Wegener granulomatosis.\\nEmergency Department Care and Disposition\\n1. Support vital respiratory function (oxygenation, ventilation) as indi-\\ncated, with rapidly impending or unresponsive respiratory failure man-\\naged via intubation and mechanical ventilation. Noninvasive positive \\npressure ventilation may prevent the need for intubation.\\n2. In general, progressive degrees of abnormal vital signs, comorbidities, \\nand advancing age confer increased need for inpatient management. \\nThe complexity of pneumonia severity scoring as a means to determine \\ndischarge or admission prevents inclusion in this manual.\\n3. Begin antibiotic treatment in all cases of suspected bacterial pneumo-\\nnia, with the specific choice(s) made considering the patient’ s recent \\nenvironment, differentiating community acquired from HCAPs, \\ncomorbidities, drug allergies, drug–drug interactions, and local resis-\\ntance patterns.\\n4. Specialty society guidelines and infectious disease consultation advice \\nchange with the advent of antimicrobials and resistance patterns. The \\nantimicrobials listed here represent a summary of current and generally \\naccepted antibiotic regimens for adults with the indicated clinical situ-\\nations. Dosages may require adjustment for renal insufficiency.\\n5. Outpatient management of uncomplicated CAP in otherwise healthy \\npatients: azithromycin, day 1 with 500 mg orally, followed by days 2 \\nto 5 with 250 mg orally or doxycycline 100 mg orally twice daily for \\n10 days (this is a low-cost alternative). The Centers for Disease Control \\nand Prevention (CDC) recommends reserving oral fluoroquinolones \\nfor those failing macrolide or tetracycline class therapy to minimize \\nresistance.\\n6. Outpatient management of CAP in patients with significant comorbi -\\ndities (and without health care–associated pneumonia suspected): levo\\xad\\nfloxacin 750 mg orally daily for 5 days OR amoxicillin \\xadclavulanate \\n875/125 mg orally twice daily for 10 days PLUS azithromycin, day 1 \\nwith 500 mg orally, followed by days 2 to 5 with 250 mg orally.\\n7. Inpatient management of CAP in patients not requiring ICU admission: \\nstart antibiotic therapy with levofloxacin 750 mg IV OR ceftriaxone 1 \\ng IV PLUS azithromycin 500 mg IV . Utilize antibiotics early in the \\ncourse of any pneumonia requiring admission.\\n8. Inpatient management of CAP in patients requiring ICU admission: \\nstart antibiotic therapy with ceftriaxone 1 g IV PLUS levofloxacin 750 \\nmg IV . If MRSA suspected, add vancomycin 10 to 15 mg/kg IV .\\n9. Inpatient management of suspected HCAP: start double coverage \\nagainst Pseudomonas with (1) levofloxacin 750 mg IV PLUS (2) \\ncefepime 1 to 2 g IV OR piperacillin/tazobactam 4.5 g IV . Also, \\ncover suspected MRSA with vancomycin 10 to 15 mg/kg IV OR line\\xad\\nzolid 600 mg IV .\\n10. Aspiration pneumonitis: prophylactic antibiotics are not recommended \\nand their indiscriminate use may contribute to organism resistance. For \\nwitnessed aspirations, immediate tracheal suction followed by bronchos-\\ncopy, if needed, to remove large particles is indicated. In pneumonitis \\n30_Cydulka_Ch30.indd   202 15/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 221, 'page_label': '203'}, page_content='CHAPTER 30: Bronchitis, Pneumonia, and Novel Respiratory Infections 203 \\nthat has already progressed to pneumonia prior to or shortly after emer-\\ngency department presentation, start antibiotic therapy with levofloxacin \\n750 mg IV PLUS clindamycin 600 mg IV .\\n11. Empyema: piperacillin/tazobactam 4.5 g IV . If MRSA suspected, \\nadd vancomycin 10 to 15 mg/kg IV . Admit the patient and consult \\nwith a pulmonologist or thoracic surgeon early for further consider -\\nation of definitive diagnostic measures and treatment options to pro-\\nmote drainage.\\n12. Lung abscess: clindamycin 600 mg IV for anaerobic cov erage plus \\nceftriaxone 1 g IV . A significant majority of lung abscesses are suc-\\ncessfully treated with inpatient medical management and surgical \\nconsultation is required in only a minority of cases.\\n13. For patients with uncomplicated pneumonia, discharge instructions \\nshould, at a minimum, include timely follo w-up with a primary care \\nphysician, smoking cessation (when applicable), and delineation  \\nof symptoms that should prompt a return visit to the emergency \\ndepartment.\\n■ ■NOVeL ReSpIRaTORY INFeCTIONS\\nSevere acute respiratory syndrome (SARS) came to worldwide attention in \\nthe winter of 2003. Numerous deaths were reported in Asia, North America, \\nand Europe. The etiologic agent is a coronavirus, SARS-CoV , spread by \\n“droplet infection.” In the event of SARS outbreak, up-to-date information \\ncan be found at the CDC website (http://www.cdc.gov/sars/who/clinicians \\n.html) as well as at the World Health Organization (WHO) website (http://\\nwww.who.int/topics/sars/en/).\\nMiddle East respiratory syndrome (MERS) was named in latter 2012 and \\nbecame a more prominent global concern in the spring of 2014. A fatality \\nrate approaching 50% was reported in the initial 100 diagnosed cases. Since \\nthese initial cases, mortality has decreased. The etiologic agent is a corona-\\nvirus. Respiratory symptoms predominate, though GI symptoms of abdomi-\\nnal pain and diarrhea may be present. Health care workers exposed via \\nairborne transmission have become more common in case reports. Current, \\nbasic steps to reduce MERS coronavirus transmission to health care workers \\ninclude wearing gloves, gown, eye protection and using a fit-tested N95 \\nrespirator facemask. Up-to-date information can be found at the CDC \\nwebsite (http://www.cdc.gov/coronavirus/mers/hcp.html) as well as at the \\nWHO website (http://www.who.int/csr/disease/coronavirus_infections/en/).\\n■ ■FURTHeR ReaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 64, “Acute Bronchitis and Upper Respiratory Tract \\nInfections,” by Cedric W. Lefebvre; Chapter 65, “Pneumonia and Pulmonary \\nInfiltrates,” by Gerald Maloney, Eric Anderson, and Donald M. Yealy, and \\nChapter 66, “Lung Empyema and Abscess,” by Eric Anderson and Sharon E. \\nMace.\\n30_Cydulka_Ch30.indd   203 15/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 222, 'page_label': '204'}, page_content='204\\nTuberculosis\\nAmy J. Behrman\\nTuberculosis (TB) is the second most common cause of infectious disease \\ndeaths globally, with one-third of the world’s population infected. Although \\nactive TB infection rates continue to decline in the United States, TB \\nremains an important public health problem, particularly among immi-\\ngrants, whose active TB case rate is 12 times higher than the US-born \\npopulation. Other risk factors include HIV infection; living or working in \\nprison, shelters, and long-term care facilities; and alcohol/drug abuse. \\nTransmission occurs by inhalation of droplet nuclei and may lead to active \\nprimary infection or latent disease (which may reactivate later). Identifying \\nand treating high-risk patients for active and latent TB is key to ongoing TB \\ncontrol.\\n■ ■CLINICAL FEATURES\\nPrimary TB\\nInitial TB infection is usually asymptomatic in immune-competent adults, \\ngenerally presenting with only a new positive reaction to TB skin testing \\n(TST) or a new positive interferon gamma release assay (IGRA). These \\npatients have normal chest radiographs (CXRs) and are presumed to have \\nlatent infections. When active primary TB does develop, symptoms often \\ninclude fever, cough, weight loss, malaise, and chest pain. Some patients \\nmay present with active pneumonitis (which may be mistaken for \\ncommunity-acquired pneumonia) or extra-pulmonary disease.\\nChildren are more likely to present with active early disease, although \\nthe presenting symptoms may be subtle even when CXRs are abnormal. \\nPresenting symptoms may include fever, cough, wheezing, poor feeding, \\nand fatigue. TB meningitis and miliary TB are more common in children \\nthan adults.\\nImmunocompromised patients are much more likely to develop rapidly \\nprogressive primary infections. All patients with active TB should be \\nevaluated for immune-compromising conditions. Symptoms may be pul-\\nmonary (fever, cough, dyspnea, hemoptysis) or extrapulmonary, reflecting \\nearly hematogenous spread to the liver, bones, central nervous system, or \\nother sites.\\nReactivation TB\\nLatent TB infections will progress to active disease (i.e., reactivation TB) \\nin 5% of cases within 2 years of primary infection; an additional 5% will \\nreactivate over their lifetimes. Reactivation rates are higher in children, the \\nelderly, persons with recent primary infection, those with immune compro-\\nmise (in particular HIV), and those with chronic diseases such as diabetes \\nand renal failure.\\nMost patients with reactivation TB present subacutely with fever, \\nmalaise, weight loss, fatigue, and night sweats. Most patients with active \\n31\\nCh A p TER\\n31_Cydulka_Ch31.indd   204 15/03/17   5:49 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 223, 'page_label': '205'}, page_content='CHAPTER 31: Tuberculosis 205 \\nTB will have pulmonary inv olvement and will develop productive \\ncoughs. Hemoptysis, pleuritic chest pain, and dyspnea may occur. Rales \\nand rhonchi may be found, but the physical examination is not usually \\ndiagnostic.\\nExtrapulmonary TB develops in up to 20% of active TB cases. Lymph-\\nadenitis, with painless enlargement and possible draining sinuses, is a com-\\nmon presentation. Patients may also present with symptomatic pleural \\neffusion, pericarditis, peritonitis, or meningitis. Additional sites of reactiva-\\ntion TB after hematogenous spread include bones, joints, adrenals, GI tract, \\nand GU tract. Extrapulmonary reactivation TB is more common and often \\nmore severe in young children and immunocompromised patients as noted \\nfor primary TB infection above.\\nMiliary TB is a multisystem disease caused by massive hematogenous \\ndissemination. It is also more common in immunocompromised patients \\nand children. Symptoms are systemic with fever, weight loss, adenopathy, \\nand malaise. Patients may present with multiorgan failure or  Adult Respi-\\nratory Distress Syndrome (ARDS).\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nVariable presentations and limited testing options make TB diagnosis par -\\nticularly challenging in the ED. Differential diagnoses may include other \\ninfectious causes of pulmonary and extrapulmonary lesions as well as \\nmalignancy. TB should always be considered in patients with prolonged \\nfebrile cough illnesses, particularly in known risk groups. TB should be \\nconsidered in any HIV patient with respiratory symptoms, even if chest \\nradiographs are normal (see Chapter 92 HIV Infections and AIDS).\\nImaging\\nCXR remains the most useful ED diagnostic tool for TB. Active primary \\npulmonary TB usually presents with parenchymal infiltrates in any lung \\narea. Hilar and/or mediastinal adenopathy may occur with or without infil-\\ntrates. Effusions, usually unilateral, may be seen with or without infiltrates.\\nReactivation TB classically presents with lesions in the upper lobes or \\nsuperior segments of the lower lobes (Fig. 31-1). Cavitation, calcification, \\nscarring, atelectasis, hilar adenopathy, and effusions may be seen. Cavita-\\ntion is associated with increased infectivity. Miliary TB may cause diffuse, \\nsmall (1 to 3 mm) nodular infiltrates. Atypical CXRs are progressively \\nmore common with worsening immune compromise. Patients co-infected \\nwith HIV and TB are particularly likely to present with atypical imaging.\\nStable scarring, volume loss, and calcified or noncalcified nodules may \\nbe found (often as incidental findings) in patients with asymptomatic latent \\nTB infection; these patients are not infectious and do not require urgent \\ntreatment or isolation. Comparison with prior films is useful in determining \\nthe likelihood of active TB infection.\\nLaboratory Tests\\nAcid-fast staining of sputum can detect mycobacteria in many patients \\nwith pulmonary TB, although the yield is lower in HIV patients. Results \\nmay be available within several hours, with potential ED utility, but there \\n31_Cydulka_Ch31.indd   205 15/03/17   5:49 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 224, 'page_label': '206'}, page_content='206 SECTION 5: Pulmonary Emergencies\\nare serious limitations. Many patients will have false negatives on a single \\nsputum sample. Microscopy of nonsputum samples (e.g., pleural fluid, \\ncerebrospinal fluid) is even less sensitive. Microscopy cannot differentiate \\nbetween TB and nontuberculous mycobacteria. Culture of sputum (or \\nother specimens) is the gold standard for diagnosing active TB. Unfortu-\\nnately, definitive culture results take weeks. When available, newer tech-\\nnologies such as TB-specific nucleic acid amplification tests (NAATs) \\ncan produce results within 24 hours, a time frame potentially useful in ED \\nmanagement. These tests have poor negative predictive value, but a patient \\nwith positive microscopy and a positive NAAT should be treated for active \\nTB unless subsequent cultures rule it out.\\nTuberculin skin tests (TSTs) identify most patients with latent, prior, \\nor active TB, but results are read 48 to 72 hours after placement, limiting \\nthe ED utility of this approach. Patients with disseminated TB, early active \\nTB, or major immune compromise (especially HIV) may have false-\\nnegative TSTs. Immigrants who received BCG vaccine in childhood may \\nhave false-positive TSTs. Interferon gamma release assays (IGRA) of \\nwhole blood may become more useful than TST for ED evaluation of sus-\\npected TB, since these tests may be resulted within hours and may have \\nbetter sensitivity and specificity in some situations. For instance, BCG \\nFIguRe 31-1. Cavitary tuberculosis of the right upper lobe.\\n31_Cydulka_Ch31.indd   206 15/03/17   5:49 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 225, 'page_label': '207'}, page_content='CHAPTER 31: Tuberculosis 207 \\nalone should not cause a positive IGRA, making it useful for ev aluating \\nimmigrants from high-prevalence countries.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Train ED and pre-hospital staff to identify patients at risk for active TB \\nas early as possible during their care so that airborne isolation and \\nrespiratory protection for staff can be implemented as soon as possi-\\nble to protect staff, visitors, and other patients. Consider the diagnosis of \\nactive TB in any patient with respiratory or systemic complaints, \\nparticularly if they are in higher risk groups, to facilitate treatment and \\nreduce exposure risks.\\n2. Initial therapy for active TB should include at least four drugs until \\nsusceptibility profiles are available. The regimen usually includes \\nisoniazid 5 mg/kg up to 300 mg PO daily in adults, rifampin 10 mg/kg \\nup to 600 mg PO daily in adults, pyrazinamide 15 to 30 mg/kg up to  \\n2 g PO daily in adults, and ethambutol 15 to 20 mg/kg up to 1.6 g PO \\ndaily in adults. Give pyridoxine 50 mg/day with INH to prevent neu-\\nropathy. Caution all patients to avoid alcohol and hepatotoxins during \\ntreatment. Directly observed therapy (DOT) may improve outpatient \\ncompliance with these complex regimens. (See http://www.cdc.gov/tb \\nfor DOT recommendations and long-term treatment options.)\\n3. Consider the possibility of multi-drug resistant (MDR) TB in patients \\nwith a prior history of TB, suboptimal prior treatment of TB, known or \\nlikely exposure to MDR TB, or persistently positive smears and symp-\\ntoms after several months of treatment, and when there is known local \\ndrug resistance. Treatment of known or suspected MDR TB begins with \\nfour to six drugs judged likely to be effective by Infectious Disease \\nconsultation.\\n4. Admission is indicated for patients with clinical instability, hypoxia, \\ndyspnea, diagnostic uncertainty, unreliable outpatient follow-up or com-\\npliance, and suspected or known MDR TB. ED physicians should know \\nlocal laws and public health resources for case reporting, involuntary \\nhospitalization, and treatment (including DOT). Patients with suspected \\nTB should wear masks during all transport, and should be admitted to \\nairborne-isolation single rooms.\\n5. Patients discharged from the ED with known or lik ely active TB infec-\\ntion must have urgent documented referral to a physician or local \\npublic health department for long-term treatment and contact \\ntracing.\\n6. Persons with latent TB infection (defined as a positive TST and/or IGRA \\nwithout active TB findings on imaging) should be referred to primary \\ncare or public health clinics for prophylaxis against reactivation TB.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 67, “Tuberculosis,” by Vu D. Phan and Janet M. \\nPoponick.\\n31_Cydulka_Ch31.indd   207 15/03/17   5:49 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 226, 'page_label': '208'}, page_content='208\\nSpontaneous and Iatrogenic \\nPneumothorax\\nMike Cadogan\\nPneumothorax occurs when air or gas enters the pleural cavity, the poten- \\ntial space between the visceral and parietal pleura, leading to partial  \\nlung collapse. Smoking is the most common risk factor for spontaneous  \\npneumothorax.\\nPrimary pneumothorax occurs in patients without known lung disease \\nand secondary pneumothorax occurs in the presence of known lung disease, \\nsuch as chronic obstructive pulmonary disease, asthma, cystic fibrosis, \\ninterstitial lung disease, infection, connective tissue disease, and cancer. \\nLatrogenic pneumothorax occurs secondary to invasive procedures such as \\nneedle biopsy of the lung, placement of a subclavian line, nasogastric tube \\nplacement or positive pressure ventilation, Tension pneumothorax results \\nfrom positive pressure in the pleural space leading to decreased venous \\nreturn, hypotension, and hypoxia. Hemopneumothorax occurs in 2% to 7% \\nof patients with spontaneous pneumothorax. Treating the underlying dis-\\nease may help decrease the risk of pneumothorax.\\n■ ■CLINICAL FEATURES\\nSudden-onset dyspnea and ipsilateral, pleuritic chest pain are the most com-\\nmon presenting symptoms. The physical examination findings are often \\nsubtle. Sinus tachycardia is the most common physical finding. In spontane-\\nous pneumothorax the classic examination findings of ipsilateral decreased \\nbreath sounds, reduced chest expansion, and hyperresonance to percussion are \\noften absent. However, in traumatic pneumothorax, the positive predictive \\nvalue of ipsilateral decreased breath sounds is 86% to 97%. Clinical hallmarks \\nof tension pneumothorax include severe progressive dyspnea, tachycardia \\n(>140 bpm), hypoxia, and ipsilateral decreased breath sounds. Tracheal \\ndeviations away from the affected side, distended neck veins, and cardiac \\napical displacement are late and infrequent signs of progressive tension.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nPneumothorax is an important differential consideration in patients with pleu-\\nritic chest pain, especially in those with underlying lung disease. Patients with \\npulmonary embolism, pneumonia, pericarditis, pleural effusions, or shingles \\ncan present with pain similar to those with pneumothorax. As clinical signs \\nand symptoms are often subtle and variable, the definitive diagnosis is usually \\nestablished with appropriate imaging. In stable patients with suspected pneu-\\nmothorax, an erect posteroanterior (PA) chest radiograph is usually the \\nprimary investigation. Characteristically this demonstrates a displaced pleural \\nline with absent lung markings extending from the visceral pleura (lung edge) \\nto the chest wall (parietal pleura). Routine expiratory radiographs do not \\nsignificantly enhance diagnostic yield. The presence of cardiophrenic recess \\nhyperlucency and costophrenic angle enlargement (deep sulcus sign) on a \\nsupine anteroposterior radiograph is suggestive of pneumothorax.\\n32\\nCh A p TER\\n32_Cydulka_Ch32.indd   208 16/03/17   9:35 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 227, 'page_label': '209'}, page_content='CHAPTER 32: Spontaneous and Iatrogenic Pneumothorax 209 \\nLarge emphysematous bullae may mimic pneumothorax. To prevent the \\npotentially disastrous consequence of inserting a chest drain into a lung \\nbulla mistaken for a pneumothorax, thoracic computed tomography (CT) \\nshould be used to clarify the diagnosis. Bedside ultrasound is a rapid, non-\\ninvasive method to diagnose pneumothorax in young, healthy patients with \\nno underlying lung disease.\\nIn normal lung, the visceral and parietal pleura are in direct contact and \\nultrasound can be used to demonstrate the lung moving back and forth \\nbeneath the ribs during respiration (lung sliding), and vertical reverberation \\nartefacts (comet-tails). Features suggesting pneumothorax include absence \\nof lung sliding, comet tail artefacts and a lung pulse in the presence of a \\ndistinct A lines and visualized lung point. Chest CT is effective at detecting \\npneumothorax, determining their size and volume, and detecting other lung \\npathology, and can differentiate large bullae from intrapleural air.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nThe ED treatment goal is the elimination of intrapleural air.\\n1.  Tension pneumothorax should be diagnosed clinically—before a \\nradiograph—and immediately treated by needle decompression  \\nfollowed by tube thoracostomy.\\n2.  Administer oxygen >28% or 2 to 4 L by nasal cannula to increase pleu-\\nral air resorption. Monitor for hypercapnia in patients with chronic \\nobstructive pulmonary disease.\\n3.  Observe patients with a small primary pneumothorax for at least 4 hours \\non supplemental oxygen, and then repeat the chest radiograph. If symp-\\ntoms and chest radiograph have improved, the patient should return in  \\n24 hours for repeat examination and then weekly until resolution. First-\\ntime spontaneous pneumothorax of <20% lung volume in a stable, healthy \\nadult may be treated initially with oxygen therapy and observation.\\n4.  Aspiration or tube thoracostomy is performed in order to rapidly reduce \\nthe volume of a closed pneumothorax and significantly shorten the time \\nto pneumothorax resolution.\\n a.  For aspiration of a small primary or secondary spontaneous pneumo-\\nthorax, insert a 14-G needle in adults (18-G needle in children) that \\nis at least 2 in. (5 cm) long, followed by syringe aspiration and needle \\nremoval. Alternatively, a small catheter or pigtail catheter may be \\nused and attached to a Heimlich valve or suction. Either of two loca-\\ntions may be used: anteriorly in the second intercostal space (ICS) at \\nthe midclavicular line (MCL) and laterally in the fourth or fifth ICS \\nat the anterior axillary line (AAL). The fifth ICS AAL is the pre-\\nferred location for needle thoracostomy decompression.\\n b.  Treat patients with a failed aspiration, large pneumothorax, recurrent \\npneumothorax, bilateral pneumothoraces, hemothorax, abnormal \\nvital signs, or severe dyspnea using chest tube thoracostomy. Use a \\nsmall 10- to 14-French chest tube for nontrauma, reserving larger \\n14- to 22-French chest tubes if a large air leak is probable, such as \\nfrom mechanical ventilation or with underlying pulmonary disease.\\n5.  Patients who require chest tube thoracostomy require admission to the \\nhospital.\\n32_Cydulka_Ch32.indd   209 16/03/17   9:35 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 228, 'page_label': '210'}, page_content='210 SECTION 5: Pulmonary Emergencies\\n■ ■TREATMENT COMpLICATIONS\\nIntervention complications include intercostal vessel hemorrhage, lung \\nparenchymal injury, empyema, and tube malfunction (development of an air \\nleak or tension pneumothorax), and re-expansion lung injury. Re-expansion \\nlung injury is uncommon and seen more often when there is collapse of the \\nlung for greater than 72 hours, large pneumothoraces, rapid re-expansion, \\nor negative pleural pressure suction of greater than 20 cm. Most patients \\nwith re-expansion injury require only observation and supplemental oxygen \\nand rarely suffer adverse outcomes.\\nIatrogenic Pneumothorax\\nIatrogenic pneumothorax is a subset of traumatic pneumothorax and occurs \\nmore often than spontaneous pneumothorax. Transthoracic needle proce-\\ndures (needle biopsy and thoracentesis) account for 50% of iatrogenic \\npneumothoraces with subclavian vein catheterization accounting for a fur -\\nther 25%. US guidance for central venous catheter insertion for thoracente-\\nsis reduces the pneumothorax complication rate. Factors associated with \\nthe increasing frequency of iatrogenic pneumothorax include underlying \\ndisease, body habitus, and experience of the operator. Although it is routine \\nto obtain a chest radiograph after central line placement or transthoracic \\nneedle procedures, chest radiograph may not identify a pneumothorax if the \\npatient is supine or if there is inadequate time for the pneumothorax to \\ndevelop, with up to one-third detected later. Treatment for iatrogenic pneu-\\nmothorax is generally the same as for spontaneous pneumothorax.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 68, “Pneumothorax,” by Bret A. Nicks and  \\nDavid Manthey.\\n32_Cydulka_Ch32.indd   210 16/03/17   9:35 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 229, 'page_label': '211'}, page_content='211\\nHemoptysis\\nNilesh Patel\\nHemoptysis is the expectoration of blood from the lungs or tracheobron-\\nchial tree. Massive hemoptysis is defined as 100 mL of blood per 24 hours \\nup to > 1000 mL per 24 hours. Minor hemoptysis is defined as the \\nproduction of smaller quantities of blood in a patient with no comorbid \\nlung disease and stable vital signs. Hemoptysis results from the disrup-\\ntion of blood vessels within the bronchial circulation which supplies \\noxygenated blood to the bronchi, bronchioles, and lung parenchyma.\\n■ ■CLINICAL FEATURES\\nHemoptysis may be the presenting symptom for many different diseases. \\nMassive hemoptysis can often be life threatening. A careful history and \\nphysical can raise suspicion for the underlying diagnosis and guide the \\nappropriate workup. The acute onset of fever, cough, and bloody sputum \\nmay indicate pneumonia or bronchitis. An indolent productive cough can \\nindicate bronchitis or bronchiectasis. Dyspnea and pleuritic chest pain are \\npotential indicators of pulmonary embolism, particularly in the presence of \\nvenous thromboembolic risk factors. Tuberculosis should be considered in \\nthe setting of fever, night sweats, and risk factors such as travel from endemic \\nregions. Bronchogenic carcinoma may present with tobacco use, chronic \\nweight loss, and a change in cough. Chronic dyspnea and minor hemoptysis \\nmay indicate mitral stenosis or alveolar hemorrhage syndromes (most com-\\nmonly seen in patients with renal disease). Consider Goodpasture’s syndrome \\nin patients with hemoptysis, hematuria, and renal insufficiency.\\nThe physical examination should begin with an assessment of airway, \\nbreathing, and circulation, with a focus on the vital signs. Common abnor -\\nmal vital signs include fever and tachypnea. Tachypnea may be a sign of \\nrespiratory compromise with hypoxemia. Hypotension is an ominous sign, \\nusually seen only in massive hemoptysis. The cardiac examination may \\nreveal signs of valvular heart disease (e.g., the diastolic murmur of mitral \\nstenosis). The nasal and oral cavities should be inspected carefully to help \\nrule out an extrapulmonary source of bleeding (pseudohemoptysis).\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nA careful history and physical examination may suggest a diagnosis, \\nalthough the cause of hemoptysis is undetermined in up to 30% of cases. \\nPulse oximetry and a chest x-ray (PA and lateral, if the patient’s condition \\nallows) are always indicated. Other tests that may be helpful include arterial \\nblood gas, hemoglobin and hematocrit levels, platelet count, coagulation \\nstudies, urinalysis, and electrocardiogram. Chest CT should be considered \\nif there is hemoptysis with an abnormal chest radiograph or if considering \\npulmonary embolism or carcinoma on the differential diagnosis. The long \\ndifferential diagnosis list includes infectious, neoplastic, and cardiac  \\netiologies. Infectious etiologies include bronchitis, bronchiectasis, bacterial \\npneumonia, tuberculosis, fungal pneumonia, and lung abscess.  \\n33\\nCh APTER\\n33_Cydulka_Ch33.indd   211 16/03/17   9:40 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 230, 'page_label': '212'}, page_content='212 SECTION 5: Pulmonary Emergencies\\nNeoplastic etiologies include bronchogenic carcinoma and bronchial  \\nadenoma. Cardiogenic etiologies include mitral stenosis and left ventricular \\nfailure. Trauma, foreign body aspiration, pulmonary embolism (hemoptysis \\nis one of the Wells criteria), primary pulmonary hypertension, pulmonary \\nvasculitis, and bleeding diathesis, and coagulopathies secondary to  \\nmedications are other potential causes.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\n1. Assess airway, breathing, and circulation in all patients who present \\nwith hemoptysis.\\n2. Administer supplemental oxygen as needed to maintain adequate \\noxygenation.\\n3. Administer normal saline or lactated Ringer’s solution initially for \\nresuscitation.\\n4. Type and cross-match blood if transfusion is necessary. T ransfuse \\npacked red blood cells as needed.\\n5. Administer fresh frozen plasma or prothrombin complex concentrates \\nto patients with coagulopathies, including those taking w arfarin; give \\nplatelets for thrombocytopenia (see Chapter 137, “Transfusion  \\nTherapy”). Other blood products can be considered as indicated.\\n6. Patients with ongoing massive hemoptysis may benefit from being placed \\nin the decubitus position, with the bleeding lung in dependent position. \\nThis maneuver can also be performed after intubation in patients on \\nmechanical ventilation.\\n7. Perform endotracheal intubation with a large diameter (8.0 mm) tube, \\nwhich facilitates bronchoscop y, if there is respiratory failure or if the \\npatient cannot clear blood or secretions from the airway. If bleeding is \\nuncontrolled, consider preferentially intubating the mainstem bronchus \\nof the unaffected lung (and using a tamponade device to stop bleeding \\nin the alternate bronchus).\\n8. Admit any patient with moderate to severe hemoptysis to the hospital, and \\nstrongly consider placement in the intensive care unit. Patients with mild \\nhemoptysis who have conditions that predispose them to severe bleeding \\nalso should be considered for admission. The advice of a pulmonologist \\nor thoracic surgeon is required for decisions as to whether bronchoscopy, \\ncomputed tomography, or angiography for bronchial artery embolization \\nmight be needed. For massive hemoptysis, emergent bronchoscopy may \\nbe indicated in the ED. If the appropriate specialists are not available, the \\npatient should be stabilized and then transferred to another facility.\\n9. Treat patients who are discharged home for sev eral days with cough \\nsuppressants, inhaled β-agonist bronchodilators as needed, and antibi-\\notics if bacterial infection is thought to be the cause. Close follow-up \\nis essential, particularly in those at high risk for neoplasm.\\n10. Most cases of mild hemoptysis are self-limited and patients can be \\ndischarged home with appropriate follow-up.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 63, “Hemoptysis,” by Troy Sims.\\n33_Cydulka_Ch33.indd   212 16/03/17   9:40 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 231, 'page_label': '213'}, page_content='213\\nAsthma and Chronic Obstructive \\nPulmonary Disease\\nStacey L. Poznanski\\nAlthough most asthmatic attacks are mild and reversible, severe attacks can \\nbe fatal and many patients develop chronic airflow limitation from perma-\\nnent airway remodeling. Asthma is the most common chronic disease of \\nchildhood, while chronic obstructive pulmonary disease (COPD) is a lead-\\ning cause of death in the world. COPD is the only major cause of death that \\nis increasing in frequency, a phenomenon attributed to tobacco abuse. The \\nprevalence has been stable in men, whereas the prevalence in women has \\ndoubled in the past few decades and women now account for >50% of \\nCOPD-related deaths.\\n■ ■CLINICAL FEATURES\\nAsthma is a chronic inflammatory disorder associated with hyperrespon-\\nsiveness of the tracheobronchial tree and a continuum of acute broncho-\\nspasm and airway inflammation. COPD has two dominant forms: (a) \\npulmonary emphysema, defined in terms of anatomic pathology, character-\\nized by destruction of bronchioles and alveoli and (b) chronic bronchitis, \\ndefined in clinical terms as a condition of excess mucous secretion in the \\nbronchial tree, with a chronic productive cough for 3 months in each of two \\nconsecutive years. The World Health Organization’s Global Institute for \\nChronic Obstructive Lung Disease definition of COPD encompasses both \\nthese forms as well as bronchiectasis, and asthma, and recognizes that most \\npatients have a combination.\\nAcute exacerbations of asthma and COPD are usually associated with a \\ntrigger, such as smoking, respiratory infections, exposure to noxious stimuli \\n(e.g., pollutants, cold, stress, antigens, or exercise), adverse response to \\nmedications (e.g., decongestants, β-blockers, nonsteroidal anti-inflammatory \\ndrugs), allergic reactions, hormonal changes during the normal menstrual \\ncycle or pregnancy, and noncompliance with prescribed therapies. Although \\nasthma exacerbations are due to expiratory airflow limitations, acute exac-\\nerbations of COPD are primarily due to ventilation–perfusion mismatch.\\nClassically, patients with exacerbations of asthma or COPD present with \\ncomplaints of dyspnea, chest tightness, wheezing, and cough. Risk factors \\nfor death from asthma exacerbation include past history of severe exacerba-\\ntion, ≥2 hospitalizations or >3 ED visits for asthma in the past year, > 2 \\ncanisters per month of inhaled short-acting β 2 agonist (SABA), low socio-\\neconomic status or history of illicit drug use, or psychiatric disease. Physi-\\ncal examination shows wheezing with prolonged expiration. Wheezing \\ndoes not correlate with the degree of airflow obstruction; a “quiet chest” \\nmay indicate severe airflow restriction. Patients with severe attacks may be \\nsitting upright with forward posturing, with pursed-lip exhalation, acces-\\nsory muscle use, paradoxical respirations, and diaphoresis. Pulsus para-\\ndoxus of 20 mm Hg or higher may be seen. Severe airflow obstruction and \\nventilation/perfusion imbalance can cause hypoxia and hypercapnia. \\nHypoxia is characterized by tachypnea, cyanosis, agitation, apprehension, \\n34\\nCh APTER\\n34_Cydulka_Ch34.indd   213 16/03/17   9:44 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 232, 'page_label': '214'}, page_content='214 SECTION 5: Pulmonary Emergencies\\ntachycardia, and hypertension. Signs of hypercapnia include confusion,  \\ntremor, plethora, stupor, hypopnea, and apnea. Impending respiratory fail-\\nure may be signaled by alteration in mental status, lethargy, minimal or \\nabsent breath sounds, acidosis, worsening hypoxia, and hypercapnia.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nEmergency department diagnosis of asthma or COPD usually is made \\nclinically, although signs and symptoms do not always correlate well with \\nseverity of airflow obstruction. Severity can be measured more objectively \\nby the forced expiratory volume in 1 second (FEV 1) and peak expiratory \\nflow rate (PEFR) in cooperative patients. A FEV 1 or PEFR <40% of \\npatients predicted in asthmatics indicates a severe exacerbation. Pulse \\noximetry is a fast, easy, and noninvasive means for assessing and monitor -\\ning oxygen saturation during treatment, but it does not aid in predicting \\nclinical outcomes and cannot predict hypercapnia or acidosis. Arterial \\nblood gas (ABG) is not needed in most patients with mild to moderate \\nexacerbations and should be reserved for evaluation of hypercapnia and \\nacidosis in severe cases. Compensated hypercapnia and hypoxia is common \\nin COPD patients; comparison with previous ABG values is helpful. Nor -\\nmal or elevated Paco2 in the setting of an acute, severe asthmatic attack is \\nan ominous finding as it indicates respiratory fatigue.\\nAsthma and COPD can coexist or be mistaken for one another; this is \\nespecially true in females. The immediate diagnostic challenge is separating \\nthese diagnoses from other serious respiratory emergencies. Important asthma \\nand COPD mimickers include acute heart failure, upper airway obstruction, \\npulmonary emboli, aspiration, endobronchial obstruction/mass, interstitial \\nlung disease, and vocal cord dysfunction. Congestive heart failure (CHF) \\ncommonly coexists or mimics COPD and can also cause wheezing. Chest \\nx-ray, brain natriuretic peptide (BNP), and signs of fluid overload (jugular \\nvenous distention or hepatojugular reflux) help differentiate COPD from \\nCHF. Chest x-ray can be used to diagnose complications such as pneumonia \\nand pneumothorax, but is not routinely indicated in mild to moderate asthma \\nexacerbations. Electrocardiograms are useful to identify dysrhythmias or \\nsuspected ischemic injury in the appropriate patient population. A high index \\nof suspicion is necessary to rule out pulmonary embolism.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\nTreatment may coincide with or precede history taking in acutely dyspneic \\npatients, as patients can decompensate rapidly.\\n1. Administer supplemental oxygen to maintain Sao 2 above 90%. Cau-\\ntion is advised, as oxygen may exacerbate hypercapnia in the setting of \\nCOPD. Monitor closely with end-tidal CO 2 and oxygen saturation \\nmonitoring as well as venous blood gases, as indicated. \\n2. Short-acting β-adrenergic agonists (SABAs) are first-line agents used \\nto treat acute bronchospasm in COPD and asthma. Aerosolized forms \\n(by nebulizer or metered-dose inhaler with a spacer) minimize \\nsystemic toxicity and are preferred. Albuterol sulfate 2.5 to 5 mg is \\nthe most common agent used. Deliver doses every 20 minutes for three \\ndoses, then 2.5 to 10 mg every 1 to 4 hours as needed, or as continuous \\n34_Cydulka_Ch34.indd   214 16/03/17   9:44 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 233, 'page_label': '215'}, page_content='CHAPTER 34: Asthma and Chronic Obstructive Pulmonary Disease 215 \\nnebulization (10 to 15 mg/h), titrating treatment to clinical response \\nand signs of toxicity (tachycardia, hypertension, and palpitations). \\nTerbutaline 0.25 mg or epinephrine 1:1000 0.3 to 0.5 mg) every 20 \\nminutes for three doses SC may be administered to patients not tolerat-\\ning aerosolized therapy. Epinephrine should be used with caution in the \\npresence of underlying cardiovascular disease.\\n3. Anticholinergics are useful adjuvants for effect on the lar ge, central \\nairways. Nebulized ipratropium (0.5 mg = 2.5 mL) added to SABAs \\nevery 20 minutes for three doses, then as needed, may improve bron-\\nchodilation and decrease the need for hospitalization.\\n4. Give corticosteroids in the ED to patients with exacerbations of asthma \\nand COPD. The initial dose is the equivalent of 40 to 60 mg of pred-\\nnisone. Neither the choice of steroid nor the route of administration is \\ncritical. If the patient is unable to take oral medication, intravenous \\nmethylprednisolone 1 mg/kg may be used. Additional doses may be \\ngiven every 4 to 6 hours. Inhaled steroids are not indicated for the treat-\\nment of acute symptoms.\\n5. Give antibiotics directed at Str eptococcus pneumoniae, Haemophilus \\ninfluenzae, and Moraxella catarrhalis to patients with COPD exacer -\\nbation who have a change in sputum volume or purulence. Commonly \\nused agents include doxycycline, the macrolides (azithromycin), or \\namoxicillin with or without clavulanic acid. Antibiotic use in asthma \\nshould be reserved for concurrent bacterial infections such as \\npneumonia.\\n6. Administer intravenous magnesium sulfate (1 to 2 g over 30 minutes) \\nto patients with severe asthma exacerbations (FEV 1 <25% predicted). \\nMagnesium sulfate is not recommended for mild or moderate asthma \\nexacerbations and should not be substituted for standard regimens. \\nCurrent evidence does not support its use in COPD exacerbations.\\n7. Mechanical ventilation is necessary in patients with respiratory muscle \\nfatigue, respiratory acidosis, altered mental status, or hypoxia refrac-\\ntory to standard therapies. Noninvasive partial pressure ventilation \\n(NPPV) has become a useful alternative to intubation and invasive \\nventilation. NPPV lowers intubation rates, short-term mortality, and \\nlength of hospitalization in COPD. NPPV can be given by continuous \\npositive airway pressure (CPAP) or bilevel positive airway pressure \\n(BiPAP). BiPAP has the advantage of reducing the work of breathing. \\nCPAP is titrated up to 15 cm H2O, while BiPAP settings are between 8 \\nand 20 cm H 2O for inspiration and 4 and 15 cm H 2O for expiration. \\nNPPV is likely to fail when there is poor mask fit, or when the patient \\nis unable to cooperate with (or tolerate) NPPV , is obtunded, cannot \\nclear airway secretions, or is hemodynamically unstable. \\n8. When NPPV is not a viable option, oral intubation is indicated. Rapid \\ninspiratory flow rates at a reduced respiratory frequenc y (12 to 14 \\nbreaths/min) plus adequate expiratory phase may help reduce air-\\ntrapping and subsequent barotrauma. Therapy is guided by pulse oxim-\\netry, capnography, and ABG results. Continue sedation and therapy for \\nbronchospasm after the patient has been placed on mechanical ventila-\\ntion as the purpose of mechanical ventilation is to eliminate the work \\nof breathing and enable rest. Mechanical ventilation itself does not \\nrelieve the airflow obstruction.\\n34_Cydulka_Ch34.indd   215 16/03/17   9:44 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 234, 'page_label': '216'}, page_content='216 SECTION 5: Pulmonary Emergencies\\n9. Ketamine has been reported as therapy for refractory asthma, but con-\\ntrolled studies are lacking. An IV bolus dose of 0.2 mg/kg followed by \\nan infusion of 0.5 mg/kg/h is sometimes used; ketamine is also a good \\nagent if intubation is needed.\\n10. Admission criteria for patients with asthma include failure of outpa-\\ntient treatment, persistent or worsening dyspnea, PEFR or FEV1 <40% \\nof predicted, hypoxia, hypercarbia, and altered mental status; presence \\nof comorbidities increases likelihood of need for admission. As com-\\npared to asthmatics, patients with acute COPD exacerbations are more \\nlikely to require admission. Indications for COPD admission include \\ntherapeutic failure, frequent exacerbations or relapse after ED treat-\\nment, severe dyspnea, significant comorbidities, arrhythmias, older \\nage, insufficient home support, worsening hypoxia and hypercapnia \\nwith acidosis, and impaired mental status.\\n11. Agents of uncertain or no benefit: In the absence of intubation, seda-\\ntives, hypnotics, and other medications that depress respiratory drive \\nare generally contraindicated. The data supporting methylxanthines in \\nacute asthma or COPD are conflicting; these medications have signifi-\\ncant side effects, and they should be a third-line option at best.\\n12. Beta-blockers may exacerbate bronchospasm. Antihistamines and \\ndecongestants should be avoided as they diminish clearance of respira-\\ntory secretions. Mucolytics should also be withheld; they may exacer -\\nbate bronchospasm. Mast cell and leukotriene modifiers have no role \\nin the treatment of acute exacerbations of asthma or COPD.\\n13. An 80%:20% mixture of helium and oxygen (Heliox) can lower airway \\nresistance and aid in drug deliv ery in the patient with very severe \\nasthma exacerbation; however, it does not reliably avert intubation, \\nchange admission rates, or decrease mortality. Care must be taken in \\nthe oxygen-dependent patient since Heliox administration may entail \\nan FiO2 less than 21%.\\n14. Administer a 5- to 10-day course of oral steroids (prednisone 40 to  \\n60 mg/dose) to patients who improve enough to be dischar ged home. \\nConsider adding inhaled corticosteroids for asthmatic patients with \\nchronic symptoms. Close follow-up care must be arranged for dis-\\ncharged patients to ensure resolution of the exacerbation and review \\nthe management plan. Despite appropriate therapy, these patients have \\nhigh relapse rates. Education of asthma and COPD patients before \\ndischarge (i.e., review of medications, inhaler techniques, use of \\nPEFR measurements, avoidance of noxious stimuli, and need to \\nfollow-up) should be an integral part of ED care.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 69, “Acute Asthma,” by Rita K. Cydulka; Chapter 70, \\n“Chronic Obstructive Pulmonary Disease,” by Rita K. Cydulka and Craig G. \\nBates.\\n34_Cydulka_Ch34.indd   216 16/03/17   9:44 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 235, 'page_label': '217'}, page_content='217\\nAcute Abdominal Pain\\nBryan E. Baskin\\nAcute abdominal pain may be due to numerous etiologies including gas-\\ntrointestinal, genitourinary, cardiovascular, pulmonary, musculoskeletal, \\ndermatologic, neurogenic, and other sources creating visceral, parietal, or \\nreferred pain to the abdomen.\\n■ ■CLINICAL FEATURES\\nConsider immediate life threats that might require emergency interven-\\ntion. Elicit time of pain onset; character, severity, location of pain and its \\nreferral (Fig. 35-1); aggravating and alleviating factors; and similar prior \\nepisodes. Cardiorespiratory symptoms, such as chest pain, dyspnea, and \\ncough; genitourinary symptoms, such as urgency, dysuria, and vaginal \\ndischarge; and any history of trauma should be elicited. In older patients \\nit is also important to obtain a history of myocardial infarction, dysrhyth-\\nmias, coagulopathies, and vasculopathies. Past medical and surgical \\nhistories should be elicited, and a list of medications, particularly \\nsteroids, antibiotics, or nonsteroidal anti-inflammatory drugs (NSAIDs), \\nshould be noted. A thorough gynecologic history is indicated in female \\npatients.\\nThe physical examination should include the patient’s general appear -\\nance. Patients with peritonitis tend to lie still. The skin should be evaluated \\nfor pallor, jaundice, or rash. The vital signs should be reviewed for signs of \\nhypovolemia due to blood loss or volume depletion. Due to medications \\nand/or the physiology of aging, elderly patients may not exhibit tachycardia \\nin the face of hypovolemia or illness. A core temperature should be \\nobtained; however, absence of fever does not rule out infection, particularly \\nin the elderly. The abdomen should be inspected for contour, scars, peristal-\\nsis, masses, distention, and pulsation. The presence of hyperactive or high-\\npitched or tinkling bowel sounds increases the likelihood of small bowel \\nobstruction.\\nPalpation is the most important aspect of the physical examination. The \\nabdomen and genitals should be assessed for tenderness, guarding, masses, \\n35\\nCh A p TER\\n6\\nSECTION\\nGastrointestinal Emergencies\\n35_Cydulka_Ch35.indd   217 16/03/17   9:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 236, 'page_label': '218'}, page_content='218 SECTION 6: Gastrointestinal Emergencies\\norganomegaly, and hernias. Rebound tenderness, often regarded as the \\nclinical criterion standard of peritonitis, has several important limitations. \\nIn patients with peritonitis, the combination of rigidity, referred tenderness, \\nand, especially, cough pain usually provides sufficient diagnostic confirma-\\ntion; false-positive rebound tenderness occurs in about one patient out of \\nfour without peritonitis. This has led some investigators to conclude that \\nrebound tenderness, in contrast to cough pain, is of no predictive value. A \\nuseful and underused test to diagnose abdominal wall pain is the sit-up test, \\nalso known as the Carnett sign. After identification of the site of maximum \\nFigure 35-1.  Differential diagnosis of acute abdominal pain by location. AKA, \\nalcoholic ketoacidosis; DKA, diabetic ketoacidoisis; LLL, lower left lobe; RLL, right \\nlower lobe.\\nRight Upper Quadrant Pain\\nAppendicitis (retrocecal)\\nBiliary colic\\nCholangitis\\nCholecystitis\\nFitz-Hugh-Curtis syndrome\\nHepatitis\\nHepatic abscess\\nHepatic congestion\\nHerpes zoster\\nMyocardial ischemia\\nPerforated duodenal ulcer\\nPneumonia (RLL)\\nPulmonary embolism\\nLeft Upper Quadrant Pain\\nGastric ulcer\\nGastritis\\nHerpes zoster\\nMyocardial ischemia\\nPancreatitis\\nPneumonia (LLL)\\nPulmonary embolism\\nSplenic rupture/distention\\nRight Lower Quadrant Pain\\nAortic aneurysm (leaking, ruptured)\\nAppendicitis\\nCrohn’s disease (terminal ileitis)\\nDiverticulitis (cecal)\\nEctopic pregnancy\\nEndometriosis\\nEpiploic appendagitis\\nHerpes zoster\\nInguinal hernia\\n(incarcerated, strangulated)\\nIschemic colitis\\nMeckel’s diverticulum\\nMittelschmerz\\nOvarian cyst (ruptured)\\nOvarian torsion\\nPelvic inflammatory disease\\nPsoas abscess\\nRegional enteritis\\nTesticular torsion\\nUreteral calculi\\nLeft Lower Quadrant Pain\\nAortic aneurysm (leaking,\\nruptured)\\nDiverticulitis (sigmoid)\\nEctopic pregnancy\\nEndometriosis\\nEpiploic appendagitis\\nHerpes zoster\\nInguinal hernia\\n  (incarcerated, strangulated)\\nIschemic colitis\\nMittelschmerz\\nOvarian cyst (ruptured)\\nOvarian torsion\\nPelvic inflammatory disease\\nPsoas abscess\\nRegional enteritis\\nTesticular torsion\\nUreteral calculi\\nAortic aneurysm (leaking, ruptured)\\nAortic dissection\\nAppendicitis (early)\\nBowel obstruction\\nDiabetic gastric paresis\\nFamilial Mediterranean fever\\nGastroenteritis\\nHeavy metal poisoning\\nHereditary angioedema\\nMalaria\\nMesenteric ischemia\\nMetabolic disorder\\n  (Addisonian crisis, AKA,\\n  DKA, porphyria, uremia)\\nNarcotic withdrawal\\nPancreatitis\\nPerforated bowel\\nPeritonitis (of any cause)\\nSickle cell crisis\\nVolvulus\\nDiffuse Pain\\n35_Cydulka_Ch35.indd   218 16/03/17   9:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 237, 'page_label': '219'}, page_content='CHAPTER 35: Acute Abdominal Pain 219 \\nabdominal tenderness, the patient is asked to fold his or her arms across the \\nchest and sit up halfway. The examiner maintains a finger on the tender \\narea, and if palpation in the semisitting position produces the same or \\nincreased tenderness, the test is said to be positive for an abdominal wall \\nsyndrome.\\nPerform a pelvic examination in all postpubertal females. During the \\nrectal examination, the lower pelvis should be assessed for tenderness, \\nbleeding, and masses.\\nElderly patients often fail to manifest the same signs and symptoms \\nas younger patients, with decreased pain perception and decreased \\nfebrile or muscular response to infection or inflammation. This is simi-\\nlarly true of diabetics and immunocompromised patients. Due to this, \\nmorbidity and mortality of elderly patients presenting to EDs with \\nabdominal pain are high. Biliary disease, bowel obstruction, diverticuli-\\ntis, cancer, and hernia are more common causes of abdominal pain in \\npatients over 50 years old. Hypotension from volume contraction, hem-\\norrhage, or sepsis can be missed if a normally hypertensive patient \\nappears normotensive. Conditions, somewhat less frequent but propor -\\ntionately higher in occurrence, among the elderly include sigmoid volvu-\\nlus, diverticulitis, acute mesenteric ischemia, and abdominal aortic \\naneurysm. Mesenteric ischemia should be considered in any patient \\nolder than 50 years with abdominal pain out of proportion to physical \\nfindings.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nSuggested laboratory studies for goal-directed clinical testing are listed in \\nTable 35-1. All women of child-bearing age with abdominal pain and/or \\nabnormal vaginal bleeding should receive a qualitative pregnancy test. A \\ncomplete blood count is neither sensitive nor specific to identify abdominal \\npathology; however, it remains the most commonly ordered test for ED \\npatients with abdominal pain.\\nPlain abdominal radiographs can be helpful in patients with suspected \\nobstruction, perforation (looking for free air), or to follow previously \\nidentified stones in renal colic patients; however, in general have low \\nsensitivity. Ultrasonography is useful for the diagnosis of cholelithiasis, \\ncholedocholithiasis, cholecystitis, biliary duct dilatation, pancreatic \\nmasses, hydroureter or hydronephrosis, intrauterine or ectopic pregnan-\\ncies, ovarian and tubal pathologies, free intraperitoneal fluid, suspected \\nappendicitis (institution specific), and abdominal aortic aneurysm. Since \\nultrasound machines are portable, a bedside ultrasound can be performed \\nquickly by an emergency provider. Computed tomography (CT) is cur -\\nrently the preferred imaging method for mesenteric ischemia, pancreati-\\ntis, aortic aneurysm, appendicitis, and urolithiasis and is superior for \\nidentifying virtually any abnormality that can be seen on plain films. \\nIntravenous contrast is essential to identify vascular lesions, is helpful to \\nidentify inflammatory conditions (i.e., appendicitis), but is not needed for \\nurolithiasis. Oral contrast aids in the diagnosis of bowel obstruction, but \\notherwise is less useful.\\n35_Cydulka_Ch35.indd   219 16/03/17   9:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 238, 'page_label': '220'}, page_content='220 SECTION 6: Gastrointestinal Emergencies\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nUnstable patients should be resuscitated immediately, then diagnosed \\nclinically with emergent surgical consultation.\\n1. The most common resuscitation need for abdominal pain patients is \\nintravenous fluids with normal saline or lactated Ringer’ s (LR) solu-\\ntion. During the initial evaluation, the patient should have nothing by \\nmouth.\\n2. The judicious use of analgesics is appropriate and may facilitate the \\nability to obtain a better history and more accurate physical examina -\\ntion. Consider morphine 0.1 mg/kg IV or hydromorphone 0.2 to 1 mg \\nIV , which can be reversed by naloxone 0.4 to 2 mg SC/IV if necessary. \\nNSAIDs such as ketorolac, 30 mg IV , or ibuprofen, (200 to 400 mg PO) \\nare useful in patients with renal colic, but their use in other conditions is \\ncontroversial and they can mask peritoneal inflammation.\\nTAble 35-1 Suggested Laboratory Studies for Goal-Directed Clinical Testing  \\nin Acute Abdominal pain\\nLaboratory Test Clinical Suspicion\\nAmylase Pancreatitis (if lipase is not available)\\nLipase Pancreatitis\\nβ-Human chorionic gonadotrophin Pregnancy\\nEctopic or molar pregnancy\\nCoagulation studies (prothrombin time/ \\npartial thromboplastin time)\\nGI bleeding\\nEnd-stage liver disease\\nCoagulopathy\\nElectrolytes Dehydration\\nEndocrine or metabolic disorder\\nGlucose Diabetic ketoacidosis\\nPancreatitis\\nGonococcal/chlamydia testing Cervicitis/urethritis\\nPelvic inflammatory disease\\nHemoglobin GI bleeding\\nLactate Mesenteric ischemia\\nLiver function tests Cholecystitis\\nCholelithiasis\\nHepatitis\\nPlatelets GI bleeding\\nRenal function tests Dehydration\\nRenal insufficiency\\nAcute renal failure\\nUrinalysis Urinary tract infection\\nPyelonephritis\\nNephrolithiasis\\nECG Myocardial ischemia or infarction\\nSource: Reproduced with permission from Fitch M. Utility and limitations of laboratory studies, in Cline \\nDM, Stead LG (eds), Abdominal Emergencies. New York: McGraw-Hill Medical; 2008, p. 19.\\n35_Cydulka_Ch35.indd   220 16/03/17   9:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 239, 'page_label': '221'}, page_content='CHAPTER 35: Acute Abdominal Pain 221 \\n3. Antiemetics, such as ondansetron 4 mg IM/IV , or metoclopramide  \\n10 mg IM or slow IV , also increase the patient’s comfort and facilitate \\nassessment of the patient’s signs and symptoms.\\n4. When appropriate, antibiotic treatment (i.e., gentamicin 1.5 mg/kg IV \\nplus metronidazole 1 g IV; or piperacillin-tazobactam, 3.375 g IV) \\nshould be initiated, depending on the suspected source of infection. See \\nspecific chapters that follow in this section for additional antibiotics and \\nguidelines.\\n5. Surgical or obstetric and gynecologic consultation should be obtained \\nfor patients with suspected acute abdominal or pelvic pathology requir -\\ning immediate intervention, including, but not limited to, abdominal \\naortic aneurysm, intraabdominal hemorrhage, perforated viscus, intesti-\\nnal obstruction or infarction, ectopic pregnancy, or gynecologic emer -\\ngencies. Historically, the “acute abdomen” or “surgical abdomen” has \\nbeen identified by the presence of pain, guarding, and rebound as indi-\\ncating a likely need for emergent surgery.\\n6. Indications for admission include toxic appearance, unclear diagnosis \\nin elderly or immunocompromised patients, inability to reasonably ex-\\nclude serious etiologies, intractable pain or v omiting, altered mental \\nstatus, and inability to follow discharge or follow-up instructions. Con-\\ntinued observation with serial examinations is an alternative. Many \\npatients with nonspecific abdominal pain can be discharged safely with \\n12 to 24 hours of follow-up and instructions to return immediately for \\nincreased pain, vomiting, fever, or failure of symptoms to resolve.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 71, “Acute Abdominal Pain,” by Mary Claire O’Brien.\\n35_Cydulka_Ch35.indd   221 16/03/17   9:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 240, 'page_label': '222'}, page_content='222\\nNausea and Vomiting\\nJonathan A. Maisel\\nAlthough nausea and vomiting are typically caused by gastrointestinal disor-\\nders, the clinician must consider systemic causes as well. Neurologic, infec-\\ntious, cardiac, endocrine, renal, obstetric, pharmacologic, toxicologic, and \\npsychiatric disorders may all be the cause of nausea and vomiting. A compre-\\nhensive history and physical examination, as well as the use of various diag-\\nnostic modalities, are needed to determine the cause and its complications.\\n■ ■CLINICAL FEATURES\\nHistory is essential in determining the cause of vomiting. Important fea-\\ntures to elicit include the onset and duration of symptoms, the frequency \\nand timing of episodes, the content of the vomitus (e.g., undigested food, \\nbile-tinged, feculent), associated symptoms (e.g., fever, abdominal pain, \\ndiarrhea), exposure to foodborne pathogens, and the presence of sick con-\\ntacts. A thorough past medical and surgical history (e.g., prior abdominal \\nsurgery) will also be valuable. Review the patient’s medication list, as a \\nvariety of agents in therapeutic or toxic doses can trigger nausea and vom-\\niting. The physical examination should initially focus on determining the \\npresence or absence of a critical, life-threatening condition. Hypotension, \\ntachycardia, lethargy, poor skin turgor, dry mucous membranes, and \\ndelayed capillary refill suggest significant dehydration. A careful abdomi-\\nnal examination will help clarify the presence or absence of a primary GI \\netiology. The extent to which the balance of the physical examination will \\nbe of value will be dictated by the history. In the event that a reliable history \\nis not available (e.g., drug overdose, cognitive impairment), a comprehen-\\nsive physical examination is warranted.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nV omiting with blood could represent gastritis, peptic ulcer disease, or car-\\ncinoma. However, aggressive nonbloody vomiting followed by hemateme-\\nsis is more consistent with a Mallory-Weiss tear. The presence of bile rules \\nout gastric outlet obstruction, such as from pyloric stenosis or strictures. \\nThe presence of abdominal distension, surgical scars, or an incarcerated \\nhernia suggests a small bowel obstruction. The presence of fever would \\nsuggest an infectious (e.g., gastroenteritis, appendicitis, cholecystitis) or \\ninflammatory cause. V omiting with chest pain suggests myocardial infarc-\\ntion. Post-tussive vomiting suggests pneumonia. V omiting with back or \\nflank pain can be seen with aortic aneurysm or dissection, pancreatitis, \\npyelonephritis or renal colic. Headache with vomiting suggests increased \\nintracranial pressure, such as with subarachnoid hemorrhage, tumor, or \\nhead injury. The presence of vertigo and nystagmus suggests either vestibu-\\nlar or CNS pathology. V omiting in a pregnant patient is consistent with \\nhyperemesis gravidarum in the first trimester; but in the third trimester, \\ncould represent preeclampsia if accompanied by hypertension. Associated \\n36\\nCh A p TER\\n36_Cydulka_Ch36.indd   222 16/03/17   10:11 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 241, 'page_label': '223'}, page_content='CHAPTER 36: Nausea and Vomiting 223 \\nmedical conditions are also useful in discerning the cause of vomiting: \\ndiabetes mellitus suggests ketoacidosis, peripheral vascular disease sug -\\ngests mesenteric ischemia, and medication use or overdose (e.g., lithium or \\ndigoxin) suggests toxicity.\\nAll women of childbearing age warrant a pregnancy test. In vomiting \\nassociated with abdominal pain, liver function tests, urinalysis, and lipase or \\namylase determinations may be useful. Electrolyte determinations and renal \\nfunction tests are usually of benefit only in patients with severe dehydration \\nor prolonged vomiting. In addition, they may confirm the presence of adrenal \\ninsufficiency, with hyperkalemia and hyponatremia. Obtain specific drug \\nlevels for acetaminophen, salicylates, and digoxin when toxicity is suspected, \\nand urine and/or serum toxicology screens when ethanol or illicit drug use is \\nsuspected. Urinalysis revealing ketones may suggest dehydration or diabetic \\nketoacidosis. The presence of nitrates, leukocyte esterase, bacteria and white \\nblood cells is diagnostic of a urinary tract infection. The presence of red \\nblood cells may suggest nephrolithiasis. The electrocardiogram and chest \\nradiograph can be reserved for patients with suspected cardiac ischemia or \\npulmonary infection. Abdominal x-rays can be used to confirm the presence \\nof intestinal obstruction. If plain x-rays are unrevealing, CT scan of the abdo-\\nmen and pelvis with IV and PO contrast is not only helpful for revealing the \\nlocation of a mechanical obstruction, but may also clarify alternative explana-\\ntions for the patient’s symptoms. CT scan of the brain will be helpful if a CNS \\nlesion is suspected. Measuring intraocular pressure with a Tono-Pen ® \\n(Reichert, Inc., Depew, NY) is useful if glaucoma is suspected.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nThe treatment of nausea and vomiting consists of correcting fluid and elec-\\ntrolyte problems. In addition, one must initiate specific therapy for any \\nlife-threatening cause identified in the initial workup.\\n1. Resuscitation of seriously ill patients requires intravenous boluses of \\nnormal saline 20 mL/kg. Boluses may be repeated as necessary , target-\\ning euvolemia. Caution should be used in the elderly, and those with \\ncompromised left ventricular function. Mildly dehydrated patients \\nmay tolerate an oral rehydration solution containing sodium as well  \\nas glucose to enhance fluid absorption. Many commercial products \\n(e.g., Pedialyte ®) are available.\\n2. Nutritional supplementation should be started as soon as nausea and \\nvomiting subside. Patients can quickly advance from clear liquids to \\nsolids, such as rice and bread. P atients may benefit from avoiding raw \\nfruit, caffeine, and lactose and sorbitol-containing products\\n3. Antiemetic agents are useful in actively vomiting patients with dehydra-\\ntion. Ondansetron 4 to 8 mg IV or ODT (children 0.15 mg/kg) is very \\neffective and well tolerated, and can be administered to pregnant women \\n(category B). Promethazine 25 mg (0.25 to 1 mg/kg in children over  \\n2 years) IM or PR every 4 to 6 hours can be effective. Prochlorperazine  \\n5 to 10 mg IM every 6 hours, or 25 mg PR every 12 hours is effective. \\nMetoclopramide 10 mg (children 0.1 mg/kg) IV/IM every 6 to 8 hours is \\nuseful and can be administered to pregnant women (category B). Meclizine \\n25 mg PO every 6 hours is effective for vomiting associated with vertigo.\\n36_Cydulka_Ch36.indd   223 16/03/17   10:11 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 242, 'page_label': '224'}, page_content='224 SECTION 6: Gastrointestinal Emergencies\\nPatients with a life-threatening cause of vomiting require admission. In \\naddition, toxic or severely dehydrated patients, particularly infants and the \\nelderly, or those still intolerant of oral fluids after hydration, warrant admis-\\nsion. Patients with an unclear diagnosis, but favorable examination findings \\nafter hydration, can be discharged home safely with antiemetics. Work \\nexcuses are indicated for patients in the food, day care, and health care \\nindustries.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 72, “Nausea and V omiting,” by Bophal Sarha Hang, \\nSusan Bork, and Jeffrey Ditkoff.\\n36_Cydulka_Ch36.indd   224 16/03/17   10:11 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 243, 'page_label': '225'}, page_content='225\\nDisorders Presenting Primarily \\nwith Diarrhea\\nJonathan A. Maisel\\nDiarrhea is defined as three or more watery stools per day. There are four \\nbasic mechanisms: increased intestinal secretion (e.g., cholera), decreased \\nintestinal absorption (e.g., enterotoxins, inflammation, or ischemia), \\nincreased osmotic load (e.g., laxatives, lactose intolerance), and abnormal \\nintestinal motility (e.g., irritable bowel syndrome). Most cases are infec-\\ntious in etiology.\\n■ ■DIARRHEA\\nClinical Features\\nDetermine if the diarrhea is acute (< 3 weeks duration) or chronic  \\n(>3 weeks duration). Acute diarrhea is more likely to represent a seri-\\nous problem, such as infection, ischemia, intoxication, or inflammation. \\nInquire about associated symptoms. Features such as fever, pain, pres-\\nence of blood, or type of food ingested may help in the diagnosis of \\ninfectious gastroenteritis, food poisoning, diverticulitis, or inflamma-\\ntory bowel disease. Neurological symptoms can be seen in certain diar -\\nrheal illnesses, such as seizure with shigellosis or hyponatremia, or \\nparesthesias and reverse temperature sensation with ciguatoxin.\\nDetails about the host can also better define the diagnosis. Malab-\\nsorption from pancreatic insufficiency or HIV-related bowel disorders \\nneed not be considered in a healthy host. Dietary practices, including \\nfrequent restaurant meals, exposure to day care centers, consumption of \\nstreet vendor food or raw seafood, overseas travel, and camping with the \\ningestion of lake or stream water, may isolate the vector and narrow the \\ndifferential diagnosis for infectious diarrhea (e.g., lakes or streams—\\nGiardia; oysters suggest Vibrio; rice suggests Bacillus cereus; eggs sug-\\ngest Salmonella; and meat suggests Campylobacter, Staphylococcus, \\nYersinia, Escherichia coli, or Clostridium). Certain medications, particu-\\nlarly antibiotics, colchicine, lithium, and laxatives, can all contribute to \\ndiarrhea. Travel may predispose the patient to enterotoxigenic E. coli or \\nGiardia. Social history, such as sexual preference, drug use, and occupa-\\ntion, may suggest diagnosis such as HIV-related illness or organophos-\\nphate poisoning.\\nThe physical examination begins with assessment of hydration status. \\nAbdominal examination can narrow the differential diagnosis and reveal \\nthe need for surgical intervention. Even appendicitis can present with diar -\\nrhea in up to 20% of cases. Rectal examination can rule out impaction or \\npresence of blood, the latter suggesting inflammation, infection, or mesen-\\nteric ischemia.\\nDiagnosis and Differential\\nThe most specific tests in diarrheal illness all involve examination of the \\nstool in the laboratory. Stool culture testing should be limited to severely \\n37\\nC HA pt ER\\n37_Cydulka_Ch37.indd   225 01/05/17   10:26 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 244, 'page_label': '226'}, page_content='226 SECTION 6: Gastrointestinal Emergencies\\ndehydrated or toxic patients, those with blood or pus in their stool, immu-\\nnocompromised patients, and those with diarrhea lasting longer than  \\n3 days. Consider testing for Salmonella, Shigella, Campylobacter, Shiga \\ntoxin-producing E. coli, or amoebic infection. Make the laboratory aware \\nof which pathogens you suspect. In patients with diarrhea > 7 days, those \\nwho have traveled abroad, or consumed untreated water, an examination \\nfor ova and parasites may be useful to rule out Giardia or Cryptosporid-\\nium. Multiple samples may be required. Assay for Clostridium difficile  \\ntoxin may be useful in ill patients with antibiotic-associated diarrhea or \\nrecent hospitalization.\\nBecause most diarrheal illnesses are viral or self-limited, laboratory \\ntesting in routine cases is not indicated. However, in extremely dehydrated \\nor toxic patients, electrolyte determinations and renal function tests may be \\nuseful. (Hemolytic-uremic syndrome, characterized by acute renal failure, \\nthrombocytopenia, and hemolytic anemia, may complicate E. coli 0157:H7 \\ninfections in children and the elderly). If toxicity is suspected, tests for \\nlevels for theophylline, lithium, or heavy metals will aid in the diagnosis. \\nRadiographs are reserved for ruling out intestinal obstruction or pneumo-\\nnia, particularly Legionella. In addition, CT scanning or angiography may \\nbe indicated in acute mesenteric ischemia.\\nEmergency Department Care and Disposition\\nThe treatment of diarrhea consists of correcting fluid and electrolyte prob-\\nlems. (Antibiotic-associated diarrhea often responds to withdrawal of the \\noffending drug.) Initiate specific therapy for any life-threatening cause \\nidentified in the initial workup.\\n1. Replacement of fluids can be intravenous (boluses of 500 mL IV in \\nadults, 20 mL/kg in children), with normal saline solution in seriously \\nill patients. Mildly dehydrated patients who are not vomiting may toler-\\nate an oral rehydrating solution containing sodium (e.g., Pedialyte ®, \\nGatorade®) and glucose to enhance fluid absorption (glucose transport \\nunaffected by enterotoxins). The goal is 30 to 100 mL/kg over the first \\n4 hours.\\n2. Once patients tolerate oral fluids, introduce a “BRAT” diet (bananas, \\nrice, apples, toast). Patients should avoid raw fruit, caffeine, lactose, and \\nsorbitol-containing products.\\nPatients with an unclear diagnosis but favorable examination findings \\nafter hydration can be discharged home safely. Toxic or severely dehy-\\ndrated patients, particularly infants and the elderly, warrant admission.\\n■ ■ACUtE INFECtIOUS AND tRAVELER’S DIARRHEA\\nNorovirus causes 50% to 80% of all infectious diarrheas in the United \\nStates, followed much less frequently by non-Shiga toxin-producing  \\nE. coli, C. difficile, invasive bacteria (Campylobacter, Shigella, Salmo-\\nnella), Shiga toxin-producing E. coli, and protozoa. A history of foreign \\ntravel, with consumption of contaminated food or drink, is associated with \\nan 80% probability of bacterial diarrhea, primarily toxin and nontoxin-\\nproducing strains of E. coli.\\n37_Cydulka_Ch37.indd   226 01/05/17   10:26 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 245, 'page_label': '227'}, page_content='CHAPTER 37: Disorders Presenting Primarily with Diarrhea 227 \\nDiagnosis and Differential\\nPatients with severe abdominal pain, fe ver, and bloody stool should \\nundergo stool studies for specific pathogens, including culture for Salmo-\\nnella, Shigella, Campylobacter, and E. coli O157:H7; assay for Shiga \\ntoxin; and microscopy or antigen assay for Entamoeba histolytica. Expo-\\nsure of a traveler or hiker to untreated water, and illness that persists for \\nmore than 7 days, should prompt an evaluation for a protozoal pathogen. \\nStool should be tested by enzyme immunoassay for E. histolytica antigen, \\nGiardia intestinalis antigen, and Cryptosporidium parvum antigen.\\nEmergency Department Care and Disposition\\nTreatment of infectious diarrhea (including viral causes) includes antibi-\\notics (see Table 37-1), antimotility agents, fluid resuscitation (oral or \\nparenteral), and dietary modification. Probiotics are safe and may be \\nbeneficial.\\nAntimotility agents, such as loperamide 4 mg initially, then 2 mg fol-\\nlowing each unformed stool (16 mg/day maximum), will shorten the \\nTablE 37-1 Antibiotic Recommendations for Infectious Diarrhea\\nOrganism primary treatment Alternative treatment\\nEmpiric Tx – Traveler’s \\nDiarrhea\\nCiprofloxacin 500 mg  \\nsingle dose or 500 mg  \\nBID × 3 days\\nAzithromycin 1000 mg \\nsingle dose or trimethoprim/\\nsulfamethoxazole 160 mg/ \\n800 mg single dose or BID × \\n3 days; or rifaximin 200 mg  \\nTID × 3 days\\nEmpiric Tx – Infectious \\nDiarrhea\\nCiprofloxacin 500 mg  \\nBID × 5 days\\nTrimethoprim/sulfamethoxa-\\nzole 160 mg/800 mg  \\nBID × 5 days\\nClostridium difficile Metronidazole 500 mg  \\nTID × 14 days\\nVancomycin 125 mg  \\nQID × 14 days\\nEscherichia coli 0157:H7 No antibiotics No antibiotics\\nSalmonella non-typhi Ciprofloxacin 750 mg  \\nBID × 5 days\\nAzithromycin 500 mg  \\ndaily × 7 days\\nShigella Ciprofloxacin 750 mg  \\nBID × 3 days\\nAzithromycin 500 mg  \\ndaily × 3 days\\nCyclospora Trimethoprim/sulfamethoxa-\\nzole 160 mg/800 mg  \\nBID × 10 days\\nGiardia Tinidazole 2 g single dose Nitazoxanide 500 mg  \\nBID × 3 days\\nVibrio cholerae Doxycycline 500 mg single \\ndose or azithromycin 1 g \\nsingle dose\\nTrimethoprim/sulfamethoxa-\\nzole 160 mg/800 mg  \\nBID × 3 days\\nEntamoeba histolytica Metronidazole 750 mg TID × \\n10 days AND paromomycin \\n10 mg/kg TID × 7 days\\nMetronidazole AND iodoquinol \\n650 mg TID × 20 days\\nListeria monocytogenes No antibiotics No antibiotics\\n37_Cydulka_Ch37.indd   227 01/05/17   10:26 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 246, 'page_label': '228'}, page_content='228 SECTION 6: Gastrointestinal Emergencies\\nduration of symptoms when combined with an antibiotic. Alternative  \\nagents include bismuth subsalicylate 30 mL or 2 tablets every 30 min-\\nutes for 8 doses, or diphenoxylate and atropine 4 mg four times daily. \\nAvoid antimotility agents in the subset of patients with bloody or sus-\\npected inflammatory diarrhea because of the potential for prolonged \\nfever, toxic megacolon in C. difficile patients, and hemolytic uremic \\nsyndrome in children infected with Shiga toxin-producing E. coli.\\nMost patients can be discharged home. Educate patients regarding the \\nneed for frequent hand washing to minimize transmission. Accordingly, \\npatients employed in the food, day care, and health care industries should \\nnot return to work until diarrhea has resolved. Any toxic-appearing patient \\nshould be admitted. Consider admission for those at extremes of age as well.\\nIndividuals should be counseled about the proper selection of food and \\nbeverages consumed when traveling abroad, as well as the use of bottled or \\nboiled water for drinking, brushing teeth, and the preparation of food and \\ninfant formula.\\n■ ■CLOSTRIDIUM DIFFICILE-ASSOCIAtED DIARRHEA  \\nAND COLItIS\\nClostridium difficile is an anaerobic bacillus, which secretes two toxins that \\ninteract in a complex manner to cause illness ranging from diarrhea to \\npseudomembranous colitis. Pseudomembranous colitis is an inflammatory \\nbowel disorder in which membrane-like yellowish plaques of exudate over-\\nlay and replace necrotic intestinal mucosa. Broad-spectrum antibiotics, \\nmost notably clindamycin, cephalosporins, ampicillin, amoxicillin, and \\nfluoroquinolones, alter gut flora in such a way that C. difficile can flourish \\nwithin the colon, causing enteropathy. Transmission of the organism can \\noccur from contact with humans and fomites. C. difficile is the most com-\\nmon cause of infectious diarrhea in hospitalized patients and is now \\nreported to affect healthy adults who were not exposed to a hospital setting.\\nClinical Features\\nOnset is typically 7 to 10 days after initiating antibiotic treatment, but may \\noccur up to several weeks following treatment. Clinical manifestations can \\nvary from frequent, watery, mucoid stools to a toxic illness, characterized \\nby profuse diarrhea, crampy abdominal pain, fever, leukocytosis, and dehy-\\ndration.\\nDiagnosis and Differential\\nThe diagnosis is confirmed by the demonstration of C. difficile toxin in \\nstool. Colonoscopy is not routinely needed to confirm the diagnosis.\\nEmergency Department Care and Disposition\\n1. Ensure contact isolation, use of personal protective equipment, and \\nappropriate hand h ygiene with soap and water (alcohol-based rubs \\nineffective).\\n2. Mild C. difficile infection in an otherwise healthy patient can be treated \\nwith discontinuing the offending antibiotic, confirmation of infection, \\nand clinical monitoring.\\n37_Cydulka_Ch37.indd   228 01/05/17   10:26 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 247, 'page_label': '229'}, page_content='CHAPTER 37: Disorders Presenting Primarily with Diarrhea 229 \\n3. Oral metronidazole 500 mg three times daily for 14 days is the treat-\\nment of choice in patients with mild to moderate disease who do not \\nrespond to conservative measures.\\n4. Patients with severe diarrhea, those with a systemic response (e.g., fever, \\nleukocytosis, or severe abdominal pain), and those whose symptoms per-\\nsist despite appropriate outpatient management, must be hospitalized and \\nshould receive vancomycin 125 mg orally four times daily for 14 days.\\n5. Patients with pseudomembranous colitis complicated by toxic megaco -\\nlon should receive metronidazole 500 mg IV every 6 hours AND van -\\ncomycin 500 mg orally every 6 hours. Toxic megacolon or intestinal \\nperforation require immediate surgical consultation. Rarely, emergency \\ncolectomy may be required for fulminant colitis.\\nUse of antidiarrheal agents is controversial. Probiotic treatment is not a \\nuseful adjunct. Relapses occur in 20% to 30% of patients. A first relapse is \\ntreated with metronidazole 500 mg orally three times daily for 14 days. A \\nsecond relapse is treated with vancomycin 125 mg orally four times daily \\nfor 14 days, followed by a four-week taper.\\n■ ■INFLAMMAtORY BOWEL DISEASE/CROHN’S DISEASE\\nCrohn’s disease is a chronic, idiopathic, granulomatous inflammatory dis-\\nease, characterized by segmental ulceration of the GI tract anywhere from \\nthe mouth to the anus.\\nClinical Features\\nThe clinical course is variable and unpredictable, with multiple remissions \\nand exacerbations. Patients commonly report a history of recurring fever, \\nabdominal pain, and diarrhea over several years before a definitive diagno-\\nsis is made. Abdominal pain, anorexia, diarrhea, and weight loss occur in \\nmost patients. Patients may also present with complications of the disease, \\nsuch as intestinal obstruction, intraabdominal abscess, or a variety of \\nextraintestinal manifestations. Perianal fissures or fistulas, abscesses, and \\nrectal prolapse can be seen in those with colonic involvement. Fistulas \\noccur between the ileum and sigmoid colon; the cecum, another ileal seg-\\nment, or the skin; or between the colon and the vagina. Abscesses can be \\nintraperitoneal, retroperitoneal, interloop, or intramesenteric. Obstruction, \\nhemorrhage, and toxic megacolon also occur. Toxic megacolon can be \\nassociated with massive GI bleeding.\\nUp to 40% of patients develop extraintestinal manifestations, including \\narthritis, uveitis, nephrolithiasis, and skin disease (e.g., erythema nodosum, \\npyoderma gangrenosum). Hepatobiliary disease, including gallstones, peri-\\ncholangitis, and chronic active hepatitis, is commonly seen, as is pancreati-\\ntis. Some patients develop thromboembolic disease as a result of a hyperco-\\naguable state. Malabsorption, malnutrition, and chronic anemia develop in \\nlongstanding disease. The recurrence rate for those with Crohn’s disease is \\n25% to 50% when treated medically; higher for patients treated surgically.\\nDiagnosis and Differential\\nThe definitive diagnosis of Crohn’s disease is usually established months \\nor years after the onset of symptoms. A careful and detailed history for \\n37_Cydulka_Ch37.indd   229 01/05/17   10:26 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 248, 'page_label': '230'}, page_content='230 SECTION 6: Gastrointestinal Emergencies\\nprevious bowel symptoms that preceded the acute presentation may pro -\\nvide clues to the correct diagnosis. Abdominal CT scanning is the most \\nuseful diagnostic test, potentially revealing bowel wall thickening, seg-\\nmental narrowing, destruction of the normal mucosal pattern, mesenteric \\nedema, abscess formation, and fistulas, as well as extraintestinal complica-\\ntions (e.g., gallstones, renal stones, sacroiliitis). Colonoscopy can detect \\nearly mucosal lesions, define the extent of colonic involvement, and iden-\\ntify colon cancer.\\nThe differential diagnosis of Crohn’s disease includes lymphoma, ileo-\\ncecal amebiasis, sarcoidosis, chronic mycotic infections, tuberculosis, \\nKaposi sarcoma, Campylobacter enteritis, and Yersinia ileocolitis. Most of \\nthese conditions are uncommon, and the latter two can be differentiated by \\nstool cultures. When confined to the colon, ischemic colitis, infectious \\ncolitis, pseudomembranous enterocolitis, irritable bowel syndrome, and \\nulcerative colitis should be considered.\\nEmergency Department Care and Disposition\\nInitial evaluation should determine the severity of the attack and identify \\nsignificant complications. Laboratory evaluation includes complete \\nblood count, chemistries, and type and cross match when indicated. \\nPlain abdominal x-rays may identify obstruction, perforation, and toxic \\nmegacolon, which may appear as a long, continuous segment of air-\\nfilled colon greater than 6 cm in diameter. CT of the abdomen is the \\nmost useful test to confirm the diagnosis, and identify both intraintesti-\\nnal and extraintestinal manifestations. Initial ED management includes \\nintravenous fluid replacement, parenteral analgesia, bowel rest, correc-\\ntion of electrolyte abnormalities, and nasogastric suction if obstruction, \\nileus, or toxic megacolon is present. Additional treatment may include \\nthe following:\\n1. Sulfasalazine 3 to 5 g/day is effectiv e for mild to moderate Crohn’s \\ndisease, but has multiple toxic side effects, including GI and hypersen-\\nsitivity reactions. Mesalamine, up to 4 g/day, is equally effective, with \\nfewer side effects.\\n2. Intravenous hydrocortisone 300 mg/day is recommended for severe \\ndisease. Oral glucocorticoids (e.g., prednisone 40 to 60 mg/day) are \\noften used as induction therapy.\\n3. Immunosuppressive drugs, 6-mer captopurine up to 1.5 mg/kg/day \\nor azathioprine up to 2.5 mg/kg/day, are used as steroid-sparing \\nagents, in healing fistulas, and in patients with serious surgical con-\\ntraindications.\\n4. Oral antibiotics are f irst-line agents for perianal disease and can help \\ninduce remission. Ciprofloxacin 1 to 1.5 mg/kg/day, metronidazole 10 \\nto 20 mg/kg/day, and rifaximin 800 mg twice daily are effective. Fulmi-\\nnant colitis should be treated intravenously with broad spectrum cover -\\nage, such as piperacillin-tazobactam 4.5 g four times daily.\\n5. Patients with medically resistant, moderate to severe Crohn’ s disease, \\nmay benefit from the antitumor necrosis factor antibody infliximab  \\n5 mg/kg intravenously, or adalimumab 160 mg subcutaneously.\\n6. Diarrhea can be controlled by loperamide 4 to 16 mg/day, diphenoxyl-\\nate 5 to 20 mg/day, or cholestyramine 4 g one to six times daily.\\n37_Cydulka_Ch37.indd   230 01/05/17   10:26 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 249, 'page_label': '231'}, page_content='CHAPTER 37: Disorders Presenting Primarily with Diarrhea 231 \\nHospital admission is recommended for those who demonstrate signs of \\nfulminant colitis, peritonitis, obstruction, significant hemorrhage, severe \\ndehydration, or electrolyte imbalance, or those with less severe disease who \\nfail outpatient management. Surgical intervention is indicated in patients \\nwith intestinal obstruction or hemorrhage, perforation, abscess or fistula \\nformation, toxic megacolon, or perianal disease, and in some patients who \\nfail medical therapy. Alterations in therapy should be discussed with a gas-\\ntroenterologist, and close follow-up must be ensured for patients discharged \\nfrom the ED.\\n■ ■ULCERAtIVE COLItIS\\nUlcerative colitis is an idiopathic chronic inflammatory and ulcerative dis-\\nease of the colon and rectum, characterized clinically by intermittent epi-\\nsodes of crampy abdominal pain, bloody diarrhea, and tenesmus, with \\ncomplete remission between bouts.\\nClinical Features\\nPatients with mild disease (60%), typically limited to the rectum, have \\nfewer than four bowel movements per day, no systemic symptoms, and few \\nextraintestinal manifestations. Patients with moderate disease (25%) have \\ncolitis extending to the splenic flexure. Severe disease (pancolitis) is associ-\\nated with frequent daily bowel movements, weight loss, fever, tachycardia, \\nanemia, and more frequent extraintestinal manifestations, including periph-\\neral arthritis, ankylosing spondylitis, episcleritis, uveitis, pyoderma gan-\\ngrenosum, erythema nodosum, hepatobiliary disease, thromboembolic \\ndisease, renal stones, and malnutrition.\\nComplications include GI hemorrhage (most common), perirectal \\nabscess and fistula formation, obstruction secondary to stricture forma-\\ntion, and acute perforation. There is a 10- to 30-fold increase in the risk \\nof developing colon carcinoma. The most feared complication is toxic \\nmegacolon, which presents with fever, tachycardia, dehydration, and a \\ntender, distended abdomen. X-ray reveals a long, continuous segment of \\nair-filled colon > 6 cm in diameter. Perforation and peritonitis are life-\\nthreatening complications.\\nDiagnosis and Differential\\nThe diagnosis of ulcerative colitis may be considered with a history of \\nabdominal cramps, diarrhea, and mucoid stools. Laboratory findings are \\nnonspecific and may include leukocytosis, anemia, thrombocytosis, \\ndecreased serum albumin levels, abnormal liver function test results, and \\nnegative stool studies for ova, parasites, and enteric pathogens. Abdominal \\nCT scanning is important for the diagnosis of nonspecific abdominal pain \\nor for suspected colitis. Colonoscopy can confirm the diagnosis and define \\nthe extent of colonic involvement. The differential diagnosis includes infec-\\ntious, ischemic, radiation, antineoplastic agent induced, pseudomembra-\\nnous, and Crohn’s colitis. When the disease is limited to the rectum, \\nconsider sexually acquired diseases, such as rectal syphilis, gonococcal \\nproctitis, lymphogranuloma venereum, and inflammation caused by herpes \\nsimplex virus, Entamoeba histolytica, Shigella, and Campylobacter.\\n37_Cydulka_Ch37.indd   231 01/05/17   10:26 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 250, 'page_label': '232'}, page_content='232 SECTION 6: Gastrointestinal Emergencies\\nEmergency Department Care and Disposition\\nPatients with severe disease should be admitted for intra venous fluid \\nreplacement, parenteral analgesia, bowel rest, correction of electrolyte \\nabnormalities, and nasogastric suction if obstruction, ileus, or toxic mega-\\ncolon is present. Consultation with both gastroenterology and surgery \\nshould be arranged for patients with significant GI hemorrhage, toxic \\nmegacolon, and bowel perforation. In addition, the following interventions \\nshould be considered:\\n1. Intravenous antibiotics, such as piperacillin-tazobactam  4.5 g every  \\n6 hours, OR a combination of ampicillin 2 g every 6 hours + metroni-\\ndazole 500 mg every 8 hours + levofloxacin 750 mg daily.\\n2. Parenteral steroid treatment with either hydr ocortisone 100 mg every \\n8 hours, methylprednisolone 16 mg every 8 hours, or prednisolone   \\n30 mg every 12 hours.\\n3. Intravenous infliximab 5 mg/kg can be effective in fulminant colitis \\nunresponsive to intravenous corticosteroids.\\nThe majority of patients with mild to moderate disease can be treated as \\noutpatients. Therapy listed below should be discussed with a gastroenter -\\nologist, and close follow-up must be ensured.\\n1. For mild active proctitis and left-sided colitis, mesalamine supposito-\\nries (1000 mg at bedtime) or enemas (4 g at bedtime) are effective. \\nHowever, topical steroid preparations (beclomethasone, hydrocorti-\\nsone) may be better tolerated.\\n2. For patients who do not respond to or tolerate topical therapy, oral mesa-\\nlamine 2.4 to 4 g/day is an effective alternative.\\n3. If topical therapy or oral mesalamine is unsuccessful, prednisone  40 to \\n60 mg/day orally can induce a remission. Once clinical remission is \\nachieved, steroids should be slowly tapered and discontinued.\\n4. Infliximab 5 mg/kg intravenously may be considered for patients who \\nare steroid dependent or refractory.\\nSupportive measures include a nutritious diet, physical and psychologi-\\ncal rest, replenishment of iron stores, dietary elimination of lactose, and \\naddition of bulking agents, such as psyllium. Antidiarrheal agents can \\nprecipitate toxic megacolon and should be avoided.\\n■ ■FURtHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 73, “Disorders Presenting Primarily with Diarrhea,” \\nby Nicholas E. Kman and Howard A. Werman.\\n37_Cydulka_Ch37.indd   232 01/05/17   10:26 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 251, 'page_label': '233'}, page_content='233\\nAcute and Chronic Constipation\\nThomas E. Carter\\nConstipation is the most common digestive complaint in the United States. \\nGut motility is affected by diet, activity level, and multiple, often overlap-\\nping, causes.\\n■ ■CLINICAL FEATURES\\nConstipation is characterized by the presence of two or more of the follow-\\ning complaints straining, hard stools, incomplete evacuation, and fewer \\nthan three bowel movements per week. Constipation is chronic in patients \\nwith symptoms for 12 weeks consecutive or nonconsecutive of the preced-\\ning 12 months. Differentiating acute from chronic and functional from \\norganic constipation can guide treatment. Functional constipation features \\ninclude changes in medications or dietary supplements, a decrease in fluid \\nor fiber intake, or a change in activity level including illness or injury. \\nOrganic constipation is suggested by acute onset, weight loss, rectal bleed-\\ning/melena, nausea/vomiting, inability to pass flatus, fever, rectal pain and \\nchange in stool caliber. Organic constipation has priority diagnosis of \\nobstruction and carcinoma. A family history of colon, ovarian or uterine \\ncancer plus an assessment of associated illnesses may elucidate other pri-\\nmary or comorbid diagnoses: cold intolerance (hypothyroidism), diverticu-\\nlitis (inflammatory stricture), or nephrolithiasis (hyperparathyroidism). \\nDiarrhea may occur with constipation/obstruction symptoms, as liquid \\nstool can pass around an impaction or obstructive source.\\nPhysical examination should focus on detection of hernias, abdominal \\nmasses, and ascites (carcinoma). Bowel sounds will be decreased in the \\nsetting of slow gut transit, but increased in the setting of obstruction. Visual \\nand digital rectal examination will detect tone, masses, foreign bodies, \\nhemorrhoids, abscesses, fecal impaction, anal fissures, or fecal blood. The \\nlatter, accompanied by weight loss or decreasing stool caliber, may confirm \\nthe presence of carcinoma. Fecal impaction may produce ulcers causing \\nrectal bleeding.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe differential diagnosis for constipation is extensive, as noted in \\nTable 38-1. Prioritize testing to evaluate organic constipation and complica-\\ntions of functional constipation based on suspicion; this may include a \\ncomplete blood count (to rule out anemia), thyroid stimulating hormone (to \\nrule out hypothyroidism), and electrolyte determinations (to rule out hypo-\\nkalemia or hypercalcemia). Flat and erect abdominal films may be useful in \\nconfirming obstruction and pseudo-obstruction or assessing stool burden. \\ncomputed tomography (CT) scan of the abdomen and pelvis with contrast \\nmay be necessary to identify organic causes of constipation including \\nobstruction, carcinoma, or impaction.\\nChronic constipation is usually a functional disorder that can be \\nworked up on an outpatient basis. However, complications of chronic \\n38\\nCh A p TER\\n38_Cydulka_Ch38.indd   233 21/04/17   10:45 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 252, 'page_label': '234'}, page_content='234 SECTION 6: Gastrointestinal Emergencies\\nconstipation, such as fecal impaction and intestinal pseudo-obstruction, \\nmay become life-threatening and will require manual, colonoscopic, or \\nsurgical intervention.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nTreatment of functional constipation is directed at severity, symptomatic \\nrelief, as well as addressing lifestyle issues. Occasionally, specific treat-\\nment is required for complications of constipation or for underlying disor -\\nders that can prevent organic constipation.\\n●■  The most important prescription for functional constipation is a dietary and \\nexercise regimen that includes fluids (1.5 L/d), fiber (10 g/d), and exercise. \\nFiber in the form of bran (1 cup/d) or psyllium 1 tsp 3 times a day increases \\nstool volume and gut motility. Ducosate sodium 100 mg daily/twice a day \\nfacilitates the mixture of stool fat and water improving symptoms of \\ndiscomfort.\\n●■  Fecal impaction is unpleasant and uncomfortable stool should be removed \\nmanually with the aid of local anesthetic lubricant and parenteral analgesia \\nor sedation as needed. In female patients, transvaginal pressure with the \\nother hand may assist evacuation. The success of any other treatment regi-\\nmen is often dependent on manual disimpaction. Following disimpaction, \\na regimen of diet, exercise, and medication should be prescribed to reestab-\\nlish fecal flow.\\n●■  Enemas of soapsuds 1500 mL PR or mineral oil 100 to 150 mL PR are \\nlow-risk treatments, well tolerated, and should follow fecal disimpaction. \\nUse care to avoid local trauma and rectal perforation.\\n●■  Medications alone may relieve mild cases of constipation. Stimulants can \\nbe either given by mouth, as with docusate sodium/sennosides 1 to 2 \\ntablets PO daily or twice daily or per rectum, as with bisacodyl 10 mg PR \\nthree times daily in adults or children. In the absence of renal failure, saline \\nlaxatives such as milk of magnesia 15 to 30 mL PO once or twice a day  \\nor magnesium citrate 240 mL PO once are useful. Hyperosmolar agents \\nsuch as lactulose or sorbitol 15 to 30 mL PO once or twice a day may be \\nhelpful, as is polyethylene glycol 17 g PO. In children, glycerin rectal \\nTAble 38-1 Differential Diagnosis of Constipation\\nAcute Causes\\nGI: quickly growing tumors, strictures, hernias, adhesions, inflammatory conditions, \\nand volvulus\\nMedicinal: narcotic analgesic, antipsychotic, anticholinergic, antacid, antihistamine\\nExercise and nutrition: decrease in level of exercise, fiber intake, fluid intake\\nPainful anal pathology: anal fissure, hemorrhoids, anorectal abscesses, proctitis\\nChronic Causes\\nGI: slowly growing tumor, colonic dysmotility, chronic anal pathology\\nMedicinal: chronic laxative abuse, narcotic analgesic, antipsychotic, anticholinergic, \\nantacid, antihistamine\\nNeurologic: neuropathies, Parkinson disease, cerebral palsy, paraplegia\\nEndocrine: hypothyroidism, hyperparathyroidism, diabetes\\nElectrolyte abnormalities: hypomagnesia, hypercalcemia, hypokalemia\\nRheumatologic: amyloidosis, scleroderma\\nToxicologic: lead, iron\\n38_Cydulka_Ch38.indd   234 21/04/17   10:45 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 253, 'page_label': '235'}, page_content='CHAPTER 38: Acute and Chronic Constipation 235 \\nsuppositories, or mineral oil (age 5 to 11 years: 5 to 15 mL PO daily; age \\n>12 years: 15 to 45 mL PO daily) have been advocated.\\n●■  Management of constipation in palliative care, chronic opioid use, or abuse \\nhas no definitive regimen. When the above measures are unsuccessful, sup-\\nport is increasing for methylnatrexone 0.15 mg/kg subcutaneous a maxi-\\nmum dose of 12 mg.\\n●■  Many constipated patients can be safely discharged from the ED with \\nestablished fecal flow or key aspects addressed (Tables 38-2 and 38-3). \\nEarly follow-up is indicated in patients with recent severe constipation; \\nTAble 38-2 Suggested Laboratory Studies for Goal-Directed Clinical Testing in \\nAcute Abdominal pain\\nLaboratory Test Clinical Suspicion\\nAmylase Pancreatitis (if lipase is not available)\\nLipase Pancreatitis\\nβ-Human chorionic gonadotrophin Pregnancy\\nEctopic or molar pregnancy\\nCoagulation studies (prothrombin time/\\npartial thromboplastin time)\\nGI bleeding\\nEnd-stage liver disease\\nCoagulopathy\\nElectrolytes Dehydration\\nEndocrine or metabolic disorder\\nGlucose Diabetic ketoacidosis\\nPancreatitis\\nGonococcal/chlamydia testing Cervicitis/urethritis\\nPelvic inflammatory disease\\nHemoglobin GI bleeding\\nLactate Mesenteric ischemia\\nLiver function tests Cholecystitis\\nCholelithiasis\\nHepatitis\\nPlatelets GI bleeding\\nRenal function tests Dehydration\\nRenal insufficiency\\nAcute renal failure\\nUrinalysis Urinary tract infection\\nPyelonephritis\\nNephrolithiasis\\nECG Myocardial ischemia or infarction\\nSource: Reproduced with permission from Cline DM, Stead LG. Abdominal Emergencies. New York: \\nMcGraw-Hill Medical; 2008.\\nTAble 38-3 Key Aspects to Address Before Discharging a Constipated patient\\nPossible obstructing lesion\\nSystemic illness\\nMedication interaction/effect\\nElectrolyte imbalance\\nPotential for intestinal perforation with self-administered enemas\\n38_Cydulka_Ch38.indd   235 21/04/17   10:45 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 254, 'page_label': '236'}, page_content='236 SECTION 6: Gastrointestinal Emergencies\\nchronic constipation associated with systemic symptoms, such as weight \\nloss, anemia, or change in stool caliber; refractory constipation; and con-\\nstipation requiring chronic laxative use. Patients with organic constipation \\nsecondary to obstruction require hospitalization and surgical evaluation.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 71, “Acute Abdominal Pain,” by Mary Claire O’Brien.\\n38_Cydulka_Ch38.indd   236 21/04/17   10:45 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 255, 'page_label': '237'}, page_content='237\\nGastrointestinal Bleeding\\nMitchell C. Sokolosky\\nGastrointestinal (GI) bleeding is a common problem in emergency medi-\\ncine and should be considered life-threatening until proven otherwise. \\nAcute upper GI bleeding is more common than lower GI bleeding. Upper \\nGI bleeding is defined as that originating proximal to the ligament of Treitz. \\nUpper GI bleeds can result from peptic ulcer disease, erosive gastritis and \\nesophagitis, esophageal and gastric varices, and Mallory–Weiss syndrome. \\nLower GI bleeds most commonly result from diverticular disease, followed \\nby colitis, adenomatous polyps, and malignancies. What may initially \\nappear to be lower GI bleeding may be upper GI bleeding in disguise.\\n■ ■CLINICAL FEATURES\\nMost patients complain of hematemesis, coffee-ground emesis, hematoche-\\nzia, or melena. Others will present with hypotension, tachycardia, angina, \\nsyncope, weakness, and confusion. Hematemesis or coffee-ground emesis \\nsuggests an upper GI source. Melena suggests a source proximal to the \\nright colon. Hematochezia (bright red or maroon-colored) indicates a more \\ndistal colorectal lesion; however, approximately 10% of hematochezia may \\nbe associated with upper GI bleeding. Weight loss and changes in bowel \\nhabits are classic symptoms of malignancy. V omiting and retching, fol-\\nlowed by hematemesis, is suggestive of a Mallory–Weiss tear. A history of \\nmedication or alcohol use should be sought. This history may suggest \\npeptic ulcer disease, gastritis, or esophageal varices. Spider angiomata, \\npalmar erythema, jaundice, and gynecomastia suggest underlying liver \\ndisease. Ingestion of iron or bismuth can simulate melena, and certain \\nfoods, such as beets, can simulate hematochezia. However, stool heme \\n(guaiac) testing will be negative.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe diagnosis may be obvious with the finding of hematemesis, coffee \\nground emesis, hematochezia, or melena. A careful ear, nose, and throat \\n(ENT) examination can exclude swallowed blood as a source. Nasogastric \\n(NG) tube placement and aspiration may detect occult upper GI bleeding. \\nA negative NG aspirate does not conclusively exclude an upper GI source. \\nGuaiac testing of NG aspirate can yield both false-negative and false-\\npositive results. Most reliable is gross inspection of the aspirate for a \\nbloody, maroon, or coffee-ground appearance. A rectal examination can \\ndetect the presence of blood, its appearance (bright red, maroon, or mela-\\nnotic), and the presence of masses. All patients with significant GI bleeding \\nrequire type and crossmatch for blood. Other important tests include a \\ncomplete blood count, electrolytes, blood urea nitrogen, creatinine, glu-\\ncose, coagulation studies, and liver function tests. The initial hematocrit \\nlevel may not reflect the actual amount of blood loss. Upper GI bleeding \\nmay elevate the blood urea nitrogen level. Routine plain radiographs are of \\nlimited value. The initial diagnostic procedure of choice for lower GI \\n39\\nCh A p TER\\n39_Cydulka_Ch39.indd   237 16/03/17   10:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 256, 'page_label': '238'}, page_content='238 SECTION 6: Gastrointestinal Emergencies\\nbleeds—angiography, scintigraph y, or endoscopy—depends on resource \\nability and consultant preference. In one study, a cause for lower GI bleed-\\ning was found in <50% of cases.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Emergency stabilization (airway, breathing, and circulation) takes \\npriority. Administer oxygen, insert lar ge-bore intravenous catheters, \\nand institute continuous monitoring.\\n2. Replace volume loss immediately with isotonic crystalloids (e.g., nor -\\nmal saline or Ringer lactate). The decision to transfuse blood is based \\non clinical factors (continued active bleeding and no improvement in \\nperfusion after administration of 2 L of crystalloids) rather than initial \\nhematocrit values. The threshold for blood transfusion should be lower \\nin the elderly.\\n3. Replace coagulation factors, as needed.\\n4. A nasogastric tube is recommended in most patients with significant GI \\nbleeding, regardless of the presumed source. If bright red blood or clots \\nare found, perform gentle gastric lavage.\\n5. Consider early therapeutic endoscopy for significant upper GI bleed-\\ning. Timing of endoscopy for diagnosis and treatment of some lower \\nGI bleeding sources can vary. It is estimated that 80% of lower GI \\nbleeding will resolve spontaneously.\\n6. Proton pump inhibitors (e.g., pantoprazole 80 mg bolus followed by \\nan infusion of 8 mg/h) are recommended for patients with non variceal \\nbleeding from peptic ulcer disease.\\n7. Consider octreotide 25 to 50 μg bolus followed by 25 to 50 μg/h intra-\\nvenously for patients with upper GI bleeding.\\n8. Balloon tamponade with the Sengstaken–Blakemore tube or its vari -\\nants should only be considered an adjunctive or temporizing measure \\nand is rarely used due to the high complication rate.\\n9. A surgical and gastroenterology consult should be obtained in patients \\nwith uncontrolled bleeding. Patients who do not respond to both phar -\\nmacologic and endoscopic treatments may require emer gent surgery.\\n10. Most patients with GI bleeding will require hospital admission and \\nearly referral to an endoscopist.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 75, “Upper Gastrointestinal Bleeding,” by Christopher \\nM. Ziebell, Andy Kitlowski, Janna M. Welch and Phillip A. Friesen; Chapter 76, \\n“Lower Gastrointestinal Bleeding,” by Bruce M. Lo.\\n39_Cydulka_Ch39.indd   238 16/03/17   10:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 257, 'page_label': '239'}, page_content='239\\nEsophageal Emergencies\\nMitchell C. Sokolosky\\nComplaints of dysphagia, odynophagia, or ingested foreign body usually \\nimply esophageal disease. Chest pain, upper gastrointestinal (GI) bleeding, \\nmalignancy, and mediastinitis may also be esophageal in nature. Many \\ndiseases of the esophagus can be evaluated over time in an outpatient set-\\nting, but several, such as esophageal foreign body and esophageal perfora-\\ntion, require emergent evaluation.\\n■ ■DYSPHAGIA\\nDysphagia is difficulty with swallowing. Most patients with dysphagia have \\nan identifiable organic cause. The two broad pathophysiologic groups of \\ndysphagia are transfer dysphagia (oropharyngeal) and transport dysphagia \\n(esophageal).\\nClinical Features\\nA careful history is the key to the diagnosis of dysphagia. Determine \\nwhether solids, liquids, or both cause the symptoms and the time course and \\nprogression of symptoms. Dysphagia for solids that progresses to liquids \\nsuggests a mechanical or obstructive process. Dysphagia for both solids and \\nliquids points to a motility disorder. A poorly chewed meat bolus may \\nobstruct the esophagus and be the presenting sign for a variety of underly-\\ning esophageal pathologies. Esophageal filling proximal to the impacted \\nbolus can cause inability to swallow secretions and can present an airway \\nor aspiration risk. Physical examination of patients with dysphagia should \\nfocus on the head and neck and the neurologic examination, although the \\nexamination is often normal.\\nDiagnosis and Differential\\nThe diagnosis of the underlying pathology of dysphagia is most often made \\noutside the emergency department (ED). ED evaluation may include \\nanteroposterior and lateral neck and chest x-rays. Direct laryngoscopy may \\nidentify lesions. Structural or obstructive causes of dysphagia include neo-\\nplasms (squamous cell is most common), esophageal strictures and webs, \\nSchatzki ring, and diverticula. Motor lesions causing dysphagia include \\nneuromuscular disorders (cerebrovascular accident is most common), acha-\\nlasia, diffuse esophageal spasm, and esophageal dysmotility.\\nEmergency Department Care and Disposition\\n1. Aspiration is a major concern with most causes of dysphagia.\\n2. Most causes of dysphagia can be further evaluated and managed in the \\noutpatient setting using a variety of tools including barium sw allow \\n(often first test), video esophagograpy, manometry, and esophagoscopy.\\n3. Many of the structural lesions ultimately will require dilatation as \\ndefinitive therapy.\\n40\\nC HAP ter\\n40_Cydulka_Ch40.indd   239 16/03/17   11:14 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 258, 'page_label': '240'}, page_content='240 SECTION 6: Gastrointestinal Emergencies\\n■ ■CHeSt PAIN OF eSOPHAGeAL OrIGIN\\nDifferentiating esophageal pain from ischemic chest pain is difficult at best \\nand may be impossible in the ED. Patients with esophageal pain report \\nsymptoms that are also found in patients with coronary artery disease, and \\nthere is no historical feature that is sensitive or specific enough to differen-\\ntiate the two. The best ED default assumption is that pain is cardiac in \\nnature and not esophageal until proven otherwise.\\nGastroesophageal Reflux Disease\\nReflux of gastric contents into the esophagus causes a wide array of symp-\\ntoms and long-term effects.\\nClinical Features\\nHeartburn is the classic symptom of gastroesophageal reflux disease \\n(GERD), although chest discomfort may be the only symptom. The asso-\\nciation of pain with meals, postural changes, and relief of symptoms with \\nantacids point to a diagnosis of GERD. Less obvious presentations of \\nGERD include pulmonary symptoms, especially asthma exacerbations, and \\nmultiple ear, nose, and throat symptoms. GERD has also been implicated \\nin the etiology of dental erosion, vocal cord ulcers and granulomas, laryn-\\ngitis with hoarseness, chronic sinusitis, and chronic cough. Over time, \\nGERD can cause complications such as strictures, inflammatory esophagi-\\ntis, and Barrett esophagus (a premalignant condition).\\nDiagnosis and Differential\\nDiagnosis is suggested by history and favorable response to antacid treat-\\nment. However, some patients with symptoms due to cardiac ischemia also \\nreport improvement with the same therapy. Unfortunately, like cardiac pain, \\nGERD pain may be squeezing or pressure-like and includes a history of \\nonset with exertion or rest. Both types of pain may be accompanied by \\ndiaphoresis, pallor, radiation, and nausea and vomiting. An ECG and chest \\nradiograph can be obtained in patients with ambiguous presentations. \\nGiven the serious outcome of unrecognized ischemic disease compared \\nwith the relatively benign nature of esophageal pain, a cautious approach is \\nwarranted.\\nEmergency Department Care and Disposition\\n1. Comprehensive treatment of reflux disease is done on an outpatient \\nbasis and involves decreasing acid production, enhancing upper tract \\nmotility, and eliminating risk factors for the disease.\\n2. Mild disease often is treated empirically with an H 2 blocker (e.g., \\nranitidine 150 mg PO twice daily) or proton pump inhibitor (e.g., \\nomeprazole 20 to 40 mg PO daily).\\n3. Prokinetic drugs (e.g., metoclopramide 10 to 15 mg PO 30 minutes \\nbefore meals and at bedtime) may reduce symptoms and decrease dose \\nby 50% in elderly patients.\\n4. Patients should avoid agents that e xacerbate GERD (ethanol, caffeine, \\nnicotine, chocolate, or fatty foods), sleep with the head of the bed \\nelevated (30°), and avoid eating within 3 hours of going to bed at night.\\n40_Cydulka_Ch40.indd   240 16/03/17   11:14 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 259, 'page_label': '241'}, page_content='CHAPTER 40: Esophageal Emergencies 241 \\nEsophagitis\\nEsophagitis can cause prolonged periods of chest pain and odynophagia. \\nEsophagitis may be inflammatory (e.g., GERD, NSAIDs, potassium chlo-\\nride, doxycycline, tetracycline, and clindamycin) or infectious if immuno-\\nsuppressed (e.g., Candida most common, herpes simplex, cytomegalovirus \\n(CMV),  and aphthous ulceration). Withdrawal of offending agent is gener-\\nally curative with medication-induced esophagitis. Patients with reflux-\\ninduced esophagitis require acid-suppressive medications. Infectious causes \\nare established by endoscopy often with biopsy and specimen cultures.\\nEsophageal Perforation\\nIatrogentic perforation is most common. Other causes include transient \\nincrease in intraesophageal pressure (Boerhaave syndrome), trauma, for -\\neign body, infection, tumor, and aortic pathology. Perforation of the \\nesophagus is associated with a high mortality rate.\\nClinical Features\\nPain is classically described as acute, severe, unrelenting, and diffuse and is \\nreported in the chest, neck, and abdomen. Pain can radiate to the back and \\nshoulders, or back pain may be the predominant symptom. Swallowing often \\nexacerbates pain. Physical examination varies with the severity of the rupture \\nand the elapsed time between the rupture and presentation. Abdominal rigid-\\nity with hypotension and fever often occur early. Tachycardia and tachypnea \\nare common. Mediastinal emphysema takes time to develop. It is less com-\\nmonly detected by examination or radiography in lower esophageal perfora-\\ntion and its absence does not rule out perforation. A Hammon crunch can \\nsometimes be auscultated. Pleural effusions develop in 50% of patients with \\nintrathoracic perforations and are uncommon in cervical perforations.\\nDiagnosis and Differential\\nChest radiography can suggest the diagnosis. Given the limitations of CT, an \\nesophagram or emergency endoscopy is most often used to confirm the diag-\\nnosis. Selection of the procedure depends upon the clinical setting and the \\nresources available. Mistaking perforation for acute myocardial infarction, \\npulmonary embolism, or an acute abdomen can lead to delays in therapy.\\nEmergency Department Care and Disposition\\n1. Rapid, aggressive management is essential.\\n2. In the ED, initiate fluid resuscitation (see Chapter 5) and give broad-\\nspectrum parental antibiotics to cover aerobic and anaerobic organisms. \\nExamples include single drug coverage such as piperacillin/tazobactam \\n3.375 g intravenously (IV) or double drug coverage with cefotaxime   \\n2 g IV or ceftriaxone 2 g IV plus clindamycin 600 mg IV or metroni-\\ndazole 15 mg/kg IV once, then 7.5 mg/kg q6h (maximum 1 g/dose).\\n3. Obtain emergent surgical consultation.\\n4. All of these patients require hospitalization.\\nSwallowed Foreign Bodies\\nChildren (18 to 48 months old) and those with mental illness account for \\nmost cases. Coins, toys, and crayons typically lodge in the anatomically \\n40_Cydulka_Ch40.indd   241 16/03/17   11:14 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 260, 'page_label': '242'}, page_content='242 SECTION 6: Gastrointestinal Emergencies\\nnarrow proximal esophagus. Adult candidates are those with esophageal \\ndisease, prisoners, and psychiatric patients. In adults, most impactions are \\ndistal. Complications include airway obstruction, stricture, and perforation. \\nOnce an object transverses the pylorus, it usually continues through the GI \\ntract. Objects that become lodged distal to the pylorus are usually irregular, \\nhave sharp edges, and are wide (>2.5 cm) or long (>6 cm)\\nClinical Features\\nObjects lodged in the esophagus can produce retrosternal pain, dysphagia, \\ncoughing, choking, vomiting, and aspiration, and the patient may be unable \\nto swallow secretions. Adults with an esophageal foreign body generally \\nprovide unequivocal history. In the pediatric patient it may be necessary to \\nrely on clues such as refusal or inability to eat, vomiting, gagging, choking, \\nstridor, neck or throat pain, dysphagia, and drooling.\\nDiagnosis and Differential\\nPhysical examination starts with an assessment of the airway. The naso-\\npharynx, oropharynx, neck, and chest should also be examined. Occasion-\\nally, a foreign body can be directly visualized in the oropharynx. Plain films \\nare used to screen for radiopaque objects. CT scanning has replaced the \\nbarium swallow test to evaluate for nonradiopaque objects.\\nEmergency Department Care and Disposition\\n1. Patients in extremis or with pending airway compromise are resuscitated \\nin standard fashion and may require active airway management.\\n2. Emergent endoscopy is indicated for complete distal obstruction of the \\nesophagus with pooling of secretions (often distal esophageal food \\nimpaction).\\n3. Hospital admission is generally not needed if the foreign body is easily \\nremoved by endoscopy without complications.\\n4. In stable patients, indirect or fiberoptic laryngoscopy may allow removal \\nof very proximal objects.\\n5. Consult surgery for worrisome foreign bodies that are in the more distal \\nGI tract.\\nFood Impaction\\nMeat is the most common cause of food impaction.\\n1. Complete esophageal obstruction requires emergency endoscopy.\\n2. Uncomplicated food impaction may be treated expectantly but should \\nnot be allowed to remain impacted for >12 to 24 hours.\\n3. The use of proteolytic enzymes (e.g., Adolph Meat Tenderizer , which \\ncontains papain) to dissolve a meat bolus is contraindicated.\\n4. Glucagon 1 to 2 mg for adults may be attempted but success rates are poor.\\nCoin Ingestion\\n1. Obtain radiographs on all children suspected of swallowing coins to \\ndetermine the presence and location of the object. Coins in the esopha-\\ngus present their circular face on anteroposterior films, as opposed to \\ncoins in the trachea, which show that face on lateral films.\\n40_Cydulka_Ch40.indd   242 16/03/17   11:14 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 261, 'page_label': '243'}, page_content='CHAPTER 40: Esophageal Emergencies 243 \\n2. Coins should be removed by endoscopy if lodged in the esophagus.\\n3. Removal of a coin with a Fole y balloon catheter should be done under \\nfluoroscopy by experienced hands. Complications include aspiration, \\nairway compromise, and mucosal laceration.\\n4. Once in the stomach, coins almost always pass spontaneously.\\nButton Battery Ingestion\\nA b utton battery lodged in the esophagus is a true emergency requiring \\nprompt removal because the battery may quickly induce mucosal injury and \\nnecrosis. Perforation may occur within 6 hours of ingestion.\\n1. Resuscitate the patient as needed.\\n2. Obtain radiographs to locate position of the battery.\\n3. Emergency endoscopy is indicated if battery is lodged in the esophagus. \\nFoley balloon catheter technique may be considered if reliable history of \\ningestion ≤2 hours is obtained.\\n4. Batteries that have passed the esophagus can be managed expectantly \\nwith 24-hour follow-up examination. Repeat x-rays at 48 hour to ensure \\npassage through pylorus. Most batteries pass through the body in 48 to \\n72 hours but may take longer.\\n5. Consult surgery if the patient develops symptoms or signs of GI tract \\ninjury.\\n6. The National Button Battery Ingestion Hotline at 202-625-3333 is a \\n24-hours, 7 days-a-week resource for help with management decisions.\\nIngestion of Sharp Objects\\n1. Sharp objects in the esophagus, stomach, or duodenum require immedi-\\nate removal by endoscopy in order to prevent complications such as \\nperforation.\\n2. If the object is distal to the duodenum at presentation and the patient is \\nasymptomatic, obtain daily plain films to document passage.\\n3. Consider surgical removal if 3 days elapse without passage.\\n4. Consult surgery immediately if the patient develops symptoms or signs \\nof intestinal injury (e.g., pain, emesis, fever, and GI bleeding).\\nNarcotic Ingestion\\n1. The packets (condoms containing up to 5 g of narcotic) ingested by a \\nnarcotic courier (body packer) are often visible on plain x-ray.\\n2. Endoscopy is contraindicated because of the risk of iatrogenic packet \\nrupture, which may be fatal.\\n3. Observation until the packet reaches the rectum is the favored treatment \\nif the packets appear to be passing intact through the GI tract.\\n4. Whole-bowel irrigation may aid in the process of packet remo val.\\n■ ■FUrtHer reADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 77, “Esophageal Emergencies” by Moss Mendelson.\\n40_Cydulka_Ch40.indd   243 16/03/17   11:14 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 262, 'page_label': '244'}, page_content='244\\nPeptic Ulcer Disease  \\nand Gastritis\\nTeresa Bowen-Spinelli\\nPeptic ulcer disease (PUD) is a chronic illness manifested by recurrent \\nulcerations in the stomach and duodenum. Acid and pepsin are crucial for \\nulcer development, but the great majority of ulcers are directly related to \\ninfection with Helicobacter pylori or nonsteroidal anti-inflammatory drugs \\n(NSAIDs) use. Gastritis is an acute or chronic gastric mucosal inflamma-\\ntion and has various causes. Dyspepsia is upper abdominal discomfort with \\nor without other symptoms that can have various causes or be functional.\\n■ ■CLINICAL FEATURES\\nPeptic ulcer disease typically presents with burning epigastric pain, though \\nit may be described as sharp, dull, and an ache, or an “empty” or “hungry” \\nfeeling. It may be relieved by the ingestion of food, milk, or antacids, pre-\\nsumably due to an acid buffering or a dilutional effect. The pain recurs as \\nthe gastric contents empty and the recurrent pain classically awakens the \\npatient at night. Atypical presentations are common in the elderly and may \\ninclude no pain, pain that is not relieved by food, nausea, vomiting, \\nanorexia, weight loss, and/or bleeding.\\nA change in the character of the pain may herald the onset of a compli-\\ncation. Abrupt onset of severe pain is typical of perforation with spillage of \\ngastric or duodenal contents into the peritoneal cavity. Back pain may \\nrepresent pancreatitis from a posterior perforation. Nausea, vomiting, early \\nsatiety, and weight loss may occur with gastric outlet obstruction or cancer. \\nV omiting blood or passing melanotic stools with or without hemodynamic \\ninstability represents a bleeding complication.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nPeptic ulcer disease cannot be definitively diagnosed on clinical grounds, \\nbut it can be strongly suspected in the presence of a “classic” history (as \\nabove) accompanied by “benign” physical examination findings and nor -\\nmal vital signs with or without mild epigastric tenderness. Examination \\nfindings that may be indicative of PUD complications include a rigid abdo-\\nmen consistent with peritonitis in perforation, abdominal distension and \\nsuccussion splash consistent with gastric outlet obstruction, occult or gross \\nrectal blood, or blood in nasogastric aspirate consistent with bleeding.\\nThe differential diagnosis of epigastric pain is extensive. Pain, radiating \\ninto the chest, and belching may point to gastroesophageal reflux disease; \\nmore severe pain in the right upper quadrant (RUQ) radiating around the \\nright side of the abdomen with tenderness suggests cholelithiasis or biliary \\ncolic; pain radiating into the back is common with pancreatitis and/or a \\nconcomitant mass may represent a pseudocyst or if the mass is pulsatile \\nmay represent an abdominal aortic aneurysm. Chronic pain, anorexia, and \\nweight loss with or without a mass may represent cancer. Myocardial \\n41\\nCh A p TER\\n41_Cydulka_Ch41.indd   244 16/03/17   11:24 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 263, 'page_label': '245'}, page_content='CHAPTER 41: Peptic Ulcer Disease and Gastritis  245 \\nischemia may present as epigastric pain and should be strongly considered \\nin the appropriate clinical setting, especially in the population of diabetics \\nand the elderly.\\nSome ancillary tests may be helpful to exclude PUD complications and \\nto narrow the differential. A normal CBC rules out chronic (but not acute) \\ngastrointestinal (GI) bleeding. Elevated liver enzymes may indicate hepati-\\ntis. Elevated lipase may indicate pancreatitis. An upright xray may show \\nfree air in the setting a perforation and an abdominal US examination may \\nshow cholecystitis, cholelithiasis, or an abdominal arotic aneurysm. An \\nECG and troponin are indicated if myocardial ischemia is suspected.\\nThe gold standard for diagnosis of PUD is visualization of an ulcer by \\nupper GI endoscopy. Endoscopy is indicated in most patients with upper GI \\nbleeding and in any patient with certain “alarm” features consistent with \\ncancer: age >55 year, unexplained weight loss, early satiety or anorexia, \\npersistent vomiting, dysphagia, anemia, abdominal mass, or jaundice. \\nBecause of the strong association of H. pylori infection with PUD, testing \\nfor the presence of H. pylori with PUD is usually indicated, but this is \\ngenerally more appropriate at the time of follow-up with gastroenterologist.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nAfter PUD is diagnosed, the goal of treatment is to heal the ulcer while \\nrelieving pain and preventing complications and avoiding recurrence. If the \\npatient is infected with H. pylori then it must be eradicated in order to pre-\\nvent ulcer recurrence. NSAIDs should be stopped whenever possible.\\n1. Proton pump inhibitors (PPIs) act to decrease acid production by block-\\ning H+ ion secretion. They serve to heal ulcers faster than other thera-\\npies and also have an inhibitory effect on H. pylori. PPIs should be taken \\nabout 30 to 60 minutes prior to a meal. Include omeprazole 20 to 40 mg \\ndaily, esomeprazole 20 to 40 mg daily, 20 to 40 mg daily, lansoprazole \\n15 to 30 mg daily, pantoprazole 20 to 40 mg daily, or rabeprazole  \\n20 mg daily.\\n2. Histamine-2 receptor antagonists (H2RAs) inhibit acid secretion and are \\navailable over the counter. H 2RAs include cimetidine 200 to 400 mg \\ntwice a day, famotidine 10 to 20 mg twice a day; nizatidine 75 to 150 \\nmg twice a day; and ranitidine 75 to 150 mg twice a day.\\n3. Liquid antacids relieve pain and heal ulcers by buf fering gastric acid. \\nDue to the minimal side effects of PPIs and H 2RAs, liquid antacids are \\ngenerally used on an as needed basis for pain relief. Typical dosing is  \\n15 mL, 1 hour after meals and at bedtime.\\n4. If present, H. pylori infection should be treated, though this would rarely \\nbe initiated in the ED. There are multiple therapies, but the most com-\\nmon is “triple therapy” formulation taken for 14 days which consists of \\na PPI, clarithromycin, and either amoxicillin or metronidazole.\\n5. Patients with complications always require consultation and most \\nrequire admission for continued treatment. For the treatment of bleeding \\n(see Chapter 39). For perforation provide resuscitation as needed, start \\nbroad-spectrum antibiotics, and obtain immediate surgical consultation. \\nFor gastric outlet obstruction provide resuscitation as needed, place a \\nnasogastric tube, and admit for continued treatment.\\n41_Cydulka_Ch41.indd   245 16/03/17   11:24 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 264, 'page_label': '246'}, page_content='246 SECTION 6: Gastrointestinal Emergencies\\n6. When uncomplicated PUD is suspected in a stable patient, the great \\nmajority can be discharged home on a PPI or an H 2RA with a liquid \\nantacid for breakthrough pain and with recommendations to follow-up \\nwith their primary care provider for further evaluation as indicated. \\nPatients with “alarm” features who are stable enough for discharge \\nshould be referred for endoscopy.\\n7. Patients should be told that PUD is a presumptive diagnosis and that  \\nfor definitive diagnosis gastroenterologists should perform an endos-\\ncopy. They should return for further evaluation or treatment if any of \\nthe following occur: worsening pain, increased vomiting, hematemesis \\nor melena, weakness or syncope, fever, or chest pain.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 7th ed., see Chapter 78, “Peptic Ulcer Disease and Gastritis,” by \\nMatthew C. Gratton and Angela Bogle.\\n41_Cydulka_Ch41.indd   246 16/03/17   11:24 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 265, 'page_label': '247'}, page_content='247\\nPancreatitis and Cholecystitis\\nRita K. Cydulka\\nAcute pancreatitis (AP) is an inflammation of the pancreas. Disease sever -\\nity ranges from mild local inflammation to multisystem organ failure \\nsecondary to a systemic inflammatory response. Cholelithiasis and alcohol \\nabuse are the most common causes, but there are many potential etiologies. \\nPatients without risk factors often develop pancreatitis secondary to \\nmedications or severe hyperlipidemia. Commonly used medications associ-\\nated with pancreatitis include acetaminophen, carbamazepine, enalapril, \\nestrogens, erythromycin, furosemide, hydrochlorothiazide, opiates, \\nsteroids, tetracycline, and trimethoprim-sulfamethoxazole.\\n■ ■PANCREATITIS\\nClinical Features\\nThe most common symptom is a midepigastric, constant, boring pain \\nradiating to the back that is worse when the patient is supine and is often \\nassociated with nausea, vomiting, and abdominal distention. Low-grade \\nfever, tachycardia, and hypotension may be present. Epigastric tenderness \\nis common, whereas peritonitis is a late finding.\\nPhysical findings are dependent on the severity of disease. Physical \\nexamination findings include epigastric tenderness, but tenderness may \\nlocalize more to the right or left upper quadrant of the abdomen. Bowel \\nsounds may be diminished and abdominal distention may be present second-\\nary to ileus. Refractory hypotensive shock, renal failure, fever, altered mental \\nstatus, and respiratory failure may accompany the most severe disease.\\nDiagnosis and Differential\\nThe diagnosis should be suspected by the history and physical examination. \\nThe presence of two of the three following features makes the diagnosis \\nmore likely: (1) history and examination findings consistent with AP,  \\n(2) lipase or amylase levels at least two to three times the upper limit of \\nnormal, or (3) imaging findings consistent with pancreatic inflammation. \\nLipase is the preferred diagnostic test as it is more accurate. There are many \\nsources of extrapancreatic amylase, making it relatively nonspecific. \\nNormal serum amylase does not exclude the diagnosis of AP. There is no \\nbenefit to ordering both tests.\\nA CBC will identify leukocytosis or anemia. Liver studies can demon-\\nstrate associated biliary involvement. An elevated alkaline phosphatase \\nlevel suggests biliary disease and gallstone pancreatitis. Persistent hypocal-\\ncemia (<7 mg/100 mL), hypoxia, increasing serum urea nitrogen, and \\nmetabolic acidosis are associated with a potentially complicated course.\\nImaging can help confirm the diagnosis of pancreatitis, evaluate biliary \\ninvolvement, and exclude causes of abdominal pain. Abdominal computed \\ntomography (CT) scan is preferred over ultrasound as the latter is often \\nlimited by bowel gas overlying the pancreas. In the face of a typical clinical \\npicture and laboratory results, emergency imaging may not be needed.\\n42\\nCh APTER\\n42_Cydulka_Ch42.indd   247 16/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 266, 'page_label': '248'}, page_content='248 SECTION 6: Gastrointestinal Emergencies\\nThe differential diagnosis includes referred chest pain secondary to \\nischemic heart disease, pulmonary pathology such as pneumonia or empy-\\nema, hepatitis, cholec ystitis or biliary colic, ascending cholangitis, renal \\ncolic, small bowel obstruction, peptic ulcer disease or gastritis, and acute \\naortic pathology such as aneurysm or dissection.\\nEmergency Department Care and Disposition\\nCare for the patient with pancreatitis includes fluid resuscitation; manage-\\nment of nausea, vomiting, and pain; and diligent monitoring of vital signs \\nand pulse oximetry.\\n1. Initiate aggressive fluid resuscitation with crystalloid intravenous fluid. \\nPressors are indicated for hypotension not responsive to adequate fluid \\nresuscitation.\\n2. All patients with nausea and vomiting should initially be NPO.\\n3. Administer antiemetics, such as ondansetron 4 mg or prochlorpera-\\nzine 5 to 10 mg to reduce vomiting.\\n4. Administer parenteral analgesia for patient comfort. Intravenous  \\nopioids such as morphine 0.1 mg/kg are often required.\\n5. Administer oxygen to maintain a pulse oximetry reading of 95%  \\noxygen saturation. Treat respiratory failure aggressively.\\n6. Treat patients with infected pseudocyst, abscess, or infected peripan-\\ncreatic fluid with imipenem-cilastatin 500 mg IV , meropenem 1 g IV , \\nor ciprofloxacin 400 mg IV and metronidazole 500 mg IV .\\n7. Patients with severe systemic disease will require intubation, intensive \\nmonitoring, bladder catheterization, and transfusion of blood and blood \\nproducts as needed. Symptomatic hypocalcemia should be corrected. \\nLaparotomy may be indicated for hemorrhage or abscess drainage.\\n8. Consult gastroenterology for patients with gallstone pancreatitis for \\nendoscopic retrograde cholangiopancreatography (ERCP) and sphinc -\\nterotomy.\\n9. Most patients will require hospitalization. Patients who demonstrate \\npoor prognostic signs (dropping hemoglobin, poor urine output, \\npersistent hypotension, h ypoxia, acidosis, or hypocalcemia) despite \\naggressive early treatment should be admitted to the intensive care unit \\nwith surgical consultation.\\n10. Patients with mild disease, no biliary tract disease, and no evidence of \\nsystemic complications may be managed as outpatients with close \\nfollow-up if they tolerate clear liquids and oral analgesics in the ED. \\nInstruct patients to increase their diet as tolerated once nausea is  \\ncontrolled.\\n■ ■ChOLECYSTITIS\\nBiliary tract emergencies most often result from obstruction of the gallblad-\\nder or biliary duct by gallstones. The four most common biliary tract \\nemergencies caused by gallstones are biliary colic, cholecystitis, gallstone \\npancreatitis, and ascending cholangitis. Biliary disease affects all age \\ngroups, especially diabetics and the elderly. Gallstones, although common \\nin the general population, remain asymptomatic in most patients. Common \\n42_Cydulka_Ch42.indd   248 16/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 267, 'page_label': '249'}, page_content='CHAPTER 42: Pancreatitis and Cholecystitis 249 \\nrisk factors for gallstones and cholecystitis include advanced age, female \\nsex and parity, obesity, rapid weight loss or prolonged fasting, familial \\ntendency, use of some medications, Asian ancestry, chronic liver disease, \\nand hemolytic disorders (e.g., sickle cell disease).\\nClinical Features\\nPatients with biliary disease present with a wide range of symptoms. \\nBiliary colic may present with epigastric or right upper quadrant pain, may \\nrange from mild to severe, and, although classically described as intermit-\\ntent or colicky, is often constant. Nausea and vomiting are usually present. \\nPain may be referred to the right shoulder or left upper back. It may begin \\nafter eating but often bears no association to meals. Acute episodes of \\nbiliary colic typically last for 1 to 5 hours, followed by a gradual or sudden \\nresolution of symptoms. Recurrent episodes are usually infrequent, gener -\\nally at intervals longer than 1 week. Biliary colic seems to follow a circa-\\ndian pattern, with highest incidence of symptoms between 9 pm and 4 am.\\nPhysical examination commonly demonstrates right upper quadrant or \\nepigastric tenderness without findings of peritonitis.\\nAcute cholecystitis presents with pain similar to that of biliary colic that \\npersists for longer than the typical 5 hours. Fever, chills, nausea, emesis, \\nand anorexia are common. Past history of similar attacks or known gall-\\nstones may be reported. As the gallbladder becomes progressively inflamed, \\nthe initial poorly localized upper abdominal pain often becomes sharp and \\nlocalized to the right upper quadrant. The patient may have moderate to \\nsevere distress and may appear toxic. Choledocholithiasis often presents \\nwith midline pain that radiates to the middle of the back.\\nExamination findings include tenderness in the right upper quadrant or \\nepigastrum, and Murphy’s sign (increased pain or inspiratory arrest during \\ndeep subcostal palpation of the right upper quadrant during deep inspira-\\ntion). Murphy’s sign is the most sensitive physical examination finding for \\nthe diagnosis of cholecystitis. Generalized abdominal rigidity suggests per-\\nforation and diffuse peritonitis. V olume depletion is common, but jaundice \\nis unusual. Acalculous cholecystitis occurs in 5% to 10% of patients with \\ncholecystitis, has a more rapid, aggressive clinical course, and occurs more \\nfrequently in patients with diabetes, the elderly, trauma or burn victims, after \\nprolonged labor or major surgery, or with systemic vasculitides.\\nAscending cholangitis, a life-threatening condition with high mortality, \\nresults from complete biliary obstruction (often a common bile duct stone; \\nless commonly a tumor) with bacterial superinfection. Patients often pres-\\nent in extremis with jaundice, fever, confusion, and shock. Examination \\nfindings can be subtle. Patients commonly have focal right upper quadrant \\npain and nausea. Jaundice may or may not be present. The Charcot triad of \\nfever, jaundice, and right upper quadrant pain is suggestive but all three \\ncomponents are usually not present at once.\\nDiagnosis and Differential\\nSuspicion of gallbladder or biliary tract disease must be maintained in any \\npatient who presents with upper abdominal pain. The differential diagnosis \\nis similar to that of AP (see Diagnosis and Differential section under the \\nsection Pancreatitis, earlier).\\n42_Cydulka_Ch42.indd   249 16/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 268, 'page_label': '250'}, page_content='250 SECTION 6: Gastrointestinal Emergencies\\nPatients with uncomplicated biliary colic usually have normal laboratory \\nfindings. The diagnosis is usually made based on the patient presentation, \\nresponse to therapy, and examining the test results in aggregate.\\nLaboratory studies that may aid in diagnosis include a white blood cell \\ncount; leukocytosis with left shift suggests acute cholecystitis, pancreatitis, \\nor cholangitis, but a normal white blood cell count does not exclude them. \\nSerum bilirubin and alkaline phosphatase levels may be normal or mildly \\nelevated in patients suffering from biliary colic or cholecystitis. Serum \\nbilirubin and alkaline phosphatase levels are usually elevated in cases of \\ncholedocholithiasis and ascending cholangitis. Serum lipase or amylase \\nlevels should be checked to help exclude associated pancreatitis.\\nUltrasound of the hepatobiliary tract is the initial diagnostic study  \\nof choice for patients with suspected biliary colic or cholecystitis  \\n(see Fig. 42-1). It can detect stones as small as 2 mm and signs of chole-\\ncystitis which include a thickened gallbladder wall (>3 to 5 mm), gallblad-\\nder distention (>4 cm in short-axis view), and pericholecystic fluid. A \\npositive sonographic Murphy’s sign is very sensitive for diagnosis of cho-\\nlecystitis when it is elicited during the scan. Ultrasound has a strong posi-\\ntive predictive value (92%) when both a sonographic Murphy’s sign and \\ngallstones are present. Choledocholithiasis is suggested when the common \\nbile duct diameter is greater than 5 to 7 mm.\\nComputed tomography of the abdomen is most useful when additional \\nintraabdominal processes are suspected. Radionuclide cholescintigraphy \\n(technetium-iminodiacetic acid [HIDA]) or diisopropyl iminodiacetic acid \\n([DISIDA] scans) offers a sensitivity of 97% and a specificity of 90% for \\ncholecystitis. A reasonable emergency department (ED) approach to sus-\\npected cholecystitis would be to obtain an ultrasound scan and then a \\nradionuclide scan if ultrasound fails to establish the diagnosis.\\nFigurE 42-1. Abdominal US demonstrating acute cholecystitis with a gallstone \\n(arrow-head ), gallbladder sludge (asterisk), and pericholecystic fluid (arrow ). Used \\nwith permission from Bart Besinger, MD, FAAEM.\\n42_Cydulka_Ch42.indd   250 16/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 269, 'page_label': '251'}, page_content='CHAPTER 42: Pancreatitis and Cholecystitis 251 \\nEmergency Department Care and Disposition\\nCare for the patient with biliary disease includes fluid resuscitation and \\nmanagement of nausea, vomiting, and pain. Uncomplicated biliary colic \\ncan be managed without the aid of consultants. ED treatment includes the \\nfollowing measures:\\n1.  Initiate aggressive fluid resuscitation with crystalloid intrav enous fluid. \\nPressors are indicated for hypotension not responsive to adequate fluid \\nresuscitation.\\n2.  Patients should be made NPO.\\n3.  Administer antiemetics, such as ondansetron 4 mg or prochlorperazine \\n5 to 10 mg to reduce vomiting.\\n4.  Administer parenteral analgesia for patient comfort. Intravenous opioids \\nsuch as morphine 0.1 mg/kg are often required. The intravenous nonste-\\nroidal anti-inflammatory drug (NSAID) ketorolac 30 mg IV may also \\nbe helpful.\\n5.  A nasogastric tube to low suction should be considered if the patient is \\ndistended or actively vomiting, or if vomiting is intractable to antiemetics.\\n6.  Patients with acute biliary obstruction may require urgent decompres-\\nsion via endoscopic sphincterotomy of the ampulla of Vater.\\n7.  Initiate early antibiotic therapy in any patient with suspected cholecysti-\\ntis or cholangitis. Adequate therapy for uncomplicated cases of \\ncholecystitis includes a parenteral third-generation cephalosporin \\n(cefotaxime or ceftriaxone 1 g IV q12 to q24h) plus metronidazole  \\n500 mg IV . Patients with ascending cholangitis, sepsis, or obvious \\nperitonitis are best managed with triple coverage by using ampicillin \\n(0.5 to 1.0 g IV q6h), gentamicin (1 to 2 mg/kg IV q8h), and clindamycin \\n(600 mg IV q6h), or the equivalent substitutes (e.g., metronidazole for \\nclindamycin, third-generation cephalosporins or piperacillin/tazobactam, \\nor a fluoroquinolone for ampicillin).\\n8.  Patients diagnosed with acute cholecystitis, gallstone pancreatitis, or \\nascending cholangitis require immediate sur gical consultation with \\nhospital admission. Patients with choledocholithiasis, gallstone \\npancreatitis, or ascending cholangitis may also require urgent gastroen-\\nterology consultation to facilitate ERCP and sphincterotomy. Signs of \\nsystemic toxicity or sepsis warrant admission to the intensive care unit \\npending surgical treatment.\\n9.  Patients with uncomplicated biliary colic whose symptoms abate with \\nsupportive therapy within 4 to 6 hours of onset can be discharged home \\nif they are able to maintain oral hydration. Oral opioid analgesics may \\nbe prescribed for the next 24 to 48 hours for the common residual \\nabdominal aching. Arrange timely outpatient follow-up with a surgical \\nconsultant or the patient’s primary care physician. Instruct patients to \\nreturn to the ED if fever develops, abdominal pain worsens, for intrac-\\ntable vomiting, or if another significant attack occurs before follow-up.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 79, “Pancreatitis and Cholecystitis,” by Bart Besinger \\nand Christine R. Stehman.\\n42_Cydulka_Ch42.indd   251 16/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 270, 'page_label': '252'}, page_content='252\\nAcute Appendicitis\\nCharles E. Stewart\\nAppendicitis is one of the most common surgical emergencies. Despite \\nadvances in laboratory testing and imaging, accurate diagnosis of appendi-\\ncitis remains a challenge. Complications from misdiagnosis of appendicitis \\ninclude intraabdominal abscess, wound infection, adhesion formation, \\nbowel obstruction, and infertility.\\n■ ■CLINICAL FEATURES\\nThe early signs and symptoms of appendicitis are quite nonspecific and \\nprogress with time. The most reliable symptom in appendicitis is abdominal \\npain. Pain commonly begins in the periumbilical or epigastric region. As \\nperitoneal irritation occurs, the pain often localizes to the right lower quad-\\nrant. The final location of the pain depends on the location of the appendix. \\nOther symptoms associated with appendicitis include anorexia, nausea, and \\nvomiting, but these symptoms are neither sensitive nor specific. As the pain \\nincreases, irritation of the bladder and/or colon may cause dysuria, tenes-\\nmus, or other symptoms. Many patients have the “bump” sign, where the \\npatient notes an increase in the abdominal pain associated with bumps in the \\nride to the hospital. Other physicians will have the patient jump up and \\ndown in the examining room to evoke the pain. (Such maneuvers illustrate \\nperitoneal irritation, but are nonspecific for appendicitis.) If the pain sud-\\ndenly decreases, the examiner should consider appendiceal perforation.\\nThe classic point of maximal tenderness is in the right lower quadrant \\njust below the middle of a line connecting the umbilicus and the right ante-\\nrior superior iliac spine (McBurney’s point). Patients may also have pain \\nreferred to the right lower quadrant when palpating the left lower quadrant \\n(Rovsing’s sign), pain elicited by extending the right leg to the hip while \\nlying in the left lateral decubitus position (psoas sign), or pain elicited by \\npassively flexing the right hip and knee and internally rotating the hip \\n(obturator sign). Patients with a pelvic appendix may be quite tender on \\nrectal examination, and patients with a retrocecal appendix may have more \\nprominent flank pain than abdominal pain. No individual physical finding \\nis sensitive or specific enough to rule in or rule out the diagnosis, and all \\nphysical findings and maneuvers depend on irritation of the peritoneum.\\nFever is a relatively late finding in appendicitis and rarely exceeds 39°C \\n(102.2°F), unless rupture or other complications occur. Meta-analysis of  \\n42 studies found that fever was the single most useful sign, followed by \\nrebound tenderness and migration of the pain to the right lower quadrant.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nEven with that caveat, the diagnosis of acute appendicitis is primarily \\nclinical. Symptoms with high sensitivity for appendicitis include fever, \\nright lower quadrant pain, pain that occurs before vomiting, and absence of \\nprior similar pain. Migration of the pain is thought to be a strong predictor \\n43\\nCh A p TER\\n43_Cydulka_Ch43.indd   252 16/03/17   11:41 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 271, 'page_label': '253'}, page_content='CHAPTER 43: Acute Appendicitis 253 \\nfor appendicitis. Physical signs with high specif icity include right lower \\nabdominal rigidity and positive psoas sign. In both children and adults, no \\nsingle historical or physical examination finding is sufficient to make an \\nunequivocal diagnosis of appendicitis. Consider appendicitis in any patient \\nwith atraumatic right-sided abdominal, periumbilical, or flank pain who has \\nnot previously undergone appendectomy.\\nAdditional studies, such as complete blood count, C-reactive protein, \\nurinalysis, and imaging studies, may be performed if the diagnosis is unclear, \\nbut lack the sensitivity to rule in or rule out the diagnosis. The combination \\nof a normal WBC and C-reactive protein may have some utility as a negative \\nscreening test, as the likelihood of both being negative despite a pathologic \\ndiagnosis of appendicitis in a patient with a low pre-test probability is quite \\nlow. Unfortunately, these tests are often elevated in multiple conditions, so \\nthe reverse has almost no value. A pregnancy test must be performed in all \\nfemales of reproductive age. A normal WBC does not rule out appendicitis. \\nUrinalysis is useful to help rule out other diagnoses, but pyuria and hematuria \\ncan occur when an inflamed appendix irritates the ureter.\\nThe differential diagnosis of right lower quadrant pain is wide and \\nincludes other gastrointestinal processes (e.g., inflammatory bowel disease, \\nhernia, abscess, volvulus, diverticulitis), gynecologic or urological pro-\\ncesses (e.g., ectopic pregnancy, ovarian torsion, renal colic, genitourinary \\n(GU) infection or abscess), or musculoskeletal processes (e.g., muscular \\nhematoma or abscess).\\nScoring systems such as the Alvarado and Samuel scoring systems have \\nbeen developed to aid in diagnosis. These scoring systems have uniformly \\nhad less sensitivity for diagnosis of appendicitis than the clinical judgment \\nof an experienced examiner and should not replace this experienced-based \\ndecision.\\nThe goal of imaging is to establish the diagnosis of appendicitis, avoid \\na negative appendectomy, and identify other potential causes of abdominal \\npain. Increased concerns about accumulated radiation exposure for chil-\\ndren, potentially childbearing females, and pregnant patients have led to \\ngrowing interest in alternatives to the CT scan. Unfortunately, imaging can \\nalso escalate the cost of the medical care.\\nPlain radiographs of the abdomen are not helpful.\\nComputed tomography (CT) is probably the imaging study of choice \\nfor most patients with an overall sensitivity of 96% and PPV of 96%. CT \\nfindings suggesting acute appendicitis include pericecal inflammation, \\nabscess, and periappendiceal phlegmon or fluid collections (Fig. 43-1). CT \\nhas been shown to change management in women, decreasing unnecessary \\ntests. CT may be conducted with or without contrast administered orally, \\nintravenously, or rectally, depending on institutional experience and prefer-\\nence. Unenhanced CT scanning has 92% sensitivity and 96% specificity. \\nNoncontrast CT should be considered an acceptable imaging modality in \\nthe workup of acute appendicitis. Clearly, no contrast should be used for \\npatients with allergy to contrast or for patients with renal disease. CT find-\\nings of appendicitis may be obscured in the thin patient, as intraperitoneal \\nfat serves as an intrinsic contrast medium in unenhanced CT.\\nUltrasonography has a high sensitivity but is limited both by operator \\nskill and in evaluating a ruptured appendix or an abnormally located  \\n(e.g., retrocecal) appendix. Reports of the effectiveness of ultrasound (US) \\n43_Cydulka_Ch43.indd   253 16/03/17   11:41 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 272, 'page_label': '254'}, page_content='254 SECTION 6: Gastrointestinal Emergencies\\ndiagnosis of appendicitis in pregnancy are conflicting, with some reporting \\nUS as useful and others reporting it as ineffective for diagnosis.\\nGraded compression ultrasonography is the initial modality of choice in \\nboth children and the pregnant patient to decrease radiation exposure. Over-\\nall sensitivity of US is 86% with positive predictive value (PPV) of 95%. \\nGiven the highly operator-dependent nature of ultrasonography, hospitals \\nthat frequently perform US for diagnosis of appendicitis may have greater \\nreproducibility of high-quality studies. The diagnostic accuracy of abdomi-\\nnal US in children is better at ruling in acute appendicitis than excluding it.\\nMagnetic resonance imaging (MRI) for the diagnosis of appendicitis \\nis accepted in many hospitals as a reliable technology that avoids com-\\npletely the ionizing radiation risks. IV gadolinium contrast with MRI \\nshould be avoided in the pregnant patient as it crosses the placenta, given \\nthe teratogenic effects seen in animal studies. Gadolinium is not given to \\npatients with renal disease as it may exacerbate the renal insufficiency.\\nThe elderly patient is more likely to have preexisting comorbidities and \\nmay be taking medications that alter presentation, management, and out-\\ncomes. Elderly patients may have decreased perceptions of symptoms. \\nPatients with communication difficulties and those with poor access to \\nmedical care may also have vague complaints, including diffuse pain, fever, \\nFigure 43-1. Acute appendicitis on contrast CT scan as evidenced by dilated and \\ninflamed appendix.\\n43_Cydulka_Ch43.indd   254 16/03/17   11:41 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 273, 'page_label': '255'}, page_content='CHAPTER 43: Acute Appendicitis 255 \\nor alteration in mental status. Such individuals commonly present later in \\nthe course of the disease and are more likely to hav e worse outcomes. In \\nthese patients, an atypical presentation is quite common and alternative or \\ncomorbid diagnoses are often found on imaging.\\nThe pediatric patient who cannot verbalize symptoms also presents a \\nsignificant challenge. Patients younger than 6 years have a high misdiagno-\\nsis rate due to poor communication skills and the association of many \\nnonspecific symptoms. Careful history from the parent or guardian and \\nequally careful physical examination are essential to accurate diagnosis. \\nCoordinate imaging studies in these patients with your surgical consultant \\nto ensure most accurate diagnosis with least radiation exposure.\\nPregnant patients are at risk for misdiagnosis. Acute appendicitis is the \\nmost common surgical emergency in pregnancy, and delay in diagnosis is \\nthe greatest cause of increased morbidity in the pregnant woman with an \\nacute abdomen. Ovarian torsion and ectopic or heterotopic pregnancy are \\nadditional considerations in the fertile female. If an abdominal US is non-\\ndiagnostic or not available, consider pelvic US, CT, or MRI.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Obtain surgical consultation before imaging when the diagnosis is \\nthought to be clear . Patient should have nothing by mouth and should \\nhave intravenous (IV) access and fluids.\\n2. The treatment for acute appendicitis is appendectomy. If the local surgi-\\ncal services are inadequate or unavailable, transfer the patient to an \\nappropriate facility.\\n3. Control pain with opioid analgesics, such as fentanyl 1 to 2 μ g/kg IV \\nevery 1 to 4 hours or morphine 0.1 mg/kg.\\n4. Antibiotics given before surgery decrease the incidence of postoperative \\nwound infection or, in cases of perforation, postoperative abscess forma-\\ntion. Several antibiotic regimens to cover anaerobes, enterococci, and \\ngram-negative intestinal flora have been recommended, including \\npiperacillin/tazobactam 3.375 g IV or ampicillin/sulbactam 3 g IV . \\nConsult with the surgeon regarding the antibiotic regimen and timing.\\n5. In patients for whom the diagnosis is not clear, admit for observation, \\nserial e xaminations, and surgical consultation. This is a safe option \\nfor high-risk patients (pediatric, geriatric, pregnant, or immunocom-\\npromised).\\n6. Stable, nontoxic-appearing patients with adequate pain control who can \\ntolerate oral hydration have no significant comorbidities, and are able to \\nreturn for reevaluation in 12 hours may be considered for discharge and \\n12-hour follow-up. These patients should be instructed to avoid strong \\nanalgesics, and should return if they develop increased pain, localization \\nof the pain, fever, nausea, or other signs or symptoms of illness that are \\nworsening or not resolving.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 81, “Acute Appendicitis,” by E. Paul DeKoning.\\n43_Cydulka_Ch43.indd   255 16/03/17   11:41 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 274, 'page_label': '256'}, page_content='256\\nDiverticulitis\\nJames O’Neill\\nDiverticulitis is a common GI disorder that occurs when small hernia-\\ntions through the wall of the colon, or diverticula, become inflamed or \\ninfected.\\n■ ■CLINICAL FEATURES\\nClassically, diverticulitis presents with left lower abdominal pain, fever, \\nand leukocytosis. The most common symptom is a steady, deep discomfort \\nin the left lower quadrant of the abdomen. Pain may be constant or intermit-\\ntent, with associated symptoms of change in bowel habits (constipation or \\ndiarrhea), nausea, vomiting, and anorexia. Urinary tract symptoms are less \\ncommon. Patients with a redundant sigmoid colon, of Asian descent, or \\nwith right-sided disease may complain of pain in the suprapubic area or \\nright lower quadrant. The presentation can mimic other diseases, such as \\nappendicitis.\\nPatients have a low-grade fever, but the temperature may be higher in \\npatients with generalized peritonitis and in those with an abscess. Physical \\nfindings range from mild abdominal tenderness to severe pain, obstruction, \\nand peritonitis. Occult blood may be present in the stool.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe differential diagnosis includes acute appendicitis, colitis (ischemic or \\ninfectious), inflammatory bowel disease (Crohn’s disease or ulcerative \\ncolitis), colon cancer, irritable bowel syndrome, pseudomembranous coli-\\ntis, epiploic appendagitis, gallbladder disease, incarcerated hernia, mesen-\\nteric infarction, complicated ulcer disease, peritonitis, obstruction, ovarian \\ntorsion, ectopic pregnancy, ovarian cyst or mass, pelvic inflammatory dis-\\nease, sarcoidosis, collagen vascular disease, cystitis, kidney stone, renal \\npathology, and pancreatic disease.\\nDiverticulitis can be diagnosed by clinical history and examination \\nalone. In stable patients with past similar acute presentations, no further \\ndiagnostic evaluation is necessary unless the patient fails to improve with \\nconservative medical treatment. If a patient does not have a prior diagnosis \\nor the current episode is different from past episodes, diagnostic imaging \\nshould be performed to rule out other intraabdominal pathology and evalu-\\nate for complications. CT scan is the preferred imaging modality for its \\nability to evaluate the severity of disease and the presence of complications. \\nCT with IV and oral contrast has documented sensitivities of 97% and \\nspecificities approaching 100%. Compression ultrasound is operator depen-\\ndent and has been shown to have sensitivity and specificity greater than \\n80% with experienced operators. Laboratory tests, such as a CBC, liver \\nfunction tests, and urinalysis, are not diagnostic but may help exclude other \\ndiagnoses.\\n44\\nCh A p TER\\n44_Cydulka_Ch44.indd   256 16/03/17   11:51 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 275, 'page_label': '257'}, page_content='CHAPTER 44: Diverticulitis 257 \\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nED care begins with fluid and electrolyte replacement, pain, and nausea control.\\n1.  Ill-appearing patients, those with uncontrolled pain, vomiting, peritoneal \\nsigns, signs of systemic infection, comorbidities, or immunosuppression, \\nand those with complicated diverticulitis (e.g., phlegmon, abscess, obstruc-\\ntion, fistula, or perforation), require admission and surgical consultation.\\n2.  Uncomplicated diverticulitis is managed with oral antibiotics and a liq-\\nuid diet, although recent data suggests that antibiotics may not be \\nrequired in uncomplicated diverticulitis.\\n3.  Outpatients should follow up with a gastroenterology specialist for an \\noutpatient colonoscopy in 6 weeks if the y show improvement. Patients \\nwith worsening of their condition during outpatient treatment will re-\\nquire admission to the hospital.\\nPlease see Table 44-1 for antibiotic recommendations.\\nTable 44-1 Antibiotics for Diverticulitis\\nOutpatient \\n4–7 days\\nFirst line Metronidazole 500  mg PO q6h\\nPLUS\\nCiprofloxacin 750 mg PO BID\\nOR\\nLevofloxacin 750 mg PO q24h\\nOR\\nTrimethoprim-sulfamethoxazole (Bactrim) 1 tab PO BID\\nAlternate Amoxicillin-clavulanate extended release 1000/62.5 mg  \\n2 tabs PO BID\\nMoxifloxacin 400 mg PO q24h\\nInpatient\\nModerate \\ndisease\\nFirst line Metronidazole 500  mg IV TID\\nPLUS\\nCiprofloxacin 400 mg IV BID\\nOR\\nLevofloxacin 750 mg IV q24h\\nOR\\nAztreonam 2 g IV TID\\nOR\\nCeftriaxone 1 g IV q24h\\nAlternative Ertapenem 1 g IV q24h\\nPiperacillin-tazobactam 4.5 g IV q8h\\nMoxifloxacin 400 mg IV q24h\\nSevere, life- \\nthreatening\\nFirst line lmipenem 500  mg IV q6h\\nMeropenem 1 g IV q8h\\nPiperacillin-tazobactam 4.5 mg IV q8h\\nAlternative Ampicillin 2 g IV q6h\\nPLUS\\nMetronidazole 500 mg IV q6h\\nPLUS\\nCiprofloxacin 400 mg IV q12h\\nOR\\nAmikacin, gentamicin, or tobramycin (Penicillin allergy: \\nAztreonam 2 g IV q6h PLUS metronidazole 500 mg IV q6h)\\n44_Cydulka_Ch44.indd   257 16/03/17   11:51 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 276, 'page_label': '258'}, page_content='258 SECTION 6: Gastrointestinal Emergencies\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 82, “Diverticulitis,” by Graham Autumn.\\n44_Cydulka_Ch44.indd   258 16/03/17   11:51 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 277, 'page_label': '259'}, page_content='259\\nIntestinal Obstruction  \\nand Volvulus\\nOlumayowa U. Kolade\\nIntestinal obstruction results from mechanical blockage or the loss of normal \\nperistalsis. Adynamic or paralytic ileus is more common and usually self-\\nlimiting. Common causes of mechanical small bowel obstruction (SBO) are \\nadhesions due to previous surgery, incarcerated hernias, or inflammatory \\ndiseases. Other causes to consider are inflammatory bowel diseases, con-\\ngenital anomalies, and foreign bodies. The most frequent causes of large \\nbowel obstructions are cancer, diverticulitis with stricture, sigmoid volvulus, \\nand fecal impaction. Consider intussusception in children. Sigmoid volvulus \\nis more common in the elderly taking anticholinergic medications while \\ncecal volvulus is more common in gravid patients. Intestinal pseudoobstruc-\\ntion (Ogilvie syndrome) may mimic large bowel obstruction. The elderly \\nand bedridden and patients taking anticholinergic medications or tricyclic \\nantidepressants are at increased risk for pseudoobstruction.\\n■ ■CLINICAL FEATURES\\nCrampy, intermittent, progressive abdominal pain and inability to have a \\nbowel movement or to pass flatus are common presenting complaints. V om-\\niting, bilious in proximal obstructions and feculent in distal obstruction, is \\nusually present. Patients with partial SBO can still pass flatus. Physical \\nsigns vary from abdominal distention, localized or general tenderness, to \\nobvious signs of peritonitis. Localization of pain and the presence of \\nabdominal surgical scars, hernia, or masses may provide clues to the site of \\nobstruction. The abdomen may be tympanitic to percussion. Active, high-\\npitched bowel sounds can be heard in mechanical SBO. Bowel sounds may \\nbe diminished or absent if the obstruction has been present for many hours. \\nRectal examination may demonstrate fecal impaction, rectal carcinoma, or \\noccult blood. Key features of ileus and mechanical bowel obstruction are \\ndescribed in Table 45-1. The presence of stool in the rectum does not \\nexclude obstruction. Consider a pelvic examination in women. Systemic \\nsymptoms and signs depend on the extent of dehydration and the presence \\nof bowel necrosis or infection.\\n45\\nCh A p TER\\nTable 45-1 Key Features of Ileus and Mechanical Bowel Obstruction\\nIleus Bowel Obstruction\\nPain Mild to moderate Moderate to severe\\nLocation Diffuse May localize\\nPhysical examination Mild distention, ± tenderness, \\ndecreased bowel sounds\\nMild distention, tenderness, \\nhigh-pitched bowel sounds\\nLaboratory Possible dehydration Leukocytosis\\nImaging May be normal Abnormal\\nTreatment Observation, hydration Nasogastric tube, surgery\\n45_Cydulka_Ch45.indd   259 01/05/17   10:27 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 278, 'page_label': '260'}, page_content='260 SECTION 6: Gastrointestinal Emergencies\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nSuspect intestinal obstruction in any patient with abdominal pain, disten-\\ntion, and vomiting, especially in patients with previous abdominal surgery, \\nabdominal/pelvic radiotherapy, or groin hernias.\\nFlat and upright abdominal radiographs and an upright chest x-ray can \\nscreen for obstruction (see Fig. 45-1), confirm severe constipation, or diag-\\nnose hollow viscous perforation with free air. The diagnostic procedure of \\nchoice in the ED is CT scanning using IV and oral contrast when possible. \\nCT scanning can delineate partial versus complete bowel obstruction, par -\\ntial SBO versus ileus, and strangulated versus simple SBO.\\nLaboratory tests may include a complete blood count, electrolytes, \\nblood urea nitrogen, creatinine, lactate levels, coagulation profile, and type \\nand cross-match. Suspect abscess, gangrene, or peritonitis if leukocytosis \\n> 20,000 or left shift is noted. An elevated hematocrit is consistent with \\ndehydration.\\nFIgure 45-1. Sigmoid volvulus. Note that the open portion of the “C” formed by \\nthe twisted large bowel points toward the left side in the case of sigmoid volvulus. \\nReproduced with permission from Wikiradiography.com.\\n45_Cydulka_Ch45.indd   260 01/05/17   10:27 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 279, 'page_label': '261'}, page_content='CHAPTER 45: Intestinal Obstruction and Volvulus  261 \\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nED care is directed at vigorous fluid resuscitation with crystalloids, careful \\nmonitoring of response, and prompt surgical consultation. Surgical inter -\\nvention is usually necessary to treat a mechanical obstruction.\\n1. Decompress the bowel with a nasogastric tube especially if vomiting or \\ndistension is present.\\n2. Administer preoperative broad-spectrum intrav enous antibiotics cov-\\nerage such as piperacillin/tazobactam 3.375 g IV every 6 hours, \\ntircarcillin-clavulanate 3.1 g IV every 6 hours or ampicillin/sulbac-\\ntam 3.0 g or double drug coverage with cefotaxime 2 g or ceftriax-\\none 2 g plus clindamycin 600 mg or metronidazole 1 g or a \\ncarbapenem, such as meropenem 1 g IV every 8 hours.\\n3. When the diagnosis is uncertain or if adynamic ileus is suspected, con-\\nservative measures, such as intravenous fluids and observation without \\nsurgical intervention, may be appropriate.\\n4. In patients with pseudoobstruction, colonoscopy is both diagnostic and \\ntherapeutic. Surgery is not indicated.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 83, “Bowel Obstruction,” by Timothy G. Price and \\nRaymond J. Orthober.\\n45_Cydulka_Ch45.indd   261 01/05/17   10:27 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 280, 'page_label': '262'}, page_content='262\\nHernia in Adults and Children\\nLouise Finnel\\nA hernia is a protrusion of any viscus from its normal cavity, for example, \\nbowel bulging through the abdominal wall. Hernias are classified by ana-\\ntomic location, hernia contents, and the status of those contents (e.g., reduc-\\nible, incarcerated, or strangulated). The most common abdominal hernias \\nare inguinal, ventral, and femoral hernias (Fig. 46-1).\\nPredisposing factors include family history, lack of developmental \\nmaturity, undescended testes, genitourinary abnormalities, conditions that \\nincrease intraabdominal pressure (e.g., ascites or pregnancy), chronic \\nobstructive pulmonary disease, and surgical incision sites.\\n■ ■CLINICAL FEATURES\\nMost hernias are detected on routine physical examination or inadvertently \\nby the patient. When the contents of a hernia can be easily returned to their \\noriginal cavity by manipulation, the hernia is defined as reducible. A hernia \\nbecomes incarcerated when its contents are not reducible. Incarcerated \\nhernias may lead to bowel obstruction and strangulation. Strangulation \\nrefers to vascular compromise of the incarcerated contents and is an acute \\nsurgical emergency. When not relieved, strangulation may lead to gangrene, \\nperforation, peritonitis, and septic shock.\\nSymptoms other than an obvious protruding mass from the abdominal \\nwall include localized pain, nausea, and vomiting. Signs of strangulation \\ninclude severe pain and tenderness, induration, and erythema over the site. \\nChildren may exhibit irritability and poor feeding. Careful evaluation for \\nobstruction is essential.\\n46\\nCh A p TER\\nInguinal ligament\\nDirect inguinal herniaFemoral hernia\\nIndirect inguinal hernia\\nFigure 46-1. Groin hernias.\\n46_Cydulka_Ch46.indd   262 16/03/17   12:03 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 281, 'page_label': '263'}, page_content='CHAPTER 46: Hernia in Adults and Children 263 \\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nPhysical examination is the predominant means of diagnosis. Laboratory \\ntesting is of minimal value. Ultrasonographic detection of hernias is opera-\\ntor and body habitus dependent but can be helpful in pediatric and pregnant \\npatients where radiation exposure is a concern (Fig. 46-2). Computed \\ntomography remains the best radiographic test for the evaluation of hernias \\nand can more easily identify the less common hernia types such as Spige-\\nlian or obturator.\\nThe differential diagnosis of a groin mass includes direct or indirect \\nhernia, testicular torsion, tumor, groin abscess, hydrocele, varicocele, and \\nhidradenitis. In children, retracted or undescended testes may be mistaken \\nfor inguinal hernias.\\nA\\nB\\nCD\\nFigure 46-2. Ultrasonographic detection of incarcerated hernia. A. An incarcer -\\nated femoral hernia is demonstrated as a small - bowel segment herniated through \\nthe femoral canal. B. In an incarcerated incisional hernia, a small-bowel segment \\n(arrow) is demonstrated as herniated through a small orifice in the abdominal \\nwall. Dilated small-bowel loops are evident proximal to the incarceration. C. In an \\numbilical hernia, a herniated small - bowel segment is demonstrated within the \\nfluid space in the hernia sac. The segment was softly strangulated at the femoral \\norifice (arrow) formed by a defect of the fascia and was easily reduced by manipula-\\ntion in this case. D.  An incarcerated obturator hernia is demonstrated deep in the \\nfemoral region. It locates posterior to the pectineus muscle (arrows) and medial to \\nthe femoral artery (A) and vein (V).Reproduced with permission from Ma OJ, Mateer \\nJR, Reardon RF, et al: Ma and Mateer’s Emergency Ultrasound, 3rd ed. New York: \\nThe McGraw-Hill Companies; 2014\\n46_Cydulka_Ch46.indd   263 16/03/17   12:04 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 282, 'page_label': '264'}, page_content='264 SECTION 6: Gastrointestinal Emergencies\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nDo not attempt reduction if signs of strangulation exist, as dead bowel may \\nthen be introduced into the abdomen (Table 46-1).\\nDefinitive Management\\n1. Adults with easily reducible hernias can be referred for outpatient surgi-\\ncal evaluation and repair. Patients should avoid heavy lifting and return \\nto the ED if herniation recurs and cannot be reduced promptly. Discuss \\nsigns of obstruction with them prior to discharge.\\n2. Incarcerated hernias that can’t be reduced with one or two attempts and \\nstrangulated hernias require emergent surgical consultation and interven-\\ntion. Give nothing by mouth, initiate intravenous fluid resuscitation and \\nadminister intravenous opioid analgesia. Broad-spectrum antibiotics, \\nsuch as cefoxitin 2 g IV or piperacillin/tazobactam 3.375 g IV , should \\nbe given if there is evidence of perforation or strangulation.\\n3. Infants with successfully reduced inguinal hernias should have sur gical \\nrepair within 24 to 72 hours because one-third will redevelop \\nincarceration.\\n4. Children with uncomplicated umbilical hernias may be discharged and \\nfollowed longitudinally by their primary care providers. Refer children \\nolder than 4 years or those with hernias greater than 2 cm in diameter for \\nsurgical evaluation.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, \\n8th ed., see Chapter 84, “Hernias in Adults,” by Donald Byars and Turan Kayagil\\nTAble 46-1 Steps for hernia Reduction\\n1. NPO—in case reduction is unsuccessful\\n2. Adequate analgesia; children will require procedural sedation\\n3. Place patient in Trendelenberg position\\n4. Externally rotate and flex ipsilateral leg\\n5. Place a padded icepack to reduce swelling and blood flow to the area\\n6. Grasp and elongate the hernia neck with one hand\\n7.  With the other hand apply firm steady pressure to proximal hernia at the site of the \\nfascial defect\\n46_Cydulka_Ch46.indd   264 16/03/17   12:04 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 283, 'page_label': '265'}, page_content='265\\nAnorectal Disorders\\nChad E. Branecki\\nAnorectal disorders range from simple local disease processes to underly-\\ning serious systemic disorders. Most anorectal diseases originate in the anal \\ncrypts, glands, internal hemorrhoidal plexus, and external hemorrhoid \\nveins. More serious life-threatening infections tend to lie in the deeper tis-\\nsues such as the ischiorectal and pelvic-rectal spaces.\\nAfter a detailed history, a digital examination of the rectum should be \\nperformed, followed by anoscopy in the left lateral decubitus position. The \\nsupine or lithotomy position can be used for debilitated patients.\\n■ ■ANAL TAGS\\nSkin tags are usually asymptomatic minor projections of the skin at the anal \\nverge, which may be from residual prior hemorrhoids. Most are asymptom-\\natic but inflammation may cause itching or pain. Inflammatory bowel disease \\nmay be associated with sentinel tags; therefore, surgical referral is warranted.\\n■ ■HEMORRHOIDS\\nEngorgement, prolapse, or thrombosis of the internal or external hemor -\\nrhoidal vein(s) is termed hemorrhoids.\\nClinical Features\\nPatients report painless, bright red rectal blood on the surface of the stool, \\ntoilet tissue, or dripping into the toilet bowl after defecation. Thrombosed \\nhemorrhoids are usually painful and may appear as a bluish-purple mass \\nprotruding from the rectum. Large hemorrhoids may result in prolapse that \\nmay spontaneously reduce or require periodic manual reduction by patients \\nor clinicians. They may become incarcerated and gangrenous, and require \\nsurgical intervention. Prolapse may cause mucous discharge and pruritus. \\nIf not reduced, severe bleeding, thrombosis, infarction, incarceration, uri-\\nnary retention, or sepsis may occur.\\nDiagnosis and Differential\\nInternal hemorrhoids are not readily palpable and are best visualized \\nthrough an anoscope. They are found at 2, 5, and 9 o’clock positions when \\npatients are prone. Constipation, pregnancy, ascites, ovarian tumors, radia-\\ntion fibrosis, and increased portal venous pressure are some of the common \\ncauses of hemorrhoids. Rectal and sigmoid colon tumors should be consid-\\nered in patients older than 40 years.\\nEmergency Department Care and Disposition\\nUnless a complication is present, management is usually nonsurgical.\\n1. Hot sitz baths for at least 15 minutes, three times per day, and after each \\nbowel movement will reduce pain and swelling. After the sitz baths, the \\nanus should be gently but thoroughly dried.\\n47\\nC HA p TER\\n47_Cydulka_Ch47.indd   265 16/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 284, 'page_label': '266'}, page_content='266 SECTION 6:  Gastrointestinal Emergencies\\n2. Topical steroids and analgesics may provide temporary relief. Bulk \\nlaxatives, such as psyllium seed compounds or stool softeners, should be \\nused after the acute phase has subsided. Laxatives causing liquid stool \\nare contraindicated as they may result in cryptitis and sepsis.\\n3. Surgical treatment is indicated for severe, intractable pain, continued \\nbleeding, incarceration, or strangulation.\\n4. Acute and recently thrombosed painful hemorrhoids (< 48 hours) can be \\ntreated with clot excision. After analgesia, with a long acting local anes-\\nthetic such as 0.5% bupivacaine with epinephrine, an elliptical skin inci-\\nsion is made over the hemorrhoids and the thrombosed clot is evacuated \\n(Fig. 47-1). Hemostasis is achieved by packing and pressure dressing. \\nThe pressure dressing may be removed after about 6 hours, when the \\npatient takes the first sitz bath. Refer to a surgeon for definitive \\nhemorrhoidectomy.\\n■ ■CRYpTITIS\\nSphincter spasm, and superficial trauma from diarrhea, or repeated pas-\\nsage of large hard stools cause breakdown of the mucosa over the crypts. \\nInfecting organisms enter the crypts and cause inflammation of anal \\nglands, abscesses formation, fissures, and fistulae. Common symptoms \\ninclude anal pain during bowel movements and itching, with or without \\nrectal bleeding. Diagnosis is made by palpation of tender, swollen crypts \\nwith associated hypertrophied papillae. Anoscopy allows visualization of \\nthe inflamed crypts in posterior midline of the anal ring. Bulk laxatives, \\nadditional roughage, hot sitz baths, and warm rectal irrigations enhance \\nhealing. Surgical treatment may be needed in refractory cases.\\n■ ■ANAL FISSURES\\nAnal fissures are superficial linear tears of the anal canal usually caused by \\nlocal trauma (e.g., passage of hard stool) and are the most common cause \\nof painful rectal bleeding.\\nClinical Features\\nPatients complain of sharp cutting pain with defecation that subsides \\nbetween bowel movements. Bleeding is bright and in small quantities. \\nRectal examination is very painful and often not possible without applica-\\ntion of topical anesthetic agents. Most fissures are located in the posterior \\nmidline. A sentinel pile may be noted in patients with chronic fissures. A \\nnon-posterior midline fissure should alert the physician to consider serious \\ncauses, such as Crohn’s disease, ulcerative colitis, carcinomas, AIDS, \\ntuberculosis, and sexually transmitted diseases.\\nTreatment is aimed at relieving sphincter spasm and pain, and prevent-\\ning stricture formation. Hot sitz baths and the addition of bran (fiber) to the \\ndiet are helpful. Use of topical analgesics or steroids may be temporarily \\nhelpful. Surgical excision of the fissure may be required if the area does not \\nheal in 6 weeks after adequate treatment.\\n47_Cydulka_Ch47.indd   266 16/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 285, 'page_label': '267'}, page_content='CHAPTER 47: Anorectal Disorders 267 \\nA\\nB\\nC\\nFigurE 47-1. Elliptical incision of thrombosed external hemorrhoid. A. Elliptical \\nincision. B. Unroofing of thrombosed external hemorrhoid. C. Evacuation of clot.\\n47_Cydulka_Ch47.indd   267 16/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 286, 'page_label': '268'}, page_content='268 SECTION 6:  Gastrointestinal Emergencies\\n■ ■FISTULA IN ANO\\nAn anal fistula is an abnormal inflammatory tract, originating from an \\ninfected anal gland. Fistulae commonly result from perianal or ischiorectal \\nabscess. Crohn’s disease, ulcerative colitis, tuberculosis, gonococcal proc-\\ntitis, and carcinomas should also be considered in the etiology. Persistent \\nbloody, malodorous discharge occurs as long as the fistula remains open. \\nBlockage of the tract causes recurrent bouts of inflammation and abscess \\nformation.\\nUltrasonography with a 7 MHz endoprobe and enhanced with 3% \\nhydrogen peroxide may aid in the diagnosis. Non-ill appearing patients can \\nbe treated with analgesics, antipyretics, and oral antibiotics such as cipro-\\nfloxacin 750 mg twice daily and metronidazole 500 mg four times daily for \\n7 days. Sitz baths and local cleaning will temporize the condition before \\nsurgery. Surgical excision is the definitive treatment and should not be \\ndelayed in ill-appearing patients.\\n■ ■ANORECTAL ABSCESSES\\nAbscesses start from the anal crypts and spread to involve the perianal, \\nintersphincteric, ischiorectal, or deep perianal space. Perianal abscess is the \\nmost common and found at the anal verge (Fig. 47-2).\\nClinical Features\\nPersistent dull, aching, throbbing pain that increases prior to defecation is \\ntypical. As the abscess progresses, pain and tenderness interfere with walk-\\ning or sitting. Fever, leukocytosis, and a painful tender mass may be present \\nupon digital rectal examination.\\nEmergency Department Care and Disposition\\nSimple isolated perianal abscess without systemic illness may be safely \\nincised in the ED. Other perirectal abscesses, such as supralevator or \\nischiorectal abscesses, should be drained in the operating room. After ade-\\nquate local and systemic analgesia, a cruciate incision is made over the \\nabscess, and the “dog ears” are excised. Packing usually is not required. \\nSitz baths should be started the next day. Antibiotics usually are not neces-\\nsary unless systemic infection or toxicity is present.\\n■ ■pROCTITIS\\nProctitis is inflammation of the rectal mucosa. Common causes include \\nprior radiation treatments, autoimmune disorders, vasculitis, ischemia, \\nsexually transmitted infections (e.g., syphilis, gonorrhea, chlamydia, lym-\\nphogranuloma venereum, herpes simplex, chancroid, human papillomavi-\\nrus), and other infectious diseases.\\nClinical Features\\nSymptoms include anorectal pain, itching, discharge, diarrhea, bleeding, \\nand lower abdominal cramping. Mucosal inflammation, erythema, bleed-\\ning, ulcers, or discharge may be noted during anoscopy.\\n47_Cydulka_Ch47.indd   268 16/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 287, 'page_label': '269'}, page_content='CHAPTER 47: Anorectal Disorders 269 \\nSupralevator\\nspace\\nPeritoneum\\nIschiorectal\\nspace\\nSubmucosal\\nspace\\nIntersphincter\\nspace\\nA Perianal\\nspace\\nRetrorectal\\nspace\\nSupralevator\\nspace\\nDeep postanal\\nspace\\nSuperficial\\npostanal space\\nB\\nHigher\\nintermuscular\\nIschiorectal\\nPerianal\\nIntersphincteric\\nPelvirectal\\nSubmucosal\\nC\\nD\\n E\\nFigurE 47-2.  A, B. Anatomic classification of anorectal spaces. C. Anorectal \\nabscesses. D. Perianal abscess. E. Complicated perirectal abscess.\\nA, B: Reproduced with permission from Reichman EF: Emergency Medicine \\nProcedures. 2nd ed. New York: McGraw-Hill Education; 2013. D: Reproduced with \\npermission from Knoop K, Stack L, Storrow A, et al: Atlas of Emergency Medicine, \\n3rd ed. New York: McGraw-Hill Education; 2010. Photo contributor: The American \\nSociety of Colon and Rectal Surgeons. E: Reproduced with permission from Knoop K, \\nStack L, Storrow A, et al: Atlas of Emergency Medicine, 3rd ed. New York: McGraw-\\nHill Education; 2010. Figure 9-35. Photo contributor: Lawrence B. Stack, MD.\\nEmergency Department Care and Disposition\\nObtain cultures if an infectious cause is suspected. Stool softeners, sitz \\nbaths, good anal hygiene, and analgesics will provide some relief. Patient \\nwith enteric pathogens and sexually transmitted infections will require \\n47_Cydulka_Ch47.indd   269 16/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 288, 'page_label': '270'}, page_content='270 SECTION 6:  Gastrointestinal Emergencies\\nantibiotics directed at the suspected underlying pathogen. Arrange outpa-\\ntient follow-up.\\n■ ■RECTAL pROLApSE\\nProlapse (procidentia) may involve the mucosa alone or all layers of the \\nrectum. In addition, intussusception of the rectum may present as a \\nprolapse.\\nClinical Features\\nMost patients complain of protruding mass, mucous discharge, associated \\nbleeding, and pruritus. Partial prolapse involves only the rectal mucosa and \\ntends to protrude only a few centimeters from the dentate line. Complete \\nprolapse involves all layers of the rectum, and appears like a red, ball-like \\nmass and may extend up to 15 cm. Often, pain is not a significant feature.\\nEmergency Department Care and Disposition\\nIn children, the prolapse can be gently reduced under proper analgesia and \\nsedation. The child should then be referred to a specialist to ensure the \\nprolapse is not due to an underlying condition. Every effort should be made \\nto prevent the child from being constipated. In adults, reduction can  \\nbe more difficult if the rectal walls have become edematous. Generous \\namounts of granulated sugar applied 15 minutes prior to the reduction may \\naid in the process with direct, continuous pressure. Lubricated gauze should \\nbe taped in place over the anal verge for a few hours after reduction. If the \\nprolapse cannot be easily reduced, or there is evidence of ischemia, emer -\\ngency surgical consultation and hospitalization are warranted.\\n■ ■ANORECTAL TUMORS\\nFactors such as smoking, anal intercourse, HIV , and genital warts are asso-\\nciated with anorectal cancer. Neoplasms that occur in this group include \\nadenocarcinoma, malignant melanoma, and Kaposi’s sarcoma. Patients \\npresent with nonspecific symptoms including sensation of a mass, pruritus, \\npain, and blood on the stool. Constipation, anorexia, weight loss, narrowing \\nof the stool caliber, and tenesmus eventually develop. Anal margin neo-\\nplasms frequently present as an ulcer that fails to heal in a timely manner. \\nVirtually all anorectal tumors can be detected by careful visual examination \\nof the perianal area, digital palpation of the distal rectum and anal canal, \\nand procto- or sigmoidoscopic examination. Complications of anorectal \\ntumors include rectal prolapse, prolonged blood loss, perirectal abscesses, \\nor fistulae. Refer all patients for proctoscopic or sigmoidoscopic examina-\\ntion and biopsy if the history or physical examination is suspicious for \\nneoplasms.\\n■ ■RECTAL FOREIGN BODIES\\nNot all patients are forthcoming with accurate history of rectal foreign body \\ninsertion. Patients may instead complain of abdominal pain, anorectal \\nbleeding, or discharge.\\n47_Cydulka_Ch47.indd   270 16/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 289, 'page_label': '271'}, page_content='CHAPTER 47: Anorectal Disorders 271 \\nClinical Features\\nMost foreign bodies are in the rectal ampulla and are palpable through \\ndigital and proctoscopic examination. Obtain abdominal and pelvis \\nx-rays to demonstrate the position, shape, and number of foreign bodies.  \\nAn upright film or CT scan may be useful to visualize a radiolucent \\nforeign body and to detect free air, indicative of perforation.\\nEmergency Department Care and Disposition\\nAlthough some low-lying rectal foreign bodies can be removed in the ED, \\nmany require surgical consultation and intervention, especially if they are \\nmade of glass or contain sharp edges.\\n1. In the ED, procedural sedation accompanied by perianal and submuco-\\nsal analgesia is used. Adequate sphincter relaxation is essential. Local \\ninfiltration anesthesia injected through a 30-gauge needle into the inter-\\nnal sphincter muscle circumferentially will provide good relaxation. \\nAnal lubrication, the aid of obstetric forceps, a speculum or snares, and \\nhaving the patient bear down may all be helpful in the extraction of the \\nforeign body.\\n2. Large bulbar objects may create a vacuum-lik e effect proximally, mak-\\ning removal by simple traction impossible. In these cases, the vacuum \\ncan be overcome by passing a catheter around the foreign body into the \\nampulla and injecting air.\\n3. Occasionally, passing a Foley catheter proximal to the foreign body , \\ninflating the balloon, and applying gentle traction may help maneuver \\nthe foreign body into a more desirable position for ease of removal.\\n4. Reevaluate the anus and rectum after foreign body removal for lacera-\\ntions and perforation.\\n■ ■pRURITUS ANI\\nPruritus ani can occur from a variety of anal and systemic problems. Com-\\nmon causes include diet, infectious agents, irritants, and tight-fitting under-\\ngarments. Pinworms (Enterobius vermicularis) are the most common cause \\nof anal pruritus in children. The skin appears normal in early mild cases. In \\nsevere exacerbations the perianal area will appear reddened, excoriated, and \\nmoist. Increased fiber, sitz baths, antihistamines, zinc oxide ointment, or \\n1% hydrocortisone cream can be used to treat acute symptoms and enhance \\nhealing. Any underlying cause should also be treated. Consider referral to \\nproctologist or dermatologist for resistant cases.\\n■ ■pILONIDAL SINUS\\nPilonidal sinuses or cysts occur in the midline in the upper part of the natal \\ncleft, which overlies the lower sacrum and coccyx. A pilonidal sinus is usu-\\nally caused by foreign body granuloma reaction to ingrowing hair. Because \\nof their proximity to the anus, infected pilonidal cysts (abscesses) are some-\\ntimes mistakenly diagnosed as perirectal abscesses.\\n47_Cydulka_Ch47.indd   271 16/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 290, 'page_label': '272'}, page_content='272 SECTION 6:  Gastrointestinal Emergencies\\nClinical Features\\nPilonidal disease may present as a painless cyst, an infected abscess, or a \\nchronic recurring cyst with drainage in the posterior midline ov er the \\nsacrum and coccyx. Ultrasound can be used to determine the extent of the \\nabscess before incision and drainage.\\nEmergency Department Care and Disposition\\nAcute infections may be drained in the ED and packed. The patient is \\nplaced prone and the buttocks are retracted. After appropriate sedation and \\nlocal anesthesia, the abscess is drained and loculations are gently broken. \\nThe wound is packed loosely with gauze, and a bulky dressing is applied. \\nThe patient is advised to start sitz baths the following day. Antibiotics or \\ncultures usually are not necessary, unless the patient is immunocompro-\\nmised or there is evidence of surrounding cellulitis.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 85, “Anorectal Disorders,” by Brian E. Burgess\\n47_Cydulka_Ch47.indd   272 16/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 291, 'page_label': '273'}, page_content='273\\nJaundice, Hepatic Disorders, \\nand Hepatic Failure\\nCem Oktay\\n■ ■JAUNDICE\\nJaundice is a yellowish discoloration of skin, sclera, and mucous mem-\\nbranes resulting from the elevated levels of bilirubin in the circulation, \\nusually presents at levels of > 2.5 mg/dL. Hyperbilirubinemia occurs as a \\nresult of (1) overproduction (e.g., hemolysis), (2) inadequate cellular \\nprocessing (e.g., infections, drugs, toxins), or (3) decreased excretion of \\nbilirubin (e.g., pancreatic tumor, gallstone in the common bile duct). The \\ncauses of jaundice can also be classified as prehepatic, hepatic, and  \\nposthepatic.\\nHyperbilirubinemia can be divided into two types: Unconjugated form \\nresults from the increased production of bilirubin or the impaired liver’s \\nability to conjugate bilirubin. Conjugated form occurs as a result of \\nimpaired excretion of conjugated bilirubin in the setting of intrahepatic or \\nextrahepatic cholestasis.\\nClinical Features\\nPreviously healthy young patients with acute hepatitis typically presents \\nwith a sudden onset of jaundice and a prodrome of fever, malaise, nausea, \\nvomiting, and right upper quadrant abdominal pain resulting from the \\nenlarged liver.\\nHistory of excessive alcohol consumption suggests alcoholic hepatitis. \\nJaundice usually develops gradually in the setting of alcoholic liver disease \\nand cirrhosis.\\nSymptoms of anorexia, weight loss, and malaise associated with pain-\\nless jaundice in older patients classically suggest hepatobiliary or pancre-\\natic malignancy.\\nLiver metastases are suspected in patients with primary tumors and an \\nenlarged, hard, tender, nodular liver accompanied by jaundice.\\nInherited diseases such as Gilbert syndrome, glucose-6-phosphate dehy-\\ndrogenase (G6PD) deficiency, can be the cause of jaundice when a family \\nhistory of jaundice or a history of recurrent mild jaundice that spontane-\\nously resolves or seen in response to a number of triggers such as certain \\nfoods, illness, or medication is present.\\nJaundice can be seen in patients with the clinical signs and symptoms of \\ncholecystitis in the setting of a retained gallstone in the common bile duct.\\nPatients with a history of biliary tract surgery, pancreatitis, cholangitis, \\nor inflammatory bowel present with jaundice due to the development of \\nbiliary tract scaring or strictures.\\nJaundice can be seen in patients with hepatomegaly, pedal edema, jugu-\\nlar venous distention, and a gallop rhythm due to the passive congestion of \\nliver or acute ischemic hepatitis in patients with chronic heart failure.\\n48\\nChAptEr\\n48_Cydulka_Ch48.indd   273 16/03/17   12:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 292, 'page_label': '274'}, page_content='274 SECTION 6: Gastrointestinal Emergencies\\nDiagnosis and Differential\\nA detailed history, a carefully conducted physical examination, and routine \\nlaboratory tests lead to accurate diagnosis in 85% of patients with jaundice. \\nInitial laboratory tests include serum bilirubin le vel (total and direct (con-\\njugated) fractions; indirect (unconjugated) fraction can be calculated by \\nsubtraction), serum transaminases and alkaline phosphatase (ALP) levels, a \\ncomplete blood count (CBC), and urinalysis to check for bilirubin and \\nurobilinogen. Additional laboratory tests are ordered according to the clini-\\ncal features to diagnose specific causes. These include serum lipase or \\namylase levels, prothrombin time (PT), electrolytes and glucose levels, \\nblood urea nitrogen (BUN) and creatinine levels, γ-glutamyl transpeptidase \\n(GGT), albumin, viral hepatitis panels, drug levels, and pregnancy test.\\nAn increased total and indirect bilirubin signifies either an overproduc-\\ntion or an injury to hepatocytes themselves. Total and direct bilirubin is \\nincreased when there is some obstruction preventing the secretion of the \\nconjugated bilirubin.\\nTransaminases (aspartate aminotransferase (AST) and alanine amino-\\ntransferase (ALT) are released into the circulation when there is hepatocyte \\ninjury or necrosis. The pattern of elevations in serum transaminases sug-\\ngests the etiology of hepatocellular disease such as viral hepatitis, toxin- or \\ndrug-induced hepatitis, or cirrhosis. Enzyme levels may be near normal in \\nthe end-stage liver failure. Jaundice is more likely to be caused by sepsis or \\nsystemic infection, pregnancy, or inborn errors of metabolism, when trans-\\naminase levels are in normal range.\\nHemolysis and hemoglobinopathy are considered when anemia is pres-\\nent in addition to normal liver transaminase levels; Coombs test and hemo-\\nglobin electrophoresis may be useful in diagnosis.\\nALP elevation is associated with biliary obstruction and cholestasis. \\nSerum GGT level is increased by alcohol consumption and drugs including \\nhepatic microsomal enzyme activity.\\nUltrasonogram of the liver, biliary tract, and pancreas is helpful in diag-\\nnosing an obstructive cause, or a mass or tumor in the liver, pancreas, and \\nportal region. Computed tomography (CT) is superior to ultrasound (US) in \\ndetecting pancreatic or intraabdominal tumors. However, CT is more costly \\nthan and has similar sensitivity to US for detection of gallstones.\\nEmergency Department Care and Disposition\\nTreatment depends on the cause of the underlying condition leading to \\njaundice and any potential complications related to it.\\nTreatment is largely supportive; isotonic IV fluid therapy is adminis-\\ntered if the patient is dehydrated. IV antibiotics are required since septic \\nshock may develop expeditiously in patients with ascending cholangitis. \\nPatients with extrahepatic obstructive jaundice without cholangitis should \\nbe admitted for drainage.\\nIf the appropriate laboratory tests have been done in the emergency \\ndepartment (ED), further outpatient workup and treatment are appropriate \\nwhen the patient is hemodynamically stable and has no evidence of \\nhepatic failure or acute biliary obstruction. However, the patient should \\nalso be reliable to present the timely follow-up and has adequate social \\nsupport.\\n48_Cydulka_Ch48.indd   274 16/03/17   12:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 293, 'page_label': '275'}, page_content='CHAPTER 48: Jaundice, Hepatic Disorders, and Hepatic Failure 275 \\n■ ■hEpAtIC DISOrDErS\\nSpecific entities addressed in this chapter include acute hepatitis, chronic \\nliver disease, and complications of cirrhosis including ascites, spontaneous \\nbacterial peritonitis (SBP), and hepatic encephalopathy.\\n■ ■ACUtE hEpAtItIS\\nHepatitis is an inflammation of the liver owing to infectious, toxic, or \\nmetabolic injury to hepatocytes. Patients can present to the ED anywhere \\nalong the spectrum of the disease from asymptomatic infection to an acute, \\nor fulminant, liver failure to chronic cirrhosis. The most common causes are \\nviral infection and toxic ingestion.\\nClinical Features\\nAcute hepatitis typically presents with nausea, vomiting, and right upper \\nquadrant abdominal pain. The patient with acute hepatitis can also have \\nfever, diarrhea, jaundice, bilirubinuria, and an enlarged, tender liver. The \\npresence of altered mental status, abnormal bleeding (bruising, bleeding \\ngums, epistaxis, blood in the stool), ascites, and lower body edema suggests \\nchronic disease or a fulminant liver failure.\\nPaying attention to the historical clues and risk factors is crucial in \\ndetermining the etiology of hepatitis. Ingestion of acetaminophen (in one-\\ntime overdose or chronically high doses), mushrooms, raw oysters, and \\nherbal remedies should be assessed in the history. Risk factors in the past \\nmedical history include chronic hepatitis, transfusion of blood products, \\npositive human immunodeficiency virus status, frequent use of pain medi-\\ncations, or depression. A social history positive for injection drug use, \\nchronic alcohol abuse, sexual promiscuity, or travel to countries with \\nendemic parasitic liver diseases represents increased risk for liver disease.\\nHepatitis A virus is transmitted by fecal-oral contamination that is asso-\\nciated with improper food handling. The most common transmission occurs \\nfrom asymptomatic children to adults.\\nHepatitis B virus (HBV) is transmitted sexually, by blood transfusion, \\nby contaminated needles, and by perinatal transmission.\\nHepatitis C virus (HCV) transmission occurs primarily through expo-\\nsure to contaminated blood or blood products. HBV and HCV can lead to \\nchronic infection, cirrhosis, and hepatocellular carcinoma.\\nOther hepatotropic viruses such as Hepatitis D and E viruses, cyto-\\nmegalovirus, herpes simplex virus, coxsackievirus, and Epstein-Barr virus \\ncan cause acute hepatitis.\\nToxic insults to the liver can cause acute hepatitis and fulminant liver \\nfailure. In addition to the most common toxic insult of acetaminophen, alco-\\nhol, a variety of prescription medications (e.g., certain antibiotics, statins, \\nisoniazid), herbal remedies (e.g., black cohosh, chaparral, Echinacea, kava), \\nand dietary supplements are associated with acute hepatitis and liver failure.\\nThe clinical presentation of infectious hepatitis varies with the individ-\\nual as well as with the specific causative virus. Asymptomatic incubation \\nperiod is followed by a prodrome of nausea, vomiting, and malaise. Later \\non, patients may note dark urine (bilirubinuria) and clay-colored stools and \\njaundice.\\n48_Cydulka_Ch48.indd   275 16/03/17   12:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 294, 'page_label': '276'}, page_content='276 SECTION 6: Gastrointestinal Emergencies\\nTablE 48-1 Clinical Features of hepatitis\\nAcute \\nhepatitis\\nChronic Disease/\\nCirrhosis \\nAcute Liver \\nFailure\\nSymptoms\\nNausea/vomiting/diarrhea + ± +\\nFever + – –\\nPain + ± ±\\nAltered mental status – ± +\\nBruising/bleeding – ± +\\nPhysical examination\\nJaundice + + +\\nHepatomegaly + – ±\\nAscites – + +\\nEdema – + –\\nSkin findings (bruising, vascular malformations) – + +\\nLab abnormalities\\nElevated ALT/AST + + ±\\nAST/ALT > 2 + ± ±\\nElevated PT/INR – ± +\\nElevated ammonia – ± +\\nLow albumin – + +\\nDirect bilirubinemia – + ±\\nIndirect bilirubinemia + + ±\\nUrobilinogen + + +\\nElevated blood urea nitrogen/creatinine – – ±\\nRadiologic findings\\nAscites – + +\\nFatty liver + – –\\nCirrhosis – + +\\nAbbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; INR, International \\nNormalized Ratio; PT, prothrombin time; +, typically present; –, typically absent; ±, variable.\\nAlcoholic liver disease can range from asymptomatic, reversible fatty \\nliver to acute alcoholic hepatitis, cirrhosis, or a combination of acute and cir-\\nrhotic features. Acute alcoholic hepatitis develops in patients with asymptom-\\natic liver disease (fatty liver can be seen on imaging) if they continue drink-\\ning. These patients may complain of gradual onset of anorexia, nausea, fever, \\ndark urine, jaundice, weight loss, abdominal pain, and generalized weakness.\\nFulminant hepatic failure is generally used to describe the development of \\nencephalopathy within 8 weeks of the onset of symptoms in a patient with a \\npreviously healthy liver. Signs and symptoms of acute failure may include \\nencephalopathy, cerebral edema, jaundice, ascites, right upper quadrant tender-\\nness, and coagulopathy. Clinical features of hepatitis are listed in Table 48-1.\\n48_Cydulka_Ch48.indd   276 16/03/17   12:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 295, 'page_label': '277'}, page_content='CHAPTER 48: Jaundice, Hepatic Disorders, and Hepatic Failure 277 \\nDiagnosis and Differential\\nTraditional liver function panels include a mix of mark ers of hepatocyte \\ninjury, usually include AST, ALT, and ALP, as well as indicators of hepato-\\ncyte catabolic activity (direct and indirect bilirubin).\\nElevations of transaminases in the hundreds of units per liter suggest \\nmild injury, or smoldering inflammation. Levels in the thousands suggest \\nextensive acute hepatic necrosis. Acute viral hepatitis may cause the levels \\nof ALT to rise several thousand units per liter. Less significant elevations, \\nless than five times normal, are typical of alcoholic liver disease. ALT is a \\nmore specific marker of hepatocyte injury than AST. Patients with acute \\nalcoholic hepatitis have AST and ALT levels that rise to several hundred \\nunits per liter. A relative predominance of AST to ALT is expected in \\npatients with alcoholic hepatitis.\\nALP elevation is associated with biliary obstruction and cholestasis; \\nelevations greater than four times normal strongly suggest cholestasis.\\nAn elevated GGT in the setting of hepatitis suggests an alcoholic cause. \\nIt is also elevated by drugs such as phenobarbital and warfarin. It may rise \\nin acute and chronic pancreatitis, acute myocardial infarction, uremia, \\nCOPD, rheumatoid arthritis, and diabetes mellitus.\\nLactate dehydrogenase (LDH) is a nonspecific marker, which limits its \\nutility.\\nSerum glucose level should immediately be checked in patients with \\naltered mental status because severe hepatocellular injury can cause hypo-\\nglycemia. Hypoxia, sepsis, intoxication, intracranial lesions, or encepha-\\nlopathy should also be considered in such a state.\\nSince nausea and vomiting may result in volume depletion and dehy-\\ndration, serum electrolytes, BUN, and creatinine levels should be \\nchecked.\\nAn elevated serum ammonia level is seen in patients with hepatic meta-\\nbolic failure caused by acute and chronic liver diseases. Very high ammonia \\nlevels signify poor prognosis.\\nProthrombin time serves as a true measure of liver function. Prolonged \\nPT or elevated INR occurs in acute hepatitis and exacerbations of chronic \\ncompensated liver disease; however, it is a common complication of \\nadvancing cirrhosis and indicates significant liver dysfunction and a poor \\nprognosis.\\nAlbumin reflects the liver’s synthetic function and may decrease in \\nadvancing cirrhosis or severe acute hepatitis. Low albumin suggests a poor \\nshort-term prognosis.\\nSerum bilirubin is somewhat insensitive for liver dysfunction. Hyper -\\nbilirubinemia in acute viral hepatitis varies in severity, and fractionation has \\nno clinical value. However, the development of severe hyperbilirubinemia \\nin primary biliary cirrhosis, alcoholic hepatitis, and acute liver failure sug-\\ngests a poor prognosis.\\nViral hepatitis serologies are often grouped into screening panels by \\nhospital laboratories; however, these tests are rarely immediately avail-\\nable. Detection of immunoglobulin M anti-hepatitis A virus antibodies is \\nstandard for diagnosing acute infection with hepatitis A virus. Acute \\nclinical illness in hepatitis B virus correlates with positive hepatitis B \\nvirus surface antigen (HBsAg). Hepatitis C virus is confirmed with posi-\\ntive anti-hepatitis C virus (anti-HCV) antibodies; however, this diagnosis \\n48_Cydulka_Ch48.indd   277 16/03/17   12:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 296, 'page_label': '278'}, page_content='278 SECTION 6: Gastrointestinal Emergencies\\nmay be masked by the 6- to 8-week delay between infection and antibody \\ndetection.\\nA CBC may be useful in detecting anemia, which suggests alcoholic \\nhepatitis, decompensated cirrhosis, gastrointestinal bleeding, or a hemo-\\nlytic process. Although white blood cell (WBC) count is not useful in \\ndiagnosis, a transient neutropenia followed by a relative lymphocytosis \\nwith atypical forms is seen with viral hepatitis.\\nThe serum acetaminophen concentration is the basis for diagnosis and \\ntreatment in patients with the suspicion of toxic ingestion.\\nDifferential diagnosis of acute hepatitis include viral hepatitis, drug- or \\ntoxin-induced hepatitis, alcoholic hepatitis, autoimmune hepatitis, chole-\\ncystitis and cholangitis, HELLP syndrome, hepatic, pancreatic, or biliary \\ntumors, and metastatic liver diseases.\\nEmergency Department Care and Disposition\\n1.  With the exception of acetaminophen toxicity (more completely dis-\\ncussed in Chapter 106), patients with acute hepatitis require supporti ve \\ntreatment with pain management, antiemetic medication, and fluid re-\\nsuscitation.\\n2.  Treat fluid and electrolyte imbalances secondary to poor oral intake, \\nexcessive diarrhea, or vomiting with intravenous crystalloids. Treat \\nhypoglycemia with 1 ampule D50W IV . Administration of antiemetics \\nmay allow resumption of oral intake.\\n3.  Admit high-risk patients, including the elderly and pregnant women, and \\npatients with significant fluid and electrolyte imbalance or refractory \\nvomiting. Other admission criteria include bilirubin ≥20 mg/dL, PT 50% \\nabove normal, hypoglycemia, low albumin, GI bleeding, encephalopa-\\nthy, immunosupression, or suspected toxin-induced hepatitis.\\n4.  Hospital admission is rarely required for patients with acute viral hepa-\\ntitis. These patients can be managed as outpatients with the emphasis on \\nrest, adequate oral intake, strict personal h ygiene, and avoidance of \\nhepatotoxins. Patients are recommended to return to the ED for poor \\noral intake, and worsening symptoms, particularly vomiting, jaundice, \\nor abdominal pain. Follow-up visits should be arranged.\\n5.  Management of alcoholic hepatitis is also supportive and can be man-\\naged as outpatients with emphasis on nutritional supplementations, \\nincluding thiamine, magnesium, potassium, and folate, and adequate \\noral intake. All patients should be advised to avoid further alcohol inges-\\ntion and hepatotoxins. Patients and family members should be referred \\nfor detoxification or alcohol-dependency treatment. Prophylactic treat-\\nment for alcohol withdrawal is considered in patients who require hos-\\npital admission.\\n6.  Patients with fulminant hepatic failure require critical care in the ED and \\nadmission to the intensiv e care unit. Aggressive support of circulation \\nand respiration, monitoring and treatment of increased intracranial pres-\\nsure if present, and correction of hypoglycemia and coagulopathy are \\nwarranted. Other treatments include oral lactulose, oral aminoglycoside \\nantibiotics (neomycin, vancomycin), and diet modification for signifi-\\ncant protein restriction. Early consultation with a hepatologist and liver \\ntransplant service is necessary.\\n48_Cydulka_Ch48.indd   278 16/03/17   12:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 297, 'page_label': '279'}, page_content='CHAPTER 48: Jaundice, Hepatic Disorders, and Hepatic Failure 279 \\n■ ■CIrrhOSIS AND ChrONIC LIVEr FAILUrE\\nCirrhosis is a chronic degenerative disease in which a critical amount of \\nliver parenchyma is replaced by fibrotic tissue. Cirrhosis is often caused by \\nalcoholic or chronic viral hepatitis; less common causes include drugs or \\ntoxins, hemochromatosis, Wilson’s disease, and primary (idiopathic) biliary \\ncirrhosis.\\nClinical Features\\nSymptoms of cirrhosis develop gradually. Patients with cirrhosis may be \\nasymptomatic or have nonspecific constitutional symptoms, such as \\nfatigue, loss of appetite, general weakness, muscle wasting, nausea, vomit-\\ning, abdominal pain, and low-grade fever. Signs and symptoms of decom-\\npensation include abdominal distension due to ascites and hepatomegaly, \\naltered mental status due to hepatic encephalopathy, pedal edema, jaundice, \\npruritus, splenomegaly, and spider angiomata.\\nAscites, which is one of the hallmarks of cirrhosis, causes a protuberant \\nabdomen. Intra-abdominal fluid can displace the diaphragm upward and \\nproduce pleural effusion with the possibility of respiratory compromise.\\nHepatic encephalopathy causes a spectrum of illness ranging from \\nchronic fatigue or mild confusion to acute lethargy. Hyperreflexia, spastic-\\nity, generalized seizure, and coma may also be present.\\nPatients with cirrhosis often present to the ED with worsening ascites \\nand edema, altered mental status, abdominal pain resulting from complica-\\ntions such as SBP, gastrointestinal and variceal bleeding, and other concur-\\nrent infections including pneumonia and urinary tract infections.\\nSpontaneous bacterial peritonitis is a subtle crucial complication of \\nascites; however, it is difficult to diagnose because signs of abdominal pain \\nand fever are not always present, and physical examination does not always \\ndemonstrate abdominal tenderness.\\nHepatorenal syndrome is a complication of cirrhosis that often accom-\\npanies SBP. This syndrome is defined as functional renal failure in cirrhotic \\npatients in the absence of intrinsic renal disease.\\nHepatic encephalopathy may be worsened or precipitated by protein \\nload from a large meal or from occult GI bleeding. Progressive liver dis-\\nease, constipation, hypo- or hyperglycemia, electrolyte imbalances, alcohol \\nwithdrawal, hypoperfusion states such as sepsis, renal failure, medications \\nsuch as antibiotics, and iatrogenic interventions can also compromise the \\nliver’s metabolic capacity and results in hepatic encephalopathy.\\nDiagnosis and Differential\\nLaboratory tests include transaminases (AST and ALT), ALP, total and \\ndirect bilirubin, LDH, albumin, ammonia, glucose, BUN and creatinine, \\nelectrolytes, PT/INR, and CBC. Transaminases may be near normal in the \\nend-stage liver failure. PT and albumin reflects the liver’s synthetic func-\\ntion. Prolonged PT is a common complication of advanced cirrhosis. Albu-\\nmin may decrease in advanced cirrhosis. High ammonia is a sign of hepatic \\nencephalopathy; however, levels of ammonia do not reliably correlate with \\nmental status. Elevated serum ammonia levels do not obviate a thorough \\nsearch for other multiple causes of altered mental status in patients with \\ncirrhosis.\\n48_Cydulka_Ch48.indd   279 16/03/17   12:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 298, 'page_label': '280'}, page_content='280 SECTION 6: Gastrointestinal Emergencies\\nPatients who are diagnosed with ascites for the first time, or who hav e \\nascites and develop fever, abdominal pain, GI bleeding, or encephalopathy \\nshould undergo paracentesis to check for SBP. A 50 cc sample of ascitic \\nfluid should be obtained for cell count, glucose and protein, Gram stain, \\nand culture to identify bacterial peritonitis.\\nA total WBC count >1000/mm 3 or a neutrophil count >250/mm 3 is \\nconsistent with a diagnosis of SBP.\\nA 10 mL of ascitic fluid should be placed in a blood culture bottle at the \\nbedside for best results. The most common isolates in SBP are Enterobac-\\nteriaceae (Escherichia coli, Klebsiella pneumoniae, etc.–63%) and Strepto-\\ncoccus pneumoniae (15%).\\nBedside US can identify ascites and guide paracentesis (Fig. 48-1). US \\nwith duplex Doppler is the test of choice for identifying portal vein and \\nhepatic vein thrombosis. Cancerous, vascular, or infectious lesions of the \\nliver can be identified with US and abdominal CT. Consider obtaining a \\nhead CT to identify intracranial hemorrhage in patients with altered mental \\nstatus.\\nEmergency Department Care and Disposition\\n1.  Admit patients with ascites if they have signif icant respiratory compro-\\nmise, abdominal pain, fever, acidosis, or leukocytosis for evaluation and \\ntreatment of SBP. Patients with new-onset or worsening hepatic \\nencephalopathy, hepatorenal syndrome, coagulopathy with bleeding, \\nsevere hyponatremia, and severe hyper- or hypovolemia should also be \\nmanaged in the hospital. Liver failure requires critical care in the ED and \\nconsultation with a gastroenterologist and a liver transplant center.\\nFigurE 48-1.  Sonographic image of ascitic fluid showing bowel loops and an \\nedematous gallbladder wall, a common finding in patients with ascites. Used with \\npermission from Michael S. Antonis, DO, sonographer.\\n48_Cydulka_Ch48.indd   280 16/03/17   12:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 299, 'page_label': '281'}, page_content='CHAPTER 48: Jaundice, Hepatic Disorders, and Hepatic Failure 281 \\n2.  Mild- to moderate-volume ascites can be managed with salt-restricted \\ndiet and diuretics as an outpatient basis in the absence of signs of infec-\\ntion and other complications. Recommended diuretics include spirono-\\nlactone, 50 to 200 mg/d, and amiloride, 5 to 10 mg/d. Furosemide can \\nbe problematic because it can lead to overdiuresis. Fluid restriction is \\nunnecessary unless serum sodium is less than 120 to 125 mEq/L.\\n3.  Paracentesis is the recommended therap y for large-volume ascites. \\nRemoval of more than 1 L of ascitic fluid can cause hypotension so close \\nmonitoring is necessary for large-volume taps. For therapeutic paracen-\\ntesis, it is recommended to administer albumin, 6 to 8 mg/L of fluid \\nremoved, for amounts greater than 4 L to prevent fluid shift and intra-\\nvascular collapse.\\n4.  Empiric antibiotic treatment is recommended in patients with SBP. \\nCefotaxime, 2 g IV in every 8 hours, is the first-line parenteral treat-\\nment. Administer IV fluoroquinolones except in patients who have \\nreceived prophylactic quinolone treatment. Consider oral fluoroquino-\\nlones to treat very mild cases and assure close follow-up.\\n5.  Lactulose is the mainstay of therapy for hepatic encephalopathy and is \\ngiven PO or PR. The oral dose is 20 g diluted in a glass of water, fruit \\njuice, or carbonated drink. 300 mL of diluted syrup with 700 mL of \\nwater or normal saline can be administered PR and the enema should be \\nretained for 30 minutes.\\n6.  Coagulopathy needs to be treated if the patient has uncontrolled bleed-\\ning or scheduled for a procedure. Giv e Vitamin K, 10 mg PO or IV . \\nConsider fresh frozen plasma in doses appropriate for patient’s PT level. \\nDecreased or malfunctioning platelets should be replaced with pooled \\ndonor platelets.\\n7.  Suspect gastroesophageal bleeding in patients with hematemesis, \\nmelena, or hematochezia. Specific treatments for v ariceal bleeding are \\naddressed in Chapter 39.\\n8.  Treat comorbidities such as electrolyte abnormalities, hypoglycemia, \\nventilatory and circulatory dysfunction, sepsis, and alcohol-related syn -\\ndromes (withdrawal, ketoasidosis, Wernicke–Korsakoff syndrome) \\naggressively.\\n9.  Choosing appropriate analgesics and sedatives in patients with compro-\\nmised liver function is a complex decision. Avoid NSAIDs due to GI \\ntoxicity and possible potentiation of renal dysfunction. Acetaminophen \\nmay be used for short-term pain relief at a reduced dose of 2 g total per \\nday, if needed. Opioids are contraindicated in patients with a history of \\nencephalopathy or substance abuse. However, fentanyl and tramadol at \\nreduced doses and increased dosing intervals are possible choices in \\nselect patients. Avoid benzodiazepine medication in patients with cir -\\nrhosis. Propofol is safe when short-term sedation is required.\\n■ ■FUrthEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 80, “Hepatic Disorders,” by Susan R. O’Mara and \\nKulleni Gebreyes.\\n48_Cydulka_Ch48.indd   281 16/03/17   12:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 300, 'page_label': '282'}, page_content='282\\nComplications of General \\nSurgical Procedures\\nDaniel J. Egan\\nAs an increasing number of surgical procedures occur in outpatient settings \\nand inpatient lengths of stay decrease, the emergency physician will \\nencounter more postoperative patients and their complications. Common \\nclinical situations presenting to the emergency department include: fever, \\nrespiratory complications, genitourinary complaints, wound infections, \\nvascular problems, and complications of drug therapy. Specific problems \\nnot covered in other chapters of this book are discussed here.\\n■ ■CLINICAL FEATURES\\nFever\\nThe causes of postoperative fever are the 5 Ws: wind (respiratory), water \\n(urinary tract infection [UTI]), wound, walking (deep venous thrombosis \\n[DVT]), and wonder drugs (drug fever or pseudomembranous colitis \\n[PMC]). Fever in the first 24 hours is usually due to atelectasis, but wound \\ninfections with necrotizing fasciitis, or clostridial infections must also be \\nconsidered. In the first 72 hours, pneumonia, atelectasis, intravenous cath-\\neter-related thrombophlebitis, and infections are the major causes. UTIs are \\nseen 1 to 5 days postoperatively. DVT does not typically occur until 5 days \\nafter the procedure, and wound infections generally manifest 7 to 10 days \\nafter surgery. Antibiotic-induced PMC is seen 6 weeks after surgery.\\nRespiratory Complications\\nPostoperative pain, splinting, and inadequate clearance of secretions lead to \\natelectasis. Fever, tachypnea, tachycardia, and mild hypoxia may be seen. \\nPneumonia may develop 24 to 96 hours later (see Chapter 30). Pulmonary \\nembolism can occur any time postoperatively (see Chapter 25).\\nGenitourinary Complications\\nUTIs occur after any procedure, but more commonly after instrumentation \\nof the GU tract or bladder catheterization. Elderly men, patients undergoing \\nanorectal or prolonged operations, and those receiving spinal or epidural \\nanesthesia are at increased risk for urinary retention presenting with lower \\nabdominal pain and the inability to urinate (see Chapter 54). Decreased \\nurine output should raise concerns for renal failure resulting from multiple \\ncauses, particularly volume depletion (see Chapter 50).\\nWound Complications\\nHematomas with pain and swelling at the surgical site result from inade-\\nquate hemostasis. A small portion of the wound may be opened to rule out \\ninfection. Seromas are collections of clear fluid under the wound. Wound \\ninfections present with pain, swelling, erythema drainage and tenderness. \\nRisk factors include extremes of age, diabetes, poor nutrition, necrotic \\n49\\nCh A p TER\\n49_Cydulka_Ch49.indd   282 16/03/17   12:36 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 301, 'page_label': '283'}, page_content='CHAPTER 49: Complications of General Surgical Procedures 283 \\ntissue, poor perfusion, foreign bodies, and hematomas. Necrotizing fasciitis \\nshould be considered in a systemically ill patient with rapidly expanding \\ninfection and pain out of proportion to examination (see Chapter 90). \\nSuperficial or deep fascial wound dehiscence can occur due to diabetes, \\npoor nutrition, chronic steroid use, and inadequate or improper closure of \\nthe wound. Operative exploration may be required to determine the extent \\nof dehiscence.\\nVascular Complications\\nSuperficial thrombophlebitis manifests with erythema, warmth, and full-\\nness of the affected vein. It usually occurs in the upper extremities after \\nintravenous catheter insertion or in the lower extremities due to stasis in \\nvaricosities. DVT most commonly occurs in the lower extremities postop-\\neratively (see Chapter 25).\\nDrug Therapy Complications\\nNumerous medications cause fever without associated concomitant infec-\\ntion. Many antibiotics prescribed perioperatively can cause antibiotic-\\ninduced diarrhea. PMC, the most serious diarrheal complication, is caused \\nby Clostridium difficile toxin. Watery or even bloody diarrhea, fever, and \\ncrampy abdominal pain are the usual complaints.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nPostoperative patients with fever should have an evaluation focusing on the \\nelements detailed above. Patients with suspected respiratory complications \\nshould have chest x-rays. Radiographs may demonstrate atelectasis, pneu-\\nmonia, or pneumothorax. Additional imaging like CT or ultrasound may be \\nindicated based on the operative procedure performed.\\nPatients with oliguria or anuria should be evaluated for signs of hypovo-\\nlemia or urinary retention. Diagnosis of PMC is established by demonstrat-\\ning C difficile cytotoxin in the stool. Nevertheless, in 27% of cases, the \\nassay may be negative.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nContact the surgeon who performed the procedure to discuss patients who \\npresent with postoperative complications. Patients who are toxic appearing, \\nhave underlying debilitating conditions or elderly require hospitalization.\\n1.  Patients with mild atelectasis and no evidence of hypox emia may be \\nmanaged as outpatients with pain control and increased deep breathing.\\n2.  Postoperative pneumonia may be polymicrobial. Admission and antibiotic \\ntherapy to cover nosocomial infections such as Pseudomonas and methi-\\ncillin-resistant Staph aureus are usually recommended (see Chapter 30).\\n3.  Nontoxic patients with UTI can be managed as outpatients with oral \\nantibiotic therapy geared toward appropriate organisms. Consider gram-\\npositive flora when instrumentation has occurred. Ill-appearing patients \\nrequire admission.\\n4.  Wound hematomas may require removal of some sutures and e vacua-\\ntion. Consultation with the surgeon before treatment is appropriate. \\n49_Cydulka_Ch49.indd   283 16/03/17   12:36 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 302, 'page_label': '284'}, page_content='284 SECTION 6: Gastrointestinal Emergencies\\nSeromas can be confirmed and treated with needle aspiration. Admis-\\nsion may not be necessary for either of these processes.\\n5.  Wound infections are often treated with oral antibiotics unless the patient \\nshows signs of systemic toxicity or carries signif icant comorbidities. \\nPerineal infections are often polymicrobial requiring parenteral antibiot-\\nics and admission. Necrotizing fasciitis needs immediate surgical \\ndebridement and broad-spectrum parenteral antibiotics (see Chapter 90).\\n6.  Patients with superficial thrombophlebitis may be treated as outpatients \\nwith nonsteroidal anti-inflammatory drugs (NSAIDs), local heat appli-\\ncation and elevation. Antibiotics may be indicated if surrounding cellu-\\nlitis or lymphangitis are noted. Suppurative thrombophlebitis requires \\nhospitalization and surgical excision.\\n7.  Patients with suspected antibiotic-induced PMC will require fluid resus-\\ncitation and likely empiric therap y. Oral or intravenous metronidazole \\nand oral vancomycin are treatments for this condition.\\n■ ■SpECIFIC CONSIDERATIONS\\nComplications of Breast Surgery\\nAlthough overall rates of complications are low following breast surgery, \\nwound infections, hematomas, seromas, pneumothorax, and necrosis of the \\nskin flaps may be seen. Lymphedema of the ipsilateral arm may occur after \\nmastectomy.\\nComplications of Gastrointestinal Surgery\\nStimulation of the splanchnic nerves during intraabdominal surgery may \\nlead to dysmotility and a paralytic ileus. After gastrointestinal surgery, \\nsmall bowel tone returns to normal within 24 hours and colonic function \\nwithin 3 to 5 days.\\nPatients develop nausea, vomiting, constipation, and abdominal disten-\\ntion and pain. An adynamic ileus typically resolves after bowel rest, naso-\\ngastric suction and intravenous hydration. Prolonged ileus should prompt \\nan investigation for nonneuronal causes like peritonitis, intra-abdominal \\nabscesses, hemoperitoneum, pneumonia, sepsis, electrolyte imbalance, or \\nmedications. Abdominal imaging, complete blood cell count, basic meta-\\nbolic panel, and urinalysis should be obtained. Occasionally, surgical inter-\\nvention may be necessary for obstruction due to adhesions.\\nIntraabdominal abscesses are caused by preoperative contamination, intra-\\noperative spillage of bowel contents or postoperative anastomotic leaks. Diag-\\nnosis is confirmed by computed tomography or ultrasonography. Antibiotic \\ntherapy as well as either percutaneous or surgical drainage will be required.\\nPancreatitis occurs especially after direct manipulation of the pancreatic \\nduct. The clinical spectrum extends from mild nausea and vomiting to \\nsevere abdominal pain and hemodynamic instability. Complications like \\npleural effusion and severe hemorrhage may occur. Serum amylase mea-\\nsurements are not specific and measurement of a lipase is more reliable.\\nCholecystitis and biliary colic have been reported as postoperative \\ncomplications. Elderly patients are more prone to develop acalculous \\ncholecystitis. Characteristic lab findings of an obstructive process may be \\nabsent.\\n49_Cydulka_Ch49.indd   284 16/03/17   12:36 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 303, 'page_label': '285'}, page_content='CHAPTER 49: Complications of General Surgical Procedures 285 \\nFistulas, internal or external, may result from either technical complica-\\ntions or direct bowel injury. Fistulas can lead to electrolyte abnormalities \\nand require surgical consultation and possible hospitalization. Anastomotic \\nleaks occur primarily after esophageal, gastric and colonic procedures and \\ncan cause devastating consequences as a result of infection. Esophageal \\nleaks occur within 10 days of the operation and carry very high morbidity \\nand mortality rates.\\nComplications of bariatric surgery remain common, although mortality \\nafter the procedures is low. In the weeks after surgery, patients are at risk \\nfor leaks and bleeding. Dumping syndrome is seen in gastric bypass proce-\\ndures due to the rapid influx of hyperosmolar chyme into the small intestine \\nresulting in fluid sequestration and hypovolemia. Patients experience \\nnausea, vomiting, epigastric discomfort, palpitations, dizziness, and some-\\ntimes syncope. Other complications include gastroesophageal reflux, vita-\\nmin and electrolyte deficiencies, ulcers, obstruction, gastric slippage, and \\nband erosion.\\nComplications of laparoscopic procedures include problems related to \\npneumoperitoneum, traumatic injury from insertion of the needle and \\ntrocar, and retained stones after cholecystectomy.\\nComplications of transabdominal feeding tubes and percutaneous endo-\\nscopic gastrostomy tubes include infections, hemorrhage, peritonitis, \\naspiration, wound dehiscence, sepsis, and obstruction of the tube. Dislodged \\ntubes should be replaced with the appropriately sized tube (same type if \\npossible, or a temporary foley catheter).\\nAcute complications arising from stomas (ileostomy or colostomy) are \\nusually due to technical errors of stoma placement. Later complications can \\nbe from the underlying disease, such as Crohn’s disease or cancer. Isch-\\nemia, necrosis, skin maceration, bleeding, parastomal hernia, and prolapse \\nmay be seen.\\nThe most common complications of colonoscopy are hemorrhage and \\nperforation. Hemorrhage occurs typically due to polypectomy, biopsies, or \\nmucosal lacerations or tearing. Perforation may be immediately apparent or \\nsymptoms may be delayed for several hours to days. Upright chest  \\nor abdominal radiographs may reveal free air but CT is most sensitive.\\nRectal surgery complications include urinary retention (frequently after \\nhemorrhoidectomy), constipation, prolapse, bleeding, and infections.\\nTetanus has been known to occur in surgical wounds although, by far, \\nthis rare disease is more common after minor trauma.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 87, “Complications of General Surgical Procedures,” \\nby Edmond A. Hooker\\n49_Cydulka_Ch49.indd   285 16/03/17   12:36 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 304, 'page_label': '286'}, page_content='49_Cydulka_Ch49.indd   286 16/03/17   12:36 PM\\nThis page intentionally left blank'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 305, 'page_label': '287'}, page_content='287\\n7\\nSECTION\\nRenal and Genitourinary \\nDisorders\\nAcute Kidney Injury\\nSum Ambur\\nPatients with acute kidney injury (AKI) present with a wide variety of \\nmanifestations depending on the underlying etiology. AKI can be caused by \\nhypovolemia, nephrotoxic medications, and anatomic problems of the \\ngenitourinary tract. Additional etiologies include cardiac, vascular, throm-\\nbotic, glomerular, and renal tubular disorders.\\n■ ■CLINICAL FEATURES\\nDeterioration in renal function leads to an excessive accumulation of \\nnitrogenous waste products in the serum and significant electrolyte abnor -\\nmalities. Patients usually have signs and symptoms of their underlying \\ncausative disorder but eventually develop stigmata of renal failure. V olume \\noverload, hypertension, pulmonary edema, mental status changes or neuro-\\nlogic symptoms, nausea and vomiting, bone and joint problems, anemia, \\nand increased susceptibility to infection (a leading cause of death) can \\noccur as patients develop more chronic uremia.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nHistory and physical examination usually provide clues to the etiology. \\nSigns and symptoms of the underlying causative disorder should be vigor -\\nously sought. Physical examination should assess vital signs and volume \\nstatus, establish urinary tract patency and output, and search for signs of \\nchemical intoxication, drug usage, muscle damage, infection, or associated \\nsystemic disease. Diagnostic studies include urinalysis, blood urea nitrogen \\nand creatinine levels, serum electrolytes, urinary sodium and creatinine, \\nand urinary osmolality. Analysis of these tests allows most patients to be \\ncategorized as prerenal, renal, or postrenal. Fractional excretion of sodium \\ncan be calculated to help in this categorization (Table 50-1). Normal urinary \\nsediment may be seen in prerenal and postrenal failure, hemolytic-uremic \\nsyndrome, and thrombotic thrombocytopenic purpura. The presence of \\nalbumin may indicate glomerulonephritis or malignant hypertension. \\nGranular casts are seen in acute tubular necrosis. Albumin and red blood \\ncell casts are found in glomerulonephritis, malignant hypertension, and \\nautoimmune disease. White blood cell casts are seen in interstitial nephritis \\n50\\nCh A p TER\\n50_Cydulka_Ch50.indd   287 16/03/17   12:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 306, 'page_label': '288'}, page_content='288 SECTION 7: Renal and Genitourinary Disorders\\nTAble 50-1 Laboratory Findings in Conditions That Cause Acute Renal Failure\\nCategory Dipstick Test\\nSediment \\nAnalysis\\nUrine \\nOsmolality \\n(mOsm/kg)\\nFractional \\nExcretion of \\nSodium (%)\\nPrerenal Trace to no protein-\\nuria, SG >1.015\\nA few hyaline casts \\npossible\\n>500 <1\\nRenal\\nIschemia Mild to moderate \\nproteinuria\\nPigmented granular \\ncasts, renal tubular \\nepithelial cells\\n<350 >1\\nNephrotoxins Mild to moderate \\nproteinuria\\nPigmented granular \\ncasts\\n<350 >1\\nAcute intersti-\\ntial nephritis\\nMild to moderate \\nproteinuria, hemo-\\nglobin, leukocytes\\nWhite cells, \\neosinophils, casts, \\nred cells\\n<350 >1\\nAcute glomer-\\nulonephritis\\nModerate to \\nsevere proteinuria, \\nhemoglobin\\nRed cells and red \\ncell casts, red cells \\ncan be dysmorphic\\n>500 Depends on \\nvolume status\\nPostrenal Trace to no protein-\\nuria; hemoglobin and \\nleukocytes possible\\nCrystals, red cells, \\nwhite cells possible\\n<350 >1\\nAbbreviation: SG, specific gravity.\\nand pyelonephritis. Crystals can be present with renal calculi and certain \\ndrugs (sulfas, ethylene glycol, and radiocontrast agents). Renal ultrasound \\nis the radiologic procedure of choice in most patients with renal failure \\nwhen upper tract obstruction and hydronephrosis are suspected. Color-flow \\nDoppler can assess renal perfusion and facilitate the diagnosis of large ves-\\nsel causes of renal failure. Bedside sonography can quickly diagnose some \\ntreatable causes and give guidance for fluid resuscitation; inspiratory col-\\nlapse of the intrahepatic inferior vena cava (IVC) can give a good measure \\nof volume status and fluid responsiveness (Fig. 50-1).\\nPrerenal failure is produced by conditions that decrease renal perfusion \\nand is the most common cause of community-acquired acute renal failure \\n(70% of cases). It is also a common precursor to ischemic and nephrotoxic \\ncauses of intrinsic renal failure. Common causes of prerenal failure \\ninclude hypovolemic states (vomiting/diarrhea, diuretics and other antihy-\\npertensives, reduced intake), fluid sequestration (cirrhosis, pancreatitis, \\nburns, septic shock, others), blood loss, or decreased cardiac output from \\ncardiac dysfunction. Intrinsic renal failure has vascular and ischemic \\netiologies; glomerular and tubulointerstitial diseases are also causative. \\nIschemic renal failure, traditionally known as acute tubular necrosis \\n(ATN), is now called acute kidney injury (AKI). AKI, due to severe and \\nprolonged prerenal etiologies, causes most cases of intrinsic renal failure. \\nAKI is also the most common cause of hospital-acquired renal failure. \\nNephrotoxins (both physician prescribed and environmental) are the sec-\\nond most common cause of AKI. Postrenal azotemia occurs primarily in \\nelderly men with high-grade prostatic obstruction. Lesions of the external \\ngenitalia (i.e., strictures) are also common causes. Significant permanent \\n50_Cydulka_Ch50.indd   288 16/03/17   12:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 307, 'page_label': '289'}, page_content='CHAPTER 50: Acute Kidney Injury 289 \\nFIgure 50-1. Ultrasound of the inferior vena cava. A. Dilated inferior vena cava \\n(arrows) with little respiratory variation as might be expected in volume overload. \\nb. An almost fully collapsed inferior vena cava at inspiration (arrows) and expira-\\ntion (arrowheads) as might be expected in prerenal acute kidney injury. Used with \\npermission from Michael B, Stone, MD, RDMS.\\nA\\nB\\n50_Cydulka_Ch50.indd   289 16/03/17   12:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 308, 'page_label': '290'}, page_content='290 SECTION 7: Renal and Genitourinary Disorders\\nloss of renal function occurs over 10 to 14 days with complete obstruction, \\nand worsens with associated UTI.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nEmergency department goals in the initial care of patients with acute renal \\nfailure focus on treating the underlying cause with an emphasis on correct-\\ning fluid and electrolyte derangements. Efforts should be made to prevent \\nfurther renal damage and provide supportive care while attempting to estab-\\nlish a diagnosis and facilitating further evaluation and treatment as appro-\\npriate. Urine output should be closely monitored and consideration should \\nbe given to placement of a Foley catheter. ECG should be performed to \\nevaluate for hyperkalemia-associated changes. Appropriate labs including \\nserum potassium, creatinine, and BUN should be obtained.\\nPrerenal Failure\\n1. Use isotonic fluids (normal saline or Lactated Ringer’s solution) for \\nvolume resuscitation.\\n2. If cardiac failure is causing prerenal azotemia, optimize cardiac output \\nto improve renal perfusion. Reducing intra vascular volume (i.e., with \\ndiuretics) may be appropriate. Bedside echocardiography as well as so-\\nnographic assessment of the IVC may help guide this decision.\\nrenal Failure (Intrinsic)\\nAdequate circulating volume must be restored first; h ypovolemia potenti-\\nates and exacerbates all forms of renal failure. Ischemia or nephrotoxic \\nagents are the most common causes of intrinsic renal failure. History, \\nphysical examination, and baseline laboratory tests should provide clues to \\nthe diagnosis. Nephrotoxic medications and intravenous contrast should be \\navoided.\\n1. Vasopressor support with norepinephrine or dopamine may be needed as \\na temporizing measure to support mean arterial pressure and support \\nrenal perfusion in the setting of shock.\\n2. Use caution with renally excreted drugs (digoxin, magnesium, seda-\\ntives, and narcotics) and intravenous contrast because therapeutic \\ndoses may accumulate to excess and cause serious side effects. Fluid \\nrestriction may be required. Restoration of adequate intravascular vol-\\nume with crystalloid infusion may be useful in the prevention of radio-\\ncontrast nephropathy.\\nPostrenal Failure\\nEstablish appropriate urinary drainage; the exact procedure depends on the \\nlevel of obstruction.\\n1. Place a Foley catheter to relie ve obstruction caused by prostatic hyper -\\ntrophy. However, there is no data to support the practice of intermittent \\ncatheter clamping to prevent hypotension and hematuria; urine should \\nbe completely and rapidly drained.\\n50_Cydulka_Ch50.indd   290 16/03/17   12:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 309, 'page_label': '291'}, page_content='CHAPTER 50: Acute Kidney Injury 291 \\n2. Percutaneous nephrostomy may be required for ureteral occlusion until \\ndefinitive surgery to correct the obstruction can take place once the \\npatient is stabilized.\\n3. For the acutely anuric patient, obstruction is the major consideration. If \\nno urine is obtained on initial bladder catheterization and a bladder scan \\nor bedside ultrasound reveals a full bladder, emergency urologic consul-\\ntation may be necessary.\\n4. With chronic urinary retention, postobstructive diuresis may occur due to \\nosmotic diuresis or tubular dysfunction. Patients may become suddenly \\nhypovolemic and hypotensive. Urine output must be closely monitored, \\nwith appropriate fluid replacement as needed.\\nDialysis\\nIf treatment of the underlying cause fails to improve renal function, or in \\ncases with severe hyperkalemia or hypervolemia, dialysis should be consid-\\nered. It is prudent to consult with a nephrologist as soon as possible if \\nurgent dialysis is a consideration.\\n1. The nephrologist usually makes decisions about dialysis. Dialysis is \\noften initiated when the blood urea nitrogen is greater than 100 mg/dL \\nor serum creatinine is greater than 10 mg/dL.\\n2. Patients with complications of acute renal failure such as cardiac insta-\\nbility (due to metabolic acidosis and h yperkalemia), intractable volume \\noverload, hyperkalemia, and uremia (i.e., encephalopathy, pericarditis, \\nand bleeding diathesis) not easily corrected by other measures should be \\nconsidered for emergency dialysis.\\nDisposition\\nPatients with new-onset renal failure usually require hospital admission, \\noften to an intensive care unit. Consider transferring patients to another \\ninstitution if nephrology consultation and dialysis facilities are not \\navailable.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 88, “Acute Kidney Injury,” by Richard Sinert and \\nPeter R. Peacock, Jr.\\n50_Cydulka_Ch50.indd   291 16/03/17   12:37 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 310, 'page_label': '292'}, page_content='292\\nRhabdomyolysis\\nAnnet Alenyo Ngabirano\\nRhabdomyolysis is the destruction of skeletal muscle, caused by any \\nmechanism that results in injury to myocytes and their membranes.  \\nTable 51-1 lists commonly recognized conditions associated with rhab-\\ndomyolysis. In general, the most common causes of rhabdomyolysis in \\nadults are alcohol and drugs of abuse, followed by medications, muscle \\ndiseases, trauma, neuroleptic malignant syndrome, seizures, immobility, \\ninfection, strenuous physical activity, and heat-related illness. Multiple \\ncauses are present in more than half of patients. In children, rhabdomy-\\nolysis is less common and is thought to be more benign.\\n51\\nCh A pter\\nTable 51-1 Common Conditions Associated with rhabdomyolysis in Adults\\nTrauma\\nCrush injury\\nElectrical or lightning injury\\nDrugs of abuse\\nAmphetamines (including \\necstasy (3, 4-methylene-\\ndioxymethamphetamine))\\nCaffeine\\nCocaine\\nEthanol\\nHeroin\\nLysergic acid diethylamide\\nMethamphetamines\\nOpiates\\nPhencyclidine\\nenvironment and \\nexcessive muscular \\nactivity\\nContact sports\\nDelirium tremens\\nDystonia\\nPsychosis\\nSeizures\\nMarathons, military basic \\ntraining\\nHeat stroke\\nGenetic disorders\\nGlycolysis and glycogenoly-\\nsis disorders\\nFatty acid oxidation \\ndisorders\\nMitochondrial and \\nrespiratory chain \\nmetabolism disorders\\nImmunologic diseases \\ninvolving muscle\\nDermatomyositis\\nPolymyositis\\nbacterial infection\\nClostridium\\nGroup A β-hemolytic \\nstreptococci\\nLegionella\\nSalmonella\\nShigella\\nStaphylococcus aureus\\nStreptococcus pneumoniae\\nViral infection\\nCoxsackievirus\\nCytomegalovirus\\nEpstein–Barr virus\\nEnterovirus\\nHepatitis virus\\nHerpes simplex virus\\nHuman immunodeficiency \\nvirus\\nInfluenza virus (A and B)\\nRotavirus\\nMycoplasma\\nIschemic injury\\nCompartment syndrome\\nCompression\\nMedications\\nAntipsychotics\\nBarbiturates\\nBenzodiazepines\\nClofibrate\\nColchicine\\nCorticosteroids\\nDiphenhydramine\\nIsoniazid\\nLithium\\nMonoamine oxidase \\ninhibitors\\nNarcotics\\nNeuroleptic agents\\nPhenothiazines\\nPropofol\\nSalicylates\\nSelective serotonin reuptake \\ninhibitors\\nStatins\\nTheophylline\\nTricyclic antidepressants\\nZidovudine\\nSome novel cancer \\nchemotherapeutic agents\\n51_Cydulka_Ch51.indd   292 16/03/17   12:49 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 311, 'page_label': '293'}, page_content='CHAPTER 51: Rhabdomyolysis 293 \\n■ ■CLINICAL FeAtUreS\\nSymptoms are usually acute in onset and include myalgias, stiffness, weak-\\nness, malaise, low-grade fever, and dark (usually brown) urine. Nausea, \\nvomiting, abdominal pain, and tachycardia can occur in severe rhabdomy-\\nolysis. Muscle symptoms, however, may be present in only half of cases. \\nSome patients may present with complications of rhabdomyolysis such as \\nacute renal failure, metabolic derangements, disseminated intravascular \\ncoagulation, and mechanical complications (e.g., compartment syndrome \\nor peripheral neuropathy) (Table 51-2).\\nAcute rhabdomyolysis may be present without any of these signs or \\nsymptoms and with normal findings on physical examination. For this \\nreason, diagnosis is often made from a significant history, an elevated \\nserum creatine kinase level or the presence of dark urine on routine \\nlaboratory testing.\\n■ ■DIAGNOSIS AND DIFFereNtIAL\\nAn elevated serum creatine kinase is the most sensitive and reliable indica-\\ntor of muscle injury. Diagnosis requires a fivefold or greater increase above \\nthe upper threshold of normal serum creatine kinase level in the absence of \\ncardiac or brain injury. Persistently elevated levels despite treatment \\nsuggest ongoing muscle necrosis.\\nMyoglobinuria develops once skeletal muscle injury is >100 gram. \\nBecause myoglobin contains heme, qualitative tests such as the dipstick test \\ndo not differentiate among hemoglobin, myoglobin, and red blood cells. \\nTherefore, suspect myoglobinuria when the urine dipstick test is positive \\nfor blood but no red blood cells are present on microscopic examination. \\nAbsence of an elevated serum myoglobin level or of myoglobinuria does \\nnot exclude the diagnosis as levels may return to normal within 1 to 6 hours \\nafter the onset of muscle necrosis.\\nOther laboratory studies are useful in identifying the common com-\\nplications of rhabdomyolysis and the underlying cause. Urinalysis \\nshould be obtained for all patients. Serum electrolyte, calcium, phos-\\nphorus, and uric acid levels help detect hyperkalemia, abnormal calcium \\nand phosphorus levels, and hyperuricemia. Serum creatinine and BUN \\nlevels are needed to identify acute renal failure. Because disseminated \\nTable 51-2 Complications of rhabdomyolysis\\nAcute renal failure\\nMetabolic derangements\\nHypercalcemia (late)\\nHyperkalemia\\nHyperphosphatemia\\nHyperuricemia\\nHypocalcemia\\nHypophosphatemia (late)\\nDisseminated intravascular coagulation\\nMechanical complications\\nCompartment syndrome\\nPeripheral neuropathy\\n51_Cydulka_Ch51.indd   293 16/03/17   12:49 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 312, 'page_label': '294'}, page_content='294 SECTION 7: Renal and Genitourinary Disorders\\nintravascular coagulation is a potential complication, a baseline CBC  \\nshould be obtained and a coagulopathic screen considered (e.g., pro-\\nthrombin time, partial thromboplastin time, fibrin split products, and \\nfibrinogen level). Other common laboratory findings in rhabdomyolysis \\ninclude elevated levels of aldolase, lactate dehydrogenase, urea, creatine, \\nand aminotransferases. Further laboratory testing should be guided by \\nthe medical history and clinical presentation.\\nOther causes of muscle pain and weakness besides rhabdomyolysis \\nshould be considered in the appropriate clinical setting. These include \\nacute myopathies, periodic paralysis, polymyositis or dermatomyositis, \\nand Guillain–Barré syndrome. Rhabdomyolysis associated with strenu-\\nous exercise, fasting, or repeat episodes of rhabdomyolysis suggests an \\ninherited metabolic myopathy.\\n■ ■eMerGeNCY DepArtMeNt CAre AND DISpOSItION\\n1. Provide aggressive IV rehydration for 24 to 72 hours. One method of \\nrehydration is rapid correction of the fluid deficit with IV crystalloids \\nfollowed by infusion of 2.5 mL/kg/h, with the goal of maintaining a \\nminimum urine output of 2 mL/kg/h. Another method titrates infusion \\nrates to a goal of 200 to 300 mL of urine output per hour.\\n2. No prospective contr olled studies have demonstrated benefit from \\nalkalinization of the urine with sodium bicarbonate or forced diure-\\nsis with mannitol or loop diuretics. Bicarbonate is widely recom-\\nmended but without an evidence base. If bicarbonate is given, maintain \\nan isotonic solution and avoid metabolic alkalosis or hypokalemia. \\nMannitol may be harmful because it may cause osmotic diuresis in \\nhypovolemic patients.\\n3. Place a urinary catheter in patients in critical condition and those with \\nacute renal failure to monitor urine output. Institute cardiac monitoring \\nas electrolyte and metabolic complications can cause dysrhythmias. For \\npatients with heart disease, comorbid conditions, or preexisting renal \\ndisease or for elderly patients, hemodynamic monitoring may be neces-\\nsary to avoid fluid overload. Serial measurements of urine pH, electro-\\nlytes, creatine kinase, calcium, phosphorus, BUN, and creatinine are \\nneeded.\\n4. Monitor electrolytes. Hypocalcemia observ ed early in rhabdomyolysis \\nusually requires no treatment. Give calcium, if needed, to treat \\nhyperkalemia-induced cardiotoxicity or profound signs and symptoms \\nof hypocalcemia. If hypercalcemia is symptomatic, continue saline \\ndiuresis. Treat hyperphosphatemia with oral phosphate binders when \\nserum levels are >7 mg/dL. Treat hypophosphatemia when the serum \\nlevel is <1 mg/dL. Hyperkalemia, which is usually most severe in the \\nfirst 12 to 36 hours after muscle injury, can be significant and prolonged. \\nTraditional insulin and glucose therapy, although recommended, may \\nnot be as effective in rhabdomyolysis-induced hyperkalemia. The use of \\nion-exchange resins (e.g., sodium polystyrene sulfonate) is effective. \\nDialysis may be needed (see Chapter 17, Fluids and Electrolytes, \\nTintinalli’s Emergency Medicine: A Comprehensive Study Guide, 8th ed.).\\n5. Avoid prostaglandin inhibitors such as nonsteroidal anti-inflammatory \\ndrugs (NSAIDs) because of their vasoconstrictive effects on the kidney.\\n51_Cydulka_Ch51.indd   294 16/03/17   12:49 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 313, 'page_label': '295'}, page_content='CHAPTER 51: Rhabdomyolysis 295 \\n6. Finally, treat the underlying cause.\\n7. The majority of healthy patients with exertional rhabdomyolysis  and \\nwithout comorbidities (i.e., heat stress, dehydration, trauma) can be \\ntreated with oral or IV rehydration, observed in the ED, and then \\nreleased. Otherwise, patients should be admitted for IV hydration, diure-\\nsis, management of complications, and treatment of the underlying \\ncause. Admit to a monitored bed to identify dysrhythmias if they occur. \\nConsult the nephrology service to evaluate the need for dialysis, espe-\\ncially for patients with hyperkalemia unresponsive to therapy.\\n■ ■FUrther reADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 89, “Rhabdomyolysis,” by Francis L. Counselman and \\nBruce M. Lo.\\n51_Cydulka_Ch51.indd   295 16/03/17   12:49 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 314, 'page_label': '296'}, page_content='296\\nEmergencies in Renal Failure  \\nand Dialysis Patients\\nJonathan A. Maisel\\nPatients with end-stage renal disease (ESRD) may sustain multiple compli-\\ncations of their disease process and treatment. Emergent dialysis is most \\ncommonly required for hyperkalemia, severe metabolic acidosis, and pul-\\nmonary edema resistant to alternative therapy. See the appropriate chapters \\nfor discussion of the management of hypertension, heart failure, bleeding \\ndisorders, and electrolyte disorders.\\n■ ■CARDIOVASCULAR COMPLICATIONS\\nElevated levels of troponin I and T are common, even in those who are \\nasymptomatic, and are associated with increased long-term risk of ischemic \\nheart disease. Myocardial infarction may be defined by a 20% or greater rise \\nin the troponin value, with at least one value above the 99th percentile. \\nHypertension occurs in most patients starting dialysis. Management includes \\ncontrol of blood volume, followed by use of adrenergic-blocking drugs, \\nangiotensin-converting enzyme inhibitors, or vasodilating agents. Conges-\\ntive heart failure (CHF) may be caused by hypertension, coronary ischemia, \\nand valvular disease, as well as uremic cardiomyopathy, fluid overload, and \\narteriovenous (A V) fistulas (high output failure). Treatment includes supple-\\nmental oxygen, bilevel positive airway pressure, nitrates, angiotensin con-\\nverting enzyme inhibitors, and possibly furosemide 60 to 100 mg IV , as its \\npulmonary vasodilator effect may provide relief, even in oliguric patients. \\nPreload can be further reduced by inducing diarrhea with sorbitol and with \\nphlebotomy (minimum 150 mL). Blood should be collected in a transfusion \\nbag so that it may be transfused back to the patient during subsequent dialy-\\nsis. Hemodialysis (HD) is the definitive treatment. Pericarditis in ESRD \\npatients is usually due to worsening uremia. Electrocardiographic (ECG) \\nchanges typical of acute pericarditis are not always seen. Pericardial friction \\nrubs are louder than in most other forms of pericarditis, often palpable, and \\nfrequently persist after the metabolic abnormalities have been corrected. \\nUremic pericarditis is treated with intensive dialysis. Cardiac tamponade is \\nthe most serious complication of uremic pericarditis. It presents with \\nchanges in mental status, hypotension, or dyspnea. An enlarged heart on \\nchest x-ray may suggest the diagnosis, which can be confirmed with echo-\\ncardiography. Hemodynamically significant pericardial effusions require \\npericardiocentesis under fluoroscopic or ultrasonographic guidance.\\n■ ■NEUROLOGIC COMPLICATIONS\\nUremic encephalopathy presents with altered mental status, cognitive defects, \\nmemory loss, slurred speech, and asterixis. The progressive neurologic symp-\\ntoms of uremia are the most common indications for initiating HD. It should \\nremain a diagnosis of exclusion until structural, vascular, infectious, toxic, \\nand metabolic causes of neurologic dysfunction have been ruled out. Periph-\\neral neuropathy, manifested by paresthesias, diminished deep tendon reflexes, \\n52\\nCh APTER\\n52_Cydulka_Ch52.indd   296 16/03/17   2:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 315, 'page_label': '297'}, page_content='CHAPTER 52: Emergencies in Renal Failure and Dialysis Patients  297 \\nimpaired vibration sense, muscle wasting, and weakness, occurs in 60% to \\n100% of patients with ESRD. Autonomic dysfunction, characterized by pos-\\ntural dizziness, gastric fullness, bowel dysfunction, reduced sweating, \\nreduced heart rate variability, and baroreceptor control impairment, is com-\\nmon in ESRD patients. Stroke is seen in 6% of HD patients, with half of cases \\nbeing hemorrhagic, typically subdural hematomas. Stroke may be caused by \\ncerebrovascular disease, head trauma, bleeding dyscrasias, anticoagulation, \\nexcessive ultrafiltration, or hypertension. Stroke should be considered in any \\nESRD patient presenting with a change in mental status.\\n■ ■hEMATOLOGIC COMPLICATIONS\\nAnemia is caused by decreased erythropoietin, blood loss from dialysis, fre-\\nquent phlebotomy, and decreased red cell survival. Factitious anemia reflects \\nchanges in plasma volume related to dialysis. Abnormal hemostasis in ESRD \\nis multifactorial in origin, resulting in an increased risk of gastrointestinal (GI) \\ntract bleeding, subcapsular liver hematomas, subdural hematomas, and intra-\\nocular bleeding. Benefit may be seen following the infusion of desmopressin \\n0.3 μg/kg or cryoprecipitate. Immunologic compromise, caused by impaired \\nleukocyte chemotaxis and phagocytosis, leads to high mortality rates from \\ninfection. Dialysis does not appear to improve immune system function.\\n■ ■GASTROINTESTINAL COMPLICATIONS\\nAnorexia, nausea, and vomiting are common symptoms of uremia, and are \\nused as an indication to initiate dialysis, and assess its efficacy. Chronic \\nconstipation is common, due to decreased fluid intake and the use of \\nphosphate-binding gels.\\n■ ■COMPLICATIONS OF hEMODIALYSIS\\nHypotension is the most frequent complication of HD. Excessive ultrafiltration \\ndue to underestimation of the patient’s ideal blood volume (dry weight) is the \\nmost common cause of intradialytic hypotension. Cardiac compensation for \\nfluid loss may be compromised by diastolic dysfunction common in ESRD \\npatients. Other causes of intradialytic hypotension include myocardial dysfunc-\\ntion from ischemia, hypoxia, arrhythmias, and pericardial tamponade, abnor-\\nmalities of vascular tone secondary to sepsis or antihypertensive medications, \\nand volume loss from inadequate oral intake, vomiting, diarrhea, GI bleeding, or \\nblood tubing or filter leaks. Treatment consists of Trendelenberg positioning, \\noral salt solution, or infusion of normal saline solution. If these interventions fail, \\nexcessive ultrafiltration is unlikely, and further evaluation will be required.\\nDialysis disequilibrium, caused by cerebral edema following large solute \\nclearances, is characterized by nausea, vomiting, and hypertension, which can \\nprogress to seizures, coma, and death. Treatment consists of terminating dialy-\\nsis, and administering mannitol intravenously to increase serum osmolality.\\n■ ■COMPLICATIONS OF VASCULAR ACCESS\\nComplications of vascular access account for more inpatient hospital days \\nthan any other complication of HD. Thrombosis or stenosis present with \\nloss of the bruit and thrill over the access. These need to be treated within \\n52_Cydulka_Ch52.indd   297 16/03/17   2:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 316, 'page_label': '298'}, page_content='298 SECTION 7: Renal and Genitourinary Disorders\\n24 hours with angiographic clot removal, angioplasty, or direct injection of \\nthrombolytic into the access. Vascular access infections often present with \\nsigns of systemic sepsis, including fever, hypotension, and an elevated \\nwhite blood cell count. Classic signs of pain, erythema, swelling, and dis-\\ncharge are often missing. Obtain both peripheral and catheter blood cul-\\ntures simultaneously. A fourfold higher colony count in the catheter culture \\nsuggests it is the source. Staphylococcus aureus is the most common infect-\\ning organism, followed by gram-negative bacteria. Patients usually require \\nhospitalization along with treatment with vancomycin 15 mg/kg IV and an \\naminoglycoside, such as gentamycin 100 mg IV . Potential life-threatening \\nhemorrhage from a vascular access may result from a ruptured aneurysm or \\nanastomosis, or overanticoagulation. Bleeding can often be controlled with \\n5 to 10 minutes of pressure at the puncture site. If this fails, the addition of \\nan adsorbable gelatin sponge soaked in reconstituted thrombin, or a pro-\\nthrombotic gauze, followed by 10 minutes of direct pressure may be effec-\\ntive. Life-threatening hemorrhage may require placement of a tourniquet \\nproximal to the access, and vascular surgery consultation. If the etiology is \\nexcessive anticoagulation, the effects of heparin can be reversed with prot-\\namine 0.01 mg per unit heparin dispensed during dialysis or 10 to 20 mg \\nprotamine if the heparin dose is unknown. If a newly inserted vascular \\naccess continues to bleed, desmopressin 0.3 μg/kg IV can be given as an \\nadjunct to direct pressure.\\n■ ■COMPLICATIONS OF PERITONEAL DIALYSIS\\nPeritonitis is the most common complication of peritoneal dialysis (PD). \\nSigns and symptoms are similar to those seen in other patients with peri-\\ntonitis, and include fever, abdominal pain, and rebound tenderness. A \\ncloudy effluent supports the diagnosis. Peritoneal fluid should be sent to \\nthe laboratory for cell count, Gram stain, culture, and sensitivity. With \\nperitonitis, cell counts usually reveal >100 leukocytes/mm 3, with > 50% \\nneutrophils. Gram stain is positive in only 10% to 40% of culture-proven \\nperitonitis. Organisms isolated include Staphylococcus epidermidis, S. \\naureus, Streptococcus species, and gram-negative bacteria. Empiric ther -\\napy begins with a few rapid exchanges of dialysate to decrease the number \\nof inflammatory cells within the peritoneum. The addition of heparin   \\n(500 to 1000 U/L dialysate) decreases fibrin clot formation. Empiric anti -\\nbiotics, covering gram-positive organisms (e.g., cephalothin or vancomy-\\ncin 500 mg/L dialysate) and gram-negative organisms (e.g., gentamycin  \\n100 mg/L dialysate), are added to the dialysate. Inpatient versus outpatient \\ntreatment of PD-related peritonitis should be based on clinical presentation.\\nInfections around the PD catheter are characterized by pain, erythema, \\nswelling, and discharge. Causative organisms are S. aureus and Pseudomo-\\nnas aeruginosa. Outpatient treatment consists of a first-generation cephalo-\\nsporin or ciprofloxacin.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 90, “End-Stage Renal Disease,” by Mathew Foley, \\nNinfa Mehta and Richard Sinert.\\n52_Cydulka_Ch52.indd   298 16/03/17   2:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 317, 'page_label': '299'}, page_content='299\\nUrinary Tract Infections  \\nand Hematuria\\nDavid R. Lane\\n■ ■URINARY TRACT INFECTIONS\\nUrinary tract infections (UTIs) are the most common bacterial infections \\ntreated in the outpatient setting. More than 50% of women experience one \\nin their lifetimes, and approximately 12% of women have a UTI annually. \\nUTIs are divided into two major categories: lower tract infections and upper \\ntract infections. Lower UTIs include urethritis, typically caused by sexually \\ntransmitted diseases and differentiated by the presence of discharge, and \\ncystitis, an acute bacterial infection of the urinary bladder. Pyelonephritis is \\nan infection of the upper urinary tract structures including the ureters and \\nkidneys. Differentiation of upper and lower UTIs is based on history and \\nphysical exam.\\nUncomplicated UTI occurs in young, healthy, nonpregnant women with \\nstructurally and functionally normal urinary tracts.\\nComplicated UTI occurs in patients who are older, healthy, nonpregnant \\nwomen with normal urinary tracts: that is, all men, and women who have a \\nstructural or functional genitourinary abnormality or an underlying predis-\\nposing medical condition that increases the risk of infection and recurrence \\nor reduces the effectiveness of antimicrobial therapy.\\nAsymptomatic bacteriuria (ABU) is the presence of significant bacteria \\nin urine without signs or symptoms that are referable to a urinary tract \\ninfection; the usual cutoff is a single organism isolated in a quantity of at \\nleast 100,000 colony forming U/mL. Screening and treatment is not gener-\\nally recommended, with the exception of women who are pregnant or men \\nwho are going to undergo a transurethral prostate resection.\\nMore than 80% of UTIs are caused by Escherichia coli. Other causative \\norganisms include Klebsiella, Proteus, Enterobacter, Pseudomonas, Chla-\\nmydia, and Staphylococcus saprophyticus.\\nClinical Features\\nTypical symptoms of cystitis include frequency, urgency, hesitancy, and \\nsuprapubic pain. Pyelonephritis is characterized by the addition of flank \\npain or costovertebral angle tenderness, particularly in conjunction with \\nfever, chills, or nausea and vomiting. If vaginal or urethral discharge is \\npresent, urethritis, vaginitis, cervicitis, or PID are more likely than UTI. As \\nin many diseases, diabetics and the elderly have a predilection for present-\\ning atypically, and weakness, malaise, generalized abdominal pain, or \\naltered mental status may be the only signs or symptoms noted.\\nDiagnosis and Differential\\nDiagnosis of UTI can be inferred from history and physical, and confirmed \\nby urine dipstick or urinalysis and culture. Clean-catch midstream collec-\\ntion of urine is as accurate as urine obtained by catheterization if the patient \\n53\\nCh A p TER\\n53_Cydulka_Ch53.indd   299 01/05/17   11:38 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 318, 'page_label': '300'}, page_content='300 SECTION 7: Renal and Genitourinary Disorders\\nfollows instructions carefully. Catheterization should only be used in a \\npatient that cannot void spontaneously , is too ill or immobilized, or is \\nextremely obese. Note that 1% to 2% of patients develop a UTI after a \\nsingle catheter insertion.\\nThe two tests of interest on urine dipstick are nitrite reaction, a measure \\nof bacteriuria, and leukocyte esterase, a measure of pyuria. Nitrite has a \\nvery high specificity (> 90%), but a low sensitivity (50%); several organ-\\nisms are not detected by this test (Enterococcus, Pseudomonas, and \\nAcinetobacter). Leukocyte esterase sensitivity (77%) is affected by high \\nlevels of protein or glucose in the urine. In addition it may be falsely \\npositive in vaginitis or cervicitis. If either nitrite or leukocyte esterase is \\npositive, the sensitivity is 75% and specificity is 82%. If both are positive, \\nthe specificity is 98% to 100%. A positive urine dipstick nitrite or leuko-\\ncyte test result supports the diagnosis of UTI; a negative test result does \\nnot exclude it.\\nUrinalysis also evaluates bacteriuria and pyuria, the urine white blood \\ncell count. Bacteriuria is defined as any bacteria on a Gram-stained speci-\\nmen of uncentrifuged urine, and has a sensitivity of 95% and specificity of \\nover 60%. False-negative results may occur in patients with low-colony-\\ncount UTI or Chlamydia infections. False-positive results can occur with \\nvaginal or fecal contamination. Pyuria is defined as greater than 2 to 5 \\nwhite blood cells per high power field in women and 1 to 2 white blood \\ncells per high power field in men. False-negative results may occur in \\nsymptomatic patients with dilute urine, incompletely treated UTI, an \\nobstructed, infected kidney, or systemic leukopenia.\\nUrine culture should only be performed for the following patients: those \\nwith complicated UTI (including men and pregnant women), those with \\nrelapse or reinfection, children, and those who are septic. Finally, imaging \\n(CT or ultrasound) should be limited to patients with severe or nonrespon-\\nsive pyelonephritis, or if there is a significant concern for a renal stone.\\nNo single test or combination of testing can effectively rule out UTI in \\nwomen presenting to the ED with symptoms of cystitis, and if test results \\nare equivocal, consider initiating empiric treatment.\\nThe differential diagnosis for patients presenting with dysuria includes \\nvaginitis and cervicitis in women and urethritis, prostatitis, and epididymi-\\ntis in men. Intraabdominal pathology, bladder or urethral structural abnor -\\nmalities or cancer, chemical irritation or allergies to hygienic products, and \\ntrauma are also considerations.\\nEmergency Department Care and Disposition\\nAppropriate antimicrobial treatment should rapidly improve symptoms in \\nall UTIs and also minimize growing community antibiotic resistance. \\nConsider using nitrofurantoin 100 mg extended release twice a day PO for \\n5 days as a first-line agent in uncomplicated UTI. Alternatives in uncompli-\\ncated UTI include TMP-SMX DS 160/800 mg twice a day for 3 days or \\nfosfomycin 3 g in a single dose. Avoid flouroquinolones in uncomplicated \\nUTI to reduce antibiotic resistance.\\nFor complicated UTI or pyelonephritis, ciprofloxacin 500 mg twice a \\nday for 7 days is considered the first-line agent. Alternatives include \\nlevofloxacin 750 mg daily for 5 days or cefpodoxime 400 mg twice a day \\nfor 7 to 14 days. If local resistance is less than 20%, TMP-SMX DS \\n53_Cydulka_Ch53.indd   300 01/05/17   11:38 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 319, 'page_label': '301'}, page_content='CHAPTER 53: Urinary Tract Infections and Hematuria 301 \\n160/800 mg twice a day for 7 to 14 days or amoxicillin-clavulanate \\n875/125 mg twice a day for 14 days are acceptable.\\nFor pregnant patients, ABU should be treated with 3 days of nitrofu-\\nrantoin and UTI should be treated with 7 days of nitrofurantoin. Fluoro-\\nquinolones and tetracyclines are teratogenic and should be avoided, and \\nTMP-SMX should be used with caution in the first and third trimesters.\\nIf there is suspicion for concomitant infection with gonorrhea or Chla-\\nmydia, antibiotic choice is more complex (see Chapter 87, \"Sexually Trans-\\nmitted Infections\").\\nIn addition to the antibiotic, prescribe a 2-day course of a bladder anal-\\ngesic such as phenazopyridine 200 mg three times a day. Discharge \\ninstructions must include return precautions for uncontrolled pain, fever, \\nvomiting, and also should encourage adequate hydration, completion of the \\nentire antibiotic course, and outpatient follow-up with a primary care \\ndoctor.\\nAdmit patients with pyelonephritis who exhibit intractable vomiting. \\nConsider admission for pregnant females (20% will develop sepsis) and \\npatients with inadequate outpatient follow-up. Parenteral antibiotic options \\nfor inpatient management of pyelonephritis include ceftriaxone 1 g IV \\ndaily, ciprofloxacin 400 mg IV every 12 hours, and piperacillin-\\ntazobactam, 3.375 g IV every 6 hours.\\n■ ■hEMATURIA\\nGross hematuria, visible to the eye, suggests a lower urinary tract source; \\nhowever, other pigments such as myoglobin can simulate hematuria. \\nMicroscopic hematuria (>3 RBCs/HPF) suggests a renal source, though it \\ncan also be present in UTI.\\nDiagnosis and Differential\\nA urine dipstick is positive with approximately 5 to 20 red blood cells per \\nmilliliter of urine. A positive dipstick should be followed by microscopy. \\nUrethral catheterization induces hematuria in 15% of patients. False-\\npositives may also result from myoglobin, free hemoglobin due to \\nhemolysis, and porphyrins. False-negative results may occur if the urine has \\na high specific gravity.\\nAny process that results in infection, inflammation, or injury to the \\nkidneys, ureters, bladder, prostate, male genitalia, or urethra may result in \\nhematuria. UTI is the most common cause of hematuria associated with \\nurgency, dysuria, and nocturia, whereas painless hematuria is largely due to \\nneoplastic, hyperplastic, or vascular causes. The most common causes of \\nhematuria in patients <40 years are infections and inflammatory condi-\\ntions, including UTI, prostatitis, urethritis, sexually transmitted diseases, \\nepididymo-orchitis, nephrolithiasis, and tuberculosis. In older patients, \\nconsider renal and bladder cancer, as well as prostate tumors and benign \\nprostatic hypertrophy in men. Consider strenuous exercise or poststrepto-\\ncoccal infection (in younger patients), as well as trauma, malignant hyper -\\ntension, eroding abdominal aortic aneurysm, coagulopathy, foreign body, \\nHenoch–Schonlein purpura, pulmonary-renal syndromes, sickle cell \\ndisease complications, and renal vein thrombosis. Hematuria in a patient \\ntaking oral anticoagulants should not be attributed to the anticoagulant \\n53_Cydulka_Ch53.indd   301 01/05/17   11:38 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 320, 'page_label': '302'}, page_content='302 SECTION 7: Renal and Genitourinary Disorders\\nalone, as the incidence of underlying disease is up to 80% in patients \\nreferred to urology. Imaging in the ED for hematuria should be limited to \\npatients with trauma, symptoms of nephrolithiasis, or high concern for \\nabdominal aortic aneurysm.\\nEmergency Department Care and Disposition\\nTreatment of hematuria is directed at the cause. ED management consists \\nof the minimization of complications and appropriate referral or admission \\nfor further evaluation. All patients with hematuria should be promptly fol-\\nlowed up by either primary care or urology.\\nAdmit patients with infection associated with an obstructive stone, \\nintractable pain or vomiting, hemodynamic instability, newly diagnosed \\nglomerulonephritis, significant anemia, renal insufficiency, bladder outlet \\nobstruction, preeclampsia, or any other potentially life-threatening cause of \\nhematuria.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 91, “Urinary Tract Infections and Hematuria,” by  \\nKim Askew.\\n53_Cydulka_Ch53.indd   302 01/05/17   11:38 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 321, 'page_label': '303'}, page_content='303\\nAcute Urinary Retention\\nCasey Glass\\n■ ■CLINICAL FEATURES\\nUrinary retention can be either acute or chronic. The most common cause \\nof retention is outlet obstruction secondary to benign prostatic hyperplasia \\n(BPH) in men, although medication use, acute neurologic dysfunction, \\nurinary tract bleeding or calculi, and other anatomic obstruction are also \\ncommon causes in both men and women. Acute syndromes typically pres-\\nent with rapid onset of lower abdominal pain occasionally radiating to the \\nlower back. Patients typically complain of difficulty voiding but some may \\nnot volunteer this information. There is a 20% chance of a recurrence in the \\nfollowing 6 months after an episode of acute obstruction. Chronic obstruc-\\ntion usually presents with lower abdominal discomfort and the patient may \\nnote incomplete voiding or the need to void frequently. Overflow inconti-\\nnence is often present.\\nThe history should address previous episodes of obstruction, recent \\nmedication changes, and over-the-counter medicine use. Assess for any \\nhistory of trauma or neurologic disability or symptoms of infection. It is \\ncritical to know if any recent urologic procedures or urinary catheteriza-\\ntions have been performed. The duration of symptoms is also important as \\nit is associated with the development of postobstructive diuresis and renal \\ndysfunction.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nCauses of urinary retention may include anatomic obstruction, neurologic \\ndysfunction, medication side effect, trauma to the genitourinary tract, infec-\\ntion, and psychological stress. Fever may indicate infection as either the \\ncause or as a result of urinary outlet obstruction. Tachycardia and hypoten-\\nsion may resolve after the obstruction is relieved. The physical examination \\nshould address the functional and anatomic assessment of the lower urinary \\ntract. Palpate the abdomen for a suprapubic mass corresponding to the \\ndistended urinary bladder. The penis should be examined for stricture at the \\nmeatus or palpable abnormalities of the penile urethra. In men the prostate \\nshould be assessed for size, texture, and tenderness. The female lower uri-\\nnary tract should be evaluated for bladder prolapse or stricture of the ure-\\nthral meatus. A pelvic exam is generally indicated to screen for infection or \\nmass as a cause of obstruction. A comprehensive neurologic examination \\nshould be performed in all patients and perineal sensation and anal sphinc-\\nter tone should be documented.\\nBedside ultrasound can be very helpful both in distinguishing the degree \\nof obstruction and in discriminating obstruction from the sensation of full-\\nness associated with bladder spasm in conditions such as inflammatory or \\ninfectious cystitis. The patient should first be encouraged to attempt to void. \\nAfter a voiding attempt the bladder is imaged with a low-frequency sector \\n54\\nCh A p TER\\n54_Cydulka_Ch54.indd   303 16/03/17   2:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 322, 'page_label': '304'}, page_content='304 SECTION 7:  Renal and Genitourinary Disorders \\nformat probe in both the transverse and sagittal views (Figure 54-1). Many \\nmanufacturers have a calculation package available to estimate the retained \\nurine volume. Residual volumes >50 to 150 cc are consistent with urinary \\nretention; however, volumes in the setting of retention are typically greater \\nthan 300 cc.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nThe goals of emergency department care are relieving the discomfort of \\nretention, assessing for any secondary injury to the renal system, and treat-\\nment of the primary cause of retention.\\n1. Most patients with bladder outlet obstruction are in distress, and passage \\nof a urethral catheter alleviates their pain and urinary retention. Copious \\nintraurethral lubrication including a topical anesthetic (2% lidocaine jelly) \\nshould be used. A 16-French Coudé catheter is recommended if straight \\ncatheters fail. The catheter should be passed to its fullest extent to obtain \\nfree urine flow before inflating the balloon. A catheter should not be \\nplaced if there is suspicion of trauma to the urethra, either secondary to a \\ntraumatic event or recent instrumentation. In most cases a catheter should \\nbe left indwelling and connected to a leg drainage bag. For cases of \\npostanesthesia-related retention it is appropriate to remove the catheter \\nafter bladder drainage and then attempt a trial of spontaneous voiding.\\nFigURe 54-1. Transverse and sagittal views of the urinary bladder. The prostate is \\nvisualized as a medium echogenicity structure posterior and caudal to the bladder. \\nAnterior-posterior, cradio-caudal, and transverse measurements of the bladder are \\nobtained for calculation of the bladder volume. Reproduced with permission from \\nCasey Glass, MD.\\n54_Cydulka_Ch54.indd   304 16/03/17   2:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 323, 'page_label': '305'}, page_content='CHAPTER 54: Acute Urinary Retention 305 \\n2. The patient with obstruction from hematuria represents a special case. A \\n3-port Foley catheter should be placed and the bladder irrig ated until \\nreturning fluid is free of blood. These patients are likely to need admis-\\nsion for continued irrigation as the catheter often becomes blocked with \\nclot following placement.\\n3. Failure to pass a urethral Foley catheter, or recent urologic procedure or \\ninstrumentation requires the involvement of a urologist for catheter \\nplacement and consultation should not be delayed. Urgent urologic con-\\nsultation is also indicated for obstruction secondary to stricture, prosta-\\ntitis, or urethral trauma. Physicians familiar with the procedure may \\nchoose to place a suprapubic urinary catheter.\\n4. Send urine for routine analysis as well as culture. Assess electrolytes, \\nblood urea nitrogen (BUN), and creatinine for postobstructiv e renal \\nfailure. Urine output should be monitored quantitatively.\\n5. Oxybutynin can be prescribed for control of bladder spasms. This anti-\\ncholinergic medicine can itself cause a functional obstruction. Patients \\nmay also require pain medication for control of discomfort from bladder \\nspasms. Treat male patients in whom BPH is the suspected etiology of \\ntheir obstruction with an α-blocker.\\n6. Antibiotics are not indicated unless there is evidence of cystitis or other \\ninfection.\\n7. If urinary retention has been chronic, postobstructive diuresis may occur \\neven in the presence of normal blood urea nitrogen and creatinine levels. \\nIn such patients, closely monitor urinary output, for 4 to 6 hours after \\ncatheterization. Hourly output of greater than 200 mL for more than 4 to \\n6 hours is an indication for admission and fluid replacement.\\n8. Address precipitating causes of retention. Discontinue offending medi-\\ncations. Infectious or neurologic causes must be completely ev aluated; \\nurgency of workup depends on patient acuity and comorbidities.\\n9. In all cases of urinary retention, urologic follow-up in 3 to 7 days is \\nindicated for a complete genitourinary ev aluation. Patients should \\nusually expect to have the catheter removed at that visit.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 92, “Acute Urinary Retention,” by David Hung-Tsang \\nYen and Chen-Hsen Lee.\\n54_Cydulka_Ch54.indd   305 16/03/17   2:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 324, 'page_label': '306'}, page_content='306\\nMale Genital Problems\\nGavin R. Budhram\\n■ ■TESTICULAR TORSION\\nTesticular torsion results from abnormal fixation of the testis within the \\ntunica vaginalis, allowing the testis to twist. It exhibits a bimodal age \\ndistribution, peaking in the perinatal period and during puberty but may \\noccur at any age. Although sometimes associated with trauma, torsion \\nusually occurs in the absence of any preceding event.\\nClinical Features\\nBecause of the potential for infarction and infertility, testicular torsion must \\nbe the primary consideration in any male complaining of testicular pain. \\nPain usually occurs suddenly, is severe, and is felt in the lower abdominal \\nquadrant, the inguinal canal, or the testis. The pain may be constant or \\nintermittent but is not positional because torsion is primarily an ischemic \\nevent. Although symptom onset tends to occur after exertion, the testicle \\nalso may twist from unilateral cremasteric muscle contraction during sleep. \\nEarly in presentation, the affected testicle is firm, tender, elevated, and in a \\ntransverse lie compared to the contralateral testicle. The unilateral absence \\nof the cremasteric reflex is a sensitive but nonspecific finding.\\nDiagnosis and Differential\\nColor-flow duplex ultrasound is the most commonly used confirmatory \\nstudy, but sensitivity ranges from 69% to 90%. In addition, urinalysis is \\ntypically ordered, but pyuria does not rule out testicular torsion.\\nTorsion of the appendages is more common than testicular torsion but is \\nnot dangerous because the appendix testis and appendix epididymis have \\nno known function. The diagnosis is supported by pain that is most intense \\nnear the head of the epididymis or testis, an isolated tender nodule, or the \\npathognomonic blue dot appearance of a cyanotic appendage with illumi-\\nnation through thin prepubertal scrotal skin. If normal intratesticular blood \\nflow can be demonstrated with color Doppler, surgical exploration is not \\nnecessary because most appendages calcify or degenerate over 10 to  \\n14 days and cause no harm. The differential for testicular torsion also \\nincludes epididymitis, inguinal hernia, hydrocele, and scrotal hematoma.\\nEmergency Department Care and Disposition\\n1.  When the diagnosis of testicular torsion is obvious, immediate urologic \\nconsultation is indicated for exploration because imaging tests can be \\ntoo time consuming. Testicular salvage rates are excellent with surgical \\ndetorsion within 6 hours of symptom onset, but decline rapidly  \\nthereafter.\\n2.  The emergency physician can attempt manual detorsion. Most testes \\ntwist in a lateral to medial direction, so detorsion is performed in a \\n55\\nCh A p TER\\n55_Cydulka_Ch55.indd   306 26/04/17   12:15 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 325, 'page_label': '307'}, page_content='CHAPTER 55: Male Genital Problems 307 \\nmedial to lateral direction, similar to the opening of a book. The \\nendpoint for successful detorsion is pain relief; urologic referral is still \\nindicated.\\n3.  Urology should be consulted early in the patient’s course even if confir-\\nmatory testing is planned. When the diagnosis of testicular torsion \\ncannot be ruled out by diagnostic studies or examination, urologic \\nconsultation is still indicated if suspicion is high.\\n■ ■EpIDIDYMITIS AND ORChITIS\\nClinical Features\\nEpididymitis is characterized by gradual onset of pain due to inflammation. \\nBacterial infection is the most common cause, with infecting agents depen-\\ndent on the patient’s age. In patients <35 years, epididymitis is due primar-\\nily to sexually transmitted diseases; culture or DNA probe for gonococcus \\nand Chlamydia is indicated in males <35 years even in the absence of \\nurethral discharge. Common urinary pathogens such as Escherichia coli \\nand Klebsiella predominate in older men. Epididymitis causes lower \\nabdominal, inguinal canal, scrotal, or testicular pain alone or in combina-\\ntion. Due to the inflammatory nature of the pain, patients with epididymitis \\nmay note transient pain relief when elevating the scrotal contents while \\nrecumbent (positive Prehn’s sign).\\nDiagnosis and Differential\\nInitially, when tenderness is well localized to the epididymis, the clinical \\ndiagnosis is clear. However, progression of inflammation results in the \\nphysical examination finding of a single, large testicular mass (epididymo-\\norchitis), which is difficult to differentiate from testicular torsion or carci-\\nnoma. Testicular malignancy should be suspected in patients presenting \\nwith asymptomatic testicular mass, firmness, or induration. Ten percent of \\ntumors present with pain due to hemorrhage within the tumor. Orchitis in \\nisolation is rare; it usually occurs in conjunction with other systemic \\ninfections, such as mumps or other viral illnesses.\\nEmergency Department Care and Disposition\\n1.  If the patient appears toxic, admission is indicated for intravenous anti-\\nbiotics (e.g., ceftriaxone 1 to 2 g every 12 hours IV or trimethoprim/\\nsulfamethoxazole 5 mg/kg IV of trimethoprim component every  \\n6 hours).\\n2.  Outpatient treatment is the norm in patients who do not appear toxic; \\nurologic follow-up within 1 week is indicated. Age < 35: T reat \\ngonorrhea and Chlamydia with ceftriaxone 250 mg IM single dose plus \\ndoxycycline 100 mg PO twice daily for 10 days. Age >35: Treat gram-\\nnegative bacilli with levofloxacin 500 mg PO daily for 10 days or \\nofloxacin 300 mg PO twice daily for 10 days.\\n3.  In addition, scrotal elevation, ice application, nonsteroidal anti-inflammatory \\ndrugs, opioids for analgesia, and stool softeners are indicated.\\n4.  Orchitis is treated with disease-specific therapy, symptomatic support, \\nand urologic follow-up.\\n55_Cydulka_Ch55.indd   307 16/03/17   2:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 326, 'page_label': '308'}, page_content='308 SECTION 7: Renal and Genitourinary Disorders\\n■ ■ACUTE pROSTATITIS\\nAcute prostatitis is a bacterial inflammation of the prostate presenting with \\nvarying complaints of suprapubic or genital pain, back pain, perineal pain, \\nvoiding difficulties, frequency, dysuria, pain with ejaculation, and fever and \\nchills. Patients at risk include those with anatomic or neurophysiologic \\nlower urinary tract obstruction, acute epididymitis or urethritis, unprotected \\nrectal intercourse, phimosis, and an indwelling urethral catheter. The caus-\\native organism is E. coli in most cases, with Pseudomonas, Klebsiella, \\nEnterobacter, Serratia, or Staphylococcus causing the remainder. Physical \\nexamination usually reveals perineal, rectal, and prostate tenderness. The \\ndiagnosis is clinical as urinalysis and culture are often negative even after \\nprostate massage. Treatment is ciprofloxacin 500 mg twice daily, or \\nlevofloxacin 500 mg PO daily, or ofloxacin 300 mg PO twice daily. All \\ntreatments should be for 2 to 4 weeks. Pain medicine may be required. \\nAdmission is not necessary unless the patient is septic, immunocompro-\\nmised, has significant comorbidities, or has worsened on outpatient therapy. \\nIn this case, IV treatment with piperacillin-tazobactam 3.375 to 4.5 g or \\ncefotaxime with an aminoglycoside may be initiated. Consider testing and \\ntreatment for gonorrhea and chlamydia in patients with risk factors for \\nsexually transmitted disease.\\n■ ■SCROTUM\\nScrotal abscesses may be localized to the scrotal wall or may arise from \\nextensions of infections of intrascrotal contents (i.e., testis, epididymis, and \\nbulbous urethra). A simple hair follicle scrotal wall abscess can be managed by \\nincision and drainage; no antibiotics are required in immunocompetent \\npatients. When a scrotal abscess is suspected to arise from an intrascrotal infec-\\ntion, ultrasound may demonstrate pathology in the testis and/or epididymis. \\nRetrograde urethrography may be needed to identify a source in the urethra. \\nDefinitive care of any complex abscess calls for a urology consultation.\\nFournier gangrene is a polymicrobial infection of the perineal subcuta-\\nneous tissues. Diabetic males are at highest risk, but any immunocompro-\\nmised state can be associated with the disease. Prompt diagnosis is essential \\nto prevent extensive tissue loss. Early surgical consultation is recommended \\nfor at-risk patients who present with scrotal, rectal, or genital pain. \\nTreatment mainstays include aggressive fluid resuscitation with normal \\nsaline solution and broad-spectrum antibiotics to cover gram-positive, \\ngram-negative, and anaerobic organisms: imipenem 1 g IV every 8 hours \\nor meropenem 500 mg to 1 g IV every 8 hours plus vancomycin 1 g IV \\nevery 12 hours if methicillin-resistant Staphylococcus aureus is suspected. \\nCare usually includes hyperbaric oxygen therapy (if readily available) and \\nsurgical debridement.\\n■ ■pENIS\\nBalanoposthitis is inflammation of the glans (balanitis) and foreskin (pos-\\nthitis). Upon foreskin retraction, the glans and prepuce appear purulent, \\nexcoriated, malodorous, and tender. Treatment consists of cleaning with \\nmild soap, ensuring adequate dryness, applying antifungal creams (nystatin \\n100,000 U/g, four times daily or clotrimazole 1% cream bid), and using an \\n55_Cydulka_Ch55.indd   308 16/03/17   2:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 327, 'page_label': '309'}, page_content='CHAPTER 55: Male Genital Problems 309 \\noral azole (fluconazole 150 mg single dose, reevaluate at 7 days for repeat \\ndosing). Urologic referral is needed for reassessment and possible circum-\\ncision in recurrent cases. An oral cephalosporin (e.g., cephalexin 500 mg, \\ntimes daily) should be prescribed in cases of secondary bacterial infection. \\nBalanoposthitis can be the sole presenting sign of diabetes.\\nPhimosis is the inability to retract the foreskin proximally (Fig. 55-1). \\nPhysiologic phimosis is common in boys but less than 10% of foreskins \\nremain nonretractile at age 3 with nearly all resolving by adolescence. \\nPathologic phimosis occurs as a result of infection, poor hygiene, or previ-\\nous injury with scarring. Hemostatic dilation of the preputial ostium \\nrelieves urinary retention until definitive dorsal slit or circumcision can be \\nperformed. Topical steroid therapy, such as hydrocortisone 1% cream for \\n4 to 6 weeks, along with daily preputial retraction, reduces the rate of \\nrequired circumcision.\\nPhimosis\\nParaphimosis\\nFiGurE 55-1. Phimosis and paraphimosis.\\n55_Cydulka_Ch55.indd   309 16/03/17   2:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 328, 'page_label': '310'}, page_content='310 SECTION 7: Renal and Genitourinary Disorders\\nParaphimosis is the inability to reduce the proximal edematous foreskin \\ndistally over the glans (see Fig. 55-1). Paraphimosis is a true urologic emer-\\ngency because the resulting glans edema and venous engorgement can \\nprogress to arterial compromise and gangrene. If surrounding tissue edema \\ncan be successfully compressed, as by wrapping the glans with 2 × 2-in.  \\nelastic bandages for 5 minutes, the foreskin may be reduced. Making \\nseveral puncture wounds with a small (22- to 25-gauge) needle may help \\nwith expression of glans edema fluid. Local anesthetic block of the penis is \\nhelpful if patients cannot tolerate the discomfort associated with edema \\ncompression and removal. If arterial compromise is suspected or has \\noccurred, local infiltration of the constricting band with 1% plain lidocaine \\nfollowed by superficial vertical incision of the band will decompress the \\nglans and allow foreskin reduction.\\nPenile entrapment injuries occur when various objects are wrapped \\naround the penis potentially occluding vascular supply. Objects may be \\nremoved by a variety of techniques including compression, cutting, cooling \\nthe penis, and possibly even urologic surgical removal. Retrograde urethro-\\ngram and Doppler studies may be employed if indicated to assess urethral \\ninjury and distal penile arterial blood supply, respectively.\\nPenile fracture occurs when there is an acute tear of the penile tunica albu-\\nginea. The penis is acutely swollen, discolored, and tender in a patient with \\nhistory of intercourse-associated trauma accompanied by a snapping sound \\nand sudden loss of erection. Retrograde urethrography may be indicated for \\nassurance of urethral integrity. Urologic consultation is indicated.\\nPeyronie disease produces progressive penile deformity, typically \\ncurvature with erections, that is painful and may result in erectile dysfunc-\\ntion or preclude successful vaginal intercourse. Examination shows a \\nthickened plaque on the dorsal penile shaft. Assurance and urologic follow-\\nup are indicated.\\nPriapism is a painful pathologic erection that may be associated with \\nurinary retention. Infection and impotence are other complications. Corpo-\\nral aspiration and instillation of an α-adrenergic antagonist (i.e., phenyleph-\\nrine) is the next step and may need to be performed by the emergency \\nphysician when urologic consultation is not available. Even when emer -\\ngency physicians provide stabilizing care, urologic consultation is indicated \\nin all cases.\\n■ ■UREThRA\\nUrethritis is characterized by purulent urethral discharge. Diagnosis is \\nclinical but is often confirmed with a first-void urine specimen. Causative \\nagents are usually Chlamydia trachomatis or Neisseria gonorrhoeae, \\nthough Trichomonas, Ureaplasma urealyticum, and herpes simplex virus \\nmay also occasionally cause urethritis. Treatment is ceftriaxone 250 mg \\nIM and azithromycin 1 g PO.\\nUrethral stricture is becoming more common due to the high incidence \\nof sexually transmitted diseases and may result in urinary retention. A \\nnormal post-void residual volume should be less than 100 mL and can be \\nestimated with bedside ultrasonography. If a patient’s bladder cannot be \\ncannulated, the differential diagnosis includes urethral stricture, voluntary \\nexternal sphincter spasm, bladder-neck contracture, or benign prostatic \\n55_Cydulka_Ch55.indd   310 16/03/17   2:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 329, 'page_label': '311'}, page_content='CHAPTER 55: Male Genital Problems 311 \\nhypertrophy. If a 14- or 16-Fr F oley cannot be passed, a Coudé catheter \\nmay be used to navigate a stricture. Retrograde urethrography can be \\nperformed to delineate the location and extent of a urethral stricture. Endos-\\ncopy is necessary to confirm bladder neck contracture or define the extent \\nof an obstructing prostate gland. Suspected voluntary external sphincter \\nspasm can be overcome by holding the patient’s penis upright and encour -\\naging him to relax the perineum and breathe slowly during the procedure. \\nAfter no more than three gentle attempts to pass a 12-Fr Coudé catheter into \\na urethra prepared with anesthetic lubricant, urologic consultation should \\nbe obtained. In an emergency situation, suprapubic cystotomy can be \\nperformed using the Seldinger technique. Urologic follow-up should occur \\nwithin 48 hours.\\nUrethral foreign bodies are associated with bloody urine and slow, \\npainful urination. Radiography of the bladder and urethral areas may \\ndisclose a foreign body. Removal of the foreign body often requires uro-\\nlogic consultation for endoscopy or open cystotomy, though a gentle \\nmilking action of the proximal end of a urethral foreign body may be \\nattempted. Retrograde urethrography or endoscopy is often required to \\nconfirm an intact urethra.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 93, “Male Genital Problems,” by Jonathan E. Davis.\\n55_Cydulka_Ch55.indd   311 16/03/17   2:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 330, 'page_label': '312'}, page_content='312\\nUrologic Stone Disease\\nGeetika Gupta\\nThe acute phenomenon of renal stones migrating down the ureter is referred \\nto as renal colic. Adults and children can develop kidney stones. In adults, \\nthe condition is more common in males than in females; kidney stones \\nusually occur in the third to fifth decade of life. There is a reoccurrence rate \\nof 37% within the first year of having a stone. Children under the age of 16 \\nyears constitute 7% of cases seen, with the distribution being equal between \\nthe sexes.\\n■ ■CLINICAL FEATURES\\nPatients usually present with an acute onset of severe pain, which may be \\nassociated with nausea, vomiting, and diaphoresis. Patients are frequently \\nanxious, pacing, or writhing and are unable to hold still or converse. The \\npain is sharp and episodic in nature due to the intermittent obstruction of \\nthe ureter and is relieved after the stone passes. The pain typically origi-\\nnates in either flank with subsequent radiation around the abdomen toward \\nthe groin. However, as the stone passes into the distal ureter, where 75% of \\nstones are diagnosed, the pain may be located in the anterior abdominal or \\nsuprapubic area. Vesicular stones may present with intermittent dysuria and \\nterminal hematuria. Children may present in a similar fashion, but up to \\n30% have only painless hematuria. Vital signs may demonstrate tachycar -\\ndia and an elevated blood pressure, which are secondary to pain. Fever may \\nbe present if there is a concomitant urinary tract infection. Examination \\nmay show costovertebral tenderness or abdominal tenderness, guarding, or \\nrigidity. Hematuria may be present in 85% of patients with renal colic.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe consideration of urologic stones and renal colic is based on clinical \\njudgment. The differential diagnosis includes abdominal aortic aneurysm \\nand aortic dissection. Other concerning possibilities include appendicitis, \\nmesenteric ischemia, cholecystitis, ectopic pregnancy, gonadal torsion, \\nrenal infarction, incarcerated hernia, epididymitis, salpingitis, pyelonephri-\\ntis, herpes zoster, drug-seeking behavior, musculoskeletal strain, and \\npapillary necrosis. Papillary necrosis may be present in patients with sickle \\ncell disease, diabetes, nonsteroidal analgesic abuse, or infection. Patients \\nreceiving outpatient extracorporeal shock wave lithotripsy for urolithiasis \\nmay present to the emergency department (ED) with renal colic because the \\nresulting “sludge” is passed in the urine.\\nObtain a urinalysis to assess for hematuria and infection. Check serum \\nrenal function, as a majority of patients who are stone formers have decreased \\ncreatinine clearance. Get a pregnancy test in females of childbearing age.\\nThe recommendation for the ideal modality of imaging is evolving. \\nImaging helps diagnose a ureteral stone, rules out other diagnoses, identi-\\nfies complications, establishes the location of the stone, and/or assists with \\n56\\nCh A p TER\\n56_Cydulka_Ch56.indd   312 01/05/17   10:30 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 331, 'page_label': '313'}, page_content='CHAPTER 56: Urologic Stone Disease 313 \\nthe management if the stone fails to pass spontaneously. Noncontrast helical \\ncomputed tomography (CT) has the overall highest sensitivity and specific-\\nity. Positive findings include changes in the ureteral caliber, suspicious \\ncalcifications, stranding of perinephric fat, and dilation of the collecting \\nsystem. It has a PPV of 96% and a NPV of 93% to 97%. It can be performed \\nquickly and can rule in or rule out other diagnoses. The disadvantage of CT \\nis radiation exposure; therefore, many facilities have adopted a low-dose \\nCT protocol. It has similar sensitivities as regular dose radiation CT for \\nstones >3 mm and individuals with a BMI > 30 (Table 56-1).\\nThe use of plain kidney-ureter-bladder film (KUB) is limited as only \\n90% of ureteral stones are radiopaque. A KUB cannot rule in or rule out a \\nureteral stone. The KUB is useful in following the progression of a stone, \\nonce visualized on CT, in the outpatient setting.\\nThe IV pyelogram (IVP) is rarely used anymore in the ED. It provides \\ninformation on renal function and anatomy and is used as an adjunct to CT.\\nUltrasound (US), an anatomic rather than a functional test, is useful in \\npatients for whom CT is not advised such as pregnant women and children. \\nIt detects hydronephrosis and larger stones but is not sensitive for midure-\\nteral or small, less than 5-mm stones. Sensitivity increases to 90% for \\nstones >6 mm. A false-positive diagnosis of hydronephrosis may be related \\nto a full bladder, renal cysts, and anatomic variation. A rapid bolus of crys-\\ntalloid can result in a false-positive diagnosis of hydroureter. Bedside US \\nby ED physicians may also decrease length of stay for selected patients.\\nTable 56-1 Ancillary Tests in Urologic Stone Disease\\nTest\\nSensitivity \\n(%)\\nSpecificity \\n(%) LR+ LR– Comments\\nNoncontrast \\nCT\\n94–97 96–99 24–∞ 0.02–\\n0.04\\nAdvantages: speed, no RCM, \\ndetects other diagnoses\\nDisadvantages: radiation, no \\nevaluation of renal function\\nIV urogram 64–90 94–100 15–∞ 0.11–\\n0.15\\nAdvantage: evaluates renal \\nfunction\\nDisadvantage: RCM (allergy, \\nnephrotoxicity, metformin \\nrelated acidosis)\\nUltrasound 63–85 79–100 10–∞ 0.10–\\n0.34\\nAdvantages: safe in preg-\\nnancy, no RCM, no radia-\\ntion, no known side effects\\nDisadvantages: insensitive \\nin middle third of the ureter, \\nmay miss smaller stones \\n(<5 mm)\\nPlain \\nabdominal \\nradiograph\\n29–58 69–74 1.9–2.0 0.58–\\n0.64\\nAdvantage: may be used to \\nfollow stones\\nDisadvantage: poor sensi-\\ntivity and specificity\\nAbbreviations: LR = likelihood ratio; RCM = radiocontrast media.\\n56_Cydulka_Ch56.indd   313 01/05/17   10:30 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 332, 'page_label': '314'}, page_content='314 SECTION 7: Renal and Genitourinary Disorders \\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nMedications\\n1.  Analgesia: Nonsteroidal anti-inflammatory drugs administered paren-\\nterally are considered the analgesics of choice. The prostaglandins \\npromote dilation of the ureter and thus aid in the alleviation of the source \\nof the pain. Ketorolac 30 mg IVP is the recommended starting dose. \\nCaution should be used in the elderly, those with bleeding tendencies, \\nand those with renal impairment. Opioids, in titrated doses such as \\nmorphine 5 mg IV or hydromorphone 1 mg IV , may also be used to \\nassist in pain control. Care must be used when utilizing these medica-\\ntions in senior, pediatric, and pregnant populations.\\n2.  Intravenous crystalloid: It is recommended to correct any v olume \\ndeficits from vomiting or decreased oral intake. Studies have not shown \\nit to be effective in pain control or stone passage.\\n3.  Antiemetics: Metoclopramide, 10 mg IV , the only antiemetic drug \\nspecifically studied for the treatment of renal colic, has been shown to \\nbe effective in providing relief from nausea and pain. Other antiemetics \\nmay also be used.\\n4.  Medical expulsion therapy: The use of α-blockers results in a 2- to 6-day \\nimprovement in rate and time to expulsion and decreased pain. Options \\ninclude tamsulosin 0.4 mg daily up to 4 weeks, terazosin 5 to 10 mg \\ndaily, and doxazosin 4 mg daily. Steroids and calcium channel blockers \\nare not recommended.\\n5.  Antibiotics: If the urinalysis shows evidence for an infection, the choice \\nof antibiotic is dictated by the local resistance patterns to gram-negative \\nrods. Patients with an infected ureteral stone without significant obstruc-\\ntion, fever, or systemic illness may be discharged with a fluoroquinolone \\nsuch as ciprofloxacin 500 mg twice a day for 10 to 14 days or \\nlevofloxacin 500 mg daily for 10 to 14 days, a third-generation cepha-\\nlosporin such as cefpodoxime 200 mg twice a day for 10 to 14 days or \\nother drugs with good local sensitivities. Close follow-up is essential.\\nPatients with a more complicated clinical situation should be admitted. \\nIntravenous antibiotic selections to consider include gentamicin or tobra-\\nmycin 1 mg/kg/dose every 8 hours and ampicillin 1 to 2 g every 4 hours; \\npiperacillin-tazobactam 3.375 g every 6 hours; cefepime 2 g every  \\n8 hours; ticarcillin-clavulanic acid 3.1 g every 6 hours, or ciprofloxacin \\n400 mg every 12 hours.\\nDisposition\\nIf the stone is passed in the ED, no treatment is necessary other than elec-\\ntive urologic follow-up. Patients with small unilateral stones less than  \\n5 mm, no complicated infection, and pain controlled by oral analgesics \\nmay be discharged with a urine strainer, prescriptions for oral analgesics \\nand medical expulsive therapy, and urologic or primary care physician \\nfollow-up within 7 days. The rate of stone passage depends on its size and \\nlocation. A stone measuring 5–6 mm in diameter takes 7 to 30 days to pass. \\nInstruct patients to return if they develop fever, persistent vomiting, or \\nuncontrolled pain.\\n56_Cydulka_Ch56.indd   314 01/05/17   10:30 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 333, 'page_label': '315'}, page_content='CHAPTER 56: Urologic Stone Disease 315 \\nUrologic consultation on an emergent basis is needed in patients with a \\ncomplete obstruction complicated by fever and/or urosepsis and in patients \\nwith a solitary or transplanted kidne y. Discuss disposition with a urologist \\nin patients with a stone larger than 5 mm, renal insufficiency, severe \\nunderlying disease, extravasation or complete obstruction, sloughed renal \\npapillae, UTI, or failed outpatient management.\\nHospitalization is indicated for patients who have a solitary or \\ntransplanted kidney with obstruction, uncontrolled severe pain, intractable \\nemesis, acute renal failure, hypercalcemic crisis, severe medical comor -\\nbidities, and urosepsis. Consider admission for patients with a fever, \\nsolitary or transplanted kidney without obstruction, obstructing stone with \\ninfection, urinary extravasation, significant medical comorbitidies, or large \\nproximal ureteral stone. (Table 56-2).\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 94, “Urologic Stone Disease,” by David E. Manthey \\nand Bret A. Nicks.\\nTable 56-2 Indications for Admission in patients with Nephrolithiasis\\nAbsolute Indications for Admission Relative Indications for Admission\\nIntractable pain or vomiting Fever\\nUrosepsis* Solitary kidney or transplanted kidney \\nwithout obstruction\\nSingle or transplanted kidney with  \\nobstruction*\\nObstructing stone with signs of urinary \\ninfection\\nAcute renal failure Urinary extravasation\\nHypercalcemic crisis Significant medical comorbidities\\nSevere medical comorbidities/advanced age Stone unlikely to pass—large stone above \\nthe pelvic brim\\n*Indication for urgent decompression.\\n56_Cydulka_Ch56.indd   315 01/05/17   10:30 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 334, 'page_label': '316'}, page_content='316\\nComplications of Urologic \\nProcedures and Devices\\nSteven Go\\n■ ■COMPLICATIONS OF URINARY CATHETERS\\nComplications related to the use of urinary catheters are not infrequent and \\ntherefore the catheters should be used only when absolutely necessary. \\nSilicone catheters are available for patients with latex allergies.\\nCatheter-Associated Urinary Tract Infection\\nCatheter-associated urinary tract infections (CA-UTIs) are a very common \\ncause of nosocomial infections. Signs and symptoms of CA-UTI include \\nfever, rigors, altered mental status, malaise, or lethargy, flank pain, costo-\\nvertebral angle tenderness, acute hematuria, and pelvic discomfort. In those \\nwhose catheters have been removed, dysuria, urgent or frequent urination, \\nor suprapubic pain or tenderness may indicate CA-UTI. Do not treat \\nasymptomatic bacteriuria in a patient with a short-term catheterization, \\nexcept in pregnancy or immediately posturologic procedure. CA-UTI in \\nspinal cord injury patients may also present with increased spasticity, auto-\\nnomic dysreflexia, and a sense of unease. Pyelonephritis is the most \\ncommon complication of CA-UTI and should be suspected when fever \\nis present. Other related infections include prostatitis, epididymitis, and \\nscrotal abscess.\\nDiagnosis of CA-UTI in the ED is made clinically with urine micros-\\ncopy. Send urine for culture. Add blood cultures if the patient is septic or \\nimmunocompromised. An ultrasound may be useful to identify urinary \\nobstruction. Remember that pyuria is universal for patients with long-term \\n(>1 month) indwelling catheters and in the absence of symptoms, pyuria \\nshould not be used in the diagnosis of infection. Hematuria is a better \\nindicator of infection. Remove the urinary catheter if clinically feasible or \\nreplace the catheter if it is > 7 days old. In patients with mild symptoms, \\nempirically treat with ciprofloxacin 500 mg twice a day, levofloxacin 500 mg  \\nonce a day, or cefpodoxime 200 mg twice a day. Tailor specific antibiotic \\nchoice to local bacterial sensitivities. Seven days is the recommended \\nduration of antimicrobial treatment for patients with CA-UTI who have \\nprompt resolution of symptoms, and 10 to 14 days of treatment is \\nrecommended for those with a delayed response. In patients with catheter-\\nassociated pyelonephritis, admission is frequently required. Check urine \\ncultures and blood cultures if there is concern for sepsis.\\nNondeflation of Foley Retention Balloon\\nNondeflation of the Foley retention balloon prevents the removal of the \\ncatheter. Cut the plastic catheter valve just proximal to the inflation port and \\ninsert a flexible guide wire to expand the channel and deflate the balloon. \\nIf this is not successful, insert a 22-G central venous catheter (CVC) over \\nthe guide wire. Once the tip of the catheter enters the balloon, remove the \\n57\\nC HAPTER\\n57_Cydulka_Ch57.indd   316 16/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 335, 'page_label': '317'}, page_content='CHAPTER 57: Complications of Urologic Procedures and Devices 317 \\nguide wire and deflate the balloon. If the inflated balloon persists, instill \\n10cc of mineral oil through the CVC and wait 15 minutes to dissolve the \\nballoon (this step may be repeated). If these methods fail, consult a urolo-\\ngist to remove the catheter.\\n■ ■COMPLICATIONS OF PERCUTANEOUS NEPHROSTOMY\\nPercutaneous nephrostomy is a urinary drainage procedure used for supra-\\nvesical or ureteral obstruction. Bleeding may occur. Check hemoglobin, \\nhematocrit, and renal function studies. Check platelet count and coagula-\\ntion studies if a coagulopathy is suspected. Treat mild bleeding by irrigating \\nthe nephrostomy tube to clear the blood clots. If bleeding fails to resolve, a \\nvascular injury may be present and emergent urology consult is indicated. \\nInitiate fluid resuscitation and blood transfusion in severe cases.\\nInfectious complications from nephrostomy tubes include bacteriuria, \\npyelonephritis, renal abscess, and urosepsis. Culture the urine and wound \\ndrainage (if any) and administer antibiotics after consulting a urologist.\\nCatheter dislodgment, tube blockage, and residual stone fragments can \\noccur. Obtain a CT scan and consult urology to treat these mechanical \\nissues.\\n■ ■LITHOTRIPSY\\nCommon post-lithotripsy complications include abdominal and flank pain, \\ngross hematuria, skin ecchymosis, and ureteral obstruction from stone frag-\\nments. However, ruptured or perforated organs, infections (pyelonephritis, \\nurosepsis, psoas abscess), vascular injury, and pancreatitis may also occur. \\nThe presence of hypotension, syncope, flank hematoma, drop in hemoglo-\\nbin, and severe pain are all harbingers of serious complications (e.g., peri-\\nnephric and renal hematomas). Administer supportive therapy with \\nIV fluids, antiemetics, and analgesics. Check blood counts, creatinine, and \\nurinalysis. Obtain cultures and administer antibiotics if indicated. If simple \\nobstruction is suspected, obtain a renal ultrasound. Obtain a CT scan if a \\nmore severe injury is suspected. Consult urology early in the process as \\nsurgical intervention may be indicated in these cases.\\n■ ■COMPLICATIONS OF URETERAL STENTS\\nA range of infectious complications can occur from ureteral stents. There-\\nfore, order a urinalysis and culture for urinary symptoms, incontinence, \\nflank pain, or change in the baseline discomfort. Treat simple infections \\nwith outpatient antibiotics in consultation with a urologist, as stent \\nremoval is not always necessary. However, if pyelonephritis or urosepsis \\nis suspected, obtain appropriate cultures, administer IV antibiotics, order \\nimaging (abdominal series, ultrasound, and CT) to verify stent placement, \\nand consult urology.\\nLate complications with long-term stent placement may be seen. New-\\nonset abdominal pain, severe flank pain, fever, irritative bladder symptoms, \\nor gross hematuria may be indicative of stent migration, obstruction, or \\ninfection. Obtain a urinalysis to evaluate for infection, imaging to evaluate \\nstent position, and urologic consultation. However, new anemia without \\n57_Cydulka_Ch57.indd   317 16/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 336, 'page_label': '318'}, page_content='318 SECTION 7: Renal and Genitourinary Disorders\\nhematuria may be indicative of a retroperitoneal hematoma and is diag-\\nnosed with CT. Assume vascular fistulization from an eroding stent in the \\npresence of severe gross hematuria, syncope, or hypotension. Resuscitate \\nthese patients, order lab studies, irrigate the bladder, and transfuse appro-\\npriately. Obtain urology consultation immediately.\\n■ ■COMPLICATIONS OF ARTIFICIAL URINARY SPHINCTERS\\nThe artificial sphincter is a device used for urinary incontinence from \\nvarious causes. Skin flora cause early infections, while later infections \\nare usually due to gram-negative pathogens. Never introduce a urinary \\ndrainage catheter through an artificial urinary sphincter. Obtain \\nurinalysis, appropriate labs, cultures, and imaging, and administer \\nIV antibiotics as indicated. Consult a urologist for further evaluation and \\nmanagement.\\n■ ■COMPLICATIONS OF ERECTILE DYSFUNCTION DEVICES\\nInjections for erectile dysfunction can result in priapism, which requires \\nemergent urologic consultation. The most common complication of \\nvacuum devices is pain from improper use, but skin necrosis and infections \\ncan occur. Infection of implanted penile prostheses (both early and late), \\nerosion of the prosthesis into the penile tissue, and prosthesis migration \\ncan occur. Administer broad-spectrum IV antibiotics if infection is present \\nand consult a urologist for device removal.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 95, “Complications of Urologic Procedures and \\nDevices,” by Elaine B. Josephson.\\n57_Cydulka_Ch57.indd   318 16/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 337, 'page_label': '319'}, page_content='319\\nVaginal Bleeding and Pelvic Pain \\nin the Nonpregnant Patient\\nJoelle Borhart\\n■ ■VAGINAL BLEEDING\\nAbnormal vaginal bleeding is a common complaint in females presenting \\nto the ED. Determination of pregnancy status in patients of reproductive \\nage is critical to formulate the appropriate differential diagnosis and to \\nguide subsequent testing and decision making.\\nClinical Features\\nAll patients should be asked about the amount and duration of bleeding. \\nReproductive and sexual history, history of sexually transmitted infections, \\ntrauma, medications, and the possibility of foreign bodies should be elic-\\nited. Symptoms of a possible bleeding disorder (history of bruising, epi-\\nstaxis, other abnormal bleeding), endocrine disorder, or liver disease should \\nbe noted. A complete abdominal and pelvic examination, including specu-\\nlum and bimanual exam, should be performed on nonvirginal patients to \\nlook for structural or traumatic causes of bleeding. Skin or conjunctiva \\npallor, abnormal vital signs, or a report of dizziness, syncope, or weakness \\ncan indicate significant blood loss.\\nDiagnosis and Differential\\nIn prepubertal girls, causes of vaginal bleeding include genital trauma and/\\nor sexual abuse, vaginitis, tumors, and foreign bodies. Bleeding coupled \\nwith vaginal discharge raises concerns for retained foreign bodies. Up to \\n20% of adolescents with abnormal uterine bleeding may have a primary \\ncoagulation disorder such as von Willebrand disease. Anovulatory cycles \\nare also common during the teenage years. In women of reproductive age \\nand perimenopausal women, bleeding can arise from the uterus or cervix \\nand is most commonly due to anovulation, pregnancy, exogenous hormone \\nuse, coagulopathy, uterine leiomyomas, cervical and endometrial polyps, \\npelvic infections, and thyroid dysfunction. In postmenopausal women, the \\nmost common causes of vaginal bleeding are exogenous estrogens, atrophic \\nvaginitis, endometrial lesions including cancer, and other tumors.\\n58\\nCh A pt E r\\n8Gynecology and Obstetrics\\nSEC t ION\\n58_Cydulka_Ch58.indd   319 16/03/17   3:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 338, 'page_label': '320'}, page_content='320 SECTION 8: Gynecology and Obstetrics\\nThe new term abnormal uterine bleeding (AUB) encompasses all causes \\nof abnormal bleeding in nonpregnant women and divides etiologies of AUB \\ninto structural and nonstructural causes. The use of the term dysfunctional \\nuterine bleeding is no longer recommended. AUB may be ovulatory or \\nanovulatory. Anovulatory cycles are common at the extremes of reproduc-\\ntive age. Patients with anovulatory cycles may present with prolonged \\nmenses, irregular cycles, or intermenstrual bleeding. Usually the bleeding \\nis painless and minimal, but severe bleeding can occur, resulting in anemia \\nand iron depletion.\\nA pregnancy test must be obtained on all women of reproductive age to \\nrule out pregnancy as a cause of bleeding. Other laboratory evaluation is \\nguided by the history and physical examination. A CBC should be checked \\nif signs of excessive bleeding or anemia are present. A prolonged PT or \\nelevated INR may identify a coagulopathy. Obtain thyroid function tests in \\npatients with symptoms and signs of thyroid dysfunction. Ultrasonography \\nis an important imaging modality to determine uterine size, characteristics \\nof the endometrium, and to detect structural abnormalities. Ultrasound may \\nbe deferred for outpatient evaluation in stable, nonpregnant patients as the \\nresults will rarely change ED management.\\nEmergency Department Care and Disposition\\nMost patients with vaginal bleeding are hemodynamically stable and need \\nno acute intervention. Patients who are unstable with persistent bleeding \\nrequire aggressive resuscitation: IV crystalloids, blood products, and gyne-\\ncologic consultation for urgent D and C.\\n1.  For unstable patients with severe bleeding high-dose IV estrogen is \\nconsidered first-line treatment. Give conjugated estrogen (e.g., Prema-\\nrin®) 25 mg IV every 2 to 6 hours until bleeding slows followed by an \\noral contraceptive. These patients should be admitted to a gynecologic \\nservice for further management.\\n2.  In stable patients short-term hormonal therapy may be prescribed to \\ntemporize an acute bleeding episode. Choices include the following:\\na. Oral contraceptive regimen: ethinyl estradiol 35 μg and norethin-\\ndrone 1 mg (e.g., Ortho-Novum 1/35®) three tablets daily for 7 days. \\nAlternatively, a taper may be given: four tablets for 2 days, three \\ntablets for 2 days, two tablets for 2 days, and one tablet for 3 days.\\nb. Medroxyprogesterone 20 mg three times per day for 7 days or 10 \\nmg per day for 10 days.\\nc. Tranexamic acid (e.g., Lysteda®), an antif ibrinolytic agent, 600 to \\n1300 mg every 8 hours for 3 days. Withdrawal bleeding may be heavy \\nand typically occurs 3 to 10 days after the hormonal therapy has stopped. \\nObtain gynecologic consultation if administration is considered.\\n3.  If there is any concern for malignancy, hormonal therapy is best deferred \\nuntil the patient is evaluated by gynecology and a decision about a \\nbiopsy is made.\\n4.  Nonsteroidal anti-inlammatory drugs (NSAIDs), such as naproxen 500 \\nmg twice daily PO or ibuprofen 400 mg every 6 hours PO, may reduce \\nbleeding.\\n5.  Stable patients may be discharged home and instructed to follow-up \\nwith their gynecologic provider.\\n58_Cydulka_Ch58.indd   320 16/03/17   3:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 339, 'page_label': '321'}, page_content='CHAPTER 58: Vaginal Bleeding and Pelvic Pain in the Nonpregnant Patient 321 \\n■ ■pELVIC pAIN\\nPelvic pain generally arises from gynecologic pathology but referred pain \\nfrom extrapelvic conditions, such as inflammatory bowel disease, urinary \\ntract infections or stones, diverticulitis, leaking abdominal aneurysm, or \\nappendicitis, need to be considered. Pregnancy should be excluded in all \\nwomen of reproductive age. Pelvic inflammatory disease is a common \\ncause of pelvic pain and is discussed in Chapter 64.\\nClinical Features\\nPelvic pain may be acute or chronic, intermittent or continuous. Attention \\nto the characteristics of the pain will aid in determining etiologies. Sudden \\nonset of unilateral pain suggests an ovarian cyst, ovarian torsion, obstruc-\\ntion, or renal lithiasis. Gradual onset suggests an infectious process or \\nslowly enlarging mass. Other attributes, such as the relationship of the pain \\nwith the menstrual cycle, aggravating and relieving factors, and associated \\nurinary, GI, and systemic symptoms assist in developing the differential \\ndiagnosis.\\nA complete abdominal and pelvic examination, including speculum and \\nbimanual exams should be performed. A pregnancy test should be done to \\nrule out pregnancy in women of reproductive age. Other testings, such as \\nurinalysis, CBC, and ultrasound, are guided by the history and physical \\nexamination.\\nDiagnosis and Differential\\nOvarian Cysts\\nSymptomatic ovarian cysts typically cause sudden-onset unilateral pain. \\nCysts can be complicated by bleeding from the cyst wall (hemorrhagic \\ncyst) or by cyst rupture. A ruptured cyst can causes abnormal vital signs and \\nan acute abdomen. Cysts that are >8 cm, multiloculated, or solid are con-\\ncerning for malignancy, dermoid cysts, or endometriomas (“chocolate \\ncysts”). In women who are postmenopausal, an ovarian mass is malignant \\nuntil proven otherwise. All patients with cysts should follow-up with their \\ngynecologic provider for further evaluation.\\nOvarian Torsion\\nOvarian torsion results in the sudden onset of severe adnexal pain from \\nischemia of the ovary. Torsion is a surgical emergency and rapid interven-\\ntion is necessary to preserve ovarian function. A history of acute onset of \\nsevere unilateral pain may be obtained, though atypical presentations are \\ncommon. Pain may develop after exertion. Risk factors for torsion include \\npregnancy (enlarged corpus luteum), large ovarian cysts or tumors, and \\nchemical induction of ovulation (ovarian hyperstimulation syndrome). \\nUltrasound with Doppler flow imaging is the diagnostic procedure of \\nchoice but is not 100% sensitive. Imaging early in the process may show \\ncongestion from venous outflow obstruction with preserved arterial flow \\nand images obtained during a transient period of detorsion may appear \\nnormal. Analgesia, gynecologic consultation, and preparation for surgery \\nare warranted if the diagnosis is suspected.\\n58_Cydulka_Ch58.indd   321 16/03/17   3:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 340, 'page_label': '322'}, page_content='322 SECTION 8: Gynecology and Obstetrics\\nEndometriosis\\nEndometriosis results from endometrium-like tissue implanted outside of \\nthe uterus causing chronic inflammation. Symptoms include recurrent pel-\\nvic pain associated with menstrual cycles, dyspareunia, and infertility. The \\ndefinitive diagnosis is usually not made in the ED. Treatment consists of \\nanalgesics and gynecologic referral.\\nLeiomyomas\\nLeiomyomas (uterine fibroids) are benign smooth muscle tumors, often \\nmultiple, seen most commonly in women in middle and later reproductive \\nyears. About 30% of women with leiomyomas will develop symptoms such \\nas abnormal vaginal bleeding, dysmenorrhea, bloating, backache, urinary \\nsymptoms, and dyspareunia. Severe pain can result with torsion of a pedun-\\nculated fibroid, or ischemia and infarction of a fibroid. Bimanual examina-\\ntion may demonstrate a mass or an enlarged uterus. Pelvic ultrasound is \\nconfirmatory. Treatment consists of NSAIDs or other analgesics for pain, \\nhormonal manipulation for excessive bleeding, and referral to a gynecolo-\\ngist for definitive therapy.\\nEmergency Department Care and Disposition\\nMost patients are ultimately discharged from the ED even though there may \\nnot be a specific diagnosis. It is common and appropriate to discharge \\npatients with a diagnosis of undifferentiated abdominal pain. Patients \\nshould receive detailed discharge instructions with strict return precautions \\noutlined. Follow-up instructions should also be very specific. Reevaluation \\nin 12 to 24 hours can be scheduled if any concern persists. Analgesics, such \\nas NSAIDs, provide effective pain control for most outpatients, although \\nsome patients will require opioids, such as oxycodone/acetaminophen \\n(5/325) one to two tablets every 4 to 6 hours PO for a few days.\\n■ ■FUrthEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 96, “Abnormal Uterine Bleeding,” by Bophal Sarha \\nHang; Chapter 97, “Abdominal and Pelvic Pain in the Nonpregnant Female,” by \\nMelanie Heniff and Heather R.B. Fleming.\\n58_Cydulka_Ch58.indd   322 16/03/17   3:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 341, 'page_label': '323'}, page_content='323\\nEctopic Pregnancy and \\nEmergencies in The First  \\n20 Weeks of Pregnancy\\nRobert Jones\\n■ ■ECTOPIC PREGNANCY\\nEctopic pregnancy (EP) is the leading cause of maternal death in the first \\ntrimester. Major risk factors include history of pelvic inflammatory disease, \\nsurgical procedures on the fallopian tubes including tubal ligation, previous \\nEP, diethylstilbestrol exposure, intrauterine device use, and assisted repro-\\nduction techniques. The most common extrauterine location is the fallopian \\ntube. This diagnosis must be considered in every woman of childbearing \\nage presenting with abdominal pain and/or vaginal bleeding.\\nClinical Features\\nThe classic triad of abdominal pain, vaginal bleeding, and amenorrhea used \\nto describe EP may be present, but many cases occur with more subtle find-\\nings. Presenting signs and symptoms may be different in ruptured versus \\nnonruptured EP. Location of the EP will also determine the clinical fea-\\ntures. The vast majority of EPs implant in the ampullary portion of the \\nfallopian tube but additional implantation locations include the cervix, \\nabdomen, and cesarean scar. Ninety percent of women with EP complain \\nof abdominal pain; 50% to 80% have vaginal bleeding; and 70% give a \\nhistory of amenorrhea. The pain described may be sudden, lateralized, \\nextreme, or relatively minor and diffuse. The presence of hemoperitoneum \\nwith diaphragmatic irritation may cause the pain to be referred to the shoul-\\nder or upper abdomen. Presenting vital signs may be entirely normal even \\nwith a ruptured EP. There is poor correlation with the volume of hemoperi-\\ntoneum and vital signs in EP. Relative bradycardia, as a consequence of \\nvagal stimulation, may be present even in cases with rupture and hemoperi-\\ntoneum. Physical examination findings are highly variable. The abdominal \\nexamination may show signs of localizing or diffuse tenderness with or \\nwithout peritoneal signs. The pelvic examination findings may be normal \\nbut more often show cervical motion tenderness, adnexal tenderness with \\nor without a mass, and possibly an enlarged uterus. Vaginal bleeding, rang-\\ning from spotting to heavy, is often present. Fetal heart tones may be heard \\nin cases of EP beyond 12 weeks of gestation.\\nDiagnosis and Differential\\nThe definitive diagnosis of EP is made either by ultrasound (US) or by \\ndirect visualization during surgery. The diagnosis of pregnancy is central to \\nthe diagnosis of possible EP and needs to be confirmed first. Urine preg-\\nnancy testing (for urinary β-human chorionic gonadotropin [β-hCG]) is a \\nqualitative screening test with a threshold for detection of >20 mIU/mL of \\nβ-hCG. Urine qualitative testing is 95% to 100% sensitive and specific as \\n59\\nCh APTER\\n59_Cydulka_Ch59.indd   323 16/03/17   3:16 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 342, 'page_label': '324'}, page_content='324 SECTION 8: Gynecology and Obstetrics\\ncompared with serum testing. Dilute urine, particularly when β-hCG levels \\nare <50 mIU/mL, may result in a false-negative result. Quantitative serum \\ntesting for the diagnosis of pregnancy is virtually 100% sensitive for detect-\\ning β-hCG levels >5 mIU/mL and should be performed when the diagnosis \\nof EP is considered but urine results are negative.\\nThe primary goal of US in suspected EP is to determine if an intrauter -\\nine pregnancy (IUP) is present, since US cannot rule out the presence of EP. \\nThe transabdominal examination is usually performed first due to its wider \\nfield of view; the transvaginal examination is performed if the transab-\\ndominal examination is not diagnostic. When US reveals an unequivocal \\nIUP and no other abnormalities, EP is effectively excluded unless the \\npatient is at high risk for heterotopic pregnancy. Actual visualization of an \\nEP with US occurs in a minority of cases. Sonographic findings of an \\nempty uterus without an adnexal mass or free fluid in a woman with a \\npositive pregnancy test result are considered indeterminate. In such situa-\\ntions, the findings must be evaluated in context with the patient’s quantita-\\ntive β-hCG level. A high β-hCG level (>6000 mIU/mL for transabdominal \\nUS or >1500 mIU/mL for transvaginal US) with an empty uterus is sug-\\ngestive of EP. If the β-hCG is low (<1500 mIU/mL transvaginal), then the \\npregnancy may indeed be intrauterine or ectopic but often too small to be \\nvisualized on US or the patient may have already had a miscarriage. In this \\nsituation, repeat quantitative β-hCG testing in 2 days must be performed. \\nβ-hCG should increase at least 66% in that period; EP has a slower rate of \\nincrease. Since many EPs will have β-hCG levels <1500 mIU/mL, quanti-\\ntative β-hCG levels should not be used to determine the need for US \\nimaging.\\nDifferential diagnosis in the patient presenting with abdominal pain, \\nvaginal bleeding, and early pregnancy includes threatened, incomplete, or \\nmissed abortion, recent elective abortion, implantation bleeding, molar \\npregnancy, heterotopic pregnancy, or corpus luteum cyst.\\nEmergency Department Care and Disposition\\nTreatment of patients with suspected EP depends on the patient’s vital \\nsigns, physical signs, and symptoms. Close communication with the \\nobstetric-gynecologic consultant is essential.\\n1. For unstable patients, insert two large-bore intra venous lines and begin \\nrapid infusion of crystalloid and/or packed red blood cells to maintain \\nblood pressure.\\n2. Perform a bedside urine pregnancy test.\\n3. Notify the obstetric-gynecologic consultant immediately if the patient is \\nunstable, even before laboratory and diagnostic tests are complete.\\n4. Draw blood for blood typing, and rhesus (Rh) factor determination (or \\ncross-matching for the unstable patients), quantitative β-hCG determi-\\nnation (if indicated), and serum electrolyte determination, as required. \\nRh-negative women with EP should receive 50 μg of anti-Rho (D) \\nimmunoglobulin.\\n5. Reliable, stable patients with indeterminate US results and a β-hCG \\nlevel below 1000 mIU/mL can be discharged with ectopic precautions \\nand follow-up in 2 days for repeat β-hCG determination and obstetric-\\ngynecologic reevaluation.\\n59_Cydulka_Ch59.indd   324 16/03/17   3:16 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 343, 'page_label': '325'}, page_content='CHAPTER 59: Ectopic Pregnancy and Emergencies 325 \\n6. Definitive treatment, as determined by the obstetric-gynecologic consul-\\ntant, may involve laparoscopy, dilation and curettage, or medical man-\\nagement with methotrexate. Methotrexate therapy, even when used in \\nproperly selected patients with EP, has a treatment failure rate of up to \\n36%, so proper selection is essential.\\n■ ■ThREATENED ABORTION AND ABORTION\\nAccording to the World Health Organization, between 20% and 40% of \\npregnancies will spontaneously abort. Approximately 75% of these sponta-\\nneous abortions will occur before 8 weeks of gestation.\\nClinical Features\\nVaginal bleeding in the first 20 weeks, with a closed cervical os, benign \\nexamination, and no passage of tissue, is termed threatened abortion. A \\ndilated cervix increases the likelihood of abortion (inevitable abortion). \\nIncomplete abortion is defined as partial passage of the conceptus and is \\nmore likely between 6 and 14 weeks of pregnancy. The patient may report \\npassage of grayish white products of conception (POC), or the POC may be \\nevident on pelvic examination. Complete abortion is passage of all fetal \\ntissue before 20 weeks gestation. All recovered POC should be sent for \\npathologic examination. Missed abortion is fetal death at less than 20 \\nweeks without passage of any fetal tissue for 4 weeks after fetal death. \\nSeptic abortion implies evidence of infection during any stage of abortion, \\nwith signs and symptoms of pelvic pain, fever, cervical motion or uterine \\ntenderness, or purulent or foul-smelling drainage.\\nDiagnosis and Differential\\nPerform a pelvic examination and obtain a complete blood count (CBC), \\nblood typing (and cross-matching for unstable patients) and rhesus (Rh) \\nfactor determination, urine pregnancy test, quantitative β -hCG, and uri-\\nnalysis. The differential diagnosis includes EP, implantation bleeding, and \\ngestational trophoblastic disease (GTD). Implantation bleeding, which is \\nusually scant and painless, is a diagnosis of exclusion. GTD is a prolifera-\\ntive disease of the trophoblast that includes complete hydatidiform mole, \\npartial mole, trophoblastic tumor, and choriocarcinoma. Patients with \\nGTD present with bleeding, an enlarged uterus out of proportion to men-\\nstrual age, and a significantly elevated β -hCG level. Also consider the \\npossibility of a molar pregnancy in patients with hyperemesis gravidarum \\nor pregnancy-induced hypertension before 24 weeks of gestation.\\nEmergency Department Care and Disposition\\nTreatment of patients with suspected threatened abortion and abortion \\ndepends on the patient’s vital signs, physical signs, and symptoms. Close \\ncommunication with the obstetric-gynecologic consultant is essential.\\n1. Patients who are symptomatic or demonstrate signs of hemodynamic \\ninstability should receive supplemental oxygen, be placed on a cardiac \\nmonitor, and have two large-bore intravenous (IV) lines established. The \\nobstetric-gynecologic consultant is consulted emergently in the unstable \\npatient.\\n59_Cydulka_Ch59.indd   325 16/03/17   3:16 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 344, 'page_label': '326'}, page_content='326 SECTION 8: Gynecology and Obstetrics\\n2. Initiate aggressive IV crystalloid and/or packed red blood cell infusion, \\nwhen appropriate, to help correct hypovolemia.\\n3. Rh-negative women with threatened abortion or abortion should receive \\nanti-Rho (D) immunoglobulin. There is no uniform agreement on dos-\\ning. Dosing recommendations range from 50 to 300 μg in these patients.\\n4. US imaging should be performed when the patient is stable.\\n5. Incomplete abortion or GTD requires dilation and curettage. The deci-\\nsion to proceed with medical treatment, such as misoprostol, or surgical \\ntreatment, such as dilation and curettage, should be made in conjunction \\nwith the consulting obstetrician. GTD patients must receive close \\nfollow-up until quantitative β-hCG has returned to zero. Failure of the \\nβ-hCG to return to normal may indicate choriocarcinoma.\\n6. Septic abortion requires gynecologic consultation and broad-spectrum \\nantibiotics such as ampicillin/sulbactam 3 g IV or clindamycin  \\n600 mg plus gentamicin 1 to 2 mg/kg IV .\\n7. Patients with threatened abortion or complete abortion may be dis-\\ncharged with close follow-up arranged. Discharge instructions include \\npelvic rest (no intercourse or tampons) and instructions to return for \\nheavy bleeding, fever, or pain.\\n■ ■NAUSEA AND VOMITING OF PREGNANCY\\nNausea and vomiting of pregnancy generally are seen in the first 12 weeks \\nand affect 60% to 80% of pregnant women. Cases can range from mild \\nsymptoms to hyperemesis gravidarum.\\nClinical Features\\nFindings on physical examination are usually normal except for signs of \\nvolume depletion. The presence of abdominal pain in nausea and vomiting \\nof pregnancy or hyperemesis gravidarum is highly unusual and should sug-\\ngest another diagnosis.\\nDiagnosis and Differential\\nDiagnostic workup may include CBC, serum electrolytes, blood urea nitro-\\ngen, creatinine, and urinalysis. Differential diagnosis includes ruptured EP, \\ncholelithiasis, cholecystitis, gastroenteritis, pancreatitis, appendicitis, hepa-\\ntitis, peptic ulcer disease, pyelonephritis, fatty liver of pregnancy, and \\nhemolysis with elevated liver enzymes and low platelets (known as HELLP \\nsyndrome).\\nEmergency Department Care and Disposition\\n1. Rehydration should begin with IV fluid such as 5% dextrose in normal \\nsaline or 5% de xtrose in Lactated Ringer’s solution. Failure to include \\ndextrose may result in prolonged ketosis.\\n2. Frequently used antiemetics are metoclopramide 10 mg IV ev ery 6 to \\n8 hours, promethazine 12 to 25 mg IV every 4 hours (pregnancy class \\nC, but widely used), and ondansetron 4 to 8 mg IV every 4 to 8 hours.\\n3. If the patient improves in the emergency department (urine ketones \\nclearing and tolerating oral liquids), she may be discharged with a \\nprescription for an antiemetic. Doxylamine with pyridoxine 50 mg PO \\n59_Cydulka_Ch59.indd   326 16/03/17   3:16 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 345, 'page_label': '327'}, page_content='CHAPTER 59: Ectopic Pregnancy and Emergencies 327 \\nevery evening may be added as maintenance therapy for nausea and \\nvomiting.\\n4. Admission is indicated for intractable vomiting, persistent ketonuria, \\nelectrolyte abnormalities, or weight loss greater than 10% of prepreg -\\nnancy weight. Systemic steroids, such as methylprednisolone, 16 mg \\nPO or IV every 8 hours for 3 days and tapered over 2 weeks to the low-\\nest effective dose can be initiated in consultation with an obstetrician.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 98, “Ectopic Pregnancy and Emergencies in the First \\n20 Weeks of Pregnancy,” by Heather A. Heaton.\\n59_Cydulka_Ch59.indd   327 16/03/17   3:16 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 346, 'page_label': '328'}, page_content='328\\nComorbid Diseases in Pregnancy\\nAbigail D. Hankin\\nMany medical conditions can present in the context of pregnancy, either \\nas a preexisting condition or arising during pregnancy. This chapter \\nfocuses on conditions that require different management when encoun-\\ntered in the pregnant patient. Some disorders are covered in other chapters \\nwithin this text, including hypertension (Chapters 26 and 61), HIV \\ninfection (Chapter 92), and cardiac rhythm disturbances (Chapter 2).\\n■ ■DIABETES\\nDiabetics are at increased risk for complications of pregnancy and acute \\ncomplications of diabetes. Many patients with gestational diabetes are man-\\naged with diet alone, though some patients require oral hypoglycemics such \\nas metformin or glyburide. Insulin therapy is necessary for some patients \\nwith gestational diabetes and nearly all patients with type I or II diabetes. \\nInsulin requirements increase as a pregnancy progresses, from 0.7 U/kg/d \\nduring the first trimester to 1.0 U/kg/d at term.\\nPregnant patients are at increased risk of diabetic ketoacidosis (DKA), \\nand DKA can occur more rapidly, and at lower glucose levels, than in non-\\npregnant patients. DKA should be considered for any pregnant diabetic \\npatient who is ill appearing and/or has a blood glucose level ≥ 180 mg/dL. \\nTreatment of DKA includes supplemental oxygen, left lateral decubitus \\npositioning, and usual DKA care: isotonic fluid resuscitation to correct vol-\\nume deficits, administration of continuous insulin, correction of electrolyte \\nabnormalities, and treatment of the underlying cause (see Chapter 129).\\nMild hypoglycemia (glucose <70 mg/dL and able to follow commands) \\nis treated with a snack of milk and crackers. Severe hypoglycemia (glucose \\n<70 mg/dL and unable to follow commands) should be treated with 50 mL \\nof 50% dextrose in water IV , with 1 to 2 mg of glucagon given IM or \\nsubcutaneous if IV access is delayed. Subsequently, the patient should be \\ngiven 5% dextrose solution IV at 50 to 100 mL/h.\\n■ ■HYPERTHYROIDISM\\nHyperthyroidism in pregnancy increases the risk of preeclampsia, congeni-\\ntal anomalies, and neonatal morbidity. Clinical features may be subtle and \\nmay mimic normal pregnancy. Treatment is with propylthiouracil (PTU). \\nPatients on PTU are at risk for purpuric rash and agranulocytosis.\\nThyroid storm presents with fever, volume depletion, or cardiac decom-\\npensation manifesting as high-output heart failure. Management is similar \\nto nonpregnant patients (see Table 60-1).\\n■ ■HYPERTENSION\\nTreatment is often considered for chronic hypertension, defined as blood \\npressure >140/90 mm Hg measured on two occasions before 20 weeks \\ngestation or sustained beyond 12 weeks gestation. Chronic hypertension is \\n60\\nC HAPTER\\n60_Cydulka_Ch60.indd   328 16/03/17   3:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 347, 'page_label': '329'}, page_content='CHAPTER 60: Comorbid Diseases in Pregnancy 329 \\ntypically treated with labetalol, nifedipine, or methyldopa while angio-\\ntensin receptor blockers and angiotensin-converting enzyme inhibitors are \\navoided in pregnancy.\\nAcute hypertensive crisis in pregnancy is treated with labetalol or \\nhydralazine (see Table 60-2).\\nWhile blood pressure is being managed, fetal well-being should be closely \\nmonitored, and clinicians should consider superimposed preeclampsia.\\n■ ■DYSRHYTHMIAS\\nDysrhythmias may be precipitated by pregnancy and labor/delivery. Supra-\\nventricular tachycardias are treated with vagal maneuvers, β-blockers, \\nadenosine, verapamil, and diltiazem at usual dosages. Patients with atrial \\nfibrillation who require anticoagulation should be managed with unfrac-\\ntionated or low-molecular-weight heparin (LMWH). Electrical cardiover -\\nsion may be used to treat dysrhythmias when indicated and have not been \\nshown to be harmful to the fetus. Amiodarone should only be used to treat \\nresistant, life-threatening dysrhythmias, as its use has been linked to fetal \\nneurotoxicity.\\nTable 60-1 Principles of Treatment of Thyroid Storm during Pregnancy\\nPrinciple Comment\\nInhibit thyroid hormone release \\nwith thionamides (PTU is pre-\\nferred over methimazole; also \\nblocks conversion of T4 to T3)\\nPropylthiouracil (PTU) 600–1000 mg PO loading dose \\nfollowed by 200–250 mg PO every 4 h (first trimester)\\nor\\nMethimazole 40 mg PO loading dose followed by  \\n25 mg PO every 4 h (second and third trimesters)\\nInhibit new thyroid hormone \\nproduction (give at least 1 h \\nafter above step)\\nlugol solution 8–10 drops every 6–8 h\\nor\\nPotassium iodine 5 drops PO every 6 h\\nor\\nIopanoic acid 1 g IV every 8 h\\nDo not use radioactive iodine because the fetus \\nwill concentrate iodine-131 after the 10th to \\n12th week of gestation, resulting in congenital \\nhypothyroidism\\nBlock peripheral thyroid \\nhormone effects\\nPropranolol 1–2 mg IV every 10–15 min and start\\nPropranolol 40 mg PO every 6 h\\nor\\nesmolol 500 μg/kg IV bolus, then 50 μg/kg/min \\nmaintenance\\nHold if evidence of heart failure is present\\nPrevent conversion of T4 to T3 Hydrocortisone 100 mg IV every 8 h\\nor\\nDexamethasone 2 mg IV every 6 h\\nSupportive care Left lateral decubitus position\\nOxygen\\nCooling blankets\\nIV fluids\\nAcetaminophen 650 mg PO every 4 h\\n60_Cydulka_Ch60.indd   329 16/03/17   3:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 348, 'page_label': '330'}, page_content='330 SECTION 8: Gynecology and Obstetrics\\n■ ■THROMBOEMBOLISM\\nDeep venous thrombosis (DVT) and pulmonary embolism (PE) are the \\nmost common causes of maternal morbidity and mortality in industrialized \\nnations. Factors associated with increased risk of thromboembolism \\ninclude advanced maternal age, increasing parity, multiple gestations, \\noperative delivery, bed rest, and obesity. Symptoms of DVT and PE may be \\nmistaken for symptoms of normal pregnancy. Table 60-3 shows the various \\nimaging modalities to consider for the diagnosis of PE in pregnancy. DVT \\nand PE are treated with unfractionated or low-molecular-weight heparin at \\nusual doses. Warfarin is contraindicated (see Chapter 25).\\nTable 60-2 Treatment of Hypertension in Pregnancy\\nAgent\\nFor Existing \\nHypertension\\nAdjunct \\nto Existing \\nTreatment\\nUrgent \\nControl \\nof Acute \\nHypertension\\nPotential \\nAdverse \\nEffects \\n(Maternal)\\nHydralazine N/A 50–300 mg \\ndaily in 2–4 \\ndivided doses; \\nuse with \\nmethyldopa \\nor labetalol to \\nprevent reflex \\ntachycardia*\\nLoading dose of \\n5 mg IV or IM, \\nmaintenance \\ndose there after \\nof 5–10 mg \\nevery 20–40 \\nmin up to 300 \\nmg; or constant \\ninfusion of \\n0.5–10 mg/h\\nDelayed \\nhypotension\\nHydrochlorothiazide N/A 12.5–50 mg \\ndaily\\nN/A Volume \\ndepletion and \\nelectrolyte \\ndisorders\\nLabetalol 200–2400 mg \\ndaily in 2–3 \\ndivided doses\\nN/A Loading dose \\nof 20 mg IV; \\nmaintenance \\ndose of 20–80 \\nmg up to 300 \\nmg; or constant \\ninfusion of 1–2 \\nmg/min\\nHeadache\\nNifedipine 30–120 mg \\ndaily as \\nslow-release \\npreparation\\nN/A 10–30 mg \\norally, repeated \\nafter 45 min if \\nneeded\\nHeadache, \\ninterference \\nwith labor\\nMethyldopa 0.5–3.0 g daily \\nin 2–3 divided \\ndoses\\nN/A N/A Sedation, \\nelevated \\nliver function \\ntests, \\ndepression\\n*Risk of fetal bradycardia and neonatal thrombocytopenia.\\nAbbreviation: N/A, not applicable.\\n60_Cydulka_Ch60.indd   330 16/03/17   3:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 349, 'page_label': '331'}, page_content='CHAPTER 60: Comorbid Diseases in Pregnancy 331 \\nTable 60-3 Imaging Modalities for Diagnosis of Pulmonary Embolism in Pregnancy\\nRadiation Limitations Disadvantages Advantages Lactation\\nChest radiograph Minimal Nonspecific and \\nnonsensitive\\nResults determine next imaging \\nstudy, requiring more time to \\ndiagnosis\\nMay identify another cause \\nof pulmonary symptoms\\nNo change\\nCT-PA High maternal breast \\nradiation; lower fetal \\nradiation than V/Q scan\\nContrast allergy and renal \\ninsufficiency\\nHyperdynamic state in pregnancy \\ncan affect interpretation\\nHigh sensitivity and \\nspecificity; needed if \\nabnormal chest radiograph\\nNo need to discard \\nbreast milk\\nV/Q scan Low breast radiation but \\nhigher fetal radiation than \\nCT-PA\\nNot useful if abnormal \\nchest radiograph, asthma, \\nCOPD, underlying \\npulmonary disease\\nIf negative or inconclusive and \\nsuspicion for PE remains, will \\nneed a CT-PA; limited availability \\nand time for isotope preparation, \\nwhich delays diagnosis\\nNegative perfusion study \\neffectively rules out PE\\nDiscard breast milk \\nfor 12 h\\nMRI/MRV No radiation Gadolinium safety for \\nfetus is unknown; do not \\nuse in maternal renal \\ninsufficiency\\nLimited availability Can detect pelvic and iliac \\nthrombosis\\nNo need to discard \\nbreast milk\\nAbbreviations: COPD, chronic obstructive pulmonary disease; CT-PA, chest CT–pulmonary angiography; V/Q scan, ventilation-perfusion scan; MRV, magnetic resonance venography.\\n60_Cydulka_Ch60.indd   331 16/03/17   3:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 350, 'page_label': '332'}, page_content='332 SECTION 8: Gynecology and Obstetrics\\n■ ■ASTHMA\\nSymptoms of acute asthma exacerbation include cough, wheezing, and \\ndyspnea. Acute therapy includes maintenance of oxygen saturation >95%, \\nadministration of inhaled β 2-agonists, systemic corticosteroids, and fetal \\nmonitoring. Aerosolized ipratropium may be added in severely obstructed \\npatients. Terbutaline sulfate, 0.25 mg SC every 20 minutes, may also be \\nused. Subcutaneous epinephrine should be avoided, if possible. Peak expi-\\nratory flow rate (PEFR) is not altered in pregnancy, with goal PEFR \\nbetween 380 and 550 L/min. Patients who are discharged home should \\nreceive oral prednisone 40 to 60 mg/d for 5 to 10 days in addition to a \\nrescue β-agonist.\\n■ ■CYSTITIS AND PYELONEPHRITIS\\nClinical features of cystitis and pyelonephritis are similar in pregnant and \\nnonpregnant women, as are the causative microbes. Cystitis may be treated \\nwith nitrofurantoin, 100 mg PO twice daily for 3 to 7 days, while \\ntrimethoprim-sulfamethoxazole should be avoided due to concerns of fetal \\nkernicterus during the third trimester. Fluoroquinolones and tetracyclines \\nshould also be avoided in pregnancy. Pregnant patients with pyelonephritis \\nare treated aggressively because of increased risk of preterm labor and \\nsepsis, and should be admitted for IV hydration and a second- or third-\\ngeneration cephalosporin. Many providers continue antibiotic suppression \\nfor the remainder of the pregnancy.\\n■ ■SICKLE CELL DISEASE\\nPregnant women with sickle cell disease are at higher risk of miscarriage, \\npreterm labor, and vasoocclusive crises. Clinical features, evaluation, and \\ntreatment are similar to nonpregnant patients. Management of vasoocclu-\\nsive crisis includes aggressive hydration, analgesia, identification and treat-\\nment of the underlying cause, and fetal monitoring. Opiates can be used, \\nwhile NSAIDs should be avoided, particularly after 32 weeks gestation. \\nBlood transfusion should be considered when conservative measures have \\nfailed, or with severe anemia, preeclampsia, hypoxemia, acute chest syn-\\ndrome, or a new-onset neurological event.\\n■ ■HEADACHES\\nHeadaches can be a presenting symptom of a wide variety of benign and \\nlife-threatening disorders, including intracranial hemorrhage, central vein \\nthrombosis, mass, infection, and preeclampsia/eclampsia. Warning symp-\\ntoms of potentially life-threatening disease include acute onset, postpartum \\nheadaches, neurological deficits, fever, and papilledema or retinal hemor -\\nrhages. If indicated, CT scan of the brain should be performed with appro-\\npriate shielding of the uterus. Migraine headaches should be treated with \\nacetaminophen, antiemetics and, if necessary, narcotics. Ergot alkaloids \\nand triptans should not be used.\\n60_Cydulka_Ch60.indd   332 16/03/17   3:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 351, 'page_label': '333'}, page_content='CHAPTER 60: Comorbid Diseases in Pregnancy 333 \\n■ ■SEIZURE DISORDERS\\nSeizure frequency may increase in patients with epilepsy due to altered \\ndrug pharmacokinetics. Acute seizure management is similar to that in \\nnonpregnant patients, with emphasis on supplemental oxygen and left lat-\\neral decubitus positioning (see Chapter 145). Status epilepticus with pro-\\nlonged maternal hypoxia and acidosis has a high mortality rate for the \\nmother and infant, and should be treated aggressively with early intubation \\nand ventilation.\\n■ ■SUBSTANCE ABUSE\\nCocaine use is associated with increased incidence of fetal death in utero, \\nplacental abruption, preterm labor, premature rupture of membranes, spon-\\ntaneous abortion, intrauterine growth restriction, and fetal cerebral infarcts. \\nTreatment of acute cocaine intoxication is unchanged in pregnancy. Acute \\nopiate withdrawal in pregnant women can be treated with clonidine, 0.1 to \\n0.2 mg SL every hour as needed for symptoms, not to exceed 0.8 mg. \\nPatients should be referred to addiction specialists for methadone or \\nbuprenorphine/naloxone therapy. Alcohol use contributes to increased rates \\nof spontaneous abortion, low birthweight, preterm deliveries, and fetal \\nalcohol syndrome. Treatment of severe alcohol withdrawal does not differ \\nfrom treatment in nonpregnant patients.\\n■ ■MEDICATIONS IN PREGNANCY AND LACTATION\\nTable 60-4 lists common emergency department medications that are \\nknown to be unsafe in pregnancy. For any drug not listed in the table, the \\nNational Library of Medicine provides detailed information online in the \\nDrugs and Lactation Database (LactMed).\\nTable 60-4 Drugs Used in Emergency Settings with Known Adverse Effects  \\nin Human Pregnancy\\nDrug Effect\\nAngiotensin-converting enzyme inhibi-\\ntors and angiotensin receptor blockers\\nRenal failure, oligohydramnios\\nAminoglycosides Ototoxicity (gentamicin class D, Black Box \\nWarning)\\nAndrogenic steroids Masculinize female fetus\\nAnticonvulsants (carbamazepine, \\nhydantoins, valproate)\\nDysmorphic syndrome, anomalies, neural tube \\ndefects\\nAntithyroid agents Fetal goiter\\nAspirin (high doses) Bleeding, antepartum and postpartum\\nCytotoxic agents (e.g., methotrexate) Multiple anomalies\\nErythromycin estolate Maternal hepatotoxicity\\nFluoroquinolones Fetal cartilage abnormality\\n(Continued)\\n60_Cydulka_Ch60.indd   333 16/03/17   3:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 352, 'page_label': '334'}, page_content='334 SECTION 8: Gynecology and Obstetrics\\n■ ■DIAGNOSTIC IMAGING IN PREGNANCY\\nThe threshold for teratogenesis from ionizing radiation is 10 rads, with the \\nfirst trimester being the most vulnerable period. The effects of radiation \\nexposure change with gestational age. No single test exceeds the terato-\\ngenic threshold, but teratogenic effects of multiple imaging should be \\nconsidered cumulatively. Ultrasound and magnetic resonance imaging have \\nnot been associated with teratogenic effects.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 99, “Comorbid Disorders in Pregnancy,” by Lori J. \\nWhelan.\\nTable 60-4 Drugs Used in Emergency Settings with Known Adverse Effects  \\nin Human Pregnancy\\nDrug Effect\\nIsotretinoin Hydrocephalus, deafness, anomalies\\nLithium Congenital heart disease (Ebstein’s anomaly)\\nNonsteroidal anti-inflammatory drugs \\n(prolonged use after 32 weeks)\\nOligohydramnios, constriction of fetal ductus \\narteriosus\\nStreptomycin Fetal cranial nerve VIII damage\\nSulfonamides Fetal hemolysis, neonatal kernicterus (near \\nterm)\\nTetracyclines Fetal teeth and bone abnormalities\\nTrimethoprim, methotrexate Folate antagonist (first trimester)\\nThalidomide Phocomelia\\nWarfarin Embryopathy—nasal hypoplasia, optic atrophy\\n(Continued)\\n60_Cydulka_Ch60.indd   334 16/03/17   3:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 353, 'page_label': '335'}, page_content='335\\nEmergencies After 20 Weeks of \\nPregnancy and The Postpartum \\nPeriod\\nKathleen Kerrigan\\n■ ■THROMBOEMBOLIC DISEASE OF PREGNANCY\\nDeep vein thrombosis (DVT) and pulmonary embolism (PE) are the lead-\\ning causes of maternal morbidity and mortality in industrialized nations. \\nSymptoms are similar to those seen in nonpregnant women. Evaluation for \\nDVT should begin with ultrasound of the lower extremities. If there is a \\nconcern for PE initiate the evaluation with a chest radiograph. d-dimer may \\nnot be helpful to diagnose or exclude thromboembolic disease as levels \\nincrease throughout pregnancy. Consensus guidelines recommend obtain-\\ning a V/Q scan or CT pulmonary angiography next if the chest radiograph \\nis nondiagnostic. DVT and PE are treated with unfractionated heparin or \\nlow-molecular-weight heparin. Do not use warfarin in pregnancy as it \\ncrosses the placenta, potentially causing fetal CNS abnormalities and \\nembryopathies such as bone and cartilage abnormalities as well as nasal \\nand limb hypoplasia.\\n■ ■CHEST PAIN\\nThe underlying causes of chest pain in pregnancy are similar to those of \\nnonpregnant women. Some disorders, such as aortic dissection and cardio-\\nmyopathy, may be associated with pregnancy. Treat pregnant women with \\nacute myocardial infarction with aspirin, heparin, and percutaneous inter -\\nvention rather than thrombolytics. Treat congestive heart failure and pulmo-\\nnary edema with standard modalities except for sodium nitroprusside. It \\nshould be avoided as it can cause thiocyanate and cyanide accumulation in \\nthe fetus.\\nChronic Hypertension\\nChronic hypertension is defined as blood pressure at or above \\n140/90 mmHg prior to pregnancy, prior to 20 weeks’ gestation or lasting  \\nmore than 12 weeks after delivery. These patients are at risk for abrup-\\ntion, preeclampsia, low birth weight, cesarean delivery, premature birth, \\nand fetal demise.\\nGestational Hypertension\\nGestational hypertension is defined as blood pressure at or above \\n140/90 mmHg after 20 weeks or in the immediate postpartum period but \\nwithout proteinuria.\\nHypertension in pregnancy is def ined as a systolic blood pressure \\n≥140 mmHg or diastolic ≥90  mmHg on two occasions at least 4 hours \\napart in a woman who was normotensive prior to 20 weeks’ gestation.\\n61\\nC HAPTER\\n61_Cydulka_Ch61.indd   335 25/03/17   12:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 354, 'page_label': '336'}, page_content='336 SECTION 8: Gynecology and Obstetrics\\nPreeclampsia\\nPreeclampsia is characterized by hypertension, greater than 140/90 mmHg, \\non two occasions at least 4 hours apart and proteinuria ≥300 mg in 24 hours \\nin patients at 20 weeks’ gestation until 4 to 6 weeks after delivery. In the \\nabsence of proteinuria, thromboc ytopenia with platelet count less than \\n100,000, elevation of liver enzymes twice normal, new renal insufficiency \\nwith a creatinine of 1.1 or a doubling of serum creatinine, pulmonary \\nedema, or new-onset mental status disturbances or visual disturbances can \\nbe used to make the diagnosis of preeclampsia. Edema may or may not be \\npresent. Symptoms of severe preeclampsia reflect end-organ involvement \\nand may include headache, visual disturbances, mental status changes, \\nedema, oliguria, dyspnea due to pulmonary edema, and abdominal pain. \\nBlood pressure in severe preeclampsia is typically elevated to 160/110 mmHg \\nor more.\\nHELLP Syndrome\\nHELLP syndrome is probably a clinical variant of preeclampsia. It is char-\\nacterized by hemolysis, elevated liver enzymes, and low platelets. Patients \\nusually complain of abdominal pain, especially epigastric and right upper \\nquadrant pain. Because the blood pressure is not always elevated, HELLP \\nsyndrome should be considered in the evaluation of all pregnant women \\ngreater than  20 weeks’ gestation with abdominal pain.\\nEclampsia\\nEclampsia is preeclampsia with seizures.\\nDiagnosis and Differential\\nPreeclampsia is a clinical diagnosis. The following laboratory abnormali-\\nties may be seen in severe preeclampsia: anemia, thrombocytopenia, ele-\\nvated creatinine, elevated liver enzymes, elevated LDH. The HELLP \\nvariant is diagnosed by laboratory tests: schistocytes on peripheral smear, \\nplatelet count lower than 150,000/mL, and elevated aspartate aminotrans-\\nferase and alanine aminotransferase levels. The differential diagnosis of \\npreeclampsia includes worsening of preexisting hypertension, transient \\nhypertension, renal disease, fatty liver disease of pregnancy, and coagula-\\ntion disorders. Focused ultrasonography or a CT scan of the pelvis and \\nabdomen should be done if concerns for subcapsular hematoma exist as this \\nhas a high risk of maternal and fetal mortality if ruptured.\\nEmergency Department Care and Disposition\\n1. Treat severe preeclampsia and eclampsia with magnesium sulfate load-\\ning dose of 4 to 6 g IV over 20 minutes, followed by a maintenance infu-\\nsion of 1 to 2  g/h to prevent seizure. Monitor serum magnesium lev els \\nand reflexes.\\n2. Treat severe h ypertension, greater than  160/110 mm Hg, with labetalol \\n20 mg IV initial bolus, followed by repeat boluses of 40 to 80  mg, if \\nneeded, to a maximum of 300 mg for blood pressure control or hydrala-\\nzine 5.0 mg IV initially, followed by 5 to 10 mg every 10 minutes.\\n3. Consult an obstetrician emergently for severe preeclampsia or eclampsia.\\n61_Cydulka_Ch61.indd   336 25/03/17   12:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 355, 'page_label': '337'}, page_content='CHAPTER 61: Emergencies After 20 Weeks 337 \\n4. Hospitalize all patients with a sustained systolic blood pressure \\n≥140 mmHg or diastolic ≥90 mmHg plus any symptoms of preeclampsia.\\n5. Definitive treatment requires delivery of the fetus.\\n6. In patients with mild preeclampsia, outpatient management may be ap-\\npropriate after consultation with an obstetrician. Arrangements must be \\nmade for frequent laboratory evaluation and close fetal surveillance.\\n■ ■VAGINAL BLEEDING DURING THE SECOND HALF  \\nOF PREGNANCY\\nPlacental abruption, placenta previa, and preterm labor are the most com-\\nmon causes of vaginal bleeding during the second half of pregnancy.\\nClinical Features\\nPlacental Abruption\\nPlacental abruption, the premature separation of the placenta from the uter-\\nine wall, must be considered in all pregnant females near term who present \\nwith painful vaginal bleeding. Clinical features include vaginal bleeding, \\nabdominal pain, uterine tenderness, hypertonic contractions, increased \\nuterine tone, fetal distress, and, in severe cases, disseminated intravascular \\ncoagulation (DIC), and fetal and/or maternal death. Vaginal bleeding may \\nbe mild or severe, depending on whether the area of abruption communi-\\ncates to the cervical os. Abruption of greater than 50% of the placenta usu-\\nally results in fetal demise. Be aware of the possibility of abruption after \\ntrauma, even minor trauma.\\nPlacenta Previa\\nPlacenta previa is the implantation of the placenta over the cervical os. \\nClinical features include painless, bright red vaginal bleeding. The amount \\nof bleeding is frequently large as opposed to normal “bloody show,” when \\na small amount of bright red blood and mucous are passed.\\nDiagnosis and Differential\\nTransabdominal ultrasound should be obtained prior to performing specu-\\nlum or digital pelvic examination to differentiate abruption placenta from \\nplacenta previa as it is contraindicated in previa. If transabdominal ultra-\\nsound is nondiagnostic, transvaginal ultrasound should be considered. The \\ntransvaginal ultrasound must be performed by someone experienced in \\ntransvaginal ultrasound, as positioning is extremely important. Ultrasound \\nis very sensitive in detecting placenta previa but has limited sensitivity in \\ndiagnosing placental abruption.\\nEmergency Department Care and Disposition\\n1. Hemodynamic instability is managed with IV normal saline or packed \\nred blood cells.\\n2. Obtain emergent obstetric consultation, complete blood count (CBC), \\ntype and cross, baseline coagulation studies, and electrolyte studies on \\nall patients.\\n3. Obtain a DIC profile on patients with suspected placental abruption.\\n61_Cydulka_Ch61.indd   337 25/03/17   12:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 356, 'page_label': '338'}, page_content='338 SECTION 8: Gynecology and Obstetrics\\n4. Give Rh (D) immune globulin 300 μg IM to Rh-negative patients.\\n5. Patients with placental abruption or placenta previa may need emergent \\ncesarean delivery.\\n6. Do not use tocolytics in patients with suspected abruption.\\nPremature Rupture of Membranes\\nPremature rupture of membranes (PROM) is rupture of membranes before \\nthe onset of labor. Clinical presentation includes a rush of fluid or continu-\\nous leakage of fluid from the v agina. Diagnosis is confirmed by finding a \\npool of fluid in the posterior fornix with pH greater than 7.0 and a ferning \\npattern on smear. Sterile speculum examination may be done; however, \\ndigital pelvic examination should be avoided because it increases the \\nrate of infection and decreases the latent period from rupture until \\ndelivery. Tests for chlamydia, gonorrhea, bacterial vaginosis, and group B \\nStreptococcus should be performed. Management of PROM depends on \\ngestational age and maturity of the fetus, condition of the fetus, concern for \\ninfection, and presence of other complicating factors. Antibiotics and ste-\\nroids may be appropriate. An obstetrics consultation should be obtained to \\nassist with treatment and admission decisions.\\n■ ■PRETERM LABOR\\nClinical Features and Diagnosis\\nPreterm labor is defined as labor before 37 weeks’ gestation. Clinical fea-\\ntures include regular uterine contractions with effacement and dilatation of \\nthe cervix. Cervical fluid should be examined for possible PROM. Only after \\npremature rupture of membranes and placenta previa have been excluded \\nshould digital examination be performed; use sterile gloves. Obtain tests for \\nchlamydia, gonorrhea, bacterial vaginosis, and group B Streptococcus. Per-\\nform an ultrasound for fetal age, weight, anatomy, and amniotic fluid level if \\npossible but obstetric consultation should not be delayed awaiting results.\\nEmergency Department Care and Disposition\\n1. Monitor mother and fetus.\\n2. Consult an obstetrician for admission and decision making regarding \\ntocolytics.\\n3. If tocolytics are initiated, administer glucocorticoids to the mother to \\nhasten fetal lung maturity if the gestational age is less than 34 weeks. \\nDexamethasone 6 mg IM is commonly used.\\n4. Do not use tocolytics if placental abruption is suspected.\\n5. Gestational age younger than 34 weeks is associated with poorer out-\\ncomes; if possible, the patient should be transferred to a tertiary care \\ncenter with a high-risk intensive care unit.\\n■ ■POSTPARTUM HEMORRHAGE\\nThe differential diagnosis of hemorrhage in the first postpartum day includes \\nuterine atony, uterine rupture, laceration of the lower genital tract, retained \\nplacental tissue, uterine inversion, and coagulopathy. After the first 24 hours, \\nretained products of conception, uterine polyps, or coagulopathy such as von \\n61_Cydulka_Ch61.indd   338 25/03/17   12:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 357, 'page_label': '339'}, page_content='CHAPTER 61: Emergencies After 20 Weeks 339 \\nWillebrand disease are more likely causes. An enlarged and “doughy” uterus \\nsuggests uterine atony; a vaginal mass suggests an inverted uterus. Bleeding \\ndespite good uterine tone and size may indicate retained products of concep-\\ntion or uterine rupture. The vagina and cervix must be inspected for lacera-\\ntions. The first priority of ED management is stabilization of the patient with \\ncrystalloid IV fluids and/or packed red blood cells, if needed. CBC, clotting \\nstudies, and type and cross must be obtained. Uterine atony is treated with \\nuterine massage and oxytocin 20 units in one liter of normal saline IV at \\n200 mL/h. Minor lacerations may be repaired in the ED. Extensive lacera-\\ntions, retained products of conception, uterine inversion, or uterine rupture \\nrequire emergency operative treatment by the obstetrician.\\n■ ■POSTPARTUM ENDOMETRITIS\\nPostpartum endometritis is a polymicrobial infection with symptoms that \\nusually begin several days after delivery. Clinical features include fever, \\nlower abdominal pain, and foul-smelling lochia. Physical examination \\nreveals uterine or cervical motion tenderness and discharge. CBC, urinaly-\\nsis, and cervical cultures should be obtained. Admission for antibiotic treat-\\nment is indicated for patients who appear ill, have had a cesarean section, \\nor who have underlying comorbidities. Antibiotic regimens for outpatients \\nmay include clindamycin or doxycycline. Do not use doxycycline in \\npatients who are breastfeeding. Inpatient regimens include clindamycin \\n450 to 900  mg IV every 8 hours plus gentamicin  1.5  mg/kg IV every 8 \\nhours or cefoxitin 1 to 2 g IV every 6 hours.\\n■ ■MASTITIS\\nMastitis is cellulitis of the periglandular breast tissue. Clinical features include \\nswelling, redness, and tender engorgement of the involved portion of the \\nbreast, with or without fever and chills. Milk stasis presents similarly, except it \\nlacks erythema, fever, or chills. For cellulitis, initiate treatment with dicloxacil-\\nlin 500 mg orally four times daily or cephalexin 500 mg orally four times daily. \\nClindamycin 300 mg PO every 6 hours may be used in patients with penicillin \\nallergy or if concerns about MRSA exist. Oral analgesics may be needed. \\nPatients should continue nursing on the affected breast. However, in cases of \\npurulent discharge, the mother should pump and discard the milk rather than \\nnurse. Differentiate mastitis from breast abscess using bedside ultrasound.\\n■ ■AMNIOTIC FLUID EMBOLISM\\nAmniotic fluid embolism is a sudden, catastrophic illness with mortality \\nrates of 60% to 80%. Clinical features include sudden cardiovascular col-\\nlapse with hypoxemia, pulmonary edema, altered mental status, seizures, \\nand DIC along with sudden onset of fetal distress. Death can occur rapidly. \\nTreatment is supportive; treat hypoxia, hypotension, and hypoperfusion.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 100, “Maternal Emergencies After 20 Weeks of Preg-\\nnancy and in the Postpartum Period,” by Janet Simmons Young.\\n61_Cydulka_Ch61.indd   339 25/03/17   12:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 358, 'page_label': '340'}, page_content='340\\nEmergency Delivery\\nStacie Zelman\\nPrecipitous delivery in an emergency setting can be a source of significant \\nanxiety for an emergency physician. While emergency delivery is a rela-\\ntively uncommon occurrence, careful preparation and education can help in \\navoiding serious complications, and result in a positive outcome for the \\nmother and child.\\n■ ■CLINICAL FEATURES\\nAny pregnant woman who is beyond 20 weeks’ gestation and appears to \\nbe in active labor should be evaluated expeditiously. Initial evaluation \\nshould include complete maternal vital signs and fetal heart monitoring. \\nA persistently slow or fast fetal heart rate (less than 110 beats/min or \\ngreater than 160 beats/min) is an indicator of fetal distress. History \\nincludes frequency and time of onset of contractions, leakage of fluid, \\nvaginal bleeding, estimated gestational age, and prenatal care. A focused \\nphysical examination should include an abdominal examination evaluat-\\ning fundal height, abdominal or uterine tenderness, and fetal position. A \\nbimanual or sterile speculum examination should be performed if no \\ncontraindications exist such as active vaginal bleeding. After the exam, \\nplace the patient in the left lateral decubitus position to prevent maternal \\nhypotension.\\nFalse labor is characterized by irregular, brief contractions usually \\nconfined to the lower abdomen. These typically painless contractions, \\ncommonly called Braxton–Hicks contractions, are irregular in intensity \\nand duration. True labor is characterized by painful, regular contractions \\nof steadily increasing intensity and duration leading to progressive cer -\\nvical dilatation. True labor typically begins in the fundal region and \\nupper abdomen and radiates into the pelvis and lower back.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nPatients without vaginal bleeding should be assessed with sterile specu-\\nlum and bimanual examinations to evaluate the progression of labor, \\ncervical dilation, and rupture of membranes. Patients with active vagi-\\nnal bleeding require initial evaluation with ultrasound to rule out pla-\\ncenta previa. Spontaneous rupture of membranes typically occurs with \\na gush of clear or blood-tinged fluid. If ruptured membranes are sus-\\npected, a sterile speculum examination should be performed and amni-\\notic fluid obtained from the fornix or vaginal vault. Amniotic fluid is \\nalkaline, will stain Nitrazine paper dark blue and will “fern” if dried on \\na slide. The presence of meconium in amniotic fluid should be noted. \\nAvoid digital examinations in the preterm patient in whom prolongation \\nof gestation is desired as even one examination increases the chance of \\ninfection.\\n62\\nCh A p TER\\n62_Cydulka_Ch62.indd   340 16/03/17   5:32 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 359, 'page_label': '341'}, page_content='CHAPTER 62: Emergency Delivery 341 \\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nIf the cervix is dilated in a woman experiencing active contractions, further \\ntransport, even short distances, may be hazardous. Preparations should be \\nmade for emergency delivery. Assess fetal position by physical examina-\\ntion, and confirm by ultrasound, if possible. Place the patient in the dorsal \\nlithotomy position. Notify an obstetrician, if one is available.\\nEmergency Delivery Procedure (Fig. 62-1)\\n1. Control of the delivery of the neonate is the major challenge.\\na. As the infant’s head emerges from the introitus, support the perineum \\nwith a sterile towel placed along the inferior portion of the perineum \\nwith one hand while supporting the fetal head with the other.\\nb. Exert mild counter-pressure to prevent the rapid expulsion of the fetal \\nhead, which may lead to third- or fourth-degree perineal tears.\\nc. As the infant’s head presents, use the inferior hand to control the fetal \\nchin while keeping the superior hand on the crown of the head, sup-\\nporting the delivery.\\nd. Ask the mother to breathe through contractions rather than bearing \\ndown and attempting to push the baby out rapidly.\\n2. After delivery of the head, palpate the neck for the presence of a nuchal \\ncord (may be present in up to 35% of deliveries).\\na. If the cord is loose, reduce it over the infant’s head; delivery may then \\nproceed as usual.\\nb. If the cord is tightly wound, clamp it in the most accessible area using \\ntwo clamps in close proximity and cut to allow delivery of the infant.\\n3. After delivery of the head, the head will restitute or turn to one side or \\nthe other.\\na. As the head rotates, hands are placed on either side, providing gentle \\ndownward traction to deliver the anterior shoulder.\\nb. Guide the shoulders upward, delivering the posterior shoulder and \\nallowing the remainder of the infant to be delivered.\\n4. Place the posterior (left) hand underneath the infant’s axilla before deliv-\\nering the rest of the body. Use the anterior hand to grasp the infant’s \\nankles and ensure a firm grip.\\n5. Wrap the infant in a towel and stimulate him or her while drying.\\n6. Double clamp the umbilical cord and cut with sterile scissors.\\n7. Place the infant in a warm incubator, where postnatal care may be pro -\\nvided and calculate Apgar scores at 1 and 5  minutes after delivery. \\nScoring includes general color , tone, heart rate, respiratory effort, and \\nreflexes.\\n8. If an episiotomy is necessary (e.g., with a breech presentation), it may \\nbe performed as follows:\\na. Inject a solution of 5 to 10  mL of 1% lidocaine with a small-gauge \\nneedle into the posterior fourchette and perineum.\\nb. While protecting the infant’s head, make a 2- to 3-cm cut with scis -\\nsors to extend the vaginal opening at the midline or 45 degrees from \\nmidline.\\nc. Support the incision with manual pressure from below, taking care \\nnot to allow the incision to extend into the rectum (less likely with the \\nmediolateral incision).\\n62_Cydulka_Ch62.indd   341 16/03/17   5:32 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 360, 'page_label': '342'}, page_content='342 SECTION 8: Gynecology and Obstetrics\\nFIGURE 62-1.  Movements of normal delivery. Mechanism of labor and delivery \\nfor vertex presentations. A.  Engagement, flexion, and descent. B.  Internal rota-\\ntion. C. Extension and delivery of the head. After delivery of the head, the neck is \\nchecked for encirclement by the umbilical cord. D.  External rotation, bringing the \\nthorax into the anteroposterior diameter of the pelvis. E. Delivery of the anterior \\nshoulder. F.  Delivery of the posterior shoulder. Note that after delivery, the head \\nis supported and used to gently guide delivery of the shoulder. Traction should be \\nminimized.\\nA B Occiput anterior\\nC D\\nE F\\n■ ■CORD pROLApSE\\nIf bimanual examination shows a palpable, pulsating cord:\\na. Do not remove the examining hand; use the hand to elevate the present-\\ning fetal part to reduce compression of the cord.\\nb. Immediate obstetric assistance is necessary, as a cesarean section is \\nindicated.\\nc. Keep the examining hand in the vagina while the patient is transported \\nand prepped for sur gery to prevent further compression of the cord by \\nthe fetal head. Do not attempt to reduce cord.\\n62_Cydulka_Ch62.indd   342 16/03/17   5:32 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 361, 'page_label': '343'}, page_content='CHAPTER 62: Emergency Delivery 343 \\n■ ■ShOULDER DYSTOCIA\\nInitially recognized after the delivery of the fetal head, when routine down-\\nward traction is insufficient to deliver the anterior shoulder. The anterior \\nshoulder is trapped behind the pubic symphysis.\\na. After delivery of the infant’ s head, the head retracts tightly against the \\nperineum (“Turtle sign”).\\nb. Upon recognizing shoulder dystocia, suction the infant’s nose and mouth \\nand call for assistance to position the mother in the e xtreme lithotomy \\nposition, with legs sharply flexed up to the abdomen (McRoberts \\nmaneuver) and held by the mother or an assistant.\\nc. Next, an assistant should apply downward suprapubic pressure to disim-\\npact the anterior shoulder from the pubic symphysis.\\nd. Do not apply fundal pressure because this will further force the shoulder \\nagainst the pelvic rim.\\ne. A Woods Corkscrewmaneuver may be attempted—place fingertips \\nbehind the anterior shoulder and in back of the posterior shoulder of the \\ninfant, and rotate the shoulder girdle 180°.\\n■ ■BREECh pRESENTATION\\nThe primary concern with breech presentation is head entrapment.\\na. Breech presentations may be classified as frank, complete, incomplete, \\nor footling.\\nb. In any breech delivery, immediate obstetric consultation should be requested.\\nc. Frank and complete breech presentations:\\n●■■Serve as a dilating wedge nearly as well as the fetal head, and delivery \\nmay proceed in an uncomplicated fashion.\\n●■■Main point is to allow the delivery to progress spontaneously. This lets \\nthe presenting portion of the fetus to dilate the cervix maximally.\\nd. Consult obstetrical texts for a detailed description of maneuvers for \\nbreech delivery.\\ne. Footling and incomplete breech positions are not considered safe for \\nvaginal delivery because of the possibility of cord prolapse or incom-\\nplete dilatation of the cervix.\\n■ ■pOSTpARTUM CARE\\nThe placenta should be allowed to separate spontaneously and assisted with \\ngentle traction. Aggressive traction on the cord risks uterine inversion, tear-\\ning of the cord, or disruption of the placenta, which can result in severe \\nvaginal bleeding. After removal of the placenta, gently massage the uterus \\nto promote contraction. Infuse oxytocin 10 to 40  U/1000  mL NS at a mod-\\nerate rate to maintain uterine contraction. Oxytocin may also be given as \\n10  U  IM. Episiotomy or laceration repair may be delayed until an experi-\\nenced obstetrician is able to close the laceration and inspect the patient for \\nfourth-degree (rectovaginal) tears.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, \\n8th ed., see Chapter 101, “Emergency Delivery,” by Sarah Elisabeth Frasure.\\n62_Cydulka_Ch62.indd   343 16/03/17   5:32 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 362, 'page_label': '344'}, page_content='344\\nVulvovaginitis\\nRobert R. Cooney\\nCauses of vulvovaginitis include infections, irritants, allergies, reaction to \\nforeign bodies, and atrophy. The normal vaginal flora help maintain an \\nacidic pH between 3.8 and 4.5, which decreases pathogen growth.\\n■ ■BACTERIAL VAGINOSIS\\nBacterial vaginosis (BV) is the most common cause of malodorous vaginal \\ndischarge. However, up to 50% of infected women are asymptomatic. BV \\noccurs when vaginal lactobacilli are replaced by anaerobes such as Gard-\\nnerella vaginalis, Mycoplasma, and Ureaplasma.\\nClinical Features\\nThe most common symptom is malodorous or “fishy smelling” vaginal \\ndischarge. Vaginal irritation, excoriation, fissures, and edema are uncom-\\nmon. A combination of history, vaginal examination, and point-of-care \\ntesting confirm the diagnosis.\\nDiagnosis and Differential\\nThe diagnosis can be made if three of the following four criteria are pres-\\nent: (1) vaginal discharge, (2) vaginal pH greater than 4.5, (3) positive \\namine test (fishy odor when 10% KOH is added to the discharge), and (4) \\nclue cells seen on saline wet preparation.\\nEmergency Department Care and Disposition\\nTreat with metronidazole 500 mg PO twice daily for 7 days. Clindamycin \\n2% intravaginal cream at night for 7 days or metronidazole 0.75% intra-\\nvaginal gel daily for 5 days are alternatives. Treatment is not recommended \\nfor male partners or asymptomatic women. To avoid a disulfram-like reac-\\ntion, patients treated with metronidazole should refrain from alcohol use \\nduring treatment and for 24 hours after ending treatment.\\nAll symptomatic pregnant women should be treated, and women at \\nhigh risk of preterm labor should be considered for treatment. Preferred \\ntreatment in pregnancy is metronidazole 250 mg PO twice daily for  \\n7 days.\\n■ ■CANDIDA VAGINITIS\\nCandida albicans is the second most common cause of infectious vaginitis. \\nConditions that promote Candida vaginitis include systemic antibiotics, \\ndiabetes, pregnancy, hormone replacement therapy, and birth control pills. \\nIncidence is decreased in postmenopausal patients. Candidiasis is not \\ntypically considered a sexually transmitted disease, though it can be trans-\\nmitted sexually.\\n63\\nCh A p TER\\n63_Cydulka_Ch63.indd   344 21/04/17   3:51 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 363, 'page_label': '345'}, page_content='CHAPTER 63: Vulvovaginitis 345 \\nClinical Features\\nThe most common symptom of Candida vaginitis is pruritus. Other symp -\\ntoms include vaginal discharge, external dysuria, and dyspareunia. Exam \\nmay reveal vulvar and vaginal edema, erythema, and a thick “cottage \\ncheese” discharge.\\nDiagnosis and Differential\\nDiagnosis is confirmed if vaginal pH is 4 to 4.5 and budding yeast or pseu-\\ndohyphae are present on microscopy. Ten percent KOH dissolves vaginal \\nepithelial cells, leaving yeast buds and pseudohyphae intact and easier to \\nsee. Use of KOH increases the sensitivity to 80%, with a specificity \\napproaching 100%.\\nEmergency Department Care and Disposition\\nSingle-dose treatment with fluconazole, 150 mg PO, is as effective as \\ntopical treatments. Almost all topically applied azoles are equally effica-\\ncious and available over-the-counter. Treatment options include clotrima-\\nzole, butoconazole, miconazole, terconazole, and tioconazole in several \\nstrengths and formulations. Pregnant patients should avoid oral fluconazole \\nand instead use intravaginal agents for 7 days. For nonpregnant patients \\nwith complicated candidiasis, fluconazole 150 mg PO is given on days 1 \\nand 3.\\n■ ■TRICHOMONAS VAGINITIS\\nTrichomoniasis is a common sexually transmitted disease caused by the \\nprotozoan Trichomonas vaginalis.\\nClinical Features\\nPresenting symptoms include a frothy, malodorous vaginal discharge, pru-\\nritus, and vaginal irritation. However, up to 50% of women harboring the \\norganism are asymptomatic.\\nDiagnosis and Differential\\nSaline wet prep shows motile, pear-shaped, flagellated trichomonads. \\nMicroscopy should be performed immediately after obtaining the sample \\nor the organisms may lose motility. The sensitivity of microscopy is 60% \\nto 70%. The sensitivity of culture is 95% but results are not readily avail-\\nable in the ED. New point-of-care PCR-based tests are now available  \\nas well.\\nEmergency Department Care and Disposition\\nThe treatment of choice for trichomoniasis is metronidazole 2 g single oral \\ndose or tinidazole 2 g single oral dose. Metronidazole 500 mg twice daily \\nfor 7 days is recommended for patients who fail single-dose therapy. Met-\\nronidazole gel is much less efficacious and thus not recommended for use. \\nSexual partners should be treated to avoid retransmission of disease. \\nPatients should also be counseled to abstain from sexual activity until treat-\\nment course is completed and they are asymptomatic.\\n63_Cydulka_Ch63.indd   345 16/03/17   5:36 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 364, 'page_label': '346'}, page_content='346 SECTION 8: Gynecology and Obstetrics\\n■ ■CONTACT VULVOVAGINITIS\\nCommon causes of contact vulvovaginitis include douches, soaps, bubble \\nbaths, deodorants, perfumes, feminine hygiene products, topical antibiot-\\nics, and tight undergarments. Patients complain of perineal burning, itch-\\ning, and local swelling. Examination findings may include redness, edema, \\nand ulceration. Vaginal pH changes may promote overgrowth of Candida, \\nobscuring the primary problem.\\nTry to identify the precipitating agent and rule out infectious causes. \\nMost cases resolve spontaneously when the precipitant is withdrawn. For \\nmore severe reactions, cool sitz baths, compresses with Burow’s solution, \\nand topical corticosteroids may help. Oral antihistamines are drying but \\nmay be helpful if a true allergy is identified. Concomitant Candida infec-\\ntions should be treated as previously discussed.\\n■ ■VAGINAL FOREIGN BODIES\\nPatients with a vaginal foreign body present with chronic, foul-smelling or \\nbloody discharge. In younger girls, common items include toilet paper, \\ntoys, and small household objects. Items seen in adults include a forgotten \\nor irretrievable tampon, packets of illegal drugs, or items used for sexual \\nstimulation. Removal of the object is usually curative.\\n■ ■ATROphIC VAGINITIS\\nAfter menopause, the lack of estrogen stimulation leads to vaginal muco-\\nsal atrophy with a subsequent loss of resistance to minor trauma or infec-\\ntion. Bleeding can occur. The vaginal pH also increases, and subsequent \\nchanges in the vaginal flora can predispose to bacterial infection with \\npurulent discharge. Treatment consists primarily of topical estrogen \\ncreams. Estrogen creams should not be prescribed in the emergency \\ndepartment for women with prior reproductive tract cancer or postmeno-\\npausal bleeding.\\n■ ■BARThOLIN GLAND CYST AND ABSCESS\\nBartholin glands are located in the labia minora at the 4 and 8 o’clock posi-\\ntion. Obstruction of the gland may result in cyst or abscess formation. \\nPatients present with pain and swelling that develops over several days. \\nExam will reveal pain, induration, and fluctuance. Patients without an \\nabscess may be treated with broad-spectrum antibiotics, analgesics, and sitz \\nbaths. In addition, patients with an abscess require an incision and drainage \\nwith the placement of a Word catheter and referral for definitive surgical \\nmanagement.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 102, “Vulvovaginitis,” by Ciara J. Barclay-Buchanan \\nand Melissa A. Barton.\\n63_Cydulka_Ch63.indd   346 16/03/17   5:36 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 365, 'page_label': '347'}, page_content='347\\nPelvic Inflammatory Disease\\nAbigail D. Hankin\\nPelvic inflammatory disease (PID) comprises a spectrum of infections of \\nthe female upper reproductive tract, including endometritis, salpingitis, \\ntubo-ovarian abscess, and pelvic peritonitis. Neisseria gonorrhoeae and \\nChlamydiatrachomatis are frequently isolated pathogens; however, many \\nother microorganisms have been associated with PID, including vaginal \\nflora, gram-negative rods, streptococci, and mycoplasmas. Risk factors for \\nPID include age (teenagers are at greatest risk), multiple sexual partners, a \\nnew sexual partner within the past 30 days, presence of other sexually \\ntransmitted diseases, and intrauterine device insertion within the prior 3 \\nweeks. PID occurs less commonly in pregnancy, but is associated with \\nincreased maternal morbidity and preterm labor. Complications of PID \\ninclude significantly increased risk for ectopic pregnancy, infertility, and \\nchronic pain, even after only a single episode of PID.\\n■ ■CLINICAL FEATURES\\nClinical diagnosis of PID is complicated due to the wide variation in symp-\\ntoms and clinical findings. Common presenting complaints include lower \\nabdominal pain (seen in >90%), vaginal discharge (75%), vaginal bleed-\\ning, urinary discomfort, fever, nausea, and vomiting. Many women with \\nPID may have nonspecific or very subtle symptoms. Physical exam may \\nshow lower abdominal tenderness, cervical motion tenderness, or uterine/\\nadnexal tenderness. Mucopurulent cervicitis is a common finding, and its \\nabsence should prompt consideration of alternative causes of the patient’s \\nsymptoms.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nGiven the clinical variability in the diagnosis of PID and the potential \\nsequelae of delayed treatment, the United States Centers for Disease Con-\\ntrol and Prevention recommends empiric treatment for PID based on the \\nminimal criteria listed in Table 64-1. No single laboratory test is highly \\nsensitive or specific for PID. Laboratory evaluation should include a preg-\\nnancy test, wet preparation of vaginal secretions, and DNA probe or culture \\nfor N. gonorroheae and Chlamydia trachomatis. Treatment, when indi-\\ncated, should not be delayed pending test results.\\nThe differential diagnosis includes gastroenteritis, diverticulitis, ectopic \\npregnancy, spontaneous or septic abortion, ovarian cyst, pyelonephritis, and \\nrenal colic.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\n1. Treatment guidelines from the Centers for Disease Control and Preven-\\ntion are outlined in Tables 64-2 and 64-3. Patients with mild to moderate \\nsymptoms may be treated with oral therapy as outpatients with appropri-\\nate oral antibiotics and adequate analgesia .\\n64\\nC HAPTER\\n64_Cydulka_Ch64.indd   347 16/03/17   5:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 366, 'page_label': '348'}, page_content='348 SECTION 8: Gynecology and Obstetrics\\n2. Suggested criteria for admission include toxic appearance, inability to \\ntolerate oral medication, nausea and vomiting, inability to exclude alter-\\nnative diagnoses or surgical emergency, failure to respond to outpatient \\nmanagement, pregnancy, immunosuppression, concern for noncompli-\\nance, and tubo-ovarian abscess.\\n3. Outpatients should be reevaluated in the emergenc y department or by \\ntheir gynecologist within 72 hours of emergency department discharge.\\n4. Provide preventative counseling and test or refer for HIV testing. The \\npatient and their sexual partner(s) must complete the full treatment \\ncourse before resuming sexual activity to prevent reinfection.\\nTable 64-1 Diagnostic Criteria for Pelvic Inflammatory Disease\\nGroup 1: Minimum criteria. empiric treatment if no other cause to explain findings.\\nUterine or adnexal tenderness\\nCervical motion tenderness\\nGroup 2: additional criteria improving diagnostic specificity.\\nOral temperature >101°F (38.3°C)\\nAbnormal cervical or vaginal mucopurulent secretions\\nElevated erythrocyte sedimentation rate\\nElevated C-reactive protein level\\nLaboratory evidence of cervical infection with Neisseria gonorrhoeae or Chlamydia \\ntrachomatis (i.e., culture or DNA probe techniques)\\nGroup 3: Specific criteria for PID based on procedures that may be appropriate \\nfor some patients.\\nLaparoscopic confirmation\\nTransvaginal US (or MRI) showing thickened, fluid-filled tubes with or without free pelvic \\nfluid or tubo-ovarian complex\\nEndometrial biopsy results showing endometritis\\nSource: Reproduced with permission from Centers for Disease Control and Prevention; Workowski \\nKA, Berman SM. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recommend Rep. \\n2010;59(RR-12):12.\\nTable 64-2 Parenteral Treatment Regimens for Pelvic Inflammatory Disease\\nCefotetan, 2 g IV every 12 h, or cefoxitin, 2 g IV every 6 h\\nplus\\nDoxycycline, 100 mg PO or IV every 12 h *\\nor\\nClindamycin, 900 mg IV every 8 h\\nplus\\nGentamicin, 2 mg/kg IV or IM loading dose, followed by gentamicin, 1.5 mg/kg every 8 h \\nmaintenance dose†\\nalternative Parenteral Regimen (limited data on effectiveness)\\nAmpicillin/sulbactam, 3 g IV every 6 h\\nplus\\nDoxycycline, 100 mg PO or IV every 12 h*\\n*PO doxycycline has the same bioavailability as IV doxycycline and avoids painful infusion.\\n†Gentamicin dosing may be 3 to 5 mg/kg every 24 h.\\nSource: Reproduced with permission from Centers for Disease Control and Prevention; Workowski \\nKA, Berman SM. Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. \\n2010;59(RR-12):12.\\n64_Cydulka_Ch64.indd   348 16/03/17   5:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 367, 'page_label': '349'}, page_content='CHAPTER 64: Pelvic Inflammatory Disease 349 \\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th edition, see Chapter 103, “Pelvic Inflamatory Disease,” by Suzanne M. \\nShepherd, Brian Weiss, and William H. Shoff.\\nTable 64-3 Oral and Outpatient Treatment Regimens for Pelvic Inflammatory \\nDisease\\nCeftriaxone, 250 mg IM once, or cefoxitin, 2 g IM once, and probenecid, 1 g PO once \\nadministered concurrently\\nor\\nOther parenteral third-generation cephalosporin (e.g., ceftizoxime or cefotaxime)\\nplus\\nDoxycycline, 100 mg PO twice a day for 14 days\\nwith or without\\nMetronidazole, 500 mg PO twice a day for 14 days\\nIf parenteral cephalosporin therapy is not feasible and community prevalence  \\nof fluoroquinolone resistance is low:\\nLevofloxacin, 500 mg PO, or ofloxacin, 400 mg twice daily every day for 14 days\\nwith or without\\nMetronidazole, 500 mg PO twice a day for 14 days\\nNote: Other parenteral third-generation cephalosporins can be substituted for ceftriaxone or cefoxitin. \\nSince the Centers for Disease Control and Prevention guidelines were published in 2006, clinically \\nsignificant resistance to the fluoroquinolones (6.7% of infections in heterosexual men, an 11-fold \\nincrease from 0.6% in 2001) has emerged in the United States. Fluoroquinolone antibiotics are no longer \\nrecommended to treat gonorrhea in the United States. Fluoroquinolones may be an alternative treatment \\noption for disseminated gonococcal infection if antimicrobial susceptibility can be documented.\\n64_Cydulka_Ch64.indd   349 16/03/17   5:44 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 368, 'page_label': '350'}, page_content='350\\nComplications of Gynecologic \\nProcedures\\nRobert R. Cooney\\nThe most common reasons for emergency department visits during the \\npostoperative period after gynecologic procedures are pain, fever, and \\nvaginal bleeding. A focused but thorough evaluation should be performed, \\nincluding sterile speculum and bimanual examination. Consultation with \\nthe gynecologist who performed the procedure is indicated.\\n■ ■COMPLICATIONS OF ENDOSCOPIC PROCEDURES\\nLaparoscopy\\nThe major complications associated with laparoscopy are thermal injury \\nof the bowel, viscus perforation, hemorrhage, vascular injury, ureteral or \\nbladder injuries, incisional hernia, and wound dehiscence. Bowel injury \\nshould be suspected if pain is greater than expected after laparoscopy. \\nThermal injury is easily missed due to delayed development of symp-\\ntoms for several days to weeks postoperatively. Patients with the above \\ntypically present with bilateral lower abdominal pain, fever, elevated \\nwhite blood cell count, and peritonitis. X-rays can show an ileus or free \\nair under the diaphragm. Early gynecology consultation should be \\nobtained.\\nHysteroscopy\\nComplications of hysteroscopy are rare but include uterine perforation, \\npostoperative bleeding, fluid overload from absorption of distention \\nmedia, gas embolism, and infection. Bleeding may originate from the \\nuterus after resection or the cervix due to lacerations or tears. Manage-\\nment includes packing of the vaginal vault and consultation with a \\ngynecologist.\\n■ ■OTHER COMPLICATIONS OF GYNECOLOGIC \\nPROCEDURES\\nVaginal Cuff Cellulitis\\nCuff cellulitis, a common early complication after hysterectomy, is an \\ninfection of the contiguous retroperitoneal space immediately above the \\nvaginal apex and the surrounding soft tissue. Patients typically present with \\nfever, abdominal pain, pelvic pain, back pain, and purulent vaginal dis-\\ncharge. Cuff tenderness and induration plus purulent discharge are promi-\\nnent during the gynecologic exam. Abscesses are rare, but will present as a \\nfluctuant mass near the cuff approximately 10 to 14 days postoperatively. \\nTreat with broad-spectrum antibiotics. Recommended regimens include \\nimipenem-cilastatin, gentamicin and clindamycin, or ciprofloxacin plus \\nmetronidazole. Admit for continuation of antibiotics and consideration of \\ndrainage by interventional radiology.\\n65\\nC HAPTER\\n65_Cydulka_Ch65.indd   350 21/04/17   3:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 369, 'page_label': '351'}, page_content='CHAPTER 65: Complications of Gynecologic Procedures 351 \\nPostoperative Wound Infection\\nPatients with wound infections generally present with fever and increasing \\npain at the surgical site. Onset is typically within 2 weeks of surgery. Exam \\nwill reveal erythema, tenderness, induration, and possibly incisional drain-\\nage. Treatment includes drainage and antibiotic treatment directed at \\nmethicillin-resistant Staphylococcus aureus and streptococci. Patients with \\ninvasive infections should be admitted.\\nUreteral Injury\\nUreteral injury can occur during abdominal hysterectomy, resulting from \\ncrushing, transecting, or ligating trauma. These patients present soon after \\nsurgery with flank pain. They may also complain of fever, costovertebral \\nangle tenderness, and hematuria. The workup includes a urinalysis and a \\nCT scan with IV contrast or an intravenous pyelogram to evaluate for \\nobstruction. These patients should be admitted for ureteral catheterization \\nand possible repair, although delayed repair after percutaneous nephros-\\ntomy is also acceptable.\\nVesicovaginal Fistula\\nVesicovaginal fistulas can occur after abdominal hysterectomy. Patients \\ntypically present 10 to 14 days following surgery with a watery vaginal \\ndischarge. Placing a cotton tampon in the vagina and instilling methylene \\nblue through a urinary catheter can confirm the diagnosis. The tampon \\nshould stain within 20 minutes. Management includes placement of a Foley \\ncatheter and prompt gynecologic consultation.\\nPostconization Bleeding\\nThe most common complication associated with loop electrocautery, laser \\nablation, and cold-knife conization of the cervix is bleeding, which can be \\nrapid and excessive. Delayed hemorrhage can occur 1 to 2 weeks postop-\\neratively. Direct visualization of the bleeding site is required. Applying \\nMonsel’s solution, direct pressure for 5 minutes with a large cotton swab, \\nor cauterization with silver nitrate is a reasonable first step. If unsuccessful, \\nthe bleeding site may be better visualized and treated in the OR.\\nSeptic Pelvic Thrombophlebitis\\nSeptic pelvic thrombophlebitis is a rare complication that may follow \\ncesarean delivery or hysterectomy. The presenting complaint is typically \\nabdominal pain and fever. CT and MRI aid in the diagnosis but do not \\nexclude the disease if negative. Patients are admitted for anticoagulation \\nand IV antibiotics.\\nInduced Abortion\\nComplications associated with induced abortion may be characterized by \\ntime of occurence. These include uterine perforation, cervical lacerations, \\nretained products of conception, and postabortal endometritis (Table 65-1). \\nPatients with retained products of conception usually present with exces-\\nsive bleeding and abdominal pain. Pelvic examination reveals an enlarged \\nand tender uterus with an open cervical os. A pelvic ultrasound should be \\n65_Cydulka_Ch65.indd   351 16/03/17   5:48 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 370, 'page_label': '352'}, page_content='352 SECTION 8: Gynecology and Obstetrics\\ndone to confirm the diagnosis. Treatment is dilatation and curettage or \\nmedical management with misoprostol. Endometritis can occur with or \\nwithout retained products of conception and is treated with antibiotics. \\nWomen who are Rh negative require Rh 0 immunoglobulin, 300 μg IM, \\nafter spontaneous or induced abortion.\\nAssisted Reproductive Technology\\nComplications related to ultrasound-guided aspiration of oocytes include \\novarian hyperstimulation syndrome, pelvic infection, intraperitoneal bleed-\\ning, and adnexal torsion. Ovarian hyperstimulation syndrome can be a life-\\nthreatening complication of assisted reproduction. Mild cases present with \\nabdominal distention, ovarian enlargement, and weight gain. In severe \\ncases, patients have rapid weight gain, tense ascites from third spacing of \\nfluid into the abdomen, pleural effusions, hemodynamic instability, oliguria \\nor electrolyte abnormalities. Renal impairment and increased coagulability \\nmay also be noted. Avoid bimanual pelvic exam to prevent rupturing the \\novaries. Workup includes CBC, electrolytes, liver enzymes, coagulation \\nstudies, and type and crossmatch. Initiate IV volume replacement and con-\\nsult with gynecology for admission.\\nPostembolization Syndrome\\nPostembolization syndrome consists of postprocedure pelvic pain, fever, \\nand leukocytosis lasting up to 7 days caused by myometrial and fibroid \\nischemia and necrosis after uterine fibroid embolization. Exam may reveal \\nvaginal discharge of fibroid expulsion. Evaluate patients for other causes of \\nfever and provide pain control. Patients with inadequate pain control or \\nthose in whom an infection is present may require admission.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 105, “Complications of Gynecologic Procedures,” by \\nNikki Waller.\\nTABLe 65-1 Complications Associated with Induced Abortion\\nTiming Complication Possible Etiologies\\nImmediate complications: \\nwithin 24 h postprocedure\\nBleeding, pain Uterine perforation, cervical \\nlacerations\\nDelayed complications: \\nbetween 24 h and 4 weeks \\npostprocedure\\nBleeding Retained products of \\nconception, postabortive \\nendometritis\\nLate complications: >4 \\nweeks postprocedure\\nAmenorrhea, psychological \\nproblems, Rh isoimmunization\\n—\\n65_Cydulka_Ch65.indd   352 16/03/17   5:48 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 371, 'page_label': '353'}, page_content='353\\nFever and Serious Bacterial \\nIllness in Children\\nTodd P . Chang\\n■ ■FEVER AND SERIOUS BACTERIAL ILLNESS (SBI)\\nFever is the most common pediatric chief complaint presenting to an emer-\\ngency department (ED) and accounts for 30% of outpatient visits. Infants \\nand children are at relatively high risk for serious bacterial illness (SBI), \\nwhich includes urinary tract infection (UTI), pneumonia, bacteremia or \\nsepsis, and meningitis—in decreasing prevalence. Neonates are at the high-\\nest risk due to their immature immune response, while infants from 1 to 3 \\nmonths of age gradually transition to the lower risk profile of older infants \\nand children. The incidence of UTI is 5% overall in children 2 months to 2 \\nyears, with a prevalence of 3% to 8% in all febrile children visiting an ED. \\nWidespread vaccination has dropped the incidence of occult bacteremia for \\nchildren 3 to 36 months of age to 0.5% to 0.7%, with further decreases \\nexpected with the 13-valent pneumococcal conjugate vaccine. Meningitis \\nrisk decreases from about 1% in the first month of life to <0.1% later in \\ninfancy and childhood.\\nClinical Features\\nIn the neonate or infant <3 months of age, the threshold for concerning \\nfever is 38°C (100.4°F); in infants and children 3 to 36 months old, the \\nthreshold is 39°C (102.2°F). In general, higher temperatures are associated \\nwith a higher incidence of SBI. Immature development may make reliable \\nexamination of younger infants difficult. Persistent crying, inability to con-\\nsole, poor feeding, or temperature instability may be the only findings \\nsuggestive of an SBI. In the neonate, there may not be any findings other \\nthan fever.\\nDiagnosis and Differential\\nInfants <3 months\\nAn ill-appearing infant should be managed aggressively for SBI, with full \\nsepsis evaluation, parenteral antibiotics, and admission, but a well-appearing \\nfebrile infant less than 3 months of age presents a challenge because history \\n66\\nCh APTER\\nPediatrics\\n 9\\nSECTION\\n66_Cydulka_Ch66.indd   353 16/03/17   5:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 372, 'page_label': '354'}, page_content='354 SECTION 9: Pediatrics\\nand physical examination are rarely helpful in diagnosing or excluding  \\nSBI in this age group. Meningismus is rarely present; rales may not be \\nappreciated without strong negative inspiratory forces; and bacteremia \\noccurs even in the well-appearing infant. A history of cough, tachypnea, or \\nhypoxemia (by pulse oximetry), however, should alert the examiner to a \\npossible lower respiratory tract infection and consideration of the diagno-\\nsis of pneumonia.\\nAll febrile infants 0 to 28 days of age should receive full SBI evalua-\\ntions, admission, and empiric antibiotic treatment. Antibiotic coverage in \\nthis age group includes ampicillin 50 mg/kg IV for Listeria monocytogenes \\nand either gentamicin 2.5 mg/kg IV or cefotaxime 50 mg/kg IV for other \\ncommon organisms. Avoid using ceftriaxone in this age group. Sepsis test-\\ning includes complete blood count (CBC), blood culture, urinalysis and \\nurine culture, and lumbar puncture for CSF indices and culture. Obtain a \\nchest radiograph if any respiratory signs described above are present, and \\norder stool studies if the infant has diarrhea.\\nFebrile infants 29 to 90 days old without a focal source may be \\nstratified to low or high risk of SBI using one of three classic criteria: \\nRochester Criteria, Boston Criteria, or Philadelphia Protocol. To meet \\nlow-risk SBI status, the infant must be well-appearing with a normal \\nurinalysis and normal White Blood Cell (WBC) count, between 5,000/\\nmm3 and 15,000/mm 3 for the Rochester and Philadelphia, and 5,000/\\nmm3 and 20,000/mm 3 for Boston. A negative CSF (WBC <  10 per hpf \\nin Boston and WBC <  8 per hpf in Philadelphia) is also required for \\nBoston and Philadelphia, and each criteria set has other parameters to \\ncomplete a low-risk status (Table 66-1). Obtain a chest radiograph for \\ninfants with a suggestion of lower respiratory tract disease. Although \\nthere is evidence to support the use of any of these three criteria, the \\noverall incidence of bacteremia is dropping due to two factors: empiric \\nantibiotic treatment of women testing positive for Group B streptococcus \\nduring the third trimester and the effects from herd immunity from \\nHaemophilus and pneumococcal vaccines.\\nAll ill-appearing infants should receive parenteral antibiotic therapy \\n(Table 66-2) and be admitted to the hospital. Infants older than 28 days at \\nlow risk for SBI may be managed conservatively as inpatients with ceftri-\\naxone 50 mg/kg IM/IV pending cultures; as inpatients without antibiotics; \\nas outpatients with ceftriaxone; or as outpatients without antibiotics. The \\nkey deciding factor should be the physician’s comfort level and the ability \\nfor close follow-up, typically within 12 to 24 hours. If antibiotics are \\nadministered (inpatient or outpatient), obtain CSF and urine and blood \\ncultures prior to administration of antibiotics.\\nWell-appearing febrile infants between the ages of 29 and 90 days \\nwith an identifiable viral source of infection (e.g., respiratory syncytial \\nvirus [RSV] or influenza) should have urinary tract infection (UTI) and \\nbacteremia ruled out before being discharged from the ED. Chest radio-\\ngraphs should be obtained at the discretion of the clinician, but are not \\nindicated for well-appearing infants over 29 days with RSV . Consider \\ndeferring lumbar puncture if a virus is identified as the cause of the \\nsymptoms.\\nSome evidence supports the use of serum biomarkers such as C-reactive \\nprotein and procalcitonin to differentiate SBI from viral illness.\\n66_Cydulka_Ch66.indd   354 16/03/17   5:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 373, 'page_label': '355'}, page_content='CHAPTER 66: Fever and Serious Bacterial Illness in Children 355 \\nTaBle 66-1 Comparison of Low-Risk Rochester Criteria, Philadelphia Protocol, and Boston Criteria for Assessment of Fever in Well-Appearing Neonates \\nand Infants*\\nLow-Risk Criteria for Serious \\nBacterial Infection* Rochester Criteria Philadelphia Protocol Boston Criteria\\nFever T ≥ 38°C (100.4°F) T ≥ 38.2°C (100.8°F) T ≥ 38°C (100.4°F)\\nAge ≤ 60 days 29–56 days 28–89 days\\nPast medical history Term infant ≥ 37 weeks gestation\\nNo perinatal or postnatal antibiotics\\nNo treatment for jaundice\\nNo chronic illnesses or admissions\\nNot hospitalized longer than mother\\nNo immunodeficiency syndrome No immunizations within 48 h\\nNo recent antibiotics\\nPhysical examination Well appearing\\nUnremarkable examination\\nSame Same\\nLaboratory values\\nBlood count WBC ≥ 5000, ≤ 15,000/mm3\\nAbsolute band count ≤ 1500/mm3\\nWBC ≤ 15,000/mm3\\nBand-to-neutrophil ratio ≤ 0.2\\nWBC ≤ 20,000/mm3\\nUrinalysis WBC ≤ 10 per high-power field WBC ≤ 10 per high-power field WBC ≤ 10 per high-power field\\nStool WBC ≤ 5 per high-power field – –\\nLumbar puncture and \\ncerebrospinal fluid findings\\nNone WBC ≤ 8 per high-power field WBC ≤ 10 per high-power field\\nNegative Gram stain\\nChest radiograph None Negative Negative if obtained\\nComments Excluded lumbar puncture, so number of \\nmissed meningitis cases is unknown. UTIs \\nmissed in those with negative urinalysis. The \\nleast sensitive of the low-risk criteria.\\nSensitivity of low-risk criteria for SBI \\n98%; specificity 44%; PPV 14%; NPV \\n99.7%\\n5% of low-risk neonates and infants had SBI  \\n(8 bacteremia, 8 UTI, 10 bacterial \\ngastroenteritis); 96% sensitive to ceftriaxone\\nAbbreviations: NPV, negative predictive value; PPV, positive predictive value; SBI, serious bacterial illness; T, temperature; UTI, urinary tract infection.\\n*Any single deviation from the criteria is interpreted as failure of low-risk criteria.\\n66_Cydulka_Ch66.indd   355 16/03/17   5:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 374, 'page_label': '356'}, page_content='356 SECTION 9: Pediatrics\\nTaBle 66-2 Suggested Guidelines for the Evaluation and Management of Neonates, \\nInfants, and Children with Fever Who Are Well Appearing, have had \\nAll Relevant Immunizations, and have No Clinical Source for Fever\\nAge Group Evaluation Treatment\\nNeonate, 0–28 days* \\nof age, ≥  38°C \\n(100.4°F)\\nSBI incidence of ill \\nappearing: 13%–21%; \\nif not ill appearing: \\n< 5%\\nCBC and blood culture\\nand\\nUrinalysis and urine culture\\nand\\nCSF cell count, Gram stain, and culture\\nChest x-ray is optional, if no \\nrespiratory symptoms\\nStool culture if diarrhea is present\\nAdmit and treat with:\\nParenteral antibiotic \\ntherapy with ampicillin, \\n50 mg/kg, and either \\ncefotaxime, 50 mg/kg,  \\nor gentamicin, 2.5 mg/kg\\nAbbreviations: CSF, cerebrospinal fluid; SBI, serious bacterial illness; UTI, urinary tract infection.\\n*For preterm infants, count age by estimated postconception date and not by actual delivery date for the \\nfirst 90 days of life.\\nInfants 3 to 36 Months\\nPhysical examination findings become more reliable with increasing age, \\nthough meningeal signs remain unreliable up to 2 years old. Viral illnesses \\naccount for most febrile illnesses in this age group. Diagnostic testing \\nshould be guided by clinical findings, including ill appearance; however, \\nUTIs are still prevalent in this age group, even with no focal symptoms \\nbesides fever. Females prior to toilet training, circumcised boys younger \\nthan 6 months of age, and uncircumcised boys under 1 year of age are at \\nrisk for occult UTI. Obtain both a urinalysis and urine culture (by catheter-\\nization or suprapubic tap) if a source for the fever is not otherwise identi-\\nfied. Consider CBC and blood culture for bacteremia/sepsis and CSF \\nstudies for meningitis, although these are much less common.\\nOlder Febrile Children\\nThe risk for bacteremia in children older than 3 years is <0.2%. CBC and \\nblood cultures are not routinely recommended in immunized older children \\nwith fever. Etiologies to consider in older febrile children include viral \\ninfections, streptococcal pharyngitis, pneumonia, and sinusitis. Testing is \\ndirected by clinical presentation.\\nemergency Department Care and Disposition\\nFor the management of pneumonia, see Chapter 71; for the management of \\nUTI, see Chapter 75; and infections of the ears, nose, and throat are covered \\nin Chapter 68. Fever is not typically harmful to children, although it makes \\nchildren uncomfortable and may potentiate seizures. Counsel parents \\nagainst \"fever phobia.\" To reduce a fever:\\n1. Remove excessive clothing and blankets to increase heat loss through \\nradiation.\\n2. Administer acetaminophen 15 mg/kg PO/PR ev ery 4 hours (up to  \\n5 times a day).\\n3. Consider ibuprofen 10 mg/kg PO in children older than 1 year of age; \\nthe dose can be repeated every 6 to 8 hours (maximum of 40 mg/kg in \\n24 hours), and can be given concurrently with acetaminophen.\\n66_Cydulka_Ch66.indd   356 16/03/17   5:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 375, 'page_label': '357'}, page_content='CHAPTER 66: Fever and Serious Bacterial Illness in Children 357 \\nPatients who are called to return to the ED for evaluation of positi ve \\nblood cultures require repeat evaluation. Patients with positive blood \\ncultures without contaminants should be hospitalized and treated with par -\\nenteral antibiotics. Well-appearing afebrile children already on antibiotics \\nshould complete the course of therapy. If the patient is afebrile, clinically \\nwell, without a focus of infection, and not currently on antibiotics, repeat \\ntesting or treatment is not usually necessary. If the child with a positive \\nblood culture remains febrile or continues to appear ill, a full sepsis workup \\n(CBC, repeat blood culture, lumbar puncture, urinalysis, and urine culture) \\nshould be performed. The patient should be hospitalized and given paren-\\nteral antibiotics (Table 66-3).\\nTaBle 66-3 Suggested Guidelines for the Evaluation and Management \\nof Neonates, Infants, and Children with Fever Who Are Well \\nAppearing, have had All Relevant Immunizations, and have No \\nClinical Source for Fever\\nAge Group Evaluation Treatment\\nInfants 57 days* to 6 \\nmonths*of age, ≥ 38°C \\n(100.4°F)\\nNon-UTI SBI incidence is \\nestimated to be negligible; \\nUTI is 3%–8%\\nUrinalysis and urine \\nculture alone\\nor\\nFor conservative \\nmanagement, treat \\ninfants 57–90 days \\nusing Philadelphia \\nProtocol or Boston \\nCriteria above\\nDischarge if negative\\nTreat for UTI with cefixime, 8 \\nmg/kg/dose daily, or cefpodox-\\nime, 5 mg/kg/dose twice a day, \\nor cefdinir, 7 mg/kg/dose twice \\ndaily for 10 days as outpatient\\nAdmit and treat with paren-\\nteral ceftriaxone if fails conser-\\nvative criteria for discharge\\nInfants 57 days to 6 \\nmonths*of age ≥ 39°C \\n(102.2°F)\\nSBI incidence is estimated \\nas < 1%; non-UTI SBI \\nincidence is estimated to be \\nnegligible; UTI is 3%–8%\\nUrinalysis and urine \\nculture alone\\nor\\nUrinalysis and urine cul-\\nture in addition to CBC \\nand blood culture\\nDischarge if negative\\nTreat for UTI as above\\nIf WBC ≥ 15,000/mm3, \\nconsider treatment with \\nceftriaxone, 50 mg/kg IV/IM, \\nand follow-up in 24 h\\nIf WBC ≥ 20,000/mm3, consider \\nchest x-ray and CSF testing†\\nInfants/children 6 to  \\n36 months of age\\nNon-UTI SBI incidence is \\n< 0.4%\\nUTI in girls ≤ 8%\\nUTI in boys (<12 months) \\n≤ 2%\\nUncircumcised boys (1–2 \\nyears) remains 2%\\nConsider Urinalysis and \\nurine culture, based on \\nthe following:\\nGirls 6–24 months\\nBoys 6–12 months\\nUncircumcised boys \\n12–24 months\\nDischarge if negative\\nTreat for UTI as above as \\noutpatient\\nAbbreviations: CSF, cerebrospinal fluid; SBI, serious bacterial illness; UTI, urinary tract infection.\\n*For preterm infants, count age by estimated postconception date and not by actual delivery date for the \\nfirst 90 days of life.\\n†Meningismus is difficult to discern in infants < 6 months of age, and especially in infants < 2 months \\nof age. Therefore, we recommend routine CSF testing in infants < 2 months of age, but selective CSF \\ntesting in infants 2–6 months of age. There is no absolute cutoff point for prediction of meningitis with \\na peripheral WBC count.\\n66_Cydulka_Ch66.indd   357 16/03/17   5:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 376, 'page_label': '358'}, page_content='358 SECTION 9: Pediatrics\\n■ ■SEPSIS\\nSepsis (bacteremia with clinical evidence of systemic infection) can rapidly \\nprogress to multiorgan failure and death. Risk factors include prematurity, \\nimmunocompromised state, recent invasive procedures, and indwelling \\nforeign objects such as catheters.\\nClinical Features\\nClinical signs may be vague and subtle in the young infant, including leth-\\nargy, poor feeding, irritability, or hypotonia. Fever is common; however, \\nvery young infants may be hypothermic. Tachypnea and tachycardia are \\nusually present as a result of fever but also may be secondary to hypoxia \\nand metabolic acidosis. Sepsis can rapidly progress to shock, manifest as \\nprolonged capillary refill, decreased peripheral pulses, altered mental sta-\\ntus, and decreased urinary output. Hypotension is usually a late sign of \\nseptic shock in infants and children; sustained tachycardia for age is often \\nthe only sign available to the clinician of impending shock.\\nDiagnosis and Differential\\nDiagnosis is based on clinical findings and confirmed by positive blood \\nculture results. Though international criteria for sepsis have been published, \\nall infants who appear toxic should be considered septic. The laboratory \\nevaluation of a child with presumed sepsis includes CBC, blood culture, \\ncomplete metabolic panel, blood lactate, catheterized urinalysis with cul-\\nture and sensitivities, chest radiograph, lumbar puncture, and stool studies \\nin the presence of diarrhea. Infants are at particular risk for hypoglycemia \\nwith SBI and sepsis, and a glucose level should always be checked.\\nemergency Department Care and Disposition\\n1. ABCs. Administer high-flow oxygen, institute cardiac monitoring, and \\nsecure IV or IO access immediately. Perform endotracheal intubation in \\nthe presence of respiratory failure or severe respiratory distress.\\n2. Treat shock with 20 mL/kg boluses of 0.9% normal saline solution; \\npreferably 60 mL/kg within 15 minutes. For infants, push actual volumes \\nusing multiple saline flushes. Repeat boluses until vital signs, perfusion, \\nmental status, and urine output improve, up to 100 mL/kg total volume.\\n3. Treat hypoglycemia with 5 mL/kg 10% dextrose.\\n4. Initiate antibiotic therapy promptly, as soon as IV access is achieved. Do \\nnot delay due to difficulty with procedures such as lumbar puncture. \\nEmpiric antibiotic choices include cefotaxime 50 mg/kg IV or piperacillin-\\ntazobactam 100 mg/kg IV; because of ceftriaxone-resistant S. pneumoniae, \\nadd vancomycin 15 mg/kg IV for ill-appearing infants.\\n5. Treat volume-refractory shock with dopamine  5 to 20 μg/kg/min or \\nnorepinephrine 0.1 to 0.2 μg/kg/min.\\n6. Consider the presence of drug-resistant organisms, immune-incompetence, \\nor infection with unusual or opportunistic organisms.\\n■ ■MENINGITIS\\nMeningitis is usually a complication of a primary bacteremia and has a \\npeak incidence in children between birth and 2 years of age. Prematurity \\nand immature immunity put children at higher risk.\\n66_Cydulka_Ch66.indd   358 16/03/17   5:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 377, 'page_label': '359'}, page_content='CHAPTER 66: Fever and Serious Bacterial Illness in Children 359 \\nClinical Features\\nMeningitis may present with the subtle signs that accompany less serious \\ninfections, such as otitis media or sinusitis. Irritability, inconsolability, \\nhypotonia, and lethargy are most common in infants. Older children may \\ncomplain of headache, photophobia, nausea, and vomiting and exhibit the \\nclassic signs of meningismus with complaints of neck pain. Occasionally, \\nmeningitis presents as a rapidly progressive, fulminant disease character -\\nized by shock, seizures, or coma, or with febrile status epilepticus.\\nDiagnosis and Differential\\nDiagnosis is made by lumbar puncture and analysis of the cerebrospinal \\nfluid (CSF). The CSF should be examined for white blood cells, glucose \\nand protein, Gram stain, and culture. Consider herpes simplex virus (HSV) \\nPCR in the seizing neonate and any child with CSF pleocytosis or xantho-\\nchromia. In the presence of known immunocompromised state, consider \\ninfections with opportunistic or unusual organisms. Perform cranial com-\\nputed tomography before lumbar puncture in the presence of focal neuro-\\nlogic signs or increased intracranial pressure.\\nemergency Department Care and Disposition\\n1. Treatment should always begin with the ABCs and restoration of oxy-\\ngenation and perfusion (see specific treatment recommendations under \\nthe section \"Sepsis\").\\n2. Empiric antibiotic therapy is based on the patient’s age and listed in \\nTable 66-4. Do not defer or delay antibiotics when meningitis is strongly \\nsuspected. Administer acyclovir 20 mg/kg IV for any suspicion of her -\\npes encephalitis.\\nTaBle 66-4 Suggested Guidelines for the Evaluation and Management \\nof Neonates, Infants, and Children with Fever Who Are Well \\nAppearing, have had All Relevant Immunizations, and have No \\nClinical Source for Fever\\nAge Group Treatment\\nNeonate, 0–28 days*of age, ≥ 38°C \\n(100.4°F)\\nSBI incidence of ill appearing: 13%–21% ; \\nif not ill appearing: < 5%\\nAdmit and treat with:\\nParenteral antibiotic therapy with ampicillin, \\n50 mg/kg, and either cefotaxime, 50 mg/kg, \\nor gentamicin, 2.5 mg/kg\\nInfant 29–56 days* of age, ≥ 38.2°C \\n(100.8°F) (Philadelphia Protocol)\\nSBI incidence of ill appearing: 13%–21%; \\nif not ill appearing: < 5%\\nDischarge if:\\n WBC ≤15,000/mm3 and ≥ 5000/mm3 and \\n< 20% band forms\\nUrinalysis negative\\nCSF WBC <10 cells/mm3\\nNegative chest x-ray or fecal leukocytes  \\nif applicable\\nAdmit if:\\nAny of above criteria are not met and treat \\nwith parenteral ceftriaxone, 50 mg/kg \\nwith normal CSF, 100 mg/kg with signs of \\nmeningitis\\n(Continued)\\n66_Cydulka_Ch66.indd   359 16/03/17   5:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 378, 'page_label': '360'}, page_content='360 SECTION 9: Pediatrics\\n3. The role of steroids in the management of meningitis is highly contro-\\nversial, but only exert possible benefit when given prior to antibiotics.\\n4. Admit, hydrate, and give meningitis doses of antibiotic for an y patient \\nsuspected of having meningitis for whom efforts at lumbar puncture fail. \\nObtain blood and urine cultures. Lumbar puncture may be successful \\nafter hydration.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 116, “Fever and Serious Bacterial Illness in Infants \\nand Children,” by Vincent J. Wang.\\nTaBle 66-4 Suggested Guidelines for the Evaluation and Management \\nof Neonates, Infants, and Children with Fever Who Are Well \\nAppearing, have had All Relevant Immunizations, and have No \\nClinical Source for Fever\\nAge Group Treatment\\nInfants 57 days*to 6 months*of age,  \\n≥ 38°C (100.4°F)\\nNon-UTI SBI incidence is estimated to be \\nnegligible. UTI is 3%–8%\\nDischarge if negative\\nTreat for UTI with cefixime, 8 mg/kg/dose \\ndaily, or cefpodoxime, 5 mg/kg/dose twice \\na day, or cefdinir, 7 mg/kg/ dose twice daily \\nfor 10 days as outpatient\\nAdmit and treat with parenteral ceftriaxone \\nif fails conservative criteria for discharge\\nInfants 57 days to 6 months*of age  \\n≥ 39°C (102.2°F)\\nSBI incidence is estimated as < 1%; \\nnon-UTI SBI incidence is estimated to be \\nnegligible. UTI is 3%–8%\\nDischarge if negative\\nTreat for UTI as above\\nIf WBC ≥ 15,000/mm3, consider treatment \\nwith ceftriaxone, 50 mg/kg IV/IM, and \\nfollow-up in 24 h\\nIf WBC ≥ 20,000/mm3, consider chest x-ray \\nand CSF testing†\\nInfants/children 6–36 months of age\\nNon-UTI SBI incidence is < 0.4%\\nUTI in girls ≤ 8%\\nUTI in boys (< 12 months) ≤ 2%\\nUncircumcised boys (1–2 years)  \\nremains 2%\\nDischarge if negative\\nTreat for UTI as above as outpatient\\n Children > 36 months and older Discharge and treat with antipyretics: \\nacetaminophen, 15 mg/kg PO/PR every  \\n4 h, or ibuprofen, 10 mg/kg PO every 6 h  \\nas needed\\nAbbreviations: CSF, cerebrospinal fluid; SBI, serious bacterial illness; UTI, urinary tract infection.\\n*For preterm infants, count age by estimated postconception date and not by actual delivery date for the \\nfirst 90 days of life.\\n†Meningismus is difficult to discern in infants < 6 months of age, and especially in infants < 2 months \\nof age. Therefore, we recommend routine CSF testing in infants < 2 months of age, but selective CSF \\ntesting in infants 2–6 months of age. There is no absolute cutoff point for prediction of meningitis with \\na peripheral WBC count.\\n(Continued)\\n66_Cydulka_Ch66.indd   360 16/03/17   5:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 379, 'page_label': '361'}, page_content='361\\nCommon Neonatal Problems\\nLance Brown\\nIn general, the signs and symptoms of illness are vague and nonspecific in \\nneonates making the identification of specific diagnoses challenging. The \\nsurvival of premature infants has produced a population of children whose \\ncorrected gestational age (chronological age since birth in weeks minus the \\nnumber of weeks of prematurity) makes them, in many ways, similar to \\nneonates. Neonates present to the emergency department (ED) with condi-\\ntions ranging from normal to critical.\\n■ ■WEIGHT GAIN, FEEDING, AND STOOLING\\nBottle-fed infants generally take 6 to 9 feedings (2 to 4 oz) in a 24-hour \\nperiod, with a relatively stable pattern developing by the end of the first \\nmonth of life. Breast-fed infants generally prefer feedings every 1 to 3 \\nhours. Infants may lose up to 12% of their birth weight during the first 3 \\nto 7 days of life. After this time, infants are expected to gain about 1 oz/d \\n(20 to 30 g/d) during the first 3 months of life. Parental perception that an \\ninfant’s food intake is inadequate may prompt an ED visit. If the patient’s \\nweight gain is adequate and the infant appears satisfied after feeding, \\nparental reassurance is appropriate.\\nRegurgitation occurs when gastric contents are effortlessly expelled, \\ntypically within 30 minutes of feeding, and, though potentially large in \\nvolume, are never projectile or bilious. Regurgitation is typically a self-\\nlimited condition and if an infant is thriving and gaining weight appropri-\\nately, reassurance is appropriate.\\nV omiting is differentiated from regurgitation by forceful contraction of \\nthe diaphragm and abdominal muscles. V omiting has a variety of causes \\nand is rarely an isolated symptom. Etiologies are diverse and include \\nincreased intracranial pressure (e.g., nonaccidental trauma), infections \\n(e.g., urinary tract infections, sepsis, or gastroenteritis), hepatobiliary dis-\\nease (usually accompanied by jaundice), and inborn errors of metabolism \\n(usually accompanied by hypoglycemia and metabolic acidosis). Bilious \\nvomiting in a neonate or infant should be considered a surgical emergency \\nwith particular concern for malrotation with midgut volvulus.\\nThe number, color, and consistency of stool in the same infant changes \\nfrom day to day and differs among infants. Normal breast-fed infants may \\ngo 5 to 7 days without stooling or have six to seven stools per day. Color has \\nno significance unless blood is present, or the stool is acholic (i.e., white).\\nInfants without normal stooling in the first 2 days of life may have \\nanatomic anomalies (e.g., intestinal stenosis or atresias), cystic fibrosis, \\nHirschsprung disease, or meconium ileus or plug. Constipation that devel-\\nops later in the first month of life suggests Hirschsprung disease, \\nhypothyroidism, anal stenosis, or anterior anus. Although bacterial infec-\\ntion may cause bloody diarrhea, this is rare in neonates. The most common \\ncause of blood in the stool in neonates is anal fissures. Breast-fed infants \\nmay have heme-positive stool from swallowed maternal blood due to \\n67\\nC HA p TE r\\n67_Cydulka_Ch67.indd   361 16/03/17   6:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 380, 'page_label': '362'}, page_content='362 SECTION 9: Pediatrics\\nbleeding nipples. Necrotizing enterocolitis may present as bloody diarrhea \\nand usually presents with other signs of sepsis (e.g., jaundice, lethargy, \\nfever, poor feeding, or abdominal distention). Abdominal radiography may \\ndemonstrate pneumatosis intestinalis or free air. Dehydrated neonates \\nshould be admitted for parenteral rehydration.\\nAbdominal distention can be normal in the neonate and is usually due \\nto lax abdominal muscles, relatively large intraabdominal organs, and swal-\\nlowed air. In general, if the neonate appears comfortable, is feeding well, \\nand the abdomen is soft, there is no need for concern.\\n■ ■BrEATHING AND CrYING\\nA normal respiratory rate for a neonate is from 30 to 60 breaths/min. \\nPeriodic breathing manifests as alternating episodes of rapid breathing \\nwith brief (< 5 to 10 seconds) pauses in respiration. Periodic breathing is \\nusually normal in neonates. Apnea is formally defined as a cessation of \\nrespiration for longer than 10 to 20 seconds with or without accompany-\\ning bradycardia and cyanosis. Apnea generally signifies critical illness \\nincluding infection, CNS injury, and metabolic disease, and prompt inves-\\ntigation and admission for monitoring and treatment should be initiated. \\nApnea may be the first sign of bronchiolitis with respiratory syncytial \\nvirus in neonates and can occur before wheezing. Chlamydia and pertus-\\nsis can also cause apnea in the young infant.\\nNoisy breathing in a neonate is usually benign. Infectious causes of \\nstridor seen commonly in older infants and young children (e.g., croup) are \\nrare in neonates. Stridor in a neonate is often due to a congenital anomaly, \\nmost commonly, laryngomalacia. Other causes include webs, cysts, atre-\\nsias, stenoses, clefts, and airway hemangiomas. Nasal congestion from a \\nmild upper respiratory tract infection may cause significant respiratory \\nproblems in a neonate. Neonates are obligate nasal breathers and feed for \\nrelatively prolonged periods while breathing only through their noses. The \\nuse of saline drops and nasal suctioning is typically effective.\\nThere are benign to life-threatening causes of prolonged crying in infants. \\nTrue inconsolability represents a serious condition in most infants and requires \\ninvestigation for injury (accidental or inflicted), infection, supraventricular \\ntachycardia (SVT), corneal abrasion, hair tourniquet, hernia or testicular tor-\\nsion, or an abdominal emergency. If, after a thorough ED evaluation, a cause \\nfor excessive crying has not been identified and the child continues to be \\ninconsolable, admission to the hospital for further evaluation is warranted.\\nIntestinal colic is a common cause of crying in infants. The cause is \\nunknown. The incidence is about 13% in neonates. The formal definition \\nincludes crying for at least 3 hours per day for at least 3 days per week over \\na 3-week period. Intestinal colic seldom lasts beyond 3 months of age. No \\neffective treatment has been identified. In general, the initial diagnosis of \\ncolic is not made in the ED and it is a diagnosis of exclusion.\\n■ ■SLEEpING, SEIZUrES, AND SEEMINGLY  \\nABNOrMAL MOVEMENTS\\nNormal newborns awaken at variable intervals that can range from about 20 \\nminutes to 6 hours. Neonates and young infants tend to have no differentia-\\ntion between day and night until approximately 3 months of age. Seizures \\n67_Cydulka_Ch67.indd   362 16/03/17   6:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 381, 'page_label': '363'}, page_content='CHAPTER 67: Common Neonatal Problems 363 \\nin neonates may present with subtle signs and symptoms including eye \\ndeviation, tongue thrusting, eyelid fluttering, periods of apnea, pedaling \\nmovements or arching. All seizures in neonates, unlike some in older \\ninfants and young children, require an extensive workup including testing \\nof serum calcium level and admission to the hospital. Seizures need to be \\ndifferentiated from benign conditions such as a Moro reflex or benign neo-\\nnatal sleep myoclonus. Benign neonatal sleep myoclonus was first \\ndescribed in 1982 and consists of lightning-like rhythmic jerks of the \\nextremities when the infant is sleeping, is stopped when the neonate is \\ntouched or awakened, occurs only during sleep, requires no workup, and is \\nbest handled with reassurance.\\n■ ■FEVEr AND SEpSIS\\nFever in the neonate (age 28 days or younger) is defined as the history of \\ndocumented fever by a parent or presence of a rectal temperature of 38°C \\n(100.4°F) or higher in the ED. Fever in the neonate must be taken seriously, \\nand at this point in time the proper management includes a complete sepsis \\nworkup, administration of parenteral antibiotics (e.g., cefotaxime and \\nampicillin), and admission to the hospital. For further detailed discussion, \\nsee Chapter 66.\\n■ ■ALTE/BrUE\\nAn apparent life-threatening event (ALTE), recently renamed brief resolved \\nunexplained event (BRUE) by the American Academy of Pediatrics, is \\ndefined as an event occurring in an infant younger than 12 months involving \\na brief, but now resolved episode of one or more of the following: (1) cyano-\\nsis or pallor; (2) irregular, decreased, or absent breathing; (3) hyper- or \\nhypotonia; or (4) altered responsiveness. According to the definition of \\nBRUE, these infants appear well on presentation to the ED and there is no \\nexplanation of the qualifying event. The new guidelines emphasize categori-\\nzation into lower risk and higher risk, with lower risk criteria being: (1) age \\n> 60 days; (2) prematurity ≥  32 weeks, and postconceptional age ≥  45 \\nweeks; (3) first BRUE; (4) duration of event < 1 minute; (5) no CPR by a \\nhealthcare provider; 6) no concerning historical or physical examination fea-\\ntures. If not considered lower risk, they are categorized as higher risk. Recom-\\nmendations for further evaluation of lower risk patients show limited benefit, \\nbut the strength of the evidence to support these recommendations is only \\nmoderate to poor. Evaluation for higher risk patients may include a complete \\nblood count; electrolytes, calcium, phosphorous, magnesium, and ammonia \\nlevels; urine toxicological screen; chest radiograph; electrocardiogram; test-\\ning for respiratory syncytial virus or pertussis; and a sepsis workup, including \\nblood, urine, and cerebrospinal fluid. A brain CT may be included in cases of \\nsuspected nonaccidental trauma. There is no relation between ALTE/BRUE \\nand sudden infant death syndrome, which are now considered distinct entities.\\n■ ■JAUNDICE\\nThere are multiple causes of jaundice, and the likelihood of any specific \\ncause is based on the age of onset. Jaundice that occurs within the first 24 \\nhours of life tends to be serious in nature and usually is addressed while the \\n67_Cydulka_Ch67.indd   363 16/03/17   6:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 382, 'page_label': '364'}, page_content='364 SECTION 9: Pediatrics\\npatient is in the newborn nursery. Jaundice that develops during the second \\nor third day of life is usually physiologic; if the neonate is gaining weight, \\nfeeding and stooling well, is not anemic, does not have an elevated direct \\n(conjugated) bilirubin level greater than one-third the total, and does not \\nhave a total bilirubin level indicating the need for phototherapy (check \\nwww.bilitool.org) reassurance and close follow-up are appropriate. Jaun-\\ndice that develops after the third day of life is generally serious. Causes \\ninclude sepsis, UTI, congenital TORCH infections, hemolytic anemia, bili-\\nary atresia, breast milk jaundice, and hypothyroidism. Workup of these \\ninfants usually includes a complete sepsis evaluation, including a lumbar \\npuncture, a peripheral blood smear, complete blood count, total and direct \\nbilirubin levels, liver function tests, reticulocyte count, and a Coombs test. \\nEmpiric antibiotics are generally administered when sepsis is suspected.\\n■ ■OrAL THrUSH AND DIApEr rASH\\nIntraoral lesions due to Candida are typically white and pasty and cover the \\ntongue, lips, gingiva, and buccal mucosa. Treatment consists of topical \\napplication of oral nystatin suspension four times a day.\\nTwo main types of diaper rash are common in neonates: contact derma-\\ntitis and candidal diaper dermatitis. Contact dermatitis is macular, erythema-\\ntous, and has sharply demarcated edges. Treatment consists of frequent \\ndiaper changes, air drying, and application of a barrier cream containing \\nzinc oxide. Candidal dermatitis presents with erythematous plaques with a \\nscalloped border and satellite lesions. Treatment consists of frequent diaper \\nchanges and application of nystatin cream at least four times a day.\\n■ ■EYE COMpLAINTS\\nRed eyes in neonates run the spectrum from benign to sight threatening. A \\ncommon benign finding is a corneal abrasion from uncoordinated hand \\nmovements and untrimmed fingernails in neonates. Fluorescein staining is \\ndiagnostic. Cloudy corneas suggest acute glaucoma. Prompt pediatric \\nophthalmologic consultation is indicated. Conjunctivitis in the neonatal \\nperiod may be related to sexually transmitted infections. Gonococcal con-\\njunctivitis typically occurs in the first few days of life and presents with \\ncopious discharge. In these cases, a sepsis workup, ocular irrigation, par -\\nenteral antibiotics, prompt ophthalmology consultation, and admission to \\nthe hospital are indicated. After the first week of life, chlamydial conjunc-\\ntivitis is more common and may range from mild to severe. Topical drops \\nare inadequate treatment for chlamydial conjunctivitis. Oral erythromycin \\nis indicated.\\n■ ■ABDOMINAL CATASTrOpHES\\nSurgically correctable abdominal emergencies in neonates are uncom-\\nmon, may present with nonspecific symptomatology, and, when \\nsuspected, require prompt consultation with an experienced pediatric \\nsurgeon. Common signs and symptoms include irritability and crying, \\npoor feeding, vomiting, constipation, and abdominal distention. Bilious \\nvomiting is suggestive of malrotation with midgut volvulus and requires \\n67_Cydulka_Ch67.indd   364 16/03/17   6:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 383, 'page_label': '365'}, page_content='CHAPTER 67: Common Neonatal Problems 365 \\nemergent surgical consultation and radiologic ev aluation (upper gastro-\\nintestinal series with small bowel follow through). Projectile vomiting \\nfollowing feeds suggests pyloric stenosis, which is evaluated with ultra-\\nsound. A groin mass may represent an incarcerated hernia; inguinal \\nhernias are common among premature infants.\\n■ ■INBOrN ErrOrS OF METABOLISM\\nTypical presentations of inborn errors of metabolism include lethargy or \\ncardiorespiratory arrest. Most neonates will have inborn errors of metabo-\\nlism diagnosed after successful resuscitation. Adding a properly obtained \\nserum ammonia level to the usual laboratories obtained during resuscitation \\nmay assist in facilitating the diagnosis of some inborn errors of metabolism.\\n■ ■CONGENITAL ADrENAL HYpErpLASIA\\nThese neonates present with virilization, ambiguous genitalia, and hyper -\\npigmentation and may be in shock on presentation. Laboratory values \\ninclude hyponatremia and hyperkalemia. In addition to usual resuscitation \\nmeasures, hydrocortisone administered intravenously, intramuscularly, or \\nintraosseously at a dose of 12.5 to 25 mg is indicated.\\n■ ■CONGENITAL HEArT DISEASE AND CYANOSIS\\nMany disorders can present with cyanosis, and differentiating among them \\ncan be a diagnostic challenge. However, symptom patterns may help dif-\\nferentiate various causes and assist in suggesting the correct diagnosis and \\ncourse of action. Rapid, unlabored respirations and cyanosis that does not \\nrespond to oxygen therapy suggest cyanotic heart disease with right-to-left \\nshunting. Irregular or shallow breathing and cyanosis suggest sepsis, CNS \\ndisease, or metabolic disorders. Labored breathing with grunting and \\nretractions is suggestive of pulmonary disease such as pneumonia or bron-\\nchiolitis. All cyanotic neonates should be admitted to the hospital for \\nmonitoring, therapy, and further investigation.\\n■ ■NONACCIDENTAL TrAUMA\\nA battered child may present with unexplained bruises at different ages, \\nskull fractures, intracranial injuries identifiable on computed tomography \\nof the head, extremity fractures, cigarette burns, retinal hemorrhages, unex-\\nplained irritability, lethargy, or coma.\\n■ ■FUrTHEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 114, “Neonatal Emergencies and Common Neonatal \\nProblems,” by Quynh H. Doan and Niranjan Kissoon; Chapter 115, “Sudden \\nInfant Death Syndrome and Apparent Life-Threatening Event,” by Claudius Ilene \\nand Joel S. Tieder.\\n67_Cydulka_Ch67.indd   365 16/03/17   6:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 384, 'page_label': '366'}, page_content='366\\nCommon Infections of the Ears, \\nNose, Neck, and Throat\\nYu-Tsun Cheng\\nThis chapter is limited to infections of the ears, nose, neck, and throat. \\nFurther information can be found in Chapter 69 “Upper Respiratory \\nEmergencies—Stridor and Drooling,” as well as Chapter 151 “Ear, Nose and \\nSinus Emergencies” and Chapter 153 “Neck and Upper Airway Disorders.”\\n■ ■ACUTE OTITIS MEDIA\\nAcute otitis media (AOM) accounts for 7.4% of all visits to emergency \\ndepartments in the United States. AOM is an infection of the middle ear \\nspace that commonly affects young children because of relative immaturity \\nof the upper respiratory tract, especially the eustachian tube. The most com-\\nmon pathogens in the post-pneumococcal vaccine era are Streptococcus \\npneumoniae (49%) and nontypeable Haemophilus influenzae (29%).\\nClinical Features\\nPeak age is 6 to 18 months. Symptoms include fever, poor feeding, irritabil-\\nity, vomiting, ear pulling, and earache. Signs include bulging, pus behind the \\ntympanic membrane (Fig. 68-1), an immobile tympanic membrane (TM), \\nloss of visualization of bony landmarks within the middle ear, and bullae on \\nthe TM (bullous myringitis). Mastoiditis is the most common suppurative \\ncomplication of AOM. The primary symptoms of mastoiditis include fever, \\nprotrusion of the auricle, and tenderness over the mastoid area.\\nDiagnosis and Differential\\nMaking an accurate diagnosis is the most important first step. The defi-\\nnition of AOM requires three equally important components: (a) acute \\nonset (< 48 hours) of signs and symptoms, (b) middle-ear effusion (see \\nFig. 68-1), and (c) signs and symptoms of middle ear inflammation. A \\nred TM alone does not indicate the presence of an ear infection. Fever and \\nprolonged crying can cause hyperemia of the TM alone. Pneumatic otos-\\ncopy can be a helpful diagnostic tool; however, a retracted drum for what-\\never reason will demonstrate decreased mobility. Other common causes of \\nacute otalgia are a foreign body in the external ear canal or otitis externa.\\nEmergency Department Care and Disposition\\n1. Treatment of pain is essential for all childr en diagnosed with AOM. \\nTopical analgesics such as benzocaine-antipyrene are recommended for \\nroutine use, unless there is a known perforation of the TM. Acetamino-\\nphen 15 mg/kg or ibuprofen 10 mg/kg can be used.\\n2. Consider the use of a wait-and-see prescription for the treatment of \\nuncomplicated AOM. Parents are given a prescription, and if the child is \\nnot better or becomes worse within 48 to 72 hours, the parents are \\nadvised to fill the prescription. Contraindications to the use of a wait-and-\\nsee prescription are as follows: age <6 months, an immunocompromised \\n68\\nCh A p TE r\\n68_Cydulka_Ch68.indd   366 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 385, 'page_label': '367'}, page_content='CHAPTER 68: Common Infections of the Ears, Nose, Neck, and Throat 367 \\nstate, ill-appearance, recent use of antibiotics, or the diagnosis of another \\nbacterial infection. If any of these conditions are met, the child should be \\nprescribed an immediate antibiotic.\\n3. Amoxicillin 40 to 45 mg/kg/dose PO given twice daily remains the first \\ndrug of choice for uncomplicated AOM.\\n4. Second-line antibiotics include amoxicillin/clavulanate 40 to 45 mg/kg/\\ndose (based on the amoxicillin component) given twice daily. Cefpodox-\\nime 5 mg/kg/dose twice daily, cefuroxime 15 mg/kg/dose twice daily, \\ncefdinir 7 mg/kg/dose twice daily, and ceftriaxone 50 mg/kg/dose IM for \\none to three daily doses are alternatives. For patients allergic to the previ-\\nously mentioned antibiotics, azithromycin 10 mg/kg/dose PO on the first \\nday followed by 5 mg/kg/dose PO for four more days can be used.\\n5. Infants younger than 60 days with AOM are at risk of infection with  \\ngroup B Streptococcus, Staphylococcus aureus, and gram-negative \\nbacilli and should undergo evaluation and treatment for presumed sepsis.\\n6. In uncomplicated AOM, symptoms resolve within 48 to 72 hours; how-\\never, the middle-ear effusion may persist as long as 8 to 12 weeks. \\nRoutine follow-up is not necessary unless the symptoms persist or \\nworsen.\\n7. If mastoiditis is suspected, obtain a CT scan of the mastoid. If the diag-\\nnosis is confirmed, obtain consultation with an otorhinolaryngologist \\nand start parenteral antibiotics.\\nFIgurE 68-1. Acute otitis media in a 3-year-old child with an outward bulge of the \\ntympanic membrane and an exudative process in the middle ear space. Used with \\npermission from Dr. Shelagh Cofer, Department of Otolaryngology, Mayo Clinic.\\n68_Cydulka_Ch68.indd   367 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 386, 'page_label': '368'}, page_content='368 SECTION 9:  Pediatrics\\nUncomplicated AOM is treated as an outpatient, whereas mastoiditis \\ntypically requires inpatient treatment.\\n■ ■OTITIS EXTErNA\\nOtitis externa (OE) is an inflammatory process involving the auricle, exter-\\nnal auditory canal (EAC), and surface of the TM. It is commonly caused by \\nPseudomonas aeruginosa and S. aureus, which often coexist.\\nClinical Features\\nPeak seasons for OE are spring and summer, and the peak age is 7 to 12 years. \\nSymptoms include earache, itching, and, less commonly, fever. Signs include \\nerythema, edema of the EAC, white exudate on the EAC and TM, pain with \\nmotion of the tragus or auricle, and periauricular or cervical adenopathy.\\nDiagnosis and Differential\\nDiagnosis for OE is based on clinical signs and symptoms. A foreign body \\nwithin the external canal should be excluded by carefully removing any \\ndebris that may be present.\\nEmergency Department Care and Disposition\\n1. Cleaning the ear canal with a small tuft of cotton attached to a wire ap-\\nplicator is the first step. Place a wick in the canal if significant edema \\nobstructs the EAC.\\n2. Consider oral analgesics, such as ibuprofen  at 10 mg/kg/dose every  \\n6 hours.\\n3. Fluoroquinolone-otic drops are no w considered the preferred agents \\nover neomycin containing drops. Ciprofloxacin with hydrocortisone, \\n0.2% and 1% suspension (Cipro HC), 3 drops twice daily or ofloxacin \\n0.3% solution 5 to 10 drops twice daily can be used. Ofloxacin is used \\nwhen TM rupture is found or suspected.\\n4. Oral antibiotics are indicated if auricular cellulitis is present.\\nFollow-up should be advised if improv ement does not occur within  \\n48 hours; otherwise routine follow-up is not necessary. Malignant OE is \\ncharacterized by systemic symptoms and auricular cellulitis. This condi-\\ntion can result in serious complications and requires hospitalization with \\nparenteral antibiotics.\\n■ ■ACUTE BACTErIAL SINUSITIS\\nSinusitis is an inflammation of the paranasal sinuses that may be secondary \\nto infection or allergy, and may be acute, subacute, or chronic. Acute bacte-\\nrial sinusitis is defined as an infection of the paranasal sinuses with com-\\nplete resolution in <30 days. The major pathogens in childhood are \\nStreptococcus pneumoniae , Moraxella catarrhalis, and nontypeable \\nHaemophilus influenzae.\\nClinical Features\\nTwo major types of sinusitis may be differentiated on clinical grounds: \\nacute severe sinusitis and mild subacute sinusitis. Acute severe sinusitis is \\n68_Cydulka_Ch68.indd   368 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 387, 'page_label': '369'}, page_content='CHAPTER 68: Common Infections of the Ears, Nose, Neck, and Throat 369 \\nassociated with elevated temperature, headaches, and localized swelling \\nand tenderness or erythema in the facial area corresponding to the sinuses. \\nSuch localized findings are seen most often in older adolescents. Mild sub-\\nacute sinusitis is manifest in childhood as a protracted upper respiratory \\ninfection associated with purulent nasal discharge persisting in excess of \\ntwo weeks. Fever is infrequent. Chronic sinusitis may be confused with \\nallergies or upper respiratory infections.\\nDiagnosis and Differential\\nThe diagnosis is made on clinical grounds without laboratory or radiographic \\nstudies. Transillumination of the maxillary or frontal sinuses is seldom help-\\nful. Nasal congestion lasting 3 to 7 days often accompanies viral upper respi-\\nratory infections and should not be diagnosed as acute sinusitis, nor treated \\nwith antibiotics. Similarly, colored drainage from the nose as a solitary \\nsymptom does not suggest a diagnosis of sinusitis and should not be treated \\nwith antibiotics. Imaging studies are not needed to confirm a diagnosis of \\nacute bacterial sinusitis in children <6 years of age with persistent symptoms.\\nEmergency Department Care and Disposition\\nPatients with mild symptoms suggestive of a viral infection can be observed \\nfor 7 to 10 days, with no antibiotics prescribed. Suspect acute bacterial \\nsinusitis if symptoms persist or are severe: fever >39°C, purulent nasal \\ndrainage for >3 days and ill-appearance.\\n1. For children with mild to moderate sinusitis, treat with amoxicillin  \\n40 to 45 mg/kg/dose PO twice daily for 10 to 14 days.\\n2. For children who present with severe symptoms, are in day care, or have \\nrecently been treated with antibiotics, prescribe amoxicillin/clavulanate \\n40 to 45 mg/kg/dose twice a day (based on the amoxicillin component), \\nor oral second- and third-generation cephalosporins such as cefuroxime \\n15 mg/kg PO twice a day or cefpodoxime 5 mg/kg PO twice a day.\\n■ ■STOMATITIS AND phArYNGITIS\\nHerpangina, hand, foot, and mouth disease (HFMD), and herpes simplex \\ngingivostomatitis are the primary infections that cause stomatitis in children \\nand are all viral. The vast majority of pharyngitis is caused by viral infec-\\ntions; however, group A β-hemolytic Streptococcus (GABHS) and Neisseria \\ngonorrhoeae are bacterial infections that require accurate diagnoses. The \\nidentification and treatment of GABHS pharyngitis is important to prevent \\nthe suppurative complications and the sequelae of acute rheumatic fever.\\nClinical Features\\nHerpangina causes a vesicular enanthem of the tonsils and soft palate, affect-\\ning children 6 months to 10 years of age during late summer and early fall. \\nThe vesicles are painful and can be associated with fever and dysphagia. \\nHFMD usually begins as macules which progress to vesicles of the palate, \\nbuccal mucosa, gingiva, and tongue. Similar lesions may present on the \\npalms of hands, soles of feet, and buttocks. Herpes simplex gingivostomati-\\ntis often presents with abrupt onset of fever, irritability, and decreased oral \\n68_Cydulka_Ch68.indd   369 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 388, 'page_label': '370'}, page_content='370 SECTION 9:  Pediatrics\\nintake with edematous and friable gingiva. Vesicular lesions often with \\nulcerations are seen in the anterior oral cavity.\\nPeak seasons for GABHS are late winter or early spring, the peak age is \\n5 to 15 years, and it is rare before the age of 2 years. Symptoms include \\nsore throat, fever, headache, abdominal pain, enlarged anterior cervical \\nnodes, palatal petechiae, and hypertrophy of the tonsils. With GABHS there \\nis usually the absence of cough, coryza, laryngitis, stridor, conjunctivitis, \\nand diarrhea. A scarlatinaform rash associated with pharyngitis may indi-\\ncate GABHS and is commonly referred to as scarlet fever.\\nEpstein-Barr Virus (EBV) is a herpes virus and often presents much like \\nstreptococcal pharyngitis. Common symptoms are fever, sore throat, and \\nmalaise. Cervical adenopathy may be prominent and often is posterior. \\nHepatosplenomegaly and splenomegaly may be present. EBV should be \\nsuspected in the child with pharyngitis nonresponsive to antibiotics in the \\npresence of a negative throat culture.\\nGonococcal pharyngitis in children and nonsexually active adolescents \\nshould alert one to the possibility of sexual abuse. Gonococcal pharyngitis \\nmay be associated with infection elsewhere including proctitis, vaginitis, \\nurethritis, or arthritis.\\nDiagnosis and Differential\\nThe diagnoses of herpangina, HFMD, and herpes simplex gingivostomati-\\ntis are based on clinical findings. To diagnose GABHS, current guidelines \\nrecommend the use of Centor criteria to determine which patients require \\ntesting: (a) tonsillar exudates, (b) tender anterior cervical lymphadenopa-\\nthy, (c) absence of cough, and (d) history of fever. With two or more crite-\\nria, testing should be performed with a rapid antigen detection test and/or \\nculture. If the rapid antigen test is negative, a confirmatory throat culture \\nis recommended.\\nDiagnosis of EBV is often clinical. A heterophile antibody (monospot) \\ncan aid in the diagnosis. The monospot may be insensitive in children <2 \\nyears of age and is often negative in the first week of illness. If obtained, \\nthe white blood cell count may show a lymphocytosis with a preponderance \\nof atypical lymphocytes. Diagnosis of gonococcal pharyngitis is made by \\nculture on Thayer-Martin medium. Vaginal, cervical, urethral, and rectal \\ncultures also should be obtained if gonococcal pharyngitis is suspected.\\nEmergency Department Care and Disposition\\n1. Treatment of herpangina, HFMD, and herpes simplex gingivostomatitis \\nis primarily supportive. Systemic analgesics such as a combination of \\nibuprofen and acetaminophen should be considered. Parenteral hydra-\\ntion may be necessary if the child cannot tolerate oral fluids. Occasion-\\nally oral narcotics may be required.\\n2. Antibiotics for the treatment of GABHS pharyngitis should be reserved \\nfor patients with a positive rapid antigen test or culture. Antibiotic \\nchoices for GABHS include penicillin V (children 250 mg PO twice \\ndaily, adolescent/adult 500 mg PO twice daily) for 7 to 10 days; \\nbenzathine penicillin G 1.2 million units IM (600,000 units IM for \\npatients weighing less than 27 kg) once; or amoxicillin 50 mg/kg once \\ndaily for 7 to 10 days.\\n68_Cydulka_Ch68.indd   370 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 389, 'page_label': '371'}, page_content='CHAPTER 68: Common Infections of the Ears, Nose, Neck, and Throat 371 \\n3. Treat gonococcal pharyngitis with ceftriaxone 250 mg IM. When \\ngonococcal pharyngitis is suspected, empiric treatment of chlamydia is \\nrecommended with azithromycin 1 g PO given in the emergency \\ndepartment. Appropriate follow-up should be encouraged for treatment \\nfailure and symptomatic contacts. Follow-up for suspected gonococcal \\npharyngitis should include local reporting agencies and social service \\ninvestigations.\\n4. EBV is usually self-limited and requires only supportive treatment in-\\ncluding antipyretics, fluids, and rest.\\n■ ■CErVICAL LYMphADENITIS\\nAcute, unilateral cervical lymphadenitis is commonly caused by S. aureus \\nor group A Streptococcus. Bilateral cervical lymphadenitis is often caused \\nby viral entities such as EBV and adenovirus. Chronic cervical lymphade-\\nnitis is less common but may be caused by Bartonella henselae or Myco-\\nbacterium species.\\nClinical Features\\nAcute cervical lymphadenitis presents with tender, >1 cm nodes often with \\noverlying erythema. Bilateral cervical lymphadenitis presents with small, \\nrubbery lymph nodes and usually self-resolves. Bartonella results from the \\nscratch of a kitten with ipsilateral cervical lymphadenitis.\\nDiagnosis and Differential\\nMost cases are diagnosed clinically, although culture may guide effective \\nantimicrobial treatment. Differential may also include sialadenitis (infec-\\ntion of the salivary glands), which is usually caused by S. aureus, as well \\nas gram-negative and anaerobic bacteria.\\nEmergency Department Care and Disposition\\n1. Either amoxicillin plus cla vulanic acid 20 mg/kg/dose given twice \\ndaily or clindamycin 10 mg/kg/dose given three times daily for 7 to \\n10 days is recommended first-line antibiotics for the treatment of \\nacute cervical lymphadenitis.\\n2. The presence of a fluctuant mass may require incision and drainage in \\naddition to antimicrobial therapy.\\nMost cases of acute bilateral cervical lymphadenitis resolve without \\nantibiotics, as they often represent viral infection or reactive enlargement. \\nChronic cases of lymphadenitis are often treated surgically, with directed \\nantimicrobial therapy in some cases depending on clinical diagnosis.\\n■ ■FUrThEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 118 “Ear and Mastoid Disorders in Infants and \\nChildren by Carmen Coombs; Chapter 120, “Nose and Sinus Disorders in \\nInfants and Children” by Joanna S. Cohen and Dewesh Agrawal; Chapter 121 \\n“Mouth and Throat Disorders in Infants and Children” by Derya Caglar, \\nRichard Kwun, and Abigail Schuh; and Chapter 122 “Neck Masses in Infants \\nand Children” by Charles E.A. Stringer and Vikram. Sabhaney\\n68_Cydulka_Ch68.indd   371 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 390, 'page_label': '372'}, page_content='372\\nUpper Respiratory Emergencies—\\nStridor and Drooling\\nChristopher S. Cavagnaro\\nThe physical sign common to all causes of upper respiratory tract obstruc-\\ntion is stridor. Laryngomalacia, due to a developmentally weak larynx, \\naccounts for 60% of stridor in the neonatal period, but is self-limited and \\nrarely requires treatment. Common causes of stridor in children >6 months \\nof age discussed here include viral croup, epiglottitis, bacterial tracheitis, \\nairway foreign body, retropharyngeal abscess, and peritonsillar abscess.\\n■ ■VIRAL CROUP (LARYNGOTRACHEOBRONCHITIS)\\nViral croup is responsible for most cases of stridor after the neonatal period. \\nIt is usually a benign, self-limited disease caused by edema and inflamma-\\ntion of the subglottic area. Croup is most prevalent in the fall and early \\nwinter, and children ages 6 months to 3 years are most commonly affected, \\nwith a peak at an age of 12 to 24 months.\\nClinical Features\\nCroup typically begins with a 1- to 3-day prodrome of cough, coryza, and \\nlow-grade fever, followed by a 3- to 4-day period of classic barking cough, \\nthough cough and stridor may be abrupt in onset. Symptoms peak on days \\n3 to 4 and are often more severe at night. Physical examination classically \\nshows stridor, with a greater inspiratory component. Severe cases may have \\nstridor at rest, tachypnea, nasal flaring, and retractions.\\nDiagnosis and Differential\\nThe diagnosis of croup is clinical: a barking, seal-like cough and history or \\nfinding of stridor in the appropriate setting is diagnostic. The differential \\ndiagnosis includes epiglottitis, bacterial tracheitis, or foreign body aspira-\\ntion. Radiographs are not necessary, unless other causes are being consid-\\nered. Neck or chest radiographs may demonstrate subglottic narrowing or \\nthe “steeple sign,” though this sign is neither sensitive nor specific for croup.\\nEmergency Department Care and Disposition\\n1. Patients with significant stridor should be kept in a position of comfort \\nwith minimal disturbance; monitor pulse oximetry and pro vide oxygen \\nas needed.\\n2. Administer dexamethasone 0.15 to 0.6 mg/kg (10 mg maximum) PO or \\nIM (may use the IV formulation orally). Nebulized budesonide (2 mg) \\nmay also be clinically useful, if unable to tolerate oral treatment. Even \\npatients with mild croup symptoms benefit from steroids; therefore, \\nmost ED patients diagnosed with croup should be treated with a single \\ndose of corticosteroids.\\n3. Nebulized racemic epinephrine (2.25%), 0.05 mL/kg/dose up to 0.5 \\nmL, should be used to treat moderate to severe cases (significant stridor \\nat rest). Alternatively L-epinephrine (1:1000), 0.5 mL/kg/dose up to  \\n69\\nC HAPTER\\n69_Cydulka_Ch69.indd   372 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 391, 'page_label': '373'}, page_content='CHAPTER 69: Upper Respiratory Emergencies—Stridor and Drooling 373 \\n5 mL, can be used. Children with stridor associated only with agitation \\ndo not need epinephrine.\\n4. Although intubation should be performed when clinically indicated, \\naggressive treatment with epinephrine usually prevents intubation. \\nWhen necessary, consider a smaller endotracheal tube than estimated by \\nage to avoid trauma to the inflamed mucosa.\\n5. Heliox (70% helium/30% oxygen mixture) has theoretical benefits for \\nsevere refractory croup given its decreased airway resistance, though \\nstudies have shown no definitive advantage and it is limited by the low \\nfractional concentration of oxygen.\\n6. Children with persistent stridor at rest, tachypnea, retractions, or \\nhypoxia, or those who require more than two treatments of epinephrine \\nshould be admitted to the hospital.\\n7. Discharge criteria include the following: at least 3 hours since the last \\ndose of epinephrine, nontoxic appearance, no clinical signs of dehydra -\\ntion, room air oxygen saturation greater than 90%, parental ability to \\nrecognize changes in the patient’s condition, and no social concerns with \\naccess to telephone and a relatively short transit time to the hospital.\\n■ ■EPIGLOTTITIS\\nEpiglottitis, or supraglottitis, is life threatening and can occur at any age. \\nHistorically caused by Haemophilus influenzae type b, vaccination has \\ndecreased the occurrence of epiglottitis. In immunized children, most cases \\nare caused by Streptococcus and Staphylococcus species. Candida may be \\na cause in immunocompromised patients.\\nClinical Features\\nClassically, there is abrupt onset of high fever, sore throat, and drooling. \\nSymptoms may progress rapidly to stridor and respiratory distress. Cough \\nmay be absent and the voice muffled. The patient is toxic in appearance and \\nmay assume a tripod or sniffing position to maintain the airway. The pre-\\nsentation in older children and adults can be subtler. The only complaint \\nmay be severe sore throat, with or without stridor. The diagnosis is sug-\\ngested by severe sore throat, a normal-appearing oropharynx, and a striking \\ntenderness with gentle movement of the hyoid.\\nDiagnosis and Differential\\nRadiographs are usually unnecessary to make the diagnosis in patients with \\na classic presentation. If the diagnosis is uncertain, then lateral neck films \\nshould be taken at the bedside in extension and during inspiration with a \\nminimum of disturbance. If it is necessary for the patient to be moved to the \\nradiology suite, a physician trained in airway management should be pres-\\nent at all times. The epiglottis is normally tall and thin, but in epiglottitis, it \\nis very swollen and appears squat and fat like a thumbprint (called the \\n“thumb sign”) at the base of the hypopharynx (Fig. 69-1). False-negative \\nradiographic evaluations do occur, and, if suspicion remains, gentle direct \\nvisualization of the epiglottis is necessary to exclude the diagnosis. Blood \\ncultures are positive in up to 90% of patients, whereas cultures from the \\nepiglottis are less sensitive.\\n69_Cydulka_Ch69.indd   373 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 392, 'page_label': '374'}, page_content='374 SECTION 9: Pediatrics\\nEmergency Department Care and Disposition\\n1. Keep the patient seated and upright. Provide oxygen and administer \\nnebulized racemic or L-epinephrine. Heliox also can be attempted.\\n2. In the event of total airway loss, attempt bag-v alve-mask ventilation.\\n3. Alert a referral center or pediatric otolaryngologist or anesthesiologist to \\ncoordinate decisions regarding definitive airway management.\\n4. The most experienced individual should perform intubation as soon  \\nas the diagnosis is made. Use sedation, paralytics, and v agolytics as \\nFigURE 69-1.  Lateral neck view of a child with epiglottitis. Courtesy of  \\nW. McAlister, MD, W ashington University School of Medicine, St. Louis, MO.\\n69_Cydulka_Ch69.indd   374 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 393, 'page_label': '375'}, page_content='CHAPTER 69: Upper Respiratory Emergencies—Stridor and Drooling 375 \\nindicated. Multiple endotracheal tube sizes must be immediately avail-\\nable. For the patient who is able to maintain their airway, use of para-\\nlytics must be accompanied by the certainty that intubation will be \\nsuccessful or that a surgical airway can immediately be performed if \\nunsuccessful.\\n5. Steroids may be employed to decrease mucosal edema of the epiglottis. \\nUse methylprednisolone 2 mg/kg IV or dexamethasone 0.15 to 0.6 \\nmg/kg IV .\\n6. Administer antibiotics: cefuroxime  50 mg/kg/dose IV , cefotaxime   \\n50 mg/kg/dose IV , or ceftriaxone 50 mg/kg/dose IV are appropriate \\nempiric options. In regions with increased cephalosporin resistance, \\nvancomycin 10 mg/kg/dose IV should be added.\\n■ ■BACTERIAL TRACHEITIS\\nBacterial tracheitis (membranous laryngotracheobronchitis or “bacterial \\ncroup”) is uncommon and can present as either a primary or secondary \\ninfection. The mean age of presentation is between 5 and 8 years of age, \\ncompared with younger ages as had been previously described. It is usually \\ncaused by Staphylococcus aureus, Streptococcus pneumoniae , or \\nβ-lactamase–producing gram-negative organisms (H. influenzae and \\nMoraxella catarrhalis).\\nClinical Features\\nPatients with bacterial tracheitis appear toxic and have more respiratory \\ndistress than do patients with croup. They commonly present with sudden \\nworsening of an upper respiratory infection with fever, sore throat, stridor, \\nand cough occasionally productive of thick sputum.\\nDiagnosis and Differential\\nIf obtained, radiographs of the lateral neck and chest usually demonstrate \\nsubglottic narrowing of the trachea with irregular densities and ragged and \\nindistinct borders. Bronchoscopy, however, is most diagnostic.\\nEmergency Department Care and Disposition\\n1. Manage patients’ airways as above for epiglottitis; patients frequently \\nrequire intubation. Ideally, perform intubation and bronchoscopy in the \\noperating room where cultures and Gram stain may be obtained to guide \\nantibiotic therapy.\\n2. Administer empiric parenteral antibiotics: ampicillin/sulbactam 50 mg/\\nkg/dose IV or ceftriaxone 50 mg/kg/dose IV plus clindamycin 10 mg/\\nkg/dose IV . In areas with increasing S. aureus resistance, consider the \\naddition of vancomycin 10 mg/kg/dose IV .\\n■ ■AIRWAY FOREIGN BODY\\nForeign body (FB) aspirations cause more than 3000 deaths each year and \\nhave a peak incidence between ages 1 and 3 years. In children younger than \\n6 months, the cause is usually secondary to a feeding by a well-meaning \\nsibling. The most common FB aspirations fall into two groups: food and \\n69_Cydulka_Ch69.indd   375 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 394, 'page_label': '376'}, page_content='376 SECTION 9: Pediatrics\\ntoys. Commonly aspirated foods include peanuts, sunflower seeds, raisins, \\ngrapes, and hot dogs, but almost any object may be aspirated. Unlike small \\nround metal objects, aspirated vegetable matter commonly causes intense \\npneumonitis and subsequent pneumonia and suppurative bronchitis. A FB \\naspiration should be suspected if there is a history of sudden onset of \\ncoughing or choking and should be considered in all children with unilat-\\neral wheezing.\\nClinical Features\\nAt presentation many patients are asymptomatic. There may or may not be \\na witnessed aspiration. The primary symptom is cough, which is classically \\nabrupt in onset, and may be associated with gagging, choking, stridor, or \\ncyanosis. Signs depend upon the location of the FB and the degree of \\nobstruction: stridor and hoarseness with a FB in the laryngotracheal area; \\nunilateral wheezing and decreased breath sounds with a bronchial FB. \\nSymptoms, however, are unreliable in localizing the level of FB. Wheeze \\nmay be present in 30% of laryngotracheal FB aspirations and stridor in up \\nto 10% of bronchial aspirations. Eighty to 90% of FBs are located in the \\nbronchi. Patients with immediate onset of severe stridor and cardiac arrest \\nusually have laryngotracheal aspirations.\\nDiagnosis and Differential\\nFB aspiration is easily confused with more common causes of respiratory \\ndiseases because patients may have fever, wheezing, or rales. While plain \\nchest radiographs may be  helpful to confirm a diagnosis, they can be nor -\\nmal in >50% of tracheal FB and 25% of bronchial FB. More than 75% of \\nFB in children <3 years of age are radiolucent. In cases of complete \\nobstruction, atelectasis may be found. In partial obstructions, a ball valve \\neffect occurs, with air trapping caused by the FB leading to hyperinflation \\nof the obstructed lung apparent during expiration. Thus, in a stable coop-\\nerative child, inspiratory and expiratory posteroanterior chest radiographs \\nmay be helpful. In a stable but noncooperative child, decubitus films may \\nbe used, but are less sensitive than fluoroscopy. FB aspiration is definitively \\ndiagnosed preoperatively in only one-third of cases; thus, if clinically sus-\\npected, bronchoscopy is indicated.\\nUpper esophageal FBs are usually radiopaque and can impinge on the \\nposterior aspect of the trachea. Patients may present with stridor, and typi-\\ncally have dysphagia. Radiographically, flat FBs such as coins are usually \\noriented in the sagittal plane when located in the trachea and in the coronal \\nplane when in the esophagus.\\nEmergency Department Care and Disposition\\n1. If FB aspiration or airway obstruction is clearly present, perform \\nbasic life support (BLS) procedures to reliev e airway obstruction (see \\nChapter 3).\\n2. If BLS maneuvers fail, perform direct laryngoscopy and e xtraction of \\nthe FB with Magill forceps. If the FB cannot be seen, orotracheal intuba-\\ntion with dislodgement of the FB distally may be lifesaving.\\n3. If an obstructive laryngotracheal FB cannot be removed or dislodged, an \\nemergent surgical airway may be required.\\n69_Cydulka_Ch69.indd   376 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 395, 'page_label': '377'}, page_content='CHAPTER 69: Upper Respiratory Emergencies—Stridor and Drooling 377 \\n4. Definitive treatment of partial airw ay obstruction usually requires rigid \\nbronchoscopy in the operating room under general anesthesia.\\n■ ■RETROPHARYNGEAL ABSCESS\\nRetropharyngeal abscesses form within a potential space present only in \\nyoung children and usually occur in children younger than 4 years of age.\\nClinical Features\\nPatients classically present with fever, drooling, and dysphagia, and may \\nhave inspiratory stridor. Patients may hold their neck in an unusual position \\nwith torticollis, hyperextension, or stiffness. Reported complications \\ninclude rapidly fatal airway obstruction from sudden rupture of the abscess \\npocket, aspiration pneumonia, empyema, mediastinitis, and erosion into the \\njugular vein and carotid artery.\\nDiagnosis and Differential\\nPhysical examination of the pharynx may show a retropharyngeal mass. \\nAlthough palpation commonly will demonstrate fluctuance, this could lead \\nto rupture of the abscess. Lateral neck radiograph performed during inspira-\\ntion may show a widened retropharyngeal space. The diagnosis is sug-\\ngested when the retropharyngeal space at C2 is twice the diameter of the \\nvertebral body or greater than one half the width of C4. CT of the neck with \\nIV contrast is very helpful for diagnosis and defining extent of the infection \\nand may help differentiate between cellulitis and abscess.\\nEmergency Department Care and Disposition\\n1. Immediate airway stabilization is the first priority. Intubate unstable \\npatients before performing CT.\\n2. Antibiotic choice is controversial because most retropharyngeal \\nabscesses contain mix ed flora. Consider ampicillin/sulbactam 50 mg/\\nkg/dose IV or clindamycin 10 mg/kg/dose IV . Substitute ceftriaxone 50 \\nmg/kg/dose IV for ampicillin/sulbactam in the penicillin-allergic patient.\\n3. Consider adjunctive treatment with parenteral steroids (e.g., dexameth-\\nasone 0.15 to 0.6 mg/kg IV to a maximum of 10 mg) to reduce inflam-\\nmation and edema.\\n4. Retropharyngeal cellulitis and some very small abscesses may improve \\nwith antibiotics alone. Most abscesses, ho wever, will require otolaryn-\\ngology consult for operative incision and drainage.\\n■ ■PERITONSILLAR ABSCESS\\nA peritonsillar abscess is a typically unilateral, deep, oropharyngeal poly-\\nmicrobial infection, most commonly seen in adolescents and young adults.\\nClinical Features\\nPatients usually appear acutely ill with sore throat, fevers, chills, dysphagia/\\nodynophagia, trismus, drooling, and a muffled “hot potato” voice. The \\nuvula is displaced away from the affected side. As a rule, the affected tonsil \\nis anteriorly and medially displaced.\\n69_Cydulka_Ch69.indd   377 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 396, 'page_label': '378'}, page_content='378 SECTION 9: Pediatrics\\nDiagnosis and Differential\\nThe diagnosis and differentiation from aperitonsillar cellulitis can typically \\nbe made through careful visualization of the oral cavity. Classic f indings \\ninclude uvular deviation away from the abscess, soft palate displacement, \\ntrismus, and localized fluctuance; airway compromise may occur. In typical \\ncases, imaging studies are unnecessary, though in patients with toxic \\nappearance or atypical exam findings, computed tomography (CT) with \\ncontrast or ultrasound is indicated.\\nEmergency Department Care and Disposition\\n1. Treat most cases with needle aspiration, antibiotics, and pain control. \\nAdminister topical (e.g., benzocaine or endocaine spray), oral (e.g., \\noxycodone or vicodin), or parenteral (e.g., fentanyl, morphine) analge-\\nsics, then aspirate the abscess using a lar ge gauge needle. Avoid deep \\npenetration, which could injure adjacent vascular structures and result in \\nsignificant bleeding. The last centimeter of the tip of a needle guard can \\nbe cut off, and carefully reattached to the aspirating syringe, covering all \\nbut the end of the needle, to limit the depth of penetration.\\n2. Consider clindamycin 10 mg/kg/dose IV or ampicillin/sulbactam   \\n50 mg/kg/dose IV . Definitive follow-up is essential in all cases. Oral \\nantibiotics for outpatient treatment include amoxicillin/clavulanate  \\n45 mg/kg/dose given twice daily or clindamycin 10 mg/kg/dose \\nevery eight hours.\\n3. Formal incision and drainage in the operating room is sometimes neces-\\nsary, especially in young or uncooperative patients. Most patients can be \\ndischarged safely on oral antibiotics following drainage.\\n4. Consider empiric IV fluid boluses, as patients may be dehydrated on \\npresentation, and/or may not drink as well after incision and drainage.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 123, “Stridor and Drooling” by Elisa Mapelli and \\nVikram Sabhaney.\\n69_Cydulka_Ch69.indd   378 20/04/17   2:43 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 397, 'page_label': '379'}, page_content='379\\nWheezing in Infants and Children\\nRichard J. Scarfone\\n■ ■ASTHMA\\nAsthma is the most common chronic disease of childhood and the most \\nfrequent reason for hospitalization of children. The primary pathologic \\nevent is airway inflammation causing recurrent episodes of wheezing, dys-\\npnea, and cough associated with airflow obstruction that is variably revers-\\nible. The most common triggers are viral infections, allergens, exercise, and \\nenvironmental irritants including cigarette smoke and cold air.\\nClinical Features\\nWheezing, a high-pitched sound that occurs when there is an elevation of \\nairway resistance, is the hallmark of an acute asthma exacerbation. Associ-\\nated findings may include cough, shortness of breath, and chest tightness \\nor pain. To optimize medical management, clinical features are used to \\nclassify severity as mild, moderate, or severe. In addition to degree of \\nwheezing, the other important clinical features used to define illness sever-\\nity include respiratory rate, work of breathing as indicated by retractions \\nand/or nasal flaring, aeration quality, and inspiratory/expiratory ratio. \\nSerial assessments are key to emergency department (ED) management \\nbecause changes in clinical status and response to treatment are usually \\nmore relevant to outcome and need for admission than the level of severity \\nat presentation.\\nHypoxemia, while frequent, is usually mild (SpO 2 > 92%) and due to \\nV/Q mismatch, which may worsen during initial treatment with bronchodi-\\nlators for a period of 1 to 2 hours. If available, end-tidal CO 2 (ETCO2) by \\ncapnometry should be monitored during severe exacerbations. Hypocapnia \\nis expected early in the course of an asthma exacerbation, thus a normal or \\nminimally elevated ETCO2 may be a sign of impending ventilatory failure.\\nDiagnosis and Differential\\nThe differential diagnosis of wheezing in infants and children is \\nextensive—asthma and bronchiolitis being the most common causes. \\nConsideration of patient age, presenting signs and symptoms, response to \\ntherapy, and time of year helps differentiate the two diseases. For children \\n>2 years old who do not have a prior history of asthma, a provisional \\ndiagnosis of asthma is made when there are signs and symptoms of \\nwheezing, shortness of breath, cough, dyspnea, diminished air entry, or \\nretractions and demonstration of reversibility with an inhaled β 2-agonist \\n(e.g., albuterol). On the other hand, children < 2 years old without a prior \\nhistory or family history of wheezing and presenting during a respiratory \\nviral epidemic with a preceding upper respiratory infection should be \\ntreated as having bronchiolitis.\\nChest radiography should be considered if the patient fails to improve \\nas expected, fever is present, there is concern for possible pneumothorax \\n70\\nC HA p T e R\\n70_Cydulka_Ch70.indd   379 20/04/17   2:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 398, 'page_label': '380'}, page_content='380 SECTION 9: Pediatrics\\n(pain or significant hypoxia) or foreign body (unilateral wheezing), or for \\npatients with focal lung findings.\\nEmergency Department Care and Disposition\\nAn inhaled β2-agonist, most often albuterol, is the mainstay of acute asthma \\ntherapy and its frequency of administration should be titrated to the child’s \\ndegree of illness.\\n1. Administer oxygen for saturations below 92%.\\n2. Deliver albuterol by metered-dose inhaler with spacer 4 to 8 puffs \\nevery 20 minutes up to three doses or nebulization 2.5 to 5  mg every \\n20 minutes up to three doses. These routes are equally effectiv e and \\neither is indicated for the initial treatment of mild to moderately ill \\npatients. Continuously nebulized albuterol 0.5  mg/kg/h is used for \\nthose who are more severely ill. Ipratropium plus albuterol is superior \\nto albuterol alone in the treatment of acute severe asthma. Ipratropium \\nshould be given concurrently with nebulized or meter-dosed albuterol \\n0.25 to 0.5  mg Q 20  minutes × 3 doses. Lev albuterol is not any more \\neffective or safer than albuterol and is more expensive.\\n3. Administer systemic corticosteroids in all b ut the most mildly ill \\npatients who respond immediately to albuterol. Early administration, \\neven at the time of triage, decreases hospital admission rates. Pred-\\nnisone or prednisolone 2  mg/kg/dose, maximum 60  mg/dose or \\ndexamethasone 0.6  mg/kg to a maximum of 10 to16 mg may be used. \\nDexamethasone’s long half-life allows for shorter duration of therapy \\nfor discharged patients. Severely ill children should be treated with \\nIV methylprednisolone 1  mg/kg/dose.\\n4. Systemic β-agonists have no advantage over inhaled albuterol except \\nfor children with poor ventilation and impaired delivery of inhaled \\nalbuterol. Terbutaline has selective β 2 activity and can be adminis-\\ntered SQ or IM 0.01 mg/kg, maximum 0.4 mg, Q 20 minutes × 3 doses \\nto those without IV access. Epinephrine continues to be used by some \\nclinicians for its α-agonist activity that may shrink edematous mucosa. \\nIt is given SQ or IM 0.01 mg/kg, maximum 0.5 mg, Q 15 minutes.\\n5. Consider magnesium sulfate 50 to 75  mg/kg, maximum 2  g, IV over \\n10 to 20 minutes in the patient with poor ventilation. An IV fluid bolus \\nof 20 cc/kg should precede magnesium administration to avoid a clini-\\ncally significant decline in blood pressure.\\n6. Other interventions, such as the use of ketamine  2 mg/kg IV followed \\nby 2 to 3 mg/kg/h or helium-oxygen (in a 60:40 or 70:30 ratio) may be \\nconsidered in a critically ill patient not responding to other measures \\nwho is otherwise approaching the need for intubation and mechanical \\nventilation.\\n7. Helium-oxygen (Heliox) as a 60:40 or 70:30 (helium:oxygen) mix \\nmay restore laminar airflow and improve alveolar ventilation. Nebu-\\nlized albuterol may be administered with this treatment. A maximum \\nFiO2 of 40% can be administered with helium, so patients requiring \\nhigh concentrations of oxygen are not candidates for this therapy.\\n8. Administer IV fluids (normal saline) to patients in status asthmaticus \\nwho have decreased oral intake or are nil per os (NPO) due to the sever-\\nity of the episode.\\n70_Cydulka_Ch70.indd   380 20/04/17   2:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 399, 'page_label': '381'}, page_content='CHAPTER 70: Wheezing in Infants and Children 381 \\n9. Admit children to the hospital who do not respond adequately to treat-\\nment (e.g., persistent hypoxemia or continuing to require alb uterol \\ntherapy at least every 2 hours) or whose caretaker may not be able to \\nprovide necessary ongoing care.\\n10. An extremely small number of children will require intubation and \\nmechanical ventilation despite aggressive management. It is best to try \\nto avoid this due to challenges in ventilatory management and the \\npotential for barotrauma; additionally, laryngoscopy during intubation \\nmay precipitate laryngospasm. In this setting, noninvasive ventilation \\nstrategies such as bilevel positive airway pressure (BiPAP) may prevent \\nthe need for mechanical ventilation. Should a patient progress to this \\nstage, the most experienced operator available should perform the pro-\\ncedure, and a carefully considered sequence of rapid-sequence intuba-\\ntion medications chosen. These often include premedication with \\natropine 0.02 mg/kg (minimum 0.5 mg, maximum 1 mg) and lidocaine \\n1.5 mg/kg and sedation with ketamine 2 mg/kg, followed by paralysis \\nusing succinylcholine 2 mg/kg or rocuronium 1 mg/kg to provide opti-\\nmal intubating conditions. Permissiv e hypercapnia is a strategy that \\nmay minimize barotrauma.\\n11. Following initial therapy , most children will improve and may be \\nobserved off of albuterol therapy. The duration of observation will \\nvary; in general, those who were sicker on arrival should be observed \\nat least 2 to 3 hours post-albuterol before making a decision to dis-\\ncharge home. Admit children to the hospital who either do not \\nrespond adequately to initial treatment or don’t maintain that response \\n(e.g., hypoxemia, work of breathing, significant tachypnea, and/or \\nfailure to normalize aeration).\\n12. Discharge planning should include an “action plan” (av ailable at \\nhttp://www.nhlbi.nih.gov/health/public/lung/asthma/actionplan_text \\n.htm), albuterol as MDI or nebulizer, oral corticosteroids, and follow-\\nup with the primary care provider.\\n■ ■BRONCHIOLITIS\\nBronchiolitis is the most frequent lower respiratory infection in the first  \\n2 years of life and is most commonly caused by respiratory syncytial virus \\n(RSV). Infection causes acute airway inflammation and edema, small air -\\nway epithelial cell necrosis and sloughing, increased mucus production and \\nmucus plugs, and bronchospasm, all of which can vary considerably \\nbetween patients and during the course of the illness.\\nClinical Features\\nMost patients have wheezing and rhinorrhea typical of an upper respiratory \\ninfection (URI) in addition to some combination of fever, tachypnea, \\ncough, rales, use of accessory muscles, and nasal flaring. Apnea and dehy-\\ndration are of great concern and may be more common in infants younger \\nthan 3 months or those born prematurely. Hypoxemia, cyanosis, altered \\nmental status, and fatigue are ominous signs and may portend respiratory \\nfailure. Disposition decisions should be made with consideration of signs \\nof severity as well as the typical time course for illness: severity increases \\nover the first 3 to 5 days with total duration of illness 7 to 14 days.\\n70_Cydulka_Ch70.indd   381 20/04/17   2:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 400, 'page_label': '382'}, page_content='382 SECTION 9: Pediatrics\\nDiagnosis and Differential\\nBronchiolitis, like asthma, typically has wheezing as its most prominent \\nclinical sign. In contrast to asthma, however, most infants with bronchiolitis \\nare unresponsive to both β-agonists and corticosteroids. Thus, it is impor -\\ntant to differentiate the two conditions. In general, patients with bronchiol-\\nitis are <2 years old (peaking presentation is 6 to12 months of age), do not \\nhave a past history or family history of wheezing or atopic disease, have a \\nURI, and present during a RSV or other respiratory viral pathogen out-\\nbreak. Diagnosis is clinical and does not require laboratory or radiologic \\nstudies.\\nRoutine testing for RSV or other pathogens is expensive and is rarely \\nhelpful; it may be indicated only if the information is necessary for infec-\\ntion control measures for hospitalized patients. Routine performance of \\nradiographs increases inappropriate antibiotic use and does not change time \\nto recovery. Radiographs are indicated only if other diseases or foreign \\nbody aspiration are suspected, or if the patient has severe disease.\\nEmergency Department Care and Disposition\\n1. Nasal suctioning and saline drops: Deep suctioning of the nasal pas-\\nsages after saline instillation may substantially decrease work of breath-\\ning, correct hypoxemia, and enable the patient to feed normally. Nasal \\nvasoconstrictors are not indicated and have resulted in tachydysrhyth-\\nmias. Mildly ill, well-hydrated patients need to be treated with suction-\\ning only.\\n2. Provide oxygen to maintain saturations > 90%. The use of heated, \\nhumidified, high-flow nasal cannula (HFNC) therapy provides deliv-\\nery of an air/oxygen blend, up to 12  L/min in infants. Its use approxi-\\nmates continuous positiv e airway pressure to improve ventilation in a \\nminimally invasive manner and should be considered for all moderately \\nto severely ill infants.\\n3. Nebulized α- and β -agonists should not be routinely used. However, \\nuse of a β 2-agonist (albuterol) might be considered for a moderately ill \\ninfant, particularly if there is a personal or family history of asthma or \\natopic disease. Nebulized epinephrine 0.5  mL of 1:1000 in 2.5  mL \\nsaline is not routinely effective but may be reserved for those ill enough \\nto require hospitalization and who had a suboptimal response to β 2-\\nagonists. If these medications are used, an objective measure (e.g., \\nrespiratory rate or bronchiolitis score) should be used to assess response; \\nlack of response should lead to a discontinuation of that therapy.\\n4. As with epinephrine, consider nebulized hypertonic saline  3% or 5%, \\n3 to 5  mL by nebulizer to decrease mucus production and viscidity for \\nhospitalized infants unresponsive to other interventions.\\n5. Provide isotonic IV fluids (normal saline) if necessary . Patients with \\nbronchiolitis may not be able to feed normally, and when respiratory \\nrates exceed 60 to 70 breaths/min there is increased risk of aspiration of \\nfeedings.\\n6. Corticosteroids should not be used routinely for patients with bronchi-\\nolitis. A large multicenter study found no benefit of dexamethasone over \\nplacebo, whereas a second study found that the combination of dexa-\\nmethasone and epinephrine was beneficial. However, the benefit was \\n70_Cydulka_Ch70.indd   382 20/04/17   2:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 401, 'page_label': '383'}, page_content='CHAPTER 70: Wheezing in Infants and Children 383 \\nmarginal and the doses of dexamethasone were large. Potential adv erse \\neffects of these medications and lack of sufficient evidence for benefit \\npreclude their routine use.\\n7. Ventilatory support: Noninv asive measures (CPAP or BiPAP) may \\nimprove oxygenation and ventilation, decrease work of breathing, and \\ndelay or obviate the need for endotracheal intubation. Additionally, \\napplication of CPAP may prevent further apnea in affected infants.\\n8. Decision for hospitalization: Caution should be the rule when mak-\\ning disposition decisions about very young infants in respiratory dis-\\ntress due to an illness without effective outpatient therapies. Careful \\nand serial observations (including pulse oximetry) and reassessment \\nare keys to determining disposition. Persistent hypoxia, significant \\ntachypnea or work of breathing, and inability to feed or maintain hy-\\ndration are all indications for hospitalization. Decision-makers must \\nalso consider where in the clinical course of illness the patient resides \\n(severity increases over the first 3 to 5 days of illness), the ability of \\ncaretakers to manage the illness, and the availability of follow-up. In \\naddition, patients with risk factors for apnea and/or severe disease \\nwith possible respiratory failure should be identified early, including \\n(a) young developmental age (<  6 to12 weeks) or prematurity (<  37 \\nweeks); (b) witnessed apnea; (c) hemodynamically significant con -\\ngenital heart disease: on medication for CHF; moderate to severe \\npulmonary hypertension; cyanotic CHD; (d) chronic lung disease: \\nbronchopulmonary dysplasia; congenital malformations; cystic fibro-\\nsis; and (e) immunocompromised state (Table 70–1).\\nTablE 70-1 Dosages of Medications for Asthma exacerbations\\nMedication American pediatric Dosages Alternate pediatric Dosages\\nbronchodilators\\nSalbutamol/\\nalbuterol (aerosol \\nor nebulized)\\n■● MDI (90 μg/puff); delivered \\nvia valved holding chamber:\\n■● ≤ 1 year: 2 puffs/dose\\n■● 1–3 years: 4 puffs/dose\\n■● ≥ 4 years: 8 puffs/dose\\n■● MDI (100 μg/puff); delivered \\nvia valved holding chamber:\\n■● ≤ 1 year: 2 puffs/dose\\n■● 1–3 years: 4 puffs/dose\\n■● 4–6 years: 6 puffs/dose\\n■● ≥ 7 years: 8 puffs/dose\\n■● Nebulization (unit dose \\nnebule or 5 mg/mL solution):\\n■● 0.15–0.3 mg/kg/dose \\n(minimum 2.5 mg)\\n■● Nebulization (unit dose nebule \\nor 5 mg/mL solution):\\n■● < 10 kg: 1.25-mg nebule or \\n0.25 mL of 5-mg/mL solution*\\n■● 10–20 kg: 2.5-mg nebule or \\n0.5 mL of 5-mg/mL solution*\\n■● > 20 kg: 5-mg nebule or 1 mL \\nof 5-mg/mL solution*\\n■● IV:\\n■● Not available\\n■● IV:\\n■● 0.5–3 mg/kg/h continuous \\ninfusion (maximum 15 mg/h)\\n■● PO:\\n■● Not recommended\\n■● PO:\\n■● Not recommended\\n(Continued)\\n70_Cydulka_Ch70.indd   383 20/04/17   2:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 402, 'page_label': '384'}, page_content='384 SECTION 9: Pediatrics\\n■ ■FURTHeR ReADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 124, “Wheezing in Infants and Children,” by Allan \\nShefrin, Alia Busuttil and Roger Zemek.\\nTablE 70-1 Dosages of Medications for Asthma exacerbations\\nMedication American pediatric Dosages Alternate pediatric Dosages\\nIpratropium \\nbromide (aerosol or \\nnebulized)\\n■● MDI (20 μg/puff); delivered \\nvia valved holding chamber:\\n■● 4–8 puffs/dose PRN, alter-\\nnated with salbutamol\\n■● MDI (20 μg/puff); delivered via \\nvalved holding chamber:\\n■● 3 puffs/dose for all patients, \\nalternated with salbutamol\\n■● Nebulization:\\n■● 250–500 μg for all patients, \\nmixed with salbutamol\\n■● Nebulization:\\n■● 250 μg for all patients, mixed \\nwith salbutamol\\nSystemic corticosteroids\\nPrednisone (PO) 1–2 mg/kg/dose (maximum \\n60 mg) for 3–10 days\\n2 mg/kg (maximum 60 mg) in ED, \\nthen 2 mg/kg/d bid for 4 days\\nMethylprednisolone \\n(IV, IM)\\n2 mg/kg/dose load, then \\n0.5–1 mg/kg/dose every 6 h\\n1 mg/kg/dose (maximum 125 mg/\\ndose), repeated every 6 h or \\nchange to oral regimen\\nDexamethasone \\n(PO, IV, IM)\\n0.6 mg/kg/dose (maximum \\n16 mg) for 1–2 days\\n■● Multiple dosing regimens:\\n■● 0.6 mg/kg/d for 1–2 days\\n■● 0.3 mg/kg/d for 3–5 days\\nOther medications\\nMagnesium sulfate \\n(IV)\\n25–75 mg/kg/dose (maximum \\n2 g) × 1\\n50 mg/kg/dose × 1 (monitor \\nblood pressure)\\nKetamine (IV)† 1–2 mg/kg/dose × 1 2 mg/kg/dose × 1 (may alleviate \\nneed for intubation, given as \\ninduction agent for intubation)\\n*Mixed in 3 mL of normal saline solution.\\n†Consider only if standard therapies have failed in order to prevent intubation.\\nAbbreviation: MDI = metered-dose inhaler.\\n(Continued)\\n70_Cydulka_Ch70.indd   384 20/04/17   2:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 403, 'page_label': '385'}, page_content='385\\nPneumonia in Infants  \\nand Children\\nAmeer P . Mody\\nPneumonia, infection of the lower respiratory tract, is one of the leading \\ncauses of pediatric morbidity and mortality throughout the world. The \\netiologic agent, clinical presentation, and severity of illness vary greatly \\nbased on the age of the child. In neonates (age 0 to 30 days), group B \\nstreptococci and other gram-negative enteric bacteria are common patho-\\ngens. Pneumonia caused by Chlamydia trachomatis has largely been \\neliminated in developed countries, but should be considered when the \\nmother had little or no prenatal care. In infants and toddlers (1 month to \\n2 years), respiratory syncytial virus (RSV), influenza virus, parainflu-\\nenza virus, and human metapneumovirus are some of the common viral \\npathogens. Streptococcus pneumoniae and Haemophilus influenzae are \\nthe most common bacterial pathogens. Pneumonia in children aged 2 to \\n5 years is most likely caused by respiratory viruses, followed by S. pneu-\\nmoniae, H. influenzae, and Staphylococcus aureus. In children 5 to 13 \\nyears of age, Mycoplasma pneumoniae is the most likely etiology of \\ncommunity-acquired pneumonia followed by S. pneumoniae and \\nChlamydophila pneumoniae. Adolescents typically follow the same sea-\\nsonal and epidemiologic patterns of healthy adults with community-\\nacquired pneumonia.\\n■ ■CLINICAL FEATURES\\nThe clinical presentation of pneumonia varies with the age of the patient, \\nalthough most pediatric patients will have some combination of fever, pre-\\nceding viral illness, tachypnea, respiratory distress, rales, and diminished \\nbreath sounds. Tachypnea is the most sensitive finding in pediatric patients \\nwith pneumonia (see Table 71-1). Symptoms of pneumonia may be subtle \\nin neonates and infants, but these patients may be more severely ill. Fever \\nor hypothermia, apnea, tachypnea, poor oral intake, vomiting, lethargy, \\ngrunting, or shock may be present in these patients. In older children and \\nteens, community-acquired pneumonia presents more similarly to adult \\npatients with a viral prodrome, fever, cough, abnormal lung sounds, vomit-\\ning, pleuritic chest pain, tachypnea, or hypoxemia. In younger children, \\nparticularly with lower lobe pneumonias, abdominal pain may be a \\n71\\nCh APTER\\nTable 71-1 Tachypnea as an Indicator for Pneumonia\\nAge Tachypnea Comments\\n0–60 days > 60 breaths/min > 70 breaths/min indicates severe disease\\n2–12 months > 50 breaths/min > 60 breaths/min indicates severe disease\\n1–5 years > 40 breaths/min > 50 breaths/min indicates severe disease\\n> 5 years > 20 breaths/min > 50 breaths/min indicates severe disease\\n71_Cydulka_Ch71.indd   385 20/04/17   2:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 404, 'page_label': '386'}, page_content='386 SECTION 9: Pediatrics\\npredominant complaint. The clinical manifestations of bacterial and viral \\npneumonias overlap in all age groups, making the clinical distinction very \\nchallenging.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nFor most pneumonias, the etiologic agent is never determined. The diag-\\nnosis of pneumonia should primarily be made on clinical grounds; chest \\nradiography is not required and not considered the gold standard for \\ndiagnosis. Chest radiography is not 100% sensitive, nor specific for the \\ndiagnosis of pneumonia, and does not distinguish between bacterial or \\nviral etiologies. The presence of fever plus tachypnea, decreased breath \\nsounds, or fine crackles predicts pneumonia with 93% to 96% sensitivity. \\nIf all four variables are present, the sensitivity is 98%. Chest radiography \\nshould be reserved for patients in which the differential diagnosis is in \\nquestion (aspirated foreign body, congestive heart failure, mediastinal \\nmass) or a complication of pneumonia is suspected (failure of outpatient \\ntherapy, pleural effusion, cavitary pneumonia, significant patient comor -\\nbidities, age < 3 months). Routine laboratory testing is not required for \\nwell-appearing children with mild community-acquired pneumonia. For \\nneonates or older patients with significant respiratory distress or toxic \\nappearance, a blood culture, complete blood count, and serum electro-\\nlytes should be obtained. Rapid viral antigen testing (if available) for \\nRSV , influenza, and human metapneumovirus can be valuable if they are \\nquick and specific, as results may negate the need for imaging, invasive \\ntesting, and antibiotic therapy.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\nThe ED care of pediatric pneumonia is age-dependent but follows the prin-\\nciples of supportive care of respiratory distress, hypoxemia, dehydration, \\nand fever. Oxygen should be given for respiratory distress or oxygen satura-\\ntions less than 92% on room air. Antipyretics should be administered for \\nfebrile patients and may resolve tachypnea associated with fever. Patients \\nwith wheezing should be given bronchodilators. Dehydration (caused by \\nrespiratory distress, increased insensible losses, and diminished oral intake \\nassociated with pneumonia) should be corrected with boluses of 20mL/kg \\nof normal saline. Antibiotic therapy should be initiated for patients based \\non suspicion of bacterial pathogen, age of patient, and severity of illness \\n(see Table 71-2).\\nNeonates with pneumonia have a significant risk for respiratory decom-\\npensation and should be admitted and monitored closely. Most healthy \\ninfants (>3 months) and children with pneumonia can be treated as outpa-\\ntients. Criteria utilized to determine need for admission include work of \\nbreathing (presence of significant tachypnea, retractions, grunting), hypox-\\nemia, poor oral intake, persistent vomiting, dehydration, and social factors \\n(access to follow-up medical care, inadequate family resources, inability to \\nfollow treatment plan). Pediatric intensive care consultation and admission \\nshould be considered for infants with severe respiratory distress, impending \\nrespiratory failure, or shock.\\n71_Cydulka_Ch71.indd   386 20/04/17   2:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 405, 'page_label': '387'}, page_content='CHAPTER 71: Pneumonia in Infants and Children  387 \\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed, see Chapter 125, “Pneumonia in Infants and Children,” by \\nJoseph E. Copeland.\\nTable 71-2 Empiric antibiotic therapy for Pneumonia\\nAge\\nBacterial  \\nPathogens\\nOutpatient \\nTreatment\\nInpatient  \\nTreatment\\nNeonates Group B Streptococcus\\nGram-negative enterics\\nListeria monocytogenes\\nInitial outpatient \\ntreatment not \\nindicated\\nAmpicillin + gentamycin \\nor cefotaxime\\n1–3 months Streptococcus \\npneumonia\\nChlamydia trachomatis\\nHaemophilus influenza\\nBortadella pertussis\\nStaphylococcus aureus\\nInitial outpatient \\ntreatment not \\nindicated\\nAmpicillin or Ceftriaxone \\nor Cefotaxime or \\nVancomycin. Macrolide \\nshould be utilized if  \\nC. trachomatis or  \\nB. pertussis is suspected\\n3 months–5 years S. pneumonia\\nH. influenzae type b\\nNontypeable  \\nH. influenza\\nS. aureus\\nAmoxicillin \\n+/− clavulanic \\nacid or cefurox-\\nime axetil\\nAmpicillin or Ceftriaxone \\nor Cefotaxime or \\nVancomycin +/− \\nmacrolide\\n5–18 years Mycoplasma pneumonia\\nS. pneumonia\\nChlamydophila \\npneumonia\\nH. influenzae type b\\nS. aureus\\nAzithromycin (if \\nM. pneumoniae \\nsuspected) or \\nAmoxicillin \\n+/− clavulanic \\nacid or cefurox-\\nime axetil\\nAmpicillin or Ceftriaxone \\nor Cefotaxime or \\nVancomycin +/− \\nmacrolide\\n71_Cydulka_Ch71.indd   387 20/04/17   2:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 406, 'page_label': '388'}, page_content='388\\nPediatric Heart Disease\\nGarth D. Meckler\\nThere are six common clinical presentations of pediatric heart disease: \\ncyanosis, shock, congestive heart failure (CHF), pathologic murmur, hyper-\\ntension, and syncope. Table 72-1 lists the most common lesions in each \\ncategory. While cyanosis and shock typically appear in the first weeks of \\nlife and are often dramatic in their presentation, the symptoms of CHF may \\nbe subtle and include respiratory distress or feeding intolerance, which may \\nbe misdiagnosed as viral upper respiratory tract illness, especially in winter \\nmonths. A high index of suspicion must therefore be maintained in order to \\nmake the correct diagnosis. This chapter focuses on conditions producing \\ncardiovascular symptoms seen in the emergency department (ED) that \\nrequire immediate recognition, therapeutic intervention, and prompt refer -\\nral to a pediatric cardiologist.\\nThe evaluation of an asymptomatic murmur is a nonemergent diagnostic \\nworkup that can be done on an outpatient basis. Innocent murmurs, often \\ndescribed as flow murmurs, are of low intensity, are brief, and occur during \\nsystole. In general, common pathologic murmurs in children are typically \\nharsh, holosystolic, continuous, or diastolic in timing, and often radiate. \\n72\\nChapter\\nTable 72-1 Clinical presentations of Congenital heart Disease\\nClinical presentation\\nCausative Conditions in \\nNeonates\\nCausative Conditions in \\nInfants and Children\\nCyanosis Transposition of the great arteries, \\nTOF, tricuspid atresia, truncus \\narteriosus, total anomalous \\npulmonary venous return\\nTOF, Eisenmenger’s complex\\nCardiovascular shock Critical AS, coarctation of the \\naorta, HLHS\\nCoarctation of the aorta \\n(infants)\\nCongestive heart \\nfailure\\nRare: PDA, HLHS PDA, VSD, ASD, \\natrioventricular canal\\nMurmur PDA, valvular defects (AS, PS) VSD, ASD, PDA, outflow \\nobstructions, valvular defects \\n(AS, PS)\\nSyncope - AS, PS, Eisenmenger’s \\ncomplex\\nHypertension - Coarctation of the aorta\\nDysrhythmias - ASD, Ebstein’s anomaly, \\npostsurgical complication \\nafter repair of congenital \\nheart defect\\nAbbreviations: AS = aortic stenosis; ASD = atrial septal defect; HLHS = hypoplastic left heart \\nsyndrome; PDA = patent ductus arteriosus; PS = pulmonic stenosis; TOF = tetralogy of Fallot;  \\nVSD = ventricular septal defect.\\n72_Cydulka_Ch72.indd   388 01/05/17   10:33 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 407, 'page_label': '389'}, page_content='CHAPTER 72: Pediatric Heart Disease 389 \\nThey may be associated with abnormal pulses or symptoms such as syn-\\ncope or CHF.\\nThe treatment of dysrh ythmias is discussed in Chapter 3, pediatric \\nhypertension is discussed in Chapter 26, and syncope is discussed in \\nChapter 78. Chest pain is usually of benign etiology in children, though \\nmay occasionally represent congenital (e.g., Anomalous Left Coronary \\nArtery arising from Pulmonary Artery, ALCAPA) or acquired (e.g., \\nKawasaki disease, myocarditis, pericarditis, cardiomyopathy) heart dis-\\nease. Myocarditis and cardiomyopathy are covered in Chapter 24, chest \\npain and acute coronary syndrome in Chapters 17 and 18, and Kawasaki \\ndisease in Chapter 83.\\n■ ■CYaNOSIS aND ShOCK\\nCardiac causes of cyanosis and shock typically present in the first 2 weeks \\nof life and present in the critically ill neonate. The differential diagnosis, \\nhowever, is broad at this age, and, in addition to congenital heart disease, \\nthe clinician should consider infection (sepsis, pneumonia), metabolic \\ndisease (see Chapter 79), and nonaccidental trauma. For the neonate pre-\\nsenting with cyanosis, the hyperoxia test helps differentiate respiratory \\ndisease from cyanotic congenital heart disease (although imperfectly). \\nWhen placed on 100% oxygen, the infant with cyanotic congenital heart \\ndisease will fail to demonstrate an increase in Pao2 or pulse oximetry, while \\nthose with respiratory causes will often respond with an improvement in \\nPao2 or pulse oximetry.\\nClinical Features\\nAcral cyanosis (blue discoloration of the distal extremities) can be normal \\nin the neonate, but central cyanosis (including the mucus membranes of the \\nmouth) is the cardinal feature of cyanotic congenital heart disease. Appre-\\nciation of cyanosis in dark-skinned neonates may be difficult, and an accu-\\nrate set of vital signs including preductal and postductal pulse oximetry \\n(i.e., right upper extremity and either lower extremity) and four-extremity \\nblood pressures are essential. Cyanosis associated with a heart murmur \\nstrongly suggests congenital heart disease, but the absence of a murmur \\ndoes not exclude a structural heart lesion. The cyanotic infant may be \\ntachypneic, as well, though the increased respiratory rate in cyanotic heart \\ndisease is often effortless and shallow unless associated with congestive \\nheart failure, which is rare in the first week of life.\\nShock with or without cyanosis, especially during the first 2 weeks of \\nlife, should alert the clinician to the possibility of ductal-dependent con-\\ngenital heart disease in which systemic (shock) or pulmonary (cyanosis) \\nblood flow depends on patency of the fetal ductus arteriosis. Shock in the \\nneonate is recognized by inspection of the patient’s skin for pallor (or, more \\noften, an “ashen grey” appearance), mottling, cyanosis, and assessment of \\nthe mental status appropriate for age. Mental status changes include apathy, \\nirritability, or frank lethargy. Tachycardia and tachypnea may be the initial \\nsigns of impending cardiovascular collapse. Distal pulses should be \\nassessed for quality, amplitude, and duration, and a differential between \\npreductal (right brachial) and postductal (femoral) pulses or blood pressure \\nis classic for ductal-dependent lesions such as coarctation of the aorta.\\n72_Cydulka_Ch72.indd   389 01/05/17   10:33 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 408, 'page_label': '390'}, page_content='390 SECTION 9: Pediatrics\\nDiagnosis and Differential\\nThe workup for congenital heart disease begins with chest radiograph and \\nelectrocardiogram (ECG) with pediatric analysis. Chest radiographs are \\nassessed for heart size, shape, and pulmonary blood flow. An abnormal \\nright position of the aortic arch may be a clue to the diagnosis of congenital \\ncardiac lesion. Increased pulmonary vascularity may be seen with signifi-\\ncant left-to-right shunting or left-sided failure. Decreased pulmonary blood \\nflow is seen with right-sided outflow lesions such as pulmonic stenosis. \\nCyanotic heart lesions often demonstrate right axis deviation and right \\nventricular hypertrophy on ECG while left outflow obstruction (e.g., coarc-\\ntation of the aorta) may show left ventricular hypertrophy. Echocardiogra-\\nphy is generally required to define the diagnosis.\\nThe differential diagnosis for cyanosis or shock due to congenital heart \\ndisease typically includes cyanotic lesions: transposition of the great ves-\\nsels, tetralogy of Fallot, and other forms of right ventricular outflow tract \\nobstruction or abnormalities of right heart formation. Acyanotic lesions that \\ncan present with shock include severe coarctation of the aorta, critical aor -\\ntic stenosis, and hypoplastic left ventricle. It should be noted that cyanosis \\nmay accompany shock of any cause.\\nTransposition of the great vessels represents the most common cya-\\nnotic defect presenting in the first week of life. This entity is easily missed \\ndue to the absence of cardiomegaly or murmur, unless there is a coexistent \\nventricular septal defect (VSD). Symptoms (before shock) include central \\ncyanosis, increased respiratory rate, and/or feeding difficulty. There is usu-\\nally a loud and single S2. Chest radiographs may show an “egg on a string” \\nshaped heart with a narrow mediastinum and increased pulmonary vascu-\\nlar markings. ECG may show right-axis deviation and right ventricular \\nhypertrophy.\\nTetralogy of Fallot is the most common cyanotic congenital heart dis-\\nease overall, and can present with cyanosis later in infancy or childhood. \\nPhysical examination reveals a holosystolic murmur of VSD, a diamond-\\nshape murmur of pulmonary stenosis, and cyanosis. Cyanotic spells in the \\ntoddler may be relieved by squatting. Chest radiograph may show a boot-\\nshape heart with decreased pulmonary vascular markings or a right-sided \\naortic arch. The ECG often demonstrates right ventricular hypertrophy and \\nright axis deviation.\\nHypercyanotic episodes, or “tet spells,” may bring children with tetral-\\nogy of Fallot to the ED in dramatic fashion. Symptoms include paroxysmal \\ndyspnea, labored respirations, increased cyanosis, and syncope. Episodes \\nfrequently follow exertion due to feeding, crying, or straining with stools \\nand last from minutes to hours.\\nLeft ventricular outflow obstruction syndromes may present with \\nshock, with or without cyanosis. Several congenital lesions fall into this \\ncategory, but in all these disorders, systemic blood flow is dependent on \\na large contribution of shunted blood through a patent ductus arteriosus. \\nWhen the ductus closes, infants present with decreased or absent \\nperfusion, pallor or an ashen appearance, hypotension, tachypnea, and \\nsevere lactic acidosis. Diminished lower extremity pulses and BP, par -\\nticularly compared to right brachial pulse and BP, are classic for coarcta-\\ntion of the aorta.\\n72_Cydulka_Ch72.indd   390 01/05/17   10:33 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 409, 'page_label': '391'}, page_content='CHAPTER 72: Pediatric Heart Disease 391 \\nemergency Department Care and Disposition\\n1. Cyanosis and respiratory distress are first managed with high-flow \\noxygen, cardiac and oxygen monitoring, and a stable intra venous or \\nintraosseous line. Caveats: neonates tolerate low oxygen saturations \\nwell due to oxygen-avid fetal hemoglobin; oxygen is a potent pulmo-\\nnary vasodilator and may lead to “pulmonary steal” of systemic blood \\nflow, worsening systemic shock in ductal-dependent systemic blood \\nflow such as coarctation of the aorta. Treatment with prostaglandins \\n(see below) is critical in these cases.\\n2. For severe shock in infants suspected of having shunt-dependent lesions, \\ngive prostaglandin E1 (PGE1) in an attempt to reopen the ductus. \\nTreatment begins with 0.05 µg/kg/min and should be tapered to the low-\\nest effective dose; the rate may be increased to 0.2 μg/kg/min if there is \\nno improvement. Side effects include fever, skin flushing, diarrhea, and \\nperiodic apnea.\\n3. Obtain immediate consultation with a pediatric cardiologist and, if the \\npatient is in shock, a pediatric intensivist.\\n4. Management of hypercyanotic spells consists of positioning the patient \\nin the knee-to-chest position and administration of morphine sulfate \\n0.2 mg/kg SC, IM, or IO. Resistant cases should prompt immediate \\nconsultation with a pediatric cardiologist for consideration of phenyl-\\nephrine for hypotension or propranolol for tachycardia.\\n5. Consider and treat noncardiac causes of symptoms; administer a fluid \\nchallenge of 10 to 20 mL/kg of normal saline solution and empiric \\nadministration of antibiotics as indicated. Fluids should be administered \\nmore judiciously to neonates with congenital heart disease, typically \\nusing10 mL/kg boluses.\\n6. Epinephrine is the initial drug of choice for hypotension. An infusion  \\nis started at 0.05 to 0.5 μ g/kg/min and titrated to the desired blood \\npressure.\\nBy definition, these children are critically ill and require admission, \\nusually to the neonatal or pediatric intensive care unit.\\n■ ■CONGeStIVe heart FaILUre\\nClinical Features\\nCongestive heart failure from congenital or acquired heart disease typi-\\ncally presents after the neonatal period, usually in the second or third \\nmonth of life (congenital) or later in childhood (acquired causes). The \\ndistinction between pneumonia and CHF in infants requires a high index \\nof clinical suspicion and is often difficult. Pneumonia can cause a previ-\\nously stable cardiac condition to decompensate; thus, both problems can \\npresent simultaneously. Presenting symptoms include poor feeding, dia-\\nphoresis, irritability or lethargy with feeding, weak cry, and, in severe \\ncases, grunting, nasal flaring, and respiratory distress. Note that the early \\ntachypnea of CHF in infants is typically “effortless” and is the first mani-\\nfestation of decompensation, followed by increased work of breathing and \\nrales on examination.\\n72_Cydulka_Ch72.indd   391 01/05/17   10:33 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 410, 'page_label': '392'}, page_content='392 SECTION 9: Pediatrics\\nDiagnosis and Differential\\nCardiomegaly evident on chest radiograph is uni versally present except in \\nconstrictive pericarditis. A cardiothoracic index greater than 0.6 on the PA \\nchest radiograph is abnormal. The primary radiographic signs of cardio-\\nmegaly on the lateral chest radiograph are an abnormal cardiothoracic \\nindex and lack of retrosternal air space due to the direct abutment of the \\nheart against the sternum.\\nOnce CHF is recognized, age-related categories simplify further dif-\\nferential diagnosis (Table 72-2). Congenital cardiac causes of CHF are \\nbest categorized by age of onset. Early-onset CHF is associated with \\nductal-dependent lesions such as coarctation of the aorta and may be \\nabrupt in onset; persistent patent ductus arteriosis (PDA) may also present \\nin the neonatal period with CHF. Rarely, sustained tachyarrhythmias may \\npresent with CHF in the neonatal period. By contrast, lesions that result in \\npulmonary overcirculation such as VSD or atrial septal defect (ASD) pres-\\nent with gradual development of failure in the second or third month of \\nlife. Onset of CHF after age 3 months usually signifies acquired heart \\ndisease such as cardiomyopathy or myocarditis. The exception is when \\npneumonia, endocarditis, or another complication causes a congenital \\nlesion to decompensate.\\nCardiomyopathy presents with respiratory distress and feeding difficul-\\nties and is easily confused with upper respiratory tract infection. A patho-\\nlogic gallop (S3 and or S4) is key to recognition. Rales and organomegaly \\nare often present, and cardiomegaly and pulmonary vascular congestion are \\nnoted on chest radiography.\\nMyocarditis is often preceded by a viral respiratory illness, presents \\nwith nonspecific symptoms, and is more common in school age children. \\nPresenting symptoms include shortness of breath, vomiting, poor feed-\\ning, lethargy, and fever. Signs of poor perfusion, organomegaly, and \\nTable 72-2 Differential Diagnosis of Congestive heart Failure Based on age at \\npresentation\\nCardiac Lesion Chest radiograph electrocardiogram\\nTetralogy of Fallot Boot-shaped heart, normal-\\nsized heart, decreased \\npulmonary vascular markings\\nRight axis deviation, right \\nventricular hypertrophy\\nTransposition of the \\ngreat arteries\\nEgg-shaped heart, narrow \\nmediastinum, increased \\npulmonary vascular marking\\nRight axis deviation, right \\nventricular hypertrophy\\nTotal anomalous \\npulmonary venous \\nreturn\\nSnowman sign, significant \\ncardiomegaly, increased \\npulmonary vascular markings\\nRight axis deviation, right \\nventricular hypertrophy, right \\natrial enlargement\\nTricuspid atresia Heart of normal to slightly \\nincreased size, decreased \\npulmonary vascular markings\\nSuperior QRS axis with right atrial \\nhypertrophy, left atrial hypertrophy, \\nleft ventricular hypertrophy\\nTruncus arteriosus Cardiomegaly, increased \\npulmonary vascular markings\\nBiventricular hypertrophy\\n72_Cydulka_Ch72.indd   392 01/05/17   10:33 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 411, 'page_label': '393'}, page_content='CHAPTER 72: Pediatric Heart Disease 393 \\ntachypnea and tachycardia are common. ECG may show dif fuse ST \\nchanges, dysrhythmias, or ectopy, which is associated with an increased \\nrisk of sudden death; a prolonged QRS duration of > 120 ms is associ-\\nated with poor clinical outcome. Chest radiograph shows cloudy lung \\nfields from inflammation or pulmonary edema. Cardiomegaly with poor \\ndistal pulses and prolonged capillary refill, however, distinguish it from \\ncommon pneumonia. Cardiac Troponin T is a highly sensitive, though \\nnonspecific, test for myocarditis and levels < 0.01 ng/mL reliably \\nexclude myocarditis.\\nUsually pericarditis presents with pleuritic and positional chest pain. \\nMuffled heart sounds and a friction rub may be present on physical \\nexamination. Cardiomegaly is seen on a chest radiograph. An echocar -\\ndiogram is performed urgently to distinguish a pericardial effusion from \\ndilated or hypertrophic cardiomyopathy, and to determine the need for \\npericardiocentesis.\\nIf an infant presents in pure right-sided CHF, the primary problem is \\nmost likely to be pulmonary, such as cor pulmonale. In early stages, \\nperiorbital edema is often the first noticeable sign. This may progress  \\nto hepatomegaly, jugular venous distention, peripheral edema, and \\nanasarca.\\nemergency Department Care and Disposition\\n1. The infant who presents with mild tachypnea, hepatomeg aly, and car-\\ndiomegaly should be seated upright in a comfortable position, oxygen \\nshould be given, and the child should be kept in a neutral thermal \\nenvironment to avoid metabolic stresses imposed by hypothermia or \\nhyperthermia.\\n2. If the work of breathing is increased or CHF is apparent on chest radio-\\ngraph, furosemide, 1 to 2 mg/kg, should be administered parenterally.\\n3. Hypoxemia is usually corrected by administration of oxygen, fluid \\nrestriction, and diuresis, although continuous positiv e airway pressure \\n(CPAP or BIPAP) is sometimes necessary.\\n4. Stabilization and improvement of left ventricular function is often f irst \\naccomplished with inotropic agents. Digoxin is used in milder forms of \\nCHF. The appropriate first digitalizing dose to be given in the ED is 20 \\nto 30 μg/kg in neonates and 30 to 50 μg/kg in infants and children \\nbetween 1 month and 2 years of age.\\n5. When CHF progresses to cardiogenic shock (absent distal pulses and \\ndecreased end-organ perfusion), continuous infusions of inotropic \\nagents, such as dopamine or dob utamine, are indicated instead of \\ndigoxin. The initial starting range for dopamine is 5 to 15 μg/kg/min \\nand dobutamine 2.5 to 15 μg/kg/min but may result in significant \\ntachycardia in infants. Milrinone is another inotrope that improves dia-\\nstolic relaxation and vasodilation without increasing myocardial oxygen \\ndemand and is given as 50 μg/kg IV over 10 to 60 minutes followed by \\ncontinuous infusion of 0.25 to 0.75 μg/kg/min.\\n6. Aggressive management of secondary derangements, including respira-\\ntory insuf ficiency, acute renal failure, lactic acidosis, disseminated \\nintravascular coagulation, hypoglycemia, and hypocalcaemia, and fever \\nshould be implemented.\\n72_Cydulka_Ch72.indd   393 01/05/17   10:33 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 412, 'page_label': '394'}, page_content='394 SECTION 9: Pediatrics\\n7. Definitive diagnosis and treatment of congenital defects presenting with \\nCHF often requires cardiac catheterization follo wed by surgical repair. \\nSee the previous section for recommendations regarding administration \\nof prostaglandin E1 as a temporizing measure before surgery.\\n■ ■FUrther reaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 126, “Congenital and Acquired Pediatric Heart \\nDisease” by Esther L.Yue and Garth D. Meckler.\\n72_Cydulka_Ch72.indd   394 01/05/17   10:33 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 413, 'page_label': '395'}, page_content='395\\nVomiting and Diarrhea in  \\nInfants and Children\\nStephen B. Freedman\\nGastroenteritis is a major public health problem, accounting for up to 20% \\nof all acute care outpatient visits to hospitals. Most children who come to \\nthe emergency department because of vomiting and/or diarrhea have a \\nself-limited viral disorder. Nevertheless, loss of water and electrolytes can \\nlead to clinical dehydration and may result in hypovolemic shock or life-\\nthreatening electrolyte disturbances.\\n■ ■CLINICAL FEATURES\\nThe evaluation of the child’s hydration status is the cornerstone to clini-\\ncal management, regardless of whether the presenting complaint is vom-\\niting or diarrhea (Table 73-1). Viral, bacterial, and other infectious \\norganisms can cause gastroenteritis, and spread most commonly occurs \\nby the fecal-to-oral route. Viral pathogens cause disease by invading \\ntissue and altering the intestine’s ability to absorb water and electrolytes. \\nBacterial pathogens cause diarrhea by producing enterotoxins and cyto-\\ntoxins and by invading the intestine’s mucosal absorptive surface. \\nDysentery occurs when bacteria invade the mucosa of the terminal ileum \\nand colon, producing diarrhea with blood, mucus, or pus. Table 73-2 lists \\ncommon infectious agents, clinical features, and treatments of diarrhea \\nin children. Infants are at greater risk for rapid dehydration and hypogly-\\ncemia, as they are with chronic illnesses, high-risk social situations, or \\nmalnutrition.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nAcute gastroenteritis is a clinical diagnosis that is characterized by the \\npresence of three or more diarrheal stools in a 24-hour period, and may be \\naccompanied by vomiting, poorly localized abdominal pain, and fever. \\nBecause gastroenteritis-induced dehydration is usually isotonic, serum \\nelectrolytes are not routinely helpful unless signs of severe dehydration \\nare present or intravenous rehydration fluids will be administered. The \\n73\\nCh A p TER\\nTable 73-1 Clinical Dehydration Score\\nScore General Appearance Eyes\\nOral Mucosa \\n(Tongue) Tears\\n0 Normal Normal Moist Normal\\n1 Thirsty, restless, lethargic \\nbut irritable\\nMildly \\nsunken\\nSticky Decreased\\n2 Drowsy/nonresponsive, \\nlimp, cold, diaphoretic\\nVery sunken Dry None\\nScore >0 = some dehydration; score >5 = moderate-severe dehydration.\\n73_Cydulka_Ch73.indd   395 20/04/17   2:45 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 414, 'page_label': '396'}, page_content='Table 73-2 Clinical Features and Treatment of Bacterial Gastroenteritis\\nOrganism Typical Clinical Features Risk Factors Complications Antimicrobial Therapy\\nShigella ■● Ranges from watery stools \\nwithout constitutional symp-\\ntoms to fever, abdominal pain, \\ntenesmus, mucoid stools, \\nhematochezia; Shigella dysen-\\nteriae serotype 1 causes more \\nsevere symptoms\\n■● Contact with infected host \\nor fomite, poor sanitation, \\ncrowded living conditions, \\nday care\\n■● Pseudomembranous colitis, toxic \\nmegacolon, intestinal perforation, \\nbacteremia, \\n■● Reiter’s syndrome, hemolytic-\\nuremic syndrome, encephalopathy, \\nseizures, hemolysis\\n■● Typically self-limited\\n■● Treat if: immunocompromised, severe \\ndisease, dysentery or systemic symptoms\\n■● If susceptibility unknown: azithromycin, \\nceftriaxone, ciprofloxacin; if susceptible, \\nampicillin or trimethoprim-sulfamethox-\\nazole\\nSalmonella ■● Nontyphoidal: May be asymp-\\ntomatic or cause watery diar-\\nrhea, mild fever, abdominal \\ncramps\\n■● Enterica serotypes: “enteric \\nfever” may include high fever, \\nconstitutional symptoms, \\nheadache, abdominal pain, \\ndactylitis, hepatospleno-\\nmegaly, rose spots, altered \\nmental status\\n■● Direct contact with animals: \\npoultry, livestock, reptiles, \\npets; consuming food \\ncontaminated by human \\ncarrier: beef, poultry, eggs, \\ndairy, water\\n■● Meningitis, brain abscess, osteo-\\nmyelitis, bacteremia, dehydration, \\nendocarditis, enteric (typhoid or \\nparatyphoid) fever\\n■● Typically self-limited\\n■● Treat if: < 3 months of age, hemoglobin-\\nopathy, immunodeficiency, chronic GI tract \\ndisease, malignancy, severe colitis, bacte-\\nremia, sepsis\\n■● Options: ampicillin, amoxicillin, \\ntrimethoprim-sulfamethoxazole; if \\nresistant, azithromycin, fluoroquinolone\\n■● Invasive disease: cefotaxime, ceftriaxone\\nCampylobacter ■● Diarrhea, hematochezia, \\nabdominal pain, fever, malaise\\n■● Contamination from poultry \\nfeces or undercooked poultry, \\nuntreated water, unpasteur-\\nized milk, pets (dogs, cats, \\nhamsters, birds); person-to-\\nperson transmission possible\\n■● Acute: dehydration, bacteremia, \\nfocal infections, febrile seizures\\n■● Convalescence: reactive arthritis, \\nReiter’s syndrome, erythema \\nnodosum, acute idiopathic poly-\\nneuritis, Miller Fisher syndrome, \\nmyocarditis, pericarditis\\n■● Often self-limited; 20% have relapse or \\nprolonged symptoms\\n■● Treat if: moderate-severe symptoms, \\nrelapse, immunocompromised, day care \\nand institutions\\n■● Options: erythromycin, azithromycin, \\nciprofloxacin\\nEscherichia coli–Shiga \\ntoxin producing\\n■● Initially nonbloody diarrhea, \\noften becoming bloody; \\nsevere abdominal pain\\n■● Food or water contaminated \\nwith human or cattle feces, \\nundercooked beef, unpas-\\nteurized milk\\n■● Hemorrhagic colitis, hemolytic-\\nuremic syndrome\\n■● None indicated; debated risk of increased \\nincidence of hemolytic-uremic syndrome \\nwith treatment\\nE. coli–enteropathogenic ■● Severe watery diarrhea, \\nusually children <2 years in \\nresource-limited countries\\n■● Food or water contaminated \\nwith feces\\n■● Dehydration ■● Treat if severe\\n■● Options: trimethoprim-sulfamethoxazole, \\nazithromycin, ciprofloxacin\\nE. coli–enterotoxigenic ■● Moderate watery diarrhea, \\nabdominal cramps; traveler’s \\ndiarrhea\\n■● Food or water contaminated \\nwith feces\\n■● Dehydration ■● Treat if severe\\n■● Options: trimethoprim-sulfamethoxazole, \\nazithromycin, ciprofloxacin\\nE. coli–enteroinvasive ■● Fever, bloody or nonbloody \\ndiarrhea, dysentery\\n■● Food or water contaminated \\nwith feces\\n■● Dehydration ■● Treat if severe\\n■● Options: trimethoprim-sulfamethoxazole, \\nazithromycin, ciprofloxacin\\nE. coli–enteroaggregative ■● Watery diarrhea, may be \\nprolonged\\n■● Food or water contaminated \\nwith feces\\n■● Dehydration ■● Treat if severe\\n■● Options: trimethoprim-sulfamethoxazole, \\nazithromycin, ciprofloxacin\\nYersinia ■● Bloody diarrhea with mucus, \\nfever, abdominal pain; pseu-\\ndoappendicitis syndrome: \\nfever, right lower quadrant \\npain, leukocytosis; Yersinia \\npseudotuberculosis causes \\nfever, scarlatiniform rash, \\nabdominal pain\\n■● Contaminated food: \\nimproperly cooked pork, \\nunpasteurized milk, \\nuntreated water; contact \\nwith animals (ungulates, \\nrodents, rabbits, birds)\\n■● Acute: bacteremia, pharyngitis, \\nmeningitis, osteomyelitis, pyomy-\\nositis, conjunctivitis, pneumonia, \\nempyema, endocarditis, acute \\nperitonitis, liver/spleen abscess; \\nconvalescence: erythema nodo-\\nsum, glomerulonephritis, reactive \\narthritis\\n■● Typically self-limited; if severe, treat  \\nwith trimethoprim-sulfamethoxazole,  \\naminoglycosides, cefotaxime, \\nfluoroquinolones, tetracycline, \\ndoxycycline, chloramphenicol\\nVibrio cholerae ■● Voluminous watery diarrhea, \\nusually without cramps or fever, \\nclassically described as “rice \\nwater” stools\\n■● Travel to affected areas, \\nconsumption of contamin ated \\nwater or food (particularly \\nundercooked seafood)\\n■● May rapidly lead to hypovolemic \\nshock, hypoglycemia, hypokalemia, \\nmetabolic acidosis, seizures\\n■● Treat if moderate or severe: azithromycin, \\ndoxycycline; ciprofloxacin or trime-\\nthoprim-sulfamethoxazole if resistant\\n396\\n73_Cydulka_Ch73.indd   396 20/04/17   2:45 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 415, 'page_label': '397'}, page_content='Table 73-2 Clinical Features and Treatment of Bacterial Gastroenteritis\\nOrganism Typical Clinical Features Risk Factors Complications Antimicrobial Therapy\\nShigella ■● Ranges from watery stools \\nwithout constitutional symp-\\ntoms to fever, abdominal pain, \\ntenesmus, mucoid stools, \\nhematochezia; Shigella dysen-\\nteriae serotype 1 causes more \\nsevere symptoms\\n■● Contact with infected host \\nor fomite, poor sanitation, \\ncrowded living conditions, \\nday care\\n■● Pseudomembranous colitis, toxic \\nmegacolon, intestinal perforation, \\nbacteremia, \\n■● Reiter’s syndrome, hemolytic-\\nuremic syndrome, encephalopathy, \\nseizures, hemolysis\\n■● Typically self-limited\\n■● Treat if: immunocompromised, severe \\ndisease, dysentery or systemic symptoms\\n■● If susceptibility unknown: azithromycin, \\nceftriaxone, ciprofloxacin; if susceptible, \\nampicillin or trimethoprim-sulfamethox-\\nazole\\nSalmonella ■● Nontyphoidal: May be asymp-\\ntomatic or cause watery diar-\\nrhea, mild fever, abdominal \\ncramps\\n■● Enterica serotypes: “enteric \\nfever” may include high fever, \\nconstitutional symptoms, \\nheadache, abdominal pain, \\ndactylitis, hepatospleno-\\nmegaly, rose spots, altered \\nmental status\\n■● Direct contact with animals: \\npoultry, livestock, reptiles, \\npets; consuming food \\ncontaminated by human \\ncarrier: beef, poultry, eggs, \\ndairy, water\\n■● Meningitis, brain abscess, osteo-\\nmyelitis, bacteremia, dehydration, \\nendocarditis, enteric (typhoid or \\nparatyphoid) fever\\n■● Typically self-limited\\n■● Treat if: < 3 months of age, hemoglobin-\\nopathy, immunodeficiency, chronic GI tract \\ndisease, malignancy, severe colitis, bacte-\\nremia, sepsis\\n■● Options: ampicillin, amoxicillin, \\ntrimethoprim-sulfamethoxazole; if \\nresistant, azithromycin, fluoroquinolone\\n■● Invasive disease: cefotaxime, ceftriaxone\\nCampylobacter ■● Diarrhea, hematochezia, \\nabdominal pain, fever, malaise\\n■● Contamination from poultry \\nfeces or undercooked poultry, \\nuntreated water, unpasteur-\\nized milk, pets (dogs, cats, \\nhamsters, birds); person-to-\\nperson transmission possible\\n■● Acute: dehydration, bacteremia, \\nfocal infections, febrile seizures\\n■● Convalescence: reactive arthritis, \\nReiter’s syndrome, erythema \\nnodosum, acute idiopathic poly-\\nneuritis, Miller Fisher syndrome, \\nmyocarditis, pericarditis\\n■● Often self-limited; 20% have relapse or \\nprolonged symptoms\\n■● Treat if: moderate-severe symptoms, \\nrelapse, immunocompromised, day care \\nand institutions\\n■● Options: erythromycin, azithromycin, \\nciprofloxacin\\nEscherichia coli–Shiga \\ntoxin producing\\n■● Initially nonbloody diarrhea, \\noften becoming bloody; \\nsevere abdominal pain\\n■● Food or water contaminated \\nwith human or cattle feces, \\nundercooked beef, unpas-\\nteurized milk\\n■● Hemorrhagic colitis, hemolytic-\\nuremic syndrome\\n■● None indicated; debated risk of increased \\nincidence of hemolytic-uremic syndrome \\nwith treatment\\nE. coli–enteropathogenic ■● Severe watery diarrhea, \\nusually children <2 years in \\nresource-limited countries\\n■● Food or water contaminated \\nwith feces\\n■● Dehydration ■● Treat if severe\\n■● Options: trimethoprim-sulfamethoxazole, \\nazithromycin, ciprofloxacin\\nE. coli–enterotoxigenic ■● Moderate watery diarrhea, \\nabdominal cramps; traveler’s \\ndiarrhea\\n■● Food or water contaminated \\nwith feces\\n■● Dehydration ■● Treat if severe\\n■● Options: trimethoprim-sulfamethoxazole, \\nazithromycin, ciprofloxacin\\nE. coli–enteroinvasive ■● Fever, bloody or nonbloody \\ndiarrhea, dysentery\\n■● Food or water contaminated \\nwith feces\\n■● Dehydration ■● Treat if severe\\n■● Options: trimethoprim-sulfamethoxazole, \\nazithromycin, ciprofloxacin\\nE. coli–enteroaggregative ■● Watery diarrhea, may be \\nprolonged\\n■● Food or water contaminated \\nwith feces\\n■● Dehydration ■● Treat if severe\\n■● Options: trimethoprim-sulfamethoxazole, \\nazithromycin, ciprofloxacin\\nYersinia ■● Bloody diarrhea with mucus, \\nfever, abdominal pain; pseu-\\ndoappendicitis syndrome: \\nfever, right lower quadrant \\npain, leukocytosis; Yersinia \\npseudotuberculosis causes \\nfever, scarlatiniform rash, \\nabdominal pain\\n■● Contaminated food: \\nimproperly cooked pork, \\nunpasteurized milk, \\nuntreated water; contact \\nwith animals (ungulates, \\nrodents, rabbits, birds)\\n■● Acute: bacteremia, pharyngitis, \\nmeningitis, osteomyelitis, pyomy-\\nositis, conjunctivitis, pneumonia, \\nempyema, endocarditis, acute \\nperitonitis, liver/spleen abscess; \\nconvalescence: erythema nodo-\\nsum, glomerulonephritis, reactive \\narthritis\\n■● Typically self-limited; if severe, treat  \\nwith trimethoprim-sulfamethoxazole,  \\naminoglycosides, cefotaxime, \\nfluoroquinolones, tetracycline, \\ndoxycycline, chloramphenicol\\nVibrio cholerae ■● Voluminous watery diarrhea, \\nusually without cramps or fever, \\nclassically described as “rice \\nwater” stools\\n■● Travel to affected areas, \\nconsumption of contamin ated \\nwater or food (particularly \\nundercooked seafood)\\n■● May rapidly lead to hypovolemic \\nshock, hypoglycemia, hypokalemia, \\nmetabolic acidosis, seizures\\n■● Treat if moderate or severe: azithromycin, \\ndoxycycline; ciprofloxacin or trime-\\nthoprim-sulfamethoxazole if resistant\\n397\\n73_Cydulka_Ch73.indd   397 20/04/17   2:45 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 416, 'page_label': '398'}, page_content='398 SECTION 9: Pediatrics\\nexception is infants in the first 6 months of life, in whom signif icant \\nsodium abnormalities may develop. Bedside glucose should be checked in \\nall patients with altered mental status; hypoglycemia can develop rapidly \\nin the setting of protracted vomiting or diarrhea in infants and toddlers. \\nStool cultures are reserved for cases in which the child has traveled to a \\nhigh-risk country, is highly or persistently febrile, has had more than  \\n10 stools in the previous 24 hours, or has blood in the stool. In the setting \\nof a known outbreak of Escherichia coli O157:H7, consider stool cultures \\nand blood tests to check for evidence of hemolysis, thrombocytopenia, \\nand acute kidney injury.\\nAlthough diarrhea is the most prominent symptom of acute gastroen-\\nteritis in infants and children, other etiologies of diarrhea that may result \\nin significant morbidity must be considered: bacterial colitis, Hirschsprung \\ndisease, partial obstruction, inflammatory bowel disease, and hemolytic \\nuremic syndrome. Acute appendicitis typically manifests with abdominal \\npain followed by vomiting associated with constipation; however, it may \\nalso cause diarrhea, particularly once the appendix has perforated (see \\nChapter 74, “Pediatric Abdominal Emergencies”).\\nV omiting is also a common and nonspecific presentation for other \\ndisease processes, such as otitis media, urinary tract infection, sepsis, \\nmalrotation, intussusception, increased intracranial pressure, metabolic \\nacidosis, and drug or toxin ingestions. Consequently, isolated vomiting, \\nthough most often of viral origin, requires a careful and thoughtful evalu-\\nation before being diagnosed as acute gastroenteritis. Specific clinical \\nfindings, such as bilious or bloody vomitus, hematochezia, or abdominal \\npain, should trigger concerns for a disease process other than simple viral \\ngastroenteritis.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nDehydration (Vomiting and/or Diarrhea)\\n1. Because most cases are self-limited, oral rehydration is generally all \\nthat is necessary. V omiting is not a contraindication to oral rehydration; \\nthe key is to give small amounts of the solution frequently. Use of a \\ncommercially available oral rehydration solution (ORS) containing \\n45 to 60  mmol/L of sodium is recommended. Many other beverages  \\ntraditionally suggested for children with vomiting and diarrhea, such as \\ntea, juice, or sports drinks, are deficient in sodium and may provide \\nexcessive sugar, resulting in amplified fluid losses. Give ORS 50 to \\n100 mL/kg of body weight, plus additional ORS to compensate for \\nongoing losses. Aim for about 30 mL (1 ounce) of ORS per kilogram of \\nbody weight per hour . Consider nasogastric administration of fluids if \\noral challenge fails.\\n2. Administer intravenous or intraosseous isotonic crystalloid to children \\nwith severe dehydration, hemodynamic compromise, or when altered \\nmental status precludes safe oral administration of fluid. Give normal \\nsaline or Ringer’s lactate as a 20-mL/kg bolus every 20  minutes until \\nperfusion improves and urine output is adequate.\\n3. Treat hypoglycemia with 10% dextrose 5  mL/kg in infants or 25% \\ndextrose 2 mL/kg in toddlers and older children.\\n73_Cydulka_Ch73.indd   398 20/04/17   2:45 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 417, 'page_label': '399'}, page_content='CHAPTER 73: Vomiting and Diarrhea in Infants and Children  399 \\nVomiting\\n1. Treat dehydration, hypoglycemia, and electrolyte abnormalities as men-\\ntioned earlier.\\n2. Ondansetron 0.15 mg/kg/dose should be administered (or 2 mg for 8 to \\n<15 kg; 4 mg for 15 to <30 kg; 8 mg if ≥30 kg) as an adjunct to oral \\nrehydration therapy in children with persistent vomiting. Oral dosing is \\npreferred as the main objective is to support the success of oral rehydra-\\ntion; intravenous ondansetron administration results in greater QT pro-\\nlongation and its use should be avoided.\\n3. Most children can be discharged if they are tolerating oral rehydration, \\nhave adequate urine output, and ongoing fluid losses have been mini-\\nmized. Continuation of a normal diet (including lactose-containing milk \\nor formula) is recommended. Patients who cannot tolerate oral fluids, \\nhave significant ongoing losses, severe electrolyte abnormalities, or \\nsurgical abdominal processes, require admission to the hospital.\\nDiarrhea\\n1. Treat dehydration and hypoglycemia as above.\\n2. Children with mild diarrhea who are not dehydrated may continue rou-\\ntine feedings. Do not withhold feedings > 4 hours in a dehydrated child \\nor for any length of time in a child who is not dehydrated. There is no \\nneed to dilute formula because more than 80% of children with acute \\ndiarrhea can tolerate full-strength milk safely.\\n3. Antidiarrheal and antimotility agents such as loperamide are not recom-\\nmended in children and are contraindicated in young children.\\n4. Antibiotics are unnecessary for the vast majority of children with acute \\ngastroenteritis and may be associated with increased risk for hemolytic \\nuremic syndrome. See Table 73-2 for specific treatment recommenda-\\ntions by pathogen.\\n5. All infants and children who appear toxic or have high-risk social situa-\\ntions, significant dehydration, significant ongoing fluid losses, altered \\nmental status, inability to drink, or laboratory evidence of hemolytic \\nanemia, thrombocytopenia, azotemia, or a significant sodium abnormal-\\nity should be admitted.\\n6. Children who respond to oral or intravenous hydration can be dis -\\ncharged. Instructions should be given to return to the emergency depart-\\nment or seek care with the primary care provider if the child becomes \\nunable to tolerate oral hydration, develops bilious vomiting, becomes \\nless alert, or exhibits signs of dehydration, such as no longer wetting \\ndiapers. Dietary recommendations include a diet high in complex carbo-\\nhydrates, lean meats, vegetables, fruits, and yogurt. Fatty foods and \\nfoods high in simple sugars should be avoided. The BRAT diet is dis-\\ncouraged because it does not provide adequate energy sources.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th edition, see Chap. 128, “V omiting, Diarrhea, and Dehydration in \\nInfants and Children,” by Stephen B. Freedman and Jennifer D. Thull-Freedman.\\n73_Cydulka_Ch73.indd   399 20/04/17   2:45 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 418, 'page_label': '400'}, page_content='400\\nPediatric Abdominal \\nEmergencies\\nJanet Semple-Hess\\n■ ■ABDOMINAL PAIN\\nThe assessment of acute abdominal pain can be challenging given the pre-\\nverbal state of young children, the varied number of diagnoses that present \\nsimilarly, and increasing appreciation of risks associated with pediatric \\ndiagnostic imaging.\\nClinical Features\\nPresenting signs and symptoms differ by age. The key gastrointestinal (GI) \\nsigns and symptoms include pain, vomiting, diarrhea, constipation, fever, \\njaundice, and masses. Abdominal pain in children younger than 2 years \\ntypically manifests as fussiness, irritability, lethargy, or grunting. Toddlers \\nand school-age children often localize pain poorly and point to their umbi-\\nlicus, or may present as refusal to ambulate. Pain may be peritoneal and \\nexacerbated by motion, or spasmodic, and associated with restlessness. \\nAbdominal pain may originate from non-GI sources, and associated symp-\\ntoms may help localize extra-abdominal causes such as cough with \\npneumonia or sore throat in streptococcal pharyngitis.\\nV omiting and diarrhea are common in children. These symptoms may \\nbe the result of a benign process or indicate the presence of a life-threaten-\\ning condition. Bilious vomiting is almost always indicative of a serious \\nprocess, especially in the neonate. Upper GI bleeding in children presents \\nwith hematemesis, which is often frightening to caretakers, but rarely seri-\\nous in an otherwise healthy infant or child. Lower GI bleeding presents \\nwith melena or hematochezia, and the distinction between painless and \\npainful rectal bleeding can help differentiate likely etiologies. Jaundice can \\nbe an ominous sign, and sepsis, congenital infections, hepatitis, anatomic \\nproblems, and enzyme deficiencies should be considered in the evaluation \\nof these patients. Abdominal masses may be asymptomatic (e.g., Wilms \\ntumor) or associated with painless vomiting (e.g., pyloric stenosis) or \\ncolicky abdominal pain (e.g., intussusception).\\nDiagnosis and Differential\\nObtain a thorough history from parent and child (if possible), including the \\nquality and location of pain, chronology of events, feedings, bowel habits, \\nfever, weight changes, and other systemic signs and symptoms. Begin the \\nphysical examination with an assessment of the child’s overall appearance, \\nvital signs, and hydration status. Observation should precede auscultation \\nand palpation. Extra-abdominal areas including the chest, pharynx, testes, \\nscrotum, inguinal area, and neck should also be evaluated. Adolescent \\nfemales who are sexually active with lower abdominal pain may require a \\nbimanual exam. The likely etiologies of abdominal pain vary with age. \\nTable 74-1 classifies emergent and nonemergent conditions by age group.\\n74\\nC HAP ter\\n74_Cydulka_Ch74.indd   400 20/04/17   2:46 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 419, 'page_label': '401'}, page_content='CHAPTER 74: Pediatric Abdominal Emergencies 401 \\nTAblE 74-1 Causes of Abdominal Pain by Age Group\\nAge emergent Nonemergent\\n0–3 months Necrotizing enterocolitis\\nVolvulus\\nIncarcerated hernia\\nTesticular torsion\\nNonaccidental trauma\\nHirschsprung’s enterocolitis\\nConstipation\\nAcute gastroenteritis\\nColic\\n3 months to 3 years Intussusception\\nVolvulus\\nTesticular torsion\\nAppendicitis\\nVaso-occlusive crisis\\nTumor\\nPneumonia\\nUrinary tract infections\\nUrinary tract infections\\nConstipation\\nHenoch–Schönlein purpura\\nAcute gastroenteritis\\n3 years through  \\nado lescence\\nAppendicitis\\nDiabetic ketoacidosis\\nVaso-occlusive crisis\\nEctopic pregnancy\\nOvarian torsion\\nTesticular torsion\\nCholecystitis\\nPancreatitis\\nUrinary tract infections\\nTumor\\nPneumonia\\nStreptococcus pharyngitis\\nInflammatory bowel disease\\nPregnancy\\nRenal stones\\nPeptic ulcer disease/gastritis\\nOvarian cysts\\nHenoch–Schönlein purpura\\nConstipation\\nAcute gastroenteritis\\nNonspecific viral syndromes\\nNeonates and Young Infants (0 to 3 Months)\\nLife-threatening abdominal conditions in young infants include necrotizing \\nenterocolitis, malrotation with midgut volvulus, incarcerated hernias, and \\nnonaccidental trauma. Other urgent conditions include pyloric stenosis and \\ntesticular torsion. Inconsolability, lethargy, and poor feeding may be the \\nonly indication of serious underlying disease. Bilious vomiting in an infant \\nindicates intestinal obstruction and should be considered a surgical emer -\\ngency until proven otherwise. Common non-life-threatening causes of \\nabdominal pain in young infants include colic (see Chapter 67) milk-\\nprotein allergy or gastroesophageal reflux. Fever requires thorough investi-\\ngation for a source (see Chapter 66). Other causes of irritability in infants \\nshould be considered, including hair or thread tourniquets of the digits and \\ngenitalia, and corneal abrasions (see Chapter 67).\\nHelpful studies in this age group include abdominal two-view radio-\\ngraphs to identify obstruction, pneumatosis intestinalis, or free air; abdom-\\ninal ultrasound to diagnose pyloric stenosis, testicular torsion, and hernias; \\nand upper GI contrast studies to identify malrotation. Useful laboratory \\nstudies include serum electrolytes to identify abnormalities resulting from \\nvomiting and dehydration and a CBC, coagulation panel, and type and \\nscreen if concern is for a surgical abdomen with perforation.\\nMalrotation of the intestine can present with life-threatening volvulus. \\nSymptoms include bilious vomiting, abdominal distention, and obstipation, \\n74_Cydulka_Ch74.indd   401 20/04/17   2:46 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 420, 'page_label': '402'}, page_content='402 SECTION 9: Pediatrics\\nor, occasionally, streaks of blood in the stool. The v ast majority of cases \\npresent within the first month of life. Patients are ill-appearing and may \\npresent in compensated or decompensated shock. A “bird’s beak” appear -\\nance on an upper GI series is suggestive of this diagnosis. Immediate \\nsurgical consultation and aggressive fluid resuscitation are critical to \\nimprove outcomes.\\nPyloric stenosis usually presents with progressive nonbilious, projectile \\nvomiting occurring just after feeding. Pyloric stenosis occurs most com-\\nmonly in the third or fourth week of life, but may be seen anywhere from \\n1 to 12 weeks of age. A left upper quadrant pyloric mass, or “olive,” may \\nbe present, but is usually difficult to detect, and peristaltic waves may be \\nnoted following a feeding trial in the ED. Ultrasound is the imaging modal-\\nity of choice. Electrolytes may demonstrate a characteristic hypochloremic \\nmetabolic alkalosis, which must be corrected prior to definitive surgical \\ncare. While pyloric stenosis is not a surgical emergency, the resultant dehy-\\ndration from persistent vomiting requires immediate medical treatment.\\nNecrotizing enterocolitis, although rare outside of the neonatal unit, \\nshould be considered in any infant younger than 3 weeks of age, especially \\nif premature. V omiting, poor feeding, and abdominal distention may be \\npresent, and abdominal films may show pneumatosis intestinalis, as well as \\nportal vein gas. Immediate surgical/neonatology consultation, NPO, IVF \\nhydration, and broad-spectrum antibiotics for intestinal flora should be \\ninstituted if suspected.\\nHirschsprung’s disease is a pathologic cause of constipation in this \\nage group, as true constipation is unusual. Key history for Hirschprung’s \\ndisease is delayed passage of meconium at birth (more than 24 hours). \\nSymptoms include infrequent and often explosive bowel movements, \\npoor feeding and growth, and progressive abdominal distension. Toxic \\nmegacolon may occur as a complication and if suspected, emergent surgi-\\ncal consultation is warranted.\\nOlder Infants and Toddlers (3 Months to 3 Years)\\nThe differential diagnosis of acute abdominal pain in this age group \\nincludes intussusception, gastroenteritis (see Chapter 73), constipation, \\nurinary tract disease (see Chapter 75), and nonaccidental trauma. Though \\nless common in this age group, acute appendicitis, diabetic ketoacidosis or \\nother metabolic diseases, tumors such as Wilm’s, neuroblastoma or hepato-\\nblastoma and malrotation with midgut volvulus must be considered.\\nImaging studies are guided by the differential diagnosis: radiographs \\ncan help rule out free air or obstruction, and confirm suspected constipa-\\ntion; ultrasound can help identify intussusception, abdominal or renal mass, \\nor appendicitis, and air-contrast enema is both diagnostic and potentially \\ntherapeutic for intussusception. A CBC and electrolytes may be helpful in \\nevaluating complications of vomiting and diarrhea, and urinalysis will \\nidentify pyelonephritis as a potential cause of abdominal pain in this age \\ngroup. A bedside glucose is helpful in the lethargic child or in cases with \\npersistent or prolonged vomiting.\\nIntussusception occurs when one portion of the bowel telescopes into \\nanother, which can result in a partial or complete obstruction, bowel-wall \\nedema, and eventually bowel ischemia. The greatest incidence occurs \\nbetween 6 to 18 months of age, and it is the most common cause of \\n74_Cydulka_Ch74.indd   402 20/04/17   2:46 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 421, 'page_label': '403'}, page_content='CHAPTER 74: Pediatric Abdominal Emergencies 403 \\nintestinal obstruction in children under 2 years of age. The classic presenta-\\ntion of intermittent paroxysms of abdominal pain with pain-free intervals \\n(or lethargy), vomiting (may be bilious), and “currant jelly stool” are not \\npresent in all patients, and bloody stools is a late sign. Stool testing may \\nreveal occult blood in 70% of intussusception cases. Providers must have a \\nhigh index of suspicion for intussusception in patients presenting with non-\\nspecific changes in mental status or who are ill-appearing without any \\napparent etiology. Ultrasound should be performed if the diagnosis is \\nambiguous, and may demonstrate the classic “target sign” (see Fig. 74-1). \\nIn more classic cases, air or barium enema should be performed, and can \\nbe both diagnostic and therapeutic. Radiologic reduction requires a readily \\navailable pediatric surgeon for irreducible cases or perforation during the \\nprocedure. Uncomplicated cases of intussusception successfully reduced \\nby enema may be discharged after observation if tolerating oral fluids and \\nhas reliable follow-up, as there is a 10% recurrence risk.\\nConstipation, defined as infrequent, hard stools, is a common cause of \\nabdominal pain in children and may be a sign of either a pathologic (e.g., \\nHirschsprung disease, cystic fibrosis, spinal cord abnormality, or infant botu-\\nlism) or functional process. History is key to the diagnosis. For neonates, \\nverify passage of meconium in the first 24 hours of life. A rectal examination \\nis recommended to assess presence of stool, rectal tone, sensation, and size \\nof the anal vault. A careful neurologic examination should be completed to \\nassess for neuromuscular causes. A single upright abdominal radiograph may \\nbe helpful to visualize fecal retention or impaction, and to help rule out the \\nconcern for obstruction. Treatment in the ED with suppositories or enemas \\nmay be necessary, and outpatient maintenance therapy such as with polyeth-\\nylene glycol for older children (older than 12 months) is essential to prevent \\nrecurrence. Admission is indicated for patients with impaction associated \\nwith vomiting, dehydration, and failure of outpatient treatment.\\nChildren (3 to 15 Years Old)\\nAcute abdominal pain in children 3 to 15 years old includes a range of \\ndiagnoses, including appendicitis (Chapter 43), constipation, gastroenteritis, \\nA\\n B\\nFigurE 74-1.  A and B. Ultrasound image of intussusception showing the \\nclassic target appearance of bowel-within-bowel. Reproduced with permission \\nfrom Ma OJ, Mateer JR, Blaivas M: Emergency Ultrasound, 2nd ed. New York: \\nMcGraw-Hill; 2008.\\n74_Cydulka_Ch74.indd   403 20/04/17   2:46 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 422, 'page_label': '404'}, page_content='404 SECTION 9: Pediatrics\\nurinary tract infection, streptococcal pharyngitis (Chapter 68), pneumonia \\n(Chapter 71), pancreatitis (Chapter 42), and functional abdominal pain. In \\nadolescents, gall bladder disease (cholelithiasis, biliary colic, or cholecys-\\ntitis), renal stones, o varian pathology (cysts or torsion), and testicular tor -\\nsion should be considered. Diabetes and diabetic ketoacidosis are more \\nprevalent in this age group and commonly present as vague abdominal pain. \\nThe presence of a parent and allowing the child to sit on the parents’ lap are \\nhelpful in examining younger children. Older children may not readily offer \\nimportant history surrounding embarrassing topics such as constipation and \\ngenital pain. Adolescents should be interviewed alone to provide confiden-\\ntiality and facilitate discussion of potentially important information sur -\\nrounding sexual activity and other sensitive subjects.\\nHenoch–Schönlein purpura (HSP) is an idiopathic vasculitis of children \\nbetween 2 and 11 years of age. HSP classically presents with palpable \\npurpura, acute abdominal pain, and arthritis. A urinalysis should be \\nobtained to identify hematuria, with subsequent renal function tests when \\nblood is present, as up to 30% of children with HSP will develop renal \\ninvolvement, sometimes months later. Abdominal pain in HSP is caused by \\nbowel wall edema and GI vasculitis, and may occur before typical rash of \\nHSP appears. Microscopic and even gross GI bleeding is not uncommon, \\nthough rarely life-threatening. Intussusception (ileo-ileo as compared to the \\nclassic ileo-colic in idiopathic intussception) occurs in 3.5%, and must be \\nconsidered in patients with significant abdominal pain. Treatment of HSP \\nis primarily supportive: joint pain responds well to nonsteroidal anti-\\ninflammatory medications; severe abdominal pain may improve with corti-\\ncosteroids. Consultation and follow-up with a pediatric rheumatologist or \\nnephrologist may be necessary for more severe symptoms or renal involve-\\nment with hypertension.\\n■ ■GAStrOINteStINAL BLeeDING\\nUpper GI (UGI) bleeding is distinguished from lower GI (LGI) bleeding \\nanatomically at the ligament of Treitz. The presentation of GI bleeding in \\nchildren varies, and includes bright red blood in small strands or clots in \\nemesis or stool, vomiting of gross blood (hematemesis), black tarry stools \\n(melena), or profuse bright red blood per rectum. Occult bleeding may \\npresent with pallor, fatigue, or anemia.\\nThe first step in management is to evaluate the need for acute resuscita-\\ntion, and distinguish the bleed as UGI or LGI. Confirmation through gastric \\nor fecal occult blood testing is useful to distinguish substances that grossly \\nmimic blood. Foods such as beets, cranberries, and red food dyes can \\nappear like blood in stool. A thorough history and physical examination is \\nimportant to determine the location, amount, and etiology of the bleed. \\nExamination for extra-GI sources is also important (e.g., epistaxis is a com-\\nmon cause of hematemesis in children). Ask about recent dental surgery or \\ngingival bleeding. Post-tonsillectomy bleeding is an important and poten-\\ntially serious cause of hematemesis. A common cause of hematemesis in \\nthe newborn is swallowed maternal blood (either post-delivery or from \\nfissures in mother’s nipples).\\nThe differential diagnosis of UGI and LGI bleeding by age group is \\nsummarized in Table 74-2. In general, UGI bleeding in children without \\n74_Cydulka_Ch74.indd   404 20/04/17   2:46 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 423, 'page_label': '405'}, page_content='CHAPTER 74: Pediatric Abdominal Emergencies 405 \\nTAblE 74-2 Age-Based Causes of Upper and Lower GI Bleeding\\nUpper GI Bleeding\\nNeonate Infant/toddler Child/Adolescent\\nCommon Common Common\\nSwallowed maternal blood/\\nmaternal \"sore nipples\"\\nNon-GI source (e.g., \\nepistaxis)\\nMallory–Weiss tear\\nMallory–Weiss tear Gastritis (especially \\nHelicobacter pylori gastritis)\\nTrauma (nasogastric tube \\nin NICU)\\nEsophagitis Esophagitis\\nUncommon Gastritis Peptic ulcer disease\\nStress ulcer/gastritis Uncommon Uncommon\\nEsophagitis/GERD Stress gastritis or ulcer Esophageal varices\\nVascular malformation Peptic ulcer disease Toxic/caustic ingestion\\nHemorrhagic disease \\nof newborn (vitamin K \\ndeficiency)\\nVascular malformation Foreign body\\nCoagulopathy/bleeding \\ndiathesis\\nGI duplication Vasculitis\\nCoagulopathy associated \\nwith infection\\nGastric/esophageal varices\\nBowel obstruction\\nToxic/caustic ingestion\\nCoagulopathy/bleeding \\ndiathesis\\nForeign body\\nVascular malformation\\nBowel obstruction\\nCrohn’s disease\\nCoagulopathy/bleeding \\ndiathesis\\nGI stromal tumors\\nDieulafoy’s lesion\\nLower GI Bleeding\\nNeonate Infant/toddler Child/Adolescent\\nCommon Common Common\\nSwallowed maternal blood Anal fissure Anal fissure\\nAnal fissure Milk/soy protein allergy Infectious gastroenteritis\\nMilk/soy protein allergy Infectious gastroenteritis Polyps; benign, familial\\nInfectious gastroenteritis Uncommon Uncommon\\nUncommon Intussusception Henoch–Schönlein purpura\\nMeckel’s diverticulum* Meckel’s diverticulum* Hemorrhoids\\nNecrotizing enterocolitis GI duplication Inflammatory bowel disease\\nVascular malformation Hemolytic-uremic syndrome Meckel’s diverticulum*\\nHemorrhagic disease of new-\\nborn (vitamin K deficiency)\\nHenoch–Schönlein purpura Hemolytic-uremic syndrome\\nIntussusception Malrotation with volvulus Vascular malformation\\nMalrotation with volvulus Polyps; benign, familial Celiac disease\\nHirschsprung-associated \\nenterocolitis (toxic megacolon)\\nCoagulopathy/bleeding \\ndiathesis\\nGI duplication Vascular malformation\\n*Most common cause of severe LGI bleeding in all ages.\\nAbbreviation: NICU, neonatal intensive care unit.\\n74_Cydulka_Ch74.indd   405 20/04/17   2:46 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 424, 'page_label': '406'}, page_content='406 SECTION 9: Pediatrics\\nunderlying portal hypertension is rarely life-threatening. While most causes \\nof LGI bleeding in children are also benign, potential emergent causes \\ninclude vascular malformations, Meckel diverticula, hemolytic uremic syn-\\ndrome, and intussusception. In cases of melena, evaluate for causes of UGI \\nbleeding and HSP. In cases of bright red blood per rectum, evaluate for anal \\nfissure. For painless hematochezia, consider Meckel diverticulum, or arte-\\nriovenous malformation. For hematochezia in the setting of abdominal \\npain, the differential is larger including HSP, hemolytic uremic syndrome, \\ninfectious gastroenteritis, inflammatory bowel disease, milk-protein allergy \\nin infants, intussusception, and necrotizing enterocolitis (neonates).\\nLaboratory studies and imaging should be completed as dictated by \\nother associated signs and symptoms. Mild bleeding can typically be man-\\naged by a consultant on an outpatient basis. Stool studies for infectious \\ncauses should be sent if suspected. Moderate and severe bleeding requires \\nacute resuscitation with isotonic crystalloid and, potentially, blood prod-\\nucts. While acute shock should be treated immediately, overexpansion of \\nintravascular volume should be avoided, particularly for variceal bleeding \\nor more chronic conditions. Consultation with a pediatric surgeon, gastro-\\nenterologist, or critical care physician may be necessary, depending on the \\netiology.\\n■ ■FUrtHer reADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 130, “Acute Abdominal Pain in Infants and Children” \\nby Ross J. Fleischman; Chapter 131, “Gastrointestinal Bleeding in Infants and \\nChildren” by Sarah M. Reid.\\n74_Cydulka_Ch74.indd   406 20/04/17   2:46 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 425, 'page_label': '407'}, page_content='407\\nPediatric Urinary Tract Infections\\nMarie Waterhouse\\nUrinary tract infections (UTIs) are relatively common in children, from \\ninfancy through adolescence. The incidence and clinical presentation of \\npediatric UTI vary by age and gender.\\n■ ■CLINICAL FEATURES\\nThere are several age-specific clinical presentations for pediatric UTI. \\nNeonates present with a clinical syndrome indistinguishable from sepsis, \\nand may often have nonspecific symptoms such as fever, jaundice, poor \\nfeeding, vomiting, irritability, or lethargy. Older infants and young chil-\\ndren typically present with gastrointestinal symptoms such as abdominal \\npain, vomiting, or decreased appetite. School-age children and adolescents \\npresent similarly to adults, and often, but not always, complain of specific \\nurinary symptoms such as dysuria, frequency, urgency, or hesitancy. \\nInfants and young children are more likely to have fever and upper tract \\ndisease, necessitating longer courses of antibiotic treatment. Adolescents \\nwithout fever, flank pain, or vomiting may be treated similarly to adults \\nwith shorter course antibiotic regimens.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe gold standard for the diagnosis of pediatric UTI is the growth of a \\nsingle urinary pathogen from a properly obtained urine culture. For infants \\nand children in diapers, urine obtained by sterile transurethral catheteriza-\\ntion is preferred. Ultrasound-guided suprapubic bladder aspiration is an \\nacceptable alternative, but is more invasive and rarely performed. For toilet-\\ntrained children who can void on command (usually ascertained by asking \\na parent, but generally at around 3 years old), urine may be collected as a \\nclean catch specimen. Bagged urine specimens have virtually no role in \\ndiagnosis of pediatric UTI, and are never appropriate for urine culture.\\nUrine microscopy and chemical test strips (dipstick) have similar test \\ncharacteristics in terms of sensitivity and specificity; however, dipstick is \\nusually faster and more convenient, and a finding of positive nitrites is \\nhighly specific for the presence of gram-negative bacteriuria, obviating the \\nneed for urine microscopy. In cases where dipstick is indeterminate (i.e., \\n“trace” leukocyte esterase), subsequent urine microscopy may be helpful in \\nincreasing diagnostic certainty. Microscopy is typically considered positive \\nif more than five white blood cells per high-power field or bacteria are seen. \\nBecause young infants void frequently, and often do not store urine in the \\nbladder long enough to accumulate leukocytes or nitrites, urinalysis is less \\nsensitive in this age group, and culture should be sent regardless of negative \\nurinalysis result.\\nYoung children may also experience urinary symptoms from urethritis \\nsecondary to irritant soaps, clothing, or poor hygiene. Physical exam should \\nassess for vaginitis in girls, or meatitis or balanitis in boys. Adolescents \\n75\\nCh A p TER\\n75_Cydulka_Ch75.indd   407 20/04/17   2:46 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 426, 'page_label': '408'}, page_content='408 SECTION 9: Pediatrics\\nmay have urinary symptoms as a manifestation of a sexually transmitted \\ndisease such as Chlamydia trachomatis. An appropriate sexual history \\nshould be obtained in teenagers, and a pelvic examination may be indicated \\nfor sexually active females (for a discussion of sexually transmitted dis-\\neases, see Chapter 87).\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nThe treatment and disposition of infants and children with UTI depend on \\nage and clinical severity. In general, antibiotics should not be given until \\nafter urine culture has been obtained. However, timely antibiotic adminis-\\ntration takes precedence in the septic patient.\\n1. Treat neonates for sepsis and obtain cultures of blood and CSF in addi-\\ntion to urine. Administer parenteral antibiotics and admit to the hospi -\\ntal: ampicillin 50 mg/kg/dose plus gentamicin 3 to 5 mg/kg/dose; or \\nampicillin 50 mg/kg/dose plus cefotaxime 50 mg/kg/dose are appro-\\npriate empiric choices.\\n2. Treat infants from 1 month to 2 years of age with an intrav enous third-\\ngeneration cephalosporin such as ceftriaxone, cefotaxime, or cefepime \\n(all are dosed at 50 mg/kg/dose). Ceftriaxone has the advantage of \\nmaintaining efficacy for 12 to 24 hours per dose. After an initial dose \\nof IV antibiotics, well-appearing infants in this age group may be \\ntreated with a course of oral antibiotics, which is equally effective to \\nparenteral treatment. Young infants must have close follow-up with \\ntheir primary care providers, and be urged to return if they cannot \\ntolerate oral therapy or are worsening. Children who are dehydrated, \\nill-appearing, have persistent vomiting, or are medically complex may \\nrequire inpatient parenteral treatment. Antibiotic choices in all cases \\nare guided by local susceptibility patterns. In communities where \\ncephalexin, amoxicillin, or trimethoprim-sulfamethoxazole resistance \\nhas emerged, a third-generation oral cephalosporin such as cefixime   \\n4 mg/kg/dose given twice daily or cefdinir 7 mg/kg/dose given twice \\ndaily should be considered. If Enterococcus faecalis has been found on \\nprior urine cultures, add amoxicillin 25 mg/kg/dose given twice daily \\nor ampicillin IV 50 mg/kg/dose to standard therapy. Treat for 7 to  \\n14 days, as short-course therapy is not effective in young children.\\n3. Children older than 2 years who are not ill-appearing and who can toler-\\nate oral fluids may be treated exclusively with oral antibiotics for a \\ncourse of 7 to 14 days, as described abo ve. Again, local antibiotic sus-\\nceptibility patterns should guide antibiotic choice.\\n4. Well-appearing adolescent females older than 13 years with simple cys-\\ntitis may be treated similarly to adults with a short course of oral antibi-\\notics (see Chapter 53).\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 132, “Urinary Tract Infection in Infants and Children,” \\nby Justin W. Sales.\\n75_Cydulka_Ch75.indd   408 20/04/17   2:46 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 427, 'page_label': '409'}, page_content='409\\nSeizures and Status Epilepticus \\nin Children\\nAra Festekjian\\nThe causes and manifestations of seizures are numerous, ranging from \\nbenign to life threatening. Seizure precipitants include fever, CNS infec-\\ntions, head injury, structural brain abnormalities, hypoglycemia, electrolyte \\nabnormalities, hypoxemia, toxin exposure, dysrhythmias, metabolic disor -\\nders, congenital infections, and neurocutaneous syndromes.\\n■ ■CLINICAL FEATURES\\nThe clinical features of seizure activity depend on the affected area of the \\nbrain and can range from classic tonic-clonic movements to subtle behav-\\nioral changes; they may be generalized (with loss of consciousness) or \\npartial (with focal motor or behavioral features). Rhythmic repetitive move-\\nments, bowel or bladder incontinence, a postictal state, and tongue biting \\nare highly suggestive of seizures.\\nMotor changes (tonic or clonic) may be focal or generalized, and sei-\\nzures may present with atony (sudden loss of tone or “drop attack”) in some \\nage groups. Additional seizure manifestations include staring spells \\n(“absence”) or changes in mental status or behavior, which can be complex, \\nsuch as automatisms (blinking, bicycling, or lip smacking in infants), vocal-\\nizations, or hallucinations.\\nAssociated clinical signs include alteration in autonomic dysfunction, \\nsuch as mydriasis, diaphoresis, tachypnea or apnea, tachycardia, hyperten-\\nsion and salivation, and postictal somnolence. Transient focal deficits may \\nrepresent Todd’s paralysis following a seizure.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe diagnosis of seizure disorder is based primarily on history and physical \\nexamination. Bedside glucose testing should be performed on all children \\nwho are seizing or postictal, but the clinical scenario should direct addi-\\ntional laboratory and imaging tests. Screening tests for electrolytes are not \\nindicated in most cases of childhood seizures including simple febrile sei-\\nzures or first time afebrile seizures, unless otherwise indicated by the spe-\\ncific history. The suggested ED evaluation of differing clinical scenarios \\npresenting with seizures is listed in Table 76-1.\\nStatus epilepticus is defined as seizure activity lasting >30 minutes or \\nmultiple seizures without a return to normal mental status between seizures. \\nFive minutes have been suggested as an operational definition because \\nseizures lasting longer than 5 minutes usually do not resolve without treat-\\nment. Status epilepticus is a medical emergency, and is more responsive to \\nmedications when treated early and aggressively.\\nSeizures must be distinguished from other events that masquerade as \\nseizures in children such as syncope, breath-holding spells, gastroesoph-\\nageal reflux (Sandifer’s syndrome), chorea (acute rheumatic fever), \\nmyoclonic jerks, rigors, startle reflex, tics, pseudo-seizures, migraine \\n76\\nCh A p TER\\n76_Cydulka_Ch76.indd   409 20/04/17   2:47 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 428, 'page_label': '410'}, page_content='410 SECTION 9: Pediatrics\\nvariants, and night terrors. Primary seizures should be distinguished \\nfrom seizures secondary to treatable or life-threatening causes such as \\ntrauma, infection, h ypoglycemia, metabolic abnormalities, or electrolyte \\nabnormalities.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. The management of the seizing child requires immediate supportive \\ncare, termination of the seizure with anticon vulsant medication, and \\ncorrection of reversible causes such as hypoglycemia or metabolic \\nabnormalities.\\n2. Ensure a patent airway, apply oxygen to all seizing patients, and assist \\nventilation as indicated. If rapid-sequence intubation is required, con -\\ntinuous EEG monitoring should be arranged alongside anticonvulsant \\nadministration as neuromuscular blockade obscures the ability to clini-\\ncally assess for ongoing seizures.\\n3. Treat hypoglycemia with 4 to 5 mL/kg 10% dextr ose in infants or  \\n2 mL/kg 25% dextrose in older children IV/IO.\\n4. Administer lorazepam, 0.1 mg/kg or midazolam  0.1 to 0.2 mg/kg IV/\\nIO. If vascular access is not available, administer midazolam 0.2 mg/kg \\nIN (maximum dose 10 mg). Repeat benzodiazepine dose in 5 minutes if \\nseizure persists and prepare to support breathing and blood pressure \\nwith repeated dosing.\\n5. Administer second-line or third-line antiepileptic drugs if more than 2 \\ndoses of benzodiazepine are required. Consider using 2 of the following \\n4 medications, and moving on to fourth-line treatments if seizures are \\nrefractory to treatment. For infants, use phenobarbital 20 mg/kg IV/IO \\n(maximum 800 mg). For older children: fosphenytoin 20 PE/kg IV/IO \\nTablE 76-1 Suggested ED Evaluation of pediatric Seizures\\nAge of child\\nSeizure duration and description of seizure activity prior to arrival\\nHistory of trauma\\nHistory of possible ingestion\\nHistory of fever\\nHistory of associated illness (vomiting or diarrhea)\\nFeeding problems (especially in an infant)\\nChanges in behavior\\nHistory of seizures and type of seizures\\nHistory of developmental delay\\nOther medical history\\nMedications\\n■● Anticonvulsants with milligrams per kilogram dose and recent changes or missed doses\\n■● Recent new medications (may alter metabolism of antiepileptic drugs)\\n■● Allergies\\nDevelopmental history\\nFamily history of seizures\\n76_Cydulka_Ch76.indd   410 20/04/17   2:47 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 429, 'page_label': '411'}, page_content='CHAPTER 76: Seizures and Status Epilepticus in Children 411 \\nover 20 minutes; valproic acid 20 mg/kg IV/IO; and levetiracetam  \\n20 to 30 mg/kg IV/IO.\\n6. Fourth-line treatment strategies include continuous infusions in the ICU \\nsetting of propofol, midazolam, or pentobarbital, or induction of general \\ninhaled anesthesia. Propofol dose is 0.5 to 2 mg/kg or 1.5 to 4 mg/kg/hr \\nIV/IO; or midazolam continuous infusion: 0.05 to 0.4 mg/kg/hr IV/IO.\\n7. Treat electrolyte abnormalities as follows: for hyponatremia < 120 mEq/L, \\n3% NaCl 4 to 6 mL/kg, for hypocalcemia, <  7 mg/dL of calcium and  \\n< 0.8 mmol/L of ionized calcium, 0.3 mL/kg of 10% calcium gluconate, \\nover 10 minutes, and for hypomagnesemia <  1.5 mEq/L, 50 mg/kg of \\nmagnesium sulfate over 20 minutes.\\n8. Children who present to the ED following a brief seizure and who regain \\na normal mental status without focal neurologic deficits are candidates \\nfor discharge and outpatient follow-up. Patients presenting to the ED \\nwith ongoing seizures meet the definition for status epilepticus and even \\nwhen seizure termination is achieved in the ED, it is suggested that they \\nbe admitted for further observation. All infants with true seizures should \\nbe admitted to the hospital. Patients with refractory seizures, those with \\nseizures from acute traumatic brain injury, CNS infection, or serious \\nmetabolic or electrolyte abnormalities typically require treatment in the \\nICU setting.\\nFebrile Seizure\\nSeizures in the setting of fever are common in children and are usually \\nbenign. Simple febrile seizures (SFS) occur between 6 months and 6 years \\nof life, are brief (<15 minutes), and generalized. Patients with SFS require \\nno specific ED evaluation or medication for their seizure, though evaluation \\nfor a treatable source of fever such as a urinary tract infection, and anti-\\npyretics may be indicated. Children experiencing SFS have the same 1% \\nrisk of developing epilepsy as the general population. Complex febrile \\nseizures (>15 minutes in duration, focal, or recurrent) carry a slightly \\nhigher risk for epilepsy, but also do not routinely require ED evaluation or \\ntreatment. Febrile status epilepticus is treated as above with the addition of \\nneuroimaging, CSF analysis and culture, and potential antibiotics and acy-\\nclovir as indicated.\\nFirst Seizure\\nThe overall risk of recurrence after a single afebrile seizure is about 40%. \\nEmergent neuroimaging is not necessary in the ED in the patient with a \\nnormal neurologic exam, though outpatient MRI and EEG may be of ben-\\nefit. Most neurologists do not recommend starting anticonvulsant medica-\\ntion after a first seizure.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 135, “Seizures in Infants and Children,” by Maija \\nHolsti.\\n76_Cydulka_Ch76.indd   411 20/04/17   2:47 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 430, 'page_label': '412'}, page_content='412\\nAltered Mental Status and \\nHeadache in Children\\nCarlo Reyes\\n■ ■HEADACHE\\nPediatric headache accounts for 1% of emergency department visits. The \\nvast majority of headaches in children have a benign etiology. Factors asso-\\nciated with serious or dangerous causes of headache include preschool age, \\noccipital location, recent onset of headache, and inability of the child to \\ndescribe the quality of the head pain.\\nClinical Features\\nHeadaches can be classified as primary or secondary. Primary headaches \\nare associated with normal physical exam findings, are self-limited, and \\nmay be recurrent. Examples of primary headache include physiologic or \\nfunctional (migraine, tension, cluster). Secondary headaches are usually \\nanatomic (vascular malformation, tumor) or infectious (sinusitis, dental \\nabscess), and have higher morbidity and mortality if left untreated. A \\ncareful history and physical examination should focus on identifying or \\nexcluding secondary headaches. Historical findings that suggest second-\\nary headache include acute onset; associated fever or stiff neck; morning \\nvomiting; behavioral changes; altered mental status; “worst ever” head-\\nache; sleep disturbance; associated trauma or toxic exposure; or aggra-\\nvation by coughing, Valsalva, or lying down. Physical findings suggestive \\nof secondary headaches include blood pressure abnormalities, nuchal \\nrigidity, head tilt, ptosis, retinal hemorrhage or papilledema, visual field \\ndefects, and neurologic findings (altered mental status, ataxia, and \\nhemiparesis).\\nDiagnosis and Differential\\nPertinent historical features of pediatric headache include severity and \\nquality of pain, age of first occurrence, precipitants, rapidity of onset, \\nlocation, duration, and associated symptoms. Physical examination \\nshould include a thorough general examination with careful attention to \\nthe neurologic examination, including cranial nerves, gait, strength, and \\nmental status. The history and physical exam should guide the work up. \\nFor instance, CT is indicated to rule out suspected intracranial hemor -\\nrhage. Magnetic resonance imaging better visualizes the posterior fossa, \\nthe most common location of pediatric brain tumors, and either modal-\\nity may be used for space-occupying lesions elsewhere. Importantly, \\nneuroimaging in children is usually not indicated unless there is an \\nabnormal neurologic exam, altered mental status, concurrent seizures, \\na recent “worst headache of life” complaint, or change in type of \\nheadache.\\n77\\nC HA pt ER\\n77_Cydulka_Ch77.indd   412 20/04/17   2:47 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 431, 'page_label': '413'}, page_content='CHAPTER 77: Altered Mental Status and Headache in Children 413 \\nEmergency Department Care and Disposition\\n1. For secondary headaches, evaluate and treat underlying cause and pain.\\n2. For primary headaches, narcotics are not recommended. Most pri-\\nmary headaches respond to ib uprofen 10  mg/kg or acetaminophen  \\n15 mg/kg.\\n3. For migraines: prochlorperazine 0.15  mg/kg, metoclopramide  \\n0.1 mg/kg, or ketorolac 0.5  mg/kg are widely used for abortive \\nmigraine therap y. Metoclopramide and prochlorperazine are often \\ngiven with diphenhydramine 1  mg/kg to prevent extrap yramidal side \\neffects. “Migraine cocktails” that include ketorolac, prochlorperazine  \\nor metoclopramide, and diphenhydramine appear effective and \\nsafe. Sumatriptan 5 to 10  mg (in children weighing 20 to 39  kg) or \\n20 mg (>  40 kg children) nasal spray or 0.1  mg/kg subcutaneously is \\ncommonly used.\\n4. Cluster and tension headaches are managed much the same way as \\nmigraines. Sumatriptan as dosed abo ve and high-flow oxygen (7  L/\\nmin non-rebreather mask) can be used for cluster headaches. Tension  \\nheadaches usually respond to first-line oral therapy such as ibuprofen  \\n10 mg/kg.\\n5. For headaches that disrupt activities of daily living or school perfor -\\nmance, refer to their primary care provider or pediatric neurologist to \\nconsider prophylactic regimens.\\n6. In general, most patients may be discharged after relief of symptoms. \\nPatients with life-threatening causes of headache require admission \\nfor definitive care. Patients with intractable pain also may need \\nadmission.\\n■ ■ALtERED MENtAL StAtUS\\nAltered mental status (AMS) in a child is defined as the failure to respond \\nto the external environment in a manner consistent with the child’s devel-\\nopmental level. In treating children with AMS, aggressive resuscitation, \\nstabilization, diagnosis, and treatment must occur simultaneously to pre-\\nvent morbidity and death.\\nClinical Features\\nThe spectrum of AMS ranges from confusion to lethargy, stupor, and coma \\nindicative of depression of the cerebral cortex or localized abnormalities of \\nthe reticular activating system. Important historical elements to consider \\ninclude prodromal events (recent illnesses, exposures, trauma), risk factors \\n(medications, social or family history, potential for abuse), and other asso-\\nciated symptoms. A head-to-toe exam should be performed to identify \\noccult infection, trauma, toxicity, or metabolic disease. A child’s mental \\nstatus can be assessed by the Glasgow coma scale, or the simpler A VPU \\nscale, where A means “alert,” V means “responsive to verbal stimuli,” P \\nmeans “responsive to painful stimuli,” and U means “unresponsive,” cor -\\nresponding to a GCS of 15, 13, 8, and 3, respectively.\\nPathologic causes of altered mental status can be divided into supra-\\ntentorial lesions, subtentorial lesions, and metabolic encephalopathy. \\nSupratentorial lesions are due to compression of the brainstem, resulting \\n77_Cydulka_Ch77.indd   413 20/04/17   2:47 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 432, 'page_label': '414'}, page_content='414 SECTION 9: Pediatrics\\nin altered level of consciousness and focal motor abnormalities with a \\nrostral-to-caudal progression of dysfunction, and fast component of nys-\\ntagmus away from the stimulus during cold caloric testing. Subtentorial \\nlesions produce rapid loss of consciousness, cranial nerve abnormalities, \\nabnormal breathing patterns, asymmetric or fixed pupils, and no eye \\nmovement during cold caloric testing. Metabolic encephalopathy pro-\\nduces decreased level of consciousness before exhibiting motor signs, \\nwhich are symmetrical when present. Pupillary reflexes are intact in \\nmetabolic encephalopathy except with profound anoxia, opiates, barbitu-\\nrates, and anticholinergics.\\nDiagnosis and Differential\\nA thorough history and physical examination are paramount to determining \\nthe diagnosis. The familiar mnemonic AEIOU TIPS (alcohol, encephalopa-\\nthy, insulin, opiates, uremia, trauma, infection, poisoning, and seizure) is \\nhelpful in organizing diagnostic possibilities (Table 77-1).\\nTAblE 77-1 AEIOU tIpS: A Mnemonic for pediatric Altered Mental  \\nStatus\\nA Alcohol.  Ethanol. Isopropyl alcohol. Methanol. Concurrent hypoglycemia is \\ncommon.\\nAcid-base and metabolic. Hypotonic and hypertonic dehydration. Hepatic \\ndysfunction, inborn errors of metabolism.\\nArrhythmia/cardiogenic. Stokes–Adams, supraventricular tachycardia, aortic \\nstenosis, heart block, pericardial tamponade, hypertensive encephalopathy.\\nE Encephalopathy. Reye’s syndrome. Parainfectious encephalomyelitis. \\nAutoimmune encephalitis.\\nEndocrinopathy. Addison’s disease can present with AMS or psychosis. \\nThyrotoxicosis can present with ventricular dysrhythmias. Pheochromocytoma can \\npresent with hypertensive encephalopathy.\\nElectrolytes. Hypo-/hypernatremia and disorders of calcium, magnesium, and \\nphosphorus can produce AMS.\\nI Insulin. AMS from hyperglycemia is rare in children, but diabetic ketoacidosis \\nis the most common cause. Hypoglycemia can be the result of many disorders. \\nIrritability, confusion, seizures, and coma can occur with blood glucose levels  \\n< 40 mg/dL.\\nIntussusception. AMS may be the initial presenting symptom.\\nO Opiates.  Common household exposures are to Lomotil, Imodium, diphenoxylate, \\nand dextromethorphan. Clonidine, an α-agonist, can also produce similar \\nsymptoms.\\nOxygen. Disorders of airway, breathing, or circulation may adversely affect \\noxygen delivery to the brain; hypercapnia from primary lung disease or neurologic \\ndysfunction also may result in altered mental status.\\nU Uremia. Encephalopathy occurs in over one-third of patients with chronic renal \\nfailure. Hemolytic-uremic syndrome can produce AMS in addition to abdominal \\npain.\\nThrombocytopenic purpura and hemolytic anemia also can cause AMS. In children \\nwith chronic renal failure, neurologic dysfunction may develop secondary to stroke, \\nhypertension, or metabolic derangements.\\n(Continued)\\n77_Cydulka_Ch77.indd   414 20/04/17   2:47 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 433, 'page_label': '415'}, page_content='CHAPTER 77: Altered Mental Status and Headache in Children 415 \\nTAblE 77-1 AEIOU tIpS: A Mnemonic for pediatric Altered Mental  \\nStatus\\nT T rauma. Hypovolemia or hemorrhage from multisystem trauma may lead to \\ninsufficient cerebral perfusion and result in altered mental status. Consider \\nconcussion, hemorrhage or contusion, or epidural or subdural hematoma. \\nRemember to look for signs of child abuse, particularly shaken baby syndrome \\nwith retinal hemorrhages.\\nTumor. Primary, metastatic, or meningeal leukemic infiltration. Intracerebral \\ntumors commonly produce focal neurologic signs, and posterior fossa tumors \\ntypically block the ventricular system and create signs and symptoms suggestive \\nof hydrocephalus. Supratentorial and infratentorial tumors may present \\nabruptly with altered mental status, fever, or meningismus after an intratumor \\nhemorrhage.\\nThermal. Hypo- or hyperthermia. Progressive hypothermia leads to insidious \\naltered mental status. Temperatures > 41°C (105.8°F) result in headache, weak-\\nness, and dizziness followed by confusion, euphoria, combativeness, and altered \\nmental status.\\nI Infection. Bacterial meningitis, encephalitis, and brain abscess are the most \\nimportant causes of AMS in children, especially AMS with fever. Brain abscess is \\ncharacterized by fever and headache before AMS changes. Presenting symptoms \\nalso include generalized or focal seizures. Any systemic infection associated \\nwith vasculitis or shock may lead to altered mental status secondary to cerebral \\nhypoperfusion.\\nIntracerebral vascular disorders. Subarachnoid, intracerebral, or intraventricu-\\nlar hemorrhages can be seen with trauma, ruptured aneurysm, or arteriovenous \\nmalformations. Venous thrombosis can follow severe dehydration or pyogenic \\ninfection of the mastoid, orbit, middle ear, or sinuses. Arterial thrombosis is \\nuncommon in children, except in those with homocystinuria. Intracerebral and \\nintraventricular hemorrhages may follow birth asphyxia or trauma in neonates, but \\nin older children, they may signify a congenital or acquired coagulopathy. Cerebral \\nemboli from bacterial endocarditis may cause altered mental status. Acute \\nconfusional migraine may be associated with profound alterations in conscious-\\nness. Children with sickle cell anemia can develop cerebral thrombosis, status \\nepilepticus, and coma.\\nP Psychogenic. Rare in children, characterized by decreased responsiveness with \\nnormal neurologic examination including oculovestibular reflexes. Psychogenic \\nunresponsiveness may be a conversion reaction, an adjustment reaction, a panic \\nstate, or malingering.\\nPoisoning/ingestion. Drugs, toxins, or illicit substances can be ingested by \\naccident, through neglect or abuse, or in a suicidal gesture.\\nS Seizure. Generalized motor seizures and absence status epilepticus are often \\nassociated with prolonged unresponsiveness in children. In a child with a history \\nof seizures who presents with AMS, consider nonconvulsive status epilepticus. \\nSeizures in a febrile child suggest intracranial infection. Shunt malfunction should \\nbe considered among patients with a ventriculoperitoneal shunt for hydrocephalus.\\nAbbreviation: AMS, altered mental status.\\nDiagnostic adjuncts largely depend on the clinical situation and must be \\ndetermined immediately after the primary and secondary survey. Rapid \\nbedside glucose determination can immediately confirm either hypoglyce-\\nmia, or hyperglycemia due to diabetic ketoacidosis. Toxicity due to poison-\\ning or ingestion may require a reversal agent. If meningitis or encephalitis \\n(Continued)\\n77_Cydulka_Ch77.indd   415 20/04/17   2:47 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 434, 'page_label': '416'}, page_content='416 SECTION 9: Pediatrics\\nis suspected, lumbar puncture should be done immediately after initial \\nresuscitation and stabilization. Neuroimaging may be indicated in the set-\\nting of trauma or suspicion of space-occupying lesion.\\nEmergency Department Care and Disposition\\nTreatment priorities should concentrate on stabilization and reversal of life-\\nthreatening conditions.\\n1. Ensure airway, breathing, and circulation. Immobilize the cervical spine \\nif trauma is suspected and obtain appropriate imaging studies when the \\npatient is stabilized.\\n2. Provide continuous pulse oximetry and supplemental oxygen as needed \\nto correct h ypoxia, including bag-valve-mask and intubation when \\nappropriate. Consider capnometry for intubated patients.\\n3. Administer fluid resuscitation with 20 mL/kg fluid boluses of isotonic \\ncrystalloid for hypotension. Fluid boluses may be repeated up to 60 mL/\\nkg. Intravenous pressors are indicated if hypotension persists.\\n4. Treat hypoglycemia with 10% dextrose 5 mL/kg in infants or 25% \\ndextrose 2 mL/kg in older children.\\n5. Control core body temperature to minimize metabolic demands. Prevent \\nhypothermia with warming lamps and treat hyperthermia when present.\\n6. Treat seizures with benzodiazepines (see Chapter 76).\\n7. For suspected opiate or clonidine overdose, administer naloxone 0.01 to \\n0.1 mg/kg IV every 2  minutes. For iatrogenic benzodiazepine overdose, \\nconsider flumazenil 0.01  mg/kg IV in the setting of known, isolated \\nbenzodiazepine ingestion.\\n8. Administer empiric antibiotics, ceftriaxone or cef otaxime 50  mg/kg/\\ndose, and consider additional vancomycin 10 mg/kg/dose for suspected \\nmeningitis.\\n9. Patients with AMS will require admission and neurologic observation. \\nOnly those with a transient, rapidly reversible, and benign cause of AMS \\nmay be discharged from the emergency department after a period of \\nobservation with follow-up scheduled within 24 hours of discharge.\\n■ ■FURtHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 136, “Headache in Children,” by David C. Sheridan \\nand Garth Meckler; Chapter 137 “Altered Mental Status in Children” by Sarah \\nMellion and Kathleen Adelgais.\\n77_Cydulka_Ch77.indd   416 20/04/17   2:47 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 435, 'page_label': '417'}, page_content='417\\nSyncope and Sudden Death  \\nin Children and Adolescents\\nDerya Caglar\\nSyncope is a presenting symptom for 1% to 3% of all pediatric emergency \\nvisits. It is more common in adolescents than younger children. Up to 50% \\nof adolescents experience at least one\\xa0syncopal episode which is usually \\ntransient and self-limited, but can be a symptom of serious cardiac disease.\\nSudden, unexpected death in children comprises 2.3% of all pediatric \\ndeaths, of which sudden cardiac death makes up about one-third. The risk \\nof sudden cardiac death is greater in patients with congenital or acquired \\nheart disease, even those that have undergone corrective surgery. Except for \\ntrauma, sudden cardiac death is the most common cause of sports-related \\ndeaths. Hypertrophic cardiomyopathy and congenital artery anomalies are \\nthe most common cause of sudden cardiac death in adolescents without \\nknown cardiac disease. Other causes of sudden cardiac death in children \\ninclude myocarditis, congenital heart disease, and conduction disturbances.\\n■ ■CLINICAL FEATURES\\nSyncope is the sudden onset of falling accompanied by a brief episode \\nof loss of consciousness. Involuntary motor movements may occur  \\nwith all types of syncopal episodes but are most common with seizures. \\nTable 78-1\\xa0lists the most common causes of syncope by category.\\nNeurally mediated syncope is the most common cause in children. This \\ntype of syncope typically lasts <1 minute and is preceded by sensations of \\nnausea, warmth, or light-headedness with a gradual visual grayout. Cardiac \\nsyncope occurs when there is an interruption of cardiac output from an \\nintrinsic problem such as tachydysrhythmia, bradydysrhythmia, outflow \\nobstruction, and myocardial dysfunction. Syncope resulting from cardiac \\ncauses usually begins and ends abruptly and may be associated with chest \\npain, palpitations, or shortness of breath. Risk factors associated with seri-\\nous causes of syncope are presented in Table 78-2. Events easily mistaken \\nfor syncope are presented in Table 78-3 in addition to common associated \\nsymptoms.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nNo specific historical or clinical features reliably distinguish between vaso-\\nvagal syncope and other causes. A thorough history and physical examina-\\ntion can help to arouse or allay suspicion of serious causes. The most \\nimportant step in evaluation of children with syncope is a detailed history, \\nincluding a thorough description of the event, associated symptoms, cir -\\ncumstances, personal or family history of cardiac disease, medications, \\ndrugs, intake, and intercurrent illness. Syncope during exercise suggests a \\nmore serious cause. Approximately 25% of children who suffer sudden \\ndeath have a history of syncope. If witnesses note that the patient appeared \\nlifeless or cardiopulmonary resuscitation was performed, a search for seri-\\nous pathologic conditions must be undertaken.\\n78\\nCh A p TER\\n78_Cydulka_Ch78.indd   417 20/04/17   2:48 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 436, 'page_label': '418'}, page_content='418 SECTION 9: Pediatrics\\nTAble 78-1 Causes of Syncope in Children and Adolescents\\nNeurally mediated: most common cause of syncope in children (80%)\\nVasovagal: < 1 min duration, prolonged standing, emotional upset, warning signs\\nOrthostatic: light-headedness with standing may precede; due to hypovolemia\\nSituational: urination, defecation, coughing, and swallowing may precipitate familial \\ndysautonomia\\nBreath-holding: 6-18 months old, crying leads to breath-holding, syncope, short-lived\\nCardiac dysrhythmias: events that usually start and end abruptly\\nProlonged Q-T syndrome\\nSupraventricular tachycardia / Wolff-Parkinson-White syndrome\\nSick sinus syndrome: associated with prior heart surgery\\nAtrioventricular block: most common in children with congenital heart disease; \\nacquired cardiac disease (myocarditis, muscular dystrophy, Lyme)\\nPacemaker malfunction\\nStructural cardiac disease:\\nHypertrophic cardiomyopathy: commonly exertional syncope; infants present with \\ncongestive heart failure and cyanosis\\nDilated cardiomyopathy: idiopathic, postmyocarditis, or congenital\\nCongenital heart disease\\nValvular diseases: aortic stenosis often congenital; Ebstein malformation; mitral valve \\nprolapse (associated with syncope but NOT increased risk of sudden death)\\nArrhythmogenic right ventricular dysplasia: congestive heart failure, cardiomegaly\\nPulmonary hypertension: dyspnea on exertion, exercise intolerance, shortness of breath\\nCoronary artery abnormalities: aberrant left main artery causing external compression \\nduring physical exercise\\nMedications and drugs: antihypertensives, tricyclic antidepressants, cocaine, diuretics, \\nantidysrhythmics\\nTAble 78-2 Risk Factors for a Serious Cause of Syncope\\nExertion preceding the event\\nAge < 6 years\\nHistory of cardiac disease or heart murmur in the patient\\nFamily history of sudden death, long QT syndrome, sensorineural hearing loss, or cardiac \\ndisease\\nRecurrent episodes\\nRecumbent episode\\nProlonged loss of consciousness\\nAssociated chest pain or palpitations\\nAbsence of premonitory symptoms or physical precipitating factors\\nUse of medications that can alter cardiac conduction\\nThe physical examination includes complete cardiovascular (heart \\nsounds, murmurs, rhythm, and the character of pulses), neurologic, and \\npulmonary examinations. Strongly consider obtaining an ECG on all \\npatients with syncope. Routine bloodwork is not indicated in children \\nwith clear vasovagal syncope. Tests should be directed by the history and \\nexam: a classic story for vasovagal syncope with a normal physical \\nexamination requires no further testing. Palpitations or exertional syn-\\ncope require ECG evaluation for potential dysrhythmias. Sudden col-\\nlapse, especially during exercise, suggests structural abnormalities, par -\\nticularly when associated with a murmur on physical examination. ECG, \\n78_Cydulka_Ch78.indd   418 20/04/17   2:48 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 437, 'page_label': '419'}, page_content='CHAPTER 78: Syncope and Sudden Death in Children and Adolescents  419 \\nchest x-ray, and echocardiography should be considered in this setting. \\nSyncope associated with chest pain may require cardiac troponins as part  \\nof the evaluation to rule out ischemic heart disease (e.g., aberrant left \\ncoronary artery). Electrolytes, thyroid studies, chest x-ray, and urine \\npregnancy testing or drug screen should be considered in the appropriate \\nclinical setting.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Strongly consider obtaining an electrocardiogram (ECG) in all patients.\\n2. If vasovagal syncope is likely, patients may be discharged home with \\nreassurance and advised to increase water and salt intake.\\n3. Consider an echocardiogram for patients with known or suspected car -\\ndiac disease. If an echocardiogram is not immediately available, the \\nurgency for obtaining the study should be determined in consultation \\nwith a cardiologist.\\n4. If no clear cause is found, the child may be discharged to be further \\nevaluated and follo wed by the primary care provider unless there are \\ncardiac risk factors or exercise-induced symptoms for which referral to \\na cardiologist is warranted.\\n5. Patients with a normal ECG but a history suggesting a dysrhythmia are \\ncandidates for outpatient monitoring and cardiac w orkup.\\n6. Children with documented dysrhythmias should be admitted. All chil-\\ndren admitted for syncope should undergo cardiac monitoring. Children \\nwho are survivors of sudden cardiac arrest should be admitted to a pedi-\\natric intensive care unit.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 127, “Syncope, Dysrhythmias, and ECG Interpreta-\\ntion,” by Andrew C. Dixon.\\nTAble 78-3 Events Easily Mistaken for Cardiovascular Syncope\\nCondition Distinguishing Characteristics\\nBasilar migraine Headache, rarely loss of consciousness, other neurologic symptoms\\nSeizure Loss of consciousness simultaneous with motor event, prolonged \\npostictaI phase\\nVertigo Rotation or spinning sensation, no loss of consciousness\\nHyperventilation Inciting event, paresthesias or carpopedal spasm, tachypnea\\nHysteria No loss of conciousness, indifference to event\\nHypoglycemia Confusion progressing to loss of consciousness, requires glucose \\nadministration to terminate\\n78_Cydulka_Ch78.indd   419 20/04/17   2:48 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 438, 'page_label': '420'}, page_content='420\\nHypoglycemia and Metabolic \\nEmergencies in Infants  \\nand Children\\nTeresa J. Riech\\n■ ■HYPOGLYCEMIA\\nHypoglycemia in children may be due to inadequate oral intake, excess \\ninsulin, low levels of hyperglycemic hormones (e.g., cortisol or growth \\nhormone), inborn errors of metabolism, or systemic infection. Prompt rec-\\nognition and treatment of hypoglycemia are essential to avoid potentially \\nsevere and permanent neurologic injury, and bedside glucose testing should \\nbe considered in any neonate, infant, or child with altered mental status.\\nClinical Features\\nHypoglycemic children may manifest symptoms related to adrenergic hor -\\nmone release including tachycardia, diaphoresis, tremors, anxiety, irritabil-\\nity, and tachypnea. Severe hypoglycemia may result in apnea or seizures, \\nparticularly in neonates and infants, who may not manifest typical signs \\nand symptoms of older children and adults. Neonates and infants with \\nhypoglycemia may also present with altered mental status and nonspecific \\nsymptoms such as poor feeding, an abnormal or high-pitched cry, tempera-\\nture instability, and irritability or lethargy. Hypoglycemia often accompa-\\nnies critical illness (sepsis) and the features of that illness may dominate the \\nclinical picture, thereby masking the signs of hypoglycemia.\\nDiagnosis and Differential\\nHypoglycemia is defined as a plasma glucose concentration less than  \\n45 mg/dL in symptomatic children and less than 35 mg/dL in asymptomatic \\nneonates. Bedside glucose testing is the most important diagnostic test in \\nany neonate or infant who is critically ill or has altered mental status. \\nAbnormal results should be confirmed with a venous sample, but treatment \\nshould not be delayed for confirmatory results. Urine testing for ketones is \\nimportant, as ketonuria is associated with ketotic hypoglycemia, adrenal \\ninsufficiency, and other inborn errors of metabolism. Absent urine ketones \\nare associated with hyperinsulinemic states, infants of a diabetic mother, as \\nwell as disorders of fatty acid oxidation and mitochondria.\\nEmergency Department Care and Disposition\\n1. For neonates administer 10% dextrose  5 mL/kg IV/IO/PO/NG. Treat \\ninfants with the same dose of 10% dextrose, or 25% dextrose 2 mL/kg IV/\\nIO/PO/NG. Give older children 2 mL/kg of 25% dextrose IV/IO/PO/NG.\\n2. Administer maintenance dextrose for persistent hypoglycemia using \\n10% dextrose at 1.5 times maintenance.\\n3. When intravenous access is not immediately available, consider \\nglucagon 0.03 mg/kg IM or subcutaneous (maximum 0.5 mg).\\n79\\nC HAPTER\\n79_Cydulka_Ch79.indd   420 26/04/17   2:29 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 439, 'page_label': '421'}, page_content='CHAPTER 79: Hypoglycemia and Metabolic Emergencies in Infants and Children  421 \\n4. If adrenal insufficiency is suspected, give hydrocortisone 25 mg IV/IM \\nfor neonates and infants, 50 mg for toddlers and school-age children, \\nand 100 mg for everyone else. Steroids should be given early in patients \\nwith hypopituitarism and adrenal insufficiency.\\n5. Consider empiric antibiotics for suspected sepsis.\\n■ ■INBORN ERRORS OF METABOLISM\\nInborn errors of metabolism are challenging childhood disorders represent-\\ning a broad spectrum of diseases with nonspecific signs and symptoms. \\nDelay in accurate diagnosis and treatment can lead to significant morbidity \\nand mortality. Despite the myriad etiologies, the principles of initial emer -\\ngency department (ED) diagnosis and management are relatively simple. \\nThe sudden acute deterioration of a healthy neonate should always prompt \\nconsideration of metabolic disease, and making a definitive diagnosis is \\nless important than having a high index of suspicion and implementing \\nsupportive care.\\nClinical Features\\nV omiting, altered mental status, and poor feeding are the most common \\nfeatures of metabolic emergencies. Seizures may accompany some meta-\\nbolic crises. Tachypnea due to metabolic acidosis and tachycardia from \\ndehydration, as well as hypotension due to hypovolemia or adrenal insuf-\\nficiency, may be noted. Rarely, some metabolic disorders may be associated \\nwith characteristic body or urine odors or other phenotypic stigmata (e.g., \\nambiguous genitalia and hyperpigmentation in congenital adrenal hyper -\\nplasia, as discussed separately below). Most metabolic toxins cross the \\nplacenta and are cleared by maternal enzymes; therefore, newborns are \\nasymptomatic, and symptoms present after feeding begins.\\nDiagnosis and Differential\\nScreening laboratory tests for suspected inborn errors of metabolism \\ninclude a bedside glucose, urine for ketones, a blood gas analysis for \\nmetabolic acidosis, serum ammonia, basic metabolic panel, and lactate \\nlevel. Figure 79-1 details the diagnostic evaluation recommended in the \\nED. Additional laboratory tests for definitive diagnosis that should be \\nconsidered based on initial screening results include liver function tests, \\nCBC, lactate dehydrogenase, creatine kinase, serum amino acids and acyl-\\ncarnitine profile, urine organic acids, and reducing substances. The dif-\\nferential diagnosis of shock in the neonate includes sepsis, congenital \\nheart defects, and abdominal catastrophes.\\nEmergency Department Care and Disposition\\nDespite the diverse etiology and complexity of inborn errors of metabo-\\nlism, ED resuscitation and stabilization of patients with these disorders are \\nrelatively simple. Neonates, infants, and children presenting in metabolic \\ncrisis, regardless of cause, show some combination of dehydration, meta-\\nbolic acidosis, and encephalopathy, which must be immediately addressed. \\nThe goals of treatment are to improve circulatory status by restoring circu-\\nlatory volume, provide energy substrate to halt catabolism, remove the \\n79_Cydulka_Ch79.indd   421 26/04/17   2:29 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 440, 'page_label': '422'}, page_content='422 SECTION 9: Pediatrics\\ninciting metabolic substrate (formula or breast milk), and help eliminate \\ntoxic metabolites.\\n1. Attend to Airway , Breathing, Circulation, and Disability (ABCD). If \\napnea, hypoventilation, or hypoxemia necessitates endotracheal intu-\\nbation, avoid prolonged use of paralytics because metabolic acidosis \\ncan be worsened by respiratory acidosis if insufficient ventilation is \\nprovided.\\n2. Restore circulation with 0.9% saline boluses of 20 mL/kg, reassessing \\nafter each bolus.\\n3. Make patients NPO, and correct hypoglycemia as abov e with D10 in \\nneonates and infants or D25 in children.\\n4. Begin 10% dextrose infusion at twice maintenance rate.\\n5. Consider broad-spectrum antibiotics.\\n6. Specific metabolic treatments are guided by the underlying defect and \\nshould be determined in consultation with a metabolic specialist. Sub-\\nstrates to facilitate shunting of metabolic pathways or hemodialysis may \\nbe needed.\\n7. Reflexive use of bicarbonate should be avoided; however, in select cases \\nof severe acidosis (pH < 7.0), treatment with 0.5 mEq/kg/h of sodium \\nbicarbonate may be considered.\\nPatients with a newly diagnosed or suspected metabolic disorder and \\nthose who are dehydrated or otherwise decompensated require admission \\nPoor feeding\\nVomiting\\nBlood glucose/Calcium/ \\nAmmonia/pH/CO2\\nUrine ketones\\nLethargy\\nConvulsion\\nComa\\nBlood glucose, calcium\\nAmmonia\\npH, CO2\\nUrine ketones\\nHypoglycemia—glycogen \\nstorage disease\\nHyperammonemia—\\nurea cycle defect\\nHyperammonemia + acidosis \\nOrganic acid disorders\\n+ Acidosis/−Urinary ketones\\nFatty acid oxidation defect  \\nNormal ammonia + acidosis\\nAminoacidopathies \\n(e.g., maple syrup urine)\\nCrisis mimics sepsis\\n(attain appropriate cultures)\\nFIgurE 79-1. Approach to suspected metabolic disorders.\\n79_Cydulka_Ch79.indd   422 26/04/17   2:29 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 441, 'page_label': '423'}, page_content='CHAPTER 79: Hypoglycemia and Metabolic Emergencies in Infants and Children  423 \\nfor dextrose and specific treatment. Transfer to a pediatric hospital may be \\nrequired (Table 79-1).\\n■ ■CONGENITAL ADRENAL HYPERPLASIA\\nCongenital adrenal hyperplasia results from deficiency in one of the \\nenzymes involved in the production of cortisol, which leads to decreased \\ncortisol levels sometimes accompanied by mineralocorticoid deficiency \\n(“salt wasting syndrome”). Steroid precursors may be shunted to androgen \\nproduction with virilization of females.\\nClinical Features\\nPatients with salt-wasting adrenal hyperplasia typically present in the sec-\\nond to fifth week of life with nonspecific symptoms including shock, vom-\\niting, lethargy, irritability, and poor feeding. On examination, females may \\nhave clitoromegaly and males may have a small penis or hypospadias. \\nHyperpigmentation may be noted on axillae and around the nipples.\\nDiagnosis and Differential\\nThe most important laboratory tests include bedside glucose and electro-\\nlytes, as hyponatremia and hyperkalemia are often present and suggest \\nthe diagnosis. Serum potassium levels of 6 to 12 mEq/kg are not unusual \\nbut are rarely associated with ECG abnormalities. Definitive diagnosis \\ndepends on analysis of blood hormone levels. If possible, blood should be \\nobtained for analysis before treatment with exogenous steroids; however, \\ntreatment should not be delayed in the critically ill neonate. The differen-\\ntial diagnosis includes sepsis, congenital heart disease, and other inborn \\nerrors of metabolism.\\nEmergency Department Care and Disposition\\n1. Administer 0.9% saline boluses of 20 mL/kg IV/IO.\\n2. Treat hypoglycemia as above.\\n3. Administer hydrocortisone IV/IO/IM: 25 mg for neonates, 50 mg for \\ntoddlers and school-age children, and 100 mg for adolescents.\\nTablE 79-1 Conditions Associated with Hypoglycemia in Infants and Children\\nNeonates Infancy and Childhood\\nInfant of a diabetic mother Idiopathic ketotic hypoglycemia/starvation\\nCongenital heart disease Diabetes mellitus/endocrine disorder\\nInfection/sepsis Infection/sepsis\\nAdrenal hemorrhage Inborn errors of metabolism\\nHypothermia Hypothermia\\nHypoglycemia-inducing drug use  \\nby mother\\nDrug induced (salicylates, etc.)\\nHyperinsulinism\\nMaternal eclampsia Idiopathic\\nFetal alcohol syndrome\\nHypopituitarism\\n79_Cydulka_Ch79.indd   423 26/04/17   2:29 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 442, 'page_label': '424'}, page_content='424 SECTION 9: Pediatrics\\n4. Treat hyperkalemia with calcium gluconate  100 mg/kg IV (1 mL/kg) \\nand bicarbonate 1 mEq/kg IV . Insulin should be avoided as it may \\ncause profound hypoglycemia.\\nNeonates with adrenal crisis from adrenal hyperplasia require hospital-\\nization. Infants with shock or severe hyperkalemia should be admitted to \\nthe ICU with endocrine consultation. Those with a known diagnosis of \\nadrenal hyperplasia who have normal vital signs and are able to tolerate \\noral intake may be discharged home after administration of hydrocortisone \\nas above with instructions to triple their usual home dose of steroid until \\nfever, vomiting, or diarrhea resolve and when next-day follow-up can be \\nassured) (Table 79-2).\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 144, “Metabolic Emergencies in Infants and \\nChildren,” by Garth Meckler, Nadeemuddin Qureshi, Mohammed Al-Mogbil, \\nand Osama Y . Kentab.\\nTablE 79-2 Management of Hypoglycemia in the ED\\nPatient Age\\nDextrose Bolus \\nDose\\nDextrose Maintenance \\nDosage\\nOther Treatments  \\nto Consider\\nNeonate D10 5 mL/kg\\nPO/NG/IV/IO\\n6 mL/Kg/h D10 Glucagon, 0.03 mg/ kg \\nIM/IV\\nHydrocortisone, 25 g \\nPO/IM/IV/IO\\nInfant D10 5 mL/kg\\nPO/NG/IV/IO\\nor\\nD25 2 mL/kg\\n6 mL/Kg/h D10 Glucagon, 0.03 mg/\\nkg IM/IV\\nHydrocortisone, 25 g \\nPO/IM/IV/IO\\nChild D25 2 mL/kg\\nPO/NG/IV/IO\\n6 mL/kg/h D10 for the first \\n10 kg + 3 mL/kg/h for \\n11–20 kg + 1.5 mL/kg/h for \\neach additional kg >20 kg\\nGlucagon, 0.03 mg/kg/\\nIM/IV,\\nHydrocortisone, 50 g \\nPO/IM/IV/IO\\nAdolescent — 6 mL/kg/h D10 for the first \\n10 kg + 3 mL/kg/h for \\n11–20 kg + 1.5 mL/kg/h for \\neach additional kg >20 kg\\nGlucagon, 0.03 mg/\\nkg IM/IV\\nHydrocortisone,100 g \\nPO/IM/IV/IO\\nAbbreviations: D10, 10% dextrose; D25, 25% dextrose; NG, (Via) nasogastric tube.\\n79_Cydulka_Ch79.indd   424 26/04/17   2:29 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 443, 'page_label': '425'}, page_content='425\\nDiabetes in Children\\nAdam Vella\\nType 1 diabetes, an autoimmune disease, is characterized by an abrupt and \\nfrequently complete decline in insulin production. Type 2 diabetes is \\nmarked by increasing insulin resistance and occurs in overweight adoles-\\ncents with a strong genetic predisposition. Diabetic ketoacidosis (DKA) is \\nthe leading cause of mortality in patients with diabetes <24 years of age, \\nand cerebral edema is the leading cause of mortality in DKA.\\nDKA is much more common in patients with type 1 diabetes than in \\nthose with type 2, but patients with type 2 diabetes may develop hypergly-\\ncemic hyperosmolar nonketotic syndrome (HHNS) with acidosis, which \\ncan result in severe total body water, potassium, and phosphorus deficits. \\nAbout 4% of children with newly diagnosed type 2 diabetes present with \\nHHNS, which has a case fatality rate of 12%.\\n■ ■CLINICAL FEATURES\\nPolyuria, polydipsia, and polyphagia are the classic triad leading to the \\ndiagnosis of type 1 diabetes. Other common symptoms include weight \\nloss, secondary enuresis, anorexia, vague abdominal discomfort, visual \\nchanges, and genital candidiasis in a toilet-trained child. Symptoms of \\nDKA include excessive thirst, weakness, vomiting, loss of appetite, \\nconfusion, abdominal pain, shortness of breath, and a generally ill-\\nappearance. Occasionally, children with DKA present to the ED com-\\nplaining primarily of abdominal pain, which may mimic acute \\nappendicitis; Kussmaul breathing (hyperpnea from acidosis) may be \\nmistaken for hyperventilation from anxiety or respiratory distress from \\npulmonary disease.\\nPremonitory symptoms of cerebral edema occur in 50% of patients and \\ninclude severe headache, declining mental status, and seizures. Cerebral \\nedema is rare (0.5% to 1% of all children presenting with DKA) but typi-\\ncally occurs 6 to 12 hours after initiating therapy. Although the etiology of \\nthis complication is unknown, it is felt that several factors may contribute, \\nincluding young age, severe hyperosmolality, severe acidosis, and failure of \\nthe serum sodium level to rise commensurately with the fall in glucose level \\nduring therapy.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe diagnosis of diabetes is established by demonstrating hyperglycemia \\nand glucosuria in the absence of other causes such as steroid therapy, \\nCushing syndrome, pheochromocytoma, hyperthyroidism, or other rare \\ndisorders. DKA is generally defined as a metabolic acidosis (pH < 7.30 or \\nserum bicarbonate level of < 15 mEq/L) with hyperglycemia (serum \\nglucose level of > 200 mg/dL) in the presence of ketonemia or ketonuria. \\nIn adolescent patients without known diabetes, consider toxic ingestions \\nof ethylene glycol, isopropyl alcohol, or salicylates.\\n80\\nCh A p TER\\n80_Cydulka_Ch80.indd   425 20/04/17   2:48 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 444, 'page_label': '426'}, page_content='426 SECTION 9: Pediatrics\\nCerebral edema in DKA is a clinical diagnosis based on altered mental \\nstatus not attributed to hypov olemia. Treatment should begin prior to \\nobtaining head CT when suspected. CT imaging can confirm the diagnosis, \\nand intracranial pressure monitoring may be indicated.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nThe treatment of DKA consists of judicious fluid resuscitation, insulin \\ntherapy, correction of electrolyte abnormalities, and close monitoring. \\nPatients should be placed on a cardiac monitor, noninvasive blood pressure \\ndevice, and pulse oximetry, and intravenous lines should be established.\\n1. Administer 10 mL/kg normal saline (NS) bolus over 1 hour if the child \\nis hemodynamically stable. If shock is suspected or hypotension is pres-\\nent give an initial 20 mL/kg NS bolus and repeat as needed until the \\nblood pressure normalizes. Once vital signs have stabilized, resist the \\ndesire to correct the fluid deficit too rapidly, especially if there is a high \\ncalculated osmolality (i.e., >340 mOsm/L).\\n2. Follow the initial bolus with NS at 1.5 times the calculated maintenance \\nrate.\\n3. If [K+] is 3.5 to 5.5 mEq/L and patient is urinating, add 30 mEq [K +]/L \\n(1/2 as KCl and 1/2 as potassium phosphate). If initial [K +] is 2.5 to  \\n3.5 mEq/L, add 40 mEq [K +]/L; consider adding more if the [K +] is \\n<2.5 mEq/L.\\n4. Begin regular insulin infusion at 0.1 U/kg/h after IV fluid bolus (if \\ngiven) is complete. Adjust dose to maintain glucose decline at 50 to 100 \\nmg/dL/h. Do not decrease insulin infusion below 0.05 U/kg/h until \\nketonuria has resolved. High-dose insulin therapy and insulin boluses \\nincrease the risk of complications and should not be given.\\n5. Add dextrose to IV fluids when blood glucose is <200 to 250 mg/dL. \\nGlucose le vels correct faster than ketoacidosis, so supplement with \\ndextrose and continue the insulin drip until ketoacidosis has resolved.\\n6. Measure serum electrolyte levels every 2 hours; measure serum glucose \\nlevel every hour.\\n7. The use of bicarbonate in the treatment of DKA is not recom-\\nmended, as it does not improve outcomes and has been associated \\nwith a fourfold increase in the development of cerebral edema. Bicar -\\nbonate administration should be limited to critically ill patients with a \\npH of < 7.0 and hemodynamic compromise unresponsive to fluid \\nresuscitation.\\n8. Management of cerebral edema. T reat patients with altered mental \\nstatus suggestive of cerebral edema with mannitol 0.25 to 1 g/kg. Con-\\nsider 3% hypertonic saline, 10 mL/kg over 30 minutes. Restrict addi-\\ntional IV fluids to minimum required to maintain IV access. Use caution \\nif endotracheal intubation is required and avoid eucapnea as severe \\nmetabolic acidosis requires a compensatory respiratory alkalosis, and a \\nrise in CO 2 may worsen systemic and intracellular acidosis, leading to \\nhyperemia and worsening of cerebral edema.\\n9. Most patients with DKA require admission to the intensive care unit, \\neven when in stable condition, because of intensive monitoring needs. \\nFurthermore, many hospitals restrict the use of insulin infusions to \\n80_Cydulka_Ch80.indd   426 20/04/17   2:48 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 445, 'page_label': '427'}, page_content='CHAPTER 80: Diabetes in Children 427 \\nintensive care settings. Patients with cerebral edema require ICU admis-\\nsion and possible intracranial pressure monitoring. Consultation with \\nthe patient’s primary care physician and a pediatric endocrinologist \\nshould be made early in the course of therapy.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 145, “Diabetes in Children,” by Adam Vella.\\n80_Cydulka_Ch80.indd   427 20/04/17   2:48 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 446, 'page_label': '428'}, page_content='428\\nFluid and Electrolyte Therapy  \\nin Infants and Children\\nRon L. Kaplan\\nThe most common disorder of fluid balance in children requiring emer -\\ngency care is dehydration. Dehydration is the result of a negative fluid \\nbalance that can result from decreased fluid intake, increased output (renal, \\nGI, or insensible losses from the skin or respiratory tract), or conditions \\nsuch as sepsis, burns, and diabetes.\\n■ ■CLINICAL FEATURES\\nThe presence of fluid and electrolyte disturbances is often suggested by a \\nthorough history. Children with chronic underlying disease are at particular \\nrisk. The clinical appearance depends on the degree of dehydration, the rate \\nat which the fluid was lost, and the age of the patient.\\nThough the gold standard for assessing dehydration is comparison of \\npre-illness weight with weight on presentation to the emergency depart-\\nment (ED), a reliable and recent pre-illness weight is rarely available in \\nthe ED. Physical examination can provide an estimation of the degree of \\ndehydration, which is typically classified as mild, moderate, or severe. \\nClinical signs and symptoms of dehydration are listed in Table 81-1. An \\nimportant exception to the reliability of signs and symptoms to predict \\ndegree of dehydration occurs in hypernatremic dehydration, when fluid \\n81\\nCh A p TER\\nTablE 81-1 Clinical Guidelines for Assessing Dehydration in Children\\nNone to Mild \\n(< 3% Body \\nWeight Loss)\\nMild to Moderate \\n(3% to 9% Body \\nWeight Loss)\\nSevere (> 9% Body \\nWeight Loss)\\nMental status Well, alert Fatigued, restless, \\nirritable\\nApathetic, lethargic, \\nunconscious\\nThirst Normal, slight \\nincrease, or \\nrefusing fluids\\nIncreased, eager to \\ndrink\\nVery thirsty or too \\nlethargic to drink\\nHeart rate Normal Normal to increased Tachycardia or \\nbradycardia in critically \\nill children\\nPulse quality Normal Normal to reduced Weak, thready\\nEyes Normal Slightly sunken Sunken\\nTears Present Decreased Absent\\nMucous membranes Moist Dry Parched\\nAnterior fontanelle Normal Sunken Sunken\\nCapillary Refill Normal 3 to 4 s > 4 s\\nExtremities Warm Warm to cool Cold, mottled, cyanotic\\nUrine output Normal Decreased Minimal\\nSource: Used with permission from Stephen Freedman, MD and Jennifer Thull-Freedman.\\n81_Cydulka_Ch81.indd   428 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 447, 'page_label': '429'}, page_content='CHAPTER 81: Fluid and Electrolyte Therapy in Infants and Children  429 \\nloss occurs primarily from the interstitial and intracellular spaces and \\nclinical signs of intrav ascular volume depletion may be minimal. In this \\nsetting, however, the skin may have a characteristic doughy feel.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nIf available, the absolute and relative fluid deficit can be calculated from a \\npre-illness weight: 1  kg of weight loss is equivalent to 1  L of fluid deficit. \\nIn the absence of a reliable pre-illness comparison weight, the diagnosis of \\ndehydration is based primarily on historical data and physical e xamination \\nfindings (Table 81-1).\\nRoutine laboratory testing is not required in mild to moderate dehydra-\\ntion, but serum electrolytes and other studies may be indicated in the setting \\nof severe dehydration, signs and symptoms of electrolyte abnormalities, or \\ncertain underlying medical conditions. A rapid bedside glucose test should \\nbe done on any child presenting with altered sensorium. Infants are at \\nparticular risk of hypoglycemia.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nThe management of fluid and electrolyte disturbances in infants and young \\nchildren revolves around a few basic principles: (a) identification and treat-\\nment of shock; (b) administration of appropriate fluids to replace fluid \\ndeficits, ongoing losses, and maintenance fluid requirements; (c) identifica-\\ntion and treatment of causes that have specific therapies (e.g., diabetic \\nketoacidosis, sepsis, and inborn errors of metabolism). The most common \\napproaches to rehydration include oral rehydration therapy and parenteral \\ntherapy, though rehydration through nasogastric tube is also effective, \\nsimple, and well tolerated.\\n1. Treat hypovolemic shock with an initial bolus of 20 mL/kg of isotonic \\ncrystalloid: normal saline (NS) or lactated Ringer (LR) solution IV/IO. \\nRepeat boluses every 10 to 20 minutes until mental status, vital signs, \\nand peripheral perfusion improve. Up to 60 mL/kg or more may be \\nneeded in the first hour; care must be taken to monitor for signs of vol-\\nume overload or myocardial dysfunction.\\n2. Oral rehydration is as effectiv e as intravenous therapy and is recom-\\nmended by the World Health Organization (WHO) for mild to moderate \\ndehydration. Administer frequent small sips of oral rehydration solu-\\ntion containing glucose and electrolytes (e.g., Rehydralyte ®) by mouth \\nor nasogastric tube. Give 50 mL/kg orally over 4 hours for mild \\ndehydration and 100 mL/kg for moderate dehydration. V omiting is not \\na contraindication to attempting oral rehydration. Ondansetron may be \\nused to facilitate oral rehydration if nausea or vomiting persists. Give \\n0.1 mg/kg IV or 0.15 mg/kg PO or by oral disintegrating tablet with a \\nmaximum dose of 8 mg.\\n3. Treat patients who cannot tolerate oral or enteral rehydration with IV or \\nIO administration of NS or LR. If shock is not present, administer  \\n20 mL/kg over 1 hour and repeat as needed. After initial volume replace-\\nment, 5% dextrose in 0.9% saline may be started at one to two times \\nmaintenance while determining disposition.\\n81_Cydulka_Ch81.indd   429 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 448, 'page_label': '430'}, page_content='430 SECTION 9: Pediatrics\\n4. For maintenance treatment, use the following formula to determine \\nfluid rate:\\nFor the first 10 kg: 100 mL/kg/d or 4 mL/kg/h\\nFor the second 10 kg: 50 mL/kg/d or 2 mL/kg/h\\nFor each kg >20 kg: 20 mL/kg/d or 1 mL/kg/h\\n Isotonic fluids such as 5% dextrose in 0.9% saline should be used for \\nmaintenance treatment after the first week of life in order to a void \\niatrogenic hyponatremia. 10% dextrose with no electrolytes should be \\nused on day 1 of life and 5% dextrose in 0.45% saline can be used on \\ndays 2 to 7 of life.\\n5. Treat specific electrolyte disturbances, as listed in T able 81-2. Of note, \\noverly rapid correction of hypo- or hypernatremia may lead to severe \\nCNS sequelae. If neurologic symptoms such as seizures or altered mental \\nstatus accompany hyponatremia, administer 2 to 3 mL/kg of 3% saline \\nuntil symptoms resolve or the serum sodium is >120 mEq/L. Otherwise, \\ncorrect the hyponatremia slowly over 48 hours to avoid CNS osmotic \\ndemyelination. Hypernatremia must be corrected slowly as well, in order \\nto prevent cerebral edema and central pontine myelinolysis.\\nTablE 81-2 Electrolyte Disorders in Infants and Children and Initial \\nManagement\\nElectrolyte \\nDisorder Common Causes\\nSymptoms and \\nSigns\\nInitial Treatment \\nRecommendations\\nHyponatremia Vomiting, diarrhea, \\nexcess free water \\nintake\\nMental status \\nchanges, seizures, \\nhyporeflexia\\nIV normal saline starting \\nwith a 20 mL/kg bolus\\nFor seizures: 4 mL/kg of \\n3% saline over 30 min\\nFurther correction slowly \\nover 48 h\\nHypernatremia Vomiting, diarrhea, \\ninsensible losses, \\ndiabetes insipidus, \\nrenal disease\\nDiarrhea, mental \\nstatus changes, \\nataxia, doughy \\nskin, seizures, \\nhyperreflexia\\nIV normal saline starting \\nwith a 20 mL/kg bolus\\nFurther correction to take \\nplace slowly over 48 h\\nHypokalemia Vomiting, DKA Muscle weakness, \\nileus\\nGenerally tolerated \\nwell, replace orally over \\nseveral days\\nIf severe: IV 0.2 to  \\n0.3 mEq/kg/h of KCl\\nHyperkalemia* Cortical adrenal \\nhyperplasia \\n(neonates), renal \\nfailure. May be due \\nto hemolysis of \\nblood sample\\nECG changes: \\npeaked T waves, \\nprolonged PR inter-\\nval, widening of QRS\\nInsulin 0.1 unit/kg plus \\n25% glucose, 0.5 g/kg IV\\nCalcium gluconate 10%, \\n1 mL/kg IV, no faster \\nthan 1 mL/min\\nAlbuterol, 0.5% solution, \\n2.5 mg via nebulization\\nFor other treatments, \\nsee Chapter 4.\\n(Continued)\\n81_Cydulka_Ch81.indd   430 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 449, 'page_label': '431'}, page_content='CHAPTER 81: Fluid and Electrolyte Therapy in Infants and Children  431 \\nMost children with mild to moderate dehydration can be managed as \\noutpatients without any laboratory evaluation in the emergency department. \\nAdmission criteria include young infants with ongoing significant fluid \\nlosses; severe dehydration; significant electrolyte or metabolic derange-\\nments; persistent vomiting and failed attempts at oral rehydration; or an \\nunderlying diagnosis requiring ongoing inpatient treatment (e.g., DKA or \\ninborn errors of metabolism).\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 129, “Fluid and Electrolyte Therapy in Infants and \\nChildren,” by Chan Melissa and Enarson Paul.\\nTablE 81-2 Electrolyte Disorders in Infants and Children and Initial \\nManagement\\nElectrolyte \\nDisorder Common Causes\\nSymptoms and \\nSigns\\nInitial Treatment \\nRecommendations\\nHypocalcemia Dietary or vitamin D \\ndeficiency, hypopar-\\nathyroid and chronic \\nrenal failure\\nVomiting, irritability, \\nmuscle weakness, \\ntetany, seizures\\nCalcium gluconate 10%, \\n1 mL/kg IV, no faster \\nthan 1 mL/min\\nHypercalcemia Malignancy, hyper-\\nvitaminosis D or A\\nFatigue, irritability, \\nanorexia, vomiting, \\nconstipation\\nIV normal saline starting \\nat 20 mL/kg\\nConsider furosemide  \\n1-2 mg/kg IV, maximum \\ndose 40 mg\\nHypomagnesemia Diarrhea, short \\ngut, diuretics, \\nchemotherapy\\nMuscle spasms, \\nweakness, ataxia, \\nnystagmus, seizures\\nECG changes: \\nprolonged PR and \\nQTc, torsades de \\npointes\\nFor seizures or \\ndysrhythmia: IV \\nmagnesium sulfate  \\n1 mEq/kg slowly over 4 h\\nAsymptomatic patients \\ncan be treated with oral \\nsupplements\\nHypermagnesemia Ingestion of \\nantacids or renal \\ndysfunction\\nHypotension, respi-\\nratory failure, loss of \\ndeep tendon reflexes\\nECG changes: \\nwidening of QRS, \\nPR, QTc\\nRemove exogenous \\nsource of magnesium\\nIf severe: calcium \\ngluconate 10%  \\n1 mL/kg IV no faster  \\nthan 1 mL/min\\n*Mild hyperkalemia usually well tolerated in neonates.\\n(Continued)\\n81_Cydulka_Ch81.indd   431 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 450, 'page_label': '432'}, page_content='432\\nMusculoskeletal Disorders  \\nin Children\\nMark X. Cicero\\n■ ■CHILDHOOD PATTERNS OF INJURY\\nThe growth plate (physis) is the weakest point in children’s long bones and \\nthe frequent site of fractures. The ligaments and periosteum are stronger \\nthan the physis; therefore, they tolerate mechanical forces at the expense of \\nphyseal injury. The blood supply to the physis arises from the epiphysis, so \\nseparation of the physis from the epiphysis may result in growth arrest. The \\nSalter–Harris classification is used to describe fractures involving the \\ngrowth plate (Figs. 82-1 and 82-2).\\n82\\nC HAPTER\\nFigure 82-1.  Salter–Harris type II fracture of distal tibia. Lateral radiograph \\nillustrating fracture extending through physeal growth plate and metaphysis with \\ndorsal displacement of epiphysis requiring reduction. Used with permission from \\nWake Medical Center, Raleigh, NC.\\n82_Cydulka_Ch82.indd   432 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 451, 'page_label': '433'}, page_content='CHAPTER 82: Musculoskeletal Disorders in Children  433 \\nSalter–Harris Type i Fracture\\nIn type I physeal fracture, the epiphysis separates from the metaph ysis. \\nThe reproductive cells of the physis stay with the epiphysis. There are \\nno bony fragments, and these injuries have a low incidence of growth \\ndisturbance. Diagnosis is suspected clinically in children with point \\ntenderness over a physis. On radiograph, there may be no abnormality; \\nthere may be an associated joint effusion; or there may be epiphyseal \\ndisplacement from the metaphysis. In the absence of epiphyseal \\ndisplacement, the diagnosis is clinical. Treatment consists of splint \\nimmobilization, ice, elevation, and referral to orthopedics. Type I frac-\\ntures of the distal fibula are not associated with growth arrest and can \\nbe followed by a primary care physician (PCP) or by orthopedics after \\nsplinting.\\nFigure 82-2.  An x-ray of a Salter–Harris type III fracture of the distal tibia, \\nalso known as Tillaux’s fracture. Note the intra-articular component extending \\nthrough the growth plate and the medial epiphysis of the tibia. Reproduced \\nwith permission from Schafermeyer RW, Tenebein M, Macias CG: Strange and \\nSchafermeyer’s Pediatric Emergency Medicine, 4th ed. New York: McGraw-Hill, \\nInc; 2015.\\n82_Cydulka_Ch82.indd   433 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 452, 'page_label': '434'}, page_content='434 SECTION 9: Pediatrics\\nSalter–Harris Type ii Fracture\\nA type II physeal fracture goes through the physis and out through the \\nmetaphysis. Growth is preserved because the physis remains with the \\nepiphysis. Diagnosis is made by noting a metaphyseal triangular-shaped \\nfragment without epiphyseal involvement on radiograph. Treatment is \\nclosed reduction (if necessary) with analgesia and sedation followed by \\nsplint or cast immobilization, and follow-up with orthopedics.\\nSalter–Harris Type iii Fracture\\nThe hallmark of type III physeal fracture is an intra-articular fracture of \\nthe epiphysis with the cleavage plane continuing along the physis. The \\nprognosis for bone growth depends on the circulation to the epiphyseal \\nbone fragment and is usually favorable. Diagnosis is made radiographi-\\ncally with an epiphyseal fragment without a metaphyseal fracture. Reduc-\\ntion of the unstable fragment with anatomic alignment of the articular \\nsurface is critical. Open reduction is sometimes required.\\nSalter–Harris Type iV Fracture\\nThe fracture line of type IV physeal fractures begins at the articular surface \\nand extends through the epiphysis, physis, and metaphysis. Diagnosis is \\nmade radiographically with both epiphyseal and metaphyseal fractures. \\nEspecially when there is displacement of the bony fragments, open reduc-\\ntion is usually required to reduce the risk of premature bone growth arrest.\\nSalter–Harris Type V Fracture\\nIn type V physeal fracture, severe compressive forces essentially crush the \\nphysis. There is usually no epiphyseal displacement. The diagnosis is often \\ndifficult. An initial diagnosis of sprain or type I injury may prove incorrect \\nwhen later growth arrest occurs. Radiographs may look normal or demon-\\nstrate focal narrowing of the epiphyseal plate. There is usually an associ-\\nated joint effusion. Treatment consists of casting, nonweight bearing, and \\nclose orthopedic follow-up in anticipation of bone growth arrest.\\nTorus Fractures, greenstick Fractures, and Plastic Deformities\\nChildren’s long bones are more compliant than those of adults and tend \\nto bo w and bend under forces where an adult’s might fracture. Torus \\n(buckle) fractures involve a bulging or buckling of the bony cortex, usu-\\nally of the metaphysis. Patients have point tenderness over the fracture \\nsite and soft tissue swelling. Radiographs may be subtle but show cortical \\ndisruption. Torus fractures are not typically angulated, rotated, or dis-\\nplaced, so reduction is not necessary. Splinting in a position of function \\nfor 3 to 4 weeks is often preferred over casting. Orthopedic follow-up is \\nusually recommended.\\nIn greenstick fractures, the cortex and periosteum are disrupted on one \\nside of the bone but intact on the other. If the degree of angulation is sig-\\nnificant, treatment is closed reduction and immobilization.\\nPlastic deformities, also known as bowing or bending fractures, are seen \\nin the forearm and lower leg in combination with a completed fracture in \\nthe companion bone. The diaphyseal cortex is deformed, but the periosteum \\n82_Cydulka_Ch82.indd   434 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 453, 'page_label': '435'}, page_content='CHAPTER 82: Musculoskeletal Disorders in Children  435 \\nis intact. Treatment requires prompt orthopedic consultation for closed \\nreduction and realignment.\\n■ ■FRACTURES ASSOCIATED WITH CHILD ABUSE\\nCertain injury patterns are consistently seen in abused children, particularly \\nmultiple fractures in various stages of healing. Please see Chapter 187 for \\ndetails.\\n■ ■SELECTED PEDIATRIC INJURIES\\nClavicle Fracture\\nClavicles are commonly fractured in children, and may occur in newborns \\nduring difficult deliveries, presenting in neonates with nonuse of the arm. If \\nthe fracture was not initially appreciated, parents may notice a bony callus \\nat age 2 to 3 weeks. In older infants and children, the usual mechanism is a \\nfall onto the outstretched arm or shoulder. Care of the patient with a clavicle \\nfracture is directed toward pain control. Even displaced fractures usually \\nheal well, although patients may have a residual bump at the fracture site. A \\nsimple sling is effective and less painful than other methods of clavicle \\nimmobilization. Newborns require no specific treatment. Orthopedic consul-\\ntation in the emergency department (ED) is required for an open fracture \\n(which also requires antibiotics), displacement of the medial clavicle, or a \\nskin-tenting fracture fragment that has the potential to convert to an open \\nfracture. Otherwise, routine follow-up with the PCP is usually adequate.\\nSupracondylar and Condylar Fractures\\nThe most common elbow fracture in childhood is the supracondylar frac-\\nture of the distal humerus. The mechanism is commonly a fall onto the \\noutstretched arm. Children complain of pain on passive elbow flexion and \\nhold the forearm pronated. The close proximity of the brachial artery to the \\nfracture predisposes the artery to injury. Subsequent arterial spasm or com-\\npression by casts may further compromise distal circulation. A forearm \\ncompartment syndrome (resulting in V olkmann ischemic contracture) may \\noccur.\\nRadiographs show the injury, but the findings may be subtle. Type I \\nfractures have no displacement or angulation, or may have a posterior fat \\npad as the only radiographic manifestation of a fracture. Confirmation of a \\nfracture may be seen on an x-ray taken 2 to 4 weeks later, when a periosteal \\nreaction is visible. Type II fractures are angulated, but the posterior cortex \\nis intact, while type III fractures are completely displaced with no cortical \\ncontact.\\nIn cases of neurovascular compromise, immediate fracture reduction \\nis indicated. If an ischemic forearm compartment is suspected after \\nreduction, surgical decompression or arterial exploration may be indi-\\ncated. Outpatient treatment is acceptable for type I fractures after appro-\\npriate immobilization. Such children need orthopedic reassessment \\nwithin 2 to 7 days. Orthopedic consultation and admission is recom-\\nmended for patients with type II or III fractures. Open reduction with \\noperative pinning is usually required.\\n82_Cydulka_Ch82.indd   435 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 454, 'page_label': '436'}, page_content='436 SECTION 9: Pediatrics\\nLateral and medial condylar fractures and intercondylar and transcondy-\\nlar fractures carry risks of neurovascular compromise, especially to the \\nulnar nerve. These patients have soft tissue swelling and tenderness while \\nmaintaining the arm in flexion. Depending on the displacement visualized \\non x-ray, patients may require open reduction.\\nradial Head Subluxation (“Nursemaid’s elbow”)\\nRadial head subluxation is a very common injury seen most often in \\nchildren 1 to 4 years of age. The typical history is that the child was lifted \\nor pulled by the hand or wrist, though 50% have no such history and parents \\nmay report a fall or simply that their child refuses to use the arm. The arm \\nis held in adduction, flexed at the elbow, with the forearm pronated. Gentle \\nexamination demonstrates no tenderness to direct palpation, but attempts to \\nsupinate the forearm or move the elbow cause pain. If the history and \\nexamination are strongly suggestive, radiographs are not needed. However, \\nif the history is atypical or there is point tenderness or signs of trauma, \\nradiographs should be obtained.\\nThere are two maneuvers for reduction. The first, the supination/flexion \\ntechnique, is performed by holding the patient’s elbow at 90° with one hand \\nand then firmly supinating the wrist and simultaneously flexing the elbow \\nso that the wrist is directed to the ipsilateral shoulder. There may be a “click” \\nwith reduction, and the child may transiently cry and resist. The second, the \\nhyperpronation technique, is reported to be more successful. The hyperpro-\\nnation technique is performed by holding the child’s elbow at 90° in one \\nhand and then firmly pronating the wrist while extending the elbow. Usually \\nthe child will resume normal activity in 5 to 10 minutes if reduction is \\nachieved. If the child is not better after a second reduction attempt, alternate \\ndiagnoses and radiographs should be considered. No specific therapy is \\nneeded after successful reduction. Parents should be reminded to avoid \\nlinear traction on the arm because there is a risk of recurrence.\\nForearm injuries\\nTorus Fractures\\nTorus fractures, also called buckle fractures, are among the most common \\npediatric bony injuries and may occur in the radius or ulna. Treatment con-\\nsists of pain management with NSAIDs, application of a volar splint, and \\nfollow-up with the PCP or orthopedics in 1 to 3 weeks.\\nFractures of the radial and ulnar Shafts\\nMetaphyseal Fractures\\nAny metaphyseal fracture with rotational deformity or more than 10 degrees \\nof angulation in children above 8 years of age, or more than 15 to 20 degrees \\nin younger children, requires consultation with an orthopedist to determine \\nthe need for reduction. Otherwise, immobilization in a splint with follow-up \\nwith orthopedics within 1 week is adequate treatment.\\nDiaphyseal Fractures\\nMost diaphyseal forearm fractures warrant urgent orthopedic consultation. \\nTransverse fractures of one or both bones may remain unstable despite \\n82_Cydulka_Ch82.indd   436 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 455, 'page_label': '437'}, page_content='CHAPTER 82: Musculoskeletal Disorders in Children  437 \\nattempts at closed reduction. Two fracture-dislocation injuries with espe -\\ncially guarded prognoses are an ulnar fracture with a radial head dislocation \\n(Monteggia’s fracture) and a radial shaft fracture with distal radioulnar joint \\ndislocation (Galeazzi’s fracture).\\nWrist Fractures\\nCarpal bone injuries are rare in young children, and gain frequency in older \\nchildren and adolescents, when athletic pursuits generate greater force. The \\nscaphoid fracture requires a high index of suspicion. Snuffbox tenderness \\nand tenderness of the lateral wrist with axial compression of the thumb \\nwarrant application of a thumb spica splint and follow-up with an orthope-\\ndist, even when radiographs show no scaphoid fracture.\\nLower extremity injuries\\nSlipped Capital Femoral Epiphysis\\nSlipped capital femoral epiphysis (SCFE) is more common in obese chil-\\ndren, with a peak incidence between ages 14 and 16 years (11 and 13 years \\nin girls). Clinically, the child presents with pain at the hip or referred to the \\nthigh or knee. With a chronic SCFE, children complain of dull pain in the \\ngroin, anteromedial thigh, and knee, which becomes worse with activity. \\nWith walking, the leg is externally rotated and the gait is antalgic. Hip \\nflexion is restricted and accompanied by external rotation of the thigh. \\nAcute SCFE is due to trauma or may occur in a patient with preexisting \\nchronic SCFE.\\nThe differential includes septic arthritis, toxic synovitis, Legg–Calvé–\\nPerthes disease, and other hip fractures. Children with SCFE are not febrile \\nor toxic and have normal white blood cell counts and erythrocyte sedimenta-\\ntion rates. Obtain bilateral hip radiographs in any adolescent with hip pain. \\nBilateral anteroposterior and frog-leg lateral radiographs of the hips are \\npreferred. Medial slips of the femoral epiphysis will be seen on anteropos-\\nterior views, whereas frog-leg views detect posterior slips. In the anteropos-\\nterior view, a line along the superior femoral neck should transect the lateral \\nquarter of the femoral epiphysis, and will not if the epiphysis is slipped.\\nThe management of SCFE is operative. Immediate non-weight-bearing \\nupon diagnosis is important and admission for surgical pinning is typical. \\nThe main long-term complication is avascular necrosis of the femoral head \\nand premature closure of the physis.\\nFemoral Fracture\\nAll femoral shaft fractures should prompt emergent orthopedic consulta-\\ntion. In infants and nonambulatory children with femoral fractures, evalua-\\ntion for nonaccidental trauma is warranted. In young children who are \\ninjured, femur fractures rarely cause hypotension. When hypotension is \\npresent, searching for another serious hemorrhagic injury is key.\\nKnee injuries\\nFractures of the Distal Femoral Physis\\nFractures through the distal femoral physis are uncommon yet carry a \\nsignificant complication rate. The popliteal artery lies close to the distal \\n82_Cydulka_Ch82.indd   437 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 456, 'page_label': '438'}, page_content='438 SECTION 9: Pediatrics\\nfemoral metaphysis and may be injured along with the peroneal nerve. \\nIn these cases, immediate orthopedic e valuation is needed.\\nPatellar Dislocation\\nOften, there is a history of the kneecap “popping” out of place. Reduction \\nis performed by extending the affected knee while gently “lifting” the \\npatella medially into place. After reduction, radiographs are obtained to \\nevaluate for fracture. A knee immobilizer and crutches are provided, and \\nfollow-up is with orthopedics.\\nTibia Fractures\\nToddler’s Fracture\\nThe toddler’s fracture is an isolated spiral fracture of the distal tibia in a \\ntoddler. The typical mechanism is external rotation of the foot with the \\nknee flexed. Clinically, there is often refusal to bear weight, and usually \\npain with palpation and rotation of the distal tibia, although swelling may \\nbe minimal or absent and occasionally there is no tenderness. Obtain \\nradiographs with standard and oblique views of the leg in the limping \\ntoddler, even in the absence of physical examination findings. Radio-\\ngraphically, a fracture line may be noticed at the distal third of the tibial \\nshaft. If a toddler’s fracture is clinically suspected and initial radiographs \\nare negative, immobilization and no immobilization are both management \\noptions with follow-up in 1 week for repeat x-rays and/or bone scan or \\nMRI. The leg should not be in a circumferential cast if the diagnosis is \\nnot clear. For fractures evident on radiograph, immobilize the leg in a \\nlong leg splint or above knee cast with adequate flexion for car seat use \\nand provide orthopedic follow-up within 72 hours for definitive casting if \\nnot done in the ED.\\nDistal tibial Salter–Harris types I and II fractures are the most \\ncommon tibial fractures in children. If any significant displacement is \\nevident, closed reduction and immobilization are usually sufficient ED \\nmanagement. The Salter–Harris type III fracture of the distal tibia typi-\\ncally requires open reduction when there is displacement. The Tillaux \\nfracture is a Salter–Harris type III fracture through the anterolateral \\nphysis: it is usually managed surgically. The triplane fracture is a Salter–\\nHarris type IV fracture. A computed tomography scan is warranted, and \\nmanagement is usually surgical.\\nFoot and Ankle injuries\\nMost nondisplaced fractures of the metatarsals and phalanges can be man-\\naged by immobilization in a posterior short-leg splint and follow-up with \\nan orthopedist. Significantly displaced fractures of the metatarsals and \\nphalanges, as well as those of the great toe, that have intra-articular involve-\\nment may require fixation, although this can typically be done on an outpa-\\ntient basis. Fractures of the base of the fifth metatarsal are common with \\ninversion injuries of the ankle as in adults. The evaluation of ankle injuries \\nshould therefore include radiographs of the foot when there is tenderness \\nover the fifth metatarsal bone.\\n82_Cydulka_Ch82.indd   438 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 457, 'page_label': '439'}, page_content='CHAPTER 82: Musculoskeletal Disorders in Children  439 \\n■ ■SELECTED NONTRAUMATIC MUSCULOSKELETAL \\nDISORDERS OF CHILDHOOD\\nKawasaki’s disease is discussed in Chapter 83.\\nAcute Septic Arthritis\\nSeptic arthritis occurs in all ages, but especially in children younger than \\n3 years. The hip is most often affected, followed by the knee and elbow. If \\nleft untreated, purulent joint infection leads to total joint destruction. \\nPlease see Chapter 180, “Acute Disorders of the Joints and Bursae” for \\nadditional information.\\nRadiographs may show joint effusion, but this is nonspecific. The dif-\\nferential includes osteomyelitis, transient synovitis, cellulitis, septic bursi-\\ntis, acute pauciarticular juvenile idiopathic arthritis (JIA), acute rheumatic \\nfever, hemarthrosis, and SCFE. Distinguishing septic arthritis from osteo-\\nmyelitis may be quite difficult. Osteomyelitis is more tender over the \\nmetaphysis, whereas septic arthritis is more tender over the joint line. Joint \\nmotion is much more limited in septic arthritis. Prompt arthrocentesis is the \\nkey to diagnosis at the bedside or, in the case of the hip, via ultrasound \\nguidance. Synovial fluid shows WBCs and organisms.\\nPrompt open joint drainage and washout in the operating room is critical \\nin the case of the hip, or arthroscopically or via arthrocentesis in more \\nsuperficial joints. In all pediatric patients, when the organism is unknown, \\ninitial treatment is vancomycin 10 mg/kg IV every 6 hours or clindamycin \\n10 mg/kg IV every 6 hours and cefotaxime 50 mg/kg. The prognosis \\ndepends on the duration between symptoms and treatment, which joint is \\ninvolved (worse for the hip), presence of associated osteomyelitis (worse), \\nand the patient’s age (worse for the youngest children).\\nHenoch–Schönlein Purpura\\nHenoch–Schönlein purpura (HSP) is a small-vessel vasculitis characterized \\nby purpura, arthritis, abdominal pain, and hematuria. See Chapter 74, \\n“Pediatric Abdominal Emergencies,” for a discussion of HSP.\\n■ ■SELECTED PEDIATRIC RHEUMATOLOGIC DISORDERS\\nTransient Synovitis of the Hip\\nTransient or toxic synovitis is the most common cause of hip pain in chil-\\ndren younger than 10 years. The peak age is 3 to 6 years, and the cause is \\nunknown. Symptoms may be acute or gradual. Patients have pain in the hip, \\nthigh, and knee, and an antalgic gait. Pain limits range of motion of the hip, \\nbut in contrast to septic arthritis, passive range of motion remains possible. \\nThere may be a low-grade fever, but patients do not appear toxic. The WBC \\nand ESR are usually normal or mildly elevated. Radiographs of the hip are \\nnormal or show a mild to moderate effusion. The main concern is differen-\\ntiation from septic arthritis, particularly if the patients are febrile, with \\nelevation of WBC or ESR and effusion. Diagnostic arthrocentesis is \\nrequired when the diagnosis is in doubt with fluoroscopic or ultrasound \\nguidance. The fluid in transient synovitis is a sterile clear transudate.\\n82_Cydulka_Ch82.indd   439 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 458, 'page_label': '440'}, page_content='440 SECTION 9: Pediatrics\\nOnce septic arthritis and hip fracture have been ruled out, patients can \\nbe treated with weight-bearing as tolerated, no strenuous acti vity for 1 to \\n2 weeks, anti-inflammatory agents such as ibuprofen 10 mg/kg every  \\n6 hours, and close follow-up.\\nLegg–Calvé–Perthes Disease\\nLegg–Calvé–Perthes disease is avascular necrosis of the femoral head, \\ncomplicated by a subchondral stress fracture. Collapse and flattening of \\nthe femoral head ensues, with a potential for subluxation. The result is a \\npainful hip with limited range of motion, muscle spasm, and soft tissue \\ncontractures. Children have a limp and chronic dull pain in the groin, \\nthigh, and knee, which becomes worse with activity. Systemic symptoms \\nare absent. Hip motion is restricted; there may be flexion and abduction \\ncontracture and thigh muscle atrophy. Initial radiographs in the first 1 to \\n3 months show widening of the cartilage space in the affected hip and \\ndiminished ossific nucleus of the femoral head. The second sign is sub-\\nchondral stress fracture of the femoral head. The third finding is \\nincreased femoral head opacification. Deformity of the femoral head \\nthen occurs, with subluxation and protrusion of the femoral head from \\nthe acetabulum.\\nBone scan and magnetic resonance imaging are very helpful in making \\nthis diagnosis by showing bone abnormalities well before plain films. The \\ndifferential diagnosis includes transient synovitis, tuberculous arthritis, \\ntumors, and bone dyscrasias.\\nIn the ED, it is key to consider this chronic and potentially crippling \\ncondition. Initial management is non-weight-bearing and referral to a pedi-\\natric orthopedist for definitive care.\\nOsgood–Schlatter Disease\\nOsgood–Schlatter disease is common, and affects boys more than girls, \\nusually between the ages of 10 and 15 years. The cause is repetitive stress \\non the tibial tuberosity by the quadriceps muscle, leading to inflammation. \\nProlonged basketball play is a frequent culprit. Children have pain and \\ntenderness over the tuberosity, and symptoms are usually bilateral. The \\npatellar tendon is thick and tender, with the tibial tuberosity enlarged and \\nindurated.\\nRadiographs show soft tissue swelling over the tuberosity and patellar \\ntendon thickening without knee effusion. Normally, the ossification site at \\nthe tubercle at this age will be irregular, but the prominence of the tubercle \\nis characteristic of Osgood–Schlatter disease.\\nThe disorder is self-limited. Acute symptoms improve after temporary \\navoidance of the offending activity. Crutches may be necessary, with a knee \\nimmobilizer or cylinder cast rarely needed. Exercises to stretch taut and \\nhypertrophied quadriceps muscles are helpful.\\nAcute rheumatic Fever\\nAcute rheumatic fever (ARF) is an acute inflammatory multisystem  \\nillness primarily affecting school-age children. It is not common in the \\nUnited States, but there have been recent epidemics. ARF is preceded by \\ninfection with certain strains of group A β -hemolytic Streptococcus, \\n82_Cydulka_Ch82.indd   440 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 459, 'page_label': '441'}, page_content='CHAPTER 82: Musculoskeletal Disorders in Children  441 \\nwhich stimulates antibody production to host tissues. Children develop \\nARF 2 to 6 weeks after symptomatic or asymptomatic streptococcal  \\npharyngitis. Arthritis, which occurs in most initial attacks, is migratory \\nand polyarticular, primarily affecting the large joints. Carditis occurs in \\n33% of patients. Sydenham chorea occurs in 10% of patients and may \\noccur months after the initial infection. The rash, erythema marginatum, \\nis fleeting, faint, and serpiginous, usually accompanying carditis. Subcu-\\ntaneous nodules, found on the extensor surfaces of extremities, are quite \\nrare. Carditis confers greatest mortality and morbidity.\\nVarious tests are used to confirm prior streptococcal infection (throat \\nculture and streptococcal serology) or to assess carditis (electrocardiogram, \\nchest radiograph, and echocardiogram). The differential includes JIA, \\nseptic arthritis, Kawasaki’s disease, leukemia, and other cardiomyopathies \\nand vasculitides. In the ED, carditis is the main management issue. Most \\npatients are admitted.\\nSignificant carditis is managed initially with prednisone 1 to 2 mg/kg/d. \\nArthritis is treated with high-dose aspirin 75 to 100 mg/kg/d to start. All \\nchildren with ARF are treated with penicillin (or erythromycin, if allergic): \\nbenzathine penicillin 600,000 to 1.2 million U IM is given based on weight \\nor oral penicillin VK 250 mg for young children and 500 mg for older \\nchildren given twice daily for 10 days. Long-term prophylaxis is indicated \\nfor patients with ARF, and lifelong prophylaxis is recommended for patients \\nwith carditis.\\nPost-infectious reactive Arthritis\\nBecause of increased group A β-hemolytic streptococcal infections, post-\\ninfectious reactive arthritis (PIRA) is also increasing. PIRA is a sterile, \\ninflammatory, nonmigratory mono- or oligoarthritis occurring with infec-\\ntion at a distant site with β-hemolytic Streptococcus, or less commonly \\nwith Staphylococcus or Salmonella. Unlike ARF, PIRA is not associated \\nwith carditis and in general is a milder illness. However, the arthritis in \\nPIRA is more severe and prolonged as compared with ARF.\\nTo make the diagnosis of PIRA, antecedent infection with group A \\nStreptococcus must be determined with throat culture or fourfold rise in \\nASO or anti-DNase B titer. PIRA is responsive to nonsteroidal anti-\\ninflammatory drugs. If group A Streptococcus is recovered from the throat, \\ntreatment with penicillin or erythromycin should be instituted.\\nJuvenile idiopathic Arthritis\\nThe group of diseases comprised by juvenile idiopathic arthritis (JIA) \\nshare the f indings of chronic noninfectious synovitis and arthritis, but \\nwith systemic manifestations. Pauciarticular disease is the most common \\nform, usually involving a single large joint such as the knee. Permanent \\njoint damage occurs infrequently. Polyarticular disease occurs in one-\\nthird of cases. Large and small joints are affected, and there may be pro-\\ngressive joint damage. Systemic JIA occurs in 20% of patients. This form \\nis associated with high fevers and chills. Extra-articular manifestations \\nare common, including a red macular coalescent rash, hepatosplenomegaly, \\nand serositis. The arthritis in this form may progress to permanent joint \\ndamage.\\n82_Cydulka_Ch82.indd   441 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 460, 'page_label': '442'}, page_content='442 SECTION 9: Pediatrics\\nIn the ED, laboratory tests focus mostly on excluding other diagnoses. \\nComplete blood count, ESR, and C-reactiv e protein may be normal. \\nArthrocentesis may be necessary to exclude septic arthritis, particularly \\nin pauciarticular disease. Radiographs initially show joint effusions but \\nare nonspecific. The diagnosis of JIA is not likely to be made in the ED.\\nInitial therapy for patients with an established diagnosis includes \\nnonsteroidal anti-inflammatory drugs. Glucocorticoids are occasionally \\nused, for example, for unresponsive uveitis or decompensated pericardi-\\ntis or myocarditis.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 140, “Musculoskeletal Disorders in Children,” by \\nKaren J.L. Black, Catherine Duffy, Courtney Hopkins-Mann, Demilola \\nOgunnaiki-Joseph, and Donna Moro-Sutherland.\\n82_Cydulka_Ch82.indd   442 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 461, 'page_label': '443'}, page_content='443\\nRashes in Children\\nLance Brown\\nThough rarely life-threatening, rashes are a common reason for emergency \\ndepartment (ED) visits in children. Helpful clues to the specific diagnosis \\nof rash in a child include signs and symptoms that preceded or presented \\nwith the exanthem, whether mucous membranes are involved, immuniza-\\ntion history, human and animal contacts, and environmental exposures. \\nIdentifying outbreaks among multiple children may be useful. Pediatric \\nexanthems can be broadly classified by etiologic agent. With few excep-\\ntions, outpatient management is appropriate for most of these conditions.\\n■ ■VIRAL INFECTIONS\\nEnterovirus\\nEnteroviruses include coxsackie viruses, echoviruses, and polioviruses \\nwith a diverse range of clinical presentations. Enterovirus infections typi-\\ncally occur in epidemics in the summer and early fall. Many enteroviral \\ninfections lack specific clinical syndromes and presentation may include \\nfever, upper and lower respiratory tract symptoms, gastrointestinal symp-\\ntoms, meningitis, and myocarditis. The rashes of enteroviral infections also \\nhave a variety of appearances, including diffuse macular eruptions, morbil-\\nliform erythema, vesicular lesions, petechial and purpural eruptions, rubel-\\nliform rash, roseola-like rash, and scarlatiniform eruptions.\\nOne distinctive enteroviral infection is hand-foot-and-mouth disease. \\nInitially, patients typically present with fever, anorexia, malaise, and a sore \\nmouth. Oral lesions appear on days 2 or 3 of illness followed by skin \\nlesions. The oral lesions start as very painful 4- to 8-  mm vesicles on an \\nerythematous base that then ulcerate. The typical location of the oral  \\nlesions is on the buccal mucosa, tongue, soft palate, and gingiva. Skin \\nlesions start as red papules that change to gray—3- to 7-mm vesicles that \\nultimately heal in 7 to 10 days. Typical locations of skin lesions include \\nthe palms, soles, and buttocks. A similar enanthum without involvement of \\nthe hands and feet is caused by a different viral subtype and is known as \\nherpangina (most commonly caused by coxsackievirus A).\\nManagement of presumed enteroviral infections typically involves \\nsymptomatic therapy ensuring adequate hydration, antipyretics/analgesics, \\nor a combined suspension of diphenhydramine liquid and Maalox® applied \\nin small quantities to the lesions (or swish and spit) three times daily and \\nbefore feeding. Occasional narcotics may be required to facilitate adequate \\noutpatient hydration.\\nMeasles\\nDue to immunizations, measles is no longer common, but recent outbreaks \\nhave occurred among unimmunized groups. Infection typically occurs in the \\nwinter and spring. The incubation period is 10 days, followed by a 3-day \\nprodrome of upper respiratory symptoms and then malaise, fever, coryza, \\nconjunctivitis, photophobia, and cough. Ill appearance is expected. Just \\n83\\nCh A p TER\\n83_Cydulka_Ch83.indd   443 20/04/17   2:50 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 462, 'page_label': '444'}, page_content='444 SECTION 9: Pediatrics\\nbefore the development of a rash, Koplik spots, tin y white lesions on the \\nbuccal mucosa, may be seen with a “grains of sand” appearance that is \\npathognomonic for measles. The exanthem develops 14 days after exposure. \\nInitially, a red, blanching, maculopapular rash develops. The rash progresses \\nfrom the head to the feet and rapidly coalesces on the face, and lasts about \\na week. As the rash resolves, a coppery brown discoloration may be seen and \\ndesquamation can occur. Measles is self-limited and treatment is supportive.\\nRubella\\nNow quite rare due to immunizations, rubella (German measles) can be \\nseen in teenagers, typically in the spring. The incubation period is 12 to  \\n25 days and prodromal symptoms are similar to measles. The rash develops \\nas fine, irregular pink macules and papules on the face that spread to the \\nneck, trunk, and arms in a centrifugal distribution. The rash coalesces on \\nthe face as the eruption reaches the lower extremities and then clears in the \\nsame order as it appeared. Lymphadenopathy typically involves the suboc-\\ncipital and posterior auricular nodes. Treatment is supportive.\\nErythema Infectiosum\\nErythema infectiosum (also known as fifth disease) is a febrile illness \\ncaused by parvovirus B19, typically occurring in the spring, and most \\ncommonly affecting children ages 5 to 15 years. The rash starts abruptly \\nas a bright red macular discoloration on the cheeks producing the \\n“slapped-cheek appearance” (Fig. 83-1). The lesions are closely grouped, \\nFIguRE 83-1.  Erythema infectiosum (fifth disease). Toddler with the classic \\nslapped cheek appearance of fifth disease. Reproduced with permission from \\nKnoop K, Stack L, Storrow A: Atlas of Emergency Medicine, 3rd ed. New York: \\nMcGraw-Hill Companies, Inc; 2010. Photo contributor: Anne W. Lucky, MD.\\n83_Cydulka_Ch83.indd   444 20/04/17   2:51 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 463, 'page_label': '445'}, page_content='CHAPTER 83: Rashes in Children 445 \\ntiny papules on an erythematous base with slightly raised edges. The eye -\\nlids and chin are characteristically spared. Circumoral pallor is typical. The \\nrash fades after 4 to 5 days. As the illness progresses, and 1 to 2 days after \\nthe facial rash appears, a nonpruritic erythematous macular or maculopapu-\\nlar rash appears on the trunk and limbs. This rash may last for 1 week and \\nis not pruritic. As the rash fades, central clearing of the lesions occurs, \\nleaving a lacy reticular appearance. Palms and soles are rarely affected.\\nThe exanthem may recur intermittently in the weeks after the onset of \\nillness. Sun exposure or hot baths may exacerbate the rash. Associated \\nsymptoms include fever, malaise, headache, sore throat, cough, coryza, \\nnausea, vomiting, diarrhea, and myalgias. Treatment is supportive.\\nEczema Herpeticum\\nIn children with existing eczema, this life-threatening, rare, viral infection \\ncan arise. The most frequent etiologic agent is herpes simplex virus. Bac-\\nterial superinfection with staphylococci or streptococci is presumed. \\nClinical manifestations of eczema herpeticum include fever and vesicular \\neruptions in areas of skin contemporaneously affected by eczematous \\nlesions (Fig. 83-2). Treatment includes acyclovir 20  mg/kg/dose PO every \\nFIguRE 83-2.  Typical appearance of eczema herpeticum. Used with permission \\nfrom University of North Carolina Department of Dermatology.\\n83_Cydulka_Ch83.indd   445 20/04/17   2:51 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 464, 'page_label': '446'}, page_content='446 SECTION 9: Pediatrics\\n6 hours and either trimethoprim-sulfamethoxazole 5  mg/kg/dose twice \\ndaily or clindamycin 10  mg/kg/dose three times daily for 10 days. Inpa-\\ntient admission is often necessary.\\nVaricella (Chicken Pox)\\nDue to immunizations, the incidence of varicella has declined dramati-\\ncally. The etiologic agent is varicella-zoster virus, a herpes virus. It \\ntypically occurs in children younger than 10 years but may occur at all \\nages. Varicella occurs most often in the late winter and early spring. \\nPatients are highly contagious from the prodrome phase of the illness \\nuntil all lesions are crusted over. The rash starts as faint red macules on \\nthe scalp or trunk. Within the first day, lesions begin to vesiculate and \\ndevelop a red base, producing the characteristic appearance (Fig. 83-3). \\nOver the next few days, groups of lesions develop, producing the classic \\nappearance of crops of lesions in multiple stages of development. Over \\nthe next 1 to 2 weeks, lesions become dry and crusted. The rash typically \\nspreads centrifugally (outward from the center). The palms and soles are \\nusually spared. Low-grade fever, malaise, and headache are frequently \\nseen but are typically mild. Treatment is symptomatic and includes \\nFIguRE 83-3. Typical rash of varicella (chicken pox). Used with permission from \\nUniversity of North Carolina Department of Dermatology.\\n83_Cydulka_Ch83.indd   446 20/04/17   2:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 465, 'page_label': '447'}, page_content='CHAPTER 83: Rashes in Children 447 \\ndiphenhydramine 1.25  mg/kg/dose, every 6 hours as needed for itching \\nand acetaminophen  15 mg/kg/dose, every 4 hours as needed for fever. \\nAlthough not needed in healthy children, varicella-zoster immune \\nglobulin and acyclovir 20  mg/kg up to 800  mg PO five times daily may  \\nbe needed for immunocompromised children.\\nRoseola Infantum (Exanthem Subitum)\\nRoseola is a common acute febrile illness in children ages 6 months to  \\n3 years and thought to be caused by human herpesvirus 6. Roseola presents \\nwith an abrupt onset, high fever lasting 3 to 5 days. As the fever begins to \\nresolve, blanching macular or maculopapular, rose or pink discrete lesions \\ndevelop (Fig. 83-4). Areas typically affected include the neck, trunk, and \\nbuttocks but the face and proximal extremities may also be involved, \\nthough mucous membranes are spared. The rash lasts 1 to 2 days and \\nrapidly fades. Associated symptoms are typically mild and may include \\nirritability when the fever is highest, cough, coryza, anorexia, and abdomi-\\nnal discomfort. The treatment is symptomatic.\\nFIguRE 83-4. An infant with roseola infantum. Reproduced with permission from \\nKnoop K, Stack L, Storrow A: Atlas of Emergency Medicine, 3rd ed. New York: \\nMcGraw-Hill Companies, Inc; 2010. Photo contributor: Raymond C. Baker, MD.\\n83_Cydulka_Ch83.indd   447 20/04/17   2:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 466, 'page_label': '448'}, page_content='448 SECTION 9: Pediatrics\\n■ ■FUNGAL INFECTIONS\\nTinea infections are common in infants and children and named for the \\nbody parts affected: tinea capitis (scalp), corporis (body), and pedis (foot) \\nare common examples. Tinea infections typically manifest as scaly patches \\nwith pruritus of varying intensity. Successful treatment for all but tinea \\ncapitis and unguium is usually accomplished with topical creams including \\nthose available over-the-counter (clotrimazole, miconazole, tolnaftate) or \\nby prescription ( ketoconazole, oxiconazole, ciclopirox, terbinafine). \\nTreatment is continued for 7 to 10 days after the resolution of lesions. Tinea \\ncapitis ranges from mild scalp scaliness with patchy alopecia to a painful, \\nboggy mass known as a kerion. Tinea capitis is treated with oral \\ngriseofulvin ultramicrosize 15 mg/kg/dose once daily and selenium \\nsulfide shampoo. Treatment of tinea capitis is usually for at least 8 weeks \\nand close follow-up is important as treatment response and liver function \\ntests need to be monitored. Tinea unguium is similarly treated with griseo-\\nfulvin for longer periods of time.\\n■ ■BACTERIAL INFECTIONS\\nImpetigo\\nImpetigo is a superficial skin infection, typically caused by group A \\nβ-hemolytic streptococci or Staphylococcus aureus. The lesions usually \\noccur in small children, often in areas of insect bites or minor trauma. The \\nlesions start as red macules and papules that form vesicles and pustules \\n(Fig. 83-5). The formation of a golden crust results from rupture of the \\nvesicles. The lesions may become confluent. With the exception of \\nregional lymphadenopathy, fever and systemic signs are rare. Most com-\\nmonly affected areas include the face, neck, and extremities. Diagnosis is \\nFIguRE 83-5.  A young girl with crusting impetiginous lesions on her chin. \\nReproduced with permission from Knoop K, Stack L, Storrow A: Atlas of Emergency \\nMedicine, 3rd ed. New York: McGraw-Hill Companies, Inc; 2010. Photo contributor: \\nMichael J. Nowicki, MD.\\n83_Cydulka_Ch83.indd   448 20/04/17   2:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 467, 'page_label': '449'}, page_content='CHAPTER 83: Rashes in Children 449 \\nbased on the appearance of the rash. Localized infections may be treated \\nwith mupirocin ointment 2% applied three times daily. Larger infections \\nshould be treated with oral cephalexin 12.5 to 25  mg/kg/dose four times \\ndaily, trimethoprim-sulfamethoxazole 5  mg/kg/dose twice daily, or \\nclindamycin 10 mg/kg/dose three times daily . Further treatment includes \\nlocal wound cleaning.\\nBullous Impetigo\\nBullous impetigo typically occurs in infants and young children. Lesions \\nare superficial, thin-walled bullae that characteristically occur on the \\nextremities, rupture easily, leave a denuded base, dry to a shiny coating, and \\ncontain fluid that harbors staphylococci. The diagnosis usually is made by \\nthe appearance of the characteristic bullae (see Fig. 83-6). Treatment \\nincludes local wound cleaning, topical mupirocin, and an oral antistaphy-\\nlococcal antibiotic such as clindamycin 10 mg/kg/dose three times daily or \\ntrimethoprim-sulfamethoxazole 5 mg/kg/dose twice daily.\\nFIguRE 83-6.  A child with bullous impetigo. Used with permission from the \\nCenters for Disease Control and Prevention.\\n83_Cydulka_Ch83.indd   449 20/04/17   2:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 468, 'page_label': '450'}, page_content='450 SECTION 9: Pediatrics\\nScarlet Fever\\nA distinctive rash is seen with scarlet fever. The etiologic agent is group A \\nβ-hemolytic streptococci (recently group C streptococci also have been \\nimplicated). Scarlet fever usually occurs in school-age children and is diag-\\nnosed by the presence of exudative pharyngitis, fever, and the characteristic \\nrash (Fig. 83-7). Associated symptoms include sore throat, fever, headache, \\nvomiting, and abdominal pain. The rash starts in the neck, groin, and axil-\\nlae, with accentuation at flexural creases (Pastia lines). The rash is red and \\npunctate, blanches with pressure, and has a rough sandpaper feel. Early in \\nthe course of illness, the tongue has a white coating through which hyper -\\ntrophic, red papillae project (“white strawberry tongue”). Hemorrhagic \\nspots may be seen on the soft palate. The rash typically develops 1 to 2 days \\nafter the illness onset. Facial flushing and circumoral pallor are character -\\nistic. Desquamation occurs with healing approximately 2 weeks after the \\nonset of symptoms.\\nFIguRE 83-7. Scarlatiniform rash of scarlet fever; texture is typically sandpaper-\\nlike. Reproduced with permission from Knoop K, Stack L, Storrow A: Atlas of \\nEmergency Medicine, 3rd ed. New York: McGraw-Hill Companies, Inc; 2010. Photo \\ncontributor: Lawrence B. Stack, MD.\\n83_Cydulka_Ch83.indd   450 20/04/17   2:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 469, 'page_label': '451'}, page_content='CHAPTER 83: Rashes in Children 451 \\nThe diagnosis generally is made on clinical grounds. Throat culture \\ntypically shows group A β-hemolytic streptococci or group C streptococci. \\nTreatment is with penicillin V 16  mg/kg/dose three times daily or \\nclindamycin 10  mg/kg/dose three times daily in the penicillin-allergic \\npatient. Antibiotic treatment shortens the course of the illness and reduces  \\nthe incidence of rheumatic fever.\\nCellulitis\\nCellulitis manifests a local inflammatory response at the site of infection \\nwith erythema, warmth, and tenderness. Fever is uncommon and likely \\nindicates a more serious systemic infection, sepsis, or an unrelated concur-\\nrent viral infection. Community-associated methicillin-resistant Staphylo-\\ncoccus aureus (CA-MRSA) is becoming an increasingly common cause of \\ncellulitis in children. Traditionally, oral cephalexin 12.5 to 25  mg/kg/dose \\nfour times daily has been the antibiotic of choice. With the rise of CA-\\nMRSA, clindamycin 10  mg/kg/dose three times daily or trimethoprim-\\nsulfamethoxazole 5 to 10  mg/kg/dose twice daily are more common \\nchoices. Identifying underlying abscesses may require needle aspiration or \\nbedside ultrasonography.\\nErysipelas is a cellulitis and lymphangitis of the skin due to group A \\nβ-hemolytic streptococci. Fever, chills, malaise, headache, and vomiting \\nare common. The face and extremities are the most common sites, and the \\nlesion typically forms in the area of a skin wound or pimple. The rash starts \\nas a red plaque that rapidly enlarges. Increased warmth, swelling, and a \\nraised, sharply demarcated, indurated border are typical. Diagnosis is by \\nhistory and the appearance of the rash. Initial treatment may be inpatient \\nwith parenteral penicillin G 50,000 U/kg/dose, every 6 hours or clindamy-\\ncin 10 mg/kg/dose, every 8 hours in the penicillin-allergic patient. Outpa -\\ntient treatment includes cephalexin 12.5 to 25 mg/kg/dose four times daily, \\ntrimethoprim-sulfamethoxazole 5 to 10  mg/kg/dose twice daily, or \\nclindamycin 10 mg/kg/dose three times daily. Rapid clinical improvement \\nis expected after treatment has begun.\\nMeningococcemia\\nMeningococcemia should be suspected in an ill-appearing febrile child \\nwith a petechial or purpuric rash. The age distribution is bimodal with \\nincreased cases in infants and toddlers 2 years of age and younger and in \\nadolescents 16 to 21 years of age. The etiologic agent is Neisseria menin-\\ngitidis and empiric treatment is cefotaxime or ceftriaxone 50  mg/kg/dose. \\nClose contacts (those exposed through child care or exposure to oral secre-\\ntions) should receive chemoprophylaxis such as rifampin 5  mg/kg orally \\nevery 12 hours for 2 days for neonates; 10  mg/kg up to 600  mg per dose \\norally every 12 hours for 2 days for children or ciprofloxacin 500 mg single \\ndose for adults.\\n■ ■INFESTATIONS\\nScabies\\nScabies is caused by infestation with the Sarcoptes scabiei mite that bur -\\nrows into the skin resulting in severe pruritus after a 4 to 6 week incubation \\nperiod. Typical findings in children include a generalized eruption with \\n83_Cydulka_Ch83.indd   451 20/04/17   2:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 470, 'page_label': '452'}, page_content='452 SECTION 9: Pediatrics\\nexcoriated linear burrows, papules, pustules, and possibly vesicles. Family \\nmembers and close contacts may have similar symptoms. Treatment con-\\nsists of topical permethrin cream applied to avoid the mucous membranes \\nand left on for 8 to 12 hours prior to washing it off. Lindane is contraindi-\\ncated in infants and young children and pregnant teens.\\nLice\\nLice is caused by Pediculus humanus capitis and is common among chil-\\ndren in school and day care. Lice are more commonly found in long straight \\nhair in which the live mites and egg sacs can be seen. Over-the-counter \\ntreatments include permethrin 1% lotion, and combination piperonyl \\nbutoxide/pyrethrum extract shampoo. A fine-toothed comb is usually \\nprovided in the product packaging for combing out the egg sacs. Repeat \\ntreatment after 1 week is typically indicated.\\n■ ■COMMON NEONATAL RAShES\\nErythema Toxicum\\nThis benign, self-limited rash occurs in up to 50% of newborns during the \\nfirst week of life. The lesions are typically erythematous macules 2 to 3 cm \\nin diameter with central pustules. The rash spontaneously resolves after \\nabout a week.\\nTransient Neonatal Pustular Melanosis\\nThis condition consists of three types of lesions: small pustules on a non-\\nerythematous base that may be present at birth, erythematous macules with \\na surrounding scale that develop as the pustules rupture, and hyperpig-\\nmented brown macules. This may last weeks to months and requires no \\ntreatment.\\nNeonatal Acne\\nThis affects up to 20% of neonates and typically appears around the third \\nweek of life. Erythematous papules and pustules are on the face and are \\ntypical. No testing or treatment is indicated.\\nSeborrheic Dermatitis\\nThis rash typically starts between 2 to 6 weeks of life and improves by 6 \\nmonths of life. Lesions are greasy yellow or red scales and typically involve \\nthe scalp (i.e., cradle cap) but may involve the eyebrows, ears, cheeks, and \\nneck. This will typically resolve in weeks to months and can be treated with \\nmineral or olive oil and gentle combing.\\nDiaper Dermatitis\\nDiaper rash is a common reason for ED visits in neonates and young \\ninfants. There are two main forms of diaper rash: irritant dermatitis and \\ncandida dermatitis. Irritant dermatitis is typically caused by prolonged \\nmoisture in the sealed diaper. The lesions are typically erythematous and \\nmacular or papular with well-demarcated borders. Treatment is frequent \\ndiaper changes and the application of a zinc oxide–containing barrier \\n83_Cydulka_Ch83.indd   452 20/04/17   2:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 471, 'page_label': '453'}, page_content='CHAPTER 83: Rashes in Children 453 \\ncream. Candida dermatitis is similar to irritant dermatitis in etiology and \\nappearance with the e xception of the presence of satellite lesions (small \\npustules beyond the margins of the main rash). Treatment is frequent diaper \\nchanges, the application of a zinc oxide–containing barrier cream, and the \\napplication of nystatin cream or ointment 100,000 U/g three times per day \\nfor 10 to 14 days.\\n■ ■OThER ETIOLOGIES\\nKawasaki’s Disease\\nKawasaki’s disease (mucocutaneous lymph node syndrome) is a general-\\nized vasculitis of unknown cause that typically occurs in children younger \\nthan 9 years. Diagnosis depends on the presence of fever for at least 5 days \\nwithout another source, along with four of the following five criteria: (a) \\nconjunctivitis; (b) rash; (c) lymphadenopathy; (d) oropharyngeal changes \\n(injection of the pharynx, cracked lips, and prominent papillae of the \\ntongue); and (e) extremity erythema and edema.\\nTypical rash appearances have been described as erythematous, morbil-\\nliform, urticarial, scarlatiniform, and erythema multiforme-like. A perineal \\nrash may be present. Associated findings may include leukocytosis, eleva-\\ntion of acute-phase reactants (e.g., erythrocyte sedimentation rate and \\nC-reactive protein), elevated liver function tests, hypoalbuminemia, ane-\\nmia, arthritis, arthralgia, and irritability. Later in the illness, findings may \\ninclude a rise in the platelet count (usually more than 1 million), desqua-\\nmation of the fingers and toes, and coronary artery aneurysms. One per -\\ncent to 2% of patients with coronary artery aneurysms develop sudden \\ncardiac death.\\nTreatment consists of intravenous immunoglobulin and aspirin. The \\nuse of steroids is controversial.\\nHenoch–Schönlein Purpura\\nHenoch–Schönlein purpura (HSP) is the most common vasculitis in \\nchildhood. There are four main features of HSP: palpable purpura ranging \\nin size from 2 to 10 mm primarily involving the buttocks, thighs, le gs, and \\narms; gastrointestinal symptoms including vomiting, diarrhea, and \\nabdominal pain; polyarthralgias; and hematuria and proteinuria. Children \\nwith HSP are generally well appearing and afebrile. HSP is typically self-\\nlimited and requires no treatment and no laboratory evaluation other than \\nurinalysis (and renal function tests in the presence of hematuria). Consid-\\neration can be given to prednisone 1  mg/kg/dose for 2 weeks followed by \\na 2-week taper for sev ere joint and gastrointestinal symptoms and \\nibuprofen 10  mg/kg/dose as needed every 6 hours for sev ere arthralgias \\nand extremity edema.\\nErythema Multiforme\\nErythema multiforme typically presents with an abrupt onset of rash without \\npruritis and is characterized by a well-appearing child with target lesions \\ncomposed of two to three zones consisting of a dark, ruddy-appearing center \\nand a lighter colored area surrounding the center with a red-appearing outer \\nring. Lesions present as coalescent plaques that frequently involve the palms \\n83_Cydulka_Ch83.indd   453 20/04/17   2:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 472, 'page_label': '454'}, page_content='454 SECTION 9: Pediatrics\\nand soles. Mucous membranes are spared. The etiology can be medication \\nexposure, but is most commonly an infection with a herpes virus (HSV-1 \\nand HSV-2). No treatment is required.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 141, “Rashes in Infants and Children,” by Gary \\nBonfante and Amy Dunn.\\n83_Cydulka_Ch83.indd   454 20/04/17   2:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 473, 'page_label': '455'}, page_content='455\\nSickle Cell Anemia in Children\\nIlene Claudius\\nSickle cell emergencies in children include vasoocclusive crises, hemato-\\nlogic crises, and infections. All children with sickle cell anemia (SCA) \\npresenting with fever, pain, respiratory distress, or a change in neurologic \\nfunction require a rapid and thorough ED evaluation.\\n■ ■VASOOCCLUSIVE CRISES\\nVasoocclusive sickle episodes are due to intravascular sickling, which leads \\nto tissue ischemia and infarction. Bones, soft tissue, viscera, and the central \\nnervous system (CNS) may be affected. Pain may be the only symptom.\\n■ ■PAIN CRISES\\nClinical Features\\nPain crises are the most common SCA-related presentation to the ED, and \\ntypically affect the long bones and back. They can be triggered by stress, \\nextremes of cold, dehydration, hypoxia, or infection, but most often occur \\nwithout a specific cause. In an individual patient, recurrent pain crises tend \\nto be similar in location and quality to previous episodes. Although, typi-\\ncally, there are no physical findings, pain, local tenderness, swelling, and \\nwarmth may occur. Low-grade temperature elevations can occur, but true \\nfever is rare. Infants and toddlers can present initially with dactylitis, a \\nswelling of hands or feet, and low-grade temperature caused by ischemia \\nand infarction of the bone marrow.\\nDiagnosis and Differential\\nDifferentiating between infection and vasoocclusive crisis can be diffi-\\ncult, particularly since infection can precipitate a pain crisis. Fever, \\nlimited range of motion of a joint, and pain that differs in location or \\nquality from previous crises should raise concern for an infection. Pain \\ncrises can be associated with leukocytosis; however, a left shift is suspi-\\ncious for infection. Sedimentation rates are unreliable markers for infec-\\ntions in SCA patients due to anemia. All pain crises represent ischemia, \\nbut bony infarcts present with severe, difficult to control pain, significant \\ntenderness, and leukocytosis. Patients with bony infarcts are at risk of fat \\nembolism.\\nPain localized to the hip or inguinal area worsening with weight-bearing \\nmay be due to avascular necrosis of the femoral head, which may demon-\\nstrate flattening and collapse of the femoral head on plain radiograph.\\nAbdominal pain resulting from vasoocclusive crises is common and is \\ntypically abrupt in onset, and poorly localized. Tenderness and guarding \\nmay be present on examination. Rebound and rigidity are usually absent. \\nIf not typical of a pain crisis, non-SCA-related causes need to be consid-\\nered (e.g., appendicitis), as well as SCA-related cholelithiasis/cholecystitis \\n84\\nCh AP t ER\\n84_Cydulka_Ch84.indd   455 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 474, 'page_label': '456'}, page_content='456 SECTION 9: Pediatrics\\n(can occur as early as 2 years of age), intrahepatic cholestasis (sudden \\nright upper quadrant pain and tenderness, jaundice, anorexia, hepatomegaly, \\nand sometimes fever), splenic sequestration, or hepatic sequestration \\n(anemia and hepatomegaly). Constipation, urinary tract infection, and \\npeptic ulcer disease are more common in SCA patients. Laboratories, \\nultrasound, and CT scan may be necessary to differentiate among these \\netiologies.\\nEmergency Department Care and Disposition\\nPain management must be individualized, using previously effective regi-\\nmens as a guide. Nonparenteral medications can be used (oral or nasal) to \\nmeet the goal of delivering analgesia within an hour of registration.\\n1. Mild pain\\na. Hydration\\ni. Oral hydration if possible\\nii. IV hydration at maintenance rate if euvolemic and not tolerating \\noral fluids\\niii. Correct dehydration\\nb. Pain control\\ni. Oral NSAIDs, such as ibuprofen 10 mg/kg\\nii. Oral narcotics, such as hydrocodone 0.15 to 0.2  mg/kg, if needed\\n2. Moderate to severe pain\\na. Hydration\\ni. IV hydration, D5½NS at 1 x the age-appropriate maintenance rate\\nb. Pain control\\ni. Oral or IV NSAIDs, such as ketorolac 0.5 mg/kg\\nii. Parenteral narcotics, such as morphine 0.1 to 0.15  mg/kg or \\nhydromorphone 0.015  mg/ kg\\niii. Maintain or escalate IV narcotic dose by 25% every 15 to 30  min-\\nutes until pain control is achieved for severe pain.\\n3. Oral antihistamines, if needed.\\n4. Oxygen for saturation <95%.\\n5. Heat may be an effective adjunct.\\n6. Packed red blood cell (PRBC) transfusions are not recommended unless \\nanother indication exists.\\n7. Admission is warranted for poor pain control or inadequate oral fluid \\nintake. Children who have presented repeatedly for the same pain crisis \\nalso should be considered for admission.\\n8. Incentive spirometry should be started in patients receiving narcotic \\nmedications.\\n9. Children discharged from the ED should continue analgesics at home on \\na scheduled basis with PCP or hematology follow-up the next day .\\n■ ■ACUtE ChESt SYNDROME\\nAcute chest syndrome (ACS) is believed to represent a combination of \\npneumonia, pulmonary infarction, and pulmonary emboli from necrotic \\nbone marrow. It is a leading cause of death in all patients with SCA, but \\nespecially those older than 10 years.\\n84_Cydulka_Ch84.indd   456 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 475, 'page_label': '457'}, page_content='CHAPTER 84: Sickle Cell Anemia in Children 457 \\nClinical Features\\nConsider ACS in all patients with SCA who present with complaints of \\nchest pain, especially when associated with tachypnea, dyspnea, cough, or \\nother symptoms of respiratory distress. Significant hypoxia and rapid dete-\\nrioration to respiratory failure can occur.\\nDiagnosis and Differential\\nChest radiographs should be obtained but may be normal during the first \\nhours to days. The diagnosis is made in the setting of a new infiltrate on \\nchest radiograph in the setting of chest pain and respiratory symptoms. \\nBoth pneumonia and acute chest syndrome typically cause leukocytosis. \\nThrombocytopenia may accompany a severe crisis. Sputum and blood cul-\\ntures are rarely positive. Pneumonia is most commonly due to atypical \\nbacteria (chlamydia, mycoplasma), but can represent community acquired \\npathogens (Streptococcus pneumoniae) as well. Asthma, cardiac volume \\noverload, and, in adulthood, pulmonary hypertension are also commonly \\nassociated with SCA.\\nEmergency Department Care and Disposition\\nBecause deterioration can be rapid, close monitoring is required, typically \\nin the ICU.\\n1. Initial stabilization: oxygen to maintain saturation >95%, hydration at \\n50% to 75% maintenance fluids, analgesia (see P ain Crisis).\\n2. Antibiotics: macrolide, such as azithromycin 10   mg/kg PO or IV , and \\nthird generation cephalosporin, such as ceftriaxone or cefotaxime 50 to \\n100 mg/kg daily IV .\\n3. Consider simple PRBC transfusion in children with symptomatic ACS \\nwho have dropped >1  g/dL from their baseline Hgb. Howev er, raising \\nhemoglobin above 10 g/dL is discouraged, so this recommendation typi-\\ncally applies to patients with a Hgb of <9  g/dL.\\n4. Consider exchange transfusion for patients with rapid progression of \\nACS, with saturation <90% despite oxygen, increasing respiratory dis-\\ntress, progressive pulmonary infiltrates, or a declining Hgb despite \\ntransfusion.\\n5. Admit all children with suspected ACS to the hospital.\\n■ ■ACUtE CENtRAL NERVOUS SYStEM EVENtS\\nClinical Features\\nConsider acute stroke in any patient with SCA who presents with sudden \\nonset headache or neurologic changes, including hemiparesis, seizures, \\nspeech defects, visual disturbances, transient ischemic attacks, vertigo, \\ncranial nerve palsies, paresthesias, altered mental status or coma. Children \\nwith SCA are at significantly higher risk of acute ischemic stroke than unaf-\\nfected children.\\nDiagnosis and Differential\\nBecause of the challenges in diagnosing acute ischemic stroke (e.g., limited \\navailability of MRI, CT negative in acute setting), providers may need to \\n84_Cydulka_Ch84.indd   457 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 476, 'page_label': '458'}, page_content='458 SECTION 9: Pediatrics\\ninitiate treatment based exclusively on clinical suspicion. As SCA patients \\nage, their risk of a hemorrhagic stroke increases as well, primarily due to \\naneurysm development. If clinical history is appropriate for a subarachnoid \\nhemorrhage, workup should proceed as for a patient without SCA. Acute \\nchest crisis, sudden severe anemia, and meningitis can cause neurologic \\nsymptoms, and appropriate tests should be sent to investigate these possi-\\nbilities in the appropriate clinical setting.\\nEmergency Department Care and Disposition\\nSuspected CNS vasoocclusion necessitates immediate stabilization and \\ncareful monitoring. Urgent exchange transfusion is preferred to standard \\ntransfusion, and the Hgb should not be raised above 10  g/dL. Transfusion \\nshould be initiated with the goal of <30% HbS. As in any ischemic stroke, \\ntemperature, glucose, and oxygenation should be monitored and controlled. \\nLimited data exists regarding the use of alteplase, and it currently has no \\nrole in the management of SCA-related ischemic stroke in children. Intra-\\ncranial hemorrhage should be managed in conjunction with a neurosur -\\ngeon. All children with suspected stroke should be admitted to the pediatric \\nintensive care unit.\\n■ ■PRIAPISM\\nClinical Features and Diagnosis\\nPriapism, a painful sustained erection >4 hours in the absence of sexual \\nstimulation, occurs when sickled cells accumulate in the corpora cavernosa. \\nIt can affect any male with SCA regardless of age, and severe prolonged \\nattacks can cause impotence. Typically, the patient has an edematous and \\ntender penis, with difficulty urinating.\\nEmergency Department Care and Disposition\\nPatients with priapism should receive vigorous oral or IV hydration and \\nappropriate analgesia. As in non-SCA priapism, needle aspiration of the \\ncorpora cavernosa and administration of a vasoconstrictor, such as \\n1:1,000,000 epinephrine solution, may be required. Transfusion is not rec-\\nommended as immediate therapy for priapism. Management and admission \\ndecisions should be made promptly in consultation with urology and pedi-\\natric hematology.\\n■ ■hEMAtOLOGICAL CRISES\\nAcute Sequestration Crises\\nClinical Features and Diagnosis\\nIntrasplenic trapping of red blood cells primarily affects children under 5 \\nyears of age, but can occur in older patients with combined forms of SCA \\n(e.g., SC disease). Often preceded by a viral syndrome, splenic sequestra-\\ntion presents with sudden-onset left upper quadrant pain; pallor and leth-\\nargy; tender splenomegaly; and progresses to hypotension, shock, and \\ndeath. A CBC shows profound anemia, with hemoglobin <6 g/dL, or >2 g/\\ndL lower than the patient’s baseline le vel. Minor episodes can occur with \\n84_Cydulka_Ch84.indd   458 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 477, 'page_label': '459'}, page_content='CHAPTER 84: Sickle Cell Anemia in Children 459 \\ninsidious onset of abdominal pain, slowly progressive splenomegaly, and a \\nmore gradual fall in hemoglobin level. Generally the hemoglobin level \\nremains >6 g/dL.\\nPatients may have accompanying mild neutropenia or thrombocytope-\\nnia. Less commonly, sequestration can occur in the liver. Clinical features \\ninclude an enlarged and tender liver with associated hyperbilirubinemia, \\nsevere anemia, and elevated reticulocyte count. Cardiovascular collapse is \\nrare in this condition.\\nEmergency Department Care and Disposition\\nHydration, PRBC transfusion, and admission are required for major \\nepisodes. Transfusion should be gradual (5 mL/kg), as return of the seques-\\ntered RBCs to the intravascular space can occur, causing hyperviscosity. \\nOccasionally, children with minor episodes can be observed, and discharged \\nwith close follow-up with a hematologist.\\n■ ■APLAStIC EPISODES\\nPotentially life-threatening aplastic episodes are precipitated primarily \\nby viral infections, typically parvovirus B19, and present with gradual \\nonset of pallor, dyspnea, and fatigue. The CBC shows an unusually low \\nhemoglobin and reticulocyte count, with normal white blood cell and \\nplatelet counts. Recovery is spontaneous within 1 to 2 weeks, and \\npatients can typically be temporized with PRBC transfusion in the ED \\nwith close outpatient follow-up in 7 to 10 days for repeat labs or \\ninpatient setting.\\n■ ■hEMOLYtIC CRISES\\nBacterial and viral infections in children with SCA can precipitate rapid \\nhemolysis, with sudden-onset of jaundice and pallor. A CBC shows \\nhemoglobin level decreased from baseline, with markedly increased \\nreticulocytosis. Specific therapy is rarely required, though transfusion \\nmay be helpful in symptomatic patients. Care should be directed toward \\ntreating the underlying infection. Close follow-up to monitor hemoglo-\\nbin level and reticulocyte count should be arranged if discharged from \\nthe ED.\\n■ ■INFECtIONS\\nClinical Features\\nPoor splenic function renders children with SCA particularly susceptible to \\nbacterial infections, particularly in early childhood. Currently, bacteremia \\nrates are 0.3% to 1.1%.\\nDiagnosis and Differential\\nRisk factors for sepsis in children with SCA include temperature >40°C, \\nWBC >30,000 or <5000 cells/mm 3, platelet count <100,000/mm 3, Hgb \\n<5 g/dL, ill appearance, and history of pneumococcal sepsis.\\n84_Cydulka_Ch84.indd   459 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 478, 'page_label': '460'}, page_content='460 SECTION 9: Pediatrics\\nEmergency Department Care and Disposition\\nChildren with a temperature above 38.5°C meeting any high-risk feature \\n(see above) should have a CBC, blood culture, reticulocyte count, and, if \\nclinically indicated, a urine culture sent and received a parenteral antibiotic \\nwith activity against Streptococcus pneumoniae and Haemophilus influen-\\nzae, such as ceftriaxone 50 mg/kg IV or IM, as soon as possible. Vancomy-\\ncin should be added if the patient is at high risk for penicillin-resistant \\npneumococcal infection. Septic shock must be managed aggressively with \\nearly goal-directed therapy. Patients with any respiratory symptoms should \\nalso get a chest radiograph. Well-appearing patients who have reliable next-\\nday follow-up can be discharged following a parenteral dose of ceftriaxone \\npending culture results. Ill-appearing patients with temperatures >39.5°C \\nshould be admitted.\\n■ ■VARIANtS OF SICKLE CELL DISEASE\\nSickle cell trait is the carrier state of SCA (heterozygous). These patients \\nare typically asymptomatic and experience sickling only in the presence of \\nextreme hypoxia or high altitude. Baseline microscopic hematuria may \\nexist. Sickle cell–hemoglobin C disease is a heterozygous condition charac-\\nterized by mild to moderate anemia and fewer complications. However, \\nsplenomegaly can persist to adulthood, and these patients remain at risk for \\nsequestration crises. Sickle cell β-thalassemia disease is a heterozygous \\ncondition with variable severity and symptoms.\\n■ ■FURthER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 142, “Sickle Cell Disease in Children,” by John \\nMarshall.\\n84_Cydulka_Ch84.indd   460 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 479, 'page_label': '461'}, page_content='461\\nHematologic-Oncologic \\nEmergencies in Children\\nIlene Claudius\\nChildhood cancer is a leading cause of death in children, but with \\nimprovements in management and outcomes, many patients with new, \\nactive, or treated malignancies present to the ED. This chapter covers the \\nmost common pediatric malignancies and hematologic issues. More infor -\\nmation on malignancy-related complications is provided in Chapter 139 \\nand hemophilia and V on Willebrand’s disease are discussed in detail in \\nChapter 135.\\n■ ■CHILDHOOD LEUKEMIA\\nAcute lymphoblastic leukemia (ALL) is the most common pediatric malig-\\nnancy, with a peak incidence between 3 to 5 years of age and a 75% to 80% \\n5-year survival.\\nClinical Features\\nPatients can present with systemic complaints (fever, weight loss) or any of \\nthe following signs or symptoms of bone marrow or extramedullary infiltra-\\ntion: pallor, fatigue, easy bruising or bleeding, fever, or bone pain (particu-\\nlarly nocturnal). Many have hepatomegaly or splenomegaly. Rarely, acute \\nmyelogenous leukemia (AML) can present with gingival hyperplasia or \\nsubcutaneous masses (chloromas).\\nDiagnosis and Differential\\nThe complete blood count (CBC) with manual differential is the most \\nuseful test, though leukocytosis and blasts may be absent early in the \\ndisease process, requiring close follow-up of patients with insidious \\ncomplaints such as bone pain. White blood cell (WBC) counts below \\n4000/mL3, mild anemia, and mild thrombocytopenia should raise suspi-\\ncion in these cases. Abnormalities of two or more cell lines make leuke-\\nmia more likely. If the CBC is concerning for acute leukemia, obtain a \\nchest radiograph (for mediastinal mass); electrolytes with creatinine, \\ncalcium, uric acid, and phosphate (for evidence of tumor lysis); liver \\nfunction tests and lactate dehydrogenase, prothrombin time (PT)/partial \\nprothrombin tine (PTT) (looking for disseminated intravascular coagula-\\ntion); peripheral smear; type and screen if anemic; and blood and urine \\ncultures if febrile.\\nThe differential diagnosis is extensive depending on the patient’s pre-\\nsenting symptom. Aplastic anemia and viral infections can cause bone \\nmarrow suppression; rheumatologic diseases can overlap with symptoms \\nand findings of leukemia; and idiopathic immune thrombocytopenia can be \\ndifficult to differentiate, though classically involves isolated destruction of \\nthe platelets without affecting other cell lines.\\n85\\nC HA pt E r\\n85_Cydulka_Ch85.indd   461 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 480, 'page_label': '462'}, page_content='462 SECTION 9: Pediatrics\\nEmergency Department Care and Disposition\\nChemotherapy need not be initiated immediately in most cases. ED care is \\ndirected at potential complications and symptoms.\\n1. Anemia\\na. Irradiated, leukodepleted packed red blood cells (PRBCs) (10 mL/\\nkg) for life-threatening hemorrhage or hemolysis. This will raise \\nhemoglobin (Hb) 2-3 g/dL.\\nb. If no hemorrhage or hemolysis, nonemergent transfusions can be \\ngiven. The clinical picture should determine need for ED transfu-\\nsions, with a goal hemoglobin (Hb) of > 8 to 10 g/dL. This should \\nbe done in coordination with an oncologist. A lower Hb should be \\nmaintained in hyperleukocytosis if the patient can tolerate this.\\n2. Thrombocytopenia\\na. Platelets (10 mL/kg) for life-threatening hemorrhage, consumption, \\nor urgent need for invasi ve procedure (e.g., lumbar puncture). Inva-\\nsive procedures require platelet count >50,000/mm 3 and surgery \\n50,000–100,000/mm3.\\nb. If no urgent indication exists, nonemergent transfusions can be given to \\nkeep platelets >10,000/mm3. This does not need to be done in the ED.\\n3. Infection: Fever (single oral temperature > 38.3°C or multiple tempera-\\ntures >38°C separated by at least an hour) and neutropenia (ANC <500/\\nmm3 or ANC<1000/mm3 with anticipated decline) typically become an \\nissue after the initiation of chemotherapy. However, granulocyte func-\\ntion is impaired in newly presenting leukemics, and fever or suspicion \\nof infection in a new leukemic should be treated emergently with broad-\\nspectrum antibiotics regardless of neutrophil count. In children with \\nknown neutropenia, consider unusual infections such as perirectal \\nabscess/cellulitis and typhlitis (an appendicitis-like syndrome), as well \\nas bacteremia. Management includes:\\na. Blood cultures\\nb. Other studies (e.g., urinalysis) as clinically indicated\\nc. Avoid rectal manipulation, including rectal temperatures.\\nd. IV cefepime (50 mg/kg) or ceftazidime (50 mg/kg) or piperacillin-\\ntazobactam (80 mg/kg)\\ne. If ill-appearing, add IV gentamycin (2.5 mg/kg).\\nf. If suspicion of gram-positive infection, add IV vancomycin (15 mg/kg).\\ng. If anaerobic source (e.g., typhlitis), add IV clindamycin (10 mg/kg) \\nor metronidazole (7.5 mg/kg).\\n4. Tumor lysis describes the release of intracellular potassium, phosphate, \\nand uric acid, and subsequent decline in serum calcium that occurs from \\nturnover of tumor cells. It typically occurs with chemotherapy, but can \\noccur prior to treatment, particularly in patients with a high tumor \\nburden (ALL or non-Hodgkin’s lymphoma). Recognition and treatment \\nof this life- and kidney- threatening condition must begin in the ED, and \\nprevention should be considered in patients with a particularly high \\nWBC count. Check laboratories every 4 hours, treat hyperkalemia in the \\nstandard fashion, aggressively hydrate, and consider allopurinol or \\nrecombinant urate oxidase (rasburicase) for uric acid management. \\nHypocalcemia is not treated unless symptomatic. Specifics of manage-\\nment are discussed in Chapter 139.\\n85_Cydulka_Ch85.indd   462 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 481, 'page_label': '463'}, page_content='CHAPTER 85: Hematologic-Oncologic Emergencies in Children 463 \\n5. Hyperleukocytosis (WBC > 100,000/mm3) typically requires treatment \\nif symptoms of stasis (e.g., stroke, visual change, dyspnea, priapism) \\noccur, or if the WBC is >200,000/mm3 for AML and >300,000/mm3 for \\nALL in the absence of symptoms. Treatment includes:\\na. Aggressive hydration with normal saline bolus of 20 mL/kg repeated \\nas tolerated.\\nb. If patient is symptomatic after hydration, arrange for leukapheresis.\\nc. Avoid PRBC transfusions and diuretics if possible.\\nd. Anticipate and initiate treatment for tumor lysis syndrome.\\ne. If asymptomatic with high levels, consider hydroxyurea which will \\nreduce the WBC count to half in 24 to 48 hours.\\n■ ■LYMpHOMA\\nHodgkin’s lymphoma is a lymphoid neoplasm preferentially affecting adoles-\\ncents. Most cases present in the cervical or supraclavicular lymph nodes \\ncausing nontender, nonerythematous, rubbery lymphadenopathy chains. \\nSystemic symptoms (e.g., fever, night sweats, weight loss) occur in 39% to \\n50% of children and teens. A chest radiograph may demonstrate an anterior \\nmediastinal mass. Non-Hodgkin’s lymphoma can originate in or outside of \\nthe lymphatic system, and occurs across ages, particularly in those with a \\nhistory of immunosuppression. Because the tumor can occur in any organ, \\npresenting signs and symptoms differ by location. A CBC, electrolytes and \\ncreatinine (looking for tumor lysis), and chest radiograph (looking for medi-\\nastinal mass) should be performed in the ED. ED care involves management \\nof acute complications, avoidance of steroid therapy except in life-threatening \\nsituations, consultation with an oncologist, and recognition of the potential \\nfor intrathoracic airway compromise in patients with a mediastinal mass. \\nCompression of the superior vena cava (SVC syndrome) or compression of \\nboth SVC and trachea (superior mediastinal syndrome) can occur, with respi-\\nratory symptoms, upper body edema, headache, and altered mental status.\\n■ ■CENtrAL NErVOUS SYStEM tUMOrS\\nBrain tumors are common pediatric malignancies, and typically present \\nwith nonspecific symptoms: headaches (especially early morning), irritabil-\\nity, emesis, and behavioral changes related to increased intracranial pres-\\nsure. In infants, overt signs of increased pressure (e.g., bulging fontanel, \\nsunsetting of eyes) can sometimes be appreciated. V omiting, ataxia, cranial \\nnerve palsies, or vague neurologic signs and symptoms can occur as well. \\nCT scan or MRI are acceptable imaging studies in the ED. Spinal cord \\ntumors can present with back pain with or without neurological signs and \\nare evaluated by MRI. Seizures should be treated if present, and dexa-\\nmethasone (1 mg/yr of age up to 10 mg) can be given to reduce vasogenic \\nedema in patients not suspected to have leukemia or lymphoma. Further \\nmanagement should be determined by oncology and neurosurgery.\\n■ ■EXtrACrANIAL SOLID tUMOrS\\nNeuroblastoma is a primitive ganglion tumor that can arise along the sym-\\npathetic nervous system, most commonly in the adrenal gland, other abdom-\\ninal location, chest, or neck. Patients can present with a painless mass, \\n85_Cydulka_Ch85.indd   463 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 482, 'page_label': '464'}, page_content='464 SECTION 9: Pediatrics\\nhepatomegaly, or symptoms of mass effect from compression of the bowel, \\nbladder, lymphatics, spinal cord, trachea, or superior vena cava. Occasionally, \\nretrobulbar metastasis can cause raccoon eyes and proptosis. Paraneoplastic \\nmanifestations can include hypertension, watery diarrhea, and opsoclonus-\\nmyoclonus syndrome (rapid, multidirectional eye movements and jerking of \\nthe extremities). CBC for evidence of bone marrow infiltration and chest \\nradiograph for mediastinal mass should be obtained in the ED. Urine levels \\nof homovanillic acid and vanillylmandelic acid are helpful diagnostically.\\nWilms tumor, or nephroblastoma, primarily affects young children \\n(<10 years of age) and typically presents with an abdominal mass with few \\nsymptoms other than those explained by local compression. Many patients \\npresent with lung metastasis or hypertension from increased renin produc-\\ntion. These masses can rupture with trauma or vigorous palpation.\\nGerm cell tumors typically present as masses in the ovary or testicle, \\nalthough extragonadal locations are common in younger children. They are \\nparticularly more common in boys with a history of an undescended testi-\\ncle. Diagnosis is by ultrasound.\\nRetinoblastoma is a white-grey intraocular malignancy that typically \\npresents in children less than 2 years of age with loss of the normal  \\nred reflex (Fig. 85-1). Strabismus, decreased visual acuity, a fixed pupil, \\nglaucoma, or an injected, painful eye are less common presentations. \\nFigurE 85-1.  Typical appearance of leukocoria in a patient with retinoblas-\\ntoma. Reproduced with permission from Shah BR, Lucchesi M. Atlas of Pediatric \\nEmergency Medicine. New York: McGraw-Hill Companies, Inc.; 2006.\\n85_Cydulka_Ch85.indd   464 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 483, 'page_label': '465'}, page_content='CHAPTER 85: Hematologic-Oncologic Emergencies in Children 465 \\nOne-quarter of cases are bilateral, and diagnosis is made through ophthal-\\nmology consultation and CT scan or MRI.\\nBone and tissue sarcomas include rhabdomyosarcoma (a painless tis-\\nsue mass), osteosarcoma (a bony tumor around the metaphysis of the knee, \\nproximal humerus, pelvis, or mandible), and Ewing’s sarcoma (a bony \\ntumor of the long bones and axial skeleton). Osteosarcoma and Ewing’s \\nsarcoma can present as a dull, aching pain, particularly at night or with \\nactivity, a tender mass that seems to appear following a minor trauma, or \\nwith systemic symptoms. Diagnosis of rhabdomyosarcoma is by ultrasound \\nor CT scan, while osteosarcoma and Ewing’s sarcoma often are seen on \\nplain radiograph, with osteosarcoma demonstrating a mixed sclerotic/lytic \\n“sunburst” appearance of periosteal reaction and Ewing’s sarcoma having \\na destructive, “moth-eaten” appearance.\\n■ ■HEMOpHILIA\\nHemophilia is an inherited deficiency of factor 8 (hemophilia A) or factor \\n9 (hemophilia B) which can be mild (>5% factor activity), moderate (1% \\nto 5% factor activity), or severe (<1% factor activity).\\nClinical Features\\nAppropriate family history or bleeding/bruising out of proportion with injury, \\nrecurrent bleeding, or in bleeding into uncommon locations (GI, joints) \\nshould raise concern for a bleeding disorder. Common issues in hemophilia \\nare hemarthroses (and resultant destructive arthropathy), muscle bleeds \\n(occasionally causing compartment syndrome), and intracranial hemorrhage.\\nDiagnosis and Differential\\nHemophilia causes an elevated PTT, with normal platelets, bleeding time, \\nand PT. Quantitative factor levels are diagnostic. Other bleeding disorders \\ninclude thrombocytopenias, vitamin K deficiency bleeding (typically 2 to \\n14 days after birth in neonates whose parents have refused prophylactic \\nvitamin K administration at birth), and von Willebrand’s disease (pro-\\nlonged bleeding in the face of normal platelet numbers with or without \\nfactor 8 deficiency).\\nEmergency Department Care and Disposition\\nTreatment is with appropriate factor replacement: up to 100% correction \\nwith severe bleeds, and less with more minor bleeds.\\n■ ■ANEMIA\\nClinical Features\\nAnemia may be asymptomatic or accompanied by pallor and fatigue or \\nheart failure.\\nDiagnosis and Differential\\nIron deficiency anemia due primarily to excessive cow’s milk intake typically \\naffects children aged 6 months to 3 years of age. Children outside of this age \\nrange should be assessed for occult GI bleeding with stool guaiac testing. \\n85_Cydulka_Ch85.indd   465 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 484, 'page_label': '466'}, page_content='466 SECTION 9: Pediatrics\\nLaboratory studies demonstrate anemia with a low reticulocyte count and \\nlow mean corpuscular volume (MCV). Hemolytic anemia can be primary or \\nsecondary to an underlying infection or intrinsic disorder. Patients have iso-\\nlated anemia with high MCV , spherocytes and schistocytes on peripheral \\nsmear, elevated indirect bilirubin, and a positive direct antibody test.\\nEmergency Department Care and Disposition\\nMost asymptomatic or minimally symptomatic patients with iron defi-\\nciency anemia can be safely discharged with careful follow-up, reduction \\nof milk intake below 24 oz/d, and initiation of iron therapy (2 to 3 mg/kg/\\ndose of elemental iron three times daily). Hemolytic anemia may require \\nmore careful observation or transfusion, based on the patient’s clinical \\nstatus and hemoglobin level. Steroids are indicated in the treatment of auto-\\nimmune hemolytic anemia. If transfusion is required, patients with very \\nlow hemoglobin levels (<5 g/dL) should receive 3 to 5 mL/kg of PRBCs \\nover 2 to 3 hours to start, while patients with a pretransfusion Hb >5 g/dL \\ncan receive 10 mL/kg to start.\\n■ ■IDIOpAtHIC tHrOMBOCYtOpENIC pUrpUrA (Itp)\\nITP is an autoimmune disorder of platelet destruction.\\nClinical Features\\nWhile often an isolated condition in preschool-aged children, ITP can be a \\nfeature of rheumatologic disorders (e.g., lupus) or infections (e.g., HIV , \\nhepatitis C), particularly in teens. Patients can present with petechiae or \\nbleeding (nares or gingiva), and, in the younger child without a coexisting \\ncondition, ITP often follows a viral infection by days to weeks.\\nDiagnosis and Differential\\nOther autoimmune and infectious disorders (lupus, HIV , hepatitis C) should \\nbe considered, particularly in the teen. In ITP, other cell lines are not \\naffected and platelets are often below 20,000/mm 3 with a large platelet \\nvolume. CBC and blood type should be sent. Disseminated intravascular \\ncoagulation and hemolytic-uremic syndrome should be considered in the ill \\npatient with thrombocytopenia.\\nEmergency Department Care and Disposition\\nITP in children carries an excellent prognosis, with 70% resolving sponta-\\nneously within 6 months, regardless of treatment. Children with minimal \\nsymptoms and platelets >20,000/mm3 are often followed without interven-\\ntion. For children with significant bleeding or platelet counts <20,000/\\nmm3, the following options exist:\\n1. Prednisone 1 to 2 mg/kg/d for 2 to 4 weeks. Steroids should only be \\nstarted in conjunction with a hematologist once leukemia has been \\nexcluded.\\n2. Intravenous immunoglobulin (IVIG)  1 g/kg over 4 to 6 hours. Pre-\\nmedication with acetaminophen and diphenhydramine is recommended.\\n3. Anti-Rh (D) immunoglobulin (WinRho®) 75 μg/kg over 1 hour can be \\nused in patients whose blood type is Rh+. Because these antibodies bind \\n85_Cydulka_Ch85.indd   466 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 485, 'page_label': '467'}, page_content='CHAPTER 85: Hematologic-Oncologic Emergencies in Children 467 \\nthe RBCs, hemolysis ensues, dropping the Hb 1 to 2 g/dL over the week \\nfollowing treatment. In 2010, a box ed warning was issued by the Food \\nand Drug Administration (FDA) in response to hemolysis-related deaths \\nof primarily older adults following use of WinRho ® for ITP, recom-\\nmending 8 hours of monitoring for signs of hemolysis (back pain, chills, \\nfever, discolored urine) and premedication with acetaminophen and \\ndiphenhydramine is recommended.\\n4. In the case of a life-threatening bleed, single-donor platelet transfusion \\n(20 to 30 mL/kg), IVIG  (1 g/kg over 30 minutes), and high-dose \\nmethylprednisolone (30 mg/kg) should be considered as a temporizing \\nmeasure. This platelet dose is much higher than the normal dose of 5 to \\n10 mL/kg of a single donor pack or 1 U/10 kg of the pooled or “random” \\ndonor packs. In a patient without antibodies, this lower dose will in-\\ncrease the platelet level by 30,000 to 50,000/mm 3.\\n■ ■NEUtrOpENIA\\nNeutropenia implies a neutrophil count below 1500/mm 3, but risk of life-\\nthreatening infections increases significantly when the count falls in severe \\nneutropenia (<500/mm3).\\nClinical Features\\nNeutropenia can be asymptomatic or associated with serious bacterial \\nillness.\\nDiagnosis and Differential\\nBenign forms of neutropenia include benign transient neutropenia (from \\nviral infections or medications), autoimmune neutropenia, and cyclic neu-\\ntropenia. More serious forms of neutropenia are chronic and persistent, \\nsuch as congenital agranulocytosis, or chemotherapy related. Neutropenia \\ncan be caused by viral suppression, sepsis-induced bone marrow suppres-\\nsion, medications, isoimmune causes in the neonate, or autoimmune causes \\n(including cyclic neutropenia with recurrent 4- to 6-day episodes on a \\n21-day cycle) in an older child. It is difficult to differentiate benign from \\nserious causes in the ED.\\nEmergency Department Care and Disposition\\nPatients with already diagnosed benign forms of neutropenia and evidence \\nof infection can typically be discharged home, though consultation with the \\npatient’s hematologist and a single dose of ceftriaxone (50 mg/kg) may be \\nconsidered depending on the clinical situation. Asymptomatic patients with \\nincidental neutropenia should see a hematologist on an outpatient basis. \\nFebrile children with undifferentiated or nonbenign neutropenia should \\nhave blood cultures sent and broad-spectrum antibiotics initiated.\\n■ ■FUrtHEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 143, “Oncologic and Hematologic Emergencies in \\nChildren,” by Megan E. Mickley, Camilo Gutierrez, and Michele Carney.\\n85_Cydulka_Ch85.indd   467 20/04/17   2:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 486, 'page_label': '468'}, page_content='468\\nRenal Emergencies in Infants  \\nand Children\\nSaranya Srinivasan\\nRenal emergencies in children represent a large and varied group of disease \\nprocesses. This chapter focuses on common renal emergencies in children, \\nincluding acute kidney injury (AKI), nephrotic syndrome, glomerulone-\\nphritis, and hemolytic-uremic syndrome.\\n■ ■ACUTE KIDNEY INJURY\\nAcute kidney injury (AKI), earlier called acute renal failure, is the abrupt \\nloss of renal function resulting in the inability of the body to maintain fluid \\nhomeostasis. AKI in children is relatively sporadic and is most often caused \\nby hypoxic injury (e.g., septic shock, dehydration) or nephrotoxins (e.g., \\nantibiotics, contrast dye, NSAIDs).\\nClinical Features\\nThe clinical presentation of AKI depends on the underlying cause, such as \\nbloody diarrhea and abdominal pain in hemolytic uremic syndrome or \\nfever, hypotension, and petechiae in sepsis. Ultimately, patients will mani-\\nfest stigmata of renal failure: nausea and anorexia due to uremia, headache \\ndue to hypertension, edema (periorbital, scrotal or labial, dependent, or \\ngeneralized) resulting in weight gain, and decreased urine output.\\nDiagnosis and Differential\\nAKI may be anatomically categorized as prerenal, renal (intrinsic), or \\npostrenal in etiology (Table 86-1). Elevated creatinine and urine output are \\nused to diagnose AKI. Urinalysis (UA) with microscopy can help distin-\\nguish between prerenal and renal AKI. In prerenal AKI, the UA may be \\nnormal except for a high specific gravity (> 1.025). For intrinsic causes \\n86\\nCh A p TER\\nTablE 86-1 Causes of Acute Kidney Injury in Infants and Children\\nprerenal/ Inadequate \\nRenal perfusion\\nRenal/Intrinsic Renal \\nDisease or Injury postrenal/ Obstruction\\nDehydration from GI losses Glomerular diseases (HSP , \\nglomerulonephritis, nephrotic \\nsyndrome, pyelonephritis)\\nNephrolithiasis\\nBlood loss from trauma Vascular disease (HUS, \\nvasculitides, thrombosis)\\nRenal vein thrombosis\\nCapillary leakage due to \\nburns/sepsis, third spacing \\ndue to septic shock\\nInterstitial disease (interstitial \\nnephritis, infections)\\nPelvic mass (lymphoma, \\nrhabdomyosarcoma)\\nDecreased cardiac output \\nin congenital heart disease, \\nmyocarditis, cardiogenic \\nshock\\nTubular diseases (ischemia, \\nnephrotoxins such as \\nantibiotics, NSAIDs,  \\ncontrast dye)\\nUrethral obstruction \\n(posterior urethral valves, \\nureteropelvic junction \\nobstruction)\\n86_Cydulka_Ch86.indd   468 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 487, 'page_label': '469'}, page_content='CHAPTER 86: Renal Emergencies in Infants and Children  469 \\nsuch as acute tubular necrosis, hyaline casts may be seen on UA with a low \\nto normal specific gravity. In glomerulonephritis, UA often shows hema-\\nturia, casts, and proteinuria while isolated proteinuria is more indicative of \\nnephrotic syndrome. Basic blood tests such as serum electrolytes (includ-\\ning sodium and potassium), BUN and creatinine, and a complete blood \\ncount (CBC) should be obtained in all cases of AKI to help identify the \\ncause and guide management. Hyperkalemia and other findings may \\nrequire emergency interventions. Additional blood tests may be indicated \\nin specific scenarios.\\nEmergency Department Care and Disposition\\nTreatment of AKI is based on the etiology. Goals of treatment include iden-\\ntifying the underlying cause and correcting fluid and electrolyte imbal-\\nances. Life-threatening complications such as severe hyperkalemia or \\nhypertensive emergency should be addressed immediately. A pediatric \\nnephrologist should be consulted for most cases of AKI as many cases \\nrequire inpatient admission.\\n1. For prerenal AKI, resuscitate with crystalloid fluids, starting with 10 to \\n20 mL/kg of normal saline without added potassium. For prerenal \\nAKI due to hemorrhagic shock, give crystalloid fluids until blood prod-\\nucts are available then transfuse packed red blood cells in aliquots of \\n10 mL/kg.\\n2. For AKI due to intrinsic renal injury or disease, treatment depends on \\nthe clinical state of the patient and the etiology of the AKI. For example, \\nit may be necessary to fluid restrict despite oliguria in order to achieve \\noverall fluid balance in hypervolemic patients. It is crucial to monitor \\nthe patient’s weight and liquid intake and output. Consider discontinuing \\nall nephrotoxic medications and treat hypertension with antihyperten-\\nsive agents.\\n3. For postrenal AKI, insert a F oley catheter to relieve the obstruction. \\nAntihypertensive agents and/or diuretics may also be necessary to con-\\ntrol significant hypertension.\\n■ ■NEphROTIC SYNDROME\\nNephrotic syndrome is a chronic disease that affects glomerular capillary \\nwall permeability causing urinary protein loss. The hallmarks of nephrotic \\nsyndrome are significant proteinuria, hypoalbuminemia, hyperlipidemia, \\nand edema.\\nClinical Features\\nPatients most commonly present with edema, which may involve the face, \\nabdomen, scrotum or labia, or lower extremities. Because periorbital edema \\nis nonspecific, patients are often misdiagnosed as having an allergic reac-\\ntion. Patients may have foamy or bloody urine. Extreme hypoalbuminemia \\nmay cause pleural effusions, bowel wall edema, or ascites. Life-threatening \\ncomplications of nephrotic syndrome include thromboembolic events (arte-\\nrial and venous) and severe infections due to an immunocompromised state \\n(due to loss of antibodies).\\n86_Cydulka_Ch86.indd   469 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 488, 'page_label': '470'}, page_content='470 SECTION 9: Pediatrics\\nDiagnosis and Differential\\nNephrotic syndrome is classified as primary (only affecting the kidney) or \\nsecondary (multisystem disease with renal involvement). Primary nephrotic \\nsyndromes include minimal change disease, focal segmental sclerosis, \\nmembranous nephropathy, membranoproliferative nephritis, and prolifera-\\ntive nephritis (which may be diffuse, focal, or mesangial). Secondary forms \\nof nephrotic syndrome include lupus, Henoch–Schönlein purpura, sickle \\ncell anemia, and drug or toxin exposure (e.g., heavy metals). TORCH infec-\\ntions may cause congenital nephrotic syndrome.\\nThere are four diagnostic criteria for nephrotic syndrome: (1) hypopro-\\nteinemia with albumin level <3  g/dL, (2) urine protein to creatinine ratio \\n>2 on first morning void or 24-hour urine protein >50 mg/kg, (3) hyper -\\ncholesterolemia (>200 mg/dL), and (4) generalized edema. Further testing \\nmay be required to distinguish primary from secondary nephrotic syn-\\ndrome. Renal biopsy is not indicated during initial episodes of acute \\nnephrotic syndrome.\\nEmergency Department Care and Disposition\\nIn the emergency department (ED), the goal is to treat the acute symptoms. \\nManaging the fluid status of the nephrotic syndrome patient can be chal-\\nlenging since patients may be intravascularly depleted but show signs of \\nfluid overload with significant edema. Treatment principles are as follows:\\n1. Treat hypovolemic shock with 20 mL/kg normal saline.\\n2. Treat mild to moderate dehydration with small, frequent amounts of a \\nlow-salt oral solution.\\n3. Treat volume overload and edema with furosemide 1 to 2  mg/kg/dose. \\nIf the serum albumin is extremely low , diuretics may be less effective, \\nso albumin 0.5 to 1 g/kg should be administered followed by a dose of \\nfurosemide.\\n4. Definitive treatment of nephrotic syndrome often includes oral cortico -\\nsteroids; however, steroid therapy should be initiated in conjunction with \\na pediatric nephrologist.\\nMany patients with nephrotic syndrome can safely be discharged home \\non a low-salt diet (< 2 g/d) with close follow-up with their PCP or nephrol-\\nogist. Indications for admission include severe edema, thrombotic compli-\\ncations, or signs and symptoms of systemic infection.\\n■ ■ACUTE GLOMERULONEphRITIS\\nAcute glomerulonephritis (GN) is the result of inflammation leading to \\nglomerular injury and is characterized by hematuria and proteinuria. Glo-\\nmerulonephritis may be immune-mediated, inherited, or post-infectious, \\nand is classified as primary (isolated renal involvement) or secondary \\n(resulting from a systemic disorder).\\nClinical Features\\nPatients typically present with bloody, foamy (from proteinuria), or tea-\\ncolored urine along with oliguria, fatigue, or lethargy. Severe hypertension \\nmay result in headaches. In post-streptococcal  GN, there may be a history \\n86_Cydulka_Ch86.indd   470 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 489, 'page_label': '471'}, page_content='CHAPTER 86: Renal Emergencies in Infants and Children  471 \\nof a sore throat, upper respiratory infection (URI), or skin infection preced-\\ning the onset of urinary symptoms by 1 to 2 weeks. In IgA nephropathy, \\nchildren may report a concurrent URI or URI symptoms within the \\npreceding week.\\nDiagnosis and Differential\\nCommon causes of acute GN include post-infectious etiologies (post-\\nstreptococcal GN), Henoch–Schönlein purpura, systemic lupus erythema -\\ntosus, and IgA nephropathy. Diagnosis of GN is made by examination of \\nthe urine. UA with microscopy demonstrates RBC casts, dysmorphic \\nRBCs, and proteinuria. Other laboratory studies should include a CBC, \\nelectrolytes, BUN and creatinine, serum albumin, and urine culture. Serum \\ncomplement levels are low in more than 90% of patients with post-\\nstreptococcal GN. Streptococcal serologic tests such as antistreptolysin-O \\nand streptozyme may also be helpful.\\nEmergency Department Care and Disposition\\nThe treatment of glomerulonephritis is determined by the underlying \\ncause. Treatment of post-streptococcal GN is primarily supportive as \\nsymptoms usually resolve within a few weeks. Depending on the sever -\\nity of disease, immunosuppressive agents may be used to treat inflam-\\nmation and ACE inhibitors may be required to treat hypertension, \\nparticularly in patients with proteinuria. Nephrology consultation is \\nindicated for patients with new-onset GN. Patients with mild disease \\nmay be discharged home on a fluid-restricted low-sodium diet with close \\nfollow-up.\\n■ ■hEMOLYTIC-UREMIC SYNDROME\\nHemolytic-uremic syndrome (HUS) is characterized by acute renal failure, \\nthrombocytopenia, and microangiopathic hemolytic anemia. Approxi-\\nmately 90% of cases are due to Shiga-toxin producing Escherichia coli \\nO157:H7, found in unpasteurized milk, undercooked meats, and contami-\\nnated produce.\\nClinical Features\\nThe majority of patients with HUS present with nausea, vomiting, and \\nbloody diarrhea. Within a week of symptom onset, oliguria, anemia, \\nseizures, and encephalopathy may occur.\\nDiagnosis and Differential\\nDiagnosis of HUS is supported by labs. A CBC will demonstrate a hemo-\\nglobin level of 5 to 9  g/dL and platelets <150,000/mm 3. Peripheral smear \\nshows schistocytes, helmet cells, and burr cells. A stool specimen to test for \\nShiga toxin and E. coli O157:H7 should also be sent.\\nEmergency Department Care and Disposition\\nTreatment of HUS in the ED is primarily supportive. Hypovolemia should \\nbe treated with 10 to 20  mL/kg boluses of normal saline while monitoring \\nfor fluid overload in oliguric patients. Platelet transfusions are not  \\n86_Cydulka_Ch86.indd   471 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 490, 'page_label': '472'}, page_content='472 SECTION 9: Pediatrics\\nrecommended as they increase thrombotic complications. Antibiotics are  \\ncontraindicated in pediatric diarrheal illnesses as they may increase \\nthe risk of HUS. Antiperistaltic agents (e.g., loperamide) are also con-\\ntraindicated as they increase the risk for systemic complications of  \\nE. coli infection. All patients with HUS require hospitalization and up to \\n70% will require dialysis.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 134, “Renal Emergencies in Children,” by Andrew \\nDixon and Brandy Stauffer.\\n86_Cydulka_Ch86.indd   472 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 491, 'page_label': '473'}, page_content='473\\nSexually Transmitted Infections\\nJennifer L. Hannum\\nThis chapter covers some of the major sexually transmitted infections \\nthat are commonly found in the United States, with the exception of \\nhuman immunodeficiency virus (HIV), which is discussed in Chapter 92. \\nVaginitis and pelvic inflammatory disease (PID) are covered separately \\nin Chapters 63 and 64.\\n■ ■GENERAL RECOMMENDATIONS\\nSexually transmitted infections are a major public health problem, and \\nemergency medicine providers are commonly called upon to identify, treat, \\nand recommend appropriate follow-up for these conditions. Complications \\nfrom such infections may contribute to infertility, cancer, or urogenital \\ncomplications. Due to issues with compliance and the challenge of obtain-\\ning consistent follow-up care in some communities, single-dose antibiotic \\ntreatment regimens are recommended, when possible. Several of these \\ninfections frequently occur together, and providers should consider addi-\\ntional screening for coexisting infections such as HIV , syphilis, and hepati-\\ntis. Test for pregnancy, advise treatment of all recent sexual partners, and \\ncounsel patients about the appropriate time frame for resuming sexual \\ncontact. Treatment regimens listed here are for adult patients who are not \\npregnant. Updated treatment recommendations are available on the Centers \\nfor Disease Control and Prevention (CDC) website (www.cdc.gov) and \\ninclude specific guidelines for the treatment of children and pregnant \\npatients. The most recent full publication with treatment guidelines for \\nsexually transmitted infections was issued by the CDC in 2010 and is avail-\\nable at https://www.cdc.gov/std/treatment/2010/default.htm.\\n■ ■CHLAMYDIAL INFECTIONS\\nClinical Features\\nChlamydia trachomatis infections in men present with urethritis, epididy-\\nmitis, orchitis, proctitis, or Reiter’s syndrome (nongonococcal urethritis, \\nconjunctivitis, and rash). Women often have asymptomatic cervicitis, but \\nmay also present with vaginal discharge, spotting, or dysuria. Consider \\n87\\nC HA p TER\\nInfectious and Immunologic \\nDiseases\\n 10\\nSECTION\\n87_Cydulka_Ch87.indd   473 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 492, 'page_label': '474'}, page_content='474 SECTION 10: Infectious and Immunologic Diseases\\nchlamydial infection in patients with sterile pyuria. Complications can \\ninclude PID, ectopic pregnancy, and infertility.\\nDiagnosis and Differential\\nDiagnosis of chlamydia is best made with indirect detection methods such \\nas enzyme-linked immunosorbent assay or DNA probes, which have a \\nsensitivity of 75% to 90%. The CDC recommends a nucleic acid amplifica-\\ntion test (NAAT) to be used as screening tests for Chlamydia. Optimal \\nspecimen types for NAAT are vaginal swabs from women and first-catch \\nurine from men.\\nEmergency Department Care and Disposition\\n1. Azithromycin 1 g PO as a single dose or doxycycline 100 mg PO twice \\ndaily for 7 days is the treatment of choice for uncomplicated urethritis or \\ncervicitis from chlamydia infection.\\n2. Alternatives include 7-day treatment with erythr omycin base 500 mg \\nPO four times daily, ofloxacin 300 mg PO twice daily, or levofloxacin \\n500 mg PO daily.\\n3. Recommend that patients avoid sexual contact for 7 days after complet -\\ning antibiotic treatment and symptoms have resolved.\\n■ ■GONOCOCCAL INFECTIONS\\nClinical Features\\nNeisseria gonorrhoeae causes urethritis, epididymitis, orchitis, and prosta-\\ntitis in men and urethritis, cervicitis, PID, and infertility in women. Many \\ngonococcal infections in women are asymptomatic and may coexist with \\nchlamydial infection. Women who are symptomatic may present with non-\\nspecific lower abdominal pain and mucopurulent vaginal discharge with \\nfindings of cervicitis or PID. Men often present with dysuria and purulent \\npenile discharge, but can also present with acute epididymitis, orchitis, or \\nprostatitis. Disseminated gonococcemia may present with fever, rash (ten-\\nder pustules on a red base, usually on the extremities, and may include \\npalms and soles), tenosynovitis, or septic arthritis.\\nDiagnosis and Differential\\nThe CDC recommends NAAT be performed on cervical, vaginal, ure-\\nthral, or urine specimens. Culture and nucleic acid hybridization tests \\nrequire endocervical or urethral swab specimens. Diagnosis of dissemi-\\nnated gonorrhea is challenging because cultures of blood, skin lesions, \\nand joint fluid yield positive results in only 20% to 50% of patients. \\nCulturing the cervix, rectum, and pharynx can be considered for \\npatients suspected of disseminated disease to improve the diagnostic \\nyield.\\nEmergency Department Care and Disposition\\n1. For uncomplicated gonorrhea, treat with dual therapy using ceftriaxone \\n250 mg IM AND azithromycin 1 g PO single dose or doxycycline 100 mg \\nPO twice daily for 7 days.\\n87_Cydulka_Ch87.indd   474 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 493, 'page_label': '475'}, page_content='CHAPTER 87: Sexually Transmitted Infections 475 \\n2. Alternative treatment options include cefixime 400 mg PO single dose \\nAND azithromycin 1 g PO single dose or doxycycline 100 mg PO \\ntwice daily for 7 days AND test-of-cure in 1 week.\\n3. Disseminated gonorrhea is treated initially with parenteral ceftriaxone 1 \\ng daily IM/IV AND azithromycin 1 g PO single dose. Duration of par -\\nenteral therapy varies and should be determined in consultation with an \\ninfectious disease specialist.\\n4. Recommend that patients avoid sexual contact for 7 days after complet -\\ning antibiotic treatment and symptoms have resolved.\\n■ ■TRICHOMONIASIS\\nClinical Features\\nPatients with Trichomonas vaginalis parasite infections can remain asymp-\\ntomatic or present with a range of symptoms up to severe inflammatory \\ndisease. In men this infection is often asymptomatic, but may present as \\nurethritis. Symptoms in women may include vulvar irritation and a mal-\\nodorous, thin watery discharge with associated burning, pruritus, dysuria, \\nurinary frequency, dyspareunia, or lower abdominal pain.\\nDiagnosis and Differential\\nMicroscopic visualization of the motile Trichomonas vaginalis parasites on \\na wet preparation of cervical smears or spun urine samples is diagnostic. \\nMotility is only present for 10 to 20 minutes after collection thereby \\ndecreasing sensitivity. Culture is the most sensitive and specific test, but \\nmay take up to 7 days. DNA probes and monoclonal antibodies are used at \\nsome institutions.\\nEmergency Department Care and Disposition\\n1. Metronidazole 2 g PO, or tinidazole 2 g PO in a single dose is the treat-\\nment of choice.\\n2. An alternative treatment regimen is metronidazole 500 mg PO twice \\ndaily for 7 days.\\n3. Metronidazole (pregnancy category B) 2 g PO in a single dose is the \\ndrug of choice for treating symptomatic pregnant patients.\\n4. Patients should avoid intercourse for 1 week after the last dose of antibiotics.\\n■ ■SYpHILIS\\nClinical Features\\nTreponema pallidum, a spirochete, causes the three stages of syphilis infec-\\ntions: primary, secondary, and tertiary stages. Primary syphilis is characterized \\nby a chancre (Fig. 87-1), a single painless ulcer with indurated borders that \\ndevelops on the penis, vulva, or other areas of sexual contact. The primary \\nchancre heals and disappears after 3 to 6 weeks, and the secondary stage \\noccurs after several additional weeks. Rash and lymphadenopathy are the most \\ncommon symptoms of secondary syphilis. The rash consists of nonpruritic \\ndull red or pink papules that begin on the trunk and flexor surfaces of the \\nextremities and subsequently spread to the palms and soles. Constitutional \\n87_Cydulka_Ch87.indd   475 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 494, 'page_label': '476'}, page_content='476 SECTION 10: Infectious and Immunologic Diseases\\nsymptoms such as fever, malaise, headache, and sore throat are common  \\nbefore spontaneous resolution of this second stage. Tertiary or latent syphilis \\ndevelops in about one-third of patients and can begin 3 to 20 years after the \\ninitial infection. Involvement of the nervous system (meningitis, dementia, \\ntabes dorsalis), cardiovascular system (thoracic aneurysm), and widespread \\ngranulomatous lesions (gummata) are characteristic of tertiary syphilis.\\nDiagnosis and Differential\\nTreponema pallidum cannot be cultured in the laboratory and testing is a \\nchallenge because there is no single optimal diagnostic test. The sensitivity \\nand specificity of tests for syphilis depend on the stage of the disease and type \\nof test. Nontreponemal tests such as Venereal Disease Research Laboratory \\n(VDRL) and rapid plasma regain (RPR) detect nonspecific antibodies that are \\nindicative of infection but do not become detectable until 1 to 4 weeks after \\na chancre appears. Positive results for these screening tests must subsequently \\nbe confirmed with an immunoassay specific for T. pallidum antibodies. A \\npresumptive diagnosis of syphilis is made if a positive result on a nontrepo-\\nnemal antibody test is supported by a positive confirmatory result on a trepo-\\nnemal antibody test. Direct visualization of organisms using darkfield \\nmicroscopy is diagnostic for primary, secondary, or early congenital syphilis.\\nEmergency Department Care and Disposition\\n1. For primary and secondary syphilis, treat patients with benzathine \\npenicillin G 2.4 million units IM as a single dose. Be aware of the \\nFIgurE 87-1. Syphilis chancre in a male. A painless ulcer caused by syphilis is \\nseen on the distal penile shaft with a smaller erosion on the glans. The ulcer is \\nquite firm on palpation. Reproduced with permission from Wolff K, Johnson RA: \\nFitzpatrick’s Color Atlas and Synopsis of Clinical Dermatology, 7th ed. New Y ork: \\nMcGraw-Hill Companies, Inc; 2013.\\n87_Cydulka_Ch87.indd   476 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 495, 'page_label': '477'}, page_content='CHAPTER 87: Sexually Transmitted Infections 477 \\nJarisch–Herxheimer reaction (fever, headache, and myalgias) that may \\ndevelop within the first 24 hours after treatment.\\n2. Alternative treatment options for primary, secondary , and early latent \\nsyphilis include doxycycline 100 mg PO twice daily for 14 days, or \\ntetracycline 500 mg PO four times daily for 28 days.\\n3. Treat tertiary syphilis with benzathine penicillin G 2.4 million units IM \\nweekly for 3 weeks.\\n■ ■HERpES SIMpLEX INFECTIONS\\nClinical Features\\nPrimary genital herpes simplex virus (HSV) infection often begins with a \\nviral prodrome lasting 2 to 24 hours that is characterized by localized or \\nregional pain, tingling, and burning. Constitutional symptoms such as head-\\nache, fever, painful inguinal lymphadenopathy, anorexia, or malaise often \\nfollow. Papules and vesicles on an erythematous base appear, with vesicular \\nerosion that occurs over a few hours to several days. In men, painful HSV \\nulcers often appear on the shaft or glans of the penis (Fig. 87-2), while in \\nFIgurE 87-2. Genital herpes in a male. Classic vesicles are shown proximally on \\nthe penis; several formerly vesicular lesions have crusted over. Reproduced with \\npermission from Goldsmith LA, Katz SI, Gilchrest BA, et al: Fitzpatrick’s Derma-\\ntology in General Medicine, 8th ed. New York: McGraw-Hill Companies, Inc; 2012.\\n87_Cydulka_Ch87.indd   477 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 496, 'page_label': '478'}, page_content='478 SECTION 10: Infectious and Immunologic Diseases\\nwomen, the painful ulcers occur on the introitus, urethral meatus, labia, and \\nperineum. Viral shedding occurs for 10 to 12 days after the onset of the \\nrash, and lesions heal completely within 3 weeks.\\nDiagnosis and Differential\\nHSV infection is diagnosed based on a characteristic history and associated \\nphysical findings. Viral cultures taken from vesicles or early ulcers are \\nmore reliable for confirmation than the classically described Tzanck smear \\nto identify intranuclear inclusions.\\nEmergency Department Care and Disposition\\n1. Treat a patient’s first episode of HSV with a 7- to 10-day course of \\nacyclovir 400 mg PO three times daily, valacyclovir 1 g PO twice daily, \\nor famciclovir 250 mg PO three times daily. Treatment hastens recovery \\nbut does not cure the infection.\\n2. For proctitis or oral infections, treat with acyclovir  400 mg five times \\ndaily for 7 to 10 days.\\n3. Patients with severe disease that require hospitalization should be treated \\nwith intravenous acyclovir 5 to 10 mg/kg body weight every 8 hours.\\n4. Recurrent episodes of genital herpes can be treated with a 5-day course \\nof valacyclovir 1 g PO daily or acyclovir 400 mg PO three times daily. \\nAntiviral therapy may reduce the severity and duration of recurrent epi-\\nsodes of HSV when initiated when symptoms begin.\\n■ ■CHANCROID\\nClinical Features\\nCaused by Haemophilus ducreyi, chancroid presents as a painful erythema-\\ntous papule at the site of infection. This lesion erodes and becomes ulcerated \\nand pustular over the next 2 days (Fig. 87-3). Up to 50% of patients have \\nmore than one lesion, with “kissing lesions” occurring from autoinoculation \\nof adjacent areas of skin. Painful lymphadenopathy develops 1 to 2 weeks \\nafter primary infection, and if treatment is not initiated these lymph nodes \\nbecome necrotic and infected buboes.\\nDiagnosis and Differential\\nChancroid is typically diagnosed clinically, with care to consider the diag-\\nnoses of syphilis and HSV . Sometimes the organism may be cultured from \\na swab of an ulcer or bubo, but a special culture medium is required that is \\nnot found in many laboratories.\\nEmergency Department Care and Disposition\\n1. Treatment regimens include azithr omycin 1 g PO as a single dose, \\nceftriaxone 250 mg IM as a single dose, erythromycin base 500 mg PO \\nthree times daily for 7 days, or ciprofloxacin 500 mg PO twice daily for \\n3 days. Symptoms often improve within 3 days, but larger ulcers may \\nrequire 2 to 3 weeks to heal.\\n2. Incision and drainage of buboes can be considered for symptomatic \\nrelief.\\n87_Cydulka_Ch87.indd   478 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 497, 'page_label': '479'}, page_content='CHAPTER 87: Sexually Transmitted Infections 479 \\n3. Test patients for other sexually transmitted infections such as HSV , \\nsyphilis, and HIV.\\n4. Recommend treatment for all sexual partners in the 10 days prior to \\ndiagnosis regardless of whether they have developed symptoms.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 149, “Sexually Transmitted Infections,” by Flavia \\nNobay and Susan B. Promes.\\nFIgurE 87-3.  Chancroid ulcer in a male. The lesion is very painful. The friable \\nbase of the ulcer is covered with yellow-gray necrotic exudates. Reproduced with \\npermission from Goldsmith LA, Katz SI, Gilchrest BA, et al: Fitzpatrick’s Derma-\\ntology in General Medicine, 8th ed. New York: McGraw-Hill Companies, Inc; 2012.\\n87_Cydulka_Ch87.indd   479 20/04/17   2:54 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 498, 'page_label': '480'}, page_content='480\\nToxic Shock Syndromes\\nSorabh Khandelwal\\n■ ■STAPHYLOCOCCAL TOXIC SHOCK SYNDROME\\nStaphylococcal toxic shock syndrome (TSS) is a severe, life-threatening \\ninfection attributed to Staphylococcus aureus that can progress rapidly to \\nmultisystem dysfunction, severe electrolyte disturbances, renal failure, and \\nshock. Risk factors for TSS include retained foreign bodies (e.g., tampons, \\nfemale barrier contraceptives), skin and soft tissue infections (e.g., abscess, \\ncellulitis, and mastitis), varicella infection, sinusitis, surgery, trauma, child-\\nbirth, and influenza.\\nClinical Features\\nTSS is characterized by high fever, profound hypotension, diffuse macular \\nrash, desquamation (1 to 2 weeks after onset of rash), and multiorgan dys-\\nfunction. The details regarding the diagnostic criteria for TSS are listed in \\nTable 88-1. Patients presenting early in the course may exhibit nonspecific \\nsymptoms such as fever, chills, malaise, myalgias, headache, sore throat, \\n88\\nC HAPTER\\nTable 88-1 Case Definition for Toxic Shock Syndrome\\nClinical criteria:\\n■● Fever: temperature ≥ 38.9°C or 102.0°F\\n■● Rash: diffuse macular erythroderma\\n■● Desquamation: 1–2 weeks after onset of rash\\n■● Hypotension: systolic blood pressure ≤ 90 mm Hg (adult) or < 5th percentile by age \\n(children < 16 years of age)\\n■● Multiorgan involvement (≥ 3 organ systems):\\n■● Gastrointestinal: vomiting and/or diarrhea at onset of illness\\n■● Muscular: severe myalgia or CPK ≥ 2 times the upper limit of normal\\n■● Mucous membrane: vaginal, oropharyngeal, or conjunctival hyperemia\\n■● Renal: BUN or serum Cr ≥ 2 times the upper limit of normal for laboratory or urinary \\nsediment with pyuria (≥ 5 leukocytes per high-power field) in the absence of urinary \\ntract infection\\n■● Hepatic: total bilirubin, ALT, or AST ≥ 2 times the upper limit of normal\\n■● Hematologic: platelet count < 100,000/mm3\\n■● Central nervous system: disorientation or alterations in consciousness without focal \\nneurologic signs when fever and hypotension are absent\\nlaboratory criteria: Negative results on the following tests, if obtained:\\n■● Blood or cerebrospinal fluid cultures (blood culture may be positive for Staphylococcus \\naureus)\\n■● Serologies for Rocky Mountain spotted fever, leptospirosis, or measles\\nCase classification:\\n■● Probable: ≥ 4 clinical criteria + laboratory criteria met\\n■● Confirmed: 5 clinical criteria + laboratory criteria met, including desquamation (unless \\ndeath occurs prior to desquamation)\\nAbbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; CPK, creatine \\nphosphokinase; Cr, creatinine.\\n88_Cydulka_Ch88.indd   480 20/04/17   2:55 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 499, 'page_label': '481'}, page_content='CHAPTER 88: Toxic Shock Syndromes 481 \\nvomiting, diarrhea, or abdominal pain. The rash associated with TSS is \\ndescribed as a “painless sunb urn” that typically fades within 3 days and is \\nfollowed by full-thickness desquamation.\\nDiagnosis and Differential\\nTSS is a clinical diagnosis characterized by an acute febrile illness asso-\\nciated with erythroderma, hypotension, and multiorgan involvement. \\nLaboratory evaluation reveals evidence of end-organ damage, and testing \\noften includes CBC, comprehensive metabolic panel, coagulation stud-\\nies, creatine phosphokinase level, urinalysis, chest radiograph, ECG, \\nblood gas, and cultures of blood and other potential sites of infection. \\nOther infections to consider in the differential diagnosis of TSS include \\nstreptococcal toxic shock syndrome (STSS), myonecrosis due to Clos-\\ntridium perfringens, TSS due to Clostridium sordellii, staphylococcal \\nscalded skin syndrome, sepsis due to other bacterial organisms, Rocky \\nMountain spotted fever, leptospirosis, and meningococcemia. Noninfec-\\ntious illnesses such as Stevens–Johnson syndrome, toxic epidermal \\nnecrolysis, and Kawasaki’s disease may also be considered in the proper \\nclinical circumstances.\\nemergency Department Care and Disposition\\nTSS is mediated by pyrogenic exotoxins released by certain strains of   \\nS. aureus, and initial management includes aggressive resuscitation to treat \\nshock and begin treating potential sources of infection. Abscesses should \\nbe drained, foreign bodies should be removed, surgical consultation \\nshould be considered for debridement of infected tissue, and appropriate \\nbroad-spectrum antibiotics are recommended.\\n1. Resuscitate patients with hypotension and shock using aggressive IV \\ncrystalloid intravenous fluids such as normal saline. Use vasopressors to \\ntreat persistent hypotension.\\n2. Treat TSS with suspected methicillin-resistant Staphylococcus aur eus \\n(MRSA) with vancomycin 15 mg/kg IV every 12 hours (maximum \\ndose 2.25 g) or linezolid 600 mg IV plus clindamycin 900 mg IV \\nevery 8 hours.\\n3. Patients with suspected methicillin-sensitive Staphylococcus aureus \\n(MSSA) can be treated with nafcillin or oxacillin 2 g IV every 4 hours, \\nplus clindamycin 900 mg IV every 8 hours.\\n4. Consider IV immunoglobulin therapy after consultation with infectious \\ndisease or critical caire specialists when no clinical improvement is seen \\nafter 6 hours of aggressive treatment.\\n■ ■STREPTOCOCCAL TOXIC SHOCK SYNDROME\\nSTSS is a clinical illness characterized by shock and multiorgan failure as \\na result of invasive infection due to group A Streptococcus (Streptococcus \\npyogenes) and other streptococcal pathogens. Risk factors for STSS include \\nthe presence of underlying medical conditions such as chronic heart, liver, \\nand kidney disease, diabetes, alcoholism, drug abuse, surgical procedures, \\ntraumatic injuries, childbirth, varicella infection, and influenza.\\n88_Cydulka_Ch88.indd   481 20/04/17   2:55 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 500, 'page_label': '482'}, page_content='482 SECTION 10: Infectious and Immunologic Diseases\\nTable 88-2 Case Definition for Streptococcal Toxic Shock Syndrome\\nClinical criteria:\\n■● Hypotension: systolic blood pressure ≤90 mm Hg (adult) or < 5th percentile by age \\n(children < 16 years of age)\\n■● Multiorgan involvement (≥ 2 organ systems):\\n■● Renal: serum Cr ≥ 2 mg/dL (≥ 177 μmol/L) for adults or ≥ 2 times the upper limit of \\nnormal for age. In patients with preexisting renal disease, > 2-fold elevation above \\nbaseline.\\n■● Coagulopathy: platelet count ≤ 100,000/mm3 (≤ 100 × 106/L) or disseminated \\nintravascular coagulation, defined by prolonged clotting times, low fibrinogen level, \\nand presence of fibrin degradation products\\n■● Hepatic: total bilirubin, ALT, or AST ≥ 2 times the upper limit of normal for the \\npatient’s age. In patients with preexisting liver disease, > 2-fold elevation above \\nbaseline.\\n■● Acute respiratory distress syndrome: acute onset of diffuse pulmonary infiltrates and \\nhypoxemia in the absence of cardiac failure or by evidence of diffuse capillary leak \\nmanifested by acute onset of generalized edema, or pleural or peritoneal effusions \\nwith hypoalbuminemia.\\n■● Skin: generalized erythematous macular rash that may desquamate\\n■● Soft tissue necrosis, including necrotizing fasciitis or myositis, or gangrene\\nlaboratory criteria:\\n■● Isolation of group A Streptococcus\\nCase classification:\\n■● Probable: All clinical criteria met + absence of other identified etiology for illness + \\nisolation of group A Streptococcus from a nonsterile site\\n■● Confirmed: All clinical criteria met + isolation of group A Streptococcus from a sterile \\nsite (e.g., blood, cerebrospinal fluid, synovial fluid, pleural fluid, or pericardial fluid)\\nAbbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; Cr, creatinine.\\nClinical Features\\nSimilar to TSS, fulminant STSS is often preceded by nonspecific symp-\\ntoms such as fever, chills, sweats, malaise, arthralgias, cough, sore throat, \\nrhinorrhea, anorexia, nausea, vomiting, abdominal pain, or diarrhea. A \\nrash is seen in a minority of cases. Pain at a localized site, often an \\nextremity or abdomen, that is out of proportion to physical findings is a \\ncommon presentation of STSS due to the strong association of STSS and \\nnecrotizing soft tissue infections. Diagnostic criteria for fulminant STSS \\nare listed in Table 88-2.\\nDiagnosis and Differential\\nSTSS is a clinical diagnosis characterized by an acute febrile illness associ-\\nated with hypotension and multiorgan involvement in the setting of a strep-\\ntococcal infection. Laboratory evaluation is similar to TSS (see above) and \\nfindings identify evidence of end-organ damage. The differential diagnosis \\nincludes many of the same disease processes as TSS (see above).\\nemergency Department Care and Disposition\\n1. Treat suspected STSS patients with aggressive isotonic fluid resuscita-\\ntion to restore volume and tissue perfusion. Large volumes of IV crys-\\ntalloid fluid (10 to 20 L/day) may be required. Use vasopressors or \\ninotropic agents for persistent hypotension.\\n88_Cydulka_Ch88.indd   482 20/04/17   2:55 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 501, 'page_label': '483'}, page_content='CHAPTER 88: Toxic Shock Syndromes 483 \\n2.  Assess the possible need for airway management, as more than half of \\npatients with STSS will dev elop ARDS and require intubation and \\nmechanical ventilation.\\n3. Obtain blood and wound cultures prior to giving antibiotics when pos-\\nsible, as the majority of patients will have positive blood cultures to \\nconfirm a streptococcal pathogen.\\n4. Broad-spectrum antimicrobial therapy is recommended. Treat suspected \\nSTSS with piperacillin-tazobactam 4.5 g IV or meropenem 1 g IV \\nplus IV clindamycin 900 mg. Add vancomycin 15 mg/kg IV (maxi-\\nmum dose 2.25 g) when MRSA infection is suspected.\\n5. Administration of IV immunoglobulin remains controversial and con-\\nsultation should be obtained prior to initiating this therapy.\\n6. Initiate an emergent surgical consultation for patients with a suspected \\nnecrotizing soft tissue infection. Patients with STSS may require \\ndebridement, fasciotomy, or amputation as the disease progresses.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 150, “Toxic Shock Syndromes,” by Stephen Y . Liang\\n88_Cydulka_Ch88.indd   483 20/04/17   2:55 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 502, 'page_label': '484'}, page_content='484\\nSepsis\\nJohn E. Gough\\nSepsis is generally defined as a suspected or confirmed infection with evi-\\ndence of systemic inflammation. Severe sepsis is sepsis with evidence of \\nnew organ dysfunction thought to be secondary to tissue hypoperfusion. \\nSeptic shock is present when cardiovascular failure occurs, reflected by \\npersistent hypotension or the need for vasopressors despite adequate fluid \\nresuscitation. The majority of sepsis cases are caused by gram-negative and \\ngram-positive bacteria; however, sepsis is a heterogeneous clinical \\nsyndrome that can be caused by any class of microorganism including \\nfungi, mycobacteria, viruses, rickettsiae, and protozoa. The most likely \\nmicroorganisms that cause sepsis varies based on possible patient exposure \\nto drug-resistant microorganisms (e.g., due to recent hospitalization or \\nother health care–associated exposure) and the specific anatomic site of \\nsuspected infection. Pneumonia, intraabdominal infection, urinary tract \\ninfection, and skin or soft tissue infections are the most common infections \\nthat precipitate sepsis.\\n■ ■CLINICAL FEATURES\\nThe presence of sepsis may be apparent on the initial presentation of a \\ncritically ill patient. In some cases, however, sepsis can be challenging to \\nidentify early in a patient’s evaluation. Abnormal vital signs such as hyper-\\nthermia or hypothermia, tachycardia, hypotension, and tachypnea may \\nsuggest sepsis as a diagnostic possibility in the right clinical circumstances. \\nIn particular, up to 40% of patients who present with undifferentiated  \\nhypotension are later diagnosed with septic shock when a source of infec-\\ntion is identified through diagnostic testing.\\nTraditionally sepsis has been categorized as a type of distributive shock \\nassociated with peripheral vasodilation, warm extremities, and a compensa-\\ntory increase in cardiac output. However, this does not accurately reflect the \\npresentation of all patients with sepsis. The combination of intravascular \\nvolume depletion and septic cardiomyopathy may also manifest as “cold \\nshock,” with impaired peripheral perfusion and cool extremities.\\nMany different abnormalities are possible with severe sepsis, reflecting \\ndifferent areas of end-organ damage. Severe sepsis is the leading cause of \\nacute lung injury and acute respiratory distress syndrome (ARDS). Wide-\\nspread inflammation secondary to sepsis commonly affects pulmonary \\nfunction even in the absence of pneumonia. Refractory hypoxemia, \\ndecreased lung compliance, and a chest x-ray demonstrating bilateral \\npulmonary alveolar infiltrates are commonly found with ARDS. Renal \\nmanifestations of severe sepsis include acute renal failure with azotemia, \\noliguria, and anuria. The most frequent hepatic abnormality is cholestatic \\njaundice and is associated with elevation in transaminases, alkaline phos-\\nphatase, and/or bilirubin. The most frequent hematologic changes associ-\\nated with sepsis are neutropenia or neutrophilia, thrombocytopenia, and \\ndisseminated intravascular coagulation (DIC). Hyperglycemia may develop, \\n89\\nCh A p TER\\n89_Cydulka_Ch89.indd   484 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 503, 'page_label': '485'}, page_content='CHAPTER 89: Sepsis 485 \\nand uncontrolled hyperglycemia is a significant risk for adv erse outcome. \\nCutaneous lesions that occur as a result of sepsis can be divided into \\nfive categories: direct bacterial involvement of the skin and underlying soft \\ntissues (cellulitis, erysipelas, and fasciitis); lesions from hematogenous \\nseeding of the skin or the underlying tissue (petechiae, pustules, cellulitis, \\necthyma gangrenosum); lesions resulting from hypotension and/or DIC \\n(acrocyanosis and necrosis of peripheral tissues); lesions secondary to \\nintravascular infections (microemboli and/or immune complex vasculitis); \\nand lesions caused by toxins (toxic shock syndrome).\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nConsider the possibility of sepsis in patients who present with criteria for \\nsystemic inflammatory response syndrome (SIRS), as detailed in Table 89-1. \\nSevere sepsis involves these criteria plus evidence of organ dysfunction \\nsuch as hypotension, elevated serum lactate level, renal dysfunction, \\nhypoxia, hyperbilirubinemia, thrombocytopenia, or coagulopathy. Septic \\nshock involves refractory hypotension, and does not typically reverse with \\nrapid volume replacement of at least 1.5 to 3.0 L of isotonic crystalloid (or \\n20 to 30 mL/kg in children). History and physical examination findings \\ncombined with initial laboratory and radiolographic investigations often \\nidentify a presumptive infection source for sepsis, which can guide empiric \\ntherapy. Focus particular attention to signs and symptoms of potential \\ninfections in the central nervous system, pulmonary system, intraabdominal \\nstructures, urinary tract, skin, and soft tissues.\\nInitial laboratory studies for patients with suspected sepsis often include \\na CBC with differential and platelet count, lactic acid level, serum electro-\\nlytes, liver function panel, renal function panel, arterial blood gas analysis, \\nblood cultures, urinalysis, and urine culture. Consider type and cross-\\nmatching blood for patients with acute anemia or refractory hypotension \\nwho may need emergent transfusion. A chest x-ray can assess for pneumo-\\nnia as a potential source of infection. Additional radiographs, CT scans, \\nultrasound, or lumbar puncture may be utilized in specific patients based on \\nclinical suspicion for potential infectious sources. Other laboratory tests \\nfor markers of sepsis may be considered, such as C-reactive protein and \\nprocalcitonin.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nStudies have shown that the cornerstones of the initial treatment and stabi-\\nlization of severe sepsis are early recognition, early reversal of hemody-\\nnamic compromise, and early empiric antibiotics for infection control. The \\ngoals of resuscitation are to improve preload, tissue perfusion, and oxygen \\ndelivery.\\n1. For patients with hypoxia or respiratory distress, provide supplemental \\noxygen to keep oxygen saturation greater than 90%, and perform endo-\\ntracheal intubation if necessary.\\n2. Initiate IV fluid resuscitation with an initial bolus of crystalloid IV fluid \\nat 20 to 30 mL/kg.\\n3. Begin vasopressors for patients in septic shock with hypotension that \\ndoes not respond to aggressive IV fluid bolus therapy. A central venous \\n89_Cydulka_Ch89.indd   485 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 504, 'page_label': '486'}, page_content='486 SECTION 10: Infectious and Immunologic Diseases\\nTable 89-1 Definition of Sepsis in Adults and Children\\n■● Systemic Inflammatory Response Syndrome (SIRS) criteria:\\n1. Fever (temperature >38.3°C) or hypothermia (temperature <36°C)\\n2. Pulse rate (>90 beats/min or >2 SDs above the normal value for age)\\n3. Tachypnea (respiratory rate >20 breaths/min)\\n4. Leukocytosis (WBC >12,000 cells/μL) or leukopenia (WBC <4000 cells/μL), or \\nnormal WBC with >10% immature forms\\n■● Sepsis: Infection (documented or suspected), and some of the following:\\n■● General Parameters: Fever (temperature >38.3°C)\\n■● Hypothermia (temperature <36°C)\\n■● Pulse rate (>90 beats/min or >2 SDs above the normal value for age)\\n■● Tachypnea\\n■● Altered mental status\\n■● Significant edema or positive fluid balance (>20 mL/kg during 24 h)\\n■● Hyperglycemia (plasma glucose > 140 mg/dL or 7.7 mmol/L) in the absence of \\ndiabetes\\n■● Inflammatory Parameters:\\n■● Leukocytosis (WBC >12,000 cells/μL)\\n■● Leukopenia (WBC <4000 cells/μL)\\n■● Normal WBC with >10% immature forms\\n■● Plasma C-reactive protein (CRP) >2 SDs above the normal value\\n■● Plasma procalcitonin >2 SDs above the normal value\\n■● Hemodynamic Parameters:\\n■● Arterial hypotension (SBP <90 mm Hg, MAP <70 mm Hg, or an SBP decrease  \\n>40 mm Hg in adults or <2 SDs below normal for age)\\n■● Organ Dysfunction Parameters:\\n■● Arterial hypoxemia (PaO2/FIO2 <300)\\n■● Acute oliguria (urine output <0.5 mL/kg per hour for at least 2 h despite adequate \\nfluid resuscitation)\\n■● Creatinine level increase >0.5 mg/dL\\n■● Coagulation abnormalities (INR >1.5 or aPTT >60 s)\\n■● Ileus (absent bowel sounds)\\n■● Thrombocytopenia (platelet count <100,000 cells/μL)\\n■● Hyperbilirubinemia (plasma total bilirubin >4 mg/dL)\\n■● Tissue Perfusion Parameters:\\n■● Hyperlactatemia (above upper limits of laboratory normal levels)\\n■● Decreased capillary refill or mottling\\n■● Severe Sepsis: Sepsis-induced tissue hypoperfusion or organ dysfunction (any of the \\nfollowing thought to be due to infection)\\n■● Sepsis-induced hypotension\\n■● Lactate level above upper limits of laboratory normal levels\\n■● Urine output <0.5 mL/kg/h for at least 2 h despite adequate fluid resuscitation\\n■● Acute lung injury with PaO2/FIO2 <250 in the absence of pneumonia as infectious source\\n■● Acute lung injury with PaO2/FIO2 <200 in the absence of pneumonia as infectious source\\n■● Creatinine level >2.0 mg/dL\\n■● Bilirubin level >2 mg/dL\\n■● Platelet count <100,000 cells/μL\\n■● Coagulopathy (INR >1.5)\\nAbbreviations: aPTT, activated partial thromboplastin time; FIO2, fraction of inspired oxygen; INR, inter -\\nnational normalized ratio; MAP , mean arterial pressure; PaO2, arterial partial pressure of oxygen; SBP , \\nsystolic blood pressure; SD, standard deviation.\\nSource: Adapted with permission from Levy M M, Fink MP , Marshall J C, et al: 2001 SCCM/ESICM  \\n/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. April 2003; 31(4):  \\n1250–1256.\\n89_Cydulka_Ch89.indd   486 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 505, 'page_label': '487'}, page_content='CHAPTER 89: Sepsis 487 \\nline is preferred b ut large peripheral lines may be used temporarily to \\nbegin treatment. Start norepinephrine 0.5 to 30 µg/min with a goal \\nmean arterial pressure of 65 mm Hg. Consider vasopressin 0.03 or 0.04 \\nU/min as a second-line agent.\\n4. Consider repeating a serum lactate level after 1 to 2 hours as one way to \\nassess restoration of adequate tissue oxygen perfusion.\\n5. Initiate appropriate broad-spectrum antibiotics based on the initial sus-\\npected source of sepsis (see Table 89-2). Empiric antibiotic therapy is \\nTable 89-2 Empiric Antibiotic Selection in Severe Sepsis and  \\nSeptic Shock\\nhost Likely pathogens Initial Antibiotic Selection\\nAdults (nonneutro-\\npenic) without an \\nobvious source of \\ninfection\\nStaphylococcus \\naureus, streptococci, \\ngram-negative bacilli, \\nothers\\nImipenem, 500 mg every 6 h to 1 g IV \\nevery 8 h\\nor\\nMeropenem, 1 g IV every 8 h\\nor\\nDoripenem, 500 mg IV every 8 h\\nor\\nErtapenem*, 1 g IV every 24 h \\nplus\\nVancomycin†, 15 mg/kg loading dose\\nAdults (nonneutro-\\npenic), suspected \\nbiliary source\\nAerobic gram-\\nnegative bacilli, \\nenterococci\\nAmpicillin/sulbactam, 3 g IV every 6 h\\nor\\nPiperacillin/tazobactam, 4.5 g IV every 6 h\\nor\\nTicarcillin/clavulanate, 3.1 g IV every 4 h\\nAdults (nonneutro-\\npenic), suspected \\npneumonia\\nStreptococcus pneu-\\nmoniae, methicillin-\\nresistant S. aureus, \\ngram-negative bacilli, \\nLegionella\\nCeftriaxone, 1–2 g IV every 12 h\\nplus\\nAzithromycin, 500 mg IV, then 250 mg  \\nIV every 24 h\\nplus\\nLevofloxacin, 750 mg IV every 24 h  \\nor moxifloxacin, 400 mg IV every 24 h\\nplus\\nVancomycin†, 15 mg/kg loading dose\\nAdults (nonneutro-\\npenic), suspected \\nillicit use of IV drugs\\nS. aureus Vancomycin†, 15 mg/kg loading dose\\nAdults with pete-\\nchial rash\\nNeisseria meningiti-\\ndis, RMSF\\nCeftriaxone, 2 g IV every 12 h\\nor\\nCefotaxime, 2 g IV every 4-6 h\\nConsider\\nAddition of doxycycline 100 mg IV every  \\n12 h for possible RMSF\\n(continued )\\n89_Cydulka_Ch89.indd   487 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 506, 'page_label': '488'}, page_content='488 SECTION 10: Infectious and Immunologic Diseases\\nTable 89-2 Empiric Antibiotic Selection in Severe Sepsis and  \\nSeptic Shock\\nhost Likely pathogens Initial Antibiotic Selection\\nAdults (nonneutro-\\npenic), suspected \\nintraabdominal \\nsource\\nMixture of aerobic \\nand anaerobic gram-\\nnegative bacilli\\nImipenem, 500 mg IV every 6 h to 1 g  \\nIV every 8 h\\nor\\nMeropenem, 1 g IV every 8 h\\nor\\nDoripenem, 500 mg IV every 8 h\\nor\\nErtapenem, 1 g IV every 24 h\\nor\\nAmpicillin/sulbactam, 3 g IV every 6 h\\nor\\nPiperacillin/tazobactam, 4.5 g IV every 6 h\\nAdults (nonneutro-\\npenic), suspected \\nurinary source \\n(hospitalized with \\npyelonephritis)\\nAerobic gram-\\nnegative bacilli, \\nenterococci\\nLevofloxacin, 750 mg IV every 24 h\\nor\\nMoxifloxacin, 400 mg IV every 24 h\\nor\\nPiperacillin/tazobactam, 4.5 g IV every 6 h\\nor\\nCeftriaxone, 1–2 g IV every 12–24 h\\nor\\nAmpicillin, 1–2 g IV every 4–6 h plus \\ngentamicin, 1.0–1.5 mg/kg every 8 h‡\\nAdults (nonneutro-\\npenic), suspected \\nurinary source \\n(complicated \\nurinary tract \\ninfection/urinary \\ncatheter)\\nEnterobacteriaceae, \\nPseudomonas aeru-\\nginosa, entero-cocci, \\nrarely S. aureus\\nPiperacillin/tazobactam, 4.5 g IV every 6 h\\nor\\nImipenem, 500 mg every 6 h to 1 g IV \\nevery 8 h\\nor\\nMeropenem, 1 g IV every 8 h\\nor\\nDoripenem, 500 mg IV every 8 h\\nor\\nAmpicillin, 1–2 g IV every 4–6 h plus \\ngentamicin, 1.0–1.5 mg/kg every 8 h‡\\nNeutropenic adults Aerobic gram-nega-\\ntive bacilli, especially \\nP . aeruginosa, S. \\naureus\\nCeftazidime, 2 g IV every 8 h\\nor\\nCefepime, 2 g IV every 8 h\\nor\\nImipenem, 500 mg IV every 6 h to 1 g  \\nIV every 8 h\\nor\\nMeropenem, 1 g IV every 8 h\\n(continued)\\n(continued )\\n89_Cydulka_Ch89.indd   488 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 507, 'page_label': '489'}, page_content='CHAPTER 89: Sepsis 489 \\nTable 89-2 Empiric Antibiotic Selection in Severe Sepsis and  \\nSeptic Shock\\nhost Likely pathogens Initial Antibiotic Selection\\nor\\nPiperacillin/tazobactam, 4.5 g IV every 6 h\\nplus\\nLevofloxacin, 750 mg IV every 24 h or  \\nmoxifloxacin, 400 mg IV every 24 h\\nplus\\nVancomycin†, 15 mg/kg loading dose \\nand consider\\nFluconazole, 400 mg IV every 24 h or \\nmicafungin, 100 mg every 24 h\\nPatients with sus-\\npected anaerobic \\nsource: intraab-\\ndominal, biliary, \\nfemale genital \\ntract infection; \\nnecrotizing cel-\\nlulitis; odontogenic \\ninfection; or \\nanaerobic soft tis-\\nsue infection\\nAnaerobic bacteria \\nplus gram-negative \\nbacilli\\nMetronidazole, 15 mg/kg IV load then  \\n7.5 mg/kg every 8 h#\\nor\\nClindamycin, 600–900 mg IV every 8 h\\nPatients with \\nindwelling vascu-\\nlar devices\\nCoagulase-negative \\nStaphylococcus, \\nmethicillin-resistant \\nS. aureus\\nVancomycin†, 15 mg/kg loading dose\\nPatients with \\npotential for \\nLegionella species \\ninfection\\nAzithromycin, 500 mg IV then 250 mg  \\nIV every 24 h\\nor\\nErythromycin, 800 mg IV every 6 h should \\nbe added to the regimen\\nAsplenic patients S. pneumoniae, \\nN. meningitidis, \\nHaemophilus influen-\\nzae, Capnocytophaga\\nCeftriaxone, 1 g IV every 24 h up to 2 g  \\nIV every 12 h if meningitis\\nAbbreviation: RMSF, Rocky Mountain spotted fever.\\n*Ertapenem has no antipseudomonal coverage and is not recommended in many intensive care units due \\nto concerns of potentiating pseudomonal antimicrobial resistance.\\n†In most communities in the United States, methicillin-resistant S. aureus colonization is extremely high, and \\nconsideration should be given to including vancomycin in addition to the antibiotic recommendations given in \\nthe table. Although initial vancomycin dosage is typically suggested at 15 mg/kg, this results in delayed time \\nto effective antimicrobial activity, and initial dosages of 25 to 30 mg/kg have been recommended by some \\nauthorities. If the patient has an allergy to vancomycin, linezolid 600 mg IV can be substituted.\\n‡Multiple daily dosing: 2 mg/kg load then 1.7 mg/kg every 8 hours.\\n#Metronidazole is often prepackaged as 500-mg bags. Dosing at 500 mg IV every 6 or 8 hours to approxi-\\nmate the mg/kg dosing may speed time to antibiotic administration by decreasing pharmacy mixing time.\\n(continued)\\n89_Cydulka_Ch89.indd   489 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 508, 'page_label': '490'}, page_content='490 SECTION 10: Infectious and Immunologic Diseases\\nideally begun after obtaining cultures, but administration should not be \\ndelayed if cultures are difficult to obtain.\\n6. Remove suspected sources of infection by assessing any indwelling \\ncatheters that could be removed and performing incision and drainage of \\nany identified abscesses.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 151, “Sepsis,” by Michael A. Puskarich and Alan E. \\nJones\\n89_Cydulka_Ch89.indd   490 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 509, 'page_label': '491'}, page_content='491\\nSoft Tissue Infections\\nJon Femling\\nSkin and soft tissue infections are common, and their successful evaluation \\nand management involve an understanding of disease severity. Infection \\nand patient characteristics help guide appropriate antibiotic treatment, out-\\npatient or inpatient options, and potential surgical therapy.\\n■ ■METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS\\nCommunity-acquired methicillin-resistant Staphylococcus aureus (MRSA) \\nis a common cause of soft tissue infections in adults and children. Under -\\nstanding treatment guidelines for community-acquired MRSA is important \\nfor managing soft tissue infections in the ED.\\nClinical Features\\nCommunity-acquired MRSA causes skin lesions that are typically warm, \\nred, tender, and commonly associated with soft tissue abscesses that may \\nbe spontaneously draining. MRSA lesions are frequently mistaken as \\nspider bites.\\nDiagnosis and Differential\\nThe diagnosis of MRSA is typically made based on clinical features. \\nConsider the likelihood of community-acquired MRSA for soft tissue \\ninfection where S. aureus or Streptococcus are typically considered com-\\nmon etiologic pathogens. This includes skin and soft tissue infections as \\nwell as sepsis and pneumonia. Bedside ultrasound may be helpful to \\nidentify abscess collections in cases where physical examination is \\nequivocal.\\nEmergency Department Care and Disposition\\n1. For many community-acquired MRSA cutaneous infections where \\nabscesses have developed, local incision and drainage is sufficient \\ntreatment to successfully manage these infections. Most patients with \\nnormal immune system function will not require additional treatment \\nwith antibiotics for small abscesses without accompanying cellulitis or \\nsystemic signs of severe illness when the lesions can be successfully \\nincised and drained.\\n2. For patients with immunocompromise, systemic illness, surrounding \\ncellulitis, or other characteristics prompting antibiotic treatment, con-\\nsider antibiotics effective against MRSA when appropriate. Options \\ninclude clindamycin 300 mg PO four times daily or trimethoprim/\\nsulfamethoxazole double strength two tablets twice a day for 7 to 10 \\ndays. Consider adding cephalexin 500 mg four times daily to cover \\nStreptococcus when using trimethoprim/sulfamethoxazole. For severe \\ninfections, vancomycin 1 g IV every 12 hours is recommended along \\nwith inpatient admission.\\n90\\nC HA p TER\\n90_Cydulka_Ch90.indd   491 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 510, 'page_label': '492'}, page_content='492 SECTION 10: Infectious and Immunologic Diseases\\n3. Patients at the extremes of age, or those who hav e systemic signs of \\nsevere illness, significant comorbidities, or large complicated lesions \\nmay benefit from an admission for parenteral antibiotics and surgical \\nconsultation when indicated.\\n■ ■NECROTIZING SOFT TISSUE INFECTIONS\\nNecrotizing soft tissue infections are aggressive and potentially life threat-\\nening infections. These infections can present with an insidious onset and \\nearly findings may appear deceptively benign. Necrotizing soft tissue infec-\\ntions represent a spectrum of conditions that may be polymicrobial or \\nmonomicrobial. Group A Streptococcus and S. aureus are often the etio-\\nlogic agents in monomicrobial infections. Clostridial infections are now \\nuncommon secondary to improved hygiene and sanitation.\\nClinical Features\\nPatients present with pain out of proportion to physical findings and a sense \\nof heaviness in the affected part. Physical findings may include a combina-\\ntion of edema, brownish skin discoloration, bullae, malodorous serosan-\\nguineous discharge, and crepitus. Patients may have low-grade fever and \\nassociated tachycardia out of proportion to the fever. Mental status changes, \\nincluding delirium and irritability, may accompany necrotizing soft tissue \\ninfections and are signs of systemic toxicity.\\nDiagnosis and Differential\\nFamiliarity with the disease and an appreciation for subtle physical findings \\nearly in its development are important factors in making the diagnosis of \\nnecrotizing soft tissue infections. Additional findings that may supplement \\nclinical suspicion include gas within soft tissue on plain radiographs, meta-\\nbolic acidosis, coagulopathy, hyponatremia, leukocytosis, anemia, throm-\\nbocytopenia, myoglobinuria, and renal or hepatic dysfunction.\\nEmergency Department Care and Disposition\\n1. When necrotizing infections are suspected, IV antibiotics should be \\nadministered as soon as possible including vancomycin  1 g IV every \\n12 hours plus meropenem 500 to 1000 mg IV every 8 hours. Alterna-\\ntively piperacillin/tazobactam 4.5 g IV every 6 hours may be used. \\nClindamycin inhibits toxin synthesis and may also be considered in \\nthe treatment regimen.\\n2. Patients with necrotizing soft tissue infections often need aggressive \\nresuscitation with crystalloid IV fluids. Consider blood transfusion with \\npacked red blood cells if significant anemia from hemolysis occurs.\\n3. Patients with necrotizing soft tissue infections can rapidly develop septic \\nshock. Patients with hypotension who also have compromised perfusion \\nin an affected extremity can present management challenges when vaso-\\nconstrictor use is considered.\\n4. Tetanus prophylaxis should be administered as indicated (see Chapter 94).\\n5. Obtain surgical consultation as soon as possible when necrotizing infec-\\ntions are suspected. Patients may require debridement, f asciotomy, or \\neven amputation. Potential roles for hyperbaric oxygen therapy or IV \\n90_Cydulka_Ch90.indd   492 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 511, 'page_label': '493'}, page_content='CHAPTER 90: Soft Tissue Infections 493 \\nimmunoglobulin remain controversial and may be considered in consul-\\ntation with surgical colleagues.\\n■ ■CELLULITIS\\nCellulitis is a subset of soft tissue infections characterized by a local soft \\ntissue inflammatory response caused by bacterial invasion of the skin. This \\ninfection is more common in the elderly, immunocompromised patients, \\nand patients with peripheral vascular disease.\\nClinical Features\\nCellulitis presents as localized tenderness, erythema, and induration of the \\nskin. Lymphangitis and lymphadenitis can accompany cellulitis and may \\nindicate a more severe infection. Patients may present with associated fever \\nand chills.\\nDiagnosis and Differential\\nHistory and physical examination are often sufficient to make the clinical \\ndiagnosis of cellulitis. Obtaining a white cell count or blood cultures rarely \\nchanges management of otherwise healthy patients with uncomplicated cel-\\nlulitis. Cellulitis of the lower extremity may sometimes mimic or be compli-\\ncated by deep venous thrombosis, and clinical uncertainty may prompt \\nadditional studies to evaluate for this possibility. In patients with signs of sys-\\ntemic toxicity, consider additional evaluation for an occult abscess using bed-\\nside ultrasound and/or cultures of blood and other suspected areas of infection.\\nEmergency Department Care and Disposition\\n1. Consider outpatient treatment of patients with uncomplicated cellulitis \\nin which MRSA is not suspected using cephalexin 500 mg PO four \\ntimes daily, dicloxacillin 500 mg PO four times daily, or clindamycin \\n300 PO mg four times daily.\\n2. When local epidemiology supports a high likelihood of MRSA, treat \\nwith antibiotics effectiv e against MRSA (see section \"Methicillin-\\nResistant Staphylococcus aureus\" above).\\n3. Recommend follow-up within a few days to e valuate the cellulitis and \\nresponse to therapy. Skin markers may be helpful to mark the extent of \\ncellulitis for serial evaluations of treatment success.\\n4. Admit patients with systemic toxicity or evidence of bacteremia to the \\nhospital for IV antibiotics. Consider risks of complications when mak-\\ning treatment decisions for patients with diabetes mellitus, alcoholism, \\nor other immunosuppressive disorders.\\n5. Initiate IV antibiotics, such as clindamycin 600 to 900 mg IV ev ery  \\n8 hours, cefazolin 1 to 2 g IV every 8 hours, or nafcillin 1 to 2 g IV \\nevery 4 hours for patients admitted for inpatient care.\\n■ ■ERYSIpELAS\\nErysipelas is a superficial cellulitis with associated lymphatic involvement \\nand is caused primarily by group A Streptococcus. Infection is often associ-\\nated with an initial portal of entry or break in the skin.\\n90_Cydulka_Ch90.indd   493 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 512, 'page_label': '494'}, page_content='494 SECTION 10: Infectious and Immunologic Diseases\\nClinical Features\\nOnset of this infection is often acute and characterized by sudden high \\nfever, chills, malaise, and nausea. Over 1 to 2 days, a small area of erythema \\nwith a burning sensation develops. The erythema of erysipelas is sharply \\ndemarcated from surrounding skin and is tense and painful. Lymphangitis \\nand lymphadenitis are common.\\nDiagnosis and Differential\\nThe diagnosis is based primarily on physical findings and history. \\nAlthough leukocytosis is common, white blood cell counts, cultures, \\nASO titers, and anti-DNase B titers are of limited use in an acute care \\nsetting. Differential diagnosis includes other forms of local cellulitis. \\nConsider surgical consultation for patients with bullae, crepitus, pain out \\nof proportion to examination, or rapidly progressing erythema with signs \\nof systemic toxicity, as these signs and symptoms may suggest necrotizing \\ninfection.\\nEmergency Department Care and Disposition\\nGuidelines no longer differentiate the treatment of nonpurulent cellulitis \\nfrom erysipelas. Patients with uncomplicated erysipelas can be treated with \\nantibiotics as detailed above for cellulitis.\\n■ ■CUTANEOUS ABSCESSES\\nCutaneous skin abscesses are frequently the result of a breakdown in the \\ncutaneous barrier, with a subsequent focal infection caused by resident \\nbacterial flora. Incision and drainage is often the only necessary treatment \\nfor simple skin abscesses.\\nClinical Features and Diagnosis\\nPatients present with an area of swelling, tenderness, and overlying ery-\\nthema. The area of swelling is often fluctuant. Cutaneous abscesses are \\nusually well-localized infections, although they may cause systemic toxic-\\nity in immunosuppressed patients. Evaluate cutaneous abscesses for predis-\\nposing injury or foreign bodies. Needle aspiration or bedside ultrasound \\nmay be useful when it is unclear whether a patient has an abscess or cel-\\nlulitis. There are several common abscess types with unique managements \\ndiscussed below.\\nEmergency Department Care and Disposition\\n1. Cutaneous skin abscesses can often be managed with local incision and \\ndrainage. In healthy, immunocompetent patients, the routine use of anti-\\nbiotics following abscess incision and drainage is typically not neces-\\nsary unless significant surrounding cellulitis or signs of severe disease \\nare present.\\n2. Bartholin gland abscess presents as unilateral painful swelling of the \\nlabia with a fluctuant 1 to 2 cm mass. Routine antimicrobial treatment is \\ntypically not necessary unless there is a suspicion of se xually transmit-\\nted disease. Treatment involves incision and drainage along the vaginal \\n90_Cydulka_Ch90.indd   494 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 513, 'page_label': '495'}, page_content='CHAPTER 90: Soft Tissue Infections 495 \\nmucosal surface of the abscess, generally followed by the insertion of a \\nWord catheter. The Word catheter can be left in place for up to 4 weeks. \\nSitz baths are recommended after 2 days. Follow-up with gynecology is \\nrecommended within 2 days in patients with severe symptoms and \\nwithin 1 week in patients with mild symptoms.\\n3. Hidradenitis suppurativa is a recurrent chronic infection involving  \\nthe apocrine sweat glands and commonly occurs in the axilla and \\ngroin. Acute abscesses can be treated with incision and drainage. \\nRefer patients with recurrent disease to a surgeon for definitive \\ntreatment.\\n4. Infected epidermoid and pilar cysts are erythematous, tender, cutaneous \\nnodules that are often fluctuant. Perform a simple incision and drainage \\nand recommend wound rechecks in 2 to 3 days. The cyst contains a \\ncapsule that must be removed to prevent recurrence, and this capsule \\nexcision is typically done at a later follow-up visit.\\n5. Pilonidal abscess presents as a tender, swollen, and fluctuant mass  \\nalong the superior gluteal fold. Treatment in the acute care setting \\nincludes incision and drainage and the patient should be rechecked  \\nin 2 to 3 days. Surgical referral is usually necessary for definitive \\ntreatment.\\n6. Folliculitis is characterized by pruritic erythematous lesions that are \\nusually <5 mm in diameter , with pustules sometimes present at the \\ncenters. These inflamed hair follicles are usually caused by bacterial \\ninvasion with S. aureus. The lesions usually resolve spontaneously with \\nsymptomatic care, but can be treated with warm compresses or topical \\nantibiotics such as bacitracin. For painful or more extensive cases, oral \\nantibiotics such as cephalexin, dicloxacillin, or azithromycin are \\nrecommended.\\n■ ■SpOROTRICHOSIS\\nSporotrichosis is caused by traumatic inoculation of the fungus Sporothrix \\nschenckii, which is commonly found on plants and in the soil.\\nClinical Features\\nAfter a 3-week incubation period, three types of infection may occur. The \\nfixed cutaneous type of infection occurs at the site of inoculation and \\nlooks like a crusted ulcer or verrucous plaque. The local cutaneous type \\nalso remains at the site of inoculation but presents as a subcutaneous \\nnodule or pustule with surrounding erythema. The lymphocutaneous type \\nis the most common of the three and presents as a painless nodule at the \\nsite of inoculation with subcutaneous nodules that migrate along lym-\\nphatic channels.\\nDiagnosis and Differential\\nThe diagnosis of sporotrichosis is based on the history and physical exam-\\nination. Tissue biopsy cultures are often diagnostic but of limited use in the \\nacute care setting. The differential diagnosis includes tuberculosis, tulare-\\nmia, cat-scratch disease, leishmaniasis, nocardiosis, and staphylococcal \\nlymphangitis.\\n90_Cydulka_Ch90.indd   495 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 514, 'page_label': '496'}, page_content='496 SECTION 10: Infectious and Immunologic Diseases\\nEmergency Department Care and Disposition\\n1. Itraconazole 100 to 200 mg/d PO for 3 to 6 months is highly effective \\nwhen treating localized or systemic sporotrichosis.\\n2. Most cases of cutaneous sporotrichosis can be treated on an outpatient \\nbasis. Patients who have systemic symptoms or who are acutely ill with \\ndisseminated disease should be admitted for possible treatment with \\namphotericin B 0.5 mg/kg/d.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 152, “Soft Tissue Infections,” by Elizabeth W. Kelly \\nand David Magilner.\\n90_Cydulka_Ch90.indd   496 20/04/17   2:56 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 515, 'page_label': '497'}, page_content='497\\nSerious Viral Infections\\nMatthew J. Scholer\\nViral illnesses are among the most common reasons that people come to an \\nemergency department. Although many viral illnesses are self-limited, \\nsome can be life-threatening, have specific treatments, or have public health \\nimplications. This chapter reviews some of the more common specific viral \\ninfections.\\n■ ■INFLUENZA\\nInfluenza infections occur worldwide with peak activity found in temperate \\nclimates between late December and early March. Influenza virus is trans-\\nmitted by aerosolized or droplet transmission from the respiratory tract of \\ninfected persons or by direct contact. After exposure, the incubation period \\nis about 1 to 4 days, and viral shedding begins 24 hours before the onset of \\nsymptoms.\\nClinical Features\\nSymptoms of influenza are often abrupt in onset and include fever with \\nchills or rigors, headache, myalgia, and generalized malaise. Additional \\nsymptoms may include cough, rhinorrhea, sore throat, and tender, enlarged \\ncervical lymph nodes. Elderly patients may not have classic symptoms and \\ncan present with only fever, malaise, confusion, and/or nasal congestion. \\nAlmost 50% of affected children have associated gastrointestinal symp-\\ntoms, but these are unusual in adults. Fever generally lasts 2 to 4 days, \\nfollowed by recovery from most of the systemic symptoms within 3 to  \\n7 days. Cough and malaise may persist for several weeks.\\nRespiratory complications of acute infection include primary influenza \\npneumonitis, secondary bacterial pneumonia, croup, and exacerbation of \\nchronic obstructive pulmonary disease. Avoid aspirin use in patients with \\nsuspected or confirmed influenza due to an association with Reye’s \\nsyndrome. Other uncommon complications include Guillain–Barré syn-\\ndrome, myocarditis, and pericarditis.\\nDiagnosis and Differential\\nA clinical diagnosis of influenza during a known outbreak can be made \\nusing history and physical examination. Rapid antigen assays can give \\nresults within 15 minutes but have variable sensitivity (10% to 80%) that \\ncan result in higher levels of false-negative results when influenza activity \\nis high. Although specificity is high (90% to 95%), false-positive results \\ncan also occur, especially when influenza activity is low. Molecular \\ndiagnostic tests are available and are more sensitive and specific than \\nantigen tests.\\nDuring influenza season, consider diagnostic testing in the outpatient \\nsetting for immunocompetent patients at high risk for influenza complica-\\ntions and within 5 days of symptom onset, and in immunocompromised \\npatients regardless of time since illness onset. Many hospitals implement \\n91\\nCh A pt E r\\n91_Cydulka_Ch91.indd   497 20/03/17   9:43 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 516, 'page_label': '498'}, page_content='498 SECTION 10: Infectious and Immunologic Diseases\\nprotocols for influenza testing of patients admitted with respiratory disease. \\nOnce influenza has been documented in the local community, influenza \\ntesting is not typically indicated for otherwise healthy outpatients with \\nsigns and symptoms consistent with influenza, especially during the peak \\nof activity.\\nEmergency Department Care and Disposition\\n1. The majority of healthy patients with acute influenza infections will \\nhave self-limited, uncomplicated illnesses that can be successfully \\ntreated with symptomatic care measures in an outpatient setting.\\n2. Patients with more severe systemic symptoms or comorbid conditions \\nmay require inpatient care with IV fluids, respiratory support, neur -\\naminidase inhibitors, and occasionally vasopressors or other critical care \\ninterventions.\\n3. Treat patients with secondary pneumonia associated with influenza \\ninfections with antibiotics that cover methicillin-resistant S. aureus.\\n4. Treatment with neuraminidase inhibitors is generally recommended for \\nany patient with suspected influenza who is hospitalized, has sev ere, \\ncomplicated or progressive illness, or is at higher risk for influenza \\ncomplications. Use of these agents for otherwise healthy adults and \\nchildren continue to be debated, and clinical benefit is likely limited to \\npatients treated within 48 hours of symptom onset.\\n5. The most commonly used oral antiviral medication for treating influenza \\nis oseltamivir 75 mg by mouth twice daily for 5 days in uncomplicated \\ndisease. Zanamivir is an inhaled medication that may cause broncho-\\nspasm and should be avoided in patients with underlying pulmonary \\ndisease. Peramivir 600 mg IV is the only intravenous antiviral medica-\\ntion approved for the treatment of influenza.\\n6. Current Centers for Disease Control and Prevention (CDC) guidelines \\nfor the diagnosis and treatment of influenza can be accessed at their \\nwebsite www.cdc.gov/flu.\\n■ ■hErpES SIMpLEX VIrUS\\nTransmission of herpes simplex virus (HSV) occurs by contact of mucous \\nmembranes or open skin with infected bodily fluids from patients with \\nulcerative lesions or infected individuals who are shedding the virus with-\\nout overt disease.\\nClinical Features\\nHSV-1 infection most commonly results in orolabial lesions, whereas \\nHSV-2 is most often found in genital herpes. Primary HSV infections typi-\\ncally produce more extensive lesions involving mucosal and extramucosal \\nsites, often accompanied by systemic signs and symptoms. Gingivostoma-\\ntitis and pharyngitis for 1 to 2 weeks are typical manifestations of primary \\nHSV-1 infection, and these lesions are small thin-walled vesicles on an \\nerythematous base within the mouth. In children younger than 5 years, \\nlesions can be associated with fever and cervical lymphadenopathy. Recur-\\nrent HSV-1 infections are typically milder and present as herpes labialis on \\nthe lower lip at the outer vermilion border.\\n91_Cydulka_Ch91.indd   498 20/03/17   9:43 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 517, 'page_label': '499'}, page_content='CHAPTER 91: Serious Viral Infections 499 \\nLess common manifestations of HSV infection include herpetic whit-\\nlow on a finger or herpes gladiatorum else where on the body in wrestlers \\nand other athletes involved in close contact sports. Herpetic keratitis \\npresents as a painful, red eye, and can be identified by characteristic den-\\ndritic lesions on fluorescein slit lamp exam. Either HSV-1 or HSV-2 can \\ncause genital lesions, and while genital HSV-2 is more common and has \\na higher relapse rate, the proportion of genital disease caused by HSV-1 \\nis increasing.\\nHSV infection within the central nervous system (CNS) is one of the \\nmost common viral causes of encephalitis in the United States. This occurs \\nmost commonly in patients between 20 and 50 years of age and HSV \\nencephalitis carries a mortality rate >70% if left untreated. HSV encepha-\\nlitis is associated with fever and neurologic symptoms such as focal motor \\nor cranial nerve deficits, ataxia, seizures, altered mental status, or behav-\\nioral abnormalities. Meningitis can occur in up to 25% of females with \\nprimary HSV-2 infections, although this typically has a benign course. \\nHSV infections in immunocompromised hosts can lead to widespread dis-\\nsemination with multi-organ involvement.\\nDiagnosis and Differential\\nThe diagnosis and initial treatment of suspected HSV infection is often \\nbased on clinical findings, as confirmatory testing may take days or weeks \\nbefore results are available. Because mucocutaneous HSV infection is a \\nlifelong condition, laboratory testing is often recommended for confirma-\\ntion. Viral culture can be obtained from an unroofed vesicle, or polymerase \\nchain reaction or direct fluorescent antibody testing can be performed on \\nswabbed tissue. A Tzanck test is generally not useful.\\nConsider the possibility of HSV infection in patients with suspected \\ninfection of the CNS, particularly in patients with altered mental status, \\ncognitive deficits, psychiatric symptoms, or seizures (see Chapter 148, \\n“Central Nervous System and Spinal Infections”). Temporal lobe lesions on \\nCT scan or MRI are suggestive of HSV encephalitis and cerebrospinal fluid \\nanalysis may demonstrate a lymphocytic pleocytosis and/or erythrocytosis. \\nPCR testing of spinal fluid is the testing modality of choice for HSV when \\nsuspected, and the viral DNA can be detected within the first 24 hours, with \\nresults remaining positive for a week or longer.\\nEmergency Department Care and Disposition\\n1. Treat severe systemic HSV infections, including suspected CNS infec -\\ntion or disseminated disease, with acyclovir 10 mg/kg IV every 8 hours. \\nAdjust dosing for immunocompromised patients with severe mucocuta-\\nneous involvement to acyclovir 5 mg/kg IV every 8 hours based on ideal \\nbody weight.\\n2. Treat mild to moderate HSV infection in immunocompetent patients \\nwith oral acyclovir  400 mg three times a day, valacyclovir 1000 mg \\nevery 12 hours, or famciclovir 250 mg three times a day. Treatment is \\nmost effective when initiated within 48 to 72 hours of symptom onset \\nand is typically continued for 7 to 10 days.\\n3. Treat recurrent HSV with or acyclovir  400 mg three times a day for  \\n5 days, valacyclovir 2000 mg every 12 hours for 1 day (labialis) or  \\n91_Cydulka_Ch91.indd   499 20/03/17   9:43 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 518, 'page_label': '500'}, page_content='500 SECTION 10: Infectious and Immunologic Diseases\\n500 mg every 12 hours for 3 days (genital), or famciclovir 1500 mg for \\none dose (orolabial) or 1000 mg for one dose (genital). Less severe \\noutbreaks may be treated with topical 5% acyclovir ointment applied \\nsix times per day for 7 days.\\n■ ■VArICELLA AND hErpES ZOStEr\\nVaricella zoster virus (VZV) is the causative organism for both varicella \\n(chickenpox) and herpes zoster (shingles) infections. Herpes zoster is reac-\\ntivation of the latent virus within a dorsal root ganglion that can occur with \\na waning immune response due to advancing age or immunosuppression. \\nThe presence of herpes zoster in an otherwise young and healthy person \\nmay be a sign of HIV infection or other immunosuppressive disorder.\\nClinical Features\\nPrimary varicella infection is a febrile illness with a superficial vesicular \\nrash that appears in crops and is concentrated on the torso and face. Lesions \\nare typically at varying stages of development, including papules, vesicles, \\nand crusted lesions. Headache, malaise, and loss of appetite are often pres-\\nent. Most infections are minor and self-limited with lesions crusting over \\nand sloughing off after 1 to 2 weeks. Varicella is contagious until all of the \\nlesions have crusted over.\\nComplications are more common in very young and very old patients \\nand those with immunocompromise. Bacterial infections of skin lesions, \\noften with group A streptococci, can cause serious illnesses including nec-\\nrotizing fasciitis. CNS complications such as cerebellar ataxia, meningitis, \\nand meningoencephalitis have been described. Infection of cerebral arteries \\nresulting in vasculopathy and stroke may also occur. Pneumonitis can be \\nsevere and is more common in pregnant women.\\nHerpes zoster causes lesions similar to those of a primary varicella \\ninfection but that occur in a unilateral and dermatomal distribution on the \\nskin. A prodrome of malaise, headache, and photophobia may occur with \\nlocalized pain, itching, and parasthesias preceding the outbreak of the rash. \\nAlthough any dermatomal level may be affected, involvement of the tri-\\ngeminal or thoracic dermatomes are common. Ocular involvement with \\nherpes zoster ophthalmicus may occur when the ophthalmic distribution of \\nthe trigeminal nerve is involved (see Chapter 149, “Ocular Emergencies”), \\nand is associated with zoster lesions on the tip or side of the nose (Hutchin-\\nson’s sign). Consider ophthalmology consultation when these are present or \\na patient has facial lesions with associated eye symptoms.\\nHerpes zoster lesions typically last about 2 weeks but may persist for a \\nmonth. Postherpetic neuralgia is pain that continues 30 days after the initial \\neruption and occurs more often with advancing age. Rash involving multi-\\nple dermatomes or crossing the midline may represent disseminated dis-\\nease, which can occur in immunocompromised patients when the virus \\nspreads to visceral organs to cause pneumonitis, hepatitis, or encephalitis.\\nDiagnosis and Differential\\nMost cases of varicella infection can be diagnosed with history and physi-\\ncal examination findings. Laboratory diagnosis with viral culture, antigen \\n91_Cydulka_Ch91.indd   500 20/03/17   9:43 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 519, 'page_label': '501'}, page_content='CHAPTER 91: Serious Viral Infections 501 \\ntesting, or PCR testing of vesicle fluid may be appropriate in patients with \\natypical illness or severe disease. Although smallpox has been eradicated, \\nit remains a potential threat as a biologic weapon, and the lesions could be \\nconfused with those of varicella. The lesions of smallpox are larger, distrib-\\nuted more on the extremities, and all lesions are at the same stage of devel-\\nopment. Obtain a chest radiograph if pneumonitis is suspected. Consider \\nadvanced testing when CNS infection is suspected, which may include an \\nMRI of the brain, lumbar puncture, and/or PCR testing.\\nEmergency Department Care and Disposition\\n1. Provide supportive care for health y children with primary varicella \\ninfection. Oral acyclovir 20 mg/kg (maximum dose of 800 mg) five \\ntimes a day for 5 days may be considered for high-risk patients such as \\nchildren >12 years of age, adults, those with chronic skin or pulmonary \\ndisorders, those receiving long-term salicylate therapy, and immuno-\\ncompromised patients.\\n2. Antiviral agents for the treatment of herpes zoster will hasten lesion \\nresolution, reduce new lesions, reduce viral shedding, and decrease \\nacute pain. Use of antiviral therap y in immunocompromised patients \\nmay reduce the risk of disseminated disease. Ideally begin antiviral \\nmedication within 72 hours of the onset of rash, although treatment can \\nbe considered at >72 hours if new vesicles are developing. Treat with a \\n7- to 10-day course of oral acyclovir 800 mg five times per day, valacy-\\nclovir 1 g three times daily or famciclovir 500 mg three times daily.\\n3. Provide appropriate analgesia for patients with herpes zoster, as lesions \\ncan be very painful.\\n4. Treat immunocompromised patients with acute varicella infections, \\nsevere herpes zoster outbreaks, visceral involvement, or disseminated \\ndisease with acyclovir 10 mg/kg IV every 8 hours.\\n■ ■EpStEIN–BArr VIrUS INFECtION\\nEpstein–Barr virus (EBV) is the causative agent of heterophile-positive \\ninfectious mononeucleosis. EBV infection is also associated with cancers \\nsuch as B-cell lymphoma, Hodgkin’s disease, Burkitt’s lymphoma, and \\nnasopharyngeal carcinoma.\\nClinical Features\\nTransmission of EBV is via salivary secretions. Close contact is required \\nfor transmission, often from an asymptomatic individual. Clinical mani-\\nfestations depend on age and immune status with peaks of infection in \\nearly childhood and young adulthood. Infants and young children are \\noften asymptomatic or have only mild pharyngitis. Teenagers and young \\nadults can develop infectious mononucleosis, which presents with fever, \\nlymphadenopathy, and pharyngitis with tonsillar exudates. Splenomegaly \\noccurs in more than half of patients. Symptoms generally resolve over  \\n2 to 3 weeks, and most patients recover uneventfully.\\nEpstein–Barr virus can affect nearly all organ systems. Neurologic com-\\nplications such as encephalitis, meningitis, and Guillain–Barré syndrome \\nhave been described. Hepatitis, myocarditis, and hematologic disorders are \\n91_Cydulka_Ch91.indd   501 20/03/17   9:43 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 520, 'page_label': '502'}, page_content='502 SECTION 10: Infectious and Immunologic Diseases\\nalso known complications. Rarely death results from splenic rupture, CNS \\ncomplications, and airway obstruction.\\nDiagnosis and Differential\\nWhen infectious mononeucleosis is suspected based on history and physi -\\ncal exam, consider a CBC and a monospot test to provide confirmation, \\nwhen indicated. Lymphocytosis with >50% lymphocytes and presence of \\natypical lymphocytes are suggestive of the diagnosis. The monospot test \\nmay be negative early in the course of disease, and repeat testing later in \\nthe course of illness may be helpful when the diagnosis remains uncertain.\\nEmergency Department Care and Disposition\\n1. Rest and analgesia are the mainstays of therapy for EBV infections.\\n2. Use of corticosteroids is associated with increased complications and is \\nrecommended only for patients with severe disease, such as upper air -\\nway obstruction, neurologic disease, or hemolytic anemia.\\n3. Advise patients to avoid all contact sports for a minimum of 3 weeks \\nafter illness onset to avoid splenic injury.\\n■ ■MEASLES\\nMeasles is caused by an RNA virus that is highly infectious and is com-\\nmunicable before symptoms begin. Measles outbreaks have occurred \\nrecently in communities where children are not appropriately vaccinated.\\nClinical Features\\nAcute measles infection occurs with fever, malaise, cough, runny nose, and \\nconjunctivitis. Small, white Koplik’s spots appear on the buccal mucosa \\nearly in the illness, followed by a red maculopapular rash that typically \\nbegins on the head and spreads throughout the body.\\nDiagnosis and Differential\\nThe diagnosis of measles is typically made based on clinical findings such \\nas the pathognomonic Koplik’s spots and characteristic rash. Confirmatory \\ntesting can be done by detection of immunoglobulin M antibodies.\\nEmergency Department Care and Disposition\\n1. Treatment for measles is supportive care, with particular attention to \\nensuring adequate nutrition, especially vitamin A intake.\\n2. Report suspected measles cases to the local health department. Coordi-\\nnate with health department officials to identify and offer post-exposure \\nprophylaxis to unvaccinated contacts when appropriate.\\n3. See http://www.cdc.gov/measles/hcp/ for current CDC guidelines for \\nthe diagnosis and treatment of measles.\\n■ ■ArBOVIrAL INFECtIONS\\nArboviral infections are spread by mosquito, tick, and fly bites with \\nincreased incidence in warmer months due to the breeding patterns of these \\narthropod vectors. West Nile virus and the viruses that cause La Cross \\n91_Cydulka_Ch91.indd   502 20/03/17   9:43 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 521, 'page_label': '503'}, page_content='CHAPTER 91: Serious Viral Infections 503 \\nencephalitis, St. Louis encephalitis, eastern equine encephalitis, and west-\\nern equine encephalitis are found in North America. Other significant \\narboviral diseases are discussed in Chapter 98, “World Travelers.”\\nClinical Features\\nMost arbovirus infections are either asymptomatic or cause a nonspecific \\nmild illness. Only a few infected individuals will develop hemorrhagic \\nfever or encephalitis. Severe human arboviral diseases most commonly \\nmanifest as one of four syndromes: fever and myalgia, arthritis and rash, \\nencephalitis, and hemorrhagic fever. Headache is a common symptom of \\nmost arboviral infections. Hemorrhagic fever presents with bleeding from \\nthe gums, petechiae, and the gastrointestinal tract. The classic presenta-\\ntion of viral encephalitis is fever, headache, and altered level of conscious-\\nness. Patients can be lethargic and confused, and occasionally present \\nwith seizures.\\nDiagnosis and Differential\\nObtaining a detailed travel and exposure history and knowing local epide-\\nmiologic patterns can help when arboviral infections are suspected. Con-\\nsider neuroimaging as a component of hospitalization for patients diagnosed \\nwith encephalitis, recognizing that MRI is more sensitive and may show \\nfoci of increased signal intensity. Cerebrospinal fluid typically shows a \\nlymphocytic pleocytosis and a slightly elevated protein level, although \\nthese findings are nonspecific. Serologic testing is the primary method for \\nconfirming arboviral infections.\\nEmergency Department Care and Disposition\\n1. Supportive and symptomatic therapy is the mainstay of management for \\narboviral infections. Specific antiviral drugs, interferon, and steroids \\nhave not been shown to be useful.\\n2. Early in the course of suspected encephalitis, patients may be treated \\nwith empiric antibiotics and acyclo vir to cover for possible bacterial \\ninfection or HSV encephalitis until confirmatory testing is complete.\\n3. Admit most patients with acute encephalitis to the hospital for support-\\nive care and additional diagnostic testing.\\n■ ■EBOLA VIrUS AND OthEr hEMOrrhAGIC FEVErS\\nViral hemorrhagic fevers are rare diseases that can elicit tremendous fear \\namong the public and health care providers, exemplified by the large Ebola \\nvirus outbreak in West Africa in 2014. Other examples of hemorrhagic \\nfever include hantavirus pulmonary syndromes and Lassa fever.\\nClinical Features\\nViral infections leading to hemorrhagic fever illnesses typically begin with \\nnonspecific symptoms such as fever, myalgia, and malaise. Progression of \\ndisease leads to gastrointestinal and other organ system involvement, where \\nincreased vascular permeability leads to hypotension, pulmonary edema, \\nand renal failure. Abnormalities in the coagulation pathways lead to diffuse \\nhemorrhage with extensive bleeding, organ dysfunction, and shock.\\n91_Cydulka_Ch91.indd   503 20/03/17   9:43 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 522, 'page_label': '504'}, page_content='504 SECTION 10: Infectious and Immunologic Diseases\\nDiagnosis and Differential\\nTravel to endemic areas of the world and/or contact with a known infected \\ntraveler are important clues when suspecting Ebola or other hemorrhagic \\nfever illnesses. Confirm these rare infections using acute serologic testing \\nto identify antibodies or reverse transcriptase polymerase chain reaction of \\nthe virus. These tests are typically performed at specialized laboratories \\nsuch as the CDC.\\nEmergency Department Care and Disposition\\n1. Prepare for patients with possible Ebola or other severe viral hemor -\\nrhagic fever illnesses by initiating appropriate screening at triage. \\nPatients who have recently traveled to endemic areas who present with \\nfever or symptoms suspicious for these illnesses should be appropri-\\nately isolated.\\n2. Use full contact and droplet precautions including gown, gloves, and \\nfacemask with eye protection, as these viruses are spread via contact \\nwith infected body fluids such as blood, vomit, and diarrhea.\\n3. Instruct staff for proper donning and removal of protective equipment to \\navoid contamination with bodily fluids.\\n4. Contact appropriate public health or ganizations when these uncommon \\ninfections are clinically suspected. Notify the hospital laboratory to take \\nproper precautions with patient specimens that will need to be sent to \\nspecialized labs.\\n5. Provide supportive care for suspected Ebola and most other viral hemor-\\nrhagic fevers using IV fluids, renal replacement, and respiratory support. \\nExperimental serologic treatments and vaccines are under development.\\n■ ■FUrthEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 153, “Serious Viral Infections,” by Sukhjit S. Takhar \\nand Gregory J. Moran.\\n91_Cydulka_Ch91.indd   504 20/03/17   9:43 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 523, 'page_label': '505'}, page_content='505\\nHIV Infection and AIDS\\nSarah Battistich\\nThe human immunodeficiency virus (HIV) and Acquired Immunodefi-\\nciency Syndrome (AIDS) remain a major cause of infectious disease deaths \\nworldwide. Despite decades of diagnostic and therapeutic advances, \\nincreased life expectancies from highly active antriretrovirals are in general \\nlimited to high-income industrialized countries, and morbidity and mortal-\\nity around the world remains high. The pandemic continues to significantly \\nimpact affect Sub-Saharan Africa, where heterosexual transmission is \\ncommon and as many as 1 in 20 individuals live with HIV and AIDS. In the \\nUnited States, there are approximately 50,000 new cases annually, with \\nhigher incidences in men who have sex with men and young minority \\npopulations.\\n■ ■CLINICAL FEATURES\\nHuman immunodeficiency virus is a cytopathic retrovirus that selectively \\nattacks host cells involved in immune function, primarily CD4+ T cells. \\nInfection ultimately results in persistent defects in cellular immunity which \\npermit the development of opportunistic infections and neoplasms. Up to \\n90% of newly infected individuals have symptoms at the time of an acute \\nHIV infection, most commonly nonspecific influenza-like symptoms that \\ncan go unrecognized. Symptoms usually develop 2 to 4 weeks after expo-\\nsure, and can last for 2 to 10 weeks. The most common symptoms include \\nfever (>90%), fatigue (70% to 90%), sore throat (>70%), rash (40% to 80%),  \\nheadache (30% to 80%), and lymphadenopathy (40% to 70%).\\nSeroconversion, which occurs when there is a detectable antibody \\nresponse to HIV , usually occurs 3 to 8 weeks after infection, although \\ndelays of up to 11 months have been reported. This is followed by a long \\nperiod of asymptomatic infection. The mean incubation time from exposure \\nto the development of AIDS in untreated patients is 8 years in adults and  \\n2 years in children under 5 years of age.\\nEarly symptomatic infection, when CD4 cell counts are 200 to \\n500 cells/mm3, is characterized by conditions that are more common and \\nmore severe in the presence of HIV infection but are not AIDS-defining \\nconditions. Examples include thrush, persistent vulvovaginal candidiasis, \\nperipheral neuropathy, cervical dysplasia, recurrent herpes zoster, and \\nidiopathic thrombocytopenic purpura. As the CD4 count drops below \\n200 cells/mm3, the frequency of opportunistic infections increases. AIDS is \\ndefined by the appearance of any indicator condition (Table 92-1) or a CD4 \\ncount lower than 200 cells/mm3. Late symptomatic or advanced HIV infec-\\ntion exists in patients with a CD4 count lower than 50 cells/mm3 or clinical \\nevidence of end-stage disease, including disseminated Mycobacterium \\navium complex (MAC) or disseminated Cytomegalovirus (CMV).\\nAntiretroviral regimens are effective in suppressing viral loads and \\nmaintaining normal CD4 counts, which has favorably changed the long-\\nterm prognosis and impact of HIV infection for patients who take these \\n92\\nCh A p TER\\n92_Cydulka_Ch92.indd   505 20/03/17   11:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 524, 'page_label': '506'}, page_content='506 SECTION 10: Infectious and Immunologic Diseases\\nTAble 92-1 Stage 3 AIDS-Defining Opportunistic Illnesses in hIV Infection\\nBacterial infections, multiple or recurrent*\\nCandidiasis of bronchi, trachea, or lungs\\nCandidiasis of esophagus\\nCervical cancer, invasive†\\nCoccidioidomycosis, disseminated or extrapulmonary\\nCryptococcosis, extrapulmonary\\nCryptosporidiosis, chronic intestinal (>1 month in duration)\\nCytomegalovirus disease (other than liver, spleen, or nodes), onset at age >1 month\\nCytomegalovirus retinitis (with loss of vision)\\nEncephalopathy attributed to HIV\\nHerpes simplex: chronic ulcers (>1 month in duration) or bronchitis, pneumonitis,  \\nor esophagitis (onset at age >1 month)\\nHistoplasmosis, disseminated or extrapulmonary\\nIsosporiasis, chronic intestinal (>1 month in duration)\\nKaposi’s sarcoma\\nLymphoma, Burkitt’s (or equivalent term)\\nLymphoma, immunoblastic (or equivalent term)\\nLymphoma, primary, of brain\\nMycobacterium avium complex or Mycobacterium kansasii, disseminated or extrapulmonary\\nMycobacterium tuberculosis of any site, pulmonary,† disseminated, or extrapulmonary\\nMycobacterium, other species or unidentified species, disseminated or extrapulmonary\\nPneumocystis jirovecii (previously known as Pneumocystis carinii) pneumonia\\nPneumonia, recurrent†\\nProgressive multifocal leukoencephalopathy\\nSalmonella septicemia, recurrent\\nToxoplasmosis of brain, onset at age >1 month\\nWasting syndrome attributed to HIV\\n*Only among children aged <13 years. (CDC. 1994. Revised classification system for human immunode-\\nficiency virus infection in children less than 13 years of age. MMWR. 1994;43 [No. RR-12].)\\n†Only among adults and adolescents aged >13 years. (CDC. 1993. Revised classification system for HIV \\ninfection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR. \\n1992;41 [No. RR-17].)\\nmedications. Access to medical care, patient compliance, and financial \\nresources to obtain medications are identified barriers to effective treat-\\nment in many parts of the world.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nHIV infection can be diagnosed by identifying HIV nucleic acid, detecting \\nviral-specific antigen, detecting antibodies to HIV , or isolating the virus by \\nculture. Mean times from transmission to detection are shortest for viral \\nload (17 days), followed by p24 antigen (22 days), enzyme-linked immu-\\nnosorbent assay positivity (25 days), and Western blot positivity (31 days). \\nAlthough viral load assays are not always available in the ED, rapid tests \\nfor the detection of the p24 viral antigen enable earlier detection of \\ninfection than relying on the development of antibody response alone. The \\ncurrent recommended testing method is detection of antibodies to HIV-1/2 \\ncombined with detection of the viral-specific p24 antigen.\\nAlthough acute HIV infection is not diagnosed in up to 75% of cases, \\nbenefits of early detection include the opportunity to limit transmission \\nto others and for individuals to start antiretroviral medications early. \\n92_Cydulka_Ch92.indd   506 20/03/17   11:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 525, 'page_label': '507'}, page_content='CHAPTER 92: HIV Infection and AIDS 507 \\nThe spectrum of disease caused by HIV infection varies, from those with \\nasymptomatic infection to those seeking care from involvement of any organ \\nsystem. In the assessment of patients with known HIV , knowledge of recent \\nCD4 count and HIV viral load can help with management, as CD4 counts \\nbelow 200 cells/mm3 and viral load greater than 50,000 copies/mL are asso-\\nciated with an increased risk of AIDS-defining illness. When these levels \\nare unavailable, a total lymphocyte count of <1700 cells/mm 3 is strongly \\npredictive of a CD4 count of <200 cells/mm 3.\\nFebrile Illness\\nSystemic symptoms such as fever, weight loss, and malaise are common \\nin HIV-infected patients and account for the majority of HIV-related ED \\npresentations. Laboratory investigation may include electrolytes, com-\\nplete blood count, blood cultures, urinalysis and culture, liver function \\ntests, and chest radiographs in the appropriate clinical settings. Selected \\npatients may benefit from specific serologic testing for syphilis, crypto-\\ncoccosis, toxoplasmosis, cytomegalovirus (CMV), and coccidioidomy-\\ncosis. Consider lumbar puncture after neuroimagingwhen CNS infection \\nis suspected.\\nIn HIV patients without specific signs or symptoms to localize the \\nsource of fever, common causes can vary by stage of disease. Patients with \\nCD4 counts higher than 500 cells/mm3 generally have febrile illnesses from \\nsources similar to those in nonimmunocompromised patients. Those with \\nCD4 counts between 200 and 500 cells/mm3 are more likely to have bacte-\\nrial respiratory infections. For patients with CD4 counts lower than \\n200 cells/mm 3, infections without localizing symptoms or findings can \\ninclude Pneumocystis jirovecii pneumonia (PCP), Mycobacterium avium \\ncomplex (MAC), Mycobacterium tuberculosis (TB), CMV , drug fever, and \\nsinusitis. Other causes may include endocarditis (see Chapter 93), \\nlymphoma, Histoplasma capsulatum, and Cryptococcus neoformans. Fever \\ncaused by the primary HIV infection itself tends to occur in the afternoon \\nor evening and is generally responsive to antipyretics.\\nImmune reconstitution inflammatory syndrome mimics an autoim-\\nmune event, with fever, lymphadenitis, and systemic symptoms that begin \\nweeks to months after starting antiretroviral treatment and often associ-\\nated with tuberculosis therapy. This rarely requires cessation of medica-\\ntions, but suspected cases should be discussed with an infectious disease \\nspecialist.\\nCMV is a common cause of serious opportunistic viral disease in HIV-\\ninfected patients. The most important manifestation is retinitis, which can \\noften be diagnosed via clinical evaluation. Disseminated disease commonly \\ninvolves the gastrointestinal, pulmonary, and central nervous systems and a \\nspecific diagnosis may require a tissue biopsy with histologic evidence of \\nviral inclusions and inflammation. Cultures, antigen-based tests, and nucleic \\nacid testing can be used to confirm CMV infection.\\nDisseminated MAC occurs predominately in patients with CD4 counts \\nbelow 100 cells/mm3 who are not on antiretroviral medications. Persistent \\nfever and night sweats are typical, often with weight loss, diarrhea, malaise, \\nand anorexia. Diagnosis is made with acid-fast stain of stool or other body \\nfluids or culture. Treatment reduces bacteremia and improves symptoms \\nbut does not completely eradicate the infection.\\n92_Cydulka_Ch92.indd   507 20/03/17   11:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 526, 'page_label': '508'}, page_content='508 SECTION 10: Infectious and Immunologic Diseases\\nPulmonary Complications\\nPulmonary presentations are among the most common reasons for ED \\nvisits by HIV-infected patients. Bacterial pneumonia outnumbers oppor -\\ntunistic infections, and Streptococcus pneumoniae is the most common \\ncause of pneumonia in HIV-infected patients in the United States and \\nWestern Europe. Productive cough, leukocytosis, and the presence of a \\nfocal infiltrate suggest bacterial pneumonia. Common HIV-related causes \\nof pulmonary abnormalities include PCP, TB, CMV , C. neoformans, \\nHistoplasma capsulatum, and neoplasms. Evaluation may include pulse \\noximetry, arterial blood gas analysis, sputum culture and Gram stain, \\nacid-fast stain, blood cultures, and chest radiography.\\nPneumocystis jirovecii pneumonia is the most frequent opportunistic \\ninfection, and the most common identifiable cause of death among AIDS \\npatients in the United States. The symptoms of PCP are often insidious, \\nand include fever, nonproductive cough, and progressive shortness of \\nbreath. Chest radiographs typically demonstrate diffuse interstitial \\ninfiltrates, although negative radiographs are reported in up to 20% of \\npatients. Elevated lactate dehydrogenase levels, although nonspecific, are \\noften seen. Hypoxia at rest or with exertion and an increased alveolar-\\narterial oxygen gradient can identify patients at risk, and a presumptive \\ndiagnosis of PCP may be made in the setting of unexplained hypoxemia. \\nDefinitive diagnosis often requires bronchoscopy.\\nTB frequently occurs in patients with CD4 T-cell counts of 200 to  \\n500 cells/mm 3. Consider TB in HIV-infected patients with pulmonary \\nsymptoms, and initiate appropriate respiratory isolation. As HIV-\\ninfection progresses, many patients do not report classic manifestations \\nof TB such as cough with hemoptysis, night sweats, prolonged fevers, \\nweight loss, and anorexia. Classic upper lobe involvement and cavitary \\nlesions are less common, particularly among late-stage AIDS patients. \\nFalse-negative purified protein derivative TB test results are frequent \\namong AIDS patients due to immunosuppression. Late-stage HIV is also \\nassociated with extrapulmonary tuberculosis, typically within lymph \\nnodes, bone marrow, CNS, GI, and urogenital systems.\\nConsider disseminated fungal infections such as C. neoformans and \\nAspergillus fumigatus in severely immunosuppressed patients. Noninfec-\\ntious causes of pulmonary complaints such as neoplasms and lymphocytic \\ninterstitial pneumonitis may also occur.\\nNeurologic Complications\\nNeurologic disease may be caused by a variety of opportunistic infec-\\ntions, neoplasms, the HIV virus itself, or even as a side effect of antiret-\\nroviral treatment. Headaches, seizures, altered mental status, meningismus, \\nor focal neurologic deficits can be caused by AIDS dementia, Toxoplasma \\ngondii, or C. neoformans. Consider neuroimaging and lumbar puncture \\nfor patients with CD4 < 200 and neurologic deficits or headaches. Initial \\nneuroimaging with a noncontrast head computed tomography (CT) scan \\nis appropriate, while a contrast-enhanced CT scan or magnetic resonance \\nimaging (MRI) may also be considered in appropriate clinical circum-\\nstances. When obtaining cerebrospinal fluid, measure an opening pres-\\nsure and order a complete cell count, glucose, protein, Gram stain, India \\n92_Cydulka_Ch92.indd   508 20/03/17   11:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 527, 'page_label': '509'}, page_content='CHAPTER 92: HIV Infection and AIDS 509 \\nink stain, bacterial, viral, and fungal cultures, toxoplasmosis and crypto-\\ncoccus antigen, and coccidioidomycosis titer.\\nAIDS dementia comple x is a progressive process heralded by gradual \\nimpairment of recent memory and other cognitive deficits caused by direct \\nHIV infection. Less common CNS infections that may present with neuro-\\nlogic symptoms include bacterial meningitis, histoplasmosis, CMV , progres-\\nsive multifocal leukoencephalopathy, herpes simplex virus, neurosyphilis, \\nand TB. HIV patients may experience HIV neuropathy characterized by \\npainful sensory symptoms of the feet.\\nOphthalmologic Manifestations\\nCMV retinitis is the most frequent and serious ocular infection and the lead-\\ning cause of blindness in AIDS patients. Early infection may be asymptom-\\natic, but may progress to changes in visual acuity, visual field abnormalities, \\nphotophobia, scotoma, eye redness, or pain. Herpes zoster ophthalmicus is \\nanother diagnosis to consider and is recognized by the typical zoster rash in \\nthe distribution of the ophthalmic branch of cranial nerve V .\\nGastrointestinal Complications\\nDiarrhea is the most frequent gastrointestinal complaint and is estimated to \\noccur in 50% to 90% of AIDS patients. Common causes include bacteria, \\nparasites, viruses, fungi, and side effects of antiviral therapy. In many cases, \\na causative organism is never found. Evaluate stool for leukocytes, ova, and \\nparasites, and consider obtaining acid-fast staining and bacterial culture. If \\nbacterial infection is suspected, treat empirically with ciprofloxacin to cover \\ncommon enteric pathogens. Cryptosporidium and Isospora are common \\nparasitic causes of diffuse watery diarrhea, and both can be identified by \\nacid-fast staining of a stool specimen. In late-stage AIDS, the most common \\ndiarrheal pathogens are MAC and CMV , each requiring biopsy for diagnosis.\\nOral candidiasis affects more than 80% of AIDS patients and can be \\nidentified by its classic appearance of white plaques easily scraped from an \\nerythematous base. Esophageal involvement may occur with Candida, \\nherpes simplex, and CMV . Complaints of odynophagia or dysphagia are \\nusually indicative of esophagitis and may be extremely debilitating and \\nmay lead to malnutrition.\\nHepatomegaly with elevated alkaline phosphatase occurs in approxi-\\nmately 50% of AIDS patients. Co-infection with hepatitis B and hepatitis C \\nis common, especially among IV drug users.\\nAnorectal disease is common in AIDS patients. Proctitis is characterized \\nby painful defecation, rectal discharge, and tenesmus. Common causative \\norganisms include Neisseria gonorrhoeae, Chlamydia trachomatis, syphilis, \\nand herpes simplex.\\nCutaneous Manifestations\\nGeneralized conditions such as xerosis, seborrheic eczema, and pruritus are \\ncommon. Kaposi sarcoma is a rash characterized by painless, raised, non-\\nblanching brown-black or purple papules and nodules and is more common \\nin homosexual men with HIV infection. Common sites are the face, chest, \\ngenitals, and oral cavity. Reactivation of varicella-zoster virus is more \\ncommon in patients with HIV infection and AIDS than in the general \\npopulation. Herpes simplex virus infections are common. HIV patients may \\n92_Cydulka_Ch92.indd   509 20/03/17   11:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 528, 'page_label': '510'}, page_content='510 SECTION 10: Infectious and Immunologic Diseases\\ndevelop bullous impetigo and Pseudomonas-associated chronic ulcerations. \\nBacterial skin infections, scabies, human papillomavirus, and hypersensi-\\ntivity reactions to medications are also common.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Maintain an awareness of possible undiagnosed HIV infection in all \\npatient populations. ED-based studies have demonstrated that a substan-\\ntial number of patients have unsuspected HIV infection that cannot be \\naccurately predicted based on demographic factors.\\n2. Base the decision to admit a patient with AIDS on severity of illness, \\nwith attention to new presentation of fever of unknown origin, hypoxia \\nworse than baseline or PaO2 below 60 mm Hg, suspected PCP, suspected \\nTB, new CNS symptoms, intractable diarrhea, suspected CMV retinitis, \\nherpes zoster ophthalmicus, or a patient unable to perform self-care.\\n3. Treatment regimens for common HIV-related infections are listed in \\nTable 92-2. Suspected bacterial sepsis and focal bacterial infections \\nshould be treated with standard antibiotics (see Chapter 89).\\nTAble 92-2 Treatment Recommendations for Common human Immunodeficiency \\nVirus-Related Infections\\nOrgan System Infection Therapy\\nSystemic Mycobacterium \\navium-intracellulare\\nClarithromycin, 500 mg PO twice a day\\nand\\nEthambutol, 15 mg/kg PO once a day\\nand\\nRifabutin, 300 mg/kg PO once a day\\nCMV infection Ganciclovir, 5 mg/kg IV twice a day for 2 weeks, \\nthen 5 mg/kg/d\\nor\\nFoscarnet, 90 mg/kg every 12 h for 3 weeks, \\nthen 90 mg/kg once a day\\nPulmonary Pneumocystis jirovecii \\n(Pneumocystis carinii ) \\npneumonia\\nTrimethoprim-sulfamethoxazole dose using \\n15–20 mg of trimethoprim component per \\nkilogram per day PO or IV in divided doses \\nthree times a day for 3 weeks\\nIf partial pressure of arterial oxygen is \\n<70 mm Hg or alveolar-arterial gradient is  \\n>35 mm Hg, then add\\nPrednisone, 40 mg twice a day for 5 days, then \\n40 mg once a day for 5 days, then 20 mg once  \\na day for 11 days\\nor\\nPentamidine, 4 mg/kg/d IV or IM for 3 weeks\\nMycobacterium \\ntuberculosis infection*\\nIsoniazid, 5 mg/kg PO once a day\\nand\\nRifampin, 10 mg/kg PO once a day or rifabutin  \\n5 mg/kg PO once a day\\nand\\nPyrazinamide, 15–30 mg/kg PO once a day\\nand\\nEthambutol, 15–20 mg/kg PO once a day\\n(Continued )\\n92_Cydulka_Ch92.indd   510 20/03/17   11:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 529, 'page_label': '511'}, page_content='CHAPTER 92: HIV Infection and AIDS 511 \\nTAble 92-2 Treatment Recommendations for Common human Immunodeficiency \\nVirus-Related Infections\\nOrgan System Infection Therapy\\nCentral nervous Toxoplasmosis† Pyrimethamine, 200-mg loading dose PO followed \\nby 50–75 mg PO once a day for 6–8 weeks\\nand\\nSulfadiazine, 1–1.5 g PO every 6 h for 6–8 weeks\\nand\\nLeucovorin, 10–25 mg once a day\\nCryptococcosis‡ Amphotericin B, 0.7 mg/kg IV once a day for \\n2 weeks\\nand\\nFlucytosine, 25 mg/kg IV four times a day for \\n2 weeks\\nthen\\nFluconazole, 400 mg/d PO for 8–10 weeks\\nOphthalmologic CMV infection§ Valganciclovir, 900 mg PO twice a day for \\n14–20 days of induction therapy, then 900 mg \\nPO daily for maintenance therapy\\nand\\nGanciclovir, 2 mg intravitreal injection 1–4 doses \\nover 7–10 days for patients with immediately \\nsight-threatening lesions\\nor\\nFoscarnet, 2.4 mg intravitreal injection 1–4 doses \\nover 7–10 days for patients with immediately \\nsight-threatening lesions\\nGI Candidiasis (thrush–\\nlimited to mouth)\\nClotrimazole, 10-mg troches five times a day\\nor\\nNystatin, 500,000 units five times a day, gargle\\nEsophagitis (primarily \\nCandida)\\nFluconazole, 100–400 mg/d PO\\nSalmonellosis† Ciprofloxacin, 500 mg PO twice a day for  \\n2–4 weeks\\nCryptosporidiosis No known effective cure; best results with \\nhighly active antiretroviral therapy\\nCutaneous Herpes simplex Acyclovir, 200 mg PO five times a day for 7 days\\nor\\nFamciclovir, 125 mg PO twice a day for 7 days\\nor\\nValacyclovir, 1 g PO twice a day for 7 days or \\nfor severe disease\\nAcyclovir, 5–10 mg/kg IV every 8 h for 7 days\\nHerpes zoster Acyclovir, 800 mg PO five times a day for  \\n7–10 days\\nor\\nFamciclovir, 500 mg PO three times a day for \\n7–10 days\\nor\\nValacyclovir, 1 g PO three times a day for  \\n7–10 days\\nor for ocular or disseminated disease\\nAcyclovir, 5–10 mg/kg PO every 8 h for 5–7 days\\n(Continued)\\n(Continued )\\n92_Cydulka_Ch92.indd   511 20/03/17   11:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 530, 'page_label': '512'}, page_content='512 SECTION 10: Infectious and Immunologic Diseases\\nTAble 92-2 Treatment Recommendations for Common human Immunodeficiency \\nVirus-Related Infections\\nOrgan System Infection Therapy\\nCandida or \\nTrichophyton infection\\nTopical clotrimazole two or three times a day \\nfor 3 weeks\\nor\\nTopical miconazole two or three times a day \\nfor 3 weeks\\nor\\nTopical ketoconazole two or three times a day \\nfor 3 weeks\\n*Specific drug regimen must be adjusted if patient is receiving highly active antiretroviral therapy.\\n†Maintenance therapy required.\\n‡Maintenance therapy required; may be discontinued if CD4+ T-cell count is >150 cells/mm 3 for  \\n>16 weeks.\\n§Maintenance therapy required until CD4+ T-cell count is >150 cells/mm 3.\\nAbbreviation: CMV = cytomegalovirus.\\n4. Many institutions have guidelines for assessing health care providers \\nwith occupational e xposures to HIV . Risks for seroconversion include \\n(1) deep injury, (2) visible blood on the injuring device, (3) needle \\nplacement in a vein or an artery of the source patient, and (4) a source \\npatient with late-stage HIV infection. Post-exposure prophylaxis \\nshould be initiated as quickly as possible, preferably within 2 hours, \\nand should be continued for 28 days. A minimum three-drug regimen \\nis recommended.\\n5. Although rarely started in the ED, antiretroviral therapy is recom-\\nmended for CD4 + counts below 350 cells/mm 3 or history of AIDS-\\ndefining illness (see Table 92-1) as well as in patients with the following \\nconditions regardless of the CD4 count: pregnancy, HIV-associated \\nneuropathy, and hepatitis B co-infection requiring treatment. Initial \\ntreatment includes two nucleoside reverse transcriptase inhibitors plus \\none or two protease inhibitors or one nonnucleoside reverse transcrip-\\ntase inhibitor drug. See the Centers for Disease Control and Prevention \\n(CDC) website: http://www.cdc.gov/hiv/.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 154, “Human Immunodeficiency Virus Infection,” by \\nRichard Rothman, Catherine A. Marco, and Samuel Yang.\\n(Continued)\\n92_Cydulka_Ch92.indd   512 20/03/17   11:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 531, 'page_label': '513'}, page_content='513\\nInfective Endocarditis\\nKristin M. Berona\\nInfective endocarditis is caused by infection and damage to the endocar -\\ndium of the heart and carries a high morbidity and mortality. This condition \\nis more common in patients with prosthetic heart valves, congenital or \\nacquired structural abnormalities of the heart or valves, or risk factors such \\nas injection drug use, implanted intravascular devices, poor dental hygiene, \\nHIV , or chronic hemodialysis.\\nStaphylococcus species are the most common cause of infective endo-\\ncarditis in patients with either native or prosthetic heart valves. Streptococ-\\ncus and Enterococcus species are other common infections associated with \\nthis condition. Endocarditis with negative blood cultures and no identified \\ncausative organism occurs in about 5% of patients. The mitral valve is the \\nmost commonly affected valve, followed by aortic, tricuspid, and pulmonic \\nin order of decreasing frequency. Infective endocarditis associated with \\ninjection drug use has a predilection for right-sided valvular lesions.\\n■ ■CLINICAL FEATURES\\nPatients present with symptoms along a continuum, from the fulminant and \\nacute onset of disease associated with fever, a new heart murmur, and acute \\nheart failure, to insidious and indolent symptoms such as malaise and \\nfatigue in a patient with a prosthetic valve. Fever is the most common \\nsymptom (80%) followed by chills, weakness, and dyspnea (40%). Other \\nnonspecific symptoms include anorexia, cough, and malaise. The most \\ncommon findings on physical examination include fever and a heart mur -\\nmur. Classic skin findings such as tender nodules on pads of fingers and \\ntoes (Osler’s nodes), painless hemorrhagic plaques on fingers and toes \\n(Janeway lesions), petechiae, and splinter hemorrhages occur in less than \\n50% of cases.\\nPatients often present with cardiac, neurologic, and embolic complica-\\ntions. Acute heart failure occurs in approximately 70% of patients due to \\ndistortion or perforation of valves or cardiac chambers, or rupture of chor -\\ndae tendinae. Other less frequent cardiac manifestations include heart \\nblocks and dysrhythmias. Neurologic complications occur in 20% to 40% \\nof patients, including ischemic stroke, brain abscess, cerebral hemorrhage, \\nmycotic aneurysm, or seizure. Other embolic events may occur in the lungs, \\nspleen, intestines, kidneys, and can cause acute limb ischemia.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nInfective endocarditis is difficult to definitively diagnose in the emergency \\ndepartment, given the necessary components for diagnosis are blood culture \\nresults, echocardiography, and clinical observation. Consider the diagnosis \\nin patients with unexplained fever and risk factors for the disease, such as \\ninjection drug users, patients with prosthetic valves, and those with new or \\nchanging murmurs or evidence of arterial emboli. The Duke criteria have \\nlong been used to make the diagnosis as detailed in Tables 93-1 and 93-2.\\n93\\nCh A p TER\\n93_Cydulka_Ch93.indd   513 20/03/17   11:51 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 532, 'page_label': '514'}, page_content='514 SECTION 10: Infectious and Immunologic Diseases\\nTablE 93-1 Duke Criteria* for Infective Endocarditis\\nMajor Criteria\\nPositive blood culture for IE\\nTypical microorganism consistent with IE from two separate blood cultures * as noted \\nbelow:\\nStreptococcus bovis, viridans streptococci, HACEK group\\nor\\nCommunity-acquired Staphylococcus aureus or enterococci in the absence of a primary \\nfocus\\nor\\nMicroorganisms consistent with IE from persistently positive blood cultures defined as:\\nAt least two positive cultures of blood samples drawn > 12 h apart\\nor\\nAll of three or a majority of four or more separate blood cultures (with first and last \\nsample drawn at least 1 h apart)\\nSingle positive blood culture for Coxiella burnetii or antiphase I immunoglobulin G \\nantibody titer of > 1:800\\nEvidence of echocardiographic involvement\\nPositive ECG for IE defined as:\\nOscillating intracardiac mass on valve or supporting structures, in the path of regurgitant \\njets, or on implanted material in the absence of an alternative anatomic explanation\\nor\\nAbscess\\nor\\nNew partial dehiscence of prosthetic valve\\nNew valvular regurgitation (worsening or changing of preexisting murmur not sufficient)\\nMinor Criteria\\nPredisposition: predisposing heart condition or injection drug use\\nFever: temperature > 38°C (100.4°F)\\nVascular phenomena: major arterial emboli, septic pulmonary conjunctival hemorrhages, \\nand Janeway lesions\\nImmunologic phenomena: glomerulonephritis, Osler nodes, Roth spots, and rheumatoid \\nfever\\nMicrobiologic evidence: positive blood culture but does not meet a major criterion as \\nnoted in Table 93-2* or serologic evidence of active infection with organism consistent \\nwith IE\\nEchocardiographic minor findings were eliminated in the modified Duke criteria\\n*Excludes single positive cultures for coagulase-negative staphylococci and organisms that do not  \\ncause IE.\\nAbbreviations: HACEK, Haemophilus, Actinobacillus, Cardiobacterium, Eikenella, and Kingella; IE, \\ninfective endocarditis.\\nWhen infective endocarditis is suspected as a likely diagnosis, obtain \\nthree sets of blood cultures prior to administration of antibiotics from \\nthree separate vascular sites, ideally with an hour elapsing between the \\nfirst and last set of cultures. Obtain an echocardiogram to look for cardiac \\nvalve vegetations and to evaluate valvular and overall cardiac function. \\nTransthoracic echocardiography is a common initial modality, although \\ntransesophageal echocardiography is more sensitive and specific for val-\\nvular pathology and may be necessary if transthoracic images are incon-\\nclusive. Additional testing includes electrocardiography, chest X-ray, and \\nlaboratory studies. Although nonspecific for infective endocarditis, \\nlaboratory abnormalities that may be present are anemia, hematuria, and \\n93_Cydulka_Ch93.indd   514 20/03/17   11:51 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 533, 'page_label': '515'}, page_content='CHAPTER 93: Infective Endocarditis 515 \\nTablE 93-2 Modified Duke Criteria for Infective Endocarditis\\nDefinite Infective Endocarditis\\nPathologic criteria\\nMicroorganisms demonstrated by culture or histologic examination of a vegetation or in a \\nvegetation that has embolized, or in an intracardiac abscess\\nor\\nPathologic lesions: vegetation or intracardiac abscess present, confirmed by histology \\nshowing active endocarditis\\nClinical Criteria, Using Specific Definitions listed in Table 93-1\\nTwo major criteria\\nor\\nOne major and three minor criteria\\nor\\nFive minor criteria\\nPossible infective endocarditis\\nOne major criterion and one minor criterion\\nThree minor criteria\\nRejected\\nFirm alternate diagnosis for manifestations of endocarditis\\nor\\nResolution of manifestations of endocarditis with antibiotic therapy for 4 days or less\\nor\\nNo pathologic evidence of infective endocarditis at surgery or autopsy after antibiotic \\ntherapy for 4 days\\nDoes not meet criteria for possible infective endocarditis\\nelevations in inflammatory markers. Investigate for potential infections \\nfrom other sources based on individual presenting complaints.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Focus initial interventions to stabilize any impairments of airway, \\nbreathing, and circulation. Patients with acute infectiv e endocarditis \\nmay present with respiratory compromise and require emergent airway \\nstabilization.\\n2. Pulmonary edema may be due to left-sided valvular rupture and may \\nbenefit from afterload reduction along with usual care for acute heart \\nfailure.\\n3. Initiate antibiotics to patients with suspected endocarditis as soon as \\nappropriate cultures are obtained. Table 93-3 lists empiric treatment \\nregimens. Definitive therapy is based on culture and sensitivity results \\nand typically requires 4 to 6 weeks of antibiotics.\\n4. Admit patients with suspected infective endocarditis to the hospital for \\ndefinitive diagnosis and management. Successful treatment often uti-\\nlizes a team approach with cardiology, infectious disease, and thoracic \\nsurgery. Patients with neurologic or other embolic phenomena may \\nbenefit from additional specialist consultation.\\n5. Guidelines for antibiotic prophylaxis were updated in 2007. Only pa-\\ntients in the highest risk group for infective endocarditis need antibiotic \\nprophylaxis for dental procedures involving manipulation of gingival \\ntissue or procedures on infected skin or soft tissue. These high-risk \\n93_Cydulka_Ch93.indd   515 20/03/17   11:51 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 534, 'page_label': '516'}, page_content='516 SECTION 10: Infectious and Immunologic Diseases\\npatients include those with a prior history of infective endocarditis, a \\nprosthetic heart v alve, unrepaired or failed repair of a congenital heart \\ndefect, or a cardiac transplant recipient with valvular regurgitation due \\nto a structurally abnormal valve. Full antibiotic prophylaxis recommen-\\ndations may be found at http://circ.ahajournals.org/content/116/15/1736 \\n.full.pdf.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 155, “Infective Endocarditis,” by Richard Rothman, \\nCatherine A. Marco, and Samuel Yang.\\nTablE 93-3 Empiric Therapy of Suspected Bacterial Endocarditis*\\npatient Characteristics Recommended Agents, Initial Dose\\nUncomplicated history Ceftriaxone, 1–2 g IV\\nor\\nNafcillin, 2 g IV\\nor\\nOxacillin, 2 g IV\\nor\\nVancomycin, 15 mg/kg\\nplus\\nGentamicin, 1–3 mg/kg IV\\nor\\nTobramycin, 1 mg/kg IV\\nInjection drug use, congenital heart disease, \\nhospital-acquired, suspected methicillin-\\nresistant Staphylococcus aureus, or already \\non oral antibiotics\\nNafcillin, 2 g IV\\nplus\\nGentamicin, 1–3 mg/kg IV\\nplus\\nVancomycin, 15 mg/kg IV\\nProsthetic heart valve Vancomycin, 15 mg/kg IV\\nplus\\nGentamicin, 1–3 mg/kg IV\\nplus\\nRifampin, 300 mg PO\\n*Based on American Heart Association, endorsed by the Infectious Disease Society of America, http://\\nwww.idsociety.org/Organ_System/, accessed April 1, 2014. Because of controversy in the literature \\nregarding the optimal regimen for empiric treatment, antibiotic selection should be based on patient \\ncharacteristics, local resistance patterns, and current authoritative recommendations.\\n93_Cydulka_Ch93.indd   516 20/03/17   11:51 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 535, 'page_label': '517'}, page_content='517\\nTetanus and Rabies\\nMichael T. Fitch\\n■ ■TETANUS\\nTetanus is an acute and frequently fatal disease resulting from an infection \\nwith the organism Clostridium tetani. The disease is exotoxin mediated and \\ncan occur after any of a variety of tissue injuries, including clean and con-\\ntaminated wounds, elective surgery, burns, puncture wounds, otitis media, \\ndental infections, animal bites, abortion, and pregnancy. Due to successful \\nvaccination campaigns, tetanus is a rare disease in developed countries but \\nremains a significant problem elsewhere in the world.\\nClinical Features\\nC. tetani is prevalent throughout the environment in soil, dust, skin sur -\\nfaces, and animal and human feces. Spores are resistant to destruction, \\nsurvive years on environmental surfaces, and are introduced into the body \\nfollowing tissue injury. Anaerobic tissue conditions lead to toxin formation \\nwhen the spores begin to germinate, and therefore crushed or devitalized \\ntissue, a retained foreign body, or infection can favor growth of the toxin-\\nproducing form of C. tetani. The incubation period ranges from <24 hours \\nto >1 month, and while most cases occur within 14 days some patients may \\npresent several months after injury. Many cases of tetatnus occur in patients \\nwhere no specific injury is recognized, and injuries are often minor and \\noccur indoors.\\nClinically, tetanus is categorized into three forms: local, cephalic, and \\ngeneralized. Local tetanus is uncommon and presents with persistent mus-\\ncle contractions in proximity to the injury site. Cephalic tetanus is rare, \\noccurs occasionally with otitis media or head injuries, and has localized \\ninvolvement of the face and cranial nerves. Generalized tetanus is the most \\ncommon form (80% of cases) and often presents with a descending pattern \\nof symptoms that begin with pain and stiffness in the jaw. Progression of \\nthe symptoms leads to trismus (lockjaw) and development of the classically \\ndescribed facial expression, risus sardonicus. Violent spasms and tonic \\ncontractions of muscle groups are responsible for the symptoms of the \\ndisease including dysphagia, opisthotonos, flexing of the arms, fist clench-\\ning, rigidity of abdominal muscles, and extension of the lower extremities. \\nAutonomic symptoms include fever, sweating, hypertension, and tachycar-\\ndia. Neonatal tetanus is a form of generalized tetanus and can occur due to \\ninadequate maternal immunization and poor umbilical cord care, with \\nsymptoms typically presenting by the second week of life and associated \\nwith an extremely high mortality rate.\\nDiagnosis and Differential\\nTetanus is diagnosed clinically, and early symptoms may include trismus, \\nneck stiffness or sore throat, and dysphagia. The tetanospasmin toxin inter-\\nferes with central and peripheral nervous system inhibitory pathways leading \\n94\\nCh A p TE r\\n94_Cydulka_Ch94.indd   517 20/03/17   11:56 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 536, 'page_label': '518'}, page_content='518 SECTION 10: Infectious and Immunologic Diseases\\nto unopposed muscle contraction, seizures, and autonomic nervous system \\ndysfunction. Prior immunization does not eliminate tetanus as a diagnostic \\npossibility. There are no confirmatory laboratory tests. Other potential diag-\\nnoses with muscular contraction or other symptoms that may be similar to \\ntetatnus include strychnine poisoning, dystonic reactions to phenothiazine, \\nhypocalcemic tetany, rabies, peritonsillar abscess, peritonitis, and meningitis.\\nEmergency Department Care and Disposition\\n1. Patients with tetanus require hospitalization to manage frequent muscle \\nspasms that may last 3 to 4 weeks. Symptoms can be triggered by noise \\nor touch and thus environmental stimuli should be minimized to prevent \\nprecipitation of convulsive spasms. The potential for laryngospasm or \\nrespiratory muscle spasms are best managed initially in an intensive care \\nunit due to concern for progression to respiratory compromise.\\n2. Administer tetanus immune globulin 3000 to 6000 units IM in a single \\ninjection a way from the site of tetanus toxoid administration. Give \\nbefore wound debridement as additional exotoxin may be released dur -\\ning wound manipulation.\\n3. Administer tetanus toxoid 0.5 mL IM at presentation, and 6 weeks and \\n6 months after presentation.\\n4. Identify and debride any wound or devitalized tissue where suspected \\ninoculation occurred to minimize further toxin production.\\n5. Antibiotics are of uncertain value in the treatment of tetanus. Metroni-\\ndazole 500 mg IV every 6 hours is recommended when indicated.\\n6. Administer benzodiazepines to treat muscle spasms. Midazolam, 0.05 \\nto 0.15 mg/kg/h IV may be given in appropriately monitored settings as \\na continuous drip when needed. Lorazepam  2 mg IV to effect may be \\nused in small quantities.\\n7. Neuromuscular blockade may be required to control ventilation and \\nmuscular spasm and to prevent fractures and rhabdomyolysis. In such \\ncases, intubated patients may receive a vecuronium bolus of 0.1  mg/kg \\nIV followed by continuous infusion at 1  μg/kg/min. Appropriate seda-\\ntion during neuromuscular blockade should be pro vided.\\n8. Labetalol 0.25 to 1 mg/min continuous IV infusion (0.3 to 1 mg/kg/h in \\nchildren) can be used to treat manifestations of sympathetic hyperactivity. \\nMagnesium sulfate 40 mg/kg loading dose followed by 2 g/h IV (1.5 g/h \\nif ≤45 kg) has been suggested as an additional treatment for this condition \\nto maintain blood levels of 2.0–4.0  mmol/L. Morphine sulfate 0.5 to  \\n1 mg/kg/h is also useful and may provide sympathetic control without \\ncompromising cardiac output. Clonidine 0.3 mg every 8 hours PO or NG \\nmay be helpful in the management of cardiovascular instability.\\n9. Patients who recover from clinical tetanus should under go active im-\\nmunization as recovery from an active infection does not confer future \\nimmunity.\\n■ ■rABIES\\nInfection with the rabies virus leads to a fatal encephalitis in humans and \\nanimals, and is most often transmitted by contact with infected animal \\nsaliva via a bite or scratch wound. While most emergency physicians never \\nencounter patients suffering from acute rabies encephalitis, it is very \\n94_Cydulka_Ch94.indd   518 20/03/17   11:56 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 537, 'page_label': '519'}, page_content='CHAPTER 94: Tetanus and Rabies 519 \\nTablE 94-1 Natural history of Clinical rabies in humans after Incubation period\\nClinical Stage\\nDefining \\nEvent\\nUsual \\nDuration\\nCommon Symptoms and  \\nSigns*\\nProdrome First symptom 2–10 days ■● Pain or paresthesia at site of bite\\n■● Malaise, lethargy\\n■● Headache\\n■● Fever\\n■● Nausea, vomiting, anorexia\\n■● Anxiety, agitation, depression\\nAcute neurologic \\nphase\\nFirst neurologic \\nsign\\n2–7 days ■● Anxiety, agitation, depression\\n■● Hyperventilation, hypoxia\\n■● Aphasia, incoordination\\n■● Paresis, paralysis\\n■● Hydrophobia, pharyngeal spasms\\n■● Confusion, delirium, hallucinations\\n■● Marked hyperactivity\\nComa Onset of coma 0–14 days ■● Coma\\n■● Hypotension, hypoventilation, apnea\\n■● Pituitary dysfunction\\n■● Cardiac arrhythmia, cardiac arrest\\nDeath or recovery \\n(extremely rare)\\nDeath or initia-\\ntion of recovery\\nMonths \\n(recovery)\\n■● Pneumothorax\\n■● Intravascular thrombosis\\n■● Secondary infections\\n*Not every symptom or sign may be present in each case.\\ncommon for patients to present for evaluation and treatment after animal \\nbites or other potential exposures to the rabies virus. In the United States, \\ndog bites, cat bites, and exposure to bats are common reasons that patients \\npresent for postexposure prophylaxis. Rabies cases in animals within the \\nUnited States are most often found in raccoons, bats, skunks, foxes, cats, \\ndogs, and cattle. Ferrets, rabbits, guinea pigs, and squirrels are generally \\nnot known to transmit rabies to humans and thus these kinds of exposures \\nare considered very low risk for rabies transmission and providers should \\ncontact local public health authorities if there are concerns about how to \\nmanage these low-risk exposures.\\nClinical Features\\nTypical incubation periods for rabies virus infections are from 20 to  \\n90 days. However, incubation periods as short as 4 days or as long as  \\n6 years have been reported, emphasizing the importance of postexposure \\nprophylaxis for patients regardless of the amount of time that has elapsed \\nsince a suspected exposure. The natural history of clinical rabies in \\nhumans is presented in Table 94- 1.\\nThe viral prodrome associated with human rabies infection includes \\nnonspecific symptoms such as malaise, lethargy, headache, fever, nausea, \\nvomiting, anxiety, and pain at the site of a bite wound. Encephalitic rabies \\n(80% of cases) is characterized by episodic hyperexcitability, disorienta-\\ntion, hallucinations, and bizarre behavior and is associated with auto-\\nnomic dysfunction, hypersalivation, hyperthermia, tachycardia, and \\ncardiac arrhythmias. Paralytic rabies (20% of cases) generally begins with \\n94_Cydulka_Ch94.indd   519 20/03/17   11:56 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 538, 'page_label': '520'}, page_content='520 SECTION 10: Infectious and Immunologic Diseases\\nprogressively worsening e xtremity paresis and bilateral facial weakness \\nand progresses to coma and organ failure.\\nRabies infections lead to coma within 10 days of onset. The clinical \\ncourse is characterized by complications such as pituitary dysfunction, \\nseizures, respiratory dysfunction, cardiac dysrhythmias, autonomic dys-\\nfunction, renal failure, and secondary bacterial infections. Almost all rabies \\ninfections are fatal with only a few case reports of patient survival.\\nDiagnosis and Differential\\nDuring the incubation period for rabies infection, there are no definitive \\ndiagnostic tests to confirm infection. The diagnosis of rabies infection is \\ntherefore clinical, and may be considered for a patient with an unexplained \\nand rapidly progressive encephalitis, especially if autonomic instability, \\ndysphagia, hydrophobia or neurologic symptoms are present. Once symp-\\ntoms are present, antigen and antibody testing of serum, cerebrospinal fluid \\n(CSF), saliva, and/or tissue biopsies can detect evidence of rabies infection. \\nCSF analysis often demonstrates pleocytosis with a mononuclear predomi-\\nnance. The final diagnosis of rabies is made by postmortem analysis of \\nbrain tissue.\\nEmergency Department Care and Disposition\\nFor the rare patient who presents with an acute rabies infection and symp-\\ntoms of clinical disease, there are no specific therapies that have demon-\\nstrated clinical benefit. Treatment of an active clinical rabies infection is \\nsupportive care with admission to a critical care environment where treat-\\nment of the associated complications and further diagnostic testing can be \\ncompleted.\\nThe more typical focus for emergency providers is to assess patients \\nwith possible exposure to the rabies virus, manage public health and animal \\ncontrol notification, and appropriately administer postexposure prophylaxis \\nfor rabies exposures.\\n1. Evaluate all patients for potential postexposure prophylaxis who ha ve \\nbeen bitten, scratched, or exposed to saliva from a wild animal or from \\na domestic animal that could be rabid.\\n2. Exposure to Bats: Provide poste xposure prophylaxis to patients who \\nhave had direct contact with a bat unless the person can be certain that \\na bite, scratch, or mucus membrane exposure did not occur. Consider \\npostexposure prophylaxis for persons who were in the same room as a \\nbat and may have been unaware if a bite or direct contact occurred. \\nWhen possible, capture and submit animals for testing to the public \\nhealth department as negative testing means postexposure prophylaxis is \\nnot necessary.\\n3. Exposures from Healthy-Appearing Domestic Animals that Can Be \\nObserved: Postexposure prophylaxis may not be immediately necessary \\nif a healthy domestic animal is available for confinement and observa-\\ntion for 10 days after the incident to watch for signs of rabies infection. \\nConsult with local animal control and/or public health officials for \\nguidance in these circumstances.\\n4. Exposures from Stray Animals and Wild Animals: Begin postexposure \\nprophylaxis for exposures from wild animals or stray animals with \\n94_Cydulka_Ch94.indd   520 20/03/17   11:56 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 539, 'page_label': '521'}, page_content='CHAPTER 94: Tetanus and Rabies 521 \\nuncertain immunization histories that cannot be observed. Report expo-\\nsures to the appropriate animal control and/or public health authorities.\\n5. Patients with wounds associated with potential rabies exposures should \\nreceive tetanus prophylaxis, wound cleansing with soap and water, irri-\\ngation with a dilute solution of povidone-iodine (1  mL povidone-iodine \\nin 9 mL of water or normal saline), antibiotics (if indicated), and rabies \\nprophylaxis.\\n6. In the United States, postexposure prophylaxis consists of a regimen of \\none dose of human rabies immunoglobulin (HRIG) and four doses of \\nrabies vaccine over a 14-day period, except for immunocompromised \\npersons, who should receive a five-dose series of vaccine over a 28-day \\nperiod. Postexposure prophylaxis recommendations are provided in \\nTable 94-2.\\nTablE 94-2 rabies postexposure prophylaxis Schedule—United States, 2010\\nImmunization Status Treatment regimen*\\nNot previously \\nimmunized\\nWound cleansing Cleanse all wounds with soap and water; \\nirrigate wounds with 9:1 diluted solution of \\npovidone-iodine (if available).\\nHRIG Administer 20 IU/kg actual body weight. \\nIf anatomically feasible, infiltrate the \\nfull dose around the wound(s) and give \\nany remaining volume IM at an anatomic \\nsite distant from vaccine administration; \\ndo not give HRIG in the same syringe as \\nvaccine. HRIG may partially suppress active \\nproduction of rabies virus antibody, so do \\nnot give more than the recommended \\ndose.\\nVaccine HDCV or PCECV 1.0 mL (deltoid area†), one \\ndose on days 0,‡ 3, 7, and 14.§\\nPreviously immunized‖ Wound cleansing Cleanse all wounds with soap and water; \\nirrigate wounds with 9:1 povidone-iodine \\nsolution.\\nHRIG HRIG should not be administered.\\nVaccine HDCV or PCECV 1.0 mL (deltoid area†), one \\ndose on days 0‡ and 3.\\n*These regimens are appropriate for all age groups, including children.\\n†The deltoid area is the only acceptable site of vaccination for adults and older children. For younger \\nchildren, the outer aspect of the thigh (anterolateral aspect) may be used. Vaccine should never be \\nadministered in the gluteal area.\\n‡Day 0 is the day the first dose of vaccine is administered.\\n§Day 28 vaccine dose no longer recommended by the Advisory Committee on Immunization \\nPractices, unless the patient is immunocompromised. See http://www.cdc.gov/rabies/resources/\\nacip_recommendations.html.\\n‖Any persons with a history of preexposure prophylaxis with HDCV or PCECV; prior postexposure \\nprophylaxis with HDCV or PCECV; or previous immunization with any other type of rabies vaccine and  \\na documented history of antibody response to the prior immunization.\\nAbbreviations: HDCV, human diploid cell vaccine; HRIG, human rabies immunoglobulin; PCECV, purified \\nchick embryo cell culture vaccine.\\n94_Cydulka_Ch94.indd   521 20/03/17   11:56 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 540, 'page_label': '522'}, page_content='522 SECTION 10: Infectious and Immunologic Diseases\\n7. HRIG provides passive immunity and is administered once at the begin-\\nning of therapy up to the seventh day after the initial exposure. The dose \\nis 20  IU/kg, with as much as possible infiltrated locally at the exposure \\nsite and the remainder administered intramuscularly in the deltoid or \\nthigh away from the site where rabies vaccine is given.\\n8. Provide active immunization with rabies vaccine (human diploid cell \\nvaccine or purified chick embryo cell culture vaccine) in the deltoid or \\nlateral thigh given on days 0, 3, 7, and 14 for patients with normal \\nimmune systems. Patients with immunocompromise should receive a \\nfifth dose of vaccine on day 28.\\n9. The Centers for Disease Control and Prevention (CDC) and state or \\ncounty health departments can provide assistance in the management of \\npostexposure prophylaxis for rabies. The most current information avail-\\nable from the CDC can be accessed at www.cdc.gov/rabies/.\\n■ ■FUrThEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 156, “Tetanus,” by Joel L. Moll and Donna L. Carden; \\nand Chapter 157, “Rabies,” by David Weber.\\n94_Cydulka_Ch94.indd   522 20/03/17   11:56 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 541, 'page_label': '523'}, page_content='523\\nMalaria\\nJennifer L. Hannum\\nMalaria, a protozoan disease transmitted by the bite of the Anopheles mos-\\nquito, is caused by the genus Plasmodium. Five species of the protozoan \\nPlasmodium infect humans: P . falciparum, P . vivax, P . ovale, P . malariae, \\nand P . knowlesi. Consider malaria in patients who have recently traveled to \\nendemic areas and present with an unexplained febrile illness.\\nMalaria transmission occurs in large areas of Central and South America, \\nthe Caribbean, sub-Saharan Africa, the Indian subcontinent, Southeast Asia, \\nthe Middle East, and Oceania (e.g.,  New Guinea, Solomon Islands). More \\nthan 50% of malaria cases in the United States, including most cases due  \\nto P . falciparum, arise from travel to sub-Saharan Africa. Resistance of  \\nP . falciparum to chloroquine and other drugs continues to spread and strains \\nof P . vivax with chloroquine resistance have also been identified.\\n■ ■CLINICAL FEATURES\\nPlasmodial sporozoites first infect the liver, where asexual reproduction \\noccurs in the exoerythrocytic stage. During this initial incubation stage, \\nwhich usually lasts 1 to 4 weeks, patients are often asymptomatic. Partial \\nchemoprophylaxis or incomplete immunity can prolong the incubation \\nperiod to months or even years. The clinical signs of malaria first appear \\nduring the erythrocytic stage, which occurs when hepatocyte rupture \\nreleases merozoites to invade erythrocytes. In P . vivax and P . ovale infection, \\na portion of the intrahepatic forms are not released, but remain dormant as \\nhypnozoites, which can reactivate a malaria infection after months or years.\\nEarly symptoms of malaria are nonspecific, including fever, chills, mal-\\naise, myalgias, and headache. Chest pain, cough, abdominal pain, or \\narthralgias may also be seen. Patients then develop a high fever, followed \\nby diaphoresis and exhaustion when fever abates. Classically, cycles of \\nfever and chills followed by profuse diaphoresis and exhaustion occur at \\nregular intervals, reflecting the ongoing and intermittent hemolysis of \\ninfected erythrocytes.\\nPhysical examination findings are nonspecific. During a febrile parox-\\nysm, most patients appear acutely ill, with high fever, tachycardia, and \\ntachypnea. Splenomegaly and abdominal tenderness are common. In  \\nP . falciparum infections, hepatomegaly, edema, and scleral icterus often \\noccur.\\nInfections caused by any species of Plasmodium can result in hemolysis \\nwith anemia, splenic enlargement, and potential splenic rupture. Severe or \\ncomplicated malaria infections may also occur, and are usually due to  \\nP . falciparum. Prostration, severe anemia, acidosis, hypoglycemia, acute \\nrenal failure, acute respiratory distress syndrome, pulmonary edema, \\njaundice, shock, and disseminated intravascular coagulation may occur in \\nsevere infections. Cerebral malaria is characterized by somnolence, coma, \\ndelirium, and seizures. In 2011, 22% of malaria cases imported to the United \\nStates were classified as severe. Blackwater fever is a severe complication \\n95\\nC HA p TER\\n95_Cydulka_Ch95.indd   523 20/03/17   12:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 542, 'page_label': '524'}, page_content='524 SECTION 10: Infectious and Immunologic Diseases\\nseen almost exclusively in P . falciparum infections, with massive intravas-\\ncular hemolysis, jaundice, hemoglobinuria, and acute renal failure.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe diagnosis of malaria relies on a history of potential exposure in an \\nendemic area, along with clinical symptoms, signs, and microscopic \\nexamination of thick and thin blood films. A thin blood film is used for \\ncounting heavy infections, while a thick blood film detects lower levels of \\nparasitemia. In early infection, especially with P . falciparum, parasitemia \\nmay be initially undetectable due to hepatic sequestration of organisms. \\nParasite load in the peripheral circulation fluctuates over time and is highest \\nduring an acute rising fever with chills. Initiate appropriate therapy when \\nmalaria is suspected, even if the parasite is not detected on initial blood \\nsmears. If plasmodia are not initially visualized and malaria is a likely \\ndiagnosis, repeat blood smears at least twice daily (preferably during \\nfebrile episodes) as long as malaria is suspected or until the patient recov-\\ners. Once plasmodia are identified, the smear can further determine the \\npercentage of red blood cells infected (which correlates with prognosis) \\nand species type (in particular P . falciparum). Newer techniques for rapid \\ndiagnosis and speciation are also available. Sensitivity of such rapid tests is \\nexcellent for P . falciparum with high parasitemia levels, but poor for the \\nother forms of malaria.\\nNonspecific laboratory findings may include normochromic normocytic \\nanemia with findings suggestive of hemolysis, a normal or mildly depressed \\ntotal leukocyte count, thrombocytopenia, an elevated erythrocyte sedimen-\\ntation rate, and mild abnormalities of liver and renal functions.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Base treatment decisions on the severity of the illness and the species of \\nthe infecting parasite.\\n2. Admit patients with uncomplicated infection due to P . falciparum to the \\nhospital and treat using one of se veral regimens (see Table 95-1). \\nArtemisinin-containing combination therapies are recommended by the \\nWorld Health Organization. As of July 2013, the Centers for Disease \\nControl and Prevention (CDC) recommends using chloroquine for  \\nP . falciparum malaria imported from areas of low chloroquine resistance \\nincluding Central America (west of the Panama Canal), Haiti, the \\nDominican Republic, and parts of the Middle East. Dose options are \\nlisted at the CDC website (http://www.cdc.gov/malaria/).\\n3. Uncomplicated malaria infections due to P . vivax, P. malariae, or  \\nP . ovale can often be treated as an outpatient. If P . knowlesi is suspected, \\nhospital admission is recommended. Recommended treatment for \\nuncomplicated malaria infection due to P . vivax, P . ovale, P . malariae, \\nand P . knowlesi is chloroquine. Treat adults with chloroquine 600  mg \\nbase (= 1  g salt) loading dose, then 300  mg base (= 500  mg salt) in  \\n6 hours, then 300 mg base per day for 2 days (total dose 1550 mg base). \\nTreat children with chloroquine 10 mg/kg base to maximum of 600  mg \\nloading dose, then 5 mg/kg base in 6 hours and 5 mg/kg base per day for \\n2 days.\\n95_Cydulka_Ch95.indd   524 20/03/17   12:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 543, 'page_label': '525'}, page_content='CHAPTER 95: Malaria 525 \\nTable 95-1 Drug Options for Therapy of Uncomplicated Plasmodium falciparum \\nMalaria\\nTreatment of Choice Is an Artemisinin-Containing Combination Therapy (ACT)\\nDrug Adult Dose pediatric Dose\\nArtemether-lumefantrine \\n(CoArtem®; each tablet \\ncontains artemether \\n20 mg and lumefantrine \\n120 mg)\\n4 tablets twice daily \\nfor 3 days (the first two \\ndoses should be about \\n8 h apart)\\n■● 5–15 kg: 1 tab initially, 1 tablet  \\nin 8 h, then 1 tablet every  \\n12 h × 2 days\\n■● 15–25 kg: 2 tablets initially,  \\n2 tablets in 8 h, then 2 tablets \\nevery 12 h × 2 days\\n■● 25–35 kg: 3 tablets initially,  \\n3 tablets in 8 h, then 3 tablets \\nevery 12 h × 2 days\\n■● >35 kg: follow adult dosing\\nArtesunate-amodiaquine \\n(where available; not \\navailable in the United \\nStates; each adult tablet \\ncontains artesunate \\n100 mg and amodia-\\nquine hydrochloride salt \\n270 mg)\\n2 tablets once daily \\nfor 3 d\\n■● 5 to <9 kg: 1 tablet/day of arte-\\nsunate (AS) 25 mg/amodiaquine \\n(AQ) 67.5 mg\\n■● 9 to <18 kg: 1 tablet/day of AS \\n50 mg/AQ 135 mg\\n■● 18 to <36 kg: 1 tablet/day of AS \\n100 mg/AQ 270 mg\\n■● ≥36 kg: 2 tablets/day of AS \\n100 mg/AQ 270 mg (adult dose)\\nAlternatives to ACT\\nDrug Adult Dose pediatric Dose\\nAtovaquone-proguanil \\n(Malarone®; each \\nadult tablet contains \\natovaquone 250 mg and \\nproguanil 100 mg; each \\npediatric tablet contains \\natovaquone 62.5 mg and \\nproguanil 25 mg)\\n4 tablets once daily for \\n3 days. Do not use for \\ntreatment if atovaquone-\\nproguanil has been taken \\nas chemoprophylaxis \\nand the patient’s current \\nillness is a suspected \\ntreatment failure.\\n■● 5–8 kg: 2 pediatric tablets × 3 days\\n■● 9–10 kg: 3 pediatric tablets × 3 days\\n■● 11–20 kg: 1 adult tablet × 3 days\\n■● 21–30 kg: 2 adult tablets × 3 days\\n■● 31–40 kg: 3 adult tablets × 3 days\\n■● >41 kg: adult dose\\nQuinine sulfate (plus dox-\\nycycline or clindamycin)\\n650 mg PO every 8 h for \\n3–7 days\\n10 mg sulfate salt/kg, up to adult \\ndose PO every 8 h for 3–7 days\\nPlus\\nDoxycycline 100 mg PO every 12 h for \\n7 days\\n2.2 mg/kg (up to adult dose of \\n100 mg) PO every 12 h for 7 days\\nOr in children under age \\n8 years\\nClindamycin 7 mg/kg PO every 8 h for 7 days\\n4. Chloroquine has no ef fect on the exoerythrocytic forms of P . vivax and  \\nP . ovale, which remain dormant in the liver. Unless treated with prima-\\nquine, relapse will occur. This treatment can be given after full recov-\\nery from the initial illness. Treat adults with primaquine phosphate  \\n30 mg of base per day for 14 days. Treat children with primaquine \\nphosphate 0.5  mg/kg base for 14 days. Primaquine should be avoided \\nin patients with glucose-6-phosphate deh ydrogenase deficiency \\nbecause of hemolysis.\\n95_Cydulka_Ch95.indd   525 20/03/17   12:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 544, 'page_label': '526'}, page_content='526 SECTION 10: Infectious and Immunologic Diseases\\n5. For severe or complicated malaria infections, antimalarial drug options \\nare listed in Table 95-2. Continue the treatment by a parenteral route for \\nat least 24 hours. Monitor blood glucose as parenteral quinidine and \\nquinine can cause severe hypoglycemia. These agents are also myocar -\\ndial depressants, and thus contraindicated in patients with heart disease. \\nCardiac monitoring is recommended during administration.\\n6. Provide aggressive supporti ve care to all hospitalized ill patients, \\nincluding appropriate IV fluid replacement, correction of metabolic \\nderangements, and advanced support (e.g.,  dialysis or mechanical \\nventilation), as necessary.\\n7. The CDC has a malaria hotline: 770-488-7788  M-F, 9 am to 5 pm EST, \\nand 770-488-7100 after hours, weekends, and holidays. The CDC web-\\nsite can be accessed at http://www.cdc.gov/malaria/ to obtain resistance \\npatterns in various countries and information on malaria prophylaxis and \\ntreatment. When resistance patters are uncertain, concern for chloro-\\nquine resistance for initial treatment should be considered.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 158, “Malaria,” by Malcolm Molyneaux.\\nTable 95-2 Antimalarial Drug Options for Severe (Complicated) Malaria\\nDrug Adult Dose pediatric Dose\\nArtesunate* (available \\nfrom the CDC if quinidine \\nfails to provide improve-\\nment; call 770-488-7788)\\n2.4 mg/kg IV at 0, 8, and 24  h, \\nthen daily. Artesunate can be \\ngiven IM if necessary.\\n2.4 milligrams/kg IV at 0, \\n8, and 24 h, then daily. \\nArtesunate can be given IM  \\nif necessary.\\nQuinidine gluconate \\n(plus doxycycline or \\nclindamycin)†\\n6.25 mg base (= 10 mg salt)/\\nkg IV load over 2 h (maximum, \\n600 mg), follow with 0.0125 mg \\nbase (= 0.02 mg salt)/kg/min \\ncontinuous infusion.\\n6.25 mg base (= 10 mg salt)/\\nkg IV load over 2 h (maximum, \\n600 mg), follow with 0.0125 mg \\nbase (= 0.02 mg salt)/kg/min \\ncontinuous infusion.\\nPlus\\nDoxycycline 2.2 mg/kg IV (up to adult \\ndose of 100 mg) every 12 h \\nfor 7 days.\\n2.2 mg/kg IV (up to adult \\ndose of 100 mg) every 12 h \\nfor 7 days\\nOr in children under age  \\n8 years\\nClindamycin 10 mg base/kg loading dose \\nIV followed by 5 mg base/kg \\nIV every 8 h for 7 days.\\n*Artesunate is considered the drug of choice by World Health Organization guidelines.\\n†Quinine dihydrochloride is an alternative to quinidine gluconate (20  mg [salt]/kg infused IV over  \\n2–4 hours, then 10 mg/kg every 8 hours, can be given IM if necessary, as 50  mg/mL solution).\\nAbbreviation: CDC = Centers for Disease Control and Prevention.\\n95_Cydulka_Ch95.indd   526 20/03/17   12:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 545, 'page_label': '527'}, page_content='527\\nFoodborne and  \\nWaterborne Diseases\\nBenjamin Weston\\nFoodborne disease may occur after consumption of food contaminated with \\nbacteria, viruses, parasites, chemicals, or biotoxins. Viruses such as norovi-\\nrus, astrovirus, rotavirus, and enteric adenovirus are the most common \\nsources, with norovirus causing over half of all cases. Bacterial disease is \\noften more severe and includes nontyphoidal Salmonella, which is the most \\ncommon cause for hospitalization and associated death in the United States. \\nOther bacterial causes may include Clostridium perfringens, Campylo-\\nbacter spp., Listeria monocytogenes, Shigella spp., Shiga toxin-producing \\nEscherichia coli, and Staphylococcus aureus. Parasitic causes include \\nGiardia lamblia, Toxoplasma gondii, Entamoeba histolytica, and Crypto-\\nsporidium. In addition, patients may experience symptoms of scombroid or \\nciguatera poisoning after eating some types of fish associated with these \\ntoxin-induced syndromes.\\nWaterborne diseases occur from ingestion or contact with contaminated \\nwater. Symptoms are most commonly gastrointestinal or dermatologic in \\nnature. Common organisms include those associated with foodborne illness \\nas well as Vibrio species, Aeromonas species, Pseudomonas aeruginosa, \\nYersinia species, hepatitis A, nontuberculous Mycobacterium, and other \\nless common organisms. The most common pathogen responsible for rec-\\nreational waterborne disease outbreaks is Cryptosporidium.\\n■ ■CLINICAL FEATURES\\nSymptoms of both foodborne and ingested waterborne illness include nau-\\nsea, vomiting, diarrhea, abdominal cramping, fever, dehydration, and mal-\\naise. A history of multiple family members or closely associated individuals \\nwith simultaneous symptoms is supportive of a suspected foodborne or \\ningested waterborne illness. Physical exam may reveal findings of dehydra-\\ntion, and some patients will have stool positive for frank or occult blood. \\nProlonged illness beyond two weeks suggests protozoan parasites. Shiga-\\ntoxin producing Escherichia coli (E. coli) infections may present with \\nvomiting, abdominal cramping, bloody diarrhea, and mild fever, and may \\nbe complicated by hemolytic uremic syndrome, especially if antibiotic \\ntreatment is prescribed.\\nPatients with scombroid fish or ciguatera poisoning have symptoms \\nsimilar to other foodborne illnesses and typically present one to six hours \\nafter ingestion. In addition to nausea and vomiting, patients with scom-\\nbroid poisoning frequently have flushing and headache due to a histamine-\\nmediated reaction. Those with ciguatera poisoning may have headaches, \\nmuscle aches, paresthesias, reversal of hot and cold sensation, or sensitiv-\\nity to extreme temperatures, due to sodium channel-mediated nerve  \\ndepolarizations.\\nThe skin manifestations of waterborne illness may include localized \\ncellulitis, painful indurated plaques of Mycobacterium marinum, or  \\n96\\nChApTER\\n96_Cydulka_Ch96.indd   527 20/03/17   12:18 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 546, 'page_label': '528'}, page_content='528 SECTION 10: Infectious and Immunologic Diseases\\nnecrotizing infections and hemorrhagic bulla associated with Vibrio   \\nvulnificus. Patients with Aeromonas hydrophila skin infections often have \\na history of trauma associated with freshwater exposure, and may have \\nfoul smelling wounds.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nDiagnostic testing is often not indicated as most of these illnesses are \\nself-limited. For those patients who are more acutely ill, or if other \\nsignificant diagnoses are being entertained, consider stool cultures with \\nGram stain, the neutrophil marker lactoferrin, electrolytes, and com-\\nplete blood count. Fecal leukocyte testing is neither sensitive nor spe-\\ncific for invasive disease, and is a poor predictor of response to \\nantibiotic treatment. Shiga toxin-producing E. coli and Vibrio cultures \\nmay require specific laboratory procedures (check local laboratory \\nguidelines). Reserve ova and parasite testing for those patients with \\nsymptoms over two weeks, immunocompromise, community water -\\nborne outbreaks, recent travel to endemic areas, or men who have sex \\nwith men. Clostridium difficile antigen testing may be indicated in those \\nwith prolonged symptoms, recent antibiotic use, significant comorbidi-\\nties, or extremes of age. Likely pathogens to consider in the differential \\ncan often be identified based on clinical features of the presenting  \\nillness (Table 96-1).\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nMost cases are self-limited and improve with supportive treatment.\\n1. Initiate rehydration with oral fluids, if tolerated. Intravenous rehydration \\nwith normal saline will benefit patients who are significantly dehydrated \\nor those with continued vomiting.\\n2. Antiemetics, such as metoclopramide 10 mg PO or IV , or ondansetron \\n4 PO or IV may facilitate oral rehydration. Antihistamines, such as \\ndiphenhydramine 25 mg PO or IV , may improve the symptoms of \\nscombroid fish poisoning.\\n3. Loperamide 4 mg initially, then 2 mg after ev ery unformed stool up to \\na maximum of 16 mg per day can be recommended for mild to moder -\\nate, nonbloody diarrhea in adults without fever.\\n4. Antibiotics are recommended for consideration in patients with mod-\\nerate to severe tra veler’s diarrhea, symptoms for more than 1 week, \\npatients requiring hospitalization, and immunocompromised hosts. \\nEmpiric antibiotics may include ciprofloxacin 500 mg PO twice per \\nday for 3 to 5 days or levofloxacin 500 mg PO once daily for 3 to \\n5 days. Antibiotics and antimotility agents are contraindicated in \\npatients with suspected E. coli 0157:H7 as these can increase the \\nrisks of developing hemolytic–uremic syndrome. For specific patho-\\ngen treatment protocols, see Tables 159-3 to 159-6 in Tintinalli’s \\nEmergency Medicine: A Comprehensive Study Guide, 8th edition, \\nChapter 159.\\n96_Cydulka_Ch96.indd   528 20/03/17   12:18 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 547, 'page_label': '529'}, page_content='CHAPTER 96: Foodborne and Waterborne Diseases  529 \\nTable 96-1 Clinical Features of Foodborne Infections\\nClinical presentation Foodborne pathogens\\nGastroenteritis with vomiting as the  \\nprimary symptom\\nViral pathogens: Norovirus, Rotavirus, \\nand Astrovirus; preformed toxins: \\nStaphylococcus aureus and Bacillus cereus\\nNoninflammatory diarrhea  \\n(watery, nonbloody)\\nCan be any enteric pathogen, but classically:\\nETEC\\nGiardia\\nVibrio cholera\\nEnteric viruses\\nCryptosporidium\\nCyclospora\\nInflammatory diarrhea  \\n(grossly bloody, fever)\\nShigella\\nCampylobacter\\nSalmonella\\nEIEC\\nShiga toxin-producing Escherichia coli \\nO157:H7 and non-O157:H7\\nVibrio parahaemolyticus\\nYersinia\\nEntamoeba\\nPersistent diarrhea (>14 days) Parasites:\\nGiardia\\nCyclospora\\nEntamoeba\\nCryptosporidium\\nNeurologic manifestations Botulism (Clostridium botulinum toxin)\\nScombroid fish poisoning\\nCiguatera fish poisoning\\nTetrodotoxin\\nToxic mushroom ingestion\\nParalytic shellfish poisoning\\nGuillain–Barré syndrome\\nSystemic illness Listeria monocytogenes\\nBrucella\\nSalmonella typhi\\nSalmonella paratyphi\\nVibrio vulnificus\\nHepatitis A and E\\nAbbreviations: EIEC, enteroinvasive E. coli; ETEC, enterotoxigenic E. coli.\\n5. Treat waterborne skin infections with tetanus vaccination and empiric \\nantibiotics (see Table 96-2). Patients with necrotizing infections should \\nhave surgical consultation to consider operative debridement.\\n6. Most patients can be treated as outpatients; admission is indicated in \\nthose appearing toxic, those with significant dehydration or uncontrolled \\nvomiting, the immunocompromised, or those at the extremes of age with \\nsignificant symptoms.\\n96_Cydulka_Ch96.indd   529 20/03/17   12:18 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 548, 'page_label': '530'}, page_content='530 SECTION 10: Infectious and Immunologic Diseases\\nTable 96-2 Treatment of Waterborne Skin Infections\\npathogen\\nClinical Features of  \\nSkin Infection Treatment\\nVibrio vulnificus Cellulitis with hemorrhagic  \\nbullae, septicemia\\nDoxycycline 100 mg IV twice \\nper day plus fourth-generation \\ncephalosporin; necrotizing infec-\\ntions require emergent surgical \\ndebridement\\nAeromonas species Cellulitis, necrotizing wound \\ninfections\\nMild infections: ciprofloxacin \\n500 mg PO twice per day; severe \\ninfections: ciprofloxacin 400 \\nmg IV twice per day plus an IV \\nantipseudomonal penicillin or \\nfourth-generation cephalosporin; \\nnecrotizing infections require \\nemergent surgical debridement\\nPseudomonas  \\naeruginosa\\nHot-tub folliculitis, cellulitis \\nin immunocompromised/\\ndiabetics\\nHot-tub folliculitis is usually \\nself-limited. Severe infection: \\nciprofloxacin 400 mg IV twice per \\nday plus an IV antipseudomonal \\npenicillin or fourth-generation \\ncephalosporin\\nMycobacterium  \\nmarinum\\nGranulomatous skin infections Clarithromycin 500 mg PO twice \\nper day or doxycycline 100 mg PO \\ntwice per day for 3 months; severe \\ncases: combine with rifampin or \\nethambutol\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, \\n8th ed., see Chapter 159, “Food and Waterborne Diseases,” by Lane M. Smith  \\nand Simon A. Mahler.\\n96_Cydulka_Ch96.indd   530 20/03/17   12:18 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 549, 'page_label': '531'}, page_content='531\\nZoonotic Infections\\nDavid Gordon\\nZoonotic infections are a class of specific diseases and infections that are \\nnaturally transmitted between vertebrate animals and humans. Transmis-\\nsion may occur via direct contact with an infected animal or animal \\nproduct, by ingestion of contaminated water or food products, by inhala-\\ntion, or through arthropod vectors—most commonly ticks. Diagnosis can \\nbe challenging because of the nonspecific nature of symptoms (e.g., fever, \\nheadache, and myalgias) which overlap with the presentation of many \\nother infectious and autoimmune diseases. Consider zoonotic infections \\nin patients presenting with viral-like illnesses in conjunction with occu-\\npational or geographical risk factors for zoonotic disease exposure and \\ntransmission. See Table 97-1 for a list of common systemic zoonotic \\n97\\nChapter\\nTable 97-1 Common Systemic Zoonotic Infections\\nagent\\nanimal \\nreservoir\\nphysical \\nFindings\\nDiagnostic \\ntests treatment\\nAeromonas \\nspecies\\nFish, reptiles Nonspecific \\nfever, severe \\ncrepitant cel-\\nlulitis with sys-\\ntemic toxicity, \\ngastroenteritis\\n— See Chapter 159, \\n“Food and Waterborne \\nIllnesses,” in Tintinalli’s \\nEmergency Medicine: \\nA Comprehensive \\nStudy Guide, 8th ed.\\nBrucella canis Dogs Nonspecific \\nfever\\nSerologic \\ntesting, blood \\nculture\\nDoxycycline plus \\ngentamicin or rifampin. \\nTMP-SMX plus \\ngentamicin in children\\nCapnocytophaga Dogs and \\ncats\\nFever, septic \\nshock, and \\nmeningitis from \\ninfected bite\\nCulture of bite \\nwound\\nAmoxicillin-clavulanate \\nor clindamycin.\\nPip-Tazo or a carbape-\\nnem plus clindamycin/\\nvancomycin for shock\\nChlamydophila \\npsittaci\\nBirds Fever, flu-like \\nillness, pneu-\\nmonia, endocar-\\nditis, sepsis\\nSerologic \\ntesting and \\nsputum \\nculture\\nDoxycycline. \\nAzithromycin and \\nlevofloxacin are \\nalternatives\\nCoxiella burnetii Cattle, \\nsheep, goats.\\nOccasionally \\ncats\\nFever, pneumo-\\nnia, hepatitis, \\nmeningitis, \\nendocarditis\\nSerologic \\ntesting, PCR\\nDoxycycline, with the \\npossible alternative of \\na fluoroquinolone or \\nmacrolide\\nEhrlichia species Ticks Nonspecific \\nfever, sepsis, \\nmeningitis, \\nhepatitis\\nClinical diagno-\\nsis, serologic \\ntesting, periph-\\neral blood \\nsmear, immu-\\nnocytologic \\ntesting, PCR\\nDoxycycline \\nrecommended \\nfor all patients \\n(even children and \\npregnancy). Rifampin \\nis alternative\\n(Continued)\\n97_Cydulka_Ch97.indd   531 20/03/17   2:03 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 550, 'page_label': '532'}, page_content='532 SECTION 10: Infectious and Immunologic Diseases\\nTable 97-1 Common Systemic Zoonotic Infections\\nagent\\nanimal \\nreservoir\\nphysical \\nFindings\\nDiagnostic \\ntests treatment\\nLeptospira \\nspecies\\nBirds, dogs, \\nrodents\\nFever, \\npneumonia,  \\nconjunctivitis, \\nlymphade-\\nnopathy\\nDarkfield \\nmicroscopic \\nexamination \\nof body fluids, \\nserologic \\ntesting\\nPenicillin G IV. \\nCeftriaxone IV alterna-\\ntive. Mild disease: oral \\ndoxycycline or amoxicil-\\nlin or azithromycin\\nFrancisella \\ntularensis\\nRabbits, \\ncats, wild \\nanimals, bit-\\ning insects\\nFever, sepsis, \\nmeningitis, \\npneumonia, \\nhepatitis, rash\\nSerologic \\ntesting (poses \\nhazards to \\nlaboratory \\nstaff)\\nIV aminoglyco-\\nsides. Alternative: \\nDoxycycline or cipro-\\nfloxacin\\nRickettsia \\nrickettsii\\nTicks Fever, diar-\\nrhea, or \\ntypical presen-\\ntation of Rocky \\nMountain \\nspotted fever\\nClinical diag-\\nnosis, rise in \\nantibody titer \\nbetween acute \\nand convales-\\ncent serum, \\nskin biopsy\\nDoxycycline or chlor-\\namphenicol\\nSalmonella \\nenterica\\nDogs, cats \\n(rarely), rep-\\ntiles (turtles)\\nFever, abdomi-\\nnal pain, sep-\\nsis, cellulitis, \\nmeningitis, \\nendocarditis, \\nseptic arthritis\\nBlood or stool \\nculture\\nFluoroquinolones \\nor third-generation \\ncephalosporins\\nStreptococcus \\niniae cellulitis\\nFish, seafood Fever, cellulitis Wound \\nculture, blood \\nculture\\nβ-Lactams except \\naztreonam. \\nAlternatives: \\nAzithromycin, clindamy-\\ncin, fluoroquinolones\\nYersinia pestis Dogs, cats, \\nrodents\\nBubonic: fever, \\nheadache, \\nbuboes, or \\npneumonic: \\ncough, chills, \\ndyspnea, shock\\nBlood culture, \\nculture of sus-\\npected sites\\nDoxycycline, fluoro-\\nquinolone, gentami-\\ncin, streptomycin, or \\nchloramphenicol\\nAbbreviations: PCR, polymerase chain reaction; Pip-Tazo, piperacillin-tazobactam; TMP-SMX, \\ntrimethoprim-sulfamethoxazole.\\n(Continued)\\ninfections and Table 97-2 for specific treatment recommendations for \\ntick-borne diseases.\\n■ ■rOCKY MOUNtaIN SpOtteD FeVer\\nRocky Mountain spotted fever (RMSF) is a tick-borne disease caused by \\nRickettsia rickettsii, a pleomorphic obligate intracellular organism. The \\nprimary vectors for transmission are the American dog tick (Dermacentor \\nvariabilis), Rocky Mountain wood tick (Dermacentor andersoni) and the \\nbrown dog tick (Rhipicephalus sanguineus). Most cases occur between \\nApril and September with peak occurrences in June and July. While \\n97_Cydulka_Ch97.indd   532 20/03/17   2:03 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 551, 'page_label': '533'}, page_content='CHAPTER 97: Zoonotic Infections 533 \\nTable 97-2 tick-borne Zoonotic Infections and Specific treatment\\ntick-borne Zoonotic Infection Specific treatment\\nRocky Mountain spotted fever Doxycycline 100 mg PO or IV twice a day for 7 days, or for 2 days after temperature normalizes. Some recommendations exist \\nfor an initial loading dose of 200 mg. For children weighing < 45 kg, the dose is 2.2 mg/kg twice daily. Although doxycycline  \\nis contraindicated for use in pregnancy, it may be warranted in life-threatening situations. Chloramphenicol is an alternative; \\nhowever, it has multiple toxic effects and contraindications, and may be difficult to obtain. Dosing is 50 mg/kg/d divided into four \\ndoses for 7 days.\\nLyme disease Primary stage or mild secondary: 14–21 days of doxycycline (100 mg PO twice a day), amoxicillin (500 mg PO three times a day in \\nadults, 50 mg/kg/d divided three times a day in children), or cefuroxime (500 mg PO twice a day in adults, 30 mg/kg/d divided three \\ntimes a day in children). Macrolides possible but less effective.\\nSevere illness, CNS positive, or high-degree heart block: ceftriaxone 2 g IV for 14–30 days.\\nA single 200-mg oral dose of doxycycline given within 72 h of a high-risk deer tick bite is effective in preventing Lyme disease.\\nTick-borne relapsing fever Doxycycline (100 mg PO/IV twice a day for 7–10 days). Alternative: erythromycin (500 mg PO/IV four times a day for 7–10 days).\\nChloramphenicol is an alternate.\\nColorado tick fever Treatment is supportive.\\nTularemia Adults: streptomycin, 1 g IM/IV twice a day, or gentamicin/tobramycin, 5 mg/kg IV divided every 8 h. Treat for 10 days.\\nChildren: streptomycin, 15 mg/kg IM twice daily (should not exceed 2 g/d).\\nMild disease: ciprofloxacin 750 mg PO twice a day or doxycycline 100 mg PO twice a day. Treat for 21 days.\\nProphylaxis for lab exposures: doxycycline 100 mg PO twice a day or ciprofloxacin 500 mg PO twice a day. Treat for 14 days.\\nBabesiosis Atovaquone (750 mg PO every 12 h) plus azithromycin (500 mg PO on day 1, then 250–1000 mg daily). Treat for 10 days.\\nIf relapse occurs, treat for the longer duration: 6 weeks or 2 weeks after negative blood smear.\\nSevere disease in adults: clindamycin (1200 mg IV twice a day or 600 mg PO three times a day) + quinine (650 mg PO three times a \\nday). Treat for 7–10 days.\\nEhrlichiosis and anaplasmosis Doxycycline, 100 mg PO twice a day for 7–14 days. For children weighing <45 kg, the dose is 2.2 mg/kg twice a day.\\n97_Cydulka_Ch97.indd   533 20/03/17   2:03 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 552, 'page_label': '534'}, page_content='534 SECTION 10: Infectious and Immunologic Diseases\\ncases have been reported in the majority of the continental United States, \\nmore than 60% ha ve originated from five states: North Carolina, Tennes-\\nsee, Oklahoma, Missouri, and Arkansas.\\nClinical Features\\nEarly findings of RMSF include fever, headache, myalgias, and malaise. \\nPatients may also present with lymphadenopathy, nausea, vomiting, and \\ndiarrhea. In some patients, particularly children, abdominal pain and edema \\nmay be present. Late in the disease course, complications may include \\nmeningitis, encephalitis, renal failure, respiratory failure, and myocarditis.\\nThe classic clinical triad for RMSF of fever, rash, and history of tick bite \\nis uncommon as only about 50% of infected patients can recall a tick bite \\nand the rash is absent in about 10% of cases. When the rash does occur, it \\ntypically develops 2 to 4 days after the onset of fever as a maculopapular \\neruption that may subsequently become petechial. Rash often appears on \\nthe ankles and wrists and then spreads centripetally to the trunk, usually \\nsparing the face, and characteristically involves the palms and soles.\\nDiagnosis and Differential\\nThe diagnosis of RMSF is largely clinical, with confirmation coming \\nafter treatment is initiated. In the absence of an alternative explanation, \\nconsider the possibility of RMSF in a febrile patient with a headache who \\nlives in or recently traveled through an endemic region in the spring or \\nsummer seasons with possible exposure to ticks. Laboratory abnormali-\\nties are usually nonspecific, but RMSF is suggested by the combination \\nof normal white and red cells, thrombocytopenia, elevated liver function \\ntests, and hyponatremia. RMSF can be confirmed—typically outside of \\nthe emergency department setting—with a rise in antibody titer between \\nacute and convalescent sera or via skin biopsy of the rash with immuno-\\nfluorescence testing.\\nThe differential diagnosis for patients with symptoms of RMSF includes \\nviral illnesses, pneumonia, meningococcemia, ehrlichiosis, Kawasaki’s \\ndisease, toxic shock syndrome, scarlet fever, and leptospirosis.\\nemergency Department Care and Disposition\\n1. Recommended treatment for adults is doxycycline 100 mg PO or IV \\ntwice a day. Some recommend an initial loading dose of 200 mg. Treat-\\nment should continue for 7 days or until 3 days after resolution of fever.\\n2. Antibiotic therapy for children weighing <45 kg is doxycycline 2.2 mg/\\nkg PO twice a day. Doxycycline has been used for short courses in chil-\\ndren without significant staining of the teeth, and is recommended as \\ntherapy by both the American Academy of Pediatrics and Centers for \\nDisease Control and Prevention as the treatment of choice for rickettsial \\ndiseases in children of all ages.\\n■ ■LYMe DISeaSe\\nLyme disease remains the most common vector-borne zoonotic infection \\nin the United States. The responsible organism is the spirochete Borrelia \\nburgdorferi and the vector is the Ixodes deer tick (also known as the \\n97_Cydulka_Ch97.indd   534 20/03/17   2:03 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 553, 'page_label': '535'}, page_content='CHAPTER 97: Zoonotic Infections 535 \\nblack-legged tick). In highly endemic areas, the transmission rate from a \\ndeer tick bite is about 3%, although there is minimal risk if the duration \\nof attachment is < 36 hours. Cases have been reported in all 48 continen-\\ntal states, but 95% of cases originate from 13 states in the northeast and \\nnorthern midwest with peak disease transmission in May through \\nAugust.\\nClinical Features\\nLyme disease is typically divided into three distinct stages although some \\npatients may not progress through all stages, and stages may overlap or be \\nseparated by periods of remission. The first stage involves early localized \\ndisease and is characterized by the rash of erythema migrans which may be \\nin conjunction with nonspecific constitutional and rheumatologic symp-\\ntoms. The characteristic rash occurs within 2 to 30 days in 60% to 80% of \\ncases, often begins at the site of the tick bite, and manifests as an ery-\\nthematous plaque with central clearing. Other associated symptoms in the \\nfirst stage of lyme disease include fatigue, headache, fever, neck stiffness, \\nmyalgias, arthralgias, and adenopathy.\\nThe second stage, early disseminated disease, occurs within a few \\ndays to 6 months after initial infection. This stage is characterized by \\nmultiple secondary annular target-shaped skin lesions, fever, adenopathy, \\nneuropathies, cardiac abnormalities, and arthritic problems. Approxi-\\nmately 15% of untreated patients develop neurologic complications such \\nas cranial neuritis that may lead to the classically described bilateral \\nfacial nerve palsy. Other neurologic manifestations include headache, \\nneck stiffness, difficulty with mentation, cerebellar ataxia, myelitis, \\nencephalitis, motor or sensory radiculoneuritis, and mononeuritis multi-\\nplex. Oligoarticular arthritis can occur, usually affecting the large joints \\nsuch as the knees. In 8% of patients, there are cardiac manifestations such \\nas myopericarditis or varying degrees of atrioventricular (A V) block, \\nwhich sometimes can require a temporary pacemaker for stabilization.\\nThe third stage, late disseminated disease, occurs months to years after \\ninitial infection. It can be characterized by chronic arthritis, myocarditis, \\nsubacute encephalopathy, axonal polyneuropathy, and leukoencephalopa-\\nthy. Symptoms can persist for a decade or more.\\nDiagnosis and Differential\\nInitial diagnosis of Lyme disease is based primarily on clinical features. \\nConfirmation may be obtained via polymerase chain reaction (PCR) test-\\ning, polyvalent fluorescence immunoassay, or western immunoblot testing. \\nDifferential diagnosis depends on clinical manifestation of the disease \\nstage, and may include southern tick-associated rash illness (STARI), cel-\\nlulitis, erythema multiforme, tinea corporis, viral or bacterial meningitis, \\nencephalitis, rheumatic fever, septic arthritis, endocarditis, and other \\ninflammatory or autoimmune conditions.\\nemergency Department Care and Disposition\\n1. Treat primary stage or mild secondary Lyme disease with 14 to 21 days \\nof doxycycline 100 mg PO twice a day in adults, 2.2 mg/kg twice daily \\nfor children <45 kg, amoxicillin 500 mg PO three times a day in adults, \\n97_Cydulka_Ch97.indd   535 20/03/17   2:03 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 554, 'page_label': '536'}, page_content='536 SECTION 10: Infectious and Immunologic Diseases\\n50 mg/kg/d divided three times a day in children, or cefuroxime 500 mg \\nPO twice a day in adults, 30 mg/kg/d divided three times a day in \\nchildren. Macrolides are less effective.\\n2. Treat severe illness, meningitis, radiculopath y, or high-degree heart \\nblock from lyme disease with ceftriaxone 2 g IV daily in adults, 50 to \\n75 mg/kg daily in children for 14 to 30 days.\\n3. Routine antibiotic prophylaxis for Lyme disease following a tick bite is \\nnot recommended. A single dose of doxycycline 200 mg in adults and 4 \\nmg/kg in children at least 8 years old may be considered for a deer tick \\nbite in areas highly endemic for Lyme disease when the suspected time \\nof tick attachment is at least 36 hours and prophylaxis can be adminis-\\ntered within 72 hours of tick removal.\\n■ ■ehrLIChIOSIS\\nEhrlichiosis is a group of zoonotic diseases caused by infection from the \\nEhrlichia genus. These are small, gram-negative pleomorphic coccobacilli \\nthat infect circulating leukocytes. The lone star tick (Amblyomma america-\\nnum) serves as the primary vector while the white-tailed deer is the major \\nanimal reservoir in the southeastern United States.\\nClinical Features\\nSymptoms usually develop within 1 to 2 weeks after a tick bite. Clinical \\nmanifestations may include fever, headache, malaise, nausea, vomiting, \\ndiarrhea, abdominal pain, and arthralgias. Fever is present in a majority of \\ncases (97%). A rash of variable appearance may be present but is not com-\\nmon. A minority of patients progress to serious complications that may \\ninclude renal failure, respiratory failure, and encephalitis.\\nDiagnosis and Differential\\nDiagnosis initially must be made on clinical grounds. Laboratory clues may \\ninclude leukocytopenia, thrombocytopenia, and elevation of hepatic \\nenzymes. During the first week of illness, a peripheral blood smear may \\nshow colonies of bacteria in the white blood cells in 20% of infected \\npatients. PCR offers a specific test for confirmation but is not sensitive \\nenough to be used to exclude illness based only on a negative result. An \\nincrease in antibody titer between the acute and convalescent phases of the \\nillness may be used for diagnosis. The gold standard for diagnosis is an \\nimmunofluorescence assay.\\nThe differential diagnosis includes RMSF, Lyme disease, babesiosis, \\nanaplasmosis, viral illnesses, cholecystitis/cholangitis, malaria, meningitis, \\nand typhoid.\\nemergency Department Care and Disposition\\n1. Doxycycline 100 mg PO twice a day in adults, 2.2 mg/kg twice daily for \\nchildren <45 kg is first-line treatment for adults and children of all ages. \\nTreatment should continue until 3 to 5 days after fever resolution or 10 \\nto 14 days after resolution of CNS symptoms in severe disease.\\n2. Rifampin 300 mg twice a day for adults can be used for patients with \\ncontraindications to doxycycline.\\n97_Cydulka_Ch97.indd   536 20/03/17   2:03 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 555, 'page_label': '537'}, page_content='CHAPTER 97: Zoonotic Infections 537 \\n■ ■tULareMIa\\nTularemia is caused by Francisella tularensis, a small, gram-negative, non-\\nmotile intracellular coccobacillus. The zoonotic vectors are ticks of the \\nDermacentor (wood tick, dog tick) and Amblyomma (lone star tick) species. \\nThe principal animal reservoirs include rabbits, hares, and deer. Methods of \\ntransmission include tick or fly bites, inhalation, and direct inoculation of \\nbroken skin or mucosa from the handling of infected animals.\\nClinical Features\\nClinical features at presentation depend on the route of inoculation. The \\nmost common ulceroglandular form is characterized by a maculopapular \\nlesion that ulcerates at the site of a tick bite or wound inoculation, fol-\\nlowed by painful regional adenopathy and systemic symptoms. Glandular  \\ntularemia consists of tender regional adenopathy without ulceration. The \\ntyphoidal form has the highest morbidity and complications such as organ \\nfailure, and it presents with fever, chills, headache, and abdominal pain. \\nOcular-oropharyngeal and pneumonic forms of the disease result from \\nairborne deposition into the eyes and lungs.\\nDiagnosis and Differential\\nLaboratory findings are nonspecific in all forms of tularemia. Diagnosis \\ncan be determined by culture, direct fluorescent antibody, or PCR from \\nspecimens obtained by skin lesion swabs, lymph node sampling, or spu-\\ntum. The multiple clinical variations of tularemia lead to a broad differ -\\nential diagnosis that include pyogenic bacterial infection, syphilis, \\nanthrax, plague, Q fever, psittacosis, typhoid, brucellosis, and rickettsial \\ninfection.\\nemergency Department Care and Disposition\\n1. Treat adults with streptomycin 1 g IM twice a day or gentamicin 5 mg/\\nkg/d IM or IV divided every 8 hours. Treat for 10 days.\\n2. Treat pediatric patients with streptomycin  15 mg/kg IM twice a day \\n(maximum daily dose 2 g), or gentamycin 2.5 mg/kg IM/IV two or \\nthree times a day. Treat for 10 days.\\n3. Treat mild disease in adults with ciprofloxacin 750 mg PO twice a day \\nor doxycycline 100 mg PO twice a day for 21 days.\\n■ ■aNthraX\\nAnthrax is an acute bacterial infection caused by Bacillus anthracis, an \\naerobic gram-positive rod that forms central oval spores. Human infection \\ncan result from inhalation of spores, inoculation of broken skin, bites from \\narthropods (fleas), or ingestion of inadequately cooked meat that is infected \\nwith the organism.\\nClinical Features\\nInhaled or pulmonic anthrax usually results from handling unsterilized, \\nimported animal hides, or imported raw wool. It results in a mediastinitis, \\nrather than a true pneumonia, and is almost always fatal. Initial \\n97_Cydulka_Ch97.indd   537 20/03/17   2:03 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 556, 'page_label': '538'}, page_content='538 SECTION 10: Infectious and Immunologic Diseases\\npresentation consists of flu-like symptoms, which progress ov er 2 to  \\n3 days to include marked mediastinal and hilar edema and respiratory \\nfailure. Cutaneous anthrax (woolsorter’s disease) accounts for 95% of all \\nanthrax infections and begins with a pruritic macule at the inoculation site \\n(most commonly fingers) that then progresses to an ulcerative lesion with \\nmultiple infectious serosanguinous vesicles containing the anthrax bacil-\\nlus. The ulcer eventually progresses to a painless black eschar and falls \\noff within 2 weeks. A small minority of untreated patients develop rapidly \\nfatal bacteremia.\\nDiagnosis and Differential\\nGram stain, direct fluorescent antibody stain, or culture of skin lesions or \\nfluid from vesicles may establish the diagnosis. Blood cultures may also be \\npositive. The differential diagnosis for inhalational anthrax includes influ-\\nenza, tuberculosis, and other causes of mediastinitis (bacterial, viral, para-\\nsitic, sarcoidosis). With symptoms suspicious for cutaneous anthrax, \\nwarfarin necrosis, calciphylaxis, ischemic necrosis, tularemia, plague, spi-\\nder/insect bite, mycobacterial infection, ecthyma gangrenosum, and asper -\\ngillosis/mucormycosis may also be considered.\\nemergency Department Care and Disposition\\n1. The initial antibiotic therapy for patients with systemic anthrax with \\npossible or confirmed meningitis consists of ciprofloxacin 400 mg IV \\nevery 8 hours plus meropenem 2 g every 8 hours plus linezolid 600 \\nmg every 12 hours. Also, a one-time infusion of raxibacumab 40 mg/\\nkg diluted over 2.25 hours should be considered. Systemic anthrax in \\npatients when meningitis has been excluded can be treated with \\nciprofloxacin 400 mg IV every 8 hours plus clindamycin 900 mg \\nevery 8 hours or linezolid 600 mg every 12 hours. Consultation with \\ninfectious disease specialists is recommended for assistance in man-\\naging these patients.\\n2. Treat cutaneous anthrax without systemic involvement with ciprofloxa-\\ncin 500 mg PO every 12 hours or doxycycline 100 mg PO every 12 \\nhours. Duration of treatment is a 7- to 10-day course if naturally \\nacquired from animals with anthrax and not suspected from a bioterror -\\nism-related or aerosolized exposure. Duration of treatment is 60 days for \\nbioterrorism-related cases.\\n3. A 60-day antibiotic course combined with a three-dose vaccination \\ncourse may be considered as postexposure prophylaxis for e xposed in-\\ndividuals, although the vaccine is not currently FDA approved for this \\npurpose.\\n■ ■pLaGUe\\nPlague is caused by Yersinia pestis, which is a gram-negative aerobic \\nbacillus. In the United States, it is found most often in rock squirrels and \\nground rodents of the southwest. The rodent flea serves as the primary \\nvector. Transmission to humans occurs through the bite of an infected \\nflea, consuming infected animals, or inhalation of animal secretions.\\n97_Cydulka_Ch97.indd   538 20/03/17   2:03 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 557, 'page_label': '539'}, page_content='CHAPTER 97: Zoonotic Infections 539 \\nClinical Features\\nAn eschar frequently develops at the site of the flea bite and is followed \\nby the development of an enlarged, suppurative, proximal lymph node \\nknown as a bubo. Sepsis and pneumonia may develop due to hematologic \\nspread of the bacteria. Bubonic plague often presents with fever, headache, \\nand buboes, while the pneumonic form of the disease is typically associ-\\nated with cough, chills, dyspnea, and shock. The pneumonic form of the \\nplague is highly contagious and can be transmitted from person to person \\nvia aerosolized respiratory secretions and can be rapidly fatal if not treated \\naggressively.\\nDiagnosis and Differential\\nDiagnosis of plague is typically made based on clinical findings in a patient \\nwith possible contact with a vector or animal host. Blood culture or culture \\nof suspected sites may reveal organisms, but treatment should be initiated \\nin suspected cases without awaiting culture results. The differential diagno-\\nsis includes lymphogranuloma venereum, syphilis, staphylococcal or strep-\\ntococcal lymphadenitis, other causes of pneumonia, or tularemia.\\nemergency Department Care and Disposition\\n1. Recommended antimicrobials are gentamicin 5 mg/kg IM/IV daily or \\nstreptomycin 15 mg/kg (or 1 g) IM twice a day. Treat for 10 days.\\n2. Pediatric dosing of gentamicin is 2 to 2.5 mg/kg/dose IM/IV ev ery  \\n8 hours.\\n3. Alternatives include doxycycline 100 mg IV twice a day (or 200 mg IV \\ndaily), ciprofloxacin 400 mg IV twice a day, or chloramphenicol  \\n25 mg/kg IV every 6 hours. Treat for 10 days.\\n■ ■FUrther reaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 160, “Zoonotic Infections” by Bryan B. Kitch and \\nJohn T. Meredith\\n97_Cydulka_Ch97.indd   539 20/03/17   2:03 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 558, 'page_label': '540'}, page_content='540\\nWorld Travelers\\nBret A. Nicks\\nPatients returning from travel abroad may present with fever or other symp-\\ntoms of infection. The evaluation of a potential infectious disease in a \\nreturning traveler requires an understanding of the geographical distribu-\\ntion of infections (Table 98-1), risk factors, incubation periods, clinical \\nmanifestations, and appropriate laboratory investigations. The Centers for \\nDisease Control and Prevention (CDC) website provides additional health \\ninformation for travelers based on specific locations around the world: \\nhttp://wwwnc.cdc.gov/travel/destinations/list/. Some specific disease pro-\\ncesses are covered elsewhere in this book: traveler’s diarrhea, enteroviral \\ninfections, gastroenteritis, giardiasis, salmonellosis, and shigellosis are \\ndiscussed in Chapters 37 and 96, anthrax and plague are discussed in Chap-\\nter 97, and malaria is discussed in Chapter 95. This chapter covers some of \\nthe other common infectious diseases that may present in patients returning \\nfrom travel outside of the United States.\\n■ ■CLINICAL FEATURES\\nThe incubation periods for many diseases are commonly longer than an \\nindividual traveler’s foreign stay, and therefore travelers who are exposed \\nto infectious diseases often develop symptoms of disease after they return \\nfrom travel. Ask patients about visits to game parks, farms, caves, health \\nfacilities, consumption of exotic foods, activities involving fresh or salt \\nwater exposure, insect exposure, sexual activities, reported epidemics in \\nthe area visited, contact with ill people, and any pre-trip immunizations \\nand prophylactic antibiotics that have been taken. Determine the chrono-\\nlogical history of disease progression, including details about the quality, \\nseverity, duration, and episodic nature of fever and chills. When complet-\\ning a complete history and physical examination, note the presence of any \\n98\\nCh A p TER\\nTable 98-1 Regional Tropical Illnesses\\nAfrica: malaria, human immunodeficiency virus, TB, hookworm, tapeworm, roundworm, \\nbrucellosis, yellow fever (and other hemorrhagic fevers such as Lassa fever or Ebola), \\nrelapsing fever, schistosomiasis, tick typhus, filariasis, strongyloidiasis\\nCentral and South America: malaria, relapsing fever, dengue fever, filariasis, TB, \\nschistosomiasis, Chagas’ disease, typhus, Zika virus\\nMexico and the Caribbean: dengue fever, hookworm, malaria, cysticercosis, amebiasis, \\nZika virus\\nAustralia, New Zealand: dengue fever, Q fever, Murray Valley encephalitis, Japanese \\nencephalitis\\nMiddle East: hookworm, malaria, anthrax, brucellosis\\nEurope: giardiasis, Lyme disease, tickborne encephalitis, babesiosis\\nChina and East Asia: dengue fever, hookworm, malaria, strongyloidiasis, hemorrhagic \\nfever, Japanese encephalitis\\nAbbreviation: TB, tuberculosis.\\n98_Cydulka_Ch98.indd   540 20/03/17   2:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 559, 'page_label': '541'}, page_content='CHAPTER 98: World Travelers 541 \\nabnormal findings such as fever , skin rash, hepatosplenomegaly, lymph-\\nadenopathy, and jaundice (Table 98-2).\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nEvaluate the results of laboratory studies to assess for abnormalities sug-\\ngestive of specific disease processes. On a CBC with differential, look for \\nlymphopenia (dengue, HIV , typhoid), eosinophilia (parasites, fungal dis-\\nease), or thrombocytopenia (malaria, dengue, acute HIV , typhoid). Con-\\nsider a blood smear and dipstick antigen test for malaria, if available, for \\ntravelers with fever who have recently visited endemic locations. Urinalysis \\nmay show proteinuria and hematuria in cases of leptospirosis. Obtain liver \\nfunction tests if physical examination identifies jaundice. Consider testing \\nfor specific diseases suspected by symptoms and risk of exposure. Obtain a \\nchest radiograph when respiratory symptoms are present, and consider a \\nliver ultrasound if amoebic liver abscess is suspected.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Dengue fever is commonly known as break-bone fever, and is spread by \\nthe day-biting Aedes aegypti mosquito and caused by one of four differ-\\nent dengue viruses. Incubation is 4 to 7 days. Symptoms are high fever, \\nheadache, nausea, vomiting, myalgias, and rash. Dengue hemorrhagic \\nfever, while classically associated with dengue in Southeast Asia, con-\\ntinues to expand globally and is characterized by high fever, vascular \\npermeability, bleeding, hepatomegaly, and shock. Make the diagnosis \\nusing PCR (1 to 8 days after symptom onset) or IgM ELISA (after  \\n4 days of symptoms). Daily blood counts are recommended. Outpatient \\ntreatment can be recommended in mild cases, with oral hydration as \\ntolerated and close follow-up for blood work. Avoid aspirin and \\nNSAIDs. Inpatient treatment is recommended for a drop of hemoglobin \\nor platelets, hemorrhagic symptoms, or abnormal vital signs.\\n2. Chikungunya is a common arbovirus infection in returning travelers. \\nSince 2013 when local transmission was first recognized in the \\nTable 98-2 physical Findings in Selected Tropical Infections\\nphysical Finding Likely Infection or Disease\\nRash Dengue fever, typhus, syphilis, gonorrhea, Ebola fever, brucellosis, \\nchikungunya, HIV seroconversion, Zika virus\\nJaundice Hepatitis, malaria, yellow fever, leptospirosis, relapsing fever\\nLymphadenopathy Rickettsial infections, brucellosis, HIV, Lassa fever, leishmaniasis, \\nEpstein–Barr virus, cytomegalovirus, toxoplasmosis, trypanosomiasis\\nHepatomegaly Amebiasis, malaria, typhoid, hepatitis, leptospirosis\\nSplenomegaly Malaria, relapsing fever, trypanosomiasis, typhoid, brucellosis,  \\nkala-azar, typhus, dengue fever, schistosomiasis\\nEschar Typhus, borreliosis, Crimean–Congo hemorrhagic fever, anthrax\\nHemorrhage Lassa, Marburg, or Ebola viruses; Crimean–Congo hemorrhagic \\nfever; meningococcemia, epidemic louse-borne typhus\\nAbbreviation: HIV, human immunodeficiency virus.\\n98_Cydulka_Ch98.indd   541 20/03/17   2:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 560, 'page_label': '542'}, page_content='542 SECTION 10: Infectious and Immunologic Diseases\\nAmericas, it has expanded to 45 countries or territories. This disease \\nspreads by day-biting mosquitos (Aedes aegypti and Aedes albopictus), \\nand presents very much like classic dengue fever with generalized \\narthralgia that progresses to chronic arthropathy in 5% to 30% of \\npatients. Use PCR to diagnose 1 to 4 days after symptom onset or test \\nfor IgM levels after 5 days of symptoms. There is no preventative vac-\\ncine and no specific medication to treat chikungunya virus infection. \\nTreatment is supportive and can include rest, fluids, and NSAIDs to \\nrelieve pain and fever. People infected with chikungunya should avoid \\nfurther mosquito exposure during the first week of illness to reduce the \\nrisk of local transmission.\\n3. Zika virus is spread through the Aedes species mosquito. First discov-\\nered in 1947, outbreaks have been reported in Africa, Southeast Asia, \\nand the Pacific Islands—including an outbreak in Brazil and the \\nAmericas starting in 2015. Symptoms are commonly fever, rash, joint \\npain, and conjunctivitis. The illness is usually mild and lasts for less \\nthan a week. Development of Guillain-Barré syndrome and congenital \\nmicrocephaly has been associated with Zika virus infection. Treatment \\nis supportive as no specific antiviral treatment is available for Zika \\nvirus disease.\\n4. Typhoid fever, also known as enteric fever, is caused by Salmonella \\ntyphi and Salmonella paratyphi. Transmission is from contaminated \\nfood or water, after contact with the infected urine or feces of symptom-\\natic individuals, or asymptomatic carriers. Incubation is 1 to 3 weeks, \\nand typhoid fever commonly lasts more than 10 days in returning travel-\\ners. Initial symptoms include fever with headache, and this progresses \\nto high fevers with chills, headache, cough, abdominal distention, myal-\\ngias, constipation, and prostration. A classic presentation is a relative \\nbradycardia despite a high fever, but this is often absent. After several \\ndays, a pale red macular rash known as “rose spots” appears on the \\ntrunk. Complications may include small bowel ulceration, anemia, dis-\\nseminated intravascular coagulopathy (DIC), pneumonia, meningitis, \\nmyocarditis, and renal failure. Diagnosis is made based on clinical find-\\nings and can be confirmed by stool culture. Treat with ceftriaxone 2 g \\nIV or IM for 14 days, or ciprofloxacin 500 to 750 mg PO twice daily \\nfor 14 days. For severe typhoid fever complicated by delirium, coma, \\nshock, or DIC, administer an initial dose of dexamethasone 3 mg/kg \\nIV . Blood transfusions may be required in severe cases.\\n5. Brucellosis is caused by the bacteria Brucella, and is most commonly \\ncontracted by contact with cattle, goats, camels, dogs, pigs, or after \\ningestion of unpasteurized milk or cheese. Symptoms include fe ver, \\nabdominal pain, back pain, fatigue, headache, joint pain, and loss of \\nappetite. Relapsing fever or a chronic low-grade fever is characteristic. \\nPatients often have lymphadenopathy, hepatomegaly, and splenomeg-\\naly, and may develop a septic arthritis. Make the diagnosis based on \\nblood culture results or confirmatory serology testing. Consult infec-\\ntious disease to align treatment with doxycycline, rifampicin, strepto-\\nmycin or gentamicin for 2 weeks with appropriate follow-up.\\n6. Rickettsial spotted fevers  are transmitted by the bite, body fluid, or \\nfeces of ixodid arthropod ticks. Mortality without treatment \\napproaches 25%. Scrub typhus (Rickettsia orientalis) and African tick \\n98_Cydulka_Ch98.indd   542 20/03/17   2:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 561, 'page_label': '543'}, page_content='CHAPTER 98: World Travelers 543 \\ntyphus (R. conorii) are the most common forms in trav elers returning \\nfrom Southeast Asia and Africa, respectively. Incubation period is  \\n3 to 14 days. Symptoms may include fever, malaise, myalgias, severe \\nheadache, rash, nausea, and vomiting followed by lymphadenopathy \\nand splenomegaly. The skin lesion in scrub typhus starts as a papule \\nat the bite site, which later becomes necrotic and forms a crusted \\nblack eschar. Make the diagnosis based on clinical findings and use \\nserologic tests to confirm the diagnosis after empiric treatment with \\ndoxycycline 100 mg twice daily for 7 to 10 days.\\n7. Epidemic Louse-Borne T yphus is common in Mexico, Guatemala, \\nEthiopia, and the Himalayas, and is caused by R. prowazekii. This ill-\\nness is distinct from the disease caused by S. typhi. Incubation period \\nis 8 to 12 days, and patients may or may not be aware of the louse \\nexposure. Symptoms include high fevers, severe headache, and a \\nmaculopapular rash between 4 and 7 days. Make the diagnosis based \\non clinical features and use serologic tests to confirm the diagnosis \\nafter empiric treatment with doxycycline 100 mg twice daily for 7 to \\n10 days.\\n8. Leptospirosis occurs after fresh water e xposure to Leptospira inter -\\nrogans or after exposure to infected dogs. Incubation period is 2 to 20 \\ndays. Symptoms include high fever, severe headache, chills, myalgias, \\nhepatitis, and conjunctival injection. Confirmation of this diagnosis is \\nby serology. Treat mild disease within 3 days of symptoms with \\namoxicillin 500 mg three times daily or doxycycline 100 mg twice \\ndaily. Treat severe cases with penicillin G 5 MU every 6 hours IV , or \\nceftriaxone 1 g IV or IM daily for 7 to 14 days.\\n9. Crimean–Congo hemorrhagic fever is a tick-borne viral disease that \\nis rising in frequency in Africa, Asia, Eastern Europe, and the Middle \\nEast. Agricultural workers are at the greatest risk, but this infection \\ncan also be acquired from contact with the blood of infected individu-\\nals. Symptoms include sudden onset of fever, headache, myalgia, \\ndizziness, and possibly mental confusion. The hemorrhagic period \\nstarts the third to fifth day of illness with epistaxis, hemoptysis, GI \\nbleeding, vaginal bleeding, or hematuria. Patients may have laboratory \\nabnormalities such as thrombocytopenia, elevated liver enzymes and \\ncreatinine, or prolonged prothrombin time and activated partial throm-\\nboplastin time. Make the diagnosis based on clinical findings and \\nconfirm with serology. Treatment is supportive and may require trans-\\nfusions or respiratory support in severe illness. For moderate to severe \\nillness, treat with ribavirin.\\n10. Yellow fever is caused by a flavivirus transmitted by a day-biting mos-\\nquito, and occurs along a broad equatorial belt in South and Central \\nAmerica and Africa. Symptoms range from a mild flu-like illness to \\nhemorrhagic fever with shock. While only 15% of patients progress to \\nsevere disease, these patients have an associated 20% to 50% mortality. \\nAfter an incubation period of 3 to 6 days, typical early symptoms \\ninclude fever, headache, myalgias, conjunctival injection, abdominal \\npain, prostration, facial flushing, and relative bradycardia. Symptoms \\nlater progress to jaundice, black emesis, and albuminuria. Severe \\nillness may progress to shock, multiorgan failure, and bleeding. Treat-\\nment is supportive including transfusion as needed.\\n98_Cydulka_Ch98.indd   543 20/03/17   2:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 562, 'page_label': '544'}, page_content='544 SECTION 10: Infectious and Immunologic Diseases\\n11. Cysticercosis is a systemic parasitic infection caused by dissemination \\nof the larval cysts of the pork tapeworm. Humans become infected by \\ningesting contaminated food or inadvertent contact with contaminated \\nsoil. Involvement of almost any tissue can occur. CNS infection is \\nknown as neurocysticercosis, and is a common infectious cause of \\nseizures worldwide. Additional symptoms of neurocysticercosis may \\ninclude headache, visual or mental status changes, stroke, meningoen-\\ncephalitis, and obstructive hydrocephalus. Noncontrast CT shows cal-\\ncifications of inactive disease, and may reveal hydrocephalus. Treat \\nwith praziquantel 17 mg/kg three times daily. Steroids are recom-\\nmended for those with encephalitis, hydrocephalus, or vasculitis.\\n12. African trypanosomiasis (African sleeping sickness) is caused by \\nthe microscopic parasite Trypanosoma brucei, and is transmitted by the \\ntsetse fly. After a bite, a localized inflammatory reaction occurs and is \\nfollowed in 2 to 3 days by a painless chancre that increases in size for \\n2 to 3 weeks and then gradually regresses. Intermittent fevers then \\ndevelop with malaise and rash. When CNS infection develops, behav-\\nioral and neurologic changes occur with a progression from encephalitis \\nto coma and eventual death. Other complications can include hemolysis, \\nanemia, pancarditis, and meningoencephalitis. Make the diagnosis \\nwith rapid evaluation of blood smears for the mobile parasite. The \\nspecific drug and treatment course will depend on the type of infection. \\nConsult infectious disease expert for diagnosis and treatment with \\npentamidine or other agents.\\n13. Chagas disease (American trypanosomiasis) is caused by the proto-\\nzoan T. cruzi and is endemic in regions of Latin America and is reported \\nas far north as Texas. This disease is spread by the nocturnal reduviid \\n“kissing bug” or “assassin” bug. Acute phase illness begins with unilat-\\neral periorbital edema or painful cutaneous edema at the site of skin \\npenetration (chagoma). The subsequent toxemic phase is characterized \\nby parasitemia with lymphadenopathy and hepatosplenomegaly. The \\nacute phase diagnosis is made by blood culture or examination of \\nperipheral blood smears demonstrating motile parasites. In the chronic \\nphase, serologic tests or tissue biopsy are useful to make the diagnosis. \\nConsult with infectious disease specialists for recommendations to treat \\nwith nifurtimox, benznidazole, or other agents.\\n14. Visceral leishmaniasis is caused by the intracellular protozoan Leish-\\nmania that is transmitted by Lutzomyia or Phlebotomus sandflies. This \\ndisease may be found in patients who serve in the military, adventure \\ntravelers, field biologists, and emigrants from endemic zones. Visceral \\nleishmaniasis presents with fever, weight loss, hepatosplenomegaly, \\npancytopenia, and hypergammaglobulinemia. Treat with pentavalent \\nantimonial compounds, such as sodium stibogluconate (available \\nthrough the CDC) or miltefosine.\\n15. Schistosomiasis larvae are released into fresh water by snails. Soon \\nafter exposure, patients develop a macular-papular pruritic dermatitis \\nover the lower legs. Four to 8 weeks later, fever occurs with headache, \\ncough, urticaria, diarrhea, hepatosplenomegaly, and hypereosinophilia. \\nWorms mature in the venous blood and deposit eggs in the bladder, GI \\ntract, brain, skin, and liver. Diagnosis is suspected from eosinophilia \\nand microscopic identification of eggs in midday urines or stools. Treat \\n98_Cydulka_Ch98.indd   544 20/03/17   2:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 563, 'page_label': '545'}, page_content='CHAPTER 98: World Travelers 545 \\nwith praziquantel 20 mg/kg, two doses in a single day, except with GI \\ninvolvement, where three doses in a single day are suggested.\\n16. Amebiasis is caused by pathogenic species such as Entamoeba histo-\\nlytica that are endemic to Asia, Africa, and Latin America. Amebiasis \\nis typically spread by asymptomatic carriers whose excrement contains \\nencysted organisms. Incubation is 1 to 3 weeks for colitis, and weeks \\nto months for liver abscess. Symptoms are commonly mild and include \\nloose stool and stomach cramping. Amebic dysentery, a severe form of \\namebiasis, includes bloody diarrhea, abdominal pain, fever, dehydra-\\ntion, and weight loss. Liver abscess, a rare complication, causes fever, \\nright upper quadrant pain, chronic abdominal pain, and weight loss. \\nStool for ova and parasites is diagnostic and an ultrasound can identify \\nliver abscess. Treat with metronidazole 500 to 750 mg PO three times \\ndaily for 10 days.\\n17. Ascariasis is caused by infection with Ascaris lumbricoides and can \\ndevelop after ingestion of street vendor foods or vegetables fertilized \\nby human or animal feces. Symptoms may include a dry cough or \\npneumonia, as young worms are expectorated and migrate from the \\nlungs to the esophagus and gut. A large worm burden can lead to mal-\\nnutrition and weakness, and a mass of worms may lead to bowel \\nobstruction. Diagnosis is with stool examination and serology. Treat \\nwith mebendazole 100 mg PO daily for 3 days or 500 mg PO as a \\nsingle dose, or albendazole 400 mg PO single dose, or ivermectin 150 \\nto 200 μg/kg PO single dose.\\n18. Enterobiasis (seatworm or pinworm) infection is typically spread via \\nthe fecal-oral route from contaminated objects. Patients experience \\nintense perianal itching, and the diagnosis can be confirmed with a \\ncellophane tape swab of the anus to identify the parasite. Treat with \\nmebendazole 100 mg PO single dose and repeat in 2 weeks, or \\nalbendazole 400 mg PO single dose and repeat in 2 weeks, or pyrantel \\npamoate 11 mg/kg (up to 1 g) PO single dose and repeat in 2 weeks.\\n19. Hookworm infection is caused by Ancylostoma duodenale and Neca-\\ntor americanus and follows exposure to contaminated soil. Worms may \\nmigrate to the lungs, be coughed up, and access the GI tract after being \\nswallowed. Symptoms include abdominal pain, severe anemia, and \\ncutaneous larva migrans with red burrows visible underneath the skin. \\nTreat with albendazole 400 mg PO single dose, mebendazole 100 mg \\nPO twice daily for 3 days or 500 mg PO single dose, or pyrantel \\npamoate, 11 mg/kg (up to 1 g) PO daily for 3 days.\\n20. Tapeworm Infections occur after ingestion of undercooked pork (Tae-\\nnia solium), beef (Taenia saginata), or fish (Diphyllobothrium latum). \\nSymptoms include diarrhea, abdominal pain, bowel obstruction, and \\ntaenia cysts in eye, heart, and brain. Diagnosis is by stool examination \\nor serology. Treat with praziquantel 5 to 10 mg/kg PO single dose.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 161, “Global Travelers,” by Raghu Venugopal and \\nShawn D’Andrea.\\n98_Cydulka_Ch98.indd   545 20/03/17   2:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 564, 'page_label': '546'}, page_content='546\\nThe Transplant Patient\\nSarah E. Unterman\\nManagement of patients with transplanted organs in the emergency depart-\\nment (ED) involves three general areas: (1) disorders specific to certain \\ntransplanted organs, (2) disorders common to many different kinds of \\ntransplant patients due to an immunosuppressed state or antirejection \\nmedications, and (3) disorders not specifically related to a transplanted \\norgan but where special care may be warranted due to associated medica-\\ntions or altered physiology. Disorders specific to the transplanted organ are \\nmanifestations of acute rejection, surgical complications specific to the \\nprocedure performed, and altered physiology (most important in cardiac \\ntransplantation). The most common conditions that prompt transplant \\npatients to present to the ED are infections (39%), noninfectious gastroin-\\ntestinal (GI) or genitourinary pathology (15%), dehydration (15%), electro-\\nlyte disturbances (10%), cardiopulmonary pathology (10%) or injury (8%), \\nand rejection (6%).\\n■ ■POSTTRANSPLANT INFECTIOUS COMPLICATIONS\\nPosttransplant infections are the most common presenting diagnosis to the \\nED for this patient population, in part due to the ongoing immunosuppres-\\nsion required for transplant recipients. Additional infection risk factors \\ninclude diabetes mellitus, advanced age, obesity, and other host factors. \\nTable 99-1 lists the broad array of potential infections and the time after \\ntransplant they are most likely to occur.\\n99\\nCh APTER\\nTable 99-1 Infections Stratified by Posttransplant Period\\nPeriod after Transplant/\\nConditions Infection Comments\\n<1 mo: resistant \\norganisms\\n■● MRSA\\n■● Vancomycin-resistant \\nEnterococcus faecalis\\n■● Candida species (including \\nnon-albicans)\\nOpportunistic infections are \\ngenerally absent during this \\nperiod as full effect of immu-\\nnosuppression not complete. \\nMRSA important in HSCT \\npatients.\\n<1 mo: complications  \\nof surgery and \\nhospitalization\\n■● Aspiration\\n■● Catheter infection\\n■● Wound infection\\n■● Anastomotic leaks and \\nischemia\\n■● C. difficile colitis\\nClostridium difficile common \\nduring this period. Early \\ngraft injuries may abscess. \\nUnexplained early signs of \\ninfection such as hepatitis, \\nencephalitis, pneumonitis, or \\nrash may be donor derived.\\n<1 mo: colonization of \\ntransplanted organ or \\nHSCT neutropenia\\n■● Aspergillus\\n■● Pseudomonas\\n■● Klebsiella\\n■● Legionella\\nMicrobiologic analysis \\nof aspirates or biopsy \\nfrom surgery essential for \\ntherapeutic decisions.\\n(Continued)\\n99_Cydulka_Ch99.indd   546 20/03/17   2:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 565, 'page_label': '547'}, page_content='CHAPTER 99: The Transplant Patient 547 \\nTable 99-1 Infections Stratified by Posttransplant Period\\nPeriod after Transplant/\\nConditions Infection Comments\\n<1 mo: HSCT-specific \\ninfections\\n■● Additional bacterial patho-\\ngens: Streptococcus viridans \\nand enterococci\\n■● Viral infections include \\nrespiratory syncytial virus \\nand HSV\\nNeutropenia and mucocuta-\\nneous injury increase risk for \\nHSCT patients. Lungs, blood-\\nstream, and GI tract most \\ncommonly affected sites.\\n1–6 mo: in patients with \\nPneumocystis jirovecii \\npneumonia and antiviral \\n(CMV, HBV) prophylaxis\\n■● Polyomavirus BK infection, \\nnephropathy\\n■● C. difficile colitis\\n■● HCV infection\\n■● Adenovirus infection, \\ninfluenza\\n■● Cryptococcus neoformans \\ninfection\\n■● Mycobacterium tuberculosis \\ninfection\\n■● Anastomotic complications\\nActivation of latent infec-\\ntions, relapse, residual, and \\nopportunistic infections \\noccur during this period. \\nViral pathogens and allograft \\nrejection cause the majority \\nof febrile episodes during \\nthis period. Polyomavirus BK, \\nadenovirus infections, and \\nrecurrent HCV are becoming \\nmore common.\\n1–6 mo: in patients with-\\nout prophylaxis\\n■● Pneumocystis\\n■● Infection with herpesviruses \\n(HSV, varicella-zoster virus, \\nCMV, Epstein–Barr virus)\\n■● HBV infection\\n■● Infection with Listeria, \\nNocardia, Toxoplasma, \\nStrongyloides, Leishmania, \\nTrypanosoma cruzi\\nDiscontinuation of prophy-\\nlaxis at the end of this period \\nmay prompt active infection, \\nespecially CMV. Graft-versus-\\nhost disease and mucocuta-\\nneous injury increase risk for \\nHSCT patients.\\n>6 mo: general ■● Community-acquired pneu-\\nmonia and urinary tract \\ninfections\\n■● Infection with Aspergillus, \\natypical molds, Mucor \\nspecies\\n■● Infection with Nocardia, \\nRhodococcus species\\nCommunity-acquired \\norganisms dominate during \\nthis period. Transplant \\nrecipients have a persistently \\nincreased risk of infection \\ndue to community-acquired \\npathogens.\\n>6 mo: late viral \\ninfections\\n■● CMV infection (colitis and \\nretinitis)\\n■● Hepatitis (HBV, HCV)\\n■● HSV encephalitis\\n■● Community-acquired viral \\ninfections (severe acute \\nrespiratory syndrome, West \\nNile)\\n■● JC polyomavirus infection \\n(progressive multifocal leu-\\nkoencephalopathy)\\n■● Skin cancer, lymphoma \\n(PTLD)\\nIn some patients, chronic \\nviral infections may cause \\nallograft injury (e.g., cir-\\nrhosis from HCV infection in \\nliver transplant recipients, \\nbronchiolitis obliterans in \\nlung transplant recipients, \\naccelerated vasculopathy in \\nheart transplant recipients \\nwith CMV infection) or a \\nmalignant condition such as \\nPTLD or skin or anogenital \\ncancers.\\nAbbreviations: CMV, cytomegalovirus; HBV, hepatitis B virus; HCV, hepatitis C virus; HSCT,hematopoietic \\nstem cell transplant; HSV, herpes simplex virus; MRSA, methicillin-resistant Staphylococcus aureus; \\nPTLD, posttransplantation lymphoproliferative disorder.\\n(Continued)\\n99_Cydulka_Ch99.indd   547 20/03/17   2:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 566, 'page_label': '548'}, page_content='548 SECTION 10: Infectious and Immunologic Diseases\\nClinical Features\\nThe most common reason for transplant recipients to present to the ED is \\nfever, although as many as half of transplant patients with serious infections \\ncan present without fever. When fever is present, the underlying cause in \\naddition to a possible infection can be drug side effects, hypersensitivity \\nreactions, rejection, or malignancy.\\nDiagnosis and Differential\\nPneumonia and urinary tract infections are the most common infections \\nfound in this population. Blood counts, inflammatory markers, and tests of \\nrenal and liver function may be helpful to obtain in this group of complex \\npatients. Maintain a low threshold for obtaining chest radiographs. Obtain \\nappropriate cultures of urine, blood, and other bodily fluids based on \\npatient symptoms, presentation, physical examination findings, and disease \\nseverity. Consider the possibility of central nervous system infections such \\nas meningitis or encephalitis and perform lumbar puncture when appropri-\\nate. Liver transplant patients are especially susceptible to intraabdominal \\ninfections during the first postoperative month. Lung transplant patients are \\nprone to pneumonia. Cardiac transplant patients may develop mediastinitis \\nduring the first postoperative month.\\nemergency Department Care and Disposition\\n1. When an infection is diagnosed in a patient with an organ transplant, \\nconsider consultation with the transplant team to help determine rec-\\nommended treatment medications and duration.\\n2. For infections of skin and superficial wounds, a broad-spectrum antibi-\\notic plus an agent specific to MRSA is recommended. Common treat-\\nment options include imipenem 500  mg IV every 6 hours, or  \\nmeropenem 1 g IV every 8 hours, or  piperacillin/tazobactam 3.375 \\nIV every 6 hours plus vancomycin 1 g IV every 12 hours or  linezolid \\n600 mg IV every 12 hours.\\n3. Pneumonia may be caused by a wide variety of organisms from com -\\nmon to atypical to opportunistic. Treatment options include imipenem \\n500 mg IV every 6 hours, mer openem 1 g IV every 8 hours, cef otax-\\nime 1 to 2  g IV every 6 to 8 hours plus  gentamicin 1 to 2  mg/kg IV \\nevery 8 hours, or  piperacillin/tazobactam 3.375 g IV every 6 hours. \\nAdd MRSA-specific therap y, listed above, and fungal therapy, listed \\nbelow, if suspected.\\n4. Intraabdominal infections may be due to enteric gram-negative aerobic, \\nobligate anaerobic bacilli and facultative bacilli, or enteric gram-posi-\\ntive streptococci. Recommended coverage is to combine metronida-\\nzole 500 mg IV every 12 hours plus one of the following agents: imi-\\npenem 500 mg IV ev ery 6 hours, meropenem 1 g IV ev ery 8 hours, \\ndoripenem 500  mg IV every 8 hours, or  piperacillin/tazobactam \\n3.375 g IV every 6 hours.\\n5. The initial treatment of suspected fungal disease is fluconazole 400 mg \\ndaily IV; amphotericin B 0.7 mg/kg/d IV has been a mainstay of treat-\\nment but has more toxicity than fluconazole. For oral or esophageal \\nCandida, treat with fluconazole 200  mg PO on day 1 followed by \\n100 mg PO daily.\\n99_Cydulka_Ch99.indd   548 20/03/17   2:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 567, 'page_label': '549'}, page_content='CHAPTER 99: The Transplant Patient 549 \\n6. Suspected CMV disease is treated with ganciclovir 5 mg/kg IV twice \\ndaily. For bone marrow transplant patients, add immunoglobulin.\\n7. Disseminated or ocular varicella and herpes simplex virus are typically \\ntreated with acyclovir 800 mg IV five times a day. Adjust dosing in the \\npresence of renal insufficiency. Alternatives include valacyclovir \\n1000 mg every 8 hours or famciclovir 500 mg every 8 hours.\\n8. Treatment for Pneumocystis jirovecii pneumonia starts with prednisone \\n80 mg/d followed immediately by antimicrobial therapy. First choice is \\ntrimethoprim/sulfamethoxazole (TMP-SMX) 15 mg/kg/d IV divided \\nevery 8 hours while critically ill. Oral therap y is TMP-SMX double \\nstrength (DS) two tablets PO every 8 hours for 3 weeks of total therapy. \\nPentamidine 4 mg/kg/d IV or IM for 3 weeks, or clindamycin 600 mg \\nIV plus primaquine 30  mg orally daily are reserved as alternative \\ntherapies if TMP-SMX is not tolerated.\\n9. Toxoplasmosis can be treated initially with pyrimethamine 200 mg \\nPO initially then 50 to 75  mg PO daily plus sulfadiazine 1 to 4  g PO \\ndaily plus folinic acid 10 mg PO daily.\\n10. Urinary tract infections (see Chapter 53), invasiv e gastroenteritis (due \\nto Salmonella, Campylobacter, and Listeria, see Chapter 37 and Chap-\\nter 96), and diverticulitis (see Chapter 44) can be treated with com-\\nmonly recommended antimicrobial agents.\\n■ ■COMPLICATIONS OF IMMUNOSUPPRESSIVE AGENTS\\nTherapeutic immunosuppression is associated with a number of adverse \\neffects and complications. These adverse effects are typically gradual in \\nonset and may include pancreatitis, bleeding, hypoglycemia or hyperglyce-\\nmia, bradycardia or tachycardia, hyperkalemia, hypertension or hypoten-\\nsion, cardiotoxicity, pulmonary edema, seizures, thromboembolic events, \\nand thrombocytopenia. Medication side effects such as fever or rigors may \\nbe similar to symptoms that would otherwise suggest an infection. A \\nheadache syndrome often indistinguishable from migraine is common in \\ntransplant recipients and usually develops within the first two months of \\nimmunosuppression, and may require an initial workup to exclude life-\\nthreatening conditions such as a mass lesion or infection. As the number of \\nimmunosuppressive drugs has increased dramatically, a complete listing of \\nadverse effects is beyond the scope of this manual. Please refer to the parent \\ntextbook, referenced at the end of this chapter, or to web resources for a \\nmore complete listing of side effects of these medications.\\nAn illness that prevents a transplant patient from successfully taking his \\nor her immunosuppressive therapy may warrant hospital admission for IV \\ntherapy. Consider discussing new medications with a member of the \\npatient’s transplant team, as starting even simple medications can precipi-\\ntate complications.\\n■ ■CARDIAC TRANSPLANTATION\\nHeart transplantation results in a denervated heart that does not respond \\nwith centrally mediated tachycardia in response to stress or exercise, but \\ndoes respond appropriately to circulating catecholamines. Patients there-\\nfore may experience fatigue or shortness of breath at the onset of exercise \\n99_Cydulka_Ch99.indd   549 20/03/17   2:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 568, 'page_label': '550'}, page_content='550 SECTION 10: Infectious and Immunologic Diseases\\nbefore an appropriate increase in heart rate occurs over time to meet the \\nmetabolic demand. A donor heart is implanted with its sinus node intact to \\npreserve normal atrioventricular conduction, and therefore a normal heart \\nrate is typically 90 to 100 beats/min. However, electrocardiograms fre-\\nquently will have two distinct P waves as the technique of cardiac trans-\\nplantation also preserves the recipient’s native sinus node at the superior \\ncavoatrial junction. The sinus node of the donor heart is easily identified by \\nits constant 1:1 relation to the QRS complex, whereas the native P wave \\nappears independently through the donor heart rhythm.\\nClinical Features\\nBecause the heart is denervated, patients experiencing myocardial ischemia \\ndo not present with angina. Instead, heart transplant recipients may present \\nwith heart failure secondary to silent myocardial infarctions. Evaluate \\ntransplant recipients who have new-onset shortness of breath, chest full-\\nness, or symptoms of congestive heart failure with an electrocardiogram \\nand serial troponin levels to evaluate for the possible presence of myocar -\\ndial ischemia or infarction.\\nAlthough most episodes of acute cardiac transplant rejection are asymp-\\ntomatic, the most common symptoms that do occur are dysrhythmias and \\ngeneralized fatigue. Consider the possibility of transplant rejection for \\npatients who present with atrial or ventricular dysrhythmia or symptoms of \\nacute heart failure. In children, rejection may present with low-grade fever, \\nfussiness, and poor feeding.\\nemergency Department Care and Disposition\\n1. Treat acute rejection with methylprednisolone 1 g IV after consultation \\nwith a representative from the transplant center. Treatment for rejection \\nis typically begun after biopsy confirmation unless the patient is hemo-\\ndynamically unstable.\\n2. Atropine has no effect on a denerv ated heart and is not recommended \\nfor bradydysrhythmias in heart transplant patients. Instead, administer \\nisoproterenol 2 to 10 μg/min IV infusion.\\n3. Treat hypotension with inotropic agents such as dopamine  2 to 20  μg/\\nkg/min IV or dobutamine 2 to 20 μg/kg/min IV .\\n4. Symptoms concerning for acute rejection or another illness requiring \\nhospitalization should prompt transfer to a transplantation center, when \\npossible.\\n■ ■LUNG TRANSPLANTATION\\nClinical Features\\nA lung transplant patient suffering rejection may develop cough, chest \\ntightness, fever, and hypoxemia. Infection, such as interstitial pneumonia, \\nmay present with a clinical picture similar to acute rejection. Acute rejec-\\ntion can manifest very quickly, with a severe and rapid decline in patient \\nstatus and in some circumstances an isolated fever may be the only initial \\nfinding. Spirometry may show a >10% drop in forced expiratory volume \\nin 1 second, and physical examination may reveal rales and adventitious \\nsounds. Chest radiograph may demonstrate bilateral interstitial infiltrates or \\n99_Cydulka_Ch99.indd   550 20/03/17   2:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 569, 'page_label': '551'}, page_content='CHAPTER 99: The Transplant Patient 551 \\neffusions but may be normal in some patients, particularly when rejection \\noccurs longer than 6 weeks after transplant. The further removed a patient \\nis from transplant, the less classic a chest radiograph may appear for acute \\nrejection. Bronchoscopy with a transbronchial biopsy is usually needed to \\nconfirm rejection and exclude infection.\\nDiagnosis and Differential\\nTo assess a lung transplant patient for findings of infection or acute rejec-\\ntion, clinicians may obtain a chest radiograph, pulse oximetry, arterial \\nblood gas analysis, spirometry, complete blood cell count, serum electro-\\nlytes, creatinine and magnesium levels, and appropriate drug levels.\\nemergency Department Care and Disposition\\n1. Initiate empiric antibiotics for suspected infection (see above recom-\\nmendations).\\n2. Treat acute rejection with methylprednisolone 1 g IV after consultation \\nwith a representative from the transplant center.\\n3. Symptoms concerning for acute rejection or another illness requiring \\nhospitalization should prompt transfer to a transplantation center, when \\npossible.\\n■ ■RENAL TRANSPLANT\\nClinical Features\\nRenal transplant recipients with symptoms of acute rejection complain of \\nvague tenderness over the allograft, which is typically located in the left or \\nright iliac fossa. Patients also may describe decreased urine output, rapid \\nweight gain from fluid retention, low-grade fever, and generalized malaise. \\nPhysical examination may reveal worsening hypertension, allograft tender-\\nness, and peripheral edema. The absence of these symptoms and signs, \\nhowever, may not entirely exclude the possibility of acute rejection, as an \\nasymptomatic decline in renal function may be the only initial finding to \\nsuggest acute rejection.\\nDiagnosis and Differential\\nEven small changes in creatinine values may be important in assessing a \\nrenal transplant patient’s risk of acute rejection. When rejection is sus-\\npected, obtain a urinalysis, renal ultrasonography, levels of immunosup-\\npressive drugs, and a thorough history and examination. Interpret changes \\nin renal function in the context of prior data such as trends of recent serum \\ncreatinine levels, recent history of rejection, or other causes of allograft \\ndysfunction. In addition to considering acute rejection, evaluate for other \\npotential causes of decreased renal function such as dehydration or cyclo-\\nsporine-induced nephrotoxicity.\\nImaging may be helpful to evaluate the graft. Renal ultrasound can \\ndetect urinary obstruction. MRI can be used to detect hematomas and fluid \\ncollections, vascular abnormalities, and infarctions caused by medication-\\ninduced vasculitis. Discuss imaging options with the transplant team, \\nparticularly before using gadolinium-based contrast agents in a renal \\ntransplant patient.\\n99_Cydulka_Ch99.indd   551 20/03/17   2:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 570, 'page_label': '552'}, page_content='552 SECTION 10: Infectious and Immunologic Diseases\\nemergency Department Care and Disposition\\n1. Treat acute rejection with methylprednisolone 1 g IV after consultation \\nwith a representative from the transplant center.\\n2. Symptoms concerning for acute rejection or another illness requiring \\nhospitalization should prompt transfer to a transplantation center, when \\npossible.\\n■ ■LIVER TRANSPLANT\\nClinical Features\\nAlthough frequently subtle in presentation, a syndrome of acute liver transplant \\nrejection includes fever, liver tenderness, lymphocytosis, eosinophilia, liver \\nenzyme elevation, and a change in bile color or production. In the perioperative \\nperiod, the differential diagnosis also includes infection, acute biliary obstruc-\\ntion, or vascular insufficiency. Diagnosis can be made with certainty only by \\nhepatic ultrasound and biopsy, which usually requires referral back to the \\ntransplant center for diagnosis and management of this complication.\\nPossible postsurgical complications in liver transplant patients include \\nbiliary obstruction, biliary leakage, and hepatic artery thrombosis. Biliary \\nobstruction follows three typical presentations: (1) intermittent episodes of \\nfever and fluctuating liver function tests, (2) a gradual worsening of liver func-\\ntion tests without symptoms, and (3) acute bacterial cholangitis with fever, \\nchills, abdominal pain, jaundice, and bacteremia. These complications can be \\ndifficult to distinguish clinically from rejection, hepatic artery thrombosis, \\nCMV infection, or a recurrence of a preexisting disease such as hepatitis.\\nIf a postsurgical biliary complication is suspected, obtain a chest radio-\\ngraph, complete blood count, serum chemistry levels, liver function tests, \\nbasic coagulation studies, and lipase levels. Consider cultures of blood, \\nurine, bile, or ascites, as appropriate. An abdominal ultrasound can evaluate \\nfor fluid collections, thrombosis of the hepatic artery or portal vein, and \\ndilatation of the biliary tree. Alternatively, abdominal computed tomogra-\\nphy can be used. Some patients may benefit from cholangiography or \\nERCP if biliary obstruction is suspected.\\nBiliary leakage is associated with 50% mortality and occurs most fre-\\nquently in the third or fourth postoperative week. This high rate of mortality \\nmay be related to concomitant hepatic artery thrombosis, infection of \\nleaked bile, or difficult repair when the tissue is inflamed. Patients most \\noften have peritoneal signs and fever, but these signs may be masked by use \\nof steroids and immunosuppressive agents. Laboratory studies may reveal \\nelevated prothrombin time and transaminase levels with little or no bile \\nproduction. This complication also may present as acute graft failure, liver \\nabscess, unexplained sepsis, or biliary tract leakage, obstruction, abscess, \\nor breakdown of the anastomosis.\\nemergency Department Care and Disposition\\n1. Treat acute rejection with methylprednisolone 1 g IV after consultation \\nwith a representative from the transplant center.\\n2. Symptoms concerning for acute rejection or another illness requiring \\nhospitalization should prompt transfer to a transplantation center, when \\npossible.\\n99_Cydulka_Ch99.indd   552 20/03/17   2:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 571, 'page_label': '553'}, page_content='CHAPTER 99: The Transplant Patient 553 \\n3. Surgical complications are best managed at the original transplant cen-\\nter, when possible. Biliary obstruction is managed with balloon dilata -\\ntion, and all patients should receive broad-spectrum antibiotics against \\ngram-negative and gram-positive enteric organisms, such as metronida-\\nzole 500 mg IV every 12 hours plus one of the following agents: imipe-\\nnem 500 mg IV every 6 hours or  piperacillin/tazobactam 3.375 g IV \\nevery 6  hours. Biliary leakage is treated surgically, and hepatic artery \\nthrombosis may require retransplantation.\\n■ ■hEMATOPOIETIC STEM CELL TRANSPLANT\\nHematopoietic stem cell transplant (HSCT) is performed for a variety of \\nconditions, including hematopoietic malignancies, severe anemia, and \\nother conditions. The most common complication of HSCT is graft-versus-\\nhost disease, affecting approximately 50% of HSCT patients.\\nClinical Features\\nA HSCT recipient presenting to the ED with nonspecific maculopapular \\nrash (see Fig. 99-1) should be evaluated for possible graft-versus-host dis-\\nease. The rash may be pruritic or painful, and frequently demonstrates a \\nFigure 99-1.  Rash of acute cutaneous graft-versus-host disease. The maculo-\\npapular lesions have acquired a brownish hue and there is slight scaling.\\nReproduced with permission from Wolff KL, Johnson R, Suurmond R. Fitzpatrick’s \\nColor Atlas & Synopsis of Clinical Dermatology. 6th ed. New York: McGraw-Hill; \\n2009. All rights reserved.\\n99_Cydulka_Ch99.indd   553 20/03/17   2:28 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 572, 'page_label': '554'}, page_content='554 SECTION 10: Infectious and Immunologic Diseases\\nbrownish hue with slight scaling. The distribution v aries greatly but often \\ninvolves palms and soles initially, and later progresses to cheek, ears, neck, \\ntrunk, chest, and upper back. In the more severe forms, skin involvement is \\nerythrodermic or may show bullae formation. Mucositis has been reported \\nto occur in 35% to 70% of patients.\\nThe second most common presentation of graft-versus-host disease is \\ndiarrhea. Upper GI symptoms such as anorexia, nausea, and emesis are \\ncommon. The patient may develop painful cramping, ileus, and, sometimes, \\nlife-threatening hemorrhage from the colon.\\nDiagnosis and Differential\\nThe initial diagnosis of graft-versus-host disease is made on clinical \\ngrounds. A patient with a significant GI hemorrhage in the early posttrans-\\nplant period may have coagulation deficits, especially thrombocytopenia. \\nThe differential diagnosis of GI bleeding in this setting includes all the \\nusual causes in addition to infection. Hepatic involvement presents with \\nhyperbilirubinemia and elevated liver function tests.\\nemergency Department Care and Disposition\\n1. Most patients with graft-versus-host disease will need supportive care in \\nconsultation with the patient’ s transplant team for management includ-\\ning possible admission or transfer to the transplant center.\\n2. Initiate prednisone 60  mg PO daily, or methylpr ednisolone at 1 to \\n2 mg/kg IV daily.\\n3. If other immunosuppressants have recently been tapered or discontin-\\nued, these are generally increased or reinstituted in the setting of a ne w \\ndiagnosis of graft-versus-host disease.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 297, “The Transplant Patient,” by J. Hayes Calvert.\\n99_Cydulka_Ch99.indd   554 20/03/17   2:28 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 573, 'page_label': '555'}, page_content='555\\nGeneral Management of the \\nPoisoned Patient\\nL. Keith French\\nDeath from unintentional poisoning is a growing problem worldwide and \\nprevention requires a multi-disciplinary approach. Knowledge of appropri-\\nate decontamination techniques and timely administration of antidotes \\ncoupled with excellent supportive care may positively alter the outcome of \\npoisoned patients.\\n■ ■CLINICAL FEATURES\\nA detailed history is essential in the evaluation of a potentially poisoned \\npatient. In the conscious, cooperative person, the specific agent(s), time, \\nroute, amount, and intent of exposure need to be determined. In the unco-\\noperative or altered patient, adjunctive information from friends, family, \\nprehospital providers, police, or bystanders may provide more accurate \\ndetails. Environmental clues such as drug paraphernalia, empty pill bottles, \\nodors, or suicide notes may aid in the diagnosis. If available, review hospi-\\ntal records for recent prescriptions or any history of psychiatric illness. \\nLoose pills with imprint codes may be identified by the pharmacy or Poison \\nCenter.\\nA thorough exam begins with a completely disrobed patient. Review all \\nvital signs and perform a comprehensive physical examination. Focus on \\nthe general appearance, level of consciousness, pupil size, mucous mem-\\nbranes, respiratory rate, breath sounds, presence of bowel sounds, skin \\ntemperature, and muscle tone as the combination of findings may suggest \\na specific toxidrome (Table 100-1). Important clinical features in the poi-\\nsoned patient include hypoglycemia, cardiac dysrhythmias, seizures, agita-\\ntion, and temperature alterations.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nA diagnosis of poisoning is established primarily through the history, \\nthough the physical examination may provide clues when a history is not \\npossible. Specific toxicology screens may be available, but are, in general, \\nof limited utility and seldom impact care or outcome (Table 100-2). False-\\nnegative or false-positive results for drugs of abuse may be confusing and \\n100\\nCh A p TER\\nToxicology and  \\nPharmacology\\n 11\\nSECTION\\n100_Cydulka_Ch100.indd   555 20/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 574, 'page_label': '556'}, page_content='556 SECTION 11: Toxicology and Pharmacology\\nTable 100-1 Common Toxidromes\\nToxidrome Examples of Agents\\nExamination Findings (most common \\nin bold)\\nAnticholinergic Atropine, Datura \\nspp., antihistamines, \\nantipsychotics\\nAltered mental status, mydriasis, \\ndry flushed skin, urinary retention, \\ndecreased bowel sounds, hyper-\\nthermia, dry mucous membranes\\nSeizures, arrhythmias, rhabdomyolysis\\nCholinergic Organophosphate and \\ncarbamate insecticides\\nChemical warfare agents \\n(Sarin, VX)\\nSalivation, lacrimation, diapho-\\nresis, vomiting, urination, def-\\necation, bronchorrhea, muscle \\nfasciculations, weakness\\nMiosis/mydriasis, bradycardia, seizures\\nEthanolic Ethanol Central nervous system depres-\\nsion, ataxia, dysarthria, odor of \\nethanol\\nExtrapyramidal Risperidone, haloperidol, \\nphenothiazines\\nDystonia, torticollis, muscle rigidity\\nChoreoathetosis, hyperreflexia, seizures\\nHallucinogenic Phencyclidine\\nPsilocybin, mescaline\\nLysergic acid diethylamide\\nHallucinations, dysphoria, anxiety\\nNausea, sympathomimetic signs\\nHypoglycemic Sulfonylureas\\nInsulin\\nAltered mental status, diaphore-\\nsis, tachycardia, hypertension\\nDysarthria, behavioral change, seizures\\nNeuromuscular \\nmalignant\\nAntipsychotics Severe muscle rigidity, hyperpy-\\nrexia, altered mental status\\nAutonomic instability, diaphoresis, mutism, \\nincontinence\\nOpioid Codeine\\nHeroin\\nMorphine\\nMiosis, respiratory depression, \\ncentral nervous system depression\\nHypothermia, bradycardia\\nSalicylate Aspirin\\nOil of Wintergreen \\n(methyl salicylate)\\nAltered mental status, respiratory \\nalkalosis, metabolic acidosis, tin-\\nnitus, tachypnea, tachycardia, dia-\\nphoresis, nausea, vomiting\\nHyperpyrexia (low grade)\\nSedative/ \\nhypnotic\\nBenzodiazepines\\nBarbiturates\\nCentral nervous system depres-\\nsion, ataxia, dysarthria\\nBradycardia, respiratory depression\\nSerotonin SSRIs\\nMAOIs\\nTricyclic antidepressants\\nAmphetamines\\nFentanyl\\nSt. John’s wort\\nAltered mental status, hyper-\\nreflexia and hypertonia (>lower \\nlimbs), clonus, tachycardia, dia-\\nphoresis\\nHypertension, flushing, tremor\\nSympathomimetic Amphetamines\\nCocaine\\nCathinones\\nAgitation, tachycardia, hyperten-\\nsion, hyperpyrexia, diaphoresis\\nSeizures, acute coronary syndrome\\nAbbreviations: MAOI = monoamine oxidase inhibitor; SSRI = selective serotonin reuptake inhibitor.\\n100_Cydulka_Ch100.indd   556 20/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 575, 'page_label': '557'}, page_content='CHAPTER 100: General Management of the Poisoned Patient 557 \\npotentially distracting. Consider empiric testing for acetaminophen and \\naspirin in all potentially poisoned patients. Complementary testing includes \\nblood glucose concentration, serum lactate/electrolytes, renal/liver func -\\ntion, urine HCG, and electrocardiography.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Gross decontamination should occur prior to patient entry into the ED. \\nObserve universal precautions and don personal protective gear. Ensure \\nthat the victim’s clothing and jewelry are removed/bagged.\\n2. The primary goal in management is resuscitation. Focus on assessment \\nand stabilization of the airway, breathing, and circulation. Supportive \\ncare is often the only required intervention in the poisoned patient. Early \\nendotracheal intubation may be necessary given the anticipated clini-\\ncal course of some toxidromes. Treat hypotension with IV crystalloid \\ninfusions (10 to 20 mL/kg in children) before initiating pressors. Treat \\nventricular dysrhythmias according to standard ACLS/PALS protocols. \\nPotentially useful medications in the management of toxin-induced car -\\ndiac arrest are listed in Table 100-3.\\n3. The proper and timely use of antidotes (Table 100-4) is paramount in \\nthe management for select poisoned patients. Rarely, however, does \\nantidotal therapy trump standard resuscitation steps. Focus first on resus-\\ncitation measures as listed above.\\n4. Altered mental status and coma are common presentations of many \\nintoxicants. Reasonable empiric treatments include supplemental oxy-\\ngen, naloxone (0.2 to 2 mg IV/IO/IM), glucose (1 to 1.5 g/kg IV/IO), and \\nthiamine (10 to 100 mg IV/IO) in the adult patient.\\n5. Seizures from toxins generally respond to benzodiazepines (first-line) \\nor barbiturates (second-line). Isoniazid (INH) poisoning may precipi-\\ntate seizures which are refractory to benzodiazepines or barbiturates.  \\nTreatment for INH poisoning requires pyridoxine. Hypoglycemia and \\nhyponatremia should be excluded as the etiology for seizures. \\nPhenytoin is not effective in toxin-induced seizures and is not \\nrecommended.\\nTable 100-2 Drug Concentrations That May Assist patient Assessment  \\nor Management\\nAcetaminophen Methanol\\nCarbamazepine Methotrexate\\nCarbon monoxide Paraquat\\nDigoxin Phenobarbital\\nEthanol Phenytoin\\nEthylene glycol Salicylate\\nIron Theophylline\\nLithium Valproic acid\\nMethemoglobin\\n100_Cydulka_Ch100.indd   557 20/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 576, 'page_label': '558'}, page_content='558 SECTION 11: Toxicology and Pharmacology\\nTable 100-4 Common Antidotes: Initial Dosages and Indications\\nAntidote pediatric Dose Adult Dose Indication\\nCalcium \\nchloride 10%\\n27.2 mg/mL  \\nelemental Ca\\n0.2–0.25 mL/kg IV 10 mL IV Calcium channel \\nantagonists\\nCalcium \\ngluconate 10%\\n9 mg/mL elemental Ca\\n0.6–0.8 mL/kg IV 10–30 mL IV Hypermagnesemia\\nHypocalcemia\\nCyanide \\nantidote kit\\nAmyl nitrite\\nNot typically used 1 ampule O2 cham-\\nber of ventilation \\nbag 30 s on/30 s off\\nCyanide\\nHydrogen sulfide \\n(use only sodium \\nnitrite)\\nSodium nitrite (3% \\nsolution)\\n0.33 mL/kg IV 10 mL IV Cyanide\\nSodium thiosulfate \\n(25% solution)\\n1.65 mL/kg IV 50 mL IV Cyanide\\nDextrose \\n(glucose)\\n0.5 g/kg IV 1 g/kg IV Insulin\\nOral hypoglycemics\\nDigoxin Fab\\nAcute toxicity\\n1–2 vials IV 5–10 vials Digoxin and other \\ncardioactive steroids\\nFlumazenil 0.01 mg/kg IV 0.2 mg IV Benzodiazepines\\nGlucagon 50–150 μg/kg IV 3–10 mg IV Calcium channel \\nblockers\\nβ-Blockers\\nHydroxocobalamin 70 mg/kg IV (maximum 5 g). Can be \\nrepeated up to 3 times. Administer with \\nsodium thiosulfate.\\nCyanide\\nNitroprusside\\nTable 100-3 potential Interventions in Toxin-Induced Cardiac Arrest\\nToxin or Toxin/Drug Class Intervention\\nToxins with a specific antidote (examples)\\nDigoxin\\nOrganophosphates\\nEnvenomation\\nAntidote\\nDigoxin Fab\\nAtropine\\nAntivenom\\nSodium channel blocker or wide-complex tachycardia Sodium bicarbonate\\nCalcium channel blocker or β-blocker High-dose insulin\\nLocal anesthetic agents\\nLipophilic cardiotoxins\\nIV lipid emulsion\\nOther Therapies to Consider\\nCardiac pacing\\nIntra-aortic balloon pump\\nExtracorporeal membrane oxygenation\\n(continued )\\n100_Cydulka_Ch100.indd   558 20/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 577, 'page_label': '559'}, page_content='CHAPTER 100: General Management of the Poisoned Patient 559 \\nTable 100-4 Common Antidotes: Initial Dosages and Indications\\nAntidote pediatric Dose Adult Dose Indication\\nIV lipid emulsion \\n20%\\n1.5 mL/kg IV bolus \\nover 1 min (may \\nbe repeated two \\ntimes at 5-min \\nintervals), followed \\nby 0.25 mL/kg per \\nminute\\n100-mL IV bolus \\nover 1 min, fol-\\nlowed by 400 mL \\nIV over 20 min\\nLocal anesthetic \\ntoxicity\\nRescue therapy for \\nlipophilic cardiotoxins\\nMethylene blue 1–2 mg/kg IV\\nNeonates: 0.3– \\n1.0 mg/kg IV\\n1–2 mg/kg IV Oxidizing toxins \\n(e.g., nitrites, benzo-\\ncaine, sulfonamides)\\nNaloxone As much as \\nrequired\\nStart: 0.01 mg IV\\nAs much as required\\nStart: 0.1–0.4 mg IV\\nOpioids\\nClonidine\\nPyridoxine Gram for gram if amount isoniazid \\ningested is known\\nIsoniazid\\nGyromitra esculenta\\nHydrazine70 mg/kg IV \\n(maximum 5 g)\\n5 g IV\\nSodium \\nbicarbonate\\n1–2 mEq/kg IV bolus followed by 2 \\nmEq/kg per h IV infusion\\nSodium channel \\nblockers\\nUrinary alkalinization\\nThiamine 5–10 mg IV 100 mg IV Wernicke’s syndrome\\nWet beriberi\\n6. Once stabilized, surface decontamination is the next priority in care. If \\nnot previously done, completely disrobe the patient. Dermal toxins must be \\nremoved from the skin by irrigation. Ocular exposure often requires pain \\ncontrol with topical agents. Copiously irrigate the eye with isotonic crystal-\\nloid. This may require several liters before restoration of physiologic pH. \\nOphthalmology consultation is recommended for all ocular alkali injuries.\\n7. Gastrointestinal decontamination is achieved via remov al of the toxin \\nfrom the stomach, binding toxin within the GI tract, or enhancing transit \\ntime through the gut. The particular method(s) utilized, if any, depends on \\nthe route, timing, amount, and nature of the toxin. Consider GI decon-\\ntamination if (1) the exposure is expected to cause significant toxicity, \\n(2) GI decontamination is expected to positively affect clinical outcome, \\nand (3) the risk/benefit ratio favors GI decontamination. GI decontamination \\nshould only be instituted when an airway is patent/protected. Table 100-5 \\nlists the indications, contraindications, and complications of several GI \\ndecontamination modalities.\\na. Inducing emesis with syrup of ipecac is no longer recommended for \\nroutine use in the ED. Orogastric lavage (OG) is now rarely used in \\nthe management of poisoned patients due to potentially serious con-\\nsequences and unproven benefit. Only consider OG lavage when the \\npoison was ingested within an hour of presentation and the nature/\\ndose of the poison is likely to cause clinical deterioration despite sup-\\nportive care or antidotal therapy. This procedure requires advance-\\n(continued)\\n100_Cydulka_Ch100.indd   559 20/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 578, 'page_label': '560'}, page_content='560 SECTION 11: Toxicology and Pharmacology\\nTable 100-5 Indications, Contraindications, and Complications  \\nof Gastrointestinal Decontamination procedures\\nOrogastric Lavage\\nIndications Rarely indicated\\nConsider for recent (<1 h) ingestion of life-threatening amount \\nof a toxin for which there is no effective treatment once \\nabsorbed\\nContraindications Corrosive/hydrocarbon ingestion\\nSupportive care/antidote likely to lead to recovery\\nUnprotected airway\\nUnstable, requiring further resuscitation (hypotension, seizures)\\nComplications Aspiration pneumonia/hypoxia\\nWater intoxication\\nHypothermia\\nLaryngospasm\\nMechanical injury to gastrointestinal tract\\nTime consuming, resulting in delay instituting other \\ndefinitive care\\nActivated Charcoal Adults 50 g orally, children 1 g/kg orally\\nIndications Ingestion within the previous hour of a toxic substance known \\nto be adsorbed by activated charcoal, where the benefits of \\nadministration are judged to outweigh the risks\\nContraindications Nontoxic ingestion\\nToxin not adsorbed by activated charcoal\\nRecovery will occur without administration of activate charcoal\\nUnprotected airway\\nCorrosive ingestion\\nPossibility of upper gastrointestinal perforation\\nComplications Vomiting\\nAspiration of the activated charcoal\\nImpaired absorption of orally administered antidotes\\nWhole-Bowel \\nIrrigation\\npolyethylene glycol 2 L/h in adults, children  \\n25 mL/kg per hour (maximum 2 L/h)\\nIndications (potential) Iron ingestion >60 mg/kg with opacities on abdominal \\nradiograph\\nLife-threatening ingestion of diltiazem or verapamil\\nBody packers or stuffers\\nSlow-release potassium ingestion\\nLead ingestion (including paint flakes containing lead)\\nSymptomatic arsenic trioxide ingestion\\nLife-threatening ingestions of lithium\\nContraindications Unprotected airway\\nGastrointestinal perforation, obstruction or ileus, hemorrhage\\nIntractable vomiting\\nCardiovascular instability\\nComplications Nausea, vomiting\\nPulmonary aspiration\\nTime consuming; possible delay instituting other  \\ndefinitive care\\n100_Cydulka_Ch100.indd   560 20/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 579, 'page_label': '561'}, page_content='CHAPTER 100: General Management of the Poisoned Patient 561 \\nment of a 36F to 40F orogastric tube into the stomach while the \\npatient lies in a left lateral position. The head of the bed should be \\ntilted down 20°. Aliquots of roughly 200 mL (10 mL/kg in children) \\nof warm tap water are instilled into the stomach, then removed via \\ngravity or suction. The procedure continues until the effluent is clear.\\nb. Activated charcoal (AC) binds a large number of xenobiotics and \\nprevents their absorption across the GI tract. AC does not effectively \\nabsorb metals, corrosives, or alcohols. AC is not recommended for \\nroutine use, and an individual risk assessment needs to be made \\nbefore administration. Consider using if the xenobiotic is still avail-\\nable for adsorption or >60 minutes after ingestion for xenobiotics that \\nslow GI motility (e.g., anticholinergics) or form bezoars (e.g., salicy-\\nlates). The recommended dose is 1 g/kg.\\nc. Whole-bowel irrigation (WBI) is accomplished through drinking or \\nNG tube instillation of polyethylene glycol. The infusion is continued \\nuntil the rectal effluent is clear or passage of foreign body (e.g., drug \\npacket) occurs. Do not use WBI if bowel sounds are absent or if ileus/\\nobstruction is suspected (Table 100-5).\\n8. Considerations for enhanced elimination depend on the specific toxin \\nand response to standard treatment. Multi-dose activated charcoal, uri -\\nnary alkalinization, and extracorporeal removal (hemodialysis) are \\nthe three of the most commonly utilized modalities. Indications and \\ncontraindications to use are listed in Tables 100-6 and 100-7.\\nTable 100-6 Indications, Contraindications, and Complications or Enhanced \\nElimination procedures\\nMultidose Activated \\nCharcoal\\nInitial dose: 50 g (1 g/kg children), repeat dose 25 g  \\n(0.5 g/kg children) every 2 h\\nIndications Carbamazepine coma (reduces duration of coma)\\nPhenobarbital coma (reduces duration of coma)\\nDapsone toxicity with significant methemoglobinemia\\nQuinine overdose\\nTheophylline overdose if hemodialysis/hemoperfusion \\nunavailable\\nContraindications Unprotected airway\\nBowel obstruction\\nCaution in ingestions resulting in reduced gastrointestinal motility\\nComplications V omiting\\nPulmonary aspiration\\nConstipation\\nCharcoal bezoar, bowel obstruction/perforation\\nUrinary Alkalinization\\nIndications Moderate to severe salicylate toxicity not meeting criteria for \\nhemodialysis\\nPhenobarbital (multidose activated charcoal superior)\\nChlorophenoxy herbicides (2-4-dichlorophenoxyacetic acid \\nand mecoprop): requires high urine flow rate 600 mL/h to be \\neffective\\nChlorpropamide: supportive care/IV dextrose normally sufficient\\n(continued )\\n100_Cydulka_Ch100.indd   561 20/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 580, 'page_label': '562'}, page_content='562 SECTION 11: Toxicology and Pharmacology\\nTable 100-7 Indications, Contraindications, and Complications of \\nExtracorporeal Removal Techniques\\nhemodialysis\\nMovement of solute down a concentration gradient across \\na semipermeable membrane\\nToxin requirements Low volume of distribution, low protein binding, low endogenous \\nclearance, low molecular weight\\nIndications Life-threatening \\npoisoning by:\\nLithium\\nMetformin lactic acidosis\\nPhenobarbital\\nSalicylates\\nValproic acid\\nMethanol/ethylene glycol\\nMetformin-induced lactic acidosis\\nPotassium salts\\nTheophylline\\nContraindications Hemodynamic instability\\nInfants (generally)\\nPoor vascular access\\nSignificant coagulopathy\\nhemoperfusion\\nMovement of toxin from blood, plasma, or plasma proteins \\nonto a bed of activated charcoal (or other adsorbent)\\nToxin requirements Low volume of distribution, low endogenous clearance, bound by \\nactivated charcoal\\nIndications Life-threatening poisoning caused by: \\nTheophylline (high-flux hemodialysis is an alternative)\\nCarbamazepine (multidose activated charcoal or high-efficiency \\nhemodialysis also effective)\\nParaquat (theoretical benefit only if instituted early after exposure)\\nContraindications Hemodynamic instability\\nInfants (generally)\\nPoor vascular access\\nSignificant coagulopathy\\nToxin not bound to activated \\ncharcoal\\nContinuous Renal \\nReplacement \\nTherapies\\nMovement of toxin and solute across a semipermeable \\nmembrane in response to hydrostatic gradient. Can be \\ncombined with dialysis\\nIndications (potential) Life-threatening ingestions of toxins when hemodialysis or \\nhemoperfusion is indicated, but is unavailable, or hemodynamic \\ninstability precludes their utilization\\nContraindications Hemodialysis or hemoperfusion is available\\nPoor vascular access\\nSignificant coagulopathy\\nTable 100-6 Indications, Contraindications, and Complications or Enhanced \\nElimination procedures\\nMultidose Activated \\nCharcoal\\nInitial dose: 50 g (1 g/kg children), repeat dose 25 g  \\n(0.5 g/kg children) every 2 h\\nContraindications Preexisting fluid overload\\nRenal impairment\\nUncorrected hypokalemia\\nComplications Hypokalemia\\nVolume overload\\nAlkalemia\\nHypocalcemia (usually mild)\\n(continued)\\n(continued )\\n100_Cydulka_Ch100.indd   562 20/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 581, 'page_label': '563'}, page_content='CHAPTER 100: General Management of the Poisoned Patient 563 \\nTable 100-7 Indications, Contraindications, and Complications of \\nExtracorporeal Removal Techniques\\nComplications of Extracorporeal Removal Techniques\\nFluid/metabolic \\ndisruption\\nRemoval of antidotes\\nLimited availability\\nLimited by hypotension (not continuous renal replacement \\ntherapy)\\nInfection/bleeding at catheter site\\nIntracranial hemorrhage secondary to anticoagulation\\n9. Intravenous Lipid Emulsion Therapy (ILET) is a potentially beneficial \\noption for the management of life-threatening cardiotoxicity precipi-\\ntated by lipid soluble xenobiotics (e.g., local anesthetics, tric yclic \\nantidepressants, lipophilic beta-blockers) when conventional therapies \\nhave failed to improve the patient’s condition.\\n10. Disposition depends on the nature of the intoxicant. Medical manage-\\nment is the priority and special attention must be made for exposures \\nthat may result in delayed toxicity.\\n11. Consider early consultation with a toxicologist and Poison Center for \\nall poisonings. Consult with a mental health specialist for all inten-\\ntional overdoses. Consider neglect or abuse in pediatric exposures.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 176, “General Management of Poisoned Patients,” by \\nShaun Greene\\n(continued)\\n100_Cydulka_Ch100.indd   563 20/03/17   2:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 582, 'page_label': '564'}, page_content='564\\nAnticholinergic Toxicity\\nO. John Ma\\n■ ■CLINICAL FEATURES\\nClinical findings include hypotension or hypertension, tachycardia, hypo-\\nactive or absent bowel sounds, urinary retention, flushed skin, hyperthermia, \\ndry skin and mucus membranes, mydriasis, confusion, agitation, disorienta-\\ntion, and auditory and visual hallucinations. Table 101-1 compares musca-\\nrinic and antimuscarinic effects.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe diagnosis is primarily clinical. In isolated anticholinergic toxicity, \\nroutine laboratory studies should be normal, and routine toxicology screen-\\ning is often of little value. Nonetheless, check electrolytes, glucose, and \\ncreatine phosphokinase levels. The differential diagnosis includes viral \\n101\\nCh A p TER\\nTAble 101-1 Muscarinic and Antimuscarinic Effects\\nOrgan Stimulation or Muscarinic Effect Antagonism or Antimuscarinic Effect\\nBrain Complex interactions\\nPossible improvement in memory\\nComplex interactions\\nImpairs memory\\nProduces agitation, delirium, and \\nhallucinations\\nFever\\nEye ↓ pupil size (miosis)\\n↓ intraocular pressure\\n↑ tear production\\n↑ pupil size (mydriasis)\\n↑ intraocular pressure\\nLoss of accommodation (blurred vision)\\nMouth ↑ saliva production ↓ saliva production\\nDry mucous membranes\\nLungs Bronchospasm\\n↑ bronchial secretions\\nBronchodilation\\nHeart ↓ heart rate\\nSlows atrioventricular conduction\\n↑ heart rate\\nEnhances atrioventricular conduction\\nPeripheral \\nvasculature\\nVasodilation (modest) Vasoconstriction (very modest)\\nGI ↑ motility\\n↑ gastric acid production\\nProduces emesis\\n↓ motility\\n↓ gastric acid production\\nUrinary Stimulates bladder contraction \\nand expulsion of urine\\n↓ bladder activity\\nPromotes urinary retention\\nSkin ↑ sweat production ↓ sweat production (dry skin)\\nCutaneous vasodilation (flushed \\nappearance)\\n101_Cydulka_Ch101.indd   564 20/03/17   2:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 583, 'page_label': '565'}, page_content='CHAPTER 101: Anticholinergic Toxicity 565 \\nencephalitis, Reye syndrome, head trauma, other intoxications, neuroleptic \\nmalignant syndrome, delirium tremens, acute psychiatric disorders, and \\nsympathomimetic toxicity.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nTreatment is primarily supportive. The goal is to prevent life-threatening \\ncomplications, which include status epilepticus, hyperthermia, cardiovas-\\ncular collapse, and rhabdomyolysis.\\n1. Place the patient on a cardiac monitor and secure intravenous or \\nintraosseous access.\\n2. Activated charcoal may decrease drug absorption, even beyond 1 hour \\nof ingestion.\\n3. Monitor temperature. Treat hyperthermia using conventional methods.\\n4. Hypertension usually does not require intervention, but should be \\ntreated conventionally as necessary.\\n5. Standard antidysrhythmics are usually effectiv e, but avoid class IA \\nmedications (e.g., procainamide). Treat dysrhythmias, widened QRS \\ncomplexes, and hypotension from sodium blocking agents (e.g., cyclic \\nantidepressants) with IV sodium bicarbonate 1  mEq/kg.\\n6. Treat agitation with benzodiazepines, such as lorazepam 2 to 4  mg IV \\nor 0.1 mg/kg). Avoid use of phenothiazines.\\n7. Treat seizures with benzodiazepines, such as lorazepam 2  mg IV or \\n0.1 mg/kg.\\n8. Physostigmine treatment is controversial. It is indicated if conventional \\ntherapy fails to control seizures, severe agitation, unstable dysrhythmias, \\ncoma with respiratory depression, malignant hypertension, or hypoten-\\nsion. The initial dose is 0.5 to 2  mg IV (0.02  mg/kg in children, \\nmaximum dose 2 mg), slowly administered over 5 minutes. When effec-\\ntive, a significant decrease in agitation may be apparent within 15 to \\n20 minutes. Physostigmine may worsen cyclic antidepressant toxicity  \\nand lead to bradycardia and asystole. It is contraindicated in patients \\nwith cardiovascular or peripheral vascular disease, bronchospasm, intes-\\ntinal or bladder obstruction, cardiac conduction disturbances, and sus-\\npected concomitant sodium channel antagonist poisoning. Observe the \\npatient for cholinergic excess.\\n9. If diagnosis of anticholinergic poisoning is unclear, then do not admin-\\nister a diagnostic challenge of physostigmine in order to avoid the small \\nbut increased risk of adverse effects in patients without anticholinergic \\ntoxicity.\\n10. Patients with mild anticholinergic toxicity can be discharged after 6 \\nhours of observ ation if their symptoms have resolved. Admit more \\nsymptomatic patients for 24 hours of observation. Patients who receive \\nphysostigmine usually require a 24-hour admission.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, \\n8th ed., see Chapter 202, “Anticholinergics,” by Dan Quan and Frank Lovecchio.\\n101_Cydulka_Ch101.indd   565 20/03/17   2:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 584, 'page_label': '566'}, page_content='566\\nPsychopharmacologic Agents\\nShan Yin\\n■ ■CYCLIC ANTIDEPRESSANTS\\nCyclic antidepressants inhibit reuptake of norepinephrine and serotonin, \\nblock sodium channels, and antagonize postsynaptic serotonin receptors. \\nThey can produce severe toxicity in overdose. Their use has declined as \\nnewer, safer agents have been developed.\\nClinical Features\\nToxicity may present with altered mental status, seizures, cardiac conduc-\\ntion or rhythm disturbances, hypotension, respiratory depression, and, in \\nsevere cases, coma. If serious toxicity is going to develop, it generally \\ndevelops within 6 hours of the ingestion.\\nDiagnosis\\nThe diagnosis is clinical. Characteristic ECG changes include sinus tachy-\\ncardia; right axis deviation of the terminal 40 ms; PR, QRS, and QT interval \\nprolongation. Right bundle-branch block, A-V blocks, and the Brugada \\npattern are less common. Amoxapine can notably cause toxicity without \\ncharacteristic ECG changes.\\nEmergency Department Care and Disposition\\nCare is primarily supportive.\\n1. Obtain IV access, and initiate cardiac rhythm and ECG monitoring.\\n2. Consider using 1 g/kg of activated charcoal PO if no contraindications \\nexist.\\n3. Hypotension is treated with isotonic crystalloids. Norepinephrine or \\nepinephrine is indicated if hypotension persists.\\n4. Treat conduction disturbances and ventricular dysrhythmias with sodium \\nbicarbonate as an IV bolus of 1 to 2 mEq/kg, repeated until the patient \\nimproves or until blood pH is 7.50 to 7.55. A continuous IV infusion \\n(150 mEq added to 1 L of 5% dextrose in water) may be used at a rate \\nof 2 to 3 mL/kg/h.\\n5. Treat torsades de pointes with 2 g of IV magnesium sulfate.\\n6. Control agitation with benzodiazepines. Avoid physostigmine.\\n7. Treat seizures with benzodiazepines. Phenobarbital, starting at 10 to \\n15 mg/kg IV , may be required for refractory seizures.\\n8. Patients who remain asymptomatic after 6 hours do not need admission \\nfor toxicologic reasons. Admit symptomatic patients to a monitored bed \\nor intensive care unit (ICU).\\n102\\nCh APTER\\n102_Cydulka_Ch102.indd   566 20/03/17   3:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 585, 'page_label': '567'}, page_content='CHAPTER 102: Psychopharmacologic Agents 567 \\n■ ■ATYPICAL ANTIDEPRESSANTS, SEROTONIN REUPTAKE \\nINhIBITORS, AND SEROTONIN SYNDROME\\nNewer antidepressants include trazodone, bupropion, mirtazapine, selective \\nserotonin reuptake inhibitors, and serotonin/norepinephrine reuptake inhib-\\nitors. They are safer than older agents but can still cause toxicity, including \\nthe serotonin syndrome.\\n■ ■TRAZODONE\\nClinical Features\\nSymptoms of toxicity include central nervous system depression, ataxia, \\ndizziness, seizures, orthostatic hypotension, vomiting, and abdominal pain. \\nECG abnormalities include QT interval prolongation, sinus bradycardia \\nand tachycardia, and torsades de pointes. Priapism can be seen at therapeu-\\ntic doses.\\nEmergency Department Care and Disposition\\nSupportive care is generally sufficient in isolated overdoses.\\n1. Initiate cardiac rhythm monitoring and obtain a 12-lead ECG.\\n2. Consider single-dose activated charcoal if no contraindications exist.\\n3. Treat hypotension with isotonic IV fluids, followed by norepinephrine.\\n4. Treat torsades de pointes with IV magnesium sulfate or overdrive pacing.\\n5. Discharge patients who remain asymptomatic for at least 6 hours, with \\npsychiatric evaluation as indicated. Admit those with neurologic and/or \\ncardiac symptoms to a monitored bed.\\n■ ■BUPROPION\\nClinical Features\\nToxicity manifests as agitation, dizziness, tremor, vomiting, drowsiness, \\nand tachycardia. Seizures are more common than with other atypical anti-\\ndepressants and can be the initial presenting sign. ECG changes include \\nsinus tachycardia, QRS interval widening, and QT interval prolongation.\\nEmergency Department Care and Disposition\\nSeizures should be anticipated.\\n1. Start a peripheral IV line and initiate cardiac rhythm monitoring.\\n2. Consider activated charcoal if no contraindications exist.\\n3. Treat seizures with benzodiazepines, followed by phenobarbital.\\n4. Administer IV sodium bicarbonate for QRS prolongation.\\n5. Consider IV lipid emulsion for refractory cardiovascular instability.\\n6. Observe asymptomatic patients for 8 hours. Monitor patients ingesting \\n>450 mg of sustained-release bupropion for up to 24 hours. Admit those \\nwith seizures, persistent tachycardia, or lethargy.\\n102_Cydulka_Ch102.indd   567 20/03/17   3:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 586, 'page_label': '568'}, page_content='568 SECTION 11: Toxicology and Pharmacology\\n■ ■MIRTAZAPINE\\nClinical Features\\nToxicity causes sedation, confusion, sinus tachycardia, and hypertension. \\nComa and respiratory depression are seen in severe cases or with co-\\ningestion of other sedatives.\\nEmergency Department Care and Disposition\\n1. Isolated overdoses can generally be managed with supportive care.\\n2. Consider single-dose activated charcoal if no contraindications exist.\\n3. Admit symptomatic patients to a monitored bed. Discharge asymptom-\\natic patients after 6 hours.\\n■ ■SELECTIVE-SEROTONIN REUPTAKE INhIBITORS\\nClinical Features\\nSelective-serotonin reuptake inhibitors (SSRIs) include fluoxetine, fluvox-\\namine, paroxetine, sertraline, citalopram, and escitalopram. Signs and \\nsymptoms may include vomiting, sedation, tremor, sinus tachycardia, \\nmydriasis, seizures, diarrhea, and hallucinations. Sinus bradycardia is more \\ncommon with fluvoxamine than with other SSRIs. QRS and QT interval \\nprolongation has been reported in citalopram and escitalopram ingestions.\\nEmergency Department Care and Disposition\\nSupportive care is generally sufficient.\\n1. Establish IV access and initiate cardiac monitoring.\\n2. Single-dose activated charcoal is appropriate for most ingestions if \\nthere are no contraindications.\\n3. Benzodiazepines are recommended for management of seizures.\\n4. Administer IV sodium bicarbonate for QRS prolongation.\\n5. Observe patients for at least 6 hours. Admit patients who are tachycardic, \\nhave altered mental status, have conduction abnormalities, or have signs \\nof serotonin syndrome.\\n■ ■SEROTONIN-NOREPINEPhRINE REUPTAKE INhIBITORS\\nClinical Features\\nSerotonin-norepinephrine reuptake inhibitors (SNRIs) include venlafaxine, \\nduloxetine, levomilnacipran, and desvenlafaxine. Overdose may cause \\nhypotension, diaphoresis, tremor, mydriasis, sedation, coma, and seizures. \\nECG changes include sinus tachycardia and QRS or QT interval widening. \\nRhabdomyolysis has been reported with venlafaxine overdoses with and \\nwithout seizures.\\nEmergency Department Care and Disposition\\nThere are no established guidelines for treating SNRI overdoses.\\n1. Initiate peripheral IV access and cardiac monitoring.\\n2. Consider single-dose activated charcoal if no contraindications exist. \\nConsider whole-bowel irrigation for venlafaxine overdoses >4000 mg.\\n102_Cydulka_Ch102.indd   568 20/03/17   3:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 587, 'page_label': '569'}, page_content='CHAPTER 102: Psychopharmacologic Agents 569 \\n3. Benzodiazepines are the anticonvulsants of choice.\\n4. Treat hypotension with fluids and a direct-acting vasopressor.\\n5. Administer IV sodium bicarbonate for QRS prolongation.\\n6. Administer IV fluid for rhabdomyolysis.\\n7. All patients require at least 6 hours of observation, or 24 hours for those \\ningesting extended-release preparations. Admit symptomatic patients to \\na monitored bed.\\n■ ■SEROTONIN SYNDROME\\nSerotonin syndrome is a potentially life-threatening adverse reaction to \\nserotoninergic medications. It can be produced by any drug or combination \\nof drugs that increase central serotonin neurotransmission, most commonly \\nantidepressants.\\nClinical Features\\nSigns and symptoms are altered mental status, hyperthermia, seizures, and \\nincreased muscle tone, particularly myoclonus. Hyperthermia is the most \\ncommon cause of death.\\nDiagnosis\\nSymptoms are nonspecific, and there are no confirmatory laboratory tests. \\nDiagnostic criteria emphasize exposure to a serotoninergic drug and pres-\\nence of myoclonus.\\nEmergency Department Care and Disposition\\nTreatment is supportive. Watch patients for rhabdomyolysis and metabolic \\nacidosis.\\n1. Endotracheal intubation and ventilatory support may be required in \\nsevere cases.\\n2. Use benzodiazepines to decrease discomfort and promote muscle \\nrelaxation.\\n3. The antiserotonergic agent cypr oheptadine may be given at an initial \\ndose of 4 to 12 mg PO, repeated with 2 mg doses at 2-hour intervals if \\nno response.\\n4. Admit all patients until symptoms resolve. Severely ill patients require \\nadmission to an ICU. Discontinue serotonergic drugs.\\n■ ■MONOAMINE OXIDASE INhIBITORS\\nMonoamine oxidase inhibitors (MAOIs) are used to treat refractory depres-\\nsion. They cause accumulation of neurotransmitters such as norepinephrine \\nin presynaptic nerve terminals and increased systemic availability of \\ndietary amines, such as tyramine. MAOIs can lead to fatal food and drug \\ninteractions and cause severe toxicity in overdose.\\nClinical Features\\nSymptoms include headache, agitation, palpitations, chest pain, and tremor. \\nSigns include sinus tachycardia, hyperreflexia, diaphoresis, fasciculations, \\nmydriasis, hyperventilation, nystagmus, flushing, muscle rigidity, and \\n102_Cydulka_Ch102.indd   569 20/03/17   3:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 588, 'page_label': '570'}, page_content='570 SECTION 11: Toxicology and Pharmacology\\nhypertension. Signs and symptoms often are delayed after ingestion and the \\ndelay can be up to 24 hours. Coma, seizures, bradycardia, hypotension, \\nhypoxia, and hyperthermia may develop. Death usually results from multi-\\norgan failure.\\nDiagnosis and Differential\\nDiagnosis is made on clinical grounds. Laboratory tests can identify com-\\nplications, including rhabdomyolysis, renal failure, hyperkalemia, meta-\\nbolic acidosis, and disseminated intravascular coagulation. The differential \\ndiagnosis includes drugs and conditions that produce a hyperadrenergic \\nstate, altered mental status, and/or muscle rigidity.\\nEmergency Department Care and Disposition\\nTreatment consists of supportive care and management of complications.\\n1. Obtain IV access and initiate cardiac rhythm monitoring.\\n2. Consider activated charcoal if no contraindications exist.\\n3. Hypertension may be treated with phentolamine, 2.5 to 5 mg IV every \\n10 to 15 minutes, followed by an infusion. An alternative agent is nitro-\\nprusside. Avoid beta-blockers.\\n4. Nitroglycerin is indicated for anginal chest pain and signs of myocar -\\ndial ischemia.\\n5. Treat hypotension with isotonic IV fluid boluses, followed by \\nnorepinephrine.\\n6. Treat ventricular dysrhythmias with lidocaine or procainamide.\\n7. Treat bradycardia with atropine , isoproterenol, dobutamine, and \\npacing.\\n8. Treat seizures with benzodiazepines. General anesthesia and muscle \\nparalysis using v ecuronium, with ongoing EEG monitoring, may be \\nnecessary.\\n9. Treat hyperthermia with benzodiazepines to reduce muscle rigidity plus \\ncooling measures. Chemical paralysis with a nondepolarizing agent \\nmay be needed for sev ere rigidity. Dantrolene 0.5 to 2.5 mg/kg IV \\nevery 6 hours could be considered if other measures have failed.\\n10. Patients who have ingested >1 mg/kg require ICU admission. Those \\nwho have ingested less can be admitted to a monitored bed. Observe \\nasymptomatic patients for 24 hours.\\n■ ■ANTIPSYChOTICS\\nAntipsychotics are used to treat psychosis, agitation, nausea, headaches, \\nhiccups, and involuntary motor disorders. Their therapeutic action involves \\nblockade of dopamine receptors.\\nClinical Features\\nCentral nervous system effects include lethargy, ataxia, dysarthria, confusion, \\nand coma. Seizures are more common with loxapine and clozapine. Antimus-\\ncarinic toxicity may be seen. Cardiovascular manifestations include ortho-\\nstatic hypotension; sinus tachycardia; PR, QRS, and QT interval prolongation; \\nand ST and T wave abnormalities. Extrapyramidal symptoms such as \\ndystonia, akathisia, and tardive dyskinesia can be seen during therapeutic use.\\n102_Cydulka_Ch102.indd   570 20/03/17   3:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 589, 'page_label': '571'}, page_content='CHAPTER 102: Psychopharmacologic Agents 571 \\nNeuroleptic malignant syndrome is a rare but potentially fatal idiosyncratic \\nreaction to antipsychotic agents. It typically develops over 1 to 3 days. It is \\ncharacterized by fever, muscular rigidity, autonomic dysfunction, and altered \\nmental status (Table 102-1). Death results from complications of muscle rigid-\\nity, such as rhabdomyolysis, renal failure, or cardiac or respiratory failure.\\nDiagnosis\\nDiagnostic studies should include a complete blood count, basic chemis-\\ntries, a pregnancy test for women of childbearing age, and an ECG. Also \\nobtain a creatine kinase level and liver function tests in patients with neu-\\nroleptic malignant syndrome.\\nEmergency Department Care and Disposition\\nTreatment is largely supportive.\\n1. Establish IV access and initiate cardiac rhythm monitoring.\\n2. Ventilatory support may be necessary for patients with respiratory \\ndepression.\\nTAblE 102-1 Diagnostic Criteria for Neuroleptic Malignant Syndrome\\nCaroff and Mann* Levenson†\\nAmerican \\nPsychiatric \\nAssociation‡\\nMajor \\ncriteria\\nFever >38°C (100.4°F)\\nMuscle rigidity\\nFever\\nMuscle rigidity\\nElevated CK level\\nFever\\nMuscle rigidity\\nMinor \\ncriteria\\nChange in mental status\\nTachycardia\\nHypertension or hypotension\\nTachypnea or hypoxia\\nDiaphoresis or sialorrhea\\nTremor\\nIncontinence\\nIncreased CK level or \\nmyoglobinuria\\nLeukocytosis\\nMetabolic acidosis\\nTachycardia\\nAbnormal blood \\npressure\\nTachypnea\\nLeukocytosis\\nDiaphoresis\\nAltered mental \\nstatus\\nDiaphoresis\\nDysphagia\\nTremor\\nIncontinence\\nAltered mental \\nstatus\\nMutism\\nTachycardia\\nLabile blood \\npressure\\nLeukocytosis\\nElevated CK level\\nDiagnostic \\nrequirement\\nBoth major and at least \\nfive minor criteria must be \\npresent, and treatment with \\nan antipsychotic must have \\nbeen within 7 days of symp-\\ntom onset (or 2–4 weeks \\nwith a depot agent).\\nAll three major \\ncriteria or two major \\nand four minor \\ncriteria must be \\npresent.\\nBoth major and \\nat least two \\nminor criteria \\nmust be present.\\n*Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am. 1993;77:185.\\n†Levenson J. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137.\\n‡  American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text \\nrevision. Washington, DC: American Psychiatric Association; 2000:795–798.\\nAbbreviation: CK, creatine kinase.\\n102_Cydulka_Ch102.indd   571 20/03/17   3:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 590, 'page_label': '572'}, page_content='572 SECTION 11: Toxicology and Pharmacology\\n3. Treat seizures with a benzodiazepine.\\n4. Treat hypotension with fluid resuscitation and nor epinephrine or \\nphenylephrine.\\n5. Treat intraventricular conduction delay and v entricular dysrhythmias \\nwith IV sodium bicarbonate. Lidocaine is an alternative for ventricular \\ndysrhythmias.\\n6. Consider IV lipid emulsion for severe quetiapine overdoses with cardio-\\nvascular instability refractory to conventional therapy.\\n7. Treatment of neuroleptic malignant syndrome includes cooling mea-\\nsures and benzodiazepines to reduce muscle rigidity. Intubation and \\nparalysis with a nondepolarizing agent may facilitate cooling. Consider \\ndantrolene (1 to 2.5 mg/kg IV load) when muscle rigidity is pro-\\nnounced. Bromocriptine may possibly shorten the duration.\\n8. Observe patients for 6 hours post-ingestion. Admit symptomatic patients \\nto a monitored bed. P atients with neuroleptic malignant syndrome war -\\nrant ICU admission.\\n■ ■LIThIUM\\nLithium is used to treat bipolar disorder and mania. Toxicity results from \\noverdose or altered renal clearance. Death is usually from respiratory or \\ncardiac failure.\\nClinical Features\\nPatients may present with tremor, muscle fasciculations or weakness, clo-\\nnus, ataxia, agitation, peripheral neuropathy, lethargy, or coma. Acute renal \\nfailure may be noted, especially in the elderly and those with preexisting \\nrenal impairment, diabetes, hypertension, or dehydration. Gastrointestinal \\nsymptoms are common in acute and chronic toxicity. Cardiac abnormalities \\nare more common in acute toxicity and include conduction disturbances \\nand ventricular dysrhythmias. Nephrogenic diabetes insipidus and hypothy-\\nroidism can be noted as adverse effects from chronic therapeutic use.\\nDiagnosis\\nAcute overdoses present with more GI than neurologic toxicity. Serum \\nlithium levels may not correlate well with symptoms. Patients with chronic \\ntoxicity display more neurologic effects at lower levels. In this setting, \\nserum lithium levels correlate better with toxicity. Acute-on-chronic inges-\\ntions have aspects of both. ECG abnormalities include QT interval prolon-\\ngation and T wave inversions.\\nEmergency Department Care and Disposition\\nStabilization includes securing the airway and ventilatory and hemody-\\nnamic support.\\n1. Obtain IV access, and initiate cardiac rhythm and ECG monitoring.\\n2. Initial laboratory studies should include renal function tests, electrolyte \\nlevels, complete blood count, thyroid-stimulating hormone and thyroid \\nhormone levels if altered level of consciousness, and serum levels of \\nlithium and other possible ingestants.\\n102_Cydulka_Ch102.indd   572 20/03/17   3:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 591, 'page_label': '573'}, page_content='CHAPTER 102: Psychopharmacologic Agents 573 \\n3. Treat seizures with IV benzodiazepines, followed by phenobarbital.\\n4. Activated charcoal does not adsorb lithium but may be helpful for other \\ningestions.\\n5. Whole-bowel irrigation may be helpful, especially for sustained-\\nrelease lithium products.\\n6. IV administration of normal saline is important. In most adults, a 2-L \\nIV bolus is given over 30 to 60 minutes followed by a continuous infu-\\nsion at 1.5 to 2 times the maintenance rate.\\n7. Sodium polystyrene sulfonate (Kaye xalate®) can bind lithium and \\nincrease the elimination but can only be given orally. Hypokalemia and \\nconstipation may develop as well.\\n8. Hemodialysis is indicated when serum lithium levels are >4 mEq/L in \\nacute overdose, or if there is severe toxicity as evidenced by coma, sei-\\nzures, or life-threatening dysrhythmias. Patients with renal failure and \\nrising lithium levels, and those who have ingested sustained-release \\npreparations may also benefit.\\n9. Monitor patients with acute ingestions for 4 to 6 hours. Admit those with \\nlithium levels >1.5 mEq/L and patients who have ingested a sustained-\\nrelease preparation. Treat patients with mild chronic toxicity with IV \\nnormal saline for 6 to 12 hours, and discharge or refer for psychiatric \\nevaluation once their lithium level decreases to <1.5 mEq. Admit pa-\\ntients with more severe chronic toxicity.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 177, “Cyclic Antidepressants,” by Frank LoVecchio; \\nChapter 178, “Atypical and Serotonergic Antidepressants” by Frank LoVecchio \\nand Erik Mattison; Chapter 179, “Monoamine Oxidase Inhibitors,” by Frank \\nLoVecchio; Chapter 180, “Antipsychotics” by Michael Levine and Frank \\nLoVecchio; and Chapter 181, “Lithium,” by Sandra M. Schneider, Daniel J. \\nCobaugh, and Benjamin D. Kessler\\n102_Cydulka_Ch102.indd   573 20/03/17   3:02 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 592, 'page_label': '574'}, page_content='574\\nSedatives and Hypnotics\\nShan Yin\\nSedative and hypnotic medications are commonly used pharmaceuticals. The \\nthree classes include barbiturates, benzodiazepines, and nonbenzodiazepines \\n(buspirone, carisoprodol, meprobamate, chloral hydrate, γ-hydroxybutyrate, \\nmelatonin, ramelteon, zaleplon, zolpidem, and zopiclone).\\n■ ■BARBITURATES\\nClinical Features\\nAmong the sedative-hypnotic class of medications, barbiturates are associ-\\nated with the greatest morbidity and mortality. Owing to safer alternatives \\nfor seizure management, the clinical use of barbiturates has declined.\\nBarbiturates cause a dose-dependent spectrum of central nervous sys-\\ntem depression. With mild to moderate ingestions, toxicity resembles that \\nof ethanol or other sedative-hypnotic medications: confusion, ataxia, \\nslurred speech, drowsiness, and disinhibition. Gastrointestinal motility may \\nbe slowed. The toxic dose will vary depending on route, speed of adminis-\\ntration, and patient tolerance. Severe intoxication follows a tenfold over -\\ndose, and loss of deep tendon and corneal reflexes may occur. Hypother -\\nmia, hypotension, and respiratory depression are common. Complicating \\nfeatures of the toxicity include hypoglycemia, aspiration pneumonia, pul-\\nmonary edema, and acute lung injury.\\nBarbiturate withdrawal syndrome may occur in the habituated patient \\nwho suddenly stops taking their medication. The syndrome occurs within \\n24 hours of cessation and begins with mild symptoms, which may become \\nsevere over the next 2 to 8 days. Short-acting barbiturates generally cause a \\nmore robust withdrawal syndrome than the long-acting products. Minor \\nsymptoms include anxiety, restlessness, depression, insomnia, anorexia, \\nnausea, and vomiting. Major symptoms include psychosis, hallucinations, \\ndelirium, generalized seizures, hyperthermia, and cardiovascular \\ncollapse. Barbiturate withdrawal has a high mortality and gradual inpatient \\nwithdrawal of the addicting agent is recommended.\\nDiagnosis and Differential\\nSerum barbiturate levels may help establish an etiology for altered mental \\nstatus in a comatose patient; however, decisions regarding management are \\nbased primarily on clinical grounds. Mixed sedative-hypnotic ingestions may \\nbe inappropriately ascribed to the barbiturate alone. Due to variability among \\npatients with barbiturate overdoses, heart rate, pupil size and reactivity, and \\nnystagmus are not clinically distinguishing signs. Skin bullae (“barbiturate \\nblisters”) are rarely evident and are not specific to barbiturates. Myocardial \\ndepression is more common with barbiturates than benzodiazepines.\\nBedside glucose measurement is imperative in the patient with altered \\nmental status and may help narrow the differential diagnosis. Other useful \\ndiagnostic testing includes arterial or venous blood gas analysis, electrocar-\\ndiogram, liver function tests, salicylate and acetaminophen concentrations, \\n103\\nCh A p TER\\n103_Cydulka_Ch103.indd   574 20/03/17   3:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 593, 'page_label': '575'}, page_content='CHAPTER 103: Sedatives and Hypnotics 575 \\nblood urea nitrogen and creatinine levels, complete blood count, and cre-\\natinine phosphate kinase.\\nEmergency Department Care and Disposition\\nTreatment begins with airway management and supportive care. Once pul-\\nmonary and cardiovascular function have been adequately assessed and \\nstabilized, enhancing elimination can be considered.\\n1. Stabilize the airway. Endotracheal intubation in the severely poisoned \\npatients is commonly required and should be initiated early in the ED \\ncourse.\\n2. Due to the potential for myocardial depression, place two large-bore IVs \\nand initiate fluid resuscitation with isotonic saline for h ypotension.\\n3. Consider empiric treatment with naloxone and thiamine early in the \\nmanagement.\\n4. Dopamine or norepinephrine  may be needed if fluid boluses fail to \\nreverse hypotension. Hypothermia between 30°C (86°F) and 36°C \\n(96.8°F) requires standard rewarming techniques.\\n5. Activated charcoal helps reduce absorption. In the awake, cooperative \\npatient, 50 to 100 g orally (1 g/kg in children) should be administered. \\nFor sedated or unconscious patients, airway protection should precede \\nthe administration of activated charcoal. Multidose charcoal may reduce \\nserum levels, but has not been shown to change clinical outcome.\\n6. Forced diuresis is not indicated due to risks of sodium and fluid overload \\nand a lack of proven efficacy.\\n7. Urinary alkalinization is not considered f irst-line therapy. While it may \\nenhance the clearance of phenobarbital and primidone, it is less effective \\nthan multidose charcoal alone, and has no role in the management of \\nshort-acting barbiturates.\\n8. Hemodialysis, hemoperfusion, and hemodiafiltration are reserved for \\npatients who deteriorate despite aggressive medical support, but are only \\neffective with phenobarbital toxicity.\\n9. Disposition depends on the degree of intoxication: evidence of toxicity \\ngreater than 6 hours from time of arrival requires hospital admission. \\nObtain psychiatric consult for intentional overdose. Toxicology or poi-\\nson center consultation is recommended to assist with management.\\n■ ■BENZODIAZEpINES\\nClinical Features\\nBenzodiazepine overdoses are common but carry a low mortality rate in \\nisolation. There is, however, variation in the clinical outcome among agents \\ndue to differences in potency. Parenteral administration in the ED may \\nproduce significant complications. Benzodiazepines, when mixed with \\nother sedative-hypnotics, may produce profound toxicity including respira-\\ntory depression, hypotension, and death.\\nThe primary effect of benzodiazepines is central nervous system depres-\\nsion and is characterized by somnolence, dizziness, slurred speech, confu-\\nsion, ataxia, incoordination, and general impairment in intellectual function. \\nNeurologic effects in the elderly, very young, or malnourished may be \\nprolonged or enhanced. Disinhibition, extrapyramidal reactions, and \\n103_Cydulka_Ch103.indd   575 20/03/17   3:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 594, 'page_label': '576'}, page_content='576 SECTION 11: Toxicology and Pharmacology\\nparadoxical excitation are uncommon but reported. Short-term, anterograde \\namnesia is a common, sometimes desirable, effect with the administration \\nof certain benzodiazepines.\\nChronic use of benzodiazepines is associated with physiologic addic-\\ntion. Withdrawal from benzodiazepines may occur following abrupt cessa-\\ntion. Symptoms are more intense following withdrawal from short-acting \\nagents. Clinical findings may mimic alcohol withdrawal and include \\nanxiety, irritability, insomnia, nausea, vomiting, tremor, and sweating. Seri-\\nous manifestations include hallucinations, psychosis, disorientation, and \\nseizures. Treatment begins with reintroduction of a benzodiazepine with \\nsubsequent, gradual tapering.\\nDiagnosis and Differential\\nThere is limited value in toxicological testing as serum levels do not correlate \\nwell with clinical findings. Qualitative urine screening is unreliable and a \\npositive test does not prove causation of clinical signs as clinical features are \\nnonspecific and may be seen with overdose of any sedative-hypnotic.\\nEmergency Department Care and Disposition\\n1. Priorities include assessment and stabilization of the airway, breathing, \\nand circulation (see the preceding section on barbiturates for guidance \\nregarding initial management, resuscitation, and laboratory monitoring).\\n2. Do not induce emesis. Activated char coal (1 g/kg in children or 50 to \\n100 g in adults) will adsorb benzodiazepines. Exercise caution in the \\nsedated patient, and secure the airway before administration. Multidose \\ncharcoal is not indicated. Gastric lavage, forced dieresis, enhanced \\nelimination, hemodialysis, and hemoperfusion are ineffective and \\nunnecessary.\\n3. Flumazenil is a unique, selective antagonist of the central ef fects of \\nbenzodiazepines. Unlike naloxone, flumazenil should not be used \\nempirically for the undifferentiated sedative-hypnotic toxidrome as it \\nmay precipitate seizures (Table 103-1). The ED applications of flumaze-\\nnil are generally limited to the setting of respiratory depression follow-\\ning procedural sedation with benzodiazepines. The dose is 0.2 mg IV \\nand titrated every minute to a maximum total dose of 3 mg (0.01 to \\n0.02 mg/kg in children). The half-life of flumazenil is approximately 1 \\nhour and rebound sedation can occur in the setting of overdose with \\nlong-acting benzodiazepines.\\n4. In general, care is supportive. Admit patients with significant alterations \\nof mental status, respiratory depression, or hypotension. Consultation \\nwith mental health specialists may be appropriate.\\nTablE 103-1 Contraindications to Flumazenil\\nOverdose of unknown agents\\nSuspected or known physical dependence on benzodiazepines\\nSuspected cyclic antidepressant overdose\\nCoingestion of seizure-inducing agents\\nKnown seizure disorder\\nSuspected increased intracranial pressure\\n103_Cydulka_Ch103.indd   576 20/03/17   3:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 595, 'page_label': '577'}, page_content='CHAPTER 103: Sedatives and Hypnotics 577 \\n■ ■NONBENZODIAZEpINE SEDATIVES\\nClinical Features\\nThe hallmark of all sedative-hypnotic medications, regardless of subclass, \\nis sedation. Exposure to nonbenzodiazepine agents is common and coinges-\\ntion with other sedatives may be synergistic and produce profound seda-\\ntion. Three agents, ethchlorvynol, glutethimide, and methaqualone, have \\nbeen removed from the markets in the United States and Canada.\\nBuspirone\\nBuspirone has a complex mechanism of action and rapid absorption. Side \\neffects include sedation, GI distress, vomiting, and dizziness. The symp-\\ntoms with overdose are exaggerations of the side effects noted with thera-\\npeutic dosing. The drug is generally well tolerated in overdose, and \\ntreatment is primarily supportive. Due to effects on the serotoninergic sys-\\ntem, serotonin syndrome has been reported. Seizures, hypotension, pria-\\npism, and dystonia are rare complications.\\nCarisoprodol and Meprobamate\\nCarisoprodol and its active metabolite, meprobamate, are marketed as \\ncentral-acting muscle relaxants and anxiolytics, respectively. In overdoses, \\nboth may cause sedation, coma, and cardiopulmonary depression. Cariso-\\nprodol, but not meprobamate, can cause myoclonus, which may be a clue \\nin an unknown overdose. Meprobamate has been associated with phar -\\nmacobezoars, and may be a cause of prolonged toxicity.\\nChloral Hydrate\\nChloral hydrate is the oldest sedative-hypnotic available today. At therapeu-\\ntic doses, chloral hydrate produces mental status depression without loss of \\nairway and respiratory reflexes. V omiting and paradoxical excitation can \\noccur in a small percentage of children. In overdose, coma and respiratory \\ndepression can occur. Chloral hydrate is a myocardial sensitizer and cardiac \\ndysrhythmias, decreased cardiac contractility, and asystole have been \\nreported. When combined with alcohol, a potent, “knock-down” cocktail \\nknown as a “Mickey Finn” is created. A withdrawal syndrome similar to \\nethanol has been described.\\nChloral hydrate may produce a characteristic pear-like odor. Abdominal \\nradiographs may aid in the diagnosis of pharmacobezoars, as chloral \\nhydrate is radiopaque. Respiratory depression and coma are treated sup-\\nportively. Treat ventricular dysrhythmias with IV β-blockers.\\nγ -Hydroxybutyrate\\nγ-Hydroxybutyrate (GHB) has been marketed as a muscle builder, fat \\nburner, antidepressant, anxiolytic, hypnotic, and cholesterol-lowering \\nmedication. The only approved use in the United States is for the treatment \\nof narcolepsy and is prescribed as its sodium salt (sodium oxybate). GHB \\nis often used illicitly and has street names including “liquid ecstasy,” \\n“Georgia home boy,” “G,” and “grievous bodily harm.” GHB has a narrow \\ntherapeutic window and may produce a range of toxicity from mild seda-\\ntion to coma. Seizures, bradycardia, hypothermia, and cardiac depression \\n103_Cydulka_Ch103.indd   577 20/03/17   3:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 596, 'page_label': '578'}, page_content='578 SECTION 11: Toxicology and Pharmacology\\nmay occur. Rapid sedation with abrupt recov ery 6 to 12 hours later is a \\ncommon feature with GHB. Due to its amnestic effects and rapid sedation, \\nGHB has been illicitly used for drug-facilitated sexual assault. Two com-\\npounds, 1,4 butanediol and γ-butyrolactone are GHB precursors and have \\nbeen abused to produce similar effects. Treatment is primarily supportive \\nwith focus on airway management. Physostigmine and neostigmine should \\nbe avoided. Rapid awaking and self-extubation may be a clue to GHB \\nintoxication. Toxicologic detection of GHB is difficulty owing to its very \\nshort half-life and rapid elimination. Withdrawal from GHB mimics alco-\\nhol withdrawal and may be severe, lasting from 3 days to 2 weeks.\\nMelatonin\\nThe endogenous hormone melatonin is secreted by the pineal gland and is \\nbelieved to help regulate the sleep–wake cycle. Melatonin can be purchased \\nwithout prescription. Side effects following therapeutic dosing include \\nheadache, dizziness, fatigue, and irritability. Overdose data are limited, and \\nsigns and symptoms exaggerate the side effects from therapeutic doses.\\nRamelteon\\nRamelteon is a relatively new medication used to treat insomnia. It binds to \\nmelatonin receptors in the brain. Absorption following oral dosing is rapid. \\nIn overdose, sedation is common and treatment is supportive. Abuse and \\nwithdrawal have not been reported.\\nTasimelteon\\nTasimelteon is used to treat non-24-hour sleep–wake disorder. It peaks \\nquickly following ingestion. There is no data on overdoses currently. Abuse \\nand withdrawal have not been reported.\\nZolpidem, Zaleplon, and Zopiclone\\nZolpidem, zaleplon, and zopiclone have gained increased popularity for the \\ntreatment of insomnia. Though initially thought to produce little or no psy-\\nchomotor impairment, addiction or withdrawal, experience has proved \\notherwise. Zaleplon appears to be less likely to cause withdrawal than \\nzolpidem or zopiclone. Side effects in therapeutic doses include nausea and \\nsomnolence. Sedation would be the expected primary effect after overdose. \\nVivid dreams, sleep-walking, and driving have been reported with zolpi-\\ndem. Fatalities following zolpidem overdoses have been reported, but are \\nusually associated with mixed ingestions. Methemoglobinemia and hemo-\\nlytic anemia have been reported after large zoplicone overdoses.\\nEmergency Department Care and Disposition\\n1. In general, management for the nonbenzodiazepines is supportive (see \\nthe preceding section on benzodiazepines for treatment priorities).\\n2. For ventricular dysrhythmias in the setting of chloral h ydrate intoxica-\\ntion, IV β-blockers (e.g., propranolol 1 mg IV or 0.01 to 0.1 mg/kg IV \\nin children) are first-line agents.\\n3. Disposition is largely guided by the degree of symptoms. Hav e a low \\nthreshold for admission of any patient with altered mental status, abnormal \\nvital signs, or dysrhythmias. Consult psychiatric services when appropriate.\\n103_Cydulka_Ch103.indd   578 20/03/17   3:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 597, 'page_label': '579'}, page_content='CHAPTER 103: Sedatives and Hypnotics 579 \\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 182, “Barbiturates,” by Chip Gresham and Frank \\nLoVecchio; Chapter 183, “Benzodiazepines,” by Dan Quan; and Chapter 184, \\n“Nonbenzodiazepine Sedatives,” by Michael Levine and Dan Quan.\\n103_Cydulka_Ch103.indd   579 20/03/17   3:10 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 598, 'page_label': '580'}, page_content='580\\nAlcohols\\nMichael Levine\\nAll alcohols are potentially toxic and cause clinical inebriation. Ethanol and \\nisopropanol are the most commonly ingested alcohols and cause direct \\ntoxicity, while methanol and ethylene glycol cause toxicity as a result of \\nconversion to toxic metabolites.\\n■ ■ETHANOL\\nEthanol is the most commonly abused drug in the world. While acute toxic-\\nity may result in death due to respiratory depression, the majority of mor -\\nbidity and mortality is due to trauma owing to impaired cognitive function. \\nBlood ethanol levels correlate poorly with the degree of intoxication due to \\nthe development of tolerance. On an average, nondrinkers metabolize etha-\\nnol at a rate of 20 mg/dL/h, whereas chronic alcoholics metabolize ethanol \\nat a rate of 30 mg/dL/h.\\nClinical Features\\nSigns and symptoms of ethanol intoxication include disinhibited behavior, \\nslurred speech, impaired coordination, followed later by respiratory and \\ncentral nervous system (CNS) depression.\\nDiagnosis and Differential\\nHead injury and hypoglycemia can present similarly to ethanol intoxica-\\ntion, and these diagnoses may coexist. Glucose should be measured in all \\npatients with altered mental status. In those patients without a clear expla-\\nnation for their altered mental status, serum ethanol levels may help con-\\nfirm intoxication, although the value may be difficult to interpret. For \\npatients with comorbid disease or injury, additional labs that may be helpful \\ninclude the following: electrolytes may demonstrate an anion gap acidosis; \\nliver enzymes may reveal hepatic damage. Obtain imaging as indicated by \\nexternal signs of trauma in the inebriated patient.\\nEmergency Department Care and Disposition\\n1. The mainstay of treatment is observation. A careful physical e xamina-\\ntion should be performed to evaluate for complicating injury or illness.\\n2. Treat hypoglycemia with IV dextrose. Thiamine 100 mg IV or IM may \\nbe given concurrently if Wernicke encephalopathy is suspected.\\n3. Consider secondary causes of deterioration or lack of improvement \\nduring observ ation and manage accordingly.\\n4. Discharge the patient once sober enough to pose no threat to self or others.\\n■ ■ISOPROPANOL\\nIsopropanol is commonly found in rubbing alcohol, solvents, skin and hair \\nproducts, paint thinners, and antifreeze. Acetone is the principal toxic \\nmetabolite.\\n104\\nC HAPTER\\n104_Cydulka_Ch104.indd   580 20/03/17   3:24 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 599, 'page_label': '581'}, page_content='CHAPTER 104: Alcohols 581 \\nClinical Features\\nClinically, isopropanol intoxication is similar to that of ethanol but pro-\\nduces a greater degree of intoxication than ethanol. Severe poisoning pres-\\nents as coma, respiratory depression, and hypotension. Hemorrhagic \\ngastritis is common and causes nausea, vomiting, abdominal pain, and \\nupper gastrointestinal (GI) bleeding.\\nDiagnosis and Differential\\nA glucose level should be measured in all patients with altered mental sta-\\ntus. Laboratory studies may reveal an elevated osmolal gap, ketonemia, and \\nketonuria, without acidosis. In the setting of upper GI bleeding, coagulation \\nstudies, a complete blood count, and a type and screen should be obtained. \\nWhen available, serum isopropanol and acetone levels confirm the diagno-\\nsis, but are not required for management.\\nEmergency Department Care and Disposition\\n1. Treat hypotension with aggressive infusion of IV crystalloids, although \\npersistent hypotension may require vasopressors. Treat significant \\nbleeding from hemorrhagic gastritis with transfusion of packed red \\nblood cells and plasma as indicated.\\n2. Do not administer metabolic blockade with fomepizole or ethanol since \\nacetone, the metabolite of isopropanol, is no more toxic than the parent \\ncompound.\\n3. Hemodialysis removes both isopropanol and acetone, and may be indi-\\ncated for refractory hypotension due to isopropanol.\\n4. Patients with prolonged CNS depression require admission. Those who \\nare asymptomatic after 6 to 8 hours of observation can be discharged or \\nreferred for psychiatric evaluation if indicated.\\n5. Charcoal does not bind alcohols, and is useful only if there is coinges-\\ntion of an absorbable substance.\\n■ ■METHANOL AND ETHYLENE GLYCOL\\nMethanol is commonly found in windshield washing fluid, solid fuel for \\nstoves, and solvents. Ethylene glycol is commonly found in antifreeze. \\nToxicity from these alcohols results from the formation of toxic metabo-\\nlites, which produce a significant anion gap metabolic acidosis. Methanol \\nleads to the formation of toxic formic acid, while ethylene glycol is metab-\\nolized into the toxic compounds glycolic acid, glyoxylic acid, and oxylic \\nacid with subsequent formation of calcium oxylate crystals.\\nClinical Features\\nThe clinical features of methanol toxicity include metabolic acidosis, CNS \\ndepression, and visual changes (classically, a complaint of looking at a \\nsnowstorm). The onset of symptoms may be delayed with concurrent etha-\\nnol consumption. Funduscopic examination may reveal retinal edema or \\nhyperemia of the optic disk.\\nEthylene glycol poisoning often exhibits three distinct clinical phases \\nafter ingestion. First, within 12 hours, CNS effects predominate: the patient \\nappears intoxicated without the odor of ethanol on the breath. Second,  \\n104_Cydulka_Ch104.indd   581 20/03/17   3:24 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 600, 'page_label': '582'}, page_content='582 SECTION 11: Toxicology and Pharmacology\\n12 to 24 hours after ingestion, cardiopulmonary effects predominate: \\nelevated heart rate, respiratory rate, and blood pressure are common. Con-\\ngestive heart failure, respiratory distress syndrome, and circulatory collapse \\nmay develop. Third, 24 to 72 hours after ingestion, renal effects predomi-\\nnate which are characterized by flank pain, costovertebral angle tenderness, \\nand acute tubular necrosis with acute renal failure. Hypocalcemia may \\nresult from precipitation of calcium oxalate into tissues leading to tetany \\nand typical ECG changes.\\nDiagnosis and Differential\\nThe diagnosis is based on clinical presentation and laboratory findings of \\nan elevated osmol gap, and/or an anion gap metabolic acidosis (which may \\ntake hours to develop). Elevated levels of methanol or ethylene glycol can \\nconfirm toxicity. An elevated osmolal gap is present early, and may be use-\\nful when methanol or ethylene glycol testing is not immediately available. \\nBasic laboratory investigations include a bedside glucose, electrolytes, \\nrenal function arterial blood gas, urinalysis, and methanol or ethylene \\nglycol level. Ethylene glycol poisoning differs from methanol poisoning in \\nthat visual disturbances and fundoscopic abnormalities are absent and \\ncalcium oxalate crystals may be present in the urine.\\nThe differential diagnosis includes other causes of an anion gap meta-\\nbolic acidosis such as salicylate or isoniazid toxicity, diabetic ketoacidosis, \\nalcoholic ketoacidosis, uremia, and lactic acidosis.\\nEmergency Department Care and Disposition\\nTreatment is based on metabolic blockade and removing toxic metabolites \\nfrom the body. Both fomepizole and ethanol have a greater affinity for \\nalcohol dehydrogenase than methanol and ethylene glycol. Indications for \\nmetabolic blockade are listed in Table 104-1.\\n1. Administer fomepizole 15 mg/kg IV load follo wed by 10 mg/kg every \\n12 hours for four additional doses. Subsequent doses should be at 15 \\nmg/kg. Fomepizole is a potent inhibitor of alcohol dehydrogenase with \\ngreater affinity and fewer side effects than ethanol. If fomepizole is not \\navailable, use ethanol 800 mg/kg IV load, followed by a continuous \\nTAblE 104-1 Indications for Metabolic Blockade with Fomepizole or Ethanol\\n1.  Elevated plasma levels: methanol >20 mg/dL (>6 mmol/L) or ethylene glycol > \\n20 mg/dL (>3 mmol/L)\\n2. If methanol or ethylene glycol level not available: \\nA.  Documented or suspected significant methanol or ethylene glycol ingestion with \\nethanol level lower than approximately 100 mg/dL (22 mmol/L)\\nB. Coma or altered mental status in patient with unclear history and:\\nUnexplained serum osmolar gap of >10 mOsm/L\\nor\\nUnexplained metabolic acidosis and ethanol level of <100 mg/dL (<22 mmol/L)*\\n*If serum ethanol level is >100 mg/dL (>22 mmol/L), patient will be protected from the formation of \\ntoxic metabolites by coingestion of ethanol, and specific metabolic blockade treatment can be delayed \\nuntil toxic alcohol level is available. If the ethanol level is likely to fall to <100 mg/dL before the toxic \\nalcohol results are back, then initiate metabolic blockade.\\n104_Cydulka_Ch104.indd   582 20/03/17   3:24 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 601, 'page_label': '583'}, page_content='CHAPTER 104: Alcohols 583 \\ninfusion of 100 mg/kg/h in the average drinker and 150 mg/kg/h in the  \\nheavy drinker. Adjust the infusion accordingly to maintain a blood \\nethanol level at 100 to 150 mg/dL. If resources are limited, oral therapy \\nwith commercial 80 proof liquor can be initiated. A load of 3 to 4 oz \\nwith maintenance of 1 to 2 oz/h is a typical dose for a 70-kg patient.\\n2. Monitor serum glucose during treatment with ethanol as hypoglycemia \\nmay be induced, especially in children. Treat hypoglycemia with 1 mL/\\nkg 50% dextrose in water in adults and 5 mL/kg 10% dextrose in \\nwater in children.\\n3. Dialysis eliminates both methanol and ethylene glycol and their toxic \\nmetabolites. Indications include metabolic acidosis or evidence of end \\norgan impairment (e.g., blindness, renal failure). Fomepizole or ethanol \\ntreatments do not alter the indications for dialysis; however, both \\nfomepizole and ethanol are dialyzed and, therefore, increase the dosing \\ninterval of fomepizole to every 4 hours. Double the infusion rate of \\nethanol during dialysis and adjust accordingly to maintain the level at \\n100 to150 mg/dL.\\n4. Continue dialysis, fomepizole, or ethanol treatment until the methanol \\nor ethylene glycol level is <20 mg/dL and the metabolic acidosis has \\nresolved.\\n5. In methanol poisoning, administer f olinic acid (leucovorin) 50 mg IV . \\nIn ethylene glycol poisoning, administer pyridoxine 100 mg IV and \\nthiamine 100 mg IV .\\n6. Administer sodium bicarbonate 1 to 2 mEq/kg and titrated to maintain \\na normal pH in methanol toxicity to increase renal excretion of formic \\nacid. Sodium bicarbonate may also be given to an ethylene glycol toxic \\npatient with metabolic acidosis.\\n7. Treat documented and symptomatic hypocalcemia in ethylene glycol \\ntoxicity with calcium gluconate or calcium chloride.\\n8. Consult a medical toxicologist or regional poison control center (800 \\n222-1222) to aid in the management of symptomatic methanol or ethyl-\\nene glycol ingestion.\\n9. Patients with suspected ethylene glycol or methanol ingestion who are \\nasymptomatic after 6 hours with no ethanol detected and no osmolar  \\ngap or metabolic acidosis may be safely discharged. In the setting of \\nco-ingestion with ethanol, it is important to ensure no metabolic \\nacidosis develops 6 hours after ethanol has been metabolized. Patients \\nwith significant signs and symptoms should be admitted to an inten-\\nsive care unit.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 185, “Alcohols,” by Jennifer P. Cohen and Dan Quan.\\n104_Cydulka_Ch104.indd   583 20/03/17   3:24 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 602, 'page_label': '584'}, page_content='584\\nDrugs of Abuse\\nD. Adam Algren\\n■ ■OPIOIDS\\nThe term opioid refers to any drug that is active at the opioid receptor, while \\nopiates refers to naturally occurring derivatives of the opium plant, such as \\nmorphine. Narcotic is a legal term and generically refers to any drug that \\ncauses sedation. Emergency physicians commonly utilize opioids as anal-\\ngesics and must be familiar with the clinical presentation and treatment of \\nopioid toxicity.\\nClinical Features\\nOpioid overdose produces a clinical toxidrome: miosis, and central nervous \\nsystem (CNS) and respiratory depression. However, normal or large pupils \\nmay be seen with diphenoxylate, meperidine, pentazocine, and propoxy-\\nphene toxicities. Severe hypoxia or co-ingestants could also produce \\nmydriasis. Severe opioid overdose, especially with heroin, may be associ-\\nated with acute lung injury. Seizures have been reported with tramadol, \\npropoxyphene, and meperidine overdoses. Meperidine, tramadol, and \\ndextromethorphan have been associated with serotonin syndrome when \\ncombined with other serotonergic agents. Methadone may prolong the QT \\ninterval and result in torsade de pointes. Opioid withdrawal is manifest by \\nabdominal pain, nausea, vomiting, diarrhea, dysphoria, piloerection, and \\nlacrimation.\\nDiagnosis and Differential\\nThe diagnosis is clinical. Qualitative immunoassay urine drug screens are \\ncommonly available but must be interpreted with caution as there are \\nnumerous agents that produce false-positive and false-negative results for \\nopioids. Toxicity from clonidine, guanfacine, and imidazolines mimics \\nopioid intoxication and produces varying degrees of miosis and CNS/\\nrespiratory depression. Because response to naloxone with these agents is \\nless reliable, consider clonidine intoxication in patients who appear opioid \\npoisoned but do not respond to naloxone. Other possible causes of CNS \\ndepression and miosis include pontine hemorrhage and toxicity from \\norganophosphates/carbamates, antipsychotics, and sedative-hypnotics \\n(i.e., GHB).\\nEmergency Department Care and Disposition\\n1. Naloxone is the primary treatment for opioid toxicity. Administer a small \\ndose of 0.1 to 0.4  mg IV , SC, or IM initially for CNS and respiratory \\ndepression to avoid precipitating withdrawal. Larger doses of 2 mg could \\nbe used in apneic patients. Repeat doses may be administered every  \\n3 minutes. The pediatric dose is 0.1  mg/kg. Given the relativ ely short \\nduration of action of naloxone, monitor closely for recurrent toxicity.\\n105\\nCh AP ter\\n105_Cydulka_Ch105.indd   584 20/03/17   3:30 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 603, 'page_label': '585'}, page_content='CHAPTER 105: Drugs of Abuse 585 \\n2. In large overdoses, consider an infusion of naloxone: tw o-thirds of the \\ndose required to initially “wake up” the patient per hour.\\n3. Consider endotracheal intubation in patients who respond poorly to \\nnaloxone and those with acute lung injury from overdose.\\n4. Patients with heroin overdose who are a wake and asymptomatic  \\n2 hours after the last naloxone dose can be discharged. Patients with \\nimmediate-acting opioid exposures require observation for at least  \\n6 hours, or 6 hours following naloxone administration if given. \\nPatients with exposure to long-acting opioids (sustained release mor -\\nphine/oxycodone, methadone, and buprenorphine) require admission \\nfor prolonged observation.\\n5. Treatment of opioid withdrawal is supporti ve (i.e., fluids, antiemetics). \\nClonidine 0.1 to 0.3 mg PO may be used to treat withdrawal.\\n■ ■COCAINe AND AMPhetAMINeS\\nCocaine and amphetamines are widely used drugs of abuse and produce \\nsimilar clinical manifestations.\\nClinical Features\\nCocaine and amphetamines induce euphoria and produce complications \\nsecondary to the enhanced release and blockade of catecholamines at the \\nsynaptic receptors. Onset of effect via intranasal, inhalational (crack use), \\nand intravenous use is rapid. Repeated drug administration leads to pro-\\nlonged effects and increased toxicity. Symptoms of sympathomimetic \\noverdose include mydriasis, hypertension, tachycardia, diaphoresis, agita-\\ntion, rhabdomyolysis, acute kidney injury, and hyperthermia.\\nCardiovascular complications include dysrhythmias, myocardial isch-\\nemia, cardiomyopathy, and aortic/coronary artery dissection. Chest pain is \\ncommon and often atypical. Patients are at risk of developing an acute \\ncoronary syndrome (STEMI and NSTEMI) related to vasospasm and \\nincreased thrombogenesis. Cocaine dysrhythmias result from sodium and \\npotassium blockade. Following cocaine use patients may develop supraven-\\ntricular tachycardia (SVT), atrial fibrillation/flutter along with wide com-\\nplex tachycardia/dysrhythmias similar to tricyclic antidepressants. The \\nBrugada pattern and prolonged QT may also be seen with cocaine. \\nAlthough amphetamines may result in SVT, other dysrhythmias are less \\ncommonly seen.\\nNeurologic complications of cocaine and amphetamines include sei-\\nzures, spinal cord infarctions, cerebral vasculitis, and ischemic/hemorrhagic \\ncerebrovascular accidents. Choreoathetoid movements and dystonic reac-\\ntions may occur. A “washout” syndrome following heavy use may result in \\nCNS depression that generally resolves within 24 hours. Amphetamine \\nusers may develop severe psychosis.\\nCocaine users can develop pulmonary complications including pneumo-\\nmediastinum, pneumothorax, bronchospasm, and pulmonary edema and \\nhemorrhage. Cocaine abuse during pregnancy increases risk for spontane-\\nous abortion, abruptio placentae, fetal prematurity, and intrauterine growth \\nretardation. “Body stuffers” (hasty ingestion of drugs to avoid police) and \\n“body packers” (ingestion of large amounts of tightly packed pure drug for \\n105_Cydulka_Ch105.indd   585 20/03/17   3:30 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 604, 'page_label': '586'}, page_content='586 SECTION 11: Toxicology and Pharmacology\\nimportation) may be asymptomatic or demonstrate signs of severe cocaine \\ntoxicity if a bag ruptures.\\nDiagnosis and Differential\\nDiagnosis of cocaine, amphetamine, or stimulant intoxication is usually \\nclinical. Urine drug screening for cocaine is reliable and can detect e xpo-\\nsure within 72 hours. Urine screens for amphetamines are less specific and \\nhave high false-negative and false-positive results.\\nAdditional laboratory evaluation for intoxicated patients includes a \\ncomplete metabolic panel to assess acid/base status, kidney function, and \\na creatine kinase (CK) to assess for rhabdomyolysis. The evaluation of \\naltered mental status or seizure may include a head CT to exclude intra-\\ncranial hemorrhage. Consider ECG, chest radiograph, and cardiac \\nenzymes in cocaine- or amphetamine-intoxicated patients presenting with \\nchest pain.\\nThe differential diagnosis includes drug intoxications (anticholinergic, \\nPCP, serotonin syndrome), sedative-hypnotic withdrawal, stroke, CNS \\ninfections, hypoglycemia, hyponatremia, and thyrotoxicosis. Concomitant \\nuse of substances such as alcohol or opioids may significantly alter the \\npresentation.\\nEmergency Department Care and Disposition\\n1. Benzodiazepines are the mainstay of treatment for cardiovascular and \\nCNS effects. Administer lorazepam 2 mg IV , or 0.1 mg/kg in children; \\nor diazepam 5  mg for agitation, hypertension, and tachycardia, and \\ntitrate to effect. Judicious use of antipsychotic medications can be con -\\nsidered for those with refractory agitation and violent behavior.\\n2. Treat seizures with benzodiazepines as noted above. In addition, pheno-\\nbarbital 15 to 20  mg/kg, propofol, and neuromuscular blockade with \\ncontinuous EEG monitoring may be necessary for status epilepticus.\\n3. Treat cardiac ischemia or acute coronary syndrome with aspirin, \\nnitrates, morphine, and benzodiazepines. Diltiazem  20  mg IV can be \\nused in those with ischemic ST changes. β-blockers are contraindicated \\ndue to unopposed β-receptor stimulation. Although coronary angiogra-\\nphy is preferred for persistent, concerning ST changes, fibrinolytic \\ntherapy may be used in those without contraindications.\\n4. Treat cocaine-induced wide complex tachydysrh ythmia and QRS inter-\\nval prolongation with sodium bicarbonate 1 to 2  mEq/kg titrated to a \\nserum pH of 7.45 to 7.55. Diltiazem 20 mg IV can be used to treat SVT. \\nTorsades de pointes can be treated with magnesium and/or ov erdrive \\npacing. Consider lipid emulsion therapy 1.5  mL/kg IV over 2  minutes \\nthen 0.25 mL/kg/min until improvement; maximum dose 10  mL/kg for \\nthose with severe, refractory cardiac toxicity.\\n5. Treat hypertension unresponsive to benzodiazepines with nitroprusside \\n0.3 μg/kg/min IV or phentolamine 2.5 to 5  mg IV .\\n6. Treat “body stuffers” with activ ated charcoal and supportive care as \\nabove. Treat asymptomatic “body packers” with activated charcoal \\nand whole-bowel irrigation using polyethylene glycol. Symptomatic \\n“body packers” with presumed rupture of ingested packets are treated \\nfor acute toxicity as above and require immediate surgical consultation \\n105_Cydulka_Ch105.indd   586 20/03/17   3:30 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 605, 'page_label': '587'}, page_content='CHAPTER 105: Drugs of Abuse 587 \\nfor possible laparotomy. Endoscopy should be av oided due to risk of \\nrupture.\\n7. Patient disposition depends on initial presentation, response to treatment, \\nstimulant involved, and expected duration of effect. Amphetamines have \\na longer duration of effect than cocaine and may require longer periods \\nof observation or hospital admission. Patients with mild toxicity that \\nresolves completely during observation may be discharged. Admit \\n“body packers” and those patients with more severe toxicity or who \\nremain symptomatic.\\n■ ■hALLUCINOGeNS\\nClinical Features\\nTable 105-1 summarizes the classification, features, complications, and \\nspecific treatments of commonly abused hallucinogens.\\nDiagnosis and Differential\\nDiagnosis is primarily clinical. Routine drug screens will not detect \\nLSD, psilocybin, or mescaline. Urine tests for phencyclidine (PCP) are \\nunreliable. Some amphetamine screens will detect methylenedioxy-\\nmethamphetamine (MDMA). Urine tests for marijuana are unreliable \\nindicators of acute use because patients may be positive for days to \\nweeks after their last use. Check glucose, electrolytes, renal function, \\nCK, and urinalysis to evaluate for hyponatremia, rhabdomyolysis, and \\nacute kidney injury.\\nExclude other causes of altered mental status, including traumatic \\ninjuries, hypoglycemia, and infection in patients with hyperthermia. \\nThe differential diagnosis of hallucinogen intoxication includes alcohol \\nand benzodiazepine withdrawal, hypoglycemia, anticholinergic poison-\\ning, thyrotoxicosis, CNS infections, structural CNS lesions, and acute \\npsychosis.\\nEmergency Department Care and Disposition\\nMost hallucinogen intoxications are managed by monitoring, providing a \\ncalm environment, and the use of benzodiazepines for agitation and sympa-\\nthomimetic symptoms. Antipsychotic medications should be used with \\ncaution as these may lower seizure threshold. β-Blockers should not be \\nused as noted above.\\n1. Treat agitation, hyperthermia, seizures, tachycardia, and h ypertension \\nwith lorazepam 1 to 2  mg IV or PO, or 0.1  mg/kg in children; or diaz-\\nepam 5 to10 mg IV or PO. Repeat dosing as needed. Consider propofol, \\nintubation, and paralysis for severe, refractory toxicity.\\n2. Consider nitroprusside or phentolamine for severe hypertension \\nrefractory to benzodiazepines.\\n3. Treat rhabdomyolysis with aggressive isotonic IV fluid administration.\\n4. Most patients with hallucinogen intoxication can be safely discharged \\nfrom the ED after a period of observation. Admit patients with persistent \\naltered mental status or serious medical complications, such as se vere \\nhyperthermia, hypertension, seizures, and rhabdomyolysis.\\n105_Cydulka_Ch105.indd   587 20/03/17   3:30 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 606, 'page_label': '588'}, page_content='588 SECTION 11: Toxicology and Pharmacology\\nTAblE 105-1 Common hallucinogens\\nDrug\\ntypical hallucinogenic \\nDose\\nDuration of \\nAction Clinical Features Complications Specific treatment\\nLysergic acid diethylamide 20–80 μg 8–12 h ■● Mydriasis\\n■● Tachycardia\\n■● Anxiety\\n■● Muscle tension\\n■● Coma\\n■● Hyperthermia\\n■● Coagulopathy\\n■● Persistent psychosis\\n■● Hallucinogen persisting \\nperception disorder\\n■● Reassurance\\n■● Benzodiazepines\\nPsilocybin 5–100 mushrooms\\n4–6 mg of psilocybin\\n4–6 h ■● Mydriasis\\n■● Tachycardia\\n■● Muscle tension\\n■● Nausea and vomiting\\n■● Seizures (rare)\\n■● Hyperthermia (rare)\\n■● Reassurance\\n■● Hydration\\n■● Benzodiazepines\\nMescaline 3–12 “buttons”\\n200–500 mg of mescaline\\n6–12 h ■● Mydriasis\\n■● Abdominal pain\\n■● Nausea/vomiting\\n■● Dizziness\\n■● Nystagmus\\n■● Ataxia\\n■● Rare ■● Supportive\\n■● Benzodiazepines\\nMethylenedioxymethamphetamine \\n(“Ecstasy”)\\n50–200 mg 4–6 h ■● Mydriasis\\n■● Bruxism\\n■● Jaw tension\\n■● Ataxia\\n■● Dry mouth\\n■● Nausea\\n■● Hyponatremia\\n■● Hypertension\\n■● Seizures\\n■● Hyperthermia\\n■● Dysrhythmias\\n■● Rhabdomyolysis\\n■● Benzodiazepines\\n■● Hydration\\n■● Active cooling\\n■● Dantrolene\\n■● Specific serotonin \\nantagonists\\n(Continued)\\n105_Cydulka_Ch105.indd   588 20/03/17   3:30 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 607, 'page_label': '589'}, page_content='CHAPTER 105: Drugs of Abuse 589 \\nTAblE 105-1 Common hallucinogens\\nDrug\\ntypical hallucinogenic \\nDose\\nDuration of \\nAction Clinical Features Complications Specific treatment\\nSynthetic cathinone derivatives \\n(“bath salts”)\\n50–300 mg of mephedrone 2–4 h ■● Agitation\\n■● Tachycardia\\n■● Hypertension\\n■● Diaphoresis\\n■● Mydriasis\\n■● Paranoia\\n■● Panic reactions\\n■● Hyperthermia\\n■● Seizures\\n■● Hyponatremia\\n■● Rhabdomyolysis\\n■● Benzodiazepines\\n■● Hydration\\n■● Active cooling\\nPhencyclidine (“angel dust”) 1–9 mg 4–6 h ■● Small or midsized pupils\\n■● Nystagmus\\n■● Muscle rigidity\\n■● Hypersalivation\\n■● Agitation\\n■● Catatonia\\n■● Coma\\n■● Seizures\\n■● Hyperthermia\\n■● Rhabdomyolysis\\n■● Hypertension\\n■● Hypoglycemia\\n■● Benzodiazepines\\n■● Hydration\\n■● Active cooling\\nMarijuana (cannabis) 5–15 mg of \\ntetrahydrocannabinol\\n2–4 h ■● Tachycardia\\n■● Conjunctival injection\\n■● Acute psychosis (rare)\\n■● Panic reactions (rare)\\n■● Supportive\\n■● Benzodiazepines\\nSynthetic cannabinoids (“K2,” \\n“Spice”)\\n2–5 mg of JWH-018 3–4 h ■● Tachycardia\\n■● Conjunctival injection\\n■● Acute psychosis\\n■● Panic reactions\\n■● Seizures (rare)\\n■● Dysrhythmias (rare)\\n■● Supportive\\n■● Benzodiazepines\\nBromo-benzodifuranyl-\\nisopropylamine (Bromo-DragonFLY)\\n200–800 μg 10–14 h ■● Agitation\\n■● Hallucinations\\n■● Seizures\\n■● Vasoconstrictor with \\nnecrosis and gangrene\\n■● Supportive\\n■● Benzodiazepines\\n(Continued)\\n105_Cydulka_Ch105.indd   589 20/03/17   3:30 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 608, 'page_label': '590'}, page_content='590 SECTION 11: Toxicology and Pharmacology\\n■ ■FUrther reADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 186, “Opioids” by Guillermo Burillo-Putze and \\nMiroOscar; Chapter 187, “Cocaine and Amphetamines” by Jane M. Prosser \\nand Jeanmarie Perrone; and Chapter 188, “Hallucinogens” by Katherine M. \\nPrybys and Karen N. Hansen.\\n105_Cydulka_Ch105.indd   590 20/03/17   3:30 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 609, 'page_label': '591'}, page_content='591\\nAnalgesics\\nJoshua N. Nogar\\nOver-the-counter analgesics, such as salicylates (ASA) and acetaminophen \\n(APAP), can result in fatal overdose, but early identification of toxicity and \\ninitiation of appropriate treatment can significantly reduce mortality from \\nthese exposures. Nonsteroidal anti-inflammatory drug (NSAID) overdoses \\nare rarely fatal and typically require only supportive care. The widespread \\navailability of these medications in over-the-counter preparations, and in \\nother products (e.g., ASA in oil of wintergreen, APAP in cough and cold \\npreparations), can lead to both intentional and accidental toxicity.\\n■ ■ASPIRIN AND SALICYLATES\\nClinical Features\\nThe features of aspirin (ASA) toxicity are summarized in Table 106-1. \\nChronic or “therapeutic” (repeated dose) poisonings are generally more seri-\\nous and associated with higher mortality than acute overdoses, and are typi-\\ncally encountered in elderly patients with multiple medical problems. Chronic \\ntoxicity develops at lower drug levels compared to acute overdoses. The \\nduration of symptoms is often prolonged and there may be a delay in diagno-\\nsis because the clinical picture can mimic infection. Chronic salicylism \\nshould be considered in any patient with unexplained nonfocal neurologic and \\nbehavioral abnormalities, especially with coexisting acid–base disturbance, \\ntachypnea, dyspnea, fever, or noncardiogenic pulmonary edema.\\nIn children, acute ASA overdoses generally present within hours of \\ningestion. Children younger than 4 years of age tend to develop early \\nmetabolic acidosis (pH <7.38), whereas children older than 4 years usually \\nmanifest a mixed acid–base disturbance as seen in adults.\\nDiagnosis and Differential\\nASA toxicity is a clinical diagnosis made in conjunction with the patient’s \\nacid–base status. Respiratory alkalosis with an anion-gap metabolic acido-\\nsis, and hypokalemia are the classic features of this poisoning. ASA blood \\nconcentrations correlate poorly with toxicity, and relying on ASA levels as \\na sole measure of toxicity is the most common pitfall in the management of \\nASA poisonings.\\n106\\nCh APTER\\nTAble 106-1 Severity Grading of Salicylate Toxicity in Adults\\nMild Moderate Severe\\nAcute ingestion (dose) <150 mg/ kg 150–300 mg/kg >300 mg/kg\\nEnd-organ toxicity Tinnitus\\nHearing loss\\nDizziness\\nNausea/vomiting\\nTachypnea\\nHyperpyrexia\\nDiaphoresis\\nAtaxia\\nAnxiety\\nAbnormal mental status\\nSeizures\\nAcute lung injury\\nRenal failure\\nCardiac dysrhythmias\\nShock\\n106_Cydulka_Ch106.indd   591 26/04/17   4:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 610, 'page_label': '592'}, page_content='592 SECTION 11: Toxicology and Pharmacology\\nCheck bedside glucose levels in all patients with altered mental status. \\nAdditional laboratory studies include electrolytes, blood urea nitrogen \\n(BUN), creatinine, complete blood count (CBC), prothrombin time (PT), \\nASA level, APAP level (to exclude coingestion), and blood gas. Hypogly-\\ncemia or hyperglycemia may be seen with severe or chronic toxicity.\\nThe differential diagnosis of ASA toxicity includes diabetic ketoaci-\\ndosis, sepsis, meningitis, acute iron poisoning, caffeine overdose, \\ntheophylline toxicity, and Reye’s syndrome.\\nemergency Department Care and Disposition\\n1. Institute cardiac monitoring and support the ABCs. Establish intravenous \\naccess early. Careful airway management is critical in ASA-poisoned \\npatients as a sudden drop in serum pH due to respiratory failure will \\nimmediately exacerbate ASA toxicity, and aggressive ventilation guided \\nby acid–base status is essential in the intubated patient. Respiratory \\nacidosis often occurs shortly after a mechanical ventilator is set to \\n“normal” rate/volume parameters, and is typically a premorbid event.\\n2. Administer activated charcoal 1 g/kg PO, NG, or OG. Whole-bowel \\nirrigation may effectively decontaminate the GI tract in the setting of \\nlarge overdose, enteric-coated, or sustained-release preparations.\\n3. Administer IV normal saline (NS) to patients with evidence of volume \\ndepletion. During initial resuscitation, monitor urine pH, ASA level, elec-\\ntrolytes (especially potassium), glucose, and acid–base status hourly. Add \\ndextrose to parenteral fluids after initial NS resuscitation. Consider 10% \\ndextrose in the setting of hypoglycemia or neurologic symptoms. Add \\npotassium 40 mEq/L after establishing adequate urine output (1 to 2 mL/\\nkg/h), if not contraindicated by initial electrolytes and renal function.\\n4. Alkalinize the serum and urine to enhance ASA protein binding and \\nurinary elimination. Administer a bolus of sodium bicarbonate 1 to  \\n2 mEq/kg, then administer a bicarbonate infusion (three ampules of \\neither 44 or 50 mEq/ampule of sodium bicarbonate added to 1L of 5% \\ndextrose in water) at two to three times the patient’s maintenance rate; \\nadjust the infusion to maintain urine pH >7.5, if possible. Bicarbonate \\nmay worsen hypokalemia and precipitate dysrhythmias; potassium \\nshould be aggressively repleted.\\n5. Consider hemodialysis for all patients with ASA levels in excess of 100 \\nmg/dL. In the setting of chronic toxicity, hemodialysis is needed at lower \\nASA levels: 60 to 80 mg/dL. Also consider hemodialysis for clinical dete-\\nrioration despite supportive care and alkalinization, renal insufficiency or \\nfailure, severe acid–base disturbance, altered mental status, or adult respi-\\nratory distress syndrome. Check serial ASA levels every 2 hours until they \\nbegin to fall, then every 4 to 6 hours until the level is nontoxic.\\n6. Enteric-coated and sustained-release preparations result in delayed peak \\nserum levels from 0 to 60 hours postingestion and their ingestion \\nrequires admission for at least 24 hours to ensure declining serial ASA \\nlevels and improving clinical status.\\n7. Discharge a patient from the ED if there is progressive clinical improve-\\nment, no significant acid–base abnormality, and a decline in serial ASA \\nlevels toward the therapeutic range. In deliberate overdoses, obtain a \\npsychiatric consultation before discharge.\\n106_Cydulka_Ch106.indd   592 26/04/17   4:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 611, 'page_label': '593'}, page_content='CHAPTER 106: Analgesics 593 \\n■ ■ACETAMINOPhEN (APAP)\\nClinical Features\\nAcute APAP toxicity can present in four classic stages outlined in  \\nTable 106-2. Massive APAP ingestions (4-hour APAP level > 800 micro-\\ngrams/mL) may cause early coma or agitation and lactic acidosis,  \\nas opposed to delayed symptom onset seen in the majority of APAP \\noverdoses.\\nDiagnosis and Differential\\nToxic exposure to APAP is likely when a patient > 6 years old ingests \\neither: (a) > 10 g or 200 mg/kg in a single ingestion or over a 24-hour \\nperiod, or (b) >6 g or 150 mg/kg/d for two consecutive days. For children \\n<6 years old, either: (a) > 200 mg/kg in a single ingestion or over an \\n8-hour period, or (b) 150 mg/kg/day for two consecutive days would be \\nconsidered toxic. Confirm toxicity with a serum APAP concentration and \\nan exact time of ingestion. Plot the serum APAP level on the Rumack–\\nMatthew nomogram (Fig. 106-1); this nomogram applies only to the set-\\nting of a single acute exposure during the window between 4 hours and  \\n24 hours postingestion. Obtain additional laboratory studies including \\nelectrolytes, glucose, BUN, creatinine, transaminases, CBC, PT, ASA, \\nurine toxicology screen, and ECG as clinically indicated (e.g., potential \\ncoingestion in the suicidal patient).\\nemergency Department Care and Disposition\\n1. Early administration of acti vated charcoal 1 g/kg PO, NG, or OG if \\npossible.\\n2. N-acetylcysteine (NAC) is the antidote for APAP poisoning. The treat-\\nment algorithm is depicted in Fig. 106-2 and dosing of NAC is outlined \\nin Table 106-3.\\nTAble 106-2 Clinical Stages of Acute Acetaminophen Toxicity\\nStage 1 Stage 2 Stage 3 Stage 4\\nTiming First 24 h Days 2 to 3 Days 3 to 4 After day 5\\nClinical \\nmanifestations\\nAnorexia\\nNausea\\nVomiting\\nMalaise\\nImprovement in \\nanorexia, nausea, \\nand vomiting\\nAbdominal pain\\nHepatic \\ntenderness\\nRecurrence  \\nof anorexia,  \\nnausea, and  \\nvomiting\\nEncephalopathy\\nAnuria\\nJaundice\\nClinical improve-\\nment and recov-\\nery (7–8 days)\\nor\\nDeterioration \\nto multi-organ \\nfailure and  \\ndeath\\nLaboratory \\nabnormalities\\nHypokalemia Elevated serum \\ntransaminases\\nElevated bilirubin \\nand prolonged \\nprothrombin time \\nif severe\\nHepatic failure\\nMetabolic acidosis\\nCoagulopathy\\nRenal failure\\nPancreatitis\\nImprovement and \\nresolution\\nor\\nContinued \\ndeterioration\\n106_Cydulka_Ch106.indd   593 26/04/17   4:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 612, 'page_label': '594'}, page_content='594 SECTION 11: Toxicology and Pharmacology\\nTake level\\nat least\\n4 h\\npostingestion\\nRecommend treatment\\nif level is above broken line\\nToxicity\\nUnlikely\\nPossible\\nToxicity\\n2000\\n1300\\n1000\\n900\\n800\\n700\\n600\\n500\\n400\\n300\\n250\\n200\\n10090\\n80\\n70\\n60\\n50\\n40\\n30\\n20\\n42 6242016\\nHours Postingestion\\n128\\n2\\n4\\n5\\n7\\n8\\n9\\n10\\n20\\n30\\nAcetaminophen Plasma Concentration\\nµg/mL\\nµM/L\\n40\\n50\\n60\\n70\\n80\\n90100\\n200\\n300\\n150\\n10\\nFigure 106-1. Rumack–Matthew nomogram.\\n3. If APAP is still detectable after the dosing regimens described in  \\nTable 106-3 are complete, continue NAC until APAP is undetectable \\nin serum.\\n4. Treat abnormalities related to fulminant hepatic failure by correcting \\ncoagulopath y and acidosis, managing cerebral edema, and supporting \\nmulti-organ failure. Consider early transfer to a transplant center.\\n5. Patients with nontoxic APAP le vels based on the Rumack–Matthew \\nnomogram may be medically cleared from the ED if there is no evi-\\ndence of other drug ingestion. Admit all patients receiving NAC \\ntherapy.\\n106_Cydulka_Ch106.indd   594 26/04/17   4:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 613, 'page_label': '595'}, page_content='CHAPTER 106: Analgesics 595 \\n<4 h from\\ningestion\\nBetween\\n4 and 24 h\\nfrom ingestion\\nUnknown\\nor >24 h \\nfrom ingestion\\nAPAP Ingestion\\nConsider GI\\ndecontamination\\nSend >4 h\\nAPAP level\\nLevel\\navailable\\n<8 h\\nLevel\\nnot available\\nuntil >8 h\\nPlot on\\nnomogram\\nGive 1st\\ndose AC\\n(within 8 h)\\nToxic:\\nAC Rx\\nNot toxic: \\nsymptomatic\\nRx\\nConsider GI\\ndecontamination\\nfor unknown\\ningestion\\nSend APAP levels \\nSend LFTs\\n(AST, ALT, PT) \\nGive 1st dose AC\\nAPAP >10 µg/mL\\nor AST/ALT\\nincreased\\nYes:\\nContinue\\nAC\\nIf \\npH <7.3\\nPT >100\\nCr >3.3\\nAMS\\nRefer to liver\\ntransplant unit\\nNo:\\nSupportive\\nRx\\nFigure 106-2.  Treatment guidelines for acetaminophen (APAP) ingestion. All \\ntimes noted are postingestion. AC, acetylcysteine; ALT, alanine aminotransferase; \\nAMS, altered mental status; AST, aspartate aminotransferase; Cr, creatinine; LFTs, \\nliver function tests; PT, prothrombin time; Rx, treatment.\\n■ ■NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS)\\nClinical Features\\nNSAID toxicity is more commonly associated with chronic therapeutic use \\nas opposed to acute overdoses. The clinical features of acute NSAID \\ntoxicity are outlined in Table 106-4.\\n106_Cydulka_Ch106.indd   595 26/04/17   4:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 614, 'page_label': '596'}, page_content='596 SECTION 11: Toxicology and Pharmacology\\nTAble 106-3 Acetylcysteine Dosing Regimens\\nOral IV Adult\\nIV Pediatric  \\n(<40 kg)\\nPreparation Available as 10% \\nand 20% solutions\\nDilute to 5% \\nsolution for oral \\nadministration\\nAvailable as 20% \\nsolution\\nAvailable as 20% \\nsolution\\nDilute to 2% \\nsolution by mixing \\n50 mL in 450 mL 5% \\ndextrose in water\\nLoading dose 140 mg/kg 150 mg/kg in 200 mL \\n5% dextrose in water \\ninfused over 15–60 min\\n150 mg/kg (7.5 mL/\\nkg) infused over  \\n15 to 60 min\\nMaintenance dose 70 mg/kg every 4 h \\nfor 17 doses\\n50 mg/kg in 500 mL \\n5% dextrose in water \\ninfused over 4 h\\nfollowed by\\n100 mg/kg in 1000 mL \\n5% dextrose in water \\ninfused over 16 h\\n50 mg/kg (2.5 mL/kg) \\ninfused over 4 h\\nfollowed by\\n100 mg/kg (5 mL/kg) \\ninfused over 16 h\\nDuration of therapy 72 h 20 h 20 h\\nComments Dilute with pow-\\ndered drink mix, \\njuice, or soda\\nServe chilled\\nDrink through a \\nstraw to reduce \\ndisagreeable smell\\nMonitor for drug-\\nrelated adverse effects \\nand anaphylactoid \\nreactions\\nMonitor for drug-\\nrelated adverse \\neffects and anaphy-\\nlactoid reactions\\n500 mL of the 2% \\nsolution prepared \\nas described above \\nis enough to treat a \\n33-kg child for the \\nfull 20-h course\\nTAble 106-4 NSAID Toxicity After an Acute Overdose\\nInitial symptoms within 4 h of ingestion Abdominal pain, nausea, vomiting\\nCentral nervous system Headache, nystagmus, diplopia, altered mental \\nstatus, coma, muscle twitching, and seizures \\n(mefenamic acid)\\nCardiovascular Hypotension, shock, bradydysrhythmia\\nElectrolyte Hyperkalemia, hypocalcemia, hypomagnesemia\\nGI and hepatic Continued abdominal pain, nausea, vomiting, \\nhepatic injury, pancreatitis (rare)\\nRenal Acute kidney injury\\nDiagnosis and Differential\\nThe manifestations of NSAID toxicity are generally nonspecific. NSAID \\nlevels are not readily available or clinically useful in assessing toxicity. \\nLaboratory evaluation should include electrolytes, glucose, renal and \\nhepatic function tests, and an APAP level. Consideration of evaluation for \\nco-ingestions should be made. Bedside glucose determination is indicated \\nfor altered mental status or seizures.\\n106_Cydulka_Ch106.indd   596 26/04/17   4:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 615, 'page_label': '597'}, page_content='CHAPTER 106: Analgesics 597 \\nemergency Department Care and Disposition\\nA general algorithm for acute NSAID overdoses is outlined in Fig. 106-3.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 189, “Salicylates,” by Rachel Levitan and Frank \\nLovecchio; Chapter 190, “Acetaminophen,” by Oliver L. Hung and Lewis S. \\nNelson; and Chapter 191, “Nonsteroidal Anti-Inflammatory Drugs,” by Joseph G. \\nRella and Wallace A. Carter.\\nReport of NSAID Overdose\\n1. Definitive airway\\n   management required?\\n2. Hypotensive\\n /uni25CF Fluid bolus\\n /uni25CF Vasopressor if refractory\\n3. Seizures\\n /uni25CF IV benzodiazepines\\nAdmit: \\nsymptomatic\\nmanagement\\nPsychiatric\\nconsultation\\nMedically\\ncleared \\nfor discharge\\nSymptomatic?\\n(altered mental status,\\nseizure, abnormal\\nvital signs, renal failure,\\nacidosis, hepatic toxicity)\\nHistory\\nQuantity and type of\\nNSAID ingested?\\nActivated charcoal\\n1 g/kg PO\\nor via nasogastric tube\\nCheck electrolytes, ECG, \\nacetaminophen,\\nand salicylate levels\\nObserve for 4 h\\nSymptomatic?\\n(altered mental status, seizure, abnormal vital signs)\\nYesN o\\nYesN o\\nFigure 106-3. Approach to treatment of acute NSAID overdose.\\n106_Cydulka_Ch106.indd   597 26/04/17   4:52 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 616, 'page_label': '598'}, page_content='598\\nXanthines and Nicotine\\nRobert J. Hoffman\\n■ ■XANTHINES\\nTheophylline, theobromine, and caffeine are methylxanthines.\\nTheophylline was once widely used for the management of asthma and \\nchronic obstructive pulmonary disease, and continues to be used for apnea \\nof prematurity. Caffeine is the most widely used psychoactive drug in the \\nworld, and is consumed primarily from beverages such as coffee, tea, and \\nenergy drinks, but is also contained in medications and dietary supple-\\nments. Caffeine is used medically in the management of apnea of prematu-\\nrity, and as an analgesic adjunct.\\nClinical Features\\nMethylxanthine toxicity can cause life-threatening cardiac, neurologic, and \\nmetabolic abnormalities. Even therapeutic concentrations of theophylline \\ncan cause significant side effects in some individuals. Elderly patients with \\nconcomitant medical problems are more susceptible to life-threatening \\ntoxicity during chronic therapeutic use than are younger patients with acute \\noverdose.\\nCardiac side effects usually include sinus tachycardia, and may include \\natrial and/or ventricular dysrhythmias. Ventricular dysrhythmias are more \\ncommon with severe toxicity, chronic toxicity, in the elderly, and those with \\nunderlying cardiac dysfunction. Hypotension may also occur as a result of \\nperipheral Beta 2 induced vasodilation.\\nNeurologic toxicity includes agitation, headache, irritability, sleepless-\\nness, tremors, hallucinations, and seizures. Methylxanthine-induced sei-\\nzures can be severe and refractory to standard treatment.\\nMetabolic side effects include hypokalemia, hyperglycemia, and meta-\\nbolic acidosis. Rhabdomyolysis has been reported with theophylline and \\ncaffeine overdose. Compartment syndrome resulting from an unclear etiol-\\nogy is also a rare, but well-described occurrence in theophylline toxicity. \\nGastrointestinal (GI) effects commonly include nausea and vomiting. Nau-\\nsea and vomiting are often severe, and poorly responsive to less potent \\nantiemetics.\\nDiagnosis and Differential\\nTherapeutic serum theophylline levels of 20 μg/mL can produce toxic \\neffects. In acute poisoning, severity of symptoms typically correlates with \\nserum concentration, but with chronic or acute on chronic toxicity symp-\\ntom severity correlates more poorly with concentration.\\nIn cases of chronic or acute on chronic toxicity, life-threatening side \\neffects can occur with little warning and before lesser symptoms manifest. \\nSmoking cessation, cirrhosis, and numerous medications, such as cimeti-\\ndine and erythromycin, increase the half-life of theophylline and increase \\nrisk of chronic toxicity. Investigations recommended for theophylline or \\n107\\nC HA p TER\\n107_Cydulka_Ch107.indd   598 20/03/17   3:41 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 617, 'page_label': '599'}, page_content='CHAPTER 107: Xanthines and Nicotine 599 \\ncaffeine toxicity includes serial measurement of the serum theophylline or \\ncaffeine concentration, serum electrolytes, and a 12-lead ECG. The differ-\\nential diagnosis includes other sympathomimetic overdose (e.g., amphet-\\namines, cocaine) as well as anticholinergic toxicity.\\nEmergency Department Care and Disposition\\nTreatment of methylxanthine poisoning consists of stabilization, gastric \\ndecontamination and elimination, treatment of life-threatening toxic \\neffects, and, in severe cases, hemoperfusion or dialysis.\\n1. Table 107-1 lists appropriate methods of GI decontamination and elimi-\\nnation in methylxanthine toxicity.\\n2. Place all patients on cardiac monitors and establish intravenous (IV) or \\nintraosseous (IO) access.\\n3. Treat nausea and vomiting with ondansetr on 4 to 8 mg IV or PO (0.1 \\nto 0.15 mg/kg). Consider ranitidine for gastric hypersecretion but avoid \\ncimetidine, which can prolong the half-life of theophylline.\\n4. Treat seizures with benzodiazepines, barbiturates, or even propofol.  \\nRapid escalation of anticonvulsant treatment is warranted when a ben-\\nzodiazepine treatment fails. Lorazepam 0.1 mg/kg IV , or 1 to 2 mg \\nempirically for adults may be used as initial treatment, repeated within \\n5 to 10 minutes if seizures do not cease. Phenobarbital 20 mg/kg or \\npentobarbital 5 mg/kg may be used in cases of benzodiazepine failure. \\nAnticipate respiratory depression and the need for ventilator assistance \\nwhen using phenobarbital after a benzodiazepine. Phenytoin is contra-\\nindicated in theophylline toxicity. Due to the common occurrence of \\nsevere seizures and status epileptics, use phenobarbital to prophylax \\nagainst seizures in cases of acute toxicity with theophylline concentra-\\ntion of 80 μ g/dL or chronic toxicity with serum concentrations of  \\n>40 μg/dL.\\n5. Administer IV isotonic crystalloid for hypotension. Consider cardiose -\\nlective beta blockers such as esmolol or metoprolol in patients with \\nhypotension unresponsive to IV fluids or conventional vasopressors.\\n6. Treat cardiac dysrhythmias with cardioselective blockers such as meto-\\nprolol and esmolol. Consider a calcium channel blocker such as diltia-\\nzem for atrial fibrillation. Hypokalemia may be severe but is typically \\nTablE 107-1 GI Decontamination for Methylxanthine Toxicity\\nGI Decontamination \\nTechnique Indication * Dosing\\nActivated charcoal \\n(single dose)\\nAcute ingestion <12 y old: 0.5–1 g/kg PO\\n>12 y old: 25–100 g PO\\nMultidose activated \\ncharcoal (requires \\nclose observation)\\nAcute ingestion Normal activated charcoal loading dose, \\nfollowed by: 0.25–0.5 g/kg PO every 2–4 h \\nfor 12 h (frequency and duration may vary)\\nWhole-bowel irrigation \\nusing iso-osmolar \\npolyethylene glycol \\nelectrolyte solution\\nAcute ingestion of \\nsustained-release \\npreparations\\n9 mo–6 y: 25 mL/kg/h\\n6–12 y old: 1000 mL/h\\n>12 y old: 1500–2000 mL/h\\nDuration: 4–6 h or until clear rectal effluent\\n*Consider contraindications; for details see http://www.clintox.org/positionstatements.cfm.\\n107_Cydulka_Ch107.indd   599 20/03/17   3:41 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 618, 'page_label': '600'}, page_content='600 SECTION 11: Toxicology and Pharmacology\\nunresponsive or poorly responsive to potassium supplementation because \\nthe force driving potassium intracellularly continues despite potassium \\nsupplementation. In cases of potassium supplementation, hyperkalemia \\nmay occur as massive quantities of potassium move extracellularly as \\nthe effect of theophylline or caffeine abates. Therefore, potassium sup-\\nplementation is not recommended unless the patient experiences a dys-\\nrhythmia likely to be the result of hypokalemia or empirically if the \\nserum potassium is <2.5 mmol/L\\n7. Consider hemodialysis or hemoperfusion in a symptomatic patient with \\na serum theophylline level >90 μg/mL after acute ingestion, or >40 μg/\\nmL in the setting of chronic toxicity and in patients with life-threatening \\nseizures or dysrhythmias.\\n8. Admit patients with seizures or ventricular dysrhythmias to an intensive \\ncare unit. Patients with mild symptoms and theophylline levels below  \\n25 μg/mL usually do not require admission or specific treatment other \\nthan symptomatic care. Decrease the dose or discontinue theophylline  \\nor caffeine. Symptomatic patients using theophylline with serum con-\\ncentrations >30 μg/mL may be given 1 to 2 doses of oral activated \\ncharcoal, regardless of when the last ingestion of theophylline medica-\\ntion occurred, as activated charcoal works by “gut dialysis” to draw \\ntheophylline from the blood across the GI surface and into the charcoal \\nsink, effectively lowering serum concentration.\\n■ ■NICOTINE\\nNicotine is present in tobacco products and smoking cessation medications, \\nand is also used as an outdoor pesticide. Pediatric exposures to nicotine \\ngum or discarded cigarette butts placed in a beverage such as a soda can are \\nrelatively common. Nicotine is rapidly absorbed through the lungs, mucous \\nmembranes, intestinal tract, and skin. Once absorbed, it binds to nicotinic \\nreceptors throughout the body including the central nervous system, auto-\\nnomic system, and neuromuscular junction.\\nClinical Features\\nNicotine toxicity affects the GI, neurologic, cardiovascular, and respiratory \\nsystems. Nausea, vomiting, bradycardia, dysrhythmias, hypoventilation, \\ncoma, and seizures can occur. In severe poisoning, nicotine can result in \\nparalysis and respiratory arrest. Table 107-2 lists the clinical effects of \\nnicotinic receptor stimulation.\\nDiagnosis and Differential\\nDiagnosis of acute nicotine toxicity is largely based on history and physical \\nexamination. The differential diagnosis for nicotine toxicity is primarily \\ncholinergic poisoning by other substances, such as organophosphate and \\ncarbamate pesticides, as well as cholinergic medication overdose.\\nEmergency Department Care and Disposition\\n1. Place patients on a cardiac monitor and establish vascular access.\\n2. In cases of dermal exposure to nicotine from a pesticide product, \\nperform decontamination as for other HAZMAT substances. This is \\n107_Cydulka_Ch107.indd   600 20/03/17   3:41 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 619, 'page_label': '601'}, page_content='CHAPTER 107: Xanthines and Nicotine 601 \\ntypically done in a dedicated location, often external to the ED. GI \\ndecontamination for nicotine exposure is not recommended, and  \\nurine acidification is contraindicated.\\n3. Treat nausea and vomiting with ondansetr on 4 to 8 mg IV or PO \\n(0.15 mg/kg).\\n4. Treat seizures or agitation with lorazepam 2 mg IV (0.1 mg/kg).\\n5. Administer isotonic crystalloid for hypotension.\\n6. Anticipate neuromuscular weakness or respiratory depression in severe \\ntoxicity and be prepared for endotracheal intubation and mechanical \\nventilation.\\n7. Patients who remain asymptomatic at least 3 hours after ingestion of \\nnicotine-containing products can be discharged. However, patients who \\ningest intact transdermal patches should be monitored for at least  \\n6 hours.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 192, “Methylxanthines and Nicotine,” by Chip \\nGresham and Daniel E. Brooks.\\nTablE 107-2 Clinical Effects of Nicotine Toxicity\\nOrgan System\\nSigns and Symptoms of Nicotine Toxicity*\\nImmediate (<1 h) Delayed (>1 h)\\nGI Hypersalivation\\nNausea\\nVomiting\\nDiarrhea\\nCardiovascular Tachycardia\\nHypertension\\nDysrhythmias\\nBradycardia\\nHypotension\\nNeurologic Tremor\\nHeadache\\nAtaxia\\nHypotonia\\nSeizure\\nComa\\nRespiratory Bronchorrhea Hypoventilation\\nApnea\\n*Onset of toxicity is varied and can be delayed for hours following dermal exposure.\\n107_Cydulka_Ch107.indd   601 20/03/17   3:41 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 620, 'page_label': '602'}, page_content='602\\nCardiac Medications\\nMichael Levine\\n■ ■DIGITALIS GLYCOSIDES\\nDigoxin is used to treat atrial fibrillation, especially with concurrent con-\\ngestive heart failure. Other cardiac glycosides are found in plants such as \\nfoxglove, oleander, and lily of the valley.\\nClinical Features\\nToxicity can occur following acute ingestion or develop during chronic \\ntherapy (Table 108-1). Acute toxicity typically presents with abrupt onset of \\nnausea and vomiting. Characteristic cardiac effects include bradydysrhyth-\\nmias and/or supraventricular tachycardia with atrioventricular block. \\nSevere toxicity can result in ventricular dysrhythmias. Chronic toxicity is \\nmore common in the elderly and often occurs as a result of renal failure or \\ndiuretic therapy. Neuropsychiatric symptoms are more common with \\nchronic toxicity, though cardiac effects are similar to those seen with acute \\ntoxicity.\\nDiagnosis and Differential\\nHyperkalemia is often seen in acute poisoning, but may be absent in \\nchronic toxicity. Serum digoxin levels are neither sensitive nor specific for \\ntoxicity. However, those patients with higher levels (>2 ng/mL) are more \\nlikely to experience toxicity. Almost any dysrhythmia, except for rapidly \\nconducted atrial dysrhythmias, may be seen with toxicity; however, the \\n108\\nCh A p TE r\\nTable 108-1 Clinical presentation of Digitalis Glycoside Toxicity\\nAcute toxicity\\nClinical history\\nGI effects\\nCentral nervous system effects\\nCardiac effects\\nElectrolyte abnormalities\\nDigoxin level\\nIntentional or accidental ingestion\\nNausea and vomiting\\nHeadache, dizziness, confusion, coma\\nBradydysrhythmias or supraventricular \\ntachydysrhythmias with atrioventricular block\\nHyperkalemia\\nMarked elevation (if obtained within 6 h)\\nChronic toxicity\\nClinical history\\nGI effects\\nCentral nervous system effects\\nCardiac effects\\nElectrolyte abnormalities\\nDigoxin level\\nTypically in elderly cardiac patients taking diuretics; \\nmay have renal insufficiency\\nNausea, vomiting, diarrhea, abdominal pain\\nFatigue, weakness, confusion, delirium, coma\\nAlmost any dysrhythmia, other than a rapidly \\nconducted atrial fibrillation, can occur; ventricular \\ndysrhythmias are common\\nNormal, low, or high serum potassium, \\nhypomagnesemia\\nMinimally elevated or within “therapeutic” range\\n108_Cydulka_Ch108.indd   602 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 621, 'page_label': '603'}, page_content='CHAPTER 108: Cardiac Medications 603 \\nmost common finding is premature ventricular beats. The differential diag-\\nnosis includes sinus node disease or toxicity from calcium channel block-\\ners, β-blockers, class IA antidysrhythmics, clonidine, other cardiotoxic \\nplants, or intrinsic conduction disease.\\nemergency Department Care and Disposition\\nAll patients require continuous cardiac monitoring, intravenous (IV)  \\naccess, and frequent reevaluation (Table 108-2).\\n1. Administer activated charcoal 1 g/kg in cases of acute toxicity in which \\nthe patient is awake and cooperative.\\n2. Use atropine 0.5 to 1 mg (0.02 mg/kg, minimum dose 0.1 mg) IV to \\ntreat bradydysrhythmias.\\n3. Administer digoxin-specific Fab for ventricular dysrhythmias, hemody-\\nnamically significant bradydysrhythmias, and hyperkalemia greater than \\n5.5 mEq/L. Dosing of digoxin-specific Fab is calculated according to \\nTable 108-3.\\n4. Hyperkalemia that is thought to be due to cardiac glycoside toxicity is \\nbest treated with Fab fragments. Hyperkalemia that is felt to be due to \\nintrinsic renal disease may be treated with dextrose followed by insulin; \\nTable 108-2 Treatment of Digitalis Glycoside poisoning\\nAsymptomatic patients\\nObtain accurate history\\nContinuous cardiac monitoring\\nIV access\\nGI decontamination (for awake, cooperative patients within 1 h of ingestion): activated \\ncharcoal, 1 g/kg orally\\nFrequent reevaluation\\nCalculate digoxin-specific Fab antibody fragment dose in anticipation of potential \\nneed: may bring to drug bedside, depending on ready availability\\nSymptomatic patients\\nObtain accurate history\\nIV access\\nContinuous cardiac monitoring\\nGI decontamination (for awake, cooperative patients within 1 h of ingestion): activated \\ncharcoal, 1 g/kg orally\\nLife-threatening dysrhythmias\\nDigoxin-specific Fab antibody fragments: IV infusion\\nAtropine (for symptomatic bradycardia): 0.5 to 1 mg IV (0.02 mg/kg, minimum dose 0.1 mg)\\nPacer: external or transvenous\\nAbbreviation: Fab, antigen-binding fragment.\\nTable 108-3 Calculation of Digoxin-Specific Fab Antibody Fragment Dose *\\nAcute life-threatening ingestion with unknown digoxin level and unknown amount \\ningested: 10 vials intravenous digoxin-specific Fab\\nA simple and accurate variation using serum digoxin level\\nNumber of vials = [serum digoxin level (ng/mL) × patient’s weight (kg)]/100\\n*The digoxin-specific Fab antibody fragments commercially available in the United States contain 38 or \\n40 mg per vial, depending on the manufacturer, but both bind approximately 0.5 mg of digoxin.\\nAbbreviation: Fab, antigen-binding fragment.\\n108_Cydulka_Ch108.indd   603 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 622, 'page_label': '604'}, page_content='604 SECTION 11: Toxicology and Pharmacology\\nother options are sodium bicarbonate, potassium-binding resin, or \\nhemodialysis. Historically, IV calcium use has been discouraged  \\nbecause of reports of ventricular dysrhythmias. However, recent \\nevidence suggests that IV calcium use is likely safe.\\n5. Admit patients with signs of mild toxicity to a monitored setting and \\nmanage those with significant toxicity in an intensiv e care unit. \\nRepeated digoxin levels following digoxin Fab are not accurate and \\nshould not be obtained.\\n■ ■β-BLOCKErS\\nβ-Blockers are used in the management of hypertension, acute coronary \\nsyndromes, dysrhythmias, congestive heart failure, thyrotoxicosis, social \\nphobias, migraines, and glaucoma. In overdose, their negative inotropic and \\nchronotropic effects result in progressive bradycardia and hypotension.\\nClinical Features\\nToxicity usually develops within 6 hours of ingestion of an immediate-\\nrelease product. With sustained-release preparations toxicity is generally \\nseen within 8 hours of ingestion. The cardiovascular system is the primary \\norgan system affected; however, other noncardiac manifestations may \\noccur (Table 108-4). Sotalol, unlike other β-blockers, is also a class III \\nantidysrhythmic, and thus may cause QT-interval prolongation and torsades \\nde pointes. The onset of toxicity from sotalol may be delayed up to 12 hours \\npostingestion.\\nDiagnosis and Differential\\nThe diagnosis is made based on clinical findings. An ECG should be \\nobtained in all cases. Laboratory studies are directed at identifying underly-\\ning medical conditions or complications. Specific drug levels are not com-\\nmonly available and correlate poorly with clinical effects. Table 108-5 lists \\nother agents that result in bradycardia and hypotension.\\nTable 108-4 Common Findings with β-Blocker Toxicity\\nCardiac\\nHypotension\\nBradycardia\\nConduction delays and blocks\\nVentricular dysrhythmias (seen with sotalol)\\nAsystole\\nDecreased contractility\\nCentral nervous system\\nDepressed mental status\\nComa\\nPsychosis\\nSeizures\\nPulmonary\\nBronchospasm\\nendocrine\\nHypoglycemia\\n108_Cydulka_Ch108.indd   604 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 623, 'page_label': '605'}, page_content='CHAPTER 108: Cardiac Medications 605 \\nTable 108-5 Toxicologic Causes of Bradycardia and hypotension\\nCauses Differentiating Features\\nβ-Blockers Relative or absolute hypoglycemia\\nCalcium channel blockers Marked hyperglycemia\\nNaturally occurring cardiac glycosides \\n(oleander, foxglove, lily of the valley, \\nrhododendron, and toad-derived bufotoxin)\\nVentricular ectopy\\nHyperkalemia\\nMay cross-react with digoxin immunoassay\\nClass IC antidysrhythmic drugs \\n(propafenone)\\nWide-complex bradycardia\\nClonidine Opioid-like manifestations: coma, miosis, \\ndecreased respirations\\nDigoxin (acute) Hyperkalemia\\nElevated level on digoxin immunoassay\\nOrganophosphates Muscarinic toxidrome\\nFigure 108-1. Management strategies in β-blocker toxicity. Cardiac function is \\nevaluated using ECG and cardiac ultrasound and/or a pulmonary artery catheter . \\nFor patients with a wide QRS interval, consider sodium bicarbonate therapy. For \\npatients with impaired myocardial contractility, consider glucagon, norepinephrine, \\ninsulin and glucose, and/or calcium therapy. For patients with preserved cardiac \\ncontractility, administer IV fluids. For patients with decreased systemic vascular \\nresistance, consider norepinephrine. For patients with bradycardia, consider atro-\\npine, glucagon, and/or cardiac pacing. (See the text for details.) IVF, IV fluids; SVR, \\nsystemic vascular resistance.\\nEvaluation\\n(e.g., ECG, cardiac ultrasound, or pulmonary artery catheter)\\nQRS >120 ms Decreased\\ncontractility\\nDecreased\\nSVR\\nBradycardia\\nSodium\\nbicarbonate\\nGlucagon\\nHigh-dose insulin\\nAdrenergic agents\\nCalcium salts\\nVasopressors Glucagon\\nAdrenergic\\nagents\\nCardiac pacing\\nHypotension\\nemergency Department Care and Disposition\\nThe goal of therapy is to restore cardiac output by increasing heart rate \\nand improving myocardial contractility (Fig. 108-1). Establish continu -\\nous cardiac monitoring and IV access. IV fluids may be administered for \\nhypotension.\\n108_Cydulka_Ch108.indd   605 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 624, 'page_label': '606'}, page_content='606 SECTION 11: Toxicology and Pharmacology\\n1. Administer activated charcoal 1 g/kg within 1 to 2 hours of ingestion \\nif no contraindications exist.\\n2. Glucagon has inotropic and chronotropic effects and is the agent of \\nchoice for the treatment of toxicity. Administer as an IV bolus of 3 to 10 \\nmg (0.05 mg/kg). Follow with a continuous infusion of 1 to 5 mg/h. \\nNausea and vomiting are common side effects. Pretreatment with anti-\\nemetics is recommended.\\n3. Use vasopressors, such as norepinephrine  2 to 30 μg/kg/min or epi-\\nnephrine 1 to 20 μg/kg/min, for refractory bradycardia and hypoten-\\nsion. Significantly higher doses may be necessary.\\n4. Calcium may be of limited benefit in cases of refractory hypotension as \\neither calcium gluconate  or calcium chloride: 10 mL of 10% (0.15 \\nmL/kg) repeated three to six times as necessary. Although calcium chlo-\\nride contains more elemental calcium than calcium gluconate, it is irri-\\ntating to soft tissues and should be administered via central line.\\n5. Hyperinsulinemia-euglycemia (HIE) therapy may improv e myocar -\\ndial contractility. Bolus regular insulin IV 1 U/kg followed by a con-\\ntinuous infusion of 1 U/kg/h. Serum glucose should be supplemented as \\nneeded and monitored frequently to avoid hypoglycemia. Monitor \\nserum potassium for severe hypokalemia.\\n6. Cardiac pacing may be attempted but it is often unsuccessful. Aggres-\\nsive measures include extracorporeal circulation or intra-aortic balloon \\npump placement. Hemodialysis may be of benefit in cases involving \\nacebutolol, atenolol, nadolol, or sotalol.\\n7. Isoproterenol, a pure β-agonist, may provide benefit.\\n8. Use magnesium sulfate, lidocaine, and overdrive pacing to treat \\nsotalol-induced ventricular dysrhythmias.\\n9. Symptomatic patients should be admitted to an ICU. Asymptomatic \\npatients who ingest can be medically cleared 6 hours after an ingestion of \\nan immediate-release drug or 8 hours after an ingestion of a sustained  \\nrelease drug. Patients who ingest sotalol should be observed for 12 hours.\\n■ ■CALCIUM ChANNEL BLOCKErS\\nCalcium channel blockers are used in the treatment of hypertension, vaso-\\nspasm, and rate control of supraventricular tachydysrhythmias. Three widely \\nused classes of calcium channel blockers are the phenylalkylamines (vera-\\npamil), benzothiazepines (diltiazem), and dihydropyridines (nifedipine, etc.).\\nClinical Features\\nToxicity usually develops within 6 hours of ingestion of an immediate-\\nrelease product. With sustained-release preparations toxicity can be delayed \\n12 to 24 hours. Toxicity primarily affects the cardiovascular system causing \\nsinus bradycardia, atrioventricular block, and hypotension. Verapamil and \\ndiltiazem have a proportionally greater effect on the myocardium than the \\ndihydropyridines. Dihydropyridine overdose can result in reflex tachycar -\\ndia. With severe toxicity, all classes of calcium channel blockers can cause \\nbradycardia, depressed myocardial contractility, and vasodilatation. \\nHyperglycemia, lactic acidosis, and noncardiogenic pulmonary edema may \\noccur. Central nervous system effects are due to hypoperfusion and other \\netiologies should be sought if the blood pressure is normal.\\n108_Cydulka_Ch108.indd   606 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 625, 'page_label': '607'}, page_content='CHAPTER 108: Cardiac Medications 607 \\nDiagnosis and Differential\\nThe diagnosis is based on clinical findings. Laboratory studies help identify \\ncomplications. Hyperglycemia is common and helps distinguish calcium \\nchannel blocker from β-blocker toxicity, which is associated with hypogly-\\ncemia. The differential diagnosis for bradycardia and hypotension is listed \\nin Table 108-5.\\nemergency Department Care and Disposition\\nTreatment is supportive, with an emphasis on increasing cardiac output and \\nsystemic vascular resistance (Fig. 108-2). Establish continuous cardiac \\nmonitoring and IV access. Administer IV fluids for hypotension.\\nFigure 108-2.  Treatment algorithm for severe calcium channel blocker toxicity \\nshowing recommended progression in therapy at each step if no response occurs. \\nAll listed modalities have been shown to be potentially beneficial and in severe \\ncases can be started simultaneously. D10W, 10% dextrose in water. The use of lipid \\nemulsion therapy should be reserved for those patients with verapamil ingestion \\nwho have progression of symptoms, refractory to optimal medical management. \\n*Calcium chloride provides three times as much elemental calcium as calcium \\ngluconate; it should be used with caution in cases of digoxin toxicity.\\nCalcium gluconate or calcium chloride 10 mL of \\n10% (0.15 mL/kg) over 5 min IV*\\nMay repeat up to three times if no response\\nEpinephrine or norepinephrine\\n1–5 µg/min (titrate to response)\\nAtropine or pacing for\\nsymptomatic bradycardia\\nExtracorporeal blood \\npressure support \\nas rescue\\nLipid emulsion (Intralipid®) 20%\\n1.5 mL/kg IV bolus over 2–3 min,\\nfollowed by 0.5 mL/kg/min infusion\\nGlucagon 3–10 mg\\n(0.03–0.05 mg/kg)\\nIV bolus, may repeat every\\n10 min, consider IV infusion\\n1–5 mg/h (0.02–0.07 mg/kg/h)\\nIf serum glucose <200 mg/dL,\\ngive 50 mL 50% dextrose IV; regular\\ninsulin 1 U/kg IV bolus, follow with\\ninsulin infusion 0.5–1.0 U/kg/h\\nand D10W 200 mL/h (5 mL/kg/h)\\n108_Cydulka_Ch108.indd   607 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 626, 'page_label': '608'}, page_content='608 SECTION 11: Toxicology and Pharmacology\\n1. Administer activated charcoal 1 g/kg within 1 to 2 hours of ingestion \\nif no contraindications exist.\\n2. Give atropine 0.5 to 1 mg IV (0.02 mg/kg, minimum dose 0.1 mg).\\n3. Calcium gluconate or calcium chloride can be administered, b ut typi-\\ncally do not result in significant improvements in hemodynamics. Cal-\\ncium chloride should be administered via a central line.\\n4. Use norepinephrine 2 to 30 μg/kg/min or epinephrine 1 to 20 μg/kg/\\nmin for refractory bradycardia and hypotension. Much higher doses may \\nbe required.\\n5. Hyperinsulinemia-euglycemia (HIE) therapy can improve myocardial \\ncontractility and blood pressure (Table 108-6). Bolus regular insulin 1 \\nU/kg IV followed by continuous infusion (1 U/kg/h). Monitor serum \\nglucose and potassium frequently.\\n6. Glucagon is variably successful in the treatment of calcium channel \\nblocker toxicity. Administer as an IV bolus of 3 to 10 mg (0.05 mg/kg) \\nfollowed by continuous infusion of 1 to 5 mg/h. Pretreatment with anti-\\nemetics is recommended.\\n7. IV fat emulsion (20% solution) may be beneficial in the case of v era-\\npamil overdose. Its use should be reserved for those failing standard \\ntherapy. Administer as a bolus of 1.5 mL/kg IV followed by a continu-\\nous infusion of 0.25 mL/kg/min for 30 to 60 minutes.\\n8. Symptomatic patients should be admitted to an ICU. Asymptomatic patients \\nmay be medically cleared following 6 hours of observation for immediate \\nrelease drugs, or after 24 hours following a sustained release drug.\\n■ ■ANTIhYpErTENSIVES\\nCommonly available antihypertensive agents include diuretics, clonidine, \\nangiotensin-converting enzyme inhibitors, and angiotensin II receptor \\nantagonists (Table 108-7). Acute overdose of diuretics are not expected to \\nresult in life-threatening clinical toxicity.\\nClinical Features\\nThiazides and loop diuretics (hydrochlorothiazide, furosemide) can cause \\nmild hypotension, tachycardia, and hypokalemia.\\nTable 108-6 protocol for hyperinsulinemia-Euglycemia Therapy in Severe \\nCalcium Channel Blocker Overdose\\nAdminister 50 mL of 50% dextrose (0.5 g/mL) in water IV.\\nAdminister regular insulin 1 U/kg IV bolus.\\nBegin regular insulin infusion at 1 U/kg/h.\\nSupplemental dextrose [10% solution (0.1 g/mL) in water at 200 mL/h (adult) or 5 mL/kg/h \\n(pediatric)] may be required.\\nMonitor serum glucose every 20 minutes. Titrate dextrose infusion rate to maintain serum \\nglucose level between 150 and 300 mg/dL.\\nOnce infusion rates have been stable for 60 minutes, glucose monitoring may be \\ndecreased to hourly.\\nMonitor serum potassium level and start IV potassium infusion if serum potassium level is \\n<2.8 mEq/L.\\n108_Cydulka_Ch108.indd   608 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 627, 'page_label': '609'}, page_content='CHAPTER 108: Cardiac Medications 609 \\nTable 108-7 Summary of Antihypertensive Drugs\\nClass Drug Mechanism of Action Clinical presentation of Toxicity Comments\\nDiuretics Acetazolamide Inhibition of proximal tubule sodium–\\nhydrogen exchange\\nHypovolemia\\nNonanion gap metabolic acidosis\\nChlorothiazide\\nChlorthalidone\\nHydrochlorothiazide\\nIndapamide\\nMetolazone\\nInhibition of distal tubule sodium chloride \\nabsorption\\nHypovolemia\\nHypercalcemia\\nBumetanide\\nFurosemide\\nInhibition of sodium-potassium chloride \\nsymporter in renal loop of Henle\\nHypovolemia\\nHypocalcemia\\nHypokalemia\\nHypomagnesemia\\nAmiloride\\nTriamterene\\nInhibition of sodium absorption and \\npotassium elimination in renal distal \\ncollecting duct\\nHypovolemia\\nHyperkalemia\\nEplerenone\\nSpironolactone\\nMineralocorticoid antagonist Hypovolemia\\nHyperkalemia\\nSympatholytics Doxazosin\\nPrazosin\\nTamsulosin\\nTerazosin\\nα1-Adrenergic receptor antagonist Orthostatic hypotension Phenylephrine may be used \\nfor refractory hypotension.\\nClonidine\\nGuanabenz\\nα2-Adrenergic receptor agonist\\nImidazoline receptor agonist\\nHypotension\\nBradycardia\\nHypotension may respond to \\nhigh-dose naloxone.\\nGuanfacine\\nOxymetazoline\\nμ-Receptor opioid agonist Neurologic depression Phenylephrine may be used \\nfor refractory hypotension.\\nTetrahydrozoline\\n(Continued)\\n108_Cydulka_Ch108.indd   609 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 628, 'page_label': '610'}, page_content='610 SECTION 11: Toxicology and Pharmacology\\nTable 108-7 Summary of Antihypertensive Drugs\\nClass Drug Mechanism of Action Clinical presentation of Toxicity Comments\\nACE inhibitors Benazepril\\nCaptopril\\nInhibition of angiotensin-converting \\nenzyme\\nInhibition of bradykininase\\nHypotension (rare)—most are asymp-\\ntomatic\\nHyperkalemia\\nEnalapril\\nFosinopril\\nMoexipril\\nPerindopril\\nQuinapril\\nTrandolapril\\nAngioedema (idiosyncratic)\\nCough (idiosyncratic)\\nAngiotensin receptor \\nblockers\\nCandesartan\\nEprosartan\\nIrbesartan\\nLosartan\\nTelmisartan\\nValsartan\\nAngiotensin II receptor antagonist Hypotension\\nHyperkalemia\\nAngioedema (less common than with \\nACE inhibitors)\\nVasodilators Hydralazine Arteriolar vasodilation Hypotension\\nMinoxidil Tachycardia\\nIncreased myocardial oxygen demand\\nLupus-like syndrome (idiosyncratic \\n reaction to hydralazine)\\nSodium nitroprusside Arteriolar and venous vasodilation (via \\nnitric oxide release)\\nHypotension\\nTachycardia\\nThiocyanate toxicity (after prolonged \\ninfusion)\\nThiosulfate should be \\n administered if cyanide \\n toxicity is considered.\\nCyanide toxicity (very rare)\\nAbbreviation: ACE, angiotensin-converting enzyme.\\n(Continued)\\n108_Cydulka_Ch108.indd   610 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 629, 'page_label': '611'}, page_content='CHAPTER 108: Cardiac Medications 611 \\nPotassium-sparing diuretics (spironolactone, triamterene, and amiloride) \\ncan cause hyperkalemia and hypovolemia.\\nemergency Department Care and Disposition\\nManagement is supportive, including correction of electrolyte abnormali -\\nties. Establish continuous cardiac monitoring and IV access in all patients.\\n1. Administer activated charcoal 1 g/kg within 1 to 2 hours of ingestion \\nif no contraindications exist, and the patient is awake, cooperative, and \\nable to drink charcoal.\\n2. Administer IV normal saline to correct hypovolemia.\\n3. Start norepinephrine for hypotension refractory to volume resuscitation.\\n4. Correct potassium abnormalities using standard measures. Patients with \\nsevere h yperkalemia from potassium-sparing diuretics may require \\ndialysis.\\n5. Most patients can be medically cleared after a 4- to 6-hour observation \\nperiod. Patients with hypotension or electrolyte abnormalities require \\nadmission.\\n■ ■CLONIDINE\\nClonidine is a centrally acting α-agonist used for the management of hyper-\\ntension and opiate withdrawal.\\nClinical Features\\nClonidine toxicity causes miosis, hypotension, and bradycardia, as well as \\nCNS and respiratory depression.\\nemergency Department Care and Disposition\\nManagement is supportive though respiratory depression and apnea, most \\ncommonly seen in children, may infrequently require endotracheal intuba-\\ntion. Establish continuous cardiac monitoring and IV access in all patients.\\n1. Administer IV normal saline for hypotension.\\n2. Use norepinephrine 2 to 30 μg/kg/min for hypotension refractory to \\nfluid resuscitation.\\n3. Give atropine 0.5 to 1 mg (0.02 mg/kg, minimum dose 0.1 mg) for \\nsymptomatic bradycardia.\\n4. Naloxone anecdotally may be effective for cases of refractory hypoten-\\nsion or altered mental status, but convincing data supporting naloxone in \\nthis setting are lacking.\\n5. Patients who remain asymptomatic after a 6-hour observation period \\ncan be medically cleared. Admit symptomatic patients to a monitored \\nsetting.\\n■ ■ANGIOTENSIN-CONVErTING ENZYME INhIBITOrS\\nAgents include captopril, enalapril, and lisinopril. Most patients with ACE-\\ninhibitor overdose remain asymptomatic. The primary toxicity in overdose \\nis hypotension, which may be treated with IV normal saline and vasopres-\\nsors. Patients should be observed for the onset of hypotension.\\n108_Cydulka_Ch108.indd   611 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 630, 'page_label': '612'}, page_content='612 SECTION 11: Toxicology and Pharmacology\\n■ ■ANGIOTENSIN II rECEpTOr ANTAGONISTS\\nAgents include iosartan, valsartan, and candesartan. As with ACE inhib-\\nitors, most patients remain asymptomatic. However, hypotension or \\nhyperkalemia may occur. Therapy is supportive and includes IV fluid \\nadministration, correction of electrolyte disturbances, and cardiac moni-\\ntoring for at least 6 hours.\\n■ ■FUrThEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 193, “Digitalis Glycosides,” by Michael Levine and \\nAaron B. Skolnik; Chapter 194, “β-Blockers,” by Jennifer L. Englund and \\nWilliam P. Kerns II; Chapter 195, “Calcium Channel Blockers,” by Alicia B. \\nMinns and Christian Tomaszewski; and Chapter 196, “Antihypertensives” by \\nFrank Lovecchio and Dan Quan.\\n108_Cydulka_Ch108.indd   612 22/04/17   4:38 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 631, 'page_label': '613'}, page_content='613\\nAnticonvulsants\\nRobert J. Hoffman\\n■ ■PHENYTOIN\\nIntentional phenytoin overdose rarely leads to death, provided adequate \\nsupportive care is administered. Most phenytoin-related deaths have been \\ncaused by rapid IV administration and hypersensitivity reactions. Phenyt-\\noin toxicity may occur after single acute exposure, and also may occur in \\npatients chronically using phenytoin. In patients using phenytoin, toxicity \\noccurs after lesser ingestions because a large quantity of phenytoin is \\nalready present in the body.\\nClinical Features\\nThe toxic effects of phenytoin depend on the duration of exposure, dosage \\ntaken, and route of administration. Life-threatening effects such as hypo-\\ntension, bradycardia, and asystole are seen with IV administration and are \\nlikely secondary to the diluent, propylene glycol. Morbidity can be avoided \\nby slowing the rate of administration during infusion. Extravasation of \\nphenytoin, but not fosphenytoin, may result in catastrophic injury with \\nsignificant loss of soft tissue or even loss of digits or the hand.\\nClinical manifestations in overdose are typically dose related and are \\nlisted in Table 109-1. The primary clinical features of overdose are related \\nto acute CNS effects while cardiovascular toxicity almost exclusively results \\nfrom IV administration. Supratherapeutic phenytoin levels commonly result \\n109\\nC H a PTER\\nTAble 109-1 Clinical Features of Phenytoin Toxicity\\nCentral nervous system Dizziness, tremor (intention), visual disturbance, horizontal \\nand vertical nystagmus, diplopia, miosis or mydriasis, oph-\\nthalmoplegia, abnormal gait (bradykinesia, truncal ataxia), \\nchoreoathetoid movements, irritability, agitation, confusion, \\nhallucinations, fatigue, coma, encephalopathy, dysarthria, \\nmeningeal irritation with pleocytosis, seizures (rare)\\nPeripheral nervous system Peripheral neuropathy, urinary incontinence\\nHypersensitivity \\n(anticonvulsant \\nhypersensitivity syndrome)\\nEosinophilia, rash, pseudolymphoma (diffuse lymphadenopa-\\nthy), systemic lupus erythematosus, pancytopenia, hepatitis, \\npneumonitis\\nGastrointestinal Nausea, vomiting, hepatotoxicity\\nDermatologic Hirsutism, acne, rashes (including Stevens–Johnson \\n syndrome)\\nOther organs Fetal hydantoin syndrome, gingival hyperplasia, coarsening \\nof facial features, hemorrhagic disease of the newborn, \\nhyperglycemia, hypocalcemia\\nParenteral toxicity May cause hypotension, bradycardia, conduction \\ndisturbances, myocardial depression, ventricular fibrillation, \\nasystole, and tissue necrosis from infiltration\\n109_Cydulka_Ch109.indd   613 20/03/17   3:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 632, 'page_label': '614'}, page_content='614 SECTION 11: Toxicology and Pharmacology\\nin cerebellar symptoms of dizziness, ataxia, and nystagmus. Skin and soft \\ntissue injury may be seen with IM injection or after e xtravasation from IV \\ninfusion. Therapeutic use has been associated with hypersensitivity reac-\\ntions and gingival hyperplasia. Phenytoin is teratogenic.\\nDiagnosis and Differential\\nDiagnosis is made by history, clinical exam, and serum drug levels. The \\ntherapeutic range is 10 to 20 µg/mL and toxicity generally correlates with \\nincreasing plasma levels (Table 109-2). Absorption is erratic, and serial \\nlevels should be obtained in cases of suspected ingestion. Electrocardio-\\ngraphic changes in toxicity include increased PR interval, widened QRS \\ninterval, and altered ST-wave and T-wave segments.\\nemergency Department Care and Disposition\\n1. Place patients on monitor and obtain IV access.\\n2. Treat acute oral overdose or severe supratherapeutic toxicity with multi-\\ndose of oral activated charcoal (1 g/kg) every 4 to 6 hours for the first \\n24 hours.\\n3. Correct acidosis to decrease free serum phenytoin.\\n4. Treat hypotension from IV administration of phenytoin with IV isotonic \\ncrystalloid and discontinuation of the infusion.\\n5. Treat bradydysrhythmias with atropine or cardiac pacing.\\n6. Treat seizures with a benzodiazepine or phenobarbital.\\n7. Admit patients with serious complications (e.g., seizures, coma, altered \\nmental status, and ataxia). Consider a patient’s ability to safely ambulate \\nwhen determining admission or discharge status. Generally , ability to \\nsafely ambulate is required for safe discharge. Observe patients with \\nmild symptoms until serum levels are declining; cardiac monitoring \\nafter isolated oral ingestion is unnecessary.\\n8. Discontinue phenytoin in cases of toxicity. The number of days to with-\\nhold phenytoin depends on the serum level. Generally, at least 1 or 2 days \\nwithout phenytoin are needed, and after 2 to 3 days the patient can return \\nto a medical provider to have his or her serum phenytoin level rechecked.\\n■ ■CaRBaMaZEPINE\\nClinical Features\\nCarbamazepine’s anticholinergic properties delay GI motility and can \\ncause delayed clinical deterioration. Manifestations of acute toxicity \\nTAble 109-2 Correlation of Plasma Phenytoin Level and Side Effects\\nTotal Plasma Level (µg/mL) T oxic Effects\\n<10 Usually none\\n10–20 Occasional mild nystagmus\\n20–30 Nystagmus\\n30–40 Ataxia, slurred speech, nausea and vomiting\\n40–50 Lethargy, confusion\\n>50 Coma, seizures\\n109_Cydulka_Ch109.indd   614 20/03/17   3:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 633, 'page_label': '615'}, page_content='CHAPTER 109: Anticonvulsants 615 \\ninclude ataxia, nystagmus, miosis or mydriasis, ileus, bowel obstruction, \\nhypertonicity, increased deep tendon reflexes, dystonic reactions, and an \\nanticholinergic toxidrome. Severe toxicity may result in coma and respira-\\ntory failure, and seizures can occur at high serum concentrations. Though \\nrare, carbamazepine can widen the QRS interval and cause cardiac dys-\\nrhythmias. Patients taking carbamazepine therapeutically will develop \\ntoxicity with lesser acute ingestions because a large quantity of carbamaze-\\npine is already present in the body.\\nDiagnosis and Differential\\nSerum carbamazepine concentrations do not correlate with severity of poison-\\ning, though concentrations >40 µg/mL may be associated with an increased \\nrisk of complications, and those more than 60 to 80 µg/mL may be fatal. A \\nfalse-positive tricyclic antidepressant result on urine drug screen can occur.\\nemergency Department Care and Disposition\\n1. Consider activated charcoal in the awake patient within 1 hour of inges-\\ntion or in patients chronically taking carbamazepine therapeutically.\\n2. Consider hemodialysis or hemodiafiltration for life-threatening \\n overdose.\\n3. Obtain an ECG to evaluate for QRS interval widening. Treat QRS inter-\\nval widening with sodium bicarbonate.\\n4. Patients can be discharged if asymptomatic, with declining serum levels \\n(below 15 µg/mL), and a normal ECG.\\n■ ■VaLPROaTE\\nClinical Features\\nIn acute overdose, valproate causes central nervous system depression. \\nOther findings include respiratory depression, hypotension, hypoglycemia, \\nhypernatremia, hypophosphatemia, and anion gap metabolic acidosis that \\nmay persist for days. Liver toxicity, cerebral edema, hyperammonemia, \\npancreatitis, and thrombocytopenia have been reported after acute over -\\ndose. Hepatic failure (microvesicular steatosis) occurs in about 1 in 20,000 \\npatients on long-term therapy, with children <3 years of age on multiple \\nantiepileptics at greatest risk.\\nDiagnosis and Differential\\nObtain a serum valproate level. The therapeutic range is 50 to 100 µg/mL; \\nadverse effects increase at concentrations >150 µg/mL and frank coma \\nmay occur with levels above 800 µg/mL. Check serum ammonia and bed-\\nside glucose in patients with altered level of consciousness. Consider liver \\nfunction tests, electrolytes, and a CBC.\\nemergency Department Care and Disposition\\n1. Consider multidose activated charcoal after ingestion of enteric-coated, \\ndelayed-release preparations and measure serial concentrations to ac-\\ncount for delayed peak serum concentration. Consider whole-bowel \\nirrigation in any enteric-coated or extended-release preparations.\\n109_Cydulka_Ch109.indd   615 20/03/17   3:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 634, 'page_label': '616'}, page_content='616 SECTION 11: Toxicology and Pharmacology\\n2. L-carnitine, 50 mg/kg/day, may hasten reco very in patients with acute \\nintoxication and increase survival from hepatotoxicity.\\n3. Hemodialysis may be useful in toxicity associated with very high serum \\nconcentrations >800 µg/mL. Hemoperfusion and hemodiafiltration can \\nbe used to treat severe overdose.\\n4. All symptomatic patients, other than those with mild symptoms, require \\nadmission. Asymptomatic patients with declining serum levels can be \\ndischarged.\\n■ ■SECOND-GENERaTION aNTICONVULSaNTS\\nAs a group, the second-generation anticonvulsants possess little toxicity in \\nacute overdose.\\n●■■Felbamate may cause aplastic anemia and hepatic failure and can crystal-\\nlize in the kidney, leading to acute renal failure in large overdose.\\n●■■Gabapentin may cause drowsiness, ataxia, nausea, and vomiting that gener-\\nally resolve in about 10 hours. Gabapentin is increasingly ab used for its \\nbenzodiazepine-like effects.\\n●■■Lacosamide may cause dizziness, headache, nausea, and diplopia during \\ntherapeutic use.\\n●■■Lamotrigine has been associated with autoimmune reactions during thera-\\npeutic use and drowsiness, vomiting, ataxia, and dizziness in overdose. Sei-\\nzures, coma, cardiac toxicity (QRS and QT-interval prolongation), and acute \\npancreatitis have been reported. Treatment includes sodium bicarbonate.\\n●■■Levetiracetam may cause lethargy, coma, and respiratory depression.\\n●■■Oxcarbazepine may cause hyponatremia and a drug rash during thera-\\npeutic use.\\n●■■Pregabalin has been reported to cause somnolence and dizziness during \\nlong-term therapeutic use. Overdose may cause depressed lev el of con-\\nsciousness. Pregabalin is increasingly abused for its benzodiazepine-like \\neffects.\\n●■■Rufinamide may cause headache, dizziness, fatigue and somnolence during \\nlong-term therapy.\\n●■■Tiagabine may cause the rapid neurologic toxicity, including lethargy, \\ncoma, seizures, myoclonus, muscular rigidity, and delirium.\\n●■■Topiramate may cause nephrolithiasis and glaucoma during therapeutic \\nuse. In o verdose, somnolence, vertigo, agitation, mydriasis, and seizures \\nhave been reported. Topiramate can produce a metabolic acidosis, which \\ncan last up to 7 days due to the long half-life of the drug.\\n●■■Zonisamide may promote renal stone formation and cause a drug rash dur-\\ning therapeutic use.\\n■ ■FURTHER REaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 197, “Anticonvulsants” by Frank LoVecchio.\\n109_Cydulka_Ch109.indd   616 20/03/17   3:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 635, 'page_label': '617'}, page_content='617\\nIron\\nO. John Ma\\n■ ■CLINICAL FEATURES\\nIron toxicity from an intentional or accidental ingestion is a common poi-\\nsoning. Based on clinical findings, iron poisoning can be divided into five \\nstages.\\nThe first stage develops within the first few hours of ingestion. Direct \\nirritative effects of iron on the gastrointestinal (GI) tract produce abdominal \\npain, vomiting, and diarrhea. V omiting is the clinical sign most consistently \\nassociated with acute iron toxicity. The absence of these symptoms within \\n6 hours of ingestion essentially excludes a diagnosis of significant iron \\ntoxicity.\\nDuring the second stage, which may continue for up to 24 hours follow-\\ning ingestion, the patient’s GI symptoms may resolve, providing a false \\nsense of security despite toxic amounts of iron absorption. While patients \\nmay be asymptomatic, they often appear ill and may have abnormal vital \\nsigns reflecting hypovolemia and metabolic acidosis.\\nThe third stage may appear early or develop hours after the second stage \\nas shock and a metabolic acidosis evolve. Iron-induced coagulopathy may \\ncause bleeding and worsen hypovolemia. Hepatic dysfunction, cardiomy-\\nopathy, and renal failure may also develop.\\nThe fourth stage develops 2 to 5 days after ingestion and is character -\\nized by elevation of aminotransferase levels and possible progression to \\nhepatic failure.\\nThe fifth stage, which occurs 4 to 6 weeks after ingestion, reflects the \\ncorrosive effects of iron on the pyloric mucosa and may cause gastric outlet \\nobstruction.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe diagnosis of iron poisoning is based on the clinical picture and the his-\\ntory provided by the patient, significant others, caretakers, or EMS provid-\\ners. When determining a patient’s potential for toxicity, the total amount of \\nelemental iron must be used in calculations. Table 110-1 reviews the pre-\\ndicted clinical effects based on the amount of iron ingested.\\nLaboratory evaluation includes serum electrolytes, renal studies, serum \\nglucose, coagulation studies, complete blood count, hepatic enzymes, and \\na serum iron level. A single serum iron level does not reflect what iron \\nlevels have been previously, what direction they are going, or the degree of \\niron toxicity in tissues; a single low serum level does not exclude the diag-\\nnosis of iron poisoning since there are variable times to peak level follow-\\ning ingestion of different iron preparations. Serum iron levels have limited \\nuse in directing management since toxicity is primarily intracellular rather \\nthan in the blood. The total iron binding capacity (TIBC) becomes falsely \\nelevated in the presence of elevated serum iron levels or deferoxamine, and \\nis of no clinical value.\\n110\\nCh A p TER\\n110_Cydulka_Ch110.indd   617 26/04/17   2:33 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 636, 'page_label': '618'}, page_content='618 SECTION 11: Toxicology and Pharmacology\\nPlain radiographs may reveal iron in the GI tract; ho wever, many iron \\npreparations are not radiopaque, so normal radiographs do not exclude iron \\ningestion.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nPatients who have remained asymptomatic for 6 hours after ingestion of \\niron, have not ingested a potentially toxic amount, and who have a normal \\nphysical examination do not require medical treatment for iron toxicity. \\nPatients whose symptoms resolve after a short period of time, and who \\nhave normal vital signs, usually have mild toxicity and require only sup-\\nportive care. This subset of patients still requires an observation period. \\nFigure 110-1 is an algorithm for the clinical management of patients after \\nan acute iron ingestion.\\nPatients who are symptomatic or demonstrate signs of hemodynamic \\ninstability after iron ingestion require aggressive management in the ED.\\n1. Place the patient on supplemental oxygen and a cardiac monitor, and \\nestablish two large-bore IV lines.\\n2. Administer vigorous intravenous (IV) crystalloid infusion to help cor-\\nrect hypovolemia and hypoperfusion.\\n3. Perform gastric lavage  in patients who present within 60  minutes of \\ningestion. Activated charcoal is not recommended.\\n4. Whole-bowel irrigation with a poly ethylene glycol solution is effica-\\ncious. Administration of 250 to 500  mL/h in children or 2  L/h in adults \\nvia nasogastric tube may clear the GI tract of iron pills before absorption \\noccurs.\\n5. Administer antiemetics such as ondansetron 4 mg IV in adults (0.1 mg/\\nkg to a maximum dose of 4  mg in pediatric patients) or promethazine \\n25 mg IV in adults.\\n6. Correct coagulopathy with vitamin K1 5 to 10 mg SC and fresh frozen \\nplasma 10 to 25 mL/kg in adults (10 mL/kg in pediatric patients). Order \\nblood for type and screen or crossmatch as necessary.\\n7. Deferoxamine is a chelating agent that can remo ve iron from tissues \\nand free iron from plasma. Deferoxamine is safe to administer to chil-\\ndren and pregnant women. Deferoxamine therapy is indicated in patients \\nTable 110-1 predicted Toxicity of Iron Ingestion\\npredicted Clinical Effects\\nElemental Iron \\nDose*\\nSerum Iron \\nConcentration†\\nNontoxic or mild GI symptoms <20 mg/kg <300 μg/dL (<54 μM/L)\\nExpected significant GI symptoms \\nand potential for systemic toxicity\\n20–60 mg/kg 300–500 μg/dL (54–90 μM/L)\\nModerate to severe systemic \\ntoxicity\\n>60 mg/kg >500 μg/dL (>90 μM/L)\\nSevere systemic toxicity and \\nincreased morbidity\\n>1000 μg/dL (>180 μM/L)\\n*Elemental iron dose by history.\\n†Serum iron concentration obtained within 4 to 6 hours of ingestion.\\n110_Cydulka_Ch110.indd   618 26/04/17   2:33 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 637, 'page_label': '619'}, page_content='CHAPTER 110: Iron 619 \\nQuantity\\ningested\\nConsider abdominal \\nradiograph\\nConsider GI \\ndecontamination\\n<20 mg/kg\\n<500 µg/dL or\\nUnavailable AND\\nNormal acid-base\\nstatus Asymptomatic\\n>500 µg/dL \\nMetabolic acidosis\\nSymptoms persistent\\nSymptoms develop\\nObtain 4 h\\npostingestion\\nserum Fe\\nVolume resuscitation\\nAssess acid-base status\\nObtain abdominal radiograph\\nConsider GI decontamination\\nConsider antiemetics\\nStabilize patient\\nVolume resuscitation\\nAssess acid-base status\\nObtain serum Fe\\nObtain abdominal radiograph\\nConsider GI decontamination\\nConsider antiemetics\\nAsymptomatic\\nat 6 h\\npostingestion\\nDischarge\\nStop\\ndeferoxamine\\nContinue deferoxamine and\\nsupportive care\\nClinically\\nstable?\\nUrine\\ncolored?\\nObtain baseline urine\\nStart IV deferoxamine\\n>60 mg/kg\\nAsymptomatic Systemic\\ntoxicity\\nGI symptoms\\nonly\\nIron Ingested\\n20–60 mg/kg\\nor unknown\\nNo\\nNo\\nYes\\nYes\\nFIgure 110-1.  Algorithm for clinical management of patients following iron \\ningestion.\\nwith systemic toxicity, metabolic acidosis, worsening symptoms, or a \\nserum iron level predictive of moderate to severe toxicity.\\nIntravenous infusion is the preferred route of deferoxamine  \\nadministration because IM absorption is unpredictable in the hypovo-\\nlemic patient. The recommended initial dose is 50  mg/kg in children \\nto an adult dose of 1000  mg IV . Since hypotension is the rate-limiting \\nfactor for IV infusion, it is recommended to begin with a slow IV \\ninfusion at 5  mg/kg/h. The deferoxamine infusion rate can be \\nincreased to 15  mg/kg/h, as tolerated, within the first hour of treat-\\nment. The recommended total amount of deferoxamine is 360  mg/kg \\nor 6 g during the first 24 hours. Initiate deferoxamine therapy without \\nwaiting for the serum iron level in any clinically ill patient with a \\nknown iron ingestion.\\nEvaluate the efficacy of deferoxamine treatment through serial urine \\nsamples. As ferrioxamine is excreted, urine changes to a classic vin rose \\nappearance. Clinical recovery is the most important factor guiding the \\ntermination of deferoxamine therapy.\\n110_Cydulka_Ch110.indd   619 26/04/17   2:33 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 638, 'page_label': '620'}, page_content='620 SECTION 11: Toxicology and Pharmacology\\n8. Patients who remain asymptomatic after 6 hours of observation, hav e a \\nnormal physical examination, and have a reliable history of an insignifi-\\ncant ingestion may be considered for discharge. Patients initially symp-\\ntomatic who become asymptomatic should be admitted for further \\nevaluation since this may represent the second stage of iron toxicity. \\nAdmit all patients who receive deferoxamine therapy to an intensive \\ncare setting. Assess all patients for suicide risk. Consider child abuse or \\nneglect in pediatric cases.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 198, “Iron,” by Stephanie H. Hernandez and Lewis S. \\nNelson.\\n110_Cydulka_Ch110.indd   620 26/04/17   2:33 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 639, 'page_label': '621'}, page_content='621\\nHydrocarbons and Volatile \\nSubstances\\nAllyson A. Kreshak\\nProducts containing hydrocarbons are found in many household and work-\\nplace settings and include fuels, lighter fluids, paint removers, pesticides, \\npolishers, degreasers, and lubricants. Some volatile substances may be \\nrecreationally abused. Exposure may cause mild to severe toxicity and, \\nrarely, sudden death.\\n■ ■CLINICAL FEATURES\\nToxicity depends on route of exposure, physical characteristics, chemical \\ncharacteristics, and the presence of toxic additives (e.g., lead or pesticides). \\nSee Table 111-1 for clinical features.\\nChemical pneumonitis is the most common pulmonary complication \\nand is most likely to occur following aspiration of a hydrocarbon with low \\nviscosity (ability to resist flow), high volatility (tendency for a liquid to \\nbecome a gas), and low surface tension (cohesive force between mole-\\ncules). Symptoms occur quickly and include cough, gagging, choking, and \\ndyspnea. Physical examination may reveal tachypnea, wheezing, grunting, \\nand an elevated temperature. Radiographic abnormalities do not always \\noccur. If radiographic findings occur, they may lag behind the clinical pic-\\nture by 4 to 24 hours, but most are apparent within 6 hours.\\nCardiac toxicity manifests as potentially lethal dysrhythmias resulting \\nfrom myocardial sensitization to circulating catecholamines (“sudden sniff-\\ning death syndrome”). Halogenated hydrocarbon solvents are most fre-\\nquently implicated, but all classes of hydrocarbons have been associated \\nwith dysrhythmias.\\n111\\nCh A p TER\\nTable 111-1 Clinical Manifestations of hydrocarbon Exposure\\nSystem Clinical Manifestations\\nPulmonary Tachypnea, grunting respirations, wheezing, retractions\\nCardiac Ventricular dysrhythmias (may occur after exposure to  \\nhalogenated hydrocarbons and aromatic hydrocarbons)\\nCentral nervous Slurred speech, ataxia, lethargy, coma\\nPeripheral nervous Numbness and paresthesias in the extremities\\nGI and hepatic Nausea, vomiting, abdominal pain, loss of appetite (mostly with \\nhalogenated hydrocarbons)\\nRenal and metabolic Muscle weakness or paralysis secondary to hypokalemia in \\npatients who abuse toluene\\nHematologic Lethargy (anemia), shortness of breath (anemia), neurologic \\ndepression/syncope (carbon monoxide from methylene chloride), \\ncyanosis (methemoglobinemia from amine-containing hydrocarbons)\\nDermal Local erythema, papules, vesicles, generalized scarlatiniform \\neruption, exfoliative dermatitis, “huffer’s rash,” cellulitis\\n111_Cydulka_Ch111.indd   621 20/03/17   4:46 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 640, 'page_label': '622'}, page_content='622 SECTION 11: Toxicology and Pharmacology\\nCentral nervous system toxicity may present as intoxication, ranging \\nfrom initial giddiness, agitation, and hallucinations to seizures, slurred \\nspeech, ataxia, and coma. Chronic exposure may cause recurrent head -\\naches, cerebellar ataxia, and mood lability.\\nGastrointestinal toxicity can include vomiting (which can lead to aspira-\\ntion), abdominal pain, anorexia, and hepatic damage (particularly from \\nhalogenated hydrocarbons such as carbon tetrachloride, methylene chlo-\\nride, trichloroethylene, and tetrachloroethylene).\\nDermal toxicity includes contact dermatitis and blistering with pro-\\ngression to full-thickness burns. Injection of hydrocarbons can cause \\ntissue necrosis. Burns can result after cutaneous contact with hot tar and \\nasphalt.\\nLess common acute toxicities include hematologic disorders such as \\nhemolysis, methemoglobinemia, carboxyhemoglobinemia (from methy-\\nlene chloride), and renal dysfunction.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nDiagnosis is made by history and physical examination findings, bedside \\nmonitoring, laboratory tests, and chest radiograph. An abdominal radio-\\ngraph may reveal ingestion of radiopaque substances (e.g., chlorinated \\nhydrocarbons).\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Secure the airway and maintain ventilation support in patients with \\nrespiratory insuf ficiency or neurologic depression. Administer oxygen \\nto symptomatic patients and place them on a cardiac monitor (see \\nTable 111-2). An EKG should be obtained.\\n2. Treat hypotension with intrav enous crystalloid infusion. Avoid cate-\\ncholamines except in cases of cardiac arrest. Treat tachydysrhyth-\\nmias with propranolol, esmolol, or lidocaine. Avoid class IA and III \\nagents.\\n3. Follow standard hazardous material measures for decontamination of \\nthe patient. Initial decontamination should ideally be done at the  \\nscene and should include removal of the patient from the exposure \\n(including clothing or dermal contact). Skin may be irrigated with \\nsoap and water. Activated charcoal is not indicated following isolated \\nhydrocarbon ingestions. The use of gastric emptying is not beneficial, \\nand this decontamination technique is not regularly employed follow-\\ning ingestion.\\n4. Meticulous wound care with potential surgical debridement is indi-\\ncated for dermal e xposures. Treat tar and asphalt injuries with imme-\\ndiate cooling and cold water, and application of ointment combined \\nwith surface-active agents (e.g., Polysorbate 80).\\n5. Prophylactic antibiotics are not generally indicated. Corticosteroid use \\nis not indicated.\\n6. Admit symptomatic patients, those exposed to hydrocarbons capable of \\nproducing delayed toxicity (e.g., halogenated hydrocarbons), and those \\nexposed to hydrocarbons with toxic additives (e.g., pesticides or organic \\nmetal compounds). Patients with severe respiratory distress may need \\n111_Cydulka_Ch111.indd   622 20/03/17   4:46 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 641, 'page_label': '623'}, page_content='CHAPTER 111: Hydrocarbons and Volatile Substances 623 \\nintubation and mechanical ventilation with high levels of PEEP. Patients \\nexposed to nonhalogenated aliphatic hydrocarbons that are asymptom-\\natic and with a normal chest radiograph may be discharged with return \\nprecautions after 6 to 8 hours of observation.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 199, “Hydrocarbons and V olatile Substances,” by \\nC. William Heise and Frank LoVecchio.\\nTable 111-2 Management of hydrocarbon Exposures\\nAirway and \\nbreathing\\nSecure airway.\\nAntidotes: Administer oxygen for carboxyhemoglobinemia and methy-\\nlene blue for methemoglobinemia.\\nProvide supplemental oxygen if wheezing.\\nAdminister inhaled β2-agonists if wheezing.\\nVentilatory support: Provide positive end-expiratory pressure or \\ncontinuous positive airway pressure as needed to achieve adequate \\noxygenation.\\nCardiac Circulation: Administer IV crystalloid fluid for initial volume \\nresuscitation of hypotensive patients.\\nDo not use catecholamines in cases of halogenated hydrocarbon \\nexposure.\\nConsider propranolol, esmolol, or lidocaine for ventricular dysrhythmias \\ninduced by halogenated hydrocarbon exposure.\\nConsult the poison control center, toxicologist, and other appropriate \\nspecialists as needed.\\nDecontamination Dermal: Remove hydrocarbon-soaked clothes, decontaminate skin with \\nsoap and water, and decontaminate eyes with saline irrigation.\\nGI: Not indicated.\\nOther Laboratory tests: Order CBC, basic metabolic panel, liver function tests \\n(serum transaminase, bilirubin, albumin levels), prothrombin time, \\npartial thromboplastin time, carboxyhemoglobin level, methemoglobin \\nlevel, and/or radiologic studies as indicated (see the text).\\nCorrect electrolyte abnormalities.\\nDo not give steroids.\\nAdminister blood products as needed.\\n111_Cydulka_Ch111.indd   623 20/03/17   4:46 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 642, 'page_label': '624'}, page_content='624\\nCaustics\\nJennifer Cullen\\nCaustics are substances that can cause histological and functional damage \\non contact and include both alkalis (pH >7) and acids (pH <7). The most \\ncommon alkali exposure is household bleach (sodium hypochlorite with \\nhydroxide), which is usually benign except in intentional ingestions. The \\nmost common acid exposures are drain cleaners (sulfuric acid), automobile \\nbatteries, and masonry cleaners (hydrochloric acid).\\n■ ■CLINICAL FEATURES\\nCommon features of caustic ingestions include dysphagia, odynophagia, \\nepigastric pain, and vomiting with gastrointestinal (GI) tract injuries. Dys-\\nphonia, stridor, and respiratory distress can be seen with laryngotracheal \\ninjury. Esophageal injuries are graded by direct endoscopic visualization: \\n(1) edema and hyperemia; (2) ulcerations, blisters, and exudates (2a—\\nnoncircumferential; 2b—circumferential); (3) deep ulceration and necrosis. \\nIntentional ingestions are associated with higher-grade injury that can lead \\nto the development of strictures. Most ingestions with serious injury are \\nsymptomatic with stridor, drooling, or vomiting, although distal GI injury \\nwithout oral or facial burns is possible. Disc battery ingestions are often \\nasymptomatic, though batteries >15 mm in diameter can become lodged in \\nthe esophagus and cause pressure necrosis.\\nCaustic exposures to the cornea are particularly serious if they involve \\nalkalis. Dermal exposures to caustics usually produce only local pain and \\nirritation. However, alkali and sodium hydrofluoric acid burns can penetrate \\ndeeply. Alkali exposures lead to liquefactive necrosis, which is more severe \\nthan the coagulation necrosis caused by most acids. Hydrofluoric acid can \\ncause systemic hypocalcemia, hypomagnesemia, and hyperkalemia with \\nsubsequent ventricular dysrhythmias.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe diagnosis is clinical. Routine laboratory tests are recommended for \\nseverely affected patients and include electrolytes, assessment of acid–\\nbase status, and monitoring for potential gastrointestinal bleeding. \\nMonitor serum calcium and magnesium levels and perform an ECG in \\npatients with hydrofluoric acid exposures, especially ingestions. Con-\\nsider chest and/or abdominal radiographs in symptomatic caustic inges-\\ntions to assess for free air or to investigate for foreign body in cases of \\nsuspected disc battery ingestion. Noncontrast CT of the chest and abdo-\\nmen may be useful if perforated viscus is suspected, especially after \\ningestion of strong acids. Early endoscopic evaluation (ideally < 12 \\nhours after ingestion) is indicated for intentional caustic ingestions, and \\nunintentional cases presenting with stridor, oral burns, vomiting, drool-\\ning, or inability to tolerate oral intake.\\n112\\nCh A p TER\\n112_Cydulka_Ch112.indd   624 20/03/17   4:56 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 643, 'page_label': '625'}, page_content='CHAPTER 112: Caustics 625 \\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nFocus treatment on decontamination, early anticipatory airway manage-\\nment, stabilization of hemodynamic status, and delineation of extent of \\ninjury.\\nDecontamination\\n1. Remove contaminated clothing and irrigate e xposed skin with copious \\namounts of water. Alkali burns may require local debridement and re-\\nmoval of devitalized tissue followed by additional irrigation.\\n2. Perform aggressive ocular decontamination with normal saline for a \\nminimum of 15 minutes with frequent monitoring of ocular pH until a \\npH of 7.5 to 8.0 is achieved.\\n3. Gastric decontamination in the form of activated char coal, ipecac, \\nor gastric lavage is contraindicated.\\nSupportive Care\\n1. Perform early oral intubation with direct visualization in symptomatic \\npatients with stridor, significant drooling, or dysphonia. Blind nasotra-\\ncheal intubation is contraindicated.\\n2. Obtain IV access and administer isotonic IV fluids for hypotension.\\n3. Obtain surgical consultation for suspected or confirmed peritonitis or \\nfree air.\\nSpecial Considerations\\n1. Treat hydrofluoric acid dermal exposures with topical calcium gluco-\\nnate gel (3.5 g mixed with 150 mL water-soluble lubricant). Consider \\nintradermal 5% calcium gluconate for large burns and calcium gluco-\\nnate infusion into the radial artery over 4 hours or given as a Bier block \\n(10 mL of 10% calcium gluconate in 40 mL saline or 5% dextrose) for \\nrefractory distal extremity burns.\\n2. Oral ingestions of hydrofluoric acid within an hour can be suctioned via \\nnasogastric tube followed by instillation of up to 300 mL of 10% cal -\\ncium gluconate. High doses of IV calcium and magnesium may be \\nneeded to treat systemic deficiencies and dysrhythmias.\\n3. Disc batteries lodged in the esophagus require emergent endoscopic \\nremoval.\\n4. Laundry detergent pod ingestions in young children may produce seri-\\nous toxicity including caustic injury, respiratory distress, and neurologic \\ndepression. Treat supportively with airway protection as needed.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 200, “Caustic Ingestions,” by Nicole C. Bouchard and \\nWallace A. Carter.\\n112_Cydulka_Ch112.indd   625 20/03/17   4:56 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 644, 'page_label': '626'}, page_content='626\\nPesticides\\nCharles W. O’Connell\\nPesticides include insecticides, herbicides, and rodenticides. In addition to \\nactive toxic ingredients, many pesticides also contain “inert” products such \\nas petroleum distillates, which may be toxic as well. Although the mainstay \\nof treatment is supportive care, some antidotes are essential.\\n■ ■INSECTICIDES\\nClinical Features\\nOrganophosphate insecticides include agents such as diazinon, acephate, \\nmalathion, parathion, and chlorpyrifos. Absorption occurs through inges-\\ntion, inhalation (e.g., nerve gas agents), and dermal routes. Toxicity is \\nproduced through binding and inhibition of acetylcholinesterase, causing \\nexcess accumulation of acetylcholine and stimulation of cholinergic recep-\\ntors, of both the muscarinic and nicotinic receptor types. The muscarinic \\nreceptor agonism results in a cholinergic crisis known as “SLUDGE” and \\n“DUMBELS” effects (Table 113-1).\\nOnset of symptoms, ranging from minutes to hours, varies based on \\namount and route of exposure. Most patients become symptomatic within \\n8 hours of acute exposure, though some fat-soluble agents (e.g., fenthion) \\ncan cause delayed symptoms with dermal exposure. Nicotinic receptor \\nstimulation leads to fasciculations and muscle weakness, which is most \\npronounced in the respiratory muscles, which leads to worsening of pulmo-\\nnary dysfunction caused by bronchorrhea from muscarinic effects. Nicotinic \\neffects can also cause tachycardia and mydriasis, paradoxical to the \\n113\\nChap TE r\\nTable 113-1 SLUDGE, DUMBELS, and “Killer Bees” Mnemonics for the Cholinergic\\nEffects of Cholinesterase Inhibition\\nS Salivation\\nL Lacrimation\\nU Urinary incontinence\\nD Defecation\\nG GI pain\\nE Emesis\\nD Defecation\\nU Urination\\nM Muscle weakness, miosis\\nB Bradycardia, bronchorrhea, bronchospasm\\nE Emesis\\nL Lacrimation\\nS Salivation\\nKiller Bees Bradycardia, bronchorrhea, bronchospasm\\n113_Cydulka_Ch113.indd   626 20/03/17   5:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 645, 'page_label': '627'}, page_content='CHAPTER 113: Pesticides 627 \\nexpected muscarinic choliner gic effects. Central nervous system (CNS) \\neffects, which often predominate in children, include tremor, restlessness, \\nconfusion, seizures, and coma.\\nA variety of subacute and chronic effects are associated with organo-\\nphosphate insecticide poisoning. An intermediate syndrome, 1 to 5 days \\nafter acute poisoning, may present with paralysis or weakness of neck, \\nfacial, and respiratory muscles, which can result in respiratory arrest if not \\ntreated. Organophosphate-induced delayed neuropathy can occur 1 to 3 \\nweeks after acute poisoning, resulting in a distal motor-sensory polyneu-\\nropathy with leg weakness and paralysis.\\nDiagnosis and Differential\\nOrganophosphate poisoning is typically a clinical diagnosis based on the \\ntoxidrome and history of exposure (Table 113-1); laboratory cholinesterase \\nassay can aid in confirmation. An ECG may be useful to monitor for pro-\\nlonged QT, which is associated with increased morbidity and mortality in \\norganophosphate poisoning.\\nemergency Department Care and Disposition\\nTreatment of org anophosphate poisoning is listed in Table 113-2, and \\nshould not be delayed pending confirmatory tests.\\n1. In symptomatic patients, administer 100% oxygen and focus on airway \\nmanagement, with gentle suctioning of secretions. Nondepolarizing \\nagents should be used for rapid sequence intubation. The use of succi-\\nnylcholine for intubation, which is metabolized by plasma cholinester -\\nase, may result in prolonged paralysis.\\n2. The key in treatment is large amounts of atropine titrated to attenuation \\nof tracheobronchial secretions. Tachycardia and dilated pupils are not \\ncontraindications to additional atropine. Of note, atropine will only \\nreverse the muscarinic effects, but not the nicotinic effects of excess \\nTable 113-2 Treatment for Organophosphate poisoning\\nDecontamination Protective clothing must be worn to prevent secondary poisoning \\nof health care workers\\nHandle and dispose of all clothes as hazardous waste. Wash \\npatient with soap and water\\nHandle and dispose of water runoff as hazardous waste\\nMonitoring Cardiac monitor, pulse oximeter, 100% oxygen\\nGastric lavage No proven benefit\\nActivated charcoal No proven benefit\\nUrinary alkalinization No proven benefit\\nAtropine 1 mg or more IV in an adult or 0.01 to 0.04 mg/kg (but never  \\n<0.1 mg) IV in children. Repeat every 5 min until tracheobronchial \\nsecretions attenuate\\nPralidoxime 1 to 2 g for adults or 20 to 40 mg/kg (up to 1 g) in children, mixed \\nwith normal saline and infused IV over 5 to 10 min\\nContinuous infusion may be employed\\nSeizures Benzodiazepines\\n113_Cydulka_Ch113.indd   627 20/03/17   5:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 646, 'page_label': '628'}, page_content='628 SECTION 11: Toxicology and Pharmacology\\nacetylcholine. Glycopyrrolate or high-dose diphenhydramine can be \\nsubstituted for atropine if it is not available.\\n3. Minimal exposures require only 6 to 8 hours of observation. Recrudes-\\ncence can occur due to reexposure to contaminated clothing, particularly \\nleather. Significant poisonings require intensive care monitoring.\\n4. Other commonly encountered pesticides and their treatment are listed in \\nTable 113-3.\\n■ ■hErBICIDES\\nHerbicides are agents used to kill weeds. In addition to intrinsic toxicity, \\nthey may also be packaged with surfactants or solvents with their own \\ntoxic effects. The most dangerous are bipyridyl herbicides, namely para-\\nquat and diquat. Nonbipyridyl herbicides and their treatments are \\ndepicted in Table 113-4.\\nTable 113-3 Nonorganophosphate Insecticide poisoning\\nagent Example Clinical Feature Diagnosis T reatment\\nCarbamates Carbaryl, pirimi-\\ncarb, propoxur, \\ntrimethacarb\\nSimilar to organo-\\nphosphates\\nDepressed \\ncholinester-\\nase levels\\nAtropine\\nOrganochlorines Chlordane, \\nheptachlor, \\ndieldrin, aldrin\\nNeurological: \\nexcitability, \\nseizures\\nHistory, \\nspecial lab\\nBenzodiazepine, \\ncooling\\nPyrethroids Pyrethrins parasthesia, \\nvomiting, \\noropharyngeal \\nirritation, allergic \\nhypersensitivty\\nHistory Bronchodilators \\nand antihista-\\nmines, supportive\\nNeonicotinoids Imidacloprid Nausea, head-\\nache, sedation\\nHistory Supportive\\nN,N-Dietyl-3- \\nmethylbenzamide\\nDEET Seizures History Benzodiazepines\\nTable 113-4 Nonbipyridyl herbicides\\nagent Example Clinical Feature Treatment\\nChlorophenoxy 2,4-dichloro-\\nphenoxyacetic \\nacid\\nMucous membrane irritation, \\npulmonary edema, muscle \\ntoxicity, hyperthermia\\nUrine alkalization\\nHemodialysis\\nGlyphosate Mucous membrane irrita-\\ntion, erosions, multiorgan \\nfailure, respiratory distress\\nObserve asymptom-\\natic patients for 6 h\\nUrea-substituted Chlorimuron, diu-\\nron, ﬂuomenturon, \\nisoproturon\\nMethemoglobinemia Methylene blue\\nOrganophosphates Butiphos SLUDGE Same as pesticides\\nN,N-Dietyl-3- \\nmethylbenzamide\\nDEET Seizures Benzodiazepines\\n113_Cydulka_Ch113.indd   628 20/03/17   5:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 647, 'page_label': '629'}, page_content='CHAPTER 113: Pesticides 629 \\nParaquat is especially toxic with lethality seen with oral doses of 10 to \\n20 mL in an adult and 4 to 5 mL in children of 20% solution. Both agents \\nare toxic via inhalation, dermal exposure, or ingestion. Due to their caustic \\nproperties, ulceration of skin and mucous membranes and gastrointestinal \\ncorrosion can occur. Paraquat ingestions result in renal, cardiac, and hepatic \\nfailure along with progressive pulmonary fibrosis from oxidative damage. \\nDue to the latter, treatment often includes restriction of supplemental oxy-\\ngen except for severe hypoxia. Decontamination of skin is important to \\nprevent continued absorption. Early after ingestion, GI decontamination \\nwith activated charcoal, fuller’s earth, or bentonite may be helpful. \\nCharcoal hemoperfusion may remove paraquat. Because of poor prognosis, \\nespecially with paraquat ingestions, admit patients with ingestion for fur -\\nther observation and treatment.\\n■ ■rODENTICIDES\\nThe most commonly used rodenticides are superwarfarins, including \\nbrodifacoum, difenacoum, and bromadiolone. Coagulopathy typically \\ndevelops within 48 hours and lasts for weeks to months due to the long \\nhalf-lives of these agents. Single small ingestions in children usually do not \\nresult in toxic effects. Acute intentional or repeated ingestions may present \\nwith delayed hemorrhage, including hematuria, gastrointestinal hemor -\\nrhage, or epistaxis. Screening for toxic effect can be performed with an INR \\nobtained 24 to 48 hours after ingestion. If the INR is elevated (>2), then \\nstart oral vitamin K1, typically at doses of 20 mg/d in adults (1 to 5 mg for \\nchildren), which can be continued for up to 10 months until the anticoagu-\\nlant effect is cleared. Acute hemorrhage requires more aggressive therapy \\nwith volume replacement, fresh frozen plasma or four-factor prothrombin \\ncomplex, IV vitamin K 1, and supportive care. Nonanticoagulant rodenti-\\ncides are described in Table 113-5.\\nTable 113-5 Nonanticoagulant rodenticides\\nagent Toxicity Clinical Effects Treatment\\nArsenic Severe Vomiting and diarrhea, \\ncardiovascular collapse\\nSupportive care, BAL \\nfor acute poisoning, \\nSuccimer\\nBarium carbonate Severe Vomiting and diarrhea, \\ndysrhythmia, respiratory \\nfailure, hyopkalemia, \\nparalysis\\nGastric lavage with \\nsodium or magnesium \\nsulfate; potassium \\nreplacement\\nWhite phosphorus Severe Burns, cardiovascular \\ncollapse\\nLavage with potassium \\npermangante\\nN-3-Pyridylmethyl-\\nN’-p-nitrophenyl \\nurea (Vacor)\\nSevere GI symptoms, insulin \\ndeﬁcient hyperglycemia \\nand DKA\\nNicotinamide IV\\nSodium ﬂuroacetate Severe Vomiting, respiratory \\ndepression, impaired con-\\nciousness, twitching, seizure\\nSupportive care\\nStrychnine Severe Awake seizure like activity Benzodiazepines\\n(Continued)\\n113_Cydulka_Ch113.indd   629 20/03/17   5:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 648, 'page_label': '630'}, page_content='630 SECTION 11: Toxicology and Pharmacology\\n■ ■FUrThEr rEaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 201, “Pesticides,” by Burillo-Putze Guillermo and \\nXarau Santiago Nogue.\\nTable 113-5 Nonanticoagulant rodenticides\\nagent Toxicity Clinical Effects Treatment\\nThallium Severe Early GI irritation, respiratory \\nfailure and dysrhythmias\\nOral Prussian blue\\nMetal phosphides Severe Vomiting, shock, \\nhypocalcemia\\nIntragastric alkalization\\nα-Napthyl-thiourea Moderate Pulmonary edema Supportive care\\nCholecalciferol Moderate Hypercalcemia Saline, furosemide, \\nsteroids\\nBromethalin Low Tremors, focal seizures Benzodiazepines\\nNorbormide Low Vasoconstrictive tissue \\nhypoxia\\nSupportive care\\nRed squill Low Vomiting, diarrhea, hyper-\\nkalemia, heart block with \\nventricular dysrhythmias\\nSupportive care\\n(Continued)\\n113_Cydulka_Ch113.indd   630 20/03/17   5:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 649, 'page_label': '631'}, page_content='631\\nMetals and Metalloids\\nD. Adam Algren\\nMetal and metalloid poisoning, although uncommon, can result in morbid-\\nity and mortality if unrecognized. Toxicity results from occupational, rec-\\nreational, or environmental exposures and results in multi-system organ \\ninvolvement.\\n■ ■LEAD POISONING\\nClinical Features\\nLead poisoning manifests with signs and symptoms affecting a variety of \\norgan systems (Table 114-1).\\nDiagnosis and Differential\\nSuspect lead poisoning in any individual demonstrating a combination of \\nabdominal pain, nausea, vomiting, and neurologic symptoms (particularly \\nchildren with encephalopathy), especially in the setting of anemia. A com-\\nplete blood count (CBC) may demonstrate normocytic or microcytic ane-\\nmia with hemolysis and basophilic stippling; however, hematologic \\nfindings are neither sensitive nor specific for lead poisoning. Lead toxicity \\nis confirmed by an elevated blood lead level, though results are often not \\nimmediately available. Radiographs may identify metaphyseal long-bone \\nlead lines, radiopaque material in the GI tract, or retained bullet fragments. \\nThe differential diagnosis of toxicity is broad and includes meningitis, \\nencephalitis, metabolic abnormalities, hypoxia, drug intoxications, arsenic, \\nmercury, and carbon monoxide poisoning.\\n114\\nCh AP t E r\\nTable 114-1 Clinical Features of Lead Poisoning\\nSystem Clinical Manifestations\\nCentral nervous Acute toxicity: encephalopathy, seizures, altered mental status, \\npapilledema, optic neuritis, ataxia\\nChronic toxicity: headache, irritability, depression, fatigue, mood  \\nand behavioral changes, memory deficit, sleep disturbance\\nPeripheral nervous Paresthesias, motor weakness (classic is wrist drop), depressed or \\nabsent deep tendon reflexes, sensory function intact\\nGI Abdominal pain (mostly with acute poisoning), constipation, \\ndiarrhea, toxic hepatitis\\nRenal Acute toxicity: Fanconi’s syndrome (renal tubular acidosis with \\naminoaciduria, glucosuria, and phosphaturia)\\nChronic toxicity: interstitial nephritis, renal insufficiency, \\nhypertension, gout\\nHematologic Hypoproliferative and/or hemolytic anemia; basophilic stippling (rare \\nand nonspecific)\\nReproductive Decreased libido, impotence, sterility, abortions, premature births, \\ndecreased or abnormal sperm production\\n114_Cydulka_Ch114.indd   631 20/03/17   5:07 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 650, 'page_label': '632'}, page_content='632 SECTION 11: Toxicology and Pharmacology\\nemergency Department Care and Disposition\\n1. Address life-threatening problems with advanced airway management \\nand fluid resuscitation.\\n2. Decontaminate the GI tract with whole-bowel irrigation using polyeth-\\nylene glycol solution in those with retained lead flecks in the GI tract. \\nLarger foreign bodies may require endoscopic or surgical removal.\\n3. Treat seizures aggressively with benzodiazepines, follo wed by barbitu-\\nrates and/or propofol, and/or general anesthesia. Avoid lumbar puncture \\nin the setting of lead-induced encephalopathy as this can precipitate \\nherniation.\\n4. Chelation therapy is the mainstay of treatment and often must be started \\nempirically (Table 114-2). Dimercaprol (BAL) can only be administered \\nintramuscularly and is contraindicated in those with peanut aller gies.\\n5. Admit patients requiring parenteral chelation therapy or those who can-\\nnot avoid further environmental lead exposure. Arrange follow up for \\npatients started on succimer (DMSA).\\n■ ■ArSENIC POISONING\\nClinical Features\\nArsenic is used in a variety of insecticides and herbicides as well as mining \\nand smelting processes. Acute ingestion results in profound vomiting and \\ndiarrhea within hours of exposure. Hypotension and tachycardia may \\ndevelop secondary to hypovolemia and direct myocardial dysfunction. \\nEncephalopathy, acute lung injury, and acute kidney injury may develop. \\nArsenic toxicity can prolong the QT interval and cases of torsades de \\nTable 114-2 Guidelines for Chelation therapy in Lead-Poisoned Patients*\\nSeverity (Blood Lead  \\nLevel [μg/dL]) Dose\\nEncephalopathy Dimercaprol, 75 mg/m2 (or 4 mg/kg) IM every 4 h for 5 days\\nand\\nEdetate calcium disodium, 1500 mg/m2 per day via \\ncontinuous infusion or in 2–4 divided doses IV for 5  days; \\nstart 4 h after dimercaprol\\nSymptomatic\\nand/or\\nAdults: blood lead >100\\nChildren: blood lead >69\\nDimercaprol\\nand\\nEdetate calcium disodium (as described above)\\nor\\nEdetate calcium disodium (alone)\\nor\\nSuccimer (as described below)\\nAsymptomatic\\nAdults: blood lead 70–100\\nChildren: blood lead 45–69\\nSuccimer, 350 mg/m2 (or 10 mg/kg) PO every 8 h for 5 days, \\nthen every 12 h for 14 days\\nAsymptomatic\\nAdults: blood lead <70\\nChildren: blood lead <45\\nRoutine chelation not indicated; remove patient from \\nsource of exposure\\n*General guidelines. Consult with medical toxicologist or regional poison center for specifics and dosing.\\n114_Cydulka_Ch114.indd   632 20/03/17   5:07 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 651, 'page_label': '633'}, page_content='CHAPTER 114: Metals and Metalloids 633 \\npointes have been reported. Chronic poisoning causes peripheral neuropa-\\nthy, malaise, and confusion. Skin findings include alopecia, hyperpigmen-\\ntation, keratoses, and transverse white nail lines (Mees’ lines).\\nDiagnosis and Differential\\nAn exposure history is most useful in identifying arsenic poisoning. How-\\never, consider the diagnosis in patients with hypotension preceded by pro-\\nfound vomiting and diarrhea. The CBC may demonstrate leukocytosis with \\nacute poisoning. An ECG may show QT-interval prolongation. The diagno-\\nsis is confirmed by documenting an elevated 24-hour urine arsenic level. \\nOther diagnoses to consider include gastroenteritis, septic shock, encepha-\\nlopathy, peripheral neuropathy, Addison’s disease, and lead, thallium, or \\nmercury poisoning.\\nemergency Department Care and Disposition\\n1. Support the ABCs: endotracheal intubation may be required to protect \\nthe airway; treat hypotension with v olume resuscitation and vasopres-\\nsors, but avoid overresuscitation that may result in pulmonary or cere-\\nbral edema. Manage dysrhythmias according to ACLS/PALS protocols, \\nbut avoid agents that prolong the QT interval (class IA, IC, and III anti-\\ndysrhythmics). Magnesium sulfate, isoproterenol, and/or overdrive pac-\\ning should be considered for treatment of torsades de pointes.\\n2. Decontaminate the gastrointestinal tract with whole-bowel irrigation  \\nusing polyeth ylene glycol solution in those with radiopaque GI \\nfragments.\\n3. Treat symptomatic patients empirically with chelation therapy  \\n(Table 114-3) using dimercaprol IM. Succimer PO is preferred for \\nclinically stable patients who can tolerate oral intake.\\n4. Hospitalize acutely poisoned patients, patients requiring dimercaprol, or \\nthose with suspected suicidal or homicidal intent. Discharge stable \\npatients with subacute or chronic poisoning if follow-up is ensured.\\n■ ■MErCUrY POISONING\\nMercury poisoning can result from exposure to elemental, inorganic, or \\norganic mercury compounds.\\nClinical Features\\nElemental mercury exposure is most likely to occur after contact with a \\nbroken thermometer, light bulb or other mercury spills. Mercury is primar-\\nily absorbed via inhalation (especially with heating or vacuuming). Inges-\\ntions of elemental mercury are nontoxic in those with normal GI tracts. \\nVapor exposure results in cough, fever, dyspnea, vomiting, and headache. \\nTable 114-3 Guidelines for Chelation therapy in Arsenic-Poisoned Patients\\nChelator Dose\\nDimercaprol 3–5 mg/kg IM every 4 h for 2 days, followed by 3–5 mg/kg IM every \\n6–12 h until able to switch to succimer\\nSuccimer 10 mg/kg PO every 8 h for 5 days, followed by 10 mg/kg PO every 12 h\\n114_Cydulka_Ch114.indd   633 20/03/17   5:07 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 652, 'page_label': '634'}, page_content='634 SECTION 11: Toxicology and Pharmacology\\nAcute lung injury can progress to respiratory failure. Classic findings \\ninclude tremor , rash, and hypertension. Inorganic mercury is used as a \\ndisinfectant and in manufacturing. Ingestion of inorganic mercury results in \\ncorrosive injury to the GI tract, with vomiting, diarrhea, abdominal pain, \\nand GI bleeding early, followed by acute kidney injury. Organic mercury is \\nfound in some fungicides and pesticides and can be absorbed when \\ningested. Poisoning tends to occur with chronic exposures and results in \\nprofound central nervous system dysfunction.\\nDiagnosis and Differential\\nA history of exposure to mercury is key to diagnosis and is confirmed by \\nan elevated 24-hour urine mercury level when toxicity is due to elemental \\nor inorganic mercury; an elevated whole blood mercury level is necessary \\nin cases of organic mercury exposure. The differential diagnosis is exten-\\nsive and includes causes of metal fume fever (elemental), encephalopathy \\nor tremor (elemental/inorganic/organic), thyroid disease, metabolic enceph-\\nalopathy, stroke, and tumor. Consider alternative causes of corrosive gastro-\\nenteritis (ingestion of iron, arsenic, phosphorus, acids, and alkalis) if \\nmercury salt ingestion is suspected.\\nemergency Department Care and Disposition\\n1. Support the ABCs with airway management and crystalloid infusion.\\n2. Consider gastric lavage in cases of inorganic mercury ingestion or acti-\\nvated charcoal in cases of organic mercury ingestion.\\n3. Begin chelation therapy prior to confirming the diagnosis (Table 114-4). \\nDimercaprol is preferred for elemental and inorganic mercury poison-\\nings. Succimer is the agent of choice in organic mercury poisonings and \\nin cases of mild or chronic elemental/inorganic mercury toxicity.\\n4. Admit patients with respiratory symptoms following elemental mercury \\nvapor e xposure, those with inorganic mercury ingestions, or patients \\nrequiring dimercaprol chelation. Ensure prompt environmental assessment \\nin cases of elemental mercury vapor exposures to prevent further toxicity.\\n■ ■POISONING WIth OthEr MEtALS\\nLess common toxic heavy metals include bismuth, cadmium, chromium, \\ncobalt, copper, silver, thallium, and zinc. Unique manifestations and treat-\\nments of these exposures are outlined in Table 114-5.\\nTable 114-4 Guidelines for Chelation therapy in Mercury-Poisoned Patients\\nElemental and Inorganic Mercury Organic Mercury\\nSevere acute \\npoisoning\\nDimercaprol, 5 mg/kg IM every 4 h \\nfor 2 days, followed by 2.5 mg/kg \\nIM every 6 h for 2 days, followed by \\n2.5 mg/kg IM every 12–24 h until \\nclinical improvement occurs or until \\nable to switch to succimer therapy\\nSuccimer, 10 mg/kg PO \\nevery 8 h for 5 days, then \\nevery 12 h for 14 days\\nMild acute poisoning \\nand chronic poisoning\\nSuccimer, 10 mg/kg PO every 8 h for \\n5 days, then every 12 h for 14 days\\nNo proven benefit for \\nchelation therapy\\n114_Cydulka_Ch114.indd   634 20/03/17   5:07 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 653, 'page_label': '635'}, page_content='CHAPTER 114: Metals and Metalloids 635 \\nTable 114-5 Miscellaneous Metal Poisoning: Unique Manifestations and \\ntreatments of Patients Poisoned by Less Common Metals\\nMetal\\nPoisoning \\nSource\\nAcute Clinical \\nManifestations\\nChronic Clinical \\nManifestations\\nSpecific \\ntreatment\\nBismuth Antidiarrheals \\n(bismuth \\nsubsalicylate), \\nimpregnated \\nsurgical packing \\npaste\\nAbdominal pain, \\nacute kidney \\ninjury\\nMyoclonic \\nencephalopathy\\nDimercaprol \\n(limited \\nevidence)\\nCadmium Contaminated \\nsoil in cadmium-\\nrich areas;  \\nalloys used in \\nwelding, solder-\\ning, jewelry, and \\nbatteries\\nIngestion: hem-\\norrhagic gastro-\\nenteritis\\nInhalation: pneu-\\nmonitis, acute \\nlung injury\\nProteinuria, \\nosteomalacia \\n(itai-itai or ouch-\\nouch disease), \\nlung cancer \\n(questionable)\\nIngestion: suc-\\ncimer (limited \\nevidence; not \\ngenerally indi-\\ncated)\\nPneumonitis: \\nchelation not \\nindicated\\nChromium Corrosion inhibi-\\ntors (e.g., heat-\\ning systems), \\npigment produc-\\ntion, leather \\ntanning, metal \\nfinishing, dietary \\nsupplements, \\nprosthetic joints\\nSkin irritation \\nand ulceration, \\ncontact dermati-\\ntis; GI irritation, \\nrenal and pulmo-\\nnary failure\\nMucous mem-\\nbrane irritation, \\nperforation of \\nnasal septum, \\nchronic cough, \\ncontact derma-\\ntitis, skin ulcers \\n(“chrome holes”), \\nlung cancer\\nAcetylcysteine \\n(animal studies \\nsuggest efficacy \\nas chelator)\\nCobalt “Hard metal \\ndust” (tungsten–\\ncobalt mixture), \\nflexible mag-\\nnets, drying \\nagents, pros-\\nthetic joints\\nContact dermati-\\ntis, asthma\\nHard metal lung \\ndisease (spec-\\ntrum ranging \\nfrom alveolitis to \\nfibrosis), cardio-\\nmyopathy, thyroid \\nhyperplasia\\nAcetylcysteine \\n(animal studies \\nsuggest efficacy \\nas chelator)\\nCopper Leaching from \\ncopper pipes \\nand containers; \\nfungicide (cop-\\nper sulfate); \\nwelding (copper \\noxide)\\nIngestion: \\nresembles \\niron poisoning; \\nblue vomitus \\n(copper salts), \\nhepatotoxicity, \\nhemolysis, met-\\nhemoglobinemia\\nInhalation: metal \\nfume fever (self-\\nlimited fever, \\nchills, cough, \\ndyspnea)\\nHepatotoxicity \\n(childhood cirrho-\\nsis or idiopathic \\ncopper toxicosis)\\nDimercaprol for \\nhepatic or hema-\\ntologic toxicity\\nSuccimer in mild \\npoisoning\\n(Continued)\\n114_Cydulka_Ch114.indd   635 20/03/17   5:07 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 654, 'page_label': '636'}, page_content='636 SECTION 11: Toxicology and Pharmacology\\n■ ■FUrthEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 203, “Metals and Metalloids,” by Heather Long and \\nLewis S. Nelson.\\nTable 114-5 Miscellaneous Metal Poisoning: Unique Manifestations and \\ntreatments of Patients Poisoned by Less Common Metals\\nMetal\\nPoisoning \\nSource\\nAcute Clinical \\nManifestations\\nChronic Clinical \\nManifestations\\nSpecific \\ntreatment\\nSilver Colloidal (metal-\\nlic) silver used \\nfor medicinal \\npurposes as \\noral solutions, \\naerosols, and \\ndouches; cau-\\nterizing and \\nantiseptic agent \\n(silver nitrate); \\njewelry, wire\\nMucosal irrita-\\ntion (silver oxide \\nand nitrate)\\nArgyria (perma-\\nnent skin discol-\\noration due to \\nsilver deposition \\nand melanocyte \\nstimulation)\\nSelenium \\n(possible role)\\nThallium Rodenticides \\n(use prohibited \\nin the United \\nStates); con-\\ntaminated herbal \\nproducts; medi-\\ncal radioisotope \\n(miniscule dose); \\nmost poison-\\nings related to \\nhomicide\\nEarly: nausea, \\nvomiting, \\nabdominal pain, \\ntachycardia\\nIntermediate \\n(>24 h): painful \\nascending neu-\\nropathy, cardiac \\ndysrhythmias, \\naltered mental \\nstatus\\nDelayed \\n(2 weeks): \\nalopecia\\nSensorimotor \\nneuropathy, psy-\\nchosis, dermati-\\ntis, hepatotoxicity\\nMultidose acti-\\nvated charcoal\\nPrussian \\nblue, 125 mg/\\nkg PO every \\n12 h (usually \\ndissolved in \\n50 mL of 15% \\nmannitol)\\nZinc Smelting, \\nelectroplating, \\nmilitary smoke \\nbombs, zinc loz-\\nenges, welding/\\ngalvanizing (zinc \\noxide)\\nIngestion: nau-\\nsea, vomiting, \\nabdominal pain \\n(resembles iron \\npoisoning)\\nInhalation: \\nmucosal irrita-\\ntion, metal fume \\nfever (zinc oxide)\\nCopper defi-\\nciency, sidero-\\nblastic anemia, \\nneutropenia\\nEdetate calcium \\ndisodium\\nSupportive care \\nfor metal fume \\nfever\\n(Continued)\\n114_Cydulka_Ch114.indd   636 20/03/17   5:07 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 655, 'page_label': '637'}, page_content='637\\nIndustrial Toxins\\nLanden Rentmeester\\nThere are over 50,000 hazardous chemicals used in various industrial pro-\\ncesses throughout the United States. Exposures are inevitable and the emer-\\ngency physician must be prepared to appropriately care for these patients. \\nMaterial Safety Data Sheets, regional poison control centers and medical \\ntoxicologists are valuable resources for information on specific hazards, opti-\\nmal management, and patient disposition. Children and pregnant women are \\npatient populations who require special attention, the former due to differ -\\nences in respiratory, dermatologic, and gastrointestinal physiology and the \\nlatter requiring a focus on maternal care in order to optimize fetal well-being.\\n■ ■RESPIRATORY TOXINS\\nClinical Features\\nPhosgene, chlorine, nitrogen dioxide, and ammonia are significant respi-\\nratory toxins seen in industrial exposures, and are further described in \\nTable 115-1. Hydrocarbons, cyanide, and carbon monoxide are also inha-\\nlational toxins that can have systemic effects.\\n115\\nCh APTER\\nTable 115-1 Toxic Industrial Exposures That Cause Respiratory Symptoms\\nAgent Irritant Signs/Symptoms/Findings Treatment\\nPhosgene Mild/none I—Eye and upper airway \\nirritation; possibly none\\nSupplemental oxygen if \\nhypoxemic (Sa02 <92%)\\nD—Dyspnea, noncardiogenic \\npulmonary edema\\nRespiratory supportive care\\nNebulized β-agonists\\nMandatory rest\\nOcular supportive care\\nChlorine Yes I—Eye and upper airway \\nirritation, nausea and vomiting \\n(low-level exposure)\\nHumidified oxygen\\nRespiratory supportive care\\nD—Pulmonary edema (high-\\nlevel exposure)\\nNebulized β-agonists\\nNebulized sodium bicarbonate\\nOcular care\\nNitrogen \\ndioxide\\nYes I—Dyspnea with transient \\nimprovement\\nHumidified oxygen\\nD—Worsening dyspnea \\ndue to pulmonary edema \\n24–72 hours after exposure; \\nmethemoglobinemia\\nRespiratory supportive care\\nEarly corticosteroid treatment\\nAmmonia Yes I—Coughing, hoarseness, \\nbronchospasm, eye and upper \\nairway irritation\\nHumidified oxygen\\nNebulized β-agonists\\nNebulized anticholinergics\\nRespiratory supportive care\\nOcular supportive care\\nAbbreviations: D = delayed; I = immediate; Sa02= arterial oxygen saturation.\\n115_Cydulka_Ch115.indd   637 20/03/17   5:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 656, 'page_label': '638'}, page_content='638 SECTION 11: Toxicology and Pharmacology\\nDiagnosis and Differential\\nExamine the upper airway for evidence of singed nasal hair , soot in the \\noropharynx, facial or oropharyngeal burns, stridor, hoarseness, dysphagia, \\ncough, carbonaceous sputum, tachypnea, retractions, accessory muscle use, \\nwheezing, or cyanosis. Diagnostic workup includes arterial blood gas \\nanalysis with carboxyhemoglobin, methemoglobin, serum lactate concen-\\ntration, chest radiography, electrocardiogram, and cardiac monitoring.\\nemergency Department Care and Disposition\\n1. Give supplemental oxygen for hypoxemia and inhaled bronchodilators \\nfor bronchospasm. A low threshold for endotracheal intubation is \\nappropriate in cases of upper airway injury.\\n2. Irrigation of the eyes and skin if necessary.\\n3. Prophylactic antibiotics and steroids are NOT routinely indicated fol-\\nlowing toxic gas inhalation, except in cases of nitrogen dioxide expo-\\nsure, but can be considered in patients with toxin-induced bronchospasm \\nor underlying reactive airway disease.\\n■ ■PhOSGENE\\nClinical Features\\nPhosgene, once used in chemical warfare, is a precursor in the production \\nof plastics, pharmaceuticals, dyes, polyurethane, and pesticides. It is also \\nproduced when chlorinated fluorocarbons are heated, a potential danger for \\nthose who work in the refrigeration or air-conditioning industries. Initial \\nsymptoms include upper airway and mucous membrane irritation, with an \\naccompanying odor of freshly mown hay. Upon reaching the lower airways, \\nphosgene converts to carbon dioxide and hydrochloric acid, in which the \\nlatter causes caustic injury, capillary leakage, and noncardiogenic pulmo-\\nnary edema. Clinically, this process is manifested as chest tightness and \\ndyspnea. Pulmonary edema may be delayed up to 24 hours, while onset \\nwithin 4 hours suggests a poor prognosis. Diagnosis is typically made on \\nhistory of exposure and clinical symptoms.\\nemergency Department Care and Disposition\\n1. Respiratory failure requires intubation and ventilation with low tidal vol-\\numes, low plateau pressures, and high positive end expiratory pressure. \\nOtherwise, refrain from supplemental oxygen unless hypoxia is present.\\n2. Nebulized Beta agonists may be beneficial if administered early.\\n3. Instruct the patient to minimize physical exertion.\\n4. Observe all patients with phosgene exposures for a minimum of  \\n24 hours.\\n■ ■ChLORINE\\nClinical Features\\nChlorine is used in a variety of industrial and water treatment processes. It \\nhas a very characteristic acrid, pungent odor and may disperse as a dense \\ngreen yellow gas. Upon exposure to water, chlorine acid derivatives are \\n115_Cydulka_Ch115.indd   638 20/03/17   5:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 657, 'page_label': '639'}, page_content='CHAPTER 115: Industrial Toxins 639 \\nproduced, leading to irritation of the mucous membranes of the eyes and \\nupper airway. With increasing exposure, the more distal airways are \\naffected, leading to pulmonary edema and acute respiratory distress syn-\\ndrome, which may be delayed up to 6 hours.\\nemergency Department Care and Disposition\\n1. Treat respiratory symptoms with humidified oxygen and bronchodilators.\\n2. Nebulized sodium bicarbonate may be of benefit within 4 hours of exposure.\\n3. Consider steroids, either intravenous or inhaled. However, there is insuf-\\nficient evidence of improved outcomes with steroid therapy.\\n4. Evaluate for dermal and corneal burns in patients with significant exposure.\\n5. Monitor patients with moderate symptoms for 24 hours.\\n■ ■NITROGEN DIOXIDE\\nClinical Features\\nNitrogen dioxide and nitrogen oxides are typically encountered in silo gas \\nand military ordinance, and are formed in any instance of air-based com-\\nbustion. A triphasic clinical course is often observed, manifested initially as \\ndyspnea and flu-like symptoms, followed by transient improvement, then \\nincreasing dyspnea 12 hours post-exposure due to pulmonary edema. Met-\\nhemoglobinemia has also been reported. Diagnosis is typically made by \\nclinical history.\\nemergency Department Care and Disposition\\n1. Initial treatment is supportive, ensuring airway inte grity and adequate \\noxygenation/ventilation.\\n2. Give supplemental humidified oxygen and bronchodilators if broncho-\\nspasm is present.\\n3. Because the respiratory effects of NO 2 exposure are delayed, patients \\nmay present with minimal symptoms despite significant exposure, and \\nearly intubation should be considered.\\n4. Early corticosteroids may reduce the risk of delayed pulmonary edema.\\n5. Most patients require hospitalization for 24 to 48 hours.\\n■ ■AMMONIA\\nClinical Features\\nAmmonia is found in many household chemicals, fertilizers, and plastic \\nproduction. It has a characteristic pungent odor and rapidly irritates the \\nmucous membranes of the upper airway. Lower airway injury may occur \\nwith massive exposure. Diagnosis is typically made by clinical history.\\nemergency Department Care and Disposition\\n1. Treat exposed patients supportively with humidified oxygen, bronchodi-\\nlators, and anticholinergics.\\n2. Provide copious irrigation and corneal burn evaluation for patients with \\neye discomfort.\\n115_Cydulka_Ch115.indd   639 20/03/17   5:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 658, 'page_label': '640'}, page_content='640 SECTION 11: Toxicology and Pharmacology\\n■ ■CYANIDE\\nClinical Features\\nCyanide is an extremely toxic chemical generated during the combustion of \\nsynthetic materials, wool, and silk. It is used in vermin extermination, pre-\\ncious metal reclamation, and chemical laboratories. It is also found naturally \\nin seeds of the Prunus species. Toxicity is caused by inhibition of cyto-\\nchrome oxidase, which subsequently disrupts oxidative phosphorylation and \\nATP production. Patients with significant exposure present with altered \\nconsciousness, hyperventilation, hypotension, and bradycardia. They will \\ntypically have normal oxygen saturation on co-oximetry. A smell of bitter \\nalmonds may be detected. Cherry-red skin is an uncommon finding.\\nDiagnosis and Differential\\nA severe, unexplained anion gap metabolic acidosis is characteristic of \\ncyanide exposure and is due to lactic acid production from anaerobic \\nmetabolism. The PaO2 of venous blood will approach that of arterial blood \\nas a result of impaired tissue oxygen consumption. An elevation of car -\\nboxyhemoglobin may also be seen in fire victims. Whole blood cyanide \\nlevels confirm exposure, but are not rapidly available. The diagnosis is \\nmade clinically and treatment initiated as soon as possible.\\nemergency Department Care and Disposition\\n1. Treat cyanide poisoning with aggressiv e supportive care and antidotal \\ntherapy, outlined in Tables 115-2 and 115-3. Nitrites induce the forma-\\ntion of methemoglobin, which binds and removes cyanide to allow \\nreactivation of oxidative phosphorylation. Sodium thiosulfate provides \\na sulfate group that is transferred to cyanide to create less toxic thio-\\ncyanate. Hydroxocobalamin directly binds cyanide, removing it from \\ncytochrome oxidase, and forming cyanocobalamin. Nitrite therapy is \\nnot contraindicated in patients with hypotension from severe cyanide \\nTable 115-2 Treatment of Cyanide Poisoning in Adults\\n100% supplemental oxygen\\nIV crystalloids and vasopressors for hypotension\\nSodium bicarbonate for acidemia\\nAND\\nCyanide antidote kit Amyl nitrite inhaler; crack vial and inhale over 30 s. *\\nSodium nitrite 3% solution: 10 mL (300 mg) IV given \\nover no less than 5 min.†\\nSodium thiosulfate 25% solution: 50 mL (12.5 g) IV.\\nRepeat sodium thiosulfate once at half dose (25 mL) if \\nsymptoms persist.\\nOR\\nHydroxocobalamin 5 g IV over 15 min.\\nIf needed, may repeat 5 g for a total of 10 g.\\n*Not necessary if IV is in place.\\n†Avoid nitrites in the presence of severe hypotension if diagnosis is unclear; consider sodium thiosulfate \\nor hydroxocobalamin.\\n115_Cydulka_Ch115.indd   640 20/03/17   5:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 659, 'page_label': '641'}, page_content='CHAPTER 115: Industrial Toxins 641 \\ntoxicity. However, nitrites are relatively contraindicated in hypotensive \\npatients with an uncertain exposure history and in victims of smoke \\ninhalation who may have concomitant carbon monoxide poisoning. The \\nlatter contraindication is due to reduced oxygen delivery from induced \\nmethemoglobinemia. In these instances, hydroxocobalamin is the ideal \\nantidote; however, sodium thiosulfate may also be used while omitting \\nthe use of nitrites from the cyanide antidote kit.\\n2. Consider activated charcoal in patients with a history of cyanide inges -\\ntion who present within 1 hour, are alert, and have a patent airway.\\n3. Admit patients receiving antidotal therapy or who may hav e ingested a \\nsubstance with the potential for delayed toxicity.\\n■ ■hYDROGEN SULFIDE\\nClinical Features\\nHydrogen sulfide is a colorless, flammable gas found in petroleum process-\\ning, as a byproduct of organic matter decomposition, and can be made from \\nhousehold products. The mechanism of toxicity is the same as cyanide, \\nexcept that the inhibition of oxidative phosphorylation quickly ceases when \\nremoved from exposure. A characteristic rotten egg’s odor is frequently \\ndescribed. Mucous membrane irritation is common, and with significant \\nTable 115-3 Treatment of Cyanide Poisoning in Children\\n100% oxygen\\nIV crystalloids and vasopressors for hypotension\\nSodium bicarbonate for acidemia\\nAND\\nCyanide antidote kit Amyl nitrite inhaler; crack vial and hold in front of nose \\nfor 15–30 s.*,†\\nSodium nitrite 3% solution: adjusted according to \\nhemoglobin level, given IV over no less than 5 min ‡ \\n(monitor methemoglobin level <30%)\\nhemoglobin (g/100 mL) Sodium Nitrite 3% Solution (mL/kg)\\n7 0.19\\n8 0.22\\n9 0.25\\n10 0.27\\n11 0.30\\n12 0.33\\n13 0.36\\n14 0.39\\nSodium thiosulfate 25% solution: 1.65 mL/kg IV.\\nRepeat sodium thiosulfate once at half dose (0.825 mL/kg) if symptoms persist.\\n*Not necessary if IV is in place.\\n†Consider withholding nitrites if suspected concomitant carbon monoxide poisoning.\\n‡Avoid nitrites in the presence of severe hypotension if diagnosis is unclear.\\n115_Cydulka_Ch115.indd   641 20/03/17   5:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 660, 'page_label': '642'}, page_content='642 SECTION 11: Toxicology and Pharmacology\\nexposure, rapid loss of consciousness, seizures, delayed pulmonary edema, \\ncorneal injury, and death may occur.\\nemergency Department Care and Disposition\\n1. Removal from the source of hydrogen sulf ide is the most important as-\\npect of care, followed by aggressive supportive care with humidified \\noxygen and decontamination.\\n2. Treat patients with persistent mental status changes or cardiovascular \\ninstability with sodium nitrite.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 204, “Industrial Toxins,” by Chip Gresham and Frank \\nLoVecchio\\n115_Cydulka_Ch115.indd   642 20/03/17   5:17 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 661, 'page_label': '643'}, page_content='643\\nVitamins and Herbals\\nJanna H. Villano\\nOver-the-counter vitamin and herbal preparations are widely used and con-\\nsidered innocuous by most of the public. Many of these products, however, \\ncan produce significant toxicity, especially if used in excess. In addition, \\nmany patients neglect to mention or are reluctant to divulge that they are \\ntaking these products.\\n■ ■CLINICAL FEATURES\\nHypervitaminosis most commonly occurs with supratherapeutic dosing, in \\npart due to lack of public awareness of the harms of excessive use. Inges-\\ntion of large doses of fat-soluble vitamins A, D, and E can produce subacute \\nor chronic toxicity. Water-soluble vitamins associated with toxicity include \\nniacin, pyridoxine, and vitamin C. Common symptoms of vitamin toxicities \\nare listed in Table 116-1.\\n116\\nC HA p TER\\nTable 116-1 Symptoms of Hypervitaminosis\\nVitamin Symptoms\\nVitamin A Subacute toxicity: red peeling rash, headache, vomiting\\nChronic toxicity: blurred vision, appetite loss, abnormal skin \\npigmentation, hair loss, dry skin, pruritus, long-bone pain, bone \\nfractures, rare cases of pseudotumor cerebri, hypercalcemia, and \\nhepatic failure\\nVitamin D Subacute toxicity: hypercalcemia, anorexia, nausea, abdominal pain, \\nlethargy, weight loss, polyuria, constipation, confusion, and coma\\nVitamin E Chronic toxicity: coagulopathy in patients on warfarin, nausea, \\nfatigue, headache, weakness, and blurred vision\\nVitamin K Acute toxicity: anaphylactoid reactions if given in parenteral  \\nform (rare)\\nVitamin B1 (thiamine) No toxicity observed with ingestion of large doses\\nVitamin B2 (riboflavin) No toxicity observed with ingestion of large doses\\nVitamin B3 (niacin) Acute toxicity: niacin flush, dose >100 mg, redness, burning, and \\nitching of the face, neck, and chest; rarely hypotension\\nChronic toxicity: doses >2000 mg/day, abnormalities of liver \\nfunction, impaired glucose tolerance, hyperuricemia, skin dryness, \\nand discoloration\\nVitamin B6 (pyridoxine) Subacute and chronic toxicity: doses >1–3 g/day orally or more \\nover several weeks, peripheral neuropathy with unstable gait, \\nnumbness of the feet, similar symptoms in the hands and arms, \\nmarked loss of position and vibration senses\\nVitamin B12 No toxicity observed with ingestion of large doses. With large IV \\ndoses: erythema of skin, mucous membranes, serum, and urine. \\nRare anaphylactoid reactions. Possible interference with serum \\ncolorimetric lab studies.\\n(Continued)\\n116_Cydulka_Ch116.indd   643 20/03/17   5:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 662, 'page_label': '644'}, page_content='644 SECTION 11: Toxicology and Pharmacology\\nMany popular herbal preparations hav e potential for serious toxicity \\nand medication interactions, despite being considered by many to be \\nnatural and safe alternatives to Western pharmaceuticals. Lack of regula-\\ntion of these products raises the potential for toxic contaminants that \\nmay independently cause acute poisoning. While generally safe, chamo-\\nmile, glucosamine, and Echinacea rarely cause anaphylaxis. Other com-\\nmonly used agents, their uses, and associated adverse events are listed in \\nTable 116-2.\\n(Continued)\\nTable 116-1 Symptoms of Hypervitaminosis\\nVitamin Symptoms\\nFolate No toxicity observed with ingestion of large doses. Masking of \\nmacrocytic anemia from vitamin B12 deficiency with large doses \\nof folate.\\nVitamin C (ascorbate) Chronic toxicity: nephrolithiasis (controversial), intrarenal \\ndeposition of oxalate crystals with renal failure; large doses can \\nproduce diarrhea and abdominal cramps.\\n(Continued)\\nTable 116-2 Commonly Used Herbal Agents and potential Adverse  \\nEffects\\nAgent General Use Adverse Effect\\nBlack cohosh† Menopause Nausea, vomiting, dizziness, weakness\\nChondroitin* Arthritis May cause GI upset\\nEphedra† Weight loss Hypertension; contraindicated for patients \\nwith hypertension, diabetes, or glaucoma\\nDrug interactions: monoamine oxidase \\ninhibitors, sympathomimetics\\nGarlic* Hypertension, colic, \\nhyperlipidemia\\nHypotension, rash, nausea, vomiting, \\ndiarrhea; death has been reported in massive \\ndoses in children\\nGingko* Dementia, vertigo, \\nperipheral arterial \\ndisease\\nMay inhibit platelet aggregation and increase \\nbleeding risk\\nMay cause GI upset\\nDrug interactions: aspirin, warfarin\\nGinseng* Impotence, fatigue, \\nulcers, stress\\nMay interact with warfarin\\nLowers blood glucose\\nMay cause insomnia, nervousness\\nJuniper† Diuretic Hallucinogenic; may also cause renal toxicity, \\nnausea, and vomiting\\nNutmeg† Dyspepsia, muscle \\naches, arthritis\\nHallucinations, GI upset, agitation, coma, \\nmiosis, and hypertension\\nPennyroyal† Rubefacient, delaying \\nmenses, abortifacient\\nHepatotoxicity\\nSt. John’s wort* Depression Phototoxicity\\nMay interact with serotonin reuptake \\ninhibitors; avoid tyramine-containing foods\\nMany drug interactions including cyclosporine \\n(transplant rejection), digoxin, indinavir\\n116_Cydulka_Ch116.indd   644 20/03/17   5:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 663, 'page_label': '645'}, page_content='CHAPTER 116: Vitamins and Herbals 645 \\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nDiagnosis is usually made clinically. A history of massive acute inges-\\ntion or chronic supratherapeutic use should be sought. Laboratory \\nstudies that may be helpful include a complete blood count, basic \\nmetabolic panel, hepatic enzymes, coagulation studies, bleeding time, \\ncreatine phosphokinase, toxicology screen, and urine pregnancy test. \\nAn ECG may be indicated if signs of sympathomimetic stimulation are \\npresent.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nBasic supportive care and discontinuation of the vitamin or herbal prepara-\\ntion are usually all that are needed to treat mild toxicity.\\n1. Consider activated charcoal 1 g/kg PO for large vitamin A or vitamin \\nD ingestions.\\n2. Treat hypercalcemia from vitamin A or D o verdose with normal saline, \\nloop diuretics, and corticosteroids (to reduce GI absorption). Refractory \\ncases may require adjunctive treatments, such as bisphosphonates and \\ncalcitonin.\\n3. Consider diagnostic and therapeutic lumbar puncture to treat idio-\\npathic intracranial hypertension (pseudotumor cerebri) from hypervi-\\ntaminosis A.\\n4. Administer diphenhydramine 25 to 50 mg IV (1 mg/kg in children) or \\nPO to patients with “niacin flush” symptoms.\\n5. Consider N-acetylcysteine 140 mg/kg PO or IV for treating se vere \\nhepatotoxicity from herbal preparations such as pennyroyal oil.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 205, “Vitamins and Herbals,” by Rick Tovar.\\nTable 116-2 Commonly Used Herbal Agents and potential Adverse  \\nEffects\\nAgent General Use Adverse Effect\\nWormwood \\n(Absinthe)†\\nDyspepsia Absinthism: restlessness, vertigo, tremor \\nparesthesias, delirium\\nYohimbine† Aphrodisiac Hallucinations, weakness, hypertension, \\nparalysis\\nDrug interactions: clonidine, cyclic \\nantidepressants\\n*Considered generally safe; rare adverse effects.\\n†Increased potential for toxicity, adverse effects more common.\\n(Continued)\\n116_Cydulka_Ch116.indd   645 20/03/17   5:31 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 664, 'page_label': '646'}, page_content='646\\nDyshemoglobinemias\\nChulathida Chomchai\\nDyshemoglobinemias result from the alteration of the hemoglobin mol-\\necule, which prevents it from carrying oxygen. Carboxyhemoglobin is \\ncreated following exposure to carbon monoxide, which is usually con-\\nsidered an environmental emergency and is discussed in Chapter 127. \\nTable 117-1 lists common pharmaceuticals capable of causing the for -\\nmation of methemoglobin.\\n■ ■CLINICAL FEATURES\\nMethemoglobinemia presents with grayish-brown discoloration of the skin \\nthat is recognized as cyanosis. Children up to the age of 4 months lack the \\nenzyme activity that normally reduces methemoglobin, thus making them \\nsusceptible to oxidant stress-induced methemoglobinemia. Three scenarios \\noccur with some frequency: children with acute gastroenteritis and \\nincreased nitrate production from bacteria in the GI tract; children exposed \\nto nitrates in water of agricultural areas where fertilizer runoff contaminates \\nwater sources; and overconsumption of nitrogenous vegetables such as \\nspinach.\\nIn drug-induced methemoglobinemia, the slate-gray to blue discolor -\\nation of the skin is apparent with levels of 10% to 15%. Symptoms occur \\nin proportion to declining oxygen delivery. Headache, nausea, and fatigue \\n117\\nCh A p TER\\nTable 117-1 Drugs Commonly Implicated in patients with Methemoglobinemia\\nOxidant Comments\\nAnalgesics\\nPhenazopyridine\\nPhenacetin\\nCommonly reported\\nRarely used\\nAntimicrobials\\nAntimalarials\\nDapsone\\nCommon\\nHydroxylamine metabolite formation is inhibited by \\ncimetidine\\nLocal anesthetics\\nBenzocaine\\nLidocaine\\nPrilocaine\\nDibucaine\\nMost commonly reported of the local anesthetics\\nRare\\nCommon in topical anesthetics\\nRare\\nNitrates/nitrites\\nAmyl nitrite\\nIsobutyl nitrite\\nSodium nitrite\\nAmmonium nitrae\\nSilver nitrate\\nWell water\\nNitroglycerin\\nCyanide antidote kit used to enhance sexual encounters\\nUsed to enhance sexual encounters\\nCyanide antidote kit\\nCold packs\\nExcessive topical use\\nProblem in infants, due to nitrate fertilizer runoff\\nRare\\nSulfonamides\\nSulfamethoxazole\\nUncommon\\n117_Cydulka_Ch117.indd   646 20/03/17   5:38 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 665, 'page_label': '647'}, page_content='CHAPTER 117: Dyshemoglobinemias 647 \\noccur at lower levels (20% to 30%). Le vels above 50% can cause loss of \\nconsciousness, myocardial ischemia, dysrhythmias, seizures, and metabolic \\nacidosis. Levels above 70% may be lethal. In patients with cardiopulmo-\\nnary disease in which there is impaired oxygen delivery, the symptoms will \\nbe manifested at lower methemoglobin levels.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe diagnosis of methemoglobinemia should be considered in patients \\npresenting with cyanosis that does not improve with administration of oxy-\\ngen. During venipuncture, blood may appear chocolate brown, a visible \\neffect that is easily identified when the blood is placed on filter paper with \\na normal patient’s blood for comparison. Levels are measured by co-\\noximetry on an arterial blood gas analyzer, with either an arterial or venous \\nsample. Standard pulse oximetry will give an erroneously high oxygen \\nsaturation level at approximately 85% and does not change despite admin-\\nistration of 100% oxygen. Pulse co-oximeters are available that can \\nnoninvasively measure both methemoglobin and carboxyhemoglobin.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nMethemoglobinemia should be treated initially with close monitoring \\nand high concentrations of inspired oxygen (Table 117-2). Methemoglo-\\nbinemia at levels above 25% and symptomatic patients with lower levels \\nshould be treated with methylene blue. The initial dose of methylene \\nblue is 1 to 2 mg/kg as a 10% solution IV , given over 15 minutes. Clinical \\nimprovement should occur within 20 minutes, after which the dose may  \\nbe repeated if improvement has not occurred. Failure to respond to a \\nsecond dose is usually due to one of five causes (in order or likelihood \\nof occurrence):\\n1. Glucose-6-phosphate dehydrogenase deficiency (G6PD): Consider  \\ntransfusion of packed red blood cells for severely elevated methemoglo-\\nbin levels in patients with suspected G6PD deficiency.\\n2. Dapsone: Compounds with long half-life, such as dapsone, can produce \\nprolonged oxidative stress. Acti vated charcoal should be given. Treat \\ndapsone-induced methemoglobinemia with a repeated dose of methy-\\nlene blue; consider the addition of IV cimetidine to impede the metabo-\\nlism of dapsone to its oxidant metabolite, hydroxylamine.\\nTable 117-2 Management of Methemoglobinemia\\nAssess airway, breathing, and circulation\\nPlace an IV line\\nAdminister oxygen\\nAttach the patient to a cardiac and pulse oximetry monitor\\nObtain an ECG\\nDecontaminate the patient as needed\\nAdminister methylene blue—if symptomatic or methemoglobin >25%\\nConsider: cimetidine for patients taking dapsone\\n117_Cydulka_Ch117.indd   647 20/03/17   5:38 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 666, 'page_label': '648'}, page_content='648 SECTION 11: Toxicology and Pharmacology\\n3. NADPH-methemoglobin reductase deficiency: Patients with congenital \\nabsence of this enzyme are not chronically cyanotic, nor do they have \\nresting methemoglobin levels above normal. However, they lack the \\nability to convert methylene blue to its active metabolite. As with G6PD \\ndeficiency, consider packed red cell or exchange transfusions for severe \\ncases, especially those with hemolysis.\\n4. Methylene blue-induced hemolysis: Paradoxically, meth ylene blue can \\nbe a source of oxidant stress. Methylene blue doses, therefore, should \\nnot exceed 7 mg/kg/d.\\n5. Sulfhemoglobinemia: This rare drug-induced dyshemoglobinemia can \\noccur with sulfur -containing pharmaceuticals and phenacetin. Patients \\nappear cyanotic at sulfhemoglobin levels of 5%, and pulse oximetry may \\nread in the 70% to 80% range, but are rarely symptomatic. Treat sulfhe-\\nmoglobinemia with supplement oxygen.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 207, “Dyshemoglobinemias,” by Brenna M. Farmer \\nand Lewis S. Nelson.\\n117_Cydulka_Ch117.indd   648 20/03/17   5:38 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 667, 'page_label': '649'}, page_content='649\\n12\\nSECTION\\nEnvironmental Injuries\\nCold Injuries\\nGerald (Wook) Beltran\\n■ ■NONFREEZING COLD INJURIES\\nTrench foot is a direct soft tissue injury that results from prolonged exposure \\nto nonfreezing cold and moisture. The foot is initially pale, mottled, pulse-\\nless, and anesthetic and does not improve quickly with rewarming. Several \\nhours after rewarming, the foot becomes hyperemic and painful as perfusion \\nreturns after 2 to 3 days. Bullae and edema are late findings. Anesthesia may \\npersist for weeks or even permanently. Hyperhidrosis and sensitivity to cold \\nare late features and may last for months to years. Chilblains (pernio) are \\npainful inflammatory lesions typically affecting the ears, hands, and feet \\ncaused by chronic exposure to intermittent damp, nonfreezing conditions. \\nLocalized edema, erythema, and cyanosis appear up to 12 hours after the \\nexposure and are accompanied by pruritis and burning paresthesias. Tender \\nblue nodules may form after rewarming and can persist for several days. \\nTreatment of trench foot and chilblains includes drying, elevation, warming, \\nand bandaging of the affected body part. With chilblains, add nifedipine  \\n20 mg PO three times daily, pentoxifyline 400 mg PO three times daily, or \\nlimaprost 20 μ g PO three times daily, as well as topical corticosteroids, \\nsuch as 0.025% fluocinolone cream.\\n■ ■FROSTBITE\\nClinical Features\\nFreezing of tissue causes frostbite. Patients initially complain of stinging, \\nburning, and numbness. Frostbite injuries are classified by the depth of \\ninjury and amount of tissue damage based on appearance after rewarming. \\nFirst-degree frostbite (frostnip) is characterized by partial thickness skin \\nfreezing, erythema, edema, lack of blistering, and no tissue loss. Second-\\ndegree frostbite is characterized by deeper, full-thickness skin freezing and \\nresults in the formation of clear bullae. The patient complains of numbness, \\nfollowed by aching and throbbing. Deep cold injury or third-degree frostbite \\ninvolves freezing of the skin and subdermal plexus leading to hemorrhagic \\nbullae and skin necrosis. Fourth-degree frostbite extends into muscle, \\n118\\nChap TER\\n118_Cydulka_Ch118.indd   649 22/04/17   4:39 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 668, 'page_label': '650'}, page_content='650 SECTION 12: Environmental Injuries\\ntendon, and bone with mottled skin, nonblanching cyanosis, and eventual  \\ndry, black, mummified eschar formation. Early injuries are better classified \\nas superficial or deep because it is difficult to initially evaluate the depth of \\ninjury. Laboratory testing and imaging are not needed to diagnose frostbite.\\nTreatment\\n1. Provide rapid rewarming in circulating water at 37°C to 39°C (98.6°F \\nto 102.2°F) for 20 to 30 minutes until tissue is pliable and erythematous.\\n2. Debridement of clear blisters and aspiration of hemorrhagic blisters are \\ncontroversial. Consult with a surgeon for local preference.\\n3. Apply topical aloe vera every 6 hours.\\n4. Provide pain management, local wound care, and dressing. Splint and \\nelevate the affected extremities. Patients may require parenteral opioids \\ninitially, followed by oral NSAIDs.\\n5. Provide tetanus immunoprophylaxis, if needed.\\n6. Patients with superficial, local frostbite may be discharged home with \\nclose follow-up arranged.\\n7. Patients with deeper injuries require admission for ongoing care.\\n8. The use of prophylactic bacitracin ointment, antibiotics, and silver  \\nsulfadiazine is controversial.\\n■ ■hYpOThERMIa\\nHypothermia, a core body temperature of <35°C (<95°F), results from \\nheat loss through conduction, convection, radiation, or evaporation.\\nClinical Features\\nThe features of hypothermia represent a continuum. Mild hypothermia (32°C \\nto 35°C [90°F to 95°F]) can present with tachycardia, tachypnea, hyperten-\\nsion, shivering, and a normal level of consciousness. As core temperatures \\nfall below 32°C (90°F), shivering ceases and heart rate and blood pressure \\ndecrease. As temperature decreases further, patients become confused, \\nlethargic, and then comatose. Pupillary reflexes are lost. Respiratory rate \\ndecreases, gag and cough reflexes are diminished, and bronchorrhea occurs. \\nAspiration is common. Impaired renal concentration results in a cold diuresis \\nand hemoconcentration. The cardiac effects of worsening hypothermia  \\nprogress from sinus bradycardia, to atrial fibrillation with slow ventricular \\nresponse, to ventricular fibrillation, to asystole. At temperatures <32°C (<90°F), \\nthe risk for dysrhythmias increases. As core body temperature falls below 28°C \\n(below 82°F), the risk for cardiac arrest increases as the potential for  \\nmalignant cardiac dysrhythmias become more pronounced.\\nDiagnosis and Differential\\nThe diagnosis of hypothermia is based on core temperature and may not be \\ninitially obvious, especially in cases where a history of prolonged environ-\\nmental exposure is missing. Low-reading thermometers are required to \\nmeasure and monitor temperature. Along with the history and physical exam, \\nlaboratory investigation is directed at determining the underlying cause and \\ncomplications. Helpful laboratory studies may include glucose, complete \\nblood count (CBC), electrolytes, thyroid-stimulating hormone, random \\n118_Cydulka_Ch118.indd   650 22/04/17   4:39 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 669, 'page_label': '651'}, page_content='CHAPTER 118: Cold Injuries 651 \\ncortisol level, clotting profile, lactic acid, lipase, creatinine, blood g as, and \\nelectrocardiogram (ECG). Acid-base disorders are common, but do not follow \\na predictable pattern. Intravascular thrombosis, embolism, and disseminated \\nintravascular coagulation (DIC) may occur. Electrocardiographic changes \\ninclude PR, QRS, and QT prolongations, T-wave inversion, and a slow positive \\ndeflection at the end of the QRS (Osborn J wave). In addition to environmen-\\ntal exposure, causes of hypothermia include hypoglycemia, hypothyroidism, \\nhypoadrenalism, hypopituitarism, central nervous system (CNS) dysfunction, \\ndrug intoxication, sepsis, and dermal disease.\\nEmergency Department Care and Disposition\\n1. Place patient in a warm environment. Initiate continuous monitoring of vital \\nsigns, pulse oximetry, and core temperature (rectal, bladder, or esophageal \\nthermometer). Indications for intubation are similar to those for normother-\\nmic patients. Initiate warmed intravenous fluids titrated to a rate based on \\nthe patient’s volume status. Remove wet clothing, dry, and cover patients.\\n2. Handle patients gently to avoid precipitation of a lethal dysrhythmia.\\n3. Attempt to palpate a pulse and detect respirations for 30 to 45 seconds. \\nIf none is detected, initiate cardiopulmonary resuscitation (CPR). Alter-\\nnatively, use bedside ultrasonography to help determine cardiovascular \\nstatus and need for CPR.\\n4. Sinus bradycardia, atrial fibrillation, and atrial flutter usually require no \\ntherapy and will resolve with rewarming. Ventricular fibrillation is typically \\nrefractory to therapy until the patient is rewarmed, although the American \\nHeart Association guidelines do recommend a single defibrillation attempt.\\n5. Rewarming techniques include passiv e rewarming, active external \\nrewarming, and active core rewarming (Table 118-1). Choice of technique \\ndepends primarily on cardiovascular status. Temperature is a secondary \\nTablE 118-1 Staging and Treatment of accidental hypothermia\\nStage Clinical Symptoms\\nTypical Core \\nTemperature Treatment\\nMild \\n(HT I)\\nConscious, shivering 35–32°C Warm environment and clothing, \\nwarm sweet drinks, and active \\nmovement (if possible)\\nHT I patients with significant trauma \\nor comorbidities or those suspected \\nof secondary hypothermia should \\nreceive HT II treatment\\nModerate \\n(HT II)\\nImpaired conscious-\\nness* (may or may \\nnot be shivering)\\n<32–28°C Active external and minimally inva-\\nsive rewarming techniques (warm \\nenvironment; chemical, electrical, or \\nforced air heating packs or blankets; \\nwarm parenteral fluids)\\nCardiac and core temperature \\nmonitoring\\nMinimal and cautious movements to \\navoid arrhythmias\\nFull-body insulation, horizontal \\nposition, and immobilization\\n(Continued)\\n118_Cydulka_Ch118.indd   651 22/04/17   4:39 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 670, 'page_label': '652'}, page_content='652 SECTION 12: Environmental Injuries\\nconsideration. Patients with a stable cardiovascular status (including  \\nsinus bradycardia and atrial fibrillation) and temperature above 30°C \\n(above 90°F) may be passively rewarmed. All patients with cardiovascular \\ninstability require rapid core rewarming; extracorporeal circuit rewarming \\n(e.g., extracorporeal membrane oxygenation or cardiopulmonary bypass) \\nis the technique of choice for these patients. Invasive rapid core  \\nrewarming in patients without cardiac instability is controversial.\\n6. Continue resuscitative efforts until the core temperature reaches   \\n32°C (90°F).\\n7. Address and treat underlying causes (e.g., dextrose 50 mL IV for  \\nhypoglycemia; treat suspected hypothyroidism and hypoadrenalism \\nwith hormone replacement).\\n8. Admit all patients with symptomatic hypothermia or with hypothermia \\nsecondary to an underlying condition. Healthy patients with mild en vi-\\nronmental hypothermia that resolves quickly may be discharged home if \\nsocial circumstances allow (Fig. 118-1).\\nTablE 118-1 Staging and Treatment of accidental hypothermia\\nStage Clinical Symptoms\\nTypical Core \\nTemperature Treatment\\nSevere \\n(HT III)\\nUnconscious,* vital \\nsigns present\\n<28°C HT II management plus:\\nAirway management as required\\nPreference to treat in an ECMO/CPB \\ncenter, if available, due to the high \\nrisk of cardiac arrest\\nConsider ECMO/CPB in cases with \\ncardiac instability that is refractory \\nto medical management\\nConsider ECMO/CPB for comorbid \\npatients who are unlikely to tolerate \\nthe low cardiac output associated \\nwith HT III\\nHT IV Vital signs absent Cardiac arrest \\nis possible \\nbelow 32°C; the \\nrisk increases \\nsubstantially \\nbelow 28°C and \\ncontinues to \\nincrease with \\nongoing cooling\\nCPR and up to three doses of \\nepinephrine and defibrillation (further \\ndosing guided by clinical response)\\nAirway management\\nTransport to ECMO/CPB†\\nPrevent further heat loss (insulation, \\nwarm environment, do not apply \\nheat to head)\\nActive external and minimally invasive \\nrewarming (see HT II) during transport \\nis recommended but controversial; do \\nnot apply heat to head\\nAbbreviations: CPB, cardiopulmonary bypass; CPR, cardiopulmonary resuscitation; ECMO, extracorporeal \\nmembrane oxygenation; HT, hypothermia.\\n*Consciousness may be impaired by comorbid illness (e.g., trauma, CNS pathology, toxic ingestion)  \\nindependent of core temperature.\\n†Transfering an HT IV patient to an ECMO/CPB center may reduce mortality by 40% to 90% (number \\nneeded to treat, approximately 2); if ECMO/CPB is not available within a few hours of transport,  \\nconsider on-site rewarming with hot packs or forced air blankets, warm IV fluid, ± warm thoracic \\nlavage, ± warm bladder lavage, and ± warm peritoneal lavage; do not apply heat to the head.\\n(Continued)\\n118_Cydulka_Ch118.indd   652 22/04/17   4:39 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 671, 'page_label': '653'}, page_content='CHAPTER 118: Cold Injuries 653 \\nFIgurE 118 -1. Transport and management of accidental hypothermia. CPB,  \\ncardiopulmonary bypass; DNR, do not resuscitate; ECMO, extracorporeal  \\nmembrane oxygenation; HT, hypothermia; ROSC, return of spontaneous circulation; \\nSBP , systolic blood pressure. Used with permission from Doug Brown, MD, FRCPC.\\nPatient’s trunk feels cold on examination or core temperature <35°C?\\nVital signs present\\nConsider\\ntermination\\nof CPR \\nCardiac arrest from alternate\\ncause prior to cooling \\nMajor trauma\\nWitnessed normothermic\\narrest\\nAvalanche burial <35 min\\nTransport to\\nnearest\\nappropriate\\nhospital or\\nmanage as per\\nsupervising MD\\nConsider tests to confirm\\nneed for ECMO/CPB \\nCore temperature <32°C\\nSerum potassium <12 mmol/L \\nPrehospital cardiac\\ninstability \\nSBP <90 mm Hg\\nVentricular arrhythmias\\nCore temperature <28°C\\nTransport to\\nnearest\\nappropriate\\nhospita l\\nTrauma\\nComorbidities\\nSuspected secondary\\n hypothermia \\nYesN o\\nYesNo\\nNo to allY es to any\\nNo to allY es to any\\nHT I, II, or III\\nActive external and\\n minimally invasive\\n rewarming (insulation,\\n hot packs, or forced air\\n blankets, warm IV fluid,\\n allow shivering)\\nMinimal and cautious\\n movements to avoid\\n arrhythmias\\nAirway management\\n if required    \\nStart CPR; do not delay\\n  transport\\nPrevent further heat loss \\nAirway management\\n  and up to 3 doses of\\n  medication/defibrillation\\nHT IV\\nDo NOT terminate CPR\\nTransport to ECMO\\nPrevent further heat loss\\n(insulation, warm environment,\\n do not apply heat to head)\\nActive external and minimall y\\ninvasive rewarming during\\ntransport is recommended\\nbut controversial; do not\\napply heat to head      \\nIf ECMO not available within\\n   6 h consider on-site\\n   rewarming with hot packs or\\n   forced air blankets, warm IVF\\n   ± warm thoracic lavage,\\n   ± warm bladder lavage ,\\ndo not apply heat to head\\nRewarm to ≥32 °C   \\nHT I\\nWarm environment\\n and clothing\\nWarm sweet drinks\\nActive movement \\nNo to allY es to anyN o to allY es to any\\nConsider\\ntermination\\nof CPR Prepare for multiorgan\\n failure and need for ECMO\\n respiratory support\\nProvide postarrest\\n management\\nConsider targeted\\n temperature management\\nYes to allN o to any\\nNo ROSC\\nROSC\\nTransport to\\nECMO\\nhospital\\nObvious signs of irreversible death\\nValid DNR order\\nConditions unsafe for rescuer\\nAvalanche burial >35 min\\n   and airway packed with snow \\nImpaired\\nconsciousness\\n118_Cydulka_Ch118.indd   653 22/04/17   4:39 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 672, 'page_label': '654'}, page_content='654 SECTION 12: Environmental Injuries\\n■ ■FURThER REaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 208, “Cold Injuries,” by Michael T. Paddock; \\nChapter 209, “Hypothermia,” by Doug Brown.\\n118_Cydulka_Ch118.indd   654 22/04/17   4:39 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 673, 'page_label': '655'}, page_content='655\\nHeat Emergencies\\nEric Kraska\\nHeat-related illness is a spectrum of disease ranging from minor heat disor-\\nders, such as prickly heat and heat cramps, to severe heat imbalance that \\nresults in life-threatening heat stroke.\\n■ ■CLINICAL FEATURES\\nMalignant Heat Illnesses\\nHeat stroke develops in the setting of unmitigated heat imbalance. The \\ncardinal features are hyperthermia (core temperature > 40°C [104°F]) \\nand end-organ injury. Height of the temperature and duration of heat \\nexposure dictate degree of injury. Neural tissue, hepatocytes, nephrons, \\nand vascular endothelium are most sensitive to heat stress. Prominent \\nneurologic abnormalities include confusion, agitation, bizarre behavior, \\nataxia, seizures, and coma. Other bedside findings include hyperventila-\\ntion, vomiting, diarrhea, and oliguria. Anhidrosis or profuse sweating \\nmay be seen. When coagulopathy/DIC develops, patients may have \\npurpura, hemoptysis, or GI bleeding.\\nHeat stroke is further classified as exertional and nonexertional. Physi-\\ncal activity during high heat/humidity produces exertional heat stroke. \\nEvaporation is the principal mechanism of heat loss, but is ineffective when \\nhumidity exceeds 75%. Nonexertional heat stoke is seen in the debilitated, \\nchronically ill, and persons who are otherwise unable to escape from hot \\nenvironments (e.g., closed vehicles, heavily bundled in crib, or isolated in \\na hot residence).\\nMinor Heat Illnesses\\nHeat syncope results from volume depletion, peripheral vasodilation, and \\ndecreased vasomotor tone. It occurs most commonly in the elderly and \\npoorly acclimatized individuals. Postural vital signs may or may not be \\ndemonstrable on presentation to the emergency department. Exclude other \\ncauses of syncope.\\nHeat cramps are characterized by painful muscle spasms, especially in \\nthe calves, thighs, and shoulders during athletic events. They usually occur \\nwhen individuals replace evaporative losses with free water but not with \\nsalt. Core body temperature may be normal or elevated.\\nHeat edema and heat rash are usually self-limited symptoms during the \\nfirst few days of heat exposure and are characterized by swelling of depen-\\ndent extremities (e.g., hands and feet) or rash found commonly over clothed \\nareas of the body.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe differential diagnosis includes infection (e.g., sepsis, meningitis, \\nencephalitis, malaria, typhoid, tetanus), endocrine disorders (e.g., diabetic \\nketoacidosis, thyroid storm), neurologic disorders (e.g., cerebrovascular \\n119\\nCh A p TER\\n119_Cydulka_Ch119.indd   655 20/03/17   5:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 674, 'page_label': '656'}, page_content='656 SECTION 12: Environmental Injuries\\naccident, status epilepticus), and toxicologic causes (e.g., amphetamines for \\nADHD, dietary supplements, anticholinergics, sympathomimetics, salicy-\\nlates, serotonin syndrome, malignant hyperthermia, neuroleptic malignant \\nsyndrome, alcohol or benzodiazepine withdrawal).\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nMalignant Heat Illnesses\\nAcute care requires accurate identification of hyperthermia with end-organ \\ninjury and rapid mitigation of the heat imbalance. Initial diagnostic studies \\nare directed at detecting end-organ damage and excluding other disease \\nprocesses. Early laboratory abnormalities associated with heat stroke \\ninclude hypoglycemia, hypophosphatemia, hypokalemia, elevated liver \\nenzymes, hypercalcemia, elevated hematocrit along with elevated creatine \\nphosphokinase and myoglobin from rhabdomyolysis. Laboratory abnor -\\nmalities of DIC and renal failure may develop with time. Obtain an EKG \\nand CXR. Neuroimaging studies and other evaluations (e.g., septic workup, \\ntoxicology screens) can be individualized as clinically indicated.\\n1. Supportive care is required for airway , breathing, and circulation. Intu-\\nbate patients with significantly altered mental status, diminished gag \\nreflex, or hypoxia. Continuously monitor vital signs and core tempera-\\nture (rectal, bladder, or esophageal thermometer). Provide high flow \\noxygen and begin IV crystalloids to maintain mean arterial pressure \\nabove 80 to 90 mm Hg. Avoid volume overload. Vasopressors may be \\nrequired.\\n2. Initiate rapid cooling until core temperature reaches 38°C (100.4°F). \\nExternal cooling is most effective. Place patient on cooling blanket, wet \\nskin and dry with fan to optimize evaporative cooling, and place ice \\npacks to the groin/axilla/neck. Cold water immersion is effective, but not \\npractical. Internal cooling measures include infusing room temperature \\nIVF, central catheter heat exchange methods, and in extreme cases, car-\\ndiopulmonary bypass. Gastric, rectal, and bladder lavage are unlikely to \\nbe more effective than external cooling measures (Table 119-1).\\n3. Seizures and excessive shi vering can be treated with benzodiazepines, \\nsuch as lorazepam 1 to 2 mg IV or diazepam 5 mg IV .\\n4. Treat rhabdomyolysis with IV hydration. To date, no prospective control \\nstudies have shown improved outcomes from alkalinization of the urine \\nor forced diuresis with mannitol or loop diuretics.\\n5. Monitor serum electrolytes every hour initially. Treat hyperkalemia and \\nDIC with standard regimens.\\n6. Antipyretics (e.g., acetaminophen, ibuprofen, and dantrolene) are inef-\\nfective and should not be used.\\n7. Most heat stroke patients require admission to the ICU.\\nMinor Heat Illnesses\\nSymptoms usually resolve independent of treatment and patients are typi-\\ncally discharged home. Heat edema treatment consists of elevation of the \\nextremities or compressive stockings. Diuretics may exacerbate volume \\ndepletion and should be avoided. Heat rash may improve with antihistamines, \\n119_Cydulka_Ch119.indd   656 20/03/17   5:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 675, 'page_label': '657'}, page_content='CHAPTER 119: Heat Emergencies 657 \\nlow-potency topical corticosteroids, or calamine lotion. Advise patients to \\nwear light, loose fitting clothing. Treatment of heat syncope and heat \\ncramps consists of rest and oral or IV rehydration.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 210, “Heat Emergencies,” by Frank LoVecchio.\\nTablE 119-1 Summary of Cooling Techniques\\nCooling Method Advantages Disadvantages Recommendations\\nEvaporative \\ncooling\\nProvides effective \\ncooling\\nCan cause shivering Strongly recommended\\nReadily available Less effective in humid \\nenvironments\\nPractical Makes it difficult to \\nmaintain electrode  \\npositionsWell tolerated\\nImmersion cooling Provides effective \\ncooling\\nCan cause shivering Recommended\\nPoorly tolerated\\nNot compatible with \\nresuscitation settings\\nIce packs on neck, \\naxillae, and groin\\nPractical Cooling times longer \\nthan other modalities\\nCan be used as adjunct \\ncooling method\\nCan be added \\nto other cooling \\nmethods\\nPoorly tolerated\\nCardiopulmonary \\nbypass\\nProvides fast and \\neffective cooling\\nInvasive Recommended in \\nsevere or resistant \\ncases when availableNot readily available\\nSetup is labor intensive\\nCooling blankets Easy to apply Have limited cooling \\nefficacy\\nNot recommended \\nwhen other methods \\navailableImpede use of other \\ncooling methods\\nCold water \\ngastric, urinary \\nbladder, rectal, or \\nperitoneal lavage\\n– Invasive Effectiveness and \\nsafety not establishedLabor intensive\\nMay lead to water \\nintoxication\\nHuman experience is \\nlimited\\n119_Cydulka_Ch119.indd   657 20/03/17   5:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 676, 'page_label': '658'}, page_content='658\\nBites and Stings\\nMichael Levine\\n■ ■WASPS, BEES, AND STINGING ANTS (HYMENOPTERA)\\nWasps, bees, and stinging ants are members of the order Hymenoptera. \\nLocal and generalized reactions may occur in response to an encounter. \\nSystemic toxicity may result from an allergic reaction or from massive \\nenvenomation as occurs classically with the so-called Africanized bees, \\nwhich often attack in large numbers. Fire ant venom may cross-react in \\nindividuals sensitized to other Hymenoptera stings.\\nClinical Features\\nLocal reactions consist of pain, erythema, edema, and pruritus at the sting \\nsite. Severe local reactions may increase the likelihood of serious systemic \\nreactions if the patient is reexposed. The local reaction to a fire ant sting \\nconsists of a sterile pustule that evolves over 6 to 24 hours, sometimes \\nresulting in necrosis and scarring. Systemic reactions may include urticaria, \\nangioedema, hypotension, and bronchospasm. In addition, those with mas-\\nsive envenomation may develop severe vomiting, diarrhea, rhabdomyolysis, \\nmyocardial injury, hepatic failure, and renal failure. Delayed reactions, \\nwhich manifest 5 to 14 days post-envenomation, infrequently occur, but \\nresemble serum sickness. Such illness is characterized by fever, malaise, \\nheadache, urticaria, lymphadenopathy, and polyarthritis.\\nEmergency Department Care and Disposition\\n1. In addition to fluid resuscitation, patients with anaphylactic or anaphy-\\nlactoid reactions should receive the following:\\na. Epinephrine 1:1000 concentration (0.3 to 0.5 cc IM in adults or 0.01 \\nmg/kg up to a maximal dose of 0.5 cc in pediatrics). Patients whose \\nsymptoms persist despite IM epinephrine or those with evidence of \\nshock should receive IV epinephrine as a continuous infusion.\\nb. Endotracheal intubation should be performed if needed for airway \\nedema.\\nc. Steroids, such as methylprednisolone  2 mg/kg, with a maximal \\nsingle dose of 125 mg, or prednisone 1 mg/kg orally, with a maximal \\nsingle dose of 60 mg.\\nd. H1 antagonists, such as diphenhydramine 1 mg/kg IV with a maxi-\\nmal single dose of 50 mg.\\ne. H2 receptor antagonists, such as famotidine 0.5 mg/kg IV with a \\nmaximal dose of 40 mg.\\nf. Bronchospasm should be treated with beta agonists, such as alb-\\nuterol 2.5 to 5 mg via nebulization.\\n2. Patients with urticaria, b ut no other systemic manifestations, should be \\ntreated with H1 and H2 blockers and steroids, but without epinephrine or \\nalbuterol.\\n3. The stinger should be removed after the patient has been stabilized.\\n120\\nC HAPTER\\n120_Cydulka_Ch120.indd   658 20/03/17   5:59 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 677, 'page_label': '659'}, page_content='CHAPTER 120: Bites and Stings 659 \\n4. Patients with a single sting who have only minor symptoms can be dis -\\ncharged home after a period of observation.\\n5. For patients with multiple stings, disposition is as follows:\\na. Admit if more than 100 stings, substantial comorbidities, extremes of \\nage, or severe systemic manifestations\\nb. Patients with < 100 stings, and who remain asymptomatic without \\nlaboratory evidence of complications (e.g., no rhabdomyolysis and \\nnormal renal function) following an observation period of 6 hours \\ncan be discharged from the Emergency Department.\\n6. Refer all patients with Hymenoptera reactions to an allergist for further \\nevaluation, prescribe a premeasured epinephrine injector (EpiPen®), and \\nadvise them to carry allergy alert identification. Instruct patients to use \\nepinephrine at the first sign of a systemic reaction.\\n■ ■BROWN RECLUSE SPIDER (LoxosceLes recLusa)\\nClinical Features\\nThe initial L. reclusa bite is painless. It evolves into a firm erythematous \\nlesion that heals over several days to weeks. Occasionally, a severe reaction \\nwith immediate pain, hemorrhagic blister formation, and local blanching \\nmay occur. These lesions often become necrotic over the next 3 to 4 days \\nand form significant eschars. Loxoscelism is a common systemic reaction \\nfollowing the bite of some South American Loxosceles species, but occurs \\ninfrequently following the bite of L. reclusa. Systemic symptoms, which are \\nmore common in children, typically occur 1 to 3 days post-envenomation, \\nand are characterized by fever, chills, vomiting, arthralgias, myalgias, pete-\\nchiae, and hemolysis. Severe cases progress to seizures, renal failure, \\n disseminated intravascular coagulation, and death.\\nDiagnosis and Differential\\nLoxosceles species are distinguished by three sets of paired e yes; most \\nother spiders have eight eyes in two rows. A pigmented, violin-shaped pat-\\ntern on the cephalothorax of the brown recluse is characteristic but unreli-\\nable. The diagnosis of L. reclusa envenomation is commonly clinical since \\nthe bite is rarely witnessed. Assays to confirm L. reclusa poisoning are not \\nclinically available. Patients with significant envenomation may exhibit \\nhemolysis, coagulopathy, or abnormal renal function. Local abscesses are \\nfrequently misdiagnosed as Loxosceles envenomation\\nEmergency Department Care and Disposition\\n1. Treatment of a brown recluse spider bite includes supportiv e measures, \\nsuch as pain medication, tetanus prophylaxis, and antibiotics if infection \\nis present. In the United States, antivenom is not commercially available \\nand is usually not needed.\\n2. Most wounds heal without intervention. Dapsone, which was once ad -\\nvocated for treatment of these envenomations, has not been clearly \\nproven to be beneficial. Due to the risk of significant adverse events and \\nthe lack of proven efficacy, its use in this setting is not recommended. \\nArrange serial wound evaluations for outpatients.\\n120_Cydulka_Ch120.indd   659 20/03/17   5:59 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 678, 'page_label': '660'}, page_content='660 SECTION 12: Environmental Injuries\\n3. Patients with systemic reactions and hemolysis should be hospitalized.\\n4. Surgery is reserved for lesions larger than 2 cm and is deferred for 2 to \\n3 weeks after the bite.\\n■ ■HOBO SPIDER (TeGeNarIa aGresTIs)\\nThe hobo spider, also known as the Northwestern brown spider, causes \\nclinical signs and symptoms that are similar to those of the brown recluse \\nspider bite. The skin site is initially painless before developing induration, \\nerythema, blistering, and necrosis. Patients may experience headache, vom-\\niting, and fatigue. There is no specific diagnostic test or therapeutic inter -\\nvention for hobo spider bites. Surgical repair for severe ulcerative lesions is \\ndelayed until the necrotizing process is complete.\\n■ ■BLACK WIDOW SPIDER (LaTrodecTus macTaNs)\\nClinical Features\\nBlack widow spider bites induce an immediate pinprick sensation that may \\nquickly spread to the entire extremity. Erythema at the site appears within \\n1 hour and often forms a “target” lesion. Systemic manifestations may \\ninclude diffuse myalgias, especially involving the larger muscle groups, \\nincluding the back, abdomen, and trunk. Severe pain may wax and wane for \\nseveral days. Other signs and symptoms include hypertension, tachycardia, \\nmuscle fasciculations, headache, nausea, vomiting, and diaphoresis. The \\nfasciculations and diaphoresis may be localized or diffuse. Serious, albeit \\nrare, acute complications include myocarditis, priapism, and dyspnea.\\nEmergency Department Care and Disposition\\n1. Initial therapy includes local wound treatment and supportive care. Lib-\\neral dosing of analgesics and benzodiazepines will relieve pain and \\ncramping.\\n2. Lacrodectus antivenom, derived from horse serum, is rapidly effective \\nfor severe envenomation even when the presentation is delayed. Fatal \\ncases of anaphylaxis have been described with this therapy, and its use \\nshould be reserved for severe cases refractory to opioid analgesics and \\nbenzodiazepines. The package insert provides dosing instructions.\\n3. Patients receiving antivenom may be discharged after a short observa-\\ntion period if symptoms of envenomation resolve.\\n■ ■TARANTULAS\\nWhen threatened, tarantulas may flick barbed hairs into their victim. \\nAlthough North American tarantula hairs rarely penetrate human skin, they \\ncan embed deeply into the conjunctiva and cornea and cause an inflamma-\\ntory response. Any patient complaining of ocular symptoms after exposure \\nto a tarantula should undergo a thorough slit lamp examination to search for \\nembedded hairs. Treatment includes topical steroids and consultation with \\nan ophthalmologist for surgical removal of the hairs.\\nTarantula bites may also occur. They are painful, and cause local ery-\\nthema and edema. Provide local wound care and analgesia.\\n120_Cydulka_Ch120.indd   660 20/03/17   5:59 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 679, 'page_label': '661'}, page_content='CHAPTER 120: Bites and Stings 661 \\n■ ■SCORPION (SCORPIONIDA)\\nClinical Features\\nAlthough highly toxic species are found in the Caribbean, Asia, and Africa, \\nthe only North American scorpion that produces systemic toxicity is the \\nbark scorpion (Centruroides sculpturatus). Venom from C. sculpturatus \\ncauses immediate pain and paresthesia. A positive “tap test” (exquisite local \\ntenderness when the area is lightly tapped) may be seen. Systemic effects \\nare relatively infrequent and occur mainly in children. Systemic manifesta-\\ntions include diffuse motor involvement and/or cranial nerve dysfunction, \\nthe latter of which may result in roving eye movements, diplopia, and dif-\\nficulty swallowing. Systemic symptoms may last 24 to 48 hours without \\nantivenom therapy.\\nEmergency Department Care and Disposition\\n1. Most patients require only oral analgesics and/or benzodiazepines.\\n2. Patients with systemic manifestations may require IV benzodiazepines \\nand opiates.\\n3. While uncommon, patients with significant hypersali vation and stridor \\nmay warrant endotracheal intubation. Atropine has been used to help with \\nsecretions, although data supporting its use for this purpose are lacking.\\n4. A F(ab) equine antivenom  is available and highly effective for those \\npatients with high-grade, systemic toxicity.\\n5. Patients without systemic symptoms may be observed briefly and dis-\\ncharged with analgesics.\\n■ ■SCABIES (sarcoPTes scaBIeI)\\nClinical Features\\nScabies bites are often concentrated in the web spaces between fingers and \\ntoes. Other common areas include the axilla and genital area, children’s faces \\nand scalps, and the female nipple. Transmission is typically by direct contact. \\nThe distinctive feature of scabies infestation is intense pruritus with “bur -\\nrows.” The female mite is easily scraped out with a blade edge. Associated \\nvesicles, papules, crusts, and eczematization may obscure the diagnosis.\\nEmergency Department Care and Disposition\\nAdvise patients to apply permethrin cream from the neck down; infants \\nmay require additional application to the scalp, temple, and forehead. The \\npatient should bathe before application, apply the medication, and then \\nbathe again in 12 hours. Reapplication is necessary only if mites are found \\n2 weeks after treatment, although the pruritus may last for several weeks \\nafter successful therapy. Ivermectin, 200 μg/kg PO, followed by a second \\ndose in 10 days, is an alternative treatment.\\n■ ■TICKS\\nThe spectrum of tick borne illness includes Lyme disease, Rocky Mountain \\nspotted fever, ehrlichiosis, babesiosis, Colorado tick fever, tularemia, and \\ntickborne encephalitis. Certain species of ticks have a neurotoxin capable \\n120_Cydulka_Ch120.indd   661 20/03/17   5:59 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 680, 'page_label': '662'}, page_content='662 SECTION 12: Environmental Injuries\\nof inducing tick paralysis, a symmetric ascending flaccid paralysis nearly \\nidentical to Guillain–Barré syndrome. Indeed, a diagnosis of Guillain–\\nBarré syndrome should not be considered until a thorough search rules out \\nthe presence of an engorged tick. The recommended method of tick \\nremoval involves grasping the tick with forceps near the point of attachment \\nand pulling with steady, gentle traction. Since disease transmission is time \\ndependent, prompt tick removal is essential.\\n■ ■CHIGGERS (TROMBICULIDAE)\\nClinical Features\\nChiggers are tiny mite larvae that cause intense pruritus when they feed on \\nhost epidermal cells. They tend to attach to skin in areas of tight-fitting \\nclothing such as near waistbands. Children who have been sitting on lawns \\nare prone to chigger lesions in the genital area. Itchiness begins within a \\nfew hours, followed by a papule that enlarges to a nodule (“chigger bite”) \\nover the next 1 to 2 days. Single bites may cause soft tissue edema, whereas \\ninfestation has been associated with fever and erythema multiforme. The \\ndiagnosis of chigger bites is based on typical skin lesions and intense \\npruritus in the context of known outdoor exposure.\\nEmergency Department Care and Disposition\\nTreatment is symptomatic with oral or topical antihistamines, although oral \\nsteroids may be required in more severe cases. Annihilation of the mites \\nrequires topical application of permethrin or other topical scabicides. The \\npackage insert provides techniques for proper use.\\n■ ■FLEAS (SIPHONAPTERA)\\nFlea bites are frequently found in zigzag lines, especially on the legs and \\nwaist. They are intensely pruritic lesions with hemorrhagic puncta, sur -\\nrounding erythema, and urticaria. Discomfort is relieved with calamine \\nlotion, cool soaks, and oral or topical antihistamines. Severe irritation may \\nrequire topical steroid creams. Patients who develop impetigo and other \\nlocal infections should be treated with topical or oral antibiotics.\\n■ ■LICE (ANOPLURA)\\nBody lice concentrate on the waist, shoulders, axillae, and neck. Their bites \\nproduce red spots that progress to papules and wheals. They are so \\nintensely pruritic that linear scratch marks are suggestive of infestation. The \\nwhite ova of head lice are adherent to the hair shaft and therefore can be \\ndistinguished from dandruff. Pubic lice are spread by sexual contact. They \\ncause intense pruritus, and their small white eggs (nits) are visible on hair \\nshafts. As with scabies, permethrin is the primary treatment for body lice \\ninfestation. Treatment of any hair-borne infestation requires application of \\npyrethrin with piperonyl butoxide after hair washing, with reapplication in \\n10 days. Wet combing hair with a fine-tooth comb will remove dead lice \\nand nits. Clothing, bedding, and personal articles should be washed in hot \\n(>52°C [125.6°F]) water to prevent reinfestation.\\n120_Cydulka_Ch120.indd   662 20/03/17   5:59 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 681, 'page_label': '663'}, page_content='CHAPTER 120: Bites and Stings 663 \\n■ ■KISSING BUGS AND BED BUGS (HEMIPTERA)\\nKissing bugs, also known as reduviid or conenose beetles, and bed bugs \\nfeed on blood of a sleeping victim. The initial bite is painless. Bedbug bites \\nare often linear. Bites are often multiple and result in wheals or hemor -\\nrhagic papules and bullae. Dark lines of bedbug excrement on bed linens \\nmay be seen. Treatment consists of local wound care, topical steroids, and \\noral antihistamines. Allergic reactions may occur in sensitized individuals.\\n■ ■SNAKE BITES\\nVenomous snake bites in North America are typically caused by pit vipers \\n(Crotaline-rattlesnakes, copperhead, water moccasin, and massasauga) or \\ncoral snakes (Elapidae).\\n■ ■PIT VIPER (CROTALINAE) BITES\\nCrotaline snakes, commonly known as pit vipers, are identified by their \\ntwo retractable fangs and by heat-sensitive depressions (“pits”) located \\nbilaterally between each eye and nostril. Only 25% of bites result in \\nenvenomation.\\nClinical Features\\nThe effects of crotaline envenomation depend on the size and species of \\nsnake, the age and size of the victim, the time elapsed since the bite, and \\nthe characteristics of the bite itself. The hallmark of pit viper envenom-\\nation is the presence of one or more fang marks combined with pain, and \\nprogressive edema extending from the site. Tender lymphadenopathy in \\nthe envenomated extremity is common. Nausea, vomiting, and a metallic \\ntaste are often described in those patients with envenomations. Severe \\nsystemic manifestations may rarely occur, and include hypotension, tachy-\\ncardia, and shock. Thrombocytopenia, coagulopathy, and hypofibrinogen-\\nemia may be observed.\\nDiagnosis and Differential\\nThe diagnosis of crotaline envenomation is based on the presence of the \\naforementioned local injuries, systemic symptoms or hematologic abnor -\\nmalities. The absence of any of these findings after 8 to 12 hours indicates \\na dry bite.\\nMinimal envenomation is defined as local swelling, no systemic signs, \\nand no laboratory abnormalities. Severe envenomation causes extensive \\nswelling, potentially life-threatening systemic signs, and markedly abnormal \\ncoagulation parameters. Initially mild envenomation syndromes may prog-\\nress to severe syndromes over several hours. Pertinent laboratory tests include \\na complete blood count, coagulation tests, urinalysis, and blood typing.\\nEmergency Department Care and Disposition\\n1. Consultation with a medical toxicologist or poison control center is \\nrecommended for all pit-viper bites.\\n2. Cardiac monitoring and IV access in the non-envenomated extremity \\nshould be established.\\n120_Cydulka_Ch120.indd   663 20/03/17   5:59 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 682, 'page_label': '664'}, page_content='664 SECTION 12: Environmental Injuries\\n3. Provide local wound care and tetanus immunization. Measure limb \\ncircumference at se veral sites above and below the wound and check \\nevery 30 to 60 minutes.\\n4. Treat patients with progressive local swelling, systemic ef fects, or \\ncoagulopathy immediately with antivenom therapy, Polyvalent Cro-\\ntalidae Immune Fab (FabA V), a sheep-derived antivenin. Administer \\nan “initial control” dose of FabA V 4 to 6 vials IV; there is no need for \\nprior skin testing. “Initial control” is defined as cessation of progres-\\nsion of all components of envenomation: local effects, systemic effects, \\nand laboratory parameters (coagulopathy and/or thrombocytopenia). \\nThe initial dose of FabA V , as well as any subsequent dose, is diluted in \\n250 mL normal saline and infused IV over 1 hour. The goal of therapy \\nis to neutralize existing venom; the dose of FabA V is the same for \\nchildren and adults although the amount of diluent may need to be \\ndecreased in small children. If an allergic reaction occurs, stop the infu-\\nsion and treat with epinephrine and antihistamines, as indicated.\\n5. If the “initial control” is not achieved with the first infusion, gi ve a \\nrepeat dose of 4 to 6 vials.\\n6. Monitor blood count and coagulation studies every 4 hours or after each \\ncourse of antivenom, whichever is more frequent. Monitor renal function.\\n7. The endpoint of antivenom therap y is the arrest of progressive symp-\\ntoms and coagulopathy. Maintenance therapy includes administration \\nof an additional 2-vial dose at 6, 12, and 18 hours after “initial control” \\nis achieved. The antivenom package insert will guide in administration. \\nThe administration of antivenom must continue until complete control \\nof the envenomation is achieved.\\n8. Compartment syndrome rarely occurs secondary to env enomation. \\nTreatment includes limb elevation and additional 4 to 6 vials of IV \\nantivenom. Fasciotomy should only be performed if compartment syn-\\ndrome is suspected and elevated compartment pressures persist despite \\nelevation and additional antivenom. Discussion with a toxicologist or \\npoison control center is recommended.\\n9. Active bleeding due to severe coagulopathy may require blood compo-\\nnent therapy, although FabA V remains the mainstay of treatment for \\ncoagulopathy or thrombocytopenia not associated with overt hemorrhage.\\n10. Observe all patients with a pit viper bite for at least 6 to 8 hours. Admit \\npatients with severe bites and those receiving antivenin to the intensive \\ncare unit. Patients with no evidence of envenomation after 8 hours may \\nbe discharged, although some advocate admitting all children with lower \\nextremity bites for 24 hours due to possibility of delayed recognition of \\nlower extremity edema. All patients who receive FabA V should be coun-\\nseled regarding the 5% risk of serum sickness. The standard treatment for \\nserum sickness is oral prednisone, 1 mg/kg/d tapering over 1 to 2 weeks.\\n■ ■CORAL SNAKE BITE\\nClinical Features\\nVenomous coral snakes in the United States are brightly colored with adja-\\ncent red and yellow bands. In the United States, only bites from the eastern \\ncoral snake (Micrurus fulvius fulvius) require significant treatment as its \\n120_Cydulka_Ch120.indd   664 20/03/17   5:59 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 683, 'page_label': '665'}, page_content='CHAPTER 120: Bites and Stings 665 \\nvenom is a potent neurotoxin that causes tremor, saliv ation, respiratory \\nparalysis, seizures, and bulbar palsies (e.g., dysarthria, diplopia, and dys-\\nphagia). Bites of the Sonoran (Arizona) coral snake are mild and only need \\nlocal care.\\nEmergency Department Care and Disposition\\n1. Consultation with a medical toxicologist or poison control center is \\nrecommended.\\n2. The toxic effects of toxic coral snake venom may be pre ventable, but \\nthey are not easily reversed. All patients who have been bitten should \\nreceive 3 to 5 vials of antivenom (M. fulvius) at the first sign of toxicity. \\nAdditional antivenom doses are required if symptoms appear. Access to \\ncoral snake antivenom is extremely limited, as it is no longer manufac-\\ntured in the United States.\\n3. Follow pulmonary function parameters and neurological exams (e.g., \\ninspiratory pressure and vital capacity) and admit to the hospital for  \\n24 to 48 hours of observation.\\n■ ■GILA MONSTER BITE\\nGila monster bites result in pain and swelling. Systemic toxicity is rare but \\nmay consist of diaphoresis, paresthesia, weakness, hypertension, and \\nangioedema. The biting animal may be tenacious, and the reptile should be \\nremoved as soon as possible. If the reptile is still attached, it may loosen its \\nbite when placed on a solid surface where it is not suspended in midair. \\nOnce removed, perform standard wound care including a search for \\nimplanted teeth. No further treatment is required. Patients should be \\nobserved for airway edema for at least 6 hours after the Gila monster is \\nremoved. Those without systemic manifestations, including angioedema, \\ncan be discharged home.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 211, “Bites and Stings,” by SchneirAaron and \\nClarkRichard F.; and Chapter 212, “Reptile Bites,” by Richard C. Dart and \\nJulian White.\\n120_Cydulka_Ch120.indd   665 20/03/17   5:59 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 684, 'page_label': '666'}, page_content='666\\nTrauma and Envenomation  \\nfrom Marine Fauna\\nChristian A. Tomaszewski\\nThe population growth along coastal areas has made exposure to hazard-\\nous marine fauna increasingly common. The popularity of home aquari-\\nums generates additional exposures inland. Marine fauna can inflict injury \\nthrough direct traumatic bite or envenomation, usually via a stinging \\napparatus.\\n■ ■CLINICAL FEATURES\\nMajor marine trauma includes bites from sharks, great barracudas, moray \\neels, seals, crocodiles, needlefish, wahoos, piranhas, and triggerfish. \\nShark bites may also cause substantial tissue loss, particularly the legs, \\nwith hemorrhagic shock. Minor trauma is usually due to cuts and scrapes \\nfrom coral which can cause local stinging pain, erythema, urticaria, and \\npruritus.\\nMarine wounds can be infected with routine skin flora, such as Staphy-\\nlococcus and Streptococcus species, along with bacteria unique to the \\nmarine environment. The most serious halophilic organism is the gram-\\nnegative bacillus Vibrio, which can cause rapid infections marked by pain, \\nswelling, hemorrhagic bullae, vasculitis, and even necrotizing fasciitis and \\nsepsis. Immunosuppressed patients, particularly those with liver disease, \\nare susceptible to sepsis and death (up to 60%) from Vibrio vulnificus. \\nAnother bacterium, Erysipelothrix rhusiopathiae, implicated in fish-\\nhandler’s disease, can cause painful, marginating plaques after cutaneous \\npuncture wounds. The unique marine bacterium Mycobacterium marinum, \\nan acid-fast bacillus, can cause a chronic cutaneous granuloma 3 to 4 weeks \\nafter exposure.\\nNumerous invertebrate and vertebrate marine species are venomous. \\nThe invertebrates belong to five phyla: Cnidaria, Porifera, Echinodermata, \\nAnnelida, and Mollusca.\\nThe four classes of Cnidaria all share stinging cells, known as nemato-\\ncysts, which deliver venom subcutaneously when stimulated. The most \\ncommon effect is local pain, swelling, pruritus, urticaria, and even blistering \\nand necrosis in severe cases. Some can cause systemic reactions due to toxic \\neffects. The Hydrozoans include hydroids, Millepora (fire corals), and Phy-\\nsalia (Portuguese man-of-war). The latter causes a linear erythematous erup-\\ntion and rarely can cause respiratory arrest, possibly from anaphylaxis. In \\naddition to local tissue injury, the Scyphozoans (true jellyfish) include \\nAtlantic Ocean larval forms that can cause a persistent dermatitis under \\nbathing suits lasting days after exposure (Seabather’s eruption). The Cubo-\\nzoans (box jellyfish), in particular Chironex fleckeri in Australia and \\nChiropsalmus in the Gulf of Mexico, can cause a cardiotoxic death after \\nsevere stings. A Hawaiian box jellyfish, Carybdea, has been implicated in \\npainful stings but no deaths. Another Australian box jellyfish, Carukia \\nbarnesi, can cause Irukandji’s syndrome, characterized by diffuse pain, \\n121\\nCh A p TER\\n121_Cydulka_Ch121.indd   666 01/05/17   11:15 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 685, 'page_label': '667'}, page_content='CHAPTER 121: Trauma and Envenomation from Marine Fauna  667 \\nhypertension, tachycardia, diaphoresis, and ev en pulmonary edema. The \\nmost innocuous Cnidaria are the anthozoans (anemones) that occasionally \\ncause a mild local reaction.\\nPorifera (the sponges) can produce a stinging, pruritic dermatitis. \\nSpicules of silica or calcium carbonate can become embedded in the skin \\nalong with toxic secretions from the sponge. Echinodermata include sea \\nurchins and sea stars. Sea urchin spines produce immediate pain with \\ntrauma; some contain venom that leads to erythema and swelling. \\nRetained spines can lead to infection and granuloma formation. The \\ncrown-of-thorns sea star, Acanthaster planci, has sharp rigid spines that \\ncause burning pain and local inflammation. Another class of echinoderms \\nare sea cucumbers, which can cause mild contact dermatitis. Annelida \\ninclude bristle and fire worms, which embed bristles in the skin, causing \\npain and erythema. Mollusca include gastropods and octopuses. Both the \\nIndo-Pacific cone shell, Conus, and the blue-ringed octopus, Hapaloch-\\nlaena, can deliver paralytic venom that can quickly lead to respiratory \\nparalysis.\\nVertebrate envenomations are primarily due to stingrays (order Rajif-\\normes) and spined venomous fish (scorpion fish, lionfish, catfish, and \\nweeverfish). The stingray whip tail has venomous spines, which puncture \\nor lacerate causing an intense painful local reaction. The spines of venom-\\nous fish have glands that force venom into the wound after puncture and \\ncause local pain, erythema, and edema. Retention of a spine tip can lead to \\ninfection. In tropical Indo-Pacific waters, bites by venomous sea snakes, \\nalthough rare, can cause neurotoxicity and myotoxicity, and even death \\nfrom ascending paralysis.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Copiously irrigate lacerations, punctures, and bite wounds; explore for \\nforeign matter and debride devitalized tissue. Soft tissue radiographs or \\nultrasound may help locate foreign bodies, which usually require re-\\nmoval especially if intraarticular. Leave lacerations open for delayed \\nprimary closure. Update tetanus, if needed.\\n2. Prophylactic antibiotic therapy is not indicated for routine minor \\nwounds in healthy patients but may be considered in selected patients \\n(Table 121-1). Antibiotic therapy for infected wounds is first directed \\ntoward likely pathogens and later by culture and sensitivity results. \\nTreat Staphylococcus and Streptococcus species with a first-\\ngeneration cephalosporin, such as cephalexin 500 mg (10 to 25 mg/\\nkg in children) four times daily PO or cefazolin 1 to 2 g (25 mg/kg \\nin children) every 8 hours IV; alternatively doxycycline 100 mg PO/\\nIV twice daily for MRSA coverage may be used in adults. Addition \\nof a third-generation cephalosporin, such as ceftriaxone 1 g (50 mg/\\nkg in children) IV daily or cefotaxime 2 g (50 mg/kg in children) IV \\nevery 8 hours, or a fluoroquinolone, such as levofloxacin or cipro-\\nfloxacin 500 mg PO/IV daily will cover ocean-related infections \\nfrom Vibrio (avoid use in children). A fluoroquinolone or third-\\ngeneration cephalosporin, or trimethoprim-sulfamethoxazole \\ndouble strength, 1 tablet (4 mg/kg trimethoprim component in \\nchildren) PO twice each day, or imipenem, 500 mg (10 to 25 mg/kg \\n121_Cydulka_Ch121.indd   667 01/05/17   11:15 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 686, 'page_label': '668'}, page_content='668 SECTION 12: Environmental Injuries\\nin children) IV every 6 hours , will cover fresh water infections from \\nAeromonas. Granulomas from Mycobacterium marinum require sev-\\neral months of treatment with clarithromycin or rifampin plus \\nethambutol.\\n3. Treatment of jellyfish stings is controv ersial and may be species \\ndependent. Regardless, initial irrigation with seawater to remove \\nnematocyst-laden tentacles may be beneficial. Hot water (111° F \\n(43.3°C) to 114° F (45.6° C) ) and topical lidocaine may lessen local \\nvenom effects. See Table 121-2 summarizing early treatment of all \\nmarine envenomations.\\nTablE 121-1 Recommendations for Antibiotic Treatment of Marine-Associated \\nWounds\\nNo Antibiotics \\nIndicated\\nprophylactic/Outpatient \\nAntibiotics\\nhospital Admission for  \\nIV Antibiotics\\nHealthy patient Late wound care Predisposing medical conditions\\nPrompt wound care Large lacerations or injuries Long delays before definitive \\nwound care\\nNo foreign body Early or local inflammation Deep wounds, significant trauma\\nNo bone or joint \\ninvolvement\\nWounds with retained foreign  \\nbodies\\nSmall or superficial \\ninjuries\\nProgressive inflammatory change\\nPenetration of periosteum, joint \\nspace, or body cavity\\nMajor injuries associated with \\nenvenomation\\nSystemic illness\\nTablE 121-2 Early Treatment of Marine Envenomations\\nMarine Organism Detoxification Further Treatment\\nPenetrating Envenomations\\nCatfish, lionfish, scorpionfish, \\nstingray\\nHot water immersion*; \\nlidocaine infiltration.\\nUsual wound care.†\\nAssess for stingray spines  \\n(x-ray or exploration).\\nObserve for development of \\nsystemic symptoms.\\nStonefish Hot water immersion*; \\nlidocaine infiltration\\nUsual wound care.†\\nAdminister stonefish antivenin  \\nif severe systemic reaction.\\nSea snake — Pressure immobilization.\\nAdminister antivenom if severe \\nsystemic reaction.\\nObserve 8 h for myotoxicity  \\nor neurotoxicity.\\nAustralian blue-ringed \\noctopus\\n— Use pressure immobilization.\\nProvide supportive care.\\n(Continued)\\n121_Cydulka_Ch121.indd   668 01/05/17   11:15 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 687, 'page_label': '669'}, page_content='CHAPTER 121: Trauma and Envenomation from Marine Fauna  669 \\nTablE 121-2 Early Treatment of Marine Envenomations\\nMarine Organism Detoxification Further Treatment\\nCone snail — Use pressure immobilization.\\nProvide supportive care.\\nSea urchin Hot water immersion*; \\ntopical lidocaine\\nExplore wound and remove any \\nspines.\\nFireworms Topical 5% acetic acid \\n(vinegar).\\nConsider topical corticosteroids.\\nRemove bristles.\\nNonpenetrating Envenomations\\nFire coral, hydroids, anemones Irrigate with seawater \\nor saline.\\nTopical corticosteroid for itching.\\nPortuguese man-of-war, blue \\nbottles, and non-box jellyfish\\nHot water immersion,* \\nsea water irrigation, \\ntopical lidocaine.\\nRemove tentacles and \\nnematocysts.\\nTopical corticosteroid for itching.\\nObserve for development of \\nsystemic symptoms.\\nSupportive care.\\nBox jellyfish Hot water immersion.*\\nIrrigate with saline or \\nseawater.\\nTopical 5% acetic acid \\n(vinegar).\\nRemove tentacles and \\nnematocysts.\\nTopical lidocaine.\\nTopical corticosteroid for itching.\\nObserve for development of \\nsystemic symptoms.\\nSupportive care.\\nAdminister Chironex antivenin.\\nIrukandji’s syndrome Irrigate with saline or \\nseawater.\\nHot water immersion.*\\nRemove tentacles and \\nnematocysts.\\nParenteral opioids for pain.\\nMagnesium for cardiac arrest.\\n*Hot water immersion = 111°F (43.3°C) to 114°F (45.6°C) water until pain relieved.\\n†Usual wound care = irrigate, explore, debride, consider antibiotics and analgesi.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 213, “Marine Trauma and Envenomation,” by John J. \\nDevlin and Kevin Knoop.\\n(Continued)\\n121_Cydulka_Ch121.indd   669 01/05/17   11:15 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 688, 'page_label': '670'}, page_content='670\\nHigh-Altitude Disorders\\nShaun D. Carstairs\\nHigh-altitude disorders are due primarily to hypoxia; the rapidity and \\nheight of ascent influence the risk of occurrence.\\n■ ■ACUTE MOUNTAIN SICKNESS\\nClinical Features\\nAcute mountain sickness (AMS) is usually seen in nonacclimated people \\nmaking a rapid ascent to higher than 2000  m (6560  ft) above sea lev el. \\nSymptoms resembling a hangover may develop within 6 hours after arrival \\nat altitude but may be delayed as long as one day. Typical symptoms \\ninclude bifrontal headache along with a combination of GI disturbance, \\ndizziness, fatigue, or sleep disturbance. Worsening headache, vomiting, \\noliguria, dyspnea, and weakness indicate progression of AMS. Physical \\nexamination findings in early AMS are limited. Postural hypotension and \\nperipheral and facial edema may occur. Localized rales are noted in up to \\n20% of cases. Funduscopy shows tortuous and dilated veins; retinal hemor-\\nrhages are common at altitudes higher than 5000  m (16,500  ft). Resting \\nSaO2 is typically normal for altitude and correlates poorly with the diagno-\\nsis of AMS.\\nDiagnosis and Differential\\nThe differential diagnosis includes hypothermia, carbon monoxide poison-\\ning, pulmonary or central nervous system infections, migraine, dehydra-\\ntion, and exhaustion. The diagnosis is based largely on history of rapid \\nascent and symptoms.\\nEmergency Department Care and Disposition\\nThe goals of treatment are to prevent progression, abort the illness, and \\nimprove acclimatization.\\n1. Terminate further ascent until symptoms resolve. For mild AMS, symp-\\ntomatic therapy includes an analgesic, such as acetaminophen or an \\nNSAID, and an antiemetic, such as ondansetron disintegrating tablets, \\n4 to 8 mg every 4 to 6 hours PO. Mild AMS usually improves or resolves \\nin 12 to 36 hours if ascent is stopped.\\n2. A decrease in altitude of 300 to 1000  m should provide prompt relief of \\nsymptoms. Immediate descent and treatment are indicated for patients \\nwith moderate AMS or if there is a change in the level of consciousness, \\nataxia, or pulmonary edema.\\n3. Low-flow oxygen also relieves symptoms.\\n4. Consider hyperbaric therapy for moderate AMS if descent is not  \\npossible.\\n5. Pharmacologic therapy for moderate AMS includes acetazolamide 125 \\nto 250  mg in adults and 2.5  mg/kg in children, PO twice daily, until \\n122\\nCh A p TE r\\n122_Cydulka_Ch122.indd   670 21/03/17   9:26 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 689, 'page_label': '671'}, page_content='CHAPTER 122: High-Altitude Disorders 671 \\nsymptoms resolve and dexamethasone 4  mg PO, IM, or IV every  \\n6 hours with a taper over several days.\\na. Indications for acetazolamide are (a) history of altitude illness, (b) \\nabrupt ascent higher than 3000  m (9840 ft), (c) AMS, and (d) symp-\\ntomatic periodic breathing during sleep at high altitude.\\nb. Acetazolamide pharmacologically produces an acclimatization \\nresponse by inducing a bicarbonate diuresis and metabolic acidosis. \\nAcetazolamide is effective for both prophylaxis and treatment.\\nc. Acetazolamide should be avoided in sulfa-allergic patients.\\n6. Patients who respond well to treatment may be discharged. Provide  \\ncounseling on preventing future episodes: graded ascent, prophylaxis \\nusing acetazolamide, and avoidance of overexertion, alcohol, and \\nrespiratory depressants. Begin prophylaxis with acetazolamide a day \\nbefore ascent and continue for at least two days after reaching high \\naltitude.\\n■ ■hIGh-ALTITUDE pULMONArY EDEMA\\nRisk factors for high-altitude pulmonary edema (HAPE) include rapid \\nascent, heavy exertion, cold, pulmonary hypertension, and use of a sleep \\nmedication. Children with acute respiratory infections may be more suscep-\\ntible to HAPE. HAPE may be fatal if not recognized and treated early.\\nClinical Features\\nHAPE usually begins on the second to fourth night at a new altitude and \\nmay progress quickly from dry cough and impaired exercise capacity to \\nresting dyspnea, productive cough, severe weakness, and cyanosis. Physi-\\ncal examination findings include tachycardia, tachypnea, localized or \\ngeneralized rales, and signs of pulmonary hypertension, such as a promi-\\nnent P2 and right ventricular heave. Resting SaO 2 is low for altitude and \\ndrops significantly with exertion. CXR abnormalities progress from inter -\\nstitial to localized to generalized alveolar infiltrates. Right axis deviation \\nand a right ventricular strain pattern are seen on EKG with progressive \\ndisease.\\nDiagnosis and Differential\\nThe differential diagnosis includes pneumonia, acute asthma, congestive \\nheart failure, myocardial ischemia, and pulmonary embolism. Decreased \\nexercise performance and dry cough are enough to suspect early HAPE. A \\nkey to diagnosis is response to treatment.\\nEmergency Department Care and Disposition\\nEarly recognition of HAPE is essential to prevent progression. General \\nmeasures include rest and keeping patients warm.\\n1. Initiate supplemental oxygen and titrate to SaO 2 ≥ 90%.\\n2. Immediate descent is the treatment of choice. Exertion by the patient \\nmust be minimized during descent. Hyperbaric treatment may be used if \\ndescent is not an option. Patients with very mild cases of HAPE may be \\nmanaged with bed rest and oxygen alone.\\n122_Cydulka_Ch122.indd   671 21/03/17   9:26 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 690, 'page_label': '672'}, page_content='672 SECTION 12: Environmental Injuries\\n3. Pharmacologic treatment is usually unnecessary if descent and oxygen \\nare available. In such cases (field conditions), options include nifedip-\\nine 20 to 30 mg extended release PO every 12 hours, or tadalafil 10 mg \\nPO twice daily. T adalafil blunts hypoxic pulmonary vasoconstriction. \\nNifedipine or tadalafil may also be used for HAPE prophylaxis in per -\\nsons with prior episodes. Inhaled albuterol 2 to 4 puffs every 4 to  \\n6 hours may be used for both prophylaxis and treatment but is not  \\nwell studied.\\n4. Patients may be discharged if clinical and radiographic improv ements \\nare noted and room air SaO 2 remains > 90%.\\n■ ■hIGh-ALTITUDE CErEBrAL EDEMA\\nClinical Features\\nHigh-altitude cerebral edema (HACE) is defined as progressive neurologic \\ndeterioration with AMS or HAPE. Patients present with altered mental \\nstatus, ataxia, stupor, and progress to coma if untreated. Focal neurologic \\nsigns such as third and sixth cranial nerve palsies may be present.\\nDiagnosis and Differential\\nThe differential diagnosis includes stroke or transient ischemic attack, \\ntumor, meningitis, encephalitis, or metabolic disturbance. Increased T2 \\nsignaling in the splenium of the corpus callosum is seen on MRI. Labora-\\ntory testing to rule out other diagnoses may be considered but should not \\ndelay treatment.\\nEmergency Department Care and Disposition\\n1. Initiate supplemental oxygen and titrate to SaO 2 ≥ 90%. Comatose pa-\\ntients require intubation and ventilation.\\n2. Immediate descent is needed. Initiate hyperbaric therapy if descent is \\nnot possible.\\n3. Administer dexamethasone 8 mg PO, IM or IV , followed by 4 mg PO, \\nIM or IV every 6 hours.\\n4. In intubated patients, monitor arterial blood gases, taking care to avoid \\nlowering PaCO 2 below 30  mmHg. Monitor intracranial pressures and \\ncerebral blood velocities by transcranial Doppler US, if possible.\\n5. Patients remaining ataxic or confused after descent require admission.\\n■ ■FUrThEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 221, “High-Altitude Disorders,” by Peter H. Hackett \\nand Christopher B. Davis.\\n122_Cydulka_Ch122.indd   672 21/03/17   9:26 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 691, 'page_label': '673'}, page_content='673\\nDysbarism and Complications  \\nof Diving\\nChristian A. Tomaszewski\\nDysbarism is commonly encountered in scuba divers and refers to complica-\\ntions associated with changes in environmental ambient pressure and with \\nbreathing compressed gases. These effects are governed by three gas laws: \\nBoyle’s law states that pressure and volume are inversely related; Henry’s \\nlaw states that, at equilibrium, the quantity of gas in solution is proportional \\nto the partial pressure of that gas; Dalton’s law states that total pressure \\nexerted by a mixture of gases is the sum of the partial pressures of each gas.\\n■ ■CLINICAL FEATURES\\nBarotrauma is the most common diving-related affliction and is caused by \\nthe direct mechanical effects of pressure, as gas-filled cavities in the body \\ncontract or expand with pressure changes. The most common form of baro-\\ntrauma occurs during descent and is middle ear squeeze, or barotitis media. \\nIt is caused by inability to equalize pressure causing tympanic membrane \\nbleeding or rupture and may result in conductive hearing loss. A forceful \\nValsalva during equalization can cause inner ear barotrauma with rupture of \\nthe round or oval window. Symptoms include tinnitus, sensorineural hear -\\ning loss, and vertigo. If the sinus ostia are occluded on descent, an impend-\\ning squeeze can cause bleeding from the maxillary or frontal sinuses, \\nresulting in pain and epistaxis.\\nBarotrauma during ascent is due to expansion of gas in body cavities. In \\nthe middle ear, the pressure differential from asymmetrical expansion can \\ncause alternobaric vertigo. Although rare, “reverse squeeze” may affect the \\near or sinuses during ascent with rupture. Pulmonary overinflation and even \\nburst lung can occur during rapid, panicked ascents if divers fail to exhale \\nor if intrinsic pulmonary air trapping exists (e.g., COPD) resulting in pneu-\\nmomediastinum, subcutaneous emphysema, or pneumothorax. The most \\nserious consequence is cerebral arterial gas embolism (CAGE). Neurologic \\nsymptoms occur on ascent or immediately upon surfacing and include loss \\nof consciousness, seizure, blindness, disorientation, hemiplegia, or other \\nsigns of stroke.\\nDivers using compressed air, caisson (tunnel) workers, and high-altitude \\npilots can all present with decompression sickness (DCS). In divers, this \\nusually results from exceeding the dive table limits for depth and time. DCS \\ncan occur within minutes to hours of surfacing, rarely days later. Excessive \\nbubble formation in tissue or circulation from saturated gas can cause both \\nacute occlusive and delayed inflammatory effects. Type I DCS, “pain-only,” \\nincludes mottled skin and deep pain of the joints, usually the shoulder or \\nknee, and is unaffected by movement. Type II, “serious,” DCS involves the \\ncentral nervous system, typically the spine. Patients may initially complain \\nof truncal constriction with ascending paralysis. Prolonged exposure at \\ndepth can lead to cardiopulmonary “chokes” with cough and hemoptysis or \\nvestibular “staggers” with vertigo and hearing loss. Because DCS and \\n123\\nCh A p TER\\n123_Cydulka_Ch123.indd   673 21/03/17   9:37 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 692, 'page_label': '674'}, page_content='674 SECTION 12: Environmental Injuries\\nCAGE can be difficult to distinguish, or present simultaneously , the term \\n“decompression illness” is now typically used for both.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nDive profile (depth, duration, and repetitiveness) and time of symptom onset \\nare the most useful historical factors in distinguishing dysbarism from other \\ndisorders. During descent, the most common maladies are the squeezes. A \\nfistula test, insufflation of the tympanic membrane on the affected side caus-\\ning the eyes to deviate to the contralateral side, may help diagnose inner ear \\nbarotrauma. During ascent, barotrauma or alternobaric vertigo is most likely \\nto occur. A chest x-ray may reveal pneumomediastinum, pneumothorax or \\nsubcutaneous air after pulmonary overinflation. If accompanied by early \\nneurological symptoms, CAGE should be considered. Laboratory testing \\nmay reveal elevated hematocrit from hemoconcentration or elevated creatine \\nphosphokinase from circulatory distribution of bubbles.\\nThe differential diagnosis for DCS is broad. Musculoskeletal com-\\nplaints could be due to joint strain or symptomatic herniated cervical disk. \\nChest pain may represent cardiac ischemia from overexertion. Immersion \\npulmonary edema from noncardiogenic causes can occur during strenuous \\ndives, particularly in cold water. Seizures at depth can result from breathing \\nenriched mixtures of oxygen exceeding 1.4 atmospheres absolute. Regard-\\nless, DCS should be suspected in patients with vague pain or neurological \\nsymptoms especially if safe diving limits, depth and time, were exceeded. \\nIf DCS is suspected, an early trial of pressure with hyperbaric oxygen usu-\\nally results in some improvement.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Decompression Illness (DCS/CAGE):\\na. Administer 100% oxygen and IV fluids.\\nb. If CAGE is suspected, place the patient in the supine position; place \\nin the left lateral decubitus position if vomiting occurs.\\nc. Rapidly arrange for recompression therapy with h yperbaric \\noxygen. Divers Alert Network (1-919-684-9111) may help provide \\nchamber locations.\\nd. Lidocaine 1 mg/kg IV bolus followed by a continuous infusion at 1 \\nmg/min may provide neuroprotection in CAGE.\\n2. Treat middle ear barotitis with decongestants and analgesics. Consider \\nantibiotics if infection is suspected. Advise patients against diving until \\nhealing is completed. Inner ear barotrauma requires bed rest with the \\nhead upright until otolaryngologic evaluation for possible surgical \\nexploration.\\n3. Pulmonary overinflation with ascent may require needle decompr es-\\nsion or tube thoracostomy acutely if a pneumothorax develops.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 214, “Diving Disorders,” by Brain Snyder and Tom \\nNeuman.\\n123_Cydulka_Ch123.indd   674 21/03/17   9:37 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 693, 'page_label': '675'}, page_content='675\\nNear Drowning\\nRichard A. Walker\\nDrowning is submersion in a liquid resulting in respiratory distress or \\nfailure. Prognosis after submersion injuries depends on the degree of \\npulmonary and central nervous system injury and, therefore, is highly \\ndependent on early rescue and resuscitation. Prevention is the most \\nimportant means to reduce associated morbidity and mortality.\\n■ ■CLINICAL FEATURES\\nUp to 20% of patients who suffer submersion injuries do not aspirate \\nwater, but sustain injury due to asphyxia. Patients who aspirate water into \\ntheir lungs have washout of surfactant, resulting in diminished alveolar \\ngas transfer, atelectasis, ventilation perfusion mismatch, and hypoxia. \\nNoncardiogenic pulmonary edema results from moderate to severe aspira-\\ntion. Physical examination findings at presentation vary. Lungs may be \\nclear or have rales, rhonchi, or wheezes. Mental status ranges from normal \\nto comatose. Patients are at risk for hypothermia even in “warm water” \\nsubmersions.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nEvaluate patients for associated injuries (e.g., traumatic injuries to the brain \\nor spinal cord) and underlying precipitating disorders including syncope, \\nseizures, hypoglycemia, and acute myocardial infarction or dysrhythmias. \\nRespiratory acidosis may be present early followed by metabolic acidosis \\nlater. Early electrolyte disturbances are unusual. A chest radiograph (CXR) \\nis usually obtained but is frequently normal in patients who are otherwise \\nasymptomatic. Without a history of diving or associated trauma, routine \\ncervical immobilization and computerized tomography (CT) of the brain \\nare not necessary.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\n1. Treatment for submersion events is summarized in Figure 124-1.\\n2. Measure core temperature. Treat hypothermia if present. (See Chap -\\nter 118, “Frostbite and Hypothermia.”) Hypothermic victims of cold-\\nwater submersion with cardiac arrest should undergo prolonged and \\naggressive resuscitation maneuvers until they are normothermic or \\nconsidered not viable.\\n3. Data do not support routine antibiotic prophylaxis for pulmonary \\naspiration.\\n4. Efforts at “brain resuscitation,” including the use of mannitol, loop \\ndiuretics, hypertonic saline, fluid restriction, mechanical hyperventila-\\ntion, controlled hypothermia, barbiturate coma, and intracranial pressure \\nmonitoring, have not shown benefit.\\n124\\nCh APTER\\n124_Cydulka_Ch124.indd   675 26/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 694, 'page_label': '676'}, page_content='676 SECTION 12: Environmental Injuries\\nIf Sao2 <95%,\\nor patient has\\nabnormal physical \\nexamination (rales, \\nrhonchi, wheezing, \\nretractions, etc.), \\napproach as if\\nGCS <13\\nIf oxygen\\nsaturations\\nand pulmonary\\nexamination are\\nnormal, patient\\nmay be safely\\ndischarged\\nhome\\nClear cervical spine\\nOxygen saturations\\n   Supplemental oxygen\\n   as necessary to keep\\n   Sao2 ≥95% Endotr\\n   cheal intubation and\\n   positive pressure\\n   ventilation as needed\\n   (CPAP , PEEP) \\nAncillary tests:\\n   consider CXR, CBC,\\n   electrolytes, glucose,\\n   troponin I, PT/PTT, U/A,\\n   CK, urine myoglobin,\\n   urine drug screen\\nMonitor:\\n   Acid-base status,\\n   temperature, volume\\n   status (urine output,\\n   CVP , etc.)\\nGCS <13\\nor Sao2 <95%\\nObserve 4–6 hours\\nClear cervical spine\\nMonitor oxygen\\nsaturations\\nAncillary tests\\n(usually not indicated)\\nGCS ≥13\\nand Sao2 ≥95%\\nSubmersion Event Algorithm\\nPrehospital Care:\\nRapid, cautious rescue\\nCervical spine precautions \\n(if injury suspected or unknown)\\nCPR as indicated\\nTransport (all patients)\\nOxygen (all patients)\\nEmergency Department Care:\\nAirway/breathing/circulation \\n(address any problems)\\nDetermine GCS\\nTreat any associated injury\\nor condition (e.g., hypovolemia,\\nhypothermia, seizure, myocardial\\ninfarction, etc.)\\nPatient needs to be\\nadmitted or transported\\nto a facility for inpatient/\\nICU monitoring\\nFigure 124-1. Drowning event algorithm. CBC =  complete blood count; CK = \\ncreatine kinase; CPAP = continuous positive airway pressure; CVP = central venous \\npressure; CXR = chest radiograph; GCS = Glasgow Coma Scale; ICU = intensive care \\nunit; PEEP = positive end-expiratory pressure; PT = prothrombin time; PTT = partial \\nthromboplastin time; Sao2 = oxygen saturation (via pulse oximetry); U/A = urinalysis.\\n124_Cydulka_Ch124.indd   676 26/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 695, 'page_label': '677'}, page_content='CHAPTER 124: Near Drowning 677 \\n5. Patients who arrive in the emergency department  in asystole or cardiac \\narrest after warm water submersion and are normothermic have a poor \\nprognosis for recovery without significant neurologic handicaps.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 215, “Drowning,” by Stephen John Cico and Linda \\nQuan.\\n124_Cydulka_Ch124.indd   677 26/04/17   2:34 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 696, 'page_label': '678'}, page_content='678\\nThermal and Chemical Burns\\nSandra L. Werner\\n■ ■THERMAL BURNS\\nThe majority of burn patients are treated and released from the ED. Of \\nthose hospitalized, more than 60% are admitted to one of the country’s 127 \\nburn centers. The risk of death from a major burn is associated with larger \\nburn size, advanced age, concomitant inhalation injury, and female sex.\\nClinical Features\\nBurns are categorized by their size and depth. Burn size is calculated as the \\npercentage of body surface area (BSA) involved. The most common \\nmethod to estimate this is the Rule of Nines (Fig. 125-1). A more accurate \\ntool, especially in infants and children, is the Lund and Browder burn dia-\\ngram (Fig. 125-2). For smaller burns, the patient’s hand can be used to \\nestimate the size of the burn. The area of the back of the patient’s hand \\nrepresents approximately 1% of BSA, and the number of “hands” repre-\\nsents the BSA burned.\\n125\\nC HA p TER\\n18% front\\n18% back\\n9%\\n9%\\n1%\\n18%\\nFigure 125-1. Rule of Nines to estimate the percentage of burn.\\n125_Cydulka_Ch125.indd   678 21/03/17   9:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 697, 'page_label': '679'}, page_content='CHAPTER 125: Thermal and Chemical Burns 679 \\nAA\\nB\\nB B\\nRelative percentages of areas affected by growth (age in years)\\nSecond-degree and\\nThird-degree =\\nTotal percent burned\\n015 10 15 Adult\\n2\\n22\\n1\\n2\\n1313\\nB\\nC CC C\\n11\\n211\\n2\\n11\\n211\\n2\\n11\\n2 11\\n2\\n2 1\\n22 1\\n2\\n1 3\\n41 3\\n4\\n8 1\\n29 1\\n2 6 1\\n2 5 1\\n2 4 1\\n2 3 1\\n2\\n2 3\\n4 3 1\\n4 44 1\\n4 4 1\\n2 4 3\\n4\\n2 1\\n2\\nA: half of head\\nB: half of thigh\\nC: half of leg 2 1\\n2 2 3\\n4 33 1\\n4 3 1\\n2\\n1 3\\n4\\nFigure 125-2. Lund and Browder diagram to estimate the percentage of a burn.\\nBurn depth historically has been described in degrees: first, second, \\nthird, and fourth. A more clinically relevant classification scheme catego-\\nrizes burns as superficial partial thickness, deep partial thickness, and full \\nthickness. Table 125-1 summarizes the characteristics of each type of \\nburn.\\nInhalation injury occurs most frequently in closed-space fires and in \\npatients with decreased cognition (intoxication, overdose, head injury). \\nBoth the upper and lower airway can be injured by heat, particulate mat-\\nter, and toxic gases. Thermal injury is usually limited to the upper airway, \\nand can result in acute airway compromise. Particulate matter can reach \\n125_Cydulka_Ch125.indd   679 21/03/17   9:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 698, 'page_label': '680'}, page_content='680 SECTION 12: Environmental Injuries\\nthe terminal bronchioles and lead to bronchospasm and edema. Clinical \\nindicators of inhalation injury include facial burns, singed nasal hair , soot \\nin the upper airway, hoarseness, carbonaceous sputum, and wheezing. \\nCarbon monoxide poisoning should be suspected in all patients with inha-\\nlation injuries. Hydrogen cyanide poisoning should be considered in fires \\ninvolving nitrogen-containing polymer products such as wool, silk, poly-\\nurethane, and vinyl.\\nDiagnosis and Differential\\nThe American Burn Association (ABA) classifies burns into major, moder-\\nate, and minor. Table 125-2 summarizes the ABA burn classifications.\\nTaBle 125-1 Burn Depth Features Classified by Degree of Burn\\nBurn Depth Histology/Anatomy Example Healing\\nSuperficial (first \\ndegree)\\nEpidermis\\nNo blisters, painful\\nSunburn 7 days\\nSuperficial partial-\\nthickness (superficial \\nsecond degree)\\nEpidermis and \\nsuperficial dermis\\nBlisters, very painful\\nHot water scald 14–21 days, no scar\\nDeep partial-\\nthickness (deep \\nsecond degree)\\nEpidermis and deep \\ndermis, sweat glands, \\nand hair follicles\\nBlisters, very painful\\nHot liquid, steam, \\ngrease, flame\\n3–8 weeks, \\npermanent scar\\nFull-thickness (third \\ndegree)\\nEntire epidermis and \\ndermis charred, pale, \\nleathery; no pain\\nFlame Months, severe \\nscarring, skin grafts \\nnecessary\\nFourth degree Entire epidermis and \\ndermis, as well as \\nbone, fat, and/or \\nmuscle\\nFlame Months, multiple \\nsurgeries usually \\nrequired\\nTaBle 125-2 Burn Depth Features: American Burn Association Burn \\nClassification\\nBurn \\nClassification Burn Characteristics Disposition\\nMajor burn Partial-thickness >25% BSA, age 10–50 years Burn center \\ntreatmentPartial-thickness >20% BSA, age <10 years or >50 years\\nFull-thickness >10% BSA in anyone\\nBurns involving hands, face, feet, or perineum\\nBurns crossing major joints\\nCircumferential burns of an extremity\\nBurns complicated by inhalation injury\\nElectrical burns\\nBurns complicated by fracture or other trauma\\nBurns in high-risk patients\\n(continued )\\n125_Cydulka_Ch125.indd   680 21/03/17   9:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 699, 'page_label': '681'}, page_content='CHAPTER 125: Thermal and Chemical Burns 681 \\nemergency Department Care and Disposition\\nManagement of patients with moderate to major burns is divided into three \\nphases: prehospital care, ED resuscitation and stabilization, and transfer to \\na burn center. Prehospital burn care consists of stopping the burning pro-\\ncess, establishing an airway, initiating fluid resuscitation, relieving pain and \\nprotecting the burn wound.\\n1. In the ED, reevaluate the airway , administer 100% O 2, and intubate \\nand ventilate the patient if there are signs of airway compromise, an \\nairway burn, or respiratory distress. Obtain an ABG, carboxyhemoglo-\\nbin level, and CXR. Monitor vital signs and oxygen saturation.\\n2. Establish 2 IV lines in unburned areas. Use a burn formula, such as the \\nParkland/Baxter formula, to guide initial fluid resuscitation (Table 125-3). \\nOngoing fluid resuscitation is further guided by vital signs, cerebral and \\nperipheral perfusion, and adequate urine output.\\n3. Evaluate and treat traumatic injuries using standard trauma resuscitation \\nguidelines (Chapter 156, “Trauma in Adults”; Chapter 157, “Trauma in \\nChildren”; Chapter 158, “Trauma in the Elderly”).\\nTaBle 125-2 Burn Depth Features: American Burn Association Burn \\nClassification\\nBurn \\nClassification Burn Characteristics Disposition\\nModerate burn Partial-thickness 15–25% BSA, age 10–50 years Hospitalization\\nPartial-thickness 10–20% BSA, age <10 years or  \\n>50 years\\nFull-thickness burns ≤10% BSA in anyone\\nNo major burn characteristics present\\nMinor burn Partial-thickness <15% BSA, age 10–50 years Outpatient \\ntreatmentPartial-thickness <10% BSA, age <10 years or >50 years\\nFull-thickness <2% in anyone\\nNo major burn characteristics present\\nAbbreviation: BSA, body surface area.\\n(continued)\\nTaBle 125-3 parkland Formula for Fluid Resuscitation\\nAdults\\nLR 4 mL × weight (kg) × % BSA burned * over initial 24 h\\nHalf over the first 8 h from the time of burn\\nOther half over the subsequent 16 h\\nExample: 70-kg adult with 40% second- and third-degree burns:\\n4 mL × 70 kg × 40 = 11,200 mL over 24 h\\nChildren\\nLR 3 mL × weight (kg) × % BSA burned * over initial 24 h plus maintenance\\nHalf over the first 8 h from the time of burn\\nOther half over the subsequent 16 h\\n*Partial- and full-thickness burns only.\\nAbbreviations: BSA, body surface area; LR, lactated Ringer’s solution.\\n125_Cydulka_Ch125.indd   681 21/03/17   9:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 700, 'page_label': '682'}, page_content='682 SECTION 12: Environmental Injuries\\n4. After initiating resuscitative measures, address burn wound care. Apply \\ncool compresses to small burns. Cover large burns with sterile dry \\nsheets as saline soaked dressings may induce hypothermia. Administra-\\ntion of empiric antibiotics and application of topical antimicrobials \\nduring resuscitation are not recommended.\\n5. Administer intravenous opioid analgesia early and titrate to pain.\\n6. Treat inhalation injuries with humidified oxygen, endotracheal intuba-\\ntion and mechanical ventilation, bronchodilators, and pulmonary toilet. \\nHyperbaric oxygen therapy is used for severe carbon monoxide \\npoisoning.\\n7. Circumferential burns of the neck, chest, or limbs may compromise \\nbreathing and circulation. Escharotomy may be required.\\n8. Update tetanus prophylaxis, if needed.\\n9. Hospitalize patients with moderate and major burns. The ABA’s criteria \\nfor referral to a burn unit are listed in Table 125-4.\\n10. Table 125-5 summarizes the care of minor burns. Patients with minor \\nburns may be discharged after ED treatment, provided close follow-up \\nis available.\\n■ ■CHEMICAL BURNS\\nMore than 25,000 products are capable of producing chemical burns. \\nChemical burn injuries represent a smaller percentage of burn injuries but \\naccount for 30% of burn deaths.\\nTaBle 125-4 American Burn Association Burn Unit Referral Criteria\\nFull-thickness/third-degree burns in any age group\\nElectrical burns, including lightning injury\\nChemical burns\\nInhalation injury\\nBurn injury in patients with preexisting medical disorders that could complicate manage-\\nment, prolong recovery, or affect mortality\\nBurn injury in any patients with concomitant trauma (such as fractures) in whom the burn \\ninjury poses the greatest risk of morbidity or mortality\\nBurn injury in children in hospitals without qualified personnel or equipment to care for children\\nBurn injury in patients who will require special social, emotional, or long-term rehabilita-\\ntive intervention\\nBurn injury in children <10 years and adults >50 years of age\\nTaBle 125-5 ED Care of Minor Burns\\nProvide appropriate analgesics before burn care and for outpatient use\\nCleanse burn with mild soap and water or dilute antiseptic solution\\nDebride wound as needed\\nApply topical antimicrobial:\\n1% silver sulfadiazine cream (not on the face or in patients with a sulfa allergy)\\nBacitracin ointment\\nTriple-antibiotic ointment (neomycin, polymyxin B, bacitracin zinc)\\nConsider use of synthetic occlusive dressings\\nProvide detailed burn care instructions with follow-up in 24–48 h\\n125_Cydulka_Ch125.indd   682 21/03/17   9:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 701, 'page_label': '683'}, page_content='CHAPTER 125: Thermal and Chemical Burns 683 \\nClinical Features\\nClinical features depend on the type of agent, concentration, volume, dura-\\ntion of exposure, and e xtent of penetration. Alkalis usually produce more \\ndamage than acids. Acids typically cause coagulation necrosis, which pro-\\nduces an eschar that limits further damage. Alkalis produce liquefaction \\nnecrosis, allowing deeper damage to occur. Hydrofluoric (HF) acid is a \\nspecial case as it rapidly penetrates intact skin and can cause progressive \\npain and deep tissue destruction without obvious superficial tissue damage. \\nSystemic toxicity, including hypotension, acidosis, and shock, may occur if \\ncertain chemicals are absorbed.\\nChemical burns of the eye are true ocular emergencies. Acid ocular \\nburns quickly precipitate proteins in the superficial eye structures resulting \\nin a “ground glass” appearance of the cornea. Alkali ocular burns are more \\nsevere due to deeper ongoing penetration. Lacrimators (tear gas and pepper \\nmace) cause ocular, mucous membrane, and pulmonary irritation.\\nDiagnosis and Differential\\nThe diagnosis of chemical burn usually is made by history of exposure to a \\nchemical agent. Chemical topical exposures should be considered in all \\ncases of skin irritation and/or pain. For ocular exposures, pH paper can \\ndistinguish alkali from acid exposure.\\nemergency Department Care and Disposition\\n1. The first priority in the treatment of chemical burns is to terminate the \\nburning process. Remo ve garments. Brush off dry chemical particles. \\nImmediately irrigate the skin copiously with water. Cover elemental \\nmetals (sodium, lithium, calcium, and magnesium) with mineral oil \\nbecause exposure to water may cause a severe exothermic reaction.\\n2. For ocular burns, begin irrig ation of each involved eye with 1 to 2 L of \\nnormal saline. In patients with acid or alkali burns, continue irrigation \\nuntil the pH is normal. Patients with alkali burns may require prolonged \\nirrigation. Visual acuity check and pH testing should follow, not precede, \\ninitial ocular irrigation. Consult with an ophthalmologist.\\n3. Treatment for specif ic chemical burns is provided in Table 125-6. \\nOptions for treating cutaneous HF acid burns are provided in Table 125-7.  \\nTaBle 125-6 Treatment of Select Chemical Burns\\nChemical Treatment Comments\\nAcids\\nAll acid burns require prompt decontamination and copious irrigation with water\\nAcetic acid Copious irrigation Consider systemic antibiotics for extensive \\nscalp burns\\nPhenol (car-\\nbolic acid)\\nCopious irrigation\\nSponge with undiluted \\npolyethylene glycol \\n200–400\\nIsopropyl alcohol may also be used\\nChromic acid Copious irrigation Observe for systemic toxicity\\n(continued )\\n125_Cydulka_Ch125.indd   683 21/03/17   9:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 702, 'page_label': '684'}, page_content='684 SECTION 12: Environmental Injuries\\nTaBle 125-6 Treatment of Select Chemical Burns\\nChemical Treatment Comments\\nFormic acid Copious irrigation Dialysis may be needed for severe toxicity\\nHydrofluoric \\nacid\\nCopious irrigation\\n10% calcium gluconate \\nintradermal\\nTopical calcium gluconate \\ngel\\nConsider intradermal injection of 10% \\ncalcium gluconate or intraarterial calcium \\ngluconate for severe cases\\nMonitor serum calcium and magnesium in \\nsevere exposure\\n25 mL of 10% calcium gluconate in 75 mL  \\nof sterile water-soluble lubricant (K-Y jelly \\nor US jelly)\\nNitric acid Copious irrigation Consult with burn specialist\\nOxalic acid Copious irrigation\\nIV calcium may be \\nrequired\\nEvaluate serum electrolytes and renal function\\nCardiac monitoring for serious dermal \\nexposure\\nAlkalis\\nAll alkali burns require prompt decontamination and copious, prolonged irrigation with \\nwater\\nPortland \\ncement\\nProlonged copious \\nirrigation\\nMay need to remove cement particles with \\na brush, such as a preoperative scrubbing \\nbrush\\nElemental Metals\\nWater is generally contraindicated in extinguishing burning metal fragments embedded in \\nthe skin\\nElemental met-\\nals (sodium, \\nlithium, \\npotassium, \\nmagnesium, \\naluminum, and \\ncalcium)\\nCover metal fragments \\nwith sand, foam from a \\nclass D fire extinguisher, \\nor mineral oil\\nExcise metal fragments \\nthat cannot be wiped \\naway\\nHydrocarbons\\nGasoline Decontamination\\nTar Cool before removal\\nRemove using antibiotic \\nointment containing \\npolyoxylene sorbitan \\n(polysorbate)\\nBaby oil can be used\\nVesicants\\nMustards Decontaminate\\nCopious irrigation\\nIf limited water supply, adsorbent powders \\n(flour, talcum powder, fuller’s earth) can be \\napplied to the mustard and then wiped away \\nwith a moist towel\\nReducing Agents\\nAlkyl mercury \\ncompounds\\nCopious irrigation\\nDebride, drain, and \\ncopiously irrigate blisters\\nBlister fluid is high in metallic mercury content\\n(continued )\\n(continued)\\n125_Cydulka_Ch125.indd   684 21/03/17   9:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 703, 'page_label': '685'}, page_content='CHAPTER 125: Thermal and Chemical Burns 685 \\nConsult with a plastic surgeon for patients with HF acid burns of the \\nhands, feet, digits, or nails.\\n4. After initial decontamination measures, initiate IV fluid resuscitation, \\nanalgesia, tetanus prophylaxis, and address systemic toxicity, as needed.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 216, “Thermal Burns,” by E. Paul DeKoning; \\nChapter 217, “Chemical Burns,” by Anthony F. Pizon and Michael J. Lynch.\\nTaBle 125-6 Treatment of Select Chemical Burns\\nChemical Treatment Comments\\nLacrimators\\nTear gas Copious irrigation May cause respiratory symptoms if inhaled\\nPepper spray Copious irrigation May cause respiratory symptoms if inhaled\\nMiscellaneous\\nWhite phos-\\nphorus\\nRemove clothing\\nCopious irrigation, keep \\nexposed skin areas wet or \\nsubmerged until all par-\\nticles have been removed \\ndue to risk of ignition \\nwhen exposed to air\\nDebride visible particles\\nSystemic toxicity is a significant concern\\nAirbag Prolonged copious \\nirrigation\\nTaBle 125-7 Options for Treatment of Hydrofluoric Acid Skin Burns\\n1. Copious irrigation for 15–30 min immediately.\\n2. Application of calcium gluconate gel, 25 mL of 10% calcium gluconate in 75 mL of \\nwater-soluble lubricant.\\n3. Further treatment options as dictated by patient response:\\na. Dermal injection of 10% calcium gluconate at the rate of 0.5 mL/cm 2 of skin \\nsurface using a small-gauge needle.\\nb. Arterial infusion over 4 h (40 mL of 5% dextrose in water with 10 mL of  \\n10% calcium gluconate).\\nc. Consider supplemental magnesium and calcium IV.\\n(continued)\\n125_Cydulka_Ch125.indd   685 21/03/17   9:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 704, 'page_label': '686'}, page_content='686\\nElectrical and Lightning Injuries\\nNorberto Navarrete\\n■ ■ELECTRICAL INJURIES\\nElectrical injuries occur with a wide spectrum of damage, from superficial \\nskin burns to multisystem injury. Electrical injuries are arbitrarily classified \\nas those of low voltage (≤1000 V) and high voltage (>1000 V).\\nClinical Features\\nElectricity-induced injuries can occur via several mechanisms: (1) direct  \\ntissue damage from the electrical energy, (2) tissue damage from thermal \\nenergy, and (3) mechanical injury from trauma induced by a fall or \\nmuscle contraction. Patients may sustain immediate cardiac dysrthymias \\nincluding ventricular fibrillation, respiratory arrest, or seizures. Cardiac \\ncomplications are more commonly seen in high-voltage injuries. Tempo-\\nrary loss of consciousness is common. Severe burns may result from \\ncontact with high-voltage lines. The size of the skin injury does not cor -\\nrelate well with internal injuries. Traumatic injuries frequently accom-\\npany electrical injuries. The details of specific immediate and delayed \\nsystemic injuries and complications are summarized in Table 126-1.\\n126\\nCh A p TER\\nTabLE 126-1 Immediate and Delayed Complications of Electrical  \\nInjuries\\nCardiovascular Sudden death (ventricular fibrillation, asystole), chest pain, dysrhyth-\\nmias, ST-T segment abnormalities, bundle branch block, myocardial \\ndamage, myocardial infarction (rare), hypotension (volume depletion), \\nhypertension (catecholamine release)\\nNeurologic Altered mental status, agitation, coma, seizures, cerebral edema, \\nhypoxic encephalopathy, headache, aphasia, weakness, paraplegia, \\nquadriplegia, spinal cord dysfunction (may be delayed), peripheral \\nneuropathy, cognitive impairment, insomnia, emotional lability\\nCutaneous Electrothermal contact injuries, noncontact arc and “flash” burns, \\nsecondary thermal burns (clothing ignition, heating of metal)\\nVascular Thrombosis, coagulation necrosis, disseminated intravascular coagula-\\ntion, delayed vessel rupture, aneurysm, compartment syndrome\\nPulmonary Respiratory arrest (central or peripheral, e.g., muscular tetany), aspira-\\ntion pneumonia, pulmonary edema, pulmonary contusion, inhalation \\ninjury\\nRenal/metabolic Acute renal failure (due to heme pigment deposition and hypovolemia), \\nmyoglobinuria, metabolic (lactic) acidosis, hypokalemia, hypocalcemia, \\nhyperglycemia\\nGastrointestinal Perforation, stress ulcer (Curling ulcer), GI bleeding, GI tract dysfunc-\\ntion, various reports of lethal injuries at autopsy\\nMuscular Myonecrosis, compartment syndrome\\n(Continued)\\n126_Cydulka_Ch126.indd   686 21/03/17   9:55 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 705, 'page_label': '687'}, page_content='CHAPTER 126: Electrical and Lightning Injuries 687 \\nDiagnosis and Differential\\nThe diagnosis of electrical injury is usually based on the history of contact \\nwith an electrical source and the typical skin or oral lesions in children. \\nHowever, patients with amnesia or any other type of altered mental status, \\nwith no skin injuries, must undergo an interview and a more detailed \\nphysical examination, especially for possible thunderstorm incidents. Lab-\\noratory and radiographic evaluation of high-voltage injures should follow \\nstandard trauma guidelines. Atrial or ventricular arrhythmias, bradyarr -\\nthymias, prolonged QT intervals or ST-T wave abnormalities may be noted \\non the ECG. An elevated serum CK, myoglobin or urine myoglobin sug-\\ngests extensive muscle injury and rhabdomyolysis. Assessment and treat-\\nment of complications associated with electrical injuries are summarized in \\nTable 126-2.\\nTabLE 126-1 Immediate and Delayed Complications of Electrical  \\nInjuries\\nSkeletal Vertebral compression fractures, long bone fractures, shoulder \\ndislocations (anterior and posterior), scapular fractures\\nOphthalmologic Corneal burns, delayed cataracts, intraocular hemorrhage or \\nthrombosis, uveitis, retinal detachment, orbital fracture\\nAuditory Hearing loss, tinnitus, tympanic membrane perforation (rare), delayed \\nmastoiditis or meningitis\\nOral burns Delayed labial artery hemorrhage, scarring and facial deformity, delayed \\nspeech development, impaired mandibular/dentition development\\nObstetric Spontaneous abortion, fetal death\\nAbbreviation: GI, gastrointestinal.\\nTabLE 126-2 Assessment and Treatment of Complications of Electrical  \\nInjuries\\nCirculatory Order cardiac monitoring and ECG. Assess indications for admission for \\ncardiac monitoring.\\nRenal Initiate fluid resuscitation and monitor urine output with a Foley \\ncatheter.\\nNervous system Order head CT as needed for altered mental status; assess for spinal \\ncord and peripheral nerve injury.\\nSkin Assess and treat cutaneous burns.*\\nMusculoskeletal Perform a careful assessment of spine, pelvis, long bones, and joints. \\nAssess for compartment syndrome and need for fasciotomy.†\\nVascular Spasm may occur leading to delayed thrombosis, aneurysm formation, \\nor muscle damage.\\nCoagulation Treat coagulation disorders by eliminating the precipitating factor \\nthrough early surgical debridement. If hemorrhage is present, replace \\ncoagulation factors.\\nLungs Assess for inhalation injury, carbon monoxide, alveolar injury from \\nblast.\\nEyes Document complete eye examination. Delayed cataracts may \\ndevelop.\\n(Continued)\\n(Continued)\\n126_Cydulka_Ch126.indd   687 21/03/17   9:55 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 706, 'page_label': '688'}, page_content='688 SECTION 12: Environmental Injuries\\nThe differential diagnosis includes other causes of arrhythmias, such as \\nmyocardial ischemia and neurologic dysfunction, such as stroke, closed \\nhead injury, and spinal cord injury.\\nEmergency Department Care and Disposition\\n1. Victims should be treated as blunt multiple trauma patients with \\nattention to adv anced life-support protocols and cervical and spine \\nimmobilization.\\n2. Assess and stabilize the airway. In facial b urns due to electric flash, \\nburn injury of the airway is not common, and the need to control the \\nairway even less so. Provide high-flow oxygen and monitor with pulse \\noximetry.\\n3. Treat ventricular fibrillation, asystole, or ventricular tachycardia using \\nstandard ACLS protocols. Other dysrhythmias are usually transient and \\ndo not need immediate therapy.\\n4. Seizures occur immediately after the electric shock. A new seizure \\nrequires standard therapy and it is necessary to consider focal cerebral \\ninjury.\\n5. In compartment syndrome, consultation with a general surgeon, trauma \\nsurgeon, or burn surgeon must be requested in a priority manner.\\n6. Monitor for hyperkalemia, rhabdomyolysis, and the potential to \\ndevelop acute kidney injury. Monitor urine output with a Foley catheter. \\nInitiate crystalloid resuscitation in patients with large burns or exten-\\nsively damaged muscle. The usual fluid replacement formulas used for \\nburn patients often underestimate fluid requirements. In severe rhabdo-\\nmyolysis or myoglobinuria, use aggressive fluid rehydration aiming for \\na urine output of 2  mL/kg/h and continuing until the serum creatine \\nkinase level is less than five times normal or urine myoglobin measure-\\nments return to normal.\\n7. Burns need to be covered with dry sterile dressings. Prophylactic sys -\\ntemic antibiotics are usually not necessary unless there are large open \\ncontaminated wounds.\\n8. Administer tetanus prophylaxis, if not up to date.\\n9. Provide pain control with opioids.\\n10. Reduce and immobilize fractures and dislocations.\\n11. For pregnant patients, consult an obstetrician for fetal monitoring and \\nadmission.\\n12. Patients with more than a minor low-voltage injury should be admitted \\nfor further monitoring (Table 126-3).\\nTabLE 126-2 Assessment and Treatment of Complications of Electrical  \\nInjuries\\nEars Assess for blast injury. Document hearing. Middle and inner ear \\ndisorders and hearing loss may occur.\\nGI Intra-abdominal injury may occur from current or blast.\\nLips and oral \\ncavity\\nWatch for delayed bleeding.\\n*Refer to Chapter 125, “Thermal and Chemical Burns.”\\n†Refer to Chapter 51, “Rhabdomyolysis.”\\n(Continued)\\n126_Cydulka_Ch126.indd   688 21/03/17   9:55 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 707, 'page_label': '689'}, page_content='CHAPTER 126: Electrical and Lightning Injuries 689 \\n13. Children with isolated oral injuries or isolated hand wounds can usu-\\nally be discharged home after consultation with an ENT specialist or \\nplastic sur geon. Provide parents with instructions for controlling \\ndelayed labial artery bleeding. Arrange close follow-up with the con-\\nsulting surgeon to assess scarring and stricture.\\n14. Asymptomatic patients who sustained a low-voltage injury (≤ 240 V) \\nand have a normal ECG on presentation and normal physical exam may \\nbe discharged home.\\n■ ■INJURIES DUE TO ELECTRONIC CONTROL DEVICES\\nElectronic control devices, such as the cattle prod, stun gun, and the \\nTASER®, deliver high-voltage, low-amperage electrical pulses that induce \\ninvoluntary muscle contraction, neuromuscular incapacitation, and/or pain. \\nThe likelihood of electrical injury is minimal. Injuries are usually limited \\nto superficial punctures, and minor lacerations and cutaneous burns. The \\nmajority of deaths that have followed the use of these devices have occurred \\nin persons who were extremely ill and agitated due to psychosis, stimulant \\ndrugs, or other conditions. Ill-appearing and agitated patients should be \\nevaluated and treated in the same way as all patients who may have sus-\\ntained blunt trauma or who have ingested unknown substances. Cardiac \\nmonitoring and other testing are not needed just because a TASER ® has \\nbeen used.\\n■ ■LIGhTNING INJURIES\\nLightning is a unidirectional extremely high-voltage current that causes \\nsubstantially different injuries from those caused by high-voltage AC elec-\\ntricity. Lightning often travels over the skin, rather than through the body \\n(flashover), which may explain why most people survive. However, a sig-\\nnificant number may have permanent sequelae.\\nClinical Features\\nClinical events occur at multiple levels due to the electric effect, the high \\ntemperature generated, and mechanical effects due to the shock wave. The \\nTabLE 126-3 Indications for Admission for patients with Electrical Injuries\\nHigh voltage >600 V\\nSymptoms suggestive of systemic injury\\nCardiovascular: chest pain, palpitations\\nNeurologic: loss of consciousness, confusion, weakness, headache, paresthesias\\nRespiratory: dyspnea\\nGastrointestinal: abdominal pain, vomiting\\nEvidence of neurologic or vascular injury to a digit or extremity\\nBurns with evidence of subcutaneous tissue damage\\nDysrhythmia or abnormal electrocardiogram\\nSuspected foul play, abuse, suicidal intent, or unreliable social situation\\nPregnancy\\nAssociated injuries requiring admission\\nComorbid diseases (cardiac, renal, neurologic)\\n126_Cydulka_Ch126.indd   689 21/03/17   9:55 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 708, 'page_label': '690'}, page_content='690 SECTION 12: Environmental Injuries\\nmost common immediate cause of death after lightning strike is primary or \\nsecondary hypoxic cardiac arrest due to respiratory arrest. In the patient \\nwith spontaneous circulation, hypertension and tach ycardia are caused by \\nsympathetic activation. Patients may experience temporary loss of con-\\nsciousness, confusion, and amnesia. Feathering or fern-shaped burns on the \\nskin are pathognomonic of lightning but are transient and rarely seen. \\nTympanic membrane rupture may occur by blast effect. Deep tissue inju-\\nries, myoglobinuria, and renal failure are uncommon. The details of spe-\\ncific immediate and delayed systemic injuries and complications are \\nsummarized in Table 126-4.\\nDiagnosis and Differential\\nThe diagnosis of lightning injury is based on history and should be consid-\\nered in any critically ill patient found outside during or after a thunder -\\nstorm. While increasingly rare, indoor exposures to lightning may occur via \\nindoor pools, use of hard-wired telephones, or in poorly constructed struc-\\ntures. Carefully assess patients for neurologic and cardiovascular complica-\\ntions, otologic and ophthalmologic injuries, and blunt trauma. Burns are \\nuncommon. Laboratory and radiographic evaluation of lightning injures \\nshould follow standard trauma guidelines. Differential diagnosis includes \\nstroke or intracranial hemorrhage, seizure disorder, and cerebral, spinal \\ncord, or other neurologic trauma.\\nEmergency Department Care and Disposition\\n1. Victims should be treated as blunt multiple trauma patients with atten-\\ntion to advanced life-support protocols and cervical and spine  \\nimmobilization.\\nTabLE 126-4 Complications Associated with Lightning Injuries\\nSystem Injury\\nCardiovascular Dysrhythmias (asystole, ventricular fibrillation/tachycardia, premature \\nventricular contractions), electrocardiographic changes, myocardial \\ninfarction (unusual)\\nNeurologic Immediate or delayed, permanent or transient; loss of consciousness, \\nconfusion, amnesia, intracranial hemorrhage, hemiplegia, amnesia, \\nrespiratory center paralysis, cerebral edema, neuritis, seizures, parkin-\\nsonian syndromes, cerebral infarction, myelopathy, progressive mus-\\ncular atrophy, progressive cerebellar syndrome, transient paralysis, \\nparesthesias, myelopathy, autonomic dysfunction\\nCutaneous Burns (first to third degree), scars, contractures\\nOphthalmologic Cataracts (often delayed), corneal lesions, uveitis, iridocyclitis, \\nvitreous hemorrhage, macular degeneration, optic atrophy, diplopia, \\nchorioretinitis, retinal detachment, hyphema\\nOtologic Tympanic membrane rupture, temporary or permanent deafness, \\ntinnitus, ataxia, vertigo, nystagmus\\nRenal Myoglobinuria, hemoglobinuria, renal failure (rare)\\nObstetric Fetal death, placental abruption\\nMiscellaneous Secondary blunt trauma, compartment syndrome, disseminated \\nintravascular coagulation\\n126_Cydulka_Ch126.indd   690 21/03/17   9:55 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 709, 'page_label': '691'}, page_content='CHAPTER 126: Electrical and Lightning Injuries 691 \\n2. In the event of mass casualties, in contrast to standard triage, pro vide \\naggressive resuscitation in patients with respiratory and cardiac arrest \\ndue to lightning strike. Respiratory arrest may outlast initial cardiac \\narrest and adequate ventilation can prevent hypoxic injury until return \\nof spontaneous circulation.\\n3. Treat arrhythmias using standard ACLS protocols.\\n4. Provide continuous monitoring of vital signs, heart rate and rhythm, and \\npulse oximetry. Provide high-flow oxygen and begin IV crystalloids.\\n5. Hypertension is frequent but transient and is not an indication for \\ntherapy. Hypotension is une xpected and should prompt investigation \\nfor hemorrhage.\\n6. Early seizures are probably due to early anoxia. Persistent seizures \\nrequire standard therapy and it is necessary to consider focal cerebral \\ninjury.\\n7. Keraunoparalysis, transient weakness in limbs following a lightning \\nstrike, should be a diagnosis of exclusion. Always investigate for other \\npossible causes of paresis secondary to blunt trauma. In pulseless \\nextremities, fasciotomies are only indicated with high intracompart-\\nmental pressure.\\n8. In patients with b urns and wounds, administer tetanus prophylaxis, if \\nnot up to date. Prophylactic antibiotics are not indicated unless there is \\ncontamination with organic material.\\n9. Admit patients with persistent musculoskeletal symptoms, neurologic, \\ncardiac rhythm, or vascular abnormalities, or signif icant burns to a \\ncritical care unit. Consult with a general surgeon, trauma surgeon, or \\nburn surgeon. All pregnant patients require obstetric consultation and \\nreferral for fetal monitoring.\\n10. Patients with minor injuries and a negative workup may be discharged \\nwith outpatient follow-up to assess delayed effects of lightning injury.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 218, “Electrical and Lightning Injuries” by Caitlin \\nBailey\\n126_Cydulka_Ch126.indd   691 21/03/17   9:55 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 710, 'page_label': '692'}, page_content='692\\nCarbon Monoxide\\nJon B. Cole\\nCarbon monoxide is a colorless, odorless, nonirritating gas that displaces \\noxygen from hemoglobin, resulting in early tissue hypoxia and delayed \\nneurologic damage. Sources of exposure to carbon monoxide include the \\nincomplete combustion of any carbonaceous fuel (e.g., gasoline, kerosene, \\nnatural gas, and charcoal) or the metabolism of inhaled methylene chloride \\n(paint stripper).\\n■ ■CLINICAL FEATURES\\nA history of exposure to gas- or propane-powered motors or heaters, \\nsmoke inhalation, or multiple victims with altered mental status, acido-\\nsis, or coma should alert one to the possibility of carbon monoxide poi-\\nsoning. The clinical features of carbon monoxide poisoning are highly \\nvariable and primarily relate to hypoxic effects on the cardiovascular and \\nneurologic systems (Table 127-1). Symptoms range from “flu-like,” such \\nas headache, dizziness, nausea, and vomiting, to coma. The “classic find-\\ning” of cherry red lips is rarely seen in living patients. Patients with \\nsignificant poisoning may experience long-term neurological and cogni-\\ntive problems.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nBlood cooximetry is the most reliable test to diagnose carbon monoxide \\npoisoning. Although elevated carboxyhemoglobin (COHb) levels confirm \\nexposure, they do not necessarily correlate with symptoms or prognosis. \\nBaseline COHb may be as high as 5% in nonsmokers and 10% in \\nsmokers. Higher levels are suggestive of CO exposure. The use of bedside \\npulse cooximetry in the ED to screen for CO exposure is still under \\ninvestigation.\\n127\\nCh A p TER\\nTable 127-1 Signs and Symptoms of Acute Carbon Monoxide poisoning\\nHeadache\\nVisual disturbances\\nVomiting\\nConfusion\\nAtaxia\\nDyspnea/tachypnea\\nSeizure\\nIschemic ECG changes and/or dysrhythmias\\nSyncope\\nRetinal hemorrhage\\nChest pain\\nBullous skin lesions\\nFocal neurologic deficit\\n127_Cydulka_Ch127.indd   692 21/03/17   10:01 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 711, 'page_label': '693'}, page_content='CHAPTER 127: Carbon Monoxide 693 \\nStandard pulse oximetry is unreliable in the presence of increasing \\nCOHb as oxygen saturation readings will be artificially high or normal. \\nAdditional laboratory and imaging abnormalities seen in symptomatic  \\npatients may include elevated anion gap metabolic acidosis, elevated \\nlactate, elevated creatine phosphokinase, elevated troponin, ECG changes \\nconsistent with ischemia, and bilateral globus pallidus lesions on brain \\nimaging.\\nThe differential diagnosis is wide due to the nonspecific nature of the \\nsymptoms and includes flu-like illness, gastroenteritis, exposure to other \\ntoxins, and infectious causes of mental status changes. Cardiovascular \\ncompromise after poisoning may represent a concomitant myocardial \\ninfarction.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nRemove patients from the source of exposure and address airway, breath-\\ning, and circulation.\\n1. Begin treatment in all patients suspected of CO poisoning with the \\nhighest concentration of supplemental oxygen av ailable (e.g., 100% \\noxygen via facemask with reservoir) and continue until the patient is \\nasymptomatic. Provide continuous monitoring of vital signs, heart rate, \\nand rhythm. Establish IV access.\\n2. Guidelines for hyperbaric oxygen therapy  (HBO) in patients with \\nsevere poisoning are listed in Table 127-2. Indications for pediatric and \\nadult HBO are similar. The threshold COHb for initiating HBO in preg-\\nnant patients is lower because of concerns for the fetus. Consult with a \\nhyperbaric specialist. Patients must have a secure airway and stable \\nhemodynamics before transport and treatment with HBO as access may \\nbe limited en route and in the hyperbaric chamber.\\n3. Guidelines for disposition are listed in Table 127-3. Ensure that the \\nhome or w ork environment is no longer a source of carbon monoxide \\nexposure.\\nTable 127-2 Commonly Utilized Indications for Referral for hyperbaric \\nOxygen Treatment\\nSyncope\\nConfusion/altered mental status\\nSeizure\\nComa\\nFocal neurologic deficit\\nPregnancy with carboxyhemoglobin >15%\\nCarboxyhemoglobin >25% in any patient\\nEvidence of acute myocardial ischemia\\n127_Cydulka_Ch127.indd   693 21/03/17   10:01 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 712, 'page_label': '694'}, page_content='694 SECTION 12: Environmental Injuries\\nTable 127-3 Disposition Considerations\\nSymptom Severity Disposition Comments\\nMinimal or no symptoms Home Assess safety issues\\nHeadache\\nVomiting\\nElevated carbon \\nmonoxide level\\nHome after symptom \\nresolution\\nAdminister 100% oxygen in ED\\nObserve 4 h\\nAssess safety issues\\nAtaxia, seizure, syncope, \\nchest pain, focal neurologic \\ndeficit, dyspnea, ECG \\nchanges\\nHospitalize\\nConsult with \\nhyperbaric specialist\\nAdminister 100% oxygen in ED\\nCarbon monoxide level, comorbid \\nconditions, including pregnancy, \\nage, and stability of the patient \\nmust be considered if considering \\ntransfer for hyperbaric oxygen\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 222, “Carbon Monoxide,” by Gerald Maloney.\\n127_Cydulka_Ch127.indd   694 21/03/17   10:01 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 713, 'page_label': '695'}, page_content='695\\nMushroom and Plant Poisoning\\nChulathida Chomchai\\n■ ■MUSHROOMS\\nMushroom poisoning occurs in four population groups: foragers who pur -\\nposefully harvest mushrooms or plants for food; teenagers and young adults \\nwho use mushrooms to get “high”; preschool-age children who acciden-\\ntally ingest mushrooms while playing outdoors; and, rarely, victims of \\nattempted homicide or suicide.\\nClinical Features\\nMushroom toxicity is divided into those with early onset, defined as within  \\n2 hours after ingestion, and delayed onset, defined as 6 hours to 20 days \\nafter ingestion. It is important to determine if patients ingested only one \\ntype or multiple types of mushrooms and the time elapsed from ingestion \\nto symptoms. Foragers may be able to provide a description of the mush-\\nroom. Clinical features of common mushroom poisonings are listed in \\nTable 128-1.\\nDiagnosis and Differential\\nMost patients who develop GI symptoms within 2 hours of ingestion \\nhave a reassuring clinical course and do not develop major organ failure \\n(Table 128-1). An exception to this is Amanita smithiana ingestion, \\nwhich results in early GI symptoms and delayed renal failure. Mush-\\nrooms with potential liver, kidney, and CNS effects are often associated \\nwith onset of vomiting that is delayed for 6 or more hours after inges-\\ntion. Toxic species include species of genera Amanita, Galerina, \\nGyromitra, and Lepiota. Ingestions may be misdiagnosed as viral gas-\\ntrointestinal illness or food poisoning if a history of mushroom ingestion \\nis not pursued.\\nEmergency Department Care and Disposition\\nConsultation with a poison center is advised as regional differences in \\nmushrooms types and toxicity exist.\\n1. Treatment regimens for mushroom poisonings are listed in Table 128-1.\\n2. Admit all patients with delayed onset of vomiting or diarrhea for \\nongoing monitoring of renal and li ver function and fluid status for  \\n48 hours.\\n3. Rapid progression to hepatic encephalopathy, hepatorenal syndrome, \\nor coagulopath y are indications for liver transplantation. Consider \\ntransfer to a liver transplant center early in the course of mushroom \\ningestion.\\n4. Patients who ingest hallucinogenic mushrooms or mushrooms with \\nmuscarinic effects only may be dischar ged when symptoms subside.\\n128\\nC H apte R\\n128_Cydulka_Ch128.indd   695 21/03/17   10:21 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 714, 'page_label': '696'}, page_content='696 SECTION 12: Environmental Injuries\\nTablE 128-1 Mushrooms: Symptoms, toxicity, and treatment\\nSymptoms Mushrooms toxicity treatment\\nGastrointestinal  \\nsymptoms\\n    Onset <2 h Chlorophyllum \\nmolybdites\\nOmphalotus illudens\\nCantharellus cibarius\\nNausea, vomiting, \\ndiarrhea (occa-\\nsional bloody)\\nIV hydration\\nAntiemetics\\n    Onset 6–24 h Amanita smithiana\\n(delayed renal failure)\\nAmanita phalloides, \\nAmanita verna, \\nAmanita virosa\\nLepiota sp.\\n(delayed liver failure)\\nGyromitra esculenta\\n(delayed onset \\nseizures)\\nInitial: nausea, \\nvomiting, diarrhea\\nDay 2: rise in AST, \\nALT\\nDay 3: hepatic fail-\\nure coagulopathy\\nrenal failure\\nhemolysis\\nAs above + \\nheadache, tremor, \\nataxia, seizures\\nIV hydration; closely \\nmonitor electrolytes, \\nglucose, renal, hepatic, \\nand coagulation functions\\nFor Amanita and Lepiota:\\nAcetylcysteine, load \\nwith 140  mg/kg PO/NG\\nPenicillin G 300,000 \\nto 1,000,000  U/kg IV \\nper day\\nSilymarin 5 mg/kg IV \\nover 1 h, then 20  mg/kg\\nIV per day (available PO \\nin the United States)\\nFor Gyromitra, treat \\nseizures with both \\nbenzodiazepines AND \\npyridoxine 5 g IV\\nMuscarinic \\n(SLUDGE) \\nsyndrome\\nInocybe sp. Salivation, lacri-\\nmation, diarrhea, \\ngastrointestinal \\ndistress, emesis\\nSupportive, atropine \\n0.01 mg/kg IV repeated \\nas needed for severe \\nsecretions   Onset <30 min Clitocybe sp.\\nCNS excitement Amanita muscaria Intoxication, dizzi-\\nness, ataxia, visual \\ndisturbances, sei-\\nzures, tachycardia, \\nhypertension, warm \\ndry skin, dry mouth, \\nmydriasis (anticho-\\nlinergic effects)\\nSupportive, sedation with \\ndiazepam 2–5 mg IV as \\nneeded for adults  Onset <30 min Amanita pantherina\\nAmanita gemmata\\nHallucinations Paneolus Visual hallucina-\\ntions, ataxia\\nSupportive, sedation with \\nor diazepam 2–5 mg IV for \\nadults  Onset <30 min Psilocybe sp.\\nGymnopillus \\nspectabilis\\nDisulfiram Coprinus atramen-\\ntarius\\nHeadache, flush-\\ning, tachycardia, \\nhyperventilation, \\npalpitations\\nSupportive IV hydration\\n   Onset 2–72 h \\nafter mushroom, \\nand <30 min \\nafter alcohol\\nClitocybe clavipes\\nAbbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; BUN, blood urea nitrogen; \\nCNS, central nervous system; IV, intravenous; PT, prothrombin time; PTT, partial thromboplastin time; SLUDGE \\nsyndrome, salivation, lacrimation, urination, defecation, gastrointestinal hypermotility, and emesis.\\n128_Cydulka_Ch128.indd   696 21/03/17   10:21 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 715, 'page_label': '697'}, page_content='CHAPTER 128: Mushroom and Plant Poisoning 697 \\n■ ■pLaNtS\\nMost patients with plant-related exposures and ingestions require no \\ntreatment and may be discharged after a short period of observation. \\nTables 128-2 and 128-3 describe the clinical symptoms and treatment \\nregimens of common and severe poisonous plant ingestions.\\nTablE 128-2 Symptoms and treatment of Severely poisonous plant Ingestions\\nplant Symptoms treatment\\nCastor bean (Ricinus \\ncommunis)\\nDelayed gastroenteritis, delirium, \\nseizures, coma, death\\nWhole-bowel irrigation\\nSupportive care\\nCoyotillo (Karwinskia \\nhumboldtiana)\\nAscending paralysis Supportive care\\nFoxglove (Digitalis \\npurpurea)\\nNausea, vomiting, diarrhea, \\nabdominal pain, confusion, \\ncardiac dysrhythmias\\nGI decontamination with \\nactivated charcoal \\nMonitoring of potassium level\\nAntidysrhythmics\\nDigoxin-specific Fab antibody \\nfor dysrhythmias\\nJequirity bean (Abrus \\nprecatorius)\\nDelayed gastroenteritis, delirium, \\nseizures, coma, death\\nWhole-bowel irrigation\\nSupportive care\\nOleander (Nerium \\noleander)\\nNausea, vomiting, diarrhea, \\nabdominal pain, confusion, \\ncardiac dysrhythmias\\nGI decontamination with \\nactivated charcoal \\nMonitoring of potassium level\\nAntidysrhythmics\\nDigoxin-specific Fab antibody \\nfor dysrhythmias\\nPoison hemlock \\n(Conium maculatum)\\nTachycardia, tremors, diaphoresis, \\nmydriasis, muscle weakness, \\nseizures, neuromuscular blockade\\nGI decontamination with \\nactivated charcoal\\nSupportive care\\nWater hemlock \\n(Cicuta maculata)\\nNausea, vomiting, abdominal \\npain, delirium, seizures, death\\nGI decontamination\\nSupportive care\\nYew (Taxus species) Common: nausea, vomiting, \\nabdominal pain\\nRare: seizures, cardiac dysrhyth-\\nmias, coma\\nGI decontamination with acti-\\nvated charcoal \\nConsider whole-bowel irrigation\\nSupportive care\\nTablE 128-3 Symptoms and treatment of Common poisonous plant Ingestions \\nor exposures\\nplant Symptoms treatment\\nAckee (Blighia sapida) Hypoglycemia Glucose\\nAloe (Aloe barbaden-\\nsis)\\nAbdominal pain, diarrhea, red \\nurine, nephritis\\nSupportive care\\nAzalea (Rhododendron \\nspecies)\\nUsually minor symptoms\\nSevere intoxication: salivation, \\nlacrimation, bradycardia, \\nhypotension, progressive \\nparalysis\\nGI decontamination with \\nactivated charcoal\\nAtropine for symptomatic \\nbradycardia\\nFluids or vasopressors for \\nhypotension\\n(Continued)\\n128_Cydulka_Ch128.indd   697 21/03/17   10:21 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 716, 'page_label': '698'}, page_content='698 SECTION 12: Environmental Injuries\\nTablE 128-3 Symptoms and treatment of Common poisonous plant Ingestions \\nor exposures\\nplant Symptoms treatment\\nCactus Pain and irritation from embed-\\nded spines\\nRemoval of spines\\nRubber cement peel\\nCaladium species Usually minor symptoms\\nSevere intoxication: burning \\nand irritation of oral mucosa, \\nswelling, drooling, dysphagia, \\nrespiratory compromise\\nIngest cold milk or ice cream for \\noral burning bradycardia\\nFluids or vasopressors for \\nhypotension\\nColchicum (autumn \\ncrocus, meadow \\nsaffron, glory lily)\\nDelayed and severe gastroen-\\nteritis → severe multi-system \\norgan failure\\nGI decontamination with \\nactivated charcoal\\nAggressive fluid resuscitation\\nDumbcane \\n(Dieffenbachia \\namoena)\\nUsually minor symptoms\\nSevere intoxication: burning \\nand irritation of oral mucosa, \\nswelling, drooling, dysphagia, \\nrespiratory compromise\\nIngest cold milk or ice cream for \\noral burning\\nAnalgesics\\nConsider steroids if severe \\nsymptoms\\nFava beans (Vicia faba) In persons with glucose-\\n6-phosphate dehydrogenase \\ndeficiency: GI upset, fever, \\nheadache, hemolytic anemia, \\nhemoglobinuria, jaundice\\nTreatment varies depending on \\ndegree of hemolysis seen\\nHenbane (Hyoscyamus \\nniger)\\nAnticholinergic symptoms: \\nhallucinations, mydriasis, \\ntachycardia, agitation, seizures, \\ncoma\\nConsider physostigmine in \\nsevere cases\\nJimsonweed (Datura \\nspecies)\\nAnticholinergic symptoms: \\nhallucinations, mydriasis, \\ntachycardia, agitation, seizures, \\ncoma\\nGI decontamination with acti-\\nvated charcoal\\nConsider whole-bowel irrigation\\nSupportive care\\nLily of the valley \\n(Convallaria majalis)\\nNausea, vomiting, diarrhea, \\nabdominal pain, confusion, \\ncardiac arrhythmias\\nGI decontamination with \\nactivated charcoal\\nMonitoring of potassium level\\nAntiarrhythmics\\nDigoxin-specific Fab antibody \\nfor arrhythmias\\nMonkshood (Aconitum \\nspecies)\\nBradycardia, heart block, tor-\\nsades de pointes, ventricular \\nfibrillation\\nGI decontamination with \\nactivated charcoal\\nSupportive care\\nNettle (stinging nettle, \\nbull nettle) (Urtica \\nspecies)\\nLocalized burning Symptomatic care\\nNightshade, common \\nor woody (Solanum \\nspecies)\\nNausea, vomiting, diarrhea, \\nabdominal pain; with larger \\ndoses: delirium, hallucinations, \\ncoma\\nSupportive care\\nNightshade, deadly \\n(Atropa belladonna)\\nAnticholinergic symptoms: \\nhallucinations, mydriasis, \\ntachycardia, agitation, seizures, \\ncoma\\nGI decontamination with \\nactivated charcoal\\nSupportive care\\n(Continued)\\n(Continued)\\n128_Cydulka_Ch128.indd   698 21/03/17   10:21 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 717, 'page_label': '699'}, page_content='CHAPTER 128: Mushroom and Plant Poisoning 699 \\nTablE 128-3 Symptoms and treatment of Common poisonous plant Ingestions \\nor exposures\\nplant Symptoms treatment\\nPeach, apricot, pear, \\ncrab apple, yam bean, \\nand hydrangea (pits or \\nseeds)\\nAcute cyanide toxicity if \\nlarge amounts are ingested: \\ndiaphoresis, nausea, vomiting, \\nabdominal pain, lethargy\\nGI decontamination with \\nactivated charcoal\\nWhole-bowel irrigation Cyanide \\nantidote therapy\\nPepper (Capsicum \\nspecies)\\nIrritation and pain on contact Copious irrigation with water\\nMilk or ice cream for oral \\nirritation\\nAnalgesics\\nPhilodendron species Usually minor symptoms\\nSevere intoxication: burning \\nand irritation of oral mucosa, \\nswelling, drooling, dysphagia, \\nrespiratory compromise\\nCold milk or ice cream for oral \\nirritation\\nAnalgesics\\nConsider steroids\\nPokeweed (Phytolacca \\namericana)\\nMucosal irritation, abdominal \\npain, nausea, vomiting, profuse \\ndiarrhea\\nSevere intoxication: coma, \\ndeath\\nGI decontamination with \\nactivated charcoal\\nSupportive care\\nPotato, eggplant (raw) \\n(Solanum species)\\nNausea, vomiting, diarrhea, \\nabdominal pain\\nWith larger doses: delirium, \\nhallucinations, coma\\nSupportive care\\nPothos (devil’s ivy, \\nEpipremnum species)\\nUsually minor symptoms\\nSevere intoxication: burning \\nand irritation of oral mucosa, \\nswelling, drooling, dysphagia, \\nrespiratory compromise\\nCold milk or ice cream for oral \\nirritation\\nAnalgesics\\nConsider steroids\\nYellow sage (Lantana \\ncamara)\\nDilated pupils, vomiting, diar-\\nrhea, weakness, coma\\nGI decontamination with \\nactivated charcoal\\nFluids\\nToxicodendron species \\n(poison ivy, oak, and \\nsumac)\\nDermatitis Skin protection\\nAntipruritic and topical \\ntherapies\\nSystemic steroids for facial, \\ngenital, or widespread \\ninvolvement\\nHolly (Ilex species) Gastroenteritis\\nCan be fatal if significant \\ningestion\\nGI decontamination with \\nactivated charcoal\\nSupportive care\\nPoinsettia (Euphorbia \\npulcherrima)\\nOccasional local irritation —\\nAmerican mistletoe \\n(Phoradendron \\nflavescens)\\nGastroenteritis GI decontamination with \\nactivated charcoal\\nSupportive care\\nEaster lily (Lilium \\nlongiflorum)\\nToxicity has not been reported \\nin humans\\nNo treatment necessary\\n(Continued)\\n128_Cydulka_Ch128.indd   699 21/03/17   10:21 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 718, 'page_label': '700'}, page_content='700 SECTION 12: Environmental Injuries\\n■ ■FURtHeR ReaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 219, “Mushroom Poisoning,” by Anne F. Brayer and \\nLynette Froula; and Chapter 220, “Poisonous Plants,” by Betty C. Chen and \\nLewis S. Nelson.\\n128_Cydulka_Ch128.indd   700 21/03/17   10:21 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 719, 'page_label': '701'}, page_content='701\\nDiabetic Emergencies\\nMichael P . Kefer\\n■ ■HYPOGLYCEMIA\\nHypoglycemia in diabetics is usually a complication of treatment with \\ninsulin or sulfonylureas (chlorpropamide, glyburide, glipizide). Hypoglyce-\\nmia is unlikely due to the glitizones (rosiglitazone, pioglitazone), glinides \\n(repaglinide, nateglinide), alpha-glucosidase inhibitors (acarbose, miglitol), \\nand rare, if ever, due to the biguanide metformin, the incretin analogues \\n(exenatide, liraglutide), or the amylin analogue pramlintide.\\nClinical Features\\nTypical signs and symptoms of hypoglycemia include sweating, shakiness, \\nanxiety, nausea, dizziness, palpitations, slurred speech, blurred vision, \\nheadache, seizure, focal neurologic deficits, and altered mental status rang-\\ning from confusion to coma.\\nDiagnosis and Differential\\nThe diagnosis is based on detecting low blood glucose during the occur -\\nrence of typical signs and symptoms which resolve with treatment. Hypo-\\nglycemia can easily be misdiagnosed as a neurologic or psychiatric \\ncondition. The differential diagnosis includes stroke, seizure disorder, head \\ninjury, multiple sclerosis, psychosis, depression, and alcohol or drug \\nintoxication.\\nEmergency Department Care and Disposition\\n1. Administer glucose. Provide a carbohydrate meal when the patient can \\ntolerate PO. Treat patients with altered mental status with 50% dextrose \\n50 mL IV . A continuous infusion of 10% dextrose solution may be \\nrequired to maintain the blood glucose above 100 mg/dL.\\n2. Administer glucagon 1 mg IM or SC if there is no IV access.\\n3. Treat refractory h ypoglycemia secondary to the sulfonylureas with \\noctreotide 50 to 100 μg SC. A continuous infusion of 125 μg/h may be \\nrequired.\\n4. Repeat blood glucose every 30 minutes initially to monitor for rebound \\nhypoglycemia.\\n129\\nC HAP t E r\\n13\\nSEC t ION\\nEndocrine Emergencies\\n129_Cydulka_Ch129.indd   701 22/04/17   4:41 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 720, 'page_label': '702'}, page_content='702 SECTION 13: Endocrine Emergencies\\n■ ■DIABEtIC KEtOACIDOSIS\\nDiabetic ketoacidosis (DKA) results from a relative insulin deficiency and \\ncounter-regulatory hormone excess causing hyperglycemia and ketonemia. \\nTable 129-2 lists important causes.\\nTablE 129-1 Disposition/Guidelines for Hospital Admission\\nInpatient care for type 2 diabetes mellitus is generally appropriate for the following \\nclinical situations:\\nLife-threatening metabolic decompensation such as diabetic ketoacidosis or \\nhyperglycemic hyperosmolar nonketotic state\\nSevere chronic complications of diabetes, acute comorbidities, or inadequate \\nsocial situation\\nHyperglycemia (>400 mg/dL [>22 mmol/L]) associated with severe volume depletion \\nor refractory to appropriate interventions\\nHypoglycemia with neuroglycopenia (altered level of consciousness, altered behavior, \\ncoma, seizure) that does not rapidly resolve with correction of hypoglycemia\\nHypoglycemia resulting from long-acting oral hypoglycemic agents\\nFever without an obvious source in patients with poorly controlled diabetes\\nTablE 129-2 Important Causes of Diabetic Ketoacidosis\\nOmission or reduced daily insulin injections\\nDislodgement/occlusion of insulin pump catheter\\nInfection\\nPregnancy\\nHyperthyroidism, pheochromocytoma, Cushing’s syndrome\\nSubstance abuse (cocaine)\\nMedications: steroids, thiazides, antipsychotics, sympathomimetics\\nHeat-related illness\\nCerebrovascular accident\\nGI hemorrhage\\nMyocardial infarction\\nPulmonary embolism\\nPancreatitis\\nMajor trauma\\nSurgery\\n5. Disposition depends on the patient’s response to treatment, cause of \\nhypoglycemia, comorbid conditions, and social situation. Most insulin \\nreactions respond rapidly. Patients can be discharged with instructions to \\ncontinue carbohydrate intake and monitor their glucose. Patients with \\nhypoglycemia due to the sulfonylureas or long acting insulins should be \\nadmitted due to the risk of rebound from these agents. See Table 129-1 \\nfor admission guidelines.\\n129_Cydulka_Ch129.indd   702 22/04/17   4:41 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 721, 'page_label': '703'}, page_content='CHAPTER 129: Diabetic Emergencies 703 \\nClinical Features\\nHyperglycemia causes an osmotic diuresis resulting in dehydration, hypo -\\ntension, and tachycardia. Ketonemia causes an acidosis with myocardial \\ndepression, vasodilation, and compensatory Kussmaul respiration. Nausea, \\nvomiting, and abdominal pain are common. The absence of fever does not \\nexclude infection. Acetone, formed from oxidation of ketone bodies, causes \\nthe characteristic fruity odor of the patient’s breath.\\nDiagnosis and Differential\\nDiagnosis of DKA is based on laboratory values of glucose >250 mg/dL, \\nanion gap >10 mEq/L, bicarbonate <15 mEq/L, pH <7.3, and a moderate \\nketonemia/ketonuria. Beware of “euglycemic ketoacidosis” where blood \\nglucose is only mildly elevated but the other criteria are present. This may \\noccur if the patient has just taken insulin, has impaired gluconeogenesis \\n(alcoholics), or takes a sodium-glucose cotransporter 2 inhibitor, such as \\ncanaglifozin.\\nAn anion gap metabolic acidosis results from formation of ketone bod-\\nies. In DKA, the conversion of acetoacetate to β-hydroxybutyrate is favored \\nwhich can result in low acetoacetate levels and high β-hydroxybutyrate \\nlevels. If the nitroprusside test is used to detect serum or urine ketones, it \\nmay be falsely low or negative as it only detects acetoacetate, not \\nβ-hydroxybutyrate.\\nOsmotic diuresis results in loss of sodium, chloride, calcium, phospho-\\nrus, and magnesium. Serum and urine glucose and ketones are elevated. \\nPseudohyponatremia is common: for each 100 mg/dL increase in blood \\nglucose, the sodium decreases by 1.6 mEq/L, though some recommend this \\ncorrection factor be 2.4, especially if glucose >400 mg/dL. Serum potas-\\nsium may be low from osmotic diuresis and vomiting, normal, or high from \\nacidosis. In acidosis, potassium is driven extracellularly. Note the acidotic \\npatient with normal or low potassium has marked depletion of total body \\npotassium.\\nLaboratory investigation includes serum pH, glucose, electrolytes, \\nblood urea nitrogen, creatinine, phosphorus, magnesium, complete blood \\ncount, urinalysis (and pregnancy if indicated), electrocardiogram, and chest \\nradiograph to assess the severity of DKA and search for the underlying \\ncause. Determine pH using venous blood. The difference between venous \\nand arterial pH (0.03) is not clinically significant, so the risk and pain of \\narterial puncture is unnecessary.\\nThe differential diagnosis includes hypoglycemia, hyperosmolar hyper-\\nglycemic state, alcoholic or starvation ketoacidosis, renal failure, lactic \\nacidosis, and ingestions such as salicylate, methanol, ethylene glycol, iron, \\nor isoniazid.\\nEmergency Department Care and Disposition\\n1. The goal of treatment is to correct the volume deficit, acid–base \\nimbalance, and electrolyte abnormalities, administer insulin, and  \\ntreat the underlying cause (Fig. 129-1). See Table 129-1 for admis-\\nsion guidelines.\\n129_Cydulka_Ch129.indd   703 22/04/17   4:41 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 722, 'page_label': '704'}, page_content='704 SECTION 13: Endocrine Emergencies\\nFigurE 129-1.  Timeline for the typical adult patient with suspected diabetic \\nketoacidosis. *IV insulin infusion <1.0 U/kg/h may require a bolus dose of regular \\ninsulin (0.1 U/kg). AG, anion gap; ARDS, acute respiratory distress syndrome; BS, \\nblood sugar; ECG, electrocardiogram; ICU, intensive care unit; I/Os, inputs/outputs; \\nNS, normal saline; TKO, to keep vein open; VBG, venous blood gas.\\nTreatment\\nBrief history/examination\\nMonitor, glucose, ECG, urine/serum ketones\\nIV    #1 NS 15–20 mL/kg/h for first hour\\n       #2 0.5 NS TKO\\nSend electrolytes, CBC, phosphate,\\ncalcium, magnesium, VBG, consider\\nblood/urine culture.  \\nIf initial [K+] >5.2 initiate IV infusion of regular\\ninsulin at 0.1–0.14 U/kg/h*. Repeat [K+]\\nSTAT in 2 h (fluid rate guide below)\\nIf initial [K+] is >3.3 and <5.2 and urine output\\nadd 20–30 mEq of K+ to each liter of fluid\\nand insulin drip as above\\nIf initial [K+] is <3.3 hold insulin drip and give\\nK+ @20–30 mEq/h until [K+] is >3.3 then\\ninitiate insulin drip as above    \\nAfter NS bolus: Generally for eunatremia or\\nhypernatremia give 0.45 NS @250–500 mL/h\\nwith K+  supplement as above.\\nFor hyponatremia continue NS at 250–500 mL/h\\nIf pH <6.9 may give 100 mmol NaHCO3 in\\n400 mL of water with 20 eq KCL at 200 mL/h.\\nRepeat every 2 h until pH > 7.0. Check [K+]\\nevery 2 h\\nActive    -Adequate fluid infusion\\nGoals: -Insulin infusing\\n   -Maintain [K+] 3.3–5.2\\n   -Lower glucose by 75 mg/dL/h\\n   -Maintain adequate electrolytes\\n    (Ca, Mg, Phos)\\nWhen glucose approaches 200 (11 mmol/L)\\nchange IV to D5 0.5 NS with 20–40 mEq KCL/L\\nand/or decrease insulin rate to 0.02–0.05 U/kg/h\\nCorrect estimated fluid deficits in the first 24–36 h\\nMaintain serum glucose 180–200 (10–11 mmol/L)\\nand continue insulin drip for at least 12 h or\\nuntil DKA resolves: glucose <200 (11 mmol/L)\\nand AG normal, pH >7.3 and HCO3 >15\\nPatient able to eat: give SC short- and long-\\nacting insulin, feed patient, discontinue IV\\ninsulin 1–2 h AFTER SC insulin    \\nTime\\n0\\n1 h\\n2 h\\n         3 h\\n4–12 h\\n12–48 h\\nComments\\nIf glucose >250 (12.8 mosm/L), urine +\\nketones, assume DKA, search for\\nprecipitant, infection, check ECG for\\nhyperkalemia, infarction, foley catheter\\nas needed\\nBegin flow sheet of vital signs, mental\\nstatus, BS, lytes, AG, venous pH, I/Os \\nPerform detailed history and exam \\nInitial electrolytes: check osmolarity, \\nAG, BS, corrected [Na+], potassium\\nInitial [K+] determines further therapy\\nAdequate urine output is essential\\nbefore initiating K+ therapy\\nRepeat glucose, electrolytes, AG\\nIf AG >25 or glucose >800\\n(44 mosmol/L) or significant\\ncomorbidity, consider ICU disposition \\nIf AG <25 and glucose <800\\n(44 mosmol/L) and no significant\\ncomorbidity, consider floor or diabetic\\nunit disposition \\nRate of hydration is dependent on\\nhemodynamics, hydration status,\\nurine output \\nPatients with pH > 6.9 do not require\\nNaHCO3\\nRecheck glucose, lytes, AG, VBG,\\nmental status, I/Os, check results of\\ninitial phosphate, magnesium, calcium.\\nCheck electrolytes every 2 h initially\\nin ED. Check glucose hourly \\nIf blood glucose does not decrease\\nby 10% (or 3 mmol/L/h) after 1 h of\\ninsulin therapy, give 0.14 U/kg bolus\\nthen resume previous rate \\nIf blood glucose decreasing faster than\\n50–75 mg/dL/h, decrease insulin drip.\\nCheck glucose hourly \\nIn young and new-onset diabetics\\navoid excess free water, monitor\\ncarefully for development of cerebral\\nedema, and have mannitol bedside \\nRecheck lytes, glucose, AG: repeat in \\n4 h If taking PO, consider oral K, Phos,\\nMg replacement as needed \\nLate complications:\\nRefractory acidosis (sepsis)\\nCerebral edema\\nVascular thrombosis (rare)\\nARDS\\nMucormycosis (rare) \\n129_Cydulka_Ch129.indd   704 22/04/17   4:41 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 723, 'page_label': '705'}, page_content='CHAPTER 129: Diabetic Emergencies 705 \\n2. Administer bicarbonate when the pH ≤6.9. Then, the benefits of cor -\\nrecting the effects of acidosis (vasodilation, hyperkalemia, depression of \\ncardiac, respiratory, and CNS systems) outweigh the risk of bicarbonate \\ntreatment (paradoxical CSF acidosis, hypokalemia, impaired oxyhemo-\\nglobin dissociation, rebound alkalosis, sodium overload).\\n3. Monitor glucose, anion gap, potassium, and bicarbonate hourly until \\nrecovery is established: glucose <200 mg/dL, bicarbonate ≥18, and \\npH >7.3.\\n4. Cerebral edema is a complication of treatment. Young age and new-on -\\nset diabetes are risk factors. If there is any change in neurologic status \\nearly in therapy, begin treatment with mannitol 1 g/kg before obtaining \\nthe diagnostic CT scan. Avoiding rapid correction of sodium, glucose, \\nand hypovolemia may reduce risk.\\n■ ■HYPErOSMOLAr HYPErGLYCEMIC StAtE\\nHyperosmolar hyperglycemic state (HHS) occurs in type 2 diabetics. \\nCauses are similar to DKA (Table 129-2). Insulin deficiency or resistance \\ncombined with physiologic stress results in an inflammatory state with \\nelevated counterregulatory hormones causing hyperglycemia. The resulting \\nosmotic diuresis causes hypovolemia and electrolyte losses.\\nClinical Features\\nThe typical patient is elderly with type 2 diabetes and presents with non-\\nspecific complaints of weakness, dyspnea, chest or abdominal pain, or \\nmental status changes, and has preexisting lung, heart, renal, or neurologic \\ndisease.\\nPhysical examination reveals signs of dehydration with orthostasis, dry \\nskin and mucous membranes, and altered mental status. Focal deficits and \\nseizures may occur.\\nDiagnosis and Differential\\nHyperosmolar hyperglycemic state is defined by laboratory values of glucose \\n>600 mg/dL, calculated serum osmolality (formula: Osm =  2 [Na+ ] +  \\nglucose/18) >315 mOsm/kg, bicarbonate >15 mEq/L, pH >7.3, and nega-\\ntive to mildly positive ketones. Marked elevation in glucose and serum \\nosmolality and the absence of a significant ketosis help distinguish HHS \\nfrom DKA. Further laboratory investigation is similar to that for DKA \\ndiscussed above.\\nEmergency Department Care and Disposition\\nTreatment consists of correcting the volume deficit, electrolyte imbalance, \\nand hyperosmolality, and treating the underlying cause (Fig. 129-2). See \\nTable 129-1 for admission guidelines.\\n129_Cydulka_Ch129.indd   705 22/04/17   4:41 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 724, 'page_label': '706'}, page_content='706 SECTION 13: Endocrine Emergencies\\nPotassium\\nNS at\\n4–14 mL/kg/h\\nSerum Na high\\nor normal Serum Na low\\n  NS at\\n4–14 mL/kg/h\\n1\\n2\\nAdminister NS 1 .0 L/h\\nTreatment of Hyperosmolar\\nHyperglycemic State \\nIV Fluids Insulin\\nEvaluate corrected\\nserum Na and\\nhydration\\nWhen serum glucose \\n≤300 mg/dL (≤16.6 mmol/L)\\nCheck electrolytes, blood urea\\nnitrogen, creatinine, and\\nglucose every 2 h until stable. \\nAfter resolution of HHS, provide\\nSC insulin as needed.\\n0.1–0.14 U/kg/h IV insulin\\ninfusion\\nGoal is glucose ↓ by 50 mg/dL/h\\n(2.8 mmol/L/h).\\nIf glucose ↓ >70 mg/dL/h\\n(>3.9 mmol/L/h), decrease\\ninsulin to 0.05 U/kg/h.\\nIf glucose ↓ <50 mg/dL/h\\n(<2.8 mmol/L), increase\\ninsulin to 0.14–0.20 U/kg/h.\\nIf serum K+ is <3.3 \\nmEq/L, give 40 mEq \\nK+ until K+ ≥3.3 mEq/L.\\nIf serum K+  ≥5.0 mEq/L,\\ndo not give K+ but check\\npotassium every 1–2 h.\\nIf serum K+  ≥3.3 but\\n<5.0 mEq/L, provide K+\\nto maintain serum\\nK = at 4–5 mEq/L.*\\nChange to D5    NS and decrease\\ninsulin to 0.05 U/kg/h to maintain\\nserum glucose between 200–250\\nmg/dL (11–13.8 mmol/L) mg/dL\\nuntil plasma  osmolality is\\n≤315 mOsm/kg.\\n1\\n2\\nFigurE 129-2.  Protocol for the management of severely ill adult patients with \\nhyperosmolar hyperglycemic state (HHS). *Concentrations of K+≥20 mEq/L should \\nbe administered via central line. D5 1/2 NS, 5% dextrose in half normal saline; \\nHHS, hyperosmolar hyperglycemic state; NS, normal saline.\\n■ ■DIABEtIC FOOt ULCErS\\nThese are classified and managed as nonlimb-threatening, limb-threaten-\\ning, or life-threatening (Table 129-3). Recommended antibiotic therapy is \\nlisted in Table 129-4.\\n129_Cydulka_Ch129.indd   706 22/04/17   4:41 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 725, 'page_label': '707'}, page_content='CHAPTER 129: Diabetic Emergencies 707 \\nTablE 129-3 Clinical Practice Pathways for Diabetic Foot Ulcer and Infection\\nExtent of \\nInfection Characteristics\\nDiagnostic \\nProcedures treatment\\nNon-limb-\\nthreatening \\ninfection\\n<2 cm cellulitis Cultures from base \\nof ulcer (with tissue \\nspecimen if possible)\\nOutpatient management \\nwith follow-up in 24–72 h\\nSuperficial ulcer Diagnostic imaging \\n(radiography, MRI, \\nnuclear scans as \\nindicated)\\nDebridement of all necrotic \\ntissue and callus\\nMild infection Serologic testing Wound care/dressing\\nNo systemic \\ntoxicity\\nCBC with differential Empiric antibiotic coverage, \\nmodified by culture findings\\nNo ischemic \\nchanges\\nESR Appropriate off-loading of \\nweight-bearing\\nNo bone or joint \\ninvolvement\\nComprehensive \\nmetabolic panel\\nWound care continued \\nwith packs, dressings, and \\ndebridement as needed\\nDoes not probe \\nto bone\\nHospital admission if \\ninfection progresses or \\nsystemic signs or symptoms \\ndevelop\\nRefer to podiatrist for follow-\\nup care, special shoes, and \\nprostheses as needed\\nLife- or \\nlimb-\\nthreatening \\ninfection\\n>2 cm cellulitis Deep culture from \\nbase of ulcer/wound \\nwith tissue specimen \\nif possible\\nHospital admission\\nDeep ulcer Diagnostic imaging \\n(radiography, MRI, \\nnuclear scan, bone \\nscan, leukocyte scan, \\narteriography)\\nSurgical debridement with \\nresection of all necrotic \\nbone and soft tissue\\nOdor or purulent \\ndrainage from \\nwound\\nSerologic testing Exploration and drainage of \\ndeep abscess\\nFever CBC with differential Empiric antibiotic cover -\\nage, modified by culture \\nfindings\\nIschemic changes ESR Surgical resection of \\nosteomyelitis\\nLymphangitis, \\nedema\\nComprehensive \\nmetabolic panel\\nWound care continued with \\npacks, dressings, debride-\\nment as needed\\nSepsis or septic \\nshock\\nBlood cultures Foot-sparing reconstructive \\nprocedures\\nRefer to podiatrist for follow-\\nup care, special shoes, and \\nprostheses as needed\\n129_Cydulka_Ch129.indd   707 22/04/17   4:41 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 726, 'page_label': '708'}, page_content='708 SECTION 13: Endocrine Emergencies\\nTablE 129-4 Antimicrobial therapy in Infected Diabetes-related Lower \\nExtremity Ulcers\\nNon-limb-threatening*\\nCephalexin, 500 mg PO every 6 h, 10-day course\\nOr\\nClindamycin, 300–450 mg PO every 6–8 h, 10-day course\\nOr\\nDicloxacillin, 500 mg PO every 6 h, 10-day course\\nOr\\nAmoxicillin-clavulanate, 875/125 mg PO every 12 h, 10-day course\\nOr\\nClarithromycin 500 mg PO every 12 h (in severe penicillin allergy)\\nLimb-threatening*\\nOral regimen†:\\n (Ciprofloxacin or levofloxacin or moxifloxacin) plus clindamycin\\n Or\\n Trimethoprim-sulfamethoxazole plus amoxicillin-clavulanate\\nIV regimens:\\n Ampicillin-sulbactam, 3 g every 6 h\\n Or\\n Piperacillin-tazobactam 4.5 g every 6–8 h\\n Or\\n Clindamycin, 900 mg every 6 h plus (ciprofloxacin, 400 mg every 8–12 h or ceftriaxone,  \\n1 g every 12 h)\\nLife-threatening*\\nIV regimens:\\nImipenem-cilastatin, 500 mg every 6 h\\nOr\\nMeropenem 1 g every 8 h\\nOr\\nVancomycin, 15–20 mg/kg every 12 h, plus metronidazole, 500 mg every 8 h, plus aztreo-\\nnam, 2 g every 6–8 h or ciprofloxacin 400 mg every 8–12 h)\\n(if MRSA coverage is warranted)\\n*See the section “Foot and Lower Extremity Complications” for definitions in Tintinalli’s Emergency \\nMedicine: A Comprehensive Study Guide, 8th ed., Chapter 224.\\n†This approach is acceptable under special circumstances with close follow-up.\\nAbbreviation: MRSA, methicillin-resistant Staphylococcus aureus.\\nNote: Adjust all dosages for renal/hepatic function and monitor blood levels where appropriate.\\n■ ■FUrtHEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 223, “Type 1 Diabetes Mellitus,” by Nikhil Goyal and \\nAdam B. Schlichting; Chapter 224, “Type 2 Diabetes Mellitus,” by Mohammad \\nJalili and Mahtab Niroomand; Chapter 225, “Diabetic Ketoacidosis,” by Andrew \\nL. Nyce, Cary L. Lubkin, and Michael E. Chansky; Chapter 227, “Hyperosmolar \\nHyperglycemic State,” by Charles S. Graffeo.\\n129_Cydulka_Ch129.indd   708 22/04/17   4:41 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 727, 'page_label': '709'}, page_content='709\\nAlcoholic Ketoacidosis\\nMichael P . Kefer\\nAlcoholic ketoacidosis (AKA) results from heavy alcohol intake, either \\nacute or chronic. Glycogen stores are depleted, activating lipolysis to sup-\\nply energy. Lipolysis and alcohol metabolism generate ketoacids, causing \\nan anion gap metabolic acidosis.\\n■ ■CLINICAL FEATURES\\nThe patient typically presents with nausea, vomiting, and abdominal pain \\nafter heavy alcohol intake. The patient appears acutely ill, dehydrated, and \\nhas abdominal tenderness that is nonspecific or is the result of other causes \\nrelated to alcohol, such as gastritis, hepatitis, or pancreatitis.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nLaboratory investigation reveals an anion gap metabolic acidosis. However, \\nthe serum pH may vary as these patients often have mixed acid–base disor-\\nders such as a metabolic acidosis from AKA and a metabolic alkalosis from \\nvomiting and dehydration. Blood glucose is low to mildly elevated. The \\nalcohol level is usually low or undetected as symptoms limit intake. Serum \\nketones, acetoacetate, and its reduced form, beta-hydroxybutyrate, are ele-\\nvated. If the nitroprusside test is used to measure serum and urine ketones, \\nacetoacetate is detected, but beta-hydroxybutyrate is not. The redox state may \\nbe such that most, or all, acetoacetate is reduced to beta-hydroxybutyrate \\nresulting in a falsely low- or false-negative result, respectively.\\nDiagnostic criteria for AKA are listed in Table 130-1. The differential \\ndiagnosis of an anion gap metabolic acidosis is listed in Table 130-2.\\n130\\nCh APTER\\nTAble 130-1 Diagnostic Criteria for Alcoholic Ketoacidosis*\\nLow, normal, or slightly elevated serum glucose\\nBinge drinking ending in nausea, vomiting, and decreased intake\\nWide anion gap metabolic acidosis\\nPositive serum ketones*\\nWide anion gap metabolic acidosis without alternate explanation\\n*The absence of ketones in the serum based on the nitroprusside test does not exclude the diagnosis.\\nTAble 130-2 The Differential Diagnosis of an Anion Gap Metabolic Acidosis Is \\nRecalled by the Acronym MUDPILES\\n■● Methanol\\n■● Uremia\\n■● Diabetic ketoacidosis\\n■● Paraldehyde\\n■● Iron, isoniazid, inhalants\\n■● Lactic acidosis\\n■● Ethanol, ethylene glycol\\n■● Salicylates\\n130_Cydulka_Ch130.indd   709 21/03/17   10:43 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 728, 'page_label': '710'}, page_content='710 SECTION 13: Endocrine Emergencies\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\n1. Administer D5NS IV until rehydrated, then D5 0.45NS  IV for mainte-\\nnance. The isotonic crystalloid solution restores intravascular volume. \\nThe glucose stimulates the patient’s endogenous insulin release, which \\ninhibits ketosis (insulin is not administered, unlike treatment for DKA).\\n2. Thiamine 100 mg IV before glucose administration may prevent pre-\\ncipitation of Wernicke’s disease.\\n3. Supplement electrolytes and other vitamins as indicated.\\n4. Continue treatment until the acidosis clears and oral intake is tolerated.\\n5. Consider other causes of an anion gap acidosis if the gap does not close \\nwith treatment.\\n6. Consider sodium bicarbonate if, despite treatment, the pH remains <7.0.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 226 “Alcoholic Ketoacidosis,” by William A. Woods \\nand Debra G. Perina.\\n130_Cydulka_Ch130.indd   710 21/03/17   10:43 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 729, 'page_label': '711'}, page_content='711\\nThyroid Disease Emergencies\\nAziz Darawsha\\n■ ■HYPOTHYROIDISM AND MYXEDEMA COMA\\nHypothyroidism may be caused by multiple factors. Myxedema coma \\n(also called myxedema crisis) is a rare, life-threatening expression of \\nhypothyroidism. It may be precipitated by infection, cold exposure, \\ntrauma, medications, or myocardial infarction. It classically occurs dur -\\ning the winter months in elderly women with undiagnosed or undertreated \\nhypothyroidism.\\nClinical Features\\nThe presentation of hypothyroidism is summarized in Fig. 131-1. \\nPatients with myxedema coma have hypothyroidism and present with \\nmetabolic and multi-organ decompensation, including hypothermia, bra-\\ndycardia, hypotension, and altered mental status. Respiratory insuffi-\\nciency and altered mental status can result from CO 2 narcosis, and a \\ndifficult airway may be encountered due to macroglossia, glottic, and \\noropharyngeal edema. Laboratory abnormalities include hypoglycemia \\nand hyponatremia.\\n131\\nC HAPTER\\nSigns\\nPeriorbital pufﬁness\\nLoss of outer third\\nof eyebrow \\nPallor\\nMacroglossia\\nHoarseness\\nBradycardia\\nHypoventilation\\nAbsent or decreased\\nbowel sounds\\nNonpitting edema\\nDelayed relaxation\\nof ankle jerks \\nPeripheral neuropathy\\nCool, rough, dry skin\\nHypothermia\\nSymptoms\\nHair loss\\nFatigue\\nDepression\\nShortness of breath\\nWeight gain\\nConstipation\\nMenstrual\\nirregularities\\nInfertility\\nMuscle cramps\\nJoint pain\\nCold intolerance\\nFigurE 131-1. Symptoms and signs of hypothyroidism.\\n131_Cydulka_Ch131.indd   711 21/03/17   11:13 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 730, 'page_label': '712'}, page_content='712 SECTION 13: Endocrine Emergencies\\nDiagnosis and Differential\\nThe diagnosis of myxedema coma is clinical. Send confirmatory thyroid  \\nstudies, but do not delay treatment for test results. Low free thyroxine \\n(FT4) and triiodothyronine (FT3), and elevated thyroid stimulating hor -\\nmone (TSH) are diagnostic. The differential diagnosis includes sepsis, \\ndepression, adrenal crisis, congestive heart failure, hypoglycemia, \\nstroke, hypothermia, meningitis, and drug overdose.\\nEmergency Department Care and Disposition\\nManagement of myxedema coma includes:\\n1. Supportive care with airway stabilization, mechanical v entilation, and \\ncardiac monitoring. Treat hypotension with fluid resuscitation. Vaso-\\npressors may be ineffective until thyroid hormone replacement is initi-\\nated. Passively rewarm hypothermic patients.\\n2. Seek out and treat precipitating causes. Administer hydr ocortisone100 \\nmg IV for suspected adrenal insufficiency. Correct hypoglycemia.\\n3. Thyroid replacement therapy: Levothyroxine (T4) 4 µg/kg, followed \\nin 24 hours by 100 µg IV , then 50 µg IV until oral medication is toler -\\nated or liothyronine (T3) 20 μg IV followed by 10 µg IV every 8 hours \\nuntil the patient is conscious for severe myxedema coma. Start with no \\nmore than 10 µg IV in the elderly and patients with cardiovascular \\ndisease. Switch to levothyroxine 50 to 200 µg/day PO when the patient \\nis ambulatory.\\n4. Admit patients to a monitored or ICU setting.\\n5. Identify and treat precipitating factors\\n●■ Infections\\n●■ Sedatives\\n●■ Anesthetic agents (e.g., etomidate)\\n●■ Cold exposure\\n●■ Trauma\\n●■ Myocardial infarction or congestive heart failure\\n●■ Cerebrovascular accident\\n●■ GI hemorrhage\\n●■■Contributing metabolic conditions include hypoxia, hypercapnia, hypo-\\nnatremia, and hypoglycemia\\n■ ■THYROTOXICOSIS AND THYROID STORM\\nHyperthyroidism refers to excess circulating hormone due to thyroid gland \\nhyperfunction, whereas thyrotoxicosis refers to excess circulating thyroid \\nhormone from any cause. Thyroid storm is an acute, life-threatening state \\nof thyrotoxicosis that is most common in patients with antecedent Graves’ \\ndisease.\\nClinical Features\\nThe clinical features of thyrotoxicosis are manifestations of enhanced adren-\\nergic activity. Signs and symptoms are shown in Table 131-1. As for thyroid \\nstorm, the leading signs and symptoms are constitutional (fever), central \\nnervous system related (agitation, confusion, delirium, stupor, coma, and \\nseizure), and cardiovascular (tachycardia, arrhythmia, and heart failure).\\n131_Cydulka_Ch131.indd   712 21/03/17   11:13 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 731, 'page_label': '713'}, page_content='CHAPTER 131: Thyroid Disease Emergencies 713 \\nTablE 131-1 Symptoms and Signs of Thyrotoxicosis\\nAffected System Symptoms Signs\\nConstitutional Lethargy\\nWeakness\\nHeat intolerance\\nDiaphoresis\\nFever\\nWeight loss\\nNeuropsychiatric Emotional lability\\nAnxiety\\nConfusion\\nComa\\nPsychosis\\nFine tremor\\nMuscle wasting\\nHyperreflexia\\nPeriodic paralysis\\nOphthalmologic Diplopia\\nEye irritation\\nLid lag\\nDry eyes\\nExophthalmos\\nOphthalmoplegia\\nConjunctival infection\\nEndocrine: thyroid gland Neck fullness\\nTenderness\\nThyroid enlargement\\nBruit\\nCardiorespiratory Dyspnea\\nPalpitations\\nChest pain\\nWidened pulse pressure\\nSystolic hypertension\\nSinus tachycardia\\nAtrial fibrillation or flutter\\nCongestive heart failure\\nGI Diarrhea Hyperactive bowel sound\\nReproductive Oligomenorrhea\\nDecreased libido\\nGynecomastia\\nTelangiectasia\\nGynecologic Menorrhagia\\nIrregularity\\nSparse pubic hair\\nHematologic Pale skin Anemia\\nLeukocytosis\\nDermatologic Hair loss Pretibial myxedema*\\nWarm, moist skin\\nPalmar erythema\\nOnycholysis\\n*Pretibial myxedema may be present in 5% of patients with Graves’ disease.\\nDiagnosis and Differential\\nAn elevated FT4 or FT3 level and a suppressed TSH level are diagnostic \\nof thyrotoxicosis. Thyroid storm is a clinical diagnosis. Fever and tachy-\\ncardia are cardinal features; laboratory tests cannot distinguish it from \\nthyrotoxicosis. The differential diagnosis for thyroid storm includes \\nsepsis, heat stroke, delirium tremens, neuroleptic malignant syndrome, \\nserotonin syndrome, pheochromocytoma, and sympathomimetic drug \\noverdose.\\nEmergency Department Care and Disposition\\nTreatment includes:\\n1. Supportive care, including airway stabilization, supplemental oxygen, \\nand cardiac monitoring. Cooling is indicated for h yperthermia. Admin-\\nister acetaminophen 325 to 650 mg PO/PR every 4 to 6 hours. Correct \\n131_Cydulka_Ch131.indd   713 21/03/17   11:13 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 732, 'page_label': '714'}, page_content='714 SECTION 13: Endocrine Emergencies\\ndehydration with IV fluids. Provide nutritional support: glucose, multi-\\nvitamins, thiamine, folate.\\n2. Inhibit thyroid hormone release with thioamides: PTU loading dose of \\n600 to 1000 mg PO and follo w with 200 to 250 mg every 4 hours or \\nmethimazole 40 mg PO as loading dose and follow with 25 mg every  \\n4 hours. PTU is preferred as it also blocks peripheral conversation of  \\nT4 to T3.\\n3. Inhibit new thyroid hormone production (at least 1 hour after step 3) \\nwith Lugol solution 8-10 drops PO e very 6-8 h or potassium iodide 5 \\ndrops PO  every 6 h or IV iopanoic acid 1 gram every 8 h for the first \\n24 h, then 500 mg twice a day or ipodate 0.5 - 3 g/day for 3 days or \\nlithium carbonate 300mg PO every 6 h.\\n4. Provide peripheral β-adrener gic receptor blockade using propranolol \\nIV in slow 1 to 2 mg boluses and repeat every 10 to 15 minutes or \\nesmolol 500 mcg/kg IV bolus followed by 50  to 200 mcg until desired \\neffect is achieved. Propranolol 20 -120 mg PO  may be used in patients \\nwith less toxicity.  Avoid propranolol  and esmolol in patients with  bron-\\nchospastic disease or severe congestive heart failure.\\n5. Prevent peripheral conversion of T4 to T3 using hydrocortisone 100 mg \\ninitially, followed by three times daily until stable or dexamethasone 2 \\nmg every 6 h.\\n6. Evaluate and treat precipitating causes. Search for an infectious source \\nin febrile patients and administer appropriate antibiotics for identified \\ninfections.\\n7. Admit patients to a monitored or ICU setting.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 228, “Hyperthyroidism” by Alzamani Mohammad \\nIdrose; Chapter 229, “Hyperthyroidism,” by Alzamani Mohammad Idrose.\\n131_Cydulka_Ch131.indd   714 21/03/17   11:13 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 733, 'page_label': '715'}, page_content='715\\nAdrenal Insufficiency\\nMichael P . Kefer\\nAdrenal insufficiency results when the physiologic demand for glucocorti-\\ncoids and mineralocorticoids exceeds the supply from the adrenal cortex. \\nThe pituitary secretes adrenocorticotropin hormone (ACTH) and associated \\nmelanocyte stimulating hormone (MSH). ACTH stimulates the adrenal \\ncortex to secrete cortisol. Cortisol has negative feedback on the pituitary to \\ninhibit secretion of ACTH and MSH.\\n■ ■CLINICAL FEATURES\\nPrimary adrenal insufficiency is due to adrenal gland failure, resulting in \\nlow cortisol and aldosterone production. Clinical features include weak-\\nness, dehydration, hypotension, anorexia, nausea, vomiting, weight loss, \\nand abdominal pain. Hyperpigmentation of skin and mucous membranes \\noccurs as a result of uninhibited MSH secretion in conjunction with \\nACTH.\\nSecondary adrenal insufficiency results from inadequate secretion of \\nACTH with resultant cortisol deficiency. Aldosterone levels are not \\naffected because of regulation by the renin-angiotensin axis and serum \\npotassium levels. Therefore, hyperpigmentation and hyperkalemia do \\nnot occur.\\nAdrenal crisis is the acute, life-threatening form of adrenal insuffi-\\nciency. Clinical features described above are severe and accompanied by \\nshock and altered mental status.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nAll patients with adrenal insufficiency have low plasma cortisol levels. \\nThe ACTH level is high in primary and low in secondary adrenal insuf-\\nficiency. Cortisol and ACTH levels are usually not available in the \\nemergency department, so the diagnosis of primary adrenal insuffi-\\nciency is based on the presence of the clinical features and lab findings \\nof hyponatremia, hyperkalemia, hypoglycemia, anemia, metabolic \\nacidosis, and prerenal azotemia. Secondary adrenal insufficiency is \\nsimilarly diagnosed, but hyperkalemia is not seen as aldosterone secre-\\ntion is normal.\\nThe most common cause of acute adrenal insufficiency is adrenal sup-\\npression from prolonged steroid use with either abrupt steroid withdrawal \\nor exposure to increased physiologic stress such as injury, illness, or \\nsurgery. It may take up to 1 year for the hypothalamic-pituitary-adrenal \\naxis to recover following prolonged suppression with steroid treatment. \\nTables 132-1 and 132-2 list causes of primary and secondary adrenal \\ninsufficiency, respectively. Consider the diagnosis of adrenal crisis in any \\npatient with unexplained hypotension refractory to pressors, especially if \\none of the causes listed is known to exist.\\n132\\nCh APTER\\n132_Cydulka_Ch132.indd   715 21/03/17   11:47 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 734, 'page_label': '716'}, page_content='716 SECTION 13: Endocrine Emergencies\\nTAble 132-1 Causes of Primary Adrenal Insufficiency\\nPrimary Adrenal Insufficiency Examples\\nAutoimmune Isolated adrenal insufficiency or associated \\nwith polyglandular insufficiencies (polyglandular \\nautoimmune syndrome type I or II)\\nAdrenal hemorrhage or thrombosis Necrosis caused by meningococcal sepsis\\nCoagulation disorders\\nOverwhelming sepsis (Waterhouse–Friderichsen \\nsyndrome)\\nDrugs Adrenal enzyme inhibitors (affect those with limited \\npituitary or adrenal reserve)\\nEtomidate\\nAminoglutethimide (can be used by body builders)\\nMitotane (orphan drug used to treat adrenocortical \\ncarcinoma)\\nKetoconazole\\nInfections Tuberculosis\\nFungal, bacterial sepsis\\nAcquired immunodeficiency syndrome involving \\nadrenal glands\\nInfiltrative disorders Sarcoidosis\\nHemochromatosis\\nAmyloidosis\\nLymphoma\\nMetastatic cancer\\nSurgery Bilateral adrenalectomy\\nBariatric surgery\\nHereditary Adrenal hypoplasia\\nCongenital adrenal hyperplasia\\nAdrenoleukodystrophy\\nFamilial glucocorticoid deficiency\\nTAble 132-2 Causes of Secondary Adrenal Insufficiency\\nSecondary Adrenal Insufficiency \\n(hypothalamic-pituitary dysfunction) Examples\\nSudden cessation of prolonged \\nglucocorticoid therapy\\nChronic use of steroid inhibits CRH and \\nACTH production\\nPituitary necrosis or bleeding Postpartum pituitary necrosis (Sheehan’s \\nsyndrome)\\nExogenous glucocorticoid administration Causes decreased production of CRH at \\nhypothalamus and ACTH at pituitary\\nBrain tumors Pituitary tumor\\nHypothalamic tumor\\nLocal invasion (craniopharyngioma)\\nPituitary irradiation\\nPituitary surgery\\nHead trauma involving the pituitary gland\\nDisrupts CRH and ACTH production capacity \\nin hypothalamic-pituitary axis\\n(Continued)\\n132_Cydulka_Ch132.indd   716 21/03/17   11:47 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 735, 'page_label': '717'}, page_content='CHAPTER 132: Adrenal Insufficiency 717 \\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\n1. Five percent dextrose in normal saline is the fluid of choice to correct \\nhypoglycemia, hyponatremia, and hypotension.\\n2. Hydrocortisone 100 mg IV pro vides glucocorticoid and mineralcorti-\\ncoid activity. If an ACTH stimulation test is planned, use dexametha-\\nsone 4 mg IV instead, which will not affect the test result.\\n3. Vasopressors are added when shock is refractory to the above.\\n4. Patients on chronic steroid therapy for adrenal insufficiency with minor \\nillness or injury should have their glucocorticoid dose tripled daily with \\nprompt follow-up.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 230, “Adrenal Insufficiency,” by Alzamani Mohammad \\nIdrose.\\nTAble 132-2 Causes of Secondary Adrenal Insufficiency\\nSecondary Adrenal Insufficiency \\n(hypothalamic-pituitary dysfunction) Examples\\nInfiltrative disorders of the pituitary  \\nor hypothalamus\\nSarcoidosis\\nHemosiderosis\\nHemochromatosis\\nHistiocytosis X\\nMetastatic cancer\\nLymphoma\\nCNS infections involving hypothalamus  \\nor pituitary\\nTuberculosis\\nMeningitis\\nFungus\\nHuman immunodeficiency virus\\nAbbreviations: ACTH, adrenocorticotropic hormone; CRH, corticotropin-releasing hormone.\\n(Continued)\\n132_Cydulka_Ch132.indd   717 21/03/17   11:47 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 736, 'page_label': '718'}, page_content='132_Cydulka_Ch132.indd   718 21/03/17   11:47 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 737, 'page_label': '719'}, page_content='719\\nEvaluation of Anemia and \\nthe Bleeding Patient\\nRita K. Cydulka\\nAnemia may be chronic and unrelated to the chief complaint, or it may \\nresult from acute blood loss as seen in trauma, gastrointestinal bleeding, or \\nother acute hemorrhage. Suspect underlying bleeding disorders in patients \\npresenting with spontaneous bleeding from multiple sites, bleeding from \\nnontraumatized sites, delayed bleeding several hours after injury, or bleed-\\ning into deep tissues or joints.\\n■ ■CLINICAL FEATURES\\nThe rate of the development of the anemia, the extent of the anemia, the age \\nof the patient, and the ability of the cardiovascular system to compensate \\nfor the decreased oxygen-carrying capacity determine the severity of the \\npatient’s symptoms and clinical presentation. Patients may complain of \\nweakness, fatigue, palpitations, orthostatic symptoms, and dyspnea with \\nminimal exertion. Patients may have pale conjunctiva, skin, and nail beds. \\nTachycardia, hyperdynamic precordium, and systolic murmurs may be \\npresent. Tachypnea at rest and hypotension are late signs. Use of ethanol, \\nprescription drugs, and recreational drugs may alter the patient’s ability to \\ncompensate for the anemia.\\nPatients with bleeding may or may not have an obvious site of hemor -\\nrhage. A history of excessive or abnormal bleeding in the patient and other \\nfamily members may indicate an underlying bleeding disorder. Historical \\ndata about liver disease and drug use, such as use of ethanol, aspirin, non-\\nsteroidal anti-inflammatory drugs, warfarin, and antibiotics should be \\ngathered. Mucocutaneous bleeding (including petechiae, ecchymoses, pur -\\npura, and epistaxis), gastrointestinal, genitourinary, or heavy menstrual \\nbleeding are features associated with qualitative or quantitative platelet \\ndisorders. Patients with deficiencies of coagulation factors often present \\nwith delayed bleeding, hemarthroses, or bleeding into potential spaces \\nbetween fascial planes and into the retroperitoneum. Patients with combi-\\nnation abnormalities of platelets and coagulation factors, such as dissemi-\\nnated intravascular coagulation, present with both mucocutaneous and \\npotential space bleeding.\\n133\\nCh A p TER\\n14\\nSECTION\\nHematologic and Oncologic \\nEmergencies\\n133_Cydulka_Ch133.indd   719 21/04/17   10:47 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 738, 'page_label': '720'}, page_content='720 SECTION 14: Hematologic and Oncologic Emergencies\\nAcquired hemolytic anemia may be autoimmune or drug-induced. \\nMicroangiopathic syndromes include thrombotic thrombocytopenic pur -\\npura (TTP) and hemolytic-uremic syndrome (HUS). The classic pentad  \\nof TTP is CNS abnormalities, renal disease, fever, microangiopathic \\nhemolytic anemia, and thrombocytopenia. HUS consists of acute \\nnephropathy or renal failure, microangiopathic hemolytic anemia, and \\nthrombocytopenia. Macrovascular hemolysis can be caused by pros-\\nthetic heart valves.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nA decreased red blood count, hemoglobin, and hematocrit are diagnostic \\nfor anemia. The initial evaluation of newly diagnosed anemia includes a \\ncomplete blood count, review of RBC indices, reticulocyte count, stool \\nhemoccult examination, urine pregnancy test in females, and examination \\nof the peripheral blood smear. The mean corpuscular volume (MCV) and \\nreticulocyte count can assist in classifying the anemia and can aid in dif-\\nferential diagnosis (Fig. 133-1).\\nLaboratory studies used to diagnose bleeding disorders can be \\ndivided into the following three categories: (a) those that test the initial \\nformation of a platelet plug (primary hemostasis); (b) those that assess \\nthe formation of cross-linked fibrin (secondary hemostasis); and  \\n(c) those that test the fibrinolytic system, which is responsible for limit-\\ning the size of the fibrin clots formed (see Tables 133-1 and 133-2). \\nInitial studies to evaluate the patient with suspected bleeding disorders \\ninclude complete blood count with platelet count, prothrombin time, and \\npartial thromboplastin time and international normalized ratio (INR). If \\nthere is a suspicion for a hemolytic anemia, further studies may be war -\\nranted (Table 133-3).\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Type and crossmatch blood in patients with anemia and ongoing blood \\nloss so that it is available for transfusion, if necessary.\\n2. Consider immediate transfusion of packed RBCs in symptomatic \\npatients who are hemodynamically unstable or ha ve evidence of tissue \\nhypoxia.\\n3. Admit patients with anemia and ongoing blood loss for further evalua-\\ntion and treatment. Admit patients with chronic anemia or newly diag-\\nnosed anemia with unclear etiology if they are hemodynamically \\nunstable, hypoxic, acidotic, or demonstrate cardiac ischemia.\\n4. Consider hematology consultation to assist in ev aluation of those pa-\\ntients with anemia of unclear etiology, anemic patients with concomitant \\nabnormalities of platelets and white blood cell counts, and patients with \\nsuspected bleeding disorders.\\n133_Cydulka_Ch133.indd   720 21/04/17   10:47 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 739, 'page_label': '721'}, page_content='721 FigurE 133-1. Flowchart for the evaluation of anemia.\\nReticulocyte\\ncount normal\\nReticulocyte\\ncount high\\nIron\\ndeficiency\\nLow ferritin Ferritin\\nnormal\\nLow/Normal\\nferritin\\nAustoimmune\\ncauses\\nCoombs\\npositive\\nCoombs\\nnegative\\nRDW normal\\nCRF = chronic renal failure\\nMCV = mean corpuscular volume\\nRDW = red cell distribution width\\nRBC = red blood cell count\\nG6PD = glucose-6-phosphate deficiency\\nHigh RDW\\nChronic\\n disease\\nCRF\\nSideroblastic\\n anemia\\nIron\\n deficiency\\nIron\\ndeficiency\\nChronic\\ndisease\\n   Anemia of chronic\\n   disease\\n   Anemia of renal\\n   insufficiency\\nG6PD\\nHemoglobinopathies\\nRed blood cell\\n membranopathies\\nMicroangiopathic\\n hemolysis\\nB12\\ndeficiency\\n   Folate\\n  deficiency\\nAlcohol abuse\\nLiver disease\\nChemotherapy\\nAplastic anemia\\nSideroblastic\\n anemia\\nSpurious\\nIron, B12, or\\n f olate\\n deficiency\\nChronic\\n disease\\nHypothyroid\\nVitamin C\\n deficiency\\nRBC normal\\nor high\\nThalassemia\\nLow MCV Normal MCV Elevated MCV\\nRDW highR DW normal RDW high RDW normal\\nAnemia\\n133_Cydulka_Ch133.indd   721 21/04/17   10:47 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 740, 'page_label': '722'}, page_content='TABlE 133-1 Initial Tests of hemostasis\\nScreening Tests Reference Value Component Measured Clinical Correlations\\nPrimary Hemostasis\\nPlatelet count 150–400/mm3 (150–400 × 109/L) Number of platelets per mm3 Decreased platelet count (thrombocytopenia): bleeding \\nusually not a problem until platelet count is < 50,000/mm 3 \\n(50 × 109/L); high risk of spontaneous bleeding, including \\nCNS bleeding, seen with count of < 10,000/mm 3 (10 ×  109/L); \\nusually due to decreased production or increased destruction \\nof platelets\\nElevated platelet count (thrombocytosis): commonly a reaction \\nto inflammation or malignancy, and occurs in polycythemia vera; \\ncan be associated with hemorrhage or thrombosis\\nBleeding time (BT) Variable\\nTypically 2.5–10.0 min using a BT \\ntemplate\\nInteraction between platelets \\nand the subendothelium\\nProlonged BT caused by:\\nThrombocytopenia (platelet count <50,000/mm3 or 50 × 109/L)\\nAbnormal platelet function (von Willebrand’s disease, \\nantiplatelet drugs, uremia, liver disease)\\nSecondary Hemostasis\\nProthrombin time (PT) and \\ninternational normalized ratio \\n(INR)\\nPT: 11–13 s; depends on reagent\\nINR: 1.0\\nExtrinsic system and common \\npathway—factors VII, X, V, \\nprothrombin, and fibrinogen\\nINR = 1.7 corresponds to \\napproximately 30% activity of \\ncoagulation factors as a whole\\nProlonged PT most commonly caused by:\\nWarfarin (inhibits production of vitamin K–dependent factors II, \\nVII, IX, and X)\\nLiver disease with decreased factor synthesis\\nAntibiotics that inhibit vitamin K–dependent factors \\n(moxalactam, cefamandole, cefotaxime, cefoperazone)\\nActivated partial thromboplastin \\ntime (aPTT)\\n22–34 s\\nDepends on type of thromboplastin \\nreagent used\\n“Activated” with kaolin\\nIntrinsic system and common \\npathway—factors XII, XI, IX, VIII, \\nX, V, prothrombin, and fibrinogen\\nProlonged aPTT most commonly caused by:\\nHeparin therapy\\nFactor deficiencies (factor levels have to be <30% of normal to \\ncause prolongation)\\nFibrinogen level Slightly variable according to \\nspecific test\\nProtein made in liver; converted \\nto fibrin as part of normal \\ncoagulation cascade\\nLow levels seen in disseminated intravascular coagulation\\nThrombin clotting time (TCT) 10–12 s Conversion of fibrinogen to fibrin \\nmonomer\\nProlonged TCT caused by:\\nLow fibrinogen level\\nAbnormal fibrinogen molecule (liver disease)\\nPresence of heparin, fibrin degradation products, or a \\nparaprotein (multiple myeloma); these interfere with the \\nconversion\\nOccasionally seen in hyperfibrinogenemia\\n“Mix” testing Variable Performed when results on one \\nor more of the above screening \\ntests is prolonged; the patient’s \\nplasma (“abnormal”) is mixed \\nwith “normal” plasma and the \\nscreening test is repeated\\nIf the mixing corrects the screening test result: one or more \\nfactor deficiencies are present\\nIf the mixing does not correct the screening test result: a \\ncirculating inhibitor is present\\n722\\n133_Cydulka_Ch133.indd   722 21/04/17   10:47 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 741, 'page_label': '723'}, page_content='TABlE 133-1 Initial Tests of hemostasis\\nScreening Tests Reference Value Component Measured Clinical Correlations\\nPrimary Hemostasis\\nPlatelet count 150–400/mm3 (150–400 × 109/L) Number of platelets per mm3 Decreased platelet count (thrombocytopenia): bleeding \\nusually not a problem until platelet count is < 50,000/mm 3 \\n(50 × 109/L); high risk of spontaneous bleeding, including \\nCNS bleeding, seen with count of < 10,000/mm 3 (10 ×  109/L); \\nusually due to decreased production or increased destruction \\nof platelets\\nElevated platelet count (thrombocytosis): commonly a reaction \\nto inflammation or malignancy, and occurs in polycythemia vera; \\ncan be associated with hemorrhage or thrombosis\\nBleeding time (BT) Variable\\nTypically 2.5–10.0 min using a BT \\ntemplate\\nInteraction between platelets \\nand the subendothelium\\nProlonged BT caused by:\\nThrombocytopenia (platelet count <50,000/mm3 or 50 × 109/L)\\nAbnormal platelet function (von Willebrand’s disease, \\nantiplatelet drugs, uremia, liver disease)\\nSecondary Hemostasis\\nProthrombin time (PT) and \\ninternational normalized ratio \\n(INR)\\nPT: 11–13 s; depends on reagent\\nINR: 1.0\\nExtrinsic system and common \\npathway—factors VII, X, V, \\nprothrombin, and fibrinogen\\nINR = 1.7 corresponds to \\napproximately 30% activity of \\ncoagulation factors as a whole\\nProlonged PT most commonly caused by:\\nWarfarin (inhibits production of vitamin K–dependent factors II, \\nVII, IX, and X)\\nLiver disease with decreased factor synthesis\\nAntibiotics that inhibit vitamin K–dependent factors \\n(moxalactam, cefamandole, cefotaxime, cefoperazone)\\nActivated partial thromboplastin \\ntime (aPTT)\\n22–34 s\\nDepends on type of thromboplastin \\nreagent used\\n“Activated” with kaolin\\nIntrinsic system and common \\npathway—factors XII, XI, IX, VIII, \\nX, V, prothrombin, and fibrinogen\\nProlonged aPTT most commonly caused by:\\nHeparin therapy\\nFactor deficiencies (factor levels have to be <30% of normal to \\ncause prolongation)\\nFibrinogen level Slightly variable according to \\nspecific test\\nProtein made in liver; converted \\nto fibrin as part of normal \\ncoagulation cascade\\nLow levels seen in disseminated intravascular coagulation\\nThrombin clotting time (TCT) 10–12 s Conversion of fibrinogen to fibrin \\nmonomer\\nProlonged TCT caused by:\\nLow fibrinogen level\\nAbnormal fibrinogen molecule (liver disease)\\nPresence of heparin, fibrin degradation products, or a \\nparaprotein (multiple myeloma); these interfere with the \\nconversion\\nOccasionally seen in hyperfibrinogenemia\\n“Mix” testing Variable Performed when results on one \\nor more of the above screening \\ntests is prolonged; the patient’s \\nplasma (“abnormal”) is mixed \\nwith “normal” plasma and the \\nscreening test is repeated\\nIf the mixing corrects the screening test result: one or more \\nfactor deficiencies are present\\nIf the mixing does not correct the screening test result: a \\ncirculating inhibitor is present\\n723\\n133_Cydulka_Ch133.indd   723 21/04/17   10:47 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 742, 'page_label': '724'}, page_content='724 SECTION 14: Hematologic and Oncologic Emergencies\\nTABlE 133-2 Additional hemostatic Tests\\nTest Reference Value\\nComponent \\nMeasured\\nClinical \\nCorrelations/\\nComments\\nFibrin degradation \\nproduct (FDP) and \\nd-dimer levels\\nFDP: variable \\ndepending on spe-\\ncific test, typically \\n<2.5–10 μg/mL \\n(2.5–10 mg/L)\\nD-Dimer: variable \\ndepending on spe-\\ncific test, typically \\n<250–500 ng/mL \\n(250–500 μg/L)\\nFDP test: measures \\nbreakdown products \\nfrom fibrinogen and \\nfibrin monomer\\nD-Dimer test: mea-\\nsures breakdown \\nproducts of cross-\\nlinked fibrin\\nLevels are elevated in \\ndiffuse intravascular \\ncoagulation, venous \\nthrombosis, pulmonary \\nembolus, and liver \\ndisease, and during \\npregnancy\\nFactor level \\nassays\\n60–130% of \\nreference value \\n(0.60–1.30 units/mL)\\nMeasures the \\npercent activity of \\na specified factor \\ncompared to normal\\nTo identify specific \\ndeficiencies and \\ndirect therapeutic \\nmanagement\\nProtein C level Variable\\nTypically 60–150%  \\nof reference value\\nLevel of protein C in \\nthe blood\\nVitamin K dependent\\nIncreases with age\\nValues higher in \\nmales than females\\nDeficiency associated \\nwith thromboembo-\\nlism in people  \\n<50 years of age\\nProtein S level Variable\\nTypically 60–150%  \\nof reference value\\nLevel of protein S in \\nthe blood\\nVitamin K dependent\\nIncreases with age\\nValues higher in \\nmales than females\\nDeficiency associated \\nwith thromboembo-\\nlism in people \\n<50 years of age\\nFactor V Leiden \\n(FVL)\\nVariable Screening test \\nlooks for activated \\nprotein C resistance, \\nand confirmatory \\ntest analyzes DNA \\nsequence of factor \\nV gene\\nFVL not inactivated by \\nactivated protein C\\nScreening assay \\nuses activated par-\\ntial thromboplastin \\ntime with and with-\\nout added activated \\nprotein C\\nHeterozygotes have \\n7× and homozygotes \\nhave a 20× increased \\nlifetime risk of venous \\nthrombosis\\nMutation associated \\nwith thromboembo-\\nlism in people  \\n<50 years of age\\n133_Cydulka_Ch133.indd   724 21/04/17   10:47 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 743, 'page_label': '725'}, page_content='CHAPTER 133: Evaluation of Anemia and the Bleeding Patient 725 \\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 231, “Anemia,” by John C. Ray and Robin R. \\nHemphill; Chapter 232, “Tests of Hemostasis,” by Stephen John Cico and \\nRobin R. Hemphill; Chapter 237, “Acquired Hemolytic Anemia,” by Laurie \\nAnn Dixon and Robin R. Hemphill.\\nTABlE 133-3 Basic Tests and Findings in the Evaluation of hemolytic Anemia\\npurpose Test Finding\\nConfirm anemia/blood \\nloss\\nHemoglobin\\nHematocrit\\nDecreased\\nDecreased\\nConfirm compensatory \\nRBC production\\nReticulocyte count Increased\\nConfirm hemolysis Peripheral smear Schistocytes—intravascular \\nhemolysis, RBCs fragmented by shear \\nmechanism\\nSpherocytes—extravascular \\nhemolysis, RBC phagocytosis by \\nmacrophages\\nConfirm hemolysis Lactate dehydrogenase\\nPotassium\\nIncreased, released by RBCs\\nIncreased, released by RBCs\\nConfirm hemolysis Haptoglobin Decreased, indicative of intravascular \\nhemolysis\\nFree haemoglobin Increased, indicative of intravascular \\nhemolysis\\nHemoglobinuria Present\\nConfirm hemoglobin \\nbreakdown\\nTotal bilirubin Increased\\nIndirect (unconjugated) \\nbilirubin\\nIncreased (hepatic conjugation of \\nbilirubin overwhelmed)\\nUrinary urobilinogen Increased\\nAbbreviation: RBC, red blood cell.\\n133_Cydulka_Ch133.indd   725 21/04/17   10:47 am'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 744, 'page_label': '726'}, page_content='726\\nAcquired Bleeding Disorders\\nAlisheba Hurwitz\\nPlatelet abnormalities, drugs, systemic illnesses, and endogenous antico-\\nagulants can cause acquired bleeding disorders.\\n■ ■ACQUIRED PLATELET DEFECTS\\nClinical Features\\nPatients with platelet disorders commonly present with petechiae or muco-\\nsal bleeding. Splenomegaly may be noted in patients experiencing platelet \\nsequestration.\\nDiagnosis and Differential\\nAcquired platelet abnormalities include quantitative and qualitative defects. \\nQuantitative platelet disorders may be caused by decreased platelet pro-\\nduction (marrow infiltration, aplastic anemia, drugs, viral infections, and \\nchronic alcohol use), or increased platelet destruction (idiopathic thrombo-\\ncytopenic purpura (ITP), thrombotic thrombocytopenic purpura (TTP), \\nhemolytic uremic syndrome, disseminated intravascular coagulation (DIC), \\nviral infections, drugs, and HELLP syndrome). Other causes include acute \\nhemorrhage, hemodialysis, and splenic sequestration. Qualitative platelet \\ndisorders are commonly associated with renal disease, liver disease, DIC, \\ndrugs (aspirin, NSAIDs, clopidogrel), and myeloproliferative disorders.\\nEmergency Department Care and Disposition\\n1. Circulatory stabilization of the acutely bleeding patient is paramount, \\nincluding volume resuscitation, packed red cell transfusion, and pressors \\nas necessary.\\n2. Perform a focused history and physical; order appropriate laboratory \\nstudies. Most evaluations of bleeding patients will include a CBC with \\nperipheral smear. Other studies to consider include PT/INR, PTT, basic \\nmetabolic panel, type and screen, and fibrinogen.\\n3. Consider platelet transfusion in patients with a platelet count <10,000/\\nmm3 or active bleeding with platelets <50,000/mm3.\\n4. Consult with a hematologist, as subtleties in diagnosis and treatment \\nexist. For example, some conditions may be worsened by platelet trans-\\nfusion (DIC and TTP).\\n■ ■BLEEDING IN IMMUNE THROMBOCYTOPENIA\\nEmergency Department Care and Disposition\\nIn general, patients with a platelet count >50,000/mm 3 require no treat-\\nment. Patients with a platelet count <30,000/mm 3 and patients with a \\nplatelet count of <50,000/mm3 with bleeding typically require treatment.\\n1. Treatment options include corticosteroids, such as prednisone 60 to  \\n100 mg PO daily (onset of action 4 to 14 days).\\n134\\nC HAPTER\\n134_Cydulka_Ch134.indd   726 21/03/17   11:53 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 745, 'page_label': '727'}, page_content='CHAPTER 134: Acquired Bleeding Disorders 727 \\n2. Immunoglobulin 1 g/kg daily IV (onset of action 1 to 3 days) is usually \\nreserved for patients with very low platelet counts and bleeding.\\n3. If transfusing platelets, generally two to three times the usual dose \\nis required due to circulating antibodies.\\n■ ■ACQUIRED COAGULATION DEFECTS\\nCoagulation disorders often present with significant hemorrhage and fre-\\nquently involve platelet defects as well.\\nBleeding in Liver Disease\\nPatients with liver disease have an increased risk of bleeding for multiple \\nreasons including decreased synthesis of vitamin K-dependent coagulation \\nfactors (II, VII, IX, and X), thrombocytopenia, and increased fibrinolysis.\\nEmergency Department Care and Disposition\\n1. Transfuse red cells as needed.\\n2. Transfuse platelets for thrombocytopenia <60,000/mm3.\\n3. Consider transfusion of fresh fr ozen plasma 15 mL/kg IV with cau-\\ntion. It may increase the risk of thrombotic complications, and it may \\nincrease portal hypertension thus worsening variceal bleeding.\\nBleeding in Renal Disease\\nA variety of hemostatic defects are associated with renal disease including \\nplatelet dysfunction due to anemia, deficiency of coagulation factors, and \\nthrombocytopenia.\\nEmergency Department Care and Disposition\\n1. Transfuse red cells as needed.\\n2. Desmopressin 0.3 µg/kg SC or IV improves platelet function rapidly.\\n3. Hemodialysis improves platelet function transiently for 1 to 2 days.\\n4. Transfuse platelets and cryoprecipitate for life-threatening bleeding \\nonly.\\nDisseminated Intravascular Coagulation\\nThe clinical features of DIC are a result of simultaneous hemorrhage and \\nthrombosis and vary according to the underlying illness. Bleeding typically \\npredominates and can range from petechiae to diffuse hemorrhaging from \\nGI/GU tracts, surgical wounds, and venipuncture sites.\\nEmergency Department Care and Disposition\\n1. Treat the underlying illness and provide hemodynamic support includ-\\ning pressors and packed red cells as necessary.\\n2. Transfuse platelets if counts <20,000/mm3, or <50,000/mm 3 with \\nactive bleeding.\\n3. Transfuse fresh frozen plasma (15 mL/kg) for bleeding patient with PT \\nor PTT that are >1.5 times the upper limit of normal, or with fibrinogen \\nlevel <150 mg/dL.\\n134_Cydulka_Ch134.indd   727 21/03/17   11:53 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 746, 'page_label': '728'}, page_content='728 SECTION 14: Hematologic and Oncologic Emergencies\\n4. Transfuse fibrinogen concentrate to patients with hypofibrinogenemia \\nand active bleeding, with the goal of raising fibrinogen levels to 100 to \\n150 mg/dL.\\n5. Administer vitamin K IV to bleeding patients with elev ated PT.\\n6. Consider heparin use for patients with a clinical picture dominated by \\nthrombosis.\\n7. Tranexamic acid should be giv en only in the setting of DIC due to \\ntrauma.\\nBleeding Due to Circulating Anticoagulants\\nPatients with acquired factor VIII inhibitors (acquired hemophilia A) pres-\\nent with spontaneous bruising and hematomas. Consult with a hematologist \\nfor management guidance. Treatment options for acute bleeding episodes \\ninclude recombinant factor VIIa and activated prothrombin complex \\nconcentrate.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 233, “Acquired Bleeding Disorders,” by Robert W. \\nShaffer and Sally A. Santen\\n134_Cydulka_Ch134.indd   728 21/03/17   11:53 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 747, 'page_label': '729'}, page_content='729\\nHemophilias and von Willebrand \\nDisease\\nColin G. Kaide\\n■ ■HEMOPHILIAS\\nThe most common hemophilias are caused by genetic deficiencies of factor \\nVIII (hemophilia A) or factor IX (hemophilia B).\\nClinical Features\\nBleeding complications depend on the severity of the disease. Patients \\nwith severe disease (factor VIII or factor IX activity level < 1%) experi-\\nence spontaneous bleeds and difficult to control bleeding after trauma. \\nPatients with moderate disease (1% to 5% factor activity level) may bleed \\nspontaneously but more commonly bleed after trauma. Patients with mild \\ndisease (5% to 40% factor activity level) usually only bleed after trauma. \\nEasy bruising, recurrent hemarthrosis, and muscle hematomas are the \\nmost common clinical manifestations. Central nervous system (CNS) \\nbleeding accounts for the most common cause of death. Retroperitoneal, \\ngastrointestinal (GI), and soft tissue bleeding can occur. Mucocutaneous \\nbleeding (dental bleeding, epistaxis, GI tract bleeding, lungs bleeding) \\ncan occur, although this is rare. Neck hematomas may obstruct the air -\\nway. Unless there is another underlying disease, most patients with \\nhemophilia do not have problems with minor cuts or abrasions. Almost \\nall cases of hemophilia occur in men with women being genetic carriers \\nof the disease. The unlikely exception occurs when a hemophiliac man \\nreproduces with a woman who is a carrier of the hemophilia gene; hemo-\\nphiliac females can result. Owing to spontaneous mutations and lyoniza-\\ntion of the X chromosome women may develop varying degrees of \\ndecreased factor levels.\\nA rare form of hemophilia occurs when a person develops a spontane-\\nous antibody to their intrinsic factor VIII. It is often (40%) associated with \\nother conditions such as autoimmune diseases, cancers, certain drugs, the \\npostpartum period. It usually happens in the sixth or seventh decade and \\naffects men and women equally. Widespread purpura and internal bleeding \\nare common with hemarthrosis less common.\\nDiagnosis and Differential\\nClinically, it is impossible to differentiate between hemophilias A and B. \\nLaboratory testing in patients with hemophilia most often shows a normal \\nprothrombin time (PT), prolonged partial thromboplastin time (PTT), and \\na normal bleeding time. However, if greater than 30% to 40% of factor \\nactivity is present, the PTT may be normal. Specific factor assays may be \\nused to differentiate between the types of hemophilia. Ten percent to 25% \\nof patients with hemophilia A and 1% to 2% of patients with hemophilia B \\nwill develop an inhibitor, which is an antibody against the deficient factor. \\nThe presence of an inhibitor makes treatment more difficult, requiring \\n135\\nC HAP t E r\\n135_Cydulka_Ch135.indd   729 21/03/17   12:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 748, 'page_label': '730'}, page_content='730 SECTION 14: Hematologic and Oncologic Emergencies\\nalternative, pre-activated factors such as recombinant factor VIIa or factor \\neight inhibitor bypassing activity (FEIBA).\\nEmergency Department Care and Disposition\\nThe mainstay of therapy is early factor replacement. Replacement factor \\nproducts are listed in Table 135-1.\\n1. Determine the type of hemophilia and the presence or absence of in-\\nhibitor. See Table 135-2 for factor replacement guidelines. Factor re-\\nplacement may need to be instituted before definitive imaging after head \\ntrauma and other life-threatening injuries. If an inhibitor is present, use \\ntherapy as outlined in Table 135-3.\\n2. Determine the desired factor activity level. Factor activity level determines \\nhow much factor replacement is required. Calculate the amount of factor \\nneeded using the patient’s weight and the desired increase in factor:\\nFactor VIII required = (Target factor – Base line factor) ×  Weight \\n(kg) × 0.5\\nFactor IX required = (Target factor – Base line factor)× Weight (kg)\\nFor severe hemophilia, assume 0% intrinsic activity. The half-life of \\nfactor VIII is approximately 8 to 12 hours. For hemophilia B, the half-\\nlife of factor IX is approximately 16 to 24 hours.\\n3. Treat patients with undiagnosed bleeding disorders with fresh frozen \\nplasma (FFP). FFP contains 1 unit of factor VIII/mL. Specif ic factor \\nassays should guide further therapy.\\nTablE 135-1 replacement Factor Products for Hemophilia treatment\\nHemophilia type Available Products * (Manufacturer/Distributor)\\nHemophilia A Recombinant Factor VIII Concentrates\\nAdvate® (Baxter)\\nHelixate FS® (Bayer/CSL Behring)\\nKogenate FS® (Bayer)\\nRecombinate® (Baxter)\\nXyntha® (Pfizer)\\nHuman Plasma-Derived Factor VIII Concentrates\\nHemofil M® (Baxter)\\nMonoclate-P® (CSL Behring)\\nHuman Plasma-Derived Factor VIII Concentrates That Contain  \\nvon Willebrand Factor\\nAlphanate® (Grifols)\\nHumate-P® (CSL Behring GmbH)\\nKoate-DVI® (Grifols/Kedrion Biopharma)\\nHemophilia B Recombinant Factor IX Concentrate\\nBeneFIX® (Pfizer)\\nHuman Plasma-Derived Factor IX Concentrates\\nAlphaNine SD® (Grifols)\\nMononine® (CSL Behring)\\n*Commercial trade names provided for ease of specific identification.\\n135_Cydulka_Ch135.indd   730 21/03/17   12:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 749, 'page_label': '731'}, page_content='CHAPTER 135: Hemophilias and von Willebrand Disease 731 \\nTablE 135-2 Initial Factor replacement Guidelines in Severe Hemophilia\\nSeverity and \\nSite\\nDesired Factor \\nLevel to Control \\nBleeding\\nHemophilia \\nA Initial \\nDose (IU/ kg)\\nHemophilia B \\nInitial Dose \\n(IU/ kg) Comments\\nMinor: skin \\n(deep laceration)\\n– – – Abrasions and \\nsuperficial lacera-\\ntions usually do not \\nrequire factor \\nreplacement. Treat \\nwith pressure and \\ntopical thrombin.\\nMinor: early \\nhemarthrosis, \\nmild muscle \\nbleeding, mild \\noral bleeding\\n0.2–0.4 IU/mL \\n(20%–40%)\\n10–20 20–30 Repeat dose every \\n12–24 h for 1–3 \\ndays until bleeding \\nepisode is resolved. \\nTypical duration of \\nreplacement is 1–3 \\ndays.\\nModerate: defi-\\nnite hemarthro-\\nsis, moderate \\nmuscle bleed-\\ning, moderate \\noral bleeding\\n0.3–0.6 IU/mL \\n(30%–60%)\\n15–30 25–50 Orthopedic consult \\nmay be required for \\nsplinting, physical \\ntherapy, and follow-\\nup. Typical duration \\nof replacement is \\n3–5 days.\\nMajor: retro-\\npharyngeal, GI, \\nintra-abdominal, \\nintrathoracic, \\nretroperitoneal\\n0.6–1.0 IU/mL \\n(60%–100%)\\n30–50 30–50 Repeat dose every \\n8–24 h until resolu-\\ntion of bleeding  \\nepisode. May \\nrequire replacement \\nfor up to 10 days.\\nCNS 1.0 IU/mL (100%) 50 50–100 Treat before CT. \\nEarly neurosurgical \\nconsultation.\\nTablE 135-3 replacement therapy for Hemophilia A and B in Patients with \\nInhibitors\\ntype of Product* Initial Dose Dosing Interval Comments\\nHuman plasma-derived \\nactivated prothrombin \\ncomplex concentrate\\n50–100 units/kg 6–12 h Total daily doses should \\nnot normally exceed  \\n200 units/kg.\\nFEIBA NF® (Baxter)\\nRecombinant activated \\nfactor VII\\n90 µg/kg 2 h Repeat until hemostasis \\nachieved or therapy \\njudged ineffective.NovoSeven RT® (Novo \\nNordisk)\\n*Commercial trade names provided for ease of specific identification.\\n135_Cydulka_Ch135.indd   731 21/03/17   12:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 750, 'page_label': '732'}, page_content='732 SECTION 14: Hematologic and Oncologic Emergencies\\n4. Treat minor bleeding in patients with mild hemophilia A with desmo-\\npressin (DDA VP) 0.3 µg/kg IV over 15 to 30 minutes or DDA VP 150 \\nµg single spray in each nostril (for children >5 years, DDA VP 150 µg \\nsingle spray in one nostril). Very mild mucosal bleeding can also be \\ntreated with antifibrinolytic agents, such as e-aminocaproic acid \\n(EACA) 75 to 100 mg/kg (up to 6 g) IV/PO every 6 hours or tranexamic \\nacid 10 to 25 mg/kg IV every 6 hours.\\n5. Indications for admission include bleeding involving the head, neck, \\npharynx, retropharynx, or retroperitoneum, potential compartment syn-\\ndrome, and inability to control pain, and treatment requiring multiple \\nfactor replacement.\\n■ ■VON WILLEBrAND DISEASE\\nClinical Features\\nvon Willebrand disease (vWD) is a group of disorders caused by a defect \\nor deficiency of von Willebrand factor (vWF). vWF is a cofactor for \\nplatelet adhesion and a carrier protein for factor VIII in the plasma. Type \\n1 vWD is most common; patients have 20% to 50% of normal vWF levels \\nand usually manifest with skin and mucosal bleeding symptoms. Patients \\nwith type 2 vWF have abnormal and dysfunctional vWF. Patients with \\ntype 3 vWF have complete vWF deficiency and have clinical presenta-\\ntions similar to hemophilia. Patients with mild vWF are frequently \\nunaware of the disease until bleeding occurs after a traumatic episode or \\nsurgical procedure.\\nDiagnosis and Differential\\nThe PT and PTT are usually normal. The bleeding time is prolonged and \\nvWF activity is low. Bleeding time, however, is rarely used anymone and \\nhas been suplanted by more specific platelet activation and aggregation \\nstudies. Variability in vWF levels can make it difficult to distinguish vWD \\nfrom hemophilia A.\\nEmergency Department Care and Disposition\\nThe treatment of vWD depends on the type of disease and the severity of \\nbleeding. Indications for admission are similar to patients with hemophilia.\\n1. The mainstay of treatment for bleeding in type 1 vWD is desmopressin \\n(DDA VP) 0.3 µg/kg (up to 20 µg) SC/IV every 12 to 24 hours for up to \\nfour doses or DDA VP 150 µg single spray in each nostril (for children \\n>5 years, DDA VP 150 µg single spray in 1 nostril). If there is no re-\\nsponse to DDA VP, administer factor VIII concentrate or cryoprecipitate \\nas described for type 2 and 3 vWD.\\n2. Factor VIII concentrate containing vWF is used to treat bleeding in \\npatients with type 2 or 3 disease (Table 135-1).\\n3. Cryoprecipitate 10 bags IV e very 12 to 24 hours can be used for type \\n1 refractory to DDA VP or type 2 or 3 vWD. There is, however, a risk of \\nviral transmission.\\n4. Platelet transfusions may benefit patients with type 3 vWD who do not \\nrespond to vWF-containing plasma products.\\n135_Cydulka_Ch135.indd   732 21/03/17   12:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 751, 'page_label': '733'}, page_content='CHAPTER 135: Hemophilias and von Willebrand Disease 733 \\n5. Oral contraceptives may help increase vWF levels and limit menstrual \\nbleeding in women with vWD and menorrhagia.\\n6. Patients who have sustained dental injuries or who require dental pro -\\ncedures may need e-aminocaproic acid (EACA) 75 to 100 mg/kg (up \\nto 6 grams) PO every 6 hours or tranexamic acid mouthwash for 5 to \\n10 days.\\n■ ■FUrtHEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 235, “Hemophilias and von Willebrand’s Disease,” by \\nRobin R. Hemphill.\\n135_Cydulka_Ch135.indd   733 21/03/17   12:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 752, 'page_label': '734'}, page_content='734\\nSickle Cell Disease and Other \\nHereditary Hemolytic Anemias\\nColleen Fant\\nInherited anemias stem from abnormal hemoglobin structure or production \\nor from abnormal RBC structure or metabolism. Anemia occurs when \\ndestruction of red blood cells exceeds production. Most patients with dys-\\nhemoglobinemia are aware of their status.\\n■ ■SICKLE CELL DISEASE\\nClinical Features\\nMost patients with sickle cell disease (SCD) (homozygous (HbSS)) or \\nsickle trait (heterozygous (HbAS)) present with symptoms related to vaso-\\nocclusive crisis, or with pain, weakness, or infections. Physical examina-\\ntion findings commonly include pallor, venous stasis changes, jaundice, \\nhepatosplenomegaly, cardiac flow murmurs, cardiomegaly, and high-output \\ncongestive heart failure (CHF).\\nPainful vasooclusive crisis in the musculoskeletal system or, in some \\ncases, organ-specific symptoms are the most common presentations to the \\nED. Crisis occurs when sickled RBCs mechanically obstruct blood flow, \\ncausing ischemia, organ damage, and infarction. Crisis-causing stresses \\ninclude fever or infection (especially encapsulated organisms Haemophilus \\ninfluenzae or Pneumococcus), cold exposure or high altitude, dehydration \\nor overexertion, medication noncompliance, or drug use.\\nAcute symptomatic anemia results from splenic sequestration, bone \\nmarrow failure (aplastic crisis), or hemolysis due to infection and presents \\nwith fatigue, weakness, dyspnea, chronic heart failure, or shock.\\nLife or limb-threatening events seen in SCD patients include acute \\nchest syndrome (vasoocclusive pulmonary insult), stroke, renal infarct, \\nmesenteric infarcts, sepsis, avascular necrosis, osteomyelitis, pneumonia, \\nor priapism.\\nDiagnosis and Differential\\nThe degree of illness guides the evaluation of an acute crisis. Although \\nworkups should be individualized, the more common, vague complaints \\n(pain, weakness, fever) must include a search for an underlying, treatable \\nevent. See Table 136-1.\\nAnemia due to splenic sequestration may present as splenomegaly with \\nor without left-upper quadrant pain and elevated reticulocyte count. Anemia \\ndue to bone marrow failure may be suggested by a depressed reticulocyte \\ncount. Leukocytosis or left shift with increased bands suggests infection. \\nAssessment of electrolytes will allow evaluation of dehydration and renal \\nfunction. Liver function tests and lipase may help evaluate abdominal pain. \\nPerform a pregnancy test on women. Febrile SCD patients without local-\\nizing symptoms should have blood cultures, urinalysis, and chest radio-\\ngraphs performed.\\n136\\nCh A pt E r\\n136_Cydulka_Ch136.indd   734 21/03/17   12:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 753, 'page_label': '735'}, page_content='CHAPTER 136: Sickle Cell Disease and Other Hereditary Hemolytic Anemias 735 \\nTAble 136-1 Guidelines for the Assessment and Management of Acute \\nVasoocclusive Crisis\\nHistory Duration and location of pain\\nHistory of fever\\nHistory of focal swelling or redness\\nPrecipitating factors for acute episode\\nMedications taken for pain relief\\nPhysical examination Assess degree of pain\\nInspect sites of pain, looking for swelling, warmth, redness\\nGeneral: respiratory distress, pallor, hydration, jaundice, rash\\nVital signs: especially temperature, pulse oximetry\\nRespiratory: lung sounds\\nHeart: cardiomegaly and systolic murmur common with chronic \\nanemia\\nAbdomen: tenderness, organomegaly\\nAncillary tests If moderate to severe pain, focal pathology is present, or pain is \\natypical for acute episode\\nObtain CBC, leukocyte differential, reticulocyte count, urinalysis\\nChest radiograph, if signs of lower respiratory tract pathology\\nBlood cultures and additional blood tests: as indicated by clinical \\ncondition\\nGeneral management Bed rest, provide warmth and a calm, relaxing atmosphere\\nDistractions where appropriate: television, music, etc.\\nOral fluids: typically about 3 L/d\\nIV fluids to correct dehydration or if reluctant to drink or \\nvomiting is present\\nOxygen: not routinely required unless hypoxemia is present\\nEncourage deep breathing, incentive spirometry\\nConsider adjuvant therapy: anxiolytic, tinzaparin, antiemetic\\nPain management Use analgesics appropriate to degree of pain\\nAcetaminophen for mild pain\\nNSAID for mild to moderate pain (avoid if renal insufficiency is \\npresent)\\nOpioids for moderate to severe pain, typical initial doses \\ninclude:\\nMorphine, 0.3 mg/kg PO or 0.1–0.15 mg/kg IV\\nHydromorphone, 0.06–0.08 mg/kg PO or 0.015–0.020 mg/kg IV\\nReassess response in 15–30 minutes, may repeat with one-\\nfourth to one-half initial dose, consider patient’s known effective \\ndose\\nDisposition and  \\nfollow-up\\nConsider admission to the hospital if:\\nAcute chest syndrome is suspected\\nSepsis, osteomyelitis, or other serious infection is suspected\\nHemoglobin is <5 g/dL\\nWhite blood cell count is >30,000/mm3\\nPlatelet count is <100,000/mm3\\nConsider discharge if:\\nPain is under control and patient can take oral fluids and \\nmedications\\nAppropriate oral analgesics are available\\nPatient is able to comply with home care instructions\\nPatient has resources for follow-up\\nAbbreviations: CBC, complete blood count; NSAID, nonsteroidal anti-inflammatory drug.\\n136_Cydulka_Ch136.indd   735 21/03/17   12:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 754, 'page_label': '736'}, page_content='736 SECTION 14: Hematologic and Oncologic Emergencies\\nTAble 136-2 Assessment and treatment of Acute Chest Syndrome\\nHistory Major presenting symptom: dyspnea, fever, cough\\nAccompanying chest, rib, bone, or joint pain\\nAssess degree or severity of pain\\nRecent or previous sepsis, infection, pneumonia, or hospitalization\\nPrior history of acute chest syndrome, especially if required intubation \\nand ventilatory support\\nPotentially infectious contacts\\nCurrent medications\\nImmunization history: especially pneumococcal and Haemophilus \\ninfluenzae type b\\nBaseline hemoglobin level and arterial oxygenation saturation\\nPhysical \\nexamination\\nGeneral: respiratory distress, pallor, hydration, jaundice, rash\\nVital signs: especially temperature, pulse oximetry\\nRespiratory: chest wall, lung sounds\\nHeart: cardiomegaly and systolic murmur common with chronic anemia\\nAbdomen: tenderness, organomegaly\\nAncillary tests Complete blood count, leukocyte differential, reticulocyte count, \\nurinalysis\\nCross-match sample: if red blood cell transfusion is contemplated\\nArterial blood gas: if moderate to severe respiratory distress and/or \\nhypoxemia on pulse oximetry\\nChest radiography\\nBlood cultures\\nAdditional blood tests: as indicated by clinical condition\\nTreatment Oxygen: adjust according to pulse oximetry\\nOral hydration: preferable\\nIV hydration: use hypotonic fluids, use a rate and dose at approxi-\\nmately 1.5 times of maintenance (overaggressive IV fluids can worsen \\nacute chest syndrome)\\nAnalgesics: if needed, generally potent parenteral opioids are used; \\nmonitor for signs of respiratory suppression\\nAntibiotics: empiric antibiotics recommended to treat community \\nacquired pneumonia\\nBronchodilators: nebulized β2-adrenergic agonists\\nChest physiotherapy\\nTransfusion: use if severe acute anemia is present\\nExchange \\ntransfusion\\nConsider when\\nSevere acute chest syndrome on admission and past history of \\nrequiring ventilatory support: useful to prevent intubation\\nDeterioration despite above management: useful to prevent \\nintensive care unit admission\\nPatient already intubated and on ventilatory support: useful to \\nshorten duration of ventilatory need\\nSuspected or confirmed fat or bone marrow embolism\\nPatients presenting with symptoms of acute chest syndrome (chest pain, \\ncough, fever, dyspnea) need immediate evaluation (Table 136-2). Chest \\nradiographs are important to identify the presence of a new infiltrate. \\nAssess oxygenation; type and cross for possible exchange transfusion.\\nRadiographs of the skeleton are indicated for atypical focal bone pain. \\nAdvanced imaging for abdominal pain or for neurologic manifestations will \\nhelp to assess these symptoms.\\n136_Cydulka_Ch136.indd   736 21/03/17   12:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 755, 'page_label': '737'}, page_content='CHAPTER 136: Sickle Cell Disease and Other Hereditary Hemolytic Anemias 737 \\nThe differential diagnosis for musculoskeletal pain includes osteomyeli-\\ntis, bony infarcts, cellulitis, and acute arthritides. For abdominal pain, the \\ndifferential includes pancreatitis, hepatitis, cholecystitis, pelvic inflamma-\\ntory disease, and pyelonephritis. Chest pain may be due to acute chest, \\npneumonia, or pulmonary embolus. Neurologic symptoms may be due to \\nmeningitis, cerebral infarct, ischemia, or hemorrhage.\\nemergency Department Care and Disposition\\nInitial management for acute crisis in SCD patients is primarily supportive \\nand includes pain management and an assessment for the underlying cause \\nof the crisis (see Tables 136-1 and 136-2).\\n1. Encourage oral rehydration if dehydration is suspected. IV crystalloid \\nmay be used as an alternative, up to 1.5 times maintenance. Hypotonic \\nfluids may reduce the tendency for sickling.\\n2. Administer opioid pain medications for sev ere pain. Individualized \\ntreatment plans are warranted for patients with frequent relapses.\\n3. Administer supplemental oxygen for hypoxia.\\n4. ECG and cardiac monitoring are appropriate for patients with cardio-\\npulmonary symptoms.\\n5. For symptoms of acute infection, cultures  should be obtained and \\nbroad-spectrum antibiotics administered. For patients with suspected \\nacute chest, antibiotics should be targeted toward community-acquired \\npneumonia.\\n6. Consider exchange transfusion  for acute crisis or complications in \\nspecific circumstances—aplastic crisis, cardiopulmonary decompensa-\\ntion, pregnancy, stroke, respiratory failure, general surgery, and priapism \\n(requires urologic consultation). Exchange transfusion is typically \\nreserved for patients with severe crises, that is, PaO 2 <60 mm Hg.\\n7. Patients with priapism lasting >4 hours should additionally recei ve \\ncorporal aspiration and injection of dilute α-adrenergic agonist.\\n8. Admission criteria include pulmonary, neurologic, aplastic, or infectious \\ncrises; splenic sequestration; intractable pain; persistent nausea and \\nvomiting; or an uncertain diagnosis.\\n9. Patients able to be discharged should receiv e oral analgesics, close fol-\\nlow-up, and instructions to return immediately for temperature above \\n38°C or worsening symptoms.\\n■ ■VArIANtS OF SICKLE CELL DISEASE\\nOther genetic variants of hemoglobinopathies exist and vary in presenta-\\ntion, from asymptomatic to SCD-like and depend upon the specific abnor -\\nmality and whether homozygous, heterozygous, or combined with sickle \\ncell trait.\\nThalassemias\\nThalassemias are hereditary disorders caused by defective synthesis of \\nglobin chains, resulting in microcytic, hypochromic, hemolytic anemia. \\nThe degree of illness depends upon the type and number of genetic \\nabnormalities.\\n136_Cydulka_Ch136.indd   737 21/03/17   12:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 756, 'page_label': '738'}, page_content='738 SECTION 14: Hematologic and Oncologic Emergencies\\nPatients with β-thalassemia minor have mild microcytic anemia and are \\ngenerally asymptomatic. Patients with β-thalassemia major (Cooley’s ane-\\nmia) develop hepatosplenomegaly, jaundice, and bony changes. They are at \\nincreased risk for infection and may develop severe anemia requiring blood \\ntransfusions. Iron overload from transfusions can cause significant morbid-\\nity and mortality.\\nGlucose-6-Phosphate Dehydrogenase Deficiency\\nGlucose-6-phosphate dehydrogenase (G6PD) deficiency is the most com-\\nmon enzymopathy of RBCs. This causes hemoglobin precipitation, RBC \\nremoval by the spleen, and hemolysis. The amount of hemolysis depends \\non degree of enzyme abnormality. Most patients are asymptomatic until an \\nexposure to an oxidative stress (e.g., medication, infection, fava beans) \\ncauses hemolysis. A serious complication of G6PD deficiency is severe \\nneonatal jaundice that presents in the first week of life. Evaluation includes \\na complete blood count and reticulocyte count, bilirubin levels, serum ami-\\nnotransferases, and lactate dehydrogenase. Treatment is determined by the \\npatient’s overall clinical condition and includes early treatment of infection \\nand may include blood transfusion for severe anemia.\\nHereditary Spherocytosis\\nHereditary spherocytosis results from an erythrocyte membrane defect \\ncreating small inflexible RBCs that are unable to pass through the spleen \\nresulting in an increased rate of destruction and a compensatory increase in \\nRBC production. Complications include aplastic or megaloblastic crises, \\ncholecystitis or cholelithiasis, splenomegaly, hemolytic crisis, and neonatal \\nhemolysis with jaundice. Treatments include blood transfusions and sple-\\nnectomy in severe cases.\\n■ ■FUrthEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 236, “Sickle Cell Disease and Hereditary Hemolytic \\nAnemias,” by Jean Williams-Johnson and Eric Williams.\\n136_Cydulka_Ch136.indd   738 21/03/17   12:06 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 757, 'page_label': '739'}, page_content='739\\nTransfusion Therapy\\nÖzlem Köksal\\nPatients are typically transfused in the emergency department to treat acute \\nblood loss and/or circulatory shock. The goal of transfusion is to improve \\noxygen delivery to tissues, provide intravascular volume expansion, and \\nreplace missing or depleted clotting factors. Great care must be taken to \\nensure that the correct blood product is delivered to the correct patient.\\n■ ■WHOLE BLOOD\\nThere are few indications for the use of whole-blood transfusion. Although \\nwhole-blood transfusion would seem ideal to replace acute blood loss, stor-\\nage of whole blood inactivates platelets and other factors. Therefore, whole \\nblood is fractionated to its components for transfusion.\\n■ ■PACKED RED BLOOD CELLS\\nPacked red blood cells (PRBCs) are prepared from whole blood by removing \\nmost platelets and/or white cells. A single unit of PRBC has 250 mL and \\nraises an adult’s hemoglobin by 1 g/dL (hematocrit by 3%). In children, \\n10 to 15 mL/kg of PRBCs raises the hemoglobin level by approximately \\n2 to 3 g/dL (hematocrit by 6% to 9%). PRBCs increase oxygen-carrying \\ncapacity in anemic patients.\\nThe decision to transfuse PRBC is based on individual clinical judg-\\nment, taking into account patient’s hemodynamic status, underlying medi-\\ncal condition, tolerance for anemia, and risk of end-organ ischemic injury. \\nAdequate oxygen delivery in healthy normovolemic patients can be main-\\ntained with hemoglobin levels as low as 7 g/dL, although patients with \\ncomorbid conditions may require transfusion at higher levels of hemoglo-\\nbin. The usual indications for PRBC transfusion include (a) acute blood \\nloss about 30% of blood volume (1500 mL in adult), (b) acute hemorrhage, \\n(c) unstable trauma patients based on inadequate response to an initial 2-L \\nbolus of IV crystalloid or 40 mL/kg in children; and (d) symptomatic \\nanemia with hemoglobin <7 g/dL or being at-risk for ischemic events, such \\nas patients with hemoglobin <8 to 9 g/dL who have sepsis or ischemic \\nheart or brain injury.\\nType and cross-match assesses ABO/Rh blood type, the presence of \\nantibodies, and patient and donor blood compatibility. Blood type can be \\ndetermined in approximately 15 minutes, whereas it takes about 45 to \\n60 minutes to perform a serologic cross-match.\\nIn critical situations, where there is no time to perform a complete ABO/\\nRh-typing, group O/Rh-negative blood (“universal donor”) can be given to \\npatients without waiting for a complete type and cross-match. Type O/Rh-\\npositive blood may be used if Rh-negative blood is unavailable, but should \\nbe avoided in girls and women of childbearing potential. Before transfu-\\nsion, blood for baseline laboratory tests, type, and crossmatching should be \\nobtained.\\n137\\nC HAP t ER\\n137_Cydulka_Ch137.indd   739 21/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 758, 'page_label': '740'}, page_content='740 SECTION 14: Hematologic and Oncologic Emergencies\\nPacked red blood cells may be further treated to minimize complica -\\ntions in special patient populations, such as neonates, transplant and \\npatients on transplant list, patients who have received prior transfusions, \\npregnant patients, immunocompromised patients, and patients with \\nhypersensitivity to plasma. Options include leukocyte-reduced, irradi-\\nated, frozen deglycerolized, washed, and Cytomegalovirus-negative \\nPRBCs.\\nOne unit of PRBC is generally transfused over 1 to 2 hours. PRBCs \\nshould be transfused more rapidly in patients with hemodynamic instabil-\\nity. Single-unit PRBC transfusions should not exceed 4 hours to prevent \\ncontamination. Micropore filters are used to filter out microaggregates of \\nplatelets, fibrin, and leukocytes. Normal saline solution is the only crystal-\\nloid compatible with PRBCs. Blood warmers or concurrently administered \\nwarmed saline solution (39°C to 43°C or 102.2°F to 109.4°F) can be used \\nto prevent hypothermia.\\n■ ■MASSIVE tRANSFUSION\\nMassive transfusion is the replacement of one blood volume or approxi-\\nmately 10 units of PRBCs in an adult within a 24-hour period. The best \\nratio of PRBCs to platelets to fresh frozen plasma (FFP) during a massive \\ntransfusion is controversial. Some experts advocate a 1:1:1 ratio, although \\nlower ratios of platelets to FFP have been used without clear evidence of \\ninferiority. Complications of massive transfusion include coagulopathy, \\ncitrate toxicity, hypocalcemia, hypomagnes, emia, and hypothermia. See \\nTable 137-1 for recognition, management, and evaluation of selected acute \\ntransfusion reactions.\\n■ ■PLAtELEtS\\nPlatelet transfusions may be used in thrombocytopenic patients to prevent \\nbleeding or to help stop active bleeding. Platelet transfusion is usually not \\nhelpful in cases of bleeding from platelet dysfunction (e.g., uremia) or from \\nthrombocytopenia due to increased consumption/sequestration until the \\nunderlying disorder (e.g., DIC) is corrected. General indications for platelet \\ntransfusion include platelet count < 5,000/mm 3 in asymptomatic patients, \\nplatelet count < 20,000/mm 3 with a coagulation disorder, low-risk proce-\\ndure, during outpatient treatment, platelet count < 50,000/mm3 with active \\nbleeding or invasive procedure within 4 hours, platelet count < 100,000/mm3 \\nwith neurologic or cardiac surgery, or as part of a massive transfusion \\nprotocol.\\nOne apheresis single-donor platelet unit will increase the platelet count \\nby up to 50,000/mm 3. Typical dose is 1 unit or 5 mL/kg. Typical dose of \\npooled donor platelet is 6 units or 5 mL/kg.\\nABO-type specific platelets are preferable. Platelets may also be \\nwashed or irradiated. The platelet count should be checked at 1 and \\n24 hours after transfusion. Transfused platelets survive 3 to 5 days unless \\nthere is a platelet- consumptive process.\\n137_Cydulka_Ch137.indd   740 21/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 759, 'page_label': '741'}, page_content='CHAPTER 137: Transfusion Therapy 741 \\nTable 137-1 transfusion Reactions\\nReaction \\ntype\\nSigns and \\nSymptoms Management Evaluation\\nAcute intra-\\nvascular \\nhemolytic \\nreaction\\nFever, chills, \\nlow back \\npain, flushing, \\ndyspnea, \\ntachycardia, \\nshock, \\nhemoglobinuria\\nImmediately stop transfu-\\nsion.\\nIV hydration to maintain \\ndiuresis; diuretics may be \\nnecessary.\\nCardiorespiratory support as \\nindicated.\\nRetype and repeat \\ncross-match.\\nDirect and indirect \\nCoombs test.\\nCBC, creatinine, \\nprothrombin time, \\nactivated partial \\nthromboplastin time.\\nHaptoglobin, indirect \\nbilirubin, lactate \\ndehydrogenase, \\nplasma free \\nhemoglobin.\\nUrine for hemoglobin.\\nDelayed \\nextravascular \\nhemolytic \\nreaction\\nOften have \\nlow-grade \\nfever but may \\nbe entirely \\nasymptomatic\\nUsually presents days to \\nweeks after transfusion.\\nRarely causes clinical \\ninstability.\\nHemolytic workup as \\nabove to investigate \\nthe possibility \\nof intravascular \\nhemolysis.\\nFebrile \\nnonhemolytic \\ntransfusion \\nreaction\\nFever, chills Stop transfusion.\\nInitially manage as in intra-\\nvascular hemolytic reaction \\n(above) because one cannot \\ninitially distinguish between \\nthe two.\\nCan treat fever and chills \\nwith acetaminophen.\\nUsually mild but can be life-\\nthreatening in patients with \\ntenuous cardiopulmonary \\nstatus.\\nConsider infectious workup.\\nPremedication with acet-\\naminophen can mask this \\nreaction.\\nHemolytic workup as \\nabove because may \\nnot be able to initially \\ndistinguish febrile from \\nhemolytic transfusion \\nreactions.\\nAllergic \\nreaction\\nMild: urticaria, \\npruritus\\nSevere: \\ndyspnea, \\nbronchospasm, \\nhypotension, \\ntachycardia, \\nshock\\nStop transfusion.\\nIf mild, reaction can be \\ntreated with diphenhydr-\\namine; if symptoms resolve, \\ncan restart transfusion.\\nIf severe, may require \\ncardiopulmonary support; \\ndo not restart transfusion.\\nFor mild symptoms \\nthat resolve with \\ndiphenhydramine, \\nno further workup is \\nnecessary, although \\nblood bank should be \\nnotified.\\nFor severe reaction, do \\nhemolytic workup as \\nabove because initially \\nmay be indistinguish-\\nable from a hemolytic \\nreaction.\\n137_Cydulka_Ch137.indd   741 21/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 760, 'page_label': '742'}, page_content='742 SECTION 14: Hematologic and Oncologic Emergencies\\n■ ■FRESH FROZEN PLASMA\\nFresh frozen plasma contains all coagulation factors and fibrinogen. FFP is \\nused for replacement of multiple coagulation deficiencies (liver failure, \\nwarfarin-induced over-anticoagulation and massive transfusion) and to cor-\\nrect coagulation defects for which no factor is available. FFP is also admin-\\nistered prior to high-risk invasive procedures if PT/INR > 1.5X normal, \\naPTT > 1.5X top of normal range, or coagulation factor assay < 25% \\nnormal activity. FFP is not indicated to treat a prolonged INR in the absence \\nof active bleeding.\\nFresh frozen plasma needs to be thawed for 20 to 40 minutes before it \\ncan be used. Each 200 to 250 mL pack of FFP contains 1 unit/mL of each \\ncoagulation factor and 2 mL fibrinogen. In general, 1 unit of FFP will \\nincrease most coagulation factors by 3% to 5% in a 70-kg adult. FFP should \\nbe ABO-type compatible. Type AB is the universal donor for FFP, and in \\nemergencies, universal donor FFP can be given minutes after thawing. \\nStarting dose is 15 mL/kg (or 4 units in a 70-kg adult). If rapid reversal of \\na vitamin K antagonist coagulopathy is needed, prothrombin complex con-\\ncentrate or recombinant activated factor VII is faster and more reliable.\\n■ ■CRYOPRECIPItAtE\\nCryoprecipitate is derived from FFP. One bag of cryoprecipitate contains \\n80 units factor VIII, 200 to 300 mL von Willebrand factor, 40 to 60 units \\nfibrinogen, factor XIII, and variable amounts of fibronectin.\\nCryoprecipitate is indicated for (a) active bleeding in patients with afi-\\nbrinogenemia or hypofibrinogenemia (fibrinogen levels < 100 mL/dL) as a \\nresult of a pathological process (DIC, severe liver disease, abruptio placen-\\ntae, amniotic fluid embolus, massive transfusion); (b) active bleeding in \\npatients with von Willebrand disease when desmopressin (DDA VP) is not \\neffective or in patients with von Willebrand disease type 2B, or if factor \\nVIII concentrate containing von Willebrand factor is not available; and \\n(c) hemophilia type A when virally inactivated factor VIII concentrates are \\nnot available. Cryoprecipitate can also be used as fibrin surgical adhesives \\nin surgical patients.\\nCryoprecipitate should be ABO-compatible. The volume of each unit is \\n20 to 50 mL. The usual dose is 1 unit/5 kg of body weight (10 to 14 units \\nfor an adult) and will raise fibrinogen concentration to 75 mL/dL.\\n■ ■FIBRINOGEN CONCENtRAtE\\nFibrinogen concentrate is derived from pooled human plasma. It used to \\ntreat bleeding episodes in patients with congenital fibrinogen deficiency.\\nFibrinogen is dosed according to the patient’s fibrinogen baseline level, \\nthe target level (usually >150 mL/dL), volume of distribution, and body \\nweight. If the baseline level is unknown, the initial dose is fibrinogen con-\\ncentrate 70 mL/kg.\\nProthrombin complex concentrate (PCC) is a blood-derived concentra-\\ntion of vitamin K-dependent clotting factors (factors II, VII, IX, and X). \\nSome PCC formulations may also contain the anticoagulant proteins C, S, \\nand antitrombin, as well as heparin. PCC administration does not necessi-\\ntate ABO-compatibility testing.\\n137_Cydulka_Ch137.indd   742 21/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 761, 'page_label': '743'}, page_content='CHAPTER 137: Transfusion Therapy 743 \\n■ ■COAGULAtION FACtOR VIIA (RECOMBINANt)\\nCoagulation factor VIIa is primarily used for treatment of hemophilia A and \\nB in patients who have developed inhibitor antibodies to factors VII or IX, \\nrespectively.\\n■ ■SPECIFIC FACtOR REPLACEMENt tHERAPY\\nTable 137-2 outlines therapy for congenital coagulation factor deficiencies.\\n■ ■COMPLICAtIONS OF tRANSFUSIONS\\nAcute complications include febrile nonhemolytic transfusion reaction \\n(most common), acute hemolytic reaction, ABO incompatibility, allergic \\nreaction and anaphylaxis, and transfusion related acute lung injury (TRALI).  \\nTable 137-2 Replacement therapy for Congenital Factor Deficiencies\\nCoagulation Factor Approximate Incidence* Replacement therapy\\nFactor I (fibrinogen) 1 per million Cryoprecipitate\\nFibrinogen concentrate\\nFactor II (prothrombin) 1 per 2 million 3- or 4-factor PCC for major \\nbleeding\\nFactor V 1 per million FFP\\nFactor VII 1 per 500,000 4-factor PCC for major bleeding\\nCoagulation factor VIIa \\n(recombinant)\\nFactor VIII† 1 per 5000–10,000 males Recombinant factor VIII\\nDesmopressin for mild hemophilia\\nVon Willebrand’s \\ndisease‡\\nUp to 1 per 100 persons Desmopressin or factor VIII \\nconcentrates (or cryoprecipitate \\nif either unavailable)\\nFactor IX† 1 per 30,000 males Recombinant factor IX\\n3- or 4-factor PCC\\nFactor X 1 per million FFP for minor bleeding episodes\\n3- or 4-factor PCC for major \\nbleeding\\nFactor XI‡ 3 per 10,000\\nAshkenazi Jews\\n1 per million in general \\npopulation\\nFFP\\nFactor XII 25 per 1000 No bleeding manifestations, \\nreplacement not required\\nFactor XIII 1 per million FFP or cryoprecipitate\\nAbbreviations: FFP , fresh frozen plasma; PCC, prothrombin complex concentrate.\\n*Source: van Herrewegen F, Meijers JC, Peters M, van Ommen CH: Clinical practice: the bleeding child. \\nPart II: disorders of secondary hemostasis and fibrinolysis. Eur J Pediatr. 2012;171:207.\\n†See Chapter 235, “Hemophilias and von Willebrand’s Disease,” in Tintinalli’s Emergency Medicine: \\nA Comprehensive Study Guide, 8th ed.\\n‡Factor XI levels correlate poorly with bleeding complications; many patients have low levels but no \\nbleeding complications.\\n137_Cydulka_Ch137.indd   743 21/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 762, 'page_label': '744'}, page_content='744 SECTION 14: Hematologic and Oncologic Emergencies\\nTwo important first steps in any confirmed or suspected transfusion reac-\\ntion are to (1) immediately stop the transfusion, and (2) contact the blood \\nbank that issued the transfusion product. (3) Table 137-1 summarizes the \\nclinical presentation, evaluation, and management of acute transfusion \\nreactions.\\nDelayed transfusion complications present days or weeks after the index \\ntransfusion and include delayed hemolytic transfusion reaction, transfusion \\nassociated graft versus host disease, posttransfusion purpura, and infectious \\ndisease transmission.\\n■ ■FURtHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 238, “Transfusion Therapy,” by Clinton J. Coil and \\nSally A. Santen.\\n137_Cydulka_Ch137.indd   744 21/03/17   12:12 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 763, 'page_label': '745'}, page_content='745\\nAnticoagulants, Antiplatelet \\nAgents, and Fibrinolytics\\nJessica L. Smith\\nAntithrombotic therapy is used to treat acute coronary syndrome, deep \\nvenous thrombosis (DVT), pulmonary embolism (PE), transient isch-\\nemic attack, and ischemic stroke. These agents are also used to prevent \\nocclusive vascular events in patients at risk. Detailed management strat-\\negies and dosing regimens are provided in Chapter 18, “Acute Coronary \\nSyndromes: Management of Myocardial Infarction and Unstable \\nAngina,” Chapter 25, “Thromboembolism,” and Chapter 141, “Stroke \\nand Transient Ischemic Attack.” This chapter provides an overview of \\nantithrombotic agents.\\n■ ■ORAL ANTICOAGULANTS\\nThe goals of anticoagulant therapy include (1) stop further acute thrombo-\\nsis, (2) reduce the risk of embolism from a thrombus, and (3) prevent the \\nformation of de novo thrombus in patients at risk.\\nWarfarin is the most commonly used oral anticoagulant in the United  \\nStates. It preferentially inhibits vitamin K-dependent cofactors in the \\nextrinsic coagulation cascade. Dosing is guided by measuring the interna-\\ntional normalized ratio (INR), and most patients are therapeutic in a range \\nof 2 to 3. Patients with mechanical heart valves or antiphospholipid anti-\\nbody syndrome require an INR of 2.5 to 3.5. It takes about 3 to 4 days to \\nreach full anticoagulation upon initiating treatment. A parenteral antico-\\nagulant should be used until the INR is maintained in the desired range for \\n2 days, as warfarin therapy causes a transient state of thrombogenesis for \\n24 to 36 hours at the start of therapy. Parenteral bridging is crucial in \\npatients with prosthetic heart valves or those who are at high risk for cata-\\nstrophic complications of intravascular thrombosis when initiating warfa-\\nrin. Warfarin use is contraindicated during pregnancy due to teratogenicity. \\nComplications of warfarin use include skin necrosis (associated with \\nprotein C deficiency) and increased bleeding risk in patients with hyper -\\ntension, anemia, prior cerebrovascular disease, gastrointestinal (GI) \\nlesions, or renal disease. A number of medications, foods, or disease states \\ninterfere with warfarin absorption or metabolism and cause clinically sig-\\nnificant consequences. There are three approaches for warfarin reversal \\ndepending on the intensity of therapy and the patient’s risk for recurrent \\nthromboembolism: stop the warfarin, administer vitamin K, and replace \\ndeficient coagulation factors. Figure 138-1 describes the management of \\nwarfarin-induced coagulopathy.\\nDirect thrombin inhibitors like dabigatran, and factor Xa inhibitors \\nlike rivaroxaban, apixaban, and edoxaban, are used in nonvalvular atrial \\nfibrillation to reduce systemic embolism and stroke risk. A normal throm-\\nbin clotting time excludes significant coagulopathy due to dabigatran. \\nIdarucizumab, 5 g IV, can be used for dabigatran reversal. It may be \\nrepeated once, if needed No other reversal agent is currently available. \\n138\\nCh A p T e R\\n138_Cydulka_Ch138.indd   745 20/04/17   3:58 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 764, 'page_label': '746'}, page_content='746 SECTION 14: Hematologic and Oncologic Emergencies\\n/uni25CF A dminister vitamin K1 5–10 mg SLOW IV\\n    bolus\\n/uni25CF A dminister 4-factor PCC 50 units/kg\\n   (max 5000 units) IV infusion if INR\\n   >6, 35 units/kg (max 3500 units) if INR\\n    4–6, and 25 units/kg (max 2500 units)\\n    if INR <4\\n/uni25CF Alternative ly, may use 3-factor PCC\\n    50 units/kg IV, FFP 10–15 mL/kg IV\\n    infusion, or rFVIIa 80 µg/kg slow IV bolus\\n/uni25CF A dditional doses of PCC, FFP , or rFVIIa\\n    may be required depending on degree\\n   of coagulopathy    \\nYes\\nNo\\nNo\\nNo\\n/uni25CF Hold the next 1 or 2 doses\\n/uni25CF A dminister oral vitamin K 2.0–2.5 mg PO \\n/uni25CF More frequent monito ring and administer\\n    more vitamin K as necessary† \\n/uni25CF Resume appropriately adjusted dose\\n    when INR is therapeutic\\nYes\\n/uni25CF Hold the next 1 or 2 doses\\n/uni25CF If high risk for bleeding* consider\\n    giving vitamin K 1–2 mg PO\\n/uni25CF More frequent monito ring \\n/uni25CF Resume appropriately adjusted dose\\n    when INR is therapeutic\\nNo significant\\nbleeding and the\\nINR is >10.0 \\nNo significant\\nbleeding and the\\nINR is between\\n4.5 and 10.0\\nYes\\n/uni25CF Lower dose or omit one dose for\\n    patients at high risk of bleeding*\\n/uni25CF More frequent monito ring\\n/uni25CF Resume appropriately adjusted dose\\n    when INR is therapeutic\\nNo significant\\nbleeding and the \\nINR is between\\n3.0 and 4.5\\nYes\\nElevated INR and\\nlife-threatening or\\nserious bleeding\\npresent\\nFigure 138-1.  Management of prolonged INR (warfarin-induced coagulopathy). \\n*High risk of bleeding: age >75 years, concurrent antiplatelet drug use, polyphar -\\nmacy, liver or renal disease, alcoholism, recent surgery, or trauma. †There are no \\nvalidated tools to predict risk of short-term major bleeding in patients with severe \\nover-anticoagulation. The decision to admit for observation relies on physician \\njudgment. FFP = fresh frozen plasma; IU = international unit; PCC = prothrombin \\ncomplex concentrate; rFVIIa = recombinant activated factor VII.\\nHemodialysis can remove 60% or more of dabigatran, but hemodialysis \\nis not effective in removing rivaroxaban. If emergency reversal is needed \\nfor dabigatran or rivaroxaban, activated prothrombin complex concentrate \\nor recombinant activated factor VII can be used. Fresh frozen plasma can \\n138_Cydulka_Ch138.indd   746 20/04/17   3:58 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 765, 'page_label': '747'}, page_content='CHAPTER 138: Anticoagulants, Antiplatelet Agents, and Fibrinolytics 747 \\nalso be used to reverse riv aroxaban, but has not been shown to have a \\nmajor benefit in dabigatran reversal.\\n■ ■hepARINS, pOLYSACChARIDeS, AND hIRUDINS\\nParenteral agents include unfractionated heparin (UFH), low-molecular-\\nweight heparin (LMWH) (e.g., enoxaparin, dalteparin), Xa inhibitors \\n(fondaparinux), and direct thrombin inhibitors (e.g., hirudin, lepirudin, \\nbivalirudin, argatroban). UFH and LMWH are used to treat and prevent \\nDVT, as well as PE, unstable angina, and acute myocardial infarction. Dos-\\ning regimens for UFH and LMWH are weight based. UFH requires moni-\\ntoring of the activated partial thromboplastin time. Therapeutic range is 1.5 \\nto 2.5 “normal” value. Heparin and LMWH may be used during pregnancy. \\nEnoxaparin 1 mg/kg SC every 12 hours may be used in outpatient manage-\\nment of DVT. The two major complications of heparin are bleeding and \\nheparin-induced thrombocytopenia (HIT). Hirudin, lepirudin, and argatro-\\nban can be used for anticoagulation in patients with HIT.\\nAlthough protamine can reverse the anticoagulation effects of heparin, \\nthe adverse effects of protamine are significant. LMWH carries a lower \\nbleeding risk than UFH, but a higher bleeding risk in patients with renal \\ndisease. LMWH may also cause pruritis, local skin reaction, or rarely, skin \\nnecrosis.\\n■ ■ANTIpLATeLeT AGeNTS\\nOral agents include aspirin, clopidogrel, prasugrel, ticagrelor, dipyridam-\\nole, and cilostazol. Aspirin is an irreversible cyclooxygenase inhibitor; its \\neffects last for the life of the platelet. Nonenteric-coated aspirin (162 to 325 \\nmg) should be administered in the setting of ACS, although it is contrain-\\ndicated during active GI hemorrhage, it is generally considered safe to give \\nto closely monitored patients with guaiac positive stool. Nonsteroidal anti-\\ninflammatories have the potential to reduce the efficacy of aspirin. Clopi-\\ndogrel, prasugrel, and ticagrelor inhibit platelet activation by rendering the \\nfibrinogen receptor ineffective. An oral loading dose of clopidogrel 600 mg \\nresults in full antiplatelet effect by 2 hours, and sustained effects last up to \\n48 hours. Side effects of aspirin are mainly GI and dose related. Complica-\\ntions of clopidogrel include dyspepsia, rash, or diarrhea. Omeprazole \\nreduces clopidogrel’s efficacy.\\nGPIIb/IIIa parenteral medications alter the common final pathway \\nreceptor in platelet aggregation. These agents should be used in consulta-\\ntion with the interventional cardiologist. Patients receiving GPIIb/IIIa \\nagents are at increased risk of bleeding complications during cardiac cath-\\neterization or coronary artery bypass surgery, but are not at increased risk \\nof intracranial hemorrhage.\\n■ ■FIBRINOLYTICS\\nFibrinolytic agents include streptokinase, anistreplase, alteplase/tPA, \\nreteplase, and tenecteplase. Although mechanisms of action vary, each \\nagent eventually converts plasminogen to plasmin, which breaks down the \\n138_Cydulka_Ch138.indd   747 20/04/17   3:58 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 766, 'page_label': '748'}, page_content='748 SECTION 14: Hematologic and Oncologic Emergencies\\nTAble 138-1 General Contraindications to Fibrinolytic Therapy\\nAbsolute\\n■● Active or recent (<14 days) internal bleeding\\n■● Ischemic stroke within the past 2–6 months\\n■● Any prior hemorrhagic stroke\\n■● Intracranial or intraspinal surgery or trauma within the past 2 months\\n■● Intracranial or intraspinal neoplasm, aneurysm, or arteriovenous malformation\\n■● Known severe bleeding diathesis\\n■● Current anticoagulant treatment (e.g., warfarin with INR >1.7 or heparin with  \\nincreased aPTT)\\n■● Current use of a direct thrombin inhibitor or direct factor Xa inhibitor with evidence  \\nof anticoagulant effect by laboratory tests\\n■● Platelet count <100,000/mm3 (<100 × 109/L)\\n■● Uncontrolled hypertension (i.e., blood pressure >185/110 mm Hg)\\n■● Suspected aortic dissection or pericarditis\\n■● Pregnancy\\nRelative*\\n■● Active peptic ulcer disease\\n■● Cardiopulmonary resuscitation for longer than 10 min\\n■● Hemorrhagic ophthalmic conditions\\n■● Puncture of noncompressible vessel within the past 10 days\\n■● Significant trauma or major surgery within the past 2 weeks to 2 months\\n■● Advanced renal or hepatic disease\\n*Concurrent menses is not a contraindication.\\nAbbreviation: aPTT = activated partial thromboplastin time.\\nfibrin in a thrombus. Alteplase/tPA theoretically causes less systemic fibri-\\nnolysis, without the antigenic side effects of streptokinase and anistreplase \\nthat prevent retreatment within 6 months and preclude treatment within  \\n12 months of a streptococcal infection. Strict adherence to established \\nguidelines and informed consent is essential. Hemorrhagic complications, \\nincluding intracranial hemorrhage, may occur. Streptokinase and anistre-\\nplase may cause hypotension or anaphylaxis. Contraindications to fibrino-\\nlytic therapy are listed in Table 138-1.\\n■ ■COMpLICATIONS OF ANTIThROMBOTIC USe\\nEmergency treatment of bleeding complications of antithrombotic therapy \\nis listed in Table 138-2.\\nTAble 138-2 emergency Treatment of Bleeding Complications of Antithrombotic \\nTherapy\\nAgent Management\\nHeparins\\nMinor bleeding Immediate cessation of heparin administration.\\nSupratherapeutic aPTT not always present.\\nAnticoagulation effect lasts up to 3 h from last IV dose.\\nObservation with serial aPTT may be sufficient.\\n(Continued)\\n138_Cydulka_Ch138.indd   748 20/04/17   3:58 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 767, 'page_label': '749'}, page_content='CHAPTER 138: Anticoagulants, Antiplatelet Agents, and Fibrinolytics 749 \\nTAble 138-2 emergency Treatment of Bleeding Complications of Antithrombotic \\nTherapy\\nAgent Management\\nMajor bleeding Protamine 1 mg IV per 100 units of total amount of IV \\nUFH administered within the past 3 h.\\nProtamine is given slowly IV over 1–3 min with a maxi-\\nmum of 50 mg over any 10-min period.\\nProtamine has an anaphylaxis risk.\\nProtamine does not completely reverse low-molecular-\\nweight heparin.\\nEnoxaparin: Protamine 1 mg IV (maximum dose, 50 mg) \\nfor every 1 mg of enoxaparin given in the previous 8 h. \\nIf 8–12 h since last enoxaparin dose, give protamine 0.5 \\nmg IV for every 1 mg of enoxaparin given.\\nDalteparin and tinzaparin: Protamine 1 mg IV per every \\n100 units of dalteparin or tinzaparin given. If aPTT \\n(measured 2–4 h after the protamine infusion) remains \\nprolonged, give a second dose of protamine 0.5 mg IV per \\n100 units of dalteparin or tinzaparin.\\nPentasaccharides\\nFondaparinux Antithrombotic effect of fondaparinux is 24–30 h.\\nFor life-threatening bleeding, anecdotal evidence \\nsuggests rFVIIa 90 µg/kg IV is effective.\\nOral Direct Thrombin Inhibitors\\nDabigatran Oral activated charcoal if recent or excessive ingestion.\\nMaintain urine output.\\nConsider hemodialysis or charcoal hemoperfusion.\\nFor life-threatening bleeding, consider in descending \\norder: aPCC, rFVIIa, or PCC.\\nFor severe bleeding or urgent reversal, administer \\nIdarucizumab 5 g IV. Dose may be repeated x 1.\\nOral Factor Xa Inhibitors\\nRivaroxaban For major bleeding, experimental evidence suggests PCC \\ncan reverse the antithrombotic effect of rivaroxaban.\\nApixaban For major bleeding, administer andexanet alfa (when \\navailable), dose not established.\\nOral Antiplatelet Agents\\nAspirin Desmopressin 0.3–0.4 µg/kg IV over 30 min.\\nPlatelet transfusion to increase count by 50,000/mm3 (typi-\\ncally requires one single donor apheresis-collected platelet \\nconcentrate or six units of random donor platelets).\\nAspirin-induced platelet inhibition may last for 7 days, so \\nrepeat platelet transfusions are sometimes required.\\nOther antiplatelet agents: \\nclopidogrel, prasugrel, \\nticagrelor\\nPlatelet transfusion to increase count by 50,000/mm3 (typi-\\ncally requires one single donor apheresis-collected platelet \\nconcentrate or six units of random donor platelets).\\nDesmopressin 0.3–0.4 µg/kg IV over 30 min.\\nNSAID-induced platelet inhibition typically lasts <1 day.\\nClopidogrel-, prasugrel-, or ticagrelor-induced platelet \\ninhibition may last up to 5–7 days.\\n(Continued)\\n(Continued)\\n138_Cydulka_Ch138.indd   749 20/04/17   3:58 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 768, 'page_label': '750'}, page_content='750 SECTION 14: Hematologic and Oncologic Emergencies\\nTAble 138-2 emergency Treatment of Bleeding Complications of Antithrombotic \\nTherapy\\nAgent Management\\nFibrinolytics\\nMinor external bleeding Manual pressure.\\nSignificant internal bleeding Immediate cessation of fibrinolytic agent, antiplatelet \\nagent, and/or heparin.\\nReversal of heparin with protamine as above.\\nTyped and cross-matched blood ordered with verification \\nof aPTT, CBC, thrombin clotting time, and fibrinogen level.\\nVolume replacement with crystalloid and packed red \\nblood cells as needed.\\nMajor bleeding or hemody-\\nnamic compromise\\nAll measures listed for significant internal bleeding.\\nFibrinogen concentrate 70 mg/kg IV, and recheck fibrino-\\ngen level; if fibrinogen level <100 mg/dL, repeat fibrino-\\ngen concentrate dose.\\nIf bleeding persists after fibrinogen concentrate or \\ndespite fibrinogen level >100 mg/dL, administer FFP  \\ntwo units IV.\\nIf bleeding continues after FFP , administer an antifibri-\\nnolytic such as aminocaproic acid 5 g IV over 60 min \\nfollowed by 1 g/h continuous IV infusion for 8 h or until \\nbleeding stops, or tranexamic acid 10 mg/kg IV every \\n6–8 h.\\nConsider platelet transfusion.\\nIntracranial hemorrhage All measures listed for significant internal and major \\nbleeding with hemodynamic compromise.\\nImmediate neurosurgery consultation.\\nAbbreviations: aPCC = activated prothrombin complex concentrate (not available in the United States); \\naPTT = activated partial thromboplastin time; FFP = fresh frozen plasma; NSAID = nonsteroidal anti-\\ninflammatory drug; PCC = prothrombin complex concentrate; rFVIIa = recombinant activated factor VII; \\nUFH = unfractionated heparin.\\n■ ■FURTheR ReADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 239, “Thrombotics and Antithrombotics,” by David E. \\nSlattery and Charles V . Pollack Jr.\\n(Continued)\\n138_Cydulka_Ch138.indd   750 20/04/17   3:58 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 769, 'page_label': '751'}, page_content='751\\nEmergency Complications  \\nof Malignancy\\nRoss J. Fleischman\\nOncologic emergencies arise from the underlying malignancy or as compli-\\ncations of therapy.\\n■ ■AIRWAY OBSTRUCTION\\nPatients with tumors of the upper and lower respiratory tract may experi-\\nence acute airway compromise due to edema, bleeding, infection, or loss of \\nprotective mechanisms. Presenting symptoms and signs include dyspnea, \\ntachypnea, wheezing, and stridor. Imaging involves plain radiographs, CT \\nscan, and/or endoscopic visualization. Emergency measures include \\nhumidified oxygen, optimal patient positioning, and possibly administra-\\ntion of a helium–oxygen mixture. If intubation is required, an “awake look” \\nwith a fiber optic bronchoscope with a 5-0 or 6-0 endotracheal tube is \\npreferred. A surgical airway such as cricothyroidotomy, transtracheal jet \\nventilation, or tracheotomy may be needed.\\n■ ■BONE METASTASES AND PATHOLOGIC FRACTURES\\nPatient with solid tumors, most commonly in breast, lung, and prostate, \\nmay present with bony metastases and pathologic fractures, usually in the \\naxial skeleton and proximal limbs. Plain radiographs may only identify \\nhalf of metastases, so negative films should be followed by CT with con-\\ntrast or MRI. Control pain with opioid analgesia. Most pathologic frac-\\ntures require surgical intervention. Painful bone metastases are treated \\nwith radiotherapy.\\n■ ■SPINAL CORD COMPRESSION\\nSpinal cord compression from metastases to the vertebral bodies may cause \\nweakness, radicular pain, and bowel or bladder dysfunction. MRI is the \\nimaging study of choice. The presentation, evaluation, and management of \\nmalignant spinal cord compromise are described in Table 139-1.\\nConsider giving corticosteroids if imaging will be delayed. Malignant \\nspinal cord compression is a radiotherapy emergency.\\n■ ■MALIGNANT PERICARDIAL EFFUSION\\nMalignant pericardial effusions are usually asymptomatic but can prog-\\nress to life-threatening cardiac tamponade. Symptoms depend on the \\nrate of accumulation (see Chapter 24, “The Cardiomyopathies, Myocar -\\nditis, and Pericardial Disease”). Patients with symptomatic effusions \\nmay present with chest heaviness, dyspnea, cough, and syncope. Physi-\\ncal examination findings include tachycardia, narrowed pulse pressure, \\nhypotension, distended neck veins, muffled heart tones, and pulsus \\nparadoxus.\\n139\\nC HAPTER\\n139_Cydulka_Ch139.indd   751 21/03/17   2:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 770, 'page_label': '752'}, page_content='752 SECTION 14: Hematologic and Oncologic Emergencies\\nEchocardiography is the test of choice as it can demonstrate the \\npresence of tamponade.  Chest radiograph may demonstrate an enlarged \\ncardiac silhouette or pleural effusion. ECG may show sinus tachycardia, \\nlow QRS amplitude, or electrical alternans. The differential diagnosis \\nincludes cardiomyopathy related to chemotherapy, such as doxorubin \\nand radiation therapy. Asymptomatic effusions do not require specific \\ntreatment. Symptomatic effusions are treated with ultrasound-guided \\npericardiocentesis.\\n■ ■SUPERIOR VENA CAVA SYNDROME\\nSuperior vena cava (SVC) syndrome most commonly occurs due to exter -\\nnal compression of the superior vena cava by an external malignant mass \\nsuch as lung cancer or lymphoma. It is less commonly caused by intravas-\\ncular thrombosis. The most common symptoms are face or arm swelling, \\ndistended neck veins, dyspnea, cough, and chest pain. CT of the chest with \\nIV contrast is the diagnostic procedure of choice. CXR will usually show a \\nmediastinal mass.\\nPatients with neurologic symptoms require urgent treatment includ-\\ning supplemental oxygen and elevation of the head and upper body. \\nDexamethasone 20 mg IV or methylprednisolone 125 to 250 mg IV \\nmay be beneficial in patients with increased intracranial pressure or \\nlymphoma. In patients without neurologic symptoms, SVC syndrome \\nusually does not cause rapid deterioration and can await consultation \\nregarding chemotherapy, radiation, or intravascular stenting. Patients \\nwith intravascular thrombosis may require anticoagulation, fibrinolysis, \\nor catheter removal.\\nTablE 139-1 Malignant Spinal Cord Compression\\nSuspect Most common cancers: lung, breast, prostate.\\nThoracic location: 70%.\\nProgressive pain and worse when supine.\\nMotor weakness: proximal legs.\\nSensory changes and bladder or bowel dysfunction: late findings.\\nImaging MRI: modality of choice, image entire vertebral column.\\nPlain radiographs: may detect vertebral body metastases but less \\nsensitive and specific for malignant spinal cord compression.\\nCT myelography: used when MRI is not available.\\nCorticosteroids Dexamethasone, 10 mg IV followed by 4 mg PO or IV every 6 h.\\nConsider starting in ED if imaging is delayed.\\nRadiotherapy Beneficial in approximately 70% of cases.\\nPrognosis highly dependent on pretreatment neurologic function.\\nSurgery Consider in highly selected cases, such as:\\nPatient in good general condition and able to undergo extensive \\nsurgery\\nAppropriate prognostic life expectancy\\nRapidly progressive symptoms\\nClinical worsening during radiotherapy\\nUnstable vertebral column\\n139_Cydulka_Ch139.indd   752 21/03/17   2:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 771, 'page_label': '753'}, page_content='CHAPTER 139: Emergency Complications of Malignancy  753 \\n■ ■HYPERCALCEMIA OF MALIGNANCY\\nHypercalcemia is most commonly seen with breast cancer, lung cancer, and \\nmultiple myeloma. The symptoms are nonspecific and include polydipsia, \\npolyuria, generalized weakness, lethargy, anorexia, nausea, constipation, \\nabdominal pain, volume depletion, and altered mentation.\\nSigns and symptoms are related to the rate of rise and may occur above \\n12 mg/dL (ionized >5.5 mg/dL). ECG may show shortened QT interval, \\nST depression, and atrioventricular blocks.\\nNormal saline infusion to restore normovolemia followed by an infusion \\nof 250 mL/h if the patient can tolerate is the mainstay of treatment. Furo-\\nsemide is not recommended unless needed to prevent volume overload in \\npatients with cardiac or renal failure. Further treatment should be discussed \\nwith the patient’s oncologist. Bisphosphonates such as zoledronic acid 4 \\nmg IV over 15 minutes or pamidronate 60 to 90 mg IV over 4 to 24 hours \\ncan prevent bone resorption. Calcitonin 4 IU/kg SC or IM causes a more \\nrapid decrease in calcium levels. Glucocorticoids may be helpful in lym-\\nphoma and multiple myeloma. Consider hemodialysis for patients with \\nprofound mental status changes and renal failure, or those who cannot tol-\\nerate a normal saline infusion (see Chapter 4, “Fluids, Electrolytes, and \\nAcid Base Disorders”).\\n■ ■HYPONATREMIA DUE TO SYNDROME OF \\nINAPPROPRIATE ANTI-DIURETIC HORMONE (SIADH)\\nInappropriate anti-diuretic hormone secretion is most commonly associ-\\nated with bronchogenic lung cancer, but can also occur from chemother -\\napy or medications. Symptoms include anorexia, nausea, headache, altered \\nmentation, and seizures. Mild hyponatremia (> 125 mEq/L) is usually \\nasymptomatic.\\nSIADH should be suspected in patients with cancer who present with \\nnormovolemic hyponatremia. Laboratory abnormalities include serum \\nosmolality <280 mOsm/L, urine osmolality >100 mOsm/L, and urine \\nsodium >20 mEq/L. The differential diagnosis includes hypothyroidism, \\nrenal failure, cirrhosis, adrenal crisis, and hypovolemia/hypervolemia.\\nMild hyponatremia >125 mEq/L is treated with a water restriction of 500 \\nmL/d and close follow-up. More severe hyponatremia is treated with furose-\\nmide 0.5 to 1 mg/kg PO with normal saline infusion to maintain normovole-\\nmia. Three percent hypertonic saline is reserved for severe hyponatremia \\n<120 mEq/L with seizures or coma. An infusion of 25 to 100 mL/h should \\nbe titrated to a correction of 0.5 to 1 mEq/h with a maximum of 12 mEq/L/d \\n(see Chapter 4, “Fluids, Electrolytes, and Acid Base Disorders”).\\n■ ■ADRENAL CRISIS\\nAdrenal crisis is most commonly caused by acute physiologic stress in the \\nface of exogenous steroid-induced adrenal suppression or malignant infil-\\ntration of adrenal tissue. Symptoms include weakness or nausea, and hypo-\\ntension unresponsive to fluids. Laboratory abnormalities may include \\nhypoglycemia, hyponatremia, and hyperkalemia. A serum cortisol level is \\nideally drawn before giving steroids. Treat acute adrenal insufficiency \\n139_Cydulka_Ch139.indd   753 21/03/17   2:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 772, 'page_label': '754'}, page_content='754 SECTION 14: Hematologic and Oncologic Emergencies\\nempirically with stress-dose hydrocortisone  100 to 150 mg IV , methyl-\\nprednisolone 20 to 30 mg IV , or dexamethasone 4 mg IV , IV crystalloids, \\nand supportive care (see Chapter 132, “Adrenal Insufficiency and Adrenal \\nCrisis”).\\n■ ■TUMOR LYSIS SYNDROME\\nTumor lysis syndrome occurs when massive quantities of potassium, phos-\\nphate, and uric acid are released. It usually occurs 1 to 3 days after chemo-\\ntherapy for acute leukemia or lymphoma. The resulting hyperuricemia, \\nhyperkalemia, hyperphosphatemia, and hypocalcemia may cause uric acid \\nprecipitates and calcium phosphate deposits in the kidney with renal \\nfailure, life-threatening arrhythmias, tetany, and seizures. Laboratory evalu-\\nation should include 12-lead ECG, basic electrolyte levels, complete blood \\ncount, uric acid, and phosphorus.\\nPreventative measures reduce the incidence of tumor lysis syndrome. \\nHyperkalemia is the most immediate life threat. Treatment of hyperkalemia \\nis with insulin, glucose, bicarbonate (if acidotic), and albuterol (see \\nChapter 4, “Fluids, Electrolytes, and Acid Base Disorders”). Avoid calcium \\nunless ventricular arrhythmias or widened QRS complexes are seen, as it \\nmay worsen calcium phosphate precipitation in the kidney. Aggressive \\ninfusion of isotonic fluids reverses volume depletion and helps to prevent \\nrenal deposition of uric acid and calcium phosphate crystals. Manage \\nhyperphosphatemia with IV insulin and glucose. Phosphate binders have a \\nlimited effect. Consider hemodialysis for potassium levels above 6.0 \\nmEq/L, uric acid levels above 10.0 mg/dL, phosphate levels above 10 mg/\\ndL, creatinine levels above 10 mg/dL, symptomatic hypocalcemia, or vol-\\nume overload. Patients with tumor lysis syndrome should be admitted to an \\nintensive care unit.\\n■ ■FEBRILE NEUTROPENIA\\nFebrile neutropenia is defined by temperatures above 38°C for an hour or a \\nsingle temperature above 38.3°C with an absolute neutrophil count below \\n1000 cells/mm3. Neutrophil counts typically reach a nadir 10 to 15 days \\nafter chemotherapy and rebound 5 days later.\\nFebrile neutropenic patients often lack localizing signs and symptoms \\nbecause of an attenuated immune response. Meticulous attention must be \\npaid to all skin surfaces, mucosal areas, and vascular access sites in which \\nthe patient may have an occult infection. Digital rectal examination is often \\nwithheld until after initial antibiotic administration because of the fear of \\ninducing bacteremia.\\nLaboratory evaluation includes complete blood count with differential, \\nblood cultures obtained through all lumens of indwelling catheters as well \\nas a peripheral site, urinalysis, urine culture, and CXR, electrolytes, renal, \\nand liver function tests. Additional studies based on symptoms may include \\nstool culture (diarrhea), sputum culture (cough), lumbar puncture (head-\\nache, stiff neck, altered mental status), wound culture (drainage), and CT or \\nultrasound (abdominal pain).\\nThe decision for empiric antibiotics and admission should be made with \\nthe patient’s oncologist. Empiric antibiotics (Table 139-2) are generally \\n139_Cydulka_Ch139.indd   754 21/03/17   2:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 773, 'page_label': '755'}, page_content='CHAPTER 139: Emergency Complications of Malignancy  755 \\nindicated for an ANC <500/mm 3. For neutrophil counts between 500 and \\n1000, the decision is based on the patient’s presentation. Add vancomycin \\nfor severe mucositis, catheter site infection, recent use of fluoroquinolone \\nprophylaxis, hypotension, residence in an institution with hospital-\\nassociated methicillin-resistant Staphylococcus aureus, or known coloniza-\\ntion with resistant gram-positive organisms.\\n■ ■HYPERVISCOSITY SYNDROME\\nHyperviscosity syndrome refers to impaired blood flow due to abnormal \\nelevations of paraproteins or blood cells. It is most common in patients \\nwith dysproteinemia (e.g., Waldenstrom’s macroglobulimenia and mul-\\ntiple myeloma), acute leukemia, or polycythemia. Hematocrits above \\n60% and WBC counts above 100,000/mm 3 may cause hyperviscosity \\nsyndromes.\\nInitial symptoms include fatigue, abdominal pain, headache, blurry \\nvision, dyspnea, fever, or altered mental status. Thrombosis or bleeding \\nmay occur. Physical exam findings may include retinal hemorrhages, \\nTablE 139-2 Initial Empiric Antibiotic Therapy in Febrile Neutropenia\\nCircumstance Drug and Adult Dosage Comments\\nOutpatient Ciprofloxacin, 500 mg PO every 8 h\\nand\\nAmoxicillin/clavulanate, 500 mg PO \\nevery 8 h\\nUseful for low-risk patients with \\ndaily assessments by a medical \\nprovider for the initial 3 days.\\nMonotherapy Cefepime, 2 g IV every 8 h\\nor\\nCeftazidime, 2 g IV every 8 h\\nor\\nImipenem/cilastatin, 1 g IV every 8 h\\nor\\nMeropenem, 1 g IV every 8 h\\nor\\nPiperacillin/tazobactam, 4.5 g IV \\nevery 6 h\\nMonotherapy with these broad-\\nspectrum agents appears to be as \\ngood as dual-drug therapy in most \\ncircumstances.\\nDual therapy One of the monotherapy agents\\nplus\\nGentamicin, 1.7 mg/kg IV every 8 h\\nor\\nTobramycin, 1.7 mg/kg IV every 8 h\\nor\\nAmikacin, 5 mg/kg IV every 8 h\\nPotential advances include syner-\\ngistic effects against some gram-\\nnegative bacteria and reduced \\nemergence of drug resistance.\\nThere is an increased risk for \\nadverse effects, including \\nnephrotoxicity, ototoxicity, and \\nhypokalemia.\\nRisk factors \\nfor severe \\ngram-positive \\ninfection (see \\ntext)\\nVancomycin, 1 g IV every 12 h\\nplus\\nCefepime, 2 g IV every 8 h\\nor\\nCeftazidime, 2 g IV every 8 h\\nor\\nImipenem/cilastatin, 1 g IV every 8 h\\nor\\nMeropenem, 1 g IV every 8 h\\nVancomycin is not usually \\nnecessary for initial empiric \\nantibiotic therapy.\\nVancomycin may be incorporated \\ninto initial therapeutic regimens \\nof high-risk patients in institutions \\nwith increased gram-positive \\ninfection rates.\\n139_Cydulka_Ch139.indd   755 21/03/17   2:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 774, 'page_label': '756'}, page_content='756 SECTION 14: Hematologic and Oncologic Emergencies\\nexudates, and “sausage-linked” vessels. Ele vated serum viscosity (> 4) or \\nrouleaux formation (red cells stacked like coins) support the diagnosis. \\nSerum viscosity measurement will not identify hyperviscosity caused by \\npolycythemia or leukemia.\\nInitial therapy consists of intravenous isotonic fluids and plasmapher-\\nesis or leukopheresis in consultation with a hematologist. A temporizing \\nmeasure in patients with coma is 1000 mL phlebotomy with simultaneous \\ninfusion of 2 to 3 L normal saline.\\n■ ■THROMBOEMBOLISM\\nThromboembolism is the second leading cause of death in cancer patients. \\nSee Chapter 25 for discussion of the diagnosis and management of deep \\nvein thrombosis and pulmonary embolism. Low-molecular-weight heparin \\n(LMWH) is the recommended initial treatment for cancer patients with \\nvenous thromboembolism and is usually continued for the duration of treat-\\nment for the clot. There is insufficient experience with the new oral antico-\\nagulants to recommend them.\\n■ ■NAUSEA AND VOMITING\\nChemotherapy commonly causes nausea and vomiting. Other causes of \\nnausea and vomiting include radiation enteritis, bowel obstruction, infec-\\ntion or tumor infiltration, and increased intracranial pressure. Treatment \\nconsists of rehydration, administration of antiemetics, and correction of \\nelectrolyte derangements (Table 139-3).\\nTablE 139-3 Antiemetic Agents for Chemotherapy-Induced Vomiting\\nClass and Agent Adult Dose Comments\\nDopamine receptor antagonists\\nMetoclopramide\\nPromethazine\\n10 mg IV or IM\\n25 mg IV or IM\\nDose-related extrapyrami-\\ndal side effects\\nIV use common but not \\napproved by the FDA\\nSerotonin antagonists\\nDolasetron\\nGranisetron\\nOndansetron\\n0.35 mg/kg IV, max  \\n12.5 mg over 5 min\\n10 μg/kg IV over 5 min\\n0.15 mg/kg IV, max 16mg \\nover 15 min\\nConstipation, headaches \\n(all)\\nCorticosteroids\\nDexamethasone 20 mg IV Mechanism unknown, no \\nimmunosuppression\\nBenzodiazepines\\nLorazepam 1 to 2 mg IV Sedation, anxiolysis\\nHistamine receptor antagonists\\nDiphenhydramine 50 mg IV or IM Minor therapeutic effect\\nAbbreviation: FDA, Food and Drug Administration.\\n139_Cydulka_Ch139.indd   756 21/03/17   2:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 775, 'page_label': '757'}, page_content='CHAPTER 139: Emergency Complications of Malignancy  757 \\n■ ■EXTRAVASATION OF CHEMOTHERAPEUTIC AGENTS\\nClinical manifestations of extravasation include pain, erythema, and swell-\\ning, usually within hours of the infusion. Consult with the patient’s oncolo-\\ngist to discuss the use of antidotes for extravasation of anthracyclines, vinca \\nalkaloids, mitomycin, cisplatin, mechlorethamine, and paclitaxel.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 240, “Emergency Complications of Malignancy,” by \\nJ. Stephan Stapczynski.\\n139_Cydulka_Ch139.indd   757 21/03/17   2:53 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 776, 'page_label': '758'}, page_content='139_Cydulka_Ch139.indd   758 21/03/17   2:53 PM\\nThis page intentionally left blank'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 777, 'page_label': '759'}, page_content='759\\nHeadache\\nSteven Go\\n■ ■CLINICAL FEATURES\\nHeadache is a common complaint for patients presenting to an emergency \\ndepartment (ED). The majority of headaches have benign causes (96%), \\nalthough evaluating patients for potential high-risk features may be useful \\nwhen screening for headaches associated with significant morbidity or \\nmortality (see Table 140-1).\\n140\\nCh A p TER\\nNeurology\\n 15\\nSECTION\\nTable 140-1 high-Risk Features for headache: Clinical “Red Flags”\\nOnset Sudden\\nTrauma\\nExertion\\nSymptoms Altered mental status\\nSeizure\\nFever\\nNeurologic symptoms\\nVisual changes\\nMedications Anticoagulants/antiplatelets\\nRecent antibiotic use\\nImmunosuppressants\\nPast history No prior headache\\nChange in headache quality, or progressive headache \\nworsening over weeks/months\\nAssociated conditions Pregnancy or postpregnancy status\\nSystemic lupus erythematosus\\nBehçet’s disease\\nVasculitis\\nSarcoidosis\\nCancer\\nPhysical examination Altered mental status\\nFever\\nNeck stiffness\\nPapilledema\\nFocal neurologic signs\\n140_Cydulka_Ch140.indd   759 21/03/17   12:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 778, 'page_label': '760'}, page_content='760 SECTION 15: Neurology\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nIdentify patients with high-risk features, such as patients older than  \\n50 years with a new or worsening headache. Sudden onset of a maxi-\\nmum intensity headache, often described as a “thunderclap headache,” \\nis associated 10% to 14% of the time with a high-risk etiology (see \\nTable 140-2).\\nAssess headache quality, pattern, frequency, intensity, location, and any \\nassociated symptoms such as fever or visual changes. Additional informa-\\ntion such as medication history, potential toxic exposures, prior headache \\nhistory, substance abuse, comorbid conditions, or family history of head-\\naches may be useful.\\nTailor the physical examination based on patient history to identify \\npotential causes of headache. Specific physical examination findings may \\nhelp to focus potential diagnoses, such as the presence of fever, hyperten-\\nsion, sinus or temporal artery tenderness, papilledema or elevated intraocu-\\nlar pressure, neck stiffness, or neurologic abnormalities.\\nWhile laboratory testing is often of limited value in the workup of an \\nacute headache, erythrocyte sedimentation rate (ESR) and/or C-reactive \\nprotein (CRP) are useful when temporal arteritis is suspected. When indi-\\ncated, a noncontrast head CT scan can be useful to evaluate for intracranial \\nhemorrhage, subdural hematoma, space-occupying lesion, signs of poten-\\ntially elevated intracranial pressure, or subarachnoid hemorrhage. Addi-\\ntional diagnostic studies may be indicated when the head CT is negative, \\nfor example, if clinical suspicion remains for a subarachnoid hemorrhage. \\nDepending on clinical suspicion, other imaging modalities may be useful, \\nsuch as MRI to assess for cerebral venous thrombosis, and MR or CT \\nangiography to evaluate for arterial dissection or small subarachnoid hem-\\norrhage. Lumbar puncture can be utilized when meningitis or encephalitis \\nis suspected (see Chapter 148, “Central Nervous System and Spinal Infec-\\ntions”) or to look for evidence of subarachnoid hemorrhage after a nega-\\ntive CT scan (see Chapter 141, “Stroke Syndromes and Spontaneous \\nSubarachnoid Hemorrhage”).\\nConsider subdural hematoma or intracerebral hemorrhage as poten-\\ntial sources of headache in elderly patients, alcoholics, substance abusers, \\nand in patients taking antiplatelet or anticoagulation medications. Consider \\nTable 140-2 Causes of Thunderclap headache\\nHemorrhage Intracranial hemorrhage\\n“Sentinel” aneurysmal hemorrhage\\nSpontaneous intracerebral hemorrhage\\nVascular Carotid or vertebrobasilar dissection\\nReversible cerebral vasoconstriction syndrome (RCVS)\\nCerebral venous thrombosis\\nPosterior reversible encephalopathy syndrome (PRES)\\nOther causes Coital headache\\nValsalva-associated headache\\nSpontaneous intracranial hypotension\\nAcute hydrocephalus (e.g., colloid cyst obstructing third ventricle)\\nPituitary apoplexy\\n140_Cydulka_Ch140.indd   760 21/03/17   12:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 779, 'page_label': '761'}, page_content='CHAPTER 140: Headache 761 \\ncerebellar hemorrhage when headache is associated with vestibular symp-\\ntoms as this may need surgical consultation.\\nHeadaches associated with brain tumors may be bilateral, unilateral, \\nconstant, or intermittent. These are classically described as worse upon \\nawakening, worsened by Valsalva maneuver, positional, and associated \\nwith nausea and vomiting. Consider the possibility of primary or metastatic \\nbrain lesions in patients with known cancer diagnoses, seizures, or mental \\nstatus changes.\\nRisk factors for cerebral venous thrombosis include patients with \\nhypercoagulable states due to oral contraceptive use, postpartum or periop-\\nerative status, clotting factor deficiencies, or polycythemia. Papilledema \\nmay be present, and neurological findings can wax and wane. Lumbar \\npuncture may demonstrate an increased opening pressure, and MR venog-\\nraphy is most useful for diagnosis.\\nTemporal arteritis (see Table 140-3) presents most commonly in \\npatients over the age of 50 and its incidence increases with age. Associated \\nsymptoms may include fatigue, fever, jaw claudication, and vision changes. \\nThe involved temporal artery may be tender, nonpulsatile, or have a dimin-\\nished pulse, but can also be normal. ESR and CRP can be helpful in estab-\\nlishing the diagnosis, and a temporal artery biopsy allows a definitive \\ndiagnosis.\\nMigraine headaches are the most common benign cause of headache \\nin ED patients. These generally have a gradual onset, last 4 to 72 hours, and \\nare typically unilateral, pulsating, and worsened by physical activity. Nau-\\nsea and vomiting, photophobia, and phonophobia are frequently present, \\nand the headache may be associated with or without an aura.\\nIdiopathic intracranial hypertension, also known as pseudotumor \\ncerebri, is most common in obese women ages 20 to 44. This may present \\nwith headaches, transient vision disturbances, back pain, and pulsatile \\ntinnitus, and when left untreated can lead to permanent vision loss. The \\ndiagnosis is most often made by the presence of papilledema, a normal \\nneurological examination, and elevated lumbar puncture opening pressure.\\nIntracranial hypotension can occur after a procedure that violates the \\ndura such as lumbar puncture or epidural anesthesia. This headache is \\ntypically worsened with upright posture and improved with lying down. \\nAlterations in hearing or vision, nausea, and vomiting may occur.\\nTable 140-3 American College of Rheumatology Criteria for Diagnosis  \\nof Temporal Arteritis\\nClinical Features Comments\\nAge at disease onset ≥50 years\\nNew headache Onset or type\\nTemporal artery abnormality Tenderness to palpation of temporal arteries\\nDecreased pulsation of temporal arteries\\nErythrocyte sedimentation rate ≥50 mm/h Westergren method\\nAbnormal artery biopsy (can be done after \\ninitiating steroids)\\nVasculitis\\nPredominance of mononuclear cell infiltration \\nor granulomatous inflammation\\nMultinucleated giant cells\\n140_Cydulka_Ch140.indd   761 21/03/17   12:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 780, 'page_label': '762'}, page_content='762 SECTION 15: Neurology\\nCluster headaches are uncommon and present with severe pain that is \\nunilateral and located in the orbital, supraorbital, or temporal area. These \\nare frequently associated with lacrimation, nasal congestion, rhinorrhea, \\nconjunctival injection, and pacing in the exam room. These symptoms tend \\nto occur daily for weeks, with periods of remission that may last for for \\nweeks to years.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Assess patients with an initial history and physical examination. When \\nindicated, utilize appropriate diagnostic testing and/or neuroimaging \\nbased on risk factors, patient history, and physical findings. Disease-\\nspecific treatment and specialty consultation are indicated in the appro-\\npriate clinical circumstances.\\n2. When temporal arteritis is suspected in patients without vision loss, \\nbegin empiric treatment with oral prednisone 60 mg daily. Consult with \\nan ophthalmologist or other appropriate specialist to arrange a temporal \\nartery biopsy to confirm the diagnosis and for appropriate follow-up and \\ncontinued treatment.\\n3. Treat patients with migraine headache with medications for symptom \\nrelief that may include dihydr oergotamine (DHE), sumatriptan, and \\ndopamine-antagonist antiemetics such as metoclopramide, chlorprom-\\nazine, or prochlorperazine (see Table 140-4). Consider dexametha-\\nsone 6 to 10 mg IV as an adjunctive therapy that may reduce migraine \\nrecurrence.\\n4. Treat patients with idiopathic intracranial hypertension with a starting \\ndose of oral acetazolamide 250 to 500 mg twice a day and recommend \\nweight loss for obese patients. During a diagnostic lumbar puncture, \\nexcess cerebrospinal fluid can be removed to reduce intracranial pres-\\nsure to 15 to 20 cm H 2O. Consult with a neurologist and/or ophthal-\\nmologist for ongoing evaluation and treatment.\\n5. Patients with intracranial hypotension due to lumbar puncture or epi-\\ndural anesthesia often respond well to symptomatic treatment. Evidence \\nof efficacy for intravenous fluids and caffeine is limited. The most effec-\\ntive treatment is an epidural blood patch, typically performed by an \\nanesthesiologist.\\n6. Treat cluster headaches with high-flow oxygen deliv ered at 12 L/min \\nfor 15 minutes via a nonrebreathing facemask. Consider sumitriptan  \\n6 mg subcutaneous injection for pain that is unresolved with oxygen \\ntherapy.\\n7. Consult with appropriate specialists based on the suspected underlying \\ncause of headache, if symptom control is not adequately achieved in the \\nED, or if admission for further diagnostic testing or treatment may be \\nneeded.\\n8. When patients are discharged home, discuss indications for return and \\nreassessment such as worsening of symptoms, failure to improve, or the \\ndevelopment of new symptoms such as fever, neck stiffness, vision \\nchanges, or neurological abnormalities. Advise patients about expected \\nside effects of medications prescribed or given in the ED. Recommend \\nappropriate follow-up and outpatient management instructions based on \\nthe suspected diagnosis.\\n140_Cydulka_Ch140.indd   762 21/03/17   12:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 781, 'page_label': '763'}, page_content='CHAPTER 140: Headache 763 \\nTable 140-4 Treatment Options for Migraine headache\\nDrug Dosing Contraindications precautions and pregnancy Category Notes\\nKetorolac 30 mg IV or IM History of peptic ulcer disease \\n(especially in elderly)\\nPregnancy Category B\\nAvoid in third trimester\\nProchlorperazine 5–10 mg IV or PR Pregnancy Category C\\nDrowsiness\\nDystonic reactions\\nantiemetic\\nConcurrent: diphenhydramine\\nMetoclopramide 10 mg IV Pregnancy Category B\\nDrowsiness\\nDystonic reactions\\nantiemetic\\nConcurrent: diphenhydramine\\nDroperidol 2.5 mg IV slow, or \\n2.5 mg IM\\nPregnancy Category C\\nQT interval prolongation and/or torsade de pointes\\nConcurrent: diphenhydramine\\nChlorpromazine 7.5 mg IV Pregnancy not classified\\nHypotension\\nDrowsiness\\nDystonic reactions\\nantiemetic\\nPretreat with: normal saline bolus to \\nminimize hypotension\\nConcurrent: diphenhydramine\\nMagnesium sulfate 2 g IV over 30 min Pregnancy Category D but effective in pre-eclampsia \\nand eclampsia\\nNonvalidated\\nMethylprednisolone 125 mg IV or IM Rescue therapy Nonvalidated\\nDexamethasone 6–10 mg IV Rescue therapy Adjunctive therapy to reduce recurrence\\nSumatriptan 6 mg SC Ischemic Heart Disease\\nUncontrolled hypertension\\nBasilar or hemiplegic migraine\\nPregnancy Category C\\nDihydroergotamine \\n(DHE)\\n1 mg IV over 3 min Pregnancy\\nUncontrolled hypertension\\nIschemic Heart Disease\\nRecent sumatriptan use (within 24 h)\\nBasilar or hemiplegic migraine\\nPregnancy Category X\\nNausea\\nVomiting\\nDiarrhea\\nAbdominal pain\\nPretreat with antiemetic\\nValproate 500 mg IV Pregnancy Pregnancy Category X Nonvalidated\\n140_Cydulka_Ch140.indd   763 21/03/17   12:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 782, 'page_label': '764'}, page_content='764 SECTION 15: Neurology\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 165, “Headache” by Michael Harrigan and Ana C.G. \\nFelix.\\n140_Cydulka_Ch140.indd   764 21/03/17   12:34 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 783, 'page_label': '765'}, page_content='765\\nStroke Syndromes and \\nSpontaneous Subarachnoid \\nHemorrhage\\nSteven Go\\nStroke encompasses any disease process that interrupts normal blood flow \\nto the brain. Ischemic strokes (87%) are more common than intracerebral \\nhemorrhage (10%) or nontraumatic subarachnoid hemorrhage (SAH) (3%) \\n(Table 141-1). A transient ischemic attack (TIA) is a transient episode of \\nneurological dysfunction caused by ischemia but without an acute infarc-\\ntion of brain tissue. TIA episodes typically lasts less than 1 to 2 hours, but \\nduration of symptoms alone can be unreliable in discriminating between \\nTIA and stroke as they are similar disease processes on a continuum of \\nseverity.\\n■ ■CLINICAL FEATURES\\nSpecific findings in patients with ischemic or hemorrhagic stroke depend \\non the regions of the brain that are compromised and the severity of the \\ninsult (Table 141-2).\\nTypical symptoms of anterior cerebral artery involvement include con-\\ntralateral leg weakness and sensory changes. A middle cerebral artery \\nstroke presents with contralateral hemiparesis (arm > leg), facial plegia, \\nand sensory loss. Aphasia is often present if the dominant hemisphere (usu-\\nally left) is affected. Inattention, neglect, and dysarthria without aphasia are \\nall signs of nondominant hemisphere involvement.\\nA posterior circulation stroke can present with subtle clinical findings. \\nUnilateral limb weakness, dizziness, vertigo, blurry vision, headache, dys-\\narthria, visual field loss, gait ataxia, cranial nerve VII dysfunction, lethargy, \\nand sensory deficits can occur alone or in various combinations. Basilar \\nartery occlusion can produce these symptoms, as well as oculomotor signs, \\nHorner’s syndrome, and rarely, a “locked-in” state. Cerebellar strokes pres-\\nent similarly to other posterior stroke syndromes, but these patients can \\ndeteriorate rapidly if a hematoma or edema is present.\\nCervical artery dissection can involve either the anterior or posterior \\narterial systems and symptoms reflect the area of compromised brain tissue. \\nA patient with an internal carotid dissection may present with unilateral \\nhead pain (68%), neck pain (39%), or face pain (10%). Vertebral artery dis-\\nsections may present with neck pain (66%) and headache (65%), which can \\nbe unilateral or bilateral.\\nIntracranial hemorrhages may be clinically indistinguishable from cere-\\nbral infarction on physical examination and patients may present with \\nsimilar neurological deficits. SAH is classically described as a sudden onset \\nof headache at its maximal intensity (“thunderclap” headache), although \\npatients with severe headaches and significant changes in intensity or qual-\\nity from previous experiences may prompt consideration for this or other \\nintracranial abnormalities in appropriate clinical circumstances. Approxi-\\nmately 20% of patients who presented with SAH had onset of symptoms \\n141\\nCh A p TER\\n141_Cydulka_Ch141.indd   765 21/03/17   12:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 784, 'page_label': '766'}, page_content='766 SECTION 15: Neurology\\nTable 141-1 Stroke Classification\\nStroke Type Mechanism Major Causes Clinical Notes\\nIschemic\\nThrombotic Narrowing of \\na damaged \\nvascular lumen \\nby an in situ \\nprocess—usually \\nclot formation\\nAtherosclerosis\\nVasculitis\\nArterial dissection\\nPolycythemia\\nHypercoagulable state\\nInfection (human immuno-\\ndeficiency virus infection, \\nsyphilis, trichinosis, tuber-\\nculosis, aspergillosis)\\nSymptoms often have \\ngradual onset and may \\nwax and wane.\\nCommon cause of tran-\\nsient ischemic attack.\\nEmbolic Obstruction of a \\nnormal vascular \\nlumen by intra-\\nvascular material \\nfrom a remote \\nsource\\nValvular vegetations\\nMural thrombi\\nParadoxical emboli\\nCardiac tumors (myxomas)\\nArterial-arterial emboli \\nfrom proximal source\\nFat emboli\\nParticulate emboli  \\n(IV drug use)\\nSeptic emboli\\nTypically sudden in \\nonset.\\nAccount for 20% of isch-\\nemic strokes.\\nHypoperfusion Low–blood flow \\nstate leading to \\nhypoperfusion of \\nthe brain\\nCardiac failure resulting in \\nsystemic hypotension\\nDiffuse injury pattern in \\nwatershed regions.\\nSymptoms may wax and \\nwane with hemodynamic \\nfactors.\\nHemorrhagic\\nIntracerebral Intraparenchymal \\nhemorrhage from \\npreviously weak-\\nened arterioles\\nHypertension\\nAmyloidosis\\nLatrogenic anticoagulation\\nVascular malformations\\nCocaine use\\nIntracranial pressure rise \\ncauses local neuronal \\ndamage.\\nSecondary vasoconstric-\\ntion mediated by blood \\nbreakdown products or \\nneuronal mechanisms \\n(diaschisis) can cause \\nremote perfusion \\nchanges.\\nRisks include advanced \\nage, history of stroke, and \\ntobacco or alcohol use.\\nMore common in those of \\nAsian or African descent.\\nNontraumatic \\nsubarachnoid\\nHemorrhage into \\nsubarachnoid \\nspace\\nBerry aneurysm rupture\\nVascular malformation \\nrupture\\nMay be preceded by \\na sentinel headache \\n(“warning leak”).\\nassociated with activities known to elevate blood pressure, such as sexual \\nintercourse, weight lifting, defecation, or coughing. Loss of consciousness, \\nseizure, diplopia, vomiting, photophobia, nuchal irritation, low-grade fever, \\nand altered mental status all may occur. The presence or absence of focal \\nneurological findings depends on the location of the aneurysm.\\n141_Cydulka_Ch141.indd   766 21/03/17   12:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 785, 'page_label': '767'}, page_content='CHAPTER 141: Stroke Syndromes and Spontaneous Subarachnoid Hemorrhage 767 \\nTable 141-2 Anterior and posterior Circulation of the Brain\\nCirculation Major Arteries Major Regions of Brain Supplied\\nAnterior (internal \\ncarotid system)\\nOphthalmic\\nAnterior cerebral\\nMiddle cerebral\\nOptic nerve and retina\\nFrontal pole\\nAnteromedial cerebral cortex\\nAnterior corpus callosum\\nFrontoparietal lobe\\nAnterotemporal lobe\\nPosterior (vertebral \\nsystem)\\nVertebral\\nPosteroinferior cerebellar\\nBasilar\\nPosterior cerebral\\nMedial temporal lobe\\nBrainstem\\nCerebellum\\nThalamus\\nAuditory/vestibular structures\\nVisual occipital cortex\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nPatients with stroke may present variably and sometimes subtly. Assess for \\nstroke risk factors based on age and comorbidities such as atrial fibrillation, \\nhypertension, diabetes, smoking, coronary atherosclerosis, valvular replace-\\nment, and recent myocardial infarction. Risk factors for SAH include \\nexcessive alcohol consumption, polycystic kidney disease, family history of \\nSAH, Marfan’s syndrome, and Ehlers–Danlos syndrome. Inquire about a \\nhistory of drug use, chiropractic manipulation, or recent activities associ-\\nated with blood-pressure elevation. Consider alternative diagnoses that may \\nmimic stroke (Table 141-3). If ischemic stroke is the primary working \\ndiagnosis and thrombolytic therapy is being considered, it is essential to \\nobtain an accurate determination of the time the patient was last known to \\nbe at their neurological baseline and whether the patient may be a candidate \\nfor thrombolytic therapy (Tables 141-4 and 141-5).\\nFocus patient assessment on the neurological examination, with particu-\\nlar emphasis on detecting motor weakness, sensory deficits, and cerebellar \\ndysfunction. Depending on clinical circumstances, investigate other find-\\nings such as meningismus, carotid bruits, signs of embolic disease, papill-\\nedema, or preretinal hemorrhage. Calculate a National Institutes of Health \\nStroke Scale (NIHSS) score if thrombolytic therapy may be considered. \\nAppropriately expedite the history, physical examination, laboratory, and \\nradiographic imaging.\\nAn emergent noncontrasted CT scan of the brain (best interpreted by a \\nneuroradiologist) is essential to determine whether hemorrhage or a stroke \\nmimic is present. Most acute ischemic strokes will not be visualized on a \\nCT scan in the early hours of a stroke.\\nThe differential diagnosis for SAH is broad and includes intracranial \\nhemorrhage, drug toxicity, ischemic stroke, meningitis, encephalitis, intracra-\\nnial tumor, venous sinus thrombosis, and primary headache syndromes. \\nModern CT scanners are reported to be 98% sensitive to detect SAH within \\n6 to 12 hours of symptom onset, 91% to 93% at 24 hours, and 50% at 1 week. \\nIf SAH is suspected and the CT is negative, many clinicians recommend a \\nlumbar puncture to assess for the presence of red blood cells or xanthochro-\\nmia as evidence of subarachnoid blood that was not visualized on CT scan. \\nHowever, some recent studies have challenged this position and suggest that \\n141_Cydulka_Ch141.indd   767 21/03/17   12:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 786, 'page_label': '768'}, page_content='768 SECTION 15: Neurology\\nTable 141-3 Stroke Mimics\\nDisorder Distinguishing Clinical Features\\nSeizures/postictal paralysis \\n(Todd’s paralysis)\\nTransient paralysis following a seizure, which typically \\ndisappears quickly; can be confused with transient \\nischemic attack.\\nSeizures can be secondary to a cerebrovascular \\naccident.\\nSyncope No persistent or associated neurologic symptoms.\\nMeningitis/encephalitis Fever, immunocompromised state may be present, \\nmeningismus, detectable on lumbar puncture.\\nComplicated migraine History of similar episodes, preceding aura, headache.\\nBrain neoplasm or abscess Focal neurologic findings, signs of infection, detectable \\nby imaging.\\nEpidural/subdural hematoma History of trauma, alcoholism, anticoagulant use, \\nbleeding disorder; detectable by imaging.\\nSubarachnoid hemorrhage Sudden onset of severe headache. *\\nHypoglycemia Can be detected by bedside glucose measurement, \\nhistory of diabetes mellitus.\\nHyponatremia History of diuretic use, neoplasm, excessive free water \\nintake.\\nHypertensive encephalopathy Gradual onset; global cerebral dysfunction, headache, \\ndelirium, hypertension, cerebral edema.\\nHyperosmotic coma Extremely high glucose levels, history of diabetes \\nmellitus.\\nWernicke’s encephalopathy History of alcoholism or malnutrition; triad of ataxia, \\nophthalmoplegia, and confusion.\\nLabyrinthitis Predominantly vestibular symptoms; patient should have \\nno other focal findings; can be confused with cerebellar \\nstroke.\\nDrug toxicity (lithium, \\nphenytoin, carbamazepine)\\nCan be detected by particular toxidromes and elevated \\nblood levels. Phenytoin and carbamazepine toxicity may \\npresent with ataxia, vertigo, nausea, and abnormal \\nreflexes.\\nBell’s palsy Neurologic deficit confined to isolated peripheral \\nseventh nerve palsy; often associated with younger \\nage.\\nMénière’s disease History of recurrent episodes dominated by vertigo \\nsymptoms, tinnitus, deafness.\\nDemyelinating disease (multiple \\nsclerosis)\\nGradual onset. Patient may have a history of multiple \\nepisodes of neurologic findings in multifocal anatomic \\ndistributions.\\nConversion disorder No cranial nerve findings, nonanatomic distribution of \\nfindings (e.g., midline sensory loss), inconsistent history \\nor examination findings.\\n*Although subarachnoid hemorrhage is a type of stroke, it has special considerations in terms of diagno-\\nsis and management. See Chapter 166, “Spontaneous Subarachnoid and Intracerebral Hemorrhage,” in \\nTintinalli’s Emergency Medicine: A Comprehensive Study Guide, 8th ed.\\n141_Cydulka_Ch141.indd   768 21/03/17   12:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 787, 'page_label': '769'}, page_content='CHAPTER 141: Stroke Syndromes and Spontaneous Subarachnoid Hemorrhage 769 \\nTable 141-4 American heart Association (AhA)/American Stroke Association \\n(ASA) 2013 Inclusion/Exclusion Criteria for IV Recombinant Tissue \\nplasminogen Activator (rtpA) in Acute Ischemic Stroke\\nInclusion Criteria\\nMeasurable diagnosis of acute \\nischemic stroke\\nUse of NIHSS score recommended. Major strokes \\n(NIHSS score >22) are more likely to have poor \\noutcomes.\\nOnset of symptoms <3 h prior to  \\nrtPA administration\\nMust be well established and is defined as the \\ntime of the witnessed onset of symptoms or the \\ntime the patient was last known at baseline.\\nAge ≥18 years No clear upper age limit.\\nexclusion Criteria\\nSignificant head trauma or prior stroke in previous 3 months\\nSymptoms suggest subarachnoid hemorrhage\\nArterial puncture at noncompressible site ≤7 days ago\\nHistory of previous intracranial hemorrhage\\nIntracranial neoplasm, arteriovenous malformation, or aneurysm*\\nRecent intracranial or intraspinal surgery*\\nPretreatment systolic blood pressure >185 mm Hg or diastolic blood pressure >110 mm \\nHg despite therapy\\nActive internal bleeding*\\nPlatelet count <100,000/mm3 If patient has no history of thrombocytopenia, rtPA \\nmay be given before this lab result is available; \\nhowever, rtPA should be stopped if the platelet \\ncount is <100,000/mm3\\nUse of heparin within preceding  \\n48 h and a prolonged activated partial \\nthromboplastin time (aPTT) greater \\nthan upper limit of normal\\nInternational normalized ratio (INR) \\n>1.7 or partial thromboplastin time \\n(PTT) >15 s\\nOral anticoagulant use in and of itself is not a \\ncontraindication to rtPA. If patient is not taking \\noral anticoagulant or heparin, rtPA may be given \\nbefore this lab result is available; however, rtPA \\nshould be stopped if these lab tests come back \\nelevated above normal limits.\\nCurrent use of direct thrombin inhibi-\\ntors or direct factor Xa inhibitors with \\nelevated sensitive laboratory tests \\n(such as aPTT, INR, platelet count, \\nand ecarin clotting time [ECT]; throm-\\nbin time [TT]; or appropriate factor Xa \\nactivity assays)*\\nBlood glucose level <50 mg/dL  \\n(2.7 mmol/L)\\nNon–contrast-enhanced CT (NECT) \\ndemonstrates multilobar infarction \\n(hypodensity >1/3 cerebral \\nhemisphere)\\nDo not give rtPA if CT shows acute intracranial \\nhemorrhage or neoplasm.\\n(Continued)\\n141_Cydulka_Ch141.indd   769 21/03/17   12:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 788, 'page_label': '770'}, page_content='770 SECTION 15: Neurology\\na lumbar puncture may be unnecessary if a third-generation CT scan done \\nwithin 6 hours of symptom onset is interpreted as negati ve by a neuroradi-\\nologist. A growing body of literature is exploring the combination of a  \\nnegative noncontrast CT with CT angiography to exclude SAH or an associ-\\nated aneurysm, with a 99.4% reported negative predictive value of this com-\\nbination. However, potential downsides to this diagnostic strategy are the \\nadditional ionizing radiation exposure and possible detection of incidental \\ncerebral aneurysms.\\nOther diagnostic tests may be useful in certain patients to exclude \\nstroke mimics or concurrent conditions. Tests such as bedside glucose, \\ncomplete blood count, ECG, pulse oximetry, electrolyte and coagulation \\nstudies, cardiac enzyme levels, toxicology screen, blood alcohol level, \\nechocardiogram, carotid duplex scanning. MRI, MR angiogram, and CT \\nangiogram may be of value when the suspicion for alternative disease enti-\\nties is high.\\nTable 141-4 American heart Association (AhA)/American Stroke Association \\n(ASA) 2013 Inclusion/Exclusion Criteria for IV Recombinant Tissue \\nplasminogen Activator (rtpA) in Acute Ischemic Stroke\\nRelative exclusion Criteria\\nOnly minor or rapidly improving stroke \\nsymptoms (clearing spontaneously)\\nSome patients may have a lower NIHSS score but \\nhave a potentially disabling condition (e.g., apha-\\nsia, hemianopia). Some studies have shown poor \\noutcomes for untreated minor strokes.\\nPregnancy No randomized controlled trials have been pub-\\nlished regarding safety or efficacy of rtPA for \\nischemic stroke in pregnancy. Case series have \\nreported mixed results.\\nSeizure at onset with postictal resid-\\nual neurologic impairments\\nrtPA can be given if the residual impairments are \\nthought to be secondary to the stroke as opposed \\nto the seizure.\\nMajor surgery or serious trauma \\nwithin preceding 14 days†\\nPrevious GI or urinary tract hemor-\\nrhage within preceding 21 days†\\nPrevious myocardial infarction within \\npreceding 3 months†\\nRationale for this criterion was a statement indi-\\ncating that myocardial rupture can result if rtPA \\nis given within a few days of acute myocardial \\ninfarction.\\nFormer exclusion Criteria from 2007 aHa/aSa Guidelines\\nEvidence of acute trauma (fracture)\\nFailure of the patient or responsible \\nparty to understand the risks and \\nbenefits of, and alternatives to, \\nthe proposed treatment after a full \\ndiscussion\\n*New exclusion criteria for 2013 AHA/ASA guidelines.\\n†Changed from absolute contraindication from 2007 AHA/ASA guidelines.\\nAbbreviation: NIHSS, National Institutes of Health Stroke Scale.\\n(Continued)\\n141_Cydulka_Ch141.indd   770 21/03/17   12:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 789, 'page_label': '771'}, page_content='CHAPTER 141: Stroke Syndromes and Spontaneous Subarachnoid Hemorrhage 771 \\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. For patients presenting with acute neurological deficits, rapidly assess \\nand stabilize any airway, breathing, and circulation abnormalities, estab-\\nlish IV access, obtain rapid bedside glucose testing, and place on cardiac \\nmonitoring and pulse oximetry. Supplemental oxygen is recommended \\nonly when patients are hypoxic to keep pulse oxygenation >94%.\\n2. Use patient history, prehospital provider information, and family mem-\\nber or bystander information to determine the last time patient was \\nknown to be at baseline neurological status.\\n3. Once the patient’s clinical condition is stabilized, immediately obtain a \\nnoncontrasted head CT and appropriate laboratory testing, including \\ncoagulation studies.\\n4. American Heart Association (AHA) and American Stroke Association \\n(ASA) recommendations for the care of patient with suspected acute \\nischemic stroke include time goals from the time of emergency depart-\\nment (ED) arrival for physician evaluation (10 minutes), activation of \\nstroke team (15 minutes), beginning head CT (25 minutes), completing \\nhead CT interpretation (45 minutes), beginning thrombolytic therapy \\n(if given, 1 hour), and admission to stroke unit (3 hours).\\n5. For a patient with acute ischemic stroke who is not a candidate for \\nthrombolysis, current guidelines recommend permissiv e hypertension \\nwith no active blood pressure management unless systolic blood pres-\\nsure is >220 mm Hg or diastolic blood pressure is >120 mm Hg. If \\nblood pressure control is needed, target a systolic blood pressure reduc-\\ntion of 15% during the first 24 hours.\\n6. If a patient is a candidate being considered for intravenous thrombolysis, \\nguidelines recommend that the patient’s blood pressure should be man-\\naged to achieve a target blood pressure of SBP ≤185 mm Hg and DBP \\n≤110 mm Hg using labetalol 10 to 20 mg IV over 1 to 2 minutes (may \\nrepeat one time) or nicardipine infusion 5 mg/h titrated to a maximum of \\nTable 141-5 American heart Association (AhA)/American Stroke Association \\n(ASA) 2013 Additional Inclusion/Exclusion Criteria for IV \\nRecombinant Tissue plasminogen Activator (rtpA) in Acute Ischemic \\nStroke for patients presenting within 3 to 4.5 hours after Onset\\nadditional Inclusion Criteria\\nMeasurable diagnosis of acute ischemic stroke\\nOnset of stroke symptoms 3–4.5 h before initiation of rtPA administration\\nadditional exclusion Criteria\\nAge >80 years\\nSevere stroke as assessed clinically (e.g., NIHSS score > 25) or by appropriate imaging \\ntechniques (i.e., involving >1/3 of middle cerebral artery territory)\\nTaking an oral anticoagulant regardless of international normalized ratio\\nHistory of previous ischemic stroke and diabetes mellitus\\nexclusion Criterion from eCaSS III Not Included in Current aHa/aSa Guidelines\\nBlood glucose >400 mg/dL\\nAbbreviations: ECASS III, European Cooperative Acute Stroke Study III; NIHSS, National Institutes of \\nHealth Stroke Scale.\\n141_Cydulka_Ch141.indd   771 21/03/17   12:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 790, 'page_label': '772'}, page_content='772 SECTION 15: Neurology\\n15 mg/h and when desired blood pressure is attained, reduced to 3 mg/h. \\nIf blood pressure cannot be adequately controlled with these measures, \\nthe patient not a good candidate to consider for thrombolytic therapy.\\n7. The U.S. Food and Drug Administration (FDA) has appro ved the use \\nof IV recombinant tissue plasminogen activator (rtPA) for patients \\nwith acute ischemic stroke ≤ 3 hours duration since symptom onset. \\nIn 2009, the AHA and the ASA recommended expansion of the treat-\\nment window to 4.5 hours for selected patients; however, this use is \\nconsidered “off-label” because the FDA has denied approval for this \\nindication. If thrombolysis is being considered, carefully review \\nrtPA inclusion and exclusion criteria prior to administration of rtPA \\n(Table 141-4). If the therapeutic window is to be extended to 3 to 4.5 \\nhours, then use the additional European Cooperative Acute Stroke \\nStudy III (ECASS III) exclusion criteria (Table 141-5) as well.\\n8. Obtain informed consent from the patient or their designee prior to \\nthrombolytic therapy. Although thrombolytic treatment of ischemic \\nstroke may be associated with improved outcomes, the risk of symp-\\ntomatic intracerebral hemorrhage is reported to be 6.4% (45% mortal-\\nity) when rtPA is given within ≤3 hours of symptom onset, and 7.9% \\n(NINDS definition) between 3 and 4.5 hours.\\n9. The total dose of rtPA is 0.9 mg/kg IV , with a maximum dose of 90 \\nmg; 10% of the dose is administered as a bolus, with the remaining \\namount infused over 60 minutes. No aspirin or heparin should be \\nadministered in the initial 24 hours after treatment. Closely monitor \\nblood pressures for patients who receive rtPA and treat as necessary. \\nIntracerebral bleeding may be the cause of any neurologic worsening, \\nand an emergent repeat noncontrasted head CT is indicated in these \\ncircumstances.\\n10. For patients diagnosed with TIA, treatment with aspirin 75 to 325 mg \\nPO daily, clopidogrel 75 mg PO daily, or the combination of aspirin \\nplus extended-release dipyridamole 25 mg PO and 200 mg PO twice \\ndaily, respectively.\\n11. For patients with acute ischemic stroke, aspirin 325 mg PO is recom-\\nmended within 24 to 48 hours, although patients should not receive any \\nantiplatelet medications in the first 24 hours after rtPA. Current guide-\\nlines do not recommend starting heparin or warfarin in the acute treat-\\nment of TIA or ischemic stroke in the ED, even in the presence of atrial \\nfibrillation.\\n12. All patients with stroke should receive appropriate supporti ve care in \\nthe ED, including aspiration prevention, normalization of glucose \\nlevel, fall precautions, and treatment for comorbidities. Admit all \\npatients with acute stroke to monitored care units familiar with the care \\nof stroke patients, preferably specialized units at designated centers.\\n13. For patients with SAH, the risk of rebleeding is greatest in the first 24 \\nhours and can be reduced by adequate blood pressure control at a  \\npatient’s prehemorrhage blood pressure or a MAP <140 mm Hg if the \\nbaseline blood pressure is unknown. If blood pressure management is \\nnecessary, administer an IV titratable antihypertensive such as labetalol \\n10 to 20 mg IV bolus over 1 to 2 minutes or continuous infusion starting \\nat 2 mg/min, titrated to effect; or nicardipine continuous infusion begin-\\nning at 5 mg and titrated by 2.5 mg/h to a maximum dose of 15 mg/h.\\n141_Cydulka_Ch141.indd   772 21/03/17   12:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 791, 'page_label': '773'}, page_content='CHAPTER 141: Stroke Syndromes and Spontaneous Subarachnoid Hemorrhage 773 \\n14. Admit patients with SAH to an intensive care unit in consultation with \\na neurosur geon. Administer nimodipine 60 mg PO every 4 hours, \\nwhich may produce modest improvements by decreasing vasospasm. \\nSeizure prophylaxis is controversial and should be discussed with the \\nadmitting specialist. Reverse any coagulopathy with vitamin K, fresh \\nfrozen plasma, and/or prothrombin concentrates.\\n15. Patients with intracerebral hemorrhage should be admitted to a moni-\\ntored critical care area for treatment with antiepileptic medications if \\nseizures occur, management of h yperglycemia, blood pressure man-\\nagement, and reversal of coagulopathy with vitamin K, fresh frozen \\nplasma, and/or prothrombin concentrates. Patients with evidence of \\nincreased intracranial pressure (ICP) should be treated with head eleva-\\ntion to 30°, analgesia, and sedation. If more aggressive ICP reduction \\nis indicated, such as with osmotic diuretics or intubation with neuro-\\nmuscular blockade with mild hyperventilation, invasive monitoring of \\nICP by neurosurgery may be necessary\\n16. Appropriate use of neurology, neurosur gery, and neurocritical care \\nspecialists early in the evaluation of patients with stroke can be helpful. \\nEmergent neurology consultation may be helpful in stroke cases as the \\nindications for intravenous thrombolysis and endovascular therapy are \\nevolving rapidly. Early neurosurgical consultation is appropriate for \\npatients with SAH and intracerebral hemorrhage when evidence of \\nincreased ICP, location of bleeding, or other conditions suggest that \\nsurgical intervention may be indicated. Consider transfer to a desig-\\nnated stroke center, as admission to specialized stroke units is associ-\\nated with improved outcomes.\\n17. The ABCD2 scoring system has been recommended for use to predict \\nstroke risk in TIA patients (Table 141-6). Using this system, the 2-day \\nrisks of subsequent stroke are as follows: 1% (ABCD 2 score 0 to 3); \\n4.1% (4 to 5); and 8.1% (6 to 7). While definitive evidence-based \\nthresholds for admission have not yet been determined, some experts \\nTable 141-6 ABCD2 Score to predict Very Early Stroke Risk after Transient \\nIschemic Attack\\nCriteria points\\nAge ≥60 years 0 = Absent\\n1 = Present\\nBlood pressure ≥140/90 mm Hg 0 = Absent\\n1 = Present\\nClinical features 0 = Absent\\n1 = Speech impairment without unilateral weakness\\n2 = Unilateral weakness (with or without speech \\nimpairment)\\nDuration 0 = Absent\\n1 = 10–59 min\\n2 = ≥60 min\\nDiabetes 0 = Absent\\n1 = Present\\nTotal Score: 0–7\\n141_Cydulka_Ch141.indd   773 21/03/17   12:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 792, 'page_label': '774'}, page_content='774 SECTION 15: Neurology\\nrecommend admission for most TIA patients for further evaluation  \\nand observation. Others recommend beginning the workup in the ED, \\nstarting antiplatelet therapy in appropriate patients, providing educa-\\ntion about risk modification, and giving explicit return precautions. An \\nindividualized approach to select low-risk, asymptomatic patients may \\ndepend on medical factors, available healthcare resources, and a favor-\\nable social situation.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 166, “Spontaneous Subarachnoid and Intracerebral \\nHemorrhage,” by Jeffrey L. Hackman, Anna M.Nelson, and O. John Ma; and \\nChapter 167, “Stroke Syndromes,” by Steven Go and Daniel J. Worman.\\n141_Cydulka_Ch141.indd   774 21/03/17   12:54 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 793, 'page_label': '775'}, page_content='775\\nAltered Mental Status and Coma\\nC. Crawford Mechem\\nMental status is the clinical state of emotional and intellectual functioning \\nof an individual. Patients presenting with altered mental status in the ED \\ncan include the diagnoses of delirium, dementia, and coma.\\n■ ■DELIRIUM\\nClinical Features\\nDelirium is a transient disorder characterized by impaired attention, percep-\\ntion, thinking, memory, and cognition. Typically, delirium develops over a \\ntime course of days. Sleep–wake cycles may be disrupted, with patients \\nexhibiting increased somnolence during the day and agitation characteristic \\nof sundowning at night. Levels of alertness may be reduced, and activity \\nlevels may fluctuate rapidly. Different caregivers witnessing completely \\ndifferent patient behaviors within a brief time span may complicate making \\nthe diagnosis. Tremor, asterixis, tachycardia, sweating, hypertension, emo-\\ntional outbursts, and hallucinations may be present. Features of delirium, \\ndementia, and psychiatric disorders are listed in Table 142-1.\\nDiagnosis and Differential\\nThe acute onset of attention deficits and cognitive abnormalities fluctuating \\nthroughout the day and worsening at night is characteristic of delirium. A \\ndetailed medication history should be obtained, as well as a mental status \\nevaluation. ED evaluation is directed at identifying an underlying process \\ncontributing to the development of delirium such as infection (Table 142-2). \\nAncillary tests may include basic metabolic panel, hepatic studies, ammo-\\nnia level, urinalysis, complete blood count, and chest radiograph. Cranial \\nCT should be performed if a mass lesion is suspected, and clinicians may \\nconsider doing a lumbar puncture if meningitis or subarachnoid hemor -\\nrhage is suspected and an alternative diagnosis is not established.\\n142\\nChapt ER\\nTAble 142-1 Features of Delirium, Dementia, and psychiatric Disorder\\nCharacteristic Delirium Dementia psychiatric Disorder\\nOnset Over days Insidious Sudden\\nCourse over 24 h Fluctuating Stable Stable\\nConsciousness Reduced or hyperalert Alert Alert\\nAttention Disordered Normal May be disordered\\nCognition Disordered Impaired May be impaired\\nOrientation Impaired Often impaired May be impaired\\nHallucinations Visual and/or auditory Often absent Usually auditory\\nDelusions Transient, poorly organized Usually absent Sustained\\nMovements Asterixis, tremor may be \\npresent\\nOften absent Absent\\n142_Cydulka_Ch142.indd   775 21/03/17   2:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 794, 'page_label': '776'}, page_content='776 SECTION 15: Neurology\\nTAble 142-2 Important Medical Causes of Delirium\\nInfectious Pneumonia\\nUrinary tract infection\\nMeningitis or encephalitis\\nSepsis\\nMetabolic/toxic Hypoglycemia\\nAlcohol ingestion\\nElectrolyte abnormalities\\nHepatic encephalopathy\\nThyroid disorders\\nAlcohol or drug withdrawal\\nNeurologic Stroke or transient ischemic attack\\nSeizure or postictal state\\nSubarachnoid hemorrhage\\nIntracranial hemorrhage\\nCNS mass lesion\\nSubdural hematoma\\nCardiopulmonary Congestive heart failure\\nMyocardial infarction\\nPulmonary embolism\\nHypoxia or carbon dioxide narcosis\\nDrug related Anticholinergic drugs\\nAlcohol or drug withdrawal\\nSedatives-hypnotics\\nNarcotic analgesics\\nSelective serotonin or serotonin-norepinephrine reuptake inhibitors\\nPolypharmacy\\nemergency Department Care and Disposition\\n1. Direct treatment at the underlying medical illness that is causing delir -\\nium. Environmental manipulation such as adequate lighting and emo-\\ntional support may help patient condition.\\n2. Treat acute episodes of agitation with haloperidol, 5 to 10 mg PO or \\nIM, with reduced dosing in the elderly. Lorazepam, 0.5 to 2 mg PO, IM, \\nor IV , may also be considered.\\n3. Consider inpatient admission for patients diagnosed with delirium \\nunless a readily reversible cause for the acute mental status change is  \\ndiscovered, treatment is initiated, and improvement is seen.\\n■ ■DEMENtIa\\nClinical Features\\nDementia implies a loss of mental capacity over time. Psychosocial level \\nand cognitive abilities deteriorate and behavioral problems develop. The \\nlargest categories of dementia are Alzheimer’s disease and vascular \\ndementia, and onset is typically insidious with gradual and progressive \\nimpairment of memory, especially recent memory. Hallucinations, delu-\\nsions, and repetitive behaviors may be present. Other features of dementia \\ninclude naming problems, forgetting items, loss of reading and direction, \\n142_Cydulka_Ch142.indd   776 21/03/17   2:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 795, 'page_label': '777'}, page_content='CHAPTER 142: Altered Mental Status and Coma 777 \\ndisorientation, inability to perform self-care tasks, and personality \\nchanges. Anxiety, depression, and speech difficulties may be observed. \\nPatients with vascular dementia may be noted to have exaggerated or asym-\\nmetric deep tendon reflexes, gait abnormalities, or extremity weakness.\\nDiagnosis and Differential\\nWhile dementia typically develops slowly over time, physical examination \\nmay identify a precipitant or underlying cause of an acute or subacute \\nchange in a patient’s level of functioning. Focal neurologic signs suggest \\nthe possibility of vascular dementia or a mass lesion. Increased motor tone \\nand other extrapyramidal signs may suggest Parkinson’s disease. Consider \\nnormal pressure hydrocephalus if urinary incontinence and gait disturbance \\nare noted. This is further suggested by excessively large ventricles on head \\nCT. Diagnostic studies may include a complete blood count, basic meta-\\nbolic profile, urinalysis, thyroid profile, serum vitamin B12 level, testing for \\nsyphilis, erythrocyte sedimentation rate, serum folate level, human immu-\\nnodeficiency virus testing, and chest radiography. Consider head CT or \\nMRI as well as lumbar puncture if the diagnosis is not readily apparent and \\nintracranial processes or central nervous system infections are suspected \\ncauses. The differential diagnosis includes delirium, depression, and other \\ntreatable causes.\\nemergency Department Care and Disposition\\n1. Initiate an appropriate workup to assess for medical causes of worsening \\nmental function.\\n2. Use antipsychotic drugs to manage persistent psychosis or severely \\ndisruptive or dangerous behavior, keeping in mind potential adverse \\nreactions.\\n3. Aim treatment of vascular dementia at addressing risk factors, such as \\nhypertension.\\n4. Many patients with newly diagnosed dementia will need inpatient ad-\\nmission for further e valuation and treatment. Discharge is appropriate \\nfor those patients who have longstanding and stable symptoms, consis-\\ntent caregivers, and reliable follow-up for outpatient evaluation.\\n■ ■COMa\\nClinical Features\\nComa is a state of reduced alertness and responsiveness from which the \\npatient cannot be aroused. Severity can be quantified using the Glasgow \\nComa Scale (Table 142-3) and the FOUR (Full Outline of UnResponsive-\\nness) score. Pupillary findings, cranial nerve testing, findings of hemipa-\\nresis, and response to stimulation can help the clinician to determine a \\nprobable general category: diffuse CNS dysfunction such as a toxic-\\nmetabolic coma or focal CNS dysfunction characteristic of structural \\ncoma. Toxic-metabolic coma is characterized by lack of focal physical \\nexamination findings. The pupils are typically small and reactive, but may \\nbe large in severe sedative poisoning as from barbiturates.\\nComa from supratentorial lesions or masses may present with progres-\\nsive hemiparesis or asymmetric muscle tone and reflexes. Coma without \\n142_Cydulka_Ch142.indd   777 21/03/17   2:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 796, 'page_label': '778'}, page_content='778 SECTION 15: Neurology\\nlateralizing signs may result from decreased cerebral perfusion from \\nincreased intracranial pressure (ICP). In addition, reflex changes in blood \\npressure and heart rate may be observed, such as the Cushing reflex \\n(hypertension and bradycardia). Coma from posterior fossa or infratento-\\nrial lesions may be abrupt in onset, with abnormal extensor posturing and \\nloss of pupillary reflexes and extraocular movements. Brainstem com-\\npression with loss of brainstem reflexes may develop rapidly. Pontine \\nhemorrhage, another infratentorial cause of coma, may present with pin-\\npoint pupils.\\nPseudocoma or psychogenic coma is a diagnostic challenge. History \\ntaking and observation of responses to stimulation reveal findings that dif-\\nfer from typical syndromes. Pupillary responses, extraocular movements, \\nmuscle tone, and reflexes are intact. Valuable tests include responses to \\nmanual eye opening (there should be little or no resistance in an unrespon-\\nsive patient) and extraocular movements. If avoidance of gaze is consis-\\ntently seen with the patient always looking away from the examiner, or if \\nnystagmus is demonstrated with caloric vestibular testing, this is strong \\nevidence for nonphysiologic or feigned unresponsiveness.\\nDiagnosis and Differential\\nHistory, examination, laboratory studies, and neuroimaging will often iden-\\ntify potential causes for a comatose state. Abrupt onset of coma suggests a \\ncatastrophic stroke or status epilepticus. Gradual onset suggests a metabolic \\nprocess or progressive lesion such as a tumor or a slowly developing intra-\\ncranial bleed. Examination may reveal signs of trauma or suggest other \\nTAble 142-3 Glasgow Coma Scale\\nComponent Score adult Child <5 years Child >5 years\\nMotor 6\\n5\\n4\\n3\\n2\\n1\\nFollows commands\\nLocalizes pain\\nWithdraws to pain\\nFlexion\\nExtension\\nNone\\nNormal spontaneous \\nmovements\\nLocalizes to supraocu-\\nlar pain (>9 months)\\nWithdraws from nail \\nbed pressure\\nFlexion to supraocular \\npain\\nExtension to \\nsupraocular pain\\nNone\\nFollows commands\\nVerbal 5\\n4\\n3\\n2\\n1\\nOriented\\nConfused speech\\nInappropriate words\\nIncomprehensible\\nNone\\nAge-appropriate \\nspeech/vocalizations\\nLess than usual ability; \\nirritable cry\\nCries to pain\\nMoans to pain\\nNo response to pain\\nOriented\\nConfused\\nInappropriate words\\nIncomprehensible\\nEye opening 4\\n3\\n2\\n1\\nSpontaneous\\nTo command\\nTo pain\\nNone\\nSpontaneous\\nTo voice\\nTo pain\\nNone\\n142_Cydulka_Ch142.indd   778 21/03/17   2:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 797, 'page_label': '779'}, page_content='CHAPTER 142: Altered Mental Status and Coma 779 \\npossibilities, such as toxidromes. Fine neurologic testing is not feasible \\nwith a comatose patient, but asymmetric findings on pupillary examination, \\nassessment of corneal reflexes, and testing of oculovestibular reflexes may \\nsuggest focal CNS lesions. Extensor or flexor posturing suggests profound \\nCNS dysfunction. A head CT should be obtained followed by lumbar \\npuncture if the scan is nondiagnostic and a subarachnoid hemorrhage or \\ninfection is suspected. Basilar artery thrombosis may be a concern in a \\ncomatose patient with a nondiagnostic head CT and an absence of alterna-\\ntive diagnoses; MRI or cerebral angiography may be considered to evaluate \\nfor this potential diagnosis. Patients who have had seizures and remain \\nunresponsive may be having electrical seizures without motor activity (non-\\nconvulsive status epilepticus), and an EEG should be performed if this is \\nsuspected. Consider toxic ingestions, infections, and nonaccidental trauma \\nin comatose children. The differential diagnosis of coma includes primary \\nCNS disorders (Table 142-4) and generalized disease processes that also \\naffect the brain.\\nTAble 142-4 Differential Diagnosis of Coma\\nComa from causes affecting the brain diffusely\\nEncephalopathies\\n■● Hypoxic encephalopathy\\n■● Metabolic encephalopathy\\n■● Hypertensive encephalopathy\\nHypoglycemia\\nHyperosmolar state (e.g., hyperglycemia)\\nElectrolyte abnormalities (e.g., hypernatremia or hyponatremia, hypercalcemia)\\nOrgan system failure\\n■● Hepatic encephalopathy\\n■● Uremia/renal failure\\nEndocrine (e.g., Addison’s disease, hypothyroidism, etc.)\\nHypoxia\\nCarbon dioxide narcosis\\nToxins\\nDrug reactions (e.g., neuroleptic malignant syndrome)\\nEnvironmental causes—hypothermia, hyperthermia\\nDeficiency state—Wernicke’s encephalopathy\\nSepsis\\nComa from primary CNS disease or trauma\\nDirect CNS trauma\\n■● Diffuse axonal injury\\n■● Subdural hematoma\\n■● Epidural hematoma\\nVascular disease\\n■● Intraparenchymal hemorrhage (hemispheric, basal ganglia, brainstem, cerebellar)\\nSubarachnoid hemorrhage\\nInfarction\\n■● Hemispheric, brainstem\\nCNS infections\\nNeoplasms\\nSeizures\\n■● Nonconvulsive status epilepticus\\n■● Postictal state\\n142_Cydulka_Ch142.indd   779 21/03/17   2:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 798, 'page_label': '780'}, page_content='780 SECTION 15: Neurology\\nemergency Department Care and Disposition\\nTreatment of coma involves supportive care and identification of the under-\\nlying cause.\\n1. Stabilize the airway, breathing, and circulation.\\n2. Identify and treat reversible causes, such as hypoglycemia and opioid  \\ntoxicity. Consider empiric naloxone. Administer thiamine before \\nglucose in hypoglycemic patients with a history of alcohol abuse or \\nmalnutrition.\\n3. Consider nonconvulsive status epilepticus in patients who have had a \\nseizure and have not returned to baseline neurological function.\\n4. If increased ICP is suspected, elevate the head of the bed to 30°. Con-\\nsider gi ving mannitol, 0.5 to 1.0 g/kg. Dexamethasone, 10 mg IV \\nreduces vasogenic brain edema associated with a tumor. Hyperventi-\\nlation may transiently lower ICP. Avoid lowering PaCO 2 below  \\n35 mm Hg.\\n5. Discharge patients with readily reversible causes of coma if home  \\ncare and follow-up care are adequate and a clear cause of the episode \\nis found and reversed. Admit all other patients for further evaluation \\nand management.\\n■ ■FURthER REaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 168, “Altered Mental Status and Coma,” by J. Stephen \\nHuff.\\n142_Cydulka_Ch142.indd   780 21/03/17   2:25 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 799, 'page_label': '781'}, page_content='781\\nAtaxia and Gait Disturbances\\nRoss J. Fleischman\\nAtaxia is uncoordinated movement while a gait disorder is an abnormal \\npattern or style of walking. Both of these are findings that can be associated \\nwith many different disease processes, and thus clinicians evaluating \\npatients with these abnormalities should view them in the context of indi-\\nvidual clinical circumstances.\\n■ ■CLINICAL FEATURES\\nWhen initially evaluating a patient with ataxia or a gait distubance, consider \\nwhether the observed abonormalities are secondary manifestations of sys-\\ntemic disease rather than primary neurologic processes. Key symptoms that \\nmay suggest systemic disease include headache, nausea, fever, and \\ndecreased level of alertness. The physical examination may also show \\nabnormalities outside of the nervous system, such as orthostatic vital sign \\nchanges that can point to hypovolemia or other systemic illness. Some \\nforms of nystagmus may be suggestive of a central nervous system (CNS) \\ndisease process.\\nWhen evaluating ataxia that is suspected as a primary problem, differ -\\nentiate between motor and sensory causes. One finding that suggests a \\ncerebellar motor lesion is dysmetria, which can be elicited by finger to nose \\ntesting where patients may undershoot or overshoot their movements. Dys-\\ndiadochokinesia may be elicited by having the patient alternately flip their \\npalms and backs of their hands on their thighs where clumsy rapid alternat-\\ning movements can be observed. Heel to shin testing by having the patient \\nslide one heel down the opposite shin can be useful for distinguishing \\nbetween primary cerebellar disease and other sensory processing abnor -\\nmalities. Overshoot of the knee or ankle signifies cerebellar disease, while \\na wavering course down the shin suggests a deficit of proprioception.\\nThe Romberg test is primarily a test of sensation and can help to distin-\\nguish sensory ataxia from motor disease. Unsteadiness with the eyes open \\nsuggests a cerebellar motor ataxia, whereas worsening symptoms with eyes \\nclosed suggests a sensory ataxia that is unmasked with the removal of \\nvisual input. Test the posterior columns of the spinal cord by evaluating \\nvibration and position sense in the lower extremities. Abnormalities attrib-\\nuted to posterior column degeneration can occur in tabes dorsalis (neuro-\\nsyphilis) and vitamin B12 deficiency.\\nObserve patient ambulation in the emergency department to fully evalu-\\nate potential ataxia or gait disturbances. Subtle proximal or distal weakness \\ncan be identified by observing the patient rise from a chair and walk on \\nheels and toes. Tandem heel-to-toe walking may elicit subtle ataxia. Broad-\\nbased, unsteady steps are characteristic of a motor ataxic gait, while a \\nsensory ataxia with loss of proprioception may be notable for abrupt move-\\nments and slapping of the feet with each impact. A senile gait that is slow, \\nbroad based, and with a shortened stride may be seen with aging, but also \\nwith neurodegenerative disease such as Parkinson’s disease and normal \\n143\\nCh A p TER\\n143_Cydulka_Ch143.indd   781 21/03/17   2:32 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 800, 'page_label': '782'}, page_content='782 SECTION 15: Neurology\\npressure hydrocephalus. Patients with Parkinson’ s disease often develop a \\nnarrow-based festinating gait with small shuffling steps that become more \\nrapid. Weakness of the peroneal muscle weakness can manifest as foot \\ndrop, and is known as an equine gait.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nTable 143-1 shows common causes of acute ataxia and gait disturbances.\\nTailor the extent of ED evaluation based on the acuity and severity of \\nsymptoms. Patients with an acute onset of new symptoms or recent progres-\\nsion of symptoms will often undergo a more extensive diagnostic workup. \\nObtain radiographic imaging with CT scan or MRI when clinically indi-\\ncated. Obtain a lumbar puncture to analyse cerebrospinal fluid when a CNS \\ninfection is suspected.\\nWernicke’s encephalopathy is characterized by ataxia, altered mental \\nstatus, and ophthalmoplegia. While it is classically associated with alcohol-\\nics, this disease can be seen in any malnourished individual. Nystagmus is \\nthe most common ocular finding. Vestibular damage may cause unsteadiness \\nTAble 143-1 Common Etiologies of Acute Ataxia and Gait Disturbances\\nSystemic conditions\\nIntoxications with diminished alertness\\nEthanol\\nSedative-hypnotics\\nIntoxications with relatively preserved alertness (diminished alertness at higher levels)\\nPhenytoin\\nCarbamazepine\\nValproic acid\\nHeavy metals—lead, organic mercurials\\nOther metabolic disorders\\nHyponatremia\\nInborn errors of metabolism\\nWernicke’s disease\\nDisorders predominantly of the nervous system\\nConditions affecting predominantly one region of the CNS\\nCerebellum\\nHemorrhage\\nInfarction\\nDegenerative changes\\nAbscess\\nCortex\\nFrontal tumor, hemorrhage, or trauma\\nHydrocephalus\\nSubcortical\\nThalamic infarction or hemorrhage\\nParkinson’s disease\\nNormal pressure hydrocephalus\\nSpinal cord\\nCervical spondylosis and other causes of spinal cord compression\\nPosterior column disorders\\nConditions affecting predominantly the peripheral nervous system\\nPeripheral neuropathy\\nVestibulopathy\\n143_Cydulka_Ch143.indd   782 21/03/17   2:32 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 801, 'page_label': '783'}, page_content='CHAPTER 143: Ataxia and Gait Disturbances 783 \\nwhile standing still, cerebellar damage may cause motor ataxia, and sen-\\nsory neuropath y may also be present. Confabulation characterizes the \\nmemory loss of Korsakoff’s syndrome. Consider vitamin B12 deficiency in \\npatients with loss of position sense in the second toe and a positive Rom-\\nberg test. A serum cyanocobalamin level and complete blood count are the \\ninitial steps in evaluation, although neurologic manifestations often precede \\nmacrocytic anemia. Neurosyphilis will cause similar symptoms of posterior \\ncolumn disease and can be screened for with VDRL or RPR tests. Gait \\nimpairments can also present in elderly patients as manifestations of Par -\\nkinson’s disease or normal pressure hydrocephalus.\\nIngestions are a common cause of acute ataxia in children. Ataxia in a \\n2- to 4-year-old may follow recent immunizations, viral illnesses, or vari-\\ncella. Cranial nerve abnormalities or motor dysfunction along with cerebel-\\nlar abnormalities may be present with posterior fossa mass lesions. Chaotic \\neye movements (opsoclonus) and myoclonic jerks of the head and chest are \\nmost commonly associated with neuroblastomas of the chest or abdomen. \\nIn the absence of post-varicella ataxia or another identifiable cause, clini-\\ncians can consider neuroimaging, lumbar puncture, and consultation as \\nclinically indicated.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Administer thiamine 100 mg IV to alcoholics and other malnourished \\nadults who might have Wernicke–Korsakoff syndrome.\\n2. Admit patients with an acute unexplained inability to walk for further \\nevaluation and diagnostic testing.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 169, “Ataxia and Gait Disturbances,” by J. Stephen \\nHuff.\\n143_Cydulka_Ch143.indd   783 21/03/17   2:32 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 802, 'page_label': '784'}, page_content='784\\nAcute Vertigo\\nSteven Go\\n■ ■CLINICAL FEATURES\\nVertigo is a perception of movement when none exists that results from a \\nmismatch between the visual, vestibular, and proprioceptive sensory sys-\\ntems. Symptoms of vertigo are classically described by patients as a sensa-\\ntion that “the room is spinning,” but can also include atypical sensations of \\nother types of movement. Vertigo is classified as peripheral or central \\n(Table 144-1). Peripheral vertigo (involving the vestibular apparatus and \\neighth cranial nerve) usually has a sudden onset with intense symptoms that \\ninclude nausea, vomiting, intolerance of head movement, and diaphoresis. \\nCentral vertigo (involving central structures such as the brainstem or  \\ncerebellum) can present either abruptly or gradually, but usually is charac-\\nterized by less severe symptoms that are not well characterized by patients. \\nClinicians can work to discriminate between these two types of vertigo \\nduring a care encounter in the Emergency Department (ED) while recog-\\nnizing that some overlap may exist between these two types of vertigo.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe differential diagnosis for an episode of vertigo (Table 144-2) may be \\nextensive, and providers should evaluate for the presence or absence of some \\n144\\nCh A p TER\\nTAble 144-1 Differentiating peripheral from Central Causes of Acute \\nUndifferentiated Vertigo\\nperipheral Central\\nOnset Sudden or insidious Sudden\\nSeverity of vertigo Intense spinning Ill defined, less intense\\nProdromal dizziness Occurs in up to 25%; often \\nsingle episode\\nOccurs in up to 25%; \\nrecurrent episodes suggest \\ntransient ischemic attacks\\nIntolerant of head movements/\\nDix–Hallpike maneuver\\nYes Sometimes\\nAssociated nausea/diaphoresis Frequent Variable\\nAuditory symptoms Points to peripheral causes May be present\\nProportionality of symptoms Usually proportional Often disproportionate\\nHeadache or neck pain Unusual More likely\\nNystagmus Rotatory-vertical, horizontal Vertical\\nCNS symptoms/signs Absent Usually present\\nHead impulse test Abnormal Usually normal\\nHINTS examination (combined \\nhorizontal head impulse test, \\nnystagmus, and test of skew)\\nPeripheral signs on all three \\nbedside tests\\nCentral signs on at least \\none of three bedside tests\\n144_Cydulka_Ch144.indd   784 22/04/17   4:42 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 803, 'page_label': '785'}, page_content='CHAPTER 144: Acute Vertigo 785 \\nkey features during the history and physical examination. Inquire about the \\nspeed of symptom onset, severity, duration, temporal pattern, head or neck \\ntrauma, chiropractic manipulation, and any associated symptoms such as \\nheadache, neck pain, or loss of consciousness. Assess risk factors for stroke \\nsuch as age, hypertension, cardiovascular disease, and coagulopathy. Physical \\nexamination should include eye (e.g., nystagmus), ear, vestibular, and neuro-\\nlogical examinations, with particular attention to potential abnormalities of \\nthe cranial nerves or cerebellar function. Since focal deficits are not universal \\nin central vertigo, further specialized neurological tests may be of value in \\nsome patients. HINTS testing consists of the Head Impulse test (evaluation \\nof the vestibulo-ocular reflex), examination for N ystagmus direction that \\nchanges with gaze direction, and Test of Skew (vertical ocular misalignment \\nduring the cover-uncover eye test). The presence of one or more findings on \\nthe HINTS exam that are consistent with central vertigo has been reported to \\nbe sensitive and specific for stroke when completed by experts, although it is \\nunclear whether this specific testing is useful for physicians without special \\ntraining. If benign paroxysmal positional vertigo (BPPV) is suspected, a \\nDix–Hallpike maneuver may be useful to help make the diagnosis (sensitivity \\n75% to 82%). Physical examination maneuvers that involve head or neck \\ntwisting should not be used if cervical artery dissection, vertebrobasilar insuf-\\nficiency, or spinal pathology are suspected.\\nLaboratory investigations are not typically indicated in the routine \\nworkup for patients with symptoms consistent with peripheral vertigo, \\nunless there is strong suspicion of a specific cause where laboratory analy-\\nsis would be helpful. Neuroimaging studies such as an emergent CT scan, \\nTAble 144-2 Causes of Acute Undifferentiated Vertigo\\nVestibular/otologic Benign paroxysmal positional vertigo\\nTraumatic: following head injury\\nInfection: labyrinthitis, vestibular neuronitis, Ramsay Hunt syndrome\\nSystemic conditions \\nwith vestibular/otologic \\neffects\\nMénière’s syndrome\\nNeoplastic\\nVascular\\nOtosclerosis\\nPaget’s disease\\nToxic or drug-induced: aminoglycosides\\nNeurologic Vertebrobasilar insufficiency or vertebral artery dissection\\nLateral Wallenberg’s syndrome\\nAnterior inferior cerebellar artery syndrome\\nNeoplastic: cerebellopontine angle tumors\\nCerebellar disorders: hemorrhage, degeneration\\nBasal ganglion diseases\\nMultiple sclerosis\\nInfections: neurosyphilis, tuberculosis\\nEpilepsy\\nMigraine headaches\\nCerebrovascular disease\\nGeneral Hematologic: anemia, polycythemia, hyperviscosity syndrome\\nToxic: alcohol\\nChronic renal failure\\nMetabolic: thyroid disease, hypoglycemia\\n144_Cydulka_Ch144.indd   785 22/04/17   4:42 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 804, 'page_label': '786'}, page_content='786 SECTION 15: Neurology\\nCONSIDER BPPV\\nDURATION OF SYMPTOMS/SIGNS\\nILL-DEFINED DIZZINESS\\nTINNITUS RECENT URI\\nOR OTITIS MEDIA\\nCONSIDER\\nBACTERIAL\\nLABYRINTHITIS\\nCONSIDER ACOUSTIC\\nNEUROMA\\nTIAs\\nCENTRAL\\nVERTIGO/MS\\nCONSIDER MÉNIÈRE\\nDISEASE\\nNO\\n1. Rx: antihistamines/antiemetics,\\n diuretics\\n2. Diet <1 g added salt per day\\n3. ENT referral\\n1. CT/MRI\\n2. Refer to neurosurgeon\\n    or ENT\\nNO NO\\nYES YES\\nNO\\n1. Confirm via Dix-Hallpike position test\\n2. Consider modified Epley maneuver\\n3. Rx: antiemetics or antivertigo drugs\\n1. Rx: antihistamines/\\n    antiemetics\\n2. Reassurance\\nNO\\nYES\\nYES\\nNO\\n1. Investigate for syncope, seizures,\\n intracranial process\\n2. ECG, neurodiagnostic imaging,\\n elecrolytes\\n3. Consider admission\\n1. Consider disequilibrium\\n of aging\\n2. Obtain orthostatic BP,\\n lytes, CBC, tilt test, ECG\\n3. Consider referral to\\n cardiologist\\n1. Obtain orthostatic BP,\\n lytes, etc.\\n2. Consider psychiatric\\n dizziness\\nYES\\n1. Consider CT, MRI, MRA\\n2. Consider admission and\\n neurology or neurosurgical\\n referral\\n1. Check for carotid bruits\\n2. Consider echocardiogram\\n3. Consider antiplatelet or\\n anticoagulant therapy\\nYES\\nBrief (5–10 min)\\nConstant\\nNO\\nLOSS OF\\nCONSCIOUSNESS\\nTRUE VERTIGO\\nCNS\\nSYMPTOMS &\\nSIGNS\\nVERTIGO\\nPRECIPITATED BY\\nSUDDEN HEAD\\nMOVEMENTS\\nHEARING\\nLOSS\\nOTHER CONDITIONS\\neg, VESTIBULAR\\n NEURONITIS\\n1. CT or MRI\\n2. Antibiotics\\n3. ENT consultation\\nElderly\\nYoung\\nYES\\nFigure 144-1.  Approach to a patient with vertigo. BP , blood pressure; BPPV, \\nbenign paroxysmal positional vertigo; CBC, complete blood count; CNS, central \\nnervous system; ENT, ear, nose, and throat; MRA, magnetic resonance angiography; \\nMS, multiple sclerosis; Rx, treatment; TIAs, transient ischemic attacks; URI, upper \\nrespiratory infection.\\nCT angiogram, MRI, or MR angiogram are not routinely indicated when \\nperipheral vertigo is suspected, but may be useful when specific causes of \\ncentral vertigo are significant concerns. Consider neuroimaging in elderly \\npatients with signs or symptoms concerning for central vertigo (such as \\ncranial nerve or cerebellar findings), significant stroke risks, coagulopathy \\n(e.g., taking anticoagulant medications), headache, head or neck trauma, or \\nintractable or persistent (>72 hours) symptoms. Figure 144-1 illustrates an \\napproach to patients with vertigo.\\n144_Cydulka_Ch144.indd   786 22/04/17   4:42 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 805, 'page_label': '787'}, page_content='CHAPTER 144: Acute Vertigo 787 \\n■ ■CAUSES OF pERIphERAL VERTIGO\\nBenign paroxysmal positional vertigo (BPPV) is believed to be caused by \\nloose otoconia that most commonly enter the posterior semicircular canal and \\ncause the inappropriate sensation of motion. Findings suggestive of BPPV are \\nlisted in Table 144-3. The Dix–Hallpike maneuver can support the diagnosis. \\nTo perform this physical examination maneuver, begin with the patient seated \\nwith the head turned 45° to the right. Rapidly lower the patient to a supine \\nposition, with the head hanging over the edge of the bed and the neck in 20° \\nof extension. A positive test is when patients experience a short-lived rotatory \\nnystagmus, with rapid eye beating toward the affected (dependent) ear that is \\nassociated with an acute episode of vertigo. After any nystagmus or symptoms \\nresolve, slowly return the patient to the sitting position. Repeat the maneuver \\nwith the head turned 45° to the left. The side with the positive test serves as \\nthe starting point for the potentially curative Epley maneuver (see below).\\nMénière’s syndrome is characterized by recurrent bouts of vertigo \\nassociated with unilateral tinnitus and a sense of fullness and diminished \\nhearing in the affected ear. Because the diagnosis requires multiple epi-\\nsodes of attacks with progressive hearing loss, Ménière’s syndrome is not \\ntypically diagnosed on the first presentation of vertigo.\\nA perilymph fistula presents with sudden onset of vertigo during \\nactivities that can cause barotrauma such as flying, scuba diving, heavy \\nlifting, and coughing. Infection can also cause a perilymph fistula, and the \\ndiagnosis can be confirmed by nystagmus elicited by pneumatic otoscopy.\\nVestibular neuronitis is characterized by the sudden onset of severe \\nvertigo sometimes associated with unilateral tinnitus and hearing loss. It is \\nthe second most common cause of peripheral vertigo, and is thought to be \\nviral in nature. Symptoms last several days to weeks before they resolve \\nspontaneously without recurrence.\\nVestibular ganglionitis causes vertigo when a neurotrophic virus such \\nas varicella zoster reactivates. The most famous variant is Ramsay Hunt \\nsyndrome (deafness, vertigo, and facial nerve palsy), which is associated \\nwith vesicles inside the external auditory canal.\\nLabyrinthitis, although commonly viral, can also be caused by bacte-\\nrial infection from otitis media, meningitis, and mastoiditis. Patients with \\nlabyrinthitis present with a sudden onset of vertigo with hearing loss and \\nmiddle ear findings.\\nOtotoxicity may induce hearing loss and vertigo. Common offenders \\ncausing peripheral ototoxicity include NSAIDs, salicylates, aminoglycosides, \\nTAble 144-3 Supportive Findings in Benign paroxysmal positional Vertigo\\nLatency period of <30 sec between the provocative head position and onset of nystagmus.\\nThe intensity of nystagmus increases to a peak before slowly resolving.\\nDuration of vertigo and nystagmus ranges from 5 to 40 sec.\\nIf nystagmus is produced in one direction by placing the head down, then the nystagmus \\nreverses direction when the head is returned to the sitting position.\\nRepeated head positioning causes both the vertigo and accompanying nystagmus to \\nfatigue and subside.\\nAbnormal horizontal head impulse test indicating abnormal vestibulo-ocular reflex function.\\nHINTS testing not indicative of stroke.\\nAbbreviation: HINTS, horizontal head impulse test, nystagmus, and test of skew.\\n144_Cydulka_Ch144.indd   787 22/04/17   4:42 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 806, 'page_label': '788'}, page_content='788 SECTION 15: Neurology\\nloop diuretics, and cytotoxic agents. Anticonvulsants, tric yclic antidepres-\\nsants, neuroleptics, hydrocarbons, alcohol, and phencyclidine may cause \\ncentrally mediated vertigo.\\nTumors of the eighth cranial nerve and cerebellopontine angle, such \\nas meningiomas, acoustic neuromas, and acoustic schwannomas, may pres-\\nent with hearing loss and subsequent gradual onset of mild vertigo. Ataxia, \\nipsilateral facial weakness, loss of the corneal reflex, and cerebellar signs \\ncan also occur.\\nVertigo may occur after closed head injury (e.g., basilar skull fracture) \\nand tends to resolve over several weeks. In the acute setting, injuries with \\nan associated intracranial hemorrhage should be excluded with neuroimag-\\ning. Postconcussive syndrome can also develop subacutely and may include \\nan unsteady gait with dizziness.\\n■ ■CAUSES OF CENTRAL VERTIGO\\nCerebellar hemorrhage or infarction typically causes moderate vertigo \\nsymptoms and can be associated with headache, nausea, and vomiting. \\nCerebellar findings such as truncal ataxia, abnormal Romberg testing, and \\ntandem gait abnormalities are often present.\\nLateral medullary infarction of the brainstem (Wallenberg syn-\\ndrome) causes vertigo and ipsilateral facial numbness, loss of the corneal \\nreflex, Horner syndrome, dysphagia, and dysphonia. Contralateral loss of \\npain and temperature sensation in the extremities also occur.\\nVertebrobasilar insufficiency may result in sudden vertigo due to \\nbrainstem transient ischemic attack that typically lasts from minutes to 24 \\nhours. Diplopia, dysphagia, dysarthria, vision changes, and syncope may \\nalso be present. Unlike other causes of central vertigo, vertebrobasilar \\ninsufficiency may be induced by movement of the head that is caused by \\npositional decreases in vertebral artery blood flow.\\nVertebral artery dissection can be caused by mechanisms that induce \\na sudden rotation of the head such as a motor vehicle crash, chiropractic \\nadjustments, or violent sneezing. Patients present with central vertigo, \\nheadache, neck pain, and a unilateral Horner’s syndrome.\\nOther potential causes of central vertigo include multiple sclerosis, \\nneoplasms of the fourth ventricle, and vestibular migraine.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. For most causes of peripheral vertigo, pharmacologic therapies in the \\nED may include anticholinergics and antihistamines (Table 144-4).  \\nDiphenhydramine 25 to 50 mg IM, IV , or PO and meclizine 25 mg PO \\nare often effective in providing symptomatic relief. Transdermal scopol-\\namine 0.5 mg is often recommended, but may be less useful for acute \\ntreatment due to its prolonged onset of action (4 to 8 hours). It may be \\nmost useful when prescribed as a discharge medication.\\n2. Second-line pharmacologic agents to consider when other medications \\nare inadequate include calcium channel blockers, neuroleptics (avoid in \\northostatic patients), and antiemetics such as ondansetron 4 mg IV . \\nBenzodiazepines prevent the process of vestibular rehabilitation and \\ncan be used sparingly for symptomatic relief.\\n144_Cydulka_Ch144.indd   788 22/04/17   4:42 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 807, 'page_label': '789'}, page_content='CHAPTER 144: Acute Vertigo 789 \\nTAble 144-4 pharmacotherapy of Vertigo and Dizziness\\nCategory Drug Dosage Indications Advantages Disadvantages\\nAnticholinergics Scopolamine 0.5 mg transdermal patch (behind \\near) three to four times a day\\nVertigo, nausea Useful if patient is \\nvomiting\\nSometimes difficult to obtain\\nAntihistamines Dimenhydrinate\\nDiphenhydramine\\nMeclizine\\n50–100 mg IM, IV, or PO every 4 h\\n25–50 mg IM, IV, or PO every 4 h\\n25 mg PO two to four times a day\\nVertigo, nausea\\nVertigo, nausea\\nVertigo, nausea\\nInexpensive\\nInexpensive\\nDrowsiness/anticholinergic effect\\nDrowsiness/anticholinergic effect\\nDrowsiness/anticholinergic effect\\nAntiemetics Hydroxyzine\\nMetoclopramide\\nOndansetron\\nPromethazine\\n25–50 mg PO four times a day\\n10–20 mg IV, PO three times a day\\n4 mg IV two to three times a day; 8 \\nmg PO twice a day\\n25 mg IM, PO, or PR three to four \\ntimes a day\\nVertigo, nausea\\nVertigo, nausea\\nVertigo, nausea\\nInexpensive\\nEffective, versatile\\nUseful if vomiting\\nDrowsiness/anticholinergic effect\\nOccasional extrapyramidal effect\\nOccasional extrapyramidal effect\\nBenzodiazepines Diazepam\\nClonazepam\\n2–5 mg PO two to four times a day\\n0.5 mg PO two times a day\\nCentral vertigo, anxiety \\nrelated to peripheral vertigo\\nCentral vertigo, anxiety \\nrelated to peripheral vertigo\\nInexpensive\\nInexpensive\\nDependency, may impair vestibu-\\nlar compensation\\nDependency, may impair vestibu-\\nlar compensation\\nCalcium antagonists Cinnarizine\\nNimodipine\\nFlunarizine\\n25 mg PO two to three times a day\\n30 mg PO two times a day\\n20 mg PO two times a day\\nPeripheral vertigo, vestibular \\nmigraine\\nPeripheral vertigo, vestibular \\nmigraine\\nMénière’s syndrome\\nNonsedating\\nNonsedating\\nWell tolerated\\nLesser clinical experience\\nLesser clinical experience\\nNot available in the United \\nStates\\n(Continued)\\n144_Cydulka_Ch144.indd   789 22/04/17   4:42 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 808, 'page_label': '790'}, page_content='790 SECTION 15: Neurology\\nTAble 144-4 pharmacotherapy of Vertigo and Dizziness\\nCategory Drug Dosage Indications Advantages Disadvantages\\nVasodilators Betahistine 48 mg PO three times a day for up to \\n6–12 months\\nMénière’s syndrome Well tolerated Little evidence of efficacy for \\nother causes of peripheral vertigo\\nCorticosteroids Methylprednisolone 100 mg/d tapered by 20 mg/d every \\nfourth day\\nVestibular neuronitis Well tolerated Efficacy largely unproven; \\nadverse effects associated with \\ncorticosteroids\\nAntivirals Valacyclovir 1000 mg three times a day for 7 days Vestibular neuronitis Well tolerated Efficacy largely unproven\\nAnticonvulsants Carbamazepine\\nTopiramate\\nValproic acid\\nGabapentin\\n200–600 mg/d\\n50–100 mg/d\\n300–900 mg/d\\n300 mg four times per day\\nVestibular paroxysmia\\nVestibular migraine \\nprophylaxis\\nVestibular migraine \\nprophylaxis\\nMS-associated dizziness\\nInexpensive\\nWell tolerated\\nWell tolerated\\nReduces acquired \\npendular nystagmus \\nof multiple sclerosis\\nMonitor CBC and liver function \\ntests\\nNot well evaluated; does not \\nabort acute vertigo\\nNot well evaluated; does not \\nabort acute vertigo\\nKnown adverse effect profile\\nβ-Blockers Metoprolol 100 mg/d Vestibular migraine \\nprophylaxis\\nLong experience Known adverse effect profile\\n(Continued)\\n144_Cydulka_Ch144.indd   790 22/04/17   4:42 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 809, 'page_label': '791'}, page_content='CHAPTER 144: Acute Vertigo 791 \\n3. Treat patients with suspected posterior canal BPPV with the Epley \\nmaneuver to move the otoconia out of the semicircular canal. With the \\npatient seated, turn the head 45° toward the affected ear. (The affected \\near is determined by the direction in which the Dix–Hallpike position \\ntest is positive.) Quickly bring the patient to the recumbent position with \\nthe head hanging 20° below the examining table. After nystagmus and \\nsymptoms resolve (or 30 to 60 seconds) gently rotate the head 90° to the \\nunaffected side. After nystagmus and symptoms resolve (or 30 to 60 \\nseconds), roll the patient onto the shoulder of the unaffected side as the \\nhead turns a further 90° so it is nearly facedown. After nystagmus and \\nsymptoms resolve (or 30 to 60 seconds), return the patient to a sitting \\nposition with legs dangling off the side of the table and the head to the \\nmidline. The patient may experience vertigo during any step of this \\nprocedure. The Epley maneuver may be repeated if necessary. If the \\nEpley maneuver is not successful in relieving symptoms, consider \\ninstructing the patient in vestibular rehabilitation exercises.\\n4. Treat vestibular neuronitis symptomatically . Methylprednisolone and \\nantivirals are of no proven benefit in this condition.\\n5. Treat vestibular ganglionitis with antiviral agents and bacterial labyrin-\\nthitis with appropriate antibiotics.\\n6. Most patients with peripheral vertigo may be discharged home with \\nfollow-up. Referral to an ENT specialist is indicated for patients with \\nsuspected perilymph fistula or labyrinthitis of suspected bacterial \\netiology.\\n7. Patients with suspected central vertigo should ha ve imaging studies \\nperformed and emergent specialty referral. Consult neurosurgery for \\npatients with posterior fossa hemorrhage or brain tumors. Other emer -\\ngent causes of central vertigo such as ischemic stroke or vertebral artery \\ndissection should receive appropriate neurology consultation.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 170, “Vertigo,” by Brian Goldman.\\n144_Cydulka_Ch144.indd   791 22/04/17   4:42 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 810, 'page_label': '792'}, page_content='792\\nSeizures and Status Epilepticus \\nin Adults\\nC. Crawford Mechem\\nA seizure is an episode of abnormal neurologic function caused by the inap-\\npropriate electrical discharge of brain neurons. Primary seizures are those \\nwithout an identified specific cause. Secondary seizures result from another \\nidentifiable neurologic condition, such as a mass, head injury, or stroke \\n(Table 145-1).\\n■ ■CLINICAL FEATURES\\nSeizures are classified as generalized or partial. Generalized seizures are \\ncharacterized by widespread involvement of the entire cerebral cortex and \\nare typically associated with an abrupt loss of consciousness. Generalized \\ntonic-clonic seizures (grand mal) often begin with a sudden onset of muscle \\nrigidity where the trunk and extremities are extended and the patient falls \\nto the ground. This rigid (tonic) phase is followed by a symmetric and \\nrhythmic (clonic) jerking of the trunk and extremities. Generalized seizures \\nare commonly associated with incontinence and an immediate postictal \\nperiod where the patient remains flaccid and unconscious. A typical epi-\\nsode may last from 60 to 90 seconds with a gradual return of consciousness \\nafterwards, although postictal confusion may persist for hours. Absence \\n(petit mal) seizures are a subclass of generalized seizures typically seen in \\n145\\nCh A p TER\\nTAblE 145-1 Common Causes of provoked (Secondary) Seizures\\n■● Trauma (recent or remote)\\n■● Intracranial hemorrhage (subdural, epidural, subarachnoid, intraparenchymal)\\n■● Structural CNS abnormalities\\n■● Vascular lesion (aneurysm, arteriovenous malformation)\\n■● Mass lesions (primary or metastatic neoplasms)\\n■● Degenerative neurologic diseases\\n■● Congenital brain abnormalities\\n■● Infection (meningitis, encephalitis, abscess)\\n■● Metabolic disturbances\\n■● Hypo- or hyperglycemia\\n■● Hypo- or hypernatremia\\n■● Hyperosmolar states\\n■● Uremia\\n■● Hepatic failure\\n■● Hypocalcemia, hypomagnesemia (rare)\\n■● Toxins and drugs (many)\\n■● Cocaine, lidocaine, antidepressants, theophylline, isoniazid\\n■● Mushroom toxicity (Gyromitra spp.)\\n■● Hydrazine (rocket fuels)\\n■● Alcohol or drug withdrawal\\n■● Eclampsia of pregnancy (may occur up to 8 weeks postpartum)\\n■● Hypertensive encephalopathy\\n■● Anoxic-ischemic injury (cardiac arrest, severe hypoxemia)\\n145_Cydulka_Ch145.indd   792 21/03/17   3:23 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 811, 'page_label': '793'}, page_content='CHAPTER 145: Seizures and Status Epilepticus in Adults 793 \\nschool-aged children and often last only a few seconds. Patients suddenly \\nlose consciousness without losing postural tone and appear confused, \\ndetached, or withdrawn. An absence seizure typically ends abruptly with a \\nreturn to normal functioning.\\nPartial seizures are due to electrical discharges that begin in a localized \\nregion of the cerebral cortex. These seizures may remain localized to one \\narea of the brain or may later spread to other regions. Partial seizures are \\ndescribed as simple, in which consciousness is not affected, or complex, in \\nwhich consciousness is altered. Complex partial seizures are often due to \\ndischarges in the temporal lobe (also termed temporal lobe seizures) and \\nmay include automatisms, visceral complaints, hallucinations, memory \\ndisturbances, distorted perception, and affective disorders.\\nStatus epilepticus is defined as a single seizure lasting for longer \\nthan 5  minutes, or as two or more seizures that occur sequentially with-\\nout an intervening reco very of consciousness. Nonconvulsive status \\nepilepticus is characterized by altered mental status without perceptible \\nmuscular convulsive activity and is confirmed by electroencephalogram \\n(EEG).\\nEclampsia is a disorder found in pregnant women from 20 weeks gesta-\\ntion up to 8 weeks postpartum and is characterized by generalized seizures, \\nhypertension, edema, and proteinuria.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nWhen a patient presents with seizure-like activity, obtain a detailed his-\\ntory and inquire about the presence of preceding aura, abrupt or gradual \\nonset, progression of motor activity, incontinence, whether the activity \\nwas local or generalized, symmetry of symptoms, duration of the episode, \\nand presence of postictal confusion or lethargy. When a patient has a \\npreviously diagnosed seizure disorder, inquire about their baseline sei-\\nzure pattern, common precipitants, and any recent changes in antiepilep-\\ntic regimen. For those patients without a history of seizures, ask about \\nrecent or remote head injury.  Consider the possibility of intracranial \\npathology if persistent, severe, or sudden-onset headaches are present. \\nConsider eclampsia in patients with a current or recent pregnancy. Other \\nfactors that may predispose to seizures include metabolic or electrolyte \\nabnormalities, hypoxia, systemic illness, cancer, sequelae of coagulopa-\\nthy or anticoagulation, exposure to industrial or environmental toxins, \\ndrug ingestion or withdrawal, and alcohol use. Seizures are a common \\nmanifestation of central nervous system (CNS) disease in patients with \\nthe human immunodeficiency virus.\\nEvaluate each patient for findings of physical injuries that may have \\noccurred during the seizure, perform a neurologic exam, and closely fol-\\nlow the level of consciousness. A transient focal deficit following a sim-\\nple or complex focal seizure is referred to as Todd’s paralysis and typi-\\ncally resolves within 48 hours. Initiate appropriate further testing for \\nneurologic findings that are new or cannot be readily attributed to a \\nbenign cause.\\nLaboratory testing should be individualized and may not be indi-\\ncated in all circumstances. In a patient with a known seizure disorder \\nwho has had a typical seizure, a glucose level and pertinent anticonvulsant \\n145_Cydulka_Ch145.indd   793 21/03/17   3:23 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 812, 'page_label': '794'}, page_content='794 SECTION 15: Neurology\\nlevels may be appropriate. In an adult with a first seizure, additional  \\nstudies are often used to assess for medical causes of seizure and may \\ninclude serum glucose, basic metabolic panel, calcium, magnesium, a \\npregnancy test, and toxicology studies, as indicated. A noncontrast head \\nCT is appropriate for a patient with a first seizure or a change in seizure \\npattern to identify a structural lesion or an acute intracranial process. \\nAdditional neuroradiographic imaging may be indicated based on CT \\nscan results or clinical circumstances. MRI is typically not necessary on \\nan emergent basis, but is often recommended as an aspect of non-\\nemergent outpatient follow-up for patients with a first-time seizure. \\nLumbar puncture is indicated if CNS infection or subarachnoid hemor -\\nrhage is suspected.\\nThe differential diagnosis of seizures includes syncope, pseudoseizures, \\nhyperventilation syndrome, movement disorders, and migraines.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. During an active seizure, take measures to protect the patient from injury \\nor aspiration. IV anticonvulsants are often not needed during an uncom-\\nplicated seizure that resolves spontaneously.\\n2. In patients with a known seizure disorder whose anticonvulsant lev els \\nare low or who have missed doses of prescribed medications, supple-\\nmental doses may be appropriate.\\n3. Oral loading of phenytoin 20  mg/kg divided into three doses given \\nevery 2 to 4 hours is time-consuming and results in a delay in reaching \\ntherapeutic levels. Alternatively, phenytoin 20mg/kg IV may be admin-\\nistered at a rate of 25  mg/min. The loading dose of fosphenytoin  is  \\n20 phenytoin equivalents (PE)/kg at a maximum IV rate of 150  PE/min.\\n4. Administer IV magnesium sulfate to patients with suspected eclamp-\\nsia. Consult an obstetrician early in the patient’s care.\\n5. Patients in status epilepticus should have IV access, cardiac monitor -\\ning, and pulse oximetry . Endotracheal intubation may be required. If \\na paralytic agent is used, a short-acting drug is preferred so that any \\nongoing seizure activity can be monitored. Otherwise, EEG monitor -\\ning should be initiated. See Fig. 145-1 for anticonvulsant medication \\noptions. Lorazepam is considered the initial anticonvulsant of \\nchoice, followed by phenytoin, fosphenytoin, or levetiracetam. In \\nrefractory cases, consider IV midazolam, propofol, phenobarbital, \\npentobarbital, or ketamine. Early neurology consultation should be \\nrequested.\\n6. Patients with a first seizure who have a normal neurologic examination, \\nno acute or chronic medical comorbidities, normal diagnostic testing \\nincluding neuroimaging, and a normal mental status can be discharged \\nfrom the ED with appropriate recommendations for outpatient follow-\\nup. Initiation of antiepileptic medication, brain MRI, and other addi-\\ntional testing may be deferred to the outpatient setting.\\n7. Instruct discharged patients to take precautions that minimize the risks \\nfor injury from further seizures. Swimming, working with hazardous \\ntools or machines, and working at heights should be prohibited. Patients \\nshould not drive vehicles until cleared by a neurologist or primary care \\nphysician, and driving privileges should conform to state laws.\\n145_Cydulka_Ch145.indd   794 21/03/17   3:23 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 813, 'page_label': '795'}, page_content='CHAPTER 145: Seizures and Status Epilepticus in Adults 795 \\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 171, “Seizures,” by Joshua G. Kornegay.\\nIntubate patient\\nContinuous\\nEEG monitoring\\nNeuro ICU\\nadmission\\nActive\\nSeizure\\n0–5 minutes\\nEstablished\\nStatus\\nEpilepticus\\nTreatment\\nGoal: 5–10 min\\nRefractory\\nStatus\\nEpilepticus\\nTreatment\\nGoal: <30 min\\nSupportive Care:\\nIV access, monitors, maintain airway, oxygen,\\ncheck point-of-care glucose and provide IV glucose if indicated\\nPatient Protection\\nIV Lorazepam:\\n2 mg up to\\n0.1 mg/kg\\nor\\nIV Diazepam:\\n10–20 mg\\nIV Fosphenytoin:\\n20 PE/kg at\\n150 mg/min_______________\\nIV Phenytoin:\\n20 mg/kg at\\n50 mg/min_______________\\nIV Levetiracetam:\\n2000–4000 mg_______________\\nIV Propofol: \\n1 mg/kg IV,\\nthen 1–10 \\nmg/kg/h; \\nor Ketamine,\\n5 mg/kg/h\\nIV\\nPhenobarbital:\\n20 mg/kg at\\n50–75\\nmg/min\\nConsider\\nintubation\\nor\\nOne of the\\nfollowing\\nor\\nIV Midazolam:\\nLoad with 0.2\\nmg/kg\\nthen infusion\\nof 0.05–2\\nmg/kg/h\\nFIGURE 145-1.  Guidelines for management of active seizures and status \\nepilepticus. ICU =  intensive care unit; PE =  phenytoin equivalent.\\n145_Cydulka_Ch145.indd   795 21/03/17   3:23 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 814, 'page_label': '796'}, page_content='796\\nAcute Peripheral Neurologic \\nLesions\\nNicholas E. Kman\\nA systematic approach to evaluating neurologic symptoms includes local-\\nizing the problem anatomically and distinguishing peripheral disorders \\nfrom those with a central etiology. Peripheral nerve disorders may affect \\nsensory, motor, and autonomic functions (Table 146-1).\\n■ ■GUILLAIN-BARRÉ SYNDROME\\nClinical Features\\nGuillain-Barré syndrome (GBS) is an acute polyneuropathy characterized \\nby immune-mediated peripheral nerve myelin sheath or axon destruction. It \\ncan be associated with a viral or febrile illness, Campylobacter jejuni infec-\\ntion, or vaccination.\\nDiagnosis and Differential\\nAlthough numerous variants exist, the typical presentation from GBS \\nincludes ascending symmetric weakness or paralysis and loss of deep ten-\\ndon reflexes. Respiratory failure and significant autonomic fluctuations \\nmay occur. Cerebrospinal fluid (CSF) analysis typically shows high protein \\nand a normal cell count (Table 146-2).\\n146\\nCh A pt ER\\nTAbLe 146-1 Differentiating Central Nervous System from peripheral Nervous \\nSystem Disorders\\nCentral peripheral\\nHistory Cognitive changes\\nSudden weakness\\nNausea, vomiting\\nHeadache\\nWeakness confined to one limb\\nWeakness with associated pain\\nPosture- or movement-dependent pain\\nWeakness after prolonged period in \\none position\\nPhysical Examination\\nReflexes Brisk reflexes (hyperreflexia)\\nBabinski’s sign\\nHoffman’s sign\\nHypoactive reflexes\\nAreflexia\\nMotor Asymmetric weakness of \\nipsilateral upper and lower \\nextremity\\nFacial droop\\nSlurred speech\\nSymmetric proximal weakness\\nSensory Asymmetric sensory loss in \\nipsilateral upper and lower \\nextremity\\nReproduction of symptoms with \\nmovement (compressive neuropathy)\\nAll sensory modalities involved\\nCoordination Discoordination without \\nweakness\\nLoss of proprioception\\n146_Cydulka_Ch146.indd   796 21/03/17   3:55 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 815, 'page_label': '797'}, page_content='CHAPTER 146: Acute Peripheral Neurologic Lesions 797 \\nTAbLe 146-2 Diagnostic Criteria for Classic Guillain-Barré Syndrome\\nRequired\\nProgressive weakness of more than one limb\\nAreflexia\\nSuggestive\\nProgression over days to weeks\\nRecovery beginning 2–4 weeks after cessation of progression\\nRelative symmetry of symptoms\\nMild sensory signs and symptoms\\nCranial nerve involvement (Bell’s palsy, dysphagia, dysarthria, ophthalmoplegia)\\nAutonomic dysfunction (tachycardia, bradycardia, dysrhythmias, wide variations in \\nblood pressure, postural hypotension, urinary retention, constipation, facial flushing, \\nanhydrosis, hypersalivation)\\nAbsence of fever at onset\\nCytoalbuminologic dissociation of cerebrospinal fluid (high protein and low white cell \\ncount)\\nTypical findings on electromyogram and nerve conduction studies\\nemergency Department Care and Disposition\\n1. Initial treatment includes supportive care which may include respiratory \\nsupport as the disease progresses.\\n2. Consultation with a neurologist for admission to a monitored setting is \\nrecommended.\\n3. Administration of IV immunoglobulin and plasmapheresis may \\nshorten the time to recovery.\\n■ ■BELL’S pALSY\\nClinical Features\\nBell’s palsy causes seventh cranial nerve dysfunction. Patients may com-\\nplain of facial weakness, articulation problems, difficulty keeping an eye \\nclosed, or inability to keep food in the mouth on one side.\\nDiagnosis and Differential\\nPhysical examination findings demonstrate weakness on one side of the \\nface, including the forehead, without other focal neurologic findings. The \\ndifferential diagnosis includes stroke, Lyme disease, GBS, parotid tumors, \\nmiddle ear lesions, cerebellopontine angle tumors, eighth cranial nerve \\nlesions, HIV , and vascular disease. Inspect the ear for ulcerations caused by \\ncranial herpes zoster activation, which is diagnostic for Ramsey–Hunt syn-\\ndrome. Bell’s Palsy is not likely if muscle strength is retained in the fore-\\nhead on examination, and such a finding suggests a possible central \\nneurologic lesion warranting radiographic imaging of the brain.\\nemergency Department Care and Disposition\\n1. Systemic corticosteroids increase the frequency of complete recovery . \\nPrescribe prednisone 1 mg/ kg per day PO for 7 days.\\n2. There is no proven benefit from administering anti viral medications \\nunless evidence of Ramsey–Hunt syndrome is noted.\\n146_Cydulka_Ch146.indd   797 21/03/17   3:55 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 816, 'page_label': '798'}, page_content='798 SECTION 15: Neurology\\n3. Treat patients with Ramsey–Hunt syndrome with antiviral medications, \\nsuch as famciclovir 500 mg PO three times a day for 7 days or valacy-\\nclovir 1 g PO three times a day for 7 days.\\n4. Advise patients to use an ophthalmic moisturizing ointment at night \\nto prevent corneal drying from incomplete eye closure.\\n5. Arrange follow-up with a primary care physician or ENT specialist to \\nensure appropriate resolution.\\n■ ■FOCAL MONONEUROpAthIES\\nClinical Features\\nFocal mononeuropathies are most often due to focal nerve compression, \\nalthough some systemic processes may also lead to mononeuropathy. \\nExamples include carpal tunnel syndrome, resulting from compression of \\nthe median nerve at the wrist, and cubital tunnel syndrome, resulting from \\ncompression of the ulnar nerve at the elbow.\\nDiagnosis and Differential\\nCarpal tunnel syndrome causes pain, paresthesias, and numbness in the \\ndistribution of the medial nerve. The presence of Tinel’s sign (light percus-\\nsion over median nerve at wrist results in electric shock sensation shooting \\ninto hand) and use of Phalen’s maneuver (holding wrists in flexion for 60 \\nseconds worsens symptoms) may help confirm the diagnosis. Cubital tun-\\nnel syndrome causes tingling in the fifth and lateral fourth fingers that may \\nprogress to paralysis and wasting of the intrinsic hand muscles. Other com-\\nmon focal neuropathies include deep peroneal entrapment (causing foot \\ndrop and numbness between the first and second toes), meralgia pares-\\nthetica (entrapment of the lateral femoral cutaneous nerve causing  \\nnumbness and pain of the anterolateral thigh), and mononeuritis multiplex \\n(dysfunction of multiple peripheral nerves separated temporally and  \\nanatomically).\\nemergency Department Care and Disposition\\n1. Conservative treatment is recommended, including anti-inflammatory \\nmedications.\\n2. Consider applying an appropriate splint for comfort. For carpal tunnel \\nsyndrome, splint the wrist in neutral position.\\n3. Direct additional treatment at the underlying cause of the neuropathy.\\n■ ■pLEXOpAthIES\\nPlexopathies can be caused by trauma, surgery, neoplasm, or radiation \\ntherapy. Brachial plexopathy causes weakness in the arm or shoulder \\ngirdle followed by pain and paresthesias. Patients have weakness in vari-\\nous distributions of the brachial plexus. ED evaluation is directed at \\nidentifying acutely reversible causes, such as joint dislocation or trau-\\nmatic injury, and referral for other causes, such as neoplasm. Lumbosa-\\ncral plexopathy is less likely due to injury and can be caused by radiation, \\ndiabetic amyotrophy, aortic aneurysm, retroperitoneal hemorrhage, or \\n146_Cydulka_Ch146.indd   798 21/03/17   3:55 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 817, 'page_label': '799'}, page_content='CHAPTER 146: Acute Peripheral Neurologic Lesions 799 \\narteriovenous malformations. Symptoms are weakness, decreased sensa-\\ntion, and possibly decreased refle xes in the areas innervated by the \\naffected portions of the plexus. Plain radiographs, MRI, and abdominal \\nCT may be useful in determining the etiology. Direct specific treatment \\nat the underlying cause.\\n■ ■NEUROMUSCULAR JUNCtION DISORDERS\\nBotulism is a toxin-mediated disorder of the neuromuscular junction that is \\ncaused by Clostridium botulinum toxin. Foodborne botulism typically \\ncomes from improperly preserved canned foods. In infantile botulism, \\norganisms arise from ingested spores, often in honey, and produce a sys-\\ntemically absorbed toxin. Clinical features appear 6 to 48 hours after inges-\\ntion and may be preceded by nausea, vomiting, and diarrhea. Consider \\nwound botulism in patients with a wound or a history of intravenous drug \\nuse. Early complaints involve the eye or bulbar musculature and progress \\nto symmetric descending weakness and potential respiratory insufficiency. \\nTreatment includes respiratory support, trivalent botulinum antitoxin 10 \\nmL IV , and admission. For infants, human botulism immunoglobulin \\ndecreases mechanical ventilation requirements and length of intensive care \\nunit stays.\\n■ ■FURthER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 172, “Acute Peripheral Neurologic Disorders,” by \\nPhillip Andrus and J. Michael Guthrie.\\n146_Cydulka_Ch146.indd   799 21/03/17   3:55 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 818, 'page_label': '800'}, page_content='800\\nPatients with chronic neurologic disorders may present to the emergency \\ndepartment with complications of their underlying medical conditions. \\nEmergency management of these disorders often centers on evaluation of \\npotential respiratory complications and an assessment for appropriate inpa-\\ntient or outpatient management of acute illness or exacerbation of chronic \\ndisease.\\n■ ■AMYOTROPHIC LATERAL SCLEROSIS\\nClinical Features\\nPatients with amyotrophic lateral sclerosis (ALS) experience progressive \\nmuscle atrophy and weakness. Limb spasticity, hyperreflexia, and  \\nemotional lability are common symptoms of upper motor neuron demyelin-\\nation, while lower motor neuron dysfunction can cause muscle  \\nweakness, atrophy, fasciculations, dysarthria, dysphagia, and difficulty with \\nmastication. In the early phase of disease, symptoms may be asymmetric. \\nRespiratory muscle weakness causes progressive respiratory difficulty that \\npresents as dyspnea with exertion or at rest. Sensory and cognitive function \\nis often spared, although up to 15% of patients may also develop dementia \\nand Parkinsonism.\\nDiagnosis and Differential\\nThe diagnosis early in the course of illness can be challenging, which con-\\ntributes to a median time to diagnosis of 14 months. Clinicians may suspect \\nALS when signs are found of upper and lower motor neuron dysfunction \\nwithout other central nervous system dysfunction. Other diagnoses to con-\\nsider that may have ALS-like symptoms are systemic illnesses such as \\ndiabetes, thyroid and parathyroid dysfunction, vitamin B 12 deficiency, \\nheavy metal toxicity, vasculitis, and CNS tumors.\\nEmergency Department Care and Disposition\\n1. A new diagnosis of ALS is uncommon to make in the emergency \\ndepartment. Stable patients with suspicious symptoms should be \\nreferred for appropriate testing by a neurologist if an initial workup does \\nnot reveal an emergent cause of neurologic symptoms.\\n2. Patients with a known diagnosis of ALS may present for emergency care \\nwith complications such as respiratory failure, aspiration pneumonia, \\nchoking episodes, or traumatic injuries.\\n3. Optimize pulmonary function based on an individual patient’s respira-\\ntory status and comorbidities using interv entions such as nebulizer \\ntreatments, steroids, antibiotics, and intubation, as indicated. While a \\nblood gas may not reliably predict impending respiratory failure, a \\nforced vital capacity <25 mL/kg or 50% decreased from predicted \\nChronic Neurologic Disorders\\nMichael T. Fitch\\n147\\nC HAPTER\\n147_Cydulka_Ch147.indd   800 21/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 819, 'page_label': '801'}, page_content='CHAPTER 147: Chronic Neurologic Disorders 801 \\nnormal increases the likelihood of pneumonia and respiratory failure \\nin these patients.\\n4. Patients with pneumonia, inability to handle secretions, respiratory dis-\\ntress, or need for ventilator support should be admitted to an appropriate \\nlevel of inpatient care.\\n■ ■MYASTHENIA GRAVIS\\nClinical Features\\nMyasthenia gravis is an autoimmune disorder of the neuromuscular junc-\\ntion that is characterized by muscle weakness and fatigue. Most patients \\nhave weakness of proximal extremity muscles, neck extensors, and facial \\nor bulbar muscles. Ptosis and diplopia are common presenting symptoms, \\nand symptoms typically worsen as the day progresses and improve with \\nrest. Severe respiratory muscle weakness causing respiratory failure is \\ncharacteristic of a myasthenic crisis.\\nDiagnosis and Differential\\nThe symptoms of myasthenia gravis can mimic those seen in many other \\ndisorders, including Lambert-Eaton syndrome, botulism, thyroid disor -\\nders, and stroke. The diagnosis can be established through administration \\nof edrophonium (an acetylecholinesterase inhibitor), electromyography, \\nand serum testing for acetylcholine receptor antibodies. Edrophonium  \\nor neostigmine is expected to improve muscle strength in objectively \\nweak limb and ocular or pharyngeal muscles and can help make an initial \\ndiagnosis.\\nEmergency Department Care and Disposition\\n1. Myasthenia gravis can be treated with the acetylcholinesterase inhibitors \\npyridostigmine or neostigmine, thymectomy, immune suppression \\nwith steroids or azathioprine, and immune modulation with plasma \\nexchange or IV immunoglobulin.\\n2. Many drugs used in the emergency department ha ve the potential to \\nimpact neuromuscular function. Check carefully for drug interactions \\nwhen treating patients with myasthenia gravis (Table 147-1).\\n3. Respiratory failure can occur in patients with infection, recent surgery, \\nor recent changes in immunosuppressant medications. When possible, \\navoid depolarizing or nondepolarizing paralytic agents if intubation is \\nrequired.\\n4. Myasthenic crisis requiring emergent intervention may occur in undiag-\\nnosed patients with myasthenia gravis, or in patients with known disease \\nwho have acute exacerbations or inadequate treatment.\\n5. Administration of edrophonium 1 mg slow IV can help to distinguish a \\nmyasthenic crisis (inadequately treated myasthenia gravis) from a cho-\\nlinergic crisis (often from overmedication). Resolution of muscle weak-\\nness within a few minutes suggests a myasthenia exacerbation that can \\nbe further treated with neostigmine 0.5 to 2 mg IM, IV , SC or in incre-\\nments of 15 mg PO.\\n147_Cydulka_Ch147.indd   801 21/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 820, 'page_label': '802'}, page_content='802 SECTION 15: Neurology\\nTablE 147-1 Drugs to Avoid in Myasthenia Gravis\\nSteroids Adrenocorticotropic hormone,* methylprednisolone,* prednisone*\\nAnticonvulsants Phenytoin, ethosuximide, trimethadione, paraldehyde, magnesium \\nsulfate, barbiturates, lithium\\nAntimalarials Chloroquine,* quinine*\\nIV fluids Sodium lactate solution\\nAntibiotics Aminoglycosides, fluoroquinolones,* neomycin,* streptomycin,* \\nkanamycin,* gentamicin, tobramycin, dihydrostreptomycin,* ami-\\nkacin, polymyxin A, polymyxin B, sulfonamides, viomycin, colisti-\\nmethate,* lincomycin, clindamycin, tetracycline, oxytetracycline, \\nrolitetracycline, macrolides, metronidazole\\nPsychotropics Chlorpromazine,* lithium carbonate,* amitriptyline, droperidol,  \\nhaloperidol, imipramine\\nAntirheumatics d-Penicillamine, colchicine, chloroquine\\nCardiovascular Quinidine,* procainamide,* β-blockers (propranolol, oxprenlol, prac-\\ntolol, pindolol, sotalol), lidocaine, trimethaphan; magnesium; calcium \\nchannel blockers (verapamil)\\nLocal anesthetics Lidocaine,* procaine*\\nAnalgesics Narcotics (morphine, hydrmorphone, codeine, Pantopon, meperidine)\\nEndocrine Thyroid replacement*\\nEye drops Timolol,* echothiophate\\nOthers Amantadine, diphenhydramine, emetine, diuretics, muscle relaxants, \\ncentral nervous system depressants, respiratory depresants, seda-\\ntives, procaine,* phenothiazines\\nNeuromuscular \\nblocking agents\\nTubocurarine, pancuronium, rocuronium, gallamine, dimthyl \\ntubocurarine, succinylcholine, decamethonium\\n■ ■MULTIPLE SCLEROSIS\\nClinical Features\\nMultiple sclerosis (MS) is caused by multifocal areas of CNS demyelin-\\nation and manifests with motor, sensory, visual, and/or cerebellar dysfunc-\\ntion. Types of MS include relapsing and remitting (90%), relapsing and \\nprogressive, and chronically progressive. Lhermitte sign is commonly \\nexperienced and is described as an electric shock sensation, vibration, or \\npain radiating down the back and often into the arms or legs from neck \\nflexion. Physical examination may show decreased strength, increased \\ntone, hyperreflexia, clonus, decrease in vibratory sense and joint proprio-\\nception, a positive Babinski reflex, and reduced pain and temperature sense. \\nOptic neuritis with loss of central vision is a presenting symptom in 30% \\nof cases and may cause an afferent papillary defect (Marcus–Gunn pupil). \\nBilateral internuclear ophthalmoplegia causes abnormal eye adduction and \\nNote: See also discussion on eMedicine from WebMD by William D. Goldenberg, MD, available at: \\nhttp://emedicine.medscape.com/article/793136-overview#a1.\\n*Case reports implicate drugs in exacerbations of myasthenia gravis.\\n147_Cydulka_Ch147.indd   802 21/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 821, 'page_label': '803'}, page_content='CHAPTER 147: Chronic Neurologic Disorders 803 \\nhorizontal nystagmus, and its presence is strongly suggestive of MS. Cog -\\nnitive and emotional problems are common as the disease progresses.\\nDiagnosis and Differential\\nA diagnosis of MS is suspected when a patient experiences two or more \\nprolonged episodes of neurologic dysfunction that suggest white matter \\npathology in more than one location in the brain and/or spinal cord. MRI \\nshows multiple discrete lesions in the supratentorial white matter, homoge-\\nneous borders around the ventricles, or infratentorial or spinal cord lesions. \\nCSF protein and γ-globulin levels are often elevated. Other conditions that \\nmimic symptoms of MS include systemic lupus erythematosus, Lyme dis-\\nease, neurosyphilis, HIV disease, and Guillain-Barré syndrome.\\nEmergency Department Care and Disposition\\n1. Consult with a neurologist for assistance in managing a patient with MS \\nand suspected exacerbation. Refer patients with new symptoms suspi-\\ncious for MS to a neurologist for further evaluation.\\n2. High-dose methylprednisolone therapy, 500 to 1000 mg per day, short-\\nens the duration of exacerbations.\\n3. Consider testing for urinary tract infections in the appropriate clinical \\nsetting, especially for patients with known bladder dysfunction and post-\\nvoid residuals >100 mL.\\n4. Evaluate for potential sources of infection when fever is present. Fe ver \\nreduction measures can help to minimize the muscle weakness that is \\nassociated with temperature elevations.\\n5. Consider inpatient admission for patients with significant exacerbations \\nwho may require IV steroids or antibiotics.\\n■ ■LAMBERT-EATON MYASTHENIC SYNDROME\\nLambert-Eaton myasthenic syndrome is an autoimmune disorder with fluc-\\ntuating proximal limb muscle weakness and fatigue. It is classically \\ndescribed in older men with lung cancer. Strength improves with sustained \\nor repeated exercise (Lambert sign). Patients complain of myalgias, stiff-\\nness, paresthesias, metallic tastes, and autonomic symptoms. Eye move-\\nments are unaffected. Electromyography is abnormal, and serum tests are \\nspecific for antibodies to voltage-gated calcium channels. Treatment is \\nmostly supportive, but neuromuscular transmission can also be enhanced \\nwith 3,4-diaminopyridine. Immunosuppressive drugs may reduce symp-\\ntom severity.\\n■ ■PARKINSON’S DISEASE\\nClinical Features\\nParkinson’s disease is a progressive extrapyramidal movement disorder \\nwith four classic signs: resting tremor, cogwheel rigidity, bradykinesia or \\nakinesia, and impaired posture and equilibrium. Initially, many patients \\ndevelop a unilateral resting upper extremity tremor, referred to as a “pill \\nrolling” tremor, which improves with intentional movement.\\n147_Cydulka_Ch147.indd   803 21/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 822, 'page_label': '804'}, page_content='804 SECTION 15: Neurology\\nDiagnosis and Differential\\nThe diagnosis of Parkinson’s disease is clinical and based on the presence \\nof the four classic signs. Parkinsonism can secondarily develop from expo-\\nsure to illicit drugs, toxins, neuroleptic medications, hydrocephalus, head \\ntrauma, and other rare neurologic conditions. Drug-induced Parkinson’s \\ndisease most commonly presents with akinesia. No radiographic imaging \\nor laboratory study is pathognomonic for making the diagnosis.\\nEmergency Department Care and Disposition\\nMost patients with known Parkinson’s disease are treated with medica-\\ntions that increase central dopamine, have anticholinergic properties, or \\nact as central dopamine receptor agonists. Medication side effects may \\ninclude psychiatric or sleep disturbances, anorexia, nausea, vomiting, \\ncardiac dysrhythmias, orthostatic hypotension, dyskinesias, and dystonia. \\nPatients being treated with medication for Parkinson’s disease who  \\npresent with new motor or psychiatric disturbances or decreased drug \\nefficacy, a “drug holiday” for 1 week can be considered in consultation \\nwith a neurologist.\\n■ ■POLIOMYELITIS AND POSTPOLIO SYNDROME\\nClinical Features\\nPoliomyelitis is caused by an enterovirus infection that can lead to paralysis \\nby motor neuron destruction and muscle denervation in some patients. \\nMost acutely infected patients are asymptomatic or have a mild viral syn-\\ndrome without paralysis. Major illness occurs in only 1% to 2% of infec-\\ntions and most commonly involves the spinal cord, resulting in asymmetric \\nproximal limb weakness and flaccidity, absent tendon reflexes, and fascicu-\\nlations. Maximal paralysis occurs within 5 days and is followed by muscle \\natrophy. Paralysis will resolve within 1 year in most patients. Other \\nsequelae include autonomic dysfunction, speech and swallowing dysfunc-\\ntion, and encephalitis. Polio was eradicated from the United States in 1979 \\nbut is still endemic in Nigeria, Pakistan, Afghanistan, and India.\\nPostpolio syndrome is the recurrence of motor symptoms after a latent \\nperiod of several decades in a patient who has a history of acute paralytic \\npoliomyelitis. Symptoms may include muscle fatigue, joint pain, or weak-\\nness of new and previously affected muscle groups. Patients may have new \\nbulbar, respiratory, or sleep difficulties.\\nDiagnosis and Differential\\nConsider an acute polio virus infection when an at-risk patient from an \\nendemic area presents with an acute febrile illness, aseptic meningitis, and \\nasymmetric flaccid paralysis with loss of deep tendon reflexes and pre-\\nserved sensation. The diagnosis can be made by evaluating cerebrospinal \\nfluid (CSF), which will demonstrate a pleocytosis and positive viral cul-\\ntures for poliovirus, or from throat or rectal swab testing.\\nOther diseases with similar neurologic symptoms include Guillain-\\nBarré syndrome, peripheral neuropathies associated with other disorders \\n(e.g., mononucleosis, Lyme disease, or porphyria), abnormal electrolyte \\n147_Cydulka_Ch147.indd   804 21/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 823, 'page_label': '805'}, page_content='CHAPTER 147: Chronic Neurologic Disorders 805 \\nlevels, toxins, inflammatory myopathies, and other viral infections  \\n(e.g., Coxsackie, mumps, echovirus, and various enteroviruses).\\nEmergency Department Care and Disposition\\nAcute care for patients suffering from a postpolio syndrome is supportive, \\nwith analgesics and anti-inflammatory medications. Muscle training and \\ndaily exercise regimens are helpful. Lamotrigine may improve quality of \\nlife for patients with postpolio syndrome. Consultation with a neurologist \\nis recommended for disposition and continued follow-up treatment.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 173, “Chronic Neurologic Disorders” by  \\n Daniel A. Handel and Sarah Andrus Gaines.\\n147_Cydulka_Ch147.indd   805 21/03/17   4:29 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 824, 'page_label': '806'}, page_content='806\\nCentral Nervous System  \\nand Spinal Infections\\nMichael T. Fitch\\nIdentifying infections in the central nervous system (CNS) can be challeng-\\ning for clinicians in the Emergency Department (ED), as invasive testing is \\noften required for definitive diagnoses. Bacterial meningitis, viral encepha-\\nlitis, brain abscess, and spinal epidural abscess are life-threatening emer -\\ngencies that can initially present with a spectrum of nonspecific symptoms \\nthat may make early diagnosis difficult. Differentiating these conditions \\nfrom viral meningitis or other conditions that can be treated with supportive \\ncare is important when a CNS infection is suspected.\\n■ ■MENINGITIS AND ENCEPHALITIS\\nClinical Features\\nMeningitis is inflammation of the membranes surrounding the brain and \\nspinal cord. Bacterial meningitis is inflammation caused by infection, often \\nwith encapsulated organisms, and is a life-threatening emergency. Even \\nwith appropriate and timely treatment this emergent CNS infection can \\nhave significant morbidity and mortality. Aseptic meningitis is diagnosed \\nwhen such inflammation is due to causes other than bacterial infection, \\nsuch as drug reactions, rheumatologic conditions, or nonbacterial infections \\nsuch as fungi or viruses. Enteroviruses and echoviruses are the most com-\\nmon causes of aseptic meningitis.\\nThe classically described clinical triad of meningitis is fever, neck stiff-\\nness, and altered mental status, although less than half of patients will ini-\\ntially present with all three of these features. Headache is a common \\nsymptom and fever is often present. Many initial symptoms such as head-\\nache, fever, neck pain, nausea, and vomiting are nonspecific and overlap \\nwith other more common conditions, which can make early diagnosis a \\nchallenge especially in very young and very old patients.\\nPhysical findings often include fever, and when CNS infection is \\nsuspected clinicians should evaluate for the presence of meningeal signs \\nsuch as nuchal rigidity (severe neck stiffness), Kernig’s sign (pain in the \\nback and legs with flexing the hip and extending the knee), and Brudz-\\ninski’s sign (flexion of the hips with passive flexion of the neck), \\nalthough these classically described findings have been demonstrated to \\nhave poor sensitivity for meningitis. Evaluate mental status and look for \\npotential neurological deficits that may accompany CNS infections such \\nas cranial nerve palsies or other focal findings. Examine the skin for \\npetechiae, splinter hemorrhages, or other findings concerning for sys-\\ntemic infection.\\nEncephalitis is an infection of the brain parenchyma that causes inflam-\\nmation within the CNS and is often caused by viral infection. This can be \\ncaused by a number of different viral pathogens including herpes simplex \\nvirus (HSV), which is the most treatable cause of encephalitis. Patients \\nwith acute viral encephalitis will present with many of the same signs and \\n148\\nC HAPTE r\\n148_Cydulka_Ch148.indd   806 21/03/17   4:35 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 825, 'page_label': '807'}, page_content='CHAPTER 148: Central Nervous System and Spinal Infections  807 \\nsymptoms as bacterial meningitis, such as fever, stif f neck, or headache. \\nAdditionally, patients diagnosed with encephalitis typically present with \\naltered mental status, cognitive deficits, psychiatric symptoms, or seizures.\\nDiagnosis and Differential\\nA promptly performed lumbar puncture (LP) to obtain cerebrospinal \\nfluid (CSF) is the appropriate diagnostic procedure for patients with \\nsuspected meningitis or encephalitis. Consider a CT scan of the brain \\nbefore the procedure when altered mental status, new onset seizures, \\nimmunocompromise, focal neurologic signs, or papilledema are present. \\nThe goal for imaging in this circumstance is to identify possible  \\ncontraindications to LP such as an occult mass or signs of brain shift or \\nherniation (see Fig. 148-1).\\nSend CSF for cell count and differential, protein and glucose levels, and \\na Gram’s stain and bacterial culture. Consider additional CSF studies for \\nimmunocompromised patients or if a specific CNS infection is suspected \\nbased on the initial CSF testing results. HSV or enterovirus PCR, bacterial \\nantigen testing, or specialized fungal testing can be considered as additional \\ntesting in appropriate clinical situations. Consider other laboratory studies \\nsuch as a complete blood count (CBC), serum glucose and electrolytes, \\nblood urea nitrogen (BUN), and creatinine to assess for other potential \\ndiagnoses. A blood culture may be helpful to identify bacterial pathogens, \\nparticularly when empiric antibiotics are given prior to lumbar  \\npuncture. See Table 148-1 for classically described findings in bacterial, \\nviral, fungal, and neoplastic meningitis, although several studies have dem-\\nonstrated that no single laboratory finding can accurately categorize the \\ncause of CSF pleocytosis in all patients. Although not typically part of an \\nED workup, characteristic findings on MRI in the medial temporal and \\ninferior frontal lobes are suggestive of HSV infection.\\nFIgure 148-1. Cranial imaging to evaluate potential contraindications for lumbar \\npuncture should be focused on identifying signs of a focal space-occupying lesion, \\nevidence of brain shift, and/or signs of severe diffuse brain swelling: (A) normal \\nbrain, (B) meningitis-associated cerebral infarct causing pronounced brain shift, \\nand (C) diffuse brain swelling associated with severe infection. Initial lumbar punc-\\nture should not be done when CT findings of significant brain shift are found, and \\nempiric therapy for meningitis should be continued in such patients. Reproduced \\nwith permission from Fitch MT, van de Beek D. Emergency diagnosis and treatment \\nof adult meningitis. Lancet Infect Dis. 2007 Mar;7(3):191–200.\\n148_Cydulka_Ch148.indd   807 21/03/17   4:35 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 826, 'page_label': '808'}, page_content='808 SECTION 15: Neurology\\nTable 148-1 Cerebrospinal Fluid (CSF) Diagnostic Evaluation\\nOpening Pressure \\n(<170 mm H2O)* Color (Clear) Gram Stain (Negative)\\nCell Count (<5 WBC,  \\n0 PMN)\\nGlucose  \\n(>40 mg/dL)\\nProtein  \\n(<50 mg/dL)\\nCytology \\n(Negative)\\nBacterial Elevated Cloudy, turbid Positive (60%–80% before \\nantibiotic, 7%–41% after \\nantibiotic)\\n>1000–2000/mm3 WBC, \\nneutrophilic predomi-\\nnance, >80% PMN\\n<40 mg/dL, CSF/ blood \\nglucose ratio <0.3–0.4\\n>200 mg/dL Negative\\nViral Normal Clear or bloody Negative <300/mm3 WBC, lym-\\nphocytic predominance, \\n<20% PMN\\nNormal <200 mg/dL Negative\\nFungal Normal to elevated Clear or cloudy Negative <500/mm3 Normal to slightly low >200 mg/dL Negative\\nNeoplastic Normal Clear or cloudy Negative <300/mm3 Normal to slightly low >200 mg/dL Positive\\n*Normal values and findings are in parentheses.\\nAbbreviation: PMN, polymorphonuclear lymphocyte.\\n148_Cydulka_Ch148.indd   808 21/03/17   4:35 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 827, 'page_label': '809'}, page_content='CHAPTER 148: Central Nervous System and Spinal Infections  809 \\nThe differential diagnosis for patients with findings concerning for \\nmeningitis or encephalitis may include subarachnoid hemorrhage, menin-\\ngeal neoplasm, brain abscess, cerebral toxoplasmosis, and other systemic \\nviral or bacterial infections.\\nemergency Department Care and Disposition\\n1. When bacterial meningitis is a likely diagnosis, begin empiric antibiotic \\ntherapy based on patient risk factors and most likely causative patho-\\ngens. Start antibiotics as soon as possible after a promptly performed LP, \\nor immediately after blood cultures are drawn if neuroimaging or other \\ndiagnostic testing will be performed.\\n2. When administering empiric antibiotics for suspected bacterial meningi-\\ntis, adults less than 50 years old should receive a third-generation \\ncephalosporin such as ceftriaxone 2 g IV plus vancomycin 15 mg/kg \\nIV . Patients at risk for Listeria monocytogenes infection (e.g., age  \\n50 years or older, pregnant women, alcoholics, immunocompromised \\npatients) should additionally receive ampicillin 2 g IV .\\n3. For patients with bacterial meningitis, adjuncti ve corticosteroids treat-\\nment started before or at the same time as the first dose of antibiotics \\nmay decrease mortality and neurologic sequelae for some subsets of \\npatients. Consider dexamethasone 10 mg IV every 6 hours for 4 days \\nin adults or 0.15 mg/kg IV every 6 hours for 4 days in children 3 months \\nand older when it is initiated before or at the same time antibiotics are \\ngiven.\\n4. Patients with suspected encephalitis should be started on acyclovir 10 \\nmg/kg IV to cover for possible HSV or herpes zoster virus infections. \\nCytomegalovirus encephalitis can be treated with ganciclovir 5 mg/kg \\nIV . Most other causes of viral encephalitis have no specific antimicrobial \\ntreatment that will impact patient outcomes, and recommended treat-\\nment in these circumstances is supportive care.\\n5. Patients with suspected bacterial meningitis or encephalitis should be \\nadmitted to the hospital for intrav enous antimicrobial agents and \\nfurther care.\\n■ ■BrAIN ABSCESS\\nClinical Features\\nA brain abscess is caused by a bacterial infection of the brain parenchyma \\nand is composed of a central purulent cavity ringed by a layer of granula-\\ntion tissue and an outer fibrous capsule. Presenting signs and symptoms are \\noften nonspecific and may include headache, neck stiffness, fever, vomit-\\ning, confusion, or changes in mental status. Patient symptoms may reflect \\nthe origin of the infection (e.g., ear or sinus pain), and symptoms may be \\npresent for 1 to 8 weeks before the diagnosis is made.\\nDiagnosis and Differential\\nNeuroimaging is needed to make the diagnosis of a brain abscess. A CT \\nscan of the head without contrast may identify abnormalities or evidence \\nof surrounding edema, but a CT scan with contrast is more likely to accu-\\nrately identify an abscess with thin rings of enhancement surrounding a \\n148_Cydulka_Ch148.indd   809 21/03/17   4:35 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 828, 'page_label': '810'}, page_content='810 SECTION 15: Neurology\\nlow-density center. MRI is another sensitiv e test for making the diagno-\\nsis. Avoid lumbar puncture if a brain abscess or other mass lesion is sus-\\npected or identified. Routine laboratory studies are usually nonspecific. \\nWhen possible, obtain blood cultures or cultures of other sites of infection \\nto guide future management.\\nThe differential diagnosis includes cerebrovascular disease, meningitis, \\nbrain neoplasm, subacute cerebral hemorrhage, and other focal brain infec-\\ntions, such as toxoplasmosis.\\nemergency Department Care and Disposition\\n1. Early empiric antibiotic therapy is recommended based on the likely \\nsource of infection (see Table 148-2).\\n2. Consult with a neurosurgeon for admission to the hospital as many pa-\\ntients will require sur gery for diagnosis, pathogen identification, and \\ndefinitive treatment.\\n■ ■EPIDUrAL ABSCESS\\nClinical Features\\nSpinal epidural abscess is a rare infection consisting of pyogenic material \\nthat accumulates in the epidural space. Up to half of these infections \\noriginate from hematogenous spread of bacteria from soft tissue, urine, or \\nTable 148-2 Guidelines for Empiric Treatment of Brain Abscess Based on \\nPresumed Source\\nPresumed Source Primary Empiric Therapy Alternative Therapy\\nOtogenic Cefotaxime 2 g IV every 4–6 h or \\nceftriaxone 2 g IV every 12 h PLUS \\nmetronidazole 500 mg IV every 8 h\\nPiperacillin/tazobactam 4.5 g IV \\nevery 6 h\\nOdontogenic Penicillin G 4 million units IV \\nevery 4 h\\nCeftriaxone 2 g IV every 12 h \\nPLUS metronidazole 500 mg IV \\nevery 6 h\\nSinogenic Cefotaxime 2 g IV every 6 h or \\nceftriaxone 2 g IV every 12 h PLUS \\nmetronidazole 500 mg IV every 8 h\\nNo recommendation\\nPenetrating trauma Cefotaxime 2 g IV every 6 h or \\nceftriaxone 2 g IV every 12 h PLUS \\nmetronidazole 500 mg IV every 8 h \\n± rifampin 10 mg/kg every 24 h\\nNo recommendation\\nAfter neurosurgical \\nprocedure\\nVancomycin loading dose 25–30 \\nmg/kg IV loading dose or linezolid \\n600 mg IV every 12 h PLUS ceftazi-\\ndime 2 g IV every 8 h ± rifampin \\n10 mg/kg every 24 h\\nCan substitute linezolid 600 \\nmg IV every 12 h instead of \\nvancomycin. Can substitute \\nmeropenem 2 g IV every 8 h OR \\npiperacillin/tazobactam 4.5 g IV \\nevery 6 h OR cefepime 2 g IV \\nevery 8 h for ceftazidime.\\nUnknown source Cefotaxime 2 g IV every 6 h PLUS \\nmetronidazole 500 mg IV every 6 h\\nNo recommendation\\nNote: See also http://www.hopkins-abxguide.org; accessed June 18, 2014.\\n148_Cydulka_Ch148.indd   810 21/03/17   4:35 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 829, 'page_label': '811'}, page_content='CHAPTER 148: Central Nervous System and Spinal Infections  811 \\nrespiratory sources. Most of these infections occur in the thoracic and \\nlumbar spine.\\nThe classic triad of back pain, fever, and neurological symptoms is \\npresent in a minority of patients, although back pain itself is very com-\\nmon and found in 70% to 90% of cases. Fever is also a common symp-\\ntom. The typical course of an untreated epidural abscess occurs in four \\nstages: (1) back pain, fever, and localized spinal tenderness; (2) spinal \\nirritation with radicular pain, hyperreflexia, and nuchal rigidity; (3) fecal \\nor urinary incontinence plus focal neurological deficits; and (4) motor \\nparalysis of the lower extremities.\\nDiagnosis and Differential\\nAssess patient’s epidural abscess risk factors such as immunocompromised \\nstates, intravenous drug abuse, spinal surgery, or recent procedures such as \\nlumbar puncture or epidural anesthesia. Physical examination findings may \\ninclude midline spine tenderness to palpation or percussion. Assess for \\nneurologic findings and findings concerning for cauda equina syndrome. \\nFor example, decreased rectal tone has a reported sensitivity of 60% to \\n80%, while decreased perineal sensation has a sensitivity of 75%.\\nThis challenging diagnosis is often delayed due to nonspecific present-\\ning symptoms and the rarity of this condition. Laboratory studies such as \\nCBC, erythrocyte sedimentation rate, and C-reactive protein may be help-\\nful. Blood cultures are positive in 40% of cases and can be helpful to guide \\ntreatment after admission to the hospital. Neuroimaging with a gadolinium \\nMRI is the preferred imaging modality for diagnosis, although a CT scan \\nwith myelography may be helpful if an MRI is not possible.\\nemergency Department Care and Disposition\\n1. Emergent consultation with a spine surgeon is important when an epi-\\ndural abscess is identif ied. While conclusive data regarding operative \\nversus IV antibiotic therapy alone are not available, many patients do \\nreceive surgical debridement.\\n2. Begin empiric antibiotic therapy if a patient with an epidural abscess \\nexhibits neurological dysfunction, signs of sepsis or systemic illness, or \\nif immediate surgery is not available. Initial antibiotic dosing in the ED \\nincludes vancomycin 25 to 30 mg/kg IV along with ceftazidime 2 g IV \\nor cefepime 2 g IV . Consider additional coverage with gentamycin  \\n5 mg/kg IV in a patient with a recent neurosurgical procedure.\\n3. Patients with epidural abscess should be admitted to the hospital for IV \\nantibiotics, close monitoring, neurological checks, and possible surgical \\ndebridement.\\n■ ■FUrTHEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 174, “Central Nervous System and Spinal Infections,” \\nby Mary E. Tanski and O. John Ma.\\n148_Cydulka_Ch148.indd   811 21/03/17   4:35 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 830, 'page_label': '812'}, page_content='148_Cydulka_Ch148.indd   812 21/03/17   4:35 PM\\nThis page intentionally left blank'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 831, 'page_label': '813'}, page_content='813\\nEye Emergencies\\nSteven Go\\n■ ■INFECTIONS AND INFLAMMATION\\nPreseptal (Periorbital) and Postseptal (Orbital) Cellulitis\\nPreseptal cellulitis is an infection of the periorbital tissues, whereas post-\\nseptal cellulitis involves the orbit. Both conditions primarily present in \\nchildren <10 years old. They may present nearly identically with typical \\nsymptoms of excessive tearing, erythema, warmth, tenderness to palpation \\nof the lids, and periorbital tissue. In preseptal cellulitis, there is NO eye \\ninvolvement. That is, visual acuity, pupillary responses, and eye appear -\\nance are normal, and there is no pain with extraocular movements. If any \\nof these characteristics are present, or if there is concern about postseptal \\ninvolvement, obtain a CT scan with contrast of the orbit (or MRI) to rule \\nout orbital involvement. Preseptal cellulitis in nontoxic patients may be \\ntreated as an outpatient with amoxicillin/clavulanic acid 20 mg/kg PO \\ndivided every 12 hours; 500 mg PO three times daily in adults or a first-\\ngeneration cephalosporin, hot packs, and with 24 to 48 hours ophthalmol-\\nogy follow-up. In cases of preseptal cellulitis that are severe or involve \\nhigh-risk patients (e.g., children <5 years or patients with significant \\ncomorbidities) or in any case of postseptal cellulitis, obtain an emergent \\nophthalmology consultation for admission for intravenous antibiotics. \\nEmpiric therapy should begin with cefuroxime 50 mg/kg IV every 8 hours \\nor ceftriaxone 50 mg/kg every 12 hours, or ampicillin–sulbactam 50 mg/\\nkg IV every 6 hours, with IV vancomycin added if methicillin-resistant \\nStaphylococcus aureus (MRSA) is suspected. Use fluoroquinolones PLUS \\nmetronidazole or clindamycin in penicillin allergic adults.\\nStye (External Hordeolum) and Chalazion\\nA stye is an acute infection of an oil gland at the lash line that appears as a \\npustule at the lid margin. A chalazion is an acute or chronic inflammation \\nof the eyelid secondary to meibomian gland blockage in the tarsal plate. \\nWhen it is acute, a chalazion may be painful, but is usually painless when \\nchronic. A stye or acute chalazion is treated with warm, wet compresses \\nfour times daily and with erythromycin 0.5% ophthalmic ointment twice \\n149\\nCh A p TE r\\nEye, Ear, Nose, Throat, and \\nOral Emergencies\\n 16\\nSECTION\\n149_Cydulka_Ch149.indd   813 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 832, 'page_label': '814'}, page_content='814 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies \\ndaily for 7 to 10 days. Refer persistent or recurrent lesions to an ophthal-\\nmologist for further evaluation and treatment.\\nBacterial Conjunctivitis\\nBacterial conjunctivitis presents as eyelash matting, mild to moderate \\nmucopurulent discharge, and conjunctival inflammation. Fluorescein \\nstaining of the cornea should be performed in patients with suspected \\nconjunctivitis to avoid missing abrasions, ulcers, and dendritic lesions. \\nPrescribe topical antibiotics for 5 to 7 days (Table 149-1). Quinolones \\n(ciprofloxacin or ofloxacin ophthalmic) may be used in children due to \\nlimited systemic absorption. Avoid gentamicin due to high incidence of \\nocular irritation. Haemophilus influenzae and Moraxella catarrhalis are \\nconsiderations in children; therefore, if erythromycin ointment is being \\nused and is ineffective, a change in antibiotics should be initiated. Contact \\nlens wearers should receive topical antibiotic coverage for Pseudomonas, \\nTaBlE 149-1 Selected Ophthalmic Medications Used in the Emergency \\nDepartment\\nDrug Indication Dose\\nCyclopentolate* Short-term mydriasis and \\ncycloplegia for examination\\n0.5% in children, 1 drop; 1% \\nin adults, 1 drop; onset 30 min, \\nduration ≤24 h\\nTropicamide* Short-term mydriasis and \\ncycloplegia for examination\\n1 to 2 drops of 0.5% or 1% solution, \\nonset 20 min; duration of action 6 h\\nHomatropine* Intermediate-term pupil \\ndilation, cycloplegia, \\ntreatment of iritis\\n1 to 2 drops of 2% solution; onset  \\n30 min; duration of action 2 to 4 days; \\nfor iritis 1 to 2 drops twice a day\\nNaphazoline and \\npheniramine*\\nConjunctival congestion/\\nitching\\n1 drop three to four times a day\\nOlopatadine Allergic conjunctivitis 0.1% solution, 1 drop twice daily, \\nonset of action 30 to 60 min, dura-\\ntion 12 h\\nTetracaine \\nophthalmic solution\\nAnesthetic for eye examina-\\ntion, foreign body removal\\n0.5% solution, 1 to 2 drops; onset of \\naction 1 min, duration 30 min\\nProparacaine \\nophthalmic solution\\nAnesthetic for eye examina-\\ntion, foreign body removal\\n0.5% solution, 1 to 2 drops; onset of \\naction 20 s, duration 15 min\\nErythromycin \\nophthalmic ointment\\nConjunctivitis. Do not use \\nfor corneal abrasion if a \\ncontact lens wearer\\nHalf inch applied to lower eyelid \\ntwo to four times a day\\nCiprofloxacin Conjunctivitis, corneal \\nabrasion if a contact lens \\nwearer\\nSolution: 1 to 2 drops when awake \\nevery 2 h for 2 days; ointment, half \\ninch applied to lower eyelid three \\ntimes a day for 2 days\\nTobramycin Conjunctivitis, corneal \\nabrasions if a contact lens \\nwearer\\n0.3% solution, 1 to 2 drops every 4 \\nh; 0.3% ointment, half inch applied \\nto lower lid two to three times a day\\nSulfacetamide \\nsodium\\nConjunctivitis. Do not use \\nfor corneal abrasion if a \\ncontact lens wearer\\n10% solution, 1 to 2 drops four \\ntimes a day\\n(Continued)\\n149_Cydulka_Ch149.indd   814 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 833, 'page_label': '815'}, page_content='CHAPTER 149: Eye Emergencies 815 \\nTaBlE 149-1 Selected Ophthalmic Medications Used in the Emergency \\nDepartment\\nDrug Indication Dose\\nOfloxacin Conjunctivitis, corneal \\nabrasions if a contact lens \\nwearer\\nConjunctivitis: 1 to 2 drops every \\n2–4 h for 2 days, then 1 to 2 drops \\nfour times a day for 5 days. Corneal \\nulcer: 1 to 2 drops every 30 min \\nwhile awake and 1 to 2 drops every \\n4–6 h after retiring for 2 days, then \\n1 to 2 drops every hour while awake \\nfor 5–7 days, then 1 to 2 drops \\nfour times a day for 2 days or until \\ntreatment completion\\nTrifluridine Herpes simplex keratitis 1 drop every 2 h\\nKetorolac Allergic conjunctivitis, \\ncorneal abrasions, \\nultraviolet keratitis\\n1 drop four times/day for 3–4 days\\nPrednisolone \\nacetate†\\nAllergic conjunctivitis, \\nuveitis\\n2 drops four times a day\\n*Agents that affect pupillary dilation or serve as a conjunctival decongestant should be avoided in \\npatients with glaucoma.\\n†Should be prescribed ONLY in conjunction with a specific recommendation from ophthalmologist.\\nsuch as ciprofloxacin or tobramycin. The lens should be discarded and \\nnot replaced until the infection has completely resolved.\\nA severe purulent discharge with a hyperacute onset (within 12 to  \\n24 hours) should prompt an emergent ophthalmology consultation for an \\naggressive workup for possible gonococcal conjunctivitis. Neisseria gonor-\\nrhoeae infections may be confirmed by Gram stain (gram-negative intracel-\\nlular diplococci). Emergency department (ED) care for N. gonorrhoeae \\ninfections include culture, parenteral ceftriaxone, and saline solution \\nirrigation to remove the discharge.\\nIf bacterial conjunctivitis is present in a neonate, suspect a sexually \\ntransmitted disease (STD) etiology. These are sight-threatening conditions \\nwhich can be difficult to diagnose, and an emergent ophthalmology evalu-\\nation in the ED is warranted. If gonorrhea is suspected, an inpatient workup \\nfor disseminated disease is indicated. If chlamydia is suspected, then asso-\\nciated pneumonia must be ruled out prior to discharge. Herpes conjunctivi-\\ntis is also a possibility. (See Herpes Simplex Virus.)\\nViral Conjunctivitis\\nViral conjunctivitis presents as watery discharge, chemosis, and conjuncti-\\nval inflammation. It is often associated with viral respiratory symptoms and \\noccasionally preauricular lymphadenopathy. Fluorescein staining should be \\ndone as in bacterial conjunctivitis, specifically in this case to rule out den-\\ndritic lesions. Treatment consists of cool compresses four times daily, \\nnaphazoline/pheniramine 0.025%/0.3% one drop three times daily, as \\nneeded, for conjunctival congestion or itching, artificial tears five or six \\ntimes a day, and ophthalmology follow-up in 7 to 14 days. If a clear distinc-\\ntion between viral and bacterial etiologies cannot be made, consideration \\n(Continued)\\n149_Cydulka_Ch149.indd   815 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 834, 'page_label': '816'}, page_content='816 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies \\nshould be made to add topical antibiotics (Table 149-1) until reexamination \\nby an ophthalmologist; ho wever, routine use of antibiotics is discour -\\naged. All the cases of viral conjunctivitis are extremely contagious and \\nappropriate transmission precautions must be taken.\\nallergic Conjunctivitis\\nAllergic conjunctivitis presents as pruritus, watery discharge, and chemosis \\nwith a history of allergies. There should be no lesions with fluorescein \\nstaining and no preauricular nodes. Conjunctival papillae are seen on slit \\nlamp examination. Treatment consists of elimination of the inciting agent, \\ncool compresses four times daily, artificial tears five or six times daily, and \\nnaphazoline/pheniramine 0.025%/0.3% one drop four times daily. Severe \\ncases may require a mild topical steroid, but steroids should be only admin-\\nistered in consultation with an ophthalmologist.\\nHerpes Simplex Virus\\nHerpes simplex virus (HSV) infection may involve the eyelids, conjunctiva, \\nor cornea. Corneal lesions stain brightly with fluorescein and can appear as \\na classic “dendrite” (a linear branching, epithelial defect with terminal \\nbulbs) or as a “geographic ulcer” (an amoeba-like ulceration with dendrites \\nat the edges) (Figure 149-1), but the presentation can be very variable and \\nsubtle. Corneal sensation can be decreased and should be checked. It is \\nessential that HSV infection should not be confused with conjunctivitis, \\nhence the necessity of a slit lamp fluorescein examination in these patients. \\nIf HSV infection is suspected, obtain an ophthalmology consult. If the \\noutbreak involves only the eyelids, acyclovir 800 mg PO five times daily \\nFigurE 149-1. Herpes simplex corneal dendrite in an infant seen with fluorescein \\nstaining. Used with permission from Allen R. Katz, Department of Ophthalmology, \\nUniversity of Nebraska Medical Center.\\n149_Cydulka_Ch149.indd   816 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 835, 'page_label': '817'}, page_content='CHAPTER 149: Eye Emergencies 817 \\nfor 7 to 10 days should be prescribed. If the conjunctiva is inv olved, pre-\\nscribe trifluorothymidine 1% drops nine times daily. In addition, erythro-\\nmycin ophthalmic 0.5% ointment twice daily and warm soaks three times \\ndaily to skin lesions can help prevent secondary bacterial infections. If \\ncorneal or deeper structure involvement is present, then antibiotic choice \\nshould be determined by the consulting ophthalmologist. Topical steroids \\nare to be strictly avoided in all cases of HSV infection. Close follow-up \\nfrom the ED and strong precautions are essential.\\nWhen conjunctivitis is present in the neonate, especially with mucocu-\\ntaneous lesions, HSV also should be suspected, even in the absence of \\nmaternal infection. As with other causes of neonatal conjunctivitis, an \\nemergent ophthalmology consult at the bedside is warranted. If HSV is \\ndiagnosed or strongly suspected, treat with acyclovir 20 mg/kg IV every 8 \\nhours and topical antivirals (1% trifluridine, 0.1% iododeoxyuridine, or 3% \\nvidarabine). Further workup for sepsis is indicated. Steroid drops should \\nnot be given.\\nHerpes Zoster Ophthalmicus\\nShingles in a trigeminal distribution with ocular involvement is termed \\nherpes zoster ophthalmicus (HZO). The presence or eventual development \\nof HZO should be suspected in any patient whose shingles involve the tip \\nof the nose (Hutchinson’s sign). Photophobia and pain secondary to iritis \\nare often present. Slit lamp examination may show a “pseudodendrite,” a \\npoorly staining mucus plaque without epithelial erosion. Acyclovir 800 \\nmg PO five times a day, famciclovir 500 mg three times daily, or valacy-\\nclovir 1000 mg three times daily for 7 to 10 days should be prescribed if \\nthe skin lesions have been present less than 7 days. In addition, erythro-\\nmycin 2% ointment and warm compresses should be applied to skin \\nlesions. Ocular involvement requires erythromycin 0.5% ophthalmic \\nointment to the eye twice daily. For comfort, oral opioid analgesia, cyclo-\\nplegic agents (cyclopentolate 1% one drop three times daily), and cool \\ncompresses are helpful. If iritis is present, prednisolone acetate 1% one \\ndrop every 1 to 6 hours is effective. However, because topical steroid use \\nin patients with herpes simplex keratoconjunctivitis may be catastrophic, \\nit is imperative that there should be no corneal lesions present on slit lamp \\nexamination before topical steroids are used. In severe cases, admission \\nand acyclovir IV may be required. For this reason, all the cases of sus-\\npected HZO require ophthalmology consultation. All patients younger \\nthan 40 years with HZO should undergo an outpatient medical evaluation \\nfor a possible immunocompromised state.\\nCorneal ulcer\\nA corneal ulcer is a serious infection of the corneal stroma caused by bac-\\nteria including Pseudomonas aeruginosa, viruses including herpes simplex \\nand varicella zoster, and fungi. Immunocompromised patients are at risk for \\nfungal or viral etiologies. It is commonly associated with trauma, especially \\nin patients who use extended-wear contact lenses and those who wear \\nlenses while sleeping. Ulcers may cause pain, redness, tearing, photopho-\\nbia, and blurry vision. Slit lamp examination shows a staining corneal \\ndefect with a surrounding white hazy infiltrate, and associated iritis and \\n149_Cydulka_Ch149.indd   817 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 836, 'page_label': '818'}, page_content='818 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies \\nsometimes a hypopyon. Topical ofloxacin 0.3% or ciprofloxacin 0.3% \\nophthalmic solution should be administered, one drop in the affected eye \\neach hour. Antifungal or antiviral antibiotics may be given to immunocom-\\npromised patients in consultation with an ophthalmologist. Topical cyclo-\\nplegics, such as cyclopentolate 1% one drop three times daily, aid in pain \\nrelief. Eye patching is strictly contraindicated because of the risk of wors-\\nening a potential Pseudomonas infection. Steroid drops should be \\navoided unless an ophthalmologist advises administration. It would be \\nideal for the patient to be seen by an ophthalmologist in the ED in order to \\nculture the ulcer prior to starting antibiotics. However, if this is not possi-\\nble, they should see the patient within 12 to 24 hours.\\niritis\\nIritis is inflammation of the anterior uveal tract (iris and ciliary body) that \\nhas many causes (Table 149-2). It presents with red eye, photophobia, and \\ndecreased vision. A hallmark physical examination sign is consensual pain \\n(pain in the affected eye when light is shined in the nonaffected eye). Slit \\nlamp examination reveals WBCs in the anterior chamber, usually with \\nassociated flare, and a hypopyon can eventually occur. Perform an exam \\nwith fluorescein dye to detect corneal abrasions, ulcers, or dendritic \\nlesions, and measure intraocular pressure (IOP), which can be elevated. \\nOnce iritis is diagnosed, undertake an appropriate ED workup for a sys-\\ntemic etiology and treat them, if found. Symptomatic treatment with \\ntropicamide (Table 149-1) is helpful. Ophthalmology consultation is \\nappropriate with follow-up in 24 to 48 hours. Steroid drops can be of \\nvalue, but should only be given if directed by the ophthalmologist.\\nEndophthalmitis\\nEndophthalmitis is an infection involving the deep structures of the globe. \\nPatients present with pain and visual loss. It is often seen as a complication \\nof globe violation either from trauma or ocular surgery. Hematologic \\nspread is possible. Pathogens include Staphylococcus, Streptococcus, \\nHaemophilus, and Bacillus species. Emergency ophthalmology consultation \\nTaBlE 149-2 Differential Diagnosis of Iritis\\nSystemic diseases\\nJuvenile rheumatoid arthritis\\nAnkylosing spondylitis\\nUlcerative colitis\\nReiter’s syndrome\\nBehçet’s syndrome\\nSarcoidosis\\nInfectious\\nTuberculosis\\nLyme disease\\nHerpes simplex\\nToxoplasmosis\\nVaricella zoster\\nSyphilis\\nAdenovirus\\nMalignancies\\nLeukemia\\nLymphoma\\nMalignant melanoma\\nTrauma/environmental\\nCorneal foreign body\\nPosttraumatic (blunt trauma)\\nUltraviolet keratitis\\n149_Cydulka_Ch149.indd   818 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 837, 'page_label': '819'}, page_content='CHAPTER 149: Eye Emergencies 819 \\nand admission are warranted. Treatment may include vitreous aspiration, \\nvitrectomy, intraocular and systemic antibiotics, and steroids.\\n■ ■TrAUMA\\nSubconjunctival Hemorrhage\\nThis injury is a disruption of conjunctival blood vessels, typically second-\\nary to trauma, sneezing, or the Valsalva maneuver. It requires no treatment \\nand usually resolves within 2 weeks. Its primary clinical importance rests \\nin the fact that it can be a sign of significant eye injury when due to trauma, \\nand recurrent episodes should prompt an evaluation for a coagulopathy.\\nCorneal abrasion and ultraviolet Keratitis\\nTraumatic abrasions may cause superficial or deep epithelial defects  \\nresulting in tearing, photophobia, blepharospasm, and pain. Administra-\\ntion of a topical anesthetic often will facilitate the examination. Propara-\\ncaine 0.5% is preferred over tetracaine because it causes less pain upon \\nadministration and provides comparable anesthesia. A corneal abrasion \\nwill glow green during a fluorescein stain examination when using the \\ncobalt blue light on the slit lamp. A careful search for an ocular foreign \\nbody (including upper lid eversion) must be done in the presence of an \\nabrasion, especially when they are multiple and linear. Once the diagnosis \\nof a simple abrasion is made, prescribe ketorolac ophthalmic solution  \\none drop four times a day for pain control. For severe pain with large \\nabrasions, opioid analgesia and/or a cycloplegic (e.g., cyclopentolate  \\n1% one drop three times a day) may be considered. Abrasions are treated \\nwith topical antibiotics (Table 149-1). Most patients are treated with \\nerythromycin ointment; however, abrasions associated with contact lens \\nwear should be treated with antipseudomonal topical antibiotics (e.g., \\nciprofloxacin, ofloxacin, or tobramycin). Patching corneal abrasions \\ntraditionally has been recommended; however, excellent patient comfort \\ncan be achieved without it. More importantly, patching does not hasten \\nthe healing of abrasions and can greatly harm the patient if lesions prone \\nto infection (e.g., contact lens abrasions or corneal ulcers) are patched. \\nPrescribing topical anesthetics is absolutely contraindicated because \\nrepeated use may cause catastrophic corneal damage. All abrasions \\nshould be reexamined in 24 to 48 hours by an ophthalmologist, with those \\nthat are large or involve the visual axis seen sooner.\\nExposure to ultraviolet light from welding (“arc welder’s keratitis”), \\ntanning beds, or prolonged sun exposure (especially when reflected off ice \\nand snow-covered slopes at high altitude) can cause a diffuse burn to the \\ncornea which appears as diffuse punctate corneal abrasions with edema. \\nSevere pain and photophobia develop 6 to 12 hours after exposure. Treat-\\nment is similar to corneal abrasions, but more aggressive pain control is \\nsometimes necessary. Healing typically occurs in 2 to 3 days.\\nCorneal Foreign Bodies\\nSuperficial foreign bodies of the cornea are removed under slit lamp \\nmicroscopy with a 25-guage needle, an eye spud, or an ophthalmic burr. \\nTopical anesthesia (e.g., proparacaine 0.5%) is used and can also be \\n149_Cydulka_Ch149.indd   819 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 838, 'page_label': '820'}, page_content='820 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies \\ninstilled in the unaffected eye to depress refle x blinking. For obvious rea-\\nsons, this procedure should be attempted only in a sober, cooperative \\npatient. Any corneal foreign body deep within the corneal stroma or in the \\ncentral visual axis should be removed by an ophthalmologist. Metallic \\nforeign bodies often leave an epithelial “rust ring” that may be removed \\nimmediately with an eye burr; however, it is often easier to remove in  \\n24 to 48 hours. A corneal abrasion will result from foreign body removal \\nand is treated in the standard manner (cycloplegics, antibiotics). All \\npatients should be referred to an ophthalmologist within 24 hours. The \\npresence of either gross or micro hyphema should prompt further inves-\\ntigation for possible globe perforation. (See Penetrating Trauma or \\nRuptured Globe.)\\nlid lacerations\\nMany small superficial lacerations to the eye lids can be repaired by emer-\\ngency physicians; however, eyelid lacerations that involve the lid margin, \\nthose within 6 to 8 mm of the medial canthus or involving the lacrimal duct \\nor sac, those involving the inner surface of the lid, wounds associated with \\nptosis, and those involving the tarsal plate or levator palpebrae muscle, \\nneed repair by an oculoplastic surgeon. Due to a high chance of morbidity, \\nlid margin lacerations >1 mm require closure by an ophthalmologist, \\nwhereas those <1 mm can heal spontaneously. For medial lid lacerations, \\ninjury to the nasolacrimal duct system should be considered. Fluorescein \\ninstilled into the tear layer that appears in an adjacent laceration confirms \\nthe injury. Nasolacrimal duct injuries, upper lid lacerations that involve the \\nlevator mechanism, and all through-and-through lid lacerations must be \\nrepaired in the operating room. All full-thickness lid lacerations should \\nbe further investigated to rule out an associated corneal laceration and \\nglobe rupture. If an ophthalmologist is not immediately available to evalu-\\nate a high-risk lid laceration, it is not unreasonable to prescribe cephalexin \\n500 mg PO four times daily, erythromycin 2% ointment four times daily, \\nand gentle cold compresses with referral for ophthalmic evaluation within \\n24 hours, as long as any sight-threatening lesions have been excluded.\\nBlunt Eye Trauma\\nAn eye speculum (or two bent paper clips) may be useful in visualization \\nof the bluntly injured eye, but care should be taken to avoid any pressure on \\nthe globe. Once the eye is visualized, the integrity of the globe and visual \\nacuity must be assessed immediately. Red flag signs such as an abnormal \\nanterior chamber depth, an irregular pupil, or blindness indicate a rup-\\ntured globe until proven otherwise, and an emergent ophthalmology referral \\nis indicated. An eye shield should be placed as soon as a globe injury is \\nsuspected to protect against further injury. If there are no hard signs of \\nglobe rupture, a complete eye exam, including slit lamp examination, \\nshould be performed to check for blowout fracture, corneal abrasions, lac-\\nerations, foreign bodies, hyphema, pupillary injury, iritis, and lens disloca-\\ntion. Postseptal hemorrhage can also occur with blunt trauma, especially \\nin those on anticoagulants. Pain, proptosis, impaired extraocular move-\\nments, decreased vision, possible afferent pupillary defect (APD), and \\nelevated IOP are the hallmarks of this condition. Orbital compartment \\n149_Cydulka_Ch149.indd   820 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 839, 'page_label': '821'}, page_content='CHAPTER 149: Eye Emergencies 821 \\nsyndrome may result and may require a lateral canthotomy to alleviate \\nsight-threatening increased IOP. A CT of the orbit is the ED test of choice \\nto confirm the presence of ruptured globe, intraocular foreign body, post-\\nseptal hemorrhage, and orbital fractures, but sensitivity can be as low as \\n70% for occult globe injury; therefore, the involvement of an ophthal-\\nmologist is mandatory for possible surgical exploration in high-risk or \\nsuspicious cases. Traumatic iritis in the absence of a corneal injury can be \\ntreated with prednisolone acetate 1% one drop every 6 hours and \\ncyclopentolate 1% one drop every 8 hours. The care of the blunt trauma \\neye patient should be discussed with an ophthalmologist, and the patient \\nshould follow-up with the ophthalmologist within 48 hours even if no sig-\\nnificant injuries are initially found.\\nHyphema\\nA hyphema is the presence of blood in the anterior chamber and often is a \\nsign of significant trauma. It also can occur spontaneously in sickle cell \\npatients and in patients with coagulopathies. Sight-threatening increases in \\nIOP can occur. In all hyphemas, emergent evaluation by an ophthalmolo-\\ngist is indicated. The patient should be placed either fully upright or \\nhead-of-bead (HOB) to 30° to 45° to allow the blood to settle inferiorly, \\nwhich allows faster improvement of vision and facilitates assessment of \\nthe hyphema size and posterior pole. A protective eye shield should be in \\nplace, except during examination and medication administration. After \\nruptured globe is excluded, the patient should be evaluated for other eye \\ninjuries and treated appropriately. Because of the 30% risk of rebleed in  \\n3 to 5 days and the potential necessity of surgical intervention, any dispo-\\nsition decisions should be made by an ophthalmologist at the bedside, \\nregardless of the size of the hyphema.\\nOrbital Blowout Fractures\\nOrbital blowout fractures commonly involve the inferior wall and medial \\nwall. The resultant entrapment of the inferior rectus muscle may cause \\nrestriction of movement, with a resultant diplopia on upward gaze. Other \\nsigns include paresthesia in the distribution of the infraorbital nerve and \\nsubcutaneous emphysema, particularly when sneezing or blowing the \\nnose. If a blowout fracture is suspected, CT of the orbit with 1.5-mm cuts \\nshould be performed, with additional studies as indicated. Because of the \\nhigh incidence of associated ocular trauma (33%), make an aggressive \\neffort to exclude associated injuries. Antibiotic prophylaxis with cepha-\\nlexin 250 to 500 mg PO four times daily for 10 days is recommended due \\nto sinus involvement. Refer all isolated blowout fractures, with or without \\nentrapment, to an ophthalmologist for a formal dilated exam to rule out \\nretinal injury.\\nPenetrating Trauma or ruptured globe\\nGlobe penetration or rupture is a catastrophic injury that must be identi-\\nfied immediately . Suggestive findings include a severe subconjunctival \\nhemorrhage, shallow or deep anterior chamber as compared with the \\nother eye, hyphema, teardrop-shaped pupil, limitation of extraocular \\nmotility, extrusion of globe contents, or a significant reduction in visual \\n149_Cydulka_Ch149.indd   821 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 840, 'page_label': '822'}, page_content='822 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies \\nacuity. However, it is important to note that penetrating injury from small \\nforeign bodies can present with a nearly normal exam. Therefore, \\nstrongly suspect a penetrating injury when the history of a high-speed for -\\neign body (e.g., the patient was hammering or grinding without eye protec-\\ntion) or a penetrating injury in proximity of the orbit is present. A \\nbright-green streaming appearance to fluorescein instilled into the tear \\nlayer (Seidel test) is pathognomonic, although it may be absent if the \\nwound has sealed. Therefore, the presence of an abrasion with this \\nmechanism does not rule out a penetrating injury. Once a globe injury \\nis suspected, any further manipulation or examination of the eye must be \\navoided. In such cases, place a protective eye shield immediately and \\nplace the patient upright and keep them NPO. Administer broad-spectrum \\nantibiotics with an antiemetic to prevent increased IOP from vomiting. \\nUpdate tetanus status if necessary. In unclear cases, it may be necessary to \\nperform a CT of the orbit to confirm the presence of an orbital foreign body \\nor a ruptured globe. However, as noted above, CT sensitivity can be low for \\noccult globe injury; therefore, an ophthalmologist should be called imme-\\ndiately if a globe rupture or a penetrating injury is strongly suspected.\\nChemical Ocular injury\\nAcid and alkali burns are managed in a similar manner. The eye should be \\nflushed immediately at the scene and sterile normal saline or Ringer lac-\\ntate irrigation solution should be continued in the ED immediately upon \\narrival (even before visual acuities or patient registration) until the pH \\nremains at or near 7.4. A topical anesthetic and a Morgan lens are used in \\nthis procedure. After the first 2 L of irrigation, the pH may be checked in the \\nlower cul-de-sac with litmus paper or the pH square on a urine dipstick 5 to \\n10 minutes after suspending irrigation (to allow time for equilibration). Irri-\\ngation should be continued until a normal pH can be maintained at least 30 \\nminutes after cessation. Irrigation volumes needed to reach normal pH may \\nexceed 8 to 10 L, depending on the caustic substance. A persistently abnor-\\nmal pH should prompt removal of any crystallized particles in the fornices \\nwith a moistened cotton-tipped applicator. Once the pH is normal, the forni-\\nces should be inspected and the eyelids everted to look for any residual \\nparticles and reswept with a moistened cotton-tipped applicator to remove \\nthem and any necrotic conjunctiva. The pH should be rechecked every 10 \\nminutes for 30 minutes to make sure that no additional corrosive is leaching \\nout from the tissues. A thorough slit lamp examination, with lid eversion, \\nshould be done to assess the amount of damage and any associated injuries. \\nIOP should be measured because it can become elevated with significant \\nburns. A cycloplegic (cyclopentolate 1%) one drop three times daily will \\nalleviate ciliary spasm, and erythromycin 0.5% ophthalmic ointment \\napplied every 1 to 2 hours while awake should be prescribed. Most patients \\nwill require opioid pain medications. Update tetanus status if necessary. If \\nthere are signs of a severe injury, such as a pronounced chemosis, conjunc-\\ntival blanching, epithelial defect, corneal edema or opacification, or \\nincreased IOP, the patient should be seen in the ED by an ophthalmologist.  \\nCertain specialized burns, such as those due to hydrofluoric acid, lye, or \\nconcrete, also should be seen by an ophthalmologist immediately. Other -\\nwise, a telephone consult with the ophthalmologist to arrange close follow-\\nup within 24 hours should be obtained for all ocular burns.\\n149_Cydulka_Ch149.indd   822 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 841, 'page_label': '823'}, page_content='CHAPTER 149: Eye Emergencies 823 \\nCyanoacrylate (Super glue or Crazy glue) Exposure\\nCyanoacrylate glue easily adheres to the eyelids and corneal surface. Its \\nprimary morbidity stems from corneal injuries from the hard particles that \\nform. Initial manual removal is facilitated by heavy application of erythro-\\nmycin 0.5% ophthalmic ointment, with special care to avoid damaging \\nunderlying structures. After the easily removable pieces are removed, the \\npatient should be discharged with erythromycin 0.5% ophthalmic oint-\\nment to be applied five times a day to soften the remaining glue. Complete \\nremoval of the residual glue can be accomplished by the ophthalmologist at \\na follow-up visit within 24 hours. Serious injury from this exposure is rare.\\n■ ■ACUTE VISUAL rEDUCTION Or LOSS\\nacute angle Closure glaucoma\\nAcute angle closure glaucoma classically presents with sudden onset of \\nsevere eye pain and/or headache, cloudy vision, colored halos around \\nlights, and vomiting. Acute attacks in patients can be precipitated in \\nmovie theaters, while reading, and after ill-advised use of dilatory agents \\nor inhaled anticholinergics or cocaine. Physical examination may reveal \\nconjunctival injection, corneal clouding, a fixed mid-dilated pupil, and \\nincreased IOP of 40 to 70 mm Hg (normal range, 10 to 20 mm Hg). All \\ncases require immediate ophthalmologic consultation. Simultaneous to \\nthe ophthalmology consult, attempts to decrease the IOP (Table 149-3) \\nshould begin immediately. Place the patient supine. Controlled compara-\\ntive efficacy data are lacking for medical treatment, so treatment recom-\\nmendations vary. However, in general, medications to administer include \\ntimolol 0.5%, apraclonidine 1.0%, and PO acetazolamide 500 mg in the \\nabsence of contraindications (acetazolamide is contraindicated in sickle \\ncell and sulfa allergic patients). If IOP is greater than 50 mm Hg, if vision \\nloss is severe, or if the patient cannot tolerate PO then IV acetazolamide  \\nshould be given instead. If IOP remains ≥ 40 mm Hg 30 minutes after \\ntreatment has begun, mannitol should be considered. Pilocarpine 1% to \\n2% one drop every 15 minutes for two doses in the affected eye and pilo-\\ncarpine 0.5% one drop in the contralateral eye may be given once the IOP \\nTaBlE 149-3 Treatment of Acute Glaucoma\\nTreatment (Wait One Minute Between \\nAdministration of Each Eye Drop) Effect\\nTopical β-blocker (timolol 0.5%), 1 drop Blocks production of aqueous humor\\nTopical α-agonist (apraclonidine 1%), 1 drop Blocks production of aqueous humor\\nCarbonic anhydrase inhibitor (acetazolamide), \\n500 mg IV or PO\\nBlocks production of aqueous humor\\nMannitol, 1 to 2 g/kg IV Reduces volume of aqueous humor\\nRecheck IOP hourly —\\nTopical pilocarpine 1% to 2%, 1 drop every 15 \\nmin for two doses; once IOP is below 40 mm Hg, \\nthen four times daily\\nFacilitates outflow of aqueous humor\\nAbbreviation: IOP , intraocular pressure.\\n149_Cydulka_Ch149.indd   823 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 842, 'page_label': '824'}, page_content='824 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies \\nis below 40 mm Hg, although some experts recommend gi ving pilocar -\\npine immediately upon diagnosis. Symptoms of pain and nausea should \\nbe treated, and the IOP should be monitored hourly. Subsequent treatment \\ndecisions and disposition of the patient should be made by an ophthal-\\nmologist at the bedside.\\nOptic Neuritis\\nOptic neuritis (ON) refers to inflammation at any point along the optic \\nnerve and presents with acute vision loss, with a particular reduction in \\ncolor vision. It is strongly associated with multiple sclerosis (MS), but \\nmany other etiologies exist (e.g., syphilis, tuberculosis, and sarcoidosis). It \\nis often painless, but can sometimes be painful, especially with extraocular \\nmovements. The red desaturation test may be helpful in identifying optic \\nneuropathies. This test is performed by having the patient look with one eye \\nat a time at a dark red object. The affected eye often will see a red object as \\npink or lighter red. An APD often can be detected, and visual field defects \\nmay be present. In anterior ON, the optic disc appears swollen (papillitis); \\nthere are no ophthalmoscopic findings in retrobulbar cases. An ophthal-\\nmologist should direct evaluation and treatment. IV steroids, followed by \\noral steroids, have been shown to accelerate visual recovery and temporar -\\nily reduce the risk of developing MS, but oral steroids alone actually \\nincrease the rate of ON reoccurrence. A new diagnosis of ON should \\nprompt a workup for MS and other causes.\\nCentral retinal artery Occlusion\\nCentral retinal artery occlusion presents as a sudden, painless, severe mon-\\nocular loss of vision, often associated with a history of amaurosis fugax. \\nOcclusion of the central retinal artery will cause complete visual loss, \\nwhereas arterial branch obstruction will cause abrupt loss of a partial visual \\nfield. Classic signs include nearly complete or complete vision loss (94% \\nwith counting fingers to light perception only), a marked APD, superficial \\nopacification or whitening of the retina in the posterior pole, and a bright \\nred macula “cherry red spot.” Segmentation of the blood column in the \\narterioles (“boxcarring”) sometimes can be seen. A thorough evaluation to \\nuncover the etiology (commonly an embolic source—carotid or cardiac, \\nvasculitis, or hypercoagulable state) is required. Giant cell arteritis must be \\nexcluded. An ophthalmologist should be contacted immediately once the \\ndiagnosis is made. In the past, digital massage, acetazolamide, and timolol \\nhave been recommended, but evidence to support these interventions is \\nsparse. Therefore, management should be directed by an ophthalmologist \\nper institutional protocols.\\nCentral retinal Vein Occlusion\\nCentral retinal vein occlusion secondary to thrombosis causes acute, pain-\\nless monocular vision loss. Examination shows optic disc edema, cotton \\nwool spots, and retinal hemorrhages in all four quadrants. This pattern is \\ndescribed as “blood-and-thunder fundus.” APD is often present. There is no \\nimmediate treatment for central retinal vein occlusion, but predisposing \\ndrugs (e.g., oral contraceptives or diuretics) should be discontinued. An \\nophthalmology consult should be obtained.\\n149_Cydulka_Ch149.indd   824 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 843, 'page_label': '825'}, page_content='CHAPTER 149: Eye Emergencies 825 \\nretinal Detachment and Floaters\\nPatients who experience sudden change in their vision due to retinal detach-\\nment or “floaters” in their visual field usually seek medical attention in the \\nED. Bilateral symptoms are almost always intracranial in origin and may \\nbe due to migraine headaches. Monocular symptoms are usually due to \\ndisorders in the symptomatic eye. Retinal detachment typically presents as \\na sudden flashes of light, floaters, or a dark veil or curtain-like defect in the \\npatient’s visual field, affecting the symptomatic eye. Presumptive diagnosis \\ncan be made by bedside ultrasonography. Urgent ophthalmologic consulta-\\ntion is necessary for indirect ophthalmoscopic evaluation, and potentially \\nlaser surgery. In contrast, new “floaters” which are small particles of vitre-\\nous gel appearing to the patient as small hazy opacities need no immediate \\nattention and can be followed up by the ophthalmologist in the office within \\n24 hours for a dilated exam.\\nTemporal arteritis (giant Cell arteritis)\\nTemporal arteritis (TA) is a systemic v asculitis that can cause a painless \\nischemic optic neuropathy. Patients are typically women older than 50 \\nyears, often with a history of polymyalgia rheumatica. Associated symp-\\ntoms include vision changes, headache, jaw claudication, scalp or temporal \\nartery tenderness, fatigue, fever, sore throat, URI symptoms, and anorexia. \\nSymptoms are usually unilateral, but may be bilateral. One-third of the \\ncases are associated with neurologic events such as transient ischemic \\nattacks or stroke. An APD is frequently present, and funduscopic examina-\\ntion may show flame hemorrhages. A sixth cranial nerve palsy may occur. \\nWhen TA is suspected, an erythrocyte sedimentation rate (ESR) and \\nC-reactive protein (CRP) should be ordered; both are elevated in TA, with \\nthe CRP the more sensitive test. Most patients with biopsy-proven cases \\nhave an ESR in the range of 70 to 110 mm/h. If TA is not treated, bilateral \\nvision loss can develop. Therefore, if there is strong suspicion of TA or \\nvision loss is present, the patient should be admitted for methylpredniso-\\nlone 250 mg IV every 6 hours. For less suspicious patients with no vision \\nloss, discharge home with prednisone 80 to 100 mg/d PO with close \\nfollow-up. Steroids should not be delayed pending results of a biopsy. Anti-\\nulcer medications should be prescribed to be given with systemic steroids.\\n■ ■OCULAr ULTrASONOGrAphY\\nOcular ultrasonography can be very useful for the emergent evaluation of \\nthe eye, especially in trauma. Ultrasonography can be useful in the emer -\\ngent diagnosis of retinal detachment, retrobulbar hematoma, lens disloca-\\ntion, vitreous hemorrhage, and elevated intracranial pressure. Care should \\nbe taken to avoid any pressure on the eye or eyelid if globe rupture is sus-\\npected and duration of ocular ultrasonography should be strictly limited.\\n■ ■FUrThEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 241, “Eye Emergencies,” by Richald A.Walker and \\nSrikar Adhikari; Chapter 119, “Eye Emergencies in Infants and Children,” by \\nJaneva Kircher and Andrew Dixon.\\n149_Cydulka_Ch149.indd   825 21/03/17   4:45 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 844, 'page_label': '826'}, page_content='826\\nFace and Jaw Emergencies\\nJeffrey G. Norvell\\n■ ■FACIAL INFECTIONS\\nFacial Cellulitis\\nCellulitis is a soft tissue infection that involves the skin and subcutaneous \\ntissues. Facial cellulitis is most commonly caused by Streptococcus pyo-\\ngenes and Staphylococcus aureus, with an increasing predominance of \\nmethicillin-resistant Staphylococcus aureus (MRSA). Less commonly, cel-\\nlulitis may represent an extension from a deeper facial infection. Cellulitis \\nis characterized by erythema, edema, warmth, pain, and loss of function. \\nClinical features of a well-defined, palpable border are absent.\\nThe diagnosis of cellulitis is clinical. Ultrasound and computed tomog-\\nraphy (CT) may be used to evaluate for abscess or more extensive infection. \\nIn most cases, treatment involves oral antibiotics for 7 to 14 days. Antibi-\\notic recommendations for conditions discussed in this chapter are listed in \\nTables 150-1 and 150-2. Consider hospitalization and parenteral antibiotics \\n150\\nCh A p TE r\\nTablE 150-1 Antibiotic Therapy for Facial Infections\\nCellulitis Oral therapy: clindamycin, dicloxacillin, or cephalosporins\\nSuspected MRSA: trimethoprim-sulfamethoxazole, clindamycin, \\ndoxycycline, or minocycline\\nParenteral therapy: vancomycin, clindamycin\\nTotal duration 7–10 days\\nErysipelas Oral therapy: penicillin\\nMethicillin-sensitive Staphylococcus aureus suspected: amoxicillin/\\nclavulanate, cephalexin, dicloxacillin\\nBullous erysipelas: trimethoprim-sulfamethoxazole, clindamycin, \\ndoxycycline, or minocycline\\nParenteral therapy: vancomycin, nafcillin, clindamycin\\nTotal duration 7–10 days\\nImpetigo Topical: mupirocin or retapamulin ointment alone or with oral therapy\\nOral therapy: dicloxacillin, amoxicillin/clavulanate, cephalexin\\nMRSA suspected: clindamycin or trimethoprim-sulfamethoxazole\\nTotal duration 7 days\\nSuppurative \\nparotitis\\nOral therapy: amoxicillin-clavulanate, clindamycin, or cephalexin and \\nmetronidazole\\nParenteral therapy: nafcillin, ampicillin-sulbactam, or vancomycin with \\nmetronidazole\\nHospital acquired or nursing home patients: include vancomycin\\nTotal duration: 10–14 days\\nMasticator \\nspace infection\\nParenteral therapy: IV clindamycin is recommended; alternatives include \\nampicillin-sulbactam, cefoxitin, or the combination of penicillin with \\nmetronidazole\\nOral therapy: clindamycin or amoxicillin-clavulanate\\nTotal duration: 10–14 days\\nAbbreviation: MRSA, methicillin-resistant Staphylococcus aureus.\\n150_Cydulka_Ch150.indd   826 21/03/17   5:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 845, 'page_label': '827'}, page_content='CHAPTER 150: Face and Jaw Emergencies 827 \\nTablE 150-2 Antibiotic Doses for Facial Infections\\nAntibiotic Dosage\\nTopical antibiotics\\nMupirocin ointment 2%, apply to lesions three times per day\\nRetapamulin ointment 1%, apply to lesions two times per day\\nOral antibiotics\\nAmoxicillin/clavulanate 875/125 mg two times per day\\nCephalexin 500 mg four times per day\\nClindamycin 300–450mg four times per day\\nDicloxacillin 500 mg four times per day\\nDoxycycline 100 mg two times per day\\nMetronidazole 500 mg every 8 hours\\nMinocycline 100 mg two times per day\\nPenicillin V 500 mg four times per day\\nTrimethoprim-sulfamethoxazole 1–2 double-strength tablets two times per day\\nParenteral antibiotics\\nAmpicillin-sulbactam 1.5–3.0 g every 6 hours\\nClindamycin 600 mg every 8 hours\\nCefazolin 1 g every 8 hours\\nMetronidazole 1 g loading dose, then 500 mg every 8 hours\\nNafcillin 1–2 g every 4 hours\\nPenicillin G 2–3 million units every 6 hours\\nVancomycin 1 g every 12 hours\\nfor patients with signs of systemic illness, failed outpatient therapy, or sig-\\nnificant comorbidities.\\nErysipelas\\nErysipelas is a superficial form of cellulitis, involving the epidermis, \\nupper levels of the dermis, and the lymphatic system. Most cases are \\ncaused by S. pyogenes; S. aureus is a rare etiology but is associated with \\nbullous disease, trauma, or the presence of a foreign body. Clinical \\nfeatures include a red, raised, puffy appearance with a sharply defined, \\npalpable border. The diagnosis is clinical. Most patients are treated with \\noral antibiotics, but hospitalization and parenteral antibiotics should be \\nconsidered for patients who fail outpatient therapy, are immunocompro-\\nmised, or exhibit evidence of systemic illness.\\nImpetigo\\nImpetigo is a superficial epidermal infection that can be divided into bul-\\nlous and nonbullous presentations. Bullous impetigo is caused by S. \\naureus and nonbullous impetigo is caused by S. aureus and S. pyogenes. \\nClinical features of nonbullous impetigo include an erythematous rash \\nwith vesicles that break and form the characteristic amber crusts. Bullous \\nimpetigo presents as vesicles that enlarge to form bullae with clear yellow \\n150_Cydulka_Ch150.indd   827 21/03/17   5:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 846, 'page_label': '828'}, page_content='828 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies\\nfluid. Topical therapy with mupirocin is appropriate for simple, nonbul-\\nlous disease. Oral antibiotics are prescribed for more extensive or bullous \\nlesions.\\n■ ■SALIVArY GLAND DISOrDErS\\nViral Parotitis (Mumps)\\nViral parotitis is an infection that can present with unilateral or bilateral \\nswelling of the parotid glands. It is most commonly caused by a paramyxo-\\nvirus. Clinical features may include a prodrome of fever, malaise, myalgias, \\nand headache followed by parotid gland swelling. The gland is tense and \\npainful, but lacks erythema and warmth. Pus cannot be expressed from \\nStensen’s duct.\\nThe diagnosis is clinical and treatment is supportive. Swelling may \\npersist for 5 days. The patient is contagious for approximately 9 days after \\nthe onset of parotid swelling. Extrasalivary gland involvement includes \\norchitis in 20% to 30% of males and oophoritis in 5% of females. Other \\nsystemic complications include pancreatitis, aseptic meningitis, hearing \\nloss, myocarditis, arthritis, hemolytic anemia, and thrombocytopenia. \\nConsider hospitalization for patients with systemic complications.\\nSuppurative Parotitis\\nSuppurative parotitis is a serious bacterial infection that occurs in patients \\nwith diminished salivary flow. Retrograde transmission of bacteria leads to \\ninfection. Factors that lead to decreased salivary flow include recent anes-\\nthesia, dehydration, prematurity, advanced age, medications (e.g., diuretics, \\nβ-blockers, antihistamines, phenothiazines, and tricyclic antidepressants), \\nand certain disorders (Sjögren’s syndrome, diabetes, hypothyroidism, \\ncystic fibrosis, and human immunodeficiency virus). Clinical features may \\ninclude fever, trismus, erythema, and pain over the parotid gland. Pus may \\nbe expressed from Stensen’s duct.\\nThe diagnosis is clinical. Ultrasound or CT may be ordered if an \\nabscess is suspected. Treatment should optimize salivary flow by using \\nsialogogues such as lemon drops and stopping any medications that cause \\ndry mouth. Oral antibiotics are appropriate for those tolerating oral intake \\nand are without trismus. Hospitalization is appropriate for patients with \\nsigns of systemic illness, immunocompromise, inability to tolerate oral \\nintake, or those that have failed outpatient therapy. Close follow-up should \\nbe arranged.\\nSialolithiasis\\nSialolithiasis is the development of stones in a stagnant salivary duct. \\nEighty percent of stones occur in the submandibular duct. Sialolithiasis \\nis typically unilateral and presents with pain, swelling, and tenderness \\nthat may be exacerbated with eating. The diagnosis is clinical. A stone \\nmay be palpated within the duct and the gland is firm. Treatment \\nincludes analgesics, massage, sialogogues such as lemon drops, and \\nantibiotics if a concurrent infection is suspected. Palpable stones may be \\nmilked from the duct. Persistent retained calculi may be removed by an \\notolaryngologist.\\n150_Cydulka_Ch150.indd   828 21/03/17   5:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 847, 'page_label': '829'}, page_content='CHAPTER 150: Face and Jaw Emergencies 829 \\nMasticator Space abscess\\nThe masticator space consists of potential spaces bounded by the mus-\\ncles of mastication. Infection is usually polymicrobial and is commonly \\nassociated with an odontogenic source. Clinical features include f acial \\nswelling, pain, erythema, and trismus. In advanced cases, signs of sepsis \\nmay be present. The diagnosis is made with contrast-enhanced CT scan. \\nBecause the masticator spaces ultimately communicate with tissue \\nplanes that extend into the mediastinum, early treatment is imperative. \\nED treatment includes stabilization, antibiotics, otolaryngology consult, \\nand hospitalization.\\n■ ■MANDIBLE DISOrDErS\\nTemporomandibular Joint Dysfunction\\nThe temporomandibular joint (TMJ) combines a hinge and a gliding action. \\nAnatomic derangements or systemic disease can cause dysfunction of this \\njoint. Clinical features include pain over the muscles of mastication or in \\nthe region of the TMJ and there may be a limited range of motion. The \\ndiagnosis is usually clinical. For patients with acute trauma, imaging with \\nCT or panoramic x-ray may be warranted. Treatment for nontraumatic \\nconditions consists of analgesics, soft diet, and referral to a dental special-\\nist. An oral and maxillofacial surgeon manages fractures.\\nTrigeminal Neuralgia\\nTrigeminal neuralgia presents with facial pain in the distribution of the fifth \\ncranial nerve. It is characterized by paroxysms of severe pain lasting \\nseconds, with normal findings on physical exam. Carbamazepine, starting \\nat 100 mg PO twice a day and then increasing dosage as needed, is an \\neffective treatment.\\nbell’s Palsy\\nBell’s palsy is characterized by an acute onset of unilateral upper and  \\nlower facial paralysis. A detailed neurologic exam is useful in ruling out \\nother conditions, such as stroke. Sparing of the forehead muscles on the \\naffected side is suggestive of a central process. Examine the ear for pres-\\nence of cranial herpes zoster. Treatment with steroids within the first 72 \\nhours of symptom onset is thought to improve chances of a full recovery. \\nThe recommended dosing is 1 mg/kg of prednisone or equivalent, up to  \\n60 mg/d, for 6 days followed by a 10-day taper. The use of antivirals is \\ncontroversial and benefit modest at best. Ocular lubricants should be used \\nto prevent dry eyes.\\nDislocation of the Mandible\\nThe mandible can be dislocated in an anterior, posterior, lateral, or superior \\nposition. Anterior dislocation is the most common. Patients with an acute \\njaw dislocation present with pain, difficulty swallowing, and malocclusion. \\nIn anterior dislocations, a history of extreme mouth opening is typical and \\nthere is difficulty with jaw movement. Other dislocations usually require \\nsignificant trauma.\\n150_Cydulka_Ch150.indd   829 21/03/17   5:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 848, 'page_label': '830'}, page_content='830 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies\\nThe diagnosis of atraumatic anterior dislocations is clinical. Imaging \\nwith panoramic x-ray or CT is indicated for all other dislocations. Treat -\\nment of anterior dislocations without fracture is closed reduction and this is \\nmade easier with analgesia, muscle relaxants, or procedural sedation. \\nReduction is most commonly done in a seated patient. The thumbs are pad-\\nded with gauze, placed over the molars, and pressure is applied downward \\nand backward. Patients with open or nonreducible dislocations, fractures, \\nor nerve injury should be referred emergently to an oral and maxillofacial \\nsurgeon. After reduction, patients should be instructed to not open their \\nmouth more than 2 cm for 2 weeks. Elective referral to an oral and maxil-\\nlofacial surgeon is recommended.\\n■ ■FUrThEr rEADING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 243, “Face and Jaw Emergencies,” by Stephanie A. \\nLareau and Corey R. Heitz.\\n150_Cydulka_Ch150.indd   830 21/03/17   5:01 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 849, 'page_label': '831'}, page_content='831\\nEar, Nose, and Sinus \\nEmergencies\\nMichael E. Vrablik\\n■ ■OTOLOGIC EMERGENCIES\\nOtitis Externa\\nOtitis externa, or “swimmer’s ear,” is characterized by pruritus, pain, and \\ntenderness of the external ear. Erythema and edema of the external auditory \\ncanal, otorrhea, crusting, and hearing impairment may also be present. Pain \\nis elicited with movement of the pinna or tragus. Risk factors for develop-\\nment of otitis externa include swimming, trauma of the external canal, and \\nany process that elevates the pH of the canal.\\nThe most common organisms implicated in otitis externa are Pseudomo-\\nnas aeruginosa, Enterobacteriaceae and Proteus species, and Staphylococcus \\naureus, with P . aeruginosa being the most common organism causing malig-\\nnant otitis externa. Otomycosis, or fungal otitis externa, is found in tropical \\nclimates and in the immunocompromised or subsequent to long-term antibi-\\notic therapy. Aspergillus and Candida are the most common fungal pathogens.\\nThe treatment of otitis externa includes analgesics, cleaning the external \\nauditory canal, acidifying agents, topical antimicrobials, and occasionally \\ntopical steroid preparations. Cleansing can be performed with irrigation of \\nthe canal using hydrogen peroxide in a 1:1 dilution with warm saline or \\nwater or with gentle suction under visualization. Ofloxacin otic 5 drops \\ntwo times daily, acetic acid/hydrocortisone otic 5 drops three times daily \\n(do not use with perforated TM), and ciprofloxacin/hydrocortisone otic 3 \\ndrops two times daily are commonly used for 7 days to treat otitis externa. \\nIf significant swelling of the external canal is present, a wick or piece of \\ngauze may be inserted into the canal to allow passage of topical medica-\\ntions. Oral antibiotics are not indicated as first-line agents unless fever or \\nperiauricular spread is present.\\nMalignant otitis externa is a potentially life-threatening infection of the \\nexternal auditory canal with variable extension to the skull base (osteomy-\\nelitis). Historically, greater than 90% of cases were caused by Pseudomo-\\nnas aeruginosa; however, 15% are now caused by methicillin-resistant \\nStaphylococcus aureus (MRSA). Elderly, diabetic, and immunocompro-\\nmised patients are most commonly affected. Diagnosis of malignant otitis \\nexterna requires a high index of suspicion. Computed tomography (CT) is \\nnecessary to determine the extent and stage of the disease. Emergent oto-\\nlaryngology (ENT) consultation, tobramycin 2 mg/kg IV and piperacillin \\n3.375 to 4.5 g IV , or ceftriaxone 1 g IV , or ciprofloxacin 400 mg IV , and \\nadmission to the hospital are needed.\\nOtitis Media\\nThe incidence and prevalence of otitis media (OM) peak in the preschool \\nyears and decline with advancing age. The most common bacterial patho-\\ngens in acute OM are Streptococcus pneumoniae, Haemophilus influenzae, \\n151\\nChap TER\\n151_Cydulka_Ch151.indd   831 21/03/17   5:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 850, 'page_label': '832'}, page_content='832 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies\\nand Moraxella catarrhalis. The predominant organisms involved in chronic \\nOM are Staphylococcus aureus, Pseudomonas aeruginosa, and anaerobic \\nbacteria.\\nPatients with OM present with otalgia, with or without fever; occasion-\\nally, hearing loss and otorrhea are present. The tympanic membrane (TM) \\nmay be retracted or bulging and will have impaired mobility on pneumatic \\notoscopy. The TM may appear red as a result of inflammation or may be \\nyellow or white due to middle-ear secretions. Additionally, assessment of \\nthe facial nerve should be performed.\\nIn the pediatric population the “wait-and-see” method can be used; \\nhowever, this treatment plan has not been studied in adults. For adults, a \\n10-day course of amoxicillin 250 to 500 mg PO three times daily for 7 to \\n10 days is the preferred initial treatment for OM. Alternative agents include \\nazithromycin 500 mg PO daily for 1 day then 250 mg PO daily for 4 days, \\nor cefuroxime 500 mg PO two times daily for 10 days. Cefuroxime or \\namoxicillin/clavulanate may be given for OM unresponsive to first-line \\ntherapy after 72 hours. Antibiotic coverage should be extended to 3 weeks \\nfor patients with OM with effusion. Analgesics should be prescribed for \\npatients with any degree of pain. Patients should follow-up with a primary \\ncare physician for reexamination and to assess the effectiveness of therapy.\\nComplications of OM include TM perforation, conductive hearing loss, \\nacute serous labyrinthitis, facial nerve paralysis, acute mastoiditis, lateral \\nsinus thrombosis, cholesteatoma, and intracranial complications. TM per -\\nforation and conductive hearing loss are most often self-limiting and often \\nrequire no specific intervention. Facial nerve paralysis is uncommon but \\nrequires emergent ENT consultation.\\nAcute Mastoiditis\\nAcute mastoiditis occurs as infection spreads from the middle ear to the \\nmastoid air cells. Patients present with otalgia, fever, and postauricular \\nerythema, swelling, and tenderness. Protrusion of the auricle with oblitera-\\ntion of the postauricular crease may be present. CT will delineate the extent \\nof bony involvement. Emergent ENT consultation, vancomycin 1 to 2 g IV \\nor ceftriaxone 1 g IV , and admission to the hospital are necessary. Surgical \\ndrainage ultimately may be required.\\nLateral Sinus Thrombosis\\nThis condition arises from extension of infection and inflammation into the \\nlateral and sigmoid sinuses. Headache is common and papilledema, sixth \\nnerve palsy, and vertigo may be present. Diagnosis may be made with CT, \\nalthough magnetic resonance imaging or angiography is more sensitive and \\nmay be necessary. Therapy consists of emergent ENT consultation, combi-\\nnation therapy with nafcillin 2 g IV , ceftriaxone 1 g IV , and metronidazole \\n500 mg IV , and hospital admission.\\nBullous Myringitis\\nBullous myringitis is a painful condition of the ear characterized by bulla \\non the TM and deep external auditory canal (EAC). Numerous pathogens \\nhave been implicated including viruses, Mycoplasma pneumoniae, and \\nChlamydia psittaci. The diagnosis is made by clinical examination. The \\n151_Cydulka_Ch151.indd   832 21/03/17   5:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 851, 'page_label': '833'}, page_content='CHAPTER 151: Ear, Nose, and Sinus Emergencies 833 \\ntreatment consists of pain control and warm compresses. Antibiotics can be \\ngiven for concomitant OM.\\nTrauma to the Ear\\nA hematoma can develop from any type of trauma to the ear. Improper \\ntreatment of ear hematomas can result in stimulation of the perichondrium \\nand development of asymmetric cartilage formation. The resultant deformed \\nauricle has been termed “cauliflower ear.” Immediate incision and drainage \\nof the hematoma with a compressive dressing is necessary to prevent reac-\\ncumulation of the hematoma. Antibiotic coverage for P . aeruginosa and S. \\naureus should be given to immunocompromised patients.\\nThermal injury to the auricle may be caused by excessive heat or cold. \\nSuperficial injury of either type is treated with cleaning, topical nonsulfa-\\ncontaining antibiotic ointment, and a light dressing. Frostbite is treated with \\nrapid rewarming by using saline soaked gauze at 38°C to 40°C. The \\nrewarming process may be very painful and analgesics will be necessary. \\nAny second- or third-degree burn requires immediate ENT or burn center \\nconsultation.\\nForeign Bodies in the Ear\\nOn examination, the foreign body is usually visualized and signs of infec-\\ntion or TM perforation should be sought. Live insects should be immobi-\\nlized with 2% lidocaine solution distilled into the ear canal before removal. \\nForeign bodies may be removed with forceps and direct visualization or \\nwith the aid of a hooked probe or suction catheter. Irrigation is often useful \\nfor small objects; however, organic material may absorb water and swell. \\nENT consultation is required for cases of foreign body with TM perforation \\nor if the object cannot be safely removed.\\nCerumen Impaction\\nCerumen impaction can cause symptoms of hearing loss, pressure, dizzi-\\nness, tinnitus and otalgia. Impaction is often precipitated by the use of \\ncotton swabs in the ear canal. Cerumen scoops/loops can be used to remove \\nthe impaction. If significant amounts of cerumen are in the canal then half-\\nstrength hydrogen peroxide, sodium bicarbonate, mineral oil, or carb-\\namide peroxide otic can be instilled in the canal to soften the cerumen and \\nhelp with removal. Additionally cerumen impactions can be removed with \\nirrigation of the EAC using body-temperature fluid via an 18ga IV catheter \\nor ear syringe making sure that the irrigation is directed to the EAC wall \\nnot the TM. Cerumen removal in the emergency department (ED) is often \\nnot required; asymptomatic or minimally symptomatic patients with ceru-\\nmen impaction may be safely discharged home with a cerumen-softening \\notic and follow-up.\\nTympanic Membrane Perforation\\nTM perforations can result from middle-ear infections, barotrauma, blunt/\\npenetrating/acoustic trauma, and, rarely, lightning strikes. Acute pain and \\nhearing loss are usually noted, with or without bloody otorrhea. Vertigo \\nand tinnitus, when present, are usually transient. As most TM perforations \\nheal spontaneously, antibiotics are not necessary unless there is persistent \\n151_Cydulka_Ch151.indd   833 21/03/17   5:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 852, 'page_label': '834'}, page_content='834 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies\\nforeign material in the canal or middle ear. Patients with perforations from  \\nisolated blunt or noise trauma can be discharged with expedited specialty \\nreferral and should be instructed not to allow water to enter the ear canal.\\nTinnitus\\nTinnitus is the perception of sound without external stimuli. It may be con-\\nstant, pulsatile, high or low pitched, hissing, clicking, or ringing in nature. \\nObjective tinnitus can be heard by the examiner, whereas the more common \\nsubjective tinnitus cannot. Causes of tinnitus include vascular, mechanical, \\nneurologic, Ménière’s disease, and others. Common medications resulting \\nin tinnitus include aspirin, nonsteroidal anti-inflammatory drugs, aminogly-\\ncosides, loop diuretics, and chemotherapeutics. If the patient’s condition \\nallows, potentially offending drugs should be stopped. Accurate diagnosis \\nusually requires referral to an otolaryngologist.\\nHearing Loss\\nCauses of sudden hearing loss are varied and may be idiopathic (most com-\\nmon), infectious, vascular or hematologic, metabolic, rheumatologic, or \\nconductive. Other causes include Ménière’s disease, Cogan’s syndrome, \\nacoustic neuroma, cochlear rupture, and ototoxic medications. Indicators of \\npoor prognosis include severe hearing loss on presentation and the presence \\nof vertigo. If the cause is not readily determined by history and physical \\nexamination, otolaryngologic consultation is necessary.\\n■ ■NaSaL EMERGENCIES aND SINUSITIS\\nEpistaxis\\nEpistaxis is classified as anterior or posterior. Posterior epistaxis is sug-\\ngested if an anterior source is not visualized, if bleeding occurs from both \\nnares, or if blood is seen draining into the posterior pharynx after anterior \\nsources have been controlled.\\n1. Perform a quick history to determine the duration and severity of the \\nhemorrhage and the contributing f actors (trauma, anticoagulant use, in-\\nfection, bleeding diathesis, etc.).\\n2. Have the patient blow his or her nose to dislodge an y clots. Instill \\n0.05% oxymetazoline 2 sprays/nostril or 0.25% phenylephrine   \\n2 sprays/nostril.\\n3. Inspect for anterior bleeding using a good light source, a nasal specu-\\nlum, and a suction catheter.\\n4. Apply direct external pressure to the cartilage just distal to the nasal \\nbones for 15 minutes while leaning forward in the “sniff ing” position. \\nReexamine the patient. Repeat once if necessary.\\n5. If bleeding continues, and an anterior source of bleeding is visualized, \\nproceed to chemical cautery. If no source is identified, proceed to  \\npacking.\\n6. Chemical cautery with silver nitrate is the standard of care for ED treat-\\nment of anterior epistaxis. Insert cotton swabs or pledgets soaked in a \\n1:1 mixture of a 4% lidocaine and 0.05% oxymetazoline into the nasal \\ncavity with bayonet forceps. After hemostasis is achieved, the mucosa is \\ncauterized by firmly rolling the tip of a silver nitrate applicator over the \\n151_Cydulka_Ch151.indd   834 21/03/17   5:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 853, 'page_label': '835'}, page_content='CHAPTER 151: Ear, Nose, and Sinus Emergencies 835 \\narea until it turns silvery-black. A small surrounding area also should be \\ncauterized to control local arterioles. Overzealous use of cautery and \\nbilateral septal cautery is discouraged because they may cause septal \\nperforation and unintended local tissue necrosis.\\n7. Anterior nasal packing may be performed with thrombogenic foams and \\ngels, commercial devices, or gauze. Dehydrated nasal sponges are avail-\\nable in several lengths to control anterior and posterior epistaxis. A film \\nof antibiotic ointment is applied, then the sponge is rapidly inserted \\nalong the floor of the nasal cavity where it expands upon contact with \\nblood or secretions. Expansion can be hastened by rehydrating the \\nsponge with sterile water from a catheter-tipped syringe. The longer \\nsponges used to control posterior hemorrhages have been associated \\nwith some morbidity and should be used only for posterior epistaxis. \\nInflatable epistaxis tamponade balloons can also be used to control ante-\\nrior and/or posterior hemorrhage, are easy to use, and are generally more \\ncomfortable than nasal sponges. Thrombogenic foams and gels are bio-\\nabsorbable, do not require removal, and are generally well tolerated. All \\nnonabsorbable nasal packs should be removed in 2 to 3 days by an ENT \\nphysician. Tranexamic acid 5 mL (500 mg) applied to the nasal mucosa \\nvia a 15-cm cotton pledget can also be used to stop epistaxis. If packing \\nor local cautery fails to control anterior bleeding, ENT consultation is \\nnecessary.\\n8. Posterior epistaxis may be treated with a dehydrated posterior sponge \\npack, as outlined above, or an inflatable balloon tamponade device. The \\nballoon devices use independently inflatable anterior and posterior bal-\\nloons to quickly control refractory epistaxis at these sites; the instruc-\\ntions for insertion are included in the balloon kit. To protect against \\npotentially serious complications, all patients with posterior packs \\nrequire ENT consultation for possible hospital admission. Posterior \\npacks are removed 2 to 3 days after placement.\\n9. All patients with nasal packs should be started on antibiotic prophylaxis \\nwith amoxicillin/clavulanate 500/125 mg PO three times daily.\\nComplications of nasal packing include vasovagal syncope, dislodg-\\nment of the pack, recurrent bleeding, sinusitis, and toxic shock syn-\\ndrome. Treatment of elevated blood pressure during an acute episode of \\nepistaxis is generally not advised except in consultation with an otolar -\\nyngologist for cases of persistent epistaxis not controlled by the above \\nmeasures.\\nNasal Fractures\\nNasal fracture is a clinical diagnosis suggested by the injury mechanism, \\nswelling, tenderness, crepitance, gross deformity, and periorbital ecchymo-\\nsis. Radiographic diagnosis usually is not necessary in the ED. Intermittent \\nice application, analgesics, and over-the-counter decongestants are the \\nnormal treatment. ENT follow-up within 6 to 10 days for reexamination \\nand possible fracture reduction is prudent.\\nA fracture of the cribriform plate may violate the subarachnoid space \\nand cause cerebrospinal fluid rhinorrhea. Symptoms may be delayed for \\nseveral weeks. If a cribriform plate injury is suspected, CT and immediate \\nneurosurgical consultation should be obtained.\\n151_Cydulka_Ch151.indd   835 21/03/17   5:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 854, 'page_label': '836'}, page_content='836 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies\\nNasal Septal Hematoma\\nA nasal septal hematoma should be suspected whenever there is trauma to \\nthe nose. A thorough evaluation of the nasal septum, with good lighting, \\nshould be performed. The septum should be visualized and palpated to \\nassess for a hematoma. A nasal septal hematoma elevates the vascular peri-\\nchondrium off of the cartilage thus disrupting the blood supply. It is impor-\\ntant to remove the hematoma to return blood supply and prevent ischemic \\nnecrosis of the septum. If a nasal septal hematoma is identified then evacu-\\nation of the hematoma is necessary.\\n1. Place patient in “sniffing position” and examine the anterior nares with \\na nasal speculum under good lighting. Have suction, irrigation, and nasal \\npacking materials ready.\\n2. Anesthetize the nasal mucosa by placing cotton pledgets soaked in 4% \\nlidocaine into the affected nare. Inf iltrative anesthesia of lidocaine \\nwithout epinephrine can be administered if needed.\\n3. Visualize the hematoma and make a horizontal incision through the \\nmucosa, avoid incising the cartilage.\\n4. Remove the hematoma.\\n5. Insert bilateral anterior nasal packing coated in antibiotic ointment.\\n6. Prescribe prophylactic antibiotics (amoxicillin/clavulanate 500/125 mg \\nPO three times daily) if the nasal packing will be in for greater than  \\n24 hours.\\n7. Patients should follow up with ENT.\\nNasal Foreign Bodies\\nNasal foreign bodies should be suspected in patients with unilateral nasal \\nobstruction, foul rhinorrhea, or persistent unilateral epistaxis. After topical \\nvasoconstriction with 0.05% oxymetazoline and possibly local anesthesia \\nwith 4% nebulized lidocaine, the foreign body should be removed under \\ndirect visualization. Tools for removal include forceps, suction catheters, \\nhooked probes, and balloon-tipped catheters. Consult ENT if removal is \\nunsuccessful.\\nSinusitis and Rhinosinusitis\\nSinusitis is inflammation of the mucosal lining of the paranasal sinuses \\n(maxillary, frontal, ethmoid). Rhinosinusitis is sinusitis also involving the \\nnasal cavity, almost always involves rhinitis, and is extremely common. It \\ncan be classified as acute, subacute, or chronic.\\nSymptoms include nasal congestion or blockage, facial pain or pressure, \\nhyposmia, nasal discharge, tooth pain, fever, and sinus pressure with head/\\nbody movement. There may be pain and tenderness with sinus percussion, \\nmucosal swelling, facial swelling, and redness.\\nComplications include meningitis, cavernous sinus thrombosis, intra-\\ncranial abscess and empyema, orbital cellulitis, and osteomyelitis. Patients \\nwith these deeper complications usually appear systemically ill or have \\nfocal neurologic findings.\\nThe diagnosis of uncomplicated acute rhinosinusitis is clinical, and \\nimaging is not necessary. CT scans are helpful in evaluating toxic patients \\nand possible intracranial extension. Patients with chronic rhinosinusitis or \\n151_Cydulka_Ch151.indd   836 21/03/17   5:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 855, 'page_label': '837'}, page_content='CHAPTER 151: Ear, Nose, and Sinus Emergencies 837 \\nrecurrent acute rhinosinusitis warrant bacterial cultures and a sinus CT, \\npreferably as an outpatient.\\nTreatment for acute uncomplicated disease is generally supporti ve. \\nNasal irrigation with or without nasal decongestants (0.05% oxymetazo-\\nline 2 sprays/nostril two times daily or 0.25% phenylephrine 2 sprays/\\nnostril four times daily) is first-line therapy. Decongestant’s use is to be \\nlimited to less than or equal to 3 days. Oral antibiotics should be reserved \\nfor patients with purulent nasal secretions and severe symptoms for more \\nthan 10 days. If prescribed, choices for a 10-day antibiotic regimen include \\namoxicillin 500 mg PO three times daily (first-line), trimethoprim/sulfa-\\nmethoxazole 160/800 mg two times daily or erythromycin 250 to 500 mg \\ntwo times daily (if penicillin allergic), and levofloxacin 500 mg daily (if \\nantibiotics in prior 6 weeks).\\n■ ■FURThER REaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 242, “Ear Disorders,” by Kathleen Hosmer; \\nChapter 244, “Nose and Sinuses,” by Henderson D.McGinnis.\\n151_Cydulka_Ch151.indd   837 21/03/17   5:58 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 856, 'page_label': '838'}, page_content='838\\nOral and Dental Emergencies\\nSteven Go \\n■ ■DENTAL ANATOMY\\nThe relevant dental anatomy is shown in Figure 152-1.\\n■ ■OROFACIAL PAIN\\nTooth Eruption and Pericoronitis\\nEruption of the primary teeth (“teething”) in children may be the primary \\ncause of pain, irritability, and drooling, but NOT fever and diarrhea; there-\\nfore, other causes of these latter symptoms must be excluded. Give the \\nchild a frozen, damp towel to suck on and acetaminophen 15 mg/kg \\norally (PO) every 6 hours to control symptoms. Topical anesthetics should \\n152\\nCh APTER\\nPermanent \\nmaxillary\\nright first molar\\nPermanent \\nmandibular\\nright third molar\\nPermanent maxillary\\nleft second premolar\\nPermanent \\nmandibular\\nleft canine\\nPrimary Teeth\\nPrimary \\nmaxillary\\nright first molar\\nPrimary maxillary\\nleft second molar\\nPrimary mandibular\\nleft caninePrimary \\nmandibular\\nright lateral incisor\\n1\\n10\\n11\\n12\\n2\\n13\\n3\\n4\\n5\\n6\\n7 89\\n14\\n15\\n16\\n17\\n18\\n19\\n20\\n21\\n222324252627\\n28\\n29\\n30\\n31\\n32\\nA\\nB\\nC\\nD E F G\\nH\\nI\\nJ\\nK\\nL\\nMNOPQ\\nR\\nS\\nT\\nPermanent Teeth\\nPatient’s right Patient’s left\\nFigurE 152-1. Identification of teeth.\\n152_Cydulka_Ch152.indd   838 22/03/17   9:33 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 857, 'page_label': '839'}, page_content='CHAPTER 152: Oral and Dental Emergencies 839 \\nbe used with great caution in young infants due to its potential to depress \\nthe gag reflex.\\nAdults and teens may experience pericoronitis (pain and local inflam-\\nmation) with the eruption of the third molars (“wisdom teeth”). Prescribe \\npenicillin VK 500 mg PO four times daily or clindamycin 300 mg PO four \\ntimes daily, ibuprofen 400 to 800 mg PO three times daily (with or without \\nhydrocodone 5 mg/acetaminophen 325 mg one to two tablets PO four \\ntimes daily), and warm saline mouth rinses. Refer the patient to an oral \\nsurgeon or a general dentist for consideration of third molar extraction.\\nDental Caries and Pulpitis\\nDental caries are caused by bacteriogenic acid eroding through the enamel. \\nExamination may reveal a grossly decayed tooth, although occasionally \\nthere is no visible pathology—in these cases, localization may be accom-\\nplished by percussing individual teeth with a metallic object. If dental car -\\nies are not treated, pulpitis is the result. Reversible pulpitis is characterized \\nby sudden, transient pain lasting seconds, often triggered by heat or cold. \\nIn contrast irreversible pulpitis pain lasts minutes to hours. Although anti-\\nbiotics such as penicillin VK 500 mg PO four times daily or clindamycin \\n300 mg PO four times daily are commonly prescribed for pulpitis, their \\nefficacy is controversial. Treat with ibuprofen 400 to 800 mg PO three \\ntimes daily, hydrocodone 5 mg/acetaminophen 325 mg one to two tablets \\nPO four times daily, and warm saline mouth rinses. A dental block may \\nalso be performed for short-term pain relief. Refer to a dentist for definitive \\nmanagement. If an abscess is present, antibiotics and incision and drainage \\nshould be considered.\\nFacial Space infections\\nOdontogenic infections can spread readily to the facial spaces. Therefore, \\nit is imperative to exclude deep-space involvement whenever a dental infec-\\ntion is encountered. Ludwig’s angina is a cellulitis involving both subman-\\ndibular spaces and the sublingual space that can spread to the neck and \\nmediastinum, causing airway compromise, overwhelming infection, and \\neven death. If dental infections spread to the infraorbital space, a cavernous \\nsinus thrombosis may result. This condition may present with limitation of \\nlateral gaze, meningeal signs, sepsis, and coma. Administer intravenous \\nantibiotics and obtain emergent surgical consultation for both conditions, \\nwith anticoagulation added for cavernous sinus thrombosis.\\nPostextraction Pain and Postextraction Alveolar Osteitis (Dry Socket)\\nPain experienced within 24 to 48 hours after a tooth extraction responds \\nwell to icepacks, head elevation, and analgesics. Postextraction alveolar \\nosteitis (“dry socket”) occurs 48 to 72 hours postoperatively when the clot \\nfrom the socket is displaced. It is associated with smoking, carbonated \\nbeverage consumption, and drinking with straws. It presents with severe \\npain along with foul odor and taste. Perform gentle saline or 0.12% \\nchlorhexidine irrigation of the socket, followed by packing the socket \\nwith eugenol-impregnated gauze, which will relieve the pain. Prescribe \\npenicillin VK 500 mg PO four times daily or clindamycin 300 mg PO four \\ntimes daily in severe cases, along with analgesia, daily packing changes, \\n152_Cydulka_Ch152.indd   839 22/03/17   9:33 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 858, 'page_label': '840'}, page_content='840 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies\\ngentle 0.12% chlorhexidine mouth rinses twice daily, and dental follo w-\\nup in 24 hours.\\nPostextraction Bleeding\\nControl bleeding after dental extraction by instructing the patient to bite on \\ngauze positioned over the bleeding site for 20 minutes. If bleeding persists, \\npack the socket with Gelfoam®, Avitene®, or Surgicel®. Loosely approximat-\\ning sutures can be used to hold these packing agents in place. Other emergency \\ndepartment (ED) treatments may include local injection of 1% lidocaine with \\nepinephrine or careful silver nitrate application. Failure of these measures \\nwarrants a screening coagulation profile and consultation with an oral surgeon.\\nPeriodontal Abscess\\nA periodontal abscess results from plaque and debris entrapped between \\nthe tooth and gingiva. For small abscesses, administer penicillin VK 500 \\nmg PO four times daily or clindamycin 300 mg PO four times daily, anal-\\ngesics, and short-term 0.12% chlorhexidine mouth rinses twice daily. \\nLarger abscesses require incision and drainage. All patients need prompt \\ndental referral.\\nAcute Necrotizing ulcerative gingivitis\\nAcute necrotizing ulcerative gingivitis (ANUG) presents with pain, ulcerated \\nor “punched out” interdental papillae, gingival bleeding, foul taste, lymph-\\nadenopathy, and fever. The associated putrid breath gives this disorder its \\nnickname of “trench mouth.” It occurs mainly in young patients with com-\\npromised resistance to infection due to HIV , stress, malnourishment, sub-\\nstance abuse, and various infections. Prescribe metronidazole 500 mg PO \\nthree times daily and 0.12% chlorhexidine mouth rinses twice daily, along \\nwith a protein-rich soft diet, multivitamins, and PO fluids. Symptomatic \\nimprovement is typically dramatic within 24 hours, and the patient should be \\nreferred for dental debridement, scaling, and workup of predisposing factors.\\nPeri-implantitis\\nDental implants are being increasingly used to replace teeth. If they become \\ninfected, they present similarly to a periodontal abscess. Irrigate around the \\nimplant with 0.12% chlorhexidine solution and administer metronidazole \\n500 mg PO three times daily or amoxicillin 500 mg PO three times daily \\nfor 10 days. Prescribe analgesics and refer the patient to a dentist for \\ndefinitive management.\\n■ ■SOFT TISSUE LESIONS OF ThE ORAL CAVITY\\nAphthous Stomatitis\\nAphthous stomatitis, or aphthous ulcer, presents with painful lesions, which \\nare frequently multiple, involve the labial and buccal mucosa, and measure \\nfrom 2 mm to several centimeters in diameter. Treat with 0.1% triamcino-\\nlone acetonide dental paste (Kenalog ® in Orobase ®) applied topically to \\nlesions two to three times a day or 0.12% chlorhexidine applied topically \\ntwice a day. The lesions often heal within 7 to 10 days.\\n152_Cydulka_Ch152.indd   840 22/03/17   9:33 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 859, 'page_label': '841'}, page_content='CHAPTER 152: Oral and Dental Emergencies 841 \\nOral Cancer\\nEmergency physicians should be vigilant for oral cancers and their precur -\\nsors because early diagnosis is associated with impro ved outcomes. Can-\\ncers can present early as leukoplakia (nonremovable white mucosal \\npatches) and erythroplakia (red patch that cannot be classified as any other \\ndisease). The most common site for oral cancer to develop is the postero-\\nlateral border of the tongue. Symptoms and signs of oral cancer include \\npain, paresthesias, persistent ulcers, bleeding, lesion rigidity, induration, \\nlymphadenopathy, and functional impairment. Refer all suspicious lesions \\nor lesions that persist >14 days despite treatment for urgent follow-up with \\nan oral surgeon for biopsy.\\n■ ■OROFACIAL TRAUMA\\nDental Fractures\\nThe Ellis system is used to classify the anatomy of fractured teeth. Ellis \\nclass 1 fractures solely involve the enamel. These injuries may be smoothed \\nwith an emery board or referred to a dentist for cosmetic repair. Ellis class \\n2 fractures reveal the creamy yellow dentin underneath the white enamel. \\nThe patient complains of air and temperature sensitivities. To decrease \\npulpal contamination, dry the dentin and promptly cover the lesion with \\ncalcium hydroxide paste or glass ionomer cement. All patients should see \\na dentist within 24 hours. Ellis class 3 fractures are tooth-threatening frac-\\ntures that involve the pulp and can be identified by a red blush in the exposed \\ndentin or a visible drop of blood after wiping the tooth. Apply a thin layer of \\ncalcium hydroxide paste to cover the pulp, followed by an overlying layer \\nof glass ionomer cement to completely cover the patch and dentin as well. \\nIdeally, a dentist should evaluate the patient in the ED, but if the amount of \\nexposed pulp is very small, the patched lesion can be evaluated by a dentist \\nwithin 24 hours. Oral analgesics may be needed, but topical anesthetics are \\ncontraindicated. The use of prophylactic antibiotics is controversial.\\nConcussions, Luxations, and Avulsions\\nConcussion injuries involve posttraumatic tenderness to percussion with no \\nmobility. Posttraumatic mobility without evidence of dislodgment is called \\nsubluxation, which has a higher incidence of future pulp necrosis. Prescribe \\nnonsteroidal anti-inflammatory drugs (NSAIDs) and soft diet, and refer \\nurgently to a dentist to rule out a more severe injury.\\nExtrusive luxation occurs when a tooth is partly avulsed out from the \\nalveolar bone. Treatment involves gentle repositioning of the tooth to its \\noriginal location (often with the aid of a dental block) and splinting with \\nzinc oxide periodontal dressing. A dentist should evaluate these patients \\nwithin 24 hours. When the tooth is laterally displaced with a fracture of the \\nalveolar bone, the condition is called lateral luxation. Although manual \\nrelocation is possible, the treatment of such injuries is best done in consulta-\\ntion with a dentist. If the alveolar bone fracture is significant, splinting by a \\ndentist in the ED is required. An intrusive luxation occurs when the tooth is \\nforced below the gingiva and often has a poor outcome. For all luxations, \\nprescribe a soft diet, meticulous oral hygiene, and 0.12% chlorhexidine \\nmouth rinses twice daily, and refer to a dentist to be seen within 24 hours.\\n152_Cydulka_Ch152.indd   841 22/03/17   9:33 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 860, 'page_label': '842'}, page_content='842 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies\\nDental avulsion is a bona fide dental emergency in which a tooth has \\nbeen completely removed from the socket. Primary teeth in children  \\nare NOT replaced because of potential damage to the permanent teeth  \\n(Fig. 152-2).\\nReplant permanent teeth that have been avulsed for less than 3 hours \\nimmediately to attempt to save the periodontal ligament fibers. At the \\nscene, handle an avulsed tooth by the crown only, rinse with water <10 \\nseconds, and replant immediately. If replantation at the scene is not pos-\\nsible due to risk of aspiration, rinse the tooth and place in a nutrient solu-\\ntion, such as Hank’s balanced salt solution (preserves cell viability for up \\nto 4 to 6 hours), cold milk, saliva, or sterile saline. Transport the tooth \\nimmediately with the patient to the ED. An effective, but somewhat unset-\\ntling, way to safely transport the avulsed tooth is underneath the tongue of \\nan alert, sober, cooperative patient or parent (if the patient is a child). Upon \\narrival in the ED, if the tooth has not already been replanted, gently rinse \\nthe tooth with Hank’s solution or sterile saline and soak in either fluid. \\nRemove the clot in the empty socket and gently irrigate with sterile normal \\nsaline. Examine the tooth to determine whether the apex at the root tip is \\nopen, then proceed with the appropriate tooth replantation procedure  \\nif indicated. (See Table 152-1 for specific recommendations for tooth  \\nreplantation.)\\nEarly consultation with a dentist is imperative, but do not delay replan-\\ntation while awaiting the arrival of the specialist. After replantation, adults \\nshould receive doxycycline 100 mg PO BID for 7 days. Children <12 \\nyears old should receive penicillin VK 12.5 mg/kg/dose four times a day \\nAge of primary\\ntooth eruption\\nPatient’s right Patient’s left\\nAge of permanent\\ntooth eruption\\n7–8 years\\n8–9 years\\n11–12 years\\n10–11 years\\n10–12 years\\n6–7 years\\n12–13 years\\n11–13 years\\n6–7 years\\n11–12 years\\n10–12 years\\n9–10 years\\n7–8 years\\n6–7 years\\n8–12 months\\n  9–11 months\\n16–22 months\\n13–19 months\\n25–33 months\\n23–31 months\\n14–18 months\\n17–23 months\\n10–16 months\\n  6–10 months\\nFigurE 152-2. Normal eruptive patterns of the primary and permanent dentition.\\n152_Cydulka_Ch152.indd   842 22/03/17   9:33 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 861, 'page_label': '843'}, page_content='CHAPTER 152: Oral and Dental Emergencies 843 \\nTABLE 152-1 Specific Recommendations for Replantation of Avulsed Teeth\\nClinical Scenario Treatment\\nMoist tooth with OPEN apex \\nstored in acceptable media and/\\nor <60 min extra oral dry time\\n1.  Gently irrigate the tooth root clean with sterile \\nsaline.\\n2.  If available, cover root with minocycline hydrochlo-\\nride microspheres (Arestin™, OraPharma, Inc.) or \\nsoak for 5 min in doxycycline solution (doxycycline, \\n1 mg/20 mL saline)\\n3. Administer local anesthesia\\n4.  Remove coagulum from the socket with a stream \\nof saline. Examine the socket. If there is a fracture \\nof the socket wall, reposition it with an appropriate \\ninstrument\\n5.  Firmly replant tooth and verify the tooth position \\nclinically and radiographically, if possible\\n6. Flexible splint for up to 2 weeks\\nMoist tooth with CLOSED apex \\nstored in acceptable media and/\\nor <60 min extra oral dry time\\n1.  Gently irrigate the tooth root clean with sterile \\nsaline\\n2. Administer local anesthesia\\n3.  Remove coagulum from the socket with a stream \\nof saline. Examine the socket. If there is a fracture \\nof the socket wall, reposition it with an appropriate \\ninstrument\\n4.  Firmly replant tooth and verify the tooth’s position \\nclinically and radiographically, if possible\\n5. Flexible splint for up to 2 weeks\\nTooth (with OPEN or CLOSED \\napex) and extra oral dry time \\n>60 min or other reason sug-\\ngesting nonviable cells\\n1.  Remove necrotic soft tissue from tooth carefully \\nwith gauze\\n2.  If available, immerse tooth in 2% stannous fluoride \\nsolution for 20 min\\n3. Administer local anesthesia\\n4.  Remove coagulum from the socket with a stream \\nof saline. Examine the socket. If there is a fracture \\nof the socket wall, reposition it with an appropriate \\ninstrument\\n5.  Firmly replant tooth and verify the tooth’s position \\nclinically and radiographically, if possible\\n6. Flexible splint for up to 4 weeks\\nfor 7 days. If a patient arrives with an empty socket and the tooth cannot be \\nlocated, search adjacent tissue for the tooth. If a missing tooth cannot be \\nfound or if a partial tooth is found, order face, neck, or chest radiographs \\nto exclude a displaced or aspirated tooth.\\nAll types of dental trauma may be associated with alveolar ridge, maxil-\\nlary, or mandible fractures; therefore, order appropriate imaging studies \\nto exclude these fractures if clinical suspicion warrants. Even with proper \\ntreatment, the prognosis of luxated or avulsed teeth can be rather poor (e.g., \\n50% pulp necrosis within 1.5 years in extrusive luxation); therefore, be \\ncertain to inform the patient of potential suboptimal outcomes and stress \\nthe importance of prompt dental follow-up.\\n152_Cydulka_Ch152.indd   843 22/03/17   9:33 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 862, 'page_label': '844'}, page_content='844 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies\\nSoft Tissue Trauma\\nStabilize dental trauma before repairing soft tissue trauma. In addition, \\nperform a thorough search for retained foreign bodies before repair and \\nupdate tetanus status if necessary. When a child presents with oral \\ntrauma, consider the possibility of abuse.\\nLaceration of the maxillary labial frenulum usually does not require \\nrepair. The lingual frenulum is very vascular and usually should be repaired \\nwith 4-0 absorbable sutures.\\nTongue lacerations pose a special challenge due to the organ’s vascular-\\nity. While massive bleeding or delayed venous swelling from tongue \\ntrauma can both obstruct the airway, the more common ED presentation \\ninvolves localized injuries. The indications for closure of tongue lacerations \\nremain controversial. Some authors recommend all lacerations be repaired \\nwhile others allow nearly any wound to heal by secondary intention. Pub-\\nlished indications for primary closure include bisection of the tongue, \\nwidely gaping wounds at rest, active bleeding, flap or U-shaped wounds, \\ninvolvement of the tongue edge, and lacerations >1 cm. There is general \\nagreement that non-gaping, superficial, linear lacerations <1 cm located on \\nthe central aspect of the dorsal tongue require no repair. An assistant may \\nbe required to hold the tongue with gauze to allow repair. Obtain local \\nanesthesia with gauze soaked with 4% lidocaine applied topically for 5 \\nminutes. In some cases, local infiltration with 1% lidocaine with epineph-\\nrine or a bilateral lingual nerve block (for lesions located within the ante-\\nrior two-thirds of the tongue) may be necessary. If greater control is \\nrequired, an anesthetized tip of the tongue may be grasped with a towel \\nclamp or a temporary silk suture may be placed. A dental bite block may be \\nuseful to prevent bites to health care providers during repair. Repair lacera-\\ntions with 4-0 or 5-0 absorbable sutures. Keep sutures loose (to avoid \\nnecrosis in case the tongue swells significantly within the first 2 days), \\nwide, and deep. Approximate all of the involved tongue layers at once with \\nsingle-interrupted sutures. Alternatively, a two- or three-layer closure tech-\\nnique may be used. Sometimes in children it is desirable to only close the \\ndeep muscle layer while eschewing surface layer closure. This avoids sur -\\nface knots which can trouble children. Align wound edges as precisely as \\npossible to avoid subsequent formation of clefts, which can have cosmetic \\nand functional consequences. Complete every exposed stitch with at least \\nfour knots to avoid the suture becoming undone by subsequent tongue \\nmovement. In approximately 7 days, sutures will fall out by themselves or \\nwill be absorbed. Aftercare is similar to that of other intraoral lacerations. \\nObtain emergent specialty consultation for tongue lacerations in patients \\nwho require procedural sedation, large or complex lacerations, full or par -\\ntial amputations, and difficulties with hemostasis.\\n■ ■FURThER READING\\nFor further reading in  Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 245, “Oral and Dental Emergencies,” by Ronald W. \\nBeaudreau.\\n152_Cydulka_Ch152.indd   844 22/03/17   9:33 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 863, 'page_label': '845'}, page_content='845\\nNeck and Upper Airway \\nDisorders\\nRebecca Kornas\\n■ ■PHARYNGITIS AND TONSILLITIS\\nClinical Features\\nViral pharyngitis/tonsillitis may present with fever, odynophagia, and pete-\\nchial or vesicular lesions on the soft palate and tonsils. Compared to bacte-\\nrial pharyngitis, viral pharyngitis is more often associated with cough, \\nrhinorrhea, and congestion. Viral infections typically lack tonsillar exudates \\nand cervical adenopathy. Bacterial pharyngitis, particularly group A \\nβ-hemolytic streptococcus (GABHS) pharyngitis, presents with acute onset \\nof fever, sore throat, odynophagia, and often headache. Patients often dis-\\nplay tonsillar erythema, exudates, and tender anterior cervical adenopathy. \\nCough, conjunctivitis, and rhinorrhea are typically lacking.\\nDiagnosis and Differential\\nThe Centor criteria for GABHS pharyngitis are (1) tonsillar exudates, (2) \\ntender anterior cervical adenopathy, (3) absence of cough, and (4) fever. \\nPerform a rapid antigen test on patients with two or more criteria and treat \\nbased on the results on the rapid test. Additional diagnostic testing should \\nbe performed if mononucleosis, influenza, or acute retroviral syndrome is \\nsuspected.\\nEmergency Department Care and Disposition\\n1. Nonbacterial causes are treated with supportive care: antipyretics, anal-\\ngesics, and IV fluids, if the patient is dehydrated.\\n2. Treat GABHS pharyngitis with a single dose of benzathine penicillin \\nG 1.2 million units IM, penicillin VK 500 mg PO twice daily for \\n10 days, or amoxicillin 500 mg twice daily or 1000 mg per day. Treat \\npenicillin-allergic patients with a first-generation cephalosporin or \\nclindamycin.\\n■ ■PERITONSILLAR ABSCESS\\nClinical Features\\nPatients appear ill and often complain of sore throat, fever, odynophagia, \\ntrismus, and dysphagia. A muffled voice may be noted. The infected tonsil \\nis typically displaced medially, causing contralateral deflection of the \\nuvula.\\nDiagnosis and Differential\\nAdditional conditions to consider include peritonsillar cellulitis, infectious \\nmononucleosis, retropharyngeal abscess, herpes simplex tonsillitis, \\n153\\nC HAPTER\\n153_Cydulka_Ch153.indd   845 22/04/17   4:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 864, 'page_label': '846'}, page_content='846 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies \\nneoplasm, and internal carotid artery aneurysm. Diagnosis is typically \\nmade through the history and physical exam. If diagnosis is in question, \\nintraoral ultrasound is very sensitive and specific. CT scan with contrast \\ncan be employed if there is concern for extension of infection beyond the \\nperitonsillar space.\\nEmergency Department Care and Disposition\\n1. Peritonsillar abscess is treated with needle aspiration with an 18-G nee-\\ndle or incision and drainage (I&D) after local anesthesia. Cut the plastic \\nneedle sheath at about 1 cm from its tip to deter from penetrating to \\nthe level of the internal carotid artery.\\n2. After adequate aspiration or drainage, patients able to tolerate PO may \\nbe discharged home on antibiotics. Give Penicillin VK PLUS metroni-\\ndazole for 10 days. Choose clindamycin for penicillin-allergic patients. \\nToxic patients should receive piperacillin-tazobactam 3.375 g IV and \\nadmitted for observation.\\n■ ■ADULT EPIGLOTTITIS (SUPRAGLOTTITIS)\\nClinical Features\\nPatients typically present with a 1- to 2-day history of worsening dyspha-\\ngia, odynophagia, and dyspnea, worse when supine, and often will have \\nanterior neck tenderness with pain on gentle palpation of the larynx and \\nupper trachea. They classically position themselves in the upright position, \\nleaning forward, mouth open, and neck extended, and may display drooling \\nand inspiratory stridor.\\nDiagnosis and Differential\\nDiagnosis is made through history and physical, lateral cervical soft tissue \\nradiograph with obliteration of the vallecula and a “thumb print sign”, and/\\nor transnasal fiberoptic laryngoscopy.\\nEmergency Department Care and Disposition\\n1. Suspected epiglottitis requires immediate otolaryngology consultation, \\nand the emergency physician must be prepared to establish a sur gical \\nairway.\\n2. Patients should remain in the upright position. Initial airway manage-\\nment consists of humidif ied oxygen, IV hydration, cardiac monitoring, \\nand pulse oximetry.\\n3. Cefotaxime 50 mg/kg plus v ancomycin 15 mg/kg IV are first-line \\nantibiotics. Penicillin allergic patients should receive a respiratory fluo-\\nroquinolone. Methylprednisolone 125 mg IV may reduce airway \\ninflammation and edema.\\n4. Endotracheal intubation is generally performed in the operating \\nroom via the “aw ake” fiberoptic method, although with sufficient \\nexpertise and equipment, intubation can be performed in the emer -\\ngency department.\\n153_Cydulka_Ch153.indd   846 22/04/17   4:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 865, 'page_label': '847'}, page_content='CHAPTER 153: Neck and Upper Airway Disorders 847 \\n■ ■RETROPHARYNGEAL ABSCESS\\nClinical Features\\nCommon symptoms include sore throat, neck pain, torticollis, and dyspha-\\ngia. Additionally, patients may have a muffled voice, cervical adenopathy, \\nand respiratory distress. Stridor is more common in children.\\nDiagnosis and Differential\\nA CT of the neck with IV contrast is the gold standard diagnostic exam and \\ndifferentiates cellulitis from an abscess.\\nEmergency Department Care and Disposition\\n1. Prepare for emergent airway management as needed.\\n2. Consult with otolaryngology early.\\n3. Administer IV fluids, clindamycin, or cefoxitin I V.\\n■ ■ODONTOGENIC ABSCESS\\nClinical Features\\nMost deep space neck infections are odontogenic, usually from the man-\\ndibular teeth. Patients may present with trismus, fever, neck mass, dyspha-\\ngia, and dyspnea. Infection can range from diffuse cellulitis to abscesses in \\nthe labial or buccal gingiva. Infections can spread through many fascial \\nlayers into potential spaces in the face, neck, and mouth.\\nDiagnosis and Differential\\nBedside ultrasound can detect superficial odontogenic abscesses, but if \\ndeep space infection is suspected, CT of the neck with IV contrast is \\nrecommended.\\nEmergency Department Care and Disposition\\n1. Perform surgical drainage of the abscess, either with I&D in the emer -\\ngency department or in the operating room.\\n2. Prescribe Penicillin VK or amoxicillin for patients who can be dis-\\ncharged after drainage. Penicillin allergic patients may be treated with \\nclindamycin or levofloxacin.\\n3. In patients with deep space neck infections, administer IV ampicillin/\\nsulbactam along with clindamycin and ciprofloxacin.\\nComplications\\nLudwig’s angina is an infection of the submental, sublingual, and subman-\\ndibular spaces. Clinical exam reveals trismus and edema of the entire upper \\nneck and floor of the mouth. Critically ill patients may have a necrotizing \\ninfection. These are associated with skin discoloration, crepitus of the \\nsubcutaneous tissue, and systemic signs of illness including fever, tachycar-\\ndia, hypotension, and confusion. Immediate surgical consultation is \\nrequired, as these patients need fasciotomy with wide local debridement \\nand broad-spectrum IV antibiotics.\\n153_Cydulka_Ch153.indd   847 22/04/17   4:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 866, 'page_label': '848'}, page_content='848 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies \\n■ ■NECK AND UPPER AIRWAY MASSES\\nClinical Features\\nNeck masses can be congenital, infectious, glandular, or neoplastic. In adults \\n>40 years old, up to 80% of lateral neck masses persistent for > 6 weeks  \\nare malignant.\\nDiagnosis and Differential\\nPatients with airway compromise or significant dysphagia or odynophagia \\nshould be evaluated using flexible nasopharyngolaryngoscopybefore CT \\nscan. CT scan is often required for planning surgical intervention and will \\nhelp to delineate the extent of the mass (Table 153-1).\\nEmergency Department Care and Disposition\\n1. Inflammatory lymph nodes should be treated with empiric antibiotics \\nsuch as cephalexin 500 mg PO three to four times daily or amoxicillin  \\n500 mg three to four times daily or clindamycin 300 mg three to four \\ntimes daily.\\n2. Empiric therapy for sialoadenitis should cover staph ylococcal infection \\nwith an antibiotic such as clindamycin.\\n■ ■POSTTONSILLECTOMY BLEEDING\\nClinical Features\\nPostoperative bleeding is a well-known complication of tonsillectomy and \\ncan cause death from airway obstruction or hemorrhagic shock. Incidence \\nranges from 1% to 8.8% with about half of patients requiring surgical inter-\\nvention to control bleeding. Most significant hemorrhage occurs between \\npostoperative days 5 and 10, but bleeding can be seen within 24 hours of \\nsurgery.\\nEmergency Department Care and Disposition\\n1. Keep the patient NPO and sitting upright.\\n2. Consult otolaryngology early.\\n3. Apply direct pressure to the bleeding tonsillar bed using a tonsillar pack \\nor 4 × 4 gauze on a long clamp moistened with either thrombin or lido -\\ncaine and epinephrine.\\nTAblE 153-1 Neck Masses in Young and Older Adults\\nYoung Adult Adult\\nReactive lymphadenopathy Metastatic aerodigestive tract carcinoma\\nMononucleosis Salivary gland infection or neoplasm\\nLymphoma\\nBranchial cleft cyst Lymphoma\\nThyroglossal duct cyst Thyroid disorder\\nTuberculosis\\n153_Cydulka_Ch153.indd   848 22/04/17   4:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 867, 'page_label': '849'}, page_content='CHAPTER 153: Neck and Upper Airway Disorders 849 \\n4. Alternatively, if the bleeding site is visualized, locally inf iltrate with \\nlidocaine and epinephrine then cauterize with silver nitrate.\\n5. Massive bleeding is rare but when it occurs the only means of protecting \\nthe airway is intubation. Plan for emergent cricothyrotomy prior to at-\\ntempting intubation.\\n■ ■COMPLICATIONS OF AIRWAY DEVICES\\nTracheostomy Tubes and Cannulas\\nEarly complications include bleeding, obstruction, dislodgement, and \\ninfection. These typically occur within the first postoperative week. Late \\ncomplications like granulation, tracheal stenosis, and fistula formation \\noccur after the first postoperative week. Emergency medicine providers \\nmust be proficient in replacing uncuffed with cuffed tracheostomy tubes for \\nmechanical ventilation, replacement of tracheostomy tubes after accidental \\ndecannulation, correction of tube obstruction, and control of bleeding or \\ninfection at the tracheostomy site.\\nTracheostomy Tube with Airway Obstruction\\nIf the tracheostomy tube is patent, leave it in place. Consider mucus plug-\\nging of the trachea or mainstem bronchi distal to the tube and attempt to \\nsuction. Preoxygenation and placement of sterile saline into the trachea will \\naid in suctioning. You may have to remove the inner cannula and occasion-\\nally the entire tracheostomy tube if suctioning fails.\\nTracheostomy Dislodgement\\nIf a suction catheter cannot be passed through the tube and on x-ray the \\ntracheostomy tube is seen extrinsically compressing the trachea, the tube is \\nlikely dislodged. Remove the entire tracheostomy tube. Insert a nasopha-\\nryngoscope or flexible bronchoscope into the visible stoma to identify the \\ntrue tracheal opening. If the opening cannot be identified obtain otolaryn-\\ngology or general surgery consultation. If the patient cannot maintain his or \\nher airway, you should orally intubate.\\nTracheostomy Site Infection\\nStomal skin infection, tracheitis, and bronchitis can be recurring problems. \\nTreat polymicrobial infections in stable patients with amoxicillin-clavulanate \\n875 mg PO twice daily. Unstable or systemically ill patients should receive \\npiperacillin-tazobactam 3.375 g IV plus vancomycin 1 g IV . Add a fluoro-\\nquinolone for Pseudomonas. Local wound infections can be treated with \\ngauze soaked in 0.25% acetic acid.\\nTracheostomy Site bleeding\\nSources of hemorrhage include granulation tissue in the stoma, trachea, or \\nthyroid or erosion of the thyroid v essels, the tracheal wall, or the innomi-\\nnate artery. Packing with saline soaked gauze can control slow bleeding \\nfrom the stoma. If this is ineffective remove the tube and examine the stoma \\nand tracheal wall. Local bleeding can be controlled with silver nitrate. If \\nbleeding is brisk, replace the tracheostomy tube with a cuffed endotracheal \\ntube with the cuff below the bleeding site.\\n153_Cydulka_Ch153.indd   849 22/04/17   4:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 868, 'page_label': '850'}, page_content='850 SECTION 16: Eye, Ear, Nose, Throat, and Oral Emergencies \\nTracheoinnominate artery fistula is a rare but life-threatening complication \\nof tracheostomy. This is typically seen during the first 3 weeks after tracheos-\\ntomy and is due to vessel erosion from high (>25 mm Hg) cuff pressures or \\ndirect pressure from the tip of the tracheal cannula against the innominate \\nartery. Some patients present with hemoptysis or a sentinel arterial bleed. \\nImmediate orolaryngologic or thoracic surgery consultation is required.\\nIf the patient presents with massive bleeding, the first maneuver is \\nto hyperinflate the cuff to control brisk bleeding while planning opera-\\ntive intervention. If bleeding persists, slowly withdraw the tube while \\nexerting anterior pressure on the anterior trachea. If these interventions fail \\nto control bleeding, place an endotracheal tube from above the tracheoin-\\nnominate fistula, using direct visualization with a flexible intubating scope \\nwhile an assistant removes the tracheostomy tube allowing the endotracheal \\ntube to pass. Then use digital pressure of the innominate artery against the \\nmanubrium to control stomal hemorrhage.\\nTracheal Stenosis\\nWeeks to months after decannulation, mucosal necrosis, and subsequent \\nscarring can cause tracheal stenosis. Patients with stenosis have dyspnea, \\nwheezing, stridor, and inability to clear secretions. Treatment in the emer -\\ngency department includes humidified oxygen, nebulized racemic epi-\\nnephrine, and steroids. Further treatment may include rigid bronchoscopy \\nlaser excision of scar bands, stenting, or tracheal reconstruction.\\nChanging a Tracheostomy Tube\\nIf the tracheostomy is less than 7 days old and the situation is not emergent, \\ntracheostomy tubes should be changed by a surgeon familiar with the proce-\\ndure, as tracts are not yet mature and manipulation may easily create a false \\npassage. Tracts can also easily collapse in patients with obesity or neck masses.\\n■ ■LARYNGECTOMY PATIENTS\\nIt is impossible to orally intubate patients after laryngectomy. Laryn-\\ngectomy patients can be emergently intubated by placing an endobronchial \\ntube into the tracheostoma. Do not advance the tube too far, as the carina \\ncan be only 4 to 6 cm from the tracheostoma.\\nSpeech Devices\\nA Passy-Muir valve is a one-way valve that fits directly over the opening of \\nan uncuffed tracheostomy tube, allowing for hands free speech. Because \\npatients exhale around the tracheostomy tube, a Passy Muir valve should \\nnot be used with a cuffed tube. If a patient with a Passy-Muir valve \\ndevelops respiratory distress or an inability to speak, your first inter -\\nvention should be to remove the speech valve. Then check the trache-\\nostomy tube for obstruction.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, \\n8th ed., see Chapter 246, “Neck and Upper Airway,” by Nicholas D. Hartman; \\nChapter 247 “Complications of Airway Devices,” by John P. Gaillard.\\n153_Cydulka_Ch153.indd   850 22/04/17   4:53 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 869, 'page_label': '851'}, page_content='851\\nDermatologic Emergencies\\nJason P . Stopyra\\n■ ■ERYTHEMA MULTIFORME AND STEVENS–JOHNSON \\nSYNDROME\\nClinical Features\\nErythema multiforme (EM) strikes all ages, with the highest incidence in \\nyoung adults (20 to 40 years of age). It affects males twice as often as \\nfemales, and occurs more commonly in the spring and fall. EM is an acute \\ninflammatory skin disease with presentations that range from a mild papu-\\nlar eruption (EM minor) to diffuse vesiculobullous lesions with mucous \\nmembrane involvement and systemic toxicity (Stevens–Johnson syn-\\ndrome). Precipitating factors include infection (mycoplasma and herpes \\nsimplex), drugs (antibiotics and anticonvulsants), and malignancy. No \\nspecific cause is found in about half of the cases.\\nMalaise, arthralgias, myalgias, fever, a generalized burning sensation, \\nand diffuse pruritus may precede the development of skin lesions. Skin \\nlesions begin as erythematous papules and macular lesions followed by the \\ndevelopment of target lesions in 24 to 48 hours. Lesions can be diffuse and \\nmay be located on the palms and soles. Urticarial plaques, vesicles, bullae, \\nvesiculobullous lesions, and mucosal (oral, conjunctival, respiratory, and \\ngenitourinary) erosions may also develop (Fig. 154-1). Systemic toxicity \\nalong with significant fluid and electrolyte deficiencies and secondary \\ninfections may be seen in severe disease.\\nDiagnosis and Differential\\nTarget lesions are highly suggestive of EM. The presence of mucosal involve-\\nment suggests Stevens–Johnson syndrome. The differential diagnosis includes \\nherpetic infections, vasculitis, toxic epidermal necrolysis, primary blistering \\ndisorders, Kawasaki disease, and the toxic and infectious erythemas.\\nEmergency Department Care and Disposition\\n1. Patients without systemic manifestation or mucous membrane in volve-\\nment may be managed as outpatients with dermatologic consultation. \\n154\\nC HAPTER\\nDisorders of the Skin\\n 17\\nSECTION\\n154_Cydulka_Ch154.indd   851 22/03/17   9:47 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 870, 'page_label': '852'}, page_content='852 SECTION 17: Disorders of the Skin\\nPrednisone 60 to 80 mg PO daily for 3 to 5 days are often prescribed for \\nmild disease but are unpro ven to change duration and outcomes. \\nAcyclovir may reduce recurrent HSV-related EM.\\n2. Admit patients with extensive disease or systemic toxicity for critical care \\nand consultation with a dermatologist and ophthalmologist. Intensively \\nmanage fluid, electrolyte, infectious, nutritional, and thermoregulatory \\nissues. Diphenhydramine and lidocaine rinses provide symptomatic \\nrelief for stomatitis. Cool Burrow’s solution (5% aluminum acetate) \\ncompresses can be applied to blistered regions.\\n■ ■TOXIC EPIDERMAL NECROLYSIS\\nToxic epidermal necrolysis (TEN) is a severe inflammatory skin disease \\nthat strikes all ages and both sexes equally. Some authorities consider TEN \\nto be a variant of Stevens–Johnson syndrome.\\nClinical Features\\nPotential etiologies include chemicals, infections, and malignancy, but \\nmedications are the most common causes of TEN. Malaise, anorexia, myal-\\ngias, arthralgias, fever, and upper respiratory infection symptoms may pre-\\ncede skin findings by 1 to 2 weeks. Skin findings progress from tender \\nerythematous areas that become confluent within hours to flaccid bullae and \\nerosions with exfoliation (Fig. 154-2). A positive Nikolsky sign is slippage \\nof the epidermis from the dermis when slight tangential pressure is applied \\nFigurE 154-1. Erythema multiforme.\\n154_Cydulka_Ch154.indd   852 22/03/17   9:47 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 871, 'page_label': '853'}, page_content='CHAPTER 154: Dermatologic Emergencies 853 \\nto the skin. Systemic toxicity as well as oral, ocular, and anogenital mucosal \\nlesions are common. TEN has a mortality rate of 25% to 35%, and poor  \\nprognostic indicators include advanced age, extensive disease, multiple \\nmedication use, leukopenia, azotemia, and thrombocytopenia.\\nDiagnosis and Differential\\nInitial diagnosis is based on the clinical features, while skin biopsy results \\ncan confirm the diagnosis. The differential diagnosis includes erythema \\nmultiforme, exfoliative dermatitis, primary blistering disorders, Kawasaki \\ndisease, and toxic infectious erythemas.\\nEmergency Department Care and Disposition\\n1. Admit patients with TEN to a critical care setting, preferably a burn unit \\nwith expertise managing appropriate cardiopulmonary, fluid, electrolyte, \\nand sepsis resuscitation.\\n2. Emergent dermatologic consultation is recommended.\\n■ ■MENINGOCOCCEMIA\\nClinical Features\\nMeningococcemia is a serious and potentially fatal systemic infection \\ncaused by Neisseria meningitides. Clinical disease usually develops within \\n3 to 4 days after exposure and can present with a fulminant course. Possible \\npresenting features can include headache, fever, altered mental status, nau-\\nsea, vomiting, myalgias, arthralgia, and neck stiffness. Dermatologic mani-\\nfestations of this infection include petechia, urticaria, hemorrhagic vesicles, \\nand macules that evolve into palpable purpura with grey necrotic centers.\\nDiagnosis and Differential\\nConsider meningococcemia in ill-appearing patients with a petechial rash \\nand associated symptoms of infection. The differential diagnosis includes \\nFigurE 154-2. Toxic epidermal necrolysis.\\n154_Cydulka_Ch154.indd   853 22/03/17   9:47 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 872, 'page_label': '854'}, page_content='854 SECTION 17: Disorders of the Skin\\nRocky Mountain spotted fever, toxic shock syndrome, gonococcemia, bac-\\nterial endocarditis, vasculitis, viral and bacterial infections, and dissemi-\\nnated intravascular coagulation.\\nEmergency Department Care and Disposition\\n1. Treat meningococcemia in adult patients with an IV third-generation \\ncephalosporin such as ceftriaxone  or cefotaxime. Consider additional \\nempiric antibiotic coverage for patients with suspected bacteremia when \\nthe pathogen is uncertain.\\n2. Admit patients with meningococcal infection for close monitoring, sup-\\nportive care, and continued antibiotic treatment.\\n■ ■PEMPHIGUS VULGARIS\\nClinical Features\\nPemphigus vulgaris is a generalized, mucocutaneous, autoimmune, blister-\\ning eruption with a grave prognosis. Primary lesions are clear, tense vesi-\\ncles or bullae that vary in diameter, and are first noted on the head, trunk, \\nand mucous membranes. Within 2 to 3 days, the bullae become turbid and \\nflaccid then rupture, producing painful, denuded areas that are slow to heal \\nand prone to secondary infection (Fig. 154-3).\\nDiagnosis and Differential\\nPemphigus vulgaris is suspected by the appearance of lesions and con-\\nfirmed by skin biopsy and immunofluorescence testing. The differential \\ndiagnosis includes bullous pemphigoid, TEN, EM major, dermatitis her -\\npetiformis, and other blistering skin diseases. Bullous pemphigoid is a \\nmucocutaneous blistering disease typically found in the elderly.\\nFigurE 154-3.  Scattered bullous lesions intermixed with erosions and painful \\ninflammatory plaques in a patient with pemphigus vulgaris.\\n154_Cydulka_Ch154.indd   854 22/03/17   9:47 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 873, 'page_label': '855'}, page_content='CHAPTER 154: Dermatologic Emergencies 855 \\nEmergency Department Care and Disposition\\n1. Treat fluid and electrolyte disturbances aggressively.\\n2. Consult with a dermatologist for management of pemphigus vulgaris. \\nCorticosteroids and immunosuppressives are the mainstays of therap y. \\nPlasmaphoresis and IV immunoglobins may also be needed.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, \\n8th ed., see Chapter 141, “Rashes in Infants and Children,” by Gary Bonfante and \\nAmy Dunn; Chapter 249, “Generalized Skin Disorders,” by Mark Sochor, \\nAmit Pandit, and William J. Brady.\\n154_Cydulka_Ch154.indd   855 22/03/17   9:47 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 874, 'page_label': '856'}, page_content='856\\nOther Dermatologic Disorders\\nJason P . Stopyra\\n■ ■HERPES ZOSTER\\nClinical Features\\nHerpes zoster results from cutaneous activation of latent varicella zoster \\nvirus along a sensory nerve root dermatome. Pain or dysesthesia in an \\ninvolved dermatome begins 3 to 5 days before lesions emerge. Erythema-\\ntous papules develop first, progress to vesicular clusters, and these lesions \\ncrust after about a week. Herpes zoster of the ophthalmic branch of the \\ntrigeminal nerve, especially if accompanied by lesions on the nose, are \\nconcerning for possible eye involvement that can lead to keratitis or corneal \\nulceration (Fig. 155-1). A thorough eye exam should be performed (see \\nChapter 149, “Ocular Emergencies”). Generalized eruptions involving \\nmore than one dermatome may occur in immunocompromised patients.\\nDiagnosis and Differential\\nThe differential diagnosis for these kinds of skin eruptions includes herpes \\nsimplex, impetigo, and contact dermatitis. The characteristic skin rash of \\nherpes zoster presents in a unilateral distribution along a single sensory \\ndermatome and is accompanied by localized pain at the site. A swab of the \\n155\\nC H a PTER\\nAB\\nOphthalmic\\nMaxillary\\nMandibular\\nAuricular\\nRami of the\\ntrigeminal N.\\nRamus of\\nvagus\\n*Overlapping of greater\\n auricular and facial\\n nerves\\n*\\nPost\\ncerv.\\nGr.\\noccipital\\nN.\\nSm.\\noccipital\\nN.\\nCervical\\ncutaneous\\nFIGURE 155-1. A. Herpes zoster in trigeminal nerve distribution. Note lesion on \\nthe tip of the nose, which suggests nasociliary branch involvement. B. Dermatomes \\nof the head and neck. cerv. = cervical; Gr. = greater; N. = nerve; Sm. = smaller. \\nA. Reproduced with permission from Fleischer A Jr, Feldman S, McConnell C,  \\net al. Emergency Dermatology: A Rapid Treatment Guide. New York, NY: McGraw-\\nHill; 2002. B. Reproduced with permission from Wolff K, Johnson R, Saavedra AP . \\nFitzpatrick’s Color Atlas & Synopsis of Clinical Dermatology, 7th ed. New York: \\nMcGraw-Hill; 2013.\\n155_Cydulka_Ch155.indd   856 22/03/17   10:31 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 875, 'page_label': '857'}, page_content='CHAPTER 155: Other Dermatologic Disorders 857 \\nbase of the vesicle can be sent for viral PCR to confirm the clinical diagno-\\nsis when uncertainty exists.\\nEmergency Department Care and Disposition\\n1. Antiviral medications started in the first 72 hours of illness shorten \\nhealing time, decrease formation of new lesions, and help prevent \\npostherpetic neuralgia. Antiviral choices include acyclovir 800  mg PO \\nfive times per day for 7 to 10 days or valacyclovir 1000  mg PO three \\ntimes a day for 7 days. Immunocompromised patients with se vere \\ndisease can be treated with acyclovir, 10  mg/kg IV every 8 hours for 7 \\nto 10 days.\\n2. Aluminum acetate compressions three times daily and analgesics pro-\\nvide symptomatic relief.\\n3. Advise patients that herpes zoster is contagious to anyone who has not \\nhad chicken pox or the varicella zoster vaccine.\\n4. Consult with an ophthalmologist if eye involvement is suspected.\\n■ ■HERPES SIMPLEX VIRUS INFECTIONS\\nHerpes simplex virus (HSV) lesions are painful grouped vesicles with an \\nerythematous base. Primary disease may be preceded with or accompanied \\nby constitutional symptoms. Tingling or burning precedes recurrent lesions. \\nOral lesions (“cold sores”) are usually caused by HSV1, but may also be \\ncaused by HSV2. The diagnosis can be confirmed with an HSV PCR test if \\nnecessary. Treatment (Table 155-1) is most effective when started within 24 \\nhours of symptom onset. See Chapter 87, “Sexually Transmitted Infec-\\ntions,” for discussion and treatment of genital herpes.\\n■ ■TINEa INFECTIONS\\nClinical Features\\nTinea refers to skin infections caused by dermatophytes (fungi).  Tinea \\ncapitis is characterized by patchy areas of alopecia with broken off hairs \\nand scales at the periphery. Tinea barbae presents with severe inflamma-\\ntory plaques and follicular pustules in the beard area. Interdigital scaling, \\nmaceration, plantar or palmar erythema or scaling, and pruritis are seen in \\nTablE 155-1 Treatment of Herpes Simplex Virus (HSV) Gingivostomatitis  \\n(Herpes Labialis)\\nCondition acyclovir Treatment V alacyclovir Treatment\\nFirst episode 400  mg PO three times a day for \\n7 days or  200 mg PO five times a \\nday for 7 days\\n1 g PO twice a day for 7  days\\nRecurrent episode 400  mg PO three times a day for \\n5 days or  800 mg PO three a day \\nfor 2–5 days\\n500 mg PO twice a day for 3  days\\nSuppression 400 mg PO twice a day 1 g PO a day, may decrease \\nto 500 mg PO a day if <10 \\noutbreaks/year\\n155_Cydulka_Ch155.indd   857 22/03/17   10:31 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 876, 'page_label': '858'}, page_content='858 SECTION 17: Disorders of the Skin\\nTinea pedis (also known as athlete’ s foot) and Tinea manuum (hand). \\nOnchomycosis may occur. Findings in Tinea cruris (commonly called jock \\nitch) include erythema with a peripheral annular scaly edge that extends \\nonto the thighs and buttocks but spares the penis and scrotum. Candida \\nintertrigo involves the skinfolds. Tinea Corporus (trunk, neck, arms, and \\nlegs lesions) are typically circular, covered with scales and surrounded by \\na raised border.\\nDiagnosis and Differential\\nIdentification of fungal elements on a potassium hydroxide preparation or \\nwith fungal culture may be completed if the diagnosis is uncertain. The \\ndifferential diagnosis includes psoriasis, atopic, seborrheic, and chronic \\ndermatitis (Table 155-2).\\nTablE 155-2 Comparison Features of Common Papulosquamous  \\nEruptions\\nCondition\\nDistinguishing \\nClinical Features Location Special Signs Comments\\nPsoriasis Erythematous, well-\\nmarginated papules \\nand plaques with \\nsilvery scale\\nTrunk, extensor \\nsurfaces, scalp\\nAuspitz sign; \\nKoebner \\nphenomenon, \\nnail pitting\\nHereditary \\npredilection; \\nonset in early \\n20s\\nSeborrheic \\ndermatitis\\nGreasy, yellow \\nscales\\nMidchest, supra-\\npubic, scalp, \\nfacial creases\\nCan overlap \\nwith psoriasis, \\n“sebopsoriasis”\\nDebilitated, \\nelderly, or \\ninfants (cradle \\ncap)\\nAtopic \\ndermatitis\\nIll-defined vesicles \\nforming plaques \\nwith scale; chronic \\nlesions lichenified\\nFlexures > trunk Spares the \\nnose\\nPruritus \\n“itch that \\nrashes”; atopic \\nindividuals\\nLichen \\nplanus\\n5 P’s: purple, \\npruritic, polygonal, \\nplanar papules\\nAny skin, mucous \\nmembranes, hair \\nfollicles\\nWickham \\nstriae; Koebner \\nphenomenon\\nAge \\n20–60 years old\\nPityriasis \\nrosea\\nLines of skin \\ntension, collarette \\nof scale\\nTrunk, in \\nChristmas tree \\npattern following \\nskin lines\\nHerald patch \\n1–2 weeks \\nbefore general \\neruption\\nSpring and fall, \\nage 15–40 years \\nold; viral exan-\\nthem, herpes  \\n6 and 7\\nTinea \\ncorporis\\nSharply demarcated, \\nerythematous, scaly \\nannular plaques; \\nmay coalesce into \\ngyrate patterns\\nTrunk, legs, arm, \\nneck\\nMay need \\nKOH/culture to \\ndiagnose; sep-\\ntate branching \\nhyphae on KOH\\nAll ages; from \\npets, soil, or \\nautoinoculation \\nfrom hands/\\nfeet; incubation \\ndays or months\\nPityriasis \\n(tinea) \\nversicolor\\nVersicolored—red, \\nsalmon, light \\nbrown, dark brown, \\nhypopigmented; \\nwell-demarcated \\nscaly patches\\nCentral upper \\nchest and back\\nSpaghetti and \\nmeatballs on \\nKOH; nonsep-\\ntate pseudo-\\nhyphae and \\nbudding yeast\\nYoung adults, \\nsummer, hot \\nhumid environ-\\nments\\n(Continued)\\n155_Cydulka_Ch155.indd   858 22/03/17   10:31 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 877, 'page_label': '859'}, page_content='CHAPTER 155: Other Dermatologic Disorders 859 \\nTablE 155-2 Comparison Features of Common Papulosquamous  \\nEruptions\\nCondition\\nDistinguishing \\nClinical Features Location Special Signs Comments\\nSecondary \\nsyphilis\\nAt 2–10 weeks, \\nmacular erythema \\non trunk, abdomen, \\ninner extremities; \\nfollowed by papular \\nor papulosquamous \\nlesions\\nPalms, soles, \\ntrunk\\nSerology Great \\nmasquerader—\\ncan take any \\nform; can be \\nconfused with \\npityriasis rosea\\nScabies Pruritic papules \\nand burrows with \\ncrusting\\nFinger webs, \\nwrists, axillae, \\nareolae, umbi-\\nlicus, abdomen, \\nwaistband, \\ngenitals\\nScrapings \\nshow mites, \\nfeces, eggs\\nCan be chronic \\n“7-year itch”; \\nintensely pru-\\nritic, especially \\nat night\\nAbbreviation: KOH = potassium hydroxide.\\n(Continued)\\nEmergency Department Care and Disposition\\n1. Treat Tinea capitis with liquid microsize griseofulvin 20 to 25  mg/kg \\nPO daily (maximum, 1  g/d) for 8 weeks, ultramicrosize griseofulvin \\n(tablets only), 10 to 15  mg/kg/d (maximum, 750  mg/d) for 8 weeks, or \\nterbinafine granules 125  mg PO daily for patients weighing <25  kg, \\n187.5 mg/d for patients weighing 25 to 35  kg, and 250 mg/d for patients \\nweighing >35 kg for 6 weeks. Consider baseline liver function tests as \\noral antifungal treatment in patients with abnormal hepatic function is \\nnot recommended. Advise patients to wash hair with selenium sulfide \\n2.5% shampoo or ketoconazole 2% shampoo three times per week for \\nthe first 2 weeks of therapy.\\n2. Treat Tinea barbae with microsize griseofulvin, 500  mg PO daily or \\nultramicrosize griseofulvin, 375 mg PO daily, for 4 to 6 weeks. Tervi-\\nnafine can also be used. Consider baseline liver function tests. Shaving \\nor depilating the hair along with warm compresses is recommended.\\n3. Treat nonbullous tinea pedis and manuum, intertrigo, tinea corpora, and \\ntinea cruris, with topical antifungal agents such as clotrimazole, \\nmiconazole, ketoconazole, or econazole twice daily for 4 weeks. Con-\\ntinue treatment 1 week after clearing has occurred. Antifungal powders \\nused on a daily basis help prevent recurrences of tinea cruris.\\n4. Onchomycosis usually requires long-term oral treatment.\\n5. Follow-up with a primary care physician or dermatologist is recom-\\nmended, especially if the lesions are not resolved in 4 to 6 weeks.\\n■ ■aLLERGIC CONTaCT DERMaTITIS\\nClinical Features\\nContact dermatitis occurs after direct contact with an irritant or allergen. \\nReactions occasionally occur after exposure to aerosolized particles, such \\nas burned poison ivy or oak. Detergents and soaps are common irritants, \\nwhile nickel, plants, cosmetic preservatives, contact lens solutions, and skin \\n155_Cydulka_Ch155.indd   859 22/03/17   10:31 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 878, 'page_label': '860'}, page_content='860 SECTION 17: Disorders of the Skin\\ntape are common allergens. Physical findings include erythema, papules, \\nvesicles, and bullae. Scaling and fissuring are seen with chronic contact \\ndermatitis.\\nEmergency Department Care and Disposition\\n1. Begin treatment by identifying and removing the likely offending agent.\\n2. Aluminum acetate (Burow’s solution) compresses tw o or three times \\nper day may ease acute irritation.\\n3. Depending on severity , topical or oral corticosteroids and oral antihis-\\ntamines can be used in medical management. Patients with extensive, \\nsevere allergic contact dermatitis may benefit from a short course of \\nsystemic corticosteroids.\\n■ ■SUNBURN aND PHOTOSENSITIVITY\\nClinical Features\\nPatients with sunburn have an inflammatory response to ultraviolet (UV) \\nradiation and may present with minimal discomfort in mild cases or extreme \\npain with extensive blistering for more severe exposures. Tender and warm \\nareas of erythema in sun-exposed areas are characteristic of sunburn. Sunburn \\nreactions develop 2 to 6 hours after exposure and peak in 1 to 3 days.\\nExogenous photosensitivity disorders result from topical application or \\ningestion of an agent that increases the skin’s sensitivity when exposed to \\nUV light. Photosensitivity disorders may be phototoxic (occur quickly with \\ncharacteristics similar to sunburn) or photoallergic (delayed onset charac-\\nterized by eczema-like changes with vesiculation). Photosensitivity erup-\\ntions occur on sun-exposed skin and are associated with topically applied \\nfurocoumarins (lime juice, various fragrances, figs, celery, parsnips), and \\nnumerous medications, including sulfonamides, thiazides, furosemide, \\nfluoroquinolones, and tetracyclines.\\nEmergency Department Care and Disposition\\n1. Sunburns are treated symptomatically with tepid baths, NSAIDs, and \\nlocal wound care including topical antibiotics to blistered areas.\\n2. Initial management of exogenous photosensitivity is similar to the sun-\\nburn reaction, including the avoidance of the sun until the eruption has \\ncleared. Identify and discontinue the causative agent, if possible.\\n■ ■SECONDaRY SYPHILIS\\nClinical Features\\nEarly secondary syphilis eruptions emerge 2 to 10 weeks after the appear -\\nance of the primary chancre (see Chapter 87, “Sexually Transmitted Infec-\\ntions”). This evanescent macular rash on the trunk and inner extremities \\nmay last only a few hours or days. Subsequent rash, often referred to as the \\n“great imitator” because of the varied clinical appearance, lasts 2 to 6 \\nweeks and may present in a variety of forms. These eruptions are often \\npapular lesions 2 to 5  mm in size, generalized, and reddish to copper in \\ncolor. Involvement of the palms and soles is a helpful diagnostic finding. \\nConsider risk factors and the possibility of secondary syphilis rash when \\n155_Cydulka_Ch155.indd   860 22/03/17   10:31 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 879, 'page_label': '861'}, page_content='CHAPTER 155: Other Dermatologic Disorders 861 \\nevaluating patients with papulosquamous conditions (Fig. 155-2). The non-\\ntreponemal serologic tests are frequently strongly reactive in secondary \\nsyphilis and can be helpful for diagnosis.\\nEmergency Department Care and Disposition\\nTreat secondary syphilis with benzathine penicillin G (single dose of 2.4 \\nmillion IM, 1.2 million units in each buttock). Doxycycline, 100  mg PO \\ntwice a day for 2 weeks, can be used in patients with penicillin allergy.\\n■ ■MOLLUSCUM CONTaGIOSUM\\nMolluscum contagiosum is a common viral infection of the epidermis \\noccurring in children, sexually active adults, and immunosuppressed indi-\\nviduals (especially patients with human immunodeficiency virus). \\nFIGURE 155-2. Secondary syphilis. Papulosquamous eruption. Used with permis-\\nsion from University of Carolina Department of Dermatology.\\n155_Cydulka_Ch155.indd   861 22/03/17   10:31 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 880, 'page_label': '862'}, page_content='862 SECTION 17: Disorders of the Skin\\nTransmission is by direct skin-to-skin contact. These lesions can present as \\na single skin-colored, pearly, umbilicated papule (1 to 2 mm) or as multiple, \\nscattered papules or nodules and plaques (5 to 10 mm) (Fig. 155-3). Autoin-\\nnoculation may lead to clustering of lesions by scratching. Most patients do \\nnot require specific treatment for this condition and it typically resolv es \\nwithin 6 months to 4 years. Options for treatment in appropriate circum-\\nstances include curettage, cryotherapy, or electrodesiccation. In individuals \\nwith human immunodeficiency virus, treatment of the underlying human \\nimmunodeficiency virus infection may lead to resolution.\\n■ ■HIDRaDENITIS SUPPURaTIVa\\nHidradenitis suppurativa is an inflammatory condition, typically affecting \\nthe apocrine gland-bearing areas of the skin with recurrent, painful, and \\ndraining nodules. The inciting event is follicular occlusion, prompting rup-\\nture of the follicular contents, and resulting intense inflammation. Axillary \\nand inguinal skin demonstrates varying numbers of inflammatory nodules, \\nmany of which may form connecting tracts, with resultant drainage onto the \\nskin surface (Fig. 155-4). See Chapter 90, “Soft Tissue Infections.”\\nEmergency Department Care and Disposition\\n1. Recommend clindamycin 1% lotion twice daily and use antibacterial \\nsoaps once to twice weekly for patients without discrete areas of abscess.\\n2. Acute abscesses can be treated with incision and drainage, although \\nminimizing this approach when possible may be appropriate due to the \\nrecurrent nature of this disease. In severe and recurrent cases, outpatient \\nsurgical referral may be indicated.\\nFIGURE 155-3. Molluscum contagiosum. Centrally umbilicated papules. Used with \\npermission from University of Carolina Department of Dermatology.\\n155_Cydulka_Ch155.indd   862 22/03/17   10:31 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 881, 'page_label': '863'}, page_content='CHAPTER 155: Other Dermatologic Disorders 863 \\n■ ■FURTHER REaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 250, “Skin Disorders: Face and Scalp,” by Dean S. \\nMorrell and Kevin W. Dahle; Chapter 251, “Skin Disorders: Trunk,” by Dean S. \\nMorrell and Kara Luersen Brooks; Chapter 252, “Skin Disorders: Groin and \\nSkinfolds,” by Dean S. Morrell and Edith V . Bowers; Chapter 253, “Skin \\nDisorders: Extremities,” by Rachna A. Bhandari and Dean S. Morrell.\\nFIGURE 155-4. Hidradenitis suppurativa involving the buttock region. Used with \\npermission from University of Carolina Department of Dermatology.\\n155_Cydulka_Ch155.indd   863 22/03/17   10:31 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 882, 'page_label': '864'}, page_content='155_Cydulka_Ch155.indd   864 22/03/17   10:31 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 883, 'page_label': '865'}, page_content='865\\nTrauma in Adults\\nRita K. Cydulka\\nTrauma care is guided by the concepts of rapid assessment, triage, resusci-\\ntation, serial reassessment, diagnosis, and therapeutic intervention.\\n■ ■CLINICAL FEATURES\\nTrauma patients can sustain a multitude of injuries. Many people will pres-\\nent with abnormal vital signs, neurologic deficits, or other gross evidence \\nof injury. These signs should prompt both a thorough search for the specific \\nunderlying injuries and rapid interventions to correct the abnormalities. \\nNonspecific signs such as tachycardia, tachypnea, or mild alterations in \\nconsciousness should similarly be presumed to signify serious injury until \\nproven otherwise. Further, without signs of significant trauma, the mecha-\\nnism of injury may suggest potential problems, which should be pursued \\ndiligently.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe assessment of trauma patients begins with a focused history from the \\npatient, family members, witnesses, or prehospital providers. Patterns of \\ninjuries, and expected physiologic responses to these injuries, can be ascer-\\ntained by collecting history regarding the circumstances of the event \\n(e.g., single vehicle crash, fall from height, smoke inhalation, or environ-\\nmental exposures), ingestion of intoxicants, preexisting medical conditions, \\nand medications.\\nTo facilitate an organized approach to the trauma patient, the examina-\\ntion is divided into primary and secondary surveys (Table 156-1). The goal \\nof the primary survey is to identify and immediately treat life-threatening \\nconditions. To do so, the acronym ABCDE encourages the clinician to \\nexamine the patient’s airway, breathing, circulation, and disability (mental \\nstatus, Glasgow Coma Scale (GCS), and neurologic examination), and to \\ncompletely expose each patient so that occult injuries or exposures are \\nvisualized. After this initial primary survey, perform a thorough head-to-toe \\nexamination (the secondary survey, Table 156-1), then proceed with appro-\\npriate diagnostic testing and further therapeutic interventions.\\n156\\nCh A p TER\\n18\\nSECTION\\nTrauma\\n156_Cydulka_Ch156.indd   865 22/03/17   10:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 884, 'page_label': '866'}, page_content='866 SECTION 18: Trauma\\nTAble 156-1 primary and Secondary Surveys in Trauma Resuscitation\\nPrimary Survey (rapid identification and management of immediately life-\\nthreatening injuries)\\nA. Airway and cervical spine\\nAssess, clear, and protect airway: jaw thrust/chin lift, suctioning.\\nPerform endotracheal intubation with in-line stabilization for patient with depressed \\nlevel of consciousness or inability to protect airway.\\nCreate surgical airway if there is significant bleeding or obstruction or laryngoscopy \\ncannot be performed.\\nb. b reathing\\nVentilate with 100% oxygen; monitor oxygen saturation.\\nAuscultate for breath sounds.\\nInspect thorax and neck for deviated trachea, open chest wounds, abnormal chest wall \\nmotion, and crepitus at neck or chest.\\nConsider immediate needle thoracostomy for suspected tension pneumothorax.\\nConsider tube thoracostomy for suspected hemopneumothorax.\\nC. Circulation\\nAssess for blood volume status: skin color, capillary refill, radial/femoral/carotid pulse, \\nand blood pressure.\\nPlace two large-bore peripheral IV catheters.\\nBegin rapid infusion of warm crystalloid solution, if indicated.\\nApply direct pressure to sites of brisk external bleeding.\\nConsider central venous or interosseous access if peripheral sites are unavailable.\\nConsider pericardiocentesis for suspected pericardial tamponade.\\nConsider left lateral decubitus position in late-trimester pregnancy.\\nD. Disability\\nPerform screening neurologic and mental status examination, assessing:\\n– Pupil size and reactivity\\n– Limb strength and movement, grip strength\\n– Orientation, Glasgow Coma Scale score\\nConsider measurement of capillary blood glucose level in patients with altered mental \\nstatus.\\ne.  e xposure\\nCompletely disrobe the patient, and inspect for burns and toxic exposures.\\nLogroll patient, maintaining neutral position and in-line neck stabilization, to inspect \\nand palpate thoracic spine, flank, back, and buttocks.\\nSecondary Survey (head-to-toe examination for rapid identification and control \\nof injuries or potential instability)\\nIdentify and control scalp wound bleeding with direct pressure, sutures, or surgical clips.\\nIdentify facial instability and potential for airway instability.\\nIdentify hemotympanum.\\nIdentify epistaxis or septal hematoma; consider tamponade or airway control if \\nbleeding is profuse.\\nIdentify avulsed teeth or jaw instability.\\nEvaluate for abdominal distention and tenderness.\\nIdentify penetrating chest, back, flank, or abdominal injuries.\\nAssess for pelvic stability; consider pelvic wrap or sling.\\nInspect perineum for laceration or hematoma.\\nInspect urethral meatus for blood.\\nConsider rectal examination for sphincter tone and gross blood.\\nAssess peripheral pulses for vascular compromise.\\nIdentify extremity deformities, and immobilize open and closed fractures and dislocations.\\n156_Cydulka_Ch156.indd   866 22/03/17   10:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 885, 'page_label': '867'}, page_content='CHAPTER 156: Trauma in Adults 867 \\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. The ED management of trauma patients begins prior to the patient’s \\narrival. Emergency medical service providers inform the receiving \\nED about the mechanism of trauma, vital sign values, suspected inju-\\nries, and treatments provided.\\n2. Airway patency is confirmed at the outset of the primary survey. In \\npatients making inadequate respiratory efforts, perform a jaw thrust, \\nand then insert an oral or nasal airway. Avoid nasal airway placement \\nin patients with suspected basilar skull fractures. Endotracheal intuba-\\ntion is indicated in comatose patients (GCS < 8) to protect the airway \\nand prevent secondary brain injury from hypoxemia. Agitated trauma \\npatients who need further diagnostic or therapeutic interventions or \\npatients whose expected course necessitates immediate operative man-\\nagement are also candidates for intubation. Whenever possible, use a \\ntwo-person spinal stabilization technique in which one caregiver pro-\\nvides in-line immobilization of the cervical spine while the other man-\\nages the airway. Trauma patients are often difficult to intubate due to \\nassociated facial trauma, cervical spine immobilization, or the presence \\nof blood or vomitus. In virtually all trauma patients requiring urgent \\nintubation, a rapid sequence intubation technique should be used. In \\ncases of extensive facial trauma or when endotracheal intubation is not \\npossible, cricothyrotomy or another advanced airway technique may be \\nused to secure the airway.\\n3. Once the airway is secured, examine the neck and thorax to detect \\nabnormalities such as a deviated trachea (tension pneumothorax), \\ncrepitus (pneumothorax), paradoxical mo vement of a chest wall seg-\\nment (flail chest), sucking chest wound, fractured sternum, or the \\nabsence of breath sounds on either side of the chest (simple or tension \\npneumothorax, massive hemothorax, or right mainstem intubation). \\nTreat tension pneumothorax immediately with needle decompression \\nfollowed by tube thoracostomy.\\n4. Rapidly assess the patient’s hemodynamic status during the primary \\nsurvey by noting the level of consciousness, skin color, and the pres-\\nence and magnitude of peripheral pulses. Note the heart rate, blood \\npressure, and pulse pressure (systolic minus diastolic blood pressure). \\nHemorrhage of up to 30% of total blood volume may be associated \\nwith only mild tachycardia and a decrease in pulse pressure, but may \\nquickly progress to shock if not recognized early. Establish two large-\\nbore peripheral IV lines, and obtain blood samples for laboratory stud-\\nies, particularly the blood type and screen. Establish a central line in \\npatients who are unstable or in whom upper extremity peripheral veins \\nare not easily cannulated. Current evidence indicates that early admin-\\nistration of tranexamic acid may reduce mortality.\\n5. Reassess hemodynamically unstable patients without an obvious indi-\\ncation for surgery after infusion of 2 L of warm crystalloid solution. If \\nthere is no marked improvement, consider the need to transfuse type O \\nblood (O-negative for females of childbearing age). An extended \\nfocused assessment with sonography for trauma (eFAST) examination \\nscreens for causes of shock immediately after the primary survey. If a \\npatient is hemodynamically stable, definitive imaging can be performed \\n156_Cydulka_Ch156.indd   867 22/03/17   10:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 886, 'page_label': '868'}, page_content='868 SECTION 18: Trauma\\nwith a CT scan of the abdomen and pelvis with IV contrast. Patients \\nwith penetrating abdominal trauma who are in shock should undergo \\nearly operative intervention.\\n6. Patients who sustain major trauma may develop a bleeding diathesis, \\nwhich results in defecti ve clotting and platelet function. If patients \\nrequire >10 units of packed red blood cells (PRBC), patients should \\nreceive PRBC in a 1:1 ratio with fresh frozen plasma. Both acidosis \\nand hypothermia contribute to the coagulopathy and should be cor -\\nrected as soon as possible.\\n7. After the primary survey and stabilization, perform an abbreviated  \\nneurologic examination, including an assessment of the patient’s level \\nof consciousness, GCS, pupillary size and reactivity, and motor func-\\ntion. A search for the cause of depressed level of consciousness \\nincludes the measurement of capillary blood glucose levels and the \\nconsideration of possible intoxicants, though one should begin with \\nthe assumption this is due to significant traumatic brain injury (TBI). \\nIn order to quickly identify potentially operative intracranial injuries \\namong patients with suspected traumatic brain injury and coma (GCS \\nof 3 to 8), defer any procedures that do not correct a specific problem \\nduring the primary survey until after the CT scan of the head is \\nperformed. Intubated patients should undergo continuous capnography. \\nGCS assessment can be insensitive in patients with normal or \\nnear-normal scores, and a GCS score of 15 does not exclude the \\npresence of TBI.\\n8. Once the patient is hemodynamically stable and the airway is secured, \\nlog-roll the patient with one team member assigned to maintain in-line \\ncervical stabilization. Palpate the spinous processes of the thoracic and \\nlumbar spine for tenderness or deformity. Consider performing a rectal \\nexamination to assess for gross blood, displaced prostate, or determining \\nrectal tone in the setting of a suspected spinal injury.\\n9. Certain conditions, such as injuries to the esophagus, diaphragm, and \\nsmall bowel, often remain undiagnosed ev en with diligent examina-\\ntion, and further imaging and hospital observation for delayed pre-\\nsentation may be required. The most frequently missed injuries are \\northopedic.\\n10. Expeditiously transport patients with hemodynamic instability and \\nongoing bleeding to the operating room or transfer them to another \\nfacility with appropriate surgical or critical care resources. Serial \\nexaminations are essential in patients without ob vious indications for \\nsurgery identified on the initial assessment. These examinations may \\nbe performed in the inpatient or, in some cases, the ED observation unit \\nsettings.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 254, “Trauma in Adults,” by Peter Cameron and \\nBarry J. Knapp.\\n156_Cydulka_Ch156.indd   868 22/03/17   10:32 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 887, 'page_label': '869'}, page_content='869\\nTrauma in Children\\nMatthew Hansen\\nTrauma is the most common cause of death in children older than 1 year. \\nDifferences in anatomy and physiology mandate modifications to trauma \\nevaluation and management in children.\\n■ ■CLINICAL FEATURES\\nHead trauma is the most frequent pediatric injury resulting in death. Over -\\nall, motor vehicle crash is the most common mechanism, and it is the lead-\\ning mechanism of traumatic death in children older than 1 year.\\nAirway: Airway management in children can be challenging. Anatomic \\ndifferences include a large occiput, large tongue, and cephalad location of \\nthe larynx.\\nBreathing: Observe the rate, depth, pattern, and work of breathing as well \\nas symmetry of rise and fall of the chest wall. Agitation or somnolence could \\nbe a result of hypoxia or hypercapnea, respectively. Children experience oxy-\\ngen desaturation more quickly due to high oxygen demand and small lungs.\\nCirculation: Recognize early signs of circulatory shock including \\ntachycardia, mental status changes, and color and perfusion abnormalities, \\nbecause hypotension is typically a terminal event in children. Estimate \\nnormal systolic blood pressure in children 1 to 10 years of age using the \\nfollowing formula: 90 + (2 × age) mm Hg; hypotension can be estimated \\nas systolic blood pressure less than 70 + (2 × age) mm Hg.\\nDisability: In younger children, the Modified Pediatric Glasgow Coma \\nScale (Table 157-1) should be used. This mirrors the Glasgow Coma Scale \\nfor eye opening and motor responses, but incorporates age-appropriate \\nmodifications for verbal responses. Perform a pupillary examination and \\nbasic assessment of tone and strength.\\nExposure: Disrobe and expose the child to completely assess for inju-\\nries. However, the ratio of surface area to mass is greater in children, \\nputting them at greater risk for hypothermia. Care should be taken to main-\\ntain normothermia.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nHead Injury\\nInfants and neonates are at the highest risk of significant intracranial \\ninjury. Mental status assessment should account for developmental stage \\nand patient anxiety. Parietal and occipital skull fractures are frequently \\n157\\nC HA p TER\\nTable 157-1 Modified pediatric Glasgow Coma Scale\\nCoos or babbles = 5\\nIrritable cry = 4\\nCries to pain = 3\\nMoans to pain = 2\\nNo response = 1\\n157_Cydulka_Ch157.indd   869 22/03/17   10:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 888, 'page_label': '870'}, page_content='870 SECTION 18: Trauma\\nassociated with intracranial bleeding. Noncontrast CT is the imaging \\nmodality of choice for intracranial injury in children. Scalp injuries, par -\\nticularly in neonates, may result in significant blood loss and shock. Please \\nsee Chapter 160 for a discussion on CT imaging in head trauma.\\nSpine Injuries\\nYoung children with spinal cord injuries often do not have associated \\nfractures since the ligaments are relatively elastic. “Clearing the cervical \\nspine” in children is challenging as there is little evidence to guide prac-\\ntice. Multisystem trauma and head trauma are general indications for \\nneck immobilization and cervical spine imaging. Please see Chapter 161 \\nfor a detailed discussion on the management of spine and spinal cord \\ninjuries. Due to the nature of spine injuries and the need to lower ionizing \\nradiation, plain films of the spine remain a useful tool.\\nChest Trauma\\nThe chest radiograph is an essential tool in the evaluation of any child with \\nchest trauma and CT imaging of the chest rarely changes management. \\nPulmonary contusions are the most common thoracic injury in children. \\nThe relatively compliant chest wall of the child means that serious injuries \\nto intrathoracic structures can be present without significant external signs. \\nRib fractures are less common in children and generally require a signifi-\\ncant mechanism of injury.\\nabdominal and Genitourinary Trauma\\nIndications for CT include suspicious mechanism of injury, tenderness on \\nexam, seatbelt sign, distention, and vomiting. A study of over 12,000 pedi-\\natric patients with blunt abdominal trauma recently found the following \\nfactors predicted very low risk for significant intraabdominal injury: (1) no \\nevidence of abdominal wall trauma/seat belt sign nor Glasgow Coma Scale \\n<14 with blunt abdominal trauma; (2) no abdominal tenderness on exami-\\nnation; and (3) no thoracic wall trauma, and no complaints of abdominal \\npain, decreased bowel sounds, or vomiting. Identification of a pelvic frac-\\nture, particularly an anterior ring fracture, should prompt investigation for \\nassociated urethral or bladder injury. The role of ultrasound for pediatric \\nabdominal trauma, especially in stable patients, is not well established.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Perform basic airway maneuvers such as jaw thrust and oropharyngeal \\nsuctioning and maintain a snif fing position to align the airway axes, \\noften by placing a towel roll under the shoulders, which is especially \\nhelpful in younger children to align the airway.\\n2. Orotracheal intubation is indicated for definitive airway management. \\nThe following formula is used to estimate the endotracheal tube size: \\nsize = 4 + (age/4), subtract ½ size for cuffed tubes which are often \\npreferred. Maintain in-line cervical spine stabilization at all times. Rapid \\nsequence intubation is the safest method of intubating a trauma patient \\nwith a full stomach. When possible, limit positive-pressure ventilation \\nbefore intubation to avoid gastric insufflation and vomiting.\\n157_Cydulka_Ch157.indd   870 22/03/17   10:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 889, 'page_label': '871'}, page_content='CHAPTER 157: Trauma in Children 871 \\n3. Vascular access can be challenging. Place two proximal IVs in critically \\nill patients. Obtain intraosseous access early, as needed. If central \\nvenous access is needed, the femoral vein is the most easily accessed \\nsite. Administer fluids in 20 mL/kg boluses of crystalloid; if there is no \\nresponse to two boluses, then administer 10 mL/kg boluses of packed \\nred blood cells. Permissive hypotension is not an evidence-based prac-\\ntice in children and may be harmful. Consider using a massive transfu-\\nsion protocol if large volume resuscitation is anticipated.\\n4. For pain control, fentanyl 1 µg/kg or morphine 0.05 to 0.1 mg/kg are \\nappropriate.\\n5. If a head injured patient has clinical signs of impending herniation, \\nmaintain the PaCO 2 at 35 to 40 mm Hg, optimize blood pressure with \\nIV fluids, and elevate the head of the bed 20° to 30°. See Table 157-2 for \\nhead injury management suggestions.\\nTable 157-2 Management of Serious Traumatic Brain Injury in Children\\nConsiderations primary Goals Comments\\nCervical spine Maintain spinal precautions\\nAirway Maintain airway, intubate \\nfor GCS <8 or as needed for \\noxygenation and ventilation\\nOxygenation and \\nventilation\\nOxygen saturation >90%; \\nPCO2 35–40 mm Hg\\nNo prophylactic hyperventilation\\nBlood pressure SBP > 70 + (2 × age) No permissive hypotension\\nCerebral perfusion \\npressure (CPP)\\nCPP = 40–65 mm Hg\\nIntracranial pressure \\n(ICP) monitoring\\nICP ≤20 mm Hg Consultation with neurosurgeon\\nGCS GCS before paralytics if \\npossible\\nSerial GCS to document changes\\nSedation and pain \\nmanagement\\nMidazolam\\nFentanyl\\nConsider paralytics once \\nthorough neurologic examination \\nis completed\\nNeuroimaging \\n(noncontrast head CT \\nand cervical spine CT \\nwhen indicated)\\nIdentify intracranial injury \\nand signs of increased \\nintracranial pressure or \\nherniation\\nTranscranial Doppler may be \\nuseful in infants with open \\nfontanelles but requires an \\nexperienced pediatric radiologist\\nGlucose Treat hypoglycemia and \\nhyperglycemia\\nMaintain normal blood glucose\\nIncreased ICP/impend-\\ning herniation\\nElevate head of bed  \\n30 degrees\\n3% normal saline 5 mL/kg bolus \\nover 10 min followed by infusion \\nof 0.1 mL/kg/h to maintain \\nserum Na within 155–165 mEq/L\\nor\\nMannitol 0.5–1 g/kg if \\nnormotensive (response is not \\ndose-dependent)\\nCore temperature Maintain temperature \\n36–38°C\\nHypothermia in children not rec-\\nommended; avoid hyperthermia\\n(Continued)\\n157_Cydulka_Ch157.indd   871 22/03/17   10:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 890, 'page_label': '872'}, page_content='872 SECTION 18: Trauma\\nTable 157-2 Management of Serious Traumatic Brain Injury in Children\\nConsiderations primary Goals Comments\\nSeizure prophylaxis Optional: consider for \\nchildren with witnessed \\nposttraumatic seizures and \\nintracranial blood\\nPhenytoin 20 mg/kg (or \\nfosphenytoin 20 PE/kg)\\nor\\nLevetiracetam 10–20 mg/kg \\n(maximum, 500 mg/dose) for first \\nweek following severe traumatic \\nbrain injury\\nAnemia Transfuse for hemoglobin \\n<7 g/dL\\nNeurosurgery/transfer ICP monitoring, evacuation of \\nintracranial blood, or cerebro-\\nspinal fluid shunt for refrac-\\ntory intracranial hypertension\\nAbbreviations: GCS, Glasgow Coma Scale; PCO2, partial pressure of carbon dioxide; PE, phenytoin \\nequivalent; SBP , systolic blood pressure.\\n6. Admit children with intracranial hemorrhage, spinal trauma, significant \\nchest trauma, abdominal trauma with internal organ injury , significant \\nburns, or other concerning injuries. Indications for referral to a pediatric \\ntrauma center are listed in Table 157-3.\\nTable 157-3 Indications for Transfer to a pediatric Trauma Center\\nMechanism of injury Ejection from motor vehicle\\nFall from a significant height\\nMotor vehicle collision with prolonged extrication\\nMotor vehicle collision with death of another vehicle occupant\\nAnatomic injury Multiple severe trauma\\nMore than three long-bone fractures\\nSpinal fractures or spinal cord injury\\nAmputations\\nSevere head or facial trauma\\nPenetrating head, chest, or abdominal trauma\\nSource: Reproduced with permission from Harris BH, Barlow BA, Ballantine TV, et al: American Pediatric \\nSurgical Association principles of pediatric trauma care. J Pediatr Surg. 1992;27:423. Copyright Elsevier.\\n■ ■FURTHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 110, “Pediatric Trauma,” by Camilo E. Gutiérrez.\\n(Continued)\\n157_Cydulka_Ch157.indd   872 22/03/17   10:49 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 891, 'page_label': '873'}, page_content='873\\nTrauma in the Elderly\\nO. John Ma\\nEmergency physicians need to be aware of the many unique mechanisms of \\ninjury and clinical features associated with geriatric trauma patients and \\napply special management principles when caring for them.\\n■ ■CLINICAL FEATURES\\nFalls are the most common cause of fatal and non-fatal injury in people \\n≥65 years of age. Syncope, which has been implicated in many cases, may \\nbe secondary to dysrhythmias, venous pooling, autonomic derangement, \\nhypoxia, anemia, or hypoglycemia. Motor vehicle crashes are the second \\nmost common cause of injury in the elderly and are the leading cause of \\ndeath. Elderly pedestrians struck by a motor vehicle are much more likely \\nto die than younger pedestrians. Intentional injuries and those caused by \\nneglect should also be considered.\\nEvaluate the geriatric trauma patient as both a medical and a trauma \\npatient. Since elderly patients may have a significant past medical history that \\nimpacts their trauma care, obtaining a precise history is vital. Family mem-\\nbers, medical records, and the patient’s primary physician may be helpful in \\ngathering information regarding the traumatic event and the patient’s previ-\\nous level of function. Document medications, such as cardiac agents, diuret-\\nics, psychotropic agents, and anticoagulants. Investigating the cause of a fall \\nmay uncover serious underlying medical causes or prevent future trauma.\\nOn physical examination, frequent monitoring of vital signs is essential. \\nAvoid feeling reassured by “normal” vital signs. A normal tachycardic \\nresponse to pain, hypovolemia, or anxiety may be absent or blunted in the \\nelderly trauma patient. Medications such as β-blockers may mask tachycar-\\ndia and delay appropriate resuscitation. Blood pressures are also misleading \\nin the elderly patient. Because of the high incidence of underlying hyperten-\\nsion, consider using a higher cutoff for hypotension than in younger patients. \\nIn blunt trauma patients ≥65 years, mortality increases when systolic blood \\npressure dips below 110 mm Hg and heart rates exceed 90 beats per minute.\\nPay special attention to anatomical variations that may make airway \\nmanagement more difficult. These include the presence of dentures, cervi-\\ncal arthritis, or temporomandibular joint arthritis. A thorough secondary \\nsurvey is essential to uncover less serious injuries. These “minor” injuries \\nmay not be severe enough to cause problems during the initial resuscitation, \\nbut cumulatively may cause significant morbidity and mortality. Seemingly \\nstable geriatric trauma patients can deteriorate rapidly and without warning.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nHead Injury\\nNever assume that alterations in mental status are due solely to any \\nunderlying dementia or senility when evaluating the elderly patient’s \\nmental status. Elderly persons suffer a much lower incidence of epidural \\n158\\nCh A p TER\\n158_Cydulka_Ch158.indd   873 22/03/17   10:58 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 892, 'page_label': '874'}, page_content='874 SECTION 18: Trauma\\nhematomas than the general population; howev er, there is a higher inci-\\ndence of subdural and intraparenchymal hematomas in the elderly than \\nin younger patients. The rate of intracranial hemorrhage approaches 7% \\nto 14% in anticoagulated patients with blunt head injury who are experi-\\nencing no or minimal symptoms. Order non-contrast head CT for \\npatients who take warfarin and have a mechanism of injury concerning \\nfor even a minor head injury.\\nCervical Spine Injuries\\nThe pattern of cervical spine injuries in the elderly is different than in \\nyounger patients, as there is an increased incidence of C1 and C2 frac-\\ntures with the elderly. Place special emphasis on maintaining cervical \\nimmobilization until the cervical spine is properly assessed. Because of \\nthe higher pre-test probability of injury, as well as the difficulties in \\ninterpreting plain radiographs in a patient with age-related degeneration, \\nCT scan is the preferred initial modality for assessing the geriatric \\ncervical spine.\\nChest Trauma\\nRib fractures are more common after blunt trauma due to osteoporotic \\nchanges. The pain associated with rib fractures, along with any decreased \\nphysiologic reserve, may predispose patients to respiratory complications. \\nMore severe thoracic injuries, such as hemopneumothorax, pulmonary \\ncontusion, flail chest, and cardiac contusion, can quickly lead to decompen-\\nsation in elderly individuals whose baseline oxygenation status may already \\nbe diminished.\\nAbdominal Trauma\\nThe abdominal examination in elderly patients is notoriously unreliable. \\nThe focused assessment with sonography for trauma (FAST) examination \\nassists in evaluating for hemoperitoneum and the need for exploratory \\nlaparotomy in hemodynamically unstable patients. The FAST examination \\nhas largely replaced diagnostic peritoneal lavage. Use CT with contrast for \\npatients who are hemodynamically stable. Ensure adequate hydration and \\nbaseline assessment of renal function prior to the contrast load for the CT \\nscan. Some patients may be volume-depleted due to medications, such as \\ndiuretics. This hypovolemia coupled with contrast administration may \\nexacerbate any underlying renal pathology.\\nOrthopedic Injuries\\nHip fractures occur primarily in four areas: intertrochanteric, transcervical, \\nsubcapital, and subtrochanteric. Intertrochanteric fractures are the most \\ncommon, followed by transcervical fractures. Be aware that pelvic and long \\nbone fractures are not infrequently the sole etiology for hypovolemia in \\nelderly patients. Coordinate timely orthopedic consultation, evaluation, and \\ntreatment with open reduction and internal fixation with the diagnosis and \\nmanagement of other injuries. Consider ordering CT of the pelvis in stable \\npatients with pelvic tenderness after an injury if plain radiographs are \\nnegative.\\n158_Cydulka_Ch158.indd   874 22/03/17   10:58 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 893, 'page_label': '875'}, page_content='CHAPTER 158: Trauma in the Elderly 875 \\nLong bone fractures of the femur, tibia, and humerus may produce a loss \\nof mobility with a resulting decrease in the independent lifestyle of elderly \\npatients. Early orthopedic consultation for intramedullary rodding of these \\nfractures may result in increased early mobilization.\\nThe incidence of Colles fractures and humeral head and surgical neck \\nfractures in elderly patients is increased by falls on the outstretched hand or \\nelbow. Localized tenderness, swelling, and ecchymosis to the proximal \\nhumerus are characteristic of these injuries. Arrange for early orthopedic \\nreferral.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nAs in all trauma patients, perform the primary and secondary surveys \\nexpeditiously.\\n1. The main therapeutic goal is maintaining adequate oxygen delivery . \\nConsider prompt tracheal intubation and use of mechanical ventila-\\ntion in patients with more severe injuries, respiratory rates > 40 breaths/\\nmin, or when the PaO 2 is <  60 mm Hg or PaCO 2 > 50 mm Hg. While \\nnonventilatory therapy helps prevent respiratory infections and is always \\ndesirable, early mechanical ventilation may avert the disastrous results \\nassociated with hypoxia.\\n2. Geriatric trauma patients can decompensate with over-resuscitation just \\nas quickly as the y can with inadequate resuscitation. During the initial \\nresuscitative phase, administer crystalloid judiciously since elderly \\npatients with diminished cardiac compliance are more susceptible to \\nvolume overload. Consider early and more liberal use of packed red \\nblood cell transfusion. This practice early in the resuscitation enhances \\noxygen delivery and helps minimize tissue ischemia.\\n3. Base deficit and lactate levels ar e useful initial indicators of shock, \\nand serial measurements can guide resuscitation progress.\\n4. Early invasive monitoring has been advocated to help physicians assess \\nthe elderly’s hemodynamic status. One study found that urgent invasive \\nmonitoring provides important hemodynamic information early, aids in \\nidentifying occult shock, limits hypoperfusion, helps prevent multiple \\norgan failure, and improves survival. Given the complications associated \\nwith pulmonary-artery catheters, research on the assessment of shock by \\nserum lactate and central or mixed venous oxygen saturation, and ongo-\\ning advances in less invasive hemodynamic monitoring and echocar -\\ndiography, the optimal approach to recognizing and treating occult \\nhypoperfusion is uncertain. A general strategy is to perform the initial \\nimaging necessary to identify life-threatening injuries (e.g., CT of the \\nhead, spine, chest, abdomen, and pelvis) and then transport to the ICU \\nfor aggressive optimization of hemodynamics, after which nonessential \\nimaging and interventions (e.g., extremity radiographs and suturing) can \\nbe performed.\\n5. Rapidly reverse anticoagulation in patients taking warf arin with intra-\\ncranial bleeding on CT scan. Lacking sufficient evidence for or \\nagainst, it is reasonable to reverse other forms of anticoagulation \\n(e.g., aspirin, clopidogrel, heparin) in patients with diagnosed intra-\\ncranial hemorrhage.\\n158_Cydulka_Ch158.indd   875 22/03/17   10:58 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 894, 'page_label': '876'}, page_content='876 SECTION 18: Trauma\\n6. Maintain a low threshold for admitting elderly patients with rib fractures \\nfor a period of observation until good pain control and pulmonary toilet \\nis assured.\\n7. Admit elderly patients with polytrauma, significant chest wall injuries, \\nabnormal vital signs, or e vidence of overt or occult hypoperfusion to \\nthe ICU.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 255, “Trauma in the Elderly,” by Ross J. Fleischman \\nand O. John Ma.\\n158_Cydulka_Ch158.indd   876 22/03/17   10:58 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 895, 'page_label': '877'}, page_content='877\\nTrauma in Pregnancy\\nJohn Ashurst\\nTrauma is the leading cause of nonobstetric morbidity and mortality in \\npregnant women. Motor vehicle collisions followed by falls and domestic \\nviolence are the most common causes of trauma in pregnancy and fetal \\nsurvival is highly dependent on maternal stabilization.\\n■ ■CLINICAL FEATURES\\nPhysiologic changes of pregnancy make it difficult to determine the \\nseverity of injury. Heart rate increases 10 to 20 beats per minute in the \\nsecond trimester while systolic and diastolic blood pressures drop 10 to \\n15 mm Hg. Blood volume can increase by 45%, but red cell mass \\nincreases to a lesser extent, leading to a physiologic anemia of pregnancy. \\nIt may be difficult to determine whether tachycardia, hypotension, or \\nanemia is due to blood loss or normal physiologic changes. Due to the \\nrelative hypervolemic state, the patient may lose 30% to 35% of blood \\nvolume before manifesting signs of shock. Pulmonary changes in preg-\\nnancy include elevation of the diaphragm and a decrease in residual \\nvolume and function residual capacity. Tidal volume increases, resulting \\nin hyperventilation with associated respiratory alkalosis. However, renal \\ncompensation causes the serum pH to remain unchanged. Gastric \\nemptying is also delayed, which places the pregnant trauma patient at a \\nhigher risk of aspiration.\\nThe anatomic changes in pregnancy affect the types of injuries that are \\ntypically seen in the mother. Splenic injury remains the most common \\ncause of abdominal hemorrhage in the pregnant trauma patient. After the \\n12th week of gestation, the enlarging uterus emerges from the pelvis and by \\n20 weeks reaches the level of the umbilicus. Uterine blood flow increases, \\nmaking severe maternal hemorrhage from uterine trauma more likely. The \\nuterus also can compress the inferior vena cava when the patient is supine, \\nleading to the “supine hypotension syndrome.” As pregnancy progresses, \\nthe small intestines are pushed cephalad, which causes an increased likeli-\\nhood of injury in penetrating trauma to the upper abdomen. The bladder \\nmoves into the abdomen in the third trimester, thereby increasing its sus-\\nceptibility to injury.\\nAbdominal trauma affects not only the mother but also the fetus. \\nFetal injuries are more likely to be seen in the third trimester and are \\noften associated with pelvic fractures or penetrating trauma in the \\nmother. Uterine rupture is rare but is associated with a very high fetal \\nmortality rate. More common complications of trauma include uterine \\nirritability, preterm labor, and placental abruption. Classically, the \\nmother will demonstrate abdominal pain, vaginal bleeding, and uterine \\ncontractions. Fetal–maternal hemorrhage occurs in more than 30% of \\ncases of significant trauma and may result in rhesus (Rh) isoimmuniza-\\ntion of Rh-negative women.\\n159\\nCh A p TER\\n159_Cydulka_Ch159.indd   877 22/03/17   11:03 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 896, 'page_label': '878'}, page_content='878 SECTION 18: Trauma\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nMaternal stability and survival offer the best chance for fetal well-being, \\nand no critical interventions or diagnostic procedures should be withheld \\nout of concern for potential adverse effects to the fetus. The initial sequence \\nof trauma resuscitation is unchanged. Special attention should be directed \\nto the gravid abdomen, examining for evidence of injury, tenderness, or \\nuterine contractions. If abdominal or pelvic trauma is suspected, perform a \\nsterile pelvic examination to assess for genital trauma, vaginal bleeding, or \\nruptured amniotic membranes after pelvic ultrasound to determine placen-\\ntal location. Fluid with a pH of 7 in the vaginal canal suggests amniotic \\nrupture, as does “ferning,” a branch-like pattern on drying of vaginal fluid \\non a microscope slide.\\nInitial laboratory studies include a complete blood count, serum chem-\\nistries, blood type, Rh status, and coagulation studies including fibrin split \\nproducts and fibrinogen to determine the presence of disseminated intravas-\\ncular coagulation. The Apt test or Kleihauer–Betke test should be obtained \\nto assess for the presence of fetal hemoglobin in the maternal blood.\\nObtain radiographs based on fundamental principles of trauma manage-\\nment. Adverse fetal effects from radiation are negligible from doses <5 rad, \\nwhich is an exposure far greater than that received from most plain radio-\\ngraphs. Reducing the number of imaging CT cuts and shielding of the \\nabdomen and pelvis when possible may decrease radiation exposure from \\nmedical imaging. Bedside ultrasonography is a highly sensitive, specific, \\nand radiation-free alternative for imaging the abdomen. In addition to \\nevaluating fetal heart rate, ultrasonography can assess gestational age, fetal \\nactivity or demise, placental location, and amniotic fluid volume. Diagnos-\\ntic peritoneal lavage has largely been replaced by ultrasonography. If it is \\nindicated, use the open supraumbilical technique.\\nAuscultate fetal heart tones to determine fetal viability and identify fetal \\ndistress early in the evaluation. A Doppler stethoscope or ultrasound facili-\\ntates this assessment. A normal fetal heart rate ranges between 120 and  \\n160 beats per minute. Fetal bradycardia is most likely a result of hypoxia \\ndue to maternal hypotension, respiratory compromise, or placental abrup-\\ntion. Fetal tachycardia is most likely due to hypoxia or hypovolemia. In the \\nsetting of blunt abdominal trauma, external fetal monitoring is indicated for \\nat least 4 to 6 hours for all patients beyond week 20 of gestation. Fetal \\ntachycardia, lack of beat-to-beat or long-term variability, or late decelera-\\ntions on tocodynamometry are diagnostic of fetal distress and may be indi-\\ncations for emergent cesarean section if beyond the viable gestational age.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nAs is the case of all trauma patients, initial priorities are the primary and \\nsecondary surveys directed at the pregnant trauma patient. Coordinate care \\nwith surgical and obstetric consultants.\\n1. Aggressive maternal resuscitation generally leads to the best possible \\nfetal resuscitation.\\n2. Initiate supplemental oxygen and crystalloid infusions at 50% above \\nthat given to nonpregnant patients. For patients beyond week 20 of \\ngestation who must remain supine, place a wedge under the right hip, \\n159_Cydulka_Ch159.indd   878 22/03/17   11:03 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 897, 'page_label': '879'}, page_content='CHAPTER 159: Trauma in Pregnancy 879 \\ntilting the patient 30° to the left, thus reducing the likelihood of supine \\nhypotension syndrome. Otherwise, keep the patient in a left lateral \\ndecubitus position.\\n3. Avoid vasopressors if possible as they can have deleterious effects on \\nuterine perfusion.\\n4. Administer tetanus prophylaxis when indicated.\\n5. Give Rho (D) immunoglob ulin for all Rh-negative pregnant patients \\nif indicated.\\n6. Institute cardiotocodynamometry as soon as possible to monitor for \\nfetal distress and uterine irritability.\\n7. Tocolytics have a variety of side effects, including fetal and maternal \\ntachycardia. Administer only in consultation with an obstetrician.\\n8. Indications for emergent laparotomy in the pregnant patient remain the \\nsame as those in the nonpregnant patient.\\n9. The decision to admit or discharge a pregnant trauma patient is first \\nbased on the nature and se verity of the presenting injuries. Women at \\n20 weeks of gestation require observation or admission for a minimum \\nof 4 to 6 hours for external tocodynamometric monitoring.\\n10. Screen for potential intimate partner violence.\\n11. Instruct discharged patients to seek medical attention immediately if \\nthey develop abdominal pain or cramps, vaginal bleeding, leakage of \\nfluid, or perception of decreased fetal activity.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 256, “Trauma in Pregnancy,” by Nicole M. Deiorio.\\n159_Cydulka_Ch159.indd   879 22/03/17   11:03 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 898, 'page_label': '880'}, page_content='880\\nHead Trauma\\nO. John Ma\\n■ ■CLINICAL FEATURES\\nTraumatic brain injury (TBI) is the impairment in brain function after direct \\nor indirect forces to the brain. The force of an object striking the head or a \\npenetrating injury causes direct injury. Indirect injuries occur from accel-\\neration/deceleration forces that result in the movement of the brain within \\nthe skull.\\nTraumatic brain injury can be classified as mild, moderate, and \\nsevere. Mild TBI includes patients with a Glasgow Coma Scale (GCS, \\nsee Table 160-1) score ≥14. Patients may be asymptomatic with only a \\nhistory of head trauma, or may be confused and amnestic of the event. \\nThey may have experienced a brief loss of consciousness and complain \\n160\\nCh A p TER\\nTable 160-1 Glasgow Coma Scale for All Age Groups\\n4 Years to Adult Child <4 Years Infant\\neye opening\\n4\\n3\\n2\\n1\\nSpontaneous\\nTo speech\\nTo pain\\nNo response\\nSpontaneous\\nTo speech\\nTo pain\\nNo response\\nSpontaneous\\nTo speech\\nTo pain\\nNo response\\nVerbal response\\n5\\n4\\n3\\n2\\n1\\nAlert and oriented\\nDisoriented \\nconversation\\nSpeaking but \\nnonsensical\\nMoans or unintel-\\nligible sounds\\nNo response\\nOriented, social, \\nspeaks, interacts\\nConfused speech, \\ndisoriented, consolable, \\naware\\nInappropriate words, \\ninconsolable, unaware\\nIncomprehensible, \\nagitated, restless, \\nunaware\\nNo response\\nCoos, babbles\\nIrritable cry\\nCries to pain\\nMoans to pain\\nNo response\\nMotor response\\n6\\n5\\n4\\n3\\n2\\n1\\n3–15\\nFollows commands\\nLocalizes pain\\nMoves or withdraws \\nto pain\\nDecorticate flexion\\nDecerebrate \\nextension\\nNo response\\nNormal, spontaneous \\nmovements\\nLocalizes pain\\nWithdraws to pain\\nDecorticate flexion\\nDecerebrate extension\\nNo response\\nNormal, spontane-\\nous movements\\nWithdraws to touch\\nWithdraws to pain\\nDecorticate flexion\\nDecerebrate \\nextension\\nNo response\\nNote: In intubated patients, the Glasgow Coma Scale verbal component is scored as a 1, and the total \\nscore is marked with a “T” (or tube) denoting intubation (e.g., 8T).\\n160_Cydulka_Ch160.indd   880 22/03/17   11:10 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 899, 'page_label': '881'}, page_content='CHAPTER 160: Head Trauma 881 \\nof a diffuse headache, nausea, and vomiting. Patients at high risk in this  \\nsubgroup include those with a skull fracture, large subgaleal swelling, \\nfocal neurologic findings, coagulopathy, age > 60 years, or drug/alcohol \\nintoxication.\\nModerate TBI includes patients with a GCS score of 9 to 13. Overall, \\n40% of these patients have an abnormality on CT scan and 8% require \\nneurosurgical intervention.\\nThe mortality of severe TBI (GCS score <9) approaches 40%. The \\nimmediate clinical priority in these patients is to prevent secondary brain \\ninjury, identify other life-threatening injuries, and identify treatable neuro-\\nsurgical conditions.\\nPrehospital medical personnel often provide critical parts of the his-\\ntory, including mechanism and time of injury, presence and length of \\nunconsciousness, initial mental status, seizure activity, vomiting, verbal-\\nization, and movement of extremities. For an unresponsive patient, con-\\ntact family and friends to gather key information including past medical \\nhistory, medications (especially anticoagulants), and recent use of alcohol \\nor drugs.\\nPerform a detailed neurologic examination that includes assessing the \\nmental status and GCS, pupils for size, reactivity, and anisocoria, cranial \\nnerve function, motor and sensory function, and any development of decor-\\nticate or decerebrate posturing.\\nSpecific Injuries\\nSkull Fractures\\nDepressed skull fractures are classified as open or closed, depending on the \\nintegrity of the overlying scalp. Although basilar skull fractures can occur \\nat any point in the base of the skull, the typical location is in the petrous \\nportion of the temporal bone. Findings associated with a basilar skull frac-\\nture include hemotympanum, cerebrospinal fluid (CSF) otorrhea or rhinor-\\nrhea, periorbital ecchymosis (“raccoon eyes”), and retroauricular \\necchymosis (Battle’s sign).\\nCerebral Contusion and Intracerebral Hemorrhage\\nCommon locations for contusions are the frontal poles, the subfrontal cor -\\ntex, and the temporal lobes. Contusions may occur directly under the site \\nof impact or on the contralateral side (contrecoup lesion). The contused \\narea is usually hemorrhagic with surrounding edema, and occasionally \\nassociated with subarachnoid hemorrhage. Neurologic dysfunction may be \\nprofound and prolonged, with patients demonstrating mental confusion, \\nobtundation, or coma. Focal neurologic deficits are usually present.\\nTraumatic Subarachnoid Hemorrhage\\nThis condition results from the disruption of subarachnoid vessels and \\npresents with blood in the CSF. Patients may complain of diffuse headache, \\nnausea, or photophobia. Traumatic subarachnoid hemorrhage may be the \\nmost common CT abnormality in patients with moderate or severe TBI. \\nSome cases may be missed if the CT scan is obtained less than 6 hours after \\ninjury.\\n160_Cydulka_Ch160.indd   881 22/03/17   11:10 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 900, 'page_label': '882'}, page_content='882 SECTION 18: Trauma\\nEpidural Hematoma\\nAn epidural hematoma results from an acute collection of blood between \\nthe inner table of the skull and the dura mater. It is typically associated with \\na skull fracture that lacerates a meningeal artery, most commonly the mid-\\ndle meningeal artery. Underlying injury to the brain may not necessarily be \\nsevere. In the classic scenario, the patient experiences loss of consciousness \\nafter a head injury. The patient may present to the ED with clear mentation, \\nsignifying the “lucid interval,” and then begin to develop mental status \\ndeterioration in the ED. A fixed and dilated pupil on the side of the lesion \\nwith contralateral hemiparesis is a classic late finding. The high-pressure \\narterial bleeding of an epidural hematoma can lead to herniation within \\nhours of injury. An epidural hematoma appears biconvex on CT scan.\\nSubdural Hematoma\\nA subdural hematoma (SDH), which is a collection of venous blood between \\nthe dura matter and the arachnoid, results from tears of the bridging veins \\nthat extend from the subarachnoid space to the dural venous sinuses. A com-\\nmon mechanism is sudden acceleration–deceleration. Patients with brain \\natrophy, such as in alcoholics or the elderly, are more susceptible to a SDH. \\nIn acute SDH, patients present within 14 days of the injury, and most \\nbecome symptomatic within 24 hours of injury. After 2 weeks, patients are \\ndefined as having a chronic SDH. Symptoms may range from a headache to \\nlethargy or coma. It is important to distinguish between acute and chronic \\nSDHs by history, physical examination, and CT scan. An acute SDH appears \\nas a hyperdense, crescent-shaped lesion that crosses suture lines.\\nHerniation\\nDiffusely or focally increased intracranial pressure (ICP) can result in her -\\nniation of the brain at several locations. Transtentorial (uncal) herniation \\noccurs when a SDH or temporal lobe mass forces the ipsilateral uncus of \\nthe temporal lobe through the tentorial hiatus into the space between the \\ncerebral peduncle and the tentorium. This results in compression of the \\noculomotor nerve and parasympathetic paralysis of the ipsilateral pupil, \\ncausing it to become fixed and dilated. When the cerebral peduncle is fur -\\nther compressed, it results in contralateral motor paralysis. The increased \\nICP and brainstem compression result in progressive deterioration in the \\nlevel of consciousness. Occasionally, the contralateral cerebral peduncle is \\nforced against the free edge of the tentorium on the opposite side, resulting \\nin paralysis ipsilateral to the lesion—a false localizing sign. Central trans-\\ntentorial herniation occurs with midline lesions in the frontal or occipital \\nlobes, or in the vertex. Bilateral pinpoint pupils, bilateral Babinski signs, \\nand increased muscle tone are found initially, which eventually develop \\ninto fixed midpoint pupils, prolonged hyperventilation, and decorticate \\nposturing. Cerebellotonsillar herniation through the foramen magnum \\noccurs much less frequently. Medullary compression causes flaccid paraly-\\nsis, bradycardia, respiratory arrest, and sudden death.\\nPenetrating Injuries\\nGunshot wounds and penetrating sharp objects can result in penetrating \\ninjury to the brain. The degree of neurologic injury will depend on the \\n160_Cydulka_Ch160.indd   882 22/03/17   11:10 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 901, 'page_label': '883'}, page_content='CHAPTER 160: Head Trauma 883 \\nenergy of the missile, whether the trajectory involves a single or multiple \\nlobes or hemispheres of the brain, the amount of scatter of bone and metal-\\nlic fragments, and whether a mass lesion is present.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nTables 160-2 and 160-3 provide evidence-based indications for obtaining a \\nCT scan of the head after injury.\\nTable 160-2 New Orleans Criteria and Canadian CT head Rule Clinical Decision \\nRules\\nNew Orleans Criteria—GCS 15* Canadian CT head Rule—GCS 13–15*\\nHeadache GCS <15 at 2 h\\nVomiting Suspected open or depressed skull fracture\\nAge >60 years Age ≥65 years\\nIntoxication More than one episode of vomiting\\nPersistent antegrade amnesia Retrograde amnesia >30 min\\nEvidence of trauma above the clavicles Dangerous mechanism (fall >3 ft or struck  \\nas pedestrian)\\nSeizure Any sign of basal skull fracture\\nIdentification of patients who have an intracranial lesion on CT\\n100% sensitive, 5% specific 83% sensitive, 38% specific\\nIdentification of patients who will need neurosurgical intervention\\n100% sensitive, 5% specific 100% sensitive, 37% specific\\n*Presence of any one finding indicates need for CT scan.\\nAbbreviation: GCS, Glasgow Coma Scale.\\nTable 160-3 CT Scanning for Adults with Brain Injury (American College of \\nEmergency physicians Guidelines)\\nadults with a Glasgow Coma Scale score of <15 at the time of evaluation should \\nundergo CT imaging\\nMild traumatic brain injury with or without loss of consciousness:  if one or more of the \\nfollowing is present:\\nGlasgow Coma Scale score <15\\nFocal neurologic findings\\nVomiting more than two times\\nModerate to severe headache\\nAge >65 years\\nPhysical signs of basilar skull fracture\\nCoagulopathy\\nDangerous mechanism of injury (e.g., fall >4 ft)\\nMild traumatic brain injury with loss of consciousness or amnesia: if one or more of the \\nfollowing is present:\\nDrug or alcohol intoxication\\nPhysical evidence above the clavicles\\nPersistent amnesia\\nPosttraumatic seizures\\n160_Cydulka_Ch160.indd   883 22/03/17   11:10 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 902, 'page_label': '884'}, page_content='884 SECTION 18: Trauma\\nApproximately 8% of patients suffering a severe TBI will have an asso-\\nciated cervical spine fracture. Obtain imaging studies of the cervical spine \\non all trauma patients who present with altered mental status, neck pain, \\nintoxication, neurologic deficit, severe distracting injury, or if the mecha-\\nnism of injury is deemed serious enough to potentially produce cervical \\nspine injury.\\nLaboratory work should include type and crossmatching, complete \\nblood count, basic metabolic panel, arterial blood gas analysis, directed \\ntoxicologic studies, and coagulation studies.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Initiate standard protocols for evaluation and stabilization of trauma \\npatients (see Chapter 156). Diligently assess for other significant \\ninjuries.\\n2. Administer oxygen, and secure cardiac monitoring and two IV lines. \\nFor patients with sev ere TBI, endotracheal intubation (via rapid \\nsequence intubation) to protect the airway and prevent hypoxemia is \\nthe top priority. Provide cervical spine immobilization, and use an \\nadequate sedation/induction agent when securing the airway.\\n3. Hypotension is associated with increased mortality rates. Restoration \\nof an adequate blood pressure is vital to maintain cerebral perfusion. \\nResuscitation with IV crystalloid fluid to a mean arterial pressure \\n(MAP) of 80 mm Hg is indicated; if aggressive fluid resuscitation is \\nnot effective, then add vasopressors to maintain a MAP of 80 mm Hg.\\n4. Obtain immediate neurosurgical consultation  after a head CT scan \\ndemonstrating intracranial injury has been identified. Patients with new \\nneurologic deficits from an acute epidural or SDH require emergent \\nneurosurgical treatment.\\n5. All patients who demonstrate signs of increased ICP should hav e the \\nhead of their bed elevated to 30° (provided that the patient is not \\nhypotensive), adequate sedation, and maintenance of adequate arterial \\noxygenation. If the patient is not hypotensive, consider administering \\nmannitol 0.25 to 1.0 g/kg IV in repetitive boluses. If the patient is \\nhypotensive or inadequately fluid resuscitated, consider administering \\nhypertonic saline as an alternative to mannitol. The adult dose of 3% \\nNaCl is 250 mL over 30 minutes.\\n6. Hyperventilation is not recommended as a prophylactic intervention to \\nlower ICP because of its potential to cause cerebral ischemia. Reserve \\nhyperventilation as a last resort for decreasing ICP; if used, implement \\nit as a temporary measure and monitor the PCO 2 closely to maintain a \\nrange of 30 to 35 mm Hg.\\n7. Patients with signs of impending brain herniation may need emergency \\ndecompression by trephination (“b urr holes”) when all other methods \\nto control the elevated ICP have failed. CT scan prior to attempting \\ntrephination is recommended to localize the lesion and direct the \\ndecompression site.\\n8. Treat seizures immediately with benzodiazepines, such as lorazepam, \\nand fosphenytoin at a loading dose of 18 to 20 mg PE per kilogram IV .\\n9. Use of prophylactic anticonvulsants remains controv ersial, and its \\nadministration should be in consultation with the neurosurgeon.\\n160_Cydulka_Ch160.indd   884 22/03/17   11:10 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 903, 'page_label': '885'}, page_content='CHAPTER 160: Head Trauma 885 \\n10. Admit patients with a basilar skull fracture or penetrating injuries (gun-\\nshot wound or stab wound) to the neurosurgical service, and start them \\non prophylactic antibiotic therapy (e.g., ceftriaxone 2 g IV and vanco-\\nmycin 1 g IV).\\n11. Discharge patients who have an initial GCS score of 15 that is main -\\ntained during an observation period and who have normal serial \\nneurologic examinations and a normal CT scan. Those who have an \\nabnormal CT scan require neurosurgical consultation and admission. \\nPatients who have an initial GCS score of 14 and a normal CT scan \\nshould be observed in the ED. If their GCS score improves to 15 and \\nthey remain symptom free and neurologically intact after serial \\nexaminations, they can be discharged home. Discharge patients home \\nwith a reliable companion who can observe them for at least 24 \\nhours, and carry out appropriate discharge instructions.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 257, “Head Trauma” by David W. Wright and Lisa H. \\nMerck.\\n160_Cydulka_Ch160.indd   885 22/03/17   11:10 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 904, 'page_label': '886'}, page_content='886\\nSpine Trauma\\nJeffrey Dan\\nSpine and spinal cord injuries (SCIs) can be devastating, life-changing \\nevents that include injury to the bony elements (vertebral fracture), the \\nneural elements (spinal cord and nerve root injury), or both.\\n■ ■CLINICAL FEATURES\\nThe spinal cord is most commonly injured by a direct mechanical cause, \\nwith resultant hemorrhage, edema, and ischemia. Patients may complain of \\nneck and back pain, and close examination may note pain or bony abnor -\\nmalities with palpation. Unstable spinal fractures may present without \\nobvious spinal cord or nerve root trauma. Symptomatic patients may com-\\nplain of paresthesias, dysesthesias, weakness, bowel or bladder inconti-\\nnence, urinary retention, or other sensory disturbances with or without \\nspecific physical examination findings. More severely injured patients may \\nhave obvious neurologic deficits.\\nComplete spinal cord lesions are characterized by the absence of sen-\\nsory and motor function below the level of injury (Figs. 161-1 and 161-2).\\nIncomplete lesions have a better prognosis, and denote some degree of \\nneurologic activity below the injury, but their initial diagnosis may be \\nobscured because of spinal shock. Spinal shock is the temporary loss or \\ndepression of spinal reflex activity below the level of injury to the spinal \\ncord. Spinal shock can persist for days to weeks and prohibit the differen-\\ntiation of an incomplete and complete lesion (Table 161-1).\\nNeurogenic shock refers to the loss of sympathetic innervation leading \\nto relative bradycardia and hypotension. Hemorrhage must be excluded as \\nthe explanation for hypotension before neurogenic shock is considered. The \\npresence of neurogenic shock may necessitate inotropic support.\\nSpinal cord injury without radiographic abnormality (SCIWORA) is an \\nentity seen most often in the pediatric population. Numbness, paresthesias, \\nor other neurologic complaints with normal plain radiographs or CT should \\nprompt further evaluation with MRI.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nConsider an injury to the spine or spinal cord in any patient with an appro-\\npriate traumatic mechanism. Suspect SCI with any neurologic complaints, \\neven if transitory. A complete neurologic examination should include motor \\nstrength and tone (corticospinal tract), pain and temperature sensation (spi-\\nnothalamic tract), proprioception and vibration sensation (dorsal columns), \\nreflexes, perianal sensation and wink, and bulbocavernosus reflex. “Sacral \\nsparing” denotes preservation of reflexes and an incomplete SCI.\\nValidated clinical guidelines exist to identify patients who may benefit \\nfrom cervical spine imaging. The NEXUS (Tables 161-2) and the Canadian \\nCervical Spine Rule for Radiography (Table 161-3) are intended for alert, \\nstable adult patients.\\n161\\nCh A p TER\\n161_Cydulka_Ch161.indd   886 22/03/17   11:17 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 905, 'page_label': '887'}, page_content='CHAPTER 161: Spine Trauma 887 \\nC1 C1 C1\\n2\\n2\\n3\\n4\\n5\\n6\\n7\\n8\\n9\\n10\\n11\\n12\\n3\\n4\\n5\\n6\\n7\\n8\\nT1\\nL1\\n2\\n3\\n4\\n5\\nC2\\nC3\\nC4\\nC5\\nC6\\nC7\\nC8\\nT1\\nT2\\nT3\\nT4\\nT5\\nT6\\nT7\\nT8\\nT9\\nT10\\nT11\\nT12\\nL1 L1\\nL2\\nL3\\nL4\\nL5\\n5\\n4\\n3\\n2\\n12\\n11\\n10\\n9\\n8\\n7\\n6\\n5\\n4\\n3\\n2\\nT1\\n7\\n6\\n5\\n4\\n3\\n2\\nS1\\nS2\\nS3\\nS4\\nVoluntary rectal toneS2,S3,S4 - Bladder\\nAnal sphincter\\nAnkle plantar flexionS1,S2\\nGastrocnemius\\nGreat toe extensionL5,S1 - Extensor\\nhallucis longus\\nAnkle dorsiflexionL4,L5\\nTibialis anterior\\nKnee flexionL4,L5,S1,S2\\nHamstrings\\nKnee extensionL2,L3,L4 - Quadriceps\\nL1,L2,L3 - Iliopsoas Hip flexion\\nT9–T12 - Abdominal muscles\\nT2–T7 - Chest muscles\\nFinger abduction\\nHand grasp\\nC8,T1 - Hand intrinsics\\nFlexor digitorum profundus\\nElbow extensionC7 ,C8 - Triceps\\nC6,C7 - Extensor\\ncarpi radialis\\nWrist extension\\nC5,C6 - Deltoid\\nBiceps\\nArm abduction\\nElbow flexion\\nS5\\nCo\\nFigure 161-1.  Spinal cord level. The spinal cord level of injury can be delineated \\nby physical examination, including a detailed neurologic examination.\\nHigh-resolution CT is more sensitive and specific for cervical spine \\nfractures than plain films, and is the modality of choice at most trauma \\ncenters for suspected cervical spine injuries. For plain radiography of the \\ncervical spine, at least three views (lateral, odontoid, and anteroposterior) \\nare necessary.\\nBoth CT and plain radiography can miss purely ligamentous injuries. \\nSensitivity is not high enough to rely on flexion-extension films. When \\nligamentous injury is suspected, reliable patients can be discharged with a \\nfirm foam collar for follow-up in 3 to 5 days with a spine surgeon. \\n161_Cydulka_Ch161.indd   887 22/03/17   11:17 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 906, 'page_label': '888'}, page_content='888 SECTION 18: Trauma\\nC2\\nC3\\nC4C5 C5C6 C6\\nT1 T1C8 C8C7 C7T2\\nT3\\nT4\\nT5\\nT6\\nT7\\nT8\\nT9\\nT10\\nT12\\nT11\\nL1\\nL2 L2L3L5 L5\\nL4 L4L3 L3S1 S1S2 S2\\nS3 S3\\nS4\\nS5 S6\\nCoc\\nC2\\nC3\\nC4 C4C5 C5C6 C6\\nT1 T1C8 C8T2T3\\nT4\\nT5\\nT6\\nT7\\nT8\\nT9\\nT10\\nT12\\nT11\\nL1L2 L2L5 L5\\nL4 L4\\nL3 L3\\nS1 S1\\nS3 S3\\nC7 C7\\nFigure 161-2. Dermatomes for sensory examination.\\nTable 161-1 Four Major Incomplete Spinal Cord Syndromes\\nSyndrome Mechanisms Symptoms\\nGeneral \\nprognosis*\\nAnterior cord Direct anterior cord \\ncompression\\nComplete paralysis below \\nthe lesion with loss of pain \\nand temperature sensation\\nPoor\\nFlexion of cervical spine\\nThrombosis of anterior \\nspinal artery\\nPreservation of propriocep-\\ntion and vibratory function\\nCentral cord Hyperextension injuries Quadriparesis—greater in \\nthe upper extremities than \\nthe lower extremities. Some \\nloss of pain and temperature \\nsensation, also greater in \\nthe upper extremities\\nGood\\nDisruption of blood flow \\nto the spinal cord\\nCervical spinal stenosis\\nBrown- Séquard Transverse hemisection \\nof the spinal cord\\nIpsilateral spastic paresis, \\nloss of proprioception and \\nvibratory sensation, and con-\\ntralateral loss of pain and \\ntemperature sensation\\nGood\\nUnilateral cord  \\ncompression\\n*Outcome improves when the effects of secondary injury are prevented or reversed.\\nAlternatively, MRI provides the most sensitive and specific view of the \\nligaments and neural structures. The mechanisms, characteristics, and sta-\\nbility of common cervical spine fractures are summarized in Table 161-4.\\n161_Cydulka_Ch161.indd   888 22/03/17   11:17 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 907, 'page_label': '889'}, page_content='CHAPTER 161: Spine Trauma 889 \\nTable 161-2 NEXUS Criteria\\nAbsence of midline cervical tenderness\\nNormal level of alertness and consciousness*\\nNo evidence of intoxication\\nAbsence of focal neurologic deficit\\nAbsence of painful distracting injury†\\n*Abnormal defined as Glasgow coma scale score <15; disorientation to person, place, time, or events; \\ninability to remember three objects at 5 minutes; delayed or inappropriate response to external stimuli.\\n†Any injury thought “to have the potential to impair the patient’s ability to appreciate other injuries.”\\nTable 161-3 Canadian Cervical Spine Rule for Radiography: Cervical Spine \\nImaging Unnecessary in patients Meeting These Three Criteria\\nAssessment Definitions\\nAssessment #1:\\nThere are no high-risk factors that  \\nmandate radiography.\\nHigh-risk factors include:\\nAge 65 years or older\\nA dangerous mechanism of injury*\\nThe presence of paresthesias in the extremities\\nAssessment #2:\\nThere are low-risk factors that allow a \\nsafe assessment of range of motion.\\nLow-risk factors include:\\nSimple rear-end motor vehicle crashes\\nPatient able to sit up in the ED\\nPatient ambulatory at any time\\nDelayed onset of neck pain\\nAbsence of midline cervical tenderness\\nAssessment #3:\\nThe patient is able to actively rotate \\nhis/her neck (regardless of pain).\\nCan rotate neck 45 degrees to the left and to \\nthe right\\n*Defined as fall from a height of >3 feet; an axial loading injury; high-speed motor vehicle crash, roll-\\nover, or ejection; motorized recreational vehicle or bicycle collision.\\nWith regard to the thoracic and lumbar spine, plain radiography may \\nstill have a role in the mildly injured patient, but CT imaging is the standard \\nat most trauma centers as it is more sensitive than plain radiography and CT \\nis better at defining the extent and stability of spinal fractures.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nTreat blunt and penetrating injuries to the spine with identification and \\nstabilization of identified injuries, and prevention of secondary injuries.\\n1. Airway and breathing should be assessed with a low threshold for endo-\\ntracheal intubation for patients with cervical spine injury at C5 and \\nabove since the diaphragm is innervated by C3 through C5. Airway \\ncompromise can also occur due to soft tissue swelling associated with \\nhigh cervical spine fractures.\\n2. Hypotension should be assumed to be from hypovolemic shock until \\nproven otherwise. Hypotensive neurogenic shock should be considered \\nif the patient has a probable spinal cord injury, does not have acute blood \\nloss, and is warm and relatively bradycardic.\\n3. Collars and long boards should be removed as soon as clinically appro-\\npriate. In patients with penetrating neck injuries who are neurologically \\n161_Cydulka_Ch161.indd   889 22/03/17   11:17 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 908, 'page_label': '890'}, page_content='890 SECTION 18: Trauma\\nTable 161-4 Cervical Spine Injuries\\nFlexion\\nAnterior subluxation (hyperflexion sprain) (stable)*\\nBilateral interfacetal dislocation (unstable)\\nSimple wedge (compression) fracture (usually stable)\\nSpinous process avulsion (clay-shoveler’s fracture) (stable)\\nFlexion teardrop fracture (unstable)\\nFlexion-rotation\\nUnilateral interfacetal dislocation (stable)\\nPillar fracture\\nFracture of lateral mass (can be unstable)\\nVertical compression\\nJefferson burst fracture of atlas (potentially unstable)\\nBurst (bursting, dispersion, axial-loading) fracture (unstable)\\nHyperextension\\nHyperextension dislocation (unstable)\\nAvulsion fracture of anterior arch of atlas (stable)\\nExtension teardrop fracture (unstable)\\nFracture of posterior arch of atlas (stable)\\nLaminar fracture (usually stable)\\nTraumatic spondylolisthesis (hangman’s fracture) (unstable)\\nLateral flexion\\nUncinate process fracture (usually stable)\\nInjuries caused by diverse or poorly understood mechanisms\\nOccipital condyle fractures (can be unstable)\\nOccipitoatlantal dissociation (highly unstable)\\nDens fractures (type II and III are unstable)\\n*Usual occurrence. Overall stability is dependent on integrity of the other ligamentous structures.\\nintact and fully conscious, spinal immobilization is no longer recom-\\nmended. Log rolling and maintenance of inline immobilization should \\nbe used while removing the board.\\n4. Patients with cervical fractures will typically require admission. Spine \\nprecautions should be maintained and assessment and stabilization of \\nother injuries should be performed.\\n5. Thoracic and lumbar fractures are high-energy fractures and patients are \\nat risk for other injuries, such as injuries to the aorta, spinal cord, \\nintraabdominal or thoracic organs. Most patients with acute fractures \\nshould be admitted to or managed by a spine surgeon. Patients with \\ncompression or wedge fractures with <40% vertebral height loss may, \\nin consultation with a spine surgeon, be treated as an outpatient, but \\npatients with burst fractures and chance fractures should be admitted. \\nImaging with CT should be considered.\\n6. Injuries to the sacral spine and nerve roots are unusual, and are usually \\nfound in association with pelvic fractures. Bladder and bowel dysfunc-\\ntion, radiculopathy and damage to the cauda equina can all result from \\nsacral fractures. Isolated coccyx fractures usually require pain control \\nand a rubber doughnut pillow.\\n7. High-dose steroids (methylprednisolone) are no longer routinely recom-\\nmended for spinal cord injuries as a result of blunt trauma due to \\n161_Cydulka_Ch161.indd   890 22/03/17   11:17 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 909, 'page_label': '891'}, page_content='CHAPTER 161: Spine Trauma 891 \\npotentially harmful side effects. If high-dose steroids are considered, \\nconsultation with the spinal surgeon is recommended prior to  \\nadministration.\\n8. Discharge patients who are adequately e valuated and found to have no \\nindications for admission with appropriate follow-up in 3 to 5 days. \\nProvide these patients with analgesics and specific return precautions.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 258, “Spine Trauma,” by Go Steven.\\n161_Cydulka_Ch161.indd   891 22/03/17   11:17 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 910, 'page_label': '892'}, page_content='892\\nFacial Injuries\\nGerald (Wook) Beltran\\nSevere facial injuries are associated with injuries to the brain, orbit, cervical \\nspine, and lungs. After stabilization of life-threatening injuries during the \\nprimary survey, a thorough secondary survey should identify facial injuries \\nthat could affect the patient’s normal appearance, vision, smell, mastica-\\ntion, and sensation.\\n■ ■CLINICAL FEATURES\\nA thorough history should begin with questions directed toward whether the \\npatient has vision changes, malocclusion, or facial numbness (Table 162-1). \\nThe physical examination begins with inspection, noting facial asymmetry, \\nfacial elongation, exophthalmos or enophthalmos, and periorbital or mastoid \\necchymosis. Next, palpate the entire face, noting step-offs and tenderness \\nthat suggest fractures, and crepitus that suggests a sinus fracture. Finally, \\nperform a focused and thorough examination of the eyes, nose, ears, and \\nmouth, as described in Table 162-1.\\n162\\nCh A p TER\\nTable 162-1 Important Clinical Issues in Facial Trauma\\nHistory\\nHow is your vision?\\nBinocular diplopia suggests entrapment of the extraocular muscles; monocular dip-\\nlopia suggests a lens dislocation.\\nDo any parts of your face feel numb?\\nAnesthesia suggests damage to the supraorbital, infraorbital, or mental nerves.\\nDoes your bite feel normal?\\nMalocclusion typically occurs with mandibular or maxillary fractures.\\nInspection\\nLateral view for dish face with Le Fort III fractures.\\nFrontal view for donkey face with Le Fort II or III fractures.\\nBird’s eye view for exophthalmos with retrobulbar hematoma.\\nWorm’s view for endophthalmos with blow-out fractures or flattening of malar promi-\\nnence with zygomatic arch fractures.\\nRaccoon’s eyes (bilateral periorbital ecchymosis) and Battle sign (mastoid ecchymosis) \\ntypically develop over several hours, suggesting basilar skull fracture.\\nPalpation\\nPalpating the entire face will detect the majority of fractures.\\nIntraoral palpation of the zygomatic arch, palpating lateral to posterior maxillary \\nmolars to distinguish bony from soft tissue injury.\\nAssess for Le Fort fractures by gently rocking the hard palate with one hand while \\nstabilizing the forehead with the other.\\n(Continued)\\n162_Cydulka_Ch162.indd   892 22/03/17   11:25 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 911, 'page_label': '893'}, page_content='CHAPTER 162: Facial Injuries 893 \\nTable 162-1 Important Clinical Issues in Facial Trauma\\nEye\\nExamine early before swelling of lids, or use retractors. Document visual acuity.\\nFat through eyelid wound indicates an orbital septum perforation.\\nWidening of the distance between the medial canthi, or telecanthus, suggests serious \\nnasoethmoidal-orbital complex trauma. Widening of the distance between the pupils, or \\nhypertelorism, results from orbital dislocation and often is associated with blindness.\\nExamine extraocular muscle movements. Limited upward gaze occurs with entrapment \\nof the inferior rectus or inferior oblique muscles, or damage to the oculomotor nerve.\\nSystematically examine the eye. Specifically, the pupil for teardrop sign pointing to \\nglobe rupture, the anterior chamber for hyphema, and swinging flashlight test for \\nafferent papillary defect. Perform a fluoroscein test for corneal abrasions or ulcers.\\nCheck intraocular pressure for evidence of orbital compartment syndrome only in \\nabsence of globe injury.\\nNose\\nCrepitus over any facial sinus suggests sinus fracture.\\nSeptal hematoma appears as blue, boggy swelling on nasal septum. Should be incised \\nand drained to avoid a saddle nose deformity.\\nEars\\nAuricular hematomas should be incised and drained to avoid a cauliflower deformity.\\nCerebrospinal fluid leak, auditory canal lacerations, and hemotympanum suggest basilar \\nskull fracture.\\nOral\\nJaw deviation due to mandible dislocation or condyle fracture. Malocclusion occurs in \\nmandible, zygomatic, and Le Fort fractures.\\nAssess for missing or injured teeth.\\nLacerations and mucosal ecchymosis suggest mandible fracture.\\nPlace finger in external ear while the patient gently opens and closes jaw to detect \\ncondyle fractures.\\nTongue blade test: Patient without fracture can bite down on a tongue blade enough to \\nbreak blade twisted by examiner.\\n(Continued)\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nDiagnosis of many maxillofacial injuries is made clinically and with radio-\\ngraphs. Plain films are helpful if CT is not available or to screen for injuries \\nin low-risk patients. Facial CT is frequently required to make the definitive \\ndiagnosis and guide surgical management. Imaging recommendations \\nbased on suspected injury sites and pretest clinical suspicion are summa-\\nrized in Table 162-2.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nDuring the primary survey of facial trauma patients, the airway must be \\nsecured and stabilized as clinically indicated. When endotracheal intubation \\nis required, the orotracheal route is preferred over the nasotracheal route \\nbecause of concern for nasocranial intubation, worsening of injury, and \\nsevere epistaxis. While rapid sequence intubation is the preferred method \\nof airway management in trauma, always plan for a difficult airway in \\npatients with facial trauma. To prevent the “can’t intubate/can’t oxygen-\\nate” failed airway, do not administer paralytics unless a patient can be \\nbagged effectively or alternative airway devices or plans are in place. \\n162_Cydulka_Ch162.indd   893 22/03/17   11:25 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 912, 'page_label': '894'}, page_content='894 SECTION 18: Trauma\\nAwake intubation with sedation and local airway anesthesia may allow \\nthe emergency physician to determine the feasibility of orotracheal intu-\\nbation while still preserving a patient’s airway reflexes. When endotra-\\ncheal intubation appears impossible or is unsuccessful, perform emergent \\ncricothyroidotomy to secure the airway. The laryngeal mask airway may \\nbe used as a temporizing measure, but it does not protect the airway from \\naspiration of stomach contents and may not be possible with injuries \\ninvolving the pharynx.\\nSevere midfacial and mandibular injuries can result in substantial hem-\\norrhage from the sphenopalatine and greater palatine branches of the \\nexternal carotid artery. Posterior nasal epistaxis can be controlled with \\nnasal tampons, dual balloon devices, or Foley catheter placement with \\nlayered gauze packing anteriorly, again being careful to avoid intracranial \\nplacement in severe midfacial fractures. Rarely, reduction of significantly \\ndisplaced nasal fractures and Le Fort injuries is needed to stop arterial \\nbleeding. If bleeding persists, immediate operative intervention may be \\nrequired to ligate injured vessels. Alternatively, arterial embolization may \\nbe pursued to control bleeding from branches of the external carotid artery.\\nManagement decisions will be dictated by the location and severity of \\nthe facial fractures, as well as concurrent injuries. Typically patients with \\nsinus fractures should receive oral or intravenous antibiotics, such as first-\\ngeneration cephalosporins, clindamycin, or amoxicillin-clavulanate.\\nFrontal sinus fractures are uncommon, and increase the immediate \\nrisk of traumatic brain injury, additional facial fractures, and cervical spine \\ninjury due to the amount of force needed to fracture the thick frontal bone. \\nBecause the dura is adherent to the posterior table of the frontal sinus, \\noperative repair of through-and-through frontal sinus fractures is necessary \\nto prevent pneumocephalus, cerebrospinal fluid (CSF) leak, and infection. \\nPatients with depressed fractures also require admission for IV antibiotics \\nand operative repair. Patients with isolated anterior table fractures of the \\nfrontal sinus may be discharged with appropriate follow-up with a facial \\nsurgeon.\\nNaso-orbito-ethmoid fractures result from significant trauma to the \\nnasal bridge, and often have associated injury to the lacrimal duct, dural \\nTable 162-2 Recommendations for Imaging Based on Level of Injury and Clinical \\nFindings\\nLevel Low Suspicion\\nSignificant Clinical \\nFindings Additional Considerations\\nFrontal bone Head CT Head CT (skull \\nwindows)\\nFacial CT with orbital involvement.\\nCervical spine CT with significant \\nclinical findings\\nMidface Waters’ view Face CT with \\ncoronal and axial \\nsections\\nCoronal face sections require \\ncervical spine clearance for \\npositioning.\\nComputer-generated, three-\\ndimensional reconstructions with \\ncomplex injuries\\nHead CT can replace Waters’ view\\nMandible Panorex Mandible CT Facial CT detects mandible fractures\\n162_Cydulka_Ch162.indd   894 22/03/17   11:25 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 913, 'page_label': '895'}, page_content='CHAPTER 162: Facial Injuries 895 \\ntears, and traumatic brain injury. Patients with these fractures require \\nadmission for specialty consultation with facial surgery and neurosurgery.\\nOrbital blowout fractures occur when a blunt object strikes the globe, \\ntransmitting force through the fluid-filled eye, and fracturing the medial or \\ninferior orbital wall. Surgery may be required if these injuries result in \\nextraocular muscle or oculomotor nerve entrapment, or significant enoph-\\nthalmos. A fracture involving the superior orbital fissure can damage the \\noculomotor and ophthalmic divisions of the trigeminal nerve (the “orbital \\nfissure syndrome”), and can involve the optic nerve as well (the “orbital \\napex syndrome”). Patients with either of these syndromes require emergent \\nophthalmologic consultation. All other patients with isolated orbital frac-\\ntures can be managed expediently as an outpatient with oral amoxicillin-\\nclavulanate, decongestants, and instructions to avoid nose blowing until \\nthe defect has been repaired. Emergent ophthalmological consultation \\nshould be requested for ocular injury associated with orbital fractures. An \\nocular compartment syndrome may occur with a retrobulbar hematoma or \\nmalignant orbital emphysema which can cause an acute ischemic optic \\nneuropathy.\\nZygoma fractures occur in two major patterns: tripod fractures and \\nisolated zygomatic arch fractures. Tripod fractures involve disruption of \\nthe infraorbital rim, the zygomaticofrontal suture, and the zygomaticotem-\\nporal junction. These fractures require admission for IV antibiotics and \\nsurgical repair. Patients with isolated fractures of the zygomatic arch may \\nhave elective outpatient repair.\\nMidfacial fractures are high-energy injuries and are often seen in \\nvictims of multisystem trauma. Patients frequently require endotracheal \\nintubation for airway control. Oral packing is often required for hemor -\\nrhage control with fractures of the hard palate. Le Fort injury patterns are \\nillustrated in Figure 162-1. Visual acuity should be tested, especially with \\nLe Fort III and IV fractures, in which the incidence of blindness is around \\nI\\nII\\nII\\nIIIIII\\nFIgure 162-1. Le Fort injury patterns. Illustration of the fracture lines of Le Fort I  \\n(alveolar), Le Fort II (zygomatic maxillary complex), and Le Fort III (craniofacial \\ndysfunction) fractures. Reproduced with permission from Tintinalli JE, Stapczynski \\nJS, Ma OJ, et al: Tintinalli’s Emergency Medicine: A Comprehensive Study Guide, \\n8th ed. New York: McGraw-Hill; 2015.\\n162_Cydulka_Ch162.indd   895 22/03/17   11:25 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 914, 'page_label': '896'}, page_content='896 SECTION 18: Trauma\\n3% most commonly secondary to injury of the optic nerve. Both Le Fort II \\nand III injuries can result in CSF leaks. Le F ort injuries require admission \\nfor management of significant associated injuries, IV antibiotics, and surgi-\\ncal repair.\\nMandible fractures are often diagnosed in the setting of malocclusion \\nand pain with attempted movement. Always look for multiple mandibular \\nfractures, with one injury at the site of impact and a second subtle injury on \\nthe opposite side of the ring. A careful intraoral examination is important \\nto exclude small breaks in the mucosa seen with open fractures, sublingual \\nhematomas, and dental or alveolar ridge fractures. Patients with closed \\nfractures may be given urgent outpatient follow-up, while open fractures \\nrequire admission for IV antibiotics and operative repair. In the patient with \\na stable airway, a Barton bandage, an ace wrap over the top of the head and \\nunderneath the mandible, will stabilize the fracture and help relieve pain.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 259, “Trauma to the Face,” by John Bailitz and Tarlan \\nHedayati.\\n162_Cydulka_Ch162.indd   896 22/03/17   11:25 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 915, 'page_label': '897'}, page_content='897\\nNeck Injuries\\nSteven Go\\nNeck trauma causes a diverse combination of injuries because of the high \\nconcentration of critical structures in the neck. Presenting signs of neck \\ninjury may be obvious, subtle, or obscured by trauma to other body regions. \\nMissed injuries and delays in diagnosis lead to increased patient morbidity \\nand mortality.\\n■ ■CLINICAL FEATURES\\nHistorical and physical examination findings of vascular, laryngotracheal, \\nor pharynoesophageal injury of the neck are characterized as hard or soft \\nsigns (Table 163-1), with 90% of patients with hard signs having an injury \\nrequiring emergent repair.\\nVascular injuries are the most common cervical injury and cause of \\ndeath from penetrating neck trauma. Symptoms include frank exsanguina-\\ntion and expanding hematomas, which may cause airway obstruction. \\nCervical artery injury can also cause various vascular and neurological \\nsigns and symptoms (Table 163-2).\\n163\\nCh A p TER\\nTable 163-1 Signs and Symptoms of Neck Injury\\nhard Soft\\nVascular injury\\nShock unresponsive to initial fluid therapy\\nActive arterial bleeding\\nPulse deficit\\nPulsatile or expanding hematoma\\nThrill or bruit\\nHypotension in field\\nHistory of arterial bleeding\\nNonpulsatile or nonexpanding hematoma\\nProximity wounds\\nlaryngotracheal injury\\nStridor\\nHemoptysis\\nDysphonia\\nAir or bubbling in wound\\nAirway obstruction\\nHoarseness\\nNeck tenderness\\nSubcutaneous emphysema\\nCervical ecchymosis or hematoma\\nTracheal deviation or cartilaginous step-off\\nLaryngeal edema or hematoma\\nRestricted vocal cord mobility\\nPharyngoesophageal injury\\nOdynophagia\\nSubcutaneous emphysema\\nDysphagia\\nHematemesis\\nBlood in the mouth\\nSaliva draining from wound\\nSevere neck tenderness\\nPrevertebral air\\nTransmidline trajectory\\n163_Cydulka_Ch163.indd   897 22/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 916, 'page_label': '898'}, page_content='898 SECTION 18: Trauma\\nLaryngotracheal injuries can present with immediate signs of impend-\\ning airway obstruction (Table 163-3) or have an insidious onset of airway \\ncompromise after a quiescent phase.\\nPharyngeal and esophageal injuries have no hard signs of injury and \\nmay initially present with few symptoms.\\nNeurologic injuries can result from injury to the cervical spine, spinal \\ncord, lower cranial nerves, or brachial plexus. Symptoms can range from \\nsensory complaints to quadriplegia.\\nStrangulation is a type of blunt neck injury whose presentation largely \\ndepends on the duration and degree of vascular compression rather than on \\nairway obstruction. Cerebral anoxia, laryngotracheal fractures, cervical \\nspine fractures, pharyngeal lacerations, and carotid artery injuries are pos-\\nsible. The most common symptoms are neck pain, voice changes, trouble \\nswallowing, and difficulty breathing, while common signs are petechiae \\nand neck contusions. However, 50% of patients have no signs of trauma \\nand 67% are asymptomatic. Some patients with ultimately life-threatening \\ninjuries are asymptomatic at presentation.\\nTable 163-2 Compiled Screening Criteria for Blunt Cerebral Vascular Injury\\n■● Signs and symptoms\\n■● Arterial hemorrhage from nose, neck, or mouth\\n■● Cervical bruit in patients <50 years old\\n■● Expanding cervical hematoma\\n■● Focal neurologic deficit: transient ischemic attack, hemiparesis, vertebrobasilar \\nsymptoms, Horner’s syndrome\\n■● Stroke on secondary CT\\n■● Neurologic deficit unexplained by head CT\\n■● Risk factors for blunt cerebral vascular injury\\n■● High-energy transfer mechanism and one of the following:\\n■● Facial fractures: Le Fort II or III fracture, mandible fracture, frontal skull fracture, \\norbital fracture\\n■● Cervical spine fracture patterns: subluxation, fractures extending into the transverse \\nforamen, fractures of C1–C3\\n■● Any basilar skull fracture or occipital condyle fracture\\n■● Petrous bone fracture\\n■● Diffuse axonal injury with Glasgow Coma Scale score ≤8\\n■● Concurrent traumatic brain and thoracic injuries\\n■● Neck hanging with anoxic brain injury\\n■● Clothesline type injury with significant swelling, pain, or altered mental status\\nTable 163-3 Clinical Factors Indicating Need for Aggressive Airway Management\\n■● Stridor\\n■● Acute respiratory distress\\n■● Airway obstruction from blood or secretions\\n■● Expanding neck hematoma\\n■● Profound shock\\n■● Extensive subcutaneous emphysema\\n■● Alteration in mental status\\n■● Tracheal shift\\n163_Cydulka_Ch163.indd   898 22/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 917, 'page_label': '899'}, page_content='CHAPTER 163: Neck Injuries 899 \\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe zone classification summarizes structures placed at risk for injury in \\npenetrating neck trauma (Fig. 163-1). Zone I structures include the lung \\napices, thoracic vessels, distal trachea, esophagus, cervical spine, and ver -\\ntebral and carotid arteries. Zone II structures include the mid-carotid and \\nvertebral arteries, jugular veins, esophagus, cervical spine, larynx, and tra-\\nchea. Zone III structures include the proximal carotid and vertebral arteries, \\noropharynx, and cervical spine.\\nIn penetrating neck trauma, a careful, structured physical exam is >95% \\nsensitive for clinically significant vascular and aerodigestive injuries. Par -\\nticular attention should be paid to whether the platysma has been violated. \\nIf violation has occurred, the presence of deep structure injury is assumed \\nuntil proven otherwise. The combination of physical examination with \\nmultidetector CT angiography (MDCTA) (100% sensitive and 97.5% spe-\\ncific for significant vascular or aerodigestive injury) has been recom-\\nmended over mandatory operative exploration and selective management \\nstrategies for diagnosis in stable patients. Additional studies may be \\nrequired if MDCTA detects a penetrating injury, but these are typically \\nordered in conjunction with the specialist who will be repairing the sus-\\npected injury. An algorithm for the diagnosis and management of penetrat-\\ning neck injuries is shown in Fig. 163-2.\\nSafely managing blunt neck trauma victims requires a heightened level \\nof suspicion and an aggressive approach to diagnosis because catastrophic \\ninjuries can present subtly. Therefore, MDCTA should be used liberally. If \\nthe MDCTA is negative, but significant suspicion of vascular injury \\nremains, formal cerebral angiography may be required. Likewise, if a \\nstrong suspicion of blunt laryngotracheal or esophageal injury remains after \\nAngle of\\nmandible\\nCricoid\\ncartilage\\nZone III\\nZone II\\nZone I\\nFIgure 163-1. Zones of the neck.\\n163_Cydulka_Ch163.indd   899 22/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 918, 'page_label': '900'}, page_content='900 SECTION 18: Trauma\\nIV antibiotics for 7-\\n10 days, nasogastric\\nor total parenteral\\nnutrition, operative\\nrepair or\\nconservative\\nmanagement\\nOperative repair\\nunless small\\nmucosal or\\nundisplaced\\nlaryngeal\\nframework fracture\\nSoft signs\\nof injury \\nNo Yes\\nCTA or selective\\ntesting CTA\\nSuspicion for\\nlaryngotracheal\\ninjury\\nPanendoscopy\\nSuspicion for\\nvascular injury\\nCTA*\\nColor Doppler\\nangiography\\n*Angiography if CTA\\nindeterminate\\nEsophagram or\\nesophagoscopy*\\n*Combined esophagram\\nand esophagoscopy have\\n100% sensitivity\\nSuspicion for\\npharyngo-\\nesophageal injury\\nStable\\nInjury violates platysma\\nNo Yes\\nObservation Hard signs\\nof injury\\nYes\\nNo\\nUnstable\\nOperating room or\\ninterventional\\nangiography\\nRepair injury\\nPositiveNegativeN egative Positive PositiveNegative\\nPenetrating\\nneck trauma\\nFIgure 163-2. Penetrating neck trauma protocol.\\n163_Cydulka_Ch163.indd   900 22/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 919, 'page_label': '901'}, page_content='CHAPTER 163: Neck Injuries 901 \\na negative MDCTA, laryngobronchoscopy, endoscopy, or swallowing stud-\\nies may be necessary.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Initiate standard ATLS protocol for the stabilization of trauma patients. \\nEstablish IV access, administer oxygen, and begin cardiac and respira-\\ntory monitoring.\\n2. Emergent airway control is indicated for patients with the clinical fac-\\ntors listed in Table 163-3. Have adjunct airway devices at hand and \\nuse paralytics with extreme caution, as these airways can be \\nextremely difficult to secure. If oral intubation is not possible or is \\ncontraindicated, a surgical airway is indicated.\\n3. Penetrating neck trauma is associated with pneumothorax and hemo-\\nthorax 20% of the time. Diagnose tension pneumothorax clinically and \\nperform immediate needle thoracostomy. Otherwise, pneumothorax \\nand hemothorax may be detected by bedside ultrasound or chest radio-\\ngraph, and tube thoracostomy is indicated.\\n4. Apply direct pressure with hemostatic dressings to control active hem-\\norrhage without occluding carotid arteries or the airway. Blind clamp-\\ning of blood vessels is contraindicated due to a risk of subsequent \\nneurovascular injury. Topical hemostatic agents may be used along \\nwith direct pressure. If direct pressure fails, inflating a Foley catheter \\nin the wound tract may help control hemorrhage. Administration of \\ntranexamic acid 1 g intravenously over 10 minutes then 1 g intrave-\\nnously over 8 hours should be considered in exsanguinating patients \\nwith wounds less than 3 hours old. Uncontrolled hemorrhage despite \\nthese measures requires emergent surgery.\\n5. Immobilize the cervical spine in patients with altered level of con-\\nsciousness, blunt trauma, or penetrating trauma with neurologic deficits \\nafter careful examination for penetrating injury, bleeding, hematoma, or \\nbruits/thrills. Cervical collars should not be placed at the expense of \\nmonitoring injuries or the ability to perform life-saving procedures.\\n6. All penetrating wounds that violate the platysma muscle mandate sur -\\ngical consultation. Unstable patients with penetrating neck trauma \\nrequire an emergent surgical or interv entional radiologic procedure. \\nTherefore, egress from the ED should not be delayed for unnecessary \\nprocedures or tests. Stable patients should undergo diagnostic evalua-\\ntion for deep structure injuries (Fig. 163-2).\\n7. Penetrating wounds that do not violate the platysma require standard \\nwound care and closure and the patient may be discharged if the y are \\nasymptomatic.\\n8. Patients with blunt neck trauma and hard signs of injury require emer -\\ngent surgical consultation (Table 163-1). Patients with stable, symp-\\ntomatic blunt neck trauma should be aggressively evaluated for injuries \\nto deep structures utilizing MDCTA and other modalities. Surgical \\nconsultation and admission for these symptomatic patients are advised \\neven if no injury is seen on the initial study.\\n9. The optimal management of asymptomatic blunt neck trauma patients \\nremains unclear. Consider liberal use of MDCTA (and other adjunctive \\ntests as necessary) and extended observation (4 to 6 hours) to detect \\n163_Cydulka_Ch163.indd   901 22/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 920, 'page_label': '902'}, page_content='902 SECTION 18: Trauma\\ndelayed respiratory and neurological dysfunction. This is especially \\nrecommended for patients with risk factors for blunt cerebral v ascular \\ninjury (Table 163-2).\\n10. Address the associated psychosocial issues of strangulation victims.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 260, “Trauma to the Neck” by Ashley S. Bean.\\n163_Cydulka_Ch163.indd   902 22/03/17   11:34 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 921, 'page_label': '903'}, page_content='903\\nCardiothoracic Injuries\\nPaul Nystrom\\nBedside diagnosis and immediate intervention by the emergency provider may \\nbe lifesaving for significant injuries associated with severe chest trauma such \\nas tension pneumothorax, hemothorax, and cardiac tamponade. Initial resusci-\\ntation and airway management should follow established principles, as dis-\\ncussed in Chapter 156, “Trauma in Adults.” It is important to avoid hypoxia \\nand hypotension to prevent secondary injury in head-injured patients. In the \\nhemodynamically unstable, polytrauma patient who requires emergency sur-\\ngery without CT imaging, exclude immediate life threats rapidly at the \\nbedside using ultrasound, radiographs, and physical examination.\\nPhysical examination should include assessment for visible trauma to \\nthe chest wall including any “seat belt sign,” focal areas of tenderness, \\nsubcutaneous emphysema, and open chest wounds. Tracheal deviation, \\nunequal chest rise, abnormal breath sounds, and bowel sounds in the chest \\nare less frequent but also important to note. Consider endotracheal intu-\\nbation for patients in respiratory distress (Table 164-1).\\n■ ■LUNG INJURIES\\nTension pneumothorax occurs when air enters the pleural space, either by \\nescaping from damaged lung, tracheobronchial tissue, or an open chest \\nwound. The pneumothorax may become pressurized during respiration \\ncausing tension with resultant respiratory and circulatory compromise. \\nPatients may have dyspnea, tachycardia, hypotension, distended neck \\nveins, tracheal deviation, and unequal breath sounds. Recognize and treat \\ntension pneumothorax immediately with needle decompression without \\nwaiting for radiographs. Insert a 14-G, 4.5-cm over-the-needle catheter in \\nthe second intercostal space at the midclavicular line (a standard 14-G IV \\ncatheter may not reach the pleural space in many patients). A rush of air \\nthrough the catheter is confirmatory. Leave the catheter in until a chest tube \\ncan be inserted, as the catheter converts the tension pneumothorax to an \\nopen pneumothorax.\\nTreat a small pneumothorax with inpatient observation; tube thora-\\ncostomy may not be necessary. Treat a large pneumothorax with tube \\nthoracostomy (24 to 28 F (8.0 to 9.3 mm)). Patients with pneumothoraces \\n164\\nCha P t ER\\nTable 164-1 Considerations for Early Ventilatory assistance after thoracic trauma\\nAltered mental status\\nHypovolemic shock\\nMultiple injuries\\nMultiple blood transfusions\\nElderly patients\\nPreexisting pulmonary disease\\nRespiratory distress\\nPoor oxygen saturation\\nSevere pulmonary contusions\\n164_Cydulka_Ch164.indd   903 22/03/17   11:40 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 922, 'page_label': '904'}, page_content='904 SECTION 18: Trauma\\nof any size and those with subcutaneous emphysema (requiring presumption \\nof an occult pneumothorax) who will be intubated or who will be trans-\\nported by air should receive a tube thoracostomy, as positive pressure venti-\\nlation and decreased barometric pressure can cause expansion of trapped air \\nand progression to a tension pneumothorax. Never clamp a chest tube, but \\nalways place it on water seal when taken off suction. See Table 164-2 for \\ncauses of failure of the lung to fully reinflate after tube thoracostomy.\\nTreat a hemothorax with tube thoracostomy. A 32- to 40-F (10.7 to \\n13.4 mm) chest tube has historically been used but the larger size may not \\nbe necessary. Indications for surgery include an immediate return of 1 L of \\nblood or ongoing bleeding of 150 to 200 mL/h for 2 to 4 hours. Consider \\nusing a heparinized autotransfusion device if massive hemothorax is sus-\\npected but do not delay tube thoracostomy.\\nPulmonary contusions are direct injuries to the lung parenchyma without \\nlaceration. Hypoxia develops as bleeding and edema compromise contused \\nlung tissue. Seventy percent of pulmonary contusions are not immediately \\nvisible on initial chest radiograph, but may appear as patchy opacities, \\ntypically within 6 hours. CT scan is much more sensitive. Initial manage-\\nment should include pain control to prevent hypoventilation, avoidance \\nof unnecessary IV fluids to prevent pulmonary edema, and strict pul-\\nmonary toilet. Administer crystalloids judiciously to maintain perfusion \\nand use blood products early in resuscitation. A trial of positive pressure \\nventilation by mask is reasonable in a patient with normal mental status who \\nrequires limited respiratory support. Patients with involvement of >25% of \\nlung tissue will likely require intubation, but should not be intubated pre-\\nemptively. If intubated, use positive-end expiratory pressure. Use diuretics \\nif the patient is thought to have volume overload.\\n■ ■ChESt WaLL INJURIES\\nA small open chest wound can progress to a tension pneumothorax through \\na one-way valve effect. Cover the wound with sterile petroleum gauze taped \\non three sides to allow air to exit but not enter. Perform tube thoracos-\\ntomy but not through the wound.\\nFlail chest occurs when a section of ribs fractures in multiple locations, \\ncausing instability of a segment of the chest wall. Intubation and positive \\npressure ventilation will stabilize the flail segment. Surgical fixation may \\nbe needed, although the greater danger is the underlying lung contusion that \\ncompromises respiration.\\nRib fractures may suggest other injuries or cause morbidity indepen-\\ndently. Fractures of the first and second ribs require great force and should \\ntherefore cause high suspicion for other major thoracic injuries including \\nmyocardial, vascular, and bronchial injuries. Multiple lower rib fractures \\nTable 164-2 Causes for Failure of Complete Lung Expansion or Evacuation of a \\nPneumothorax\\nImproper connections or leaks in the external tubing or water-seal collection apparatus\\nImproper positioning of the chest tube\\nOcclusion of bronchi or bronchioles by secretions or foreign body\\nTear of one of the large bronchi\\nLarge tear of the lung parenchyma\\n164_Cydulka_Ch164.indd   904 22/03/17   11:40 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 923, 'page_label': '905'}, page_content='CHAPTER 164: Cardiothoracic Injuries 905 \\nshould raise suspicion for liver or splenic injuries. The focus of diagnostic \\nimaging is to e xclude other injuries such as pneumothorax, pulmonary \\ncontusion, and intraabdominal injury.\\nEven in the absence of coexisting injury, the pain of rib fractures \\nmay eventually lead to splinting, ventilatory compromise, and pneumo-\\nnia. Consider intercostal nerve blocks and epidural anesthesia for pain \\ncontrol. Patients being discharged should generally receive nonsteroidal \\nanti-inflammatory drugs (NSAIDs) and opioid analgesics. Remind \\nthem to breathe deeply or perform incentive spirometry exercises. \\nAdmit patients with multiple fractures, medical comorbidities, or older \\nage for a period of observation until they are stabilized on a regimen of \\npain control and pulmonary toilet. Do not attempt to stabilize the chest \\nwall with tape or binding. Assess patients with a sternal fracture for \\ncardiac injury by ECG, serial troponin measurements, and cardiac \\nmonitoring.\\nAssume patients with subcutaneous emphysema have a pneumothorax \\neven if not seen on the initial chest radiograph. Supine chest radiograph is a \\nrelatively insensitive screening tool for pneumothorax and for hemothoraces \\nof <200 mL. Up to 1000 mL may appear as only diffuse haziness. Lung \\ncollapse from intubation of a mainstem bronchus can have a similar appear-\\nance. If the patient can safely sit up, upright and expiratory views can \\nincrease sensitivity. Ultrasound has been shown to have good sensitivity \\nfor pneumothorax, with loss of the sliding pleura sign while a hemotho-\\nrax will show fluid in the dependent portion of the chest. CT scan is \\nhighly sensitive for both of these conditions. If subclavian venous cannula-\\ntion is attempted, it should be done on the side of the suspected injury so that \\nan iatrogenic pneumothorax does not result in bilateral pneumothoraces.\\nPenetrating wounds should never be deeply probed. A small stab wound \\nmay develop into a delayed pneumothorax; repeat the ultrasound or chest \\nradiograph at 4 to 6 hours after the initial presentation.\\n■ ■PNEUMOMEDIaStINUM aND tRaChEOBRONChIaL \\nINJURIES\\nPneumomediastinum is most often caused by ruptured alveoli with dissec-\\ntion of air to the mediastinum and does not require treatment in the asymp-\\ntomatic patient. Coughing, heavy breathing (such as seen in drug inhalation), \\nor exertion can rupture alveoli and release air into the mediastinum. How-\\never, pneumomediastinum can also be the result of injuries to the trachea \\nand large airways from high energy or major deceleration. Dyspnea, \\nhemoptysis, subcutaneous emphysema in the neck, a crunching sound with \\nthe cardiac cycle, and a massive continued air leak through a chest tube \\nsuggest tracheobronchial injury.\\n■ ■DIaPhRaGMatIC INJURIES\\nAll penetrating injuries from the level of the nipples to the umbilicus have \\nthe potential to injure the diaphragm. Small lacerations can be asymptom-\\natic and then progress to the rupture of abdominal contents into the chest \\nweeks to months later. The diagnosis is obvious if imaging shows hernia-\\ntion of abdominal contents into the chest or coiling of a gastric tube within \\n164_Cydulka_Ch164.indd   905 22/03/17   11:40 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 924, 'page_label': '906'}, page_content='906 SECTION 18: Trauma\\nthe chest. Subtle abnormalities may also be seen on chest radiograph, CT, \\nor upper GI series with contrast. Laparotomy and laparoscopy remain the \\ngold standards to exclude diaphragmatic injuries. All diaphragmatic lacera-\\ntions require surgical repair.\\n■ ■PENEtRatING CaRDIaC INJURIES\\nThe right ventricle is the most commonly injured portion of the heart \\nbecause of its large anterior exposure. Accumulation of blood in the peri-\\ncardial space compresses the heart, which prevents diastolic filling. The \\ndiagnosis is typically made by bedside ultrasound. Pericardiocentesis \\nshould only be attempted for a patient in shock with confirmed cardiac \\ntamponade since it is technically difficult and may result in laceration of a \\ncoronary artery or injury to the myocardium. Stable patients should have a \\npericardial window or thoracotomy performed in the operating room.\\nPatients with penetrating chest injuries with signs of life in the field but \\nwho subsequently become pulseless may be candidates for ED thoracotomy. \\nRelieving cardiac tamponade, controlling hilar bleeding, cross clamping the \\ndescending aorta, or repairing a myocardial laceration may be lifesaving. \\nStab wounds to the heart are more likely to be amenable to repair than inju-\\nries from gunshot wounds. Once the chest is opened, the heart is delivered \\nfrom the pericardium so that potential injuries can be visualized. Direct \\ndigital pressure, staples, sutures, or a Foley catheter with inflated balloon \\nmay be used to temporize bleeding lacerations on the way to the operating \\nroom for definitive repair.\\n■ ■BLUNt INJURIES tO thE hEaRt\\nBlunt cardiac injury can lead to death from damage to cardiac structures, \\ncoronary artery injury and thrombosis, and contusion of the myocardium \\nresulting in impaired contractility and arrhythmias. ECG changes consistent \\nwith ischemia suggest coronary artery dissection or thrombosis, which are \\nevaluated and treated by cardiac catheterization and stenting. A direct blow \\nto the chest such as when a young athlete is struck by a hard ball can induce \\nventricular fibrillation cardiac arrest even without myocardial injury (com-\\nmotio cordis). Treat according to advanced cardiac life support (ACLS) \\nalgorithms because there is usually no structural damage to the heart.\\nA patient with cardiac injury may present with chest pain, tachycardia \\nunexplained by hemorrhage, and arrhythmias. Bedside echocardiography \\nby the emergency provider should be performed as a first screen for cardiac \\ntamponade and grossly impaired contractility. Treat tamponade the same \\nas tamponade from penetrating cardiac injury. Patients with hypoten-\\nsion not explained by another cause, arrhythmias, and impaired contractility \\nshould undergo further evaluation by formal echocardiography and cardiac \\nenzymes, with transesophageal echocardiogram being three times more \\nsensitive than transthoracic echocardiogram for blunt myocardial injury. \\nGive antiarrhythmic and inotropic medications according to ACLS algo-\\nrithms. Indications for admission include abnormalities on echocardiogram, \\nECG, or cardiac enzymes. Discharge patients with normal vital signs, nor -\\nmal initial ECG, no underlying cardiac disease, and age <55 years after  \\n4 to 6 hours of normal cardiac monitoring.\\n164_Cydulka_Ch164.indd   906 22/03/17   11:40 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 925, 'page_label': '907'}, page_content='CHAPTER 164: Cardiothoracic Injuries 907 \\n■ ■tRaUMa tO thE GREat VESSELS\\nTrauma to the major thoracic vessels is often lethal, with 90% of those \\nsustaining blunt aortic injury dying at the scene. The most common site of \\nblunt aortic injury is at the proximal descending aorta between the left \\nsubclavian artery and the ligamentum arteriosum. Injury to the subclavian \\nand innominate arteries can be related to shoulder belts, fractures of the first \\nand second ribs, and proximal clavicle. Half of patients present without \\nexternal physical findings, so suspicion for this injury needs to be high with \\nmechanisms involving high-speed deceleration.\\nTable 164-3 shows radiographic findings of thoracic aortic injury, \\nalthough a normal chest radiograph does not exclude major vascular injury. \\nAll the patients with a mechanism highly concerning for great vessel injury \\nshould undergo CT angiogram with IV contrast. Conventional aortography \\nis still used in some cases to assess injuries and guide operative planning. \\nTransesophageal echocardiogram is useful for diagnosing aortic intimal \\nlesions, but is contraindicated in airway compromise or suspected cervical \\nspinal injury.\\nIndications for immediate operation for vascular injury are hemody-\\nnamic instability, radiographic evidence of a rapidly expanding hematoma, \\nor large-volume chest tube output. Control hypertension in order to \\ndecrease shear stress on the vessel wall by titration of narcotic pain medica-\\ntions and sedatives. A short-acting β-blocker, such as esmolol, may be \\ntitrated to a systolic blood pressure of 100 to 120 mm Hg and a heart rate \\nabove 60 beats/min. If bradycardia prevents further dosing of a β-blocker, \\ninfuse an arterial dilator such as sodium nitroprusside. Do not use sodium \\nnitroprusside without a β-blocker secondary to the reflex tachycardia that \\nmay develop.\\nTable 164-3 Radiographic Findings Suggestive of a Great Vessel Injury\\nFractures\\nSternum\\nScapula\\nMultiple ribs\\nClavicle in multisystem-injured patients\\nFirst and second rib\\nMediastinal Clues\\nObliteration of the aortic knob contour\\nWidening of the mediastinum\\nDepression of the left mainstem bronchus\\nLoss of paravertebral pleural stripe\\nCalcium layering at aortic knob\\nAbnormal general appearance of mediastinum\\nDeviation of nasogastric tube to the right\\nLateral displacement of the trachea\\nOther Findings\\nApical pleural hematoma (cap)\\nMassive left hemothorax\\nObvious diaphragmatic injury\\nSource: Reproduced with permission from Mattox KL, Moore EE, Feliciano DV: Trauma, 7th ed. New \\nYork, NY: McGraw-Hill; 2013.\\n164_Cydulka_Ch164.indd   907 22/03/17   11:40 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 926, 'page_label': '908'}, page_content='908 SECTION 18: Trauma\\n■ ■ESOPhaGEaL aND thORaCIC DUCt INJURIES\\nPenetrating and occasionally blunt trauma may cause injury to the thoracic \\nesophagus. If suspected, evaluate the patient by esophagram with water-\\nsoluble contrast, which is less likely to cause mediastinitis. A negative \\nstudy with water-soluble contrast should be followed by the use of barium \\ncontrast, which has a higher sensitivity for injury. Flexible esophagoscopy \\nis an alternative modality for assessing injury. Delayed diagnosis of esoph-\\nageal injury has a high mortality if mediastinitis ensues. Injuries to the area \\nof the left proximal subclavian vein may result in chylothorax, causing \\ndelayed pleural effusion with a mortality rate of approximately 50%. Initial \\ntreatment is chest tube insertion.\\n■ ■PERICaRDItIS\\nPatients may develop chest pain, fever, and a friction rub 2 to 4 weeks \\nafter cardiac trauma or surgery which may indicate pericarditis. ECG \\nmay show diffuse ST-segment elevation consistent with pericarditis. \\nPericardial and pleural effusions may be seen on echocardiography and \\nchest radiograph, respectively. Treatment is with nonsteroidal anti-\\ninflammatory medications.\\n■ ■FURthER REaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 254, “Trauma in Adults,” by Peter Cameron and Barry J. \\nKnapp; Chapter 261, “Pulmonary Trauma,” by David Jones, Anna Nelson,  \\nO. John Ma; Chapter 262, “Cardiac Trauma,” by Christopher Ross and Theresa \\nSchwab.\\n164_Cydulka_Ch164.indd   908 22/03/17   11:40 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 927, 'page_label': '909'}, page_content='909\\nAbdominal Injuries\\nO. John Ma\\nThe primary goal in the evaluation of abdominal trauma is to promptly \\nrecognize conditions that require immediate surgical exploration. The most \\ncritical error is to delay operative intervention when it is needed.\\n■ ■CLINICAL FEATURES\\nSolid Organ Injuries\\nInjury to the solid organs causes morbidity and mortality, primarily as a \\nresult of acute blood loss. An increase in pulse pressure may be the only \\nclue to loss of ≤15% of total blood volume. As blood loss continues, heart \\nand respiratory rate increase. Hypotension may not occur until a 30% \\ndecrease in circulating volume occurs. The spleen is the most frequently \\ninjured organ in blunt abdominal trauma and is commonly associated with \\nother intra-abdominal injuries. The liver also is commonly injured in blunt \\nand penetrating injuries. Kehr sign, representing referred left shoulder pain, \\nis a classic finding in splenic rupture. Lower left rib fractures should \\nheighten clinical suspicion for splenic injury. Some patients with solid \\norgan injury occasionally present with minimal symptoms and nonspecific \\nfindings on physical examination. This is commonly seen in younger \\npatients and those with distracting injuries, head injury, or intoxication. \\nSerial physical examinations on an awake, alert, and reliable patient are \\nimportant for identifying intra-abdominal injuries.\\nHollow Visceral Injuries\\nThese injuries produce symptoms by the combination of blood loss and \\nperitoneal contamination. Perforation of the stomach, small bowel, or \\ncolon is accompanied by blood loss from a concomitant mesenteric \\ninjury. Gastrointestinal contamination will produce peritoneal signs over \\ntime. Patients with head injury, distracting injuries, or intoxication may \\nnot exhibit peritoneal signs initially.\\nSmall bowel and colon injuries are most frequently the result of pene-\\ntrating trauma. However, a deceleration injury can cause a bucket-handle \\ntear of the mesentery or a blow-out injury of the antimesenteric border. \\nSuppurative peritonitis may develop from small bowel and colonic injuries. \\nInflammation may take 6 to 8 hours to develop.\\nRetroperitoneal Injuries\\nThe diagnosis of retroperitoneal injuries can be challenging. Signs and \\nsymptoms may be subtle or absent at initial presentation. Duodenal injuries \\nmost often are associated with high-speed vertical or horizontal decelerat-\\ning trauma. These injuries may range in severity from an intramural hema-\\ntoma to an extensive crush or laceration. Duodenal ruptures are usually \\ncontained within the retroperitoneum. Clinical signs of duodenal injury are \\noften slow to develop. Patients may present with abdominal pain, fever, \\n165\\nCh A p TER\\n165_Cydulka_Ch165.indd   909 22/03/17   11:46 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 928, 'page_label': '910'}, page_content='910 SECTION 18: Trauma\\nnausea, and vomiting, although these symptoms may take hours to become \\nclinically apparent.\\nPancreatic injury often accompanies rapid deceleration injury or a \\nsevere crush injury. Unrestrained drivers who hit the steering column or \\nbicyclists who fall against a handlebar are at risk for pancreatic injuries. \\nPancreatic injuries can present with subtle signs and symptoms, making the \\ndiagnosis elusive.\\nDiaphragmatic Injuries\\nPresentation of diaphragm injuries is often insidious. Only occasionally is \\nthe diagnosis obvious when bowel sounds can be auscultated in the thoracic \\ncavity. Herniation of abdominal contents into the thoracic cavity or a naso-\\ngastric tube coiled in the thorax confirms the diagnosis on chest radiograph. \\nIn most cases, however, the only finding on chest radiograph is blurring of \\nthe diaphragm or an effusion.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nPlain Radiographs\\nA chest radiograph is helpful in evaluating for herniated abdominal con-\\ntents in the thoracic cavity and for evidence of free air under the diaphragm. \\nAn anteroposterior pelvis radiograph is important for identifying pelvic \\nfractures, which can produce significant blood loss and be associated with \\nintra-abdominal injury.\\nUltrasonography\\nThe focused assessment with sonography for trauma (FAST) examination \\n(Table 165-1) is a widely accepted primary diagnostic study. The underly-\\ning premise of the FAST exam is that many clinically significant injuries \\nwill be associated with free intraperitoneal fluid. The greatest benefit of \\nTABLE 165-1 Advantages and Disadvantages of the Focused Assessment with \\nSonography for Trauma Examination\\nAdvantages Disadvantages\\nAccurate, sensitive, and specific for \\ndetecting free intraperitoneal fluid\\nInability to determine the exact etiology of \\nthe free intraperitoneal fluid\\nRapid (<4 min) Operator-dependent\\nNoninvasive\\nRepeatable\\nPortable\\nDifficulty in interpreting the images in \\npatients who are obese or have subcutane-\\nous air or excessive bowel gas\\nNo nephrotoxic contrast material needed Inability to distinguish intraperitoneal \\nhemorrhage from ascites\\nNo radiation exposure\\nCan evaluate for free pericardial and  \\npleural fluid\\nCannot evaluate the retroperitoneum as well \\nas CT scan\\nCan evaluate for pneumothorax\\nNo risk for patients who are pregnant, \\ncoagulopathic, or have had previous \\nabdominal surgery\\n165_Cydulka_Ch165.indd   910 22/03/17   11:46 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 929, 'page_label': '911'}, page_content='CHAPTER 165: Abdominal Injuries 911 \\nFAST is the rapid identification of free intraperitoneal fluid in the hypoten-\\nsive patient with blunt abdominal trauma. Since the FAST examination can \\nreliably detect small amounts of free intraperitoneal fluid and can estimate \\nthe rate of hemorrhage through serial examinations, it has essentially \\nreplaced diagnostic peritoneal lavage (DPL) for blunt abdominal trauma in \\nthe majority of North American trauma centers.\\nComputed Tomography\\nAbdominopelvic CT with IV contrast (Table 165-2) is the noninvasive gold \\nstandard study for the diagnosis of abdominal injury (unless the patient has \\nan allergy to iodinated contrast). The addition of PO contrast is too time-\\nconsuming to be practical in trauma management. The major advantage of \\nIV contrast CT over other diagnostic modalities is that the precise \\nlocation(s) and grade of injury can be identified. CT can quantify and dif-\\nferentiate the amount and type of free fluid in the abdomen. Because CT \\ncan evaluate for retroperitoneal injuries, it is the ideal study for assessment \\nof the duodenum and pancreas. The use of multiphasic CT (arterial, portal, \\nand equilibrium phases) accurately identifies life-threatening mesenteric \\nhemorrhage and transmural bowel injuries.\\nDiagnostic Peritoneal Lavage\\nThe wide availability of CT and ED ultrasound has relegated DPL  \\n(Table 165-3) to a second-line screening test for evaluating abdominal \\nTABLE 165-2 Advantages and Disadvantages of CT in Abdominal Trauma\\nAdvantages Disadvantages\\nAbility to precisely locate intra-abdominal \\nlesions\\nExpense\\nAbility to evaluate the retroperitoneum Need to transport the trauma patient to the \\nradiology suite\\nAbility to identify injuries that may be \\nmanaged nonoperatively\\nNeed for contrast materials\\nNoninvasive Radiation exposure\\nTABLE 165-3 Advantages and Disadvantages of Diagnostic peritoneal Lavage in \\nAbdominal Trauma\\nAdvantages Disadvantages\\nSensitivity Invasive\\nAvailability Potential for iatrogenic injury\\nRelative speed with which it can be \\nperformed\\nLack of specificity\\nLow complication rate Inability to identify injuries that may be \\nmanaged nonoperatively\\nAbility to detect early evidence of bowel \\nperforation\\nMisapplication for evaluation of retroperito-\\nneal injuries\\nNo nephrotoxic contrast material needed\\nNo radiation exposure\\n165_Cydulka_Ch165.indd   911 22/03/17   11:46 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 930, 'page_label': '912'}, page_content='912 SECTION 18: Trauma\\ntrauma. For blunt trauma, indications for DPL include (a) patients who \\nare too hemodynamically unstable to leave the ED for CT and (b) unex-\\nplained hypotension in patients with an equivocal physical examination. \\nDPL is considered positive if more than 10 mL of gross blood is aspirated \\nimmediately, the red blood cell count is higher than 100,000 cells/mm 3, \\nthe white blood cell count is higher than 500 cells/mm 3, bile is present, or \\nif vegetable matter is present.\\nThe only absolute contraindication to DPL is when surgical manage-\\nment is clearly indicated, in which case the DPL would delay patient trans-\\nport to the operating room. Relative contraindications include patients with \\nadvanced hepatic dysfunction, severe coagulopathies, previous abdominal \\nsurgeries, or a gravid uterus.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Initiate standard protocols for evaluation and stabilization of trauma \\npatients. See Chapter 156.\\n2. Administer oxygen as needed, attach cardiac monitoring, and secure two \\nlarge-bore IV lines.\\n3. Administer IV crystalloid fluid to hypotensi ve abdominal trauma \\npatients. Transfuse with O-negative or type-specific packed red blood \\ncells as indicated.\\n4. Order laboratory work for abdominal trauma patients based on the \\nmechanism of injury (blunt vs penetrating); labs may include type and \\ncrossmatching, complete blood count, electrolytes, lactate level, directed \\ntoxicologic studies, coagulation studies, hepatic enzymes, and lipase.\\n5. Table 165-4 lists the indications for exploratory laparotomy. When a \\npatient presents to the ED with an obvious high-velocity gunshot wound \\nto the abdomen, do not delay transport of the patient to the operating \\nroom by performing a FAST examination unless there is a suspicion for \\nTABLE 165-4 Indications for Laparotomy\\nBlunt penetrating\\nAbsolute Anterior abdominal injury with \\nhypotension\\nAbdominal wall disruption\\nPeritonitis\\nFree air under diaphragm on chest \\nradiograph\\nPositive FAST or DPL in hemodynami-\\ncally unstable patient\\nCT-diagnosed injury requiring surgery \\n(i.e., pancreatic transection, duodenal \\nrupture, diaphragm injury)\\nInjury to abdomen, back, and flank \\nwith hypotension\\nAbdominal tenderness\\nGI evisceration\\nHigh suspicion for transabdominal \\ntrajectory after gunshot wound\\nCT-diagnosed injury requiring surgery \\n(i.e., ureter or pancreas)\\nRelative Positive FAST or DPL in hemodynami-\\ncally stable patient\\nSolid visceral injury in stable patient\\nHemoperitoneum on CT without clear \\nsource\\nPositive local wound exploration after \\nstab wound\\nAbbreviations: DPL, diagnostic peritoneal lavage; FAST, focused assessment with sonography for \\ntrauma.\\n165_Cydulka_Ch165.indd   912 22/03/17   11:46 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 931, 'page_label': '913'}, page_content='CHAPTER 165: Abdominal Injuries 913 \\ncardiac injury. If organ evisceration is present, cover the wound with a \\nmoist, sterile dressing before surgery.\\n6. For an equivocal stab w ound to the abdomen, obtain surgical consulta-\\ntion for local wound exploration. If the local wound exploration demon-\\nstrates no violation of the anterior fascia, the patient can be discharged \\nhome.\\n7. For the hemodynamically stable, blunt trauma patient with a positive \\nFAST examination, further evaluation with CT may be warranted before \\nadmission to the surgical service.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 263, “Abdominal Trauma,” by L. Keith French, \\nStephanie Gordy, and O. John Ma.\\n165_Cydulka_Ch165.indd   913 22/03/17   11:46 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 932, 'page_label': '914'}, page_content='914\\nPenetrating Trauma to The Flank \\nand Buttocks\\nSum Ambur\\nChallenges in evaluating penetrating trauma to the flank and buttocks \\ninclude recognizing peritoneal and retroperitoneal injuries and determining \\nwhich patients need immediate surgery and which can be managed more \\nconservatively. Trajectories and resultant severity and pattern of injury can \\nvary widely with both stab and gunshot wounds. Hemodynamically unsta-\\nble patients need immediate operative intervention. Mechanism and time of \\ninjury, weapon characteristics, and determining the bullet path or stab \\nwound depth may also assist in determining the initial diagnostic approach \\nif the patient is otherwise stable.\\n■ ■PENETRATING FLANK TRAUMA\\nClinical Features\\nPresentation may vary from stable vital signs with an innocuous-appearing \\nwound to hemodynamic shock and peritonitis. Gross blood on rectal \\nexamination suggests bowel injury. Blood at the urethral meatus or hema-\\nturia suggests genitourinary injury.\\nDiagnosis and Differential\\nCT imaging is the diagnostic modality of choice for hemodynamically \\nstable patients. Protocols vary by institution, but may include PO or rectal \\ncontrast if there is suspicion for hollow viscous injury. Contrast-enhanced \\nCT can also often help determine stab wound depth. Bedside ultrasound \\n(eFAST exam) can be used to assess for intraabdominal free fluid and thus \\nhelp predict the need for surgical intervention.\\nEmergency Department Care and Disposition\\n1.  Follow standard trauma resuscitation protocols. Patients who require \\nemergent exploratory laparotomy include those who are hemodynami-\\ncally unstable, display peritonitis, and have sustained gunshot wounds to \\nthe flank.\\n2.  If there is concern that the peritoneum is violated or the patient dis-\\nplays signs of peritonitis, administer broad-spectrum antibiotics, such as \\npipercillin/tazobactam 3.375 g IV.\\n3.  Many patients with stab wounds can be managed conservatively. High-\\nrisk patients (stab wounds with penetration beyond deep fascia) require \\nsurgical consultation and admission. Low-risk patients (stab wounds \\nsuperficial to deep fascia) may be discharged if serial examinations are \\nunremarkable and the patient remains stable throughout an observation \\nperiod.\\n166\\nCh APTER\\n166_Cydulka_Ch166.indd   914 22/03/17   11:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 933, 'page_label': '915'}, page_content='CHAPTER 166: Penetrating Trauma to The Flank and Buttocks 915 \\n■ ■PENETRATING BUTTOCK TRAUMA\\nClinical Features\\nGunshot wounds are much more likely to require laparotomy than stab \\nwounds. Gunshot wounds above the level of the greater trochanter and \\ngross hematuria predict the need for surgery. Rectal examination to assess \\nfor gross blood, evaluation of lower extremity pulses, and neurologic \\nexamination to assess for sciatic and femoral nerve injury should be  \\nperformed.\\nDiagnosis and Differential\\nHemodynamically stable patients should undergo CT with oral, IV , and \\nrectal contrast (to avoid missed colon and rectal injuries). Cystourethro-\\ngram should be performed on patients with findings of hematuria or \\nwounds near the genitourinary tract. CT angiography or traditional angiog-\\nraphy and venography may be indicated if a pelvic hematoma is found on \\nCT. Bedside ultrasound (eFAST exam) can also be used to assess for \\nintraabdominal free fluid and thus help predict the need for surgical  \\nintervention.\\nEmergency Department Care and Disposition\\n1.  Follow standard trauma resuscitation protocols. Patients who are hemo-\\ndynamically unstable, display peritonitis, or are likely to have intrapel-\\nvic or transabdominal bullet paths require exploratory laparotomy.\\n2.  If the patient displays signs of peritonitis or there is high suspicion for \\nperitoneal violation, administer antibiotics, such as pipercillin/tazobac-\\ntam 3.375 g IV.\\n3.  Interventional angiography may be required to treat extensive intra-\\npelvic bleeding.\\n4.  Wound exploration is of limited value. Only very superficial stab wounds \\nmay be managed and discharged from the ED. Most patients with pen-\\netrating trauma to the buttocks require admission and observation due \\nto the risk of occult injuries.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 264, “Trauma to the Flank and Buttocks,” by Alicia \\nDevine.\\n166_Cydulka_Ch166.indd   915 22/03/17   11:50 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 934, 'page_label': '916'}, page_content='916\\nGenitourinary Injuries\\nThomas Dalton\\nGenitourinary (GU) injuries frequently occur in the setting of polytrauma, \\nso a thorough evaluation is necessary to avoid missing significant injuries.\\n■ ■CLINICAL FEATURES\\nInjuries should be suspected with any blunt or penetrating trauma near the \\nGU tract, including any rapid deceleration, which can cause major vascular \\nor parenchymal injury even without specific signs or symptoms. Hematuria \\nof any amount raises the index of suspicion for GU injury, and difficulty \\nwith urination can be due to bladder or urethral injury or associated con-\\ncomitant spinal cord injury. Flank contusions or hematomas, evidence of \\nlower rib fractures, or penetrating flank injuries raise concern for renal \\ninjury. Lower abdominal pain, tenderness, ecchymosis, or evidence of a \\npelvic fracture as well as perineal or scrotal edema are consistent with pos-\\nsible bladder injury. Vaginal bleeding, a high-riding prostate, a perineal \\nhematoma, and/or blood at the urethral meatus are concerning for urethral \\ndisruption.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThere is no direct relationship between the degree of hematuria and the \\nseverity of renal injury. There is some evidence that microscopic hematuria \\nin patients with a blood pressure <90 mm Hg or any gross hematuria is \\nassociated with a more significant renal injury. In children where renal \\ntrauma is being considered, isolated microscopic hematuria with <50 red \\nblood cells per high-powered field makes a significant renal injury less \\nlikely. An IV contrast-enhanced abdominal/pelvic CT scan is the imaging \\n“gold standard” for the stable trauma patient with a suspected kidney \\ninjury. A 10-minute delayed image is needed to ascertain whether there is \\nany urine extravasation but can be omitted if the kidney is normal and there \\nare no fluid collections. A retrograde cystogram (plain film or CT) is the \\n“gold standard” for demonstrating bladder injury, and a retrograde urethro-\\ngram is indicated for demonstrating urethral injuries. Color Doppler ultra-\\nsonography is the preferred imaging technique for investigating closed \\nscrotal and testicular injuries. A focused assessment with sonography in \\ntrauma (FAST) exam can detect intra-abdominal fluid collections but \\ncannot reliably evaluate renal, bladder, or ureteral injuries Table 167-1.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\nTake a standardized approach to all multiple trauma patients to identify and \\ntreat life-threatening injuries (primary survey) and then perform a thorough \\nsecondary survey, including a GU examination, to diagnose all injuries. \\nObtain appropriate diagnostic imaging and laboratory testing as indicated \\nby the initial history and examination.\\n167\\nCh APTER\\n167_Cydulka_Ch167.indd   916 22/03/17   11:56 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 935, 'page_label': '917'}, page_content='CHAPTER 167: Genitourinary Injuries 917 \\n■ ■MANAGEMENT OF SPECIFIC INJURIES\\nKidney\\nKidney injuries include contusions, hematomas, lacerations, and com-\\npletely shattered kidneys with or without vascular injuries. Eighty percent \\nof patients with kidney injury have additional visceral or skeletal injuries \\nthat complicate their management. Most renal injuries are handled nonop-\\neratively, but indications for operative treatment include life-threatening \\nbleeding from the kidney; expanding, pulsatile, or non-contained hema-\\ntoma (thought to be from an avulsion injury); renal avulsion injury; and \\nextravasation from the renal pelvis or from a ureteral injury. There are little \\ndata to support specific treatment recommendations for patients with iso-\\nlated renal trauma. Patients with microscopic hematuria and no indication \\nfor imaging can be discharged home with instructions for no strenuous \\nactivity and follow-up in 1 to 2 weeks for repeat urinalysis. Those with a \\ncontusion (normal imaging and microscopic hematuria) can be discharged \\nas above. Those with a higher-grade injury and/or gross hematuria should \\nbe admitted for observation (to include repeat hematocrit and urinalysis), \\nhydration, and rest until gross hematuria clears, or general improvement \\nensues.\\nUreter\\nUreteral injuries are almost always due to iatrogenic complications of \\ninstrumentation or penetrating trauma. Notably the absence of hematuria \\ndoes not exclude an injury. In a stable patient a delayed CT scan of the \\nTable 167-1 Imaging for Genitourinary Trauma\\nInjury Imaging Comments\\nMultisystem trauma or \\nsuspected renal paren-\\nchymal or vascular injury\\nAbdominal-pelvic IV \\ncontrast CT scan\\nInclude pelvis to view entire GU tract\\nDelayed films needed to identify \\nurinary extravasation\\nAny visceral injury \\nresulting in free \\nintraperitoneal fluid\\nFAST Identifies free fluid, but does not \\nspecify type of visceral injury and \\ndoes not identify renal vascular \\ninjury\\nRenal artery injury Renal angiography Details vascular injuries\\nUreteral injury Abdominal-pelvic IV \\ncontrast CT scan\\nDelayed films needed to identify \\nextravasation; obtain IV pyelogram \\nor retrograde pyelogram if still \\nsuspicious with negative CT\\nBladder injury Retrograde cystogram Can use plain radiographs or CT scan\\nUrethral injury Retrograde urethrogram Discuss sequencing with radiologist, \\nbecause if performed prior to \\nabdominal-pelvic contrast CT scan, \\ncan interfere with diagnosis\\nScrotal/testicular injury Color Doppler US Contrast-enhanced US or MRI if \\nsuspicion is high and initial US is \\nnegative\\n167_Cydulka_Ch167.indd   917 22/03/17   11:56 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 936, 'page_label': '918'}, page_content='918 SECTION 18: Trauma\\nabdomen and pelvis with IV contrast can identify ureteral injuries. If the \\nCT scan is non-diagnostic and there is a high concern for an injury then an \\nIV pyelogram or retrograde pyelogram is indicated. Treatment is operative, \\nincluding stenting in some cases.\\nbladder\\nBladder injuries occur in about 2% of blunt abdominal trauma patients and \\n80% are associated with pelvic fractures. Gross hematuria is present in \\nabout 95% of patients with significant injury and warrants a retrograde \\ncystogram. Bladder injuries can also be present in pelvic fractures with \\nonly the presence of microscopic hematuria but the degree of microscopic \\nhematuria warranting a cystogram is unclear. Extraperitoneal rupture is \\nmost common and can usually be treated by bladder catheter drainage \\nalone. Intraperitoneal rupture always requires surgical exploration and \\nrepair. A retrograde cystogram can be performed by infusing ~350 ml of \\ncontrast material to distend the bladder. Passive bladder filling is not sensi-\\ntive enough to exclude a bladder rupture. Sonographic diagnosis of a blad-\\nder injury is not accurate.\\nUrethra\\nPosterior urethral injuries (membranous and prostatic urethra) are typi-\\ncally related to major blunt force trauma and are associated with pelvic \\nfractures. Treatment is via suprapubic bladder drainage followed by \\nsurgical repair in several weeks. Because a urinary catheter can disrupt a \\npartial posterior urethral injury, one should not be placed if there is sus-\\npicion of injury without first obtaining a retrograde urethrogram. Ante-\\nrior urethral injuries usually occur due to direct trauma such as from a \\nstraddle injury or a direct blow to the bulbar or penile urethra. The \\nabsence of hematuria does not rule-out a urethral injury. If there is con-\\ncern for an injury, then avoid placing a foley catheter and obtain a retro-\\ngrade urethrogram by injecting 20 to 30 mL of contrast into the urethra \\nand obtain a radiograph. If a foley catheter has already been placed, then \\na 16-gauge angiocatheter can be used to inject contrast between the cath-\\neter and urethra. Treatment is supportive, which may include a urinary \\ncatheter. Penetrating trauma to the anterior urethra generally requires \\noperative repair.\\nTesticles and Scrotum\\nEvaluate blunt testicular trauma with an ultrasound examination. If testicu-\\nlar rupture is present, exploration and repair is indicated. If the testicle is \\nintact, conservative treatment with ice, elevation, scrotal support, and pain \\nmedication is appropriate. Hematomas and hematoceles are managed on a \\ncase-by-case basis. Penetrating testicular trauma warrants surgical explora-\\ntion and repair. Scrotal lacerations can be directly repaired and scrotal \\navulsions require surgical repair with the testicle covered in the remaining \\nscrotum.\\nPenis\\nSimple contusions are managed conservatively with cold packs, rest, and \\npain medications. Simple lacerations involving skin only can be directly \\n167_Cydulka_Ch167.indd   918 22/03/17   11:56 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 937, 'page_label': '919'}, page_content='CHAPTER 167: Genitourinary Injuries 919 \\nrepaired, but deeper lacerations and/or penetrating injuries require \\noperative exploration and repair. Amputation requires microsurgical reim-\\nplantation if the amputated segment is viable. Penile fractures require \\nexploration and repair.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 265, “Genitourinary Trauma,” by Matthew C. Gratton \\nand French L. Keith.\\n167_Cydulka_Ch167.indd   919 22/03/17   11:56 AM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 938, 'page_label': '920'}, page_content='920\\nTrauma to The Extremities\\nAmy M. Stubbs\\nIsolated penetrating trauma to the extremities that is associated with vascu-\\nlar injury has a nearly 10% incidence of mortality or limb loss. Early iden-\\ntification of injuries requiring imaging and/or surgical intervention has \\nreduced the rates of limb loss and disability.\\n■ ■CLINICAL FEATURES\\nAs with all traumatic injuries, a thorough primary survey with attention to \\nlife-threatening injuries should be accomplished prior to a detailed extrem-\\nity exam. Direct pressure or a tourniquet should be applied to actively \\nbleeding injuries. Once an extremity injury is identified, a meticulous vas-\\ncular and neuromuscular exam should then be performed.\\nNote pulses distal to the injury, capillary refill, and the color and tem-\\nperature of the limb. Use a Doppler to detect a signal in the absence of a \\npulse. Any “hard” signs of arterial injury should prompt immediate surgical \\nconsultation and intervention. Soft signs of arterial injury should also be \\nnoted and require further evaluation, typically imaging and observation \\n(Table 168-1).\\nDocument the size and shape of each wound, as well as any bony \\ndeformities or soft tissue defects. Evaluate the surrounding area for pain \\nwith palpation or range of motion. Carefully evaluate joints in the proxim-\\nity of the wound for the possibility of an open joint. Perform detailed \\nstrength and sensory exams on the affected limb to check for peripheral \\nnerve injury. Consult the appropriate surgical specialist for signs of injury \\nto an artery, nerve, joint, or bone, or suspicion of compartment syndrome \\n(see Fig. 168-1).\\n168\\nCh A p TER\\nTablE 168-1 Clinical Manifestations of Extremity Vascular Trauma\\nHard signs\\nAbsent or diminished distal pulses\\nObvious arterial bleeding\\nLarge expanding or pulsatile hematoma\\nAudible bruit\\nPalpable thrill\\nDistal ischemia (pain, pallor, paralysis, paresthesias, coolness)\\nSoft signs\\nSmall, stable hematoma\\nInjury to anatomically related nerve\\nUnexplained hypotension\\nHistory of hemorrhage\\nProximity of injury to major vascular structures\\nComplex fracture\\n168_Cydulka_Ch168.indd   920 21/04/17   3:57 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 939, 'page_label': '921'}, page_content='CHAPTER 168: Trauma to The Extremities 921 \\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nObtain ankle-brachial indexes (ABIs) on the affected and unaffected limb \\nusing a Doppler and manual blood pressure cuff. Though they have vari-\\nable sensitivity and specificity for arterial injury and do not reliably detect \\nnonocclusive injuries such as intimal flaps or pseudoaneurysms, a result of \\n<0.9 is concerning for arterial injury. Soft signs of vascular injury or an \\nabnormal ABI requires further imaging.\\nAt minimum, AP and lateral films of the affected limb are necessary to \\nevaluate for bone or joint injuries. Retained foreign bodies or embolized \\nbullet fragments may also be seen. Image the joint above and below the \\ninjury site.\\nPenetrating\\nExtremity\\nTrauma\\nMedical history and physical examination\\nHard signs\\nABI\\nCT angiography\\nPositive\\n(occlusion or\\nextravasation)\\nNegative or\\nminimal\\n(no occlusive\\narterial injury)\\nObservation\\nObservation\\n>0.9<0.9\\nImmediate\\nvascular\\nsurgery consult\\nSoft signs\\nNo signs of\\nvascular injury\\n(no hard or\\nsoft signs)\\nFigurE 168-1.  Algorithm for penetrating extremity trauma. ABI, ankle-brachial \\nindex.\\n168_Cydulka_Ch168.indd   921 22/03/17   12:00 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 940, 'page_label': '922'}, page_content='922 SECTION 18: Trauma\\nCT angiography has largely supplanted conventional angiography in the \\nevaluation of vascular injuries as it is widely available, rapid, relatively \\nnoninvasive, and provides high-quality images that may also be useful in \\nevaluating concurrent injuries. Ultrasound is neither as sensitive nor as \\nspecific as angiography and cannot reliably rule out a vascular injury.\\nLaboratory testing is not required, though a CBC, type and screen, or \\ncreatinine may be indicated in certain settings, such as when there is pro-\\nfuse bleeding or concern exists for renal insufficiency when angiography is \\na consideration.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1.  Immediate operative interv ention is typically indicated when hard \\nsigns of vascular injury are identified. For certain injuries, imaging, \\nin consultation with the vascular surgeon, may be appropriate prior to \\nsurgical repair.\\n2.  In the absence of arterial injury, 24-hour admission for observation and \\nserial exams may be reasonable.\\n3.  Control bleeding with direct pressure, pressure dressings, or a tourni-\\nquet. Vessels should not be clamped or ligated to avoid injury to adjacent \\nnerves.\\n4.  Bone or joint capsule injuries should be evaluated by an orthopedic sur-\\ngeon as patients are at risk for infection, posttraumatic arthritis, and loss \\nof function. Fractures due to penetrating injuries should be treated as \\nopen fractures, requiring surgical debridement and admission for intra-\\nvenous antibiotics, such as a cephalosporin plus gentamycin.\\n5.  Update tetanus and irrigate wounds with, at minimum, 500 to 1000 cc \\nof saline or tap water at high pressure (15 to 20 pounds per square inch). \\nGrossly contaminated or older wounds may require gentle scrubbing \\nand/or debridement.\\n6.  Closure of the wound depends on the timing of presentation and amount \\nof contamination. Repair low-risk wounds and arrange follow-up in 24 \\nto 48 hours. Wounds with tissue destruction, gross contamination, or re-\\ntained foreign bodies should be repaired via delayed primary closure \\nafter 72 to 96 hours. If there is no fracture, antibiotics are generally not \\nindicated for low risk injuries, but should be considered for high-risk \\ncases such as hand injuries, gross contamination, or immunocompro-\\nmised patients.\\n7.  The decision to remove foreign bodies such as bullet fragments depends \\non the size, location, and composition of the object. As aggressive explo-\\nration may cause further tissue damage and increase infection risk; the \\nrisk/benefit ratio should be carefully considered.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 266, “Trauma to the Extremities,” by James Heilman.\\n168_Cydulka_Ch168.indd   922 22/03/17   12:00 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 941, 'page_label': '923'}, page_content='923\\nInjuries to the Bones, Joints, \\nand Soft Tissue\\n 19\\nSECTION\\nInitial Evaluation and \\nManagement of Orthopedic \\nInjuries\\nGregory M. Johnston\\nOrthopedic injuries have implications beyond localized pain and swelling \\nat the site of injury. The clinician must methodically evaluate the patient to \\nprevent missing an occult or concomitant injury. Prompt recognition and \\nappropriate treatment are needed to prevent prolonged pain, temporary or \\npermanent disability, or even death.\\n■ ■CLINICAL FEATURES\\nKey to any emergency department encounter is obtaining a concise history \\nfrom the patient and, when this is not feasible, from pre-hospital personnel \\nor family members, and performing a meticulous physical examination. For \\ninstance, a patient may present with a deformed lower extremity, but a his-\\ntory of a fall from height will cue the clinician to consider the possibility of \\na concomitant spinal injury, or the spontaneous occurrence of a fracture in a \\npatient with a history of malignancy may indicate a pathologic fracture. The \\nclinician should conduct systematic palpation, since it is not uncommon for \\nthe pain of a fracture or dislocation to be referred to another area. Other \\nessential aspects of the physical examination include inspection for swelling, \\ndiscoloration, and deformity, documentation of both active and passive range \\nof motion proximal and distal to the reported injury, and assessment of neu-\\nrovascular status to include sensorimotor testing of peripheral nerve function. \\nVascular status should be assessed as soon as possible, since rapid correction \\nof circulatory compromise can prevent ischemia, tissue loss, or amputation.\\nDiagnostic imaging should not be used as a substitute for physical \\nexamination, since it is possible for an occult fracture to escape detection \\non initial radiographic imaging. In addition, some fractures may only be \\ndetected on specialized radiographic views. If a patient has significant ten-\\nderness to palpation, pain with weight bearing, or with passive range of \\nmotion, then the possibility of an occult fracture should be considered. A \\nnegative plain film report does not exclude a significant injury. In such \\ninstances the fracture may only be detected by more advanced imaging \\nmodalities such as CT, bone scan, or MRI.\\n169\\nCh A p TER\\n169_Cydulka_Ch169.indd   923 22/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 942, 'page_label': '924'}, page_content='924 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nConsider obtaining studies of joints above and below the suspected frac-\\nture site, since additional injuries may be present. Pediatric patients pres-\\nent a special challenge due to the presence of ossifying growth centers. If \\na fracture is suspected, it is often helpful to obtain comparison films of the \\nunaffected side. While many injuries may be treated in the emergency \\ndepartment and then routinely referred for outpatient follow-up, more \\nsignificant injuries mandate immediate discussion with the orthopedic \\nsurgeon. Digital imaging is becoming more common, so it is often \\npossible for the consulting orthopedist to conduct a contemporaneous \\nreview of the diagnostic studies when consulted by the emergency physi-\\ncian. This is not always feasible in rural medical facilities or military \\nenvironments; therefore, overreliance on technology should not supplant \\nthe fundamental skill of describing radiographs. The following is a recom-\\nmended way to verbally describe the fracture to the consultant in order to \\nbest communicate the findings of the radiograph:\\n●■■Open (overlying skin disrupted) versus closed (overlying skin intact): \\nOpen injuries frequently require urgent operative intervention, and man-\\ndate thorough irrigation and prophylactic antibiotics to prevent the \\nmorbid sequelae of osteomyelitis and sepsis. Tetanus prophylaxis, admin-\\nistration of first-generation cephalosporin, i.e., Cefazolin, and the inclu-\\nsion of an aminoglycoside for contaminated wounds, i.e., Gentamicin, \\nare recommended.\\n●■■Location of the fracture: Orthopedic conventions include midshaft, junc-\\ntion of the proximal and middle thirds, junction of middle and distal \\nthirds, anatomic bone y reference points, e.g., supracondylar or intertro-\\nchanteric, and intra-articular. The later has operative implications due to \\nthe association of traumatic arthritis in cases not operatively managed.\\n●■■Orientation of the fracture: (see Fig. 169-1).\\n●■■Displacement and separation: Amount (in millimeters or percentage) and \\ndirection the distal fragment is detached and de viated from the proximal \\nfragment. A separated fragment is maintained in anatomic alignment, but \\nis offset from normal anatomic position.\\n●■■Shortening: reduction (in millimeters or centimeters) in bone length \\ndue to impaction or overriding fragments. Frequently requires sur gical \\nintervention.\\n●■■Angulation: Degree and direction of the angle formed by the distal \\nfragment.\\n●■■Rotational deformity: Degree distal fragment is twisted on axis relative to \\nthe proximal fragment. Found on physical examination, and is not typically \\ndiscernable by radiographs.\\n●■■Concomitant dislocation or subluxation: Complete loss of proper joint \\nalignment (dislocation) compared to partial loss of joint surface contact \\n(subluxation). Frequently requires surgical intervention.\\n●■■Salter-Harris fractures: Injuries to the epiphyseal plate of a growing \\nchild (see Fig. 169-2 and Table 169-1). Types I and V may not be noted \\non radiographs, and should be suspected clinically, immobilized and \\nreferred for follow-up. Unlike type I, type V injuries are associated with \\nan axial loading force.\\n169_Cydulka_Ch169.indd   924 22/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 943, 'page_label': '925'}, page_content='CHAPTER 169: Initial Evaluation and Management of Orthopedic Injuries 925 \\nBAC\\nED\\nGF\\nFIgurE 169-1.  Fracture Line Orientation. A. Transverse. B. Oblique. C. Spiral. \\nD. Comminuted. E. Segmental. F. Torus. G. Greenstick.\\n169_Cydulka_Ch169.indd   925 22/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 944, 'page_label': '926'}, page_content='926 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nTablE 169-1 Description of Salter-harris Fractures\\nSalter Type What Is Broken Off\\nI The entire epiphysis\\nII The entire epiphysis along with a portion of the metaphysis\\nIII A portion of the epiphysis\\nIV A portion of the epiphysis along with a portion of the metaphysis\\nV Compression injury of the epiphyseal plate (nothing is “broken off”)\\nII I III\\nIV V\\nFIgurE 169-2.  Epiphyseal plate fractures based on the classification of Salter \\nand Harris.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Control pain and swelling: Swelling intensifies pain and when un-\\nchecked can result in neurov ascular compromise. Administer narcotic \\nanalgesics. Avoid use of oral analgesics in individuals with possible \\noperative lesions.\\n2. Remove constricting items such as jewelry , watches, and rings as soon \\nas possible.\\n3. Apply cold packs to reduce swelling and also to reduce pain.\\n4. Elevate the affected extremity.\\n169_Cydulka_Ch169.indd   926 22/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 945, 'page_label': '927'}, page_content='CHAPTER 169: Initial Evaluation and Management of Orthopedic Injuries 927 \\n5. Withhold oral intake: Pending complete ev aluation and treatment. A \\npatient who does not require an operation may still require procedural \\nsedation.\\n6. Reduce fracture deformity and dislocations: Application of gradual and \\nsteady longitudinal traction is sufficient to reduce most fractures. \\nReduction will decrease swelling and pain, relieve tension on neurovas-\\ncular structures adjacent to the deformity, reduce the risk of converting \\na closed fracture to an open one, and restore circulation to a pulseless \\nextremity. Techniques for dislocation reduction vary based upon the site \\nof injury. The best results are achieved when the patient is relaxed and \\nsedated.\\n7. Recognize injuries that require orthopedic consultation: Many ortho -\\npedic injuries can be treated in the ED and discharged to home with \\noutpatient follow-up. Some injuries require inpatient management due \\nto co-morbid health conditions or issues related to pain control or \\nambulatory dysfunction, such as hip fractures. Other injuries, such as \\nopen fractures, compartment syndrome, irreducible dislocations, \\ncirculatory compromise, and injuries needing surgical intervention, \\nrequire direct communication and urgent consultation in the ED with \\nthe on-call orthopedic surgeon.\\n8. Splinting and immobilization: Reduces pain, facilitates healing, and \\nhelps to prevent re-injury of the affected extremity (see Table 169-2).\\nTablE 169-2 Immobilization Devices and Uses\\nImmobilization Technique Clinical Application\\nShoulder immobilizer Clavicle fracture\\nAcromioclavicular separation\\nShoulder dislocation (postreduction)\\nHumeral neck fracture\\nSling A variety of upper -extremity injuries, in conjunction with \\nother immobilization techniques; may be used alone for \\nnondisplaced or clinically suspected fracture of the radial \\nhead\\nLong-arm gutter Elbow fracture other than nondisplaced radial head \\nfracture\\nReduced elbow dislocation\\nSugar-tong Wrist or forearm fracture\\nShort-arm gutter Metacarpal or proximal phalanx fracture. (Ulnar gutter for \\nfourth or fifth ray; radial gutter for second [index] or third \\n[middle] ray)\\nThumb spica Scaphoid fracture (proven or suspected)\\nThumb metacarpal or proximal thumb phalanx fracture\\nKnee immobilizer Fracture or reduced subluxation of patella\\nKnee dislocation, postreduction (temporary)\\nTibial plateau fracture\\nKnee ligament injury\\nSuspected meniscal tear (provided the knee can be fully \\nextended)\\n(Continued)\\n169_Cydulka_Ch169.indd   927 22/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 946, 'page_label': '928'}, page_content='928 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nTablE 169-2 Immobilization Devices and Uses\\nImmobilization Technique Clinical Application\\nPosterior ankle mold \\n(consider above-the-knee \\nextension and/or adjunctive \\nuse of ankle sugar-tong for \\nunstable ankle injuries)\\nAnkle dislocation or fracture-dislocation\\nUnstable ankle fracture (high distal fibular fracture or medial \\nand/or posterior malleolar fracture)\\nWidened medial mortise (indicates disruption of stabilizing \\nmedial structures)\\nMetatarsal fracture (alternative immobilization dressings \\nmay be used)\\nAnkle stirrup Simple ankle sprain\\nStable lateral malleolus fracture (below the superior border \\nof the talus) without other ankle involvement (no medial \\nswelling or tenderness, posterior malleolus intact)\\nHard-soled shoe Toe fracture\\nSome metatarsal fractures\\nShort-leg walking boot Some toe or foot contusions or fractures where \\nweightbearing is allowed\\n■ ■FURThER READING\\nFor Further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 267, “Initial Evaluation and Management of Ortho-\\npedic Injuries,” by Jeffrey S. Menkes.\\n(Continued)\\n169_Cydulka_Ch169.indd   928 22/03/17   12:14 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 947, 'page_label': '929'}, page_content='929\\nHand and Wrist Injuries\\nRobert R. Cooney\\n■ ■HAND INJURIES\\nThe hand is innervated by the median, ulnar, and radial nerves. Motor func-\\ntion of the median nerve can be screened by flexing the thumb distal pha-\\nlanx against resistance, the ulnar nerve by spreading the fingers against \\nresistance, and the radial nerve by maintaining extension of the finger MCP \\njoints against resistance. Sensory innervation (Fig. 170-1) is best screened \\nby the presence of normal two-point discrimination (<5 mm). Injuries \\nrequiring hand surgery consultation are listed in Tables 170-1 and 170-2.\\nTendon injuries can be easily missed. Up to 90% of a tendon can be \\nlacerated with preserved range of motion without resistance, so test func-\\ntion against resistance and compare to the uninjured side. Pain along the \\ncourse of the tendon suggests a partial laceration even if strength is normal. \\nAlthough extensor tendon repair has often been performed by the emer -\\ngency physician, there is a movement toward operative repair. Flexor \\ntendon repair should be performed by the hand surgeon. It is acceptable to \\nstabilize the injury by closing the skin and splinting until definitive repair \\nby the hand surgeon. Follow-up and rehabilitation of all tendon injuries are \\nnecessary, even those not requiring repair.\\nMallet finger results when complete rupture of the extensor tendon \\noccurs at the level of the distal phalanx. On examination, the distal inter -\\nphalangeal (DIP) joint is flexed at 40°. Splint the DIP joint in slight \\nhyperextension.\\n170\\nC HA pt ER\\nM\\nPCM\\nM\\nU\\nM\\nR\\nDCU\\nFIgure 170-1. The cutaneous nerve supply in the hand. DCU, dorsal cutaneous \\nbranch of ulnar nerve; M, median nerve; PCM, palmar cutaneous branch of median \\nnerve; R, superficial radial nerve; U, ulnar nerve.\\n170_Cydulka_Ch170.indd   929 21/04/17   3:59 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 948, 'page_label': '930'}, page_content='930 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nTable 170-1 Immediate Hand Surgery Consultation Guidelines\\nVascular injury with signs of tissue ischemia or poorly controlled hemorrhage\\nIrreducible dislocations\\nGrossly contaminated wounds\\nSevere crush injury\\nOpen fracture\\nCompartment syndrome\\nHigh-pressure injection injury\\nHand/finger amputation\\nTable 170-2 Delayed Hand Surgery Consultation Guidelines\\nExtensor/flexor tendon laceration\\nFlexor digitorum profundus rupture (Jersey finger)\\nExtensor digitorum rupture (mallet finger)\\nNerve injury (proximal to mid middle phalanx)\\nClosed fractures\\nDislocations\\nLigamentous injuries with instability\\nBoutonniere deformity results from an injury at the dorsal surface of \\nthe proximal interphalangeal (PIP) joint that disrupts the extensor hood \\napparatus. Lateral bands of the extensor mechanism become flexors of the \\nPIP joint and hyperextensors of the DIP joint. Splint the PIP joint in \\nextension.\\nDIP joint dislocations are uncommon because of the firm attachment \\nof skin and fibrous tissue to underlying bone. Dislocations are usually dor-\\nsal. Reduction is performed under digital block anesthesia. The dislocated \\nphalanx is distracted using longitudinal traction, slightly hyperextended, \\nthen repositioned. Splint the joint in full extension. An irreducible joint may \\nbe from an entrapped volar plate, profundus tendon, or avulsion fracture.\\nPIP joint dislocations are usually dorsal with rupture of the volar plate. \\nClosed reduction is as described above for the DIP joint. Splint the joint in \\n30° flexion. Lateral dislocation results from rupture of one of the collateral \\nligaments. An irreducible joint or evidence of complete ligamentous disrup-\\ntion warrants surgical intervention.\\nMetacarpal phalangeal (MCP) joint dislocations are usually dorsal \\nand require surgical reduction due to volar plate entrapment. Attempt \\nclosed reduction with the wrist flexed and pressure applied to the proximal \\nphalanx in a distal and volar direction. Splint with the MCP joint in flexion.\\nThumb IP joint dislocations usually involve volar plate rupture and are \\noften open. Closed reduction is as described above for the DIP joint. Place \\nin a splint with 15° to 20° of flexion.\\nThumb MCP dislocations are usually dorsal and involve volar plate \\nrupture. Reduce by flexing and abducting the metacarpal and apply \\npressure directed distally to the base of the proximal phalanx. Place in a \\nthumb spica splint.\\n170_Cydulka_Ch170.indd   930 22/03/17   12:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 949, 'page_label': '931'}, page_content='CHAPTER 170: Hand and Wrist Injuries 931 \\nThumb MCP ulnar collateral ligament ruptur e (gamekeeper’s or \\nskier’s thumb) results from forced radial abduction at the MCP joint, with \\nthe rupture occurring at the insertion on the proximal phalanx. The joint \\ncapsule and volar plate are usually involved. A complete tear is diagnosed \\nwhen abduction stress on the proximal phalanx causes more than 30° to 35° \\nof radial angulation relative to the metacarpal. Place in a thumb spica splint. \\nComplete tears mandate surgical referral.\\nDistal phalanx fractures most commonly involve the tuft. These are \\nassociated with nail bed laceration. Place a volar or hairpin splint to the DIP \\njoint. Avulsion fractures of the base often represent associated tendon \\ninvolvement.\\nProximal and middle phalanx fractures of the base and neck that are \\nnondisplaced and stable can be treated with buddy taping. Transverse or \\nspiral midshaft fractures or intraarticular fractures often require surgical \\nfixation. Place a gutter splint with the MCP joint flexed at 70°, the IP joints \\nin extension.\\nMetacarpal (MC) fractures most commonly involve the fourth or fifth \\nMC neck (boxer’s fracture). Skin lacerations over the fracture should raise \\nconcern for a “fight bite.” Angulation more than 20° in the fourth MC, 40° \\nin the fifth MC, or 15° in the second or third MC should be reduced. Place \\nan ulnar gutter splint for fractures of the fourth or fifth MC and a radial \\ngutter splint for fractures of the second or third MC with the wrist extended \\nat 20° and the MCP joint flexed at 70°. Thumb MC fractures usually \\ninvolve the base with intraarticular involvement (Bennett and Rolando \\nfractures). Place in a thumb spica splint.\\nCompartment syndrome of the hand may result from crush injury or \\nextravasation of IV fluids or radiocontrast media. The patient will com-\\nplain of pain that is out of proportion to exam findings. On examination, \\nthe hand, at a resting position, is extended at the MCP joint and slightly \\nflexed at the PIP joint. There is tense edema and pain with passive stretch \\nof the involved compartment. This is an orthopedic emergency and the \\ndiagnosis is made clinically due to the difficulty in obtaining accurate \\ncompartment pressures.\\nHigh-pressure injection injury occurs when substances in a high pres-\\nsure device (>2000 psi), such as grease, paint, or hydraulic fluid, are injected \\ninto the hand. Oil-based paint causes a severe tissue reaction that can result \\nin ischemia and eventual need for amputation. Obtain hand and forearm \\nradiographs searching for radiopaque substances and subcutaneous air. \\nWhile it appears benign, this injury requires emergent surgical evaluation.\\n■ ■WRISt INJURIES\\nScapholunate dissociation presents with wrist tenderness and swelling at \\nthe scapholunate joint. The PA radiograph demonstrates a space between \\nthe scaphoid and lunate that is >3 mm. Treat with a radial gutter splint and \\nprompt referral.\\nPerilunate and lunate dislocations are best noted on lateral wrist \\nradiograph. In both injuries, the normal alignment of the radius-lunate-\\ncapitate (the “3 C’s” sign) is lost. With a perilunate dislocation, the lunate \\nremains aligned with the radius, but the carpals are dislocated, usually \\ndorsal to the lunate. With a lunate dislocation, the lunate dislocates volar to \\n170_Cydulka_Ch170.indd   931 22/03/17   12:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 950, 'page_label': '932'}, page_content='932 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nthe radius, but the remainder of the carpus aligns with the radius. Lunate \\ndislocation on PA radiograph has a triangular shape, the “piece of pie” sign, \\nand on lateral view, the “spilled teacup” sign. Emergent consult for closed \\nreduction or surgical repair is indicated.\\nCarpal bone fractures are managed as summarized in Table 170-3. \\nThe scaphoid is the most common carpal bone fractured. Fracture of the \\nscaphoid, lunate, or capitate can cause avascular necrosis of the bone. \\nScaphoid and lunate fractures are often not detected on plain radiographs, \\nso ED diagnosis and treatment should be based on clinical findings alone.\\nColles, Smith, and Barton fractures involve the distal radius at the \\nmetaphysis (Table 170-4). Most of these fractures can be treated with \\nclosed reduction and a sugar-tong splint.\\nRadial styloid fracture can produce carpal instability with scapholu-\\nnate dissociation as major carpal ligaments insert here. Splint the wrist in \\nmild flexion and ulnar deviation.\\nTable 170-3 Summary of Carpal Bone Fractures and ED Management\\nCarpal Bone\\nMechanism  \\nof Injury Examination\\nInitial ED \\nManagement\\nScaphoid Fall on outstretched \\nhand\\nSnuffbox tenderness. \\nPain with radial \\ndeviation and flexion\\nShort arm, thumb \\nspica, in dorsiflexion \\nwith radial deviation\\nTriquetrum Avulsion fracture—\\ntwisting of hand \\nagainst resistance or \\nhyperextension\\nBody fracture—direct \\ntrauma\\nTenderness at the \\ndorsum of the wrist, \\ndistal to the ulnar \\nstyloid\\nShort arm, sugar-tong \\nsplint\\nLunate Fall on outstretched \\nhand\\nTenderness at shallow \\nindentation of the \\nmiddorsum of the wrist, \\nulnar and distal to Lister \\ntubercle\\nShort arm, thumb \\nspica splint\\nTrapezium Direct blow to thumb; \\nforce to wrist while \\ndorsiflexed and \\nradially deviated\\nPainful thumb movement \\nand weak pinch strength\\nSnuffbox tenderness\\nShort arm, thumb \\nspica splint\\nPisiform Fall directed on the \\nhypothenar eminence\\nTender pisiform, promi-\\nnent at the base of the \\nhypothenar eminence\\nShort arm, volar splint \\nin 30° of flexion and \\nulnar deviation\\nHamate Interrupted swing of \\na golf club, bat, or \\nracquet\\nTenderness at the hook \\nof the hamate, just \\ndistal and radial to the \\npisiform\\nShort arm, volar wrist \\nsplint with fourth and \\nfifth metacarpal joints \\nin flexion\\nCapitate Forceful dorsiflexion \\nof the hand with \\nradial impact\\nTenderness over the \\ncapitate just proximal to \\nthe third metacarpal\\nShort arm, volar wrist \\nsplint\\nTrapezoid Axial load onto the \\nindex metacarpal\\nTenderness over the \\nradial aspect of the base \\nof the index metacarpal\\nShort arm, thumb \\nspica splint\\n170_Cydulka_Ch170.indd   932 22/03/17   12:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 951, 'page_label': '933'}, page_content='CHAPTER 170: Hand and Wrist Injuries 933 \\nUlnar styloid fracture may result in radioulnar joint instability. Place \\nan ulnar gutter splint with the wrist in neutral position and slight ulnar \\ndeviation.\\n■ ■FURtHER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 268, “Injuries to the Hand and Digits,” by Moira \\nDavenport and Peter Tang; Chapter 269, “Wrist Injuries,” by Robert Escarza, \\nMaurice F. Loeffel ,III, and Dennis T. Uehara.\\nTable 170-4 Radiographic Appearance of Distal Radius Fractures\\nColles’ fracture\\nDorsal angulation of the plane of the distal radius\\nDistal radius fragment is displaced proximally and dorsally\\nRadial displacement of the carpus\\nUlnar styloid may be fractured\\nSmith’s fracture\\nVolar angulation of the plane of the distal radius\\nDistal radius fragment is displaced proximally and volarly\\nRadial displacement of the carpus\\nThe fracture line extends obliquely from the dorsal surface to the volar surface 1 to  \\n2 cm proximal to the articular surface\\nBarton’s fracture\\nVolar and proximal displacement of a large fragment of radial articular surface\\nVolar displacement of the carpus\\nRadial styloid may be fractured\\n170_Cydulka_Ch170.indd   933 22/03/17   12:27 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 952, 'page_label': '934'}, page_content='934\\nForearm and Elbow Injuries\\nSandra L. Najarian\\n■ ■SOFT TISSUE INJURIES\\nBiceps and Triceps Tendon Ruptures\\nClinical Features\\nPatients with proximal long-head biceps tendon ruptures typically describe \\na “snap” or “pop” and complain of pain in the anterior shoulder. Examina-\\ntion reveals tenderness, swelling, and crepitus over the bicipital groove in \\nthe anterior shoulder. A mid-arm “ball” (the distally retracted biceps) \\nappears when the elbow is flexed. Elbow flexion strength is maintained due \\nto the preserved action of the brachialis and supinators. This is in contrast \\nto distal biceps tendon rupture where elbow flexion and supination is weak. \\nExamination of distal biceps rupture reveals swelling, ecchymosis, tender -\\nness, and inability to palpate the tendon in the antecubital fossa. With the \\npatient seated, the elbow flexed 60 to 80 degrees, and forearm resting on \\nthe patient’s lap, the examiner squeezes the muscle belly of the biceps caus-\\ning the forearm to supinate (biceps squeeze test). If no supination is noted, \\nthen this is a positive test indicating a distal biceps tendon rupture. Triceps \\ntendon ruptures are rare, and the majority occur distally. Patients present \\nwith pain, swelling, and tenderness proximal to the olecranon; a sulcus with \\na proximal mass (the proximally retracted triceps tendon) may be palpable. \\nForearm extension is weak. A modified Thompson test can be used to \\nassess triceps function. With the arm supported, elbow flexed at 90 degrees, \\nand forearm hanging in a relaxed position, squeezing the triceps muscle \\nshould produce extension of the forearm unless a complete tear is present.\\nDiagnosis and Differential\\nDiagnosis is clinical. Obtain radiographs to exclude an associated avulsion \\nfracture.\\nEmergency Department Care and Disposition\\nTreatment includes sling, ice, analgesics, and referral to an orthopedic sur -\\ngeon for definitive management. Complete tendon tears in young active \\nindividuals often require surgical repair.\\nOveruse Syndromes\\nClinical Features\\nLateral epicondylitis or \"tennis elbow\" is more common than medial \\nepicondylitis or \"golfer’s elbow.\" Lateral epicondylitis affects the forearm \\nand wrist extensors, and medial epicondylitis affects the forearm and wrist \\nflexors. Patients with medial epicondylitis may develop an ulnar neuropathy. \\nBoth syndromes result from repetitive activity involving these muscle \\ngroups.\\n171\\nChap TER\\n171_Cydulka_Ch171.indd   934 22/03/17   12:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 953, 'page_label': '935'}, page_content='CHAPTER 171: Forearm and Elbow Injuries 935 \\nTaBlE 171-1 Sensory and Motor Function Testing of the Radial, Median,  \\nand Ulnar Nerves\\nRadial Median Ulnar\\nTest for sensory \\nfunction\\nDorsum of the thumb \\nand index web space\\nTwo-point discrimination \\nover the tip of the index \\nfinger\\nTwo-point discrimi-\\nnation over the little \\nfinger\\nTest for motor \\nfunction\\nExtend both wrist \\nand fingers against \\nresistance\\n“OK” sign with thumb and \\nindex finger; abduction \\nof the thumb (recurrent \\nbranch)\\nAbduct index finger \\nagainst resistance\\nDiagnosis and Differential\\nDiagnosis is clinical. Radiographs may help in ruling out an associated \\navulsion fracture of the lateral or medial epicondyle.\\nEmergency Department Care and Disposition\\nManagement is conservative including rest, ice, anti-inflammatory medica-\\ntions, and bracing. Occupational therapy can be useful in treating these \\nsyndromes. Surgery is reserved for refractory cases.\\n■ ■ELBOW DISLOCaTIONS\\nClinical Features\\nThe majority of elbow dislocations are posterolateral and often occur as a \\nresult of a fall on an outstretched hand. On examination, the patient holds \\nthe elbow in 45 degrees of flexion. Significant swelling of the elbow often \\nobscures the olecranon, which is directed posteriorly. Neurovascular \\nassessment is essential (Table 171-1). An open dislocation, absence of \\nradial pulse before reduction, and presence of systemic injuries are all fac-\\ntors associated with arterial injury.\\nDiagnosis and Differential\\nRadiographs confirm the diagnosis. The lateral view reveals both the ulna \\nand radius displaced posterior. The AP view reveals either medial or lateral \\ndisplacement of the ulna and radius with maintenance of their normal rela-\\ntionship to each other. The presence of associated fractures, especially to \\nthe radial head and coronoid process, can render the elbow joint unstable \\nand complicate treatment.\\nEmergency Department Care and Disposition\\nThe goals of treatment are reduction with procedural sedation and recog-\\nnition of neurovascular complications, associated fractures, and postre-\\nduction instability. Intra-articular lidocaine may provide analgesia for \\nclosed reduction.\\n1. Several methods can be used for reduction. With the first two-person \\nmethod (Fig. 171-1), start by placing the patient supine, and apply \\ngentle longitudinal traction on the wrist and forearm while an assistant \\napplies countertraction on the arm. Correct any medial or lateral \\n171_Cydulka_Ch171.indd   935 22/03/17   12:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 954, 'page_label': '936'}, page_content='936 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nA\\nB\\nFIguRE 171-1.  Traction and flexion method of reducing a posterior elbow \\ndislocation. A. Side-to-side manipulation is used to correct medial or lateral dis-\\nplacement. B. The elbow is then flexed while maintaining longitudinal traction.\\ndisplacement with the other hand. Then, apply downward pressure on \\nthe proximal forearm to disengage the coronoid process from the olec-\\nranon. A palpable clunk indicates a successful reduction. With the \\nsecond two-person method (Fig. 171-2), start with the patient supine \\nwith the arm adducted across the torso and elbow slightly flexed. The \\npatient may also be positioned prone with the affected arm abducted \\nand the elbow slightly flexed. The assistant applies longitudinal traction \\n171_Cydulka_Ch171.indd   936 22/03/17   12:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 955, 'page_label': '937'}, page_content='CHAPTER 171: Forearm and Elbow Injuries 937 \\nA\\nB\\nFIguRE 171-2.  Olecranon manipulation method of reducing a posterior elbow \\ndislocation with the patient positioned prone (A) or supine (B).\\non the wrist and forearm, while the operator holds the elbow with both \\nthumbs behind the olecranon. Apply firm pressure with thumbs to push \\nthe olecranon over the trochlea and back into position. The single-\\nperson method (Fig. 171-3) starts with the patient prone and the \\naffected arm on the stretcher with the elbow flexed over the edge of the \\nstretcher. Place a pillow or folded blanket under the humerus and hang \\na 5-lb weight to the wrist. The elbow should spontaneously reduce over \\nseveral minutes. Gentle pressure to the olecranon can aid the reduction.\\n171_Cydulka_Ch171.indd   937 22/03/17   12:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 956, 'page_label': '938'}, page_content='938 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\n2. After the reduction, range the elbow fully to assess stability.\\n3. Assess neurovascular status after reduction and ov er a period of \\nobservation.\\n4. Obtain post reduction films.\\n5. Immobilize the elbow in a long arm posterior splint with the elbow \\nin slightly less than 90 de grees of flexion and the forearm in mild \\npronation. Arrange for close orthopedic follow-up.\\n6. Immediate orthopedic consultation is necessary for patients with insta-\\nbility, neurovascular compromise, or open dislocations. Admission may \\nbe necessary to monitor neurovascular status.\\n■ ■ELBOW FRaCTURES\\nClinical Features\\nRadial head fractures present with pain, swelling, and tenderness over the \\nlateral elbow, and inability to fully extend the elbow. Supracondylar and \\nintercondylar fractures present with significant swelling, tenderness, and \\nlimited range of motion at the elbow. Supracondylar fractures may \\nresemble a posterior elbow dislocation. Olecranon fractures present with \\npain, swelling, and crepitus over the posterior elbow. Epicondyle, con-\\ndyle, trochlear, capitellum, and coronoid fractures are uncommon and can \\noccur in association with other elbow injuries such as dislocations. An \\nEssex–Lopresti lesion, a radial head fracture with associated distal radio-\\nulnar joint dissociation, presents with wrist and forearm pain in addition \\nto lateral elbow pain. A neurovascular assessment is essential in all elbow \\nfractures. Potential complications of supracondylar fractures are numer -\\nous (Table 171-2). A decreased or absent radial pulse is common in \\nchildren and often secondary to brachial artery injury, even if the hand \\nappears warm and perfused. Signs of V olkmann ischemic contracture \\nAB\\nFIguRE 171-3. A. Hanging arm method of reducing a posterior elbow dislocation. \\nB. Gentle manipulation can be applied to the olecranon, if necessary.\\n171_Cydulka_Ch171.indd   938 22/03/17   12:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 957, 'page_label': '939'}, page_content='CHAPTER 171: Forearm and Elbow Injuries 939 \\nTaBlE 171-2 Complications of Supracondylar Fractures\\nEarly complications Neurologic\\nRadial nerve injury\\nMedian nerve (anterior interosseous branch) injury\\nUlnar nerve injury\\nVascular\\nVolkmann’s ischemic contracture (compartment syndrome of the \\nforearm)\\nLate complications Nonunion\\nMalunion\\nMyositis ossificans\\nLoss of motion\\n(compartment syndrome of the forearm) include refusal to open the hand, \\npain with passive extension of the fingers, and forearm tenderness. \\nAbsence of radial pulse alone does not constitute ischemia unless accom-\\npanied by these other signs.\\nDiagnosis and Differential\\nFracture lines may not be visible on standard AP and lateral radiographs of \\nthe elbow. Abnormal fat pads, a visible posterior fat pad, or a prominent \\nanterior fat pad (“sail sign”) may be the only evidence of injury. Disruption \\nof the radiocapitellar line may be another clue to injury. A line drawn from \\nthe center of the radial shaft should transect the radial head and capitellum \\nin all views. On the lateral view, a line drawn along the anterior cortex of \\nthe humerus (anterior humeral line) should transect the posterior two-thirds \\nof the capitellum. If the anterior humeral line transects the anterior one-\\nthird of the capitellum, then this is suggestive of a distal humerus or supra-\\ncondylar fracture. CT imaging can be considered for certain elbow \\nfractures, such as coronoid or comminuted intra-articular fractures.\\nEmergency Department Care and Disposition\\nImmobilization in a splint and orthopedic referral are appropriate for \\nnondisplaced fractures. Nondisplaced radial head fractures with no mobil-\\nity restrictions are treated with sling immobilization. Immediate orthope-\\ndic consultation is warranted for all displaced fractures, open fractures, \\nand evidence of neurovascular compromise. Admit patients who have \\ndisplaced fractures with significant swelling for observation of neurovas-\\ncular status.\\n■ ■FOREaRM FRaCTURES\\nClinical Features\\nBoth bone forearm fractures present with swelling, tenderness, and defor -\\nmity of the forearm. Isolated ulna or radius fractures present with localized \\nswelling and tenderness. Monteggia fracture-dislocation, a fracture of the \\nproximal third of the ulna with a radial head dislocation, presents with \\nsignificant pain and swelling over the elbow. Galeazzi fracture-dislocation, \\na fracture of the distal radius with an associated distal radioulnar joint \\n171_Cydulka_Ch171.indd   939 22/03/17   12:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 958, 'page_label': '940'}, page_content='940 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\ndislocation, presents with localized tenderness and swelling over the distal \\nradius and wrist.\\nDiagnosis and Differential\\nAP and lateral radiographs confirm the diagnosis. In a Monteggia fracture, \\nthe radiocapitellar line is disrupted, and the apex of the ulna fracture points \\nin the direction of the radial head dislocation. In a Galeazzi fracture, the \\ndistal radioulnar joint space is widened on the AP view, and the ulna is \\ndisplaced dorsally on the lateral view.\\nEmergency Department Care and Disposition\\nTreat nondisplaced fractures, torus or greenstick fractures with less than  \\n15 degrees angulation with long arm splint immobilization and referral to \\northopedics. Immediate orthopedic consultation is necessary for all dis-\\nplaced fractures. Closed reduction is often adequate for both bone fractures \\nin children. Open reduction and internal fixation are usually required for \\ndisplaced fractures in adults and for Monteggia and Galeazzi fracture-\\ndislocations (Table 171-3).\\nTaBlE 171-3 Immobilization and Follow-Up Guidelines\\nInjury Splint Referral\\nSoft tissue injuries\\nBiceps tendon rupture\\nTriceps tendon rupture\\nLateral/medial epicondylitis\\nSling immobilization\\nSling immobilization\\nForearm counterforce brace\\n1 week\\n1 week\\n2–4 week PRN\\nElbow dislocation\\nStable/postreduction\\nUnstable/postreduction\\nIrreducible\\nLong arm posterior splint, forearm in \\npronation\\nLong arm posterior splint (presurgical \\nstabilization)\\nLong arm posterior splint (presurgical \\nstabilization)\\n1 day\\nImmediate\\nImmediate\\nElbow fractures\\nDistal humerus nondisplaced\\nSupracondylar\\nIntercondylar\\nLong arm posterior splint, forearm \\nneutral\\nLong arm posterior splint (presurgical \\nstabilization)\\nLong arm posterior splint, forearm \\nneutral\\n1 week\\nImmediate\\n1–2 days\\nLateral condyle/epicondyle\\nNondisplaced\\nDisplaced\\nLong arm posterior splint, forearm in \\nsupination, wrist extended\\nLong arm posterior splint (presurgical \\nstabilization)\\n1–2 days\\nImmediate\\nMedial condyle/epicondyle\\nNondisplaced\\nDisplaced\\nLong arm posterior splint, forearm in \\npronation, wrist flexed\\nLong arm posterior splint (presurgical \\nstabilization)\\n1-2 days\\nImmediate\\nArticular surface Long arm posterior splint, forearm neutral1-2 days\\n(Continued)\\n171_Cydulka_Ch171.indd   940 22/03/17   12:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 959, 'page_label': '941'}, page_content='CHAPTER 171: Forearm and Elbow Injuries 941 \\nTaBlE 171-3 Immobilization and Follow-Up Guidelines\\nInjury Splint Referral\\nCoronoid\\nNondisplaced or minimally \\ndisplaced\\nMarkedly displaced or \\nunstable\\nLong arm posterior splint, elbow past \\n90 degrees, forearm in supination\\nLong arm posterior splint (presurgical \\nstabilization)\\n1–2 days\\nImmediate\\nOlecranon Long arm posterior splint, forearm \\nneutral\\n<24 h\\nRadial head\\nNondisplaced\\nDisplaced or range of \\nmotion block\\nSling immobilization with early range \\nof motion\\nLong arm posterior splint\\n1 week\\n<24 h\\nForearm fractures\\nBoth bones\\nPediatric\\nGreenstick\\nDisplaced\\nLong arm posterior splint\\nLong arm posterior splint (prereduction \\nstabilization)\\n1 week\\nImmediate\\nAdult\\nNondisplaced\\nDisplaced\\nAnteroposterior long arm splint\\nLong arm posterior splint (presurgical \\nstabilization)\\n1 week\\n<24 h\\nIsolated ulna shaft Long arm posterior splint, forearm \\nneutral or sugar tong splint if stable \\nand nondisplaced\\n1 week\\nProximal two thirds of radius Long arm posterior splint, forearm \\nneutral\\n1 week\\nMonteggia’s Long arm posterior splint (presurgical \\nstabilization)\\nImmediate\\nGaleazzi’s Long arm posterior splint (presurgical \\nstabilization)\\nImmediate\\n■ ■FURThER REaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 270, “Elbow and Forearm Injuries,” by Yvonne C. \\nChow\\n(Continued)\\n171_Cydulka_Ch171.indd   941 22/03/17   12:47 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 960, 'page_label': '942'}, page_content='942\\nShoulder and Humerus Injuries\\nSandra L. Najarian\\n■ ■STERNOCLAVICULAR SPRAINS AND DISLOCATIONS\\nClinical Features\\nPatients with simple sprains have pain and tenderness localized to the joint, \\nwhereas patients with dislocations have severe pain, which is exacerbated \\nby arm motion and lying supine. In anterior dislocations, the medial clavi-\\ncle is visibly prominent and palpable anterior to the sternum. In posterior \\ndislocations, the medial clavicle is less visible and often not palpable. \\nSymptoms of hoarseness, dysphagia, dyspnea, upper extremity paresthesia, \\nor weakness may indicate life-threatening injuries to mediastinal structures, \\nsuch as pneumothorax or compression or laceration of surrounding great \\nvessels, trachea, and esophagus.\\nDiagnosis and Differential\\nComputed tomography (CT) is the imaging test of choice. However, the \\ncontrast may be needed to detect injury to adjacent mediastinal structures. \\nConsider septic arthritis in the nontraumatic patient, especially in injection \\ndrug users.\\nEmergency Department Care and Disposition\\nTreatment for sternoclavicular sprains and uncomplicated anterior disloca-\\ntions includes ice, analgesics, and sling immobilization. Attempted closed \\nreduction is not necessary as this injury is often unstable. Posterior disloca-\\ntions require immediate orthopedic consultation for open reduction and \\ninternal fixation.\\n■ ■CLAVICLE AND SCAPULA FRACTURES\\nClinical Features\\nPatients with clavicle fractures present with pain, swelling, and tenderness \\nover the clavicle. The scapula is a well-protected bone; therefore, fractures \\nusually occur in association with injuries to the ipsilateral lung, thorax, and \\nshoulder girdle. Patients have pain and localized tenderness over the \\nscapula, hold their arm in adduction, and resist any arm movement.\\nDiagnosis and Differential\\nRoutine radiographs may miss some clavicle and scapular fractures. CT can \\nconfirm the diagnosis as well as identify any associated pathology.\\nEmergency Department and Disposition\\nThe majority of clavicle and scapula fractures can be managed conserva-\\ntively with sling immobilization, ice, and analgesics. Early range-of-motion \\nexercises are important. Orthopedic consultation is warranted for clavicle \\n172\\nCh APTER\\n172_Cydulka_Ch172.indd   942 22/03/17   12:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 961, 'page_label': '943'}, page_content='CHAPTER 172: Shoulder and Humerus Injuries 943 \\nfractures that are open, have neurovascular compromise, or have persistent \\nskin tenting. Clavicle fractures that are severely comminuted or displaced \\nmay benefit from operative intervention so consider early referral to ortho-\\npedics in those instances. Presence of a scapula fracture mandates investi-\\ngation for associated intrathoracic injuries. Displaced glenoid articular \\nfractures, angulated glenoid neck fractures, and certain acromial and cora-\\ncoid fractures may require surgical intervention.\\n■ ■ACROMIOCLAVICULAR JOINT INJURIES\\nClinical Features\\nAcromioclavicular joint injuries range from mild sprain to complete disrup-\\ntion of all ligaments that attach the scapula and clavicle. AC joint injuries \\noccur from a direct force to the joint with the arm adducted or from a fall \\non the outstretched hand with an indirect force transmitted to the joint. \\nClassification of these injuries and their physical findings are described in \\nTable 172-1.\\nDiagnosis and Differential\\nDiagnosis is clinical. Acromioclavicular radiographs can help determine \\nthe severity of the injury and identify any associated fractures.\\nTablE 172-1 Classification and Physical Findings in Acromioclavicular Joint \\nInjuries\\nType Injury Mechanism Radiograph/Exam\\nI Sprained \\nacromioclavicular \\nligaments\\nRadiograph: Normal\\nExam: Tenderness over \\nacromioclavicular joint\\nII Acromioclavicular \\nligaments \\nruptured; \\ncoracoclavicular \\nligaments sprained\\nRadiograph: Slight widening  \\nof acromioclavicular joint; \\nclavicle elevated 25%–50%  \\nabove acromion; may be \\nslight widening of the \\ncoracoclavicular interspace\\nExam: Tenderness and \\nmild step-off deformity of \\nacromioclavicular joint\\nIII Acromioclavicular \\nligaments \\nruptured; \\ncoracoclavicular \\nligaments \\nruptured; deltoid \\ntrapezius muscles \\ndetached\\nClavicle elevated \\n100% above acromion; \\ncoracoclavicular interspace \\nwidened 25%–100%\\nExam: Distal end of clavicle \\nprominent; shoulder droops\\n(Continued )\\n172_Cydulka_Ch172.indd   943 22/03/17   12:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 962, 'page_label': '944'}, page_content='944 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nTablE 172-1 Classification and Physical Findings in Acromioclavicular Joint \\nInjuries\\nType Injury Mechanism Radiograph/Exam\\nIV Rupture of all sup-\\nporting structures; \\nclavicle displaced \\nposteriorly in \\nor through the \\ntrapezius\\nRadiograph: May appear \\nsimilar to type II and III; \\naxillary radiograph required \\nto visualize posterior \\ndislocation\\nExam: Possible posterior \\ndisplacement of clavicle\\nV Rupture of all \\nsupporting \\nstructures (more \\nsevere form of \\ntype III injury)\\nRadiograph: \\nAcromioclavicular joint \\ndislocated; generally \\n200%–300% disparity \\nof coracoclavicular inter-\\nspace compared to normal \\nshoulder\\nExam: More pain; gross \\ndeformity of clavicle\\nVI Acromioclavicular \\nligaments dis-\\nrupted; coracocla-\\nvicular ligaments \\nmay be disrupted; \\ndeltoid and \\ntrapezius muscles \\ndisrupted\\nRadiograph: \\nAcromioclavicular joint \\ndislocated; clavicle \\ndisplaced inferiorly\\nExam: Severe swelling; \\nmultiple associated injuries\\n(Continued)\\nEmergency Department Care and Disposition\\nTreatment for type I and II injuries includes sling immobilization, rest, ice, \\nand analgesics. Early range-of-motion exercises are recommended at 7 to \\n14 days post injury. Treatment for type III is controversial, but the trend \\nfavors conservative management with sling immobilization rather than \\noperative management. Treatment for type IV through VI is operative and \\nwarrants orthopedic consultation.\\n■ ■GLENOhUMERAL JOINT DISLOCATION\\nClinical Features\\nAnterior shoulder dislocations, the most common type of shoulder disloca-\\ntions, are generally the result of an abduction, extension, and external \\nrotation force on the arm. Patients present with pain, holding their arm in \\nslight abduction and external rotation. The affected shoulder loses its nor -\\nmal contour. Patients resist any adduction or internal rotation. The humeral \\nhead is sometimes palpable anteriorly. Decreased pinprick sensation over \\nthe skin of the lateral deltoid is a sign of axillary nerve injury. Posterior \\nshoulder dislocations often result from an indirect, abduction and internal \\n172_Cydulka_Ch172.indd   944 22/03/17   12:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 963, 'page_label': '945'}, page_content='CHAPTER 172: Shoulder and Humerus Injuries 945 \\nrotational force or from a direct blow to the anterior shoulder. Patients  \\npresent with pain, anterior flattening of the normal shoulder contour, and \\nprominence of the posterior shoulder. Patients are unable to externally \\nrotate or abduct the affected arm. Inferior shoulder dislocations (luxatio \\nerecta) result from a hyper abduction force. Patients present with their arm \\ncompletely abducted, elbow flexed, and hand resting on or behind their \\nhead. The humeral head is palpable on the lateral chest wall. Superior \\nshoulder dislocations are very rare.\\nDiagnosis and Differential\\nAnteroposterior and scapular “Y” view radiographs confirm the type of \\ndislocation and identify any associated fractures. The presence of minor \\nfractures, such as Hill–Sachs lesions (humeral head defects) or Bankart \\nlesions (glenoid labral defects), does not change ED management. Con-\\nsider omitting prereduction radiographs in patients, who have a history of \\nrecurrent shoulder dislocation, presenting with signs and symptoms of a \\nrecurrence in the absence of trauma.\\nEmergency Department Care and Disposition\\nReduction techniques include traction, leverage, and scapular manipula-\\ntion. Be familiar with at least two or three techniques. The most common \\ntechniques are detailed below. Procedural sedation is recommended; how-\\never, an intraarticular injection of 10 to 20 mL of 1% lidocaine can facilitate \\nreduction and may obviate the need for sedation.\\n1. Modified Hippocratic technique. This method uses traction-\\ncountertraction. Place the patient supine with their arm abducted and  \\nthe elbow flexed 90°. A sheet is placed across the thorax of the patient \\nand tied around the waist of the assistant. Another sheet is placed \\naround the patient’s flexed elbow and the clinician’s waist. Gradually \\napply traction to the patient’s proximal forearm while the assistant \\nprovides countertraction. Gentle internal and external rotation may \\nhelp the reduction.\\n2. Snowbird technique. This is another v ersion of the traction-\\ncountertraction technique where the patient is sitting and the elbow is \\nflexed to 90°. A belt or strap is placed around the proximal forearm \\nwith the loop of the belt hanging. The clinician can step on the belt \\nloop to provide traction using downward pressure while an assistant \\nuses a sheet around the patient’s torso to provide countertraction. \\nGentle external rotation of the arm can aid the reduction.\\n3. Stimson technique. Place the patient prone with the affected arm hang-\\ning over the side of the stretcher. Attach at 10-lb weight to the wrist. \\nInject intraarticular lidocaine. Reduction generally occurs in 20 to  \\n30 minutes after the muscles have completely relaxed.\\n4. Scapular manipulation technique. Scapular manipulation accom -\\nplishes reduction by repositioning the glenoid fossa rather than the \\nhumeral head. The first step is to apply traction to the patient’s arm held \\nin 90° of forward flexion. This can be accomplished in the prone posi-\\ntion or in a seated position with an assistant applying traction. Position \\nthe arm in slight external rotation. Push the scapular tip as far medially \\n172_Cydulka_Ch172.indd   945 22/03/17   12:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 964, 'page_label': '946'}, page_content='946 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nas possible while stabilizing the superior aspect of the scapula with the \\nother hand. A small amount of dorsal displacement of the scapula tip is \\nrecommended.\\n5. External rotation (Kocher’ s) technique. Place the patient supine \\nwith the arm adducted to the side. With the patient’s elbow flexed \\nto 90°, slowly and gently externally rotate the arm. No traction is \\napplied. Reduction is subtle and usually occurs before reaching the \\ncoronal plane.\\n6. Milch technique. With the patient supine, slowly abduct and externally \\nrotate the arm to the overhead position. Apply gentle traction with the \\nelbow fully extended. If reduction is not achieved, attempt to manipulate \\nthe humeral head into the glenoid fossa with the free hand.\\n7. Cunningham technique. With the patient seated and the clinician \\nsitting to the side of the patient, ha ve the patient rest their hand of the \\naffected extremity on the clinician’s shoulder. The affected arm should \\nbe fully adducted with the elbow flexed. The clinician then gently \\nmassages the trapezius and deltoid, which helps relax the patient. It is \\nimportant for the patient to remain seated in an upright position with \\ntheir scapula and shoulders retracted as much as possible. Continue to \\nmassage the biceps at mid-humeral level as the patient elevates and \\nshrugs or retracts their shoulders. Once the patient is relaxed, the \\nhumerus will reduce back into place.\\nOnce reduced, assess neurovascular status and provide sling immobili-\\nzation in order to maintain the shoulder in adduction and internal rotation. \\nPost reduction radiographs are useful for confirmation and documentation \\nof successful reduction. Urgent orthopedic follow-up is necessary. Com-\\nplications include recurrence, rotator cuff tears, humeral head defects, \\nglenoid labral defects, and neurovascular injuries. Early operative repair \\nmay decrease the incidence of recurrence.\\n■ ■hUMERUS FRACTURES\\nClinical Features\\nPatients with proximal humeral fractures have pain, swelling, tenderness, \\necchymosis, and crepitus about the shoulder. Range of motion is severely \\nlimited; patients hold their arm closely against the chest wall. Patients with \\nhumeral shaft fractures present with pain, swelling, localized tenderness, \\nlimited mobility, and crepitus on palpation. Shortening of the arm can be \\nseen in displaced fractures. A careful neurovascular exam is essential. \\nInjuries to the axillary nerve and artery are common in proximal humerus \\nfractures. The radial nerve is most frequently injured in humeral shaft \\nfractures and manifests as weak wrist extension, wrist drop, or altered \\nsensation in the dorsal web space of the thumb index web space.\\nDiagnosis and Differential\\nRadiographs confirm the diagnosis. The Neer classification system divides \\nthe proximal humerus into four parts (articular surface of the humeral head, \\ngreater tubercle, lesser tubercle, and diaphysis of the humerus) and is used \\nto guide treatment.\\n172_Cydulka_Ch172.indd   946 22/03/17   12:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 965, 'page_label': '947'}, page_content='CHAPTER 172: Shoulder and Humerus Injuries 947 \\nEmergency Department Care and Disposition\\nProximal humerus fractures that are nondisplaced or one-part fractures \\n(displaced <1 cm or angulated <45°) require sling immobilization, ice, \\nanalgesics, and orthopedic referral. Humeral shaft fractures that are nondis-\\nplaced require a coaptation splint (sugar tong), hanging cast, or functional \\nbracing. In addition, humeral shaft fractures that have less than 20° angula-\\ntion in the sagittal plan, less than 30° of varus or valgus deformity, and are \\nshortened less than 2 cm can be managed conservatively. Multipart proxi-\\nmal humeral fractures, significantly displaced or angulated shaft fractures, \\nopen fractures, or fractures with neurovascular injuries require immediate \\northopedic consultation.\\n■ ■BRAChIAL PLEXUS INJURIES\\nClinical Features\\nTraumatic brachial plexus injuries are the most common form of plexus \\ninjuries, often resulting from penetrating, compression, or closed traction \\nmechanisms. Injuries can be classified into supraclavicular (roots and \\ntrunks) or infraclavicular (cords and terminal nerve) injuries. Patients com-\\nplain of constant, burning arm pain and will have sensory and motor defi-\\ncits. Patients may have significant swelling and soft tissue injury to the \\nneck and shoulder girdle. Horner’s syndrome may be present if the adjacent \\nganglions are damaged. Unless the patient is responsive, the neurologic \\nimpairment is often not appreciated clinically until after the initial stabiliza-\\ntion and treatment. Figure 172-1 demonstrates the sensory distributions of \\nthe cervical roots and peripheral nerves.\\nDiagnosis\\nDiagnosis is largely clinical. MRI and CT myelography are frequently \\nobtained. Electromyography and nerve conduction velocity studies can aid \\nin the diagnosis. Sometimes surgical exploration is necessary.\\nAnterior\\n(volar)\\nPosterior\\n(dorsal)\\nAnterior\\n(volar)\\nPosterior\\n(dorsal)\\nC6\\nC7\\nC7\\nC8\\nT1\\nC6\\nUpper lateral cutaneous \\nnerve of arm\\nMedial cutaneous nerve \\nof arm and intercostal \\nbrachial nerve\\nCutaneous branches \\nof radial nerve\\nMedial cutaneous \\nnerve of forearm\\nLateral cutaneous \\nnerve of forearm\\nUlnar nerve\\nRadial nerve\\nMedian nerve\\nFIgurE 172-1. Sensory distribution of the brachial plexus.\\n172_Cydulka_Ch172.indd   947 22/03/17   12:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 966, 'page_label': '948'}, page_content='948 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nEmergency Department Care and Disposition\\nThe location and extent of nerv e damage guides treatment and determines \\nprognosis. It is important to be able to recognize this injury and refer \\nappropriately.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 271, “Shoulder and Humerus Injuries,” by Lars Petter \\nBjoernsen and Alexander Ebinger.\\n172_Cydulka_Ch172.indd   948 22/03/17   12:57 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 967, 'page_label': '949'}, page_content='949\\nPelvis, Hip, and Femur Injuries\\nJeffrey G. Norvell\\n■ ■PELVIC INJURIES\\nClinical Features\\nSigns and symptoms of pelvic injuries vary from local pain and tenderness \\nto pelvic instability and severe shock. Examine the patient for pain, pelvic \\ninstability, deformities, lacerations, ecchymoses, and hematomas. Avoid \\nexcessive movement of unstable fractures as this could produce further \\ninjury and cause additional blood loss. Rectal examination may reveal dis-\\nplacement of the prostate or rectal injury. Blood at the urethral meatus \\nsuggests urethral injury. A vaginal speculum examination may be indicated \\nto detect lacerations that would suggest an open fracture. If a pelvic fracture \\nis found, assume associated intraabdominal, retroperitoneal, gynecologic, \\nor urologic injuries exist until proven otherwise.\\nDiagnosis and Differential\\nIn patients with a suspected pelvic fracture, obtain a standard anteroposte-\\nrior (AP) pelvis radiograph to evaluate for bony injury. Other radiographic \\nviews include lateral views, AP views of the hemipelvis, internal and \\nexternal oblique views of the hemipelvis, or inlet and outlet views of the \\npelvis. CT is superior to pelvic radiographs for identifying pelvic fractures \\nand evaluating pelvic ring instability. Therefore, consider CT if there is a \\nhigh suspicion for fracture but negative pelvic radiographs. In an unstable \\nblunt trauma patient, use an AP pelvic radiograph to identify a pelvic frac-\\nture quickly, allowing for emergent stabilization maneuvers and therapeu-\\ntic interventions. Routine pelvic radiographs are not needed in stable \\ntrauma patients who will undergo an emergent CT of the abdomen and \\npelvis.\\nPelvic fractures include those that involve a break in the pelvic ring, \\nfractures of a single bone without a break in the pelvic ring, and acetabular \\nfractures. Single bone fractures are described in Table 173-1.\\nAcetabular fractures are commonly associated with lateral compression \\nforces or hip dislocations and can be diagnosed with pelvis radiographs and \\nJudet views. CT is more sensitive than radiography in detecting acetabular \\ninjury and is helpful in preoperative planning.\\nEmergency Department Care and Disposition\\n1. Due to associated hemorrhage and other injuries, patients with pelvic \\nfractures may need resuscitation with crystalloid and blood products.\\n2. Stabilize an unstable pelvic fracture with a pelvic binding device or \\nbedsheet to stabilize fracture ends.\\n3. In hemodynamically unstable patients, evaluate for other locations of bleed-\\ning such as the thorax and the peritoneal cavity using a chest radiograph and \\nthe focused abdominal sonogram for trauma (FAST) examination.\\n173\\nCha P t ER\\n173_Cydulka_Ch173.indd   949 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 968, 'page_label': '950'}, page_content='950 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nTablE 173-1 avulsion and Single Bone Fractures\\nFracture\\nDescription/\\nMechanism of \\nInjury\\nClinical Findings/\\nassociated \\nInjuries treatment\\nDisposition and \\nFollow-Up\\nIliac wing \\n(Duverney) \\nfracture\\nDirect trauma, \\nusually lateral to \\nmedial\\nSwelling, tender-\\nness over iliac \\nwing; abdominal \\npain; ileus; ace-\\ntabular fractures; \\nserious injury \\ninfrequent\\nAnalgesics, non-\\nweight-bearing \\nuntil hip abduc-\\ntors pain-free, \\nusually nonopera-\\ntive\\nDischarge with \\northopedic \\nfollow-up in  \\n1–2 weeks; \\nadmit for open \\nfracture or con-\\ncerning abdomi-\\nnal examination\\nSingle \\nramus of \\npubis or \\nischium\\nFall or direct \\ntrauma in elderly; \\nexercise-induced \\nstress fracture in \\nyoung or in preg-\\nnant women\\nLocal pain and \\ntenderness; may \\nhave inability to \\nambulate\\nAnalgesics, \\ncrutches\\nDischarge with \\nPCP or orthope-\\ndic follow-up in  \\n1–2 weeks\\nIschium \\nbody\\nExternal trauma \\nor from fall in \\nsitting position; \\nleast common \\npelvic fracture\\nLocal pain and \\ntenderness; pain \\nwith hamstring \\nmovement\\nAnalgesics, bed \\nrest, donut-ring \\ncushion, crutches\\nDischarge with \\northopedic \\nfollow-up in  \\n1–2 weeks\\nSacral \\nfracture\\nTransverse frac-\\ntures from direct \\nanteroposterior \\ntrauma; upper \\ntransverse frac-\\ntures from fall in \\nflexed position\\nPain on rectal \\nexamination; \\nsacral root injury \\nwith upper trans-\\nverse fractures; \\nvertical fractures \\nmay transect the \\npelvic ring\\nAnalgesics, bed \\nrest, surgery \\nmay be needed \\nfor displaced \\nfractures or neu-\\nrologic injury\\nDischarge with \\northopedic \\nfollow-up in  \\n1–2 weeks; ortho-\\npedic consultation \\nfor displaced \\nfractures or neu-\\nrologic deficits\\nCoccyx \\nfracture\\nFall in sitting \\nposition; more \\ncommon in \\nwomen\\nPain, tenderness \\nover sacral region; \\npain on compres-\\nsion during rectal \\nexamination\\nAnalgesics, \\nbed rest, stool \\nsofteners, sitz \\nbaths, donut-ring \\ncushion\\nPCP or orthopedic \\nfollow-up in  \\n2–3 weeks; surgi-\\ncal excision of \\nfracture fragment \\nif chronic pain\\nAnterior-\\nsuperior \\niliac spine\\nForceful sartorius \\nmuscle contrac-\\ntion (e.g., adoles-\\ncent sprinters)\\nPain with hip flex-\\nion and abduction\\nAnalgesics, \\nbed rest for \\n3–4 weeks \\nwith hip flexed \\nand abducted, \\ncrutches\\nDischarge with \\northopedic \\nfollow-up in  \\n1–2 weeks\\nAnterior-\\ninferior \\niliac spine\\nForceful rectus \\nfemoris muscle \\ncontraction (e.g., \\nadolescent soccer \\nplayers)\\nPain in groin; pain \\nwith hip flexion\\nAnalgesics, bed \\nrest for  \\n3–4 weeks \\nwith hip flexed, \\ncrutches\\nDischarge with \\northopedic \\nfollow-up in  \\n1–2 weeks\\nIschial \\ntuberosity\\nForceful contrac-\\ntion of ham-\\nstrings\\nPain with sitting \\nor flexing the \\nthigh\\nAnalgesics, bed \\nrest for 3–4 weeks \\nin extension, \\nexternal rotation, \\ncrutches\\nDischarge with \\northopedic \\nfollow-up in  \\n1–2 weeks\\nAbbreviation: PCP , primary care physician.\\n173_Cydulka_Ch173.indd   950 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 969, 'page_label': '951'}, page_content='CHAPTER 173: Pelvis, Hip, and Femur Injuries 951 \\n4. After excluding other sources of hemorrhage, treatment for ongoing \\nhemodynamic instability in patients with pelvic fractures includes angi-\\nography with embolization and external fixation.\\n5. An algorithm for treating severe pelvic fractures is listed in Figure 173-1.\\n6. With the exception of lateral compression type I and AP compression \\ntype I injuries, all other pelvic ring fractures require open reduction and \\ninternal fixation (ORIF).\\n7. Acetabular fractures require orthopedic consultation and hospital admis-\\nsion. Nondisplaced fractures may be treated with analgesia and bed rest. \\nDisplaced fractures are treated with early ORIF.\\n8. The treatment and disposition of single bone fractures are listed in  \\nTable 173-1.\\n■ ■hIP FRaCtURES\\nClinical Features\\nThe vast majority of hip fractures occur in elderly patients with osteoporo-\\nsis or other bony pathology who present after a fall (Table 173-2). The \\naffected leg is classically shortened and externally rotated. Patients with hip \\nfractures may complain of pain at the site of injury or in the groin and knee. \\nAfter performing a primary survey and stabilizing the patient, examine the \\npatient for pain, shortening, rotation, deformities, pelvic or sacral tender -\\nness, and neurovascular status. If no significant abnormalities are found, \\ncarefully evaluate range of motion. A history of fall or significant trauma \\nshould prompt the examiner to evaluate for other injuries.\\nUnstable patient\\nto whom a pelvic \\nbinding device has\\nbeen applied\\nResults of FAST\\nexam performed\\nduring primary\\nsurvey\\nPatient is \\nhemodynamically\\nstable or responded \\nto initial resuscitation\\nCT scan\\nNegative Positive\\n*If unavailable or significant delay,  then consider \\nextraperitoneal packing in OR while waiting.\\nLaparotomyAngiography*\\nPelvis Fracture\\nFIgurE 173-1. Suggested algorithm for pelvic fracture treatment. FAST, focused \\nabdominal sonogram for trauma; OR, operating room.\\n173_Cydulka_Ch173.indd   951 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 970, 'page_label': '952'}, page_content='952 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nTablE 173-2 Proximal Femur Fractures: Demographics and Clinical Features\\nFracture\\nIncidence/\\nDemographics Mechanism\\nClinical \\nFindings\\nConcomitant \\nInjuries\\nFemoral head Isolated fracture \\nrare; seen in \\n6–16% of hip \\ndislocations\\nUsually result \\nof high-energy \\ntrauma; dash-\\nboard to flexed \\nknee most  \\ncommon\\nLimb shortened \\nand exter-\\nnally rotated \\n(anterior dislo-\\ncation); short-\\nened, flexed, \\nand internally \\nrotated (poste-\\nrior dislocation)\\nClosed head \\ninjury; intra-\\nthoracic and/or \\nintraabdominal \\ninjuries; pelvic \\nfracture, knee \\ninjuries\\nFemoral neck Common in older \\npatients with \\nosteoporosis; \\nrarely seen in \\nyounger patients\\nLow-impact \\nfalls or torsion \\nin elderly; high-\\nenergy trauma \\nor stress frac-\\ntures in young\\nRanges from \\npain with \\nweight-bearing \\nto inability to \\nambulate; limb \\nmay be short-\\nened and exter-\\nnally rotated\\nIpsilateral \\nfemoral shaft \\nfracture\\nGreater  \\ntrochanteric\\nUncommon; \\nolder patients or \\nadolescents\\nDirect trauma \\n(older patients); \\navulsion due to \\ncontraction of \\ngluteus medius \\n(young patients)\\nAmbulatory; \\npain with \\npalpation or \\nabduction\\n—\\nLesser  \\ntrochanteric\\nUncommon; ado-\\nlescents (85%) \\n> adults\\nAvulsion due to \\nforceful contrac-\\ntion of iliopsoas \\n(adolescents); \\navulsion of \\npathologic bone \\n(older adults)\\nUsually ambu-\\nlatory; pain \\nwith flexion or \\nrotation\\n—\\nIntertrochanteric Common in older \\npatients with \\nosteoporosis; \\nrare in younger \\npatients\\nFalls; high-\\nenergy trauma\\nSevere pain; \\nswelling; limb \\nshortened \\nand externally \\nrotated\\nAnemia from \\nblood loss into \\nthigh; concomi-\\ntant traumatic \\ninjuries\\nSubtrochanteric Similar to inter-\\ntrochanteric; \\n15% of hip \\nfractures\\nFalls; high-\\nenergy trauma; \\nmay also be \\npathologic\\nSevere pain; \\necchymosis; \\nlimb shortened, \\nabducted, and \\nexternally \\nrotated\\nVascular inju-\\nries, anemia/\\nhypovolemic \\nshock from \\nfracture itself or \\nother traumatic \\ninjuries\\nDiagnosis and Differential\\nRadiographic evaluation of the hip includes AP and lateral views. Other \\nradiographic views that may be helpful include an AP pelvis, which allows \\na comparison of both sides, and Judet views. Radiographs of the femur and \\nknee may also be indicated. Significant pain with weight-bearing or inability \\n173_Cydulka_Ch173.indd   952 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 971, 'page_label': '953'}, page_content='CHAPTER 173: Pelvis, Hip, and Femur Injuries 953 \\nto bear weight in patients with normal radiographs should raise suspicion for \\noccult fracture, especially at the femoral neck or acetabulum. MRI is very  \\nsensitive (nearly 100%) for identifying occult hip fractures and may identify \\nother sources of pain. CT may be useful in identifying fractures not seen on \\nradiographs, but it is not as sensitive as MRI. The differential diagnosis \\nincludes pelvic fracture, hip dislocation, femur fracture, sprains, and strains.\\nEmergency Department Care and Disposition\\n1. The treatment of hip fractures is listed in Table 173-3.\\n2. If clinical suspicion of an occult fracture is high, obtain an MRI scan in \\nthe ED. Alternatively, arrange follow-up MRI within 24 to 48 hours and \\nhave the patient remain non-weight-bearing.\\n3. Traction devices may be used for immobilization of subtrochanteric \\nfractures; however, they are contraindicated in femoral neck fractures.\\nTablE 173-3 Proximal Femur Fractures: treatment Issues\\nFracture ED Management\\nDisposition and \\nFollow-Up Complications\\nFemoral head Immediate ortho-\\npedic consultation; \\nemergent closed \\nreduction of dis-\\nlocation; ORIF if \\nclosed reduction is \\nunsuccessful\\nAdmission to  \\northopedic or \\ntrauma service\\nAVN; posttraumatic \\narthritis; sciatic \\nnerve injury; hetero-\\ntopic ossification\\nFemoral neck Orthopedic consul-\\ntation; ranges from \\nnonoperative to \\ntotal hip arthroplasty\\nAdmission to  \\northopedic service\\nAVN; infection; DVT \\nand/or pulmonary \\nembolus\\nGreater trochanteric Analgesics; \\nprotected weight-\\nbearing\\nOrthopedic follow-\\nup 1–2 weeks; \\npossible ORIF if dis-\\nplacement >1 cm\\nNonunion rare\\nLesser trochanteric Analgesics; weight-\\nbearing as toler-\\nated; evaluate for \\npossible pathologic \\nfracture\\nOrthopedic or PCP \\nfollow-up in  \\n1–2 weeks; admit \\nor urgent follow-up \\nfor pathologic  \\nfracture\\nNonunion rare\\nIntertrochanteric Orthopedic  \\nconsultation\\nAdmit for eventual \\nORIF; may need \\npreoperative testing \\nand clearance by \\nPCP or hospitalist\\nDVT and/or  \\npulmonary embolism; \\ninfection\\nSubtrochanteric Orthopedic con-\\nsultation; consider \\nHare® or Sager® \\nsplint\\nAdmit for ORIF DVT and/or  \\npulmonary embolism; \\ninfection; malunion \\n(shortened limb); \\nnonunion\\nAbbreviations: AVN, avascular necrosis; DVT, deep venous thrombosis; ORIF, open reduction and internal \\nfixation; PCP , primary care physician.\\n173_Cydulka_Ch173.indd   953 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 972, 'page_label': '954'}, page_content='954 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\n■ ■hIP DISLOCatIONS\\nHip dislocations may be anterior or posterior, and commonly result from a \\nhigh-speed motor vehicle crash. Ninety percent of hip dislocations are \\nposterior, and they may be associated with acetabular fractures. On exami-\\nnation, the extremity is shortened, internally rotated, and adducted. With \\nanterior dislocations the extremity is held in abduction and external rota-\\ntion. Assess the patient’s neurovascular status. Obtain radiographs of the \\nhip and pelvis to evaluate for hip dislocation. Further assessment of the \\nacetabulum and femur may be done with Judet views or CT.\\nHip dislocations are true orthopedic emergencies and should be reduced \\nwithin 6 hours because delays in reduction are associated with a higher \\nincidence of avascular necrosis. One of the most common methods for hip \\nreduction is described in Figure 173-2. After reduction, gently test range of \\nmotion and repeat the neurovascular exam. Order post-reduction radio-\\ngraphs or CT to confirm reduction and evaluate for injuries not apparent on \\ninitial radiographs. Coordinate post-reduction care with the orthopedist.\\nDownward pressure on pelvis\\nDownward pressure \\non pelvis\\nExternal and internal rotation \\nand upward pull on femur\\nFollowing reduction\\nA\\nB\\nUpward pull \\non femur\\nFIgurE 173-2. A and B. Allis maneuver for reduction of posterior hip dislocation.\\n173_Cydulka_Ch173.indd   954 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 973, 'page_label': '955'}, page_content='CHAPTER 173: Pelvis, Hip, and Femur Injuries 955 \\nProsthetic hips may dislocate relatively easily from minor trauma or \\nmovements that flex the hip past 90 degrees. It is advisable to discuss the \\ntreatment plan with the consulting orthopedist prior to any reduction \\nmaneuvers. Most dislocations of prosthetic hips are posterior and can be \\nreduced using the techniques described here.\\n■ ■FEMORaL ShaFt FRaCtURES\\nFractures of the femoral shaft occur most commonly in younger patients \\nsecondary to high-energy trauma. Pathologic fractures can occur due to \\nmalignancies. Clinical features include shortening, pain, swelling, and \\ndeformity. Assess the patient for neurovascular status, signs of an open \\nfracture, and other injuries. ED treatment includes splinting the extremity \\nwith a traction splint unless the patient has a sciatic nerve injury, knee injury, \\nvascular injury, or open fracture. Splint without traction if these conditions \\nexist. Open femur fractures require broad-spectrum antibiotics and copious \\nirrigation. Obtain early orthopedic consultation for definitive management.\\n■ ■FURthER REaDING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 272, “Pelvis Injuries,” by Melissa A. Barton, H. Scott \\nDerstine, and Ciara J. Barclay-Buchanan; and Chapter 273, “Hip and Femur  \\nInjuries,” by Mark Steele and  Amy M. Stubbs.\\n173_Cydulka_Ch173.indd   955 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 974, 'page_label': '956'}, page_content='956\\nKnee and Leg Injuries\\nSandra L. Najarian\\n■ ■FRACTURES\\nClinical Features\\nPatients with patellar fractures present with focal tenderness, swelling, \\nand often a loss of the extensor mechanism. Patients with femoral condyle \\nfractures present with pain, swelling, deformity, rotation, shortening, and \\nan inability to ambulate. Popliteal artery injury, deep peroneal nerve \\ninjury, ipsilateral hip dislocation or fracture, and quadriceps mechanism \\ninjury can be associated with femoral condyle fractures. Tibial spine \\nfractures present with tenderness, swelling, inability to extend the knee, \\nand a positive Lachman’s test. Patients with tibial plateau fractures have \\npain, swelling, and limited range of motion. Ligamentous instability is \\npresent in about one-third of these fractures. Patients with tibial shaft \\nfractures present with pain, swelling, and crepitance about the knee. Dis-\\ntal tibial fractures involving the articular surface (tibial plafond or Pilon \\nfracture) present with pain, swelling, and tenderness about the ankle. The \\nrisk of compartment syndrome is high with tibial fractures and mandates \\na thorough neurovascular exam. Proximal fibular fractures may be associ-\\nated with ankle injuries. Patients with isolated fibular shaft fractures may \\nbe able to bear weight.\\nDiagnosis and Differential\\nThe Pittsburgh Knee Rules (Fig. 174-1) or the Ottawa Knee Rules  \\n(Table 174-1) should be used to determine if radiography is needed. \\nThese rules have been validated in both children and adults. In sus-\\npected tibial and fibular injuries, radiographs of the ankle and knee may \\nbe necessary to exclude associated fractures. CT scanning may be con-\\nsidered if x-rays are negative, and the patient is unable to bear weight.\\nEmergency Department Care and Disposition\\nTable 174-2 describes the mechanism and treatment for the various \\nknee fractures. Most tibial fractures require emergent orthopedic con-\\nsultation. Indications for emergent operative repair include open frac-\\ntures, vascular compromise, or compartment syndrome. Patients may \\nbe placed in long-leg immobilization and discharged home if they have \\na low-energy mechanism, have their pain well controlled, and are not \\nat risk for compartment syndrome. Treatment for isolated fibular shaft \\nfractures includes splinting, ice, elevation, and orthopedic or primary \\ncare physician follow-up. Proximal fibular fractures associated with \\nankle injuries require surgical intervention and urgent orthopedic \\nconsult.\\n174\\nCh A p TER\\n174_Cydulka_Ch174.indd   956 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 975, 'page_label': '957'}, page_content='CHAPTER 174: Knee and Leg Injuries 957 \\nFIgurE 174-1. Pittsburgh Knee Rules for radiography. Reproduced with permis-\\nsion from Seaberg DC, Yealy DM, Lukens T , et al: Multicenter comparison of two \\nclinical decision rules for the use of radiography in acute, high-risk knee injuries, \\nAnn Emerg Med. 1998;Jul;32(1):8-13.\\nFall or blunt-trauma mechanism\\nAge <12 or age >50 years\\nAble to walk four\\nweight-bearing steps \\nin ED\\nNo knee radiography\\nNo knee radiography\\nKnee radiography\\nKnee radiography\\nYes\\nYesN o\\nNo Yes\\nNo\\nTabLE 174-1 Ottawa Knee Rules: Radiograph If One Criterion Is Met\\nPatient age >55 years (rules have been validated for children 2–16 years of age)\\nTenderness at the head of the fibula\\nIsolated tenderness of the patella\\nInability to flex knee to 90 degrees\\nInability to transfer weight for four steps both immediately after the injury and in the ED\\nTabLE 174-2 Mechanism of Knee Injury and Treatment\\nFracture Mechanism T reatment\\nPatella Direct blow (i.e., fall, \\nmotor vehicle crash) or \\nforceful contraction of \\nquadriceps muscle\\nNondisplaced fracture with intact extensor \\nmechanism: knee immobilizer, rest, ice, \\nanalgesia. Follow-up for serial radiographs\\nDisplaced >3 mm, articular incongruity >2 mm, \\nor with disruption of extensor mechanism:  \\nabove treatment plus early referral for ORIF\\nSeverely comminuted fracture: surgical \\ndebridement of small fragments and suturing \\nof quadriceps and patellar tendons\\nOpen fracture: irrigation and antistaphylococcal \\nantibiotics in the ED; debridement and \\nirrigation in the operating room\\nFemoral \\ncondyles\\nFall with axial load with \\nvalgus/varus/rotational \\nforces, or a blow to the \\ndistal femur\\nIncomplete or nondisplaced fractures in any age \\ngroup or stable impacted fractures in the elderly: \\nlong leg splinting and orthopedic referral\\nDisplaced fractures or fractures with any \\ndegree of joint incongruity: splinting and \\northopedic consult for ORIF\\n(Continued)\\n174_Cydulka_Ch174.indd   957 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 976, 'page_label': '958'}, page_content='958 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\n■ ■DISLOCATIONS\\nClinical Features\\nPatella dislocation results in pain and deformity of the knee. Tearing of the \\nmedial knee joint capsule can occur. Knee dislocation results in significant \\nligamentous and capsular disruption. Spontaneous reduction occurs in 50% \\nof patients. Multidirectional instability of the knee should raise the suspi-\\ncion for a spontaneously reduced knee dislocation. Knee dislocations have \\na high incidence of associated injures, such as popliteal artery injury and \\nperoneal nerve injury.\\nDiagnosis and Differential\\nRadiographs may help exclude associated fractures. Some authors recom-\\nmend arteriography for all patients with confirmed knee dislocations. \\nOthers advocate for Doppler pressure indices (ankle-brachial index) and \\nserial vascular exams if distal pulses are present, and there are no other \\nsigns of vascular injury (including ischemia, hemorrhage, or an expand-\\ning hematoma).\\nEmergency Department Care and Disposition\\nProcedural sedation is recommended to facilitate otherwise painful reduc-\\ntions. For patellar dislocation, flexing the hip and hyperextending the knee \\nhelp slide the patella back into place. Knee immobilization and orthopedic \\nor primary care physician follow-up are necessary. For knee dislocation, \\nearly reduction is essential along with documentation of pre-and post-\\nreduction neurovascular status. Splinting the affected knee in 20 degrees of \\nflexion is essential. Immediate orthopedic and vascular surgery consulta-\\ntion is warranted for all knee dislocations, and admission is mandatory for \\nobservation of neurovascular status.\\nTabLE 174-2 Mechanism of Knee Injury and Treatment\\nFracture Mechanism T reatment\\nTibial spines \\nand tuberosity\\nForce directed against \\nflexed proximal tibia in \\nan anterior or posterior \\ndirection (i.e., motor \\nvehicle crash, sporting \\ninjury)\\nIncomplete or nondisplaced fractures: immobi-\\nlization in full extension (knee immobilizer) and \\northopedic referral in 2–7 days\\nComplete or displaced fracture: early \\northopedic referral, often requires ORIF\\nTibial \\ntuberosity\\nSudden force to flexed \\nknee with quadriceps \\ncontracted\\nIncomplete or small avulsion fracture:  \\nimmobilization\\nComplete avulsion: ORIF\\nTibial plateau Valgus or varus forces \\ncombined with axial \\nload that drives the \\nfemoral condyle into the \\ntibia (i.e., fall, leg hit by \\ncar bumper)\\nNondisplaced, lateral fracture: knee immobi-\\nlizer with non-weight-bearing and orthopedic \\nreferral in 2–7 days\\nDepression of articular surface: early \\northopedic consult for ORIF\\nAbbreviation: ORIF, open reduction internal fixation.\\n(Continued)\\n174_Cydulka_Ch174.indd   958 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 977, 'page_label': '959'}, page_content='CHAPTER 174: Knee and Leg Injuries 959 \\n■ ■TENDON, LIGAMENTOUS, AND MENISCAL INJURIES\\nClinical Features\\nPatients with quadriceps or patellar tendon rupture have pain and swelling \\nabout the knee and will not be able to extend the knee against resistance. \\nA palpable defect is present above or below the knee depending on which \\ntendon is involved. Patients with Achilles tendon rupture have severe pain \\nin the calf and are unable to perform toe walk, run, or climb stairs. A \\npalpable defect is often present in the Achilles tendon 2 to 6 cm above the \\ncalcaneus. A positive Thompson test is diagnostic; with the patient lying \\nprone and knee flexed at 90 degrees, the foot fails to plantar flex when the \\ncalf is squeezed. Most ligamentous injuries present with hemarthroses, \\nthough serious ligamentous injuries may present with little pain and no \\nhemarthrosis due to complete disruption of the capsule. Patients with \\nanterior cruciate ligament (ACL) tears often describe a “pop” and signifi-\\ncant swelling over the next several hours after injury. Lachman’s test is the \\nmost sensitive test for ACL injuries. The anterior drawer and pivot shift \\ntest are also useful for diagnosis. Posterior cruciate ligament (PCL) inju-\\nries may result in a positive posterior drawer test; the composite history \\nand exam findings, however, are more accurate for diagnosis of PCL \\ninjury. Medial and lateral collateral ligament injuries are diagnosed with \\nabduction (valgus) and adduction (varus) stress testing in 30 degrees flex-\\nion. Laxity greater than 1 cm without a firm end point compared with the \\nother knee is diagnostic for a complete torn medial or lateral collateral \\nligament. Stress testing should be repeated in extension. If laxity is pres-\\nent in extension, then this indicates injury to the cruciate ligament and \\nposterior or posterolateral capsule. Peroneal nerve injury may occur with \\nlateral injuries. Symptoms of meniscal injury include painful locking of \\nthe knee, a popping, clicking or snapping sensation, or a sense of instabil-\\nity with activity or joint swelling after activity. McMurray’s test and other \\ntests for meniscal injury are not sensitive. Ligamentous injuries may be \\npresent as well. A patient with a ‘‘locked knee’’ from a torn meniscus will \\nnot be able to actively or passively range the affected knee and will have \\nsignificant pain.\\nDiagnosis and Differential\\nThe diagnosis is largely clinical. A high-riding patella may be seen on the \\nlateral radiograph of the knee with patellar tendon rupture. Ultrasound or \\nMRI can help identify Achilles tendon rupture when the diagnosis is not \\nclear. Radiographs are usually normal or show a joint effusion in ligamen-\\ntous or meniscal injuries. An avulsion fracture at the site of the lateral \\ncapsular ligament on the lateral tibial condyle (Segond fracture) is associ-\\nated with ACL rupture. Outpatient MRI or arthroscopy provides definitive \\ndiagnosis.\\nEmergency Department Care and Disposition\\nTreatment of patellar or quadriceps tendon rupture includes knee immobi-\\nlization and orthopedic consultation for surgical repair, usually within the \\nfirst 7 to 10 days after the injury. Treatment of Achilles tendon rupture \\nincludes splinting in plantar flexion, non-weight-bearing, and referral to \\n174_Cydulka_Ch174.indd   959 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 978, 'page_label': '960'}, page_content='960 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\northopedics for possible surgical repair. Treatment for ligamentous and \\nmeniscal injuries includes knee immobilization, ice, elevation, analgesics, \\nand orthopedic referral. Treatment for a ‘‘locked knee’’ includes analgesia \\nand closed reduction. Procedural sedation may be necessary. Place the \\npatient supine with the knee flexed 90 degrees over the side of the bed. \\nApply longitudinal traction to the knee, and at the same time, apply internal \\nand external rotation to the knee to unlock the joint. Consult orthopedics if \\nthe reduction is not successful.\\n■ ■OVERUSE INJURIES\\nPatellar tendonitis or “jumper’s knee” presents with pain over the patellar \\ntendon worsened by running up hills, jumping, or standing from a seated \\nposition. Treatment includes heat, nonsteroidal anti-inflammatory drugs \\n(NSAIDs), and quadriceps-strengthening exercises. Steroid injections \\nshould be avoided. Shin splints and stress fractures can present with pain \\nover the anterior leg. Patients typically describe a change or sudden increase \\nin their training pattern. Patients present with activity-induced pain relieved \\nby rest, which can progress to constant pain. Radiographs are often normal. \\nDiscontinuation of the activity for several weeks is the treatment for both \\nshin splints and stress fractures. If a stress fracture is suspected, an outpa-\\ntient bone scan or MRI can confirm the diagnosis.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 274, “Knee Injuries” by Rachel R. Bengtzen, \\nJeffrey N. Glaspy and Mark T. Steele; Chapter 275, “Leg Injuries” by Paul R. \\nHeller.\\n174_Cydulka_Ch174.indd   960 22/04/17   4:44 pm'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 979, 'page_label': '961'}, page_content='961\\nAnkle and Foot Injuries\\nSarah Elisabeth Frasure\\n■ ■ANKLE INJURIES\\nTendon and Ligament Injuries\\nClinical Features\\nTendon injuries typically result from hyperdorsiflexion (peroneal tendon \\ninjury) or sudden plantarflexion (Achilles tendon injury). Patients with an \\nAchilles tendon rupture complain of severe pain and are unable to walk on \\ntheir toes, run, or climb stairs. Ligamentous sprains are caused by inversion \\nand eversion injuries. The most common ankle sprain involves the anterior \\ntalofibular ligament. Though an isolated sprain of the medial deltoid liga-\\nment is rare, it is occasionally associated with a fibular fracture (Maison-\\nneuve fracture) or syndesmotic ligament injury. Any injury with signs of \\nneurovascular compromise requires immediate attention.\\nDiagnosis and Differential\\nEvaluate the ankle as well as the joints above and below the injury. A posi-\\ntive Thompson test (with the patient lying prone and knee flexed at 90°, the \\nfoot fails to plantarflex when the calf is squeezed) is diagnostic of Achilles \\ntendon rupture. Palpate the proximal fibula for tenderness resulting from a \\nfracture or fibulotibialis ligament tear. Squeeze the fibula toward the tibia \\nto evaluate for syndesmotic ligament injury. If tenderness is isolated to the \\nposterior aspect of the lateral malleolus, then a peroneal tendon subluxation \\nmay be present.\\nThe Ottawa Ankle Rules were developed to help clinicians determine \\nwhen imaging studies are necessary for patients with ankle injuries (see \\nFig. 175-1).\\nJoint stability dictates the treatment plan for an ankle sprain. Instability \\nis usually suspected based on the physical examination and imaging stud-\\nies. The examiner may perform the anterior drawer and talar tilt tests to \\nassess stability. If the examiner is unable to perform reliable stress testing, \\nthe injury is considered potentially unstable. Asymmetry of the gap \\nbetween the talar dome and the malleoli on the talus x-ray view also sug-\\ngests joint instability.\\nEmergency Department Care and Disposition\\n1. If the patient has a stable joint and is able to bear weight, then protec-\\ntion with an elastic bandage or ankle brace, rest, ice, compression, and \\nelevation (PRICE) for up to 72 hours is indicated. Prescribe analgesics, \\nand add motion and strength exercises within 48 to 72 hours. If pain \\npersists beyond one week, the patient should follow up with an orthope-\\ndist for a repeat evaluation.\\n2. A patient with a stable joint who is unable to bear weight requires an \\nankle brace, crutches, and orthopedic follow-up.\\n175\\nCh A pt ER\\n175_Cydulka_Ch175.indd   961 22/03/17   2:18 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 980, 'page_label': '962'}, page_content='962 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\n3. A patient with an unstable joint requires a posterior splint, crutches, \\nand timely referral to an orthopedist for definitive care.\\n4. Treatment of Achilles tendon rupture includes splinting in plantar \\nflexion, crutches to ensure nonweightbearing, and early referral to an \\northopedist for possible operative repair.\\nDislocations  Posterior dislocations, the most common type of ankle dis-\\nlocations, occur with a backward force on the plantarflex ed foot. This \\ninjury usually results in the rupture of the tibiofibular ligaments or a \\nlateral malleolus fracture. Reduce ankle dislocations immediately if vas-\\ncular compromise (absent pulses or a dusky foot) or skin tenting are pres-\\nent. First, provide analgesia and sedation as needed. Grasp the heel and \\nfoot with both hands and apply axial traction while reducing the ankle \\ninto anatomical alignment. Following successful reduction, assess post-\\nreduction neurovascular status, apply a splint, obtain post-reduction \\nradiographs, and immediately consult orthopedics.\\nFractures  Ankle fractures are classified as unimalleolar, bimalleolar,  \\nand trimalleolar. Bimalleolar and trimalleolar fractures require defini-\\ntive open reduction and internal fixation (ORIF) by an orthopedist. ED \\ncare includes initial reduction as needed, posterior splinting, elevation, \\nice application, and orthopedic consultation. Treat unimalleolar frac-\\ntures with nonweightbearing status and posterior splinting. Manage \\nminimally displaced avulsion fractures of the fibula (< 3 mm in \\ndiameter) like ankle sprains. Ankle fractures may be occult and are \\noccasionally associated with injuries to other parts of the lower extrem-\\nity (Table 175-1). Patients with open fractures require initial reduction \\nas needed, wet sterile dressing, splinting, tetanus toxoid as necessary, a \\nfirst generation cephalosporin such as cefazolin 1 g IV , and immediate \\northopedic consultation.\\nMalleolar\\nzone\\nPosterior\\nedge or tip\\nof lateral\\nmalleolus\\nLateral view Medial view\\nMidfoot\\nzone\\nBase of the fifth metatarsal Navicular\\nPosterior\\nedge or tip\\nof medial\\nmalleolus\\nFIgure 175-1.  Ottawa ankle rules for ankle and midfoot injuries. Ankle radio-\\ngraphs are required only if there is any pain in the malleolar zone or midfoot zone \\nalong with bony tenderness in any of these four locations or the inability to bear \\nweight both immediately after the injury and in the ED.\\n175_Cydulka_Ch175.indd   962 22/03/17   2:18 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 981, 'page_label': '963'}, page_content='CHAPTER 175: Ankle and Foot Injuries 963 \\n■ ■FOOt INJURIES\\nClinical Features\\nThe foot is divided into the hindfoot, midfoot, and forefoot. The Chopart \\njoint separates the hindfoot from the midfoot. The Lisfranc joint separates \\nthe midfoot from the forefoot.\\nDiagnosis and Differential\\nPay special attention on physical examination to the base of the fifth \\nmetatarsal and the base of the second metatarsal. If plain radiographs are \\nnondiagnostic, CT is indicated for suspected Lisfranc joint injuries.\\nHindfoot Injuries\\nCalcaneal injuries require a large force, and associated injuries are com-\\nmon. Measure Boehler’s angle on a lateral radiograph view (formed by the \\nintersection of a line connecting the posterior tuberosity and apex of the \\nposterior facet, and a line from the posterior facet to the apex of the anterior \\nfacet) if concerned for a calcaneal compression fracture. An angle <20° is \\nsuggestive of a fracture. Treat with a posterior splint, elevation, analgesics, \\nand orthopedic consultation. Manage small avulsion fractures of the talus \\nwith posterior splinting and timely orthopedic follow-up. Subtalar disloca-\\ntions, as well as major fractures of the talar neck or body, require immediate \\northopedic consultation.\\nMidfoot Injuries\\nInjuries of the tarsometatarsal joint combined with pain with midfoot tor -\\nsion are suspicious for a Lisfranc injury. Lisfranc joint injuries are often \\nTAbLe 175-1 Associated and Occult Injuries of the Ankle\\nInjury Clinical Suspicion Confirmatory test\\nImportant to identify in the ED\\nMaisonneuve fracture\\nPeroneal tendon dislocation\\nExamine proximal fibula and \\nshaft, tenderness to palpation; \\nproximal fracture and syndes-\\nmosis tear indicate unstable \\nfracture\\nPalpable anterior tendon \\ndislocation or subluxation\\nFibula radiograph\\nClinical examination\\nUsually identified in follow-up \\nof ankle sprains\\nOsteochondral injuries\\nSyndesmosis tear\\nAnterior calcaneal process \\nfracture\\nLateral talar process \\nfracture\\nOs trigonum\\nDiffuse ankle swelling, passive \\nplantarflexion\\nSignificant ankle pain, positive \\nsqueeze test\\nTenderness more inferoante-\\nrior than a typical ankle sprain\\nTenderness just distal to the \\ntip of fibula\\nTenderness anterior to Achilles \\ntendon\\nAnkle mortise view/CT\\nWidened mortise with \\nweight bearing\\nLateral ankle \\nradiograph/CT\\nAnkle mortise view/CT\\nLateral ankle radiograph\\n175_Cydulka_Ch175.indd   963 22/03/17   2:18 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 982, 'page_label': '964'}, page_content='964 SECTION 19: Injuries to the Bones, Joints, and Soft Tissue\\nTAbLe 175-2 Summary of Emergent Care of Bony Foot Injuries\\nFracture or Injury \\ntype ED Imaging ED Care*\\nOrthopedic Referral \\n(immediate: within 24 h; \\nearly: within 2 wk)\\nhome Care/\\nWeight-Bearing \\nStatus\\nAdvice on Long-term \\nCare and Management\\nSpecial \\nConsiderations\\nCalcaneal, intra- and \\nextra-articular\\nPlain films, Boehler angle; \\nCT for subtle findings\\nPosterior splint Intra-articular: immediate; \\nextra-articular: early\\nNWBS; RICE Possible surgery\\nTalus fracture CT Posterior splint Major: immediate; minor: \\nearly\\nNWBS; RICE Possible surgery Risk of avascular \\nnecrosis\\nLisfranc CT Splint Displaced: ortho consult \\nin ED; nondisplaced: early\\nNWBS; RICE Possible surgery Risk of compartment \\nsyndrome; arthritis\\nNavicular fracture Plain films or CT Splint Nondisplaced: early; \\ndisplaced: immediate\\nNWBS; RICE Possible surgery Risk of avascular \\nnecrosis; non-union\\nCuboid fracture Plain films or CT Splint Early NWBS; RICE Comminuted: possible \\nsurgery\\nCuneiform fracture Plain films or CT Splint Early NWBS; RICE Medial: possible surgery\\nJones Plain films; CT for athletes Splint Early NWBS; RICE Athletes: possible surgery\\nMetatarsal fracture Plain films Posterior splint Within a week for a cast NWBS; RICE Surgery not likely\\nStress fracture Clinical Cessation of \\ncausative activity\\nPhalange fracture Plain films Buddy taping Hard-soled shoe and \\nweight bearing as \\ntolerated\\nOpen fractures of \\nany kind\\nConsider antibiotics, Td Pain control Ortho consult in ED\\n*All patients with fractures should receive adequate analgesia, and splints should be well padded.\\nAbbreviations: NWBS, nonweightbearing status; ortho, orthopedist; RICE, rest, ice, compression, elevation; Td, Tetanus booster.\\n175_Cydulka_Ch175.indd   964 22/03/17   2:18 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 983, 'page_label': '965'}, page_content='CHAPTER 175: Ankle and Foot Injuries 965 \\nassociated with a fracture, most frequently noted at the base of the second \\nmetatarsal. A gap of >1 mm between the bases of the first and second \\nmetatarsal bones on plain film is considered unstable. If standard radio-\\ngraphs are nondiagnostic, complete workup may require CT imaging. Iso-\\nlated navicular, cuboid, and cuneiform injuries are rare and treated \\nconservatively.\\nForefoot\\nTreat nondisplaced metatarsal shaft fractures with a posterior splint or ortho-\\npedic shoe. Fractures with greater than 3 to 4 mm displacement on plain \\nfilms, however, require surgical reduction. Treat pseudo Jones fractures \\n(nondisplaced avulsion fractures of the tuberosity of the fifth metatarsal) \\nwith a walking cast. Manage true Jones fractures (metaphyseal-diaphyseal \\njunction fracture of the fifth metatarsal) with a nonweightbearing cast and \\ntimely orthopedic follow-up for potential surgery. Nondisplaced phalangeal \\nfractures require buddy taping and a stiff-sole (orthopedic) shoe. Treat dis-\\nplaced phalangeal fractures and dislocations with a digital block, reduction \\nby manual traction, and buddy taping. Recommended imaging and care for \\nfoot injuries can be found in Table 175-2.\\n■ ■FURthER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 276, “Ankle Injuries,” by Daniel A. Handel and Sarah \\nAndrus Gaines; and Chapter 277, “Foot Injuries,” by Sarah Andrus Gaines and \\nDaniel A. Handel.\\n175_Cydulka_Ch175.indd   965 22/03/17   2:18 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 984, 'page_label': '966'}, page_content='966\\nCompartment Syndrome\\nSandra L. Najarian \\nElevated pressures within a confined muscle compartment can lead to \\nfunctional and circulatory impairment of that limb. The most common \\ncompartments affected are in the lower leg and forearm. This syndrome \\ndevelops as a result of external compressive forces on a limb or from \\nany mechanism that increases the compartmental size and pressure \\n(Table 176-1).\\n■ ■CLINICAL FEATURES\\nSevere and difficult-to-control pain, pain out of proportion to examination, \\nand pain with passive stretch of the limb are the hallmark symptoms of this \\ndisease. Nerve dysfunction often accompanies the pain and causes burning \\nor dysesthesias in the sensory distribution of the nerve. Motor function can \\nbe impaired as well. On exam, the compartment is often swollen, firm, and \\ntender to palpation. Since tissue pressure does not typically exceed arterial \\npressure, the affected limb often has normal distal pulse, temperature, and \\ncolor. Symptoms can begin within a few hours after the injury or up to 48 \\nhours after the inciting event.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nDiagnosis is largely clinical. Direct measurement of the compartment is \\nnecessary when the diagnosis is in question or in patients who are obtunded \\nor sedated. Several commercial devices are available to measure compart-\\nment pressures. Normal compartment pressure is <  10 mm Hg. The exact \\npressure elevation at which cell death occurs is unclear. Pressures between \\n30 to 50 mm Hg are felt to be detrimental if left untreated for several hours. \\nThe diastolic blood pressure minus the measured tissue pressure, or “delta \\npressure,” better predicts the potential for irreversible muscle damage. A \\ndelta pressure of 30 mm Hg is most commonly used to diagnose acute \\n176\\nCh A p TER\\nTable 176-1 Causes of Compartment Syndrome\\nOrthopedic Tibial fractures\\nForearm fractures\\nVascular Ischemic-reperfusion injury\\nHemorrhage\\nIatrogenic Vascular puncture in anticoagulated patients\\nIV/intra-arterial drug injection\\nConstrictive casts\\nSoft tissue injury Prolonged limb compression\\nCrush injury\\nBurns\\nHematologic Hemophilia\\nAdverse effects of anticoagulants (warfarin)\\n176_Cydulka_Ch176.indd   966 22/03/17   2:56 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 985, 'page_label': '967'}, page_content='CHAPTER 176: Compartment Syndrome 967 \\ncompartment syndrome. Hypotensive patients do not tolerate elevated com-\\npartment pressures as well as normotensive patients. The differential diag-\\nnosis for compartment syndrome includes other causes of pain, such as \\nfracture, hematoma, or infection, and other causes of neurologic or vascular \\ncompromise.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\nOnce the diagnosis is confirmed, surgical fasciotomy is necessary. Admit \\nall patients to the operating room or appropriate inpatient service for obser-\\nvation and serial examinations.\\n1. While definitive management is being arranged, administer supplemen-\\ntal oxygen, correct hypotension, remove constrictive casts or dressings, \\nand place the affected limb at the level of the heart.\\n2. Reverse anticoagulation in anticoagulated patients, and replace fac -\\ntor levels in hemophiliacs.\\n3. Functional outcomes are favorable when diagnosis and treatment of \\ncompartment syndrome occurs within 6 hours of its onset. F asciot-\\nomy may be futile if tissue pressures have been elevated to 24 to 48 \\nhours as permanent dysfunction may already be present.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 278, “Compartment Syndrome” by Paul R. Haller.\\n176_Cydulka_Ch176.indd   967 22/03/17   2:56 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 986, 'page_label': '968'}, page_content='176_Cydulka_Ch176.indd   968 22/03/17   2:56 PM\\nThis page intentionally left blank'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 987, 'page_label': '969'}, page_content='969\\nNeck and Back Pain\\nAmy M. Stubbs\\nNeck and back pain are major causes of disability in the United States and \\nare commonly seen in the ED. While the majority of cases have nonspecific \\nor benign etiologies, serious underlying pathology may exist. Clinicians \\nmust be vigilant in obtaining a thorough history, focusing on risk factors for \\npathology, and physical examination that includes a detailed neurologic \\nexamination.\\n■ ■CLINICAL FEATURES\\nNeck and back pain have myriad causes, but can often be classified into \\ntwo groups: uncomplicated musculoskeletal pain and those with pain \\nattributable to radiculopathy (spinal nerve root compression) or myelop-\\nathy (spinal cord compression) (see Tables 177-1, 177-2, and 177-3). \\nThoracolumbar pain may also be categorized by symptom duration: \\nacute (< 6 weeks), subacute (6 to 12 weeks), or chronic (> 12 weeks).\\nThe history should include the onset, circumstances, location, radia-\\ntion, duration, and exacerbating/alleviating factors of the pain. Historical \\nrisk factors or symptoms concerning for serious pathology should be \\nsought (see Table 177-4).\\nExamination should include evaluation of mobility and range of motion. \\nThe patient should be exposed, observing and palpating the neck and back \\nfor point tenderness, deformity, lymphadenopathy, or signs of infection. A \\nthorough neurologic examination, including assessment of specific nerve \\nroots’ strength, sensation, and reflexes, is essential (see Tables 177-2 \\nand 177-3). Specific examination maneuvers should be performed as \\nindicated for the complaint (see Table 177-5).\\nA rectal examination evaluating for tone, sensation, and masses is requi-\\nsite if concern exists for spinal cord compression or other serious pathology.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe differentials for neck and back pain are broad but can generally be \\nguided by the history and physical examination. The majority of patients \\nwith neck and back pain will not require emergent imaging or diagnostic \\ntesting.\\n177\\nCh A p TER\\n20\\nSECTION\\nNontraumatic Musculoskeletal \\nDisorders\\n177_Cydulka_Ch177.indd   969 22/03/17   2:51 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 988, 'page_label': '970'}, page_content='970 SECTION 20: Nontraumatic Musculoskeletal Disorders\\nTaBle 177-2 Signs and Symptoms of Cervical Radiculopathy\\nDisk \\nSpace\\nCervical \\nRoot pain Complaint\\nSensory \\nAbnormality\\nMotor \\nWeakness\\nAltered \\nReflex\\nC1–C2 C2 Neck, scalp Scalp\\nC4–C5 C5 Neck, shoulder, \\nupper arm\\nShoulder Infraspinatus, \\ndeltoid, biceps\\nReduced \\nbiceps reflex\\nC5–C6 C6 Neck, shoulder, \\nupper medial, \\nscapular area, \\nproximal forearm, \\nthumb, index \\nfinger\\nThumb and \\nindex finger, \\nlateral forearm\\nDeltoid, biceps, \\npronator teres, \\nwrist extensors\\nReduced \\nbiceps and \\nbrachioradialis \\nreflex\\nC6–C7 C7 Neck, posterior \\narm, dorsum \\nproximal forearm, \\nchest, medial \\nthird of scapula, \\nmiddle finger\\nMiddle finger, \\nforearm\\nTriceps, \\npronator teres\\nReduced \\ntriceps reflex\\nC7–T1 C8 Neck, posterior \\narm, ulnar side of \\nforearm, medial \\ninferior scapular \\nborder, medial \\nhand, ring, and \\nlittle fingers\\nRing and little \\nfingers\\nTriceps, flexor \\ncarpi ulnaris, \\nhand intrinsics\\nReduced \\ntriceps reflex\\nTaBle 177-1 Differentiating Cervical Radiculopathy from Uncomplicated \\nMusculoskeletal Neck pain\\nFactors Favoring Cervical Radiculopathy \\nor Myelopathy*\\nFactors Favoring Uncomplicated \\nMusculoskeletal Neck pain*\\nPain from the neck radiates down the arm  \\nin dermatome pattern.\\nTenderness of involved muscles; examiner \\nmay find a focal point of tenderness.\\nSensory changes along dermatome \\ndistribution.\\nAtrophy or thinning of shoulder muscles \\nmay occur after rotator cuff injury.\\nPushing down on top of head, with neck in \\nextension (chin up) and head leaning toward \\nsymptomatic side elicits pain, typically \\ntoward or down the arm (positive Spurling’s \\nsign); 90% specific, 45% sensitive.\\nPain increases with shoulder abduction \\non the side of neck pain (increased pain \\ncould derive from rotator cuff-related pain; \\nradicular pain may decrease with this \\nmaneuver).\\nPain may worsen with Valsalva, which \\nincreases intrathecal pressure.\\nRepetitive movement of arm or shoulder \\nat work or play; may be new activity.\\nFlex neck forward until chin meets chest \\nor pain stops movement. An electric shock \\nsensation radiating down spine into both \\narms is a positive result (lhermitte’s sign). \\nOccasionally, paresthesias occur.\\nHistory of recent injury or recent event of \\nawkward position (such as neck or head \\nposition during sleep in an unfamiliar \\nsetting) or awkward standing posture to \\naccommodate a special situation.\\nDepressed reflexes or, uncommonly, \\nincreased reflexes (see also Table 177-2).\\nPain is accompanied by “stiffness” of \\ninvolved muscle group.\\n*Patient in either pain category is not expected to have all, or majority, of listed signs.\\n177_Cydulka_Ch177.indd   970 22/03/17   2:51 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 989, 'page_label': '971'}, page_content='CHAPTER 177: Neck and Back Pain 971 \\nTaBle 177-3 Symptoms and Signs of Lumbar Radiculopathies\\nDisk \\nSpace\\nNerve \\nRoot pain Complaint Sensory Change Motor W eakness\\nAltered \\nReflex\\nL2–3 L3 Medial thigh, knee Medial thigh, knee Hip flexors None\\nL3–4 L4 Medial lower leg Medial lower leg Quadriceps Knee jerk\\nL4–5 L5 Anterior tibia, \\ngreat toe\\nMedial foot Extensor hallicus \\nlongus\\nBiceps \\nfemoris\\nL5–S1 S1 Calf, little toe Lateral foot Foot plantar flexors Achilles\\nTaBle 177-4 Risk Factors for Serious Causes of Neck and Back pain\\nRisk Factors Concern\\nHistorical Risk Factors\\nPain >6 weeks\\nAge <18, >50\\nMajor trauma\\nMinor trauma in elderly or rheumatologic disease\\nHistory of cancer\\nFever and rigors\\nWeight loss\\nInjection drug use\\nImmunocompromised\\nNight pain\\nUnremitting pain, even when supine\\nIncontinence\\nSaddle anesthesia\\nSevere/progressive neurologic deficit\\nAnticoagulants and coagulopathy\\nTumor, infection\\nCongenital anomaly, tumor, infection\\nFracture\\nFracture\\nTumor\\nInfection\\nTumor, infection\\nInfection\\nInfection\\nTumor, infection\\nTumor, infection\\nEpidural compression\\nEpidural compression\\nEpidural compression\\nEpidural compression\\nPhysical Risk Factors\\nFever\\nPatient writhing in pain\\nUnexpected anal sphincter laxity\\nPerianal/perineal sensory loss\\nMajor motor weakness/gait disturbance\\nPositive straight leg raise test\\nInfection\\nInfection, vascular cause\\nEpidural compression\\nEpidural compression\\nNerve root or epidural compression\\nHerniated disk\\nTaBle 177-5 Diagnostic Maneuvers for Neck and Back pain\\nExam Finding/Maneuver Significance\\nSpurling’s sign: Downward pressure with head in exten-\\nsion and leaning toward symptomatic sign produces pain\\nCervical radiculopathy\\nabduction relief sign: Relief placing hand of affected \\narm on top of head\\nDisc protrusion/radiculopathy\\nlhermitte’s sign: Forward neck flexion causes electric \\nshock like pain in spine/arms\\nCord compression\\nHoffman’s sign: Flexion of thumb and index finger when \\nflicking tip of middle finger with hand in relaxed position\\nUpper motor neuron lesion\\nStraight leg test: Hip flexion to ~70 with knee in \\nextension produces pain in affected leg below knee\\nL4/L5 or L5/S1 disc herniation\\nCrossed leg test: Hip flexion to ~70 with knee in extension \\nin opposing leg produces pain in affected leg below knee\\nL4/L5 or L5/S1 disc herniation\\n177_Cydulka_Ch177.indd   971 22/03/17   2:51 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 990, 'page_label': '972'}, page_content='972 SECTION 20: Nontraumatic Musculoskeletal Disorders\\nImaging is usually not indicated in cases of acute, nontraumatic neck or \\nback pain without concerning historical features or exam findings. Plain films \\nof the spine have low sensitivity but may be considered as an initial imaging \\nstep if clinical suspicions include tumor, fracture, or infection. For patients \\nwith pain and neurologic deficits, MRI is the definitive test. CT scan is \\nhelpful for identification of disorders of the bony skeleton, but its sensitivity \\nfor nerve root or spinal cord disorders is poor. CT myelography can serve as \\nan alternative to MRI, if the latter is contraindicated or unattainable.\\nPlain films or CT scan of the cervical spine should be considered in \\npatients with chronic neck pain not previously imaged or those with a his-\\ntory or trauma, surgery, malignancy, or rheumatologic disease. Flexion-\\nextension films or MRI may be considered if instability or ligamentous \\ninjury is suspected. If radiographs are normal, or show only degenerative \\ndisease, and the patient has a benign examination, no further imaging is \\nrequired. For patients with back pain, in whom plain thoracic and/or lumbar \\nradiographs are indicated (as discussed above), anteroposterior and lateral \\nviews suffice. Careful attention should be paid to end plate erosions, disc \\nspace narrowing, or lytic lesions, which are worrisome for infection or \\nneoplasm. Advanced imaging is necessitated by the presence of neurologi-\\ncal deficits or abnormal plain radiographs.\\nLaboratory testing will not be useful in the majority of patients with \\nneck and back pain. If serious pathology is suspected, a complete blood \\ncount, erythrocyte sedimentation rate (ESR), and urinalysis should be \\nordered. ESR has a sensitivity of 90% to 98% for infectious causes of back \\npain. Urinalysis is useful to rule out urinary or renal pathology as a pain \\nsource. Postvoid residual (PVR) assessment, with ultrasound or catheter -\\nization, should be performed on patients with complaints or exam findings \\nconcerning for epidural compression. Urinary retention is the most \\ncommon finding in cauda equina syndrome, and PVR volume exceeding \\n500 mL, alone or in combination with other concerning findings, is an \\nimportant predictor of MRI-proven cauda equina compression.\\nMechanical disorders, such as strain caused by trauma, are often \\ncharacterized by delayed pain and paraspinous pain and stiffness. See \\nChapters 161 and 163 for further discussion of traumatic neck and back \\ninjuries.\\nCervical disc herniation, spondylosis, or stenosis can lead to radiculopathy \\nor myelopathy. Signs and symptoms of radiculopathy include pain and \\nweakness in a dermatomal distribution. Lower extremity hyperreflexia, a \\npositive Babinski sign, and loss of sphincter tone are suspicious for myelop-\\nathy; any of these findings necessitate MRI. Metastatic cancer may cause a \\nradiculopathy or myelopathy and should be included in the differential for \\nchronic pain. Osteomyelitis, epidural abscess, hematoma, and transverse \\nmyelitits may cause neck pain with neurologic deficits, although these \\ndisorders are more commonly observed in the thoracic or lumbar spine.\\nNeck pain can be caused by a variety of other disorders such as myofas-\\ncial pain syndrome, lymphadenopathy, temporal arteritis, ischemic heart \\ndisease, and neurodegenerative disorders. The distribution of symptoms in \\nthese disorders will typically not be dermatomal, and other historical \\nfeatures will usually distinguish them.\\nThe majority of patients with back pain have nonspecific back pain; they \\nhave no radiculopathy or myelopathy and no specific etiology is found. \\n177_Cydulka_Ch177.indd   972 22/03/17   2:51 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 991, 'page_label': '973'}, page_content='CHAPTER 177: Neck and Back Pain 973 \\nThese patients typically have benign examinations and mo vement often \\nexacerbates their pain. Diagnostic evaluation is negative.\\nAs with neck pain, disc herniation and degenerative changes of the \\nthoracic or lumbar spine can be a cause of acute or chronic back pain. More \\nthan 95% of disc herniations are at the L4–L5 or L5–S1 nerve roots, com-\\npression of which can cause sciatica. These patients may have leg pain, \\nneurologic deficits localized to a unilateral nerve root, and a positive \\nstraight-leg test. Spinal nerve root compression can occur at any level in the \\nthoracic or lumbar spine, with associated radicular symptoms. Epidural \\ncompression syndromes, which include spinal cord compression, cauda \\nequina syndrome, and conus medullaris syndrome, may cause pain, neuro-\\nlogic deficits, or autonomic dysfunction at any cord level. The thoracic \\nspine is the most common site of compression due to neoplasm; however, \\nif suspected, the entire spinal cord should be imaged, as 10% of patients \\nwill have additional metastatic lesions.\\nInfectious causes of back pain, including osteomyelitis, discitis, and \\nepidural abscess, are often missed on initial presentation. A high level of \\nsuspicion should be maintained in patients with risk factors such as immu-\\nnocompromise, recent back surgery, retained hardware, or intravenous drug \\nuse. Plain films may show bony destruction in patients with osteomyelitis, \\nbut x-rays are often initially normal in cases of infectious back pain. MRI \\nis typically required for diagnosis. The ESR will be elevated in the majority \\nof cases.\\nOther causes of back pain may originate from the spine itself or from \\nnonspinal causes. Spinal stenosis can cause low back and leg pain that \\nmimics claudication, worsening with walking and improving with rest. \\nAnkylosing spondylitis, an autoimmune arthritis, causes chronic back pain \\nand is identifiable by a characteristic squaring of vertebral bodies on radi-\\nography. Transverse myelitis, an inflammatory disorder of the spinal cord, \\nmay mimic a compression syndrome. Ruptured abdominal aneurysm, \\npyelonephritis, pancreatitis, or renal infarction should be considered in \\npatients with nonspecific back pain accompanied by concerning history or \\nexam findings.\\n■ ■EMERGENCY DEpARTMENT CARE AND DISpOSITION\\n1. Patients with neck and back pain that have progressive neurologic defi-\\ncits, myelopathy, or intractable pain should be imaged as indicated \\n(typically MRI) and admitted to the appropriate service for further \\nmanagement. Dexamethasone 10 mg IV should be gi ven prior to \\nimaging for suspected epidural compression.\\n2. Suspected or proven spinal infections require emergent consultation  \\nwith a spinal surgeon. Empiric broad-spectrum antibiotics, such as \\nvancomycin 1 g IV and piperacillin-tazobactam 3.375 g IV , should \\nbe given unless explicit instructions to withhold are given by the \\nconsultant.\\n3. Patients with a stable or mild radiculopathy may be managed conserva -\\ntively with pain medication, routine activity as tolerated, and strict \\nreturn precautions for worsening symptoms. Outpatient MRI and neuro-\\nsurgical follow-up should be considered for patients who have failed \\nconservative treatment.\\n177_Cydulka_Ch177.indd   973 22/03/17   2:51 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 992, 'page_label': '974'}, page_content='974 SECTION 20: Nontraumatic Musculoskeletal Disorders\\n4. Pain management may include NSAIDs, acetaminophen, or muscle \\nrelaxants used alone or in combination; all have been shown to be effec-\\ntive. A short course of oral opioids may be prescribed for patients with \\nmoderate to severe pain, but long-term use is discouraged. The evidence \\nfor manipulation, soft-collars, corticosteroids, or other alternative treat-\\nments is limited and should generally not be prescribed from the ED. \\nChronic pain often requires a multidisciplinary approach.\\n5. The majority of patients with neck or back pain will have a benign \\ncourse and improve with time. Patients may be prescribed pain medicine \\nas appropriate and activity as tolerated. Return precautions and instruc-\\ntion for follow-up should be provided.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 279, “Neck and Back Pain,” by David Della-Giustina, \\nJeffrey S. Dubin, and William Frohna.\\n177_Cydulka_Ch177.indd   974 22/03/17   2:51 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 993, 'page_label': '975'}, page_content='975\\nShoulder Pain\\nAndrew D. Perron\\nShoulder pain is a common musculoskeletal complaint, especially in \\npatients older than 40 years. Occupational, recreational, and normal daily \\nactivities stress the shoulder joint and may result in pain from acute injury \\nor, more commonly, chronic overuse conditions. Complicating the evalua-\\ntion of shoulder pain is that the origin of pain may be from pathology intrin-\\nsic to the shoulder joint or from extrinsic disorders causing referred pain.\\n■ ■CLINICAL FEATURES\\nThe pain of musculoskeletal shoulder pathology often is described by patients \\nas an aching sensation, particularly in the setting of a more chronic process. \\nNighttime pain is a common feature of intrinsic shoulder pathology. Specific \\nmotions may exacerbate it, and this history is helpful in making a specific \\ndiagnosis. Decreased range of motion, crepitus, weakness, or muscular atro-\\nphy may be associated with certain conditions. Any systemic symptoms such \\nas shortness of breath, fever, or radiation of pain from the chest or abdomen \\nshould raise suspicion for extrinsic and potentially life-threatening problems.\\n■ ■DIAGNOSIS AND DIFFERENTIAL\\nThe primary diagnostic maneuver is a thorough history and physical \\nexamination. Knowledge of shoulder anatomy aids in identifying spe-\\ncific injuries (Figs. 178-1 and 178-2). Examination of the shoulder joint \\n178\\nCh APTER\\nScapula\\nSupraspinatus\\nAcromion\\nInfraspinatus\\nTeres minor\\nFigure 178-1. Posterior view of the shoulder illustrating rotator cuff muscles.\\n178_Cydulka_Ch178.indd   975 22/03/17   3:22 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 994, 'page_label': '976'}, page_content='976 SECTION 20: Nontraumatic Musculoskeletal Disorders\\nBiceps tendon \\nlong head\\nSubscapularis\\nAcromion\\nCoracoid\\nSupraspinatus\\nScapula\\nFigure 178-2. Anterior view of the shoulder illustrating the supraspinatus muscle \\nand the long head of the biceps.\\nshould include range of motion and muscle strength testing, palpation \\nfor local tenderness or other abnormality, and identification of any neu-\\nrovascular deficit. Specific tests for impingement and individual tests of \\nrotator cuff muscle function are often helpful in intrinsic disease. Absent \\nsignificant trauma, plain radiographic studies of the shoulder joint are \\nrarely diagnostic but may be helpful to exclude bony abnormalities in \\nselected patients or to evaluate for abnormal calcifications. In patients in \\nwhom extrinsic causes of shoulder pain are suspected, further diagnostic \\ntesting may be indicated, such as laboratory studies, additional radio-\\ngraphs, and an electrocardiogram.\\nThe differential diagnosis includes a variety of intrinsic musculoskel-\\netal disorders, and individual patients may exhibit considerable overlap in \\ntheir symptoms manifesting a combination of specific conditions. Impinge-\\nment syndrome is a term that has been adopted to encompass many painful \\nshoulder syndromes that result most frequently from repetitive overhead \\nuse of the arm. The pathologic entities included in this syndrome are sub-\\nacromial tendonitis and bursitis, supraspinatus tendonitis, rotator cuff \\ntendonitis, and the painful arc syndrome. Impingement syndrome is a \\npainful overuse condition characterized by positive findings with impinge-\\nment testing and relief of pain with anesthetic injection of the subacromial \\nspace. Subacromial bursitis is generally seen in patients younger than  \\n25 years and will present with positive impingement tests with different \\ndegrees of tenderness at the lateral proximal humerus or in the subacro-\\nmial space. Rotator cuff tendonitis is distinguished by an incidence pri-\\nmarily in individuals 25 to 40 years of age and findings of tenderness of \\nthe rotator cuff with mild to moderate muscular weakness. In more chronic \\ndisease, crepitus, decreased range of motion, and osteophyte formation \\nvisible on plain radiograph also may be apparent. Rotator cuff tears occur \\n178_Cydulka_Ch178.indd   976 22/03/17   3:22 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 995, 'page_label': '977'}, page_content='CHAPTER 178: Shoulder Pain 977 \\nprimarily in patients older than 40 years and are associated with muscular \\nweakness (especially with abduction and external rotation) and cuff ten -\\nderness. Ninety percent will be chronic tears with a history of minimal or \\nno trauma; in severe disease, muscular atrophy may be present. Acute tears \\nmay occur in patients of any age and result from significant force produc-\\ning a tearing sensation with immediate pain and disability. In patients \\nbetween the ages of 30 and 50 years, abnormal calcifications on radio-\\ngraph in the clinical setting of a painful shoulder with rotator cuff tender -\\nness and often crepitus suggest the diagnosis of calcific tendonitis.  \\nOsteoarthritis is characteristically associated with degenerative disease in \\nother joints (primary) or previous fracture or other underlying disorder \\n(secondary). The hallmark of adhesive capsulitis is significantly painful \\nand limited range of motion often, but not always, associated with a period \\nof immobilization. Radiographs should be obtained to exclude posterior \\nglenohumeral dislocation. Biceps tendon pathology can also manifest as \\nshoulder pain. The proximal long head of the biceps inserts on the superior \\naspect of the shoulder. Tendinopathy, subluxation, dislocation, and partial \\nor complete tears can produce pain. Biceps tendinopathy can arise due to \\ninflammation (tendonitis) or collagen tears around the tendon (tendinosis) \\nand may be acute or chronic. Diagnosis is made by palpating the proximal \\ntendon along the bicipital groove or resisted forearm supination. Repro-\\nduction of pain by these maneuvers suggests biceps pathology. Tendinitis \\nand subluxation can be managed with sling immobilization, analgesics, \\nanti-inflammatory agents, and frequent ice application, followed by early \\nmobilization.\\nOther causes of shoulder pain that should be considered are a number \\nof extrinsic conditions. Pancoast tumor may compress the brachial plexus \\nand manifest as shoulder pain. Degenerative disease of the cervical spine, \\nbrachial plexus disorders, and suprascapular nerve compression are neu-\\nrologic processes that should be sought in patient evaluation. Vascular \\npathology, notably axillary artery thrombosis, also may cause shoulder \\npain. Acute cardiac, aortic, pulmonary, and abdominal pathology may \\ncause pain referred to the shoulder, and the clinician must remain alert to \\nthis possibility.\\n■ ■EMERGENCY DEPARTMENT CARE AND DISPOSITION\\n1. For intrinsic disease, the primary goals of emergency department care \\nare to reduce pain and inflammation and prevent progression of disease. \\nFor most conditions, this translates to relative rest of the joint assisted \\nby use of a sling as full immobilization is not suggested. Treatment also \\nincludes nonsteroidal anti-inflammatory drugs, opioid analgesics as \\nneeded, and the application of cold packs. Range-of-motion exercises \\nshould be encouraged as soon as pain allows to prevent loss of flexibility \\nand to maintain strength.\\n2. Joint space injection with glucocorticoids such as triamcinolone 20 to \\n40 mg with or without a local anesthetic such as lidocaine should be \\nused judiciously in view of the potential deleterious effects on soft \\ntissues, tendon rupture with direct injection, and a recommended limita-\\ntion of three injections into a single area. F or all intrinsic disorders, \\nfollow-up with a primary care physician with expertise in joint disease \\n178_Cydulka_Ch178.indd   977 22/03/17   3:22 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 996, 'page_label': '978'}, page_content='978 SECTION 20: Nontraumatic Musculoskeletal Disorders\\nor orthopedic referral is suggested within 7 to 14 days. Physical therapy \\nreferral for stretching and strengthening also may be valuable.\\n3. In extrinsic disease, the treatment and referral pattern will depend on the \\ndiagnosis. Neurologic problems will require analgesia and anti-inflammatory \\nmedications and may require neurology or neurosurgical follow-up.  \\nVascular causes of shoulder pain must be evaluated carefully and, with \\naxillary artery thrombosis, immediate consultation made to initiate throm-\\nbolysis. Treatment of other extrinsic conditions depends on the specific \\ndiagnosis.\\n■ ■FURThER READING\\nFor further reading in Tintinalli’s Emergency Medicine: A Comprehensive Study \\nGuide, 8th ed., see Chapter 280, “Shoulder Pain,” by David Della-Giustina and \\nDavid Hile.\\n178_Cydulka_Ch178.indd   978 22/03/17   3:22 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 997, 'page_label': '979'}, page_content='979\\nHip and Knee Pain\\nAugusta Czysz\\nHip and knee pain are common complaints, especially among athletes and \\nthe obese due to increased forces on their joints. Knee pain is usually due \\nto local pathology, whereas hip pathology commonly causes referred pain \\nin the buttocks and lower extremity and may be due to extraarticular pathol-\\nogy. Each pain has a broad differential diagnosis, but a focused history and \\nphysical examination will often lead to the diagnosis (Table 179-1).\\n■ ■PSOAS ABSCESS\\nAbscess of the psoas muscle usually occurs through hematogenous spread \\nand may present with abdominal pain radiating to the hip or flank, fever, \\nand limp, or other constitutional symptoms. Eighty percent of the time, it is \\ncaused by Staphylococcus aureus. The diagnosis is made by CT. Treatment \\nincludes organism-specific antibiotics and surgical drainage.\\n■ ■REGIONAL NERVE ENTRAPMENT SYNDROMES\\nMeralgia paresthetica, a compressive inflammation of the lateral femoral \\ncutaneous nerve, causes pain in the hip, thigh, or groin, along with burning \\nor tingling paresthesias, and hypersensitivity to light touch. Address the \\nsource of nerve irritation (e.g., obesity, pregnancy, tight pants, belt) and \\nprovide nonsteroidal anti-inflammatory drugs (NSAIDs) to treat in the \\nED. Obturator nerve entrapment usually occurs after pelvic fractures, with \\nmasses, or in athletes with a fascial band at the distal obturator canal, which \\ncauses pain in the groin and down the inner thigh. Surgery may be needed \\nfor pain relief. Ilioinguinal nerve entrapment is associated with pregnancy \\nor hypertrophy of the abdominal wall musculature and causes groin pain. \\nPiriformis syndrome, irritation of the sciatic nerve from the piriformis \\nmuscle, manifests as pain in the buttocks and hamstring muscles that wors-\\nens with sitting, climbing stairs, or squatting. ED treatment is conservative \\nfor all of these nerve entrapment syndromes (Table 179-2).\\n179\\nCh APTER\\nTable 179-1 Suggested Clues for the Differential Diagnosis of hip and Knee Pain\\nDetermine the location of the pain to narrow down the potential diagnosis.\\nDetermine the activities that bring on the pain.\\nComplaints that the joint “gives out” or “buckles” generally are due to pain and reflex \\nmuscle inhibition rather than an acute neurologic emergency. This complaint may also \\nrepresent patellar subluxation or ligamentous injury and joint instability.\\nPoor conditioning or quadriceps weakness generally causes anterior knee pain of the \\npatellofemoral syndrome; therapy should address this weakness.\\nLocking of the knee suggests a meniscal injury, which may be chronic.\\nA popping sensation or sound at the onset of pain is reliable for a ligamentous injury.\\nA recurrent knee effusion after activity suggests a meniscal injury.\\nPain at the joint line of the knee (palpable indentation between distal femur and proximal \\ntibia) suggests a meniscal injury.\\n179_Cydulka_Ch179.indd   979 22/03/17   3:26 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 998, 'page_label': '980'}, page_content='980 SECTION 20: Nontraumatic Musculoskeletal Disorders\\nTable 179-2 Selected Syndromes by Location\\nDiagnosis Category Diagnosis Pain Location\\nNerve entrapment Meralgia paresthetica\\nObturator nerve entrapment\\nIlioinguinal nerve entrapment\\nPiriformis syndrome (sciatic \\nnerve compression by \\npiriformis muscle)\\nAnterolateral thigh pain or \\nparesthesias\\nGroin and inner thigh pain\\nGroin pain\\nButtocks and hamstrings pain\\nHip bursitis Trochanteric bursitis\\nIschiogluteal bursitis\\nIliopectineal and iliopsoas \\nbursitis\\nHip pain when lying on side  \\nor with hip abduction and \\nadduction\\nIschial pain\\nAnterior pelvis and groin, hip \\nextension\\nKnee bursitis Pes anserine bursitis\\nPrepatellar bursitis\\nAnterior medial knee pain\\nPain anterior to patella\\nHip overuse syndromes External snapping hip \\nsyndrome (coxa saltans)\\nFascia lata syndrome\\nPosterior lateral hip pain\\nLateral thigh pain\\nKnee overuse \\nsyndromes\\nPatellofemoral syndrome \\n(runner’s knee)\\nAnterior knee pain, worse with \\nprolonged knee flexion\\nMedial plica syndrome Anterior medial knee pain, knee \\nsnapping during repeated flexion/\\nextension\\nIliotibial band syndrome or \\nsnapping knee syndrome\\nPain over lateral epicondyles, or \\nsnapping when iliotibial band \\npasses over femoral condyle\\nPopliteus tendinitis Posterior lateral knee pain, worse \\non downhill exercise\\nPatellar tendinitis (jumper’s \\nknee)\\nInferior patellar or proximal \\npatellar tendon pain\\nQuadriceps tendinitis Proximal patellar pain\\nPopliteal (Baker) cyst Posterior knee pain\\n■ ■BURSAL SYNDROMES OF ThE hIP AND KNEE\\nInflamed or infected hip and knee bursae may cause localized pain. \\nInflammatory changes may be due to repetitive minor trauma,\\xa0rheuma-\\ntologic disorders such as psoriatic arthritis, rheumatoid arthritis\\xa0 or \\nankylosing spondylitis\\xa0and crystalline disease including gout and pseu-\\ndogout. Infection may be difficult to distinguish clinically from more \\nbenign disorders; analysis of bursal aspirate will help. Treatment is \\ndirected at the underlying cause. NSAIDs, rest, heat, and time are the \\nbasis of treatment for inflammatory conditions. Steroid injections into \\nreadily accessible bursae may be useful if infection has been excluded. \\nAvoid injecting tendons with\\xa0steroids. Treat infections with antibiotics  \\n(see Chapter 180, “Acute Disorders of the Joints and Bursae,” for spe-\\ncific recommendations). Admit immunocompromised patients with \\nsuspected infections for IV antibiotics and orthopedic surgery consulta-\\ntion (Table 179-2).\\n179_Cydulka_Ch179.indd   980 22/03/17   3:26 PM'),\n",
       " Document(metadata={'producer': 'PyPDF', 'creator': 'PyPDF', 'creationdate': '', 'source': 'C:\\\\Linkdin projects\\\\Medical - system\\\\Medical-system\\\\data\\\\Emergency\\\\Tintinalli’s Emergency Medicine Manual ( PDFDrive ).pdf', 'total_pages': 1089, 'page': 999, 'page_label': '981'}, page_content='CHAPTER 179: Hip and Knee Pain 981 \\n■ ■MYOFASCIAL SYNDROMES/OVERUSE SYNDROMES\\nRepetitive microtrauma that outpaces the body’s ability to heal results in \\noveruse syndromes. Treatment generally consists of NSAIDs, heat, and \\nrest, followed by gradual resumption of activities, physical therapy, and \\nstrengthening where appropriate (Table 179-2).\\n■ ■BONE/ARTICULAR DERANGEMENTS\\nOsteonecrosis (also called aseptic necrosis, ischemic necrosis, or avascular \\nnecrosis) is bone infarction caused by a lack of blood supply. It may be an \\nidiopathic or a primary disorder, secondary to a systemic condition, or due \\nto trauma. Conditions associated with osteonecrosis of the femoral head \\ninclude\\xa0 femoral neck fracture, hip dislocation, occult or minor trauma, \\nsickle cell disease, collagen vascular diseases, alcohol abuse, renal trans-\\nplant, systemic lupus erythematosus, dysbarism, chronic pancreatitis, exog-\\nenous steroid administration, Cushing disease, decompression sickness, \\nGaucher disease, and renal osteodystrophy. Osteonecrosis of the hip may \\ncause pain anywhere from the buttock to the knee. X-ray, CT, or MRI may \\naid in diagnosis. Joint replacement may be needed.\\nOsteomyelitis is an infection of the bone that results in bony destruction \\ncommonly caused by Staphylococcus aureus. Patients have local pain and \\nmay have associated warmth, swelling, and erythema. Imaging may be \\nnormal. MRI is the preferred imaging study but bone biopsy is required for \\nconfirmation. The acutely ill patient should receive high-dose, broad-\\nspectrum, parenteral antibiotics based on the patient’s risk factors and \\nmost likely organisms (Table 179-3).\\nTable 179-3 Risk Factors, Likely Infecting Organism, and Recommended Initial \\nEmpiric Antibiotic Therapy for Osteomyelitis\\nRisk Factor Likely Infecting Organism\\nRecommended Initial \\nEmpiric Antibiotic Therapy*\\nElderly, hematog-\\nenous spread\\nStaphylococcus aureus, including \\nMRSA, gram-negative bacteria\\nVancomycin plus piperacillin-\\ntazobactam, or imipenem\\nSickle cell disease Salmonella, gram-negative \\nbacteria (S. aureus becoming \\nmore common)\\nCiprofloxacin; consider \\nvancomycin\\nDiabetes mellitus, or \\nvascular insufficiency\\nPolymicrobial: S. aureus, \\nStreptococcus agalactiae, and \\nStreptococcus pyogenes plus \\ncoliforms and anaerobes\\nVancomycin plus piperacillin-\\ntazobactam, or imipenem\\nInjection drug user S. aureus, including MRSA, and \\nPseudomonas\\nVancomycin\\nDeveloping nations Mycobacterium tuberculosis See Chapter 31, “Tuberculosis”\\nNewborn S. aureus including MRSA, \\ngram-negative bacteria, group B \\nStreptococcus\\nVancomycin plus ceftazidime\\nChildren S. aureus including MRSA Vancomycin plus ceftazidime\\n(Continued)\\n179_Cydulka_Ch179.indd   981 22/03/17   3:26 PM'),\n",
       " ...]"
      ]
     },
     "execution_count": 212,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "extracted_data\n",
    "# txt_extracted"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 225,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "1089"
      ]
     },
     "execution_count": 225,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(extracted_data)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 226,
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import List\n",
    "from langchain.schema import Document\n",
    "\n",
    "def filter_to_miniDocs(docs: List[Document]) -> List[Document]:\n",
    "    \"\"\"\n",
    "     Givin you a list of document object, return a new list of documents objects\n",
    "     containing only 'source' in metadata and the orignal page_content  \n",
    "    \"\"\"\n",
    "    minimal_docs: List[Document] = []\n",
    "    for doc in docs:\n",
    "        src = doc.metadata.get(\"source\")\n",
    "        minimal_docs.append(\n",
    "            Document(\n",
    "                page_content=doc.page_content, metdata = {\"source\" : src}\n",
    "            )\n",
    "        )\n",
    "    return minimal_docs\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 227,
   "metadata": {},
   "outputs": [],
   "source": [
    "minimal_docs = filter_to_miniDocs(extracted_data)\n",
    "# minimal_docs #it should return sorce and page_content\n",
    "# abdelrhman_hassan_data = filter_to_miniDocs(txt_extracted)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 228,
   "metadata": {},
   "outputs": [],
   "source": [
    "# chunking\n",
    "def txt_split(docs):  \n",
    "    text_splitter = RecursiveCharacterTextSplitter(\n",
    "        chunk_size = 500,\n",
    "        chunk_overlap=20,\n",
    "        length_function = len\n",
    "    )\n",
    "    chunks = text_splitter.split_documents(docs)\n",
    "    return chunks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 229,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Numebr of chunks:  6129\n",
      "Numebr of chunks:  11\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(metadata={}, page_content='AI and Machine Learning Experience:\\n- 4 years in machine learning and deep learning\\n- Worked with CNN, RNN, LSTM, GRU, and Transformers\\n- Experience building custom models from scratch\\n- Experience training Seq2Seq models\\n- Implemented violence detection with video models\\n- Implemented seismic detection for NASA Space Apps\\n- Strong in feature extraction, embeddings, and classification workflows'),\n",
       " Document(metadata={}, page_content='Seismic Detection Program | Built an AI model to identify seismic activity within noisy datasets \\nusing realtime signal processing | NASA Space Apps Challenge  \\nâ€¢ ASL Action Detection | Developed real-time Arabic Sign Language recognition using MediaPipe and \\nTransformers for gesture classification  \\nâ€¢ Lip Reading Model | Designed an RNN-based system to predict spoken words from silent videos to \\nsupport accessibility applications'),\n",
       " Document(metadata={}, page_content='â€¢ Violence Detection | Created a real-time violence detection system using CNN-LSTM with OpenCV \\non surveillance footage  \\nâ€¢ Road Sign Detection | Built a CNN-based model to detect and classify road signs from live video \\nfeeds for autonomous driving  \\nâ€¢ Smart Driving System | Combined lane detection, traffic sign recognition, and obstacle avoidance \\nusing computer vision for smart vehicle navigation'),\n",
       " Document(metadata={}, page_content='â€¢ Face Recognition Attendance | Developed a Tkinter app using OpenCV and face_recognition for \\nautomated attendance logging  \\nâ€¢ Encrypted Banking System (Tkinter) | Created a full GUI banking system in Tkinter with character\\nmapbased encryption for secure login, deposits, and withdrawals  \\nâ€¢ Sign Language Data Tool | Built a dual-screen GUI using Tkinter and OpenCV for webcam-based \\ngesture data collection with label control'),\n",
       " Document(metadata={}, page_content='â€¢ Sign Classifier (29 Classes) | Trained a CNN-LSTM model to classify 29 real-time sign gestures \\ncaptured from webcam input  \\nâ€¢ Transformer Translator | Built a sequence-to-sequence Transformer model using HuggingFace for \\nmultilingual translation tasks  \\nâ€¢ Weather Prediction (ML) | Developed a machine learning model (Random Forest, SVM) to forecast \\nweather based on structured historical data'),\n",
       " Document(metadata={}, page_content='â€¢ Segmented Image Classifier | Trained a CNN to classify segmented image categories (buildings, \\noceans, clothes) using Keras and OpenCV  \\nâ€¢ Intelligent AI Travel Recommendation System | Designed and developed an end-to-end AI\\npowered travel planning platform using LangChain and RAG to generate fully customized itineraries \\nbased on client profiles and multi-source travel documents. Built a retrieval pipeline using'),\n",
       " Document(metadata={}, page_content='FAISS/ChromaDB with OpenAI embeddings to extract knowledge from multiple city PDFs, enabling \\ndynamic reasoning about allowed destinations, food preferences, activity constraints, and travel \\nconditions. Engineered advanced prompt-chaining logic for contextual ranking of cities, relevance \\nscoring, activity matching, and itinerary optimization. Implemented automated PDF itinerary \\ngeneration and a structured data-entry interface for travel agents, reducing manual workload and'),\n",
       " Document(metadata={}, page_content='ensuring consistent, high-quality travel recommendations. The system demonstrates strong \\nintegration of LLMs, vector search, document intelligence, and applied AI in a real business \\nworkflow. \\nâ€¢ Built a Large Language Model (LLM) from Scratch | Designed and implemented a Transformer-based LLM in \\nPyTorch with custom tokenization (BPE/WordPiece), multi-head self-attention, normalization layers, residual'),\n",
       " Document(metadata={}, page_content='connections, masking mechanisms, end-to-end training pipeline, and inference system supporting text \\ngeneration and abstractive text summarization..'),\n",
       " Document(metadata={}, page_content='Name: Abdelrhman Hassan Gabry (Bedo Gabry)\\nCountry: Egypt\\nPhone: 01093411611\\nEmail: Abdelrhman14hassan@gmail.com'),\n",
       " Document(metadata={}, page_content='Programming Experience:\\n- 5 years Python experience\\n- Strong OOP knowledge\\n- Experienced with OpenCV, MediaPipe, TensorFlow, Keras, PyTorch\\n- Experienced with HuggingFace Transformers\\n- Familiar with LangChain and Pinecone\\n- GUI development using Tkinter and Kivy\\n- Arduino programming (C language)\\n- Face recognition libraries')]"
      ]
     },
     "execution_count": 229,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "chunks = txt_split(minimal_docs)\n",
    "print(\"Numebr of chunks: \", len(chunks))\n",
    "# chunks_txt = txt_split(abdelrhman_hassan_data)\n",
    "# print(\"Numebr of chunks: \", len(chunks_txt))\n",
    "# chunks_txt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 230,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.embeddings import HuggingFaceEmbeddings\n",
    "\n",
    "def download_embeddings():\n",
    "\n",
    "    model_name = \"sentence-transformers/all-MiniLM-L6-v2\"\n",
    "    embeddings = HuggingFaceEmbeddings(\n",
    "        model_name=model_name\n",
    "    )\n",
    "    return embeddings\n",
    "\n",
    "embeddings = download_embeddings()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 231,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 231,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "import os\n",
    "dotenv_path = r\"C:\\Linkdin projects\\Medical - system\\Medical-system\\.env\"  # Use raw string for Windows paths\n",
    "load_dotenv(dotenv_path=dotenv_path)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Set API keys for OpenAI and Pinecone so libraries can access them securely"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 232,
   "metadata": {},
   "outputs": [],
   "source": [
    "PINECONE_API_KEY  = os.getenv(\"PINECONE_API_KEY\")\n",
    "OPENAI_API_KEY  = os.getenv(\"OPENAI_API_KEY\")\n",
    "\n",
    "os.environ[\"PINECONE_API_KEY\"] = PINECONE_API_KEY\n",
    "os.environ[\"OPENAI_API_KEY\"] = OPENAI_API_KEY"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "initializes the Pinecone client so you can start working with your indexes.\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 233,
   "metadata": {},
   "outputs": [],
   "source": [
    "from pinecone import Pinecone\n",
    "Pinecone_api_key = PINECONE_API_KEY\n",
    "\n",
    "pc = Pinecone(api_key=Pinecone_api_key)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": 234,
   "metadata": {},
   "outputs": [],
   "source": [
    "from pinecone import ServerlessSpec \n",
    "\n",
    "# index_name = \"abderlhmans-medical-chatbot\" old\n",
    "index_name = \"medical-chatbot-abdelrhman\"  # new\n",
    "\n",
    "if not pc.has_index(index_name):\n",
    "    pc.create_index(\n",
    "        name = index_name,\n",
    "        dimension=384,  # Dimension of the embeddings\n",
    "        metric= \"cosine\",  # Cosine similarity\n",
    "        spec=ServerlessSpec(cloud=\"aws\", region=\"us-east-1\")\n",
    "    )\n",
    "\n",
    "\n",
    "index = pc.Index(index_name)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "for existing data\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 235,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load Existing index \n",
    "\n",
    "from langchain_pinecone import PineconeVectorStore\n",
    "# Embed each chunk and upsert the embeddings into your Pinecone index.\n",
    "docsearch = PineconeVectorStore.from_existing_index(\n",
    "    index_name=index_name,\n",
    "    embedding=embeddings\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "For uploading data\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 236,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_pinecone import PineconeVectorStore\n",
    "\n",
    "docsearch = PineconeVectorStore.from_documents(\n",
    "    documents=chunks,\n",
    "    embedding=embeddings,\n",
    "    index_name=index_name\n",
    ")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 134,
   "metadata": {},
   "outputs": [],
   "source": [
    "dswitch = Document(\n",
    "    page_content=\"Abdelrhman Hassan is a highly talented AI Engineer with strong expertise in machine learning, computer vision, LLMOps, and advanced neural network architectures.\",\n",
    "     metadata = {\"source\" : \"Linkdin\"},\n",
    ")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "To Add Any Document Into Data We Use\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 135,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "['c7a40dbe-5452-41f8-b1ad-be318912f3fe']"
      ]
     },
     "execution_count": 135,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "docsearch.add_documents(documents=[dswitch])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 237,
   "metadata": {},
   "outputs": [],
   "source": [
    "retriever = docsearch.as_retriever(search_type = \"similarity\", search_kwargs={\"k\" : 3}) # top 3 k"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 240,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(id='d626b35b-6cbf-4cbc-831a-4a9d7d0e1347', metadata={}, page_content='Beaudreau.\\n152_Cydulka_Ch152.indd   844 22/03/17   9:33 AM'),\n",
       " Document(id='4dea8603-3117-4804-93d2-832cc87de91b', metadata={}, page_content='09_Cydulka_Ch09.indd   83 15/03/17   10:49 AM'),\n",
       " Document(id='f42452cc-4d69-49e1-8b61-7cc102cc59fe', metadata={}, page_content='167_Cydulka_Ch167.indd   919 22/03/17   11:56 AM')]"
      ]
     },
     "execution_count": 240,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "retrieved_docs = retriever.invoke(\"Hi\")\n",
    "retrieved_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 138,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_openai import ChatOpenAI\n",
    "\n",
    "chatModel = ChatOpenAI(model=\"gpt-4o-mini\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 183,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.chains import create_retrieval_chain\n",
    "from langchain.chains.combine_documents import create_stuff_documents_chain\n",
    "from langchain_core.prompts import ChatPromptTemplate"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 245,
   "metadata": {},
   "outputs": [],
   "source": [
    "# from langchain.prompts import ChatPromptTemplate\n",
    "\n",
    "system_prompt = (\n",
    "    \"You are an Medical assistant for question-answering tasks. \"\n",
    "    \"You are a knowledgeable assistant. Answer questions using ONLY the information below.\"\n",
    "    \"You are a knowledgeable medical assistant. \"\n",
    "    \"Answer questions **using only the retrieved context** provided below. \"\n",
    "    \"If the answer is not in the context, say 'I don't know.' \"\n",
    "    \"Keep your answer concise and under three sentences or more but it must be effective.\\n\\n\"\n",
    "    \"Context:\\n{context}\"\n",
    ")\n",
    "\n",
    "prompt = ChatPromptTemplate.from_messages(\n",
    "    [\n",
    "        (\"system\", system_prompt),\n",
    "        (\"human\", \"{input}\"),\n",
    "    ]\n",
    ")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 242,
   "metadata": {},
   "outputs": [],
   "source": [
    "question_answer_chain = create_stuff_documents_chain(chatModel, prompt)\n",
    "rag_chain = create_retrieval_chain(retriever, question_answer_chain)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 243,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Acromegaly is a disorder in which the abnormal release of a particular chemical from the pituitary gland in the brain causes increased growth in bone and soft tissue, as well as a variety of other disturbances throughout the body. Gigantism is the condition when this abnormality occurs before bone growth stops, leading to unusual height. When the abnormality occurs after bone growth has stopped, it is called acromegaly.\n"
     ]
    }
   ],
   "source": [
    "response = rag_chain.invoke({\"input\": \"what is Acromegaly and gigantism?\"})\n",
    "print(response['answer'])\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 246,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "I don't know.\n"
     ]
    }
   ],
   "source": [
    "response = rag_chain.invoke({\"input\": \"hi\"})\n",
    "print(response['answer'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 199,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "I don't know.\n"
     ]
    }
   ],
   "source": [
    "response = rag_chain.invoke({\"input\": \"i have a mid-abdominal cramps what is this\"})\n",
    "print(response['answer'])"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.11.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
